,brief_title,conditions,date_processed,enrollment,id,intervention,location_countries,overall_status,sponsors,start_date,study_type,title
0,Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukapheresis Products,"SOLID TUMOR, ADULT; HEALTHY DONORS; COVID DONORS","February 08, 2021",1000,NCT00571389,,UNITED STATES,Recruiting,"BioCytics, Inc.",November 2007,Observational,"A Study to Facilitate Development of an Ex-Vivo Device Platform for Circulating Tumor Cell and Immune Cell Harvesting, Banking, and Apoptosis-Viability Assay"
1,"Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment",HAIRY CELL LEUKEMIA (HCL); CHRONIC LYMPHOCYTIC LEUKEMIA (CLL); NON-HODGKINS LYMPHOMA (NHL); CUTANEOUS T CELL LYMPHOMA (CTCL); ADULT T CELL LYMPHOMA (ATL),"February 08, 2021",1263,NCT01087333,,UNITED STATES,Recruiting,National Cancer Institute (NCI),"March 2, 2010",Observational,Collection of Human Samples to Study Hairy Cell and Other Leukemias and to Develop Recombinant Immunotoxins for Cancer Treatment
2,"Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life",BREAST CANCER,"February 08, 2021",935,NCT01134172,SURVEY WEB-BASED OR TELEPHONE INTERVIEW; SURVEY WEB-BASED OR TELEPHONE INTERVIEW,UNITED STATES,"Active, not recruiting",Memorial Sloan Kettering Cancer Center,May 2010,Observational,"Breast Cancer and the Workforce: Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life (BCW)"
3,Viral Infections in Healthy and Immunocompromised Hosts,ANOGENITAL HERPES; COVID; HERPES LABIALIS,"February 08, 2021",1000,NCT01306084,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"March 15, 2011",Observational,Viral Infections in Healthy and Immunocompromised Hosts
4,Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS,HIV-1 INFECTION,"February 08, 2021",334,NCT01435018,ETOPOSIDE (ET); BLEOMYCIN AND VINCRISTINE (BV); PACLITAXEL (PTX); CO-FORMULATED EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (EFV/FTC/TDF),BRAZIL,Completed,AIDS Clinical Trials Group,"October 1, 2013",Interventional,A Randomized Comparison of Three Regimens of Chemotherapy With Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings
5,Food: A Three-Arm Study Examining Food Insecurity Interventions,CANCER PATIENTS,"February 08, 2021",668,NCT01603316,SURVEYS; FOCUS GROUPS,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"May 8, 2012",Interventional,Food: A Three-Arm Randomized Controlled Study Examining Food Insecurity Interventions
6,Vaginal Cleansing Before Cesarean Delivery to Reduce Infection,COMPLICATIONS; CESAREAN SECTION,"February 08, 2021",608,NCT02495753,VAGINAL CLEANSING; ABDOMINAL CLEANSING,UNITED STATES,Recruiting,Washington University School of Medicine,August 2015,Interventional,Vaginal Cleansing Before Cesarean Delivery to Reduce Infection: A Randomized Trial
7,Community-Acquired Pneumonia : Evaluation of Corticosteroids,COMMUNITY ACQUIRED PNEUMONIA,"February 08, 2021",1200,NCT02517489,HYDROCORTISONE; PLACEBO,FRANCE,Recruiting,"University Hospital, Tours","October 28, 2015",Interventional,Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
8,Exercise in Genetic Cardiovascular Conditions,HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME,"February 08, 2021",4299,NCT02549664,,AUSTRALIA,"Active, not recruiting",Yale University,May 2015,Observational [Patient Registry],"Exercise in Genetic Cardiovascular Conditions (Lifestyle and Exercise in Hypertrophic Cardiomyopathy ""LIVE-HCM""/Lifestyle and Exercise in the Long QT Syndrome ""LIVE-LQTS"""
9,Uveitis/Intraocular Inflammatory Disease Biobank (iBank),UVEITIS,"February 08, 2021",650,NCT02656381,,UNITED STATES,Recruiting,National Eye Institute (NEI),"July 26, 2016",Observational,Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
10,Reshaping the Path of Vascular Cognitive Impairment (VCI),TRANSIENT ISCHEMIC ATTACK; VASCULAR COGNITIVE IMPAIRMENT; SUBCORTICAL VASCULAR DEMENTIA,"February 08, 2021",88,NCT02669394,RESISTANCE EXERCISE TRAINING; CONTROL: STRETCHING AND RELAXATION PROGRAM,CANADA,Recruiting,University of British Columbia,January 2016,Interventional,Reshaping the Path of Vascular Cognitive Impairment With Resistance Training
11,"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","COMMUNITY-ACQUIRED PNEUMONIA, INFLUENZA, COVID","February 08, 2021",7100,NCT02735707,FIXED-DURATION HYDROCORTISONE; SHOCK-DEPENDENT HYDROCORTISONE; CEFTRIAXONE; MOXIFLOXACIN OR LEVOFLOXACIN; PIPERACILLIN-TAZOBACTAM; CEFTAROLINE; AMOXICILLIN-CLAVULANATE; MACROLIDE ADMINISTERED FOR 3-5 DAYS; MACROLIDE ADMINISTERED FOR UP TO 14 DAYS; FIVE-DAYS OSELTAMIVIR; TEN-DAYS OSELTAMIVIR; LOPINAVIR/RITONAVIR; HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE + LOPINAVIR/RITONAVIR; INTERFERON-Β1A; ANAKINRA; FIXED-DURATION HIGHER DOSE HYDROCORTISONE; TOCILIZUMAB; SARILUMAB; VITAMIN C; THERAPEUTIC ANTICOAGULATION; SIMVASTATIN; CONVALESCENT PLASMA; PROTOCOLISED MECHANICAL VENTILATION STRATEGY; ERITORAN; APREMILAST; ASPIRIN; CLOPIDOGREL; PRASUGREL; TICAGRELOR,AUSTRALIA,Recruiting,MJM Bonten,"April 11, 2016",Interventional,"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia"
12,Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription,MILD COGNITIVE IMPAIRMENT,"February 08, 2021",216,NCT02737878,AEROBIC TRAINING; RESISTANCE TRAINING; BALANCE AND TONE TRAINING; BALANCE AND TONE TRAINING,CANADA,Recruiting,University of British Columbia,April 2016,Interventional,Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription: Understanding Training Type and Exploring Mechanisms
13,MR-Evaluation of Renal Function In Septic Patients,"SEPSIS, SEVERE; ACUTE KIDNEY INJURY; COVID","February 08, 2021",20,NCT02765191,PLASMA EXPANSION WITH RINGER'S ACETATE,SWEDEN,Recruiting,Uppsala University,April 2016,Interventional,MR-Evaluation of Renal Function In Septic Patients
14,A Patient-Centered PaTH to Addressing Diabetes,OBESITY; DIABETES; COVID,"February 08, 2021",2000000,NCT02788903,WEIGHT COUNSELING; TELEMEDICINE,,"Active, not recruiting",Milton S. Hershey Medical Center,March 2016,Observational,A Patient-Centered PaTH to Addressing Diabetes: Impact of State Health Policies on Diabetes Outcomes and Disparities
15,Exercise Program in Cancer and Cognition,BREAST CANCER,"February 08, 2021",182,NCT02793921,MODERATE-INTENSITY AEROBIC EXERCISE INTERVENTION,UNITED STATES,Recruiting,University of Pittsburgh,April 2016,Interventional,Influence of Exercise on Neurocognitive Function in Breast Cancer
16,Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems,ARTHRITIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES; HEART FAILURE; HYPERTENSION; ANXIETY; CHRONIC PAIN; DEPRESSION; FIBROMYALGIA; INSOMNIA; IRRITABLE BOWEL SYNDROME; PROBLEM DRINKING; SUBSTANCE USE DISORDER,"February 08, 2021",4025,NCT02868983,INTEGRATION,UNITED STATES,"Active, not recruiting",University of Vermont,April 2016,Interventional,Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
17,Investigating Gains in Neurocognition in an Intervention Trial of Exercise,"HEALTHY; COGNITIVE FUNCTION 1, SOCIAL","February 08, 2021",639,NCT02875301,150 MINUTES WEEK; 225 MINUTES WEEK; STRETCH AND TONE,UNITED STATES,Recruiting,University of Pittsburgh,"September 6, 2017",Interventional,Investigating Gains in Neurocognition in an Intervention Trial of Exercise
18,Lung Cancer Screening Decisions,LUNG CANCER SCREENING,"February 08, 2021",200,NCT02899754,LUNG CANCER SCREENING DECISION TOOL; CONTROL INTERVENTION,UNITED STATES,Recruiting,VA Office of Research and Development,"January 28, 2019",Interventional,Incorporating Veterans Preferences Into Lung Cancer Screening Decisions
19,Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism,ALCOHOL DEPENDENCE,"February 08, 2021",100,NCT02901041,ZONISAMIDE; TAKE CONTROL; PLACEBO (FOR ZONISAMIDE),UNITED STATES,"Active, not recruiting",Boston University Charles River Campus,"September 21, 2017",Interventional,Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
20,Study of Biomarker-Based Treatment of Acute Myeloid Leukemia,PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA,"February 08, 2021",2000,NCT03013998,SAMALIZUMAB (BAML-16-001-S1); BI 836858 (BAML-16-001-S2); LABORATORY BIOMARKER ANALYSIS; DAUNORUBICIN (BAML-16-001-S1); CYTARABINE (BAML-16-001-S1); AZACITIDINE (BAML-16-001-S2); AG-221 (BAML-16-001-S3); AZACITIDINE (BAML-16-001-S3); ENTOSPLETINIB (BAML-16-001-S4); AZACITIDINE (BAML-16-001-S4); ENTOSPLETINIB (BAML-16-001-S5); DECITABINE (BAML-16-001-S5); ENTOSPLETINIB (BAML-16-001-S6); DAUNORUBICIN (BAML-16-001-S6); CYTARABINE (BAML-16-001-S6); PEVONEDISTAT (BAML-16-001-S9); AZACITIDINE (BAML-16-001-S9); AG-120 (BAML-16-001-S16); AZACITIDINE (BAML-16-001-S16); GILTERITINIB (BAML-16-001-S8); DECITABINE (BAML-16-001-S8); ACALABRUTINIB (BAML-16-001-COV1); STANDARD THERAPY (BAML-16-001-COV1); AZD5153 (BAML-16-001-S10); VENETOCLAX (BAML-16-001-S10); TP-0903 (BAML-16-001-S14); DECITABINE (BAML-16-001-S14),UNITED STATES,Recruiting,"Beat AML, LLC",November 2016,Interventional,A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)
21,An ACT-enhanced Weight Management and Fitness Program for Navy Personnel,OBESITY; OVERWEIGHT,"February 08, 2021",164,NCT03029507,ACT ENHANCED SHIPSHAPE; STANDARD SHIPSHAPE (SS),UNITED STATES,Recruiting,Veterans Medical Research Foundation,"December 8, 2017",Interventional,An Acceptance and Commitment Therapy (ACT)-Enhanced Weight Management and Fitness Program for Navy Personnel
22,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19),ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",75,NCT03042143,HUMAN UMBILICAL CORD DERIVED CD362 ENRICHED MSCS; PLACEBO (PLASMA-LYTE 148),UNITED KINGDOM,Recruiting,Belfast Health and Social Care Trust,"January 7, 2019",Interventional,"Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST): An Open Label Dose Escalation Phase 1 Trial Followed by a Randomized, Double-blind, Placebo-controlled Phase 2 Trial (COVID-19)"
23,"Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age",RESPIRATORY SYNCYTIAL VIRUS INFECTIONS,"February 08, 2021",32,NCT03102034,D46/NS2/N/ΔM2-2-HINDIII; PLACEBO,UNITED STATES,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"April 6, 2017",Interventional,"Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, D46/NS2/N/ΔM2-2-HindIII, Lot RSV#011B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age"
24,A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease,CROHN'S DISEASE,"February 08, 2021",1250,NCT03105102,PLACEBO FOR RISANKIZUMAB SC; RISANKIZUMAB IV; PLACEBO FOR RISANKIZUMAB IV; RISANKIZUMAB SC,ARGENTINA,Enrolling by invitation,AbbVie,"April 9, 2018",Interventional,"A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease"
25,Strategies to Assist With Management of Pain,CHRONIC LOW BACK PAIN,"February 08, 2021",766,NCT03115359,MINDFULNESS MEDITATION; COGNITIVE BEHAVIORAL THERAPY,UNITED STATES,Recruiting,"University of Wisconsin, Madison","June 30, 2017",Interventional,A Comparative Effectiveness Randomized Controlled Trial of Mindfulness Meditation Versus Cognitive Behavioral Therapy for Opioid-Treated Chronic Low Back Pain
26,Tele-Exercise and Multiple Sclerosis,MULTIPLE SCLEROSIS,"February 08, 2021",833,NCT03117881,DIRECTCAM; TELECAM; RDIRECTCAM,UNITED STATES,Recruiting,University of Alabama at Birmingham,"January 8, 2018",Interventional,Comparative Effectiveness Trial Between a Clinic- and Home-Based Complementary and Alternative Medicine Telerehabilitation Intervention for Adults With Multiple Sclerosis (MS)
27,Impact of CMS Reimbursement Policy Supporting Care Coordination in Louisiana,"DIABETES MELLITUS, TYPE 2; CHRONIC DISEASE","February 08, 2021",22242,NCT03136471,,UNITED STATES,"Active, not recruiting",Tulane University,January 2017,Observational,Natural Experiments of the Impact of Population-Targeted Health Policies to Prevent Diabetes and Its Complications
28,Infant Mental Health-Home Visiting Randomized Controlled Trial,INFANT MENTAL HEALTH,"February 08, 2021",148,NCT03175796,INFANT MENTAL HEALTH-HOME VISITING,UNITED STATES,Completed,University of Michigan,"October 12, 2017",Interventional,Infant Mental Health-Home Visiting Randomized Controlled Trial
29,"Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT",IDIOPATHIC PULMONARY FIBROSIS; PRIMARY SCLEROSING CHOLANGITIS; COVID PNEUMONIA,"February 08, 2021",30,NCT03183570,[18F]FP-R01-MG-F2,UNITED STATES,Recruiting,Stanford University,"November 8, 2017",Interventional,"Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CT"
30,Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes,TYPE2 DIABETES; DIABETIC KIDNEY DISEASE,"February 08, 2021",300,NCT03184662,HIPA; COUNSELING PA,BELGIUM,Recruiting,Poitiers University Hospital,"February 12, 2018",Interventional,Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
31,The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients,CRITICAL ILLNESS; VITAMIN D DEFICIENCY; COVID,"February 08, 2021",2400,NCT03188796,CHOLECALCIFEROL; PLACEBO,AUSTRIA,Recruiting,Medical University of Graz,"October 10, 2017",Interventional,"The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients With Severe Vitamin D Deficiency: a Multicenter, Placebo-controlled Double-blind Phase III Randomized Controlled Trial (RCT)"
32,COMparison Between All immunoTherapies for Multiple Sclerosis.,RELAPSING-REMITTING MULTIPLE SCLEROSIS,"February 08, 2021",3526,NCT03193866,RITUXIMAB,SWEDEN,"Active, not recruiting",Karolinska Institutet,"February 1, 2017",Observational [Patient Registry],"COMparison Between All immunoTherapies for Multiple Sclerosis. An Observational Long-term Prospective Cohort Study of Safety, Efficacy and Patient's Satisfaction of MS Disease Modulatory Treatments in Relapsing-remitting Multiple Sclerosis"
33,Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination,PARENTS,"February 08, 2021",800,NCT03209713,HPV VACCINE EDUCATION; TEXT MESSAGING REMINDER,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"June 28, 2017",Interventional,Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination
34,TRACERx Renal CAPTURE Sub-study,RENAL CELL CARCINOMA; CANCER; HEALTHY VOLUNTEERS,"February 08, 2021",360,NCT03226886,,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"February 5, 2012",Observational,TRACERx Renal (TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx)) CAPTURE: COVID-19 Antiviral Response in a Pan-tumour Immune Study
35,DVD Lifestyle Intervention,OBESITY,"February 08, 2021",500,NCT03260140,BEHAVIORAL LIFESTYLE INTERVENTION,UNITED STATES,"Active, not recruiting",VA Office of Research and Development,"February 15, 2018",Interventional,DVD Lifestyle Intervention (D-ELITE)
36,Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders,EATING DISORDER,"February 08, 2021",180,NCT03261050,COUNTER ATTITUDINAL THERAPY; INTERPERSONAL THERAPY,UNITED STATES,Recruiting,Oregon Research Institute,"July 10, 2017",Observational,Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders
37,Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients,CRITICAL ILLNESS; COMMUNICATION DISABILITIES,"February 08, 2021",155,NCT03276559,EMPOWER; ENHANCED USUAL CARE,UNITED STATES,Recruiting,Weill Medical College of Cornell University,"July 12, 2017",Interventional,Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients
38,Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders,ANXIETY; DEPRESSION,"February 08, 2021",240,NCT03301922,METACOGNITIVE THERAPY AND WORK-FOCUSED INTERVENTIONS; WAITING LIST,NORWAY,Recruiting,Norwegian University of Science and Technology,"October 31, 2017",Interventional,Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders: A Randomized Waiting List Controlled Trial
39,Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics,COVID,"February 08, 2021",20,NCT03305341,COVID-19 THERAPEUTIC BIOLOGICS - SPIKE-GM-CSF PROTEIN LACTATED RINGER'S INJECTION,UNITED STATES,"Active, not recruiting","Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair","July 18, 2020",Interventional,"Conducting an Initial Small, Controlled Clinical Pharmacology Trial to Assess for Therapeutic Biologics Activity (Proof-of-Concept) That Suggests the Potential for Clinical Benefits of COVID-19 Patients."
40,Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma,HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE NECK,"February 08, 2021",300,NCT03323463,F-FMISO PET/CT SCAN; 30 GY OVER 3 WEEKS; CISPLATIN; CARBOPLATIN; 5FLUOROURACIL; PROTON THERAPY,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"October 16, 2017",Interventional,A Prospective Single Arm Non-inferiority Trial of Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma (Major De-escalation to 30Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma)
41,An 18-Month Psychotherapy of Borderline Personality Disorder,BORDERLINE PERSONALITY DISORDER,"February 08, 2021",45,NCT03329677,TRANSFERENCE-FOCUSED PSYCHOTHERAPY (TFP),UNITED STATES,Recruiting,Weill Medical College of Cornell University,"January 1, 2016",Interventional,An 18-Month Psychotherapy of Borderline Personality Disorder
42,Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections,RESPIRATORY TRACT INFECTIONS; CORONAVIRUS INFECTION,"February 08, 2021",20,NCT03331445,NITRIC OXIDE 0.5 % / NITROGEN 99.5 % GAS FOR INHALATION,CANADA,Recruiting,Chris Miller,"October 24, 2017",Interventional,"An Open Label Safety Study of Inhaled Gaseous Nitric Oxide (gNO) for Adults & Adolescents With Non-Tuberculous Mycobacteria, Burkholderia Spp, Aspergillus Spp and Corona-like Viral (Sub-Study) Infections"
43,The Helping Older People Engage Project: Improving Social Well-Being in Later Life,LONELINESS; QUALITY OF LIFE,"February 08, 2021",300,NCT03343483,VOLUNTEERING; LIFE REVIEW,UNITED STATES,Recruiting,University of Rochester,"December 1, 2017",Interventional,The Getting Active Project (GAP): A Randomized Trial of Volunteering to Reduce Loneliness in Later Life
44,Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP),COVID,"February 08, 2021",20,NCT03348670,COVID-19 THERAPEUTIC BIOLOGICS - SPIKE-GM-CSF PROTEIN LACTATED RINGER'S INJECTION,UNITED STATES,"Active, not recruiting","Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair","July 20, 2020",Interventional,"Conducting an Initial Small, Controlled Clinical Trial to Assess for COVID-19 Therapeutic Biologics Activity (Proof-of-concept) That Suggests the Potential for Clinical Benefits of COVID-19 Patients."
45,Efficacy of Family Programs for Improving Child and Family Health and Development,"BEHAVIOR, INFANT","February 08, 2021",1200,NCT03367845,CONTROL; SENSITIVITY INTERVENTION; COUPLES' INTERVENTION; SENSITIVITY AND COUPLES' INTERVENTION,UNITED STATES,Recruiting,University of Notre Dame,"January 11, 2017",Interventional,Efficacy of Family Programs for Improving Child and Family Health and Development
46,Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS,"RESPIRATORY DISTRESS SYNDROME, ADULT; SARS-CoV2","February 08, 2021",20,NCT03376854,HYPOTHERMIA; NEUROMUSCULAR BLOCKING AGENTS; STANDARD OF CARE,UNITED STATES,Recruiting,"University of Maryland, Baltimore","May 1, 2018",Interventional,Pilot Randomized Clinical Trial of Therapeutic Hypothermia Plus Neuromuscular Blockade vs. Standard of Care in COVID-19 Patients With Moderate to Severe ARDS - the Cooling to Help Injured Lungs (CHILL) Pilot Study
47,Scaling Up Science-based Mental Health Interventions in Latin America,DEPRESSION; PROBLEMATIC ALCOHOL USE,"February 08, 2021",3091,NCT03392883,LADDR,COLOMBIA,"Active, not recruiting",Dartmouth-Hitchcock Medical Center,"February 13, 2018",Interventional,Scaling Up Science-based Mental Health Interventions in Latin America
48,Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease,CROHN'S DISEASE; ULCERATIVE COLITIS; HEALTHY CONTROLS,"February 08, 2021",160,NCT03397108,,CANADA,Recruiting,The Hospital for Sick Children,"July 4, 2017",Observational,Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease
49,A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis,ULCERATIVE COLITIS (UC),"February 08, 2021",760,NCT03398135,RISANKIZUMAB; PLACEBO FOR RISANKIZUMAB,ARGENTINA,Enrolling by invitation,AbbVie,"August 28, 2018",Interventional,"A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis"
50,Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease,CROHN DISEASE,"February 08, 2021",600,NCT03440372,OZANIMOD; PLACEBO,ARGENTINA,Recruiting,Celgene,"February 27, 2018",Interventional,"Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease"
51,Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease,CROHN DISEASE,"February 08, 2021",600,NCT03440385,OZANIMOD; PLACEBO,AUSTRALIA,Recruiting,Celgene,"March 7, 2018",Interventional,"Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease"
52,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,"CANCER, METASTATIC; CANCER; CANCER OF PANCREAS; CANCER OF LIVER; CANCER OF STOMACH; CANCER LIVER; CANCER OF RECTUM; CANCER OF KIDNEY; CANCER OF ESOPHAGUS; CANCER OF CERVIX; CANCER OF COLON; CANCER OF LARYNX; CANCER, LUNG; CANCER, BREAST; CANCER, ADVANCED; CANCER PROSTATE; CANCER OF NECK; CANCER OF SKIN; NEUROENDOCRINE TUMORS; CARCINOMA; MISMATCH REPAIR DEFICIENCY; BRCA GENE REARRANGEMENT; NON HODGKIN LYMPHOMA; LEUKEMIA; NON SMALL CELL LUNG CANCER; CHOLANGIOCARCINOMA; GLIOBLASTOMA; CENTRAL NERVOUS SYSTEM TUMOR; MELANOMA; UROTHELIAL CARCINOMA; BLADDER CANCER; OVARIAN CANCER; ENDOMETRIAL CANCER; TESTICULAR CANCER; BREAST CANCER; COVID","February 08, 2021",1500,NCT03452774,CLINICAL TRIAL MATCHING,UNITED STATES,Recruiting,"Massive Bio, Inc.","January 1, 2018",Observational [Patient Registry],SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
53,A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease,CROHN DISEASE,"February 08, 2021",485,NCT03464097,OZANIMOD; PLACEBO,ARGENTINA,Recruiting,Celgene,"June 27, 2018",Interventional,"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease"
54,Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP),RECURRENT RESPIRATORY PAPILLOMATOSIS; HUMAN PAPILLOMA VIRUS,"February 08, 2021",400,NCT03465280,MICRODEBRIDER; COLD-STEEL SURGERY (FORCEPS); CARBON DIOXIDE LASER; POTASSIUM TITANYL PHOSPHATE (KTP) LASER; PULSED DYE LASER; RADIOFREQUENCY ABLATION; MONOPOLAR SUCTION DIATHERMY; PLASMA COAGULATION; OTHER; ADJUVANT THERAPIES,UNITED KINGDOM,Recruiting,Newcastle-upon-Tyne Hospitals NHS Trust,"April 1, 2018",Observational [Patient Registry],Airway Intervention Registry (AIR) Extension: Recurrent Respiratory Papillomatosis
55,Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients,SICKLE CELL DISEASE (SCD),"February 08, 2021",100,NCT03474965,CRIZANLIZUMAB,BELGIUM,Recruiting,Novartis Pharmaceuticals,"October 1, 2018",Interventional,"A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive Crisis"
56,Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial,"MULTIPLE SCLEROSIS, RELAPSING-REMITTING","February 08, 2021",900,NCT03500328,EARLY AGGRESSIVE THERAPY OR TRADITIONAL THERAPY,UNITED STATES,Recruiting,Johns Hopkins University,"May 2, 2018",Interventional,"A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis"
57,Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners,RESPIRATORY INFECTION; RESPIRATORY INFECTIONS IN CHILDREN,"February 08, 2021",406,NCT03540706,CARE WITH C-REACTIVE PROTEIN ASSAY IN MICRO METHOD,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 1, 2018",Interventional,Impact of the Use of C-reactive Protein in a Micro-method on the Prescription of Antibiotics in General Practitioners Consulting in the Office
58,Pre Bypass Ultrafiltration (PBUF) in Children Requiring Cardiopulmonary Bypass,CONGENITAL HEART DISEASE,"February 08, 2021",200,NCT03576534,USE OF PREBYPASS ULTRAFILTRATION (PBUF),UNITED STATES,Recruiting,Boston Children's Hospital,"October 3, 2019",Interventional,"Pre Bypass Ultrafiltration (PBUF) Improves Intraoperative Glucose, Sodium, Potassium and Lactate Levels in Children Requiring Cardiopulmonary Bypass"
59,Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain,"ACUTE PAIN; LOW BACK PAIN, MECHANICAL","February 08, 2021",1180,NCT03581123,SUPPORTED-SELF MANAGEMENT (SSM); SPINAL MANIPULATION THERAPY (SMT); SMT + SSM; STANDARD MEDICAL CARE (SMC),UNITED STATES,Recruiting,University of Minnesota,"October 25, 2018",Interventional,Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back
60,Group Lifestyle Balance™ for Individuals With Traumatic Brain Injury (GLB-TBI),TRAUMATIC BRAIN INJURY,"February 08, 2021",57,NCT03594734,GROUP LIFESTYLE BALANCE™; ATTENTION CONTROL GROUP,UNITED STATES,"Active, not recruiting",Baylor Research Institute,"January 8, 2019",Interventional,Efficacy of an Evidence-based Weight-loss Intervention Post Traumatic Brain Injury
61,Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis,SEPSIS; SEPTIC CARDIOMYOPATHY; CARDIOMYOPATHIES,"February 08, 2021",290,NCT03620409,,GERMANY,Recruiting,Jena University Hospital,"May 9, 2018",Observational,Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis
62,"A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019 (COVID-19)",NEOPLASMS; LYMPHOMA; HEMATOLOGIC NEOPLASMS; CORONAVIRUS DISEASE,"February 08, 2021",242,NCT03648372,TAK-981; STANDARD OF CARE,UNITED STATES,Recruiting,"Millennium Pharmaceuticals, Inc.","October 1, 2018",Interventional,"An Open Label, Dose-Escalation, Phase I Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of TAK-981 in Adult Patients With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019"
63,ACT1ON Phase 2 (SMART Pilot) and Phase 3 (Efficacy Trial Development),"DIABETES MELLITUS, TYPE 1; OVERWEIGHT AND OBESITY","February 08, 2021",69,NCT03651622,"HYPOCALORIC, LOW CARBOHYDRATE DIET; HYPOCALORIC, MODERATE LOW FAT DIET; MEDITERRANEAN DIET, NO CALORIC RESTRICTION",UNITED STATES,"Active, not recruiting","University of North Carolina, Chapel Hill","November 12, 2018",Interventional,Accelerating Solutions to Optimize Glycemic Control and Weight Management In Young Adults With Type 1 Diabetes
64,Lessening Organ Dysfunction With VITamin C,SEPSIS; VITAMIN C; INTENSIVE CARE UNIT; COVID; PANDEMIC; CORONAVIRUS,"February 08, 2021",800,NCT03680274,VITAMIN C; CONTROL,CANADA,Recruiting,Université de Sherbrooke,"November 8, 2018",Interventional,Lessening Organ Dysfunction With VITamin C (LOVIT)
65,Effects of Sleep Disruption on Drug Response,"LOW BACK PAIN, RECURRENT; HEALTHY","February 08, 2021",250,NCT03680287,WITHIN-SUBJECT TEST OF BLINDED STUDY MEDICATION,UNITED STATES,Recruiting,Johns Hopkins University,"October 7, 2019",Interventional,Effects of Sleep Disruption on Drug Response
66,Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD,SUBSTANCE USE DISORDER; POST-TRAUMATIC STRESS DISORDER; MORAL INJURY,"February 08, 2021",24,NCT03681288,MINDFUL SELF-COMPASSION,UNITED STATES,"Active, not recruiting",VA Office of Research and Development,"May 21, 2019",Interventional,Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD
67,Systematic Multi-domain Alzheimer's Risk Reduction Trial,DEMENTIA; ALZHEIMER DISEASE,"February 08, 2021",172,NCT03683394,SMARRT INTERVENTION; HEALTH EDUCATION INTERVENTION,UNITED STATES,"Active, not recruiting",Kaiser Permanente,"August 30, 2018",Interventional,Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot
68,LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A,CENTRAL NERVOUS SYSTEM LYMPHOMA,"February 08, 2021",44,NCT03684980,VORAXAZE; METHOTREXATE; RITUXIMAB; LEUCOVORIN; GLUCARPIDASE,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"November 14, 2018",Interventional,LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
69,Prednisolone in Early Diffuse Systemic Sclerosis,SYSTEMIC SCLEROSIS,"February 08, 2021",72,NCT03708718,PREDNISOLONE 5 MG; PLACEBO ORAL CAPSULE; FROM AUGUST 2020 'NO ADDITIONAL TREATMENT',UNITED KINGDOM,Recruiting,Prof. Ariane herrick,"December 21, 2017",Interventional,"A Phase II Randomised Study of Oral Prednisolone in Early Diffuse Cutaneous Systemic Sclerosis (Initially Double-blind, Then Switched to Open-label Because of Covid-19)"
70,Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program,OVERWEIGHT AND OBESITY,"February 08, 2021",450,NCT03710746,PROJECT HEALTH; RESPONSE AND ATTENTION TRAINING,UNITED STATES,Recruiting,Oregon Research Institute,"October 8, 2018",Interventional,Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program
71,Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder,MAJOR DEPRESSIVE DISORDER; MAJOR DEPRESSIVE EPISODE,"February 08, 2021",12506,NCT03716869,UNIVERSAL SCREENING ARM,UNITED STATES,"Active, not recruiting",Milton S. Hershey Medical Center,"July 1, 2018",Interventional,Randomized Controlled Trial of Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder
72,Back Side of the Moon: Nutritional Therapy,NUTRITIONAL DEFICIENCY; HOSPITALISM,"February 08, 2021",50,NCT03724045,BACK SIDE OF THE MOON,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"January 1, 2019",Interventional,Back Side of the Moon Study: What is the Efficiency of Nutritional Therapy (Calories and Nitrogen) in ICU and on the Ward and What is the Metabolic Profile of Patients After ICU? Could Supplemental Nutrition Fill the Gap?
73,Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation,EXERCISE; LUNG TRANSPLANTATION,"February 08, 2021",112,NCT03728257,LTGO-HOME BASED EXERCISE; ENHANCED USUAL CARE,UNITED STATES,Recruiting,University of Pittsburgh,"March 25, 2019",Interventional,Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation
74,A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD,INFLUENZA; INFLUENZA-LIKE ILLNESS,"February 08, 2021",15000,NCT03734237,EGG BASED INFLUENZA VACCINES; RECOMBINANT INFLUENZA VACCINES; CELL-CULTURE BASED INFLUENZA VACCINES,UNITED STATES,Recruiting,Henry M. Jackson Foundation for the Advancement of Military Medicine,"November 6, 2018",Interventional,A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
75,Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID),POST INTENSIVE CARE SYNDROME,"February 08, 2021",200,NCT03738774,,UNITED STATES,Recruiting,Vanderbilt University Medical Center,"January 2, 2019",Observational,Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)
76,Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin,OVERACTIVE BLADDER SYNDROME,"February 08, 2021",140,NCT03758235,INCOBOTULINUMTOXINA 100 UNT INJECTION [XEOMIN]; ONABOTULINUMTOXINA 100 UNT [BOTOX],ITALY,"Active, not recruiting",University Of Perugia,"September 1, 2018",Interventional,Incobotulinumtoxin Versus Onabotulinumtoxin in the Treatment of Patients With Overactive Bladder Syndrome
77,Self-help Guided by Lay Providers for Anxiety in Older Adults,GENERALIZED ANXIETY DISORDER,"February 08, 2021",130,NCT03768544,SELF-HELP GUIDED BY A LAY PROVIDER; WAITING LIST WHERE PARTICIPANTS WAIT FOR DELAYED TREATMENT,CANADA,Recruiting,Laval University,"March 11, 2019",Interventional,Generalized Anxiety Disorder in Older Adults : Efficacy of a Self-help Treatment Guided by Trained Lay Providers
78,Exploring 'VOLITION' in Context - a Study to Inform the Implementation of a New Intervention,DECISION MAKING; AGED; MULTIMORBIDITY; GENERAL PRACTICE,"February 08, 2021",150,NCT03786315,,UNITED KINGDOM,Recruiting,University of Exeter,"January 4, 2021",Observational,Exploring 'VOLITION' in Context - a Study to Inform the Implementation of a New Intervention
79,CoYoT1 to California,TYPE 1 DIABETES MELLITUS,"February 08, 2021",80,NCT03793673,COYOT1 CARE; STANDARD CARE,UNITED STATES,"Active, not recruiting",Children's Hospital Los Angeles,"January 20, 2019",Interventional,CoYoT1 to California - Telemedicine to Engage Young Adults With Diabetes
80,"Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study",SPINAL CORD INJURIES; TRAUMATIC BRAIN INJURY; SPINA BIFIDA; CEREBRAL PALSY; STROKE; PARKINSON DISEASE; MULTIPLE SCLEROSIS,"February 08, 2021",108,NCT03797378,EM2M,UNITED STATES,Recruiting,University of Alabama at Birmingham,"August 9, 2019",Interventional,"The M2M LEADERS Project: Lakeshore Examination of Activity, Disability, and Exercise Response Study (LEADERS)"
81,Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",35,NCT03807804,HLCM051,JAPAN,Recruiting,Healios K.K.,"January 1, 2019",Interventional,"An Open-label, Standard Therapy as a Controlled, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of HLCM051(MultiStem) in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by Pneumonitis"
82,Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study,LOWER RESPIRATORY TRACT INFECTION; PARAINFLUENZA; IMMUNOCOMPROMISED; COVID,"February 08, 2021",250,NCT03808922,DAS181; PLACEBO; DAS181 COVID-19; DAS181 OL,AUSTRALIA,Recruiting,"Ansun Biopharma, Inc.","May 23, 2019",Interventional,A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
83,Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity,UPPER LIMB SPASTICITY,"February 08, 2021",83,NCT03821402,DAXI FOR INJECTION DOSE LOW DOSE; DAXI FOR INJECTION DOSE MEDIUM DOSE; DAXI FOR INJECTION DOSE HIGH DOSE; PLACEBO,UNITED STATES,Completed,"Revance Therapeutics, Inc.","December 12, 2018",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging, Multi-Center Trial to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Upper Limb Spasticity in Adults After Stroke or Traumatic Brain Injury"
84,Evaluating the Impact of a Culinary Coaching Tele-medicine Program,OVERWEIGHT; OBESITY,"February 08, 2021",78,NCT03823469,CCTP; NUTRITIONAL COUNSELING,ISRAEL,Recruiting,Spaulding Rehabilitation Hospital,"May 20, 2019",Interventional,Evaluating the Impact of a Culinary Coaching Telemedicine Program on Body Weight and Metabolic Outcomes - A Randomized Controlled Trial
85,RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD),POSTTRAUMATIC STRESS DISORDER; TRAUMATIC BRAIN INJURY,"February 08, 2021",108,NCT03827057,RECONSOLIDATION OF TRAUMATIC MEMORIES (RTM); PROLONGED EXPOSURE (PE),UNITED STATES,Recruiting,Uniformed Services University of the Health Sciences,"June 12, 2019",Interventional,RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD)
86,Peer Mentoring to Improve Self-management in Youth With IBD,PEDIATRIC CROHNS DISEASE; PEDIATRIC ULCERATIVE COLITIS; INFLAMMATORY BOWEL DISEASES,"February 08, 2021",300,NCT03827109,GROUP EDUCATIONAL ACTIVITIES; IBD EDUCATIONAL WEBSITE; MONTHLY CHECK-IN CALLS FROM PROGRAM COORDINATOR; MENTOR; FUN GROUP ACTIVITIES; PARENT SUPPORT GROUP,UNITED STATES,Recruiting,Laura Mackner,"June 12, 2019",Interventional,Peer Mentoring to Improve Self-management in Youth With IBD
87,Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia,PNEUMONIA,"February 08, 2021",90,NCT03852537,METHYLPREDNISOLONE; USUAL CARE,UNITED STATES,Recruiting,Mayo Clinic,"December 2, 2019",Interventional,SMART Trial: Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia
88,Azithromycin-Prevention in Labor Use Study (A-PLUS),MATERNAL DEATH; MATERNAL INFECTIONS AFFECTING FETUS OR NEWBORN; NEONATAL SEPSIS; MATERNAL SEPSIS DURING LABOR; NEONATAL DEATH; POSTPARTUM SEPSIS,"February 08, 2021",34000,NCT03871491,AZITHROMYCIN; PLACEBO,BANGLADESH,Recruiting,NICHD Global Network for Women's and Children's Health,"September 1, 2020",Interventional,Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial
89,Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA),STROKE,"February 08, 2021",65,NCT03873467,GROUP LIFESTYLE BALANCE; USUAL CARE,UNITED STATES,"Active, not recruiting",Baylor Research Institute,"July 8, 2019",Interventional,Efficacy of an Evidence-based Healthy Lifestyle Intervention for People Following CVA
90,Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old,"TUBERCULOSIS; PEDIATRIC ALL; BEHAVIOR, HEALTH","February 08, 2021",300,NCT03881228,INCREASING THE COMPLETION OF IPT,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"December 1, 2019",Interventional,Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old Who Are Household Contacts of Persons With Tuberculosis
91,Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI),PREVENTIVE HEALTH SERVICES (PREV HEALTH SERV),"February 08, 2021",1000,NCT03885232,EXPERIMENTAL: PIVOT WITH MI; ACTIVE COMPARATOR: CONTROL,UNITED STATES,Enrolling by invitation,"University of Colorado, Denver","September 1, 2019",Interventional,Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI)
92,"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19",COVID; YELLOW FEVER,"February 08, 2021",132,NCT03891420,GALIDESIVIR; PLACEBO,BRAZIL,Recruiting,BioCryst Pharmaceuticals,"April 9, 2020",Interventional,"A Phase 1b Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Pharmacokinetics, and Anti-viral Effects of Galidesivir Administered Via Intravenous Infusion to Subjects With Yellow Fever or COVID-19"
93,Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations,ISCHEMIC HEART DISEASE; HOPELESSNESS; PHYSICAL ACTIVITY; MOTIVATION; SOCIAL SUPPORT; COVID,"February 08, 2021",225,NCT03907891,MOTIVATIONAL SOCIAL SUPPORT FROM NURSE; MOTIVATIONAL SOCIAL SUPPORT FROM NURSE WITH ADDITIONAL SUPPORT FROM SIGNIFICANT OTHER; ATTENTION CONTROL,UNITED STATES,Recruiting,University of Illinois at Chicago,"August 1, 2019",Interventional,A Randomized Controlled Trial to Reduce Hopelessness Through Enhanced Physical Activity in Adults With Ischemic Heart Disease
94,A Sports Injury Prevention Program to Reduce Subsequent Injuries After Concussion,BRAIN CONCUSSION; MUSCULOSKELETAL INJURY; LOCOMOTION; POSTURAL BALANCE,"February 08, 2021",40,NCT03917290,NEUROMUSCULAR TRAINING,UNITED STATES,Recruiting,"University of Colorado, Denver","April 2, 2019",Interventional,A Sports Injury Prevention Program to Reduce Subsequent Injuries After Concussion
95,Navigating New Motherhood 2,POSTPARTUM HEALTH; BREASTFEEDING; CONTRACEPTION; PREVENTIVE CARE / ANTICIPATORY GUIDANCE; RETENTION IN CARE,"February 08, 2021",400,NCT03922334,PATIENT NAVIGATION PROGRAM,UNITED STATES,Recruiting,Northwestern University,"January 21, 2020",Interventional,Navigating New Motherhood 2: Patient Navigation to Improve Outcomes Among Low-income Women in the Postpartum Period
96,Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx,HODGKIN LYMPHOMA; NON-HODGKIN LYMPHOMA; LYMPHOMA; BREAST CANCER,"February 08, 2021",18,NCT03923504,PHYSICAL ACTIVITY INTERVENTION (PAI); HEALTHY LIVING CONTROL,UNITED STATES,Recruiting,Virginia Commonwealth University,"May 10, 2019",Interventional,Improving Exercise Capacity With a Tailored Physical Activity Intervention in Lymphoma and Breast Cancer Patients Undergoing Treatment
97,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19,CHRONIC PAIN; CHRONIC PAIN SYNDROME; CHRONIC PAIN DUE TO INJURY; CHRONIC PAIN DUE TO TRAUMA; FIBROMYALGIA; SEIZURES; HEPATITIS C; CANCER; CROHN DISEASE; HIV/AIDS; MULTIPLE SCLEROSIS; TRAUMATIC BRAIN INJURY; SICKLE CELL DISEASE; POST TRAUMATIC STRESS DISORDER; TOURETTE SYNDROME; ULCERATIVE COLITIS; GLAUCOMA; EPILEPSY; INFLAMMATORY BOWEL DISEASES; PARKINSON DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CHRONIC TRAUMATIC ENCEPHALOPATHY; ANXIETY; DEPRESSION; INSOMNIA; AUTISM; OPIOID-USE DISORDER; BIPOLAR DISORDER; COVID; SARS-COV INFECTION; COVID; CORONAVIRUS INFECTION; CORONAVIRUS,"February 08, 2021",200000,NCT03944447,"CANNABIS, MEDICAL",UNITED STATES,Recruiting,"OMNI Medical Services, LLC","December 1, 2018",Interventional,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
98,Taking Time to Connect: A Study of Programs for Hispanic Mothers Diagnosed With Cancer and Their Children,CANCER SURVIVORSHIP,"February 08, 2021",156,NCT03951454,CONEXIONES; TAKING TIME,UNITED STATES,Enrolling by invitation,New Mexico State University,"April 16, 2019",Interventional,Taking Time to Connect: A Randomized Clinical Trial for Hispanic Mothers Diagnosed With Cancer
99,Effects of Physical Exercise on Postmenopausal Risk Factors in Women With Osteopenia,"OSTEOPENIA, OSTEOPOROSIS","February 08, 2021",27,NCT03959995,HIGH INTENSITY RESISTANCE (HIT-RT) AND ENDURANCE EXERCISE (HIIT); WELLNESS,GERMANY,Completed,University of Erlangen-Nürnberg Medical School,"January 15, 2019",Interventional,Effects of an Optimized 13-month Physical Exercise on (Early)-Postmenopausal Risk Factors in Women With Osteopenia and Osteoporosis (Actlife)
100,Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19),ARDS,"February 08, 2021",740,NCT03963622,RESPIRATORY MECHANICS; STANDARD VENTILATION STRATEGY,CANADA,Recruiting,Unity Health Toronto,"November 23, 2020",Interventional,Careful Ventilation in Acute Respiratory Distress Syndrome
101,Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity,CARDIOTOXICITY; CARDIAC REHABILITATION,"February 08, 2021",340,NCT03964142,CARDIAC REHABILITATION,SPAIN,Recruiting,Hospital Clinico Universitario de Santiago,"August 1, 2018",Interventional,Randomized Controlled Trial on Comprehensive Exercise-based Cardiac Rehabilitation Programs for the Prevention of Anthracyclines and/or Anti-HER2 Antibodies-induced Cardiotoxicity in Breast Cancer
102,Comparative Effectiveness of IIMR Versus CDSMP,MENTAL ILLNESS; CHRONIC DISEASE,"February 08, 2021",600,NCT03966872,INTEGRATED ILLNESS MANAGEMENT AND RECOVERY; CHRONIC DISEASE SELF-MANAGEMENT PROGRAM,UNITED STATES,"Active, not recruiting",Dartmouth-Hitchcock Medical Center,"September 2, 2019",Interventional,Comparative Effectiveness of Integrated Illness Management and Recovery Versus the Chronic Disease Self-Management Program
103,PREDICT 2: Personalized Responses to Dietary Composition Trial 2,DIABETES; HEART DISEASES; DIET HABIT; DIET MODIFICATION; MICROBIAL COLONIZATION; HEALTHY; OBESITY; METABOLISM,"February 08, 2021",1139,NCT03983733,DIETARY INTERVENTION,UNITED STATES,Completed,Zoe Global Limited,"June 10, 2019",Interventional,PREDICT 2: Personalized Responses to Dietary Composition Trial 2
104,What Are the Clinical Factors Associated With a Significant Pain Reduction Following Physiotherapy in Patients With Temporomandibular Disorders?,TEMPOROMANDIBULAR DISORDERS,"February 08, 2021",100,NCT03990662,PHYSIOTHERAPY - MANUAL THERAPY,ITALY,Recruiting,Istituto Stomatologico Italiano,"June 14, 2019",Observational,Predictors of Pain Reduction Following Manual Therapy in Patients With Temporomandibular Disorders: a Prospective Observational Study
105,HealthAtWork - a Measure for Increased Coping and Work Inclusion,MUSCULOSKELETAL PAIN; MENTAL HEALTH WELLNESS 1; WORK-RELATED CONDITION,"February 08, 2021",1000,NCT04000035,HEALTH AND WORK ENVIRONMENT INFORMATION AND PROCESSES,NORWAY,Recruiting,University Hospital of North Norway,"March 1, 2019",Interventional,HealthAtWork - a Measure for Increased Coping and Work Inclusion - An Analysis of Effect of Preventive Information Given at the Workplace - Part 1: Quantitative Data Collection
106,Making Mindfulness Matter© in Children With Epilepsy,EPILEPSY IN CHILDREN; MINDFULNESS; QUALITY OF LIFE,"February 08, 2021",100,NCT04020484,MAKING MINDFULNESS MATTER© (M3),CANADA,Recruiting,Lawson Health Research Institute,"December 2, 2019",Interventional,A Live-Online Mindfulness-based Intervention for Families of Children With Epilepsy: Making Mindfulness Matter© Randomized Control Trial
107,Nurse-led Alcohol Brief Intervention Plus Mobile Personalized Chat-based Support on Reducing Alcohol Use in University Students,ALCOHOL MISUSE,"February 08, 2021",770,NCT04025151,ALCOHOL BRIEF INTERVENTION; 12-PAGE HEALTH WARNING LEAFLET; REGULAR MESSAGES THROUGH INSTANT MESSAGING (IM); REAL-TIME CHAT-BASED SUPPORT THROUGH IM APPS; GENERAL HEALTH THROUGH IM APPS; AUDIT SCORE INTERPRETATION SHEET ADAPTED FROM THE DEPARTMENT OF HEALTH OF HONG KONG,HONG KONG,Not yet recruiting,The University of Hong Kong,"September 30, 2020",Interventional,Nurse-led Alcohol Brief Intervention Plus Mobile Personalized Chat-based Support on Reducing Alcohol Use in University Students: a Pragmatic Randomized Controlled Trial
108,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine,HEALTHY VOLUNTEER; COVID,"February 08, 2021",300,NCT04025580,FLUCELVAX; FLUVIRIN; FLUZONE HIGH DOSE,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"October 2, 2019",Interventional,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine
109,Exercising With Anxiety: Can Cognitive Behavioural Techniques Help People With Anxiety-related Disorders Exercise More?,ANXIETY DISORDERS; POSTTRAUMATIC STRESS DISORDER; OBSESSIVE-COMPULSIVE DISORDER,"February 08, 2021",59,NCT04026152,RESISTANCE TRAINING; UNIFIED PROTOCOL,CANADA,Completed,University of Regina,"July 14, 2019",Interventional,Using the Unified Protocol to Reduce Exercise Anxiety and Improve Adherence to a Resistance Training Program for People With Anxiety-Related Disorders: A Randomized Controlled Trial
110,The Causal Effects of Old Age Pensions,AGING,"February 08, 2021",1459,NCT04029194,ASSISTANCE WITH OLD AGE PENSION APPLICATION,INDIA,"Active, not recruiting","National Bureau of Economic Research, Inc.","February 4, 2019",Interventional,The Causal Effects of Old Age Pensions
111,Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: RCT,METABOLIC SYNDROME,"February 08, 2021",64,NCT04039165,PP-MI INTERVENTION,UNITED STATES,Recruiting,Massachusetts General Hospital,"July 25, 2019",Interventional,Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: A Randomized Controlled Pilot Trial
112,Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study,ANXIETY DISORDER OF CHILDHOOD; FEAR; SHYNESS,"February 08, 2021",90,NCT04039243,BEING BRAVE; PARENT EDUCATION,UNITED STATES,Recruiting,Massachusetts General Hospital,"September 27, 2019",Interventional,Addressing Anxiety in 2-Year-Olds: A Pilot Screening and Intervention Study
113,Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients,TRICHURIS INFECTION; HELMINTHIASIS,"February 08, 2021",176,NCT04041453,IVERMECTIN; ALBENDAZOLE,ARGENTINA,Completed,Alejandro Krolewiecki,"October 9, 2019",Interventional,"Prospective, Parallel-group, Open-label Randomized Controlled Trial of Four Treatment Regimes for Trichuriasis in Pediatric Patients"
114,Live@Home.Path: Innovating the Clinical Pathway for Home Dwelling Persons With Dementia and Their Families,DEMENTIA; HOME-DWELLING; CAREGIVER,"February 08, 2021",312,NCT04043364,LIVE,NORWAY,Recruiting,University of Bergen,"August 1, 2019",Interventional,"LIVE@Home.Path: a Mixed Method, Stepped Wedge and Randomized Controlled Trial Innovating the Clinical Pathway for Home-dwelling Persons With Dementia and Their Families"
115,Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease,ALZHEIMER DISEASE; ALZHEIMER DEMENTIA,"February 08, 2021",15,NCT04055376,GENUS DEVICE (ACTIVE SETTINGS); GENUS DEVICE (SHAM SETTINGS),UNITED STATES,"Active, not recruiting",Massachusetts Institute of Technology,"August 14, 2019",Interventional,Chronic Treatment of Alzheimer's Disease With Gamma Frequency Stimulation
116,Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients,CANCER,"February 08, 2021",180,NCT04055948,ONE-ON-ONE TEACHING SESSIONS; TELEPHONE BOOSTER CONTACT,UNITED STATES,Recruiting,Case Comprehensive Cancer Center,"December 1, 2019",Interventional,Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Patients With Cancer
117,Sero-epidemiological Survey of England in 2019/2020,SEROGROUP C MENINGOCOCCAL MENINGITIS; DIPHTHERIA; COVID,"February 08, 2021",3800,NCT04061382,VENEPUNCTURE; ORAL FLUID SWAB,UNITED KINGDOM,Recruiting,University of Oxford,"October 15, 2019",Observational,Serum Testing of Representative Youngsters: Sero- Epidemiological Survey of England in 2019/2020
118,Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women,AGING PROBLEMS; FRAILTY; FALL INJURY; ACCIDENTAL FALL; FEAR OF FALLING,"February 08, 2021",200,NCT04061785,JUDO4BALANCE - 12 WEEK JUDO INSPIRED EXERCISE PROGRAM,SWEDEN,Recruiting,Dalarna University,"September 30, 2019",Interventional,Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women
119,Adaptability and Resilience in Aging Adults-2,AGING; CHRONIC LOW-BACK PAIN,"February 08, 2021",60,NCT04068922,RESILIENCE INTERVENTION,UNITED STATES,Recruiting,University of Florida,"January 21, 2020",Interventional,Adaptability and Resilience in Aging Adults-2
120,The Development and Effectiveness of Museum-Based Experiences for Individuals With Chronic Pain,CHRONIC PAIN,"February 08, 2021",64,NCT04091893,USUAL CARE/WAIT LIST; ART RX; ARTFUL MEDITATION,UNITED STATES,"Active, not recruiting","University of California, Davis","October 12, 2019",Interventional,The Analgesic Museum: The Development and Effectiveness of Museum-Based Experiences to Reduce Social Isolation and Pain Among Individuals With Chronic Pain
121,PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock,SEPTIC SHOCK; PLATELET SIGNAL PROCESSING DEFECT; INFLAMMATORY RESPONSE; DISSEMINATED INTRAVASCULAR COAGULATION; COVID; NEUTROPHIL EXTRACELLULAR TRAP FORMATION,"February 08, 2021",150,NCT04107402,"ASSESSMENT OF COAGULOPATHY, PLATELETS ACTIVATION AND PLATELETS-NEUTROPHILS INTERPLAY",BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"March 15, 2019",Interventional,Prospective Evaluation of PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock Patients. Impact of Platelets Metabolism to Inflammatory Response.
122,RTLS Technology Study,INPATIENTS; STAFF,"February 08, 2021",2000,NCT04114110,RTLS DATA,UNITED KINGDOM,"Active, not recruiting",The Royal Wolverhampton Hospitals NHS Trust,"January 6, 2020",Observational,"A Retrospective, Observational Analysis Using Real Time Location Systems (RTLS) Technology to Explore the Effects of Clinical Staffing on Hospital Productivity and Patient Health Outcomes"
123,Supportive Care Delivered by Telemedicine to Cancer Patients at Home,CANCER; SUPPORTIVE CARE,"February 08, 2021",466,NCT04136340,IN-PERSON IN CLINIC FOLLOW-UP VISIT; TELEMEDICINE FOLLOW-UP VISIT,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"October 24, 2019",Interventional,Virtual Visits by Supportive Care Specialists to Cancer Patients at Home: A Randomized Controlled Pilot Noninferiority Trial of Video Telemedicine
124,Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS),INSOMNIA; SCHIZOPHRENIA; SCHIZOAFFECTIVE DISORDER,"February 08, 2021",120,NCT04144231,ICBT-I; GCBT-I,FINLAND,Recruiting,Helsinki University Central Hospital,"December 19, 2019",Interventional,Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia - A Randomized Controlled Clinical Trial (SLEEPINS)
125,A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy,B CELL ALL; B-CELL LYMPHOMA; B-CELL NON HODGKIN LYMPHOMA,"February 08, 2021",90,NCT04148430,ANAKINRA,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"October 30, 2019",Interventional,A Phase II Study of IL-1 Receptor Antagonist Anakinra to Prevent Severe Neurotoxicity and Cytokine Release Syndrome in Patients Receiving CD19-Specific Chimeric Antigen Receptor (CAR) T Cells And to Treat Systemic Inflammation Associated With COVID-19
126,Scaling Up Maternal Mental Health Care by Increasing Access to Treatment (SUMMIT),PERINATAL DEPRESSION,"February 08, 2021",1368,NCT04153864,BRIEF BEHAVIORAL ACTIVATION TREATMENT,CANADA,Recruiting,"Mount Sinai Hospital, Canada","January 6, 2020",Interventional,Scaling Up Maternal Mental Health Care by Increasing Access to Treatment (SUMMIT): A Study Protocol for Perinatal Depression and Anxiety
127,Measurement of Agricultural and Dietary Glyphosate Exposure Among Pregnant Women,EXPOSURE TO HERBICIDES,"February 08, 2021",40,NCT04155463,ORGANIC DIET; CONVENTIONAL DIET,,Not yet recruiting,Boise State University,January 2021,Interventional,Measurement of Agricultural and Dietary Glyphosate Exposure Among Pregnant Women
128,Neurally Targeted Cognitive Training to Augment CBT Outcomes in Pediatric Anxiety,ANXIETY DISORDERS,"February 08, 2021",54,NCT04157296,COGNITIVE BEHAVIORAL THERAPY (CBT); COMPUTERIZED COGNITIVE TRAINING (CCT),UNITED STATES,Recruiting,University of Michigan,"February 4, 2020",Interventional,Neurally Targeted Cognitive Training to Augment Cognitive Behavioral Therapy (CBT) Outcomes in Pediatric Anxiety
129,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects,"FLU, HUMAN; INFLUENZA, HUMAN; COVID","February 08, 2021",3350,NCT04160975,VIDEO ABOUT SAFETY AND EFFECTIVENESS OF ADULT SEASONAL FLU VACCINATION; MESSAGE DIRECTING SUBJECTS TO INFORMATION ON COVID-19 VACCINE SAFETY AND EFFICACY,UNITED STATES,Enrolling by invitation,Harvard University,"December 20, 2019",Interventional,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects
130,Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study,MALNUTRITION; ONCOLOGIC COMPLICATIONS; ONCOLOGY; QUALITY OF LIFE,"February 08, 2021",586,NCT04168814,OBSERVATIONAL TEST,SPAIN,Completed,Universidad Pontificia Comillas,"June 10, 2020",Observational,An Observational Study of the Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients While Receiving Immunotherapy in Spain: the NutriOncoSearch (NOS) Study
131,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",BREAST DUCTAL CARCINOMA IN SITU; COVID INFECTION; HEREDITARY BREAST CARCINOMA; INVASIVE BREAST CARCINOMA,"February 08, 2021",600,NCT04169542,QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 21, 2019",Observational,"Potential Impact of the COVID -19 Pandemic on Financial Toxicity in Breast Cancer Surgical Patients: The Impact on Out of Pocket Costs, Lost Wages and Economic Strain"
132,Advocating for Supports to Improve Service Transitions,AUTISM SPECTRUM DISORDER; AUTISM,"February 08, 2021",180,NCT04173663,ASSIST,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"January 3, 2020",Interventional,Project ASSIST: Advocating for Supports to Improve Service Transitions
133,CBT to Reduce Insomnia and Improve Social Recovery in Early Psychosis,PSYCHOTIC DISORDERS; PSYCHOSIS; SLEEP,"February 08, 2021",44,NCT04180709,SLEEPIO,UNITED KINGDOM,Recruiting,University of Cambridge,"October 30, 2020",Interventional,Randomised Study of Web-based CBT Intervention (Sleepio) to Reduce Insomnia and Improve Social Recovery in Early Psychosis (CRISP)
134,Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience,ABORTION; CONTRACEPTION,"February 08, 2021",100,NCT04181021,VALUES CLARIFICATION AND ATTITUDES TRANSFORMATION (VCAT) WORKSHOP,ETHIOPIA,Enrolling by invitation,Ibis Reproductive Health,"November 25, 2019",Interventional,Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience in Socially Franchised Facilities in Ethiopia: A Cluster Randomized Study
135,"A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites",ALLERGIC TO HOUSE DUST MITES,"February 08, 2021",28,NCT04184895,ASP2390; PLACEBO,GERMANY,Recruiting,"Astellas Pharma Global Development, Inc.","October 7, 2020",Interventional,"A Phase 1 Multiple Ascending Intradermal Dose Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites"
136,"Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response",UVEITIS,"February 08, 2021",300,NCT04193020,SURVEILLANCE CARD,POLAND,Recruiting,Wroclaw Medical University,"January 1, 2020",Observational [Patient Registry],Impact of Lifestyle and Treatment on the Recurrency and Severity of Acute and Chronic Inflamatory Eye Diseases: Protocol on Prospective Cohort Study
137,Safety and Immunogenicity of a Nipah Virus Vaccine,NIPAH VIRUS INFECTION,"February 08, 2021",274,NCT04199169,HEV-SG-V; NORMAL SALINE PLACEBO,UNITED STATES,Recruiting,Auro Vaccines LLC,"February 18, 2020",Interventional,"A Phase 1 Randomized, Placebo-controlled, Observer-blind Trial to Assess the Safety and Immunogenicity of a Nipah Vaccine, HeV-sG-V (Hendra Virus Soluble Glycoprotein Vaccine), in Healthy Adults"
138,New Oxymetry Indices in Critical Limb Ischemia,CRITICAL LIMB ISCHEMIA,"February 08, 2021",300,NCT04209998,TRANSCUTANEOUS OXIMETRY,FRANCE,Recruiting,"University Hospital, Angers","January 16, 2020",Observational,"New Oxymetry Indices in Critical Limb Ischemia (French Original Title is ""Nouveaux Indices Oxymétriques Chez Les Patients Vus Pour Suspicion d'Ischémie Critique du membrE inférieur"")"
139,Improving Aging in Place in Subsidized Housing,PHYSICAL DISABILITY; COGNITIVE IMPAIRMENT; PHYSICAL ACTIVITY,"February 08, 2021",70,NCT04212442,INDEPENDENT LIVING PROGRAM FOR AFFORDABLE HOUSING.,UNITED STATES,Recruiting,University of Pennsylvania,"January 13, 2020",Interventional,Improving Aging in Place for Older Adults in Subsidized Housing
140,MBCT Delivered Via Group Videoconferencing for ACS Syndrome Patients With Depressive Symptoms,ACUTE CORONARY SYNDROME; DEPRESSION; MYOCARDIAL INFARCTION; UNSTABLE ANGINA; STEMI; NSTEMI - NON-ST SEGMENT ELEVATION MI,"February 08, 2021",20,NCT04231097,MBCT INTERVENTION FOR ACS PATIENTS,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 24, 2020",Interventional,Mindfulness-Based Cognitive Therapy Delivered Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms
141,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,LOWER RESPIRATORY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; COVID,"February 08, 2021",250,NCT04233268,RAPID PATHOGEN DETECTION,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"April 6, 2020",Observational,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study
142,Evaluating Impacts of CSS for Veterans and Their Families in Ukraine,"PSYCHOSOCIAL PROBLEM; PSYCHOLOGICAL DISTRESS; ENGAGEMENT, PATIENT","February 08, 2021",1387,NCT04234815,CETA SHORT SESSION (CSS); PSYCHOEDUCATION AND SAFETY,UKRAINE,Recruiting,Johns Hopkins Bloomberg School of Public Health,"February 28, 2020",Interventional,Evaluating Impacts of a Brief Psychosocial Workshop for Veterans and Their Families in Ukraine
143,Primary Care Clinical Excellence Incentive Study,BEHAVIORAL ECONOMICS; PRIMARY HEALTH CARE; HEALTH MAINTENANCE; DIABETES; COLORECTAL CANCER SCREENING; CERVICAL CANCER SCREENING; CHLAMYDIA SCREENING; HPV SCREENING,"February 08, 2021",225,NCT04237883,STANDARD COMMUNICATION EMAIL; SOCIAL COMPARISON INTERVENTION; LEADERSHIP TRAINING,UNITED STATES,Completed,"University of California, Los Angeles","November 1, 2019",Interventional,Effects of Social Comparison Performance Feedback on Primary Care Quality
144,Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds,INVASIVE FUNGAL INFECTIONS,"February 08, 2021",50,NCT04240886,FOSMANOGEPIX,BELGIUM,Recruiting,Amplyx Pharmaceuticals,"January 4, 2020",Interventional,"A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of APX001 in the Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare Molds"
145,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,COVID INFECTIONS,"February 08, 2021",80,NCT04244591,METHYLPREDNISOLONE THERAPY; STANDARD CARE,CHINA,Completed,Peking Union Medical College Hospital,"January 26, 2020",Interventional,"Glucocorticoid Therapy for Critically Ill Patients With Severe Acute Respiratory Infections Caused by COVID-19: a Prospective, Randomized Controlled Trial"
146,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",NEW CORONAVIRUS,"February 08, 2021",50,NCT04245631,RECOMBINASE AIDED AMPLIFICATION (RAA) ASSAY,CHINA,Recruiting,Beijing Ditan Hospital,"January 1, 2020",Observational,"Development of a Simple, Fast and Portable Recombinase Aided Amplification (RAA) Assay for 2019-nCoV"
147,DiaBetter Together for Young Adults With Type 1 Diabetes,TYPE 1 DIABETES,"February 08, 2021",186,NCT04247620,DIABETTER TOGETHER; PEER MENTOR DELIVERY,UNITED STATES,Enrolling by invitation,Baylor College of Medicine,"December 15, 2020",Interventional,"DiaBetter Together: A Strengths-based, Peer Mentor Transition RCT for Young Adults With Type 1 Diabetes"
148,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,COVID COMPLICATED WITH REFRACTORY INTESTINAL INFECTIONS,"February 08, 2021",0,NCT04251767,WASHED MICROBIOTA TRANSPLANTATION; PLACEBO,CHINA,Withdrawn,The Second Hospital of Nanjing Medical University,"February 5, 2020",Interventional,"Washed Microbiota Transplantation for Patients With 2019-nCoV Infection: a Randomized, Double-blind, Placebo-controlled Study"
149,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,PNEUMONIA CAUSED BY HUMAN CORONAVIRUS (DISORDER),"February 08, 2021",150,NCT04251871,"CONVENTIONAL MEDICINES (OXYGEN THERAPY, ALFA INTERFERON VIA AEROSOL INHALATION, AND LOPINAVIR/RITONAVIR) AND TRADITIONAL CHINESE MEDICINES (TCMS) GRANULES; CONVENTIONAL MEDICINES (OXYGEN THERAPY, ALFA INTERFERON VIA AEROSOL INHALATION, AND LOPINAVIR/RITONAVIR)",CHINA,Recruiting,Beijing 302 Hospital,"January 22, 2020",Interventional,"Effects of Traditional Chinese Medicines (TCMs) on Patients With COVID-19 Infection: A Perspective, Open-labeled, Randomized, Controlled Trial"
150,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,COVID,"February 08, 2021",20,NCT04252118,MSCS,CHINA,Recruiting,Beijing 302 Hospital,"January 27, 2020",Interventional,Safety and Efficiency of Mesenchymal Stem Cell in Treating Pneumonia Patients Infected With COVID-19
151,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,"PNEUMONIA, PNEUMOCYSTIS; CORONAVIRUS","February 08, 2021",30,NCT04252274,DARUNAVIR AND COBICISTAT,CHINA,Recruiting,Shanghai Public Health Clinical Center,"January 30, 2020",Interventional,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19
152,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,COVID; SARS-CoV2,"February 08, 2021",308,NCT04252664,REMDESIVIR; REMDESIVIR PLACEBO,CHINA,Suspended,Capital Medical University,"February 12, 2020",Interventional,"A Phase 3 Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir in Hospitalized Adult Patients With Mild and Moderate COVID-19."
153,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",2019-NCOV,"February 08, 2021",100,NCT04254874,ABIDOL HYDROCHLORIDE; ABIDOL HYDROCHLORIDE COMBINED WITH INTERFERON ATOMIZATION,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"An Open, Prospective/Retrospective, Randomized Controlled Cohort Study to Compare the Efficacy of Two Therapeutic Schemes(Abidol Hydrochloride,Abidol Hydrochloride Combined With Interferon Atomization)in the Treatment of 2019-nCoV Pneumonia."
154,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",2019-NCOV,"February 08, 2021",400,NCT04255017,ABIDOL HYDROCHLORIDE; OSELTAMIVIR; LOPINAVIR/RITONAVIR,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"An Open, Prospective/Retrospective, Randomized Controlled Cohort Study to Compare the Efficacy of Three Antiviral Drugs(Abidol Hydrochloride, Oseltamivir and Lopinavir/Ritonavir) in the Treatment of 2019-nCoV Pneumonia."
155,2019-nCoV Outbreak and Cardiovascular Diseases,CARDIOVASCULAR DEATH; MAJOR ADVERSE CARDIOVASCULAR EVENTS,"February 08, 2021",12000,NCT04255940,,CHINA,Recruiting,Qilu Hospital of Shandong University,"January 20, 2020",Observational,Impact of a Novel Coronavirus (2019-nCoV) Outbreak on Public Anxiety and Cardiovascular Disease Risk in China
156,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,SUSCEPTIBILITY TO VIRAL AND MYCOBACTERIAL INFECTION,"February 08, 2021",102456,NCT04256395,MOBILE INTERNET SURVEY ON SELF-TEST,CHINA,Completed,Beijing Tsinghua Chang Gung Hospital,"February 1, 2020",Observational,Registry Study on the Efficacy of a Self-test and Self-alert Applet in Detecting Susceptible Infection of COVID-19 --a Population Based Mobile Internet Survey
157,A Trial of Remdesivir in Adults With Severe COVID-19,COVID; REMDESIVIR; SARS-CoV2,"February 08, 2021",237,NCT04257656,REMDESIVIR; REMDESIVIR PLACEBO,CHINA,Terminated,Capital Medical University,"February 6, 2020",Interventional,"A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir in Hospitalized Adult Patients With Severe COVID-19."
158,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,CORONAVIRUS,"February 08, 2021",345,NCT04259892,2019-NCOV PCR,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","February 4, 2020",Observational,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection
159,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,VIRUS; PNEUMONIA,"February 08, 2021",30000,NCT04260308,,CHINA,Recruiting,Huazhong University of Science and Technology,"February 3, 2020",Observational,"A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia in Wuhan, China"
160,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,2019-NCOV,"February 08, 2021",380,NCT04260594,ARBIDOL; BASIC TREATMENT,,Not yet recruiting,Jieming QU,"February 7, 2020",Interventional,"Randomized, Open, Multicenter Study on the Efficacy and Safety of Arbidol Hydrochloride Tablets in Treating Pneumonia in Patients Infected With Novel Coronavirus (2019-ncov)."
161,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",2019-NCOV PNEUMONIA,"February 08, 2021",60,NCT04261270,ASC09F+OSELTAMIVIR; RITONAVIR+OSELTAMIVIR; OSELTAMIVIR,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"A Randomized,Open,Controlled Small Sample Clinical Study to Evaluate the Efficacy and Safety of ASC09/Ritonavir Compound Tablets and Ritonavir for 2019-nCoV Pneumonia"
162,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,2019-NCOV,"February 08, 2021",80,NCT04261426,INTRAVENOUS IMMUNOGLOBULIN; STANDARD CARE,,Not yet recruiting,Peking Union Medical College Hospital,"February 10, 2020",Interventional,"A Randomized, Open-label, Controlled, Single-center Study to Evaluate the Efficacy of Intravenous Immunoglobulin Therapy in Patients With Severe 2019- nCoV Pneumonia"
163,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,"PNEUMONIA, PNEUMOCYSTIS; CORONAVIRUS; COVID","February 08, 2021",30,NCT04261517,HYDROXYCHLOROQUINE,CHINA,Completed,Shanghai Public Health Clinical Center,"February 6, 2020",Interventional,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
164,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,2019-NCOV,"February 08, 2021",160,NCT04261907,ASC09/RITONAVIR GROUP; LOPINAVIR/RITONAVIR GROUP,,Not yet recruiting,First Affiliated Hospital of Zhejiang University,"February 7, 2020",Interventional,"A Randomized, Open-label, Multi-centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Pneumonia Caused by Novel Coronavirus Infection"
165,French COVID Cohort,CORONAVIRUS INFECTION,"February 08, 2021",5000,NCT04262921,,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","February 8, 2020",Observational,Clinical Characterisation Protocol for Severe Emerging Infections
166,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,2019-NCOV SEVERE PNEUMONIA,"February 08, 2021",100,NCT04263402,METHYLPREDNISOLONE; METHYLPREDNISOLONE,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"An Open, Prospective/Retrospective, Randomized Controlled Cohort Study to Compare the Efficacy of Different Hormone Doses in the Treatment of 2019-nCoV Severe Pneumonia"
167,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,"VITAMIN C; PNEUMONIA, VIRAL; PNEUMONIA, VENTILATOR-ASSOCIATED","February 08, 2021",56,NCT04264533,VC; STERILE WATER FOR INJECTION,CHINA,Terminated,ZhiYong Peng,"February 14, 2020",Interventional,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia: a Prospective Randomized Clinical Trial
168,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,2019-NCOV; IMMUNOGLOBULIN OF CURED PATIENTS,"February 08, 2021",10,NCT04264858,IMMUNOGLOBULIN OF CURED PATIENTS; Γ-GLOBULIN,CHINA,Not yet recruiting,"Wuhan Union Hospital, China","March 17, 2020",Interventional,An Exploratory Clinical Study on the Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured 2019-nCoV Pneumonia Patients
169,Immunoregulatory Therapy for 2019-nCoV,"2019 NCOV, PD-1","February 08, 2021",120,NCT04268537,PD-1 BLOCKING ANTIBODY+STANDARD TREATMENT; THYMOSIN+STANDARD TREATMENT; STANDARD TREATMENT,,Not yet recruiting,"Southeast University, China","February 10, 2020",Interventional,Immunoregulatory Therapy for 2019-nCoV-induced Severe Pneumonia Patients
170,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,"PNEUMONIA, VIRAL; PNEUMONIA, VENTILATOR-ASSOCIATED","February 08, 2021",16,NCT04269525,UC-MSCS,CHINA,Recruiting,ZhiYong Peng,"February 6, 2020",Interventional,Clinical Research Regarding the Availability and Safety of UC-MSCs Treatment for Serious Pneumonia and Critical Pneumonia Caused by the 2019-nCOV Infection
171,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,2019-NCOV,"February 08, 2021",500,NCT04270383,,CHINA,Not yet recruiting,Beijing Children's Hospital,"February 15, 2020",Observational,A Multicenter Observational Study About the Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children
172,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,2019-NCOV,"February 08, 2021",0,NCT04272710,,CHINA,Withdrawn,Chongqing Medical University,"January 25, 2020",Observational,Prognostic Characteristics Difference Between the Hypertension Patients With and Without ACEI Treatment When Suffered With 2019-nCoV Infection in China
173,Efficacy and Safety of Corticosteroids in COVID-19,COVID; NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",86,NCT04273321,METHYLPREDNISOLONE,CHINA,Completed,Beijing Chao Yang Hospital,"February 14, 2020",Interventional,Efficacy and Safety of Corticosteroids in COVID-19: A Prospective Randomized Controlled Trails
174,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,COVID THALIDOMIDE,"February 08, 2021",100,NCT04273529,THALIDOMIDE; PLACEBO,,Not yet recruiting,First Affiliated Hospital of Wenzhou Medical University,"February 20, 2020",Interventional,"The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia: a Prospective, Multicenter, Randomized, Double-blind, Placebo, Parallel Controlled Clinical Study"
175,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,COVID THALIDOMIDE,"February 08, 2021",40,NCT04273581,PLACEBO; THALIDOMIDE,,Not yet recruiting,First Affiliated Hospital of Wenzhou Medical University,"February 18, 2020",Interventional,"The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe New Coronavirus (COVID-19) Pneumonia: a Prospective, Multicenter, Randomized, Double-blind, Placebo, Parallel Controlled Clinical Study"
176,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,2019 NOVEL CORONAVIRUS PNEUMONIA; COVID,"February 08, 2021",48,NCT04273646,UC-MSCS; PLACEBO,CHINA,Not yet recruiting,"Wuhan Union Hospital, China","April 20, 2020",Interventional,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19
177,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),NOVEL CORONAVIRUS PNEUMONIA; 2019-NCOV,"February 08, 2021",18,NCT04273763,BROMHEXINE HYDROCHLORIDE TABLETS; ARBIDOL HYDROCHLORIDE GRANULES; RECOMBINANT HUMAN INTERFERON Α2B SPRAY,CHINA,"Active, not recruiting",Second Affiliated Hospital of Wenzhou Medical University,"February 16, 2020",Interventional,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
178,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,CRITICALLY ILL; CORONAVIRUS INFECTION,"February 08, 2021",117,NCT04274322,NUTRITION SUPPORT,CHINA,"Active, not recruiting",Peking University Third Hospital,"February 19, 2020",Observational,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool (COV_NUTRIC)
179,The Application Value of Non-contact Infrared Thermometers in Temperature Screening in the General Population,NON-CONTACT INFRARED THERMOMETER; RAPID SCREENING,"February 08, 2021",572,NCT04274621,,CHINA,Completed,Ningbo No. 1 Hospital,"February 14, 2020",Observational,"The Application Value of Non-contact Infrared Thermometers in Temperature Screening in the General Population: a Real-world, Prospective, Observational Study"
180,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,2019-NCOVS INFECTION PNEUMONIA,"February 08, 2021",20,NCT04275245,MEPLAZUMAB FOR INJECTION,CHINA,Recruiting,Tang-Du Hospital,"February 3, 2020",Interventional,"Single Center, Single Arm, Open Clinical Study to Access Safety and Initial Efficacy of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia"
181,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,2019 NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",426,NCT04275388,"XIYANPING INJECTION; LOPINAVIR / RITONAVIR, ALPHA-INTERFERON NEBULIZATION,ABIDOR HYDROCHLORIDE",,Not yet recruiting,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,"May 15, 2020",Observational,Retrospective Cohort to Evaluate the Effectiveness and Safety of Xiyanping Injection Combined With Conventional Treatment for New Coronavirus Infection Pneumonia (Common Type)
182,Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,CORONAVIRUS INFECTION,"February 08, 2021",27,NCT04275414,BEVACIZUMAB INJECTION,CHINA,Completed,Qilu Hospital of Shandong University,"February 15, 2020",Interventional,Effecacy and Safety of Bevacizumab in Severe Patients With Covid-19: a Pilot Study (BEST-CP)
183,The COVID-19 Mobile Health Study (CMHS),COVID,"February 08, 2021",450,NCT04275947,"NCAPP, A CELL PHONE-BASED AUTO-DIAGNOSIS SYSTEM",CHINA,Recruiting,Chinese Alliance Against Lung Cancer,"February 14, 2020",Observational,"The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp"
184,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",NOVEL CORONAVIRUS INFECTION,"February 08, 2021",127,NCT04276688,LOPINAVIR/RITONAVIR; RIBAVIRIN; INTERFERON BETA-1B,HONG KONG,Completed,The University of Hong Kong,"February 10, 2020",Interventional,"An Open-label Randomized Controlled Trial on Lopinavir/ Ritonavir, Ribavirin and Interferon Beta 1b Combination Versus Lopinavir/ Ritonavir Alone, as Treatment for 2019 Novel Coronavirus Infection"
185,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,PATHOGEN INFECTION COVID INFECTION,"February 08, 2021",100,NCT04276896,INJECTION AND INFUSION OF LV-SMENP-DC VACCINE AND ANTIGEN-SPECIFIC CTLS,CHINA,Recruiting,Shenzhen Geno-Immune Medical Institute,"March 24, 2020",Interventional,Phase I/II Multicenter Trial of Lentiviral Minigene Vaccine (LV-SMENP) of Covid-19 Coronavirus
186,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,CORONAVIRUS,"February 08, 2021",24,NCT04276987,MSCS-DERIVED EXOSOMES,CHINA,Completed,Ruijin Hospital,"February 15, 2020",Interventional,A Pilot Clinical Study on Aerosol Inhalation of the Exosomes Derived From Allogenic Adipose Mesenchymal Stem Cells in the Treatment of Severe Patients With Novel Coronavirus Pneumonia
187,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",CORONAVIRUS INFECTION (COVID); PULMONARY ARTERIAL HYPERTENSION; URINARY TRACT INFECTIONS IN CHILDREN; HYPERTENSION; PAIN; HYPERPHOSPHATEMIA; PRIMARY HYPERALDOSTERONISM; EDEMA; HYPOKALEMIA; HEART FAILURE; HEMOPHILIA; MENORRHAGIA; INSOMNIA; PNEUMONIA; SKIN INFECTION; ARRYTHMIA; ASTHMA IN CHILDREN; BRONCHOPULMONARY DYSPLASIA; ADRENAL INSUFFICIENCY; FIBRINOLYSIS; HEMORRHAGE; ATTENTION DEFICIT HYPERACTIVITY DISORDER; MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C); KAWASAKI DISEASE; COAGULATION DISORDER; DOWN SYNDROME,"February 08, 2021",5000,NCT04278404,"THE POP02 STUDY IS COLLECTING BODILY FLUID SAMPLES (I.E., WHOLE BLOOD, EFFLUENT SAMPLES) OF CHILDREN PRESCRIBED THE FOLLOWING DRUGS OF INTEREST PER STANDARD OF CARE:",CANADA,Recruiting,Duke University,"March 5, 2020",Observational,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs"
188,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,COVID; CHINESE MEDICINE,"February 08, 2021",300,NCT04278963,YINHU QINGWEN DECOCTION; YINHU QINGWEN DECOCTION(LOW DOSE); CHINESE MEDICINE TREATMENT; STANDARD WESTERN MEDICINE TREATMENT,CHINA,Suspended,China Academy of Chinese Medical Sciences,"February 27, 2020",Interventional,"Adaptive, Randomized, Single-blind, Three-arm Parallel Controlled Clinical Trial of Yinhu Qingwen Decoction in the Treatment of Mild / Common CoVID-19"
189,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,PULMONARY FIBROSIS DUE TO COVID,"February 08, 2021",160,NCT04279197,FUZHENG HUAYU TABLET; VITAMIN C TABLETS; PLACEBO; RESPIRATORY FUNCTION REHABILITATION TRAINING,CHINA,Recruiting,ShuGuang Hospital,"April 23, 2020",Interventional,The Efficacy of Treating Pulmonary Fibrosis and Pulmonary Function Injury in COVID-19 With the Fuzheng Huayu Tablets: a Multicenter Randomized Controlled Trial
190,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,CORONAVIRUS,"February 08, 2021",100,NCT04279782,COMPREHENSIVE TREATMENT,CHINA,Recruiting,"Third Affiliated Hospital, Sun Yat-Sen University","January 20, 2020",Observational,Investigation on Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection in Isolation Unit
191,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,CORONAVIRUS,"February 08, 2021",20,NCT04279795,,CHINA,Recruiting,"Third Affiliated Hospital, Sun Yat-Sen University","January 20, 2020",Observational,Study on Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations in Patients
192,The Investigation of the Neonates With or With Risk of COVID-19,NEONATAL INFECTION; PERINATAL PROBLEMS; INFECTIOUS DISEASE,"February 08, 2021",100,NCT04279899,,CHINA,Recruiting,Children's Hospital of Fudan University,"February 1, 2020",Observational,A Multicenter Observational Study of the Perinatal-neonatal Population With or With Risk of COVID-19 in China
193,NK Cells Treatment for COVID-19,NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",30,NCT04280224,NK CELLS,CHINA,Recruiting,Xinxiang medical university,"February 15, 2020",Interventional,Clinical Investigation of Natural Killer Cells Treatment in Pneumonia Patients Infected With 2019 Novel Coronavirus
194,Fingolimod in COVID-19,CORONAVIRUS DISEASE (COVID),"February 08, 2021",0,NCT04280588,FINGOLIMOD 0.5 MG,CHINA,Withdrawn,First Affiliated Hospital of Fujian Medical University,"February 22, 2020",Interventional,Efficacy of Fingolimod in the Treatment of New Coronavirus Pneumonia (COVID-19)
195,Adaptive COVID-19 Treatment Trial (ACTT),COVID,"February 08, 2021",1062,NCT04280705,PLACEBO; REMDESIVIR,DENMARK,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"February 21, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults"
196,Clinical Outcomes of Patients With COVID19,CORONAVIRUS DISEASE 2019,"February 08, 2021",0,NCT04280913,RETROSPECTIVE ANALYSIS,CHINA,Withdrawn,Guangzhou Institute of Respiratory Disease,"February 22, 2020",Observational,Clinical Outcomes of Hospitalized Patients With Coronavirus Disease 2019
197,A New Screening Strategy for 2019 Novel Coronavirus Infection,NOVEL CORONAVIRUS INFECTION PNEUMONIA,"February 08, 2021",230,NCT04281693,STANDARD SCREENING STRATEGY; NEW SCREENING STRATEGY,CHINA,Not yet recruiting,Affiliated Hospital to Academy of Military Medical Sciences,February 2020,Interventional,Identification of a New Screening Strategy for 2019 Novel Coronavirus Infection
198,Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling,INFLUENZA,"February 08, 2021",76,NCT04282135,MCC IMS,GERMANY,Completed,Klinikum Bayreuth GmbH,"February 15, 2020",Observational,Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling
199,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),COVID; COVID IMMUNISATION,"February 08, 2021",120,NCT04283461,MRNA-1273,UNITED STATES,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"March 16, 2020",Interventional,"Phase I, Open-Label, Dose-Ranging Study of the Safety and Immunogenicity of 2019-nCoV Vaccine (mRNA-1273) in Healthy Adults"
200,Humanistic Care in Patients With Coronavirus Disease 2019,CORONAVIRUS DISEASE 2019,"February 08, 2021",0,NCT04283825,PSYCHOLOGICAL AND PHYSICAL REHABILITATION BASED HUMANISTIC CARE,,Withdrawn,Second Affiliated Hospital of Xi'an Jiaotong University,"February 22, 2020",Interventional,The Therapeutic Efficacy of Psychological and Physical Rehabilitation Based Humanistic Care in Patients With Coronavirus Disease 2019
201,Humanistic Care in Healthcare Workers in Coronavirus Disease 2019,CORONAVIRUS DISEASE 2019,"February 08, 2021",0,NCT04283838,HUMANISTIC CARE,,Withdrawn,Second Affiliated Hospital of Xi'an Jiaotong University,"February 22, 2020",Interventional,The Effect of Humanistic Care in Healthcare Workers Participated in the Treatment of Coronavirus Disease 2019
202,CT Scores Predict Mortality in 2019-nCoV Pneumonia,CT SCORES PREDICT MORTALITY IN 2019-NCOV PNEUMONIA,"February 08, 2021",39,NCT04284046,CT SCORE,CHINA,Completed,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","January 31, 2020",Observational,CT Scores Predict Mortality in 2019-nCoV Pneumonia
203,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,CORONAVIRUS DISEASE 2019; NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",0,NCT04285190,T89,,Withdrawn,"Tasly Pharmaceuticals, Inc.","February 26, 2020",Interventional,A Clinical Study to Investigate the Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With Coronavirus Disease 2019 (COVID-19)
204,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,COVID,"February 08, 2021",8,NCT04285801,,HONG KONG,Completed,Chinese University of Hong Kong,"February 14, 2020",Observational,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study
205,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,NOVEL CORONAVIRUS INFECTIOUS DISEASE (COVID),"February 08, 2021",520,NCT04286503,CARRIMYCIN; LOPINAVIR/RITONAVIR TABLETS OR ARBIDOL OR CHLOROQUINE PHOSPHATE; BASIC TREATMENT,,Not yet recruiting,Beijing YouAn Hospital,"February 23, 2020",Interventional,"The Efficacy and Safety of Carrimycin Treatment in Patients With Novel Coronavirus Infectious Disease (COVID-19) : A Multicenter, Randomized, Open-controlled Study"
206,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,COVID,"February 08, 2021",0,NCT04287686,RECOMBINANT HUMAN ANGIOTENSIN-CONVERTING ENZYME 2 (RHACE2),CHINA,Withdrawn,The First Affiliated Hospital of Guangzhou Medical University,February 2020,Interventional,"A Randomized, Open Label, Controlled Clinical Study to Evaluate the Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) in Adult Patients With COVID-19"
207,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),CORONA VIRUS DISEASE 2019(COVID),"February 08, 2021",100,NCT04288102,UC-MSCS; SALINE CONTAINING 1% HUMAN SERUM ALBUMIN（SOLUTION WITHOUT UC-MSCS）,CHINA,Completed,Beijing 302 Hospital,"March 5, 2020",Interventional,"A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients"
208,Eculizumab (Soliris) in Covid-19 Infected Patients,CORONAVIRUS,"February 08, 2021",,NCT04288713,ECULIZUMAB,,Available,Hudson Medical,,Expanded Access,Soliris to Stop Immune Mediated Death In Covid 19 Infected Patients. A Trial of Distal Complement Inhibition.
209,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,INFECTION VIRAL,"February 08, 2021",300,NCT04290780,NOSOCOMIAL INFECTION/HOSPITAL ACQUIRED INFECTION,FRANCE,Recruiting,Hospices Civils de Lyon,"March 9, 2020",Observational,Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
210,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,"CORONAVIRUS INFECTION; PNEUMONIA, VIRAL; DYSPNEA","February 08, 2021",0,NCT04290858,NITRIC OXIDE,,Withdrawn,Xijing Hospital,"March 1, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy in Spontaneous Breathing Patients With Mild/Moderate COVID19 Infection: a Randomized Clinical Trial
211,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,CORONAVIRUS; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",0,NCT04290871,NITRIC OXIDE GAS,,Withdrawn,Xijing Hospital,"March 23, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy for Severe Acute Respiratory Syndrome Due to COVID-19.
212,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,COVID,"February 08, 2021",550,NCT04291053,HUAIER GRANULE,,Not yet recruiting,Tongji Hospital,"April 1, 2020",Interventional,"The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19: a Prospective, Multicenter, Randomized, Parallel Controlled Clinical Study"
213,Quality of Life and Addiction Among Hospital Night Workers,HEALTH SERVICES RESEARCH; QUALITY OF LIFE; ADDICTION; SUBSTANCE-RELATED DISORDERS; HEALTH PERSONNEL,"February 08, 2021",1800,NCT04291534,,FRANCE,Recruiting,University Paris 7 - Denis Diderot,"June 15, 2020",Observational,Quality of Life and Addiction Among Hospital Night Workers - Descriptive Study of APHP Workers in Paris
214,Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism,SELECTIVE MUTISM,"February 08, 2021",11,NCT04291638,REMOTE CAREGIVER TRAINING; REMOTE INTENSIVE GROUP BEHAVIORAL TREATMENT (IGBT),UNITED STATES,Completed,Florida International University,"March 6, 2020",Interventional,Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism
215,Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,COVID,"February 08, 2021",11,NCT04291729,GANOVO+RITONAVIR+/-INTERFERON NEBULIZATION,CHINA,Completed,The Ninth Hospital of Nanchang,"February 17, 2020",Interventional,An Open Clinical Trial to Evaluate Ganovo（Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
216,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,PNEUMONIA CAUSED BY HUMAN CORONAVIRUS,"February 08, 2021",400,NCT04292327,,CHINA,"Active, not recruiting",Fujian Provincial Hospital,"January 1, 2020",Observational,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus(2019-nCoV)
217,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,CORONAVIRUS,"February 08, 2021",15,NCT04292340,,CHINA,Recruiting,Shanghai Public Health Clinical Center,"February 1, 2020",Observational,The Efficacy and Safety of Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of Novel Coronavirus Pneumonia Patient (COVID-19) : An Observational Study
218,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,COVID,"February 08, 2021",1113,NCT04292730,REMDESIVIR; STANDARD OF CARE,CHINA,Completed,Gilead Sciences,"March 15, 2020",Interventional,A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate COVID-19 Compared to Standard of Care Treatment
219,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19),COVID,"February 08, 2021",4891,NCT04292899,REMDESIVIR; STANDARD OF CARE,CHINA,Completed,Gilead Sciences,"March 6, 2020",Interventional,A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe COVID-19
220,Prognostic Factors of Patients With COVID-19,"SARS-CoV2; OUTCOME, FATAL","February 08, 2021",201,NCT04292964,,CHINA,Completed,Chongqing Medical University,"March 1, 2020",Observational,Prognostic Factors of Patients With COVID-19
221,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,COVID,"February 08, 2021",0,NCT04293692,UC-MSCS; PLACEBO,CHINA,Withdrawn,Puren Hospital Affiliated to Wuhan University of Science and Technology,"February 24, 2020",Interventional,Human Umbilical Cord Mesenchymal Stem Cells Treatment for Pneumonia Patients Infected by 2019 Novel Coronavirus
222,Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients,COVID; RECOMBINANT HUMAN INTERFERON Α1Β,"February 08, 2021",328,NCT04293887,RECOMBINANT HUMAN INTERFERON Α1Β,,Not yet recruiting,Tongji Hospital,"March 1, 2020",Interventional,"Randomized, Open, Blank Control Study on the Efficacy and Safety of Recombinant Human Interferon α1β in the Treatment of Patients With New Type of Coronavirus Infection in Wuhan"
223,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),COVID,"February 08, 2021",80,NCT04295551,LOPINAVIR / RITONAVIR TABLETS COMBINED WITH XIYANPING INJECTION; LOPINAVIR/RITONAVIR TREATMENT,,Not yet recruiting,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,"March 14, 2020",Interventional,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
224,Medical Masks vs N95 Respirators for COVID-19,CORONAVIRUS; N95; MEDICAL MASK,"February 08, 2021",576,NCT04296643,MEDICAL MASK; N95 RESPIRATOR,CANADA,Recruiting,McMaster University,"April 1, 2020",Interventional,Medical Masks Versus N95 Respirators to Prevent 2019 Novel Coronavirus Disease (COVID-19) in Healthcare Workers: A Randomized Trial
225,Urinary Incontinence and Sedentary Behaviour in Nursing Homes,URINARY INCONTINENCE IN OLD AGE; SEDENTARY BEHAVIOR,"February 08, 2021",458,NCT04297904,SEDENTARY BEHAVIOUR; URINARY INCONTINENCE,SPAIN,Recruiting,University of Vic - Central University of Catalonia,"February 20, 2020",Observational,"Associations Between Urinary Incontinence, Sedentary Behaviour and Other Health-related Outcomes in Nursing Homes in Catalonia: the OsoNaH Project"
226,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),INFLUENZA INFECTION; SAD-RV INFECTION AND COVID,"February 08, 2021",280,NCT04298060,DAS181; PLACEBO,CHINA,Not yet recruiting,"Ansun Biopharma, Inc.",July 2020,Interventional,A Phase IIb Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Severe Influenza Infection
227,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,COVID; ENDOTRACHEAL INTUBATION,"February 08, 2021",0,NCT04298814,SEVERE COVID-19 PNEUMONIA WITH ET,CHINA,Withdrawn,Tongji Hospital,"August 7, 2020",Observational,Analysis of Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia
228,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA,"February 08, 2021",20,NCT04299152,STEM CELL EDUCATOR-TREATED MONONUCLEAR CELLS APHERESIS,,Not yet recruiting,Tianhe Stem Cell Biotechnologies Inc.,"November 10, 2020",Interventional,Clinical Application of Stem Cell Educator Therapy for the Treatment of Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
229,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,MENTAL DISORDER,"February 08, 2021",3428,NCT04299711,EXPOSED TO THE NOVEL CORONAVIRUS DISEASE 2019,,Not yet recruiting,University of Macau,"October 15, 2020",Observational,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019: A Longitudinal Study Protocol
230,Safety and Immunity of Covid-19 aAPC Vaccine,TREAT AND PREVENT COVID INFECTION,"February 08, 2021",100,NCT04299724,PATHOGEN-SPECIFIC AAPC,CHINA,Recruiting,Shenzhen Geno-Immune Medical Institute,"February 15, 2020",Interventional,Safety and Immunity Evaluation of A Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine
231,Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs,PRETERM LABOR; PRETERM BIRTH,"February 08, 2021",6500,NCT04301518,MULTIMODAL INTERVENTION STRATEGY,UNITED STATES,Recruiting,"Sera Prognostics, Inc.","November 6, 2020",Interventional,Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
232,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,COVID,"February 08, 2021",24,NCT04302519,DENTAL PULP MESENCHYMAL STEM CELLS,,Not yet recruiting,"CAR-T (Shanghai) Biotechnology Co., Ltd.","March 5, 2020",Interventional,Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
233,Accurate Classification System for Patients With COVID-19 Pneumonitis,PNEUMONITIS,"February 08, 2021",669,NCT04302688,,CHINA,Completed,Renmin Hospital of Wuhan University,"December 10, 2019",Observational,Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram
234,Expanded Access Remdesivir (RDV; GS-5734™),CORONAVIRUS DISEASE 2019,"February 08, 2021",,NCT04302766,REMDESIVIR,,Available,U.S. Army Medical Research and Development Command,,Expanded Access,Intermediate-Size Patient Population Expanded Access Treatment Protocol for Coronavirus Disease 2019 (COVID-19) Remdesivir (RDV; GS-5734™)
235,Vitamin D Intervention in Infants - 6 Years Follow-up (VIDI2),BONE STRENGTH; GROWTH; BODY COMPOSITION; INFECTION; ALLERGIC DISEASES; DENTAL HEALTH,"February 08, 2021",832,NCT04302987,,FINLAND,Recruiting,University of Helsinki,"November 1, 2019",Observational,VITAMIN D INTERVENTION IN INFANTS: Effects of Early Vitamin D Exposure on Childhood Health at 6 Years - a Follow-up Study
236,"Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19",SARS-CoV2 INFECTIONS; COVID,"February 08, 2021",320,NCT04303299,ORAL,THAILAND,Recruiting,Rajavithi Hospital,"August 19, 2020",Interventional,"A 6 Week Prospective, Open Label, Randomized, in Multicenter Study of, Oseltamivir Plus Hydroxychloroquine Versus Lopipinavir/ Ritonavir Plus Oseltamivir Versus Darunavir/ Ritonavir Plus Oseltamivir Plus Hydroxychloroquine in Mild COVID-19 AND Lopipinavir/ Ritonavir Plus Oseltamivir Versus Favipiravir Plus Lopipinavir / Ritonavir Versus Darunavir/ Ritonavir Plus Oseltamivir Plus Hydroxychloroquine Versus Favipiravir Plus Darunavir and Ritonavir Plus Hydroxychloroquine in Moderate to Critically Ill COVID-19"
237,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,COVID; CORONAVIRUS; ACUTE RESPIRATORY ILLNESSES,"February 08, 2021",40000,NCT04303507,CHLOROQUINE OR HYDROXYCHLOROQUINE; PLACEBO,INDONESIA,Recruiting,University of Oxford,"April 29, 2020",Interventional,"Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting; a Randomised, Placebo-controlled Prophylaxis Study (COPCOV)"
238,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,COVID,"February 08, 2021",2300,NCT04304053,TREATMENT AND PROPHYLAXIS; STANDARD PUBLIC HEALTH MEASURES,SPAIN,Completed,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","March 18, 2020",Interventional,Treatment of Non-severe Confirmed Cases of COVID-19 and Chemoprophylaxis of Their Contacts as Prevention Strategy: a Cluster Randomized Clinical Trial (PEP CoV-2 Study)
239,A Pilot Study of Sildenafil in COVID-19,COVID,"February 08, 2021",10,NCT04304313,SILDENAFIL CITRATE TABLETS,CHINA,Recruiting,Tongji Hospital,"February 9, 2020",Interventional,A Pilot Study of Sildenafi in the Treatment of COVID-19
240,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",SARS-CoV2,"February 08, 2021",1000,NCT04304690,BLOOD SAMPLE,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 16, 2020",Interventional,"COVID-19 Seroconversion Among Medical and Paramedical Staff in Emergency, ICU and Infectious Disease Services During the 2020 Epidemic"
241,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,COVID PNEUMONIA,"February 08, 2021",140,NCT04305106,BEVACIZUMAB,CHINA,Recruiting,Qilu Hospital of Shandong University,"March 17, 2020",Interventional,The Efficacy and Safety of Bevacizumab in Severe or Critical Patients With COVID-19--a Multicenter Randomized Controlled Clinical Trial
242,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,"CORONAVIRUS INFECTION; PNEUMONIA, VIRAL; ACUTE RESPIRATORY DISTRESS SYNDROME","February 08, 2021",70,NCT04305457,NITRIC OXIDE,UNITED STATES,"Active, not recruiting",Massachusetts General Hospital,"March 21, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy in Spontaneous Breathing Patients With Mild/Moderate COVID-19: a Randomized Clinical Trial
243,Social Media Use During COVID-19,CORONAVIRUS; DEPRESSION; ANXIETY; STRESS,"February 08, 2021",1145,NCT04305574,USE OF SOCIAL MEDIA DURING COVID-19,SINGAPORE,Completed,Jean Liu,"March 7, 2020",Observational,Getting it Right: Towards Responsible Social Media Use During a Pandemic
244,Blood Donor Recruitment During Epidemic of COVID-19,BLOOD DONATION,"February 08, 2021",19491,NCT04306055,QUESTIONNAIRE WITH PRECAUTION INFORMATION; EXPERIMENTAL: QUESTIONNAIRE WITHOUT PRECAUTION INFORMATION,CHINA,Completed,Guangzhou Blood Center,"March 13, 2020",Interventional,"Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China"
245,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,SARS (SEVERE ACUTE RESPIRATORY SYNDROME); CORONAVIRUS,"February 08, 2021",200,NCT04306393,NITRIC OXIDE GAS,UNITED STATES,Recruiting,Massachusetts General Hospital,"March 21, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy for Mechanically Ventilated Patients With Severe Acute Respiratory Syndrome Caused by SARS-CoV2: a Randomized Clinical Trial.
246,TCM Differentiation and Treatment Protocol of COVID-19,COVID,"February 08, 2021",340,NCT04306497,TCM PRESCRIPTIONS,CHINA,Completed,"Jiangsu Famous Medical Technology Co., Ltd.","January 22, 2020",Observational,Clinical Trial of TCM Differentiation and Treatment Protocol of COVID-19 in Jiangsu Province
247,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,COVID; SARS; CYTOKINE STORM; CYTOKINE RELEASE SYNDROME; TOCILIZUMAB,"February 08, 2021",120,NCT04306705,TOCILIZUMAB; STANDARD OF CARE; CONTINUOUS RENAL REPLACEMENT THERAPY,CHINA,Recruiting,Tongji Hospital,"February 20, 2020",Observational,A Retrospective Study of Evaluating Safety and Efficacy of Tocilizumab Compared to Continuous Renal Replacement Therapy in Controlling CRS Triggered by COVID-19
248,Acute Respiratory Failure and COVID-19 in Real Life,CORONAVIRUS INFECTION; RESPIRATORY FAILURE; VENTILATOR LUNG,"February 08, 2021",50,NCT04307459,STANDARD OPERATING PROCEDURES,ITALY,Recruiting,University of Milan,"March 19, 2020",Observational,Acute Respiratory Failure and Continuous Positive Airway Pressure Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: a Real Life Evaluation
249,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),COVID,"February 08, 2021",65,NCT04307693,LOPINAVIR/RITONAVIR; HYDROXYCHLOROQUINE SULFATE,"KOREA, REPUBLIC OF",Terminated,Asan Medical Center,"March 11, 2020",Interventional,Randomized Controlled Clinical Trials of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
250,Influence of the COvid-19 Epidemic on STRESS,"STRESS, PSYCHOLOGICAL","February 08, 2021",50000,NCT04308187,,FRANCE,Not yet recruiting,"University Hospital, Clermont-Ferrand","March 11, 2020",Observational [Patient Registry],The COVISTRESS Study: Influence of the COvid-19 Epidemic on STRESS
251,Tetrandrine Tablets Used in the Treatment of COVID-19,"CORONA VIRUS DISEASE 2019,COVID","February 08, 2021",60,NCT04308317,TETRANDRINE,CHINA,Enrolling by invitation,Henan Provincial People's Hospital,"March 5, 2020",Interventional,Clinical Study of Tetrandrine Tablets Adjuvant Treatment With COVID-19
252,Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,CORONAVIRUS INFECTION; ACUTE RESPIRATORY DISTRESS SYNDROME; SARS-COV INFECTION; CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",1309,NCT04308668,HYDROXYCHLOROQUINE; PLACEBO,CANADA,Completed,University of Minnesota,"March 17, 2020",Interventional,Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial
253,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,COVID,"February 08, 2021",150,NCT04310228,FAVIPIRAVIR COMBINED WITH TOCILIZUMAB; FAVIPIRAVIR; TOCILIZUMAB,CHINA,Recruiting,Peking University First Hospital,"March 8, 2020",Interventional,"Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019-A Multicenter, Randomized and Controlled Clinical Trial Study"
254,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,COVID; SEVERE PNEUMONIA; CHINESE MEDICINE,"February 08, 2021",116,NCT04310865,YINHU QINGWEN GRANULA; YIN HU QING WEN GRANULA(LOW DOES); STANDARD MEDICAL TREATMENT,CHINA,Suspended,Zhong Wang,November 2020,Interventional,"An Adaptive, Randomized, Double-blind, Parallel-controlled Clinical Trial of Yinhu Qingwen Granula for the Treatment of Severe CoVID-19"
255,Losartan for Patients With COVID-19 Not Requiring Hospitalization,CORONAVIRUS INFECTION; ACUTE RESPIRATORY DISTRESS SYNDROME; SARS-COV INFECTION,"February 08, 2021",580,NCT04311177,LOSARTAN; PLACEBO,UNITED STATES,"Active, not recruiting",University of Minnesota,"April 9, 2020",Interventional,Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization
256,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,COVID,"February 08, 2021",100,NCT04311398,NEW QIASTAT-DX FULLY AUTOMATIC MULTIPLE PCR DETECTION PLATFORM,CHINA,Not yet recruiting,Huashan Hospital,"May 13, 2020",Observational,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System
257,Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,CRITICAL COVID WITH RESPIRATORY FAILURE; ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS); CORONAVIRUS INFECTION; ACUTE LUNG INJURY,"February 08, 2021",196,NCT04311697,AVIPTADIL BY INTRAVENOUS INFUSION + STANDARD OF CARE; NORMAL SALINE INFUSION + STANDARD OF CARE,UNITED STATES,"Active, not recruiting","NeuroRx, Inc.","May 15, 2020",Interventional,ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory Failure
258,Losartan for Patients With COVID-19 Requiring Hospitalization,CORONAVIRUS INFECTION; ACUTE RESPIRATORY DISTRESS SYNDROME; SARS-COV INFECTION,"February 08, 2021",200,NCT04312009,LOSARTAN; PLACEBO,UNITED STATES,Recruiting,University of Minnesota,"April 13, 2020",Interventional,Randomized Controlled Trial of Losartan for Patients With COVID-19 Requiring Hospitalization
259,Sequential Oxygen Therapy Strategy for Patients With COVID-19,CORONAVIRUS DISEASE-2019,"February 08, 2021",30,NCT04312100,OXYGEN TREATMENT,CHINA,Recruiting,Henan Provincial People's Hospital,"February 1, 2020",Observational,Sequential Oxygen Therapy Strategy for Patients With COVID-19
260,NO Prevention of COVID-19 for Healthcare Providers,CORONAVIRUS INFECTION; HEALTHCARE ASSOCIATED INFECTION,"February 08, 2021",470,NCT04312243,INHALED NITRIC OXIDE GAS,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 7, 2020",Interventional,Nitric Oxide Gas Inhalation for Prevention of COVID-19 in Healthcare Providers
261,Myocardial Damage in COVID-19,COVID; CARDIOVASCULAR DISEASES,"February 08, 2021",500,NCT04312464,NON,CHINA,Enrolling by invitation,"Wuhan Union Hospital, China","January 1, 2020",Observational,Retrospective Study of Myocardial Damage in COVID-19
262,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,COVID,"February 08, 2021",100,NCT04312997,PUL-042 INHALATION SOLUTION; PLACEBO,UNITED STATES,Recruiting,"Pulmotect, Inc.","June 16, 2020",Interventional,A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
263,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,COVID,"February 08, 2021",200,NCT04313023,PUL-042 INHALATION SOLUTION; PLACEBO,UNITED STATES,Recruiting,"Pulmotect, Inc.","June 9, 2020",Interventional,A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
264,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,COVID,"February 08, 2021",108,NCT04313127,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR),CHINA,"Active, not recruiting",CanSino Biologics Inc.,"March 16, 2020",Interventional,"A Single-center,Open-label，Dose-escalating Phase I Clinical Trial to Evaluate Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Healthy Adults Aged 18-60 Years Old"
265,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,USE OF STEM CELLS FOR COVID TREATMENT,"February 08, 2021",5,NCT04313322,WJ-MSCS,JORDAN,Recruiting,Stem Cells Arabia,"March 16, 2020",Interventional,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells
266,Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,"COVID; PNEUMONIA, VIRAL; INFLUENZA WITH PNEUMONIA; FLU SYMPTOM; FLU LIKE ILLNESS; PNEUMONIA, INTERSTITIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PNEUMONIA ATYPICAL","February 08, 2021",200,NCT04313946,SCANNING CHEST X-RAYS AND PERFORMING AI ALGORITHMS ON IMAGES,ITALY,Recruiting,Professor Adrian Covic,"March 18, 2020",Observational,The Benefits of Artificial Intelligence Algorithms (CNNs) for Discriminating Between COVID-19 and Influenza Pneumonitis in an Emergency Department Using Chest X-Ray Examinations
267,Mechanisms for Covid-19 Disease Complications,COVID; CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04314232,,NORWAY,Recruiting,"University Hospital, Akershus","March 18, 2020",Observational,"Changes in Organ Specific Biomarkers, Virus Expression and Prognosis of Covid-19"
268,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,"CORONAVIRUS; IATROGENIC DISEASE; ACUTE KIDNEY INJURY; ARDS, HUMAN","February 08, 2021",1000,NCT04314817,ANY DRUG USED TO TREAT COVID-19,FRANCE,Recruiting,Groupe Hospitalier Pitie-Salpetriere,"March 17, 2020",Observational,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019
269,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,COVID,"February 08, 2021",1912,NCT04315298,SARILUMAB; PLACEBO,UNITED STATES,Completed,Regeneron Pharmaceuticals,"March 18, 2020",Interventional,"An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19"
270,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,SARS PNEUMONIA,"February 08, 2021",38,NCT04315480,TOCILIZUMAB,ITALY,"Active, not recruiting",Università Politecnica delle Marche,"March 12, 2020",Interventional,Tocilizumab (RoActemra) as Early Treatment of Patients Affected by SARS-CoV2 (COVID-19) Infection With Severe Multifocal Interstitial Pneumonia
271,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,INFECTION VIRAL,"February 08, 2021",20,NCT04315870,PREGNANT WOMEN WITH LABORATORY-CONFIRMED 2019-N-COV,ITALY,Recruiting,Federico II University,"January 1, 2020",Observational [Patient Registry],Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy
272,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),COVID; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",500,NCT04315896,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,MEXICO,"Active, not recruiting","National Institute of Respiratory Diseases, Mexico","April 14, 2020",Interventional,Hydroxychloroquine Treatment for Severe COVID-19 Respiratory Disease: Randomised Clinical Trial (HYDRA Trial)
273,Trial of Treatments for COVID-19 in Hospitalized Adults,CORONAVIRUS INFECTION,"February 08, 2021",3100,NCT04315948,REMDESIVIR; LOPINAVIR/RITONAVIR; INTERFERON BETA-1A; HYDROXYCHLOROQUINE; STANDARD OF CARE,AUSTRIA,"Active, not recruiting","Institut National de la Santé Et de la Recherche Médicale, France","March 22, 2020",Interventional,"Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults"
274,NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",90,NCT04315987,NESTACELL®; PLACEBO,BRAZIL,Not yet recruiting,Azidus Brasil,June 2020,Interventional,Exploratory Clinical Study to Assess the Efficacy of NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia
275,Acute Kidney Injury in Patients Hospitalized With COVID-19,COVID; ACUTE KIDNEY INJURY; KIDNEY FUNCTION,"February 08, 2021",287,NCT04316299,,CHINA,Completed,Zhenhua Zen,"February 26, 2020",Observational,"Acute Kidney Injury in Patients Hospitalized With COVID-19 in Wuhan, China: a Single-center Retrospective Observational Study"
276,Norwegian Coronavirus Disease 2019 Study,CORONAVIRUS INFECTION,"February 08, 2021",53,NCT04316377,HYDROXYCHLOROQUINE SULFATE,NORWAY,"Active, not recruiting","University Hospital, Akershus","March 25, 2020",Interventional,Norwegian Coronavirus Disease 2019 Study: An Open Labeled Randomized Controlled Pragmatic Trial to Evaluate the Antiviral Effect of Chloroquine in Adult Patients With SARS-CoV-2 Infection
277,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04316728,VIVADIAG™ COVID-19 LGM/IGG RAPID TEST,ITALY,Not yet recruiting,"Centro Studi Internazionali, Italy",March 2020,Interventional,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in a Cohort of Negative Patients for Coronavirus Infection for the Early Detection of Positive Antibodies for COVID-19
278,Mechanisms for Organ Dysfunction in Covid-19,"COVID; ORGAN DYSFUNCTION SYNDROME SEPSIS; ORGAN DYSFUNCTION SYNDROME, MULTIPLE; SEPTIC SHOCK; ACUTE KIDNEY INJURY; ACUTE RESPIRATORY DISTRESS SYNDROME","February 08, 2021",100,NCT04316884,,SWEDEN,Recruiting,Uppsala University,"March 12, 2020",Observational,Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19
279,Predictors of Respiratory Failure in SARS-Cov-2 Infection,SARS-CoV2 PNEUMONIA,"February 08, 2021",350,NCT04316949,,ITALY,Recruiting,University of Bologna,"March 20, 2020",Observational,Predictors of Respiratory Failure Requiring ICU Admission Among Hospitalized Patients With SARS-Cov-2 Infection
280,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,COVID,"February 08, 2021",243,NCT04317040,CD24FC; PLACEBO,UNITED STATES,"Active, not recruiting","OncoImmune, Inc.","April 8, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Multi-site, Phase III Study to Evaluate the Safety and Efficacy of CD24Fc in COVID-19 Treatment"
281,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),COVID PNEUMONIA,"February 08, 2021",400,NCT04317092,TOCILIZUMAB INJECTION,ITALY,"Active, not recruiting","National Cancer Institute, Naples","March 19, 2020",Interventional,Multicenter Study on the Efficacy and Tolerability of Tocilizumab in the Treatment of Patients With COVID-19 Pneumonia
282,Counseling of Pregnant Women During Corona,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",200,NCT04317365,WOMEN RECEIVING EXTRA REMEMBERING BY HEALTHCARE,EGYPT,Completed,Aljazeera Hospital,"March 24, 2020",Interventional,Effect of Counseling Between Pregnant Women During Corona Infection
283,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),COVID; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",400,NCT04318015,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,MEXICO,Recruiting,"National Institute of Respiratory Diseases, Mexico","April 14, 2020",Interventional,Chemoprophylaxis With Hydroxychloroquine in Healthcare Personnel in Contact With COVID-19 Patients: A Randomized Controlled Trial (PHYDRA Trial)
284,Hypertension in Patients Hospitalized With COVID-19,COVID; HYPERTENSION,"February 08, 2021",275,NCT04318301,,CHINA,Completed,Zhenhua Zen,"March 21, 2020",Observational,"Hypertension in Patients Hospitalized With COVID-19 in Wuhan, China: A Single-center Retrospective Observational Study"
285,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,HEALTH CARE WORKER PATIENT TRANSMISSION; CORONAVIRUS; CORONAVIRUS INFECTION; IMMUNOLOGICAL ABNORMALITY,"February 08, 2021",400,NCT04318314,COPAN SWABBING AND BLOOD SAMPLE COLLECTION,UNITED KINGDOM,Recruiting,"University College, London","March 18, 2020",Observational [Patient Registry],COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
286,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04318366,OBSERVATIONAL STUDY,ITALY,Recruiting,Università Vita-Salute San Raffaele,"March 19, 2020",Observational,"Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response"
287,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",COVID,"February 08, 2021",3400,NCT04318418,,ITALY,Completed,Neuromed IRCCS,"March 23, 2020",Observational,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19"
288,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,COVID,"February 08, 2021",605,NCT04318431,DATA COLLECTION AND RHINOPHARYNGEAL SWAB,FRANCE,Completed,Centre Hospitalier Intercommunal Creteil,"April 14, 2020",Interventional,"Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children, a Cross-sectional, Prospective, Multicentre, Observational Study in Primary Care."
289,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),COVID; CORONAVIRUS INFECTION,"February 08, 2021",1600,NCT04318444,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,UNITED STATES,Recruiting,Columbia University,"March 29, 2020",Interventional,Hydroxychloroquine Post Exposure Prophylaxis (PEP) for Household Contacts of COVID-19 Patients: A NYC Community-Based Randomized Clinical Trial
290,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,INFECTION VIRAL,"February 08, 2021",200,NCT04319016,PREGNANT WOMEN WITH LABORATORY-CONFIRMED 2019-N-COV,ITALY,Recruiting,Federico II University,"January 1, 2020",Observational [Patient Registry],Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy
291,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,"TRANSPLANT RECIPIENT; INFECTIONS, CORONAVIRUS","February 08, 2021",50,NCT04319172,,SPAIN,Recruiting,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,"March 12, 2020",Observational,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients
292,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",HEALTHY PEOPLE,"February 08, 2021",200,NCT04319211,"DETERMINATION OF PHYSICAL ACTIVITY, QUALITY OF LIFE, STRESS LEVELS OF ISOLATED PEOPLE AT HOME WITH THE DANGER OF CORONAVIRUS.",TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,"March 25, 2020",Observational,"Investigation of Physical Activity, Quality of Life and Stress Levels of Individuals Who Live in Their Homes Isolated Because of Coronavirus (COVID-19) Disease"
293,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,COVID,"February 08, 2021",400,NCT04319315,SURVEY,EGYPT,Recruiting,Assiut University,"March 11, 2020",Observational,Impact of Social Media on Knowledge Dissemination Between Physicians During COVID-19 Virus Outbreak
294,Mindfulness During COVID-19,MIGRAINE DISORDERS; STRESS; ANXIETY,"February 08, 2021",233,NCT04319445,MINDFULNESS SESSION(S),UNITED STATES,"Active, not recruiting",Wake Forest University Health Sciences,"March 22, 2020",Interventional,Mindfulness During COVID-19 - Remote Mindfulness Sessions
295,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,SARS COV-2 INFECTION,"February 08, 2021",10,NCT04319731,HUMAN AMNIOTIC FLUID,UNITED STATES,Recruiting,University of Utah,"March 20, 2020",Interventional,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure
296,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,COVID; MYOCARDIAL INJURY; MYOCARDITIS,"February 08, 2021",500,NCT04320017,"ELECTROCARDIOGRAM, TRANSTHORACIC ECHOCARDIOGRAPHY AND CLINICO-BIOLOGICAL PARAMETERS IN ROUTINE CARE",FRANCE,Recruiting,Groupe Hospitalier Pitie-Salpetriere,"March 20, 2020",Observational,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19
297,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),CORONAVIRUS; PNEUMONIA; OXYGEN TOXICITY,"February 08, 2021",216,NCT04320056,STANDARD ADMINISTRATION OF OXYGEN FLOW; AUTOMATED OXYGEN ADMINISTRATION - FREEO2,CANADA,Recruiting,Laval University,"April 20, 2020",Interventional,Automated Oxygen Titration - Monitoring and Weaning in Patients With Infectious Pneumonia Requiring Oxygen - Impact on the Number of Interventions for Healthcare Workers. An Innovative Device to Manage Patients With COVID-19 Pneumonia COVID Study (Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decreaseduring Pneumonia)
298,Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff,2019 NOVEL CORONAVIRUS INFECTION,"February 08, 2021",2944,NCT04320238,RECOMBINANT HUMAN INTERFERON ALPHA-1B; THYMOSIN ALPHA 1,CHINA,Recruiting,Shanghai Jiao Tong University School of Medicine,"January 21, 2020",Interventional,An Clinic Trial of Recombinant Human Interferon Alpha Nasal Drops to Prevent Coronavirus Disease 2019 in Medical Staff in Epidemic Area
299,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",PHARMACOLOGICAL ACTION,"February 08, 2021",200,NCT04320277,BARICITINIB,ITALY,Not yet recruiting,Hospital of Prato,"May 16, 2020",Interventional,"Baricitinib Combined With Antiviral Therapy in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study"
300,Acute Encephalopathy in Critically Ill Patients With COVID-19,COVID; ENCEPHALOPATHY; CRITICALLY ILL,"February 08, 2021",250,NCT04320472,FOLLOW UP,BRAZIL,"Active, not recruiting",Ictal Group,"March 23, 2020",Observational [Patient Registry],Outcomes in Patients With Acute Encephalopathy and SARS-Cov-2 Infection
301,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,SARS-CoV2; SEVERE ACUTE RESPIRATORY SYNDROME; COVID,"February 08, 2021",25,NCT04320511,CT-V,UNITED STATES,Recruiting,William Beaumont Hospitals,"June 24, 2020",Observational,"COVID CT, Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2"
302,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",450,NCT04320615,TOCILIZUMAB (TCZ); PLACEBO,CANADA,Completed,Hoffmann-La Roche,"April 3, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia"
303,Risk Factors for Community- and Workplace Transmission of COVID-19,CORONAVIRUS,"February 08, 2021",250000,NCT04320732,OBSERVATION OF BEHAVIOR AND COVID-19 INFECTION WILL BE CONDUCTED.,NORWAY,Recruiting,Oslo University Hospital,"March 27, 2020",Observational,Risk Factors for Community- and Workplace Transmission of COVID-19
304,COVID-19 Pandemic Response Network,COVID; SARS-CoV2; CORONAVIRUS; INFLUENZA -LIKE ILLNESS; LOWER RESP TRACT INFECTION; UPPER RESP TRACT INFECTION,"February 08, 2021",200000,NCT04320862,,UNITED STATES,Recruiting,Duke University,"April 3, 2020",Observational,Pandemic Response Network: Duke Community Health Watch
305,Non-contact Endoscopy at Covid-19 Outbreak,GASTROINTESTINAL DISEASE; INFECTIOUS DISEASE,"February 08, 2021",5,NCT04320953,NON-CONTACT MCE SYSTEM,CHINA,Completed,Changhai Hospital,"March 16, 2020",Interventional,Non-contact Endoscopy at Covid-19 Outbreak
306,The Impact of Camostat Mesilate on COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",580,NCT04321096,CAMOSTAT MESILATE; PLACEBO ORAL TABLET,DENMARK,"Active, not recruiting",University of Aarhus,"April 4, 2020",Interventional,"The Impact of Camostat Mesilate on COVID-19 Infection: An Investigator-initiated Randomized, Placebo-controlled, Phase IIa Trial"
307,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,CORONAVIRUS INFECTION; POST-EXPOSURE PROPHYLAXIS,"February 08, 2021",1220,NCT04321174,LOPINAVIR/RITONAVIR,CANADA,Recruiting,Darrell Tan,"April 17, 2020",Interventional,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
308,Outcomes and Prognostic Factors in COVID-19,COVID; ELDERLY PATIENTS; CRITICAL ILLNESS; SURVIVAL; OLD AGE,"February 08, 2021",4000,NCT04321265,,DENMARK,Recruiting,"Heinrich-Heine University, Duesseldorf","March 19, 2020",Observational,Outcomes and Prognostic Factors in Coronavirus Disease (COVID-19) in Very Old Intensive Care Patients
309,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),"CORONAVIRUS INFECTION; PNEUMONIA, VIRAL","February 08, 2021",440,NCT04321278,HYDROXYCHLOROQUINE + AZITHROMYCIN; HYDROXYCHLOROQUINE,BRAZIL,Completed,Hospital Israelita Albert Einstein,"March 28, 2020",Interventional,Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
310,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,"INFECTIONS, RESPIRATORY; FEVER; COUGH","February 08, 2021",533,NCT04321369,TESTING SENSITIVITY FOR SARS-COV-2 VIRUS IN SYMPTOMATIC INDIVIDUALS,UNITED STATES,Completed,Dr. Deneen Vojta,"March 9, 2020",Observational,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals
311,Hyperimmune Plasma for Critical Patients With COVID-19,COVID,"February 08, 2021",49,NCT04321421,HYPERIMMUNE PLASMA,ITALY,Completed,Foundation IRCCS San Matteo Hospital,"March 17, 2020",Interventional,Plasma From Donors Recovered From New Coronavirus 2019 As Therapy For Critical Patients With Covid-19
312,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,SARS-COV INFECTION; COVID; ACUTE RESPIRATORY DISTRESS SYNDROME ARDS,"February 08, 2021",700,NCT04321616,HYDROXYCHLOROQUINE; REMDESIVIR; (STANDARD OF CARE) SOC,NORWAY,Recruiting,Oslo University Hospital,"March 28, 2020",Interventional,The (Norwegian) NOR Solidarity Multicenter Trial on the Efficacy of Different Anti-viral Drugs in SARS-CoV-2 Infected Patients
313,"Behavior, Environment And Treatments for Covid-19",CORONAVIRUS,"February 08, 2021",100000,NCT04321811,"OBSERVATION OF PATIENTS WITH KNOWN, SUSPECTED, OR AT RISK FOR COVID-19 INFECTION",UNITED STATES,Recruiting,xCures,"March 21, 2020",Observational [Patient Registry],A PATIENT-CENTRIC OUTCOMES REGISTRY OF PATIENTS WITH KNOWN OR SUSPECTED NOVEL CORONAVIRUS INFECTION SARS-COV-2 (COVID-19)
314,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,SARS-CoV2; CORONAVIRUS; COVID; 2019-NCOV; 2019NCOV,"February 08, 2021",7576,NCT04321928,PERSONALIZED HEALTH EDUCATION; GENERAL HEALTH EDUCATION,HUNGARY,Recruiting,University of Pecs,"April 1, 2020",Interventional,Personalized Health Education Against the Health Damage of COVID-19 Epidemic in Hungary (PROACTIVE-19)
315,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,COVID,"February 08, 2021",800,NCT04321993,BARICITINIB (JANUS KINASE INHIBITOR),CANADA,Recruiting,Lisa Barrett,"April 17, 2020",Interventional,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
316,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),CORONAVIRUS INFECTION,"February 08, 2021",630,NCT04322123,HYDROXYCHLOROQUINE ORAL PRODUCT; HYDROXYCHLOROQUINE + AZITHROMYCIN,BRAZIL,"Active, not recruiting",Hospital do Coracao,"April 1, 2020",Interventional,"An Open-label, Randomized Controlled Trial of Hydroxychloroquine and Azithromycin for COVID-19 Infection on Hospitalized, Noncritical Patients"
317,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,SEVERE ACUTE RESPIRATORY SYNDROME (ARDS) SECONDARY TO SARS-CoV2 INFECTION,"February 08, 2021",220,NCT04322188,,ITALY,Completed,A.O. Ospedale Papa Giovanni XXIII,"March 19, 2020",Observational,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications
318,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.,CORONAVIRUS,"February 08, 2021",300,NCT04322279,SEROLOGY; SEQUENCING,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","March 9, 2020",Observational,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. (CoV-CONTACT-SERO)
319,Escin in Patients With Covid-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",120,NCT04322344,ESCIN; STANDARD THERAPY,ITALY,Recruiting,University of Catanzaro,"March 23, 2020",Interventional,Efficacy and Safety of Escin as add-on Treatment in Covid-19 Infected Patients
320,Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,VIRUS DISEASES; INFECTION VIRAL; CORONAVIRUS INFECTION,"February 08, 2021",226,NCT04322396,AZITHROMYCIN; HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET; PLACEBO ORAL TABLET,DENMARK,Recruiting,"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","April 6, 2020",Interventional,"Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID: A Randomized, Placebo-controlled Double-blinded Trial Evaluating Treatment With Azithromycin and Hydroxychloroquine to Patients With COVID-19"
321,"Simple, Safe, Same: Lung Ultrasound for COVID-19","CORONAVIRUS; EPIDEMIC DISEASE; PNEUMONIA, VIRAL","February 08, 2021",100,NCT04322487,LUNG ULTRASOUND,ITALY,Recruiting,Catholic University of the Sacred Heart,"April 8, 2020",Observational,"Proposal for International Standardization of the Use of Lung Ultrasound for COVID-19 Patients; a Simple, Quantitative, Reproducible Method"
322,Biomarkers for Identification of COVID-19 Infection,CORONAVIRUS,"February 08, 2021",110,NCT04322513,BIOMARKERS EXPRESSION,ITALY,Recruiting,University of Catanzaro,"March 24, 2020",Observational,Biomarkers Identification for Diagnosis and Treatment of SARS-COV-2 Infection
323,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,"CORONAVIRUS INFECTION; PNEUMONIA, VIRAL","February 08, 2021",310,NCT04322565,COLCHICINE,ITALY,Recruiting,Azienda Ospedaliero-Universitaria di Parma,"April 20, 2020",Interventional,Colchicine to Counteract Inflammatory Response in COVID-19 Pneumonia
324,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),CORONAVIRUS INFECTION,"February 08, 2021",4506,NCT04322682,COLCHICINE; PLACEBO ORAL TABLET,BRAZIL,Completed,Montreal Heart Institute,"March 23, 2020",Interventional,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
325,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,CORONA VIRUS DISEASE,"February 08, 2021",20,NCT04322773,ROACTEMRA IV; ROACTEMRA SC; KEVZARA SC; STANDARD MEDICAL CARE,DENMARK,Terminated,Marius Henriksen,"April 5, 2020",Interventional,"Effectiveness of Interleukin-6 Receptor Inhibitors in the Management of Patients With Severe SARS-CoV-2 Pneumonia: An Open-Label, Multicenter Sequential and Cluster Randomized Trial"
326,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?","COVID, CORONAVIRUS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, INFLUENZA, ELECTRONIC HEALTH RECORDS, EPIDEMIOLOGY, COMORBIDITY, INCIDENCE, UNITED KINGDOM","February 08, 2021",1302508,NCT04322786,ACE INHIBITOR,,"Active, not recruiting","University College, London","January 1, 1998",Observational,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective? An Analysis Using UK Based Electronic Health Records of 5.6 Million Individuals."
327,"Yoga, Aerobic and Stretching Exercise Effects on Neurocognition",AGING; COGNITIVE DECLINE,"February 08, 2021",168,NCT04323163,PHYSICAL ACTIVITY,UNITED STATES,Recruiting,University of Illinois at Urbana-Champaign,"January 1, 2021",Interventional,"Yoga, Aerobic and Stretching Exercise Effects on Neurocognitive Performance: A Randomized Controlled Trial"
328,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,COVID,"February 08, 2021",40,NCT04323228,ORAL SUPPLEMENT ENRICHED IN ANTIOXIDANTS; CELLULOSE-CONTAINING PLACEBO CAPSULES,SAUDI ARABIA,Recruiting,King Saud University,"September 1, 2020",Interventional,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation on the Cytokine Storm and Progression of COVID-19: A Randomized Controlled Trial
329,Traditional Chinese Medicine for Severe COVID-19,COVID,"February 08, 2021",50,NCT04323332,TRADITIONAL CHINESE MEDICINE PRESCRIPTION,CHINA,Not yet recruiting,Xiyuan Hospital of China Academy of Chinese Medical Sciences,March 2020,Interventional,A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Traditional Chinese Medicine as an Adjuvant Treatment for Patients With Severe COVID-19
330,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,COVID,"February 08, 2021",1000,NCT04323345,NATURAL HONEY; STANDARD CARE,EGYPT,Recruiting,Misr University for Science and Technology,"April 15, 2020",Interventional,"The Efficacy of Natural Honey in Patients Infected With Novel Coronavirus (COVID-19) : A Randomized, Controlled ,Single Masked , Investigator Initiated, Multi-center Trial"
331,Use of Ascorbic Acid in Patients With COVID 19,HOSPITALIZED PATIENTS WITH COVID PNEUMONIA,"February 08, 2021",500,NCT04323514,VITAMIN C,ITALY,Recruiting,University of Palermo,"March 13, 2020",Interventional,Use of Ascorbic Acid in Patients With COVID 19
332,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2,SARS-COV INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA,"February 08, 2021",278,NCT04323527,CHLOROQUINE DIPHOSPHATE,BRAZIL,Completed,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,"March 23, 2020",Interventional,"Efficacy and Safety of Chloroquine Diphosphate for the Treatment of Hospitalized Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV2: a Phase IIb, Double-blind, Randomized Adaptive Clinical Trial"
333,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,"SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA; CORONAVIRUS INFECTION; ARDS, HUMAN","February 08, 2021",173,NCT04323592,METHYLPREDNISOLONE; STANDARD CARE,ITALY,Completed,University of Trieste,"March 23, 2020",Observational [Patient Registry],Prolonged Low Doses of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
334,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,COVID,"February 08, 2021",0,NCT04323631,HYDROXYCHLOROQUINE; THE CONTROL GROUP WILL NOT RECEIVE HYDROXYCHLOROQUINE,,Withdrawn,Rambam Health Care Campus,"April 30, 2020",Interventional,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death
335,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),COVID; CORONAVIRUS; SURGERY,"February 08, 2021",1000,NCT04323644,SURGERY,SPAIN,Recruiting,University of Birmingham,"January 1, 2020",Observational,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)
336,Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),SARS-CoV2 INFECTION,"February 08, 2021",,NCT04323761,REMDESIVIR,AUSTRALIA,Approved for marketing,Gilead Sciences,,Expanded Access,Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection
337,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,CORONAVIRUS,"February 08, 2021",50000,NCT04323787,OBSERVATIONAL,UNITED STATES,Recruiting,Mayo Clinic,"March 30, 2020",Observational,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)
338,Convalescent Plasma to Stem Coronavirus (CSSC-001),CORONAVIRUS; CONVALESCENCE,"February 08, 2021",500,NCT04323800,ANTI- SARS-COV-2 PLASMA; SARS-COV-2 NON-IMMUNE PLASMA,UNITED STATES,Recruiting,Johns Hopkins University,"June 10, 2020",Interventional,"Convalescent Plasma to Stem Coronavirus: A Randomized, Blinded Phase 2 Study Comparing the Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19"
339,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),PREGNANCY; CORONAVIRUS; COVID,"February 08, 2021",2000,NCT04323839,PREGNANT WOMEN UNDER INVESTIGATION FOR CORONAVIRUS OR DIAGNOSED WITH COVID-19; POSTPARTUM WOMEN UNDER INVESTIGATION FOR CORONAVIRUS OR DIAGNOSED WITH COVID-19,UNITED STATES,Enrolling by invitation,"University of California, San Francisco","March 20, 2020",Observational [Patient Registry],PRIORITY (Pregnancy Coronavirus Outcomes Registry)
340,Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.,EARLY CPAP VENTILATION IN COVID PATIENTS,"February 08, 2021",3000,NCT04323878,,ITALY,Recruiting,Mario Negri Institute for Pharmacological Research,"June 1, 2020",Observational,EC-COVID-PCS - Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.
341,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,SARS-CoV2,"February 08, 2021",16,NCT04324021,EMAPALUMAB; ANAKINRA,ITALY,Terminated,Swedish Orphan Biovitrum,"April 2, 2020",Interventional,"A Phase 2/3, Randomized, Open-label, Parallel Group, 3-arm, Multicenter Study Investigating the Efficacy and Safety of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and Anakinra, an Interleukin-1(IL-1) Receptor Antagonist, Versus Standard of Care, in Reducing Hyper-inflammation and Respiratory Distress in Patients With SARS-CoV-2 Infection."
342,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04324047,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"March 27, 2020",Observational,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients
343,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,CORONAVIRUS INFECTION,"February 08, 2021",239,NCT04324073,SARILUMAB,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 27, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI
344,DIgital Online SuPport for COVID-19 StrEss,COVID; PSYCHOSOCIAL STRESS; MENTAL HEALTH,"February 08, 2021",600,NCT04324190,GUIDED ONLINE SUPPORT PROGRAM; WHO RECOMMENDATIONS (WAITING CONDITION),GERMANY,Recruiting,Gunther Meinlschmidt,"April 8, 2020",Interventional,Online Support for Psychosocial Stress in the Context of the COVID-19 Pandemic
345,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",4000,NCT04324463,COLCHICINE; INTERFERON-BETA; ASPIRIN; RIVAROXABAN,BRAZIL,Recruiting,Population Health Research Institute,"April 21, 2020",Interventional,"Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial"
346,DAS181 for Severe COVID-19: Compassionate Use,COVID,"February 08, 2021",4,NCT04324489,DAS181,CHINA,Completed,Renmin Hospital of Wuhan University,"March 6, 2020",Interventional,DAS181 for Severe COVID-19: Compassionate Use
347,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,CORONAVIRUS; COVID; SARS-COV INFECTION; RESPIRATORY FAILURE; CYTOKINE STORM,"February 08, 2021",30,NCT04324528,VV-ECMO + CYTOKINE ADSORPTION (CYTOSORB ADSORBER); VV-ECMO ONLY (NO CYTOKINE ADSORPTION),GERMANY,Recruiting,Dr. Alexander Supady,"March 27, 2020",Interventional,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
348,A Study of a Candidate COVID-19 Vaccine (COV001),CORONAVIRUS,"February 08, 2021",1090,NCT04324606,CHADOX1 NCOV-19; MENACWY; CHADOX1 NCOV-19 FULL BOOST; CHADOX1 NCOV-19 HALF BOOST; MENACWY BOOST; PARACETAMOL; CHADOX1 NCOV-19 0.5ML BOOST,UNITED KINGDOM,"Active, not recruiting",University of Oxford,"April 23, 2020",Interventional,"A Phase I/II Study to Determine Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 in UK Healthy Adult Volunteers"
349,Prognostic Factors Keeping Track for COVID-19 Pneumonia,"PNEUMONIA, VIRAL; HYPERTENSION; DIABETES MELLITUS; OBESITY; CARDIOVASCULAR DISEASES; OBSTRUCTIVE LUNG DISEASE","February 08, 2021",198,NCT04324684,,ITALY,Completed,Catholic University of the Sacred Heart,"March 31, 2020",Observational,Time of Recovery and Prognostic Factors of COVID-19 Pneumonia
350,"""COVID-19 and Diabetes Outcomes""",CORONAVIRUS; DIABETES,"February 08, 2021",5309,NCT04324736,NO INTERVENTIONAL STUDY,FRANCE,"Active, not recruiting",Nantes University Hospital,"March 10, 2020",Observational,"""Coronavirus SARS-CoV2 and Diabetes Outcomes"" : CORONADO"
351,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04324866,NASOPHARYNGEAL SWAB,,Not yet recruiting,Universita di Verona,"April 1, 2020",Observational,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy
352,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,COVID,"February 08, 2021",90,NCT04324996,"NK CELLS,IL15-NK CELLS,NKG2D CAR-NK CELLS,ACE2 CAR-NK CELLS,NKG2D-ACE2 CAR-NK CELLS",CHINA,Recruiting,Chongqing Public Health Medical Center,"February 21, 2020",Interventional,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells Secreting IL15 Superagonist and GM-CSF-neutralizing scFv for Therapy of COVID-19
353,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,CORONAVIRUS INFECTION,"February 08, 2021",5000,NCT04325048,CORDIO APP,,Not yet recruiting,Cordio Medical,April 2020,Observational [Patient Registry],Single-Arm Observational Study Designed to Clinically Evaluate Cordio Application in Adult Patients Positive to COVID-19
354,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY COVID,"February 08, 2021",19,NCT04325061,DEXAMETHASONE,SPAIN,Terminated,Dr. Negrin University Hospital,"April 3, 2020",Interventional,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19
355,Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY,COVID; CARDIOVASCULAR DISEASES,"February 08, 2021",1000,NCT04325412,,NETHERLANDS,Recruiting,UMC Utrecht,"March 23, 2020",Observational [Patient Registry],Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY
356,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,COVID,"February 08, 2021",584,NCT04325633,1: NAPROXEN; 2: STANDARD OF CARE,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 13, 2020",Interventional,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection
357,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,SARS (SEVERE ACUTE RESPIRATORY SYNDROME); COVID,"February 08, 2021",2000,NCT04325646,HUMAN BIOLOGICAL SAMPLES,FRANCE,Recruiting,Institut Pasteur,"March 13, 2020",Observational,Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples
358,Convalescent Plasma to Limit Coronavirus Associated Complications,CORONAVIRUS,"February 08, 2021",0,NCT04325672,CONVALESCENT PLASMA,,Withdrawn,Mayo Clinic,"April 1, 2020",Interventional,"Convalescent Plasma to Limit Coronavirus Associated Complications: An Open Label, Phase 2A Study of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19"
359,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,"ANGINA PECTORIS; ACUTE CORONARY SYNDROME; CORONARY SYNDROME; CORONARY ARTERY DISEASE; ANGIOPLASTY; STENT RESTENOSIS; HYPERTENSION; HEART FAILURE, SYSTOLIC; DEPRESSION, ANXIETY; COVID; ISOLATION, SOCIAL","February 08, 2021",200,NCT04325867,TELE-MEDICINE PLATFORM,ROMANIA,Recruiting,Professor Adrian Covic,"March 31, 2020",Interventional,"Integrated Distance Management Strategy for Patients With Cardiovascular Disease (Ischaemic Coronary Artery Disease, High Blood Pressure, Heart Failure) in the Context of the COVID-19 Pandemic"
360,Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,CORONAVIRUS,"February 08, 2021",259,NCT04325893,HYDROXYCHLOROQUINE; PLACEBO,FRANCE,Terminated,"University Hospital, Angers","April 1, 2020",Interventional,"Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and at Risk of Secondary Complication: a Prospective, Multicentre, Randomised, Double-blind Study"
361,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,PRONE POSITIONING; HIGH FLOW NASAL CANNULA; ACUTE RESPIRATORY DISTRESS SYNDROME; CORONAVIRUS INFECTION,"February 08, 2021",346,NCT04325906,HIGH FLOW NASAL CANNULA (HFNC); PRONE POSITIONING (PP),UNITED STATES,Recruiting,Rush University Medical Center,"April 2, 2020",Interventional,Early Prone Positioning Combined With High-Flow Nasal Cannula Versus High-Flow Nasal Cannula in COVID-19 Induced Moderate to Severe ARDS
362,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,CORONAVIRUS INFECTION,"February 08, 2021",170,NCT04325919,NO INTERVENTION,HONG KONG,Recruiting,Chinese University of Hong Kong,"February 24, 2020",Observational,"Comprehensive Clinical, Virological, Microbiological, Immunological and Laboratory Monitoring of Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)"
363,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,PULMONARY ALVEOLAR PROTEINOSIS; COPD; IDIOPATHIC PULMONARY FIBROSIS; VIRAL PNEUMONIA; CORONAVIRUS INFECTION; INTERSTITIAL LUNG DISEASE,"February 08, 2021",10,NCT04326036,MICROCANNULA HARVEST ADIPOSE DERIVED TISSUE STROMAL VASCULAR FRACTION (TSVF); CENTRICYTE 1000; IV DEPLOYMENT OF CSVF IN STERILE NORMAL SALINE IV SOLUTION; LIBERASE ENZYME (ROCHE); STERILE NORMAL SALINE FOR INTRAVENOUS USE,UNITED STATES,Recruiting,"Black Tie Medical, Inc.","March 25, 2020",Interventional,Use of cSVF For Residual Lung Damage (COPD/Fibrotic Lung Disease After Symptomatic COVID-19 Infection For Residual Pulmonary Injury or Post-Adult Respiratory Distress Syndrome Following Viral (SARS-Co-2) Infection
364,Early CPAP in COVID-19 Patients With Respiratory Failure.,CPAP VENTILATION; COVID; EMERGENCY DEPARTMENTS,"February 08, 2021",900,NCT04326075,CPAP TREATMENT,ITALY,Recruiting,Mario Negri Institute for Pharmacological Research,"December 1, 2020",Interventional,EC-COVID-RCT. Early CPAP in COVID Patients With Respiratory Failure. A Randomized Clinical Trial
365,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,"DISEASE, INFECTIOUS; RESPIRATORY DISEASE; SAFETY ISSUES; EFFECTIVENESS","February 08, 2021",240,NCT04326114,INSPIRATORY TRAINING DEVICE; EXPIRATORY TRAINING DEVICE,,Not yet recruiting,Universidad Complutense de Madrid,"July 26, 2020",Interventional,Effectiveness and Safety of Respiratory Training Devices in the Prevention and Severity of COVID-19: A Randomized Controlled Clinical Trial
366,Audio Data Collection for Identification and Classification of Coughing,COVID; CORONAVIRUS INFECTION; HAY FEVER; ASTHMA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; INFLUENZA; COMMON COLD; RESPIRATORY TRACT INFECTIONS; HEALTHY,"February 08, 2021",1000,NCT04326309,,UNITED STATES,Recruiting,HealthMode Inc.,"March 25, 2020",Observational,Audio Data Collection for Identification and Classification of Coughing
367,Evaluation of Novel Diagnostic Tests for COVID-19,ACUTE DISEASE; CORONAVIRUS; RESPIRATORY VIRAL INFECTION,"February 08, 2021",200,NCT04326387,SAMBA II (DIAGNOSTIC FOR THE REAL WORLD); PUBLIC HEALTH ENGLAND GOLD STANDARD; CAMBRIDGE VALIDATED VIRAL DETECTION METHOD; RADIOLOGICAL DETECTION,UNITED KINGDOM,Recruiting,CCTU- Cancer Theme,"April 6, 2020",Observational,Evaluation of Novel Diagnostic Tests for 2019-nCOV
368,Active Monitoring And Determinants of Incidence Infection of COVDI-19,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04326400,,SPAIN,Recruiting,"Fundación Teófilo Hernando, Spain","March 23, 2020",Observational,Active Monitoring And Determinants of Incidence Infection of COVDI-19 in a Hospital Population (AMADIICH) Study Protocol
369,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04326426,TRADIPITANT; PLACEBO,UNITED STATES,Enrolling by invitation,Vanda Pharmaceuticals,"April 13, 2020",Interventional,"ODYSSEY: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Treating Inflammatory Lung Injury and Improving Clinical Outcomes Associated With Severe or Critical COVID-19 Infection"
370,Treating COVID-19 With a Bidirectional Oxygenation Valve,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04326452,BIDIRECTIONAL OXYGENATION MOUTHPIECE,UNITED STATES,Recruiting,TMC HealthCare,"March 27, 2020",Interventional,The Use of a Bidirectional Oxygenation Valve in the Management of Respiratory Failure Due to COVID-19 Infection
371,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,PNEUMONITIS; CORONAVIRUS INFECTION,"February 08, 2021",80,NCT04326725,PLAQUENIL 200MG TABLET,TURKEY,"Active, not recruiting",Istinye University,"March 20, 2020",Observational,"Proflaxis for Healthcare Professionals Using Hydroxychloroquine Plus Vitamin Combining Vitamins C, D and Zinc During COVID-19 Pandemia: An Observational Study"
372,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,CORONA VIRUS DISEASE 19 (COVID),"February 08, 2021",180,NCT04326790,COLCHICINE; STANDARD TREATMENT,GIBRALTAR,Recruiting,National and Kapodistrian University of Athens,"April 3, 2020",Interventional,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention
373,Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),COVID,"February 08, 2021",80,NCT04326920,SARGRAMOSTIM; CONTROL,BELGIUM,"Active, not recruiting","University Hospital, Ghent","March 24, 2020",Interventional,"A Prospective, Randomized, Open-label, Interventional Study to Investigate the Efficacy of Sargramostim (Leukine®) in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 (Corona Virus Disease) Patients With Acute Hypoxic Respiratory Failure."
374,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,INFECTION VIRAL; CORONAVIRUS; ARDS; PNEUMONIA,"February 08, 2021",500,NCT04327180,,FRANCE,Recruiting,"University Hospital, Lille","March 30, 2020",Observational,PCR-COVID-19 Predictors of Positivity in Patients Admitted to ICU for Respiratory Infection: A Prospective Observational Cohort Study
375,BCG Vaccination to Protect Healthcare Workers Against COVID-19,CORONAVIRUS DISEASE 2019 (COVID); RESPIRATORY ILLNESS; CORONAVIRUS INFECTION; COVID,"February 08, 2021",10078,NCT04327206,BCG VACCINE; 0.9%NACL,AUSTRALIA,Recruiting,Murdoch Childrens Research Institute,"March 30, 2020",Interventional,BCG Vaccination to Reduce the Impact of COVID-19 in Healthcare Workers (BRACE) Trial
376,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04327349,CONVALESCENT PLASMA,"IRAN, ISLAMIC REPUBLIC OF",Enrolling by invitation,Mazandaran University of Medical Sciences,"March 28, 2020",Interventional,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial
377,Sarilumab COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",420,NCT04327388,SARILUMAB SAR153191; PLACEBO,ARGENTINA,Completed,Sanofi,"March 28, 2020",Interventional,"An Adaptive Phase 3, Randomized, Double-blind, Placebo-controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID19"
378,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,"CORONAVIRUS INFECTION; PNEUMONIA, VIRAL; ACUTE RESPIRATORY DISTRESS SYNDROME","February 08, 2021",299,NCT04327401,DEXAMETHASONE,BRAZIL,Terminated,Hospital Sirio-Libanes,"April 13, 2020",Interventional,"COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)"
379,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,CARDIOVASCULAR DISEASES; CARDIOVASCULAR RISK FACTOR; SARS,"February 08, 2021",728,NCT04327479,ASSESSMENT OF CARDIOVASCULAR DISEASES AND CARDIOVASCULAR RISK FACTORS,GERMANY,Recruiting,"University Hospital, Essen","March 26, 2020",Observational [Patient Registry],Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection
380,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,"SARS (SEVERE ACUTE RESPIRATORY SYNDROME); CYTOKINE STORM; ARDS, HUMAN; COVID; SARS-CoV2; ACUTE RESPIRATORY FAILURE","February 08, 2021",200,NCT04327505,HYPERBARIC OXYGEN,GERMANY,Recruiting,Karolinska Institutet,"June 3, 2020",Interventional,"A Randomized, Controlled, Open Label, Multicentre Clinical Trial to Explore Safety and Efficacy of Hyperbaric Oxygen for Preventing ICU Admission, Morbidity and Mortality in Adult Patients With COVID-19"
381,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",COVID; PHYSICIAN-PATIENT RELATIONS,"February 08, 2021",200,NCT04327531,TURKISH PHYSICIANS,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 26, 2020",Observational,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study"
382,In-depth Immunological Investigation of COVID-19.,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04327570,PATIENT SAMPLING,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"March 27, 2020",Observational [Patient Registry],In-depth Characterisation of the Dynamic Host Immune Response to Coronavirus SARS-CoV-2
383,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,COVID,"February 08, 2021",375,NCT04327674,,DENMARK,Recruiting,University of Aarhus,"March 14, 2020",Observational [Patient Registry],The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19
384,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,SARS-COV INFECTION,"February 08, 2021",120,NCT04327804,ODD/EVEN BIRTH YEAR INTERVENTION GROUPS,UNITED STATES,Recruiting,Dr. Deneen Vojta,"March 25, 2020",Observational,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research
385,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,SARS-CoV2 INFECTION,"February 08, 2021",4000,NCT04328012,LOPINAVIR/RITONAVIR; LOSARTAN; PLACEBOS,UNITED STATES,Recruiting,Bassett Healthcare,"April 6, 2020",Interventional,Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial)
386,Household Transmission Investigation Study for COVID-19 in Tropical Regions,CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; SARS-COV INFECTION,"February 08, 2021",1300,NCT04328129,HUMAN BIOLOGICAL SAMPLES,FRENCH GUIANA,Recruiting,Institut Pasteur,"March 23, 2020",Interventional,Household Transmission Investigation Study for Coronavirus Disease 2019 (COVID-19) in Tropical Regions
387,Effectiveness of Hydroxychloroquine in Covid-19 Patients,COVID,"February 08, 2021",75,NCT04328272,HYDROXYCHLOROQUINE 200 MG ORAL TABLET; AZITHROMYCIN 500MG ORAL TABLET; GLUCOSE TABLETS,PAKISTAN,Not yet recruiting,Prof. Dr. Umar Farooq,"March 28, 2020",Interventional,Effectiveness of Hydroxychloroquine in Covid-19 Patients: A Single Centred Single-blind RCT Study
388,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,COVID,"February 08, 2021",1200,NCT04328285,HYDROXYCHLOROQUINE; PLACEBO OF HYDROXYCHLOROQUINE; LOPINAVIR AND RITONAVIR; PLACEBO OF LPV/R TABLETS,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire de Saint Etienne,"April 14, 2020",Interventional,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers : A Randomized Double-blind Placebo-controlled Clinical Trial
389,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,COVID,"February 08, 2021",1500,NCT04328441,BCG VACCINE; PLACEBO,NETHERLANDS,"Active, not recruiting",UMC Utrecht,"March 25, 2020",Interventional,"Reducing Health Care Workers Absenteeism in COVID-19 Pandemic by Enhanced Trained Immune Responses Through Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial."
390,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,CORONAVIRUS,"February 08, 2021",120,NCT04328454,RETROSPECTIVE ANALYSIS,CHINA,Recruiting,Shanghai 10th People's Hospital,"January 30, 2020",Observational,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 in Chibi Hospital of Hubei Province
391,Pre-exposure Prophylaxis for SARS-Coronavirus-2,COVID; CORONAVIRUS INFECTION; ARDS; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",1500,NCT04328467,HYDROXYCHLOROQUINE; PLACEBO,UNITED STATES,"Active, not recruiting",University of Minnesota,"April 6, 2020",Interventional,Pre-exposure Prophylaxis for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial
392,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,COVID,"February 08, 2021",1200,NCT04328480,COLCHICINE; LOCAL STANDARD OF CARE,ARGENTINA,Recruiting,Estudios Clínicos Latino América,"April 17, 2020",Interventional,The ECLA PHRI COLCOVID Trial
393,The Vietnam Chloroquine Treatment on COVID-19,SARS-CoV2 INFECTION; COVID,"February 08, 2021",250,NCT04328493,CHLOROQUINE PHOSPHATE,VIETNAM,Recruiting,"Oxford University Clinical Research Unit, Vietnam","April 7, 2020",Interventional,A Multi Center Randomized Open Label Trial on the Safety and Efficacy of Chloroquine for the Treatment of Hospitalized Adults With Laboratory Confirmed SARS-CoV-2 Infection in Vietnam
394,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),COVID; CORONAVIRUS INFECTION; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); SARS-CoV2,"February 08, 2021",829,NCT04328961,HYDROXYCHLOROQUINE SULFATE; ASCORBIC ACID,UNITED STATES,Completed,University of Washington,"March 31, 2020",Interventional,"Efficacy of Hydroxychloroquine for Post-exposure Prophylaxis (PEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Adults Exposed to Coronavirus Disease (COVID-19): a Blinded, Randomized Study"
395,ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic,HISTORY OF CARDIOVASCULAR DISEASE TREATED WITH RAS BLOCKERS AND WITH SARS-CoV2 INFECTION,"February 08, 2021",554,NCT04329195,1: DISCONTINUATION OF RAS BLOCKER THERAPY; 2: CONTINUATION OF RAS BLOCKER THERAPY,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 9, 2020",Interventional,ACE Inhibitors or ARBs Discontinuation for Clinical Outcome Risk Reduction in Patients Hospitalized for the Endemic Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Infection: the Randomized ACORES-2 Study
396,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),COVID; RESPIRATORY DISEASE,"February 08, 2021",200,NCT04329507,BREATH TEST,UNITED KINGDOM,Recruiting,NHS Lothian,"March 25, 2020",Observational,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS)
397,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,PERCEIVED STRESS; ANXIETY; SLEEP DISTURBANCE,"February 08, 2021",101,NCT04329533,"""CALM"" IS A MINDFULNESS MEDITATION MOBILE APP",UNITED STATES,Completed,University of Arizona,"April 13, 2020",Interventional,Effects of a Mobile Meditation App on Stress During COVID-19 Pandemic in Outpatient Obstetrics and Gynecology Patients; a Randomized Controlled Trial
398,Understanding COVID-19,SARS-CoV2 VIRAL KINETICS AND HOST IMMUNE RESPONSES,"February 08, 2021",250,NCT04329546,NA (NO INTERVENTION),SWITZERLAND,Recruiting,"University Hospital, Geneva","March 27, 2020",Observational,How Immune Responses Shape Virological and Clinical Characteristics of COVID-19: a Prospective Cohort Study
399,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,COVID; LIVER CIRRHOSIS,"February 08, 2021",50,NCT04329559,,CHINA,Recruiting,Hepatopancreatobiliary Surgery Institute of Gansu Province,"March 30, 2020",Observational [Patient Registry],Clinical Characteristics of COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study
400,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,COVID,"February 08, 2021",400,NCT04329572,HYDROXYCHLOROQUINE SULFATE; AZITHROMYCIN TABLETS,BRAZIL,Suspended,Azidus Brasil,"April 23, 2020",Interventional,"Open, Multicentric, Non Randomized, Exploratory Clinical Trial to Assess the Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Acute Respiratory Syndrome (COVID-19) Caused by SARS-CoV-2 Virus"
401,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,COVID,"February 08, 2021",148,NCT04329611,HYDROXYCHLOROQUINE,CANADA,Terminated,Dr. Michael Hill,"April 13, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Oral Hydroxychloroquine for the Treatment of SARS-CoV-2 Positive Patients for the Prevention of Severe COVID-19 Disease."
402,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",200,NCT04329650,SILTUXIMAB; METHYLPREDNISOLONE,SPAIN,Recruiting,Judit Pich Martínez,"April 15, 2020",Interventional,"Phase 2, Randomized, Open-label Study to Compare Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia"
403,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,COVID,"February 08, 2021",85,NCT04329832,HYDROXYCHLOROQUINE; AZITHROMYCIN,UNITED STATES,"Active, not recruiting","Intermountain Health Care, Inc.","March 30, 2020",Interventional,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 (HAHPS): A Prospective Pragmatic Trial
404,Acceptance and Commitment Therapy Delivered by Automated Software Messaging,HIP OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; MENTAL STRESS; CORONAVIRUS,"February 08, 2021",90,NCT04329897,SOFTWARE MESSAGING,UNITED STATES,Completed,University of Iowa,"April 5, 2020",Interventional,Acceptance and Commitment Therapy Delivered by Automated Software Messaging
405,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),COVID,"February 08, 2021",173,NCT04329923,HYDROXYCHLOROQUINE SULFATE 400 MG TWICE A DAY; HYDROXYCHLOROQUINE SULFATE 600 MG TWICE A DAY; HYDROXYCHLOROQUINE SULFATE 600 MG ONCE A DAY; PLACEBO ORAL TABLET,UNITED STATES,Terminated,"Ravi Amaravadi, MD","April 9, 2020",Interventional,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)
406,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),CONTACT PERSON FROM COVID CONFIRMED PATIENT,"February 08, 2021",2486,NCT04330144,HYDROXYCHLOROQUINE AS POST EXPOSURE PROPHYLAXIS; OTHERS(NO INTERVENTION),,Not yet recruiting,Gangnam Severance Hospital,"April 1, 2020",Interventional,A Study of Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)
407,Clinical Characteristics and Outcomes of Pediatric COVID-19,"COVID; SARS-CoV2 INFECTION; PEDIATRIC ALL; PNEUMONIA, VIRAL; PANDEMIC RESPONSE","February 08, 2021",12500,NCT04330261,EXPOSURE (NOT INTERVENTION) - SARS-COV-2 INFECTION,CANADA,Recruiting,University of Calgary,"March 18, 2020",Observational,Clinical Characteristics and Outcomes of Children Potentially Infected by Severe Acute Respiratory Distress Syndrome (SARS)-CoV-2 Presenting to Pediatric Emergency Departments
408,Coronavirus (COVID-19) ACEi/ARB Investigation,HYPERTENSION; COVID,"February 08, 2021",2414,NCT04330300,THIAZIDE OR THIAZIDE-LIKE DIURETICS; CALCIUM CHANNEL BLOCKERS; ACE INHIBITOR; ANGIOTENSIN RECEPTOR BLOCKER,IRELAND,Suspended,"National University of Ireland, Galway, Ireland","April 30, 2020",Interventional,The CORONAvirus Disease 2019 Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker InvestigatiON (CORONACION) Randomized Clinical Trial
409,"Mindfulness-based ""STOP (Stop, Take a Breath, Observe, Proceed) Touching Your Face"" Intervention",FACE-TOUCHING BEHAVIOR,"February 08, 2021",1094,NCT04330352,"MINDFULNESS-BASED ""STOP TOUCHING YOUR FACE"" PRACTICE",CHINA,Completed,Sir Run Run Shaw Hospital,"April 2, 2020",Interventional,"""STOP Touching Your Face"": a Randomized Controlled Trial of Brief Mindfulness-based Intervention"
410,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",COVID; IMMUNOMEDIATED INFLAMMATORY DISEASE IN TREATMENT WITH BIOLOGICAL AGENTS AND / OR JAK INHIBITORS,"February 08, 2021",800,NCT04330495,HIDROXICLOROQUINA; CONTROL GROUP,,Not yet recruiting,Instituto de Investigación Marqués de Valdecilla,"April 6, 2020",Interventional,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection"
411,Impact of the Coronavirus (COVID-19) on Patients With Cancer,CANCER; COVID,"February 08, 2021",50,NCT04330521,,UNITED STATES,Recruiting,Stanford University,"April 8, 2020",Observational,Impact of the Coronavirus (COVID-19) on Patients With Cancer
412,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,COVID,"February 08, 2021",66,NCT04330586,CICLESONIDE METERED DOSE INHALER [ALVESCO],"KOREA, REPUBLIC OF",Recruiting,Korea University Guro Hospital,"April 1, 2020",Interventional,A Trial of Ciclesonide to Assess The Antiviral Effect for Adults With Mild-to-moderate COVID-19
413,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,COVID,"February 08, 2021",12000,NCT04330599,,UNITED KINGDOM,Recruiting,Queen Mary University of London,"May 1, 2020",Observational,Longitudinal Population-based Observational Study of COVID-19 in the UK Population
414,Treatment of COVID-19 Patients With Anti-interleukin Drugs,COVID,"February 08, 2021",342,NCT04330638,USUAL CARE; ANAKINRA; SILTUXIMAB; TOCILIZUMAB,BELGIUM,"Active, not recruiting","University Hospital, Ghent","April 3, 2020",Interventional,"A Prospective, Randomized, Factorial Design, Interventional Study to Compare the Safety and Efficacy of Combinations of Blockade of Interleukin-6 Pathway and Interleukin-1 Pathway to Best Standard of Care in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure and Systemic Cytokine Release Syndrome"
415,Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial,COVID,"February 08, 2021",2900,NCT04330690,INTERFERON BETA-1A; REMDESIVIR,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"March 18, 2020",Interventional,"A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)"
416,Protective Role of Inhaled Steroids for Covid-19 Infection,COVID INFECTION; HOSPITALIZATION IN RESPIRATORY DISEASE DEPARTMENT,"February 08, 2021",436,NCT04331054,2: USUAL PRACTICE + SYMBICORT RAPIHALER; 1: USUAL PRACTICE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 13, 2020",Interventional,Protective Role of Inhaled Steroids for Covid-19 Infection
417,Survey of the Anxiety Associated With the COVID-19 Pandemic,ANXIETY RELATED TO THE COVID PANDEMIC,"February 08, 2021",7500,NCT04331106,ONLINE QUESTIONNAIRE,GERMANY,Recruiting,"Charite University, Berlin, Germany","March 27, 2020",Observational,Online-based Survey of the Anxiety Associated With the COVID-19 Pandemic in the General Population in Germany
418,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,COVID,"February 08, 2021",12000000,NCT04331171,WEB APPLICATION USERS,FRANCE,Recruiting,Weprom,"March 17, 2020",Observational [Patient Registry],Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage
419,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,COVID,"February 08, 2021",2,NCT04331366,GO2 PEEP MOUTHPIECE,UNITED STATES,Completed,Emory University,"April 8, 2020",Interventional,GO2 PEEP Study: The Use of a Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19
420,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,COVID,"February 08, 2021",30,NCT04331470,LEVAMISOLE PILL + BUDESONIDE+FORMOTEROL INHALER; LOPINAVIR/RITONAVIR + HYDOXYCHLOROQUINE,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Fasa University of Medical Sciences,"April 4, 2020",Interventional,Evaluation of Efficacy of Pharmacotherapy Treatment of COVID- 19 Infection Using Oral Levamisole and Formoterol+Budesonide Inhaler and Comparison of This Treatment Protocol With Standard National Treatment of the Disease
421,COVID-19 Symptom Tracker,COVID,"February 08, 2021",10000000,NCT04331509,NO INTERVENTION,UNITED KINGDOM,Recruiting,King's College London,"March 23, 2020",Observational,COVID-19 Symptom Tracker
422,Renin-Angiotensin System Inhibitors and COVID-19,COVID; HYPERTENSION; CARDIOVASCULAR DISEASES,"February 08, 2021",2000,NCT04331574,,ITALY,Recruiting,Societa Italiana dell'Ipertensione Arteriosa,"March 10, 2020",Observational [Patient Registry],Phase IV Observational Study to Associate Hypertension and Hypertensinon Treatment to COVID19
423,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,COVID,"February 08, 2021",400,NCT04331600,CHLOROQUINE PHOSPHATE; TELEMEDICINE,POLAND,Recruiting,Wroclaw Medical University,"April 16, 2020",Interventional,"Multicenter, Randomized, Open-label, Non-commercial, Investigator-initiated Study to Evaluate the Efficacy and Safety of Chloroquine Phosphate in Combination With Telemedicine Care in the Risk Reduction of COVID-19 Related Hospitalization or Death, in Ambulatory Patients With COVID-19 Being at Risk of Serious Complications"
424,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; VIRUS; PNEUMONIA; ACUTE LUNG INJURY,"February 08, 2021",9,NCT04331613,CASTEM,CHINA,Recruiting,Chinese Academy of Sciences,"January 27, 2020",Interventional,Safety and Efficacy Study of Human Embryonic Stem Cells Derived M Cells (CAStem) for the Treatment of Severe COVID-19 Associated With or Without Acute Respiratory Distress Syndrome (ARDS)
425,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,COVID; PNEUMONIA,"February 08, 2021",64,NCT04331665,RUXOLITINIB,CANADA,Not yet recruiting,"University Health Network, Toronto","April 20, 2020",Interventional,A Single Arm Open-label Clinical Study to Investigate the Efficacy and Safety of Ruxolitinib for the Treatment of COVID-19 Pneumonia
426,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",COVID,"February 08, 2021",32,NCT04331795,TOCILIZUMAB; TOCILIZUMAB,UNITED STATES,Completed,University of Chicago,"April 4, 2020",Interventional,Early Institution of Tocilizumab Titration in Non-Critical Hospitalized COVID-19 Pneumonitis
427,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),CORONAVIRUS INFECTION,"February 08, 2021",228,NCT04331808,TOCILIZUMAB,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 30, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Tocilizumab Trial - CORIMUNO-19 - TOCI (CORIMUNO-TOCI)
428,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,COVID,"February 08, 2021",440,NCT04331834,HYDROXYCHLOROQUINE; PLACEBOS,SPAIN,Suspended,Barcelona Institute for Global Health,"April 3, 2020",Interventional,"Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic: A Multicentre, Double-Blinded Randomized Controlled Trial"
429,An Observational Study of Patients With Coronavirus Disease 2019,COVID; CORONAVIRUS,"February 08, 2021",5000,NCT04331886,,UNITED STATES,Recruiting,"Target PharmaSolutions, Inc.","April 13, 2020",Observational,An Observational Study of Patients With Coronavirus Disease 2019
430,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,COVID,"February 08, 2021",120,NCT04331899,PEGINTERFERON LAMBDA-1A; PLACEBO,UNITED STATES,"Active, not recruiting",Stanford University,"April 24, 2020",Interventional,"A Phase 2 Randomized, Single-Blind Study of a Single Dose of Peginterferon Lambda-1a (Lambda) Compared With Placebo in Outpatients With Mild COVID-19"
431,COVID-19 Biological Samples Collection,INFECTION VIRAL,"February 08, 2021",2000,NCT04332016,BIOLOGICAL SAMPLES COLLECTION,FRANCE,Recruiting,"University Hospital, Bordeaux","April 2, 2020",Observational,Biological Samples Collection From Patients and Caregivers Treated at Bordeaux University Hospital for Asymptomatic and Symptomatic Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Infection (COVID-19).
432,TOFAcitinib in SARS-CoV2 Pneumonia,SARS-CoV2 RELATED INTERSTITIAL PNEUMONIA,"February 08, 2021",50,NCT04332042,TOFACITINIB,ITALY,Not yet recruiting,Università Politecnica delle Marche,"April 10, 2020",Interventional,TOFAcitinib in Patients With Early Onset SARS-CoV2 Interstitial Pneumonia
433,Hyperbaric Oxygen for COVID-19 Patients,COVID,"February 08, 2021",20,NCT04332081,HYPERBARIC OXYGEN THERAPY (HBOT),UNITED STATES,Terminated,NYU Langone Health,"April 6, 2020",Interventional,Open Label Single-Center Study of Emergency Hyperbaric Oxygen for Respiratory Distress in Patients With COVID-19
434,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",COVID,"February 08, 2021",276,NCT04332094,TOCILIZUMAB; HYDROXYCHLOROQUINE; AZITHROMYCIN,SPAIN,Recruiting,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,"April 2, 2020",Interventional,"Pilot, Randomized, Multicenter, Open-label Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of SARS-CoV-2 Infection (COVID-19)"
435,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,COVID; SARS-CoV2,"February 08, 2021",2271,NCT04332107,AZITHROMYCIN; PLACEBOS,UNITED STATES,Recruiting,Thomas M. Lietman,"May 22, 2020",Interventional,Azithromycin for Prevention of Disease Progression in Patients With Mild or Moderate COVID-19
436,Convalescent Plasma for Patients With COVID-19: A Pilot Study,CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",10,NCT04332380,PLASMA,COLOMBIA,Completed,Universidad del Rosario,"May 1, 2020",Interventional,Convalescent Plasma for Patients With COVID-19: A Pilot Study
437,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",CORONAVIRUS; RESPIRATORY FAILURE; CORONAVIRUS SARS-ASSOCIATED AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE; SARS-CoV2,"February 08, 2021",60,NCT04332666,ANGIOTENSIN 1-7; PLACEBOS,,Not yet recruiting,Erasme University Hospital,"September 30, 2020",Interventional,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial"
438,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",92,NCT04332835,PLASMA; STANDARD THERAPY,COLOMBIA,Completed,Universidad del Rosario,"August 8, 2020",Interventional,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study"
439,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,COVID PNEUMONIA,"February 08, 2021",30,NCT04332913,,ITALY,Recruiting,University of L'Aquila,"April 1, 2020",Observational,Efficacy and Safety of Tocilizumab in the Treatment of Patients With Respiratory Distress Syndrome and Cytokine Release Syndrome Secondary to COVID-19: a Proof of Concept Study
440,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,CORONAVIRUS; ACUTE RESPIRATORY INFECTION; SARS-COV INFECTION,"February 08, 2021",479,NCT04332991,HYDROXYCHLOROQUINE; PLACEBO,UNITED STATES,Completed,Massachusetts General Hospital,"April 2, 2020",Interventional,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
441,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,COVID,"February 08, 2021",228,NCT04333225,HYDROXYCHLOROQUINE,UNITED STATES,Completed,Baylor Research Institute,"April 3, 2020",Interventional,A Prospective Clinical Study of Hydroxychloroquine in the Prevention of SARS- CoV-2 (COVID-19) Infection in Healthcare Workers After High-risk Exposures
442,Study Testing Convalescent Plasma vs Best Supportive Care,"PNEUMONIA, INTERSTITIAL","February 08, 2021",115,NCT04333251,HIGH-TITER ANTI-SARS-COV-2 PLASMA; OXYGEN THERAPY,,Not yet recruiting,Baylor Research Institute,"April 1, 2020",Interventional,Evaluating Convalescent Plasma to Decrease Coronavirus Associated Complications. A Phase I Study Comparing the Efficacy and Safety of High-titer Anti-Sars-CoV-2 Plasma vs Best Supportive Care in Hospitalized Patients With Interstitial Pneumonia Due to COVID-19
443,Safety in Convalescent Plasma Transfusion to COVID-19,COVID,"February 08, 2021",20,NCT04333355,CONVALESCENT PLASMA,MEXICO,Recruiting,Hospital San Jose Tec de Monterrey,"May 8, 2020",Interventional,Phase 1 Study to Evaluate the Safety of Convalescent Plasma as an Adjuvant Therapy in Patients With SARS-CoV-2 Infection
444,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",47,NCT04333368,UMBILICAL CORD WHARTON'S JELLY-DERIVED HUMAN; NACL 0.9%,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"April 6, 2020",Interventional,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS
445,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,COVID,"February 08, 2021",3170,NCT04333407,ASPIRIN 75MG; CLOPIDOGREL 75MG; RIVAROXABAN 2.5 MG; ATORVASTATIN 40MG; OMEPRAZOLE 20MG,UNITED KINGDOM,Recruiting,Imperial College London,"April 3, 2020",Interventional,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
446,"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",SEVERE COVID PNEUMONIA,"February 08, 2021",390,NCT04333420,SOC + IFX-1; SOC + PLACEBO,GERMANY,Recruiting,InflaRx GmbH,"March 31, 2020",Interventional,"A Pragmatic Adaptive Randomized, Controlled Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 Pneumonia"
447,Piclidenoson for Treatment of COVID-19,COVID; CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04333472,PICLIDENOSON; PLACEBO,ISRAEL,Recruiting,Can-Fite BioPharma,"January 6, 2021",Interventional,"Piclidenoson for Treatment of COVID-19 - A Randomized, Double-Blind, Placebo-Controlled Trial"
448,Application of Desferal to Treat COVID-19,COVID,"February 08, 2021",50,NCT04333550,DEFEROXAMINE,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Kermanshah University of Medical Sciences,April 2020,Interventional,Application of Iron Chelator (Desferal) to Reduce the Severity of COVID-19 Manifestations
449,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,COVID,"February 08, 2021",210,NCT04333589,FAVIPIRAVIR,CHINA,Recruiting,Peking University First Hospital,"April 1, 2020",Interventional,"The Mechanism, Clinical Outcome and Therapeutic Intervention of Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive"
450,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,COVID,"February 08, 2021",5,NCT04333628,CHLOROQUINE; STANDARD CARE,ISRAEL,Terminated,"HaEmek Medical Center, Israel","June 1, 2020",Interventional,"Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 in A Two Staged, Multicenter, Open Label and Randomized Trial"
451,Hydroxychloroquine in Outpatient Adults With COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",8,NCT04333654,HYDROXYCHLOROQUINE SAR321068; PLACEBO,BELGIUM,Terminated,Sanofi,"April 12, 2020",Interventional,"A Phase 1b, Randomized, Double-blinded, Placebo-controlled Study of Hydroxychloroquine in Outpatient Adults With COVID-19"
452,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,VASCULAR SURGICAL PROCEDURES; COVID; POSTOPERATIVE COMPLICATIONS,"February 08, 2021",50,NCT04333693,VASCULAR SURGERY,SPAIN,Not yet recruiting,Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery,"April 1, 2020",Observational [Patient Registry],Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study (Covid-VAS)
453,CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,COVID,"February 08, 2021",30000,NCT04333732,MR OR M-M-R II ® VACCINE; PLACEBO,GHANA,Recruiting,Washington University School of Medicine,"September 4, 2020",Interventional,"An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults"
454,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,CORONAVIRUS,"February 08, 2021",132,NCT04333849,,FRANCE,Completed,"University Hospital, Angers","March 25, 2020",Observational,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19
455,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,SARS-CoV2,"February 08, 2021",500,NCT04333862,,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","March 19, 2020",Observational,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy
456,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis,AORTIC VALVE STENOSIS,"February 08, 2021",71,NCT04333875,TAVR OR SAVR,SWITZERLAND,"Active, not recruiting","University Hospital Inselspital, Berne","March 20, 2020",Observational [Patient Registry],Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis - a Collateral Effect of the SARS-CoV-2 Pandemic (AS DEFER)
457,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,SARS-CoV2 (COVID) INFECTION; ADVANCED OR METASTATIC HEMATOLOGICAL OR SOLID TUMOR,"February 08, 2021",219,NCT04333914,AUTOPHAGY INHIBITOR (GNS651); STANDARD OF CARE; AVDORALIMAB; MONALIZUMAB,FRANCE,Recruiting,Centre Leon Berard,"April 15, 2020",Interventional,"A Prospective, Controlled, Randomized, Multicenter Study of the Efficacy of an Autophagy Inhibitor (GNS561), an Anti-NKG2A (Monalizumab) and an Anti-C5aR (Avdoralimab) Compared to the Standard of Care in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection."
458,COVID-19 in Patients With HIV,HIV/AIDS; COVID; SARS-CoV2,"February 08, 2021",500,NCT04333953,NO INTERVENTION,UNITED STATES,Recruiting,University of Missouri-Columbia,"April 1, 2020",Observational [Patient Registry],Prospective Observational Study for Patients With HIV and Confirmed SARS-CoV-2
459,Vitamin D on Prevention and Treatment of COVID-19,PATIENTS INFECTED WITH COVID,"February 08, 2021",200,NCT04334005,VITAMIN D,SPAIN,Not yet recruiting,Universidad de Granada,"April 10, 2020",Interventional,Effect of Vitamin D Administration on Prevention and Treatment of Mild Forms of Suspected Covid-19
460,Treatment of SARS Caused by COVID-19 With Ruxolitinib,COVID; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",20,NCT04334044,RUXOLITINIB ORAL TABLET,MEXICO,Recruiting,Grupo Cooperativo de Hemopatías Malignas,"September 1, 2020",Interventional,Treatment of Severe Acute Respiratory Syndrome Caused by COVID-19 With Ruxolitinib
461,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,COVID,"February 08, 2021",1363,NCT04334148,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,UNITED STATES,"Active, not recruiting",Adrian Hernandez,"April 22, 2020",Interventional,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial (HERO-HCQ Trial)
462,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,COVID,"February 08, 2021",528,NCT04334252,QUESTIONNAIRE,BELGIUM,Completed,Jessa Hospital,"April 17, 2020",Observational,Descriptive Study Regarding the Ambulant Screening Protocol for COVID-19 in Times of High SARS CoV-2 Prevalence
463,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,COVID,"February 08, 2021",750,NCT04334265,ANLUOHUAXIAN,CHINA,Recruiting,Peking University First Hospital,"April 1, 2020",Interventional,"Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019-A Multicenter, Open, Randomized Controlled Study"
464,"International COVID19 Clinical Evaluation Registry,",COVID,"February 08, 2021",8168,NCT04334291,OBSERVATIONAL (REGISTRY),SPAIN,Completed,IVAN J NUÑEZ GIL,"March 23, 2020",Observational [Patient Registry],International COVID19 Clinical Evaluation Registry: HOPECOVID19. (Health Outcome Predictive Evaluation for COVID19)
465,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,COVID,"February 08, 2021",1550,NCT04334382,HYDROXYCHLOROQUINE; AZITHROMYCIN,UNITED STATES,Recruiting,"Intermountain Health Care, Inc.","April 2, 2020",Interventional,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial
466,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),TELEREHABILITATION,"February 08, 2021",30,NCT04334434,TELEREHABILITATION,TURKEY,Completed,"Kubra Koce, MSc PT","July 30, 2020",Interventional,Investigation Of The Effectiveness Of The Telerehabilitation Applied To Individuals Over The Age Of 65 Who Experience Social Isolation At Houses Due To The Coronavirus (Covid-19) Pandemic
467,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,SARS-CoV2; COVID,"February 08, 2021",120,NCT04334460,BLD-2660,BRAZIL,"Active, not recruiting",Blade Therapeutics,"May 4, 2020",Interventional,"Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Antiviral Activity of BLD-2660 in Hospitalized Subjects With Recently Diagnosed COVID-19 Compared to Standard of Care Treatment"
468,A Study of Quintuple Therapy to Treat COVID-19 Infection,COVID; CORONAVIRUS INFECTION; CORONAVIRUS-19; SARS-CoV2,"February 08, 2021",600,NCT04334512,HYDROXYCHLOROQUINE; AZITHROMYCIN; VITAMIN C; VITAMIN D; ZINC,UNITED STATES,Recruiting,ProgenaBiome,"June 22, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Quintuple Therapy to Treat COVID-19 Infection"
469,LIBERATE Trial in COVID-19,CORONAVIRUS; RESPIRATORY DISTRESS SYNDROME; SARS-COV INFECTION,"February 08, 2021",230,NCT04334629,IBUPROFEN,UNITED KINGDOM,Recruiting,King's College London,"May 26, 2020",Interventional,"Lipid Ibuprofen Versus Standard of Care for Acute Hypoxemic Respiratory Failure Due to COVID-19: a Multicentre, Randomised, Controlled Trial"
470,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,COVID; PNEUMONIA,"February 08, 2021",194,NCT04334850,COMBINED USE OF A RESPIRATORY BROAD PANEL MULTIPLEX PCR AND PROCALCITONIN; USUAL ANTIBIOTIC TREATMENT,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 20, 2020",Interventional,"Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia : a Multicenter, Parallel-group, Open-label, Randomized Controlled Trial"
471,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers,SARS-CoV2,"February 08, 2021",340,NCT04334876,SARS-COV-2 IGG ANTIBODY TESTING KIT,,Not yet recruiting,Indiana University,"April 1, 2020",Observational,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers and Candidacy for Convalescent Plasma Therapy/Prophylaxis
472,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,CORONAVIRUS INFECTION,"February 08, 2021",4000,NCT04334928,EMTRICITABINE/TENOFOVIR DISOPROXIL; HYDROXYCHLOROQUINE; PLACEBO: EMTRICITABINE/TENOFOVIR DISOPROXIL PLACEBO; PLACEBO: HYDROXYCHLOROQUINE,SPAIN,Recruiting,Plan Nacional sobre el Sida (PNS),"April 15, 2020",Interventional,Prevention of SARS-CoV-2 (COVID-19) Through Pre-Exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial Controlled With Placebo
473,SARS-COV2 Pandemic Serosurvey and Blood Sampling,SARS-CoV2 VIRUS,"February 08, 2021",15000,NCT04334954,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"August 26, 2020",Observational,SARS-COV2 Pandemic Serosurvey and Blood Sampling
474,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,COVID; CORONAVIRUS INFECTION; SARS-CoV2; 2019-NCOV; 2019 NOVEL CORONAVIRUS,"February 08, 2021",13,NCT04334967,HYDROXYCHLOROQUINE; VITAMIN C,UNITED STATES,Suspended,Providence Health & Services,"March 30, 2020",Interventional,Randomized Study to Evaluate the Safety and Antiviral Efficacy of Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care Treatment
475,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",COVID,"February 08, 2021",24,NCT04334980,BACTRL-SPIKE,AUSTRALIA,Recruiting,Symvivo Corporation,"November 2, 2020",Interventional,"A Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Immunogenicity of the bacTRL-Spike Oral Candidate Vaccine for the Prevention of COVID-19 in Healthy Adults"
476,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,2019-NCOV (COVID); INTERSTITIAL PNEUMONIA,"February 08, 2021",300,NCT04335019,PULMONARY ULTRASOUND,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Observational,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +
477,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),SARS-CoV2,"February 08, 2021",284,NCT04335032,EICOSAPENTAENOIC ACID GASTRO-RESISTANT CAPSULES; PLACEBO,,Not yet recruiting,S.L.A. Pharma AG,"November 9, 2020",Interventional,"A Randomised, Double-blind, Placebo Controlled Study of Eicosapentaenoic Acid (EPA-FFA) Gastro-resistant Capsules to Treat Hospitalised Subjects With Confirmed SARS-CoV-2"
478,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),SARS-CoV2 INFECTION,"February 08, 2021",5,NCT04335071,TOCILIZUMAB (TCZ); PLACEBO,SWITZERLAND,Terminated,"University Hospital Inselspital, Berne","April 26, 2020",Interventional,"CORON-ACT - a Multicenter, Double-blind, Randomized Controlled Phase II Trial on the Efficacy and Safety of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)"
479,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",COVID; CORONAVIRUS INFECTION; SARS-CoV2; CORONAVIRUS INFECTION; COVID; CORONAVIRUS; CORONAVIRUS-19; CORONAVIRUS 19,"February 08, 2021",600,NCT04335084,HYDROXYCHLOROQUINE; VITAMIN C; VITAMIN D; ZINC,UNITED STATES,Recruiting,ProgenaBiome,"June 22, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection"
480,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,COVID,"February 08, 2021",214,NCT04335097,BIOSENSORS,NORWAY,Recruiting,Lars Wik,"April 22, 2020",Interventional,"Sensor Based Vital Signs Monitoring of Patients With Clinical Manifestation of Covid 19 Disease During Home Isolation, a Randomized Feasibility Study"
481,Study of Open Label Losartan in COVID-19,COVID,"February 08, 2021",34,NCT04335123,LOSARTAN,UNITED STATES,Completed,University of Kansas Medical Center,"April 4, 2020",Interventional,An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19
482,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,COVID,"February 08, 2021",200,NCT04335136,RHACE2 APN01; PHYSIOLOGICAL SALINE SOLUTION,AUSTRIA,Completed,Apeiron Biologics,"April 30, 2020",Interventional,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
483,Cardiovascular Complications and COVID-19 (CovCardioVasc-Study),COVID; ACUTE CORONARY SYNDROME; MYOCARDIAL INFARCTION; MYOCARDITIS; VENOUS THROMBOEMBOLISM; DEEP VEIN THROMBOSIS; PULMONARY EMBOLISM,"February 08, 2021",100,NCT04335162,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"February 28, 2020",Observational,Cardiovascular Complications in Patients With COVID-19
484,COVID-19 Registry Rhineland-Palatinate (Germany),COVID,"February 08, 2021",4000,NCT04335188,PROSPECTIVE OBERSERVATIONAL REGISTRY,GERMANY,Recruiting,IHF GmbH - Institut für Herzinfarktforschung,"April 6, 2020",Observational,"COVID-19 Registry Rhineland-Palatinate (Germany) - COVID-19 Disease Registry a National, Multicentre, Non-interventional, Prospective Observational Study"
485,Defibrotide in COVID-19 Pneumonia,PATIENTS WITH COVID PNEUMONIA WILL ALLOW TO DETECT AN ABSOLUTE REDUCTION IN THE RATE OF RESPIRATORY-FAILURE,"February 08, 2021",50,NCT04335201,DEFIBROTIDE INJECTION,,Not yet recruiting,IRCCS San Raffaele,"April 6, 2020",Interventional,Use of Defibrotide to Reduce Progression of Acute Respiratory Failure Rate in Patients With COVID-19 Pneumonia
486,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,"SCLERODERMA; SCLERODERMA, SYSTEMIC; SYSTEMIC SCLEROSIS","February 08, 2021",172,NCT04335279,SPIN-CHAT PROGRAM,CANADA,Completed,Lady Davis Institute,"April 9, 2020",Interventional,A Partially Nested RCT to Evaluate the Effectiveness of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together (SPIN-CHAT) Program to Reduce Anxiety Among At-Risk Scleroderma Patients
487,Checkpoint Blockade in COVID-19 Pandemic,"COVID; PNEUMONIA, VIRAL","February 08, 2021",24,NCT04335305,TOCILIZUMAB; PEMBROLIZUMAB (MK-3475),SPAIN,Recruiting,MedSIR,"April 9, 2020",Interventional,"A Randomized, Controlled, Open-Label, Phase II Trial to Evaluate the Efficacy and Safety of Tocilizumab Combined With Pembrolizumab (MK-3475) in Patients With Coronavirus Disease 2019 (COVID-19)-Pneumonia"
488,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",SARS-CoV2,"February 08, 2021",11,NCT04335552,STANDARD OF CARE; HYDROXYCHLOROQUINE; AZITHROMYCIN,UNITED STATES,Terminated,Duke University,"April 17, 2020",Interventional,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection"
489,Cardiovascular Manifestations of COVID-19,CARDIOVASCULAR DISEASES; COVID,"February 08, 2021",500,NCT04335630,"ELECTROCARDIOGRAM, TELEMETRY, ECHOCARDIOGRAM, LABORATORY VALUES",UNITED STATES,Recruiting,Memorial Hermann Health System,"March 30, 2020",Observational,Cardiovascular Manifestations of Hospitalized Patients With Coronavirus Disease 2019
490,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; AXIAL SPONDYLOARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; GIANT CELL ARTERITIS,"February 08, 2021",333,NCT04335747,COVID-19 INFECTION,DENMARK,Recruiting,Salome Kristensen,"April 23, 2020",Observational,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases
491,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",PEDIATRIC RESPIRATORY DISEASES; COVID; FATIGUE POST VIRAL,"February 08, 2021",350,NCT04335773,,NORWAY,Recruiting,"University Hospital, Akershus","April 3, 2020",Observational [Patient Registry],"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology"
492,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,ACUTE RESPIRATORY DISTRESS SYNDROME; SARS-CoV2; COVID; COVID; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",651,NCT04335786,VALSARTAN (DIOVAN); PLACEBO ORAL TABLET,NETHERLANDS,Recruiting,Radboud University,"April 17, 2020",Interventional,"PRAETORIAN-COVID: A Double-blind, Placebo-controlled Randomized Clinical Trial With Valsartan for PRevention of Acute rEspiraTORy dIstress Syndrome in hospitAlized patieNts With SARS-COV-2 (COVID-19) Infection Disease"
493,Video-Based Exercises and Well-Being During Social Isolation,SOCIAL ISOLATION; PHYSICAL INACTIVITY; WELL-BEING,"February 08, 2021",68,NCT04335851,VIDEO BASED AEROBIC EXERCISE,TURKEY,Completed,Biruni University,"April 6, 2020",Interventional,Effectiveness of Video-Based Exercises on Physical and Emotional Well-Being During COVID-19 Induced Social Isolation
494,Rutgers COVID-19 Cohort Study,CORONAVIRUS; SARS-CoV2,"February 08, 2021",750,NCT04336215,NON-INTERVENTIONAL,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","April 7, 2020",Observational,"Cohort Study of SARS-CoV-2 Incidence, Transmission, and Disease Severity in Healthcare Workers"
495,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,COVID,"February 08, 2021",20,NCT04336254,ALLOGENEIC HUMAN DENTAL PULP STEM CELLS (BSH BTC & UTOOTH BTC); INTRAVENOUS SALINE INJECTION (PLACEBO),CHINA,Recruiting,Renmin Hospital of Wuhan University,"April 6, 2020",Interventional,"Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe Pneumonia of COVID-19：a Single-center, Prospective, Randomised Clinical Trial"
496,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,SARS-CoV2; COVID,"February 08, 2021",160,NCT04336332,HYDROXYCHLOROQUINE SULFATE + AZITHROMYCIN; HYDROXYCHLOROQUINE SULFATE,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","April 1, 2020",Interventional,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19
497,Outcomes of Patients With COVID-19 in the Intensive Care Unit,CORONAVIRUS INFECTION; COVID; VIRAL PNEUMONIA HUMAN CORONAVIRUS,"February 08, 2021",150,NCT04336345,,MEXICO,Completed,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"April 1, 2020",Observational [Patient Registry],Outcomes of Patients With COVID-19 in the Intensive Care Unit: A National Observational Study (Mexico COVID-19 ICU Study)
498,Impact of Covid-19 in Congenital Heart Disease,CONGENITAL HEART DISEASE; COVID,"February 08, 2021",5000,NCT04336384,,FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Impact of Covid-19 in Congenital Heart Disease - COVID-CHD
499,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",CORONAVIRUS INFECTION,"February 08, 2021",120,NCT04336410,INO-4800; CELLECTRA® 2000,UNITED STATES,"Active, not recruiting",Inovio Pharmaceuticals,"April 3, 2020",Interventional,"Phase 1 Open-label Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers"
500,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,COVID,"February 08, 2021",100,NCT04336462,OXYHYDROGEN; OXYGEN,CHINA,Recruiting,Shanghai Asclepius Meditec Inc.,"February 15, 2020",Interventional,"A Multi-center, Randomized, Parallel-Controlled Clinical Trial of the Application of A Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19"
501,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,COVID,"February 08, 2021",100,NCT04336657,QUESTIONNAIRE; IGG,EGYPT,Recruiting,Assiut University,April 2020,Observational,COVID-19-Like Illness: Did we Have Unusual Severe Respiratory Tract Infections October-December 2019 Before WHO Announcement ?
502,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,SARS-CoV2; INFECTION VIRAL; HEALTHCARE WORKER; PROPHYLAXIS,"February 08, 2021",440,NCT04336748,HYDROXYCHLOROQUINE,,Not yet recruiting,Medical University of Vienna,April 2020,Interventional,"Low-dose Hydroxychloroquine for Primary Prophylaxis Against SARS-CoV-2 in Health-care Workers - a Randomized, Double-blind, Controlled Trial"
503,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,CORONAVIRUS; COVID; INFECTION VIRAL,"February 08, 2021",914,NCT04336761,NASOPHARYNGEAL SWAB,FRANCE,Recruiting,"University Hospital, Lille","April 15, 2020",Observational,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France
504,CAPTION AI to Minimize Risk of COVID Exposure,COVID,"February 08, 2021",0,NCT04336774,CAPTION AI,UNITED STATES,Withdrawn,Duke University,July 2020,Interventional,Use of Caption AI to Perform a Clinically Indicated Transthoracic Echocardiogram in Patients Being Evaluated for or Positive for COVID-19
505,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",COVID; CORONAVIRUS INFECTION; PREGNANCY RELATED,"February 08, 2021",100,NCT04336787,SURVEY,TURKEY,Not yet recruiting,Istanbul Kültür University,"April 12, 2020",Observational,"Determination Of Physical Activity, Sleep And Stress Level Of Pregnant Women In The Covıd-19 Quarantine Period"
506,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,COVID,"February 08, 2021",100,NCT04336904,FAVIPIRAVIR; PLACEBO,ITALY,"Active, not recruiting",Giuliano Rizzardini,"March 25, 2020",Interventional,"A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Patients With COVID-19-Moderate Type"
507,Covid-19 Pediatric Observatory,COVID,"February 08, 2021",250,NCT04336956,HOSPITALIZED CHILDREN WITH COVID19,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"April 7, 2020",Observational [Patient Registry],Covid-19 Pediatric Observatory
508,Renin Angiotensin System - CoronaVirus,COVID,"February 08, 2021",50,NCT04337008,BLOOD DRAW,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"April 3, 2020",Interventional,Renin Angiotensin System - CoronaVirus
509,Distress in Crisis Situations During COVID-19,"STRESS, PSYCHOLOGICAL","February 08, 2021",2000,NCT04337047,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,Wefight,"March 31, 2020",Observational,Distress During the COVID-19 Pandemic in France: a National Assessment of At-risk Populations
510,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,MAGEC ROD,"February 08, 2021",100,NCT04337151,MAGEC SPINE ROD; TITANIUM BLOOD TEST,UNITED KINGDOM,Recruiting,Royal National Orthopaedic Hospital NHS Trust,April 2020,Observational,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment
511,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100,NCT04337190,BLOOD SAMPLING,FRANCE,Recruiting,"University Hospital, Angers","April 3, 2020",Observational,Impact of Previous Treatment With Angiotensin II Receptor Blockers in Patients With SARS-Cov2 Infection Admitted to the Intensive Care Unit on Survival and Severity of the Disease (COVID-ARA2)
512,"Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study",COVID; MATERNAL-FETAL RELATIONS,"February 08, 2021",40,NCT04337320,NEWBORNS FROM COVID 19 POSITIVE MOTHERS,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 15, 2020",Observational,Maternal And Neonatal Outcome of Pregnant Patients With COVID-19
513,Evaluation of Covid 19 Anxiety in Endometriosis Patients,ENDOMETRIOSIS; COVID,"February 08, 2021",80,NCT04337346,,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"April 5, 2020",Observational [Patient Registry],Endometriosis Patients Covid 19 Anxiety
514,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,SEVERE/VERY SEVERE COVID ILLNESS,"February 08, 2021",,NCT04337359,RUXOLITINIB,,No longer available,Novartis Pharmaceuticals,,Expanded Access,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness
515,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2,SARS-CoV2,"February 08, 2021",627,NCT04337424,SAMPLING SALIVARY,FRANCE,Completed,"University Hospital, Montpellier","April 13, 2020",Observational,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2
516,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),CORONAVIRUS,"February 08, 2021",200,NCT04337489,SENSIUMVITALS WEARABLE SENSOR,,Not yet recruiting,Imperial College London,"July 28, 2020",Observational,REmote MOniToring usE in Suspected Cases of COVID-19 (Coronavirus): REMOTE-COVID Trial
517,Clinical and Radiomic Model of COVID-19,CORONAVIRUS; MACHINE LEARNING,"February 08, 2021",300,NCT04337502,MACHINE LEARNING MODEL,CHINA,Completed,Maastricht University,"December 23, 2019",Observational,A Clinical and Radiological Model to Predict the Prognosis for COVID-19 Patients
518,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,COVID,"February 08, 2021",6000,NCT04337541,SURGICAL FACIAL MASK,DENMARK,Completed,"Rigshospitalet, Denmark","April 2, 2020",Interventional,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System
519,Beat COVID-19 - Observational Trial,COVID,"February 08, 2021",100000,NCT04337762,,UNITED STATES,Recruiting,Beat COVID LLC,"April 6, 2020",Observational,A Virtual Observational Protocol to Gain Longitudinal Data in Participants to Help Understand COVID-19 Spread and Disease Progression
520,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04337788,TELEHEALTH APPLICATIONS,,Not yet recruiting,"University Hospital, Limoges",May 2020,Interventional,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With Symptoms of Confirmed or Probable COVID-19 Disease
521,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",143,NCT04337918,NORS (NITRIC OXIDE RELEASING SOLUTION); NORS (NITRIC OXIDE RELEASING SOLUTION),CANADA,"Active, not recruiting",Sanotize Research and Development corp.,"May 8, 2020",Interventional,"Multi-Center, Randomized, Controlled, Phase II Clinical Efficacy Study Evaluating Nitric Oxide Releasing Solution Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers and Individuals at Risk of Infection"
522,Hemodynamic Characteristics of Patients With SARS-CoV-2,CORONAVIRUS; SARS-CoV2; COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; SHOCK; ACUTE CIRCULATORY FAILURE; LEFT VENTRICULAR DYSFUNCTION; FLUID OVERLOAD,"February 08, 2021",200,NCT04337983,TRANSPULMONARY THERMODILUTION; ECHOCARDIOGRAPHY,FRANCE,Recruiting,Bicetre Hospital,"March 13, 2020",Observational,Hemodynamic Characteristics of Patients With SARS-CoV-2: PiCCOVID Study
523,Dynamic Evaluation of COVID-19 Diagnostic Tests,COVID,"February 08, 2021",8,NCT04337996,COVID-19 DIAGNOSTIC TEST,FRANCE,Completed,Tourcoing Hospital,"July 13, 2020",Interventional,Dynamic Evaluation of COVID-19 Diagnostic Tests
524,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,COVID,"February 08, 2021",152,NCT04338009,DISCONTINUATION OF ARB/ACEI; CONTINUATION OF ARB/ACEI,UNITED STATES,Enrolling by invitation,University of Pennsylvania,"March 31, 2020",Interventional,The Randomized Elimination or Prolongation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Coronavirus Disease 2019
525,TXA and Corona Virus 2019 (COVID19) in Outpatients,COVID,"February 08, 2021",100,NCT04338074,TRANEXAMIC ACID TABLETS; PLACEBO ORAL TABLET,UNITED STATES,Recruiting,University of Alabama at Birmingham,"June 1, 2020",Interventional,Exploratory Studies of the Effect of Tranexamic Acid Treatment on the Progression of COVID19 in Outpatients
526,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,COVID; CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04338100,FOLLOW-UP AT 14 DAYS,,Not yet recruiting,"University Hospital, Angers","April 6, 2020",Observational,Point Of Care UltraSonography to Perform Risk-stratification of Patients With Suspected or Confirmed COVID-19 - POCUSCO Study
527,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,COVID,"February 08, 2021",60,NCT04338126,TRANEXAMIC ACID; PLACEBO ORAL TABLET,UNITED STATES,Not yet recruiting,University of Alabama at Birmingham,"September 30, 2021",Interventional,Exploratory Studies of the Effect of Tranexamic Acid Treatment on the Progression of COVID19 in Inpatients
528,CAP-1002 in Severe COVID-19 Disease,COVID,"February 08, 2021",,NCT04338347,CAP-1002 ALLOGENEIC CARDIOSPHERE-DERIVED CELLS,UNITED STATES,No longer available,Capricor Inc.,,Expanded Access,CAP-1002 Treatment in Patients With Severe COVID-19 and in Critical Condition as Indicated by Life Support Measurements
529,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,COVID,"February 08, 2021",,NCT04338360,COVID-19 CONVALESCENT PLASMA,UNITED STATES,Approved for marketing,Mayo Clinic,,Expanded Access,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19
530,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,COVID PNEUMONIA; LUNG ULTRASOUND,"February 08, 2021",50,NCT04338568,LUNG ULTRASOUND,BELGIUM,Recruiting,Hasselt University,"April 16, 2020",Interventional,Accuracy and Inter-observer Variability of Lung Ultrasound in COVID-19 Pneumonia
531,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,"EMERGENCY SERVICE, HOSPITAL; GENERAL SURGERY","February 08, 2021",10000,NCT04338672,COVID-19 PANDEMIC,ISRAEL,Recruiting,Sheba Medical Center,"April 5, 2020",Observational,The Impact of the Coronavirus Disease 2019 (Covid-19) Outbreak on Emergency Room Attendances of Surgical Patients at a Tertiary Medical Center
532,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",COVID,"February 08, 2021",500,NCT04338698,HYDROXYCHLOROQUINE; OSELTAMIVIR; AZITHROMYCIN,PAKISTAN,Recruiting,Shehnoor Azhar,"April 22, 2020",Interventional,Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment
533,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,COVID; NINTEDANIB; SAFETY; EFFECT OF DRUGS,"February 08, 2021",96,NCT04338802,NINTEDANIB 150 MG; PLACEBO,,Not yet recruiting,Huilan Zhang,"April 2, 2020",Interventional,"Efficacy and Safety of Nintedanib Ethanesulfonate Soft Capsule in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID-9(COVID 19) : a Single-center, Randomized, Placebo-controlled Study"
534,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,COVID,"February 08, 2021",260,NCT04338828,NITRIC OXIDE GAS; INHALED SUPPLEMENTAL OXYGEN,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 18, 2020",Interventional,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the Emergency Department
535,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection,CORONAVIRUS INFECTION,"February 08, 2021",3133,NCT04338841,HOME-COV RULE IMPLEMENTATION,BELGIUM,Completed,"University Hospital, Angers","April 9, 2020",Interventional,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With Confirmed or Probable SARS-CoV-2 Infection. A Before and After Implementation of a Consensus Help-decision Making Rule Study
536,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,COVID,"February 08, 2021",0,NCT04338906,CAMOSTAT MESILATE; PLACEBO; HYDROXYCHLOROQUINE,,Withdrawn,"Heinrich-Heine University, Duesseldorf",May 2020,Interventional,Evaluation of the Efficacy and Safety of Camostat Mesilate + Hydroxychloroquine Combination Therapy in Hospitalized Patients With Moderate COVID-19 Infection
537,COVID-19 and Deep Venous Thrombosis,COVID; DEEP VEIN THROMBOSIS (DVT)/THROMBOPHLEBITIS,"February 08, 2021",12,NCT04338932,,BELGIUM,Completed,Jessa Hospital,"April 17, 2020",Observational,COVID-19 and Deep Venous Thrombosis: a Cross-sectional Study
538,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,COVID,"February 08, 2021",800,NCT04338945,COVID-SURGRES QUESTIONAIRE,ITALY,Completed,Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,"March 15, 2020",Observational,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy: an Italian Polispecialistic Society of Young Surgeons (S.P.I.G.C.) Survey
539,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,COVID,"February 08, 2021",200,NCT04338958,RUXOLITINIB,GERMANY,Recruiting,University of Jena,"April 22, 2020",Interventional,A Phase-II Clinical Trial for First Line Treatment of Stage II/III Covid-19 Patients to Treat Hyperinflammation
540,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,"CHARACTERISTICS DISEASES; OUTCOME, FATAL","February 08, 2021",200,NCT04339322,FOLLOW UP,,Not yet recruiting,Assiut University,"May 1, 2020",Observational,Characteristics and Outcome of COVID-19 Among Egyptian Patients
541,COVID-19 Risk Stratification,CORONAVIRUS; CORONAVIRUS SARS-ASSOCIATED AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE,"February 08, 2021",1326,NCT04339387,,UNITED STATES,Completed,Brigham and Women's Hospital,"March 1, 2020",Observational,COVID-19 Risk Stratification
542,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,COVID,"February 08, 2021",25,NCT04339426,ATOVAQUONE/AZITHROMYCIN,UNITED STATES,Recruiting,HonorHealth Research Institute,"April 20, 2020",Interventional,"Open-Label, Non-Randomized Study to Evaluate Anti-Malarial/Anti-Infective Combination Therapies in Patients With Confirmed COVID-19 Infection"
543,Max COVID19- Study,COVID,"February 08, 2021",10000,NCT04339608,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 2, 2020",Observational,"A Prospective, Longitudinal, Observational Study of Healthcare Workers and the General Population to Watch for Flu-like Symptoms in Suspicion of COVID 19"
544,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,COVID; DRUG EFFECT; DRUG INTERACTION; ADVERSE DRUG EVENT,"February 08, 2021",12123,NCT04339634,SIMULATION OF REPURPOSED DRUGS FOR COVID-19,UNITED STATES,"Active, not recruiting",Tabula Rasa HealthCare,"April 7, 2020",Observational,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy
545,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,COVID,"February 08, 2021",30,NCT04339660,UC-MSCS; PLACEBO,CHINA,Recruiting,Puren Hospital Affiliated to Wuhan University of Science and Technology,"February 1, 2020",Interventional,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia
546,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.,THE GOLD STANDARD FOR CURRENT SARS COV2 DETECTION IS RT-PCR,"February 08, 2021",56000,NCT04339686,THORACIC CT SCAN,FRANCE,Recruiting,Poitiers University Hospital,"April 20, 2020",Observational,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. Comparison to Virological Testing and Multiparametric Gold Standard
547,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,COVID; VIRUS DISEASES; MACROPHAGE ACTIVATION SYNDROME; CORONAVIRUS INFECTION,"February 08, 2021",102,NCT04339712,ANAKINRA; TOCILIZUMAB,GREECE,Completed,Hellenic Institute for the Study of Sepsis,"April 2, 2020",Interventional,Efficiency in Management of Organ Dysfunction Associated With Infection by the Novel SARS-CoV-2 Virus (COVID-19) Through a Personalized Immunotherapy Approach: the ESCAPE Clinical Trial
548,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,HEALTHY VOLUNTEER; MOOD DISORDER; ANXIETY DISORDER; PREEXISTING MEDICAL CONDITION,"February 08, 2021",10000,NCT04339790,,UNITED STATES,"Active, not recruiting",National Institute of Mental Health (NIMH),"April 7, 2020",Observational,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers
549,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,COVID; RESPIRATORY FAILURE,"February 08, 2021",3,NCT04339816,AZITHROMYCIN; HYDROXYCHLOROQUINE; PLACEBO,CZECHIA,Terminated,"Frantisek Duska, MD, PhD","May 13, 2020",Interventional,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care Due to Coronavirus Disease 2019 (COVID-19)- Randomised Controlled Trial
550,Eating Habits of Adults During the Quarantine,HEALTH BEHAVIOR; EATING BEHAVIOR,"February 08, 2021",673,NCT04339842,ASSESSMENT OF DIETARY CHANGES IN ADULTS IN THE QUARANTINE,CYPRUS,Completed,Eliz Arter,"April 10, 2020",Observational,Eating Habits of Adults During the Quarantine
551,NOsocomial Dissemination Risk of SARS-Cov2,SARS-CoV2,"February 08, 2021",2523,NCT04339881,,FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"April 17, 2020",Observational [Patient Registry],NOsocomial Dissemination Risk of SARS-Cov2
552,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),CORONAVIRUS INFECTION; COVID; COVID; SARS-CoV2,"February 08, 2021",500,NCT04339998,POINT-OF-CARE ULTRASONOGRAPHY (POCUS),UNITED STATES,Recruiting,University of Minnesota,"April 15, 2020",Observational,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)
553,COVID-19 Convalescent Plasma,CORONAVIRUS,"February 08, 2021",10,NCT04340050,ANTI-SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,Completed,University of Chicago,"April 10, 2020",Interventional,Pilot Study for Use of Convalescent Plasma Collected From Patients Recovered From COVID-19 Disease for Transfusion as an Empiric Treatment During the 2020 Pandemic at the University of Chicago Medical Center
554,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",CANCER,"February 08, 2021",394,NCT04340219,SURVEY ADMINISTRATION,BELGIUM,Completed,"University Hospital, Ghent","March 30, 2020",Observational,"A Prospective Cohort Study Investigating Oncology-patient-reported Anxiety, Mood, and Quality of Life During the COVID-19 Pandemic (ONCOVID Trial)"
555,Safety and Efficacy of Baricitinib for COVID-19,COVID,"February 08, 2021",80,NCT04340232,BARICITINIB,UNITED STATES,Not yet recruiting,"University of Colorado, Denver",November 2020,Interventional,Safety and Efficacy of Baricitinib for COVID-19
556,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,HYDROXYCHLOROQUINE; ANTIMALARIALS; ENZYME INHIBITORS; ANTIRHEUMATIC AGENTS,"February 08, 2021",280,NCT04340349,HYDROXYCHLOROQUINE SULFATE; BROMHEXINE 8 MG; HYDROXYCHLOROQUINE SULFATE PLACEBO; BROMHEXINE 8 MG PLACEBO,MEXICO,Enrolling by invitation,Instituto Nacional de Rehabilitacion,"May 11, 2020",Interventional,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE Trial)
557,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,COVID; ECMO,"February 08, 2021",10,NCT04340414,LOW FLOW ECMO DRIVING BY CVVH MACHINE,CHINA,Recruiting,Peking Union Medical College Hospital,"February 20, 2020",Interventional,Safety and Effectiveness Study of Low Flow Extracorporeal Membrane Oxygenation（CO2 Removal） Driving by Continuous Hemofiltration Machine the Severe New Corovirus Pneumonia (NCP)
558,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,"PNEUMONIA, VIRAL; CRITICALLY ILL; CORONAVIRUS INFECTION","February 08, 2021",1003,NCT04340466,NO INTERVENTION,FRANCE,Completed,Centre Hospitalier Universitaire de Nīmes,"April 3, 2020",Observational [Patient Registry],French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management: the FRENCH CORONA Study
559,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,COVID; TRAUMA; ULTRASOUND,"February 08, 2021",20,NCT04340479,ULTRASOUND LUNG IMAGING AS PART OF FAST+ EVALUATION,UNITED STATES,Recruiting,"University of Colorado, Denver","July 30, 2020",Observational [Patient Registry],The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation
560,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,COVID,"February 08, 2021",17,NCT04340544,HYDROXYCHLOROQUINE; PLACEBO,GERMANY,Terminated,University Hospital Tuebingen,"April 22, 2020",Interventional,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease
561,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,SARS-COV INFECTION,"February 08, 2021",200,NCT04340557,LOSARTAN,UNITED STATES,Recruiting,Sharp HealthCare,"March 27, 2020",Interventional,Randomized Open Label Study of Standard of Care Plus an Angiotensin II Receptor Blocker Compared to Standard of Care Alone to Minimize the Progression to Respiratory Failure in SARS-CoV-2 Infection
562,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,CARDIOVASCULAR DISEASE ACUTE; CARDIOMYOPATHIES; COVID,"February 08, 2021",140,NCT04340921,COVID-19 EXPOSURE,UNITED KINGDOM,Recruiting,Barts & The London NHS Trust,"May 14, 2020",Observational,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury
563,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,LIVER DISEASES; LIVER CANCER; COVID,"February 08, 2021",120,NCT04341012,COLLECTION OF BREATH SAMPLE,UNITED STATES,Recruiting,Mayo Clinic,"September 10, 2019",Observational,Development of a Breath Analysis Test for Disease Diagnosis and Prognosis
564,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,COVID; LUNG INJURY,"February 08, 2021",84,NCT04341038,TACROLIMUS; METHYLPREDNISOLONE,SPAIN,Recruiting,Hospital Universitari de Bellvitge,"April 1, 2020",Interventional,Open Randomized Single Centre Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With Severe Lung Injury Secondary to COVID-19
565,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,SOLID ORGAN TRANSPLANT REJECTION; COVID,"February 08, 2021",500,NCT04341103,,,Not yet recruiting,CareDx,"April 1, 2020",Observational,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
566,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),CORONAVIRUS DISEASE 2019 COVID,"February 08, 2021",384,NCT04341116,TJ003234; PLACEBO,UNITED STATES,Recruiting,I-Mab Biopharma Co. Ltd.,"April 11, 2020",Interventional,"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)"
567,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,COV2 POSITIVE CAREGIVERS,"February 08, 2021",550,NCT04341142,SEROLOGICAL TESTS WILL BE APPLIED ON PATIENTS BLOOD SAMPLING,FRANCE,Recruiting,Hospices Civils de Lyon,"April 9, 2020",Interventional,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER
568,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",COVID; SARS-CoV2,"February 08, 2021",160,NCT04341168,THIS STUDY IS NON- INTERVENTIONAL,GERMANY,Not yet recruiting,University Hospital of Cologne,April 2020,Observational,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults"
569,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,CANCER & COVID,"February 08, 2021",1000,NCT04341207,HYDROXYCHLOROQUINE; AZITHROMYCIN,FRANCE,Recruiting,"Gustave Roussy, Cancer Campus, Grand Paris","April 3, 2020",Interventional,COVID 19 - Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease Upon Hydroxychloroquine and Azithromycin Therapy in French Cancer Patients
570,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),"ARDS, HUMAN; COVID","February 08, 2021",200,NCT04341285,ECMO IMPLANTATION,GERMANY,Not yet recruiting,University Hospital Tuebingen,"August 1, 2020",Interventional,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID)
571,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),COVID,"February 08, 2021",508,NCT04341389,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR); PLACEBO,CHINA,"Active, not recruiting","Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China","April 12, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector) in Healthy Adults Aged Above 18 Years"
572,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,COVID; SARS-COV INFECTION,"February 08, 2021",60,NCT04341415,AURICULAR NEUROMODULATION; CONTROL,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"April 9, 2020",Interventional,Randomized Double Blinded Monocentric Clinical Trial to Assess the Impact of Auricular Vagus Nerve Neuromodulation in COVID-19 Positive Inpatients Outcome.
573,Will Hydroxychloroquine Impede or Prevent COVID-19,COVID; CORONAVIRUS; CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",624,NCT04341441,HYDROXYCHLOROQUINE - DAILY DOSING; HYDROXYCHLOROQUINE - WEEKLY DOSING; PLACEBO ORAL TABLET; MONITORING VISIT - BASELINE; MONITORING VISIT - WEEK 4; MONITORING VISIT - WEEK 8; WEEKLY ASSESSMENT,UNITED STATES,Terminated,Henry Ford Health System,"April 7, 2020",Interventional,Will Hydroxychloroquine Impede or Prevent COVID-19: WHIP COVID-19 Study
574,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,GYNECOLOGICAL CANCER,"February 08, 2021",305,NCT04341480,CHEMOTHERAPY,CHINA,"Active, not recruiting",Tongji Hospital,"July 1, 2020",Observational,"The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19, a Prospective Cohort Study"
575,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",86,NCT04341493,NITAZOXANIDE 500 MG; HYDROXYCHLOROQUINE,MEXICO,Recruiting,Hugo Mendieta Zeron,"April 6, 2020",Interventional,Treatment With Hydroxychloroquine vs Nitazoxanide + Hydroxychloroquine in Patients With COVID-19 With Risk Factors for Poor Outcome
576,Non-contact ECG Sensor System for COVID19,COVID,"February 08, 2021",100,NCT04341506,NON-CONTACT ECG,UNITED STATES,Recruiting,Northwestern Medicine,"September 8, 2020",Observational,Evaluating Non-contact ECG Sensor System for Early Detection of COVID19
577,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",CORONAVIRUS INFECTION; POST-TRAUMATIC STRESS DISORDER,"February 08, 2021",1464,NCT04341519,PTSD; BURNOUT,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 6, 2020",Observational,"""Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers"" ""Impact Psychologique de l'épidémie COVID-19 Chez Les Patients, Familles et Soignants de Reanimation"" ""BURDENCOV"""
578,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",161,NCT04341584,ANAKINRA,FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"April 8, 2020",Interventional,"CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection, Nested In The CORIMUNO-19"
579,ASC Therapy for Patients With Severe Respiratory COVID-19,RESPIRATORY TRACT DISEASES,"February 08, 2021",0,NCT04341610,STEM CELL PRODUCT,DENMARK,Withdrawn,"Rigshospitalet, Denmark","April 20, 2020",Interventional,"Allogeneic Adipose Tissue Derived Mesenchymal Stromal Cell Therapy for Treating Patients With Severe Respiratory COVID-19. A Danish, Double-blind, Randomized Placebo-controlled Study"
580,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",30,NCT04341675,SIROLIMUS; PLACEBO,UNITED STATES,Recruiting,University of Cincinnati,"April 24, 2020",Interventional,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia (The SCOPE Trial)
581,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,COVID,"February 08, 2021",50,NCT04341688,GARGLE/MOUTHWASH,,Not yet recruiting,Aga Khan University,"February 1, 2021",Interventional,"A Double Blind, Randomized Controlled Pilot Trial of Gargling Agents in Reducing Intraoral Viral Load Among Laboratory Confirmed COVID-19 Patients: GARGLES STUDY"
582,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,"EFFICACY, SELF; SATISFACTION, PATIENT; TELEMEDICINE","February 08, 2021",450,NCT04341714,SATISFACTION EVALUATION,FRANCE,Recruiting,Pierre and Marie Curie University,"March 16, 2020",Observational,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic
583,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection",CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04341727,HYDROXYCHLOROQUINE SULFATE; AZITHROMYCIN; CHLOROQUINE SULFATE,UNITED STATES,Suspended,Washington University School of Medicine,"April 4, 2020",Interventional,"WU 352: Open-label, Randomized Controlled Trial of Hydroxychloroquine Alone or Hydroxychloroquine Plus Azithromycin or Chloroquine Alone or Chloroquine Plus Azithromycin in the Treatment of SARS CoV-2 Infection"
584,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,"PNEUMONIA, VIRAL; COVID","February 08, 2021",106,NCT04341766,NO SPECIAL INTERVENTION,FRANCE,Completed,Centre Hospitalier Intercommunal Creteil,"March 31, 2020",Observational [Patient Registry],Prospective Descriptive Study on the Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid19
585,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,INFECTION VIRAL; CORONAVIRUS; COVID,"February 08, 2021",1000,NCT04341792,,FRANCE,Recruiting,"University Hospital, Lille","April 11, 2020",Observational,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient Admitted to Emergency Departments During an Epidemic
586,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",COVID; SARS-CoV2 INFECTION,"February 08, 2021",27,NCT04341870,SARILUMAB; AZITHROMYCIN; HYDROXYCHLOROQUINE,FRANCE,Suspended,Assistance Publique - Hôpitaux de Paris,"April 11, 2020",Interventional,"Efficacy of Sarilumab + Azithromycin + Hydroxychloroquine, and Sarilumab Alone, for Adult Patients Hospitalized With Moderate to Severe COVID-19: a Multicenter Open-label 1:1 Randomized Controlled Trial"
587,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,DYSFUNCTIONAL WORRY,"February 08, 2021",670,NCT04341922,INTERNET-DELIVERED COGNITIVE BEHAVIOR THERAPY (ICBT) FOR DYSFUNCTIONAL WORRY RELATED TO THE COVID-19 PANDEMIC,SWEDEN,"Active, not recruiting",Karolinska Institutet,"May 9, 2020",Interventional,Evaluation of a Brief Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic: A Randomized Controlled Trial
588,Effects of DPP4 Inhibition on COVID-19,CORONAVIRUS INFECTION; TYPE 2 DIABETES,"February 08, 2021",20,NCT04341935,LINAGLIPTIN; INSULIN REGIMEN,UNITED STATES,Not yet recruiting,University of Miami,"June 30, 2021",Interventional,Effects of DPP4 Inhibition on COVID-19 Patients With Type 2 Diabetes
589,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,RESPIRATORY FAILURE; COVID,"February 08, 2021",100,NCT04342104,MONITORING FOR AGGRAVATION; EVALUATE HACOR SCORE EFFECTIVITY IN THIS PATIENTS,SPAIN,Recruiting,Hospital General Universitario Morales Meseguer,"April 1, 2020",Observational,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure
590,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,CORONAVIRUS INFECTION; HYDROXYCHLOROQUINE ADVERSE REACTION,"February 08, 2021",0,NCT04342156,HYDROXYCHLOROQUINE SULFATE 200 MILLIGRAM (MG) TAB,,Withdrawn,Tan Tock Seng Hospital,April 2020,Interventional,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19- A Cluster Randomized Controlled Trial (SHARP COVID-19 RCT)
591,University of Utah COVID-19 Hydrochloroquine Trial,CORONAVIRUS INFECTION; CORONAVIRUS; INFECTIOUS DISEASE,"February 08, 2021",400,NCT04342169,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,UNITED STATES,Recruiting,University of Utah,"April 4, 2020",Interventional,Hydroxychloroquine for Outpatients With Confirmed COVID-19
592,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),COVID,"February 08, 2021",426,NCT04342182,CONVALESCENT PLASMA,NETHERLANDS,"Active, not recruiting",Erasmus Medical Center,"April 8, 2020",Interventional,Convalescent Plasma Therapy From Recovered Covid-19 Patients as Therapy for Hospitalized Patients With Covid-19
593,Acquiring Convalescent Specimens for COVID-19 Antibodies,COVID; CORONAVIRUS INFECTION; CORONAVIRUS INFECTION,"February 08, 2021",50,NCT04342195,BLOOD DRAW,UNITED STATES,Recruiting,Columbia University,"March 25, 2020",Observational,Acquiring Convalescent Specimens to Isolate and Identify Potent Monoclonal Antibodies Against COVID-19
594,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,MUSCULOSKELETAL PAIN,"February 08, 2021",500,NCT04342208,,,Not yet recruiting,Istanbul University-Cerrahpasa,"April 10, 2020",Observational,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak
595,Hydroxychloroquine for COVID-19,"COVID, HYDROXYCHLOROQUINE SULFATE","February 08, 2021",220,NCT04342221,HYDROXYCHLOROQUINE SULFATE; PLACEBO,GERMANY,Recruiting,University Hospital Tuebingen,"March 29, 2020",Interventional,Randomized Controlled Trial of Hydroxychloroquine Versus Placebo for the Treatment of Adult Patients With Acute Coronavirus Disease 2019 - COVID-19
596,COVID-19 Endoscopy Survey,COVID,"February 08, 2021",163,NCT04342637,PRACTICE DETAILS,EGYPT,Completed,Al-Azhar University,"April 10, 2020",Observational,Gastrointestinal Endoscopy in the Era of COVID-19: a Multinational Survey
597,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,COVID; SARS-COV INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA; CLINICAL TRIAL,"February 08, 2021",152,NCT04342650,CHLOROQUINE DIPHOSPHATE; PLACEBO ORAL TABLET,BRAZIL,Completed,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,"April 8, 2020",Interventional,"Phase IIb Study to Evaluate the Efficacy and Safety of Chloroquine Diphosphate in the Treatment of Patients With Comorbidities, Without Severe Acute Respiratory Syndrome, Under the New Coronavirus (SARS-CoV2): a Double-blind, Randomized, Placebo-controlled Clinical Trial"
598,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",COVID; CORONAVIRUS,"February 08, 2021",152,NCT04342663,FLUVOXAMINE; PLACEBO,UNITED STATES,Completed,Washington University School of Medicine,"April 10, 2020",Interventional,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection"
599,The Role of Resistant Starch in COVID-19 Infection,COVID,"February 08, 2021",1500,NCT04342689,DIETARY SUPPLEMENT CONTAINING RESISTANT STARCH; PLACEBO STARCH,UNITED STATES,Recruiting,Yale University,"June 3, 2020",Interventional,The Role of Resistant Starch in COVID-19 Infection
600,A Study on the Prospective Cohort Library of COVID-19 in Southeran,FOLLOW-UP; COVID; INFECTIOUS DISEASES; RESPIRATORY,"February 08, 2021",504,NCT04342702,,CHINA,"Active, not recruiting",Second Affiliated Hospital of Wenzhou Medical University,"March 16, 2020",Observational,A Study on the Prospective Cohort Library of Novel Coronavirus Pneumonia in Southeran
601,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,COVID; CORONAVIRUS INFECTION,"February 08, 2021",520,NCT04342728,ASCORBIC ACID; ZINC GLUCONATE; ASCORBIC ACID AND ZINC GLUCONATE; STANDARD OF CARE,UNITED STATES,Enrolling by invitation,The Cleveland Clinic,"April 8, 2020",Interventional,"Coronavirus Disease 2019- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ) Research Study A Randomized, Open Label Single Center Study"
602,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",HEALTH CARE WORKER (HCW); COVID,"February 08, 2021",100000,NCT04342806,,UNITED STATES,Recruiting,Duke University,"April 10, 2020",Observational [Patient Registry],Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study
603,COVID-19 Community Research Partnership,CORONAVIRUS; COVID,"February 08, 2021",150000,NCT04342884,,UNITED STATES,Recruiting,Wake Forest University Health Sciences,"April 8, 2020",Observational,"A Multicenter, Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records"
604,A Study of LY3127804 in Participants With COVID-19,COVID; PNEUMONIA,"February 08, 2021",95,NCT04342897,LY3127804; PLACEBO,UNITED STATES,Terminated,Eli Lilly and Company,"April 20, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19"
605,Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,COVID,"February 08, 2021",0,NCT04343001,ASPIRIN; LOSARTAN; SIMVASTATIN,NIGERIA,Withdrawn,London School of Hygiene and Tropical Medicine,October 2020,Interventional,"Aspirin, Losartan and Simvastatin in Hospitalised COVID-19 Patients: a Multinational Randomised Open-label Factorial Trial"
606,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",54,NCT04343053,SARS-COV-2 INFECTION,ITALY,"Active, not recruiting",University Hospital of Ferrara,"April 8, 2020",Interventional,"Patterns and Changes in Platelet Reactivity, Thrombotic Status and Endothelial Function in Hospitalized Patients With SARS-Cov-2 Infection"
607,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,COVID,"February 08, 2021",16,NCT04343092,IVERMECTIN (IVM),IRAQ,Completed,University of Baghdad,"April 18, 2020",Interventional,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (An Externally Controlled Pilot Trial)
608,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",COVID- INFECTION WITH SARS-CoV2 VIRUS,"February 08, 2021",92,NCT04343144,NIVOLUMAB INJECTION,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 15, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-19-Nivolumab Trial
609,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,COVID,"February 08, 2021",48,NCT04343183,HYPERBARIC OXYGEN THERAPY,UNITED STATES,Not yet recruiting,Ochsner Health System,April 2020,Interventional,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection
610,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),COVID; VIRAL RESPIRATORY ILLNESSES,"February 08, 2021",800,NCT04343248,NITAZOXANIDE; PLACEBO; VITAMIN SUPER B-COMPLEX,UNITED STATES,Recruiting,Romark Laboratories L.C.,"May 12, 2020",Interventional,"A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)"
611,Convalescent Plasma in the Treatment of COVID 19,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2); COVID; CORONAVIRUS,"February 08, 2021",48,NCT04343261,CONVALESCENT PLASMA,UNITED STATES,Completed,Saint Francis Care,"April 10, 2020",Interventional,Convalescent Plasma in the Treatment of COVID 19
612,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,"ADDICTION, SUBSTANCE; COVID","February 08, 2021",100,NCT04343339,,FRANCE,Completed,"University Hospital, Montpellier","April 8, 2020",Observational,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment - EPILOGUE
613,Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19,RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100,NCT04343404,,FRANCE,Completed,"University Hospital, Strasbourg, France","April 1, 2020",Observational,STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
614,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,CORONAVIRUS DISEASE 2019,"February 08, 2021",86,NCT04343651,PLACEBOS; LERONLIMAB (700MG),UNITED STATES,"Active, not recruiting","CytoDyn, Inc.","April 1, 2020",Interventional,"A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)"
615,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,MENTAL STRESS; MENTAL HEALTH WELLNESS 1; DEPRESSION; ANXIETY; BEHAVIOR PROBLEM; EMOTIONAL PROBLEM,"February 08, 2021",10000,NCT04343664,,INDONESIA,Not yet recruiting,Tjhin Wiguna,"August 1, 2020",Observational [Patient Registry],Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia
616,COPING With COVID-19( CWC-19),COVID,"February 08, 2021",0,NCT04343690,CRISIS MANAGEMENT COACHING,UNITED STATES,Withdrawn,Duke University,"March 27, 2020",Interventional,Effectiveness of Crisis Management Coaching on Faculty and Trainee Wellness During COVID-19 Crisis
617,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,SARS-COV INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA,"February 08, 2021",416,NCT04343729,METHYLPREDNISOLONE SODIUM SUCCINATE; PLACEBO SOLUTION,BRAZIL,"Active, not recruiting",Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,"April 18, 2020",Interventional,"Efficacy of Injectable Methylprednisolone Sodium Succinate in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome Under the New Coronavirus (SARS-CoV2): a Phase IIb, Randomized, Double-blind, Placebo-controlled, Clinical Trial."
618,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,COVID,"February 08, 2021",20,NCT04343742,CHLORINE DIOXIDE 3000 PPM,COLOMBIA,Recruiting,Genesis Foundation,"April 1, 2020",Observational,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19
619,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,COVID,"February 08, 2021",52,NCT04343755,CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",Hackensack Meridian Health,"April 9, 2020",Interventional,Phase IIa Study Exploring the Safety and Efficacy of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Hospitalized Subjects With COVID-19 Infection
620,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",COVID,"February 08, 2021",60,NCT04343768,HYDROXYCHLOROQUINE; LOPINAVIR / RITONAVIR; INTERFERON BETA-1A; INTERFERON BETA-1B,"IRAN, ISLAMIC REPUBLIC OF",Completed,Shahid Beheshti University of Medical Sciences,"April 9, 2020",Interventional,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial"
621,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,SARS-CoV2; COVID,"February 08, 2021",353,NCT04343781,OBSERVATION,FRANCE,Completed,"University Hospital, Angers","March 22, 2020",Observational,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19
622,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,COVID,"February 08, 2021",200,NCT04343794,BIOVITALS,HONG KONG,Recruiting,The University of Hong Kong,"April 1, 2020",Interventional,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19
623,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",5220,NCT04343898,NO INTERVENTION,UNITED STATES,"Active, not recruiting",Brigham and Women's Hospital,"April 1, 2020",Observational,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19
624,Pyridostigmine in Severe SARS-CoV-2 Infection,COVID; SARS-CoV2,"February 08, 2021",436,NCT04343963,PYRIDOSTIGMINE BROMIDE; PLACEBO,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"April 4, 2020",Interventional,Pyridostigmine in Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2 Infection
625,Pegylated Interferon Lambda Treatment for COVID-19,COVID; COVID,"February 08, 2021",20,NCT04343976,PEGYLATED INTERFERON LAMBDA,UNITED STATES,Enrolling by invitation,Raymond Chung,"June 22, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Pegylated Interferon Lambda vs. Placebo in Subjects Infected With COVID-19
626,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,COVID,"February 08, 2021",90,NCT04343989,CLAZAKIZUMAB 25 MG; CLAZAKIZUMAB 12.5 MG; PLACEBO,UNITED STATES,"Active, not recruiting",NYU Langone Health,"March 31, 2020",Interventional,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
627,LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID),COVID; LUNG CANCER,"February 08, 2021",200,NCT04344002,,SPAIN,Recruiting,Spanish Lung Cancer Group,"April 21, 2020",Observational [Patient Registry],Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease
628,COVID-19 Plasma Collection,COVID,"February 08, 2021",2000,NCT04344015,PLASMA DONATION,UNITED STATES,Recruiting,Thomas Jefferson University,"April 13, 2020",Interventional,Collection of COVID-19 Convalescent Plasma
629,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),CORONAVIRUS,"February 08, 2021",260,NCT04344041,"CHOLECALCIFEROL 200,000 IU; CHOLECALCIFEROL 50,000 IU",FRANCE,Recruiting,"University Hospital, Angers","April 15, 2020",Interventional,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)
630,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,COVID,"February 08, 2021",24,NCT04344080,CYTOSORB-THERAPY,GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"April 1, 2020",Interventional,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19
631,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,CORONAVIRUS INFECTION; OXYGEN DEFICIENCY,"February 08, 2021",25,NCT04344106,PRONE POSITIONING,FRANCE,Recruiting,ELHARRAR Xavier,"April 1, 2020",Interventional,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study (ProCov)
632,Assessment of Chilbains Occuring During Covid-19 Infection,SKIN MANIFESTATIONS; COVID; CHILBLAINS,"February 08, 2021",30,NCT04344119,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 9, 2020",Observational,Assessment of Skin Manifestations Occuring During Covid-19 Infection With a Special Focus on Chilbains
633,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,COVID,"February 08, 2021",693,NCT04344145,,BELGIUM,Completed,Université Libre de Bruxelles,"April 16, 2020",Observational,"Burnout, Emotional Distress and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population"
634,CovidDB: The Covid-19 Inpatient Database,COVID,"February 08, 2021",5000,NCT04344171,,GERMANY,Recruiting,ClarData,"March 30, 2020",Observational,CovidDB: The Covid-19 Inpatient Database
635,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),"COVID; LUNG INJURY, ACUTE; KIDNEY INJURY","February 08, 2021",60,NCT04344184,L-ASCORBIC ACID; PLACEBO,UNITED STATES,Not yet recruiting,Virginia Commonwealth University,January 2021,Interventional,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
636,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",SURGERY; COVID; ASYMPTOMATIC PATIENT; COVID; PREVENTIVE MEASURES,"February 08, 2021",1200,NCT04344197,GLOBAL SURVEY,ITALY,Completed,University of Rome Tor Vergata,"April 2, 2020",Observational,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey"
637,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,"COVID; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 1","February 08, 2021",149,NCT04344210,TELE-INTERVENTIONS RELATED TO DIABETES MANAGEMENT AND MENTAL WELL-BEING,BRAZIL,Completed,Federal University of Rio Grande do Sul,"April 17, 2020",Interventional,Impact of Tele-Interventions During the COVID-19 Pandemic on Glycemic Control and Attitude Toward the Disease in Patients With Diabetes Mellitus - A Randomized Clinical Trial
638,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,COVID,"February 08, 2021",48,NCT04344236,SALINE ORAL/NASAL RINSE; 0.5% POVIDONE/IODINE ORAL/NASAL RINSE; 0.12% CHLORHEXIDINE ORAL/NASAL RINSE,UNITED STATES,Recruiting,NYU Langone Health,"April 9, 2020",Interventional,"A Phase II, Randomized, Open-label, Single-institution Study of the Effects of Povidone Iodine Oral Gargles and Nasal Rinses on Viral Load in Patients With COVID-19"
639,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,IBD; COVID,"February 08, 2021",850,NCT04344249,,FRANCE,Recruiting,Nantes University Hospital,"April 10, 2020",Observational [Patient Registry],Prospective Multicenter Cohort of Patients With Inflammatory Bowel Disease Treated by Infliximab or Vedolizumab During COVID-19 Pandemic
640,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,VIRAL PNEUMONIA HUMAN CORONAVIRUS; COVID,"February 08, 2021",11,NCT04344288,PREDNISONE; CONTROL GROUP,FRANCE,Terminated,Hospices Civils de Lyon,"April 21, 2020",Interventional,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
641,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,"INFECTION VIRAL; INFECTION, HOSPITAL; COVID","February 08, 2021",2878,NCT04344327,,FRANCE,Completed,French Cardiology Society,"April 10, 2020",Observational,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF
642,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,SARS-CoV2 INFECTION,"February 08, 2021",122,NCT04344379,HYDROXYCHLOROQUINE; AZITHROMYCIN; HYDROXYCHLOROQUINE PLACEBO,FRANCE,Suspended,Assistance Publique - Hôpitaux de Paris,"April 17, 2020",Interventional,Randomized Multicenter Study Evaluating the Efficacy of Azithromycin and Hydroxychloroquine in the Prevention of SARS-CoV-2 Infection in the Hospital Population Exposed to Virus
643,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),COVID,"February 08, 2021",100,NCT04344431,HYPERBARIC OXYGEN TREATMENT (HBOT) I.E. INHALATION OF PRESSURIZED OXYGEN DELIVERED BY A HYPERBARIC CHAMBER (DRUG/DEVICE),FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"April 14, 2020",Interventional,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)
644,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,COVID,"February 08, 2021",600,NCT04344444,HYDROXYCHLOROQUINE; AZITHROMYCIN,UNITED STATES,"Active, not recruiting",LCMC Health,"April 13, 2020",Interventional,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease: A Randomized Clinical Trial
645,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",COVID,"February 08, 2021",80,NCT04344457,HYDROXYCHLOROQUINE; INDOMETHACIN; ZITHROMAX ORAL PRODUCT,UNITED STATES,Recruiting,"Perseverance Research Center, LLC","April 16, 2020",Interventional,"An Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects Positive With SARS-CoV-2 With Mild Symptoms"
646,Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients,VENTILATOR ASSOCIATED PNEUMONIA,"February 08, 2021",10000,NCT04344509,BACTERIAL SPECIES ISOLATED,,Not yet recruiting,Poitiers University Hospital,June 2020,Observational,Microbial Etiology of Ventilator-associated Pneumonia (VAP) in COVID-19 Infected Patients
647,Convalescent Plasma vs. Standard Plasma for COVID-19,COVID,"February 08, 2021",500,NCT04344535,CONVALESCENT PLASMA; STANDARD DONOR PLASMA,UNITED STATES,Enrolling by invitation,Stony Brook University,"April 8, 2020",Interventional,Convalescent Plasma to Reduce Complications Associated With COVID-19 Infection: A Randomized Trial Comparing the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma vs. Standard Plasma in Hospitalized Patients With COVID- 19 Infection
648,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,COVID,"February 08, 2021",10,NCT04344548,ALLOGENEIC NK TRANSFER,COLOMBIA,Not yet recruiting,Universidad Nacional de Colombia,"April 13, 2020",Interventional,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia
649,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,COVID; HYPOXIC RESPIRATORY FAILURE,"February 08, 2021",70,NCT04344561,POSTURAL POSITIONING,UNITED STATES,Recruiting,Johns Hopkins University,"May 25, 2020",Interventional,UPright Incline Positioning in COVID-19 Patients for Oxygen SATuration Improvement With Hypoxemic Respiratory Failure (UPSAT)
650,Awake Prone Position for Early Hypoxemia in COVID-19,COVID,"February 08, 2021",560,NCT04344587,SELF-PRONE POSITION RECOMMENDATION; USUAL CARE,SPAIN,Enrolling by invitation,Boston University,"April 23, 2020",Interventional,Awake Prone Position for Early Hypoxemia in COVID-19
651,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,SARS-CoV2,"February 08, 2021",164,NCT04344600,PEGINTERFERON LAMBDA ALFA-1A SUBCUTANEOUS INJECTION; SALINE,UNITED STATES,Recruiting,Johns Hopkins University,"May 29, 2020",Interventional,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 Infection
652,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,SURGERY; PERIOPERATIVE COMPLICATION; COVID,"February 08, 2021",905,NCT04344665,VIRTUAL CARE AND REMOTE AUTOMATED MONITORING,CANADA,"Active, not recruiting",Population Health Research Institute,"April 23, 2020",Interventional,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial
653,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,ACUTE HYPOXEMIC RESPIRATORY FAILURE; COVID,"February 08, 2021",550,NCT04344730,DEXAMETHASONE INJECTION; PLACEBO; CONVENTIONAL OXYGEN; CPAP; HFNO; MECHANICAL VENTILATION,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 10, 2020",Interventional,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 pneumonia_COVIDICUS
654,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",COVID PNEUMONIA,"February 08, 2021",808,NCT04344756,TINZAPARIN OR UNFRACTIONATED HEPARIN,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 20, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-COAG Trial
655,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",COVID PNEUMONIA,"February 08, 2021",130,NCT04344782,BEVACIZUMAB INJECTION,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 15, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-19- BEVA Trial
656,Impact of Covid-19 on Egyptian Health Care Workers and General Population Mental Health,MENTAL HEALTH ISSUE,"February 08, 2021",300,NCT04344834,ONLINE QUESTIONNAIRE,,Not yet recruiting,Assiut University,May 2020,Observational,Impact of Covid-19 on Egyptian Population Mental Health
657,Impact of COVID19 Outbreak in Cardiac Acute Care,ACUTE CORONARY SYNDROME; HEART FAILURE; COVID,"February 08, 2021",500,NCT04344912,DATA COLLECTION,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"March 20, 2020",Observational [Patient Registry],Impact of COVID19 Outbreak in Cardiac Patients Admitted in Intensive Care Unit : the CCU-COVID19 Study
658,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,COVID,"February 08, 2021",50,NCT04344925,AEROSOL-REDUCING MASK; STANDARD MASK,CANADA,Recruiting,Lawson Health Research Institute,"April 18, 2020",Observational,Non-invasive Positive Pressure Ventilation Mask to Minimize Mask Leak and Potential Aerosolization Leading to Spread of Virus Such as COVID-19: A Non-inferiority Trial
659,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,COVID PANDEMIC FROM ETHICAL VIEW,"February 08, 2021",874,NCT04344938,QUESTIONNAIR ABOUT EMERGING LEGAL AND EHICAL DISPUTES OVER PATIENT CONFIDENTIALITY,,Not yet recruiting,Assiut University,April 2020,Observational,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality
660,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial","PNEUMONIA, VIRAL; COVID","February 08, 2021",60,NCT04344951,UNIKINON (CHLOROQUINE PHOSPHATE) 200MG TABLETS,GREECE,Recruiting,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,"April 6, 2020",Interventional,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial"
661,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,"COLON POLYP; COLON DISEASE; REFLUX, GASTROESOPHAGEAL; VARICES, ESOPHAGEAL","February 08, 2021",186,NCT04344964,NONE - NA,AUSTRALIA,Completed,Austin Health,"April 15, 2020",Observational,Endoscopy-related Phone Consultation During the COVID-19 Outbreak: Impact on Attendance and Patient/Consultant Perspectives From a Tertiary Australian Hospital
662,Collection of Anti-SARS-CoV-2 Immune Plasma,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",1500,NCT04344977,,UNITED STATES,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"June 1, 2020",Observational,A Pilot Study for Collection of Anti-SARS-CoV-2 Immune Plasma
663,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,SARS-CoV2; SYSTEMIC LUPUS ERYTHEMATOSUS; RHEUMATOID ARTHRITIS; SJOGREN'S SYNDROME; PSORIATIC ARTHRITIS,"February 08, 2021",572,NCT04345159,QUESTIONNAIRE BY PHONE CALL,FRANCE,Completed,Fondation Ophtalmologique Adolphe de Rothschild,"April 17, 2020",Observational,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease
664,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,COVID,"February 08, 2021",10,NCT04345276,DANOPREVIR+RITONAVIR,CHINA,Completed,Huoshenshan Hospital,"March 18, 2020",Interventional,An Open Clinical Trial to Evaluate Danoprevir Sodium Tablets Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
665,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,COVID; CORONAVIRUS INFECTION; VIRAL PNEUMONIA,"February 08, 2021",1100,NCT04345289,CONVALESCENT ANTI-SARS-COV-2 PLASMA; INFUSION PLACEBO,DENMARK,Recruiting,Thomas Benfield,"May 1, 2020",Interventional,"Efficacy and Safety of Treatment With Convalescent Plasma for Adults With COVID-19 Pneumonia. A Double-blinded, Randomized, Multicenter Placebo-controlled Trial"
666,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",COVID; SARS-CoV2,"February 08, 2021",500,NCT04345315,SEROLOGICAL TEST; RAPID MOLECULAR TEST; NEXT GENERATION SEQUENCING (NGS) ANALYSIS; SERUM CHEMISTRY ANALYSIS,ITALY,Recruiting,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,"March 27, 2020",Observational,Correlative Study on Cancer Patients and Healthcare Professionals Exposed to SARS-CoV-2 Infection
667,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,COVID,"February 08, 2021",60,NCT04345406,ACEIS; CONVENTIONAL TREATMENT,EGYPT,Not yet recruiting,Tanta University,"April 15, 2020",Interventional,Randomized Trial of ACEIs in Treatment of COVID-19
668,Remdesivir vs Chloroquine in Coronavirus Disease,COVID,"February 08, 2021",120,NCT04345419,CHLOROQUINE OR HYDROXYCHLOROQUINE; REMDESIVIR,EGYPT,Recruiting,Tanta University,"June 16, 2020",Interventional,Remdesivir in COVID-19 Treatment: A Randomised Trial
669,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,COVID,"February 08, 2021",310,NCT04345445,TOCILIZUMAB; METHYLPREDNISOLONE,MALAYSIA,Not yet recruiting,University of Malaya,"April 15, 2020",Interventional,"An Open-label, Randomized, Cross-over Interventional Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression"
670,Testing for COVID-19 Infection in Asymptomatic Persons,COVID INFECTION,"February 08, 2021",500,NCT04345510,,,Not yet recruiting,German Cancer Research Center,"April 20, 2020",Observational,Testing for COVID-19 Infection in Asymptomatic Persons
671,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients,COVID,"February 08, 2021",278,NCT04345523,BLOOD AND DERIVATIVES.; STANDARD OF CARE,SPAIN,Recruiting,Cristina Avendaño Solá,"April 3, 2020",Interventional,"Multi-center, Randomized Clinical Trial of Convalescent Plasma Therapy Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients"
672,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,COVID,"February 08, 2021",400,NCT04345536,,NORWAY,Recruiting,Oslo University Hospital,"March 15, 2020",Observational [Patient Registry],Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital
673,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,FLU LIKE SYMPTOM; FLU LIKE ILLNESS,"February 08, 2021",18,NCT04345549,INDIVIDUALISED AYURVEDA,UNITED KINGDOM,Completed,Aarogyam UK,"February 26, 2020",Interventional,Ayurveda Self-Management for Flu Like Symptoms in People Self-Isolated for 7 Days During the Coronavirus Disease 2019 (COVID-19) Outbreak
674,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),SARS-CoV2; ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",30,NCT04345601,MESENCHYMAL STROMAL CELLS; SUPPORTIVE CARE,UNITED STATES,Recruiting,Baylor College of Medicine,January 2021,Interventional,"Single Donor Banked Bone Marrow Mesenchymal Stromal Cells for the Treatment of COVID-19 Induced ARDS: A Non-Blinded Randomized, Controlled Study"
675,A Study of Auxora in Patients With Severe COVID-19 Pneumonia,PNEUMONIA,"February 08, 2021",400,NCT04345614,AUXORA; PLACEBO,PUERTO RICO,Recruiting,"CalciMedica, Inc.","April 8, 2020",Interventional,"A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA)"
676,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,LIVER CIRRHOSES,"February 08, 2021",1000,NCT04345640,NO INTERVENTION,INDIA,Recruiting,"Institute of Liver and Biliary Sciences, India","April 10, 2020",Observational,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver - The Pan Asia-Pacific Prospective Multi-centre Observational Study (APCOLIS STUDY)
677,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,COVID,"February 08, 2021",44,NCT04345653,HYDROXYCHLOROQUINE SULFATE (HCQ),UNITED STATES,"Active, not recruiting",Hackensack Meridian Health,"April 14, 2020",Interventional,"Feasibility, Safety and Early Efficacy Trial of Hydroxychloroquine as Primary Prevention of Corona Virus Disease 2019 in High Risk Health Care Providers"
678,Anti COVID-19 Convalescent Plasma Therapy,COVID,"February 08, 2021",20,NCT04345679,ANTI-SARS-COV-2 CONVALESCENT PLASMA,,Not yet recruiting,Orthosera Kft.,"April 14, 2020",Interventional,Anti COVID-19 Convalescent Plasma Therapy
679,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,COVID,"February 08, 2021",17,NCT04345692,HYDROXYCHLOROQUINE,UNITED STATES,Terminated,Queen's Medical Centre,"March 26, 2020",Interventional,"A Randomized, Controlled Clinical Trial of the Safety and Efficacy of Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients"
680,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,COVID; SARS-CoV2,"February 08, 2021",200,NCT04345848,ENOXAPARIN,SWITZERLAND,Recruiting,"University Hospital, Geneva","April 28, 2020",Interventional,"Preventing COVID-19-associated Thrombosis, Coagulopathy and Mortality With Low- and High-dose Anticoagulation: a Multicentric Randomized, Open-label Clinical Trial"
681,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),"CORONAVIRUS INFECTION; PNEUMONIA, VIRAL","February 08, 2021",7,NCT04345861,HYDROXYCHLOROQUINE + PLACEBO; HYDROXYCHLOROQUINE + AZITHROMYCIN,FRANCE,Terminated,"University Hospital, Montpellier","April 11, 2020",Interventional,Randomized Trial Assessing Efficacy and Safety of Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for Hospitalized Adults With COVID-19 Pneumonia
682,Spironolactone in Covid-19 Induced ARDS,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",60,NCT04345887,SPIRONOLACTONE 100MG; PLACEBO ORAL TABLET,TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,"April 21, 2020",Interventional,The Effect of Spironolactone on Oxygenation in Covid-19 ARDS Patients
683,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",COVID,"February 08, 2021",120,NCT04345991,TRANSFUSION OF COVID-19 CONVALESCENT PLASMA,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 15, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - CORIMUNO-CORIPLASM : EFFICACY OF CONVALESCENT PLASMA TO TREAT SARS-COV2 INFECTED PATIENTS
684,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,COVID,"February 08, 2021",200,NCT04346017,CYTOKINES DOSAGE; COMPLEMENT DOSAGE,BELGIUM,Recruiting,Francis Corazza,"March 20, 2020",Interventional,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in SARS-Cov-2 Infected Patients With a Systemic Inflammatory Response Syndrome
685,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04346043,,EGYPT,Not yet recruiting,Ain Shams University,"April 20, 2020",Observational,Strain Study: To Access the Egyptian COVID-19 Whole Genome (Dominant Strain) by Next Generation Sequencing (NGS) and Compare to the International Worldwide Database
686,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,CORONAVIRUS DISEASE (COVID); COVID,"February 08, 2021",500,NCT04346056,,EGYPT,Recruiting,Ain Shams University,"April 14, 2020",Observational,Retrospective Study From November 2019 -Febrauary 2020 on Severe Respiratory Illness to Access the Presence or Absence of COVID-19 in Patients Samples by Real-time PcR
687,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,STRESS,"February 08, 2021",30,NCT04346082,ONLINE MINDFULNESS GROUP,HONG KONG,Not yet recruiting,Chinese University of Hong Kong,"August 1, 2020",Interventional,Feasibility and Acceptability of Online Based Mindfulness Interventions to Relieve Distress During COVID-19 Outbreak in a Chinese Population: a Proof-of-concept Trial
688,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,PATIENT SAFETY,"February 08, 2021",132,NCT04346121,"GPS REPORTS OF POTENTIAL PATIENT SAFETY INCIDENTS, NON-COVID-19 RELATED",FRANCE,Completed,Nantes University Hospital,"April 28, 2020",Observational,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.
689,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,COVID PNEUMONIA,"February 08, 2021",165,NCT04346147,IMATINIB TABLETS; BARICITINIB ORAL TABLET; SUPPORTIVE TRATMENT,SPAIN,Recruiting,Hospital Universitario de Fuenlabrada,"April 13, 2020",Interventional,"Prospective, Phase II, Randomized, Open-label, Parallel Group Study to Evaluate the Efficacy of Baricitinib, Imatinib or Supportive Treatment in Patients With SARS Cov2 Pneumonia"
690,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",COVID; CONJUNCTIVITIS,"February 08, 2021",25,NCT04346160,SCHIRMER TEST I,ITALY,Not yet recruiting,G. d'Annunzio University,"April 14, 2020",Observational,Tear Fluid miRNA Analysis in Sars-Cov2 Conjunctivitis
691,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,COVID,"February 08, 2021",30000,NCT04346186,IGM AND IGG DIAGNOSTIC KITS TO SARS-COV-2; ELISA-TEST FOR IGM AND IGG TO SARS-COV-2,DENMARK,Enrolling by invitation,Herlev Hospital,"April 15, 2020",Observational,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff
692,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,COVID,"February 08, 2021",177,NCT04346199,ACALABRUTINIB,ARGENTINA,Completed,AstraZeneca,"June 12, 2020",Interventional,"A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19"
693,Oropharyngeal Dysphagia in Patients With COVID-19,OROPHARYNGEAL DYSPHAGIA; COVID; SARS-CoV2; NUTRITION,"February 08, 2021",300,NCT04346212,SWALLOWING EVALUATION WITH THE EAT-10 AND THE VOLUME-VISCOSITY SWALLOWING TEST (V-VST),SPAIN,Recruiting,Hospital de Mataró,"April 14, 2020",Observational,Oropharyngeal Dysphagia and Malnutrition in Patients Infected by SARS-CoV-2: Prevalence and Needs of Compensatory Treatment and Follow up in Patients Admitted by COVID-19 at the Consorci Sanitari Del Maresme
694,CoVid-19 - Infection and Antibody Formation in the Viennese Population,VIRUS DISEASES; COVID,"February 08, 2021",5500,NCT04346264,NO INTERVENTION PLANNED DUE TO THE OBSERVATIONAL STUDY DESIGN ONLY A DIAGNOSTIC TESTING,AUSTRIA,Enrolling by invitation,Ludwig Boltzmann Institute for Lung Health,"April 27, 2020",Observational,CoVid-19 - Infection and Antibody Formation in the Viennese Population - Data From the Vienna Health Study LEAD
695,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),"COVID; ARDS, HUMAN; ARDS; SARS-CoV2","February 08, 2021",,NCT04346277,"IC14, A MONOCLONAL ANTIBODY AGAINST CD14",ITALY,Available,Implicit Bioscience,,Expanded Access,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)
696,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,COVID,"February 08, 2021",86,NCT04346329,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,COLOMBIA,Not yet recruiting,Universidad Nacional de Colombia,"April 20, 2020",Interventional,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to SARS-Cov-2
697,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),COVID; MECHANICAL VENTILATION; ACUTE RESPIRATORY FAILURE,"February 08, 2021",1122,NCT04346342,,NETHERLANDS,Completed,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"March 6, 2020",Observational,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) - an Observational Study of Invasively Ventilated Patients in the Netherlands
698,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,COVID PNEUMONIA,"February 08, 2021",126,NCT04346355,TOCILIZUMAB,ITALY,Terminated,Azienda Unità Sanitaria Locale Reggio Emilia,"March 31, 2020",Interventional,An Open-label Randomized Multicenter Study to Evaluate the Efficacy of Early Administration of Tocilizumab (TCZ) in Patients With COVID-19 Pneumonia
699,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",20,NCT04346368,BM-MSCS; PLACEBO,CHINA,Not yet recruiting,Guangzhou Institute of Respiratory Disease,April 2020,Interventional,Safety and Efficacy of Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells in Severe Patients With Coronavirus Disease 2019 (COVID-19): A Phase 1/2 Randomized Controlled Trial
700,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,COVID; HYPOXEMIA,"February 08, 2021",12,NCT04346420,STANDARD INTERFACE; DOUBLE-TRUNK MASK,BELGIUM,Completed,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"April 9, 2020",Interventional,Impact of the Double-Trunk Mask on Oxygenation Titration in Patients With COVID-19
701,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,COVID,"February 08, 2021",29,NCT04346446,CONVALESCENT PLASMA TRANSFUSION; SUPPORTIVE CARE; RANDOM DONOR PLASMA,INDIA,Completed,"Institute of Liver and Biliary Sciences, India","April 20, 2020",Interventional,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients: A Pilot Randomized Controlled Trial
702,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,"PNEUMONIA, VENTILATOR-ASSOCIATED; CORONAVIRUS INFECTION","February 08, 2021",10,NCT04346589,ANTI-CORONAVIRUS ANTIBODIES (IMMUNOGLOBULINS)OBTAINED WITH DFPP FROM CONVALESCENT PATIENTS,ITALY,Recruiting,A.O. Ospedale Papa Giovanni XXIII,"April 15, 2020",Interventional,A Pilot Study to Explore the Efficacy and Safety of Rescue Theraphy With Antibodies From Convalescent Patients Obtained With Double -Filtration Plasmapheresis (DFPP) and Infused in Critically Ill Ventilated Patients With Coronavirus Disease 2019 (COVID-19)
703,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,COVID-2019,"February 08, 2021",132,NCT04346602,ALL TREATMENT ABOUT COVID-2019,CHINA,Recruiting,Jilin University,"February 1, 2020",Observational,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019
704,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,COVID INFECTION,"February 08, 2021",120,NCT04346615,ZAVEGEPANT (BHV-3500); PLACEBO,UNITED STATES,Recruiting,"Biohaven Pharmaceuticals, Inc.","April 25, 2020",Interventional,"BHV3500-203: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of Zavegepant* (BHV-3500) Intranasal (IN) for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen"
705,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,SARS-CoV2; COVID,"February 08, 2021",120,NCT04346628,FAVIPIRAVIR; PLACEBO; STANDARD OF CARE TREATMENT,UNITED STATES,Enrolling by invitation,Stanford University,"July 12, 2020",Interventional,"A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild or Asymptomatic COVID-19"
706,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,SARS-CoV2; CORONAVIRUS INFECTION; ASYMPTOMATIC CONDITION; COVID,"February 08, 2021",400,NCT04346667,HYDROXYCHLOROQUINE SULFATE REGULAR DOSE; HYDROXYCHLOROQUINE SULFATE LOADING DOSE; CHLOROQUINE; PLACEBO,PAKISTAN,Recruiting,"Government of Punjab, Specialized Healthcare and Medical Education Department","April 14, 2020",Interventional,Use and Dosage of Hydroxychloroquine and Chloroquine to Convert Real Time Polymerase Chain Reaction (RT-PCR) Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Infectious Disease 2019 (COVID-19) Patients to RT- PCR-Negative as a Means to Reduce Hospitalization Rate
707,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,ACUTE RESPIRATORY TRACT INFECTION; ACUTE RESPIRATORY INSUFFICIENCY; PNEUMONIA; SEPTIC SHOCK; HYPOXEMIA,"February 08, 2021",320,NCT04346693,STANDARD THERAPY RECOMMENDED BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION.; STANDARD THERAPY RECOMMENDED BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION AND DALARGIN INTRAMUSCULAR INJECTION; STANDARD THERAPY RECOMMENDED BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION AND DALARGIN INHALATION; STANDARD THERAPY RECOMMENDED BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION AND DALARGIN INTRAMUSCULAR INJECTION COMBINED WITH DALARGIN INHALATION,RUSSIAN FEDERATION,Completed,Burnasyan Federal Medical Biophysical Center,"April 8, 2020",Interventional,An Open Randomized Study of the Effectiveness of the Drug Dalargin for the Prevention and Treatment of Symptoms of Pulmonary Complications in Patients With Coronavirus Infection (SARS-COVID-19)
708,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",SARS-CoV2; COVID,"February 08, 2021",120,NCT04346797,ECULIZUMAB,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 16, 2020",Interventional,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort"
709,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,"COVID; BURNOUT, CAREGIVER; INTENSIVE CARE UNIT; STRESS, PSYCHOLOGICAL","February 08, 2021",100,NCT04346810,PATIENT MANAGEMENT SUFFERING OF CORONAVIRUS INFECTION,,Not yet recruiting,Hôpital Raymond Poincaré,"April 15, 2020",Observational,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit
710,Telerehabilitation for Patients Diagnosed With Coronavirus,TELEREHABILITATION; CORONAVIRUS,"February 08, 2021",30,NCT04346927,TELEREHABILITATION; EXERCISE BROCHURE,,Not yet recruiting,Yasemin Çırak,"August 10, 2020",Interventional,Investigation of the Effects of Exercise Using Telerehabilitation in Patients Diagnosed With Coronavirus (COVID-19) and Followed at Home
711,The Effectiveness of Telerehabilitation-Based Exercises in Elderly People,TELEREHABILITATION; ELDERLY PEOPLE; SOCIAL ISOLATION,"February 08, 2021",30,NCT04346940,TELEREHABILITATION; EXERCISE BROCHURE,,Not yet recruiting,Istinye University,"August 10, 2020",Interventional,The Effectiveness of Telerehabilitation-Based Exercises in Elderly People Under Social Isolation Process Due to Coronavirus
712,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),HEALTHY LIFESTYLE,"February 08, 2021",128,NCT04346953,VIDEO BASED EXERCISE,,Not yet recruiting,Istinye University,"August 20, 2020",Interventional,Investigation Of The Effectiveness Of Video-Based Exercise Program Applied To Adult Individuals Who Experience Social Isolation At Houses Due To The Coronavirus (COVID-19) Pandemic
713,The Effectiveness of Video-Based Exercises in Young Adults,SOCIAL ISOLATION; EXERCISE; HEALTHY,"February 08, 2021",128,NCT04346966,STUDY GROUP,,Not yet recruiting,Istinye University,"August 20, 2020",Interventional,The Effectiveness of Video-Based Exercises in Young Adults Under Social Isolation Process Due to Coronavirus
714,Telerehabilitation-based Yoga and Mindfulness Home Program in Postmenopausal Women Having Social Isolation,TELEREHABILITATION,"February 08, 2021",50,NCT04346979,TELEREHABILITATION-BASED; VIDEO-BASED,,Not yet recruiting,Istinye University,"August 1, 2020",Interventional,"The Effect of Telerehabilitation Based Yoga and Mindfulness Home Program on Psychological Resilience, Body Awareness and Physical Activity in Postmenopausal Women Having Social Isolation"
715,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,"PNEUMONIA, VIRAL; RESPIRATORY FAILURE","February 08, 2021",320,NCT04347031,MEFLOQUINE; HYDROXYCHLOROQUINE; MEFLOQUINE + AZITHROMYCIN + / - TOCILIZUMAB; HYDROXYCHLOROQUINE + AZITHROMYCIN + / - TOCILIZUMAB,RUSSIAN FEDERATION,Completed,Burnasyan Federal Medical Biophysical Center,"April 8, 2020",Interventional,"An Open Randomized Study of the Effectiveness of the Drug Mefloquine, Tablets 250 mg, Produced by FSUE SPC ""Farmzashita"" of the Federal Medical Biological Agency, FMBA of Russia (Russia) for the Treatment of Patients With COVID19"
716,Implementation of Physiotherapy on COVID-19 Patients in ICU,SARS-CoV2; COVID,"February 08, 2021",150,NCT04347070,PHSYIOTHERAPY,FRANCE,"Active, not recruiting","University Hospital, Montpellier","April 1, 2017",Observational,"Implementation of Physiotherapy on COVID-19 Patients in Intensive Care Units : a Retrospective, Multicentric, International Study"
717,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,COVID,"February 08, 2021",40,NCT04347174,SUSPENSION OF HEAT KILLED (AUTOCLAVED) MYCOBACTERIUM W; PLACEBO,INDIA,Completed,Cadila Pharnmaceuticals,"April 30, 2020",Interventional,A Clinical Trial to Evaluate the Safety and Efficacy of Mycobacterium W in Critically Ill Patients Suffering From COVID 19 Infection
718,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,SOLID TUMOR; SARS-CoV2; HEMATOLOGICAL MALIGNANCY,"February 08, 2021",138,NCT04347226,BMS-986253,UNITED STATES,Recruiting,Matthew Dallos,"April 16, 2020",Interventional,A Randomized Phase 2 Study of Anti-IL-8 Therapy Versus Standard of Care in the Treatment of Hospitalized Patients With Severe COVID-19
719,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),CORONAVIRUS DISEASE 2019,"February 08, 2021",390,NCT04347239,PLACEBOS; LERONLIMAB (700MG),UNITED STATES,Recruiting,"CytoDyn, Inc.","April 15, 2020",Interventional,"A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)"
720,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,SARS-CoV2,"February 08, 2021",1000,NCT04347278,PATIENTS WITH THE TREATMENT AGAINS COVID19,SPAIN,Recruiting,Instituto de Investigación Marqués de Valdecilla,"April 22, 2020",Observational [Patient Registry],Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry
721,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,COVID DISEASE,"February 08, 2021",1000,NCT04347369,OTHER,CHINA,Recruiting,Xinqiao Hospital of Chongqing,"January 17, 2020",Observational,a Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease
722,Honey & Nigella Sativa Trial Against COVID-19,CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",313,NCT04347382,HONEY; NIGELLA SATIVA / BLACK CUMIN; PLACEBOS,PAKISTAN,Completed,Sohaib Ashraf,"April 30, 2020",Interventional,"The Role of Honey and Nigella Sativa in the Management of COVID-19; A Randomized Controlled, Open-label, Add-on Trial in Pakistan"
723,Seroprevalence of SARS-Cov-2 Antibodies in Children,COVID; CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04347408,COVID-19 ANTIBODY TESTING (IGG AND IGM),UNITED KINGDOM,Recruiting,"Queen's University, Belfast","May 6, 2020",Observational,Seroprevalence of SARS-Cov-2 Antibodies in Children - a Prospective Multicentre Cohort Study
724,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,COVID,"February 08, 2021",20,NCT04347460,,GERMANY,Recruiting,Technische Universität München,"March 27, 2020",Observational,"Establishing a Covid-19 Prospective Cohort to Document Cases of Secondary Hemophagocytic Lymphohistiocytosis (sHLH, Synonoums to Macrophage Activation Syndrome)"
725,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,"SARS-CoV2, COMMUNITY-ACQUIRED PNEUMONIA,COVID","February 08, 2021",0,NCT04347512,HYDROXYCHLOROQUINE AND AZITHROMYCIN TREATMENT ARM.; HYDROXYCHLOROQUINE; CONTROL ARM,,Withdrawn,"University Hospital, Strasbourg, France","June 2, 2020",Interventional,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA
726,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,COVID,"February 08, 2021",90,NCT04347538,SALINE NASAL IRRIGATION; SALINE WITH BABY SHAMPOO NASAL IRRIGATION,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"May 1, 2020",Interventional,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19
727,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,CONVALESCENT PLASMA FOR COVID,"February 08, 2021",575,NCT04347681,CONVALESCENT PLASMA FROM RECOVERED COVID 19 DONOR,SAUDI ARABIA,Recruiting,King Fahad Specialist Hospital Dammam,"April 18, 2020",Interventional,A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19
728,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,SARS-CoV2; IMMUNIZATION; INFECTION,"February 08, 2021",400,NCT04347694,,AUSTRIA,Recruiting,Medical University of Vienna,"April 11, 2020",Observational,COVID-19 Serology in Nephrology Health Care Workers
729,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,COVID INFECTION; RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; HYDROXYCHLOROQUINE,"February 08, 2021",500,NCT04347798,HYDROXYCHLOROQUINE/CHLOROQUINE,CANADA,Enrolling by invitation,University of Alberta,September 2020,Observational [Patient Registry],IMPACT RAPPORT: IMPact of Antimalarials on Covid Infections: a Case Control sTudy of RAPPORT
730,Predict Adverse Events by Covid-19 Nephritis,COVID,"February 08, 2021",100,NCT04347824,,GERMANY,Recruiting,University Hospital Goettingen,"April 27, 2020",Observational,Covid-19 Associated Nephritis as Early Predictor for Complicated Course of Disease
731,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),SARS-CoV2; COVID,"February 08, 2021",500,NCT04347850,BLOOD SAMPLE,FRANCE,Recruiting,"University Hospital, Montpellier","February 1, 2020",Observational,"A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) Infection, From Diagnosis to Long-term Follow-up"
732,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,COVID; BCG VACCINATION,"February 08, 2021",100,NCT04347876,TUBERCULIN TEST,EGYPT,Recruiting,Assiut University,"April 11, 2020",Observational,Outcome of COVID-19 Cases Admitted to Hospital and ICU With Positive Tuberculin Test: Can Previous BCG Alter the Prognosis?
733,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,COVID,"February 08, 2021",0,NCT04347889,HYDROXYCHLOROQUINE; VITAMIN C,,Withdrawn,Stony Brook University,"April 20, 2020",Interventional,Prophylactic Hydroxychloroquine vs Vitamin C in Healthcare Workers at Risk of COVID-19: A RCT
734,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,COVID,"February 08, 2021",60,NCT04347915,CLEVUDINE; PLACEBO,"KOREA, REPUBLIC OF",Recruiting,Bukwang Pharmaceutical,"May 6, 2020",Interventional,"A Single Blind, Randomized, Placebo-controlled, Multi-center Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients Diagnosed With Moderate COVID-19"
735,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,COVID; ARDS; SARS-CoV2,"February 08, 2021",15,NCT04347928,,FRANCE,Completed,"University Hospital, Lille","April 20, 2020",Observational,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19
736,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,"ARDS, HUMAN; MECHANICAL VENTILATION COMPLICATION; COVID","February 08, 2021",200,NCT04347941,PRONE POSITIONING; STANDARD OF CARE.,IRELAND,Recruiting,University College Hospital Galway,"July 11, 2020",Interventional,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE
737,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),COVID,"February 08, 2021",40,NCT04347954,POVIDONE-IODINE 2%; POVIDONE-IODINE 0.5%; ISOTONIC SALINE 0.9%,UNITED STATES,Completed,Stanford University,"August 15, 2020",Interventional,Effect of PVP-I Nasal Sprays vs Normal Saline Nasal Sprays on SARS-CoV-2 Nasopharyngeal Titers
738,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,"RESPIRATORY DISTRESS SYNDROME, ADULT; COVID","February 08, 2021",122,NCT04347980,DEXAMETHASONE AND HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE,FRANCE,Recruiting,Centre Chirurgical Marie Lannelongue,April 2020,Interventional,"Dexamethasone Combined With Hydroxychloroquine Compared to Hydroxychloroquine Alone for Treatment of Severe Acute Respiratory Distress Syndrome Induced by Coronavirus Disease 19 (COVID-19): a Multicentre, Randomised Controlled Trial"
739,"A Prospective ""Universal"" Observational Database for COVID-19",COVID,"February 08, 2021",5000,NCT04347993,,UNITED STATES,Recruiting,Hackensack Meridian Health,"March 27, 2020",Observational [Patient Registry],Real World Observational Database for COVID-19 Treatment and Outcomes
740,Safety and Efficacy of Ruxolitinib for COVID-19,COVID,"February 08, 2021",80,NCT04348071,RUXOLITINIB,,Not yet recruiting,"University of Colorado, Denver",November 2020,Interventional,Safety and Efficacy of Ruxolitinib for COVID-19
741,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,CORONAVIRUS DISEASE (COVID),"February 08, 2021",3000,NCT04348214,,EGYPT,Recruiting,Ain Shams University,"April 22, 2020",Observational,Screening and Risk Assessment of Healthcare Workers and Infection Control in University and COVID-19 Quarantine Hospitals Using Real-time Geospatial Mapping for Emergency Healthcare Resource Mobilization and Management
742,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,VENTILATOR ASSOCIATED PNEUMONIA,"February 08, 2021",120,NCT04348227,ENHANCED HYGIENE MEASURES,TUNISIA,"Active, not recruiting",Hôpital Universitaire Fattouma Bourguiba,"January 1, 2019",Observational [Patient Registry],How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?
743,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,COVID,"February 08, 2021",90,NCT04348240,,UNITED STATES,Recruiting,National Institute of Dental and Craniofacial Research (NIDCR),"April 16, 2020",Observational,Transmissibility and Viral Load of SARS-CoV-2 Through Oral Secretions
744,Hydrocortisone for COVID-19 and Severe Hypoxia,COVID; HYPOXIA,"February 08, 2021",1000,NCT04348305,HYDROCORTISONE; SODIUM CHLORIDE 9MG/ML,DENMARK,"Active, not recruiting",Scandinavian Critical Care Trials Group,"April 17, 2020",Interventional,Low-dose Hydrocortisone in Patients With COVID-19 and Severe Hypoxia - the COVID STEROID Trial
745,BCG Vaccine for Health Care Workers as Defense Against COVID 19,CORONAVIRUS; CORONAVIRUS INFECTION; CORONAVIRUS AS THE CAUSE OF DISEASES CLASSIFIED ELSEWHERE,"February 08, 2021",1800,NCT04348370,BCG VACCINE; PLACEBO VACCINE,UNITED STATES,Recruiting,Texas A&M University,"April 20, 2020",Interventional,Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses
746,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,COVID,"February 08, 2021",150,NCT04348383,DEFIBROTIDE 25 MG/KG 24 HOURS CONTINUOUS INFUSION FOR 15 DAYS; PLACEBO 250 CC 24 HOURS CONTINUOUS INFUSION FOR 15 DAYS,SPAIN,Recruiting,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,"April 8, 2020",Interventional,"Phase IIb Prospective, Multi-center, Randomized, Parallel, Double Blind, Placebo Controlled Trial to Evaluate Defibrotide Intravenous Infusion in the Prevention and Treatment of COVID-19 Respiratory Distress and Cytokine Release Syndrome"
747,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,COVID,"February 08, 2021",300,NCT04348396,,ITALY,Recruiting,Istituto Nazionale di Ricovero e Cura per Anziani,"April 3, 2020",Observational,ReportAge-COVID Project: Clinical and Biological Predictors of COVID-19 Disease in Older Patients
748,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,COVID,"February 08, 2021",50,NCT04348409,NITAZOXANIDE TABLETS; PLACEBO,BRAZIL,Recruiting,Azidus Brasil,"May 25, 2020",Interventional,"Proof of Concept, Multicentre, Parallel, Randomized, Double-blind Clinical Trial to Assess the Safety and Efficacy of Nitazoxanide 600 mg Compared to Placebo in the Treatment of Hospitalized Patients With COVID-19 in Moderate Condition."
749,Evaluating the Immune Response for COVID-19,COVID,"February 08, 2021",1000,NCT04348422,COVID-19 RT-PCR; COVID-19 SEROLOGY; SYMPTOMS QUESTIONNARE,ISRAEL,Recruiting,Assaf-Harofeh Medical Center,"May 1, 2020",Observational,Evaluation of the Immune Response in Symptomatic and Asymptomatic Patients' Diagnosed Witih COVID-19
750,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",COVID,"February 08, 2021",100,NCT04348435,HB-ADMSCS; PLACEBOS,UNITED STATES,Enrolling by invitation,Hope Biosciences,"May 14, 2020",Interventional,"A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs to Provide Immune Support Against COVID-19"
751,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",COVID,"February 08, 2021",100,NCT04348448,CANAKINUMAB 150 MG/ML [ILARIS],,Not yet recruiting,AUSL Romagna Rimini,April 2020,Observational,Observational Study on the Use of Canakinumab Administered Subcutaneously in the Treatment of Patients With COVID-19 Pneumonia
752,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,COVID; RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100,NCT04348461,ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STROMAL CELLS,,Not yet recruiting,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,"April 6, 2020",Interventional,"Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19"
753,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,COVID,"February 08, 2021",200,NCT04348474,HYDROXYCHLOROQUINE SULFATE; AZITHROMYCIN TABLETS,BRAZIL,Suspended,Azidus Brasil,"April 20, 2020",Interventional,"Open Label, Multicentric, Non Randomized, Exploratory Clinical Trial to Assess the Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Mild Acute Respiratory Syndrome (COVID-19) Caused by SARS-CoV-2 Virus"
754,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,COVID,"February 08, 2021",17,NCT04348500,CLAZAKIZUMAB,UNITED STATES,"Active, not recruiting",Cedars-Sinai Medical Center,"April 24, 2020",Interventional,A Phase II Trial to Evaluate the Safety and Tolerability of Clazakizumab® (Anti-IL- 6 Monoclonal) Compared to Placebo for the Treatment of COVID-19 Infection
755,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,PULMONARY INFECTION; COVID,"February 08, 2021",60,NCT04348513,T3 SOLUTION FOR INJECTION; PLACEBO,GREECE,Recruiting,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,"May 29, 2020",Interventional,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection (Thy-Support)
756,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,PATIENT SAFETY,"February 08, 2021",1000,NCT04348552,"PRIMARY CARE PROFESSIONALS REPORTS OF POTENTIAL PATIENT SAFETY INCIDENTS, NON-COVID-19 RELATED",FRANCE,Recruiting,Nantes University Hospital,"April 28, 2020",Observational,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study
757,CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),COVID,"February 08, 2021",1200,NCT04348656,CONVALESCENT PLASMA,CANADA,Recruiting,Hamilton Health Sciences Corporation,"May 14, 2020",Interventional,A Randomized Open-Label Trial of CONvalenscent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness (CONCOR-1)
758,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,CORONAVIRUS INFECTION,"February 08, 2021",94,NCT04348695,RUXOLITINIB PLUS SIMVASTATIN; STANDARD OF CARE,SPAIN,Recruiting,Fundación de investigación HM,"April 12, 2020",Interventional,Randomized Phase II Clinical Trial of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.Ruxo-Sim-20 Clinical Trial.
759,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,COMMUNICABLE DISEASE; COVID; SARS-CoV2; INFECTIOUS DISEASE; CORONAVIRUS; VIRUS,"February 08, 2021",200,NCT04348864,"COVID-19 ANTIGEN/ANTIBODY RAPID TESTING, MOBILE DEVICE IMAGE CAPTURE AND TELEMEDICINE SUPPORT; TELEMEDICINE",UNITED STATES,Recruiting,Neuroganics LLC,"April 16, 2020",Interventional,Assessment of COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
760,Plasma Rich Antibodies From Recovered Patients From COVID19,CORONAVIRUS DISEASE (COVID),"February 08, 2021",20,NCT04348877,ANTIBODY-RICH PLASMA FROM COVID-19 RECOVERED PATIENTS,EGYPT,Not yet recruiting,Ain Shams University,"April 20, 2020",Interventional,Plasma Rich Antibodies From Recovered Patients From COVID19
761,Birth Experience During COVID-19 Confinement,POSTPARTUM DEPRESSION,"February 08, 2021",927,NCT04348929,SELF-ADMINISTERED QUESTIONNAIRES,FRANCE,Recruiting,"Central Hospital, Nancy, France","April 16, 2020",Interventional,Birth Experience During COVID-19 Confinement (Confinement and Fostering Intrapartum Care)
762,"A COVID-19 Symptom, Exposure and Immune Response Registry",COVID,"February 08, 2021",10000,NCT04348942,,UNITED STATES,"Active, not recruiting",ObvioHealth,"May 29, 2020",Observational [Patient Registry],COVID-19 Study - A Primarily Prospective Observational Study of COVID-19 Clinical Characteristics and Acquired Immune Response Within the General Population
763,Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",202,NCT04349098,SELINEXOR; PLACEBO,AUSTRIA,Completed,Karyopharm Therapeutics Inc,"April 17, 2020",Interventional,A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients With Severe COVID-19 Infection
764,Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort.,PSYCHOLOGICAL,"February 08, 2021",280,NCT04349163,QUESTIONNAIRE,FRANCE,Completed,"University Hospital, Angers","May 10, 2020",Observational,Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period
765,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,COVID; CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",56000,NCT04349202,EUROIMMUN ASSAY,UNITED STATES,Recruiting,William Beaumont Hospitals,"April 10, 2020",Observational,Beaumont Health Large-scale Automated Serologic Testing for COVID-19
766,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,COVID; SARS-CoV2; HYDROXYCHLOROQUINE; PROPHYLAXIS; HEALTHCARE WORKER,"February 08, 2021",0,NCT04349228,HYDROXYCHLOROQUINE (HCQ); PLACEBO ORAL TABLET,TUNISIA,Withdrawn,Abderrahmane Mami Hospital,"April 28, 2020",Interventional,"Assessment of the Efficacy and Safety of Hydroxychloroquine (HCQ) Administered as a Prophylaxis for Health Professionals Exposed to COVID19 and Working in Medical Intensive Care Units, in Tunisia. Multicentric Randomized Comparative Study"
767,Efficacy and Safety of Favipiravir in Management of COVID-19,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04349241,FAVIPIRAVIR; STANDARD OF CARE THERAPY,EGYPT,Completed,Ain Shams University,"April 18, 2020",Interventional,Efficacy and Safety of Favipiravir in Management of COVID-19
768,Early Extubation for Patients With Acute Hypoxemic Respiratory Failure,MECHANICAL VENTILATION; CORONAVIRUS INFECTION,"February 08, 2021",108,NCT04349332,HELMET NON-INVASIVE VENTILATION (NIV),UNITED STATES,Recruiting,University of Chicago,"August 13, 2020",Interventional,Early Extubation for Patients With Acute Hypoxemic Respiratory Failure
769,Saved From COVID-19,COVID,"February 08, 2021",350,NCT04349371,CHLOROQUINE; PLACEBO ORAL TABLET,UNITED STATES,Recruiting,Columbia University,April 2020,Interventional,Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
770,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,COVID POSITIVE,"February 08, 2021",1800,NCT04349410,"HYDROXYCHLOROQUINE, AZITHROMYCIN; HYDROXYCHLOROQUINE, DOXYCYCLINE; HYDROXYCHLOROQUINE, CLINDAMYCIN; HYDROXYCHLOROQUINE, CLINDAMYCIN, PRIMAQUINE - LOW DOSE.; HYDROXYCHLOROQUINE, CLINDAMYCIN, PRIMAQUINE - HIGH DOSE.; REMDESIVIR; TOCILIZUMAB; METHYLPREDNISOLONE; INTERFERON-ALPHA2B; LOSARTAN; CONVALESCENT SERUM",UNITED STATES,Completed,The Camelot Foundation,"April 11, 2020",Interventional,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol
771,Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19,COVID,"February 08, 2021",40,NCT04349540,NO INTERVENTION,UNITED KINGDOM,"Active, not recruiting",Great Ormond Street Hospital for Children NHS Foundation Trust,"April 15, 2020",Observational,A Prospective Non Interventional Study to Evaluate the Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 Infection
772,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,COVID,"February 08, 2021",456,NCT04349592,HYDROXYCHLOROQUINE; AZITHROMYCIN; PLACEBO TABLET; PLACEBO CAPSULES,QATAR,Recruiting,Hamad Medical Corporation,"April 14, 2020",Interventional,Randomized Placebo-controlled Trial of Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19
773,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID; SARS-CoV2; PNEUMONIA,"February 08, 2021",200,NCT04349618,PROTECTIVE VENTILATION; ULTRAPROTECTIVE VENTILATION,FRANCE,Recruiting,Hospices Civils de Lyon,"April 15, 2020",Interventional,Open Label Randomized Controlled Trial of Ultraprotective Ventilation Without Extracorporeal Circulation in Patients With COVID 19 Pneumonia and Moderate to Severe ARDS
774,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,COVID,"February 08, 2021",56,NCT04349631,HB-ADMSCS,UNITED STATES,"Active, not recruiting",Hope Biosciences,"April 22, 2020",Interventional,"A Phase II, Open Label, Single-Center, Clinical Trial to Assess Efficacy of HB-adMSCs to Provide Immune Support Against Coronavirus Disease"
775,ICU Trial in Critical Ill COVID-19 Patients,"RISK FACTOR, CARDIOVASCULAR; COVID; CRITICAL ILLNESS; COURSE ILLNESS","February 08, 2021",50,NCT04349982,"BIOMARKER (TROPT, MYOGLOBIN, CK, CK-MB, LDH, D-DIMER, CRP, PCT)",AUSTRIA,Recruiting,Medical University of Graz,"April 8, 2020",Observational [Patient Registry],Prospective Observational ICU Trial in Critical Ill COVID-19 Patients (POINT-C) Cardiovascular Risk and the Effects on Myocardial Events in Critical Ill COVID-19 Patients
776,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),COVID,"February 08, 2021",120,NCT04350073,Q-NRG METOBOLIC CART DEVICE; MUSCLESOUND ULTRASOUND; MULTIFREQUENCY BIOIMPEDANCE SPECTROSCOPY,UNITED STATES,Recruiting,Duke University,"April 20, 2020",Observational,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)
777,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,COVID INFECTION; SARS-CoV2; RESPIRATORY FAILURE; PALLIATIVE SITUATION,"February 08, 2021",0,NCT04350086,TREATMENT WITH DEXMEDETOMIDINE,FRANCE,Withdrawn,"University Hospital, Limoges","April 20, 2020",Interventional,Prospective Study of the Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection
778,Emotional Burden of Healthcare Professionals and Covid Infection 19,EMOTIONNAL DISTRESS; COVID,"February 08, 2021",200,NCT04350099,QUETIONNARY,FRANCE,Recruiting,"University Hospital, Limoges","April 15, 2020",Observational,Emotional Burden of Healthcare Professionals and the Epidemic Related to Covid Infection 19 -
779,Double Therapy With IFN-beta 1b and Hydroxychloroquine,COVID,"February 08, 2021",60,NCT04350281,INTERFERON BETA-1B; HYDROXYCHLOROQUINE,HONG KONG,Completed,The University of Hong Kong,"April 9, 2020",Interventional,"An Open-label Randomized Controlled Trial on Interferon β-1b and Hydroxychloroquine Combination Versus Hydroxychloroquine Alone, as Treatment for COVID-19 Infection"
780,Trial to Study the Benefit of Colchicine in Patients With COVID-19,COVID,"February 08, 2021",102,NCT04350320,COLCHICINE TABLETS; STANDARD THERAPY FOR COVID-19 ACCORDING TO THE STABLISHED HOSPITAL PROTOCOLS.,SPAIN,Completed,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,"April 30, 2020",Interventional,"Administration of Colchicine Plus Standard Treatment vs. Standard Therapy, in Hospitalized Patients With COVID-19, Within the First 48 Hours, and no Severity Criteria."
781,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,COVID; CORONAVIRUS; COVID,"February 08, 2021",0,NCT04350450,HYDROXYCHLOROQUINE,UNITED STATES,Withdrawn,Montefiore Medical Center,April 2020,Interventional,"Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore: a Review of Process Feasibility, Safety, and Clinical Outcomes"
782,COVID-19 Remote Monitoring,COVID; CARDIAC ARRHYTHMIAS,"February 08, 2021",0,NCT04350476,VITALCONNECT VITAL SIGN PATCH,,Withdrawn,Vivek Reddy,"April 17, 2020",Interventional,Remote Monitoring in Patients With Coronavirus Disease (COVID-19)
783,Polyvalent Immunoglobulin in COVID-19 Related ARds,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",138,NCT04350580,HUMAN IMMUNOGLOBULIN; PLACEBO,FRANCE,Recruiting,Centre Hospitalier St Anne,"April 11, 2020",Interventional,Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
784,Dapagliflozin in Respiratory Failure in Patients With COVID-19,COVID,"February 08, 2021",1250,NCT04350593,DAPAGLIFLOZIN 10 MG; PLACEBO,ARGENTINA,"Active, not recruiting",Saint Luke's Health System,"April 22, 2020",Interventional,"An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients With COVID-19"
785,Interferon Beta 1a in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",40,NCT04350671,INTERFERON BETA-1A; LOPINAVIR / RITONAVIR; SINGLE DOSE OF HYDROXYCHLOROQUINE,"IRAN, ISLAMIC REPUBLIC OF",Enrolling by invitation,Shahid Beheshti University of Medical Sciences,"April 15, 2020",Interventional,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial"
786,Umifenovir in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",40,NCT04350684,UMIFENOVIR; INTERFERON-Β 1A; LOPINAVIR / RITONAVIR; SINGLE DOSE OF HYDROXYCHLOROQUINE; STANDARDS OF CARE,"IRAN, ISLAMIC REPUBLIC OF",Enrolling by invitation,Shahid Beheshti University of Medical Sciences,"April 15, 2020",Interventional,"Efficacy and Safety of Umifenovir as an Adjuvant Therapy Compared to the Control Therapeutic Regiment of Interferon Beta 1a, Lopinavir / Ritonavir and a Single Dose of Hydroxychloroquine in Moderate to Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial"
787,Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",50,NCT04350710,PEEP TRIAL,FRANCE,Recruiting,"University Hospital, Angers","March 18, 2020",Observational,Evaluation of Respiratory Mechanics and Lung Recruitment in Patients With SARS-CoV-2 Associated Acute Respiratory Distress Syndrome
788,Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,CORONAVIRUS INFECTION; COVID,"February 08, 2021",350,NCT04350723,AWAKE PRONING,CANADA,Recruiting,St. Joseph's Healthcare Hamilton,"June 10, 2020",Interventional,Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial
789,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",ACUTE LUNG INJURY (ALI) ASSOCIATED WITH COVID; INFLAMMATORY LUNG CONDITIONS ASSOCIATED WITH COVID,"February 08, 2021",54,NCT04350736,TD-0903; PLACEBO,UNITED KINGDOM,Completed,Theravance Biopharma,"April 23, 2020",Interventional,"A Phase 1, Double-blind, Randomized, Placebo-controlled, Sponsor-open, SAD and MAD Study in Healthy Subjects to Evaluate the Safety, Tolerability, and PK of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19"
790,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,CORONAVIRUS DISEASE (COVID),"February 08, 2021",900,NCT04350931,INTRADERMAL INJECTION OF BCG VACCINE; PLACEBO,EGYPT,Not yet recruiting,Ain Shams University,"April 20, 2020",Interventional,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19
791,Impact of the COVID-19 Pandemic in Gynecological Oncology,GYNECOLOGIC CANCER; BREAST NEOPLASM FEMALE; UTERINE NEOPLASMS; OVARIAN NEOPLASMS; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS; VAGINAL NEOPLASMS,"February 08, 2021",205,NCT04351139,MODIFICATION OF THE PLANNED THERAPEUTIC MANAGEMENT,FRANCE,Completed,Hospices Civils de Lyon,"May 6, 2020",Observational,Impact of the COVID-19 Pandemic on Changes in Therapeutic Strategies in Gynecological Oncology
792,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,CORONAVIRUS DISEASE 2019 (COVID) PNEUMONIA,"February 08, 2021",516,NCT04351152,LENZILUMAB; STANDARD OF CARE,BRAZIL,Recruiting,"Humanigen, Inc.","May 5, 2020",Interventional,"A Phase 3 Randomized, Placebo-Controlled Study of Lenzilumab in Hospitalized Patients With Severe and Critical COVID-19 Pneumonia"
793,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,SARS-CoV2; SYMPTOMATIC CONDITION; COVID,"February 08, 2021",400,NCT04351191,HYDROXYCHLOROQUINE SULFATE REGULAR DOSE; HYDROXYCHLOROQUINE SULFATE LOADING DOSE; CHLOROQUINE; PLACEBO,PAKISTAN,Recruiting,"Government of Punjab, Specialized Healthcare and Medical Education Department","April 15, 2020",Interventional,Use and Dosage of Hydroxychloroquine and Chloroquine to Convert Symptomatic RT-PCR Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Infectious Disease 2019 (COVID-19) Patients to RT- PCR-Negative as a Means to Reduce Hospitalization Rate
794,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),COVID,"February 08, 2021",227,NCT04351243,GIMSILUMAB; PLACEBO,UNITED STATES,"Active, not recruiting",Kinevant Sciences GmbH,"April 12, 2020",Interventional,"A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)"
795,Efficacy of Faviprevir in COVID-19 Treatment,COVID,"February 08, 2021",90,NCT04351295,FAVIPIRAVIR; PLACEBOS,EGYPT,Recruiting,Tanta University,"April 20, 2020",Interventional,Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 Treatment
796,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,COVID,"February 08, 2021",300,NCT04351347,IVERMECTIN; NITAZOXANIDE WITH IVERMECTIN,EGYPT,Recruiting,Tanta University,"June 16, 2020",Interventional,Clinical Study Evaluating the Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment
797,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,SARS-CoV2; RHEUMATIC DISEASES; RHEUMATOID ARTHRITIS; CHRONIC PAIN,"February 08, 2021",318,NCT04351399,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,"University Hospital, Lille","April 27, 2020",Observational,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak
798,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,SARS-CoV2,"February 08, 2021",3140,NCT04351490,ZINC GLUCONATE; 25-OH CHOLECALCIFEROL,,Not yet recruiting,"University Hospital, Lille",April 2020,Interventional,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Institutionalized Aged Patients Infected With COVID-19
799,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,SARS CORONAVIRUS (SARS-CoV2) INFECTION,"February 08, 2021",10000,NCT04351503,STUDY A; STUDY B; STUDY C; STUDY D,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","April 9, 2020",Observational,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City
800,Test and Treat COVID 65plus+,SARS-CoV2; COVID,"February 08, 2021",0,NCT04351516,HYDROXYCHLOROQUINE; PLACEBO,GERMANY,Withdrawn,University Hospital Tuebingen,"April 21, 2020",Interventional,Randomized Controlled Trial of Hydroxychloroquine Versus Placebo in Early Ambulatory Diagnosis and Treatment of Elderly COVID19 Patients
801,Austrian COVID-19 Registry,INFECTIOUS DISEASE; COVID,"February 08, 2021",1000,NCT04351529,,AUSTRIA,Recruiting,Arbeitsgemeinschaft medikamentoese Tumortherapie,"April 1, 2020",Observational [Patient Registry],Austrian COVID-19 Registry (AGMT_COVID-19)
802,Ayurveda for Flu Like Illness During Covid-19 Outbreak,FLU LIKE ILLNESS,"February 08, 2021",32,NCT04351542,AYURVEDA; USUAL CARE,UNITED KINGDOM,Completed,Aarogyam UK,"March 6, 2020",Interventional,Ayurveda for Flu-like Illness During the Covid 19 Outbreak: Non Randomised Single-blind Controlled Trial
803,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics;,EVALUATING THE EFFECT OF SOCIAL MEDIA USAGE IN PROVIDING HEALTHCARE SERVICES DURING THE PERIOD OF 19 COVID PANDEMICS,"February 08, 2021",874,NCT04351568,QUESIONNAIR,EGYPT,Recruiting,Assiut University,"April 1, 2020",Observational,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services; During the Period of 19 Covid Pandemics
804,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,COVID,"February 08, 2021",215,NCT04351581,DISCONTINUATION OF ACEI/ARB; CONTINUATION OF ACEI/ARB,DENMARK,Recruiting,"University Hospital, Gentofte, Copenhagen","May 18, 2020",Interventional,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19
805,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,COVID,"February 08, 2021",20,NCT04351620,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,University of Chicago,April 2020,Interventional,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19
806,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,SARS-CoV2; OSTEOPOROSIS,"February 08, 2021",52,NCT04351633,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,"University Hospital, Lille","April 23, 2020",Observational,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak
807,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),COVID,"February 08, 2021",500,NCT04351646,,UNITED KINGDOM,Not yet recruiting,"St George's, University of London","April 15, 2020",Observational,Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak (DARTS)
808,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,COVID,"February 08, 2021",8,NCT04351659,BLOOD DONATION FROM CONVALESCENT DONOR,SINGAPORE,Recruiting,KK Women's and Children's Hospital,"April 14, 2020",Observational,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19
809,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,SARS-CoV2; COVID,"February 08, 2021",130,NCT04351711,IMMUNOLOGICAL PROFILING,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nīmes,"April 9, 2020",Observational,Immunological Profiling of Patients With COVID-19 in Respiratory Distress
810,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),COVID,"February 08, 2021",500,NCT04351724,CHLOROQUINE OR HYDROXYCHLOROQUINE; LOPINAVIR/RITONAVIR; BEST STANDARD OF CARE; RIVAROXABAN; THROMBOPROPHYLAXIS; CANDESARTAN; NON-RAS BLOCKING ANTIHYPERTENSIVES; REMDESIVIR; ASUNERCEPT 400MG; ASUNERCEPT 100MG; ASUNERCEPT 25MG; PENTAGLOBIN,AUSTRIA,Recruiting,Medical University of Vienna,"April 16, 2020",Interventional,"A Multicenter, Randomized, Active Controlled, Open Label, Platform Trial on the Efficacy and Safety of Experimental Therapeutics for Patients With COVID-19 (Caused by Infection With Severe Acute Respiratory Syndrome Coronavirus-2)"
811,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,COVID,"February 08, 2021",804,NCT04351763,AMIODARONE; VERAPAMIL,POLAND,Recruiting,Nicolaus Copernicus University,"April 27, 2020",Interventional,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms
812,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,COVID; MENTAL HEALTH; PSYCHOEDUCATION; ANXIETY,"February 08, 2021",66,NCT04351789,PSYCHOEDUCATIONAL INTERVENTION,DENMARK,Recruiting,"Copenhagen University Hospital, Hvidovre","May 1, 2020",Interventional,Impact of a Minimal Psychoeducational Intervention Versus Standard of Care on Anxiety Among Hospitalized COVID-19 Patients in Denmark: a Randomized Clinical Trial
813,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,COVID,"February 08, 2021",180,NCT04351802,LUNG ULTRASOUND,UNITED KINGDOM,Recruiting,University Hospital Plymouth NHS Trust,"May 11, 2020",Observational,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study
814,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",500,NCT04351854,RETROSPECTIVE DATA COLLECTION,GERMANY,Recruiting,University of Cologne,"April 20, 2020",Observational,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room
815,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,ARDS; HYPERCAPNIC RESPIRATORY FAILURE; AKI,"February 08, 2021",20,NCT04351906,ECCO2R,GERMANY,Recruiting,University of Giessen,"May 3, 2020",Interventional,Low-flow Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform for Correction of Hypercapnia in COVID-19-associated Acute Respiratory Distress Syndrome
816,Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+),PATIENTS WITH COVID,"February 08, 2021",0,NCT04351919,HYDROXYCHLOROQUINE; AZITHROMYCIN,TUNISIA,Withdrawn,Abderrahmane Mami Hospital,"May 5, 2020",Interventional,"Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+), inTunisia"
817,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,COVID,"February 08, 2021",2000,NCT04352348,BLOOD SAMPLES; FECES SAMPLES (COVI-BIOME ANCILLARY STUDY); SWEAT SAMPLES (COVIDOG ANCILLARY STUDY); SALIVA SAMPLES; 6 MINUTES WALK TEST; PHONE CALL; URINE SAMPLES,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"March 31, 2020",Interventional,Cohort of Patients Infected With SARS-CoV2 or Suspected of Being (COVID-19 in Ile-de-France)
818,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),COVID,"February 08, 2021",256,NCT04352400,NAFAMOSTAT MESILATE; PLACEBO,,Not yet recruiting,University Hospital Padova,April 2020,Interventional,RAndomized Clinical Trial in COvid19 Patients to Assess the Efficacy of the Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor NAfamostat (RACONA Study)
819,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,COVID,"February 08, 2021",42,NCT04352465,METHOTREXATE; METHOTREXATE; METHOTREXATE,BRAZIL,Not yet recruiting,Azidus Brasil,"May 1, 2020",Interventional,Treatment of Acute Respiratory Syndrome Resulting From the Inflammatory Process of COVID-19 Infection Using Methotrexate-loaded Nanoparticles: A Phase I/II Study
820,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,COVID,"February 08, 2021",347,NCT04352491,NO INTERVENTION,INDIA,Completed,"Institute of Liver and Biliary Sciences, India","April 24, 2020",Observational,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease (FEELIV COVID)
821,Influence Physical Activity Psychological Responses COVID-19 Pandemic,SEDENTARY BEHAVIOR; MENTAL HEALTH WELLNESS 1,"February 08, 2021",3500,NCT04352517,ONLINE SURVEY,BRAZIL,Recruiting,University of Extremadura,"March 16, 2020",Observational,Influence of Physical Activity on Psychological Responses During Coronavirus Disease (COVID-19) Pandemic: a Multi-center and Observational Study
822,COVID19-hematological Malignancies: the Italian Hematology Alliance,SARS-CoV2 INFECTION; HEMATOLOGICAL MALIGNANCIES,"February 08, 2021",250,NCT04352556,,ITALY,Recruiting,Ospedale di Circolo - Fondazione Macchi,"April 7, 2020",Observational,SARS-CoV-2 Infection in Patients With Hematological Malignancies: the Italian Hematology Alliance
823,COVID-19 and Vaccination Attitudes,COVID,"February 08, 2021",1194,NCT04352582,SURVEY,UNITED KINGDOM,Completed,"University Hospital, Geneva","April 14, 2020",Observational,COVID-19 and Vaccination Attitudes
824,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),COVID,"February 08, 2021",744,NCT04352608,TWO DOSES OF MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE EMERGENCY VACCINATION SCHEDULE; TWO DOSES OF HIGH DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE EMERGENCY VACCINATION SCHEDULE; TWO DOSES OF PLACEBO AT THE EMERGENCY VACCINATION SCHEDULE; TWO DOSES OF MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE ROUTINE VACCINATION SCHEDULE; TWO DOSES OF HIGH DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE ROUTINE VACCINATION SCHEDULE; TWO DOSES OF PLACEBO AT THE ROUTINE VACCINATION SCHEDULE,CHINA,"Active, not recruiting","Sinovac Research and Development Co., Ltd.","April 16, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18~59 Years"
825,The Covid-19 HEalth caRe wOrkErS (HEROES) Study,COVID; MENTAL HEALTH DISORDER; STRESS DISORDER; ANXIETY; DEPRESSION; SARS-CoV2,"February 08, 2021",2000,NCT04352634,EXPOSURE TO THE SARS-COV-2 AND ITS CONSEQUENCES,ARGENTINA,Recruiting,University of Chile,"April 26, 2020",Observational,The Impact of the Covid-19 Pandemic on the Mental Health of Workers in Health Services: The Covid-19 HEalth caRe wOrkErS (HEROES) Study
826,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,SURGERY; COMPLICATION OF SURGICAL PROCEDURE; COVID,"February 08, 2021",120,NCT04352699,,FRANCE,Completed,Centre Hospitalier Universitaire de Nice,"March 15, 2020",Observational,Outcomes of naïve Patients Operated on for an Urological Cancer or Emergency During Periods of Social COVID-19 Containment: is it Reasonable to Limit Access to Surgical Care for All?
827,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,COVID,"February 08, 2021",2000,NCT04352751,CONVALESCENT PLASMA,PAKISTAN,Recruiting,Hilton Pharma,"May 1, 2020",Interventional,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020
828,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,COVID,"February 08, 2021",5000,NCT04352764,CORONACIDETM COVID-19 IGM/IGG RAPID TEST AND PREMIER BIOTECH COVID-19 IGM/IGG RAPID TEST,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"March 27, 2020",Observational [Patient Registry],Use of the ANTIBODY BASED LATERAL FLOW IMMUNOASSAY TESTS FOR SARSCoV-2 THAT CAUSES CORONAVIRUS DISEASE 2019 (COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
829,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,COVID PNEUMONIA; CYOTOKINE STORM,"February 08, 2021",20,NCT04352803,AUTOLOGOUS ADIPOSE MSC'S,,Not yet recruiting,Regeneris Medical,April 2020,Interventional,IV Infusion of Autologous Adipose Derived Mesenchymal Cells for Abatement of Respiratory Compromise in SARS-CoV-2 Pandemic (COVID-19)
830,Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）,COVID; ECHOCARDIOGRAPHY,"February 08, 2021",51,NCT04352842,ECHOCARDIOGRAPHY,CHINA,Completed,RenJi Hospital,"January 21, 2020",Observational,Cardiac Structural and Functional Characteristics in COVID-19: A Dynamic Echocardiographic Study
831,PROLIFIC ChemoprophylaxisTrial (COVID-19),COVID,"February 08, 2021",1000,NCT04352933,HYDROXYCHLOROQUINE - DAILY DOSING; HYDROXYCHLOROQUINE - WEEKLY DOSING; MATCHED PLACEBO HYDROXYCHLOROQUINE,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"May 11, 2020",Interventional,ChemoPROphyLaxIs For covId-19 Infectious Disease (the PROLIFIC Trial)
832,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,PROPHYLAXIS; COVID; HEALTH CARE WORKER; HYDROXYCHLOROQUINE,"February 08, 2021",374,NCT04352946,HYDROXYCHLOROQUINE PRE-EXPOSURE PROPHYLAXIS; PLACEBO ORAL TABLET,UNITED STATES,Not yet recruiting,GeoSentinel Foundation,"April 24, 2020",Interventional,"Protecting Health Care Workers From COVID-19 With Hydroxychloroquine Pre-exposure Prophylaxis: A Randomized, Placebo-controlled Trial"
833,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,COVID; MOUTHWASH; SALIVA,"February 08, 2021",175,NCT04352959,MOUTHRINSE WITH BÊTA-CYCLODEXTRIN AND CITROX; MOUTHRINSE WITHOUT BÊTA-CYCLODEXTRIN AND CITROX,FRANCE,Completed,Claude Bernard University,"April 27, 2020",Interventional,"COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses: Double-blind, Randomized, Placebo-controlled Clinical Study"
834,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,"SEPTIC SHOCK; ENDOTOXEMIA; COVID; CORONAVIRUS INFECTION; SEPSIS, SEVERE","February 08, 2021",,NCT04352985,TORAYMYXIN PMX-20R (PMX CARTRIDGE),UNITED STATES,Available,Spectral Diagnostics (US) Inc.,,Expanded Access,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19
835,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,SARS-CoV2; CHRONIC PAIN,"February 08, 2021",312,NCT04353011,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,"University Hospital, Lille","April 20, 2020",Observational,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak
836,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",850,NCT04353037,GROUP A HCQ; GROUP B CONTROL,UNITED STATES,Recruiting,UnitedHealth Group,"April 7, 2020",Interventional,PATCH 2 & 3: (Prevention and Treatment of COVID-19 With Hydroxychloroquine) An Open Label Multi-arm Randomized Trial of Hydroxychloroquine in the Prevention and Treatment of COVID-19
837,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",450,NCT04353128,MELATONIN 2MG; PLACEBO ORAL TABLET,SPAIN,Recruiting,Instituto de Investigación Hospital Universitario La Paz,"April 20, 2020",Interventional,Multicenter Randomized Controlled Trial of the Efficacy of Melatonin in the Prophylaxis of SARS-coronavirus-2 Infection Among High Risk Contacts.
838,International Lung UltraSound Analysis (ILUSA) Study,"COVID; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY RELATED; PREGNANCY, HIGH RISK; PREGNANCY DISEASE; PNEUMONIA; PNEUMONIA, VIRAL; DIAGNOSES DISEASE","February 08, 2021",1850,NCT04353141,STANDARDIZED LUNG ULTRASOUND (LUS) EXAMINATION,BELGIUM,Recruiting,KU Leuven,"April 28, 2020",Observational,A Prospective International Lung UltraSound Analysis (ILUSA) Study in Tertiary Maternity Wards During the SARS-CoV-2 Pandemic
839,The RAPID COVID TRIAGE Algorithm,COVID,"February 08, 2021",20,NCT04353154,SPARTAN CUBE POINT-OF CARE COVID-19 TEST,,Not yet recruiting,Ottawa Heart Institute Research Corporation,"April 15, 2020",Observational,"Development and Evaluation of Applying a Point-of-Care COVID-19 Test Strategy to Triage Patients Presenting With Acute Coronary Syndromes, Respiratory or Hemodynamic Instability and Out of Hospital Cardiac Arrests"
840,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized),COVID,"February 08, 2021",100000,NCT04353180,DRUG ISOTRETINOIN (13 CIS RETINOIC ACID ) CAPSULES+STANDARD TREATMENT; ISOTRETINOIN(AEROSOLIZED 13 CIS RETINOIC ACID) +STANDARD TREATMENT; ISOTRETINOIN (13 CIS RETINOIC ACID ) CAPSULES; AEROSOLIZED 13 CIS RETINOIC ACID; STANDARD TREATMENT,EGYPT,Not yet recruiting,Kafrelsheikh University,February 2021,Interventional,Isotretinoin in Treatment of COVID-19 (Randomized)
841,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,COVID; SARS-CoV2,"February 08, 2021",60,NCT04353206,MULTIPLE DOSES OF ANTI-SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,Recruiting,Noah Merin,"June 27, 2020",Interventional,A Feasibility Study Assessing the Safety of Multiple Doses of Anti-SARS-CoV-2 Plasma in Mechanically Ventilated Intubated Patients With Respiratory Failure Due to COVID-19
842,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System,COVID; CORONAVIRUS INFECTION; MYOCARDIAL INJURY; PNEUMONIA,"February 08, 2021",130,NCT04353245,BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM,BRAZIL,Not yet recruiting,University of Sao Paulo General Hospital,"June 1, 2020",Observational [Patient Registry],Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System: Effect of Hydroxychloroquine / Azithromycin Combined Therapy
843,Trial of Hydroxychloroquine In Covid-19 Kinetics,COVID; CORONAVIRUS INFECTION,"February 08, 2021",58,NCT04353271,HYDROXYCHLOROQUINE; PLACEBO,UNITED STATES,Terminated,University of South Alabama,"April 17, 2020",Interventional,A Randomized Phase 2/3 Trial of Hydroxychloroquine In Covid-19 Kinetics
844,Camostat Mesylate in COVID-19 Outpatients,COVID,"February 08, 2021",114,NCT04353284,CAMOSTAT MESILATE; PLACEBO,UNITED STATES,Recruiting,Yale University,"June 19, 2020",Interventional,"The Effect of Camostat Mesylate on COVID-19 Infection in Ambulatory Patients: An Investigator-Initiated Randomized, Placebo-Controlled, Phase IIa Trial"
845,COVID 19-Caregivers IGg Seroconversion,"INFECTION, COVID","February 08, 2021",130,NCT04353323,BLOOD SAMPLING,FRANCE,Not yet recruiting,"University Hospital, Limoges","May 25, 2020",Observational,Comparison of the Proportion of Covid19 Seroconversion of Caregivers Working or Not in the COVID Sector
846,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,COVID; CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04353336,CHLOROQUINE OR HYDROXYCHLOROQUINE,EGYPT,Recruiting,Tanta University,"March 23, 2020",Interventional,Clinical Study Evaluating the Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Treatment
847,WGS Analysis of COVID-19 Positive Patients,CORONAVIRUS INFECTION; COVID,"February 08, 2021",5000,NCT04353401,,UNITED STATES,Enrolling by invitation,Vanda Pharmaceuticals,"August 3, 2020",Observational,Whole-Genome Sequencing Analysis of COVID-19 Positive Patients
848,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,COVID,"February 08, 2021",4000,NCT04353518,SUSPENSION OF HEAT KILLED (AUTOCLAVED) MYCOBACTERIUM W; PLACEBO,INDIA,Recruiting,Cadila Pharnmaceuticals,"June 30, 2020",Interventional,"A Randomized, Double-blind, Two Arm, Placebo Controlled Clinical Trial to Evaluate the Efficacy and Safety of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19."
849,Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures,"TRANSMISSION, PATIENT PROFESSIONAL; HIGH-FLOW NASAL CANNULA","February 08, 2021",80,NCT04353531,HIGH-FLOW NASAL CANNULA; SURGICAL MASK; BRONCHOSCOPY EXAMINATION; INTUBATION; TRACHEOSTOMY; NEBULIZATION; PULMONARY FUNCTION TEST,UNITED STATES,Recruiting,Rush University Medical Center,"May 20, 2020",Observational,An Observational Study to Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures
850,Renal Outcome in Patients With COVID-19,ACUTE KIDNEY INJURY; CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04353583,,GERMANY,Recruiting,University of Giessen,"April 21, 2020",Observational [Patient Registry],Renal Outcome in Patients With Coronavirus Disease 2019 (COVID-19)
851,Stopping ACE-inhibitors in COVID-19,SARS-CoV2; COVID,"February 08, 2021",208,NCT04353596,"ACE INHIBITOR, ANGIOTENSIN RECEPTOR BLOCKER",AUSTRIA,Recruiting,Medical University Innsbruck,"April 15, 2020",Interventional,Stopping ACE-inhibitors in COVID-19: A Randomized Controlled Trial
852,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",SARS-CoV2; CHRONIC INFLAMMATORY RHEUMATISM; AUTOIMMUNE DISEASES,"February 08, 2021",13770,NCT04353609,,FRANCE,Recruiting,"University Hospital, Lille","April 18, 2020",Observational,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases : a Retrospective Multicenter Observational Study"
853,Modulation of Hyperinflammation in COVID-19,COVID; SARS,"February 08, 2021",40,NCT04353674,CONTROL GROUP; SLEDD WITH A L-MOD,CANADA,Recruiting,Lawson Health Research Institute,"April 28, 2020",Interventional,Novel Extracorporeal Treatment to Modulate Hyperinflammation in COVID-19 Patients
854,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,"INFECTION VIRAL; THROMBOSES, VENOUS; COVID","February 08, 2021",38,NCT04354155,ENOXAPARIN PREFILLED SYRINGE [LOVENOX],UNITED STATES,Recruiting,Johns Hopkins All Children's Hospital,"June 2, 2020",Interventional,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
855,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,SARS-CoV2; COVID,"February 08, 2021",140,NCT04354259,PEGINTERFERON LAMBDA-1A; PLACEBO,CANADA,Recruiting,"University Health Network, Toronto","May 13, 2020",Interventional,"Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19"
856,Evaluation of Dental Emergency Treatments During COVID19 Crisis,OROFACIAL PAIN; OROFACIAL EDEMA; DENTAL TRAUMA; ORAL INFECTION,"February 08, 2021",840,NCT04354272,QUESTIONNAIRE,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 13, 2020",Observational,Evaluation of the Management of Dental Emergencies During COVID 19 Crisis
857,DAS181 for STOP COVID-19,COVID,"February 08, 2021",0,NCT04354389,DAS181; PLACEBO; DAS181,ITALY,Withdrawn,"Ansun Biopharma, Inc.","July 25, 2020",Interventional,"DAS181 for COVID-19: A Phase II Multicenter, Randomized, Placebo-Controlled, Double-Blind Study"
858,Treatment for COVID-19 in High-Risk Adult Outpatients,COVID; SARS-CoV2,"February 08, 2021",300,NCT04354428,ASCORBIC ACID; HYDROXYCHLOROQUINE SULFATE; AZITHROMYCIN; FOLIC ACID; LOPINAVIR 200 MG / RITONAVIR 50 MG [KALETRA],UNITED STATES,"Active, not recruiting",University of Washington,"April 16, 2020",Interventional,Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults: An Adaptive Randomized Platform Trial
859,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,COVID; SARS-CoV2; PREGNANT WOMEN; HYDROXYCHLOROQUINE,"February 08, 2021",0,NCT04354441,HYDROXYCHLOROQUINE SULFATE 200 MG; PLACEBO ORAL TABLET,,Withdrawn,Sir Mortimer B. Davis - Jewish General Hospital,May 2020,Interventional,Randomized Trial Evaluating Effect of Outpatient Hydroxychloroquine on Reducing Hospital Admissions in Pregnant Women With SARS-CoV-2 Infection: HyPreC Trial
860,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,MULTIPLE SCLEROSIS; COVID,"February 08, 2021",3000,NCT04354519,,UNITED KINGDOM,Recruiting,Swansea University,"March 14, 2020",Observational [Patient Registry],The UK MS Regsiter COVID-19 Substudy
861,French Single Centre Experience of Critically Ill Patients With Covid 19,EPIDEMIOLOGY; SARS-CoV2; COVID; CRITICAL CARE; PROGNOSTIC; SURVIVAL,"February 08, 2021",200,NCT04354558,,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","July 1, 2020",Observational,Epidemiology and Outcomes of Critically Ill Patients With Covid 19: a French Single Centre Experience
862,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,COVID; RESPIRATORY FAILURE,"February 08, 2021",20,NCT04354584,,DENMARK,Recruiting,Hvidovre University Hospital,"April 6, 2020",Observational,"Early and Late Pulmonary and Systemic Inflammation in Critically Ill, Mechanically Ventilated Patients With Verified COVID-19"
863,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,COVID,"February 08, 2021",200,NCT04354597,HCQ & AZ,JORDAN,Not yet recruiting,King Hussein Cancer Center,"May 1, 2020",Interventional,"A Multicenter, Open-label, Pilot Study on Using Hydroxychloroquine (HCQ) and Azithromycin (AZ) Prophylaxis for Healthcare Workers With a Potential Risk of Exposure to COVID-19 Patients"
864,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,COVID,"February 08, 2021",57,NCT04354610,BIOLOGICAL SAMPLES SPECIFIC TO RESEARCH; CLINICAL EXAMINATION; TELEPHONE FOLLOW-UP,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","April 27, 2020",Interventional,Prediction of Acute Heart or Kidney Injury With Cardiovascular-renal Biomarkers in Patients Hospitalised for Severe or Critical Covid-19 Infection
865,COVID-19 and Cancer Consortium Registry,COVID; INVASIVE MALIGNANCY (ANY TYPE),"February 08, 2021",10000,NCT04354701,WEB-BASED REDCAP SURVEY,UNITED STATES,Recruiting,Vanderbilt-Ingram Cancer Center,"March 17, 2020",Observational [Patient Registry],The COVID-19 and Cancer Consortium (CCC19) Registry
866,Ruxolitinib to Combat COVID-19,COVID,"February 08, 2021",0,NCT04354714,RUXOLITINIB; PERIPHERAL BLOOD DRAW,,Withdrawn,Washington University School of Medicine,"June 30, 2020",Interventional,A Pilot Study of Ruxolitinib to Combat COVID-19
867,AiM COVID for Covid 19 Tracking and Prediction,COVID,"February 08, 2021",80,NCT04354753,NO INTERVENTION,UNITED KINGDOM,Completed,Aarogyam UK,"March 28, 2020",Observational,AiM COVID for Covid 19 Tracking and Prediction
868,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,COVID,"February 08, 2021",10,NCT04354766,BLOOD SAMPLE,FRANCE,Recruiting,Hospices Civils de Lyon,"April 29, 2020",Observational,Generation of Human Monoclonal Antibodies Neutralizing SARS-Cov-2 From B Cells of Convalescent Patients
869,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SARS-CoV2; CORONAVIRUS INFECTION; COVID,"February 08, 2021",3301,NCT04354779,A SPECIFICALLY DESIGNED SELF-ADMINISTERED QUESTIONNAIRE,AUSTRIA,Completed,AUVA,"May 11, 2020",Observational,Antikörperseroprävalenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem österreichischen Schlüsselkollektiv an Arbeitnehmer*Innen
870,Asymptomatic COVID-19 Infection Among Healthcare Workers,IMMUNOLOGIC ACTIVITY ALTERATION,"February 08, 2021",500,NCT04354792,SERUM SARS COV 2 IGG SCREENING IN HEALTH CARE WORKERS,EGYPT,Completed,Kasr El Aini Hospital,"May 1, 2020",Observational,Asymptomatic SARS- CoV2 Infection Among Healthcare Workers in Three University Hospitals: A Cross Sectional Study.
871,Administration of Chlorpromazine as a Treatment for COVID-19,COVID,"February 08, 2021",100,NCT04354805,CHLORPROMAZINE,EGYPT,Not yet recruiting,Cairo University,"August 1, 2020",Interventional,Administration of Chlorpromazine as a Treatment for COVID-19
872,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),HIV-1-INFECTION; CANCER; PRIMARY IMMUNE DEFICIENCY DISORDER; IMMUNOSUPPRESSION DISORDERS; COVID,"February 08, 2021",1000,NCT04354818,,AUSTRALIA,Recruiting,Kirby Institute,"May 11, 2020",Observational [Patient Registry],Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
873,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,COVID,"February 08, 2021",131,NCT04354831,ANTI-SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",Medical College of Wisconsin,"May 11, 2020",Interventional,"An Open Label, Phase 2 Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection"
874,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,COVID,"February 08, 2021",454,NCT04354857,OLFACTORY AND GUSTATORY TESTS,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nīmes,"March 27, 2020",Observational,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection
875,COVID-19 PrEP HCW HCQ Study,COVID,"February 08, 2021",130,NCT04354870,HYDROXYCHLOROQUINE (HCQ),UNITED STATES,Completed,NYU Langone Health,"April 3, 2020",Interventional,Off Label Study to Evaluate the Efficacy of HCQ for Pre-exposure Prophylaxis (PrEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Health Care Workers (HCWs) Who Are at High Risk of Occupational Exposure to SARS-CoV-2
876,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,COVID,"February 08, 2021",90,NCT04355026,BROMHEXINE ORAL TABLET AND/OR HYDROXYCHLOROQUINE TABLET,SLOVENIA,Recruiting,General and Teaching Hospital Celje,"April 10, 2020",Interventional,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia
877,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",COVID - 19,"February 08, 2021",250,NCT04355052,HYDROXYCHLOROQUINE IN COMBINATION WITH CAMOSTAT MESYLATE; HYDROXYCHLOROQUINE IN COMBINATION OF AZITHROMYCIN,ISRAEL,Recruiting,Sheba Medical Center,"April 11, 2020",Interventional,"An Open-Label Study to Compare the Efficacy, Safety, and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in Hospitalized Patients Suffering From a Mild or Moderate SARS CoV 2 Virus"
878,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),COVID,"February 08, 2021",150,NCT04355143,COLCHICINE TABLETS; CURRENT CARE PER UCLA TREATING PHYSICIANS,UNITED STATES,Recruiting,"University of California, Los Angeles","May 1, 2020",Interventional,"Randomized, Open-Label, Controlled Trial of Colchicine to Reduce Cardiac Injury in Hospitalized COVID-19 Patients (COLHEART-19)"
879,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",PREGNANCY,"February 08, 2021",2200,NCT04355234,IDENTIFY SARS-COV-2 INFECTION BY SEROLOGY; COLLECTION OF BIOLOGICAL SAMPLES,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 4, 2020",Interventional,"Prevalence and Impact of SARS-COV-2 Infection in Pregnant Women, Fetuses and Newborns"
880,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,COVID,"February 08, 2021",20,NCT04355247,METHYLPREDNISOLONE 80 MG/ML INJECTABLE SUSPENSION,PUERTO RICO,Recruiting,Auxilio Mutuo Cancer Center,"April 14, 2020",Interventional,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm
881,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),COVID,"February 08, 2021",4100,NCT04355338,,BRAZIL,Recruiting,Butantan Institute,"October 25, 2020",Observational,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil
882,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),"NEW CORONAVIRUS DISEASE (COVID), INFECTION WITH SARS-CoV2","February 08, 2021",400,NCT04355351,BLOOD SAMPLING; ADDITIONAL BLOOD TUBES,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"May 5, 2020",Interventional,Study of Immune Response During SARS-CoV-2 Infection
883,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100,NCT04355364,DORNASE ALFA INHALATION SOLUTION [PULMOZYME]; STANDARD PROCEDURE,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"April 21, 2020",Interventional,Efficacy and Safety of Dornase Alfa Aerosol in ARDS Secondary to SARS-CoV-2 Coronavirus Respiratory Infection - COVID-19
884,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),PNEUMONIA; CORONAVIRUS INFECTION; COVID,"February 08, 2021",230,NCT04355429,CAPTOPRIL 25MG,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"May 5, 2020",Interventional,Efficacy of Captopril Nebulization in Covid-19 Patients Suffering of SARS CoV-2 Pneumonia. A Randomized Phase II Study
885,Evolution of Facial Trauma During COVID Containment Measures,MAXILLOFACIAL INJURIES; SKULL FRACTURES; COVID,"February 08, 2021",300,NCT04355442,FACIAL FRACTURES REDUCTION OR OSTEOSYNTHESIS,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Evolution of Maxillofacial Trauma Activity During COVID-19 Containment Measures: a French Multicentric Comparative Observational Study
886,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,COVID; VIRAL INFECTION,"February 08, 2021",150,NCT04355481,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 17, 2020",Observational,Study of the Dissemination of SARS-COV-2 in the Environment of Infected Patients Admitted to Intensive Care Unit
887,SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19,"COVID; PNEUMONIA, VIRAL; ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)","February 08, 2021",,NCT04355494,ECULIZUMAB,FRANCE,Available,Alexion Pharmaceuticals,,Expanded Access,SOLIRIS® (Eculizumab) for the Treatment of Participants With Coronavirus Disease 2019 (COVID 19) - An Expanded Access Program for Hospital-based Emergency Treatment
888,Computed Tomography for COVID-19 Diagnosis,COVID,"February 08, 2021",10735,NCT04355507,CHEST COMPUTED TOMOGRAPHY (CT); REVERSE-TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR),FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"March 1, 2020",Observational,Computed Tomography for Coronavirus Disease 19 Diagnosis
889,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,COVID INFECTION,"February 08, 2021",1000,NCT04355533,SEROLOGY TEST; NASOPHARYNGEAL SWAB; RECTAL SWAB; SALIVA SAMPLE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"July 29, 2020",Interventional,Seroprevalence and Antibody Profiling Against SARS-CoV2 in Children and Their Parents
890,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,MULTIPLE SCLEROSIS; NMO SPECTRUM DISORDER; COVID,"February 08, 2021",2000,NCT04355611,EVALUATION OF THE EPIDEMIOLOGICAL CHARACTERISTICS OF CORONAVIRUS INFECTION (SARS-COV-2),FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 20, 2020",Observational,Cohort Study Evaluating the Epidemiological Characteristics of Coronavirus Infection (SARS-CoV-2) in Patients With MS or NMO
891,Kidney Involvement in COVID-19 Disease (COVKID),COVID; KIDNEY INJURY,"February 08, 2021",80,NCT04355624,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 15, 2020",Observational,Characterization of Kidney Involvement in COVID-19 Disease: a French Multi-center Prospective Observational Study
892,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04355637,INHALED BUDESONIDE,ARGENTINA,Recruiting,Sara Varea,"April 21, 2020",Interventional,Treatment With Inhaled Corticosteroids in Patients Hospitalized Because of COVID19 Pneumonia
893,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",0,NCT04355676,SELINEXOR,,Withdrawn,Karyopharm Therapeutics Inc,"April 30, 2020",Interventional,"A Phase 2 Randomized, Open-Label, Multicenter Study to Evaluate the Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Patients With Moderate or Severe COVID-19"
894,Covid-19 in Lupus Patients,SYSTEMIC LUPUS ERYTHEMATOSUS; COVID,"February 08, 2021",130,NCT04355702,,FRANCE,Recruiting,"University Hospital, Montpellier","March 1, 2020",Observational,Manifestations Related to Covid-19 in Patients With Systemic Lupus Erythematosus
895,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,COVID; SARS-CoV2,"February 08, 2021",200,NCT04355715,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2019",Observational,Evaluation of a COVID-19 Screening Strategy Combining Chest Low Dose CT and RT-PCR Test for Patients Admitted for Surgical or Interventional Procedures During the COVID 19 Outbreak
896,Use of UC-MSCs for COVID-19 Patients,"CORONAVIRUS INFECTION; ARDS; ARDS, HUMAN; ACUTE RESPIRATORY DISTRESS SYNDROME; COVID","February 08, 2021",24,NCT04355728,UMBILICAL CORD MESENCHYMAL STEM CELLS + HEPARIN ALONG WITH BEST SUPPORTIVE CARE.; VEHICLE + HEPARIN ALONG WITH BEST SUPPORTIVE CARE,UNITED STATES,Completed,Camillo Ricordi,"April 25, 2020",Interventional,Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients With Acute Respiratory Distress Syndrome (ARDS)
897,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",COVID,"February 08, 2021",115,NCT04355741,EXPOSURE,PORTUGAL,Completed,Universidade Nova de Lisboa,"April 20, 2020",Observational,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease"
898,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,RESPIRATORY INSUFFICIENCY,"February 08, 2021",40,NCT04355754,VENTIL - A GAS FLOW DIVIDER,POLAND,Recruiting,Medical University of Gdansk,"April 15, 2020",Interventional,Assesment of Usefulness of Ventil Device for Mechanical Ventilation in ICU Patients
899,Convalescent Plasma in Outpatients With COVID-19,COVID,"February 08, 2021",600,NCT04355767,CONVALESCENT PLASMA; SALINE,UNITED STATES,Enrolling by invitation,Stanford University,"August 11, 2020",Interventional,Clinical-trial of COVID-19 Convalescent Plasma in Outpatients
900,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,COVID,"February 08, 2021",,NCT04355793,RUXOLITINIB,,Available,Incyte Corporation,,Expanded Access,An Open-Label Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection
901,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,COVID,"February 08, 2021",4035,NCT04355871,,SPAIN,Completed,Fundacion SEIMC-GESIDA,"March 18, 2020",Observational,Characteristics and Predictors of Death Among Hospitalized Patients With COVID-19 in Spain
902,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,COVID,"February 08, 2021",100,NCT04355884,"STANDARD 12-LEAD ECG, NT-PROBNP, ECHOCARDIOGRAPHY",HONG KONG,Not yet recruiting,The University of Hong Kong,"April 20, 2020",Observational,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in COVID-19 Survivors
903,CoVID-19 Plasma in Treatment of COVID-19 Patients,COVID,"February 08, 2021",100,NCT04355897,CONVALESCENT COVID 19 PLASMA,UNITED STATES,Recruiting,The Christ Hospital,"April 28, 2020",Interventional,Convalescent CoVID-19 Plasma in the Treatment of High Risk CoVID-19 Disease
904,Telmisartan for Treatment of COVID-19 Patients,COVID DRUG TREATMENT,"February 08, 2021",400,NCT04355936,TELMISARTAN ARM WILL RECEIVE 80 MG TELMISARTAN TWICE DAILY PLUS STANDARD CARE.,ARGENTINA,Completed,Laboratorio Elea Phoenix S.A.,"May 19, 2020",Interventional,Telmisartan for Treatment of COVID-19 Patients: an Open Label Randomized Trial
905,Sevoflurane in COVID-19 ARDS (SevCov),"ARDS, HUMAN; CORONAVIRUS","February 08, 2021",64,NCT04355962,SEVOFLURANE; INTRAVENOUS DRUG,SWITZERLAND,Recruiting,University of Zurich,"April 23, 2020",Interventional,Sevoflurane Sedation in COVID-19 ARDS Patients to Reduce Lung Injury: a Randomized Controlled Trial
906,Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections,"DISSEMINATED INTRAVASCULAR COAGULATION; CRITICAL ILLNESS; SARS-CoV2; VIRAL INFECTION; COAGULATION DISORDER, BLOOD; COVID","February 08, 2021",60,NCT04356144,THROMBIN GENERATION ASSAY (TGA); THROMBOMODULIN MODIFIED THROMBIN GENERATION ASSAY (TGA-TM),AUSTRIA,Recruiting,Medical University of Vienna,"April 15, 2020",Observational,Coagulation Assays in the Critically Ill Patient: a New Approach Using the Thrombomodulin-modified Thrombin Generation Assay (TGA-TM)
907,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),DEPRESSION; GENERALIZED ANXIETY; ADHERENCE TO NON-PHARMACOLOGICAL EPIDEMIOLOGICAL INTERVENTIONS (NPIS),"February 08, 2021",10084,NCT04356365,CROSS-SECTIONAL STUDY INVESTIGATING THE ASSOCIATION OF NPIS WITH MENTAL HEALTH,NORWAY,Completed,University of Oslo,"March 31, 2020",Observational,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)
908,Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation,INFECTION WITH CORONAVIRUS SARS-CoV2,"February 08, 2021",300,NCT04356378,DATA RECORD,FRANCE,Recruiting,CHU de Reims,"June 2, 2020",Observational,Long Term Physical Functional Performance in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation: a Multicentric Observational Study
909,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,"AMD, ACEI'S/ARB PREVENT/WORSEN RISK OF COVID INFECTION","February 08, 2021",6000000,NCT04356417,- SYNTHETIC ANTI-MALARIAL DRUGS,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Observational,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse: Cases of Synthetic Antimalarial Drugs and Anti-hypertensive Drugs
910,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,"RESPIRATORY FAILURE; VENTILATORY FAILURE; COVID; PNEUMONIA; ARDS, HUMAN","February 08, 2021",500,NCT04356443,AIRGO RESPIRATORY MONITOR,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 15, 2020",Observational,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection
911,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,COVID; SARS-CoV2; CONVALESCENCE; PLASMA; DOSES,"February 08, 2021",90,NCT04356482,CONVALESCENT PLASMA,MEXICO,Recruiting,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,"May 20, 2020",Interventional,DETERMINATION OF THE DOSE AND EFFECTIVENESS OF CONVALESCENT PLASMA IN SEVERELY AND VERY SEVERELY ILL PATIENTS BY COVID-19
912,Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation,CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",820,NCT04356495,VITAMINS; TELMISARTAN; CICLESONIDE; INTERFERON Β-1B,FRANCE,Recruiting,"University Hospital, Bordeaux","July 29, 2020",Interventional,Randomized Trial to Evaluate the Safety and Efficacy of Outpatient Treatments to Reduce the Risk of Worsening in Individuals With COVID-19 With Risk Factors (COVERAGE France)
913,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,"COVID; SARS-CoV2; 2019-NCOV; PNEUMONIA, VIRAL","February 08, 2021",15,NCT04356508,NIVOLUMAB,,Not yet recruiting,Dr Gerry Gin Wai Kwok,"April 14, 2020",Interventional,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1
914,Convalescent Plasma Trial in COVID -19 Patients,SARS-CoV2; COVID,"February 08, 2021",40,NCT04356534,PLASMA THERAPY USING CONVALESCENT PLASMA WITH ANTIBODY AGAINST SARS-COV-2; ROUTINE CARE FOR COVID-19 PATIENTS,BAHRAIN,Completed,Royal College of Surgeons in Ireland - Medical University of Bahrain,"April 19, 2020",Interventional,Use of Convalescent Plasma Therapy for COVID-19 Patients With Hypoxia: a Prospective Randomized Trial
915,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,COVID,"February 08, 2021",300,NCT04356560,"COVID-19 TEST, POLYMERASE CHAIN REACTION FOR SARS-COV-2",DENMARK,Enrolling by invitation,"Rigshospitalet, Denmark","March 23, 2020",Observational,"SARS-CoV-2 Surveillance of Patients and Healthcare Workers at the Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet University Hospital of Copenhagen, Denmark"
916,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,COVID; SEROLOGY,"February 08, 2021",287,NCT04356586,,BELGIUM,Completed,Sciensano,"May 4, 2020",Observational [Patient Registry],Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms
917,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,COVID,"February 08, 2021",50,NCT04356677,50 MG/ML VIRAZOLE; 100 MG/ML VIRAZOLE,,Not yet recruiting,"Bausch Health Americas, Inc.",February 2021,Interventional,"An Open-Label Study to Evaluate the Safety and Efficacy of VIRAZOLE® (RIBAVIRIN FOR INHALATION SOLUTION, USP) in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19"
918,Etoposide in Patients With COVID-19 Infection,COVID,"February 08, 2021",64,NCT04356690,ETOPOSIDE,UNITED STATES,Recruiting,Boston Medical Center,"May 8, 2020",Interventional,"A Phase II Single-Center, Randomized, Open-Label, Safety and Efficacy Study of Etoposide in Patients With COVID-19 Infection"
919,Nebulised Rt-PA for ARDS Due to COVID-19,COVID,"February 08, 2021",24,NCT04356833,NEBULISED RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA),UNITED KINGDOM,Recruiting,"University College, London","April 22, 2020",Interventional,"A Pilot, Open Label, Phase II Clinical Trial of Nebulised Recombinant Tissue-Plasminogen Activator (Rt-PA)"
920,COVID-19 and Psychotic Symptoms in France,MENTAL DISORDER,"February 08, 2021",600,NCT04356885,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Impact of Containment and Quarantine During COVID-19 Outbreack on Psychotic Symptoms in the General Population in France
921,Efficacy of Tocilizumab on Patients With COVID-19,SARS-CoV2,"February 08, 2021",243,NCT04356937,TOCILIZUMAB; PLACEBOS,UNITED STATES,Completed,Massachusetts General Hospital,"April 20, 2020",Interventional,Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized Non-Critically Ill Patients With COVID-19
922,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,SEPSIS; BLOOD COAGULATION DISORDERS; THROMBIN; DISSEMINATED INTRAVASCULAR COAGULATION; COVID,"February 08, 2021",175,NCT04356950,THROMBIN GENERATION TEST ASSAY; FIBRIN GENERATION MARKERS ASSAYS,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire de Nīmes,"April 28, 2020",Observational,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients: Thrombin Generation Potential in COVID-19 Infected Patients
923,Measles Vaccine in HCW,COVID,"February 08, 2021",200,NCT04357028,MEASLES-MUMPS-RUBELLA VACCINE; PLACEBOS,EGYPT,Suspended,Kasr El Aini Hospital,"July 13, 2020",Interventional,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial)
924,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being","ALL, ADULT","February 08, 2021",500,NCT04357041,,UNITED STATES,"Active, not recruiting","Clinical Nutrition Research Center, Illinois Institute of Technology","April 17, 2020",Observational,"Effects of Stay-at-home Guidance on Dietary Intake, Physical Activity and Overall Well-being During COVID-19 Public Health Crisis"
925,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,COVID,"February 08, 2021",10,NCT04357106,CONVALESCENT PLASMA,MEXICO,Recruiting,Centro de Hematología y Medicina Interna,"April 13, 2020",Interventional,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma
926,The RIsk Stratification in COVID-19 Patients in the ICU Registry,CRITICAL ILLNESS; ARDS; INFLAMMATORY RESPONSE; COVID; CIRCULATORY SHOCK,"February 08, 2021",10000,NCT04357275,ICU TREATMENT,SWITZERLAND,Recruiting,University of Zurich,"March 13, 2020",Observational [Patient Registry],The RIsk Stratification in COVID-19 Patients in the ICU Registry
927,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,MYOCARDIAL INFARCTION,"February 08, 2021",6332,NCT04357314,,FRANCE,Completed,French Cardiology Society,"March 1, 2020",Observational,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study
928,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",122,NCT04357327,RAPID SALIVARY TEST,ITALY,Completed,Università degli Studi dell'Insubria,"April 16, 2020",Interventional,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19): a Diagnostic Accuracy Study
929,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,COVID; PNEUMONIA; SARS PNEUMONIA,"February 08, 2021",40,NCT04357340,PULMONARY PHYSIOTHERAPY TECHNIQUES,"IRAN, ISLAMIC REPUBLIC OF",Completed,Tehran University of Medical Sciences,"April 2, 2020",Interventional,Efficacy of Pulmonary Physiotherapy on Hospitalized Patients With Novel Coronavirus 2019 Pneumonia
930,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),COVID; VIRUS DISEASES; CORONAVIRUS INFECTION; LOWER RESPIRATORY TRACT INFECTION VIRAL,"February 08, 2021",500,NCT04357366,ANAKINRA,GREECE,Recruiting,Hellenic Institute for the Study of Sepsis,"April 15, 2020",Interventional,"suPAR-guided Anakinra Treatment for Validation of the Risk and Early Management of Severe Respiratory Failure by COVID-19: The SAVE Open-label, Non-randomized Single-arm Trial"
931,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,"ANXIETY STATE; COVID; ISOLATION, SOCIAL; HEALTH PERSONNEL ATTITUDE","February 08, 2021",187,NCT04357418,IT IS A SURVEY,FRANCE,Completed,"Centre hospitalier de Ville-Evrard, France","April 1, 2020",Observational,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives (ICOS)
932,COVID-19 Among Egyptian Health Care Providers,COVID,"February 08, 2021",565,NCT04357431,SELF-ADMINISTERED QUESTIONNAIRE,EGYPT,Completed,Assiut University,"April 22, 2020",Observational,"Knowledge, Attitude, Perceived Worry and Stigma About COVID-19 Among Egyptian Health Care Providers"
933,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,COVID,"February 08, 2021",30,NCT04357444,1: ILT101; 2: PLACEBO COMPARATOR,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 23, 2020",Interventional,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19
934,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,COVID; HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",212,NCT04357457,ALMITRINE; PLACEBO,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"September 3, 2020",Interventional,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia: a Randomized Controlled Double-blind Study From the Skip-icu Consortium
935,COVID-19 Epidemic Response Study,FEVER; PNEUMONIA; COUGH,"February 08, 2021",400,NCT04357496,,,Not yet recruiting,Centogene AG Rostock,"December 20, 2020",Observational,COVID-19 Epidemic Response Study: A National Observational Longitudinal Non-Interventional Protocol
936,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,COVID,"February 08, 2021",314,NCT04357535,ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE-I) AND ANGIOTENSIN II RECEPTOR BLOCKERS (ARB),SAUDI ARABIA,Completed,Hakeam Abdulaziz Hakeam,"May 10, 2020",Observational,Prognosis of SARS-Cov 2 Positive Patients Receiving Angiotensin Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Antagonists (ARBs)
937,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,COVID; CANCER,"February 08, 2021",1000,NCT04357574,TELEHEALTH,UNITED STATES,Enrolling by invitation,Duke University,"April 14, 2020",Observational,Assessing the Provider Implementation and Experience of TeleHealth During COVID-19 and Impact on Acute Encounters
938,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,SARS VIRUS,"February 08, 2021",99,NCT04357613,EXPERIMENTAL DRUG,FRANCE,Not yet recruiting,Versailles Hospital,"September 1, 2020",Interventional,A RANDOMIZED NON-COMPARATIVE PHASE 2 PILOT STUDY TESTING THE VALUE OF IMATINIB MESYLATE AS AN EARLY TREATMENT OF COVID-19 DISEASE IN AGED HOSPITALIZED PATIENTS.
939,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),HIV PATIENTS,"February 08, 2021",1040,NCT04357639,NO INTERVENTION,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 28, 2020",Observational [Patient Registry],Prospective Description Study of the Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19
940,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,SEVERE ACUTE RESPIRATORY SYNDROME; RESPIRATORY FAILURE; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",60,NCT04357730,ALTEPLASE 50 MG [ACTIVASE]; ALTEPLASE 50 MG [ACTIVASE],UNITED STATES,Recruiting,Denver Health and Hospital Authority,"May 14, 2020",Interventional,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection: A Phase 2a Clinical Trial
941,COVID-19 Pandemic Burden in Severe Mental Disease Patients,PSYCHOLOGICAL DISTRESS; COVID; SEVERE MENTAL DISORDER,"February 08, 2021",400,NCT04357769,PSS (PERCEIVED STRESS SCALE); GAD-7 (7-ITEM GENERALIZED ANXIETY DISORDER); PHQ-9 (9-ITEM PATIENT HEALTH QUESTIONNAIRE); SPEQ (SPECIFIC PSYCHOTIC EXPERIENCES QUESTIONNAIRE) - PARANOIA AND GRANDIOSITY SUBSCALES; ZARITT BURDEN INTERVIEW,ITALY,Completed,Federico II University,"April 10, 2020",Observational,A Study of Perceived Distress and Psychological Burden in Patients Suffering From Severe Mental Diseases During the COVID-19 Pandemic in Italy
942,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,COVID; HYPOXIA,"February 08, 2021",20,NCT04357782,L-ASCORBIC ACID,UNITED STATES,Completed,Hunter Holmes Mcguire Veteran Affairs Medical Center,"April 16, 2020",Interventional,"Administration of Intravenous Vitamin C in Novel Coronavirus Infection and Decreased Oxygenation (AVoCaDO): A Phase I/II Safety, Tolerability, and Efficacy Clinical Trial"
943,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),COVID,"February 08, 2021",30,NCT04357808,SARILUMAB; STANDAR OF CARE,SPAIN,"Active, not recruiting",Maria del Rosario Garcia de Vicuña Pinedo,"April 13, 2020",Interventional,Randomized Open Pilot Study to Evaluate the Efficacy of Subcutaneous Sarilumab in Patients With Moderate-severe COVID-19 Infection
944,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,COVID; COVID; SARS-CoV2,"February 08, 2021",100,NCT04357834,EQUIPMENT WITH SMARTWATCH THROUGHOUT HOSPITAL STAY ON THE GENERAL WARD,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","May 1, 2020",Observational,Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories. The WAVE Study.
945,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,COVID; ENDOTHELIAL DYSFUNCTION; THROMBOSIS; CRITICALLY ILL,"February 08, 2021",100,NCT04357847,,FRANCE,Recruiting,"University Hospital, Rouen","April 9, 2020",Observational,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection
946,Clinical Trial of Sarilumab in Adults With COVID-19,SARS-CoV2; SARS,"February 08, 2021",120,NCT04357860,SARILUMAB 200 MG/1.14 ML SUBCUTANEOUS SOLUTION [KEVZARA]; SARILUMAB 400 MG/2.28 ML SUBCUTANEOUS SOLUTION [KEVZARA]; BEST AVAILABLE TREATMENT,SPAIN,Not yet recruiting,Maimónides Biomedical Research Institute of Córdoba,"April 27, 2020",Interventional,Clinical Trial of Sarilumab in Adults Hospitalized With COVID-19 Presenting Cytokine Release Syndrome
947,Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey,HEALTHY,"February 08, 2021",1000,NCT04357886,,TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,May 2020,Observational,New Coronavirus Awareness
948,Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",145,NCT04357938,CT-IMAGING,GERMANY,"Active, not recruiting",Jena University Hospital,"April 15, 2020",Observational,Risk Stratification With Chest Computed Tomography to Rule-out Suspected SARS-CoV-2 Infections of Unspecific Symptomatic Patients Before Hospital Admission
949,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,CORONAVIRUS; COVID,"February 08, 2021",300,NCT04357977,RBA-2,UNITED STATES,Not yet recruiting,"Kaligia Biosciences, LLC",April 2020,Observational,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device
950,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,COVID,"February 08, 2021",128,NCT04357990,VIRUXAL ORAL AND NASAL SPRAY; PLACEBO,ICELAND,Recruiting,Kerecis Ltd.,"September 4, 2020",Interventional,"Use of a Medical Device, Viruxal Oral and Nasal Spray, for Treating the Symptoms of COVID-19 Via Application to the Naso- and Oropharyngeal Mucosa"
951,Plasma Adsorption in Patients With Confirmed COVID-19,RESPIRATORY FAILURE; ARDS,"February 08, 2021",2000,NCT04358003,MARKER THERAPEUTICS D2000 CARTRIDGE (D2000) FOR USE WITH THE SPECTRA OPTIA® APHERESIS SYSTEM (OPTIA SPD PROTOCOL),UNITED STATES,Recruiting,Marker Therapeutics AG,"May 20, 2020",Interventional,Plasma Adsorption in Patients With Confirmed COVID-19 Infection
952,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),COVID CARDIAC; COVID 16 ARRHYTHMIA; COVID DEATH,"February 08, 2021",10000,NCT04358029,,UNITED STATES,Recruiting,Vivek Reddy,"April 9, 2020",Observational,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)
953,PSYCHIATRIC Disorders and Covid-19,PSYCHIATRIC DISORDER; COVID,"February 08, 2021",250,NCT04358042,"BRIEF PSYCHIATRIC RATING SCALE; DEPRESSION, ANXIETY AND STRESS SCALE; IMPACT OF EVENT SCALE-REVISED; CONNOR-DAVIDSON RESILIENCE SCALE 10 ITEMS (CD-RISC 10)",FRANCE,Recruiting,Nantes University Hospital,"April 24, 2020",Observational [Patient Registry],"PSYCHIatric Disorders and Covid-19 (PSYCHIC) : Observatory of the Psychiatric, Somatic and Pharmacological Impacts of the COVID-19 Pandemic on Patients Hospitalized for Psychiatric Disorders and Suspected to be Infected by COVID-19"
954,Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,COVID; SARS-CoV2,"February 08, 2021",20,NCT04358068,HYDROXYCHLOROQUINE (HCQ); AZITHROMYCIN (AZITHRO); PLACEBO FOR HYDROXYCHLOROQUINE; PLACEBO FOR AZITHROMYCIN,UNITED STATES,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"May 1, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19"
955,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,COVID,"February 08, 2021",20,NCT04358081,HCQ; HCQ+AZT; PLACEBO,UNITED STATES,Completed,Novartis Pharmaceuticals,"May 1, 2020",Interventional,"A Multi-center, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease"
956,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,COVID,"February 08, 2021",,NCT04358211,BIOLOGICAL: COVID-19 CONVALESCENT PLASMA,UNITED STATES,Available,"Nakhle Saba, MD",,Expanded Access,Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19
957,Liver Injury in Patients With COVID-19,LIVER INJURY,"February 08, 2021",320,NCT04358380,LIVER INJURY,ARGENTINA,Enrolling by invitation,"Austral University, Argentina","April 15, 2020",Observational,Liver Injury in Hospitalized Patients With COVID-19 in Latin America: Clinical Characteristics and Prognostic Factors
958,Rhu-pGSN for Severe Covid-19 Pneumonia,SARS-CoV2,"February 08, 2021",60,NCT04358406,RECOMBINANT HUMAN PLASMA GELSOLIN (RHU-PGSN); PLACEBO,ROMANIA,Recruiting,BioAegis Therapeutics Inc.,"July 30, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study To Evaluate Efficacy And Safety Of Recombinant Human Plasma Gelsolin (Rhu-pGSN) Added To Standard Of Care In Subjects With Severe Covid-19 Pneumonia"
959,COVID-19 Mortality Prediction Model,COVID; PNEUMONIA; MECHANICAL VENTILATION,"February 08, 2021",114,NCT04358510,COVIAGE,UNITED STATES,Completed,Dascena,"April 1, 2020",Observational,"Mortality Prediction Model for the Triage of COVID-19, Pneumonia and Mechanically Ventilated ICU Patients"
960,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,COVID,"February 08, 2021",230,NCT04358536,COVX,UNITED STATES,Completed,Dascena,"April 1, 2020",Observational,Classification of COVID-19 Infection in Posteroanterior Chest X-rays With Common Deep Learning Architectures
961,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,COVID,"February 08, 2021",50,NCT04358549,FAVIPIRAVIR + STANDARD OF CARE; STANDARD OF CARE,UNITED STATES,"Active, not recruiting","Fujifilm Pharmaceuticals U.S.A., Inc.","April 17, 2020",Interventional,"Open Label, Randomized, Controlled Phase 2 Proof-of-Concept Study of the Use of Favipiravir Compared to Standard of Care in Hospitalized Subjects With COVID-19"
962,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,"CORONAVIRUS INFECTION; COVID; PNEUMONIA, VIRAL","February 08, 2021",,NCT04358588,INO (INHALED NITRIC OXIDE) DELIVERED VIA THE INOPULSE DELIVERY SYSTEM,,No longer available,Bellerophon,,Expanded Access,"Expanded Access: Pulsed, Inhaled Nitric Oxide (iNO) for the Treatment of Patients With Mild or Moderate Coronavirus Disease (COVID-19)"
963,Baricitinib Therapy in COVID-19,COVID; PNEUMONIA,"February 08, 2021",12,NCT04358614,BARICITINIB 4 MG ORAL TABLET,ITALY,Completed,Fabrizio Cantini,"March 16, 2020",Interventional,Baricitinib Therapy in COVID-19: A Pilot Study on Safety and Clinical Impact
964,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,"ACUTE RESPIRATORY DISTRESS SYNDROME; INFLAMMATION; DEXMEDETOMIDINE; CYTOKINE STORM; DELIRIUM, EMERGENCE","February 08, 2021",80,NCT04358627,DEXMEDETOMIDINE INJECTABLE PRODUCT,,Not yet recruiting,Hospital Clinic of Barcelona,"April 15, 2020",Observational,Impact of Dexmedetomidine Infusion on the Time Course and Outcomes of Acute Respiratory Distress Syndrome (ARDS) in Patients Affected by the SARS-CoV-2 (COVID-19) Admitted to Critical Care Unit
965,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,"CRITICAL ILLNESS; SARS-CoV2; SARS PNEUMONIA; CORONAVIRUS INFECTION; STRESS DISORDERS, POST-TRAUMATIC","February 08, 2021",1784,NCT04358640,,FRANCE,Completed,Centre Hospitalier Universitaire de Nīmes,"April 9, 2020",Observational,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey
966,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04358783,PLASMA; BEST AVAILABLE THERAPY,MEXICO,Recruiting,Hospital Universitario Dr. Jose E. Gonzalez,"April 27, 2020",Interventional,"Phase II, Randomized, Double-blind, Controlled Clinical Trial Evaluating the Efficacy and Safety of Plasma From Patients Cured of COVID-19 Compared to the Best Available Therapy in Subjects With SARS-CoV-2 Pneumonia"
967,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",COVID,"February 08, 2021",480,NCT04358809,SUSPENSION OF HEAT KILLED (AUTOCLAVED) MYCOBACTERIUM W; PLACEBO,INDIA,Recruiting,Cadila Pharnmaceuticals,"June 30, 2020",Interventional,"A Randomized, Double-blind, Two Arm, Controlled Clinical Trial to Compare the Efficacy and Safety of Mycobacterium w (Mw) Administered Along With Standard of Care Versus Placebo Administered Along With Standard of Care, in Adult, COVID 19 Positive Patients Hospitalized But Not Critically Ill."
968,Keto-diet for Intubated Critical Care COVID-19,COVID,"February 08, 2021",0,NCT04358835,KETOGENIC DIET; STANDARD OF CARE,,Withdrawn,Johns Hopkins University,"September 1, 2020",Interventional,Keto-diet for Intubated Critical Care COVID-19 (KICC-COVID19)
969,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),COVID; DESATURATION OF BLOOD,"February 08, 2021",30,NCT04358926,HYPERBARIC OXYGEN THERAPY,ISRAEL,Completed,Assaf-Harofeh Medical Center,"April 30, 2020",Interventional,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)
970,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",404,NCT04358939,PRONE DECUBITUS,FRANCE,Recruiting,"University Hospital, Tours","April 27, 2020",Interventional,Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
971,Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients,CARDIOMYOPATHIES,"February 08, 2021",50,NCT04358952,GLOBAL LONGITUDINAL STRAIN,FRANCE,Recruiting,"University Hospital, Toulouse","April 4, 2020",Observational,Imaging Cardiac Phenotype of SARS-Cov-2 (Covid19) Infected Patients
972,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,COVID,"February 08, 2021",1200,NCT04359095,EMTRICITABINE/TENOFOVIR; COLCHICINE PILL; ROSUVASTATIN; STANDARD TREATMENT,COLOMBIA,Recruiting,Universidad Nacional de Colombia,"August 18, 2020",Interventional,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia: A Pragmatic Randomized Controlled Trial
973,COVID-19 and the Developement of Phobic Fears of Disease,COVID,"February 08, 2021",600,NCT04359121,QUESTIONNAIRES FOR SPECIFIC PHOBIA,AUSTRIA,Recruiting,Medical University of Graz,"April 15, 2020",Observational,COVID-19 and the Developement of Phobic Fears of Disease
974,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,"COVID DISEASE; THROMBOEMBOLISM, VENOUS","February 08, 2021",90,NCT04359212,THROMBOPROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT HEPARIN OR FONDAPARINUX,ITALY,Completed,Quovadis Associazione,"May 1, 2020",Observational,Increased Risk of Venous Thromboembolism and Higher Hypercoagulable State in Patients Recovered in Intensive Care Unit and in Medical Ward for Coronavirus Disease 2019 (COVID-19)
975,A Comparison of 3D and 2D Telemedicine During Covid 19,TELEHEALTH,"February 08, 2021",80,NCT04359225,3D TELEMEDICINE; 2D TELEMEDICINE,UNITED KINGDOM,Not yet recruiting,NHS Greater Glasgow and Clyde,"June 30, 2020",Interventional,A Comparison of 3D and 2D Telemedicine: Communication During Covid 19
976,Different PEEP Settings of COVID-19 Induced ARDS,COVID; MECHANICAL VENTILATION PRESSURE HIGH; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",20,NCT04359251,GAS EXCHANGES AT DIFFERENT PEEP; LUNG MECHANICS AT DIFFERENT PEEP; HEMODYNAMICS CHANGES AT DIFFERENT PEEP,CHINA,Completed,"Southeast University, China","March 5, 2020",Interventional,Avoiding High PEEP in COVID-19 Induced ARDS: a Multi-center Study
977,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,COVID,"February 08, 2021",392,NCT04359264,CASH TRANSFER,CANADA,"Active, not recruiting",Unity Health Toronto,"April 20, 2020",Interventional,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial (DISTANSE COVID-19 RCT)
978,A Randomized Trial of Anticoagulation Strategies in COVID-19,COVID,"February 08, 2021",77,NCT04359277,ENOXAPARIN HIGHER DOSE; LOWER-DOSE PROPHYLACTIC ANTICOAGULATION,UNITED STATES,Terminated,NYU Langone Health,"April 21, 2020",Interventional,A Randomized Trial of Anticoagulation Strategies in COVID-19
979,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,"ARDS, HUMAN; COVID","February 08, 2021",15,NCT04359290,RUXOLITINIB ADMINISTRATION,GERMANY,"Active, not recruiting",Philipps University Marburg Medical Center,"July 1, 2020",Interventional,"Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS A Single-arm, Open-label, Proof of Concept Study"
980,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,COVID,"February 08, 2021",50,NCT04359303,SYSTEMIC INDIRECT ENDOVENOUS OZONE THERAPY,SPAIN,Not yet recruiting,Javier Hidalgo Tallón,July 2020,Interventional,Randomized Clinical Trial to Evaluate Efficacy and Safety of Systemic Indirect Endovenous Ozone Therapy (SIEVOT) as Adjuvant Treatment in COVID19 Non-intubated Patients
981,Azithromycin in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",40,NCT04359316,HYDROXYCHLOROQUINE; AZITHROMYCIN,"IRAN, ISLAMIC REPUBLIC OF",Not yet recruiting,Shahid Beheshti University of Medical Sciences,"April 20, 2020",Interventional,"Efficacy and Safety of Azithromycin Compared to the Base Therapeutic Regiment of Hydroxychloroquine in Moderate to Severe COVID-19: A Randomized, Controlled, Double-Blind, Clinical Trial"
982,Estrogen Patch for COVID-19 Symptoms,COVID,"February 08, 2021",110,NCT04359329,ESTRADIOL PATCH,UNITED STATES,Recruiting,Sharon Nachman,"April 20, 2020",Interventional,Phase II Clinical Trial of Estradiol to Reduce Severity of COVID19 Infection in COVID19+ and Presumptive COVID19+ Patients
983,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ELECTRIC IMPEDANCE; PRONE POSITIONING,"February 08, 2021",16,NCT04359407,PRONE POSITIONING,SWITZERLAND,Recruiting,Walid HABRE,"April 27, 2020",Observational,The Effect of Prone Positioning on Lung Aeration and Ventilation-perfusion Matching in Mechanically Ventilated Patients With Coronavirus Disease Related Acute Respiratory Distress Syndrome
984,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,COVID,"February 08, 2021",150,NCT04359459,,,Not yet recruiting,University Medical Center Groningen,June 2020,Observational,"Nasal CIliated EPithelial Genetic And Single Cell RNA prOfiLes of miLd, Severe and Very Severe COVID-Nineteen patIents (CIPOLLINI) Study"
985,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",210,NCT04359511,PREDNISONE; HYDROCORTISONE,,Not yet recruiting,"University Hospital, Tours",June 2020,Interventional,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia in Grand Ouest Interregion France
986,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,COVID,"February 08, 2021",200,NCT04359537,HYDROXYCHLOROQUINE SULFATE 200 MG; PLACEBO,PAKISTAN,Recruiting,Shaheed Zulfiqar Ali Bhutto Medical University,"May 1, 2020",Interventional,Comparative Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 in Healthcare Personnel
987,COVID-19 Recovered Volunteer Research Participant Pool Registry,RECOVERED FROM COVID,"February 08, 2021",10000,NCT04359602,,UNITED STATES,Recruiting,"University of California, Los Angeles","April 8, 2020",Observational [Patient Registry],COVID-19 Recovered Volunteer Research Participant Pool Registry
988,Favipiravir in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",40,NCT04359615,FAVIPIRAVIR; HYDROXYCHLOROQUINE,"IRAN, ISLAMIC REPUBLIC OF",Not yet recruiting,Shahid Beheshti University of Medical Sciences,"April 20, 2020",Interventional,"Efficacy and Safety of Favipiravir Compared to the Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized, Controlled, Double-Blind, Clinical Trial"
989,Nebulised Dornase Alfa for Treatment of COVID-19,COVID; HYPOXIA,"February 08, 2021",50,NCT04359654,DORNASE ALFA INHALATION SOLUTION [PULMOZYME],UNITED KINGDOM,Recruiting,"University College, London","June 16, 2020",Interventional,"A Single-site, Randomised, Controlled, Parallel Design, Open-label Investigation of an Approved Nebulised Recombinant Human DNase Enzyme (Dornase Alfa) to Reduce Hyperinflammation in Hospitalised Participants With COVID-19"
990,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,COVID; SEVERE PNEUMONIA,"February 08, 2021",30,NCT04359667,TOCILIZUMAB 20 MG/ML INTRAVENOUS SOLUTION [ACTEMRA],CROATIA,Recruiting,"University Hospital for Infectious Diseases, Croatia","June 16, 2020",Observational,Prognostic Value of Serum Interleukin-6 (IL-6) and Soluble Interleukin-6 Receptor (sIL-6R) in Severe Coronavirus Disease (COVID-19) Pneumonia Treated With Tocilizumab - a Prospective Single Center Study (UHID-COVID19)
991,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,COVID; VIRAL RESPIRATORY ILLNESSES,"February 08, 2021",1407,NCT04359680,NITAZOXANIDE; PLACEBO; VITAMIN SUPER B-COMPLEX,UNITED STATES,"Active, not recruiting",Romark Laboratories L.C.,"May 13, 2020",Interventional,"A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection"
992,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,SARS-CoV2,"February 08, 2021",1576,NCT04359693,,FRANCE,Completed,"University Hospital, Lille","April 22, 2020",Observational,Impact of SARS-CoV-2 Infection on the Incidence of Ventilator-acquired Infections
993,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,SARS-CoV2,"February 08, 2021",30,NCT04359706,,FRANCE,Recruiting,"University Hospital, Lille","May 8, 2020",Observational,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With SARS-CoV2
994,COVID-19 Patient Positioning Pragmatic Trial,COVID,"February 08, 2021",503,NCT04359797,PRONE; USUAL CARE,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"April 27, 2020",Interventional,Pragmatic Trial Exploring Impact of Patient Positioning in the Management of Patients Infected With COVID-19: Supine vs. Prone
995,Plasma Therapy of COVID-19 in Severely Ill Patients,SARS-CoV2 INFECTION,"February 08, 2021",219,NCT04359810,CONVALESCENT PLASMA (ANTI-SARS-COV-2 PLASMA); NON-CONVALESCENT PLASMA (CONTROL PLASMA),BRAZIL,Recruiting,Max R. O'Donnell,"April 21, 2020",Interventional,"A Phase 2, Multi-Center, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Human Anti-SARS-CoV-2 Convalescent Plasma in Severely Ill Adults With COVID-19"
996,A Study to Explore the Role of Gut Flora in COVID-19 Infection,GUT MICROBIOME; GASTROINTESTINAL MICROBIOME; COVID; COVID; CORONAVIRUS INFECTION; CORONAVIRUS; CORONAVIRIDAE INFECTIONS; CORONAVIRUS 19; CORONAVIRUS-19; COVID,"February 08, 2021",250,NCT04359836,THERE IS NO INTERVENTION IN THIS STUDY,UNITED STATES,Recruiting,ProgenaBiome,"April 16, 2020",Observational,A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection
997,Sequencing and Tracking of Phylogeny in COVID-19 Study,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04359849,,UNITED KINGDOM,Recruiting,Portsmouth Hospitals NHS Trust,May 2020,Observational,Sequencing and Tracking of Phylogeny in COVID-19 Study
998,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID INFECTION,"February 08, 2021",50,NCT04359862,SEVOFLURANE; PROPOFOL,SPAIN,Recruiting,Fundación para la Investigación del Hospital Clínico de Valencia,"April 16, 2020",Interventional,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
999,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,CARDIOVASCULAR DISEASES; MENTAL DISORDER,"February 08, 2021",22000,NCT04359875,PHONE-CALL SCREENING AND MANAGEMENT BY A MEDICAL STUDENT/GENERAL PRACTITIONER TANDEM,FRANCE,Not yet recruiting,"University Hospital, Tours",April 2020,Interventional,Does a Systematic Phone-call by a Medical Student/General Practitioner Team in Patients Suffering From a Chronic Condition During the COVID-19 Containment Period Impact One-month Hospitalization's Rate in France? A Cluster Randomized Trial
1000,Sarilumab for Patients With Moderate COVID-19 Disease,COVID,"February 08, 2021",120,NCT04359901,SARILUMAB,UNITED STATES,Recruiting,Westyn Branch-Elliman,"April 10, 2020",Interventional,Sarilumab for Patients With Moderate COVID-19 Disease: A Randomized Controlled Trial With a Play-The-Winner Design
1001,Neurocognitive Impairment in Patients With COVID-19,CRITICAL ILLNESS; COVID; CENTRAL NERVOUS SYSTEM INJURY; DELIRIUM; ENCEPHALOPATHY,"February 08, 2021",80,NCT04359914,,GERMANY,Recruiting,University of Rostock,"April 15, 2020",Observational,Biomarker-guided Assessment of Neurocognitive Impairment in Patients With COVID-19 - a Multicenter Case-control Study
1002,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,SARS-CoV2; COVID; CARDIOVASCULAR DISEASES; CARDIOVASCULAR RISK FACTOR,"February 08, 2021",10000,NCT04359927,,SPAIN,Recruiting,Hospital Clinic of Barcelona,"April 20, 2020",Observational [Patient Registry],Long-term Effects of Coronavirus 2019 Disease on the Cardiovascular System in Patients Who Have Undergone a Diagnostic Nasopharyngeal Swab for SARS-CoV-2. CV COVID-19 Registry
1003,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",COVID INFECTION,"February 08, 2021",1600,NCT04359953,HYDROXYCHLOROQUINE; AZITHROMYCIN; TELMISARTAN,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 25, 2020",Interventional,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19: a Randomized, Multicenter, Adaptative Study"
1004,Study of Hemostasis in Case of Severe COVID-19,COVID INFECTION,"February 08, 2021",50,NCT04359992,EXTRA BLOOD SAMPLE,,Not yet recruiting,"University Hospital, Strasbourg, France","April 17, 2020",Observational,Study of Hemostasis in Case of Severe COVID-19
1005,Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19,SARS-CoV2; COVID; ARDS; ALI; ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS); DYSPNEA,"February 08, 2021",288,NCT04360096,RLF-100 (AVIPTADIL); PLACEBO; NEBULIZED ADMINISTRATION OF RLF-100 OR PLACEBO,,Not yet recruiting,"NeuroRx, Inc.","January 10, 2021",Interventional,Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19
1006,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04360122,LEVAMISOLE; ISOPRINOSINE; LEVAMISOLE AND ISOPRINOSINE,EGYPT,Not yet recruiting,Ain Shams University,"May 20, 2020",Interventional,Impact of Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19
1007,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,COVID,"February 08, 2021",1500,NCT04360278,,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"April 21, 2020",Observational,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19
1008,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,COVID,"February 08, 2021",100,NCT04360356,IVERMECTIN PLUS NITAZOXANIDE; STANDARD CARE,,Not yet recruiting,Tanta University,May 2020,Interventional,Clinical Trial Evaluating Safety and Efficacy of Ivermectin and Nitazoxanide Combination as Adjuvant Therapy in COVID-19 Newly Diagnosed Egyptian Patients: A Tanta University Hope
1009,Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",,NCT04360486,ANTI-SARS-COV-2 CONVALESCENT PLASMA,AFGHANISTAN,Available,U.S. Army Medical Research and Development Command,,Expanded Access,Expanded Access Protocol For The Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)
1010,Long Term Outcomes of Patients With COVID-19,CRITICAL ILLNESS; CORONAVIRUS INFECTION; RESPIRATORY FAILURE; COVID,"February 08, 2021",500,NCT04360538,QUALITY OF LIFE; IMPACT EVENT SCORE; HOSPITAL ANXIETY AND DEPRESSION SCALE,UNITED STATES,Recruiting,University of Chicago,"April 8, 2020",Observational,Long Term Outcomes of Patients With COVID-19
1011,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,COVID,"February 08, 2021",40,NCT04360551,TELMISARTAN 40MG; PLACEBO,UNITED STATES,Recruiting,University of Hawaii,"July 1, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients"
1012,Solid Organ Transplant Recipients With SARS-CoV-2 French Registry,SARS-CoV2,"February 08, 2021",300,NCT04360707,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 8, 2020",Observational,Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France
1013,Precision Immunology to Determine the Immune Response in Patients With COVID-19,SARS-CoV2; COVID,"February 08, 2021",200,NCT04360733,BLOOD DRAW,GERMANY,Recruiting,University of Bonn,"April 20, 2020",Observational,Precision Immunology Approach to Better Understand the Divergent Host Responses Towards Infection With SARS-CoV-2
1014,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,COVID; HIV,"February 08, 2021",0,NCT04360759,CHLOROQUINE OR HYDROXYCHLOROQUINE,SOUTH AFRICA,Withdrawn,University of Cape Town,"May 1, 2020",Interventional,Multi-centre Randomised Controlled Trial of Chloroquine/Hydroxychloroquine Versus Standard of Care for Treatment of Mild Covid-19 in HIV-positive Outpatients in South Africa
1015,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",PREGNANCY,"February 08, 2021",3600,NCT04360811,COVID 19 DIAGNOSTIC TEST BY PCR,FRANCE,Recruiting,"University Hospital, Toulouse","April 17, 2020",Interventional,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic by Creation and Analysis of a Biological and Tissue Collection of Pregnancy Outcomes"
1016,Covid-19 Associated Coagulopathy,COVID ASSOCIATED COAGULOPATHY,"February 08, 2021",170,NCT04360824,INTERMEDIATE DOSE THROMBOPROPHYLAXIS; STANDARD OF CARE THROMBOPROPHYLAXIS,UNITED STATES,Recruiting,University of Iowa,"May 6, 2020",Interventional,COVID-19-associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults With COVID-19
1017,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,COVID; VIRUS; PNEUMONIA; ATELECTASIS,"February 08, 2021",10,NCT04360837,ALVEOLAR RECRUITMENT,HUNGARY,Recruiting,Szeged University,"May 6, 2020",Interventional,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill COVID-19 Patients Under Electric Impedance Tomography (EIT)
1018,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,ONLINE THERAPY,"February 08, 2021",10000,NCT04360850,ONLINE SURVEY,UNITED STATES,Recruiting,University of Washington,"April 24, 2020",Observational,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic
1019,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,SMOKING CESSATION,"February 08, 2021",150,NCT04360863,TELEPHONE SURVEY,HONG KONG,Recruiting,The University of Hong Kong,"April 24, 2020",Observational,The Impact of Coronavirus Disease (COVID-19) Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong: A Survey Study
1020,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,COVID; ARDS,"February 08, 2021",0,NCT04360876,DEXAMETHASONE INJECTION; PLACEBOS,,Withdrawn,"University of Colorado, Denver","September 1, 2020",Interventional,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial
1021,Evaluation of Antibody Tests for COVID-19,COVID; CORONAVIRUS,"February 08, 2021",461,NCT04360954,DIAGNOSTIC TEST,UNITED STATES,Completed,Washington University School of Medicine,"April 23, 2020",Observational,Evaluation of Commerical Antibody Tests for COVID-19
1022,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,COVID,"February 08, 2021",80,NCT04360980,COLCHICINE TABLETS,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Shahid Beheshti University of Medical Sciences,"March 20, 2020",Interventional,Effects of Standard Protocol Therapy With or Without Colchicine in Covid-19 Infection: A Randomized Double Blind Clinical Trial
1023,Physical Activity in University Students Around COVID-19 Confinement,PHYSICAL ACTIVITY,"February 08, 2021",25000,NCT04361019,ON-LINE SURVEY,SPAIN,Recruiting,Basque Country University,"April 16, 2020",Observational,Physical Activity in University Students Around COVID-19 Confinement: Determinants and Consequences on Health Status and Quality of Life
1024,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",COVID; INTENSIVE CARE UNIT,"February 08, 2021",260,NCT04361032,TOCILIZUMAB INJECTION; DEFEROXAMINE,TUNISIA,Not yet recruiting,Abderrahmane Mami Hospital,"September 4, 2020",Interventional,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia. Multicentric, Comparative, Randomized Study"
1025,Atrium COVID-19 Syndromic and Serologic Surveillance,CORONAVIRUS; COVID,"February 08, 2021",450000,NCT04361123,DAILY SYNDROMIC SURVEILLANCE; MONTHLY SEROLOGIC IGM/G TEST,UNITED STATES,Enrolling by invitation,"Michael Runyon, MD","May 6, 2020",Observational,"A Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records"
1026,Leflunomide in Mild COVID-19 Patients,COVID,"February 08, 2021",20,NCT04361214,LEFLUNOMIDE,UNITED STATES,Recruiting,University of Chicago,"May 5, 2020",Interventional,Leflunomide for the Treatment of Ambulatory Patients With Mild COVID-19
1027,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,COVID; INFECTIOUS DISEASE,"February 08, 2021",220,NCT04361253,HIGH-TITER COVID-19 CONVALESCENT PLASMA (HT-CCP); STANDARD PLASMA (FFP),UNITED STATES,Recruiting,Brigham and Women's Hospital,"April 30, 2020",Interventional,"A Prospective, Randomized, Double-Masked, Placebo-Controlled Trial of High-Titer COVID-19 Convalescent Plasma (HT-CCP) for the Treatment of Hospitalized Patients With COVID-19 of Moderate Severity"
1028,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,COVID,"February 08, 2021",100,NCT04361318,HYDROXYCHLOROQUINE PLUS NITAZOXANIDE; STANDARD CARE,,Not yet recruiting,Tanta University,May 2020,Interventional,Clinical Trial Evaluating Safety and Efficacy of Hydroxychloroquine and Nitazoxanide Combination as Adjuvant Therapy in Covid-19 Newly Diagnosed Egyptian Patients: A Tanta University Hope
1029,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,COVID INFECTION; ENCEPHALITIS,"February 08, 2021",2,NCT04361344,BLOOD SAMPLES,FRANCE,Terminated,Centre Hospitalier de PAU,"May 19, 2020",Interventional,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection - MARNEVO-Covid
1030,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04361396,COLLECTION OF SAMPLES,FRANCE,Recruiting,Centre Hospitalier René Dubos,"June 16, 2020",Interventional,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum During an Emergency Laparoscopy Conducted on Confirmed or Suspected COVID-19 Patients
1031,Isotretinoin in Treatment of COVID-19,COVID,"February 08, 2021",300,NCT04361422,ISOTRETINOIN ONLY PRODUCT IN ORAL DOSE FORM,,Not yet recruiting,Tanta University,"December 1, 2020",Interventional,Evaluation of the Safety and Efficacy of Isotretinoin in Treatment of COVID-19: Clinical Study
1032,Lung Recruitment Device for COVID-19,COVID; PHYSIOTHERAPY,"February 08, 2021",50,NCT04361435,CHEST PHYSIOTHERAPY USING A NON-INVASIVE OSCILLATING DEVICE,,Not yet recruiting,St. Justine's Hospital,"May 1, 2020",Interventional,Comparison of Two Methods to Airway Clearance in Patients Admitted to Intensive Care Unit for COVID-19: A Pilot Corssover Randomized Controlled Trial
1033,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,COVID; SARS-CoV2; DIAGNOSIS; POLYMERASE CHAIN REACTION,"February 08, 2021",30,NCT04361448,SAMLING OF OROPHARYNX AND NASOPHARYNX,BELGIUM,Not yet recruiting,Jessa Hospital,"April 20, 2020",Interventional,Comparison of the Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR
1034,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),CORONAVIRUS INFECTION; SARS-CoV2; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); PULMONARY DISEASE,"February 08, 2021",0,NCT04361461,HYDROXYCHLOROQUINE SULFATE; HYDROXYCHLOROQUINE SULFATE + AZYTHROMYCIN,BRAZIL,Withdrawn,Apsen Farmaceutica S.A.,"April 30, 2020",Interventional,Hydroxychloroquine or Hydroxychloroquine Associated With Azithromycin for Inpatients With Moderate or Severe Lung Disease Due to SARS-CoV-2 (COVID-19)
1035,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,BUDESONIDE; OLFACTION DISORDERS; SARS-CoV2; ANOSMIA,"February 08, 2021",120,NCT04361474,BUDESONIDE NASAL; PHYSIOLOGICAL SERUM,FRANCE,"Active, not recruiting",Fondation Ophtalmologique Adolphe de Rothschild,"May 18, 2020",Interventional,A Randomized Controlled Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
1036,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,COVID,"February 08, 2021",100,NCT04361500,SERAPH 100,GERMANY,Recruiting,Hannover Medical School,"April 15, 2020",Observational [Patient Registry],Registry for the Evaluation of Safety and Effectiveness of the Seraph 100 Microbind Affinity Blood Filter in the Therapy of COVID-19 Patients (COSA)
1037,Pilot Study on Cytokine Filtration in COVID-19 ARDS,CORONAVIRUS INFECTION; ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",40,NCT04361526,CYTOKINE ADSORPTION,SPAIN,Recruiting,Manuel Castellà,"April 17, 2020",Interventional,Pilot Study on Cytokine Filtration in COVID-19 ARDS (CytokCOVID19)
1038,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CHRONIC RENAL FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; MALIGNANT NEOPLASM; SARS CORONAVIRUS 2 INFECTION,"February 08, 2021",0,NCT04361552,BEST PRACTICE; TOCILIZUMAB,UNITED STATES,Withdrawn,Emory University,"April 7, 2020",Interventional,"Tociluzumab for Cytokine Release Syndrome With SARS-CoV-2: An Open-Labeled, Randomized Phase 3 Trial"
1039,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,COVID BY SARS-CoV2 INFECTION,"February 08, 2021",50,NCT04361565,,FRANCE,Enrolling by invitation,Centre Hospitalier Universitaire de Nice,"March 20, 2020",Observational,Prevalence and Clinical Evolution of Olfactory and Taste Disorders in Patients Infected by SARS-CoV-2
1040,COVID-19 in Liver Transplant Recipients,LIVER TRANSPLANT; COMPLICATIONS; COVID; RESPIRATORY FAILURE,"February 08, 2021",200,NCT04361591,OBSERVATIONAL ONLY,SPAIN,Recruiting,Hospital Clinic of Barcelona,"March 1, 2020",Observational [Patient Registry],COVID-19 in Liver Transplant Recipients in Spain: a Nationwide Prospective Study
1041,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,ADULT PATIENTS LIVING WITH HIV (PLWHIV) WITH CONFIRMED INFECTION WITH SARS-CoV2 SINCE 1ST JANUARY 2020,"February 08, 2021",270,NCT04361604,BIOLOGICAL COLLECTION (PATIENTS CO INFECTED HIV SRAS-COV-2); AUTO-QUESTIONNAIRES (PATIENTS CO INFECTED HIV SRAS-COV-2); QUALITATIVE INTERVIEWS (IN 40 PATIENTS : 20 WITH COVID-19 AND 20 WITHOUT COVID-19),FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Observational,Clinical Characterisation Protocol for COVID-19 in People Living With HIV
1042,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,COVID,"February 08, 2021",120,NCT04361643,"LENALIDOMIDE AS A 5 MG CAPSULE PO DAILY, DAYS 1, 3, AND 5.; PLACEBO",SPAIN,Not yet recruiting,Hospital Universitario Getafe,"October 27, 2020",Interventional,Double-blind Randomized Controlled Clinical Trial of Low-dose Lenalidomide in the Treatment of COVID-19 Disease
1043,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,COVID,"February 08, 2021",10,NCT04361786,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection: Search for Acquired Thrombophilia and Interferon-alpha Signature
1044,The COVID-19 ICU PRAYER Study,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04361838,PRAYER,UNITED STATES,Recruiting,Kansas City Heart Rhythm Institute,"June 1, 2020",Interventional,Impact of Multi-Denominational Prayer on Morbidity and Mortality of Patients Admitted to the Intensive Care Unite With Corona Virus Infection
1045,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),CARDIOVASCULAR PREVENTION BEHAVIOUR,"February 08, 2021",1900,NCT04361877,,GERMANY,Recruiting,Klinikum der Universitaet Muenchen,"March 30, 2020",Observational,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial)
1046,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",13,NCT04361903,RUXOLITINIB ORAL TABLET,,Not yet recruiting,Azienda USL Toscana Nord Ovest,"April 25, 2020",Observational,COVID-19: Ruxolitinib for the Treatment of cytokinE Storm resPiratory dIstREss Syndrome. RESPIRE Study
1047,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),COVID,"February 08, 2021",37,NCT04361916,HOME CARE MONITORING,ITALY,Terminated,Mario Negri Institute for Pharmacological Research,"April 21, 2020",Interventional,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino)
1048,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),COVID PNEUMONIA,"February 08, 2021",24,NCT04361942,MESENCHYMAL STROMAL CELLS; PLACEBO,SPAIN,Recruiting,Red de Terapia Celular,"May 1, 2020",Interventional,"Double Blind, Placebo-controlled, Phase II Trial to Evaluate Safety and Efficacy of Allogenic Mesenchymal Stromal Cells MSV_allo for Treatment of Acute Respiratory Failure in Patients With COVID-19 Pneumonia (COVID_MSV)"
1049,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,COVID,"February 08, 2021",50,NCT04361981,DEEP VENOUS DISEASE DIAGNOSTIC,SPAIN,Not yet recruiting,Sociedad Espanola de Angiologia y Cirugia Vascular,April 2020,Observational [Patient Registry],National Cohort Study to Assess the Influence of COVID-19 Infection in Thromboembolic Venous Disease:
1050,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,RESPIRATORY INFECTIONS,"February 08, 2021",24,NCT04362059,COVSURF DRUG DELIVERY SYSTEM; STANDARD OF CARE,UNITED KINGDOM,Recruiting,University Hospital Southampton NHS Foundation Trust,"June 18, 2020",Interventional,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19
1051,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,COVID,"February 08, 2021",462,NCT04362085,THERAPEUTIC ANTICOAGULATION,CANADA,Recruiting,Unity Health Toronto,"May 11, 2020",Interventional,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG)
1052,Early Treatment of Cytokine Storm Syndrome in Covid-19,CYTOKINE STORM; COVID,"February 08, 2021",30,NCT04362111,ANAKINRA; NORMAL SALINE,UNITED STATES,Recruiting,University of Alabama at Birmingham,"July 29, 2020",Interventional,Early Treatment of Cytokine Storm Syndrome in Covid-19
1053,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.,COVID,"February 08, 2021",0,NCT04362124,VACCINE BCG; PLACEBO,COLOMBIA,Withdrawn,Universidad de Antioquia,August 2020,Interventional,"Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection in Medellín, Colombia, 2020"
1054,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",CYTOKINE STORM (COVID),"February 08, 2021",432,NCT04362137,RUXOLITINIB; PLACEBO,ARGENTINA,Completed,Novartis Pharmaceuticals,"May 2, 2020",Interventional,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)"
1055,Long-term Impact of Infection With Novel Coronavirus (COVID-19),COVID,"February 08, 2021",800,NCT04362150,,UNITED STATES,"Active, not recruiting","University of California, San Francisco","April 21, 2020",Observational,Long-term Impact of Infection With Novel Coronavirus (LIINC): An Observational Study
1056,Study for Testing and Reviewing Improvised PPE Effectiveness 3 (STRIPE-3),HEALTHY,"February 08, 2021",10,NCT04362163,SNORKEL-BASED IMPROVISED PERSONAL PROTECTIVE EQUIPMENT,UNITED KINGDOM,Completed,Guy's and St Thomas' NHS Foundation Trust,"May 1, 2020",Observational,Study for Testing and Reviewing Improvised PPE Effectiveness 3 (STRIPE-3) - a Third Comparative Trial Assessing the Safety of Improvised PPE
1057,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,COVID; CORONAVIRUS; SARS-CoV2,"February 08, 2021",1000,NCT04362176,PATHOGEN REDUCED SARS-COV-2 CONVALESCENT PLASMA; PLACEBO,UNITED STATES,Recruiting,Vanderbilt University Medical Center,"April 24, 2020",Interventional,Passive Immunity Trial for Our Nation (PassItOn)
1058,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,COVID,"February 08, 2021",100,NCT04362189,HB-ADMSC; PLACEBO,UNITED STATES,"Active, not recruiting",Hope Biosciences,"June 30, 2020",Interventional,"A Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19"
1059,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,SARS-CoV2,"February 08, 2021",150,NCT04362267,SELF-ADMINISTERED QUESTIONNAIRE; SARS-COV2 TESTING,FRANCE,Recruiting,"University Hospital, Lille","June 15, 2020",Observational,Incidence of SARS-Cov2 Infection Among HCW in Lille University Hospital
1060,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,"BURNOUT, PROFESSIONAL; DEPRESSION; MEDICAL ERRORS; COVID","February 08, 2021",85,NCT04362319,QUESTIONNAIRE FORMS,MALAYSIA,Completed,University of Malaya,"May 15, 2020",Observational,Burnout and Medical Errors in the Anaesthesiology Fraternity in an Exclusively Covid-19 Hospital: the Malaysian Experience
1061,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",COVID,"February 08, 2021",25,NCT04362332,CHLOROQUINE SULFATE; HYDROXYCHLOROQUINE; STANDARD SUPPORTIVE CARE,NETHERLANDS,Terminated,UMC Utrecht,"April 14, 2020",Interventional,"An Open Label Cluster Randomized Controlled Trial of Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19"
1062,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,COVID,"February 08, 2021",100,NCT04362345,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 9, 2020",Observational,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia in France
1063,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,"STRESS - PREVENTION OF SLEEP DISORDERS, PTSD AND DEPRESSION","February 08, 2021",120,NCT04362358,ONLINE COGNITIVE BEHAVIORAL THERAPY (CBT); ONLINE BIBLIOTHERAPY PROGRAMME,,Not yet recruiting,"University Hospital, Strasbourg, France","May 1, 2020",Interventional,Efficacy of an Online Cognitive Behavioral Therapy (CBT) Programme Aiming at Reducing the Stress of Health Workers Involved in the Care of Patients During the Covid-19 Epidemic: a Randomized-controlled Trial
1064,Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,PNEUMONIA AND CYTOKINE RELEASE SYNDROME (COVID),"February 08, 2021",451,NCT04362813,CANAKINUMAB; PLACEBO,FRANCE,"Active, not recruiting",Novartis Pharmaceuticals,"April 30, 2020",Interventional,"Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Canakinumab on Cytokine Release Syndrome in Patients With COVID-19-induced Pneumonia (CAN-COVID)"
1065,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,COVID,"February 08, 2021",180,NCT04362865,,UNITED STATES,Recruiting,National Cancer Institute (NCI),"April 27, 2020",Observational,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection
1066,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),NEUROLOGIC MANIFESTATIONS; PSYCHIATRIC DISORDERS; COVID,"February 08, 2021",2000,NCT04362930,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 27, 2020",Observational,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders: An Observational Study of the Covid-19 Neurological and Psychiatric Manifestations
1067,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,COVID,"February 08, 2021",576,NCT04362943,BARICITINIB OR ANAKINRA,SPAIN,Recruiting,Complejo Hospitalario Universitario de Albacete,"April 20, 2020",Observational,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults
1068,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,COVID; PREGNANCY RELATED; NEONATAL INFECTION,"February 08, 2021",200,NCT04362956,,ARGENTINA,Recruiting,Fundacion Infant,"July 10, 2020",Observational,Clinical and Immunologic Impact of SARS-CoV-2 in Hospitalized Pregnant Women and Neonates in Argentina
1069,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",COVID,"February 08, 2021",300,NCT04362969,,ECUADOR,Not yet recruiting,"Hospital San Carlos, Madrid",May 2020,Observational,"Clinical Characteristics of Patients With SARS-CoV-2 (COVID-19) Infection in Guayaquil, Ecuador: COVID-EC Study"
1070,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,COVID; CORONAVIRUS INFECTION; CORONAVIRUS; SARS-CoV2,"February 08, 2021",1517,NCT04362995,,UNITED STATES,Recruiting,St. Jude Children's Research Hospital,"April 23, 2020",Observational,SJTRC-St. Jude Tracking of Viral and Host Factors Associated With COVID-19: A Prospective Adaptive Cohort Study
1071,COVID 19 Biomarkers,COVID,"February 08, 2021",150,NCT04363008,SERUM INFLAMMATORY BIOMARKERS,CANADA,Recruiting,University of British Columbia,"March 30, 2020",Observational,"COVID-19 Inflammatory Blood Biomarkers for Clinical Management, Prognosis and Evaluation of Interventions"
1072,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,COVID,"February 08, 2021",,NCT04363034,CONVALESCENT PLASMA,,Available,University of Arkansas,,Expanded Access,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program
1073,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",SARS VIRUS,"February 08, 2021",125,NCT04363047,40ML BLOOD SAMPLE,UNITED KINGDOM,Enrolling by invitation,University of Manchester,"October 1, 2020",Observational,Immune Cells and the Coronavirus for Inflammatory Arthritis
1074,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,COVID PNEUMONIA,"February 08, 2021",104,NCT04363060,AZITHROMYCIN WITH AMOXICILLIN/CLAVULANATE; AMOXICILLIN/CLAVULANATE,FRANCE,Not yet recruiting,Nantes University Hospital,"April 30, 2020",Interventional,Azithromycin With Amoxicillin/Clavulanate Versus Amoxicillin/Clavulanate Alone in COVID-19 Patients With Pneumonia and Hospitalized in a Non-intensive Care Unit Ward (AziA): a Superiority Open-label Randomized Controlled Trial
1075,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,COVID,"February 08, 2021",1000,NCT04363099,OBSERVATIONAL,FRANCE,Recruiting,Maison de Sante Pluridisciplinaire de Creil,"March 1, 2020",Observational,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.
1076,Global Mental Health of Urban Mothers,PERINATAL DEPRESSION; COVID; ANXIETY; PTSD; PREGNANCY RELATED,"February 08, 2021",200,NCT04363177,WEB-BASED PSYCHOSOCIAL PEER-TO-PEER SUPPORT,CHINA,Not yet recruiting,Karolinska Institutet,"November 1, 2020",Interventional,Mental Health of Urban Mothers (MUM) Study: A Multi-center Randomized Controlled Trial
1077,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),SARS-CoV2; COVID,"February 08, 2021",300,NCT04363203,HYDROXYCHLOROQUINE; AZITHROMYCIN; PLACEBO ORAL TABLET,UNITED STATES,Suspended,Salomeh Keyhani MD,"April 30, 2020",Interventional,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)
1078,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,COVID,"February 08, 2021",66,NCT04363216,ASCORBIC ACID,,Not yet recruiting,Thomas Jefferson University,May 2020,Interventional,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment
1079,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals,OCCUPATIONAL STRESS,"February 08, 2021",250,NCT04363229,MASLACH BURNOUT INVENTORY QUESTIONNAIR,,Not yet recruiting,Assiut University,July 2020,Observational,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals
1080,ACCESS A Master Digital Surveillance Protocol for COVID-19,CORONAVIRUS; COVID; COVID; COVID; CORONAVIRUS INFECTION; CORONAVIRUS INFECTION,"February 08, 2021",1000000,NCT04363268,,UNITED STATES,Recruiting,Medable Inc.,"April 20, 2020",Observational,"ACCESS (American COVID-19 Collaborative, Enabling Seamless Science) Master Digital Surveillance and Associated Clinical Trials Protocol for COVID-19"
1081,Obstructive Sleep Apnea & Covid-19 Outcomes,COVID; OBSTRUCTIVE SLEEP APNEA; PNEUMONIA,"February 08, 2021",320,NCT04363333,HOME SLEEP APNEA TESTING OR IN-HOSPITAL POLYSOMNOGRAPHY,TURKEY,"Active, not recruiting",Koç University,"April 27, 2020",Observational,Impact of Obstructive Sleep Apnea on Covid-19 Outcomes (OSACOVID-19 Study): A Prospective Observational Cohort Study
1082,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,COVID,"February 08, 2021",5,NCT04363346,FT516,UNITED STATES,"Active, not recruiting","Masonic Cancer Center, University of Minnesota","May 14, 2020",Interventional,Study of FT516 Safety and Feasibility for the Treatment of Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients With Hypoxia
1083,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,COVID,"February 08, 2021",90,NCT04363372,MRX-4DP0004; PLACEBO,UNITED KINGDOM,Recruiting,4D pharma plc,June 2020,Interventional,"A Pilot, Multiple Dose Study to Evaluate the Efficacy and Safety of MRx-4DP0004 in Hospitalised Patients With Symptoms of COVID-19 (SARS-CoV-2 Infection)"
1084,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,COVID,"February 08, 2021",500,NCT04363385,BIOLOGICAL TEST,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 31, 2020",Interventional,Cohort of Patients With Covid19: Constitution of Blood Samples Collections With Clinical Characterization
1085,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",70,NCT04363437,COLCHICINE; USUAL CARE,UNITED STATES,Recruiting,Maimonides Medical Center,"April 26, 2020",Interventional,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 (the COMBAT-COVID-19 Pilot Study)
1086,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),COVID; CORONAVIRUS INFECTION; WUHAN CORONAVIRUS; PROPHYLAXIS; HEALTHCARE WORKER; SARS-CoV2; HYDROXYCHLOROQUINE,"February 08, 2021",1700,NCT04363450,HYDROXYCHLOROQUINE; PLACEBO,UNITED STATES,Recruiting,Louisiana State University Health Sciences Center in New Orleans,"April 27, 2020",Interventional,Hydroxychloroquine as Primary Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)
1087,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,COVID; OXYGEN THERAPY; PRONE POSITION; SPONTANEOUS VENTILATION; RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",400,NCT04363463,PRONE POSITION,FRANCE,Recruiting,Centre Hospitalier Régional d'Orléans,"August 28, 2020",Interventional,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress
1088,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),COVID,"February 08, 2021",60,NCT04363489,WEARABLE MEDICAL DEVICE (EMPATICA E4); COVID-19 PCR SWAB; PULSE OXIMETER,,Not yet recruiting,King's College London,"August 1, 2020",Observational,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers)
1089,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,COVID,"February 08, 2021",30,NCT04363502,CLAZAKIZUMAB; PLACEBO,UNITED STATES,Recruiting,Johns Hopkins University,"May 7, 2020",Interventional,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
1090,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,DEEP VEIN THROMBOSIS,"February 08, 2021",50,NCT04363528,DOPPLER ECHO,FRANCE,Recruiting,Versailles Hospital,"April 24, 2020",Interventional,Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
1091,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,COVID; THERMOTHERAPY,"February 08, 2021",274,NCT04363541,ELECTRIC PAD FOR HUMAN EXTERNAL PAIN THERAPY,MEXICO,Recruiting,Instituto Nacional de Perinatologia,"August 27, 2020",Interventional,"A Multicenter, Open-label, Parallel-group, Randomized, Adaptive Trial to Evaluate Local Thermotherapy in Patients With Mild-to-moderate COVID-19, to Prevent Disease Progression"
1092,Serology COVID-19 From the Cornwall Hospital Union,CORONAVIRUS INFECTION,"February 08, 2021",2587,NCT04363593,SEROLOGICAL TEST; SERUM TEST,FRANCE,Completed,Centre Hospitalier de Cornouaille,"May 4, 2020",Interventional,Serology COVID-19 From the Cornwall Hospital Union
1093,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,CHRONIC FATIGUE SYNDROME; INTENSIVE CARE UNIT; MUSCLE,"February 08, 2021",82,NCT04363606,QUESTIONNAIRES; BLOOD TEST; MAXIMAL EFFORT TEST; ACTIGRAPHY; NEUROMUSCULAR EVALUATION,FRANCE,Recruiting,Centre Hospitalier Universitaire de Saint Etienne,"May 27, 2020",Interventional,Chronic Fatigue Etiology and Recovery in Covid-19 Patients : the Role of Fatigability and Stay in Intensive Care
1094,Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection,SARS-CoV2; CANCER,"February 08, 2021",1231,NCT04363632,,FRANCE,Completed,Centre Leon Berard,"April 2, 2020",Observational [Patient Registry],Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection
1095,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),REMOTE CONSULTATION; COVID,"February 08, 2021",30,NCT04363671,,FRANCE,Not yet recruiting,Hôpital Cochin,May 2020,Observational,Qualitative Study of the Experience of Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine
1096,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",100,NCT04363736,TOCILIUZUMAB,UNITED STATES,Completed,Hoffmann-La Roche,"May 5, 2020",Interventional,"A Phase-II, Open-Label, Randomized, Multicenter Study to Investigate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of 8 mg/kg or 4mg/kg Intravenous Tocilizumab in Patients With Moderate to Severe COVID-19 Pneumonia"
1097,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,COVID; NEUROLOGICAL COMPLICATION,"February 08, 2021",30,NCT04363749,"HYPOXIA : 14.3 AND 12.7% FIO2, HYPERCAPNIA 7% CO2, INSPIRATORY MECHANICAL CONSTRAINT",,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 27, 2020",Interventional,Do Respiratory Control Center Anomalies Explain the Lack of Respiratory Sensations Perceptions Observed in Patients Affected by COVID-19 ?
1098,Comparison of VieScope vs. Macintosh Laryngoscope for Intubation in Level Cpersonal Protective Equipment Conditions,TRACHEAL INTUBATION; INFECTION; PROJECTION,"February 08, 2021",35,NCT04363775,THE STANDARD MACINTOSH LARYNGOSCOPE; THE VIE SCOPE LARYNGOSCOPE,POLAND,Completed,Lazarski University,"January 20, 2020",Interventional,Comparison of VieScope Versus Macintosh Laryngoscope for Emergency Intubation Under Level C Personal Protective Equipment Conditions
1099,Needle Stick Injuries in Emergency Medical Service Practice,CARDIAC ARREST; NEEDLE STICK; INJURIES; GLOWE,"February 08, 2021",300,NCT04363788,DOUBLE GLOVES,POLAND,Completed,Lazarski University,"February 28, 2020",Observational,Should we Use Double Gloves During Procedures With Suspected/Confirmed COVID-19 Patient?
1100,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,COVID,"February 08, 2021",100,NCT04363814,BACTEK-R,DOMINICAN REPUBLIC,Recruiting,Inmunotek S.L.,"June 10, 2020",Interventional,"A Prospective, Open-label, Randomized Pilot Study (Including a Control Group) of BACTEK-R (MV130), Administered Sublingually to Assess the Clinical Impact in Subjects With Mild Pneumonia Due to COVID-19"
1101,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),COVID; HYDROXYCHLOROQUINE; PROPHYLAXIS; TREATMENT; SARS-CoV2,"February 08, 2021",2300,NCT04363827,HYDROXYCHLOROQUINE,ITALY,Recruiting,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,"May 14, 2020",Interventional,PROTECT: A Randomized Study With Hydroxychloroquine Versus Observational Support for Prevention or Early Phase Treatment of Coronavirus Disease (COVID-19)
1102,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",COVID; VITAMIN D DEFICIENCY; COAGULOPATHY; DISSEMINATED INTRAVASCULAR COAGULATION,"February 08, 2021",1080,NCT04363840,ASPIRIN 81 MG; VITAMIN D,,Not yet recruiting,Louisiana State University Health Sciences Center in New Orleans,May 2020,Interventional,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations"
1103,Tocilizumab Treatment in Patients With COVID-19,SARS-CoV2,"February 08, 2021",200,NCT04363853,TOCILIZUMAB,MEXICO,"Active, not recruiting",Instituto Nacional de Cancerologia de Mexico,"June 1, 2020",Interventional,Treatment of Serious and Critical Patients With COVID-19 With Tocilizumab
1104,Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),COVID; SARS-CoV2,"February 08, 2021",0,NCT04363866,HYDROXYCHLOROQUINE; PLACEBO,UNITED STATES,Withdrawn,Oregon Health and Science University,August 2020,Interventional,A Randomized-Control Pilot Study to Assess Hydroxychloroquine in Patients Infected With SARS-CoV-2 (COVID-19)
1105,Anakinra for COVID-19 Respiratory Symptoms,COVID INFECTION; ANAKINRA TREATMENT; OPTIMIZED STANDARD OF CARE (OSOC),"February 08, 2021",71,NCT04364009,ANAKINRA PLUS OSOC; OSOC,FRANCE,Terminated,"University Hospital, Tours","April 27, 2020",Interventional,"Efficacy and Safety of ANAkinra During Adult "" COVID-19 "" With Aggravating Respiratory Symptoms: a Multicenter Open-label Controlled Randomized Trial"
1106,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,PREVENTION OF COVID,"February 08, 2021",300,NCT04364022,LOPINAVIR/RITONAVIR,SWITZERLAND,Recruiting,Calmy Alexandra,"April 23, 2020",Interventional,Efficacy of Pragmatic Same-day Ring COVID-19 Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland: an Open-label Cluster Randomized Trial
1107,COVID-19 Search in Conjunctival Cells,COVID; PULMONARY DISEASE,"February 08, 2021",50,NCT04364594,CONJUNCTIVAL SWAB,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"March 26, 2020",Interventional,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Diagnostic Targets for Customized Medicine.
1108,Observational Cohort of COVID-19 Patients at Raymond-Poincare,COVID,"February 08, 2021",500,NCT04364698,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 7, 2020",Observational,Observational Cohort of COVID-19 Patients at Raymond-Poincare
1109,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,COVID; SARS-CoV2,"February 08, 2021",2000,NCT04364711,,,Not yet recruiting,UMC Utrecht,"May 1, 2020",Observational,Multi-centre EuRopean Study of MAjor Infectious Disease Syndromes (MERMAIDS) - Acute Respiratory Infections (MERMAIDS ARI) 2.0
1110,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,COVID; CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04364737,CONVALESCENT PLASMA; SALINE SOLUTION,UNITED STATES,Recruiting,NYU Langone Health,"April 17, 2020",Interventional,CONTAIN COVID-19: Convalescent Plasma to Limit Coronavirus Associated Complications: a Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV2 Plasma to Placebo in COVID-19 Hospitalized Patients
1111,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),COVID,"February 08, 2021",252,NCT04364763,RBT-9 (90 MG); 0.9% SODIUM CHLORIDE (NORMAL SALINE),UNITED STATES,Recruiting,"Renibus Therapeutics, Inc.","August 5, 2020",Interventional,"A Phase 2, Randomized, Placebo-Controlled Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)"
1112,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,COVID; SARS-CoV2,"February 08, 2021",300,NCT04364802,POVIDONE-IODINE NASAL SPRAY AND GARGLE; POVIDONE-IODINE NASAL SPRAY AND GARGLE; POVIDONE-IODINE NASAL SPRAY AND GARGLE,UNITED STATES,Recruiting,Alexandra Kejner,"April 29, 2020",Interventional,Povidone-Iodine Intranasal for Prophylaxis in Front-line Health-care Personnel and Inpatients During the Sars-CoV-2 Pandemic
1113,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,COVID,"February 08, 2021",0,NCT04364815,HYDROXYCHLOROQUINE PLUS STANDARD PREVENTIVE MEASURES; PLACEBO PLUS STANDARD PREVENTIVE MEASURES,PHILIPPINES,Withdrawn,University of the Philippines,December 2020,Interventional,"Efficacy and Safety of Hydroxychloroquine for COVID-19 Post-Exposure Prophylaxis of Healthcare Workers in the Philippine General Hospital and UP Manila National Institutes of Health: A Randomized, Double-blind, Placebo-controlled Trial"
1114,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,COVID,"February 08, 2021",1000,NCT04364828,WHOLE GENOME ANALYSIS; T-CELL RECEPTOR (TCR) REPERTOIRE; SARS-COV-2 VIRAL COMPOSITION,,Not yet recruiting,University Hospital Tuebingen,January 2021,Interventional,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression
1115,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,CORONAVIRUS INFECTION; COVID,"February 08, 2021",700,NCT04364893,SUSPENSION OR MAINTENANCE OF ANGIOTENSIN RECEPTOR BLOCKERS AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS,BRAZIL,Recruiting,D'Or Institute for Research and Education,"April 9, 2020",Interventional,Suspension of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Hospitalized Patients With Coronavirus Infection (COVID-19). A Randomized Trial
1116,"ARB, ACEi, DRi in COVID-19",HYPERTENSION; COVID,"February 08, 2021",10,NCT04364984,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,UKRAINE,Recruiting,Medical Practice Prof D. Ivanov,"April 1, 2020",Observational [Patient Registry],"ARB, ACEi, DRi Usage in COVID-19"
1117,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,"CORONAVIRUS; CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; PNEUMONIA; PNEUMONIA, VIRAL; LUNG DISEASES; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTIONS; CORONAVIRIDAE INFECTIONS; NIDOVIRALES INFECTIONS; RNA VIRUS INFECTIONS; VIRUS DISEASE; IMMUNOLOGIC DISEASE; ARDS; IMMUNOLOGIC FACTORS; PHYSIOLOGICAL EFFECTS OF DRUGS; ANTIVIRAL AGENTS; ANTI-INFECTIVE AGENTS; ANALGESICS; ANTIMETABOLITES, ANTINEOPLASTIC","February 08, 2021",86,NCT04365101,CYNK-001,UNITED STATES,Recruiting,Celularity Incorporated,"May 13, 2020",Interventional,A Phase I/II Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) for the Treatment of Adults With COVID-19
1118,Progesterone for the Treatment of COVID-19 in Hospitalized Men,COVID; SARS-CoV2,"February 08, 2021",40,NCT04365127,PROGESTERONE 100 MG,UNITED STATES,Completed,Sara Ghandehari,"April 27, 2020",Interventional,"A Single Center, Randomized, Controlled Trial of the Safety and Efficacy of Progesterone for the Treatment of COVID-19 in Hospitalized Men"
1119,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),COVID; SARS-CoV2,"February 08, 2021",45,NCT04365153,CANAKINUMAB INJECTION 600MG; CANAKINUMAB INJECTION 300MG; PLACEBOS,UNITED STATES,"Active, not recruiting",The Cleveland Clinic,"April 24, 2020",Interventional,Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function in SARSCoV2 Associated Acute Myocardial Injury With Heightened Inflammation
1120,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),RESPIRATORY TRACT INFECTIONS; RESPIRATORY TRACT DISEASE,"February 08, 2021",100,NCT04365166,,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"April 21, 2020",Observational,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2
1121,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,COVID,"February 08, 2021",0,NCT04365231,HYDROXYCHLOROQUINE AND AZITHROMYCIN TREATMENT; CONVENTIONAL MANAGEMENT OF PATIENTS,,Withdrawn,"Hospital St. Joseph, Marseille, France","April 1, 2020",Interventional,Efficacy Evaluation of Hydroxychloroquine Azithromycin in the Treatment of COVID-19 in Pregnant Women: an Open-label Randomized Clinical Trial
1122,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),COVID,"February 08, 2021",220,NCT04365257,PRAZOSIN; STANDARD OF CARE,UNITED STATES,Recruiting,Johns Hopkins University,"May 13, 2020",Interventional,Alpha-1 Adrenergic Receptor Antagonism to Prevent COVID-19 Cytokine Storm Syndrome and Acute Respiratory Distress Syndrome: A Randomized Study Comparing the Efficacy of Prazosin vs. Standard of Care for SARS-CoV-2 Infection
1123,Protective Effect of Aspirin on COVID-19 Patients,NOVEL CORONAVIRUS PNEUMONIA; ASPIRIN; TREATMENT,"February 08, 2021",128,NCT04365309,ASPIRIN 100MG,CHINA,Enrolling by invitation,Xijing Hospital,"February 10, 2020",Interventional,Protective Effect of Aspirin on COVID-19 Patients
1124,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),SARS-CoV2 INFECTION,"February 08, 2021",160,NCT04365322,ADDITIONAL BIOLOGICAL SAMPLES,FRANCE,Recruiting,Centre Hospitalier Universitaire de Besancon,"April 20, 2020",Observational [Patient Registry],Étude Des réponses Immunitaires Lymphocytaires spécifiques Chez Des Patients infectés Par le Virus SARS-CoV-2 : Caractéristiques Des Réponses Effectrices et Mémoires
1125,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,OCCUPATIONAL STRESS,"February 08, 2021",50,NCT04365335,ASSESSMENT OF WORK-RELATED STRESS; SALIVA SAMPLE COLLECTION; CARDIAC AND ELECTRODERMAL RECORDINGS; ASSESSMENT OF BEHAVIORAL RESPONSE TO EMOTIONAL STIMULATION,FRANCE,Completed,Direction Centrale du Service de Santé des Armées,"April 25, 2020",Observational,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic
1126,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,MENTAL HEALTH WELLNESS 1,"February 08, 2021",300,NCT04365348,,HONG KONG,Recruiting,The University of Hong Kong,"April 27, 2020",Observational,Exploring the Psychological Impact of the COVID-19 Outbreak on COVID-19 Survivors and Their Families
1127,The Psychological Impact of the COVID-19 on Students.,MENTAL HEALTH WELLNESS 1,"February 08, 2021",300,NCT04365361,,HONG KONG,Recruiting,The University of Hong Kong,"April 26, 2020",Observational,Exploring the Psychological Impact of the COVID-19 on Higher Education Students
1128,Convalescent Plasma for COVID-19,BLOOD PLASMA THERAPY; COVID,"February 08, 2021",10,NCT04365439,BLOOD PLASMA,,Not yet recruiting,Enos Bernasconi,"April 27, 2020",Interventional,Convalescent Plasma for the Treatment of Moderate-severe COVID-19: A Proof-of-principle Study
1129,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,"COVID; DIABETES MELLITUS, TYPE 2; CKD","February 08, 2021",170,NCT04365517,SITAGLIPTIN,ITALY,Not yet recruiting,University of Milan,"December 29, 2020",Interventional,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
1130,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,COVID,"February 08, 2021",2000,NCT04365530,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"April 1, 2020",Observational,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City
1131,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,COVID,"February 08, 2021",640,NCT04365582,AZITHROMYCIN; HYDROXYCHLOROQUINE; LOPINAVIR 200MG/RITONAVIR 50MG TAB,FRANCE,Suspended,Groupe Hospitalier Paris Saint Joseph,"May 7, 2020",Interventional,A Randomized Trial of Efficacy and Safety of an Early OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome: a Strategy to Prevent Hospitalization
1132,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),SARS-CoV2; COVID,"February 08, 2021",200,NCT04365595,"QUESTIONNAIRES, SPIROMETRY",SWITZERLAND,Recruiting,University of Zurich,"June 3, 2020",Observational,Recovery in Patients With SARS-CoV-2 Associated Respiratory Failure
1133,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,INTUBATION COMPLICATION; INTUBATION; DIFFICULT OR FAILED; CARDIAC ARREST; INFLUENZA; SAFETY ISSUES,"February 08, 2021",90,NCT04365608,DIRECT LARYNGOSCOPY; VIE SCOPE LARYNGOSCOPY,POLAND,Completed,Lazarski University,"March 20, 2020",Interventional,Safety and Efficacy of Endotracheal Intubation by Paramedics in Suspected/Confirmed COVID-19 Patients Under Cardiac Arrest Using Vie Scope Laryngoscope
1134,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,COVID,"February 08, 2021",306,NCT04365634,,CHINA,Completed,Tongji Hospital,"February 2, 2020",Observational,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients by Univariate and Multivariate Analysis.
1135,Cardiovascular Effects of COVID-19,COVID,"February 08, 2021",500,NCT04365699,AT-001,UNITED STATES,Recruiting,NYU Langone Health,"April 8, 2020",Interventional,A Single-center Registry and Embedded Interventional Study of the Effects of COVID-19 With and Without Treatment With AT-001 on Cardiac Structure and Function in Patients Hospitalized for Management of COVID-19 Infection
1136,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",COVID,"February 08, 2021",200,NCT04365725,REMDESIVIR,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 5, 2020",Observational,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections."
1137,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,COVID,"February 08, 2021",270,NCT04365738,REHABILITATION,TURKEY,Completed,Istanbul Bilgi University,"March 11, 2020",Interventional,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection: Prospective Randomized Controlled Trial
1138,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,COVID; ARDS; PNEUMONIA,"February 08, 2021",400,NCT04365764,,FRANCE,Recruiting,Groupe Hospitalier Pitie-Salpetriere,"March 14, 2020",Observational,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study
1139,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,COVID,"February 08, 2021",403,NCT04365816,INTERVIEW,FRANCE,Completed,"University Hospital, Grenoble","April 30, 2020",Observational,Evaluation of the Repercussions of the Coronavirus (Covid 19) Infection on Nutritional Health Status and Nutritional Care : an Observational French Cohort Study One Month After Their Discharge From Hospital
1140,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,"LONELINESS, WORRY, RUMINATION, HEALTH ANXIETY, DEPRESSION, ANXIETY","February 08, 2021",10084,NCT04365881,CROSS-SECTIONAL OBSERVATIONAL STUDY,NORWAY,Completed,Modum Bad,"March 31, 2020",Observational,Loneliness During the Non-pharmacological Epidemiological Interventions for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology
1141,The Prone Position in Covid-19 Affected Patients,SARS-CoV2,"February 08, 2021",56,NCT04365959,PRONE POSITION,ITALY,"Active, not recruiting",University of Milano Bicocca,"March 20, 2020",Observational,"Study of the Feasibility and Usefulness of the Prone Position in Patients With Respiratory Distress From Covid-19 Not Intubated, in Spontaneous Breath in Oxygen Therapy or Cpap"
1142,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,ANXIETY,"February 08, 2021",20,NCT04365972,ATTENTION BIAS MODIFICATION (ABM),ISRAEL,Completed,Tel Aviv University,"April 23, 2020",Interventional,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic: An Open Pilot Trial
1143,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME (SARS); CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04365985,NALTREXONE; KETAMINE; PLACEBO,UNITED STATES,Recruiting,William Beaumont Hospitals,"April 29, 2020",Interventional,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
1144,A Novel Nomogram to Predict Severity of COVID-19,COVID DISEASE; NOMOGRAM MODEL,"February 08, 2021",1000,NCT04366024,OTHER,CHINA,Recruiting,Xinqiao Hospital of Chongqing,"January 17, 2020",Observational,A Novel Nomogram to Predict Severity of COVID-19
1145,Ramipril for the Treatment of COVID-19,COVID,"February 08, 2021",560,NCT04366050,RAMIPRIL 2.5 MG ORAL CAPSULE; PLACEBO ORAL CAPSULE,UNITED STATES,Recruiting,"University of California, San Diego","May 11, 2020",Interventional,"A Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy of Ramipril to Prevent ICU Admission, Need for Mechanical Ventilation or Death in Persons With COVID-19"
1146,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,COVID,"February 08, 2021",60,NCT04366063,CELL THERAPY PROTOCOL 1; CELL THERAPY PROTOCOL 2,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Royan Institute,"April 5, 2020",Interventional,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 2-3 Clinical Trial
1147,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,"COVID; SARS-CoV2; PNEUMONIA, VIRAL; CORONAVIRUS INFECTION","February 08, 2021",152,NCT04366089,"OXYGEN-OZONE THERAPY, PROBIOTIC SUPPLEMENTATION AND STANDARD OF CARE; SIVOMIXX (200 BILLION); AZITHROMYCIN; HYDROXYCHLOROQUINE",ITALY,Recruiting,"Roberto Poscia MD, PhD","March 26, 2020",Interventional,Oxygen-Ozone as Adjuvant Treatment in Early Control of Disease Progression in Patients With COVID-19 Associated With Modulation of the Gut Microbial Flora
1148,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,"ARDS; COVID; INFLUENZA, HUMAN","February 08, 2021",16,NCT04366115,AVM0703; PLACEBO,,Not yet recruiting,AVM Biotechnology LLC,January 2021,Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study Evaluating AVM0703 in Patients With Acute Respiratory Distress Syndrome"
1149,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,COVID,"February 08, 2021",120,NCT04366141,COVID-19 BARRIER BOX,CANADA,Recruiting,University of British Columbia,"May 1, 2020",Interventional,The Impact of a Barrier Enclosure on Endotracheal Intubation Duration and First Pass Attempt - A Randomized Controlled Trial
1150,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,COVID; CANCER,"February 08, 2021",809,NCT04366154,QUESTIONNAIRE,FRANCE,"Active, not recruiting",Centre Francois Baclesse,"April 15, 2020",Observational,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers
1151,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,CARDIAC SURGERY; COVID,"February 08, 2021",100,NCT04366167,CARDIAC SURGERY,UNITED KINGDOM,Recruiting,Barts & The London NHS Trust,"April 18, 2020",Observational,An Observational Cohort Study to Explore Patient Outcome From Heart Surgery During the Covid-19 Pandemic (CardiacCovid)
1152,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,COVID,"February 08, 2021",314,NCT04366180,PROBIOTIC; CONTROL,SPAIN,Recruiting,Biosearch S.A.,"April 24, 2020",Interventional,Multicentric Study to Assess the Effect of Consumption of Lactobacillus Coryniformis K8 on Healthcare Personnel Exposed to COVID-19
1153,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,COVID; SARS-CoV2,"February 08, 2021",143,NCT04366206,,FRANCE,Recruiting,Centre Hospitalier Intercommunal Robert Ballanger,"March 14, 2020",Observational [Patient Registry],Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est
1154,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods.",COVID; SARS-CoV2; LUNG CANCER,"February 08, 2021",2000,NCT04366219,,,Not yet recruiting,Centre Hospitalier le Mans,June 2020,Observational,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods."
1155,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation,COVID,"February 08, 2021",2,NCT04366232,ANAKINRA ALONE (STAGES 2B/3); ANAKINRA AND RUXOLITINIB (OVERCOME STAGE 3); STANDARD OF CARE,FRANCE,Terminated,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"August 19, 2020",Interventional,"Interleukin-1 (IL-1) and Interferon Gamma (IFNg) Inhibition During COVID 19 Inflammation: Randomized, Controlled Study Assessing Efficacy and Safety of Anakinra and Ruxolitinib"
1156,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,SARS-CoV2,"February 08, 2021",72,NCT04366245,HYPERIMMUNE PLASMA; STANDARD OF CARE FOR SARS-COV-2 INFECTION,SPAIN,Recruiting,Andalusian Network for Design and Translation of Advanced Therapies,"April 23, 2020",Interventional,"Phase I / II Multicentre, Randomized and Controlled Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection"
1157,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,COVID,"February 08, 2021",106,NCT04366271,MESENCHYMAL CELLS; STANDARD OF CARE,SPAIN,Recruiting,"Hospital Infantil Universitario Niño Jesús, Madrid, Spain","May 7, 2020",Interventional,Phase II Clinical Trial to Explore the Efficacy of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With Severe Pulmonary Involvement by COVID-19
1158,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,CARDIAC ARREST; EMERGENCIES,"February 08, 2021",41,NCT04366297,INTRAVENOUS ACCESS; INTRAOSSEOUS ACCESS,POLAND,Completed,Lazarski University,"January 12, 2020",Interventional,Intraosseous Versus Intravenous Access During COVID-19 Patients Performed by Paramedics Wearing Level C Personal Protective Equipment. A Multi-center Prospective Randomized Crossover Single-blinded Simulation Trial
1159,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,SARS-CoV2,"February 08, 2021",26,NCT04366323,ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS,SPAIN,"Active, not recruiting",Andalusian Network for Design and Translation of Advanced Therapies,"April 27, 2020",Interventional,"Phase I / II Clinical Trial, Multicenter, Randomized and Controlled, to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19"
1160,Repurposing of Chlorpromazine in Covid-19 Treatment,COVID,"February 08, 2021",40,NCT04366739,CHLORPROMAZINE (CPZ); STANDARD OF CARE (SOC),FRANCE,Not yet recruiting,Centre Hospitalier St Anne,"April 29, 2020",Interventional,Repurposing of Chlorpromazine in Covid-19 Treatment
1161,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,COVID; PNEUMONIA; ARDS; HEMOSTASIS; COAGULATION,"February 08, 2021",100,NCT04366752,VENOUS ULTRASOUND; BLOOD SAMPLE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","April 22, 2020",Observational,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy
1162,COVID-19 Survival - The COVIVA Study,COVID; SARS-CoV2,"February 08, 2021",1500,NCT04366765,,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","March 19, 2020",Observational,Coronavirus Disease 19 Survival - The COVIVA Study
1163,Thrombosis and Covid-19,THROMBOSIS; COVID; SARS-CoV2,"February 08, 2021",341,NCT04366778,TEM-TPA,FRANCE,Completed,Hospices Civils de Lyon,"May 1, 2020",Observational,Evaluation of TEM-tPA (Thromboelastometry With tPA) to Detect Covid-19 Patients at High Risk of Thrombosis
1164,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,PNEUMONIA; CORONAVIRUS INFECTION IN 2019 (COVID); SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA,"February 08, 2021",10,NCT04366791,LOW DOSE RADIATION THERAPY,UNITED STATES,Suspended,Emory University,"April 23, 2020",Interventional,The RESCUE 1-19 Trial: Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19
1165,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,POST PARTUM DEPRESSION,"February 08, 2021",120,NCT04366817,PSYCHOLOGICAL ASSESSMENT,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Interventional,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic
1166,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",MODERATE TO SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH COVID,"February 08, 2021",,NCT04366830,REMESTEMCEL-L,UNITED STATES,No longer available,Mesoblast International Sàrl,,Expanded Access,"Intermediate-size Expanded Access of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells for Acute Respiratory Distress Syndrome Due to COVID-19 Infection"
1167,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),COVID; ARDS,"February 08, 2021",500,NCT04366856,1: PRONE POSITIONING; 2: NO INSTRUCTION REGARDING POSITIONING,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 26, 2020",Interventional,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study)
1168,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,COVID,"February 08, 2021",45,NCT04366882,CT-SCAN WITH MINIMAL INVASIVE AUTOPSY,BELGIUM,Recruiting,Jessa Hospital,"April 14, 2020",Interventional,"Increasing Our Understanding of COVID-19: Minimal Invasive Autopsies to Investigate Clinical, Radiological, Microbiological and Histopathological Changes in Deceased COVID-19 Patients"
1169,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,SARS-CoV2; COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); CYTOKINE RELEASE SYNDROME; CYTOKINE STORM,"February 08, 2021",1008,NCT04366908,BAT + CALCIFEDIOL; BAT,,Not yet recruiting,Maimónides Biomedical Research Institute of Córdoba,"April 28, 2020",Interventional,Prevention and Treatment With Calcifediol of COVID-19 Coronavirus-induced Acute Respiratory Syndrome (SARS)
1170,European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,"COVID; SARS-CoV2; ARDS, HUMAN; REFRACTORY HYPOXEMIA; CARDIOGENIC SHOCK; SEPTIC SHOCK; EXTRACORPOREAL MEMBRANE OXYGENATION","February 08, 2021",150,NCT04366921,,AUSTRIA,Recruiting,Maastricht University Medical Center,"April 10, 2020",Observational,European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID Patients in ECMO
1171,Study of the Pathogenesis of Olfactory Disorders in COVID-19,CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; SARS-CoV2,"February 08, 2021",26,NCT04366934,NASAL SWAB; TASTE AND OLFACTORY FUNCTION EVALUATION,FRANCE,Completed,Institut Pasteur,"May 4, 2020",Observational,Study of the Pathogenesis of Olfactory Disorders in COVID-19
1172,Intravascular Access in Suspected/Confirmed COVID-19 Patient,EMERGENCY MEDICINE; CARDIOPULMONARY ARREST; SHOCK,"February 08, 2021",60,NCT04366947,NIO® (INTRAOSSEOUS ACCESS); STANDARD OF CARE (INTRAVENOUS ACCESS),POLAND,Completed,Lazarski University,"April 14, 2020",Interventional,Comparison of Intraosseous Versus Intravenous Access in Suspected/Confirmed COVID-19 Patient in Prehospital Setting
1173,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",2712,NCT04366960,ENOXAPARIN,ITALY,Recruiting,Niguarda Hospital,"May 14, 2020",Interventional,Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients: Comparison of 40 mg o.d. Versus 40 mg b.i.d. A Randomized Clinical Trial
1174,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,COVID,"February 08, 2021",25000,NCT04366986,TESTED FOR SARS-COV-2 (REGARDLESS OF THE RESULT); CLINICAL DIAGNOSIS OF COVID-19 BY A HEALTH CARE PROFESSIONAL,UNITED STATES,Recruiting,Pregistry,"June 23, 2020",Observational [Patient Registry],International Registry of Coronavirus Exposure in Pregnancy (IRCEP)
1175,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),COVID,"February 08, 2021",1000,NCT04367064,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 25, 2020",Observational,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study)
1176,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),ARDS,"February 08, 2021",400,NCT04367077,MULTISTEM; PLACEBO,UNITED STATES,Recruiting,"Athersys, Inc","April 28, 2020",Interventional,A Phase 2/3 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease (COVID-19)
1177,Electrocardiogram Analysis in COVID-19 Patients,SARS-COV INFECTION,"February 08, 2021",1000,NCT04367129,ECG,ITALY,Recruiting,University Hospital of Ferrara,"April 14, 2020",Observational,Electrocardiogram Analysis in COVID-19 Patients
1178,Rapid Detection of COVID-19 by Portable and Connected Biosensor,SARS-CoV2,"February 08, 2021",200,NCT04367142,COVID-19 RT-PCR; BIOSENSOR,,Not yet recruiting,"University Hospital, Lille",September 2020,Observational,Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept
1179,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,COVID,"February 08, 2021",174,NCT04367168,COLCHICINE; PLACEBO ORAL TABLET,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"May 27, 2020",Interventional,"Double-blind, Placebo-controlled Clinical Trial of the Use of Colchicine for the Management of Patients With Mild and Severe SARS-Cov2 Infection"
1180,African Covid-19 Critical Care Outcomes Study,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",2000,NCT04367207,,SOUTH AFRICA,Recruiting,University of Cape Town,"May 1, 2020",Observational [Patient Registry],"African Covid-19 Critical Care Outcomes Study: An African, Multi-centre Evaluation of Patient Care and Clinical Outcomes for Patients With COVID-19 Admitted to High-care or Intensive Care Units"
1181,Health Behavior Change During COVID-19 Pandemic,HEALTH BEHAVIOR,"February 08, 2021",6079,NCT04367337,NO INTERVENTION,AUSTRALIA,"Active, not recruiting","University of Social Sciences and Humanities, Warsaw","March 25, 2020",Observational,Health Behavior Change During COVID-19 Pandemic: the Focus on Handwashing
1182,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,COVID; SARS-CoV2; CORONAVIRUS INFECTION; MYOSITIS; MYOCARDITIS,"February 08, 2021",500,NCT04367350,LABORATORY BIOMARKERS; MUSCLE ULTRASOUND,GERMANY,Recruiting,University Hospital Tuebingen,"March 20, 2020",Observational [Patient Registry],Prospective Registry for Multimodal Assessment of Neuromuscular Pathology Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
1183,Social Media and COVID-19,CORONAVIRUS; DEPRESSION; ANXIETY; STRESS,"February 08, 2021",151,NCT04367363,SOCIAL MEDIA & NEWS CONSUMPTION,SINGAPORE,Completed,Jean Liu,"March 17, 2020",Observational,Tracking WhatsApp Behaviors During a Crisis: A Longitudinal Observation of Messaging Activities During the COVID-19 Pandemic
1184,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",COVID,"February 08, 2021",600,NCT04367402,BIOMEDOMICS COVID-19 IGM-IGG RAPID TEST,ITALY,Recruiting,Azienda Ospedaliera San Paolo,"March 30, 2020",Observational,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients"
1185,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,COVID; RT-DDPCR MULTIPLEX,"February 08, 2021",130,NCT04367545,SALIVA COLLECTION,FRANCE,Completed,"University Hospital, Rouen","April 16, 2020",Interventional,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic
1186,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,RUMINATION; ANXIETY; STRESS; DEPRESSIVE SYMPTOMS,"February 08, 2021",100,NCT04367636,BEHAVIORAL: OCAT-SHAM; BEHAVIORAL: OCAT; PSYCHO-EDUCATION VIDEO,BELGIUM,Not yet recruiting,University Ghent,"April 20, 2020",Interventional,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19: Validation of a New Online Treatment
1187,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,COVID,"February 08, 2021",99,NCT04367662,BLOOD SAMPLING,FRANCE,Completed,"University Hospital, Rouen","April 9, 2020",Interventional,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19
1188,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,COVID; TERMINAL RENAL INSUFFICIENCY,"February 08, 2021",300,NCT04367714,,DENMARK,Recruiting,Region MidtJylland Denmark,"March 15, 2020",Observational [Patient Registry],Antistof Respons Mod SARS-CoV-2 Hos Dialysepatienter i Forbindelse Med COVID-19
1189,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",ASYMPTOMATIC CONDITION; INFECTION VIRAL; CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CORONAVIRIDAE INFECTIONS; RNA VIRUS INFECTIONS; VIRUS DISEASES; COMMUNICABLE DISEASE,"February 08, 2021",10000,NCT04367740,TO ASSESS FOR DEVELOPMENT OF IGG ANTIBODIES AGAINST SARS-COV2,UNITED STATES,Enrolling by invitation,"University of North Carolina, Chapel Hill","April 28, 2020",Observational,ScreenNC: A Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the SARS-CoV-2 Infection
1190,Cardiac Injury in COVID-19: a Pathology Study,COVID,"February 08, 2021",60,NCT04367792,,ITALY,"Active, not recruiting",A.O. Ospedale Papa Giovanni XXIII,"April 23, 2020",Observational,Pathology and Pathogenesis of Cardiac Injury in COVID-19 Infections in Humans
1191,COVID-19 Infection in Patients With Hepatocellular Carcinoma,HEPATOCELLULAR CARCINOMA; COVID,"February 08, 2021",50,NCT04367805,NASOPHARYNGEAL COVID 19 RT-PCR,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","April 27, 2020",Observational,Impact of COVID-19 Infection in Patients With Hepatocellular Carcinoma: An Ambispective Study Nestled in the CHIEF Cohort
1192,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,COVID; VENOUS THROMBOSES; ARTERIAL THROMBOSIS,"February 08, 2021",100,NCT04367831,ENOXAPARIN PROPHYLACTIC DOSE; HEPARIN INFUSION; HEPARIN SC; ENOXAPARIN/LOVENOX INTERMEDIATE DOSE,UNITED STATES,Recruiting,Columbia University,"May 2, 2020",Interventional,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19: A Cluster Based Randomized Selection Trial (IMPROVE-COVID)
1193,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,COVID; CORONAVIRUS INFECTION; CORONAVIRUS,"February 08, 2021",1000,NCT04367857,COVID-19 SEROLOGY; HEALTH CARE WORKER SURVEY,UNITED STATES,Recruiting,Columbia University,"April 18, 2020",Observational [Patient Registry],SARS-CoV-2 Seroprevalence Among Healthcare Workers: ARMOR Study Demonstration Project
1194,COVID-19 Detection Test in Oncology,ONCOLOGY,"February 08, 2021",2500,NCT04367870,,FRANCE,Recruiting,UNICANCER,"May 23, 2020",Observational,COVID-19 Serodiagnosis in Oncology
1195,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",COVID; INFLUENZA VACCINATION; ACE INHIBITORS; ARB,"February 08, 2021",2574,NCT04367883,ACE INHIBITOR; ARB,SPAIN,Recruiting,Consorci Sanitari de Terrassa,"March 1, 2020",Observational,Evaluation of Influenza Vaccination and Treatment With ACEI and ARB in the Evolution of SARS-Covid19 Infection
1196,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,COVID OUTBREAK AND SOLID ORGAN TRANSPLANTATION,"February 08, 2021",1819,NCT04367896,SURVEY GROUP,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"March 24, 2020",Observational,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY
1197,Positive Affect Regulation sKills at Northwestern University,ANXIETY; DEPRESSION; SOCIAL ISOLATION,"February 08, 2021",1000,NCT04367922,POSITIVE EMOTION SKILLS COURSE,UNITED STATES,Recruiting,Northwestern University,"April 27, 2020",Interventional,"A Positive Affect Regulation sKills Intervention to Decrease Stress During a Pandemic: A Single Arm, Non-Randomized Trial of a Public Platform"
1198,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,RESPIRATORY FAILURE; COVID,"February 08, 2021",30,NCT04368000,INTERMITTENT PRONE POSITIONING INSTRUCTIONS; USUAL CARE POSITIONING WITH NO INSTRUCTIONS,UNITED STATES,Terminated,University of Utah,"April 29, 2020",Interventional,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization
1199,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",COVID,"February 08, 2021",400,NCT04368013,EXTENDED SAMPLING AND PROCEDURES,SWEDEN,Not yet recruiting,Johan Normark,"April 28, 2020",Interventional,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial"
1200,SARS-CoV-2 (COVID-19) and Surgery,"SURGICAL PROCEDURE, UNSPECIFIED","February 08, 2021",350,NCT04368026,NO INTERVENTION (SURVEY STUDY FOR MEDICAL DOCTORS).,POLAND,Recruiting,Jagiellonian University,"March 30, 2020",Observational,Surgical Care in Poland After COVID19 Outbreak - a National Survey Study
1201,COVID-19 Active Research Experience (CARE),COVID,"February 08, 2021",100000,NCT04368065,,UNITED KINGDOM,Recruiting,Iqvia Pty Ltd,"April 2, 2020",Observational [Patient Registry],Registry to Study Factors That May Impact COVID-19 Occurrence and Severity
1202,COVID-19 Immune Repertoire Sequencing,COVID; SARS-CoV2; CORONAVIRUS INFECTION; RDT; B CELL,"February 08, 2021",100,NCT04368143,,BELGIUM,Recruiting,"Institute of Tropical Medicine, Belgium","April 1, 2020",Observational [Patient Registry],COVID-19 Immune Repertoire Sequencing
1203,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,COVID,"February 08, 2021",90,NCT04368156,GAMMACORE® (VAGUS NERVE STIMULATION),SPAIN,Recruiting,Carlos Tornero,"April 20, 2020",Interventional,"A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIOR)"
1204,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,POSTNATAL DEPRESSION,"February 08, 2021",501,NCT04368208,ASSESSMENT OF POSTNATAL DEPRESSION USING THE THE EDINBURGH QUESTIONNAIRE BETWEEN 4 AND 6 WEEKS AFTER DELIVERY,FRANCE,Completed,Poitiers University Hospital,"April 29, 2020",Observational,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression
1205,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,COVID,"February 08, 2021",576,NCT04368221,,FRANCE,"Active, not recruiting",Rennes University Hospital,"May 4, 2020",Observational,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
1206,Duke COVID-19 Shared Data and Specimen Repository,COVID,"February 08, 2021",100000,NCT04368234,,UNITED STATES,Recruiting,Duke University,"April 18, 2020",Observational [Patient Registry],Duke Shared Data and Specimen Repository Regarding COVID-19 Patients
1207,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,COVID,"February 08, 2021",40,NCT04368260,CONTROL SWAB; PROTOTYPE SWAB,UNITED STATES,Recruiting,University of Virginia,"April 24, 2020",Interventional,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic
1208,Telemedicine for Follow-up of Systemic Lupus Erythematosus,SLE,"February 08, 2021",150,NCT04368299,TELEMEDICINE; STANDARD CARE,HONG KONG,Recruiting,Chinese University of Hong Kong,"May 1, 2020",Interventional,"Use of Telemedicine for Follow-up of Systemic Lupus Erythematosus (""TeleSLE"") in the COVID-19 Outbreak: a Pragmatic Randomised Controlled Trial"
1209,Psychological Impairment Due to Covid-19,PSYCHOLOGICAL DISTRESS; QUALITY OF LIFE,"February 08, 2021",100,NCT04368312,NO INTERVENTION,,Not yet recruiting,"University Hospital, Essen","May 6, 2020",Observational,Psychological Impairment Due to Covid-19 in Hospital Staff
1210,Lung Ultrasound to Diagnose COVID-19,COVID; LUNG ULTRASOUND; RESPIRATORY COMPLICATION,"February 08, 2021",100,NCT04368338,COVID-19 RT-PCR; LUNG ULTRASOUND,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","April 28, 2020",Observational,Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room
1211,Bacteriotherapy in the Treatment of COVID-19,COVID; PNEUMONIA; DIARRHEA,"February 08, 2021",70,NCT04368351,SIVOMIXX (200 BILLION); AZITHROMYCIN; HYDROXYCHLOROQUINE,ITALY,"Active, not recruiting",University of Roma La Sapienza,"March 1, 2020",Observational,Evaluation of the Impact of Bacteriotherapy in the Treatment of COVID-19
1212,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,"PNEUMONIA, VIRAL; CORONAVIRUS INFECTION; RESPIRATORY FAILURE; EMBOLISM AND THROMBOSIS","February 08, 2021",5,NCT04368377,TIROFIBAN INJECTION; CLOPIDOGREL; ACETYLSALICYLIC ACID; FONDAPARINUX,ITALY,Completed,University of Milan,"April 6, 2020",Interventional,Platelet Inhibition With GP IIb/IIIa Inhibitor in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). A Compassionate Use Protocol
1213,Neuroradiolological Analysis of COVID-19 Patients,COVID,"February 08, 2021",100,NCT04368390,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 3, 2020",Observational,Imaging Analysis of COVID-19 + Patients With Abnormal Neurological Examination
1214,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,"ACUTE MYOCARDIAL INFARCTION; VENTRICULAR TACHYCARDIA; SUDDEN CARDIAC DEATH; STROKE, ACUTE","February 08, 2021",50,NCT04368637,,JORDAN,Recruiting,Jordan Collaborating Cardiology Group,"May 3, 2020",Observational,"Acute Cardiovascular Events Triggered by COVID-19-Related, Non-infectious Stress The Jordan COVID-9 caRdiovascular Events (JoCORE) Study"
1215,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,JOB STRESS; WORKPLACE STRESS; COMPASSION FATIGUE; PSYCHOLOGICAL TRAUMA; HEALTHCARE WORKERS; HEALTHCARE PROVIDERS,"February 08, 2021",60,NCT04368676,SUDARSHAN KRIYA YOGA (SKY); HEALTH ENHANCEMENT PROGRAM,CANADA,Recruiting,Lawson Health Research Institute,"June 25, 2020",Interventional,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness (BREATH): an RCT for Frontline Hospital and Long-term Care Home Staff Managing the COVID-19 Pandemic
1216,"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",SARS-CoV2 INFECTION; COVID,"February 08, 2021",43998,NCT04368728,BNT162B1; BNT162B2; PLACEBO,ARGENTINA,"Active, not recruiting",BioNTech SE,"April 29, 2020",Interventional,"A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS"
1217,Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge,COVID-2019 PNEUMONIA; PULMONARY REHABILITATION,"February 08, 2021",200,NCT04368793,REMOTE PULMONARY REHABILITATION,CHINA,Recruiting,China-Japan Friendship Hospital,"April 6, 2020",Observational,Intelligence-based Remote Pulmonary Rehabilitation and Efficacy Among Discharged COVID-19 Patients
1218,imPROving prenaTal carE During ConfinemenT,PREGNANCY RELATED; COVID,"February 08, 2021",108,NCT04368832,REMOTE CONSULTATION,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","April 25, 2020",Observational,ImPROving prenaTal carE During ConfinemenT: Impact of Confinement on the Quality of Prenatal Care Perceived in Low-risk Pregnancy
1219,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,COVID; COMORBIDITIES AND COEXISTING CONDITIONS,"February 08, 2021",100,NCT04368845,TELEREHABILITATION,GREECE,Recruiting,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,"May 11, 2020",Interventional,"A Telerehabilitation Approach to Improve Long-term Physical Ability and Quality of Life in Patients With Severe Acute Respiratory Syndrome Coronavirus (SARSCoV-2, COVID-19) Immediately After Hospitalization. The ATHLOS Study"
1220,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,COVID,"February 08, 2021",200,NCT04368871,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 28, 2020",Observational,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study
1221,Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients,COVID,"February 08, 2021",1000,NCT04368884,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 22, 2020",Observational,"A Prospective, Longitudinal, Observational Study to Assess the Seroconversion Status of Front Line Health Care Workers and Comparison With the Suspected or Confirmed Cases of COVID-19 Patients at Max Health Care (Project D)"
1222,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,SARS-CoV2; COVID; COVID; ANDROGENETIC ALOPECIA; ANDROGEN RECEPTOR ABNORMAL; ANDROGEN DEFICIENCY,"February 08, 2021",200,NCT04368897,CAG LENGTH <22; CAG LENGTH >=22,SPAIN,Recruiting,"Applied Biology, Inc.","May 1, 2020",Observational,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
1223,Management of Covid-19 Patients During Home Isolation,COVID,"February 08, 2021",60,NCT04368923,OXYGEN THERAPY; PHYSICAL THERAPY,EGYPT,"Active, not recruiting",Cairo University,"March 15, 2020",Interventional,Management of Covid-19 Patients During Home Isolation
1224,ARDS Caused by COVID-19,ACUTE RESPIRATORY FAILURE WITH HYPOXIA,"February 08, 2021",500,NCT04368975,,SPAIN,Recruiting,Hospital Clinic of Barcelona,"March 12, 2020",Observational [Patient Registry],Main Features and Ventilatory Management of Patients With ARDS Caused by COVID-19
1225,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,COVID,"February 08, 2021",1419,NCT04368988,"SARS-COV-2 RS - PHASE 1; SARS-COV-2 RS/MATRIX-M ADJUVANT - PHASE 1; NORMAL SALINE SOLUTION (NSS), PLACEBO - PHASE 1; NORMAL SALINE SOLUTION (NSS), PLACEBO - PHASE 2; SARS-COV-2 RS/MATRIX-M ADJUVANT, DAY 0 - PHASE 1; NORMAL SALINE SOLUTION (NSS), PLACEBO, DAY 21 - PHASE 1; SARS-COV-2 RS/MATRIX-M ADJUVANT, DAYS 0 AND 21 - PHASE 2; NORMAL SALINE SOLUTION (NSS), PLACEBO, DAY 189 - PHASE 2; SARS-COV-2 RS/MATRIX-M ADJUVANT, DAY 0 - PHASE 2; NORMAL SALINE SOLUTION (NSS), PLACEBO, DAY 21 - PHASE 2; SARS-COV-2 RS/MATRIX-M ADJUVANT - DAY 189 - PHASE 2",AUSTRALIA,"Active, not recruiting",Novavax,"May 25, 2020",Interventional,"A 2-Part, Phase 1/2, Randomized, Observer-Blinded Study To Evaluate The Safety And Immunogenicity Of A SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Or Without MATRIX-M™ Adjuvant In Healthy Subjects"
1226,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",VOLUNTEERS FROM THE INSTITUTE CURIE AND INSTITUTE PASTEUR STAFF WHO ARE NOT SHOWING ACTIVE SARS-CoV2 INFECTION,"February 08, 2021",2800,NCT04369066,BLOOD SAMPLES (COLLECTION OF 5 ML OF BLOOD IN A DRY TUBE); NASOPHARYNGEAL SWABS,FRANCE,Recruiting,Institut Curie,"April 28, 2020",Interventional,"COVID-19 Study of the Serological Response Against the SARS-CoV-2 Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur"
1227,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,RESPIRATORY FAILURE,"February 08, 2021",30,NCT04369274,MECHANICAL VENTILATION WITH THE AUTOMATED BVM COMPRESSOR,,Not yet recruiting,Massachusetts General Hospital,May 2020,Interventional,A Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Ventilation for the Treatment of COVID-19 ARDS
1228,Anxiety And Depression During COVID-19 IN INDIA,COVID,"February 08, 2021",1000,NCT04369300,REGISTERY DATA COLLECTION,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 24, 2020",Observational [Patient Registry],Prevalence Of Anxiety And Depression During COVID-19
1229,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",COVID,"February 08, 2021",200,NCT04369365,AZITHROMYCIN 500 MILLIGRAM (MG) ORAL TABLET; PLACEBO,AUSTRIA,Recruiting,Prof. Dr. Matthias Preusser,"April 27, 2020",Interventional,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic"
1230,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,ANXIETY; WELL-BEING,"February 08, 2021",200,NCT04369378,MEDITATION APP USAGE,UNITED STATES,Recruiting,Lake Erie College of Osteopathic Medicine,"August 19, 2020",Interventional,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic
1231,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,KIDNEY TRANSPLANT; COMPLICATIONS; CORONAVIRUS INFECTION,"February 08, 2021",115,NCT04369456,BLOOD SAMPLE,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 22, 2020",Interventional,Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
1232,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,"COVID SEVERE PNEUMONIA; ACUTE LUNG INJURY; ACUTE RESPIRATORY DISTRESS SYNDROME; PNEUMONIA, VIRAL","February 08, 2021",270,NCT04369469,RAVULIZUMAB; BEST SUPPORTIVE CARE,FRANCE,"Active, not recruiting",Alexion Pharmaceuticals,"May 11, 2020",Interventional,"A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared With Best Supportive Care in Patients With COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome"
1233,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",24,NCT04369599,V/Q VEST,UNITED STATES,Suspended,Emory University,"August 11, 2020",Interventional,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest
1234,"The Psychological, Social, and Economic Impacts of COVID-19",COVID; CHRONIC DISEASE; PSYCHIATRIC DISORDER; CARDIOVASCULAR DISEASES,"February 08, 2021",1000,NCT04369690,,CANADA,Recruiting,University of Ottawa,"April 3, 2020",Observational,"How Are You Coping? Assessing the Psychological, Social, and Economic Impacts of an Emerging Pandemic"
1235,Treating COVID-19 With Hydroxychloroquine (TEACH),COVID,"February 08, 2021",626,NCT04369742,HYDROXYCHLOROQUINE (HCQ); PACEBO: CALCIUM CITRATE,UNITED STATES,Suspended,NYU Langone Health,"April 15, 2020",Interventional,"Treating COVID-19 With Hydroxychloroquine: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial in Hospitalized Adults"
1236,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",COVID; THERAPEUTIC VACCINE; BCG; SARS-CoV2; TRANSMISSION,"February 08, 2021",1000,NCT04369794,BCG; PLACEBO,BRAZIL,Recruiting,"University of Campinas, Brazil","August 10, 2020",Interventional,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement"
1237,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,COVID,"February 08, 2021",507,NCT04369807,OUTPATIENT MRI,UNITED KINGDOM,Recruiting,Perspectum,"April 21, 2020",Observational,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection
1238,C5a Receptor Expression - COVID-19 (C5-COV),COVID,"February 08, 2021",100,NCT04369820,DRAW BLOOD,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"March 31, 2020",Interventional,C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19
1239,Obstetric and Perinatal Outcomes of Women With COVID-19,PREGNANT WOMEN,"February 08, 2021",1300,NCT04369859,EXAMINE THE IMPACT OF COVID-19 DURING PREGNANCY,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"April 23, 2020",Observational,Obstetric and Perinatal Outcomes of Women With COVID-19: A Prospective Cohort Study
1240,Observational Study of COVID-19 Treatment Efficacy,CORONAVIRUS; CORONAVIRUS INFECTION; CORONAVIRUS INFECTION; COVID; SARS-CoV2; CORONAVIRUS AS THE CAUSE OF DISEASES CLASSIFIED ELSEWHERE; SARS-ASSOCIATED CORONAVIRUS AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE; COVID; CORONAVIRUS DISEASE; CORONAVIRUS SARS-ASSOCIATED AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE,"February 08, 2021",1000,NCT04369989,NO INTERVENTION,UNITED STATES,Enrolling by invitation,OSF Healthcare System,"April 14, 2020",Observational,Observational Study of COVID-19 Treatment Efficacy
1241,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,SARS-CoV2; HEALTHCARE WORKERS,"February 08, 2021",374,NCT04370015,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,,Not yet recruiting,"Services Institute of Medical Sciences, Pakistan","May 15, 2020",Interventional,Efficacy and Safety of Hydroxychloroquine in Primary Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers at Risk of Exposure: Randomised Control Trial
1242,HUNgarian COronaVirus Disease-19 Epidemiological Research,CORONAVIRUS INFECTION,"February 08, 2021",11200,NCT04370067,,HUNGARY,Recruiting,Semmelweis University Heart and Vascular Center,"May 1, 2020",Observational [Patient Registry],Hungarian CoronaVirus Disease-19 Epidemiological Research
1243,Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers,SARS-CoV2,"February 08, 2021",4000,NCT04370119,NASAL SWAB; SERUM TESTING,GERMANY,Recruiting,University Medicine Greifswald,"April 27, 2020",Observational,Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
1244,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,DIABETES; COVID,"February 08, 2021",610,NCT04370171,CARE MODALITIES; TELECONSULTATION EITHER BY PHONE OR BY COMPUTER CONSULTATION,FRANCE,Completed,"University Hospital, Strasbourg, France","May 4, 2020",Observational,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic: Prospective Observational Study
1245,Covid-19 Epidemic on Acute Stroke Management,"STROKE, ACUTE","February 08, 2021",300,NCT04370197,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","March 3, 2020",Observational,Impact of th Covid-19 Epidemic on Acute Stroke Management
1246,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,SLEEP DISTURBANCE,"February 08, 2021",247,NCT04370210,QUESTIONNAIRES,FRANCE,Completed,Centre Hospitalier René Dubos,"May 4, 2020",Observational,"Sleep Quality During COVID-19 Containment in Children 7 to 12 Years Old, Whether or Not Usually Followed in Child Psychiatry"
1247,Ozone Auto-hemotherapy for COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",208,NCT04370223,OZONE AUTO-HEMOTHERAPY,SPAIN,Not yet recruiting,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,"May 25, 2020",Interventional,A Trial of Ozone Auto-hemotherapy in Adults Hospitalized With Covid-19 Pneumonia
1248,INB03 for the Treatment of Pulmonary Complications From COVID-19,COVID,"February 08, 2021",366,NCT04370236,INB03; PLACEBO,UNITED STATES,Recruiting,"Inmune Bio, Inc.","October 21, 2020",Interventional,"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of INB03 in the Treatment of Participants With Pulmonary Complications From Coronavirus Disease (COVID-19)"
1249,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",400,NCT04370249,PULMONARY ULTRASOUND,FRANCE,Recruiting,Nantes University Hospital,"April 9, 2020",Observational,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19
1250,Multi-site Adaptive Trials for COVID-19,COVID,"February 08, 2021",233,NCT04370262,SOC + INTRAVENOUS FAMOTIDINE; SOC + PLACEBO,UNITED STATES,Completed,Northwell Health,"April 7, 2020",Interventional,"A Multi-site, Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Standard of Care (SOC) Plus Famotidine vs SOC Plus Placebo for the Treatment of COVID-19 in Hospitalized Adults"
1251,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,"COVID; PNEUMONIA, VIRAL","February 08, 2021",235,NCT04370275,,ITALY,Recruiting,Ospedale di Latisana,"April 23, 2020",Observational,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia: a Multicenter Study in the Italian Outbreak
1252,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,COVID,"February 08, 2021",20,NCT04370288,"MCN (METHYLENE BLUE, VITAMIN C, N-ACETYL CYSTEINE)","IRAN, ISLAMIC REPUBLIC OF",Recruiting,Mashhad University of Medical Sciences,"April 19, 2020",Interventional,The Clinical Trial of Application of Methylene Blue Vial for Treatment of Covid-19 Patients
1253,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,ARTHROSCOPY,"February 08, 2021",79,NCT04370678,CHANGE IN PREFERENCE TO SURGERY UNDER COVID-19 PANDEMIC.,DENMARK,Completed,Region Zealand,"April 17, 2020",Observational,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures: COVID-19 Effect on Arthroscopic Patients in a University Hospital in Denmark
1254,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,COVID,"February 08, 2021",18,NCT04370782,HYDROXYCHLOROQUINE; AZITHROMYCIN; ZINC SULFATE; DOXYCYCLINE,UNITED STATES,Completed,"St. Francis Hospital, New York","April 28, 2020",Interventional,A Randomized Study Evaluating the Safety and Efficacy of Hydroxychloroquine and Zinc in Combination With Either Azithromycin or Doxycycline for the Treatment of COVID-19 in the Outpatient Setting
1255,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,COVID,"February 08, 2021",500,NCT04370808,EXPOSURE,PORTUGAL,Not yet recruiting,University of Lisbon,June 2020,Observational,VITACOV: Vitamin D-related Polymorphisms and Vitamin D Levels as Risk Biomarkers of COVID-19 Infection Severity
1256,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",OCCUPATIONAL EXPOSURE TO SARS-CoV2; COVID,"February 08, 2021",20000,NCT04370821,,UNITED STATES,Recruiting,Villanova University,"May 9, 2020",Observational [Patient Registry],"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers"
1257,Tocilizumab for Patients With Cancer and COVID-19 Disease,HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM; PNEUMONIA; PNEUMONITIS; SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",1,NCT04370834,TOCILIZUMAB,UNITED STATES,Terminated,National Cancer Institute (NCI),"May 28, 2020",Interventional,Tocilizumab in Hospitalized Cancer Patients With Coronavirus 2019 (SARS-CoV-2) and Severe Complications of Coronavirus Disease 19 (COVID-19)
1258,Recruit Blood Donors Via SMS During Epidemic of COVID-19,BLOOD DONATION,"February 08, 2021",456517,NCT04370886,BLOOD DONATION SMS,CHINA,Completed,Guangzhou Blood Center,"April 30, 2020",Interventional,Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19
1259,Provider Burnout During COVID-19,"PERCEIVED ORGANIZATIONAL SUPPORT, ANXIETY, BURNOUT","February 08, 2021",0,NCT04370938,COPING STRATEGIES VIDEO,UNITED STATES,Withdrawn,University of Pittsburgh,"April 29, 2020",Interventional,Exploring Provider Burnout During the COVID-19 Pandemic
1260,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,ARDS; COVID,"February 08, 2021",25,NCT04371029,PSG,FRANCE,Recruiting,"University Hospital, Bordeaux","April 28, 2020",Interventional,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS
1261,Proactive Care of Ambulatory COVID19 Patients,COVID; AZITHROMYCIN; AMBULATORY,"February 08, 2021",64,NCT04371107,CONSULTATION; AZITHROMYCIN,FRANCE,Not yet recruiting,"Centre Hospitalier Universitaire, Amiens","April 29, 2020",Interventional,Proactive Care of Ambulatory COVID19 Patients: Open-labeled Randomized Trial
1262,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,"RESILIENCE, PSYCHOLOGICAL; LONELINESS; YOUTH; SURVEYS AND QUESTIONNAIRES","February 08, 2021",800,NCT04371250,SURVEY AND QUESTIONNAIRE,BELGIUM,"Active, not recruiting",Erasme University Hospital,"April 30, 2020",Observational,Mental Health Implications During and After the COVID-19 Pandemic Lock-down Measures in Youth (18 - 25 Years Old) in French-Speaking Belgium and Italy: Resilience and Loneliness Evaluation.
1263,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,COVID; CARDIOVASCULAR RISK FACTOR,"February 08, 2021",5500,NCT04371289,,ITALY,Not yet recruiting,Istituto Auxologico Italiano,April 2020,Observational,"Cardiovascular Risk in COVID-19 Patients: Metabolic, Prothrombotic and Proinflammatory Mechaninsms Associated With Outcome and With Cardiorespiratory Features During the Acute Viral Disease and at Short Term Follow-up"
1264,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,"BURNOUT, PROFESSIONAL; MEDICAL ERRORS; DEPRESSION","February 08, 2021",145,NCT04371302,QUESTIONNAIRE,,Not yet recruiting,University of Malaya,"May 1, 2020",Observational,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit of an Exclusively Covid-19 Hospital: the Malaysian Experience
1265,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",CORONAVIRUS INFECTION; PEDIATRIC CANCER; ADULT CHILDREN; CANCER,"February 08, 2021",400,NCT04371315,,UNITED STATES,Recruiting,St. Jude Children's Research Hospital,"April 27, 2020",Observational,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children"
1266,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,EMERGENCIES,"February 08, 2021",1860,NCT04371328,RECOP UNIT PATIENT,FRANCE,"Active, not recruiting","University Hospital, Toulouse","March 13, 2020",Observational [Patient Registry],"Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection (Unit ""COVID Possible"")"
1267,Outcomes of Covid-19 Protective Measures in Endoscopy,COVID DISEASE; ENDOSCOPY UNIT,"February 08, 2021",100,NCT04371354,,SPAIN,Recruiting,Fundacion Miguel Servet,"April 27, 2020",Observational,Outcomes After Implementation of a Protective Protocol for Covid-19 in Large Spanish Endoscopy Units.
1268,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",COVID,"February 08, 2021",208,NCT04371367,AVDORALIMAB; PLACEBO,FRANCE,"Active, not recruiting",Assistance Publique Hopitaux De Marseille,"April 27, 2020",Interventional,"A Double-blind, Randomized Study Versus Placebo of Avdoralimab (IPH5401), an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia"
1269,MSCs in COVID-19 ARDS,MESENCHYMAL STROMAL CELLS; REMESTEMCEL-L; ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",223,NCT04371393,REMESTEMCEL-L; PLACEBO,UNITED STATES,"Active, not recruiting",Icahn School of Medicine at Mount Sinai,"April 30, 2020",Interventional,Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome
1270,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,COVID,"February 08, 2021",0,NCT04371406,HYDROXYCHLOROQUINE AND AZITHROMYCIN; AZINC,,Withdrawn,Assistance Publique - Hôpitaux de Paris,April 2020,Interventional,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients: Randomized Controlled Trial: MG-COVID
1271,COVID-19 Health Messaging to Underserved Communities,CORONAVIRUS,"February 08, 2021",15475,NCT04371419,MESSAGING,UNITED STATES,Completed,"National Bureau of Economic Research, Inc.","May 13, 2020",Interventional,COVID-19 Health Messaging to Underserved Communities
1272,Genetics of COVID-19 Susceptibility and Manifestations,COVID; CORONAVIRUS 2019,"February 08, 2021",2500,NCT04371432,,UNITED STATES,Recruiting,National Human Genome Research Institute (NHGRI),"February 11, 2021",Observational,Genetics of COVID-19 Susceptibility and Manifestations
1273,Covid-19 Pandemic Triage Score,SARS-CoV2; COVID,"February 08, 2021",50,NCT04371471,STC-19 SCORE,FRANCE,Completed,Groupe Hospitalier de la Rochelle Ré Aunis,"March 1, 2020",Observational,Covid-19 Pandemic Triage Score in Patients With Known or Suspected SARS-CoV-2 Infection
1274,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,COVID BY SARS-CoV2 INFECTION,"February 08, 2021",115,NCT04371510,BLOOD SAMPLE,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 22, 2020",Interventional,Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients
1275,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,CORONAVIRUS INFECTION,"February 08, 2021",1100,NCT04371523,APO-HYDROXYCHLOROQUINE; MATCHED PLACEBO,CANADA,Not yet recruiting,St. Joseph's Healthcare Hamilton,"May 1, 2020",Interventional,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers (PROVIDE): A Parallel Randomized Controlled Trial
1276,Predicting Death and ICU Admission in COVID-19 Patients in ED,COVID,"February 08, 2021",300,NCT04371562,,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"March 1, 2020",Observational,Predicting ICU Admission and Death for COVID-19 Patients in the Emergency Department. Comparison of Five Scoring Systems.
1277,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,COVID PNEUMONIA,"February 08, 2021",60,NCT04371601,OSELTAMIVIR; HORMONES; OXYGEN THERAPY; MESENCHYMAL STEM CELLS,CHINA,"Active, not recruiting",Fuzhou General Hospital,"March 1, 2020",Interventional,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019
1278,Sirolimus in COVID-19 Phase 1,SARS-CoV2; COVID,"February 08, 2021",0,NCT04371640,SIROLIMUS 1 MG/ML; PLACEBO,UNITED STATES,Withdrawn,Walter K. Kraft,"July 6, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Virological Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sirolimus Adjuvant Therapy in Patients With Coronavirus Disease (COVID-19)"
1279,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",40,NCT04371679,NO INTERVENTIONS PLANNED,BELGIUM,Recruiting,Hasselt University,"April 1, 2020",Observational,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients
1280,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,SARS-CoV2,"February 08, 2021",100,NCT04371692,SELF-ADMINISTERED QUESTIONNAIRE; SARS-COV2 TESTING,,Not yet recruiting,"University Hospital, Lille",April 2020,Observational,Prevalence of SARS-Cov2 Infection Among HCW in Lille University Hospital
1281,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,COVID,"February 08, 2021",100,NCT04371744,,FRANCE,Completed,Assistance Publique Hopitaux De Marseille,"April 17, 2020",Observational [Patient Registry],"QT-Logs : a Clinical Study to Monitor Cardiac Safety, With Artificial Intelligence for QT Interval Analysis of ECG Data From Smartwatches, in Patients Receiving Hydroxychloroquine Treatment for COVID-19"
1282,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,COVID,"February 08, 2021",56,NCT04371822,SNPP PROTOPORPHYRIN PLUS SUNLIGHT EXPOSURE; SNPP PROTOPORPHYRIN PLUS SUNLIGHT EXPOSURE; SNPP PROTOPORPHYRIN PLUS SUNLIGHT EXPOSURE; SULFONATOPORPHYRIN(TPPS) PLUS SUNLIGHT EXPOSURE.; PLACEBO,EGYPT,Not yet recruiting,Kafrelsheikh University,August 2020,Interventional,Efficacy of Based MRI Contrast Media Against Covid-19
1283,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,HIV-INFECTION/AIDS; CORONAVIRUS INFECTION,"February 08, 2021",1500,NCT04371835,,NIGERIA,Recruiting,Kirby Institute,"August 12, 2020",Observational,"COVID-19 in People Living With HIV: Evaluation of Risk Factors and Outcomes in Resource-limited Settings. A Pooled Substudy of ADVANCE, D²EFT, DolPHIN2 and NAMSAL"
1284,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study,EATING HABITS,"February 08, 2021",2465,NCT04371848,,CANADA,"Active, not recruiting",Laval University,"April 16, 2020",Observational,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity Among Adults From the Province of Québec in Canada: a NutriQuébec Sub-study
1285,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,COVID,"February 08, 2021",0,NCT04371926,HYDROXYCHLOROQUINE SULFATE,,Withdrawn,Texas Cardiac Arrhythmia Research Foundation,June 2020,Interventional,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT)
1286,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),COVID,"February 08, 2021",330,NCT04371952,DOXYCYCLINE; PLACEBO,FRANCE,Not yet recruiting,Nantes University Hospital,"June 1, 2020",Interventional,"Doxycycline Versus Placebo in COVID-19 + Patients Without Hospitalization Criteria: Prospective, Multicenter, Randomized, Double-blind Study"
1287,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",COVID,"February 08, 2021",24,NCT04371965,POVIDONE-IODINE,FRANCE,Completed,Poitiers University Hospital,"September 1, 2020",Interventional,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With SARS-CoV-2"
1288,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,"COVID; CORONAVIRUS; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS; GLUCOSE METABOLISM DISORDERS; METABOLIC DISEASE; ENDOCRINE SYSTEM DISEASES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; LINAGLIPTIN; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SARS-CoV2; HYPOGLYCEMIC AGENTS; RESPIRATORY TRACT DISEASES; INCRETINS; HORMONES","February 08, 2021",100,NCT04371978,LINAGLIPTIN 5 MG,ISRAEL,Recruiting,Rabin Medical Center,"October 1, 2020",Interventional,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
1289,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),COVID,"February 08, 2021",100,NCT04372004,DIAGNOSTIC TESTS FOR COVID-19 INFECTION,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"May 8, 2020",Interventional,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)
1290,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,COVID; SARS-CoV2,"February 08, 2021",1,NCT04372017,HYDROXYCHLOROQUINE; VITAMIN D,UNITED STATES,"Active, not recruiting",Sanford Health,"May 14, 2020",Interventional,"Randomized, Double-Blind, Controlled Trial of Hydroxychloroquine vs Placebo as Post-Exposure Prophylaxis Against COVID-19 Infection"
1291,Health Care Use During the Covid19 Crisis,HEALTH CARE UTILIZATION,"February 08, 2021",10000,NCT04372030,ONLINE QUESTIONNAIRE,,Not yet recruiting,Université Catholique de Louvain,"May 1, 2020",Interventional,"Utilisation de Soins Pendant la Crise Covid-19 : Recours, Report et Renoncement (US3R)"
1292,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,SLEEP HYGIENE,"February 08, 2021",1200,NCT04372043,QUESTIONNAIRE,LEBANON,Not yet recruiting,Saint-Joseph University,"April 30, 2020",Observational,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.
1293,The COVID-ICU Healthcare Professional Study,COVID; CRITICAL CARE; INTENSIVE CARE UNITS; HEALTH PERSONNEL,"February 08, 2021",2200,NCT04372056,VIEWS AND EXPERIENCES OF HEALTH CARE PROFESSIONALS WORKING IN INTENSIVE CARE UNITS DURING THE COVID-19 PANDEMIC,NORWAY,Recruiting,Oslo University Hospital,"May 6, 2020",Observational,A Norwegian Study on Views and Experiences of Health Care Professionals Working in Intensive Care Units During the COVID-19 Pandemic.
1294,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,SARS-CoV2,"February 08, 2021",480,NCT04372082,STANDARD OF CARE (SOC); HYDROXYCHLOROQUINE; ASSOCIATION OF DILTIAZEM AND NICLOSAMIDE,,Not yet recruiting,"University Hospital, Lille",May 2020,Interventional,"Efficacy of HYdroxychloroquine and DILtiazem-nIClosamide Combination for the Treatment of Non-severe Forms of SARS-CoV2 Infection in Patients With Co-morbidities: Multicenter, Randomized, Open-labeled Controlled Trial"
1295,A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",379,NCT04372186,PLACEBO; TOCILIZUMAB,BRAZIL,"Active, not recruiting","Genentech, Inc.","May 14, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia"
1296,SEVERITY SCORE FOR COVID-19 PNEUMONIA,COVID; PNEUMONIA,"February 08, 2021",248,NCT04372199,,ITALY,Recruiting,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"April 29, 2020",Observational [Patient Registry],VALIDATION OF A SEVERITY SCORE TO IDENTIFY PATIENTS ADMITTED FOR COVID-19 PNEUMONIA AT HIGH RISK FOR AN INTENSIVE APPROACH
1297,Convalescent Plasma for the Treatment of Patients With COVID-19,COVID; SARS-CoV2,"February 08, 2021",,NCT04372368,COVID-19 CONVALESCENT PLASMA,UNITED STATES,No longer available,"University of Colorado, Denver",,Expanded Access,Convalescent Plasma for the Treatment of Patients With COVID-19
1298,SQuISH-COVID: A Pilot Study,SEPSIS; COVID,"February 08, 2021",300,NCT04372472,,UNITED STATES,"Active, not recruiting","Cytovale, Inc.","April 7, 2020",Observational,SQuISH-COVID: A Pilot Study
1299,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,VENTILATOR ASSOCIATED PNEUMONIA; CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04372576,ASSESSMENT OF VENTILATOR-ASSOCIATED PNEUMONIA CRITERIA,HUNGARY,Recruiting,Semmelweis University,"April 16, 2020",Observational,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients
1300,Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC),COVID; PNEUMONIA,"February 08, 2021",1203,NCT04372589,HEPARIN,BRAZIL,"Active, not recruiting",University of Manitoba,"May 20, 2020",Interventional,"Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC), in Collaboration With Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-4)"
1301,Duvelisib to Combat COVID-19,COVID,"February 08, 2021",28,NCT04372602,DUVELISIB; PERIPHERAL BLOOD DRAW; PLACEBO,UNITED STATES,Recruiting,Washington University School of Medicine,"October 12, 2020",Interventional,A Pilot Study of Duvelisib to Combat COVID-19
1302,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,COVID,"February 08, 2021",600,NCT04372628,LOPINAVIR/RITONAVIR 400 MG/100 MG; PLACEBO,UNITED STATES,Recruiting,Vanderbilt University Medical Center,"June 1, 2020",Interventional,Trial of Early Therapies During Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19
1303,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,"COVID; ARDS, HUMAN; MECHANICAL VENTILATION","February 08, 2021",200,NCT04372680,CTUS EXAMINATION,FRANCE,Recruiting,"University Hospital, Toulouse","April 22, 2020",Interventional,"WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound: a Prospective, Multicenter, Randomized, Open-label, Parallel-group Clinical Trial"
1304,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,DISTANCE LEARNING-ONLINE LEARNING; TRADITIONAL CLASSROOM-BASED LEARNING; CORONAVIRUS DISEASE SOCIAL DISTANCING MEASURES; NURSING STUDENTS' PERCEPTION AND ACHIEVEMENT,"February 08, 2021",180,NCT04372693,IMPLIMINTING ONLINE DISTANCE LEARNING,EGYPT,Enrolling by invitation,Cairo University,"September 1, 2020",Interventional,Unplanned Shifting the Traditional Classroom-Based to Online Distance Learning as a Result of (COVID-19) Social Distancing Measures: Nursing Students' Perception and Achievement
1305,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,COVID,"February 08, 2021",80,NCT04372979,TRANSFUSION OF SARS-COV-2 CONVALESCENT PLASMA.; TRANSFUSION OF STANDARD PLASMA.,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 14, 2020",Interventional,Evaluation Of Efficacy Of COVID-19 Convalescent Plasma Versus Standard Plasma In The Early Care Of COVID-19 Patients Hospitalized Outside Intensive Care Units.
1306,Screening of Cancer Patients to Assess Impact of COVID-19,COVID; CANCER,"February 08, 2021",1000,NCT04373005,NASOPHARYNGEAL (NP) SWAB,CANADA,"Active, not recruiting","University Health Network, Toronto","May 11, 2020",Observational,A Research Platform to Screen Patients in Oncology and Assess Impact - RESPONSE
1307,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",144,NCT04373044,BARICITINIB; HYDROXYCHLOROQUINE; PLACEBO ADMINISTRATION,UNITED STATES,Recruiting,University of Southern California,"May 1, 2020",Interventional,A Phase II Randomized Double-Blind Trial of Baricitinib or Placebo Combined With Antiviral Therapy in Patients With Moderate and Severe COVID-19
1308,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,COVID,"February 08, 2021",42,NCT04373096,CURRENT IPAC-UHN PPE; MODIFIED IPAC-UHN PPE,CANADA,Recruiting,"University Health Network, Toronto","December 7, 2020",Interventional,Development of a Novel Hood Shield to Enhance PPE Security and Minimize COVID-19 Transmission to Front-line Health Care Workers Performing High-risk Procedures
1309,Stroke Rehabilitation Outcome During COVID-19 Lockdown,STROKE; REHABILITATION; COVID; COHORT STUDIES,"February 08, 2021",36,NCT04373109,OBSERVATION,SWITZERLAND,Completed,Jeremia Held,"April 16, 2020",Observational,Stroke Rehabilitation Outcome During COVID-19 Lockdown
1310,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",COVID; CRITICAL ILLNESS; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION,"February 08, 2021",2500,NCT04373135,BRIEF EDUCATIONAL VIDEO,UNITED STATES,"Active, not recruiting","University of California, Los Angeles","May 8, 2020",Interventional,A Study to Evaluate Health Behavior and Access Impacts Due to COVID-19 and for Community Engagement of Stakeholders Surrounding Scarce Resource Allocation Policy.
1311,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",CORONAVIRUS,"February 08, 2021",1000,NCT04373148,THERE IS NO INTERVENTION,UNITED STATES,Recruiting,Stanford University,"April 8, 2020",Observational,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19"
1312,Home Pulse Oximeter Use in Patients With COVID-19,SARS-CoV2; COVID; COVID,"February 08, 2021",209,NCT04373161,HOME PULSE OXIMETRY MONITORING,UNITED STATES,Completed,Swedish Hospital,"March 20, 2020",Interventional,Utilizing Home Pulse Oximetry for Patients With COVID-19 To Monitor Disease Progression
1313,Human Ab Response & immunoMONItoring of COVID-19 Patients,SARS-CoV2 CORONAVIRUS; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",75,NCT04373200,BLOOD SAMPLES COLLECTION; SALIVA COLLECTION,FRANCE,Recruiting,Rennes University Hospital,"May 25, 2020",Interventional,Human Ab Response & immunoMONItoring of COVID-19 Patients
1314,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,PLETH VARIABILITY INDEX,"February 08, 2021",30,NCT04373213,PLETH VARIABILITY INDEX,TURKEY,Not yet recruiting,Erzincan University,"May 5, 2020",Observational,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index
1315,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,COVID; NON-SPECIFIC EFFECTS OF VACCINES; MORBIDITY; ABSENTEEISM; HETEROLOGOUS IMMUNITY,"February 08, 2021",1293,NCT04373291,BCG-DENMARK; SALINE,DENMARK,"Active, not recruiting",Bandim Health Project,"May 18, 2020",Interventional,Using BCG Vaccine to Enhance Non-specific Protection of Health Care Workers During the COVID-19 Pandemic. A Randomized Controlled Multi-center Trial
1316,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,BURNOUT,"February 08, 2021",882,NCT04373382,PEER RESILIENCE CHAMPION; ENRICHED SURVEY FEEDBACK,CANADA,"Active, not recruiting","Mount Sinai Hospital, Canada","July 27, 2020",Interventional,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic
1317,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,SARS-CoV2,"February 08, 2021",1344,NCT04373460,SARS-COV-2 CONVALESCENT PLASMA; PLASMA FROM A VOLUNTEER DONOR,UNITED STATES,Recruiting,Johns Hopkins University,"June 3, 2020",Interventional,Comparison of the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune) Plasma Among Outpatients With Symptomatic COVID-19
1318,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,COVID WITH POSITIVE RT-PCR,"February 08, 2021",160,NCT04373486,,FRANCE,Completed,"University Hospital, Strasbourg, France","March 3, 2020",Observational,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels
1319,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,COVID; THROMBOSIS; PULMONARY EMBOLISM; DEEP VEIN THROMBOSIS,"February 08, 2021",602,NCT04373707,ENOXAPARIN; ENOXAPARIN,FRANCE,Recruiting,"Central Hospital, Nancy, France","May 13, 2020",Interventional,Effectiveness of Weight-adjusted Prophylactic Low Molecular Weight Heparin Doses Compared With Lower Fixed Prophylactic Doses to Prevent Venous Thromboembolism in COVID-2019. The Multicenter Randomized Controlled Open-label Trial COVI-DOSE
1320,Early Intervention in COVID-19: Favipiravir Verses Standard Care,CORONAVIRUS INFECTION,"February 08, 2021",450,NCT04373733,FAVIPIRAVIR; STANDARD OF CARE MANAGEMENT,UNITED KINGDOM,Recruiting,Chelsea and Westminster NHS Foundation Trust,"May 1, 2020",Interventional,A Randomised Controlled Trial of Early Intervention in Patients HospItalised With COVID-19: Favipiravir and StaNdard Care vErsEs Standard CaRe
1321,Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,SARS-CoV2; COVID,"February 08, 2021",186,NCT04373759,CARDIOPULMONARY RESUSCITATION; MODIFIED RANKIN SCORE,FRANCE,Completed,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"May 2, 2020",Observational [Patient Registry],Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs
1322,C-reactive Protein Levels Among Individuals With COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",3000,NCT04373798,C-REACTIVE PROTEIN,DENMARK,Recruiting,Henning Bliddal,"May 4, 2020",Observational,Triage Strategies Based on C-reactive Protein Levels Among Individuals With COVID-19: A Prospective Cohort Study
1323,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,COVID; ICU ACQUIRED WEAKNESS; WEANING FAILURE,"February 08, 2021",60,NCT04373811,LUNG ULTRASOUND; MUSCLE ULTRASOUND,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"April 16, 2020",Observational,Quality of Life and Functional Prognosis at One Year of Patients With COVID-19 Admitted in Post-ICU Setting
1324,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,COVID,"February 08, 2021",50,NCT04373824,IVERMECTIN,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 25, 2020",Interventional,To Study the Effectiveness of Ivermectin With Standard of Care Treatment Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study
1325,COVID-19 Among Healthcare Workers in Belgian Hospitals,SARS-CoV2; COVID,"February 08, 2021",850,NCT04373889,,BELGIUM,"Active, not recruiting",Sciensano,"April 22, 2020",Observational,"SARS-COV-2 Prevalence, Seroprevalence and Seroconversion Among Healthcare Workers in Belgium During the 2020 COVID-19 Outbreak"
1326,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,COVID; SARS-CoV2,"February 08, 2021",240,NCT04374019,IVERMECTIN; CAMOSTAT MESILATE; ARTEMESIA ANNUA; ARTESUNATE,UNITED STATES,Recruiting,Susanne Arnold,"May 1, 2020",Interventional,"Randomized, Multi-arm Phase II Trial of Novel Agents for Treatment of High-risk COVID-19 Positive Patients"
1327,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,COVID INFECTION,"February 08, 2021",120,NCT04374032,METENKEFALIN + TRIDECACTIDE; THE STANDARD OF CARE,BOSNIA AND HERZEGOVINA,Completed,Bosnalijek D.D,"May 1, 2020",Interventional,"An Open-label, Prospective, Randomized, Comparative Clinical Trial to Evaluate the Efficacy and Safety of ENKORTEN® as an Immunomodulatory Therapy, Within the Usual Therapeutically Established Protocol, for the Treatment of Patients With Moderate to Severe COVID-19 Infection"
1328,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,SARS-CoV2,"February 08, 2021",50,NCT04374045,ECG-HOLTER,FRANCE,Completed,Centre Hospitalier Universitaire de Saint Etienne,"April 30, 2020",Observational [Patient Registry],Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study
1329,Less Frequency Hemodialysis and COVID-19,END STAGE RENAL DISEASE,"February 08, 2021",50,NCT04374058,LESS-FREQUENCY HEMODIALYSIS,ARGENTINA,"Active, not recruiting",Dialisis Madariaga,"March 20, 2020",Observational,Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease
1330,Early Short Course Corticosteroids in COVID-19,"COVID; PNEUMONIA, VIRAL","February 08, 2021",250,NCT04374071,METHYLPREDNISOLONE,UNITED STATES,Completed,Henry Ford Health System,"March 12, 2020",Observational,Early Short Course Corticosteroids in Hospitalized Patients With COVID-19
1331,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,COVID; CONVALESCENCE,"February 08, 2021",60,NCT04374084,MOXIBUSTION PLUS CUPPING,CHINA,Recruiting,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,"May 10, 2020",Interventional,Moxibustion Plus Cupping in Convalescent Patients With COVID-19: A Randomized Clinical Trial
1332,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,POST TRAUMATIC STRESS DISORDER; ANXIETY; DEPRESSION,"February 08, 2021",1778,NCT04374097,,NORWAY,Completed,University of Oslo,"March 31, 2020",Observational,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak
1333,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,COVID; HYPERTENSION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR RISK FACTOR,"February 08, 2021",1000,NCT04374110,CLINICAL DATA,POLAND,Recruiting,"Institute of Cardiology, Warsaw, Poland","May 5, 2020",Observational [Patient Registry],Prospective Monitoring of Drug Safety and the Occurrence of Complications During Hospitalization in Patients With Cardiovascular Diseases With COVID-19
1334,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,COVID,"February 08, 2021",111,NCT04374123,SEROLOGICAL SCREENING FOR IGG AND IGM ANTIBODIES AGAINST COVID-19,ECUADOR,Completed,Instituto Ecuatoriano de Enfermedades Digestivas,"April 20, 2020",Observational,COVID-19 Serologic Screening and a Strict Protocol in the Management of a Referral Gastrointestinal Endoscopy Unit: a Prospective Study
1335,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,CYTOKINE RELEASE SYNDROME; COVID,"February 08, 2021",20,NCT04374149,THERAPEUTIC PLASMA EXCHANGE; RUXOLITINIB,UNITED STATES,"Active, not recruiting",Prisma Health-Upstate,"April 30, 2020",Interventional,"Interventional Study to Evaluate the Efficacy of Therapeutic Plasma Exchange (TPE) Alone or in Combination With Ruxolitinib in COVID-19 Positive Patients With PENN Grade 2, 3, 4 Cytokine Released Syndrome (CRS)"
1336,Trial to Promote Recovery From COVID-19 With Endocrine Therapy,COVID; SARS-CoV2,"February 08, 2021",60,NCT04374279,BICALUTAMIDE 150 MG ORAL TABLET,UNITED STATES,Not yet recruiting,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"February 5, 2021",Interventional,A Phase II Trial to Promote Recovery From COVID-19 With Endocrine Therapy
1337,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),COVID; SARSCOV2 CONVALESCENT PLASMA,"February 08, 2021",,NCT04374370,SARSCOV2 CONVALESCENT PLASMA,UNITED STATES,Available,AdventHealth,,Expanded Access,Severe Acute Respiratory Syndrome Coronavirus 2 of the Genus Betacoronavirus (SARSCoV2) Convalescent Plasma (CP) Expanded Access Protocol (EAP)
1338,COVID-19 Pandemic and Female Sexual Behavior,SEXUAL BEHAVIOR; COVID,"February 08, 2021",58,NCT04374422,FSFI SURVEY,TURKEY,Completed,Acibadem University,"April 10, 2020",Observational,Effect of SARS- COVID-19 Pandemic on Female Sexual Behavior
1339,A Study of N-acetylcysteine in Patients With COVID-19 Infection,COVID,"February 08, 2021",84,NCT04374461,N-ACETYLCYSTEINE; PERIPHERAL BLOOD,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"May 1, 2020",Interventional,Phase II Study of N-acetylcysteine in Severe or Critically Ill Patients With Refractory COVID-19 Infection
1340,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),OLFACTORY DISORDER,"February 08, 2021",0,NCT04374474,OLFACTORY RETRAINING; CORTICOSTEROID NASAL IRRIGATION; SMELL HOUSEHOLD ITEMS; NASAL IRRIGATION,CANADA,Withdrawn,Lawson Health Research Institute,"January 10, 2021",Interventional,Olfactory Retraining Therapy and Budesonide Nasal Rinse for Anosmia Treatment in Patients Post-CoVID 19. A Randomized Controlled Trial
1341,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,COVID,"February 08, 2021",100,NCT04374487,CONVALESCENT PLASMA; STANDARD CARE THERAPY,INDIA,"Active, not recruiting",Max Healthcare Insititute Limited,"May 9, 2020",Interventional,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications"
1342,Community Pharmacists Behaviour During Covid-19,COVID,"February 08, 2021",318,NCT04374513,,EGYPT,Completed,Damanhour University,"April 2, 2020",Observational,"SURVEY of RETAIL PHARMACISTS KNOWLEDGE, ROLE & BEHAVIOR DURING COVID-19 VIRUS OUTBREAK"
1343,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,CORONAVIRUS DISEASE 2019 )COVID),"February 08, 2021",182,NCT04374526,COVID-19 CONVALESCENT PLASMA,ITALY,Recruiting,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"May 27, 2020",Interventional,Early transfusIon of COVID-19 Convalescent Plasma in Elderly COVID-19 Patients to Prevent Disease Progression.
1344,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,CORONAVIRUS,"February 08, 2021",116,NCT04374539,PLASMA EXCHANGE; STANDAR MEDICAL TREATMEN,SPAIN,Recruiting,Fundacion Clinic per a la Recerca Biomédica,"April 29, 2020",Interventional,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial
1345,Asymptomatic COVID-19 Trial,SARS-CoV2 INFECTION,"February 08, 2021",0,NCT04374552,HYDROXYCHLOROQUINE SULFATE &AZITHROMYCIN; PLACEBO,UNITED STATES,Withdrawn,"Rutgers, The State University of New Jersey","May 5, 2020",Interventional,RCT in Asymptomatic Volunteers With COVID-19 Comparing Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone vs Standard of Care Without Antibiotics
1346,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,CORONAVIRUS INFECTION; SARS-CoV2; SARS PNEUMONIA; PNEUMONIA,"February 08, 2021",29,NCT04374565,HIGH-TITER ANTI-SARS-COV-2 (COVID 19) CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",University of Virginia,"May 5, 2020",Interventional,Efficacy and Safety of High-Titer Anti-SARS-CoV-2 (COVID19) Convalescent Plasma for Hospitalized Patients With Infection Due to COVID-19 to Decrease Complications: A Phase II Trial
1347,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,PNEUMONIA; COVID,"February 08, 2021",180,NCT04374591,SODIUM BICARBONATE,EGYPT,"Active, not recruiting",Mansoura University,"August 1, 2020",Interventional,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia: A Preliminary Report of Short Term Follow up
1348,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,"COVID; CRITICAL ILLNESS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSES; VENOUS THROMBOSES, DEEP; VENOUS THROMBOSIS PULMONARY; PULMONARY EMBOLISM; PULMONARY EMBOLISM AND THROMBOSIS; SARS-CoV2; SARS-COV INFECTION","February 08, 2021",230,NCT04374617,DUPLEX ULTRASOUND AND COMPUTED TOMOGRAPHY ANGIOGRAPHY,SPAIN,Completed,Hospital Universitari Vall d'Hebron Research Institute,"April 1, 2020",Observational,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19
1349,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population,DEPRESSION; COVID,"February 08, 2021",500,NCT04374643,SLEF QUESTIONNAIRES FULFILMENT,FRANCE,Recruiting,"University Hospital, Montpellier","April 1, 2020",Observational,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population : PsyConfPop
1350,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,"CONJUNCTIVITIS; SARS-CoV2; COVID; OCULAR INFECTION, VIRAL; OCULAR INFLAMMATION","February 08, 2021",50,NCT04374656,,UNITED STATES,Recruiting,Johns Hopkins University,"May 18, 2020",Observational,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients Presenting With Conjunctivitis to the Ophthalmology Clinics During the COVID-19 Pandemic
1351,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",COVID,"February 08, 2021",700,NCT04374695,,,Not yet recruiting,Versailles Hospital,"May 1, 2020",Observational,"Association Between Hypertension, Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19"
1352,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,PERCEIVED STRESS; ANXIETY; SLEEP DISTURBANCE; BURNOUT; PTSD,"February 08, 2021",328,NCT04374786,CALM MEDITATION APP,UNITED STATES,Enrolling by invitation,University of Arizona,"May 15, 2020",Interventional,Effects of a Mobile App on Health and Well-being During COVID-19 Pandemic in House Staff at Banner University Medical Center Phoenix
1353,Effect of COVID-19 Pandemic on Pediatric Cancer Care,COVID,"February 08, 2021",20,NCT04374838,,EGYPT,Recruiting,South Egypt Cancer Institute,"May 15, 2020",Observational,Effect of COVID-19 Pandemic on Pediatric Cancer Care
1354,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,COVID PATIENTS,"February 08, 2021",58,NCT04374903,HCQ & AZ VS HCQ+SIR,JORDAN,Not yet recruiting,King Hussein Cancer Center,"May 1, 2020",Interventional,"Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients: A Pilot, Multicenter Randomized Open-Label Trial"
1355,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,PRE-EXPOSURE PROPHYLAXIS; CORONAVIRUS; SARS-CoV2,"February 08, 2021",988,NCT04374942,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,CANADA,Enrolling by invitation,Megan Landes,"April 30, 2020",Interventional,"Protecting Frontline Health Care Workers From COVID-19 With Hydroxychloroquine Pre-exposure Prophylaxis: A Randomized, Placebo-controlled Multi-Site Trial in Toronto, Canada"
1356,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,COVID,"February 08, 2021",24,NCT04375046,RECOMBINANT BACTERIAL ACE2 RECEPTORS -LIKE ENZYME OF B38-CAP (RBACE2),,Not yet recruiting,Kafrelsheikh University,September 2020,Interventional,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2
1357,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",58,NCT04375098,COVID-19 CONVALESCENT PLASMA,CHILE,Completed,Pontificia Universidad Catolica de Chile,"May 4, 2020",Interventional,Efficacy and Safety of Early Anti-SARS-COV-2 Convalescent Plasma in Patients Admitted for COVID-19 Infection: a Randomized Phase II Trial
1358,Treatment of Angiotensin Peptide (1-7) for COVID-19,COVID,"February 08, 2021",20,NCT04375124,BIOLOGICAL/VACCINE: ANGIOTENSIN PEPTIDE (1-7) DERIVED PLASMA,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"April 25, 2020",Interventional,Evaluation of the Possible Role of Angiotensin Peptide (1-7) on Treatment of COVID-19
1359,Correlation Between Oxidative Stress Status and COVID-19 Severity,OXIDATIVE STRESS,"February 08, 2021",90,NCT04375137,OXIDATIVE STRESS ELISA KIT,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Shahid Beheshti University of Medical Sciences,"April 20, 2020",Observational,Correlation Between Oxidative Stress Markers and COVID-19 Severity Index
1360,Monocytes and NK Cells Activity in Covid-19 Patients,COVID; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; IMMUNOMODULATION,"February 08, 2021",150,NCT04375176,STUDY OF IMMUNE-MEDIATED MECHANISMS IN PATIENTS TESTED POSITIVE FOR SARS-COV-2,ITALY,Recruiting,Università degli Studi dell'Insubria,"April 27, 2020",Observational,Study of Immune-mediated Mechanisms in Patients Tested Positive for SARS-CoV-2: Phenotypic and Functional Analysis of Monocytes and NK Cells in the Blood of Subjects Affected by Covid 19
1361,Colchicine in COVID-19: a Pilot Study,COVID,"February 08, 2021",308,NCT04375202,COLCHICINE 1 MG ORAL TABLET,ITALY,Recruiting,University Of Perugia,"April 18, 2020",Interventional,Treatment With COLchicine of Patients Affected by COVID-19: a Pilot Study
1362,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,CORONAVIRUS INDUCED DISEASE-2019 (COVID),"February 08, 2021",46,NCT04375397,IBRUTINIB; PLACEBO,UNITED STATES,Recruiting,AbbVie,"June 6, 2020",Interventional,IbrutiNib in SARS CoV-2 Induced Pulmonary Injury and Respiratory Failure (iNSPIRE)
1363,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,HAND ECZEMA; HAND DERMATITIS; COVID,"February 08, 2021",7000,NCT04375410,,DENMARK,Enrolling by invitation,Vendsyssel Hospital,"April 22, 2020",Observational,Re-opening of the Country and Dermal Consequences of Mandatory Intensified Handwash and Hand Disinfection Among a Danish Pediatric Population During the COVID19 Pandemic
1364,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,FEMORAL NECK FRACTURES; SARS-CoV2,"February 08, 2021",442,NCT04375501,"SURGERY: DYNAMIC HIP SCREW, HEMIARTHROPLASTY, HIP REPLACEMENT, INTRAMEDULLARY NAIL",UNITED KINGDOM,Completed,Barts & The London NHS Trust,"February 1, 2020",Observational,The Effects of Coronavirus on Perioperative Morbidity and Mortality in a High-risk Population: A Multicentre Cohort Study
1365,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),"COVID; STRESS, PSYCHOLOGICAL","February 08, 2021",1565,NCT04375644,QUESTIONNAIRES ON PSYCHOLOGICAL QUALITY OF LIFE,FRANCE,Completed,Hospices Civils de Lyon,"May 7, 2020",Observational,Impact of the COVID-19 Pandemic on the Quality of Psychological Life of Healthcare Professionals
1366,"Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial",EPIGENETIC AGING; IMMUNOSENESCENCE,"February 08, 2021",85,NCT04375657,TRIIM TREATMENT; ACTIVE CONTROL,UNITED STATES,Recruiting,"Intervene Immune, Inc.",October 2020,Interventional,"Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial"
1367,COVID19-FOIE National Observatory,LIVER DISEASES; COVID,"February 08, 2021",1000,NCT04375670,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 11, 2020",Observational,COVID19-FOIE National Observatory. An Ambispective Cohort Study of All Consecutive Patients
1368,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,COVID (NEW CORONAVIRUS) INFECTION,"February 08, 2021",60,NCT04375709,PHYSICAL EXERCISE; EDUCATION SESSIONS,SWITZERLAND,Recruiting,Kantonsspital Winterthur KSW,"March 15, 2020",Observational,Health-related Quality of Life (HRQOL) and Physical Performance in Individuals After COVID-19 Induced Hospitalisation and the Impact of a Standard Care Follow-up Program: a Longitudinal Observational Cohort Study
1369,London's Exogenous Surfactant Study for COVID19,"ARDS, HUMAN; COVID","February 08, 2021",20,NCT04375735,BOVINE LIPID EXTRACT SURFACTANT,,Not yet recruiting,Lawson Health Research Institute,"July 1, 2020",Interventional,Phase I/II Trial: Exogenous Surfactant Administration for Patients With COVID-19
1370,Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,ACUTE MYOCARDITIS,"February 08, 2021",400,NCT04375748,PERFORMING ROUTINE CARE (CLINICAL AND PARACLINICAL TESTS); EXAMINATIONS FOR THE RESEARCH:,FRANCE,Recruiting,"University Hospital, Toulouse","April 15, 2020",Observational,"Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 Cases During the Covid-19 Pandemic, Case Characteristics and Prognoses"
1371,COVID-19: Human Epidemiology and Response to SARS-CoV-2,CORONAVIRUS DISEASE 2019 (COVID); SARS-CoV2,"February 08, 2021",5605,NCT04375761,COLLECTION OF BIOLOGICAL SAMPLES; SYMPTOM AND EXPOSURE SURVEYS,UNITED STATES,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"May 1, 2020",Observational,Human Epidemiology and Response to SARS-CoV-2 (DAIT-COVID-19-001)
1372,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),COVID,"February 08, 2021",10,NCT04375774,FFP2; FACIAL MASK; MFS,BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,May 2020,Interventional,Verification of Alternative Do-it-yourself Equipment Respirators
1373,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,COVID; CORONAVIRUS INFECTION; CORONAVIRUS; VIRUS DISEASES; RNA VIRUS INFECTIONS,"February 08, 2021",240,NCT04376034,CONVALESCENT PLASMA 1 UNIT; CONVALESCENT PLASMA 2 UNITS; STANDARD OF CARE,UNITED STATES,Recruiting,West Virginia University,"April 16, 2020",Interventional,Convalescent Plasma Collection From Individuals That Recovered From COVID19 and Treatment of Critically Ill Individuals With Donor Convalescent Plasma
1374,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,COVID,"February 08, 2021",200,NCT04376398,,BELGIUM,Completed,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"April 6, 2020",Observational [Patient Registry],Survey on Patients With Suspected or Confirmed COVID-19 Requiring Anesthesia Care for Their Intervention
1375,Host-pathogen Interactions During SARS-CoV-2 Infection,"INFECTION, CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2","February 08, 2021",450,NCT04376476,BLOOD SAMPLE; LOW OR UPPER RESPIRATORY TRACT SAMPLE; STOOL COLLECTION OR FECAL SWAB; BLOOD SAMPLE FOR WHOLE GENOME SEQUENCING; PHONE CALL,FRANCE,Recruiting,Hospices Civils de Lyon,"May 5, 2020",Interventional,Host-pathogen Interactions During Paediatric and Adult SARS-CoV-2 Infection (COVID-19)
1376,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),ANXIETY,"February 08, 2021",300,NCT04376515,HOPE INTERVENTION,UNITED STATES,"Active, not recruiting","University of California, Irvine","March 20, 2020",Interventional,HOPE Intervention for COVID-19
1377,Use of the Nasal Cannula During COVID-19,COVID,"February 08, 2021",100,NCT04376580,,ARGENTINA,Enrolling by invitation,Tiva Group,"April 30, 2020",Observational,Incidence and Implications With the Use of Nasal Cannulas During COVID-19
1378,PET/CT Imaging in COVID-19 Patients,COVID; SARS-CoV2 INFECTION,"February 08, 2021",10,NCT04376593,18F-ΑVΒ6-BP,UNITED STATES,Enrolling by invitation,"University of California, Davis","May 1, 2020",Interventional,18F-αvβ6-binding-peptide PET/CT in Patients Post SARS CoV2 Infection
1379,Quality of Life and Long-term Outcomes After Hospitalization for COVID-19,QUALITY OF LIFE; LONG-TERM OUTCOMES; CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04376658,COVID-19,BRAZIL,Recruiting,Hospital Moinhos de Vento,"July 15, 2020",Observational,Assessment of Health-related Quality of Life and Long-term Outcomes After Hospitalization for COVID-19: A Multicenter Prospective Cohort Study
1380,Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",800,NCT04376684,OTILIMAB; PLACEBO; STANDARD OF CARE,ARGENTINA,"Active, not recruiting",GlaxoSmithKline,"May 28, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease"
1381,Surgical Telemedicine in the COVID-19 Pandemic Era,COVID; SURGERY,"February 08, 2021",180,NCT04376710,COMPLETION OF PRE-PANDEMIC SURVEY; COMPLETION OF SURVEY AFTER PEAK OF PANDEMIC; COMPLETION OF POST TELEMEDICINE ENCOUNTER SURVEY,UNITED STATES,Completed,"University of Colorado, Denver","July 1, 2020",Observational,Surgical Telemedicine in the COVID-19 Pandemic Era
1382,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,TRANSPLANTATION,"February 08, 2021",3602,NCT04376775,TRANSPLANT PATIENT,FRANCE,"Active, not recruiting","University Hospital, Bordeaux","May 11, 2020",Observational,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation
1383,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,COVID,"February 08, 2021",15,NCT04376788,EXCHANGE BLOOD TRANSFUSION FROM NORMAL DONOR; PLASMA FROM CONVALESCENT PATIENTS WITH COVID-19; METHYLENE BLUE 5 MG/ML,EGYPT,Recruiting,Ain Shams University,"May 20, 2020",Interventional,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19
1384,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,COVID; FAVIPIRAVIR; KALETRA; HYDROXYCHLOROQUINE; LOPINAVIR/RITONAVIR,"February 08, 2021",40,NCT04376814,FAVIPIRAVIR; HYDROXYCHLOROQUINE; LOPINAVIR / RITONAVIR,"IRAN, ISLAMIC REPUBLIC OF",Completed,Baqiyatallah Medical Sciences University,"March 29, 2020",Interventional,"The Regimen of Favipiravir Plus Hydroxychloroquine Can Accelerate Recovery of the COVID-19 Patients With Moderate Severity in Comparison to Lopinavir/Ritonavir Plus Hydroxychloroquine Regimen: an Open-label, Non-randomized Clinical Trial Study"
1385,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,SEVERE SARS-CoV2 PNEUMONIA,"February 08, 2021",270,NCT04376840,BLOOD SAMPLE AND DATA RECORD,FRANCE,Recruiting,CHU de Reims,"May 28, 2020",Interventional,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia
1386,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,COVID,"February 08, 2021",50,NCT04376853,APPLE WATCH SERIES 5,GERMANY,Recruiting,University Hospital Heidelberg,"April 15, 2020",Observational,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch
1387,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),COVID,"February 08, 2021",384,NCT04376879,DATA MONITORING FOR 48H WITHIN THE FIRST 24 HOURS OF ADMISSION FOR COVID-19,FRANCE,Recruiting,"Central Hospital, Nancy, France","May 16, 2020",Observational,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)
1388,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),COVID; PNEUMONIA; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",30,NCT04376905,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Assessment of Extra Vascular Lung Water and Pulmonary Permeability by Transpulmonary Thermodilution in Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
1389,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,CAREGIVERS; COVID,"February 08, 2021",300,NCT04376944,SURVEY,FRANCE,Recruiting,"University Hospital, Montpellier","April 1, 2020",Observational,Evaluating Effectiveness of Barrier Measures to Limit Nosocomial Transmission: Covid-19 Prevalence Survey Among Caregivers With Various Exposures
1390,Slovenian National COVID-19 Prevalence Study,COVID; SARS-CoV2,"February 08, 2021",3000,NCT04376996,NO INTERVENTION PLANNED DUE TO THE OBSERVATIONAL STUDY DESIGN - ONLY A DIAGNOSTIC TESTING,SLOVENIA,Recruiting,University of Ljubljana,"April 20, 2020",Observational,Slovenian National COVID-19 Prevalence Study
1391,The Role of Ultrasound in COVID-19,COVID,"February 08, 2021",1000,NCT04377035,,DENMARK,Recruiting,"University Hospital, Gentofte, Copenhagen","March 31, 2020",Observational,The ECHOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart and Lung by Ultrasound
1392,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,PARENTAL STRESS; DEPRESSION; ANXIETY,"February 08, 2021",2880,NCT04377074,,NORWAY,Completed,University of Oslo,"March 31, 2020",Observational,Parenting in a Pandemic: Parental Stress During the COVID-19 and Its Association With Depression and Anxiety
1393,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,ANXIETY; HEALTHY VOLUNTEERS,"February 08, 2021",5000,NCT04377100,COMPUTER TASK QUESTIONNAIRES,UNITED STATES,Recruiting,National Institute of Mental Health (NIMH),"February 11, 2021",Interventional,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses
1394,Innovative Tool to Limit Spread of SARS-CoV-2 (COVID 19) in Residential Aged Care Facilities,COVID; INFLUENZA; GASTROENTERITIS,"February 08, 2021",34,NCT04377165,GAMIFICATION; NEWSFEED FUNCTION,,Terminated,The University of Queensland,"May 6, 2020",Interventional,Innovative Tool to Limit Spread of SARS-CoV-2(COVID 19) in Residential Aged Care
1395,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,COVID; CYTOKINE STORM,"February 08, 2021",2000,NCT04377308,FLUOXETINE,UNITED STATES,Recruiting,University of Toledo Health Science Campus,"May 1, 2020",Interventional,Fluoxetine to Reduce Intubation and Death After COVID19 Infection
1396,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),ARDS; COVID,"February 08, 2021",40,NCT04377334,MSC,GERMANY,Not yet recruiting,University Hospital Tuebingen,October 2020,Interventional,Prospective Phase II Study: MSCs in Inflammation-Resolution Programs of SARS-CoV-2 Induced ARDS
1397,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,ANXIETY; DEPRESSION; PREGNANCY RELATED,"February 08, 2021",8500,NCT04377412,PANDEMIC CONTROL MEASURES,ALBANIA,Recruiting,"Żelazna Medical Centre, LLC","May 1, 2020",Observational,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic - a Web-based Cross-sectional Survey
1398,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,"NEUROLOGICAL DISEASES OR CONDITIONS; STROKE, ACUTE; SEIZURE DISORDER","February 08, 2021",0,NCT04377425,COVID-19 SWAP TEST PCR,DENMARK,Withdrawn,Aarhus University Hospital,"May 7, 2020",Observational,"COVID-19 Prevalence, Morbidity and Long Term Cognitive Deficits in Consecutive Patients Presenting With Acute Neurological Symptoms"
1399,COVID-19 - Quality of Life After Infection,COVID; QUALITY OF LIFE,"February 08, 2021",200,NCT04377464,"SF12, EQ-5D-5L AND WORK STATUS STANDARDIZED QUANTITATIVE ASSESSMENTS",,Not yet recruiting,Chinese University of Hong Kong,"May 5, 2020",Observational,COVID-19 - Quality of Life After Infection
1400,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),COVID,"February 08, 2021",30,NCT04377477,SINGLE FRACTION WHOLE LUNG RADIOTHERAPY,ITALY,Recruiting,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,"May 10, 2020",Interventional,Pilot Study on the Feasibility of Low Dose Radiotherapy for SARS-Cov-2 Pneumonitis (COVID-19 Low Dose Radiotherapy - COLOR 19)
1401,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,COVID; HEMOSTASIS; COAGULATION,"February 08, 2021",100,NCT04377490,VENOUS ULTRASOUND; BLOOD SAMPLE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","May 4, 2020",Observational,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
1402,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,CYTOKINE RELEASE SYNDROME; COVID,"February 08, 2021",40,NCT04377503,TOCILIZUMAB 180 MG/ML; METHYLPREDNISOLONE SODIUM SUCCINATE,,Not yet recruiting,Hospital Sao Domingos,May 2020,Interventional,Comparison of the Efficacy and Safety of Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19. A Prospective Randomized Controlled Phase II Trial
1403,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,HOSPITALIZED CHILDREN; COVID INFECTION,"February 08, 2021",100,NCT04377568,CONVALESCENT PLASMA (CP),CANADA,Recruiting,The Hospital for Sick Children,"October 7, 2020",Interventional,"A Randomized, Multicentered, Open-label Phase 2 Clinical Trial of the Safety and Efficacy of Human Coronavirus- Immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children"
1404,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",PUBLIC HEALTH; DEMOGRAPHY; PANDEMICS; CORONAVIRUS INFECTION; NEWS; GLOBAL HEALTH; PERCEPTION,"February 08, 2021",18251,NCT04377581,,UNITED STATES,Completed,Milton S. Hershey Medical Center,"April 9, 2020",Observational,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior"
1405,Haemoglobin Concentration on COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04377607,FILE SCANNING,TURKEY,Recruiting,Nevsehir Public Hospital,"November 1, 2020",Observational,An Important Index on Severity of Coronavirus Disease: Erythrocyte Haemoglobin Concentration
1406,Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),COVID,"February 08, 2021",500,NCT04377620,PLACEBO; RUXOLITINIB,RUSSIAN FEDERATION,Recruiting,Incyte Corporation,"May 24, 2020",Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)"
1407,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,SARS-CoV2; COVID,"February 08, 2021",660,NCT04377646,HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE (PLACEBO); ZINC; ZINC (PLACEBO),TUNISIA,Not yet recruiting,Military Hospital of Tunis,"May 4, 2020",Interventional,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers (COVID-Milit)
1408,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,COVID,"February 08, 2021",9,NCT04377659,TOCILIZUMAB,UNITED STATES,"Active, not recruiting",Memorial Sloan Kettering Cancer Center,"May 1, 2020",Interventional,A Phase II Study of IL-6 Receptor Antagonist Tocilizumab to Prevent Respiratory Failure and Death in Patients With Severe COVID-19 Infection
1409,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04377672,ANTI-SARS-COV-2 HUMAN CONVALESCENT PLASMA,UNITED STATES,Recruiting,Johns Hopkins University,"May 28, 2020",Interventional,Safety and Pharmacokinetics of Human Convalescent Plasma in High Risk Children Exposed or Infected With SARS-CoV-2
1410,Prediction of Clinical Course in COVID19 Patients,COVID,"February 08, 2021",800,NCT04377685,CT-SCAN,FRANCE,Recruiting,Centre Hospitalier Universitaire de Saint Etienne,"March 1, 2020",Observational,"Prediction of Clinical Course in COVID19 Patients Using Unsupervised Classification Approaches of Clinical, Biological and the Multiparametric Signature of the Chest CT Scan Performed at Admission"
1411,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,COVID,"February 08, 2021",400,NCT04377711,CICLESONIDE; PLACEBO,UNITED STATES,Recruiting,Covis Pharma S.à.r.l.,"June 8, 2020",Interventional,"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ciclesonide Metered-Dose Inhaler in Non-hospitalized Patients 12 Years of Age and Older With Symptomatic COVID-19 Infection"
1412,Spread and Course of COVID-19 Infections,COVID; VIRUS DISEASE,"February 08, 2021",3000,NCT04377724,,SWITZERLAND,"Active, not recruiting",Goldhahn Jörg,"April 27, 2020",Observational,Longitudinal Serological Study on the Spread and Course of COVID-19 Infections
1413,Incidence of Covid-19 in School Children,"INFECTION; VIRAL, CORONAVIRUS","February 08, 2021",0,NCT04377737,RT-PCR COVID-19,FRANCE,Withdrawn,Fondation Lenval,"May 15, 2020",Interventional,Incidence of Covid-19 in School Children During the Pandemic Period in Nice
1414,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,COVID PNEUMONIA,"February 08, 2021",500,NCT04377750,TOCILIZUMAB,ISRAEL,Recruiting,Hadassah Medical Organization,"April 8, 2020",Interventional,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation
1415,Developement and Evaluation of Serological Assays for COVID-19,COVID,"February 08, 2021",500,NCT04377763,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"July 15, 2020",Observational,Developement and Evaluation of Serological Assays for COVID-19
1416,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",KIDNEY TRANSPLANT; PANCREAS TRANPLANT; PANCREATIC ISLET TRANSPLANTATION,"February 08, 2021",644,NCT04377776,PRACTICE DETAILS,ITALY,Completed,IRCCS San Raffaele,"May 4, 2020",Observational,Observational Study to Assess the Health Status of Transplanted Patients (Kidney or Pancreas or Pancreatic Islet Transplantation) at Transplant Medicine Unit (MITRA) During the COVID-19 Pandemic
1417,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,COVID,"February 08, 2021",447,NCT04377789,QUERCETIN PROPHYLAXIS; QUERCETIN TREATMENT,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 20, 2020",Interventional,The Possible Effect of Quercetin on Prophylaxis and Treatment of COVID-19
1418,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,COVID,"February 08, 2021",400,NCT04377802,MOLECULAR TESTING FOR VIRUS RNA USING RT-PCR,SAUDI ARABIA,Not yet recruiting,King Fahad Specialist Hospital Dammam,"May 17, 2020",Interventional,"Safe Return to Regular Clinical Operation After COVID-19 Pandemic; (Oncology Center, Prospective Cohort)"
1419,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,COVID; ANOSMIA,"February 08, 2021",569,NCT04377815,GENERAL PUBLIC COHORT,UNITED KINGDOM,Completed,"University College, London","April 23, 2020",Observational,FORECAST Study: Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste
1420,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,CARDIOVASCULAR DISEASES; COVID,"February 08, 2021",300,NCT04377997,ENOXAPARIN,,Not yet recruiting,Massachusetts General Hospital,"May 15, 2020",Interventional,"A Randomized, Open-Label Trial of Therapeutic Anticoagulation in COVID-19 Patients With an Elevated D-Dimer"
1421,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,COVID; CYTOKINE STORM; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",18,NCT04378244,DELTAREX-G,,Not yet recruiting,Aveni Foundation,"January 12, 2021",Interventional,CORONA: A Phase 1/2 Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
1422,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,DEPRESSIVE SYMPTOMS; GENERALIZED ANXIETY,"February 08, 2021",70,NCT04378257,THERAPIST GUIDED E-THERAPY; SELF-HELP THERAPY,,Not yet recruiting,Sultan Qaboos University,"June 1, 2020",Interventional,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic: An Open-Label 12 - Weeks Randomized Controlled Trail
1423,Assessment of the Psycho-social Impact of COVID-19 Outbreak,SARS-CoV2; COVID; QUALITY OF LIFE; MENTAL HEALTH WELLNESS 1; SOCIAL DISTANCE; SARS (DISEASE); PSYCHOLOGICAL,"February 08, 2021",56442,NCT04378452,COM-COVID ANONIMOUS SURVEY,SPAIN,"Active, not recruiting",Fundació Institut Germans Trias i Pujol,"March 31, 2020",Observational [Patient Registry],Assessment of the Psycho-social Impact of COVID-19 Outbreak (COM-COVID)
1424,Mindfulness Takes Practice,STRESS; HABITS,"February 08, 2021",174,NCT04378530,PERSONALIZED ANCHORING STRATEGY; NON-ANCHORING STRATEGY CONTROL; FIXED ANCHORING STRATEGY,UNITED STATES,"Active, not recruiting",Arizona State University,"July 27, 2020",Interventional,Mindfulness Takes Practice: mHealth Tools for Building Persistent Mindfulness Meditation Habits
1425,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,"SARS-CoV2; RESPIRATORY DISTRESS SYNDROME, ADULT; CORONAVIRUS INFECTION; CRITICAL ILLNESS","February 08, 2021",1589,NCT04378582,RISK FACTORS,BRAZIL,Completed,University of Sao Paulo General Hospital,"May 7, 2020",Observational,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
1426,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,FOOD INSECURITY,"February 08, 2021",1000,NCT04378595,DURING COVID-19 PANDEMIC; AFTER COVID-19 PANDEMIC,UNITED STATES,Recruiting,University of Texas at Austin,"April 10, 2020",Observational,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin Federally Qualified Health Centers
1427,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,SARS-CoV2; END STAGE RENAL FAILURE ON DIALYSIS,"February 08, 2021",500,NCT04378686,DIALYSIS,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"April 23, 2020",Observational,A Comparative Study of Symptom-driven Surveillance vs. Cross-sectional Serological Screening of SARS-CoV-2 Infection of Patients With End-stage Kidney Disease Receiving Renal Replacement Therapy
1428,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),COVID; HYDROGEN/OXYGEN MIXED GAS; DYSPNEA,"February 08, 2021",90,NCT04378712,HYDROGEN OXYGEN GENERATOR WITH NEBULIZER; STANDARD-OF-CARE,CHINA,Completed,Guangzhou Institute of Respiratory Disease,"January 21, 2020",Interventional,"Effects of Hydrogen/Oxygen Mixed Gas Inhalation for Patients With Coronavirus Disease 2019 (COVID-19) Who Had Dyspnea: A Multicenter, Open-label Clinical Trial"
1429,Social Media and Covid19 Pandemic,SOCIAL MEDIA; CORONAVIRUS INFECTION,"February 08, 2021",212,NCT04378738,SURVEY,TURKEY,Enrolling by invitation,Acibadem University,"May 1, 2020",Interventional,The Role of Social Media as an Information Source in Covid19 Pandemic
1430,Immunophenotyping Assessment in a COVID-19 Cohort,CORONAVIRUS DISEASE 2019 (COVID); SARS-CoV2,"February 08, 2021",2000,NCT04378777,BIOLOGICAL SAMPLE COLLECTION; DATA COLLECTION: CLINICAL CARE ASSESSMENTS,UNITED STATES,Enrolling by invitation,National Institute of Allergy and Infectious Diseases (NIAID),"May 1, 2020",Observational,A Prospective Cohort Study to Assess Longitudinal Immune Responses in Hospitalized Patients With COVID-19 (DAIT-COVID-19-002)
1431,Mindfulness Training for Seniors,WELL AGING,"February 08, 2021",53,NCT04378803,MINDFULNESS TRAINING (MT) CONNECT,UNITED STATES,Completed,University of Miami,"May 13, 2020",Interventional,Mindfulness Training for Older Adults During the COVID-19 Pandemic
1432,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19",COVID; MEAN PLATELET VOLUME; PLATELET DESTRUCTION,"February 08, 2021",40,NCT04378829,"PLATELET COUNT, PLATELET, MEAN PLATELET VOLUME AND PLATELET DISTRIBUTION WIDTH IN COVID-19",TURKEY,Recruiting,Konya Training and Research Hospital,"September 12, 2020",Observational,"Does the Platelet Count, Mean Platelet Volume and Platelet Distribution Width Change in COVID-19 Pandemic, ?"
1433,COVID-19 and ICU-acquired MDR Bacteria,SARS-CoV2; CRITICAL ILLNESS,"February 08, 2021",690,NCT04378842,,FRANCE,Recruiting,"University Hospital, Lille","May 18, 2020",Observational,Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria
1434,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,COVID; DRUG EFFECT; DRUG INTERACTION; ADVERSE DRUG EVENT,"February 08, 2021",100,NCT04378881,,UNITED STATES,"Active, not recruiting",Tabula Rasa HealthCare,"June 1, 2020",Observational,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations
1435,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes","COVID, SEPSIS OR OTHER CAUSES; ACUTE RESPIRATORY DISTRESS SYNDROME","February 08, 2021",90,NCT04378920,LEAF-4L6715,FRANCE,Recruiting,Institut de cancérologie Strasbourg Europe,"April 14, 2020",Interventional,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes"
1436,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",50,NCT04379037,TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION,ARGENTINA,Recruiting,Nemechek Technologies,"June 27, 2020",Interventional,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients
1437,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress,"BURNOUT, PROFESSIONAL; PSYCHOLOGICAL DISTRESS","February 08, 2021",342,NCT04379063,COVID-19 PANDEMIC,CANADA,"Active, not recruiting",Jon Bailey,"May 13, 2020",Observational,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress Among Physicians (COPING Survey): A Longitudinal Survey
1438,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,COVID; LYMPHOCYTOPENIA,"February 08, 2021",48,NCT04379076,INTERLEUKIN-7; PLACEBOS,UNITED KINGDOM,Recruiting,Revimmune,"May 14, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection in UK"
1439,Neurologic Manifestations of COVID 19 in Children,COVID; NEUROLOGIC MANIFESTATIONS,"February 08, 2021",500,NCT04379089,OBSERVATIONAL STUDY ONLY,UNITED STATES,Recruiting,University of Pittsburgh,"April 29, 2020",Observational,Neurologic Manifestations of COVID 19 in Children
1440,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),COVID,"February 08, 2021",60,NCT04379154,VOLATILE ORGANIC COMPOUNDS ANALYSIS,FRANCE,Recruiting,Hopital Foch,"April 14, 2020",Interventional,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by (SARS-CoV-2): Predictive Interest in Short-term Evolution
1441,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,DIGESTIVE CANCER; GYNAECOLOGICAL CANCER; HEAD AND NECK CANCER,"February 08, 2021",112,NCT04379232,SCREENING TEST FOR COVID ( RT PCR AND CT CHEST),FRANCE,Completed,Hospices Civils de Lyon,"March 19, 2020",Observational,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center: A Retrospective Observational Cohort Study
1442,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,HIV; PRE-EXPOSURE PROPHYLAXIS,"February 08, 2021",4200,NCT04379245,"DATA RESEARCH, DATABASE ANALYSIS",FRANCE,Completed,Hospices Civils de Lyon,"April 30, 2020",Observational,Study of the Attack Rate of COVID-19 Infection in Patients Infected With HIV and/or on Pre-exposure Prophylaxis (PrEP) and Possible Impact of Treatment With an HIV Protease Inhibitor
1443,Analysis of Mortality of Critically Ill Patients With COVID-19,"COVID; CRITICAL ILLNESS; EFFECTIVENESS; OUTCOME, FATAL","February 08, 2021",650,NCT04379258,,,Not yet recruiting,Hospital Universitario Getafe,"May 11, 2020",Observational [Patient Registry],"Epidemiological Analysis of the Mortality of Critically Ill Patients With the COVID-19 Admitted to the Intensive Care Unit: An Observational, Prospective and Multicenter Study"
1444,"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",COVID,"February 08, 2021",230,NCT04379271,IMU-838; PLACEBO,BULGARIA,Recruiting,Immunic AG,"June 11, 2020",Interventional,"A Prospective, Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19"
1445,Risks of COVID19 in the Pregnant Population,COVID,"February 08, 2021",100,NCT04379284,BIOSPECIMEN COLLECTION,UNITED STATES,Recruiting,Mayo Clinic,"May 8, 2020",Observational,Risks of COVID19 in the Pregnant Population
1446,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),COVID,"February 08, 2021",1800,NCT04379297,,LUXEMBOURG,"Active, not recruiting",Luxembourg Institute of Health,"April 10, 2020",Observational,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE)
1447,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),COVID,"February 08, 2021",54,NCT04379310,ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS,TURKEY,Completed,Nisantasi University,"May 1, 2020",Observational,Evaluation of Demographic and Clinical Parameters on Admission and Medications Used for Comorbidities in Patients With Covid-19 Pneumonia: A Single Center Experience in Turkey
1448,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,COVID; SARS-CoV2,"February 08, 2021",500,NCT04379336,BACILLE CALMETTE-GUÉRIN (BCG); PLACEBO COMPARATOR,SOUTH AFRICA,Recruiting,TASK Applied Science,"May 4, 2020",Interventional,"Reducing Morbidity and Mortality in Health Care Workers Exposed to SARS-CoV-2 by Enhancing Non-specific Immune Responses Through Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial"
1449,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,HEALTH BEHAVIOR; COVID,"February 08, 2021",45,NCT04379375,NUDGE,UNITED STATES,Terminated,Medical College of Wisconsin,"July 27, 2020",Interventional,Using Behavioral Nudges to Improve Preventive Health Behaviors That Limit COVID-19 Spread
1450,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),COVID,"February 08, 2021",1500,NCT04379440,,ITALY,Recruiting,Raffaele Antonelli Incalzi,"April 25, 2020",Observational [Patient Registry],"Geriatric Population COVID-19 Syndromic Characteristics and Clinical Outcomes: a Multi-setting, Multi-domain Observational Study (GEROCOVID Observational)"
1451,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,CORONARY ARTERY DISEASE,"February 08, 2021",10,NCT04379453,ROBOT ASSISTED PERCUTANEOUS CARDIOVASCULAR INTERVENTION,BRAZIL,Recruiting,Hospital Israelita Albert Einstein,"April 27, 2020",Interventional,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses
1452,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,COVID,"February 08, 2021",60,NCT04379466,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 5, 2020",Observational,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19
1453,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),COVID; SARS-CoV2 INFECTION,"February 08, 2021",562,NCT04379479,DIALYZABLE LEUKOCYTE EXTRACT; PLACEBO ORAL,MEXICO,Not yet recruiting,"National Polytechnic Institute, Mexico",May 2020,Interventional,Assessment of the Clinical Effect of Dialyzable Leukocyte Extracts in Individuals With Acute Respiratory Infection (Suspected or Confirmed Cases of COVID-19) (FUTURE-T)
1454,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,COVID; COVID; SARS-CoV2; SARS-CoV2,"February 08, 2021",0,NCT04379492,HYDROXYCHLOROQUINE; PLACEBO,UNITED STATES,Withdrawn,Memorial Sloan Kettering Cancer Center,"May 5, 2020",Interventional,"Single-center, Phase II, Randomized Double-blind, Placebo-controlled Study of Hydroxychloroquine Compared to Placebo as Treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection"
1455,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,MALIGNANT NEOPLASM; SARS CORONAVIRUS 2 INFECTION,"February 08, 2021",44,NCT04379518,RECOMBINANT INTERFERON ALFA-2B; RINTATOLIMOD,UNITED STATES,Recruiting,Roswell Park Cancer Institute,"September 4, 2020",Interventional,Phase 1/2A Study of Rintatolimod and IFN-Alpha Regimen in Cancer Patients With Mild or Moderate COVID-19 Infection
1456,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,PNEUMONIA; CORONAVIRUS INFECTION,"February 08, 2021",230,NCT04379531,LOW-DOSE CHEST CT,RUSSIAN FEDERATION,Completed,Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department,"April 25, 2020",Interventional,Low-dose Computed Tomography in COVID-19 Pneumonia: a Prospective Moscow Study
1457,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,CORONAVIRUS; RESPIRATORY FAILURE,"February 08, 2021",125,NCT04379544,OBSERVATION ONLY,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"April 23, 2020",Observational [Patient Registry],Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19
1458,"Diet, Body Composition, Lifestyle and Cardiovascular Health of Healthy and Active Adults From Slovenia","DIET, HEALTHY; BODY WEIGHT; TIME RESTRICTED FEEDING; SLEEP; CARDIOVASCULAR RISK FACTOR; MOTIVATION","February 08, 2021",93,NCT04379622,"DIETARY INTAKE, BODY COMPOSITION, LIFESTYLE, AND CVD RISK FACTORS",SLOVENIA,Completed,Barbara Jakše s.p.,"May 22, 2020",Observational,"Differences in Dietary Intake, Body Composition, Lifestyle and Various Cardiovascular Diseases Risk Factors Among Healthy and Active Vegetrians and Non Vegetarians"
1459,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,MS (MULTIPLE SCLEROSIS); COVID; SUPPORT GROUPS,"February 08, 2021",32,NCT04379661,ONLINE SUPPORT GROUP,UNITED STATES,Completed,Columbia University,"May 7, 2020",Interventional,SUNLIGHT Study: Online Support Groups for Multiple Sclerosis (MS) to Address COVID-19
1460,Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device,BLOOD PRESSURE,"February 08, 2021",30,NCT04379986,SENSBIOSYS,SWITZERLAND,Not yet recruiting,"Stéphane Cook, Prof","May 1, 2020",Interventional,Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device
1461,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,COVID; VIRAL PNEUMONIA,"February 08, 2021",60,NCT04380376,MELPHALAN; STANDARD OF CARE,RUSSIAN FEDERATION,Recruiting,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute","April 30, 2020",Interventional,"Single-center, Prospective, Open-label, Comparator Study, Blind for Central Accessor to Access the Efficacy, Safety, and Tolerability of Inhalations of Low-doses of Melphalan in Patients With Pneumonia With Confirmed or Suspected COVID-19"
1462,Atorvastatin as Adjunctive Therapy in COVID-19,COVID,"February 08, 2021",300,NCT04380402,ATORVASTATIN,,Not yet recruiting,Mount Auburn Hospital,"May 20, 2020",Interventional,Prospective Randomized Open-label Trial of Atorvastatin as Adjunctive Treatment of COVID-19
1463,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),COVID,"February 08, 2021",372,NCT04380519,RPH-104 80 MG; OLOKIZUMAB 64 MG; PLACEBO,RUSSIAN FEDERATION,Completed,"R-Pharm International, LLC","April 23, 2020",Interventional,"An International, Multicenter, Randomized, Double-blind, Adaptive Placebo-controlled Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe SARS-CoV-2 Infection (COVID-19)"
1464,Tableted COVID-19 Therapeutic Vaccine,COVID,"February 08, 2021",20,NCT04380532,V-SARS,CANADA,"Active, not recruiting",Immunitor LLC,"May 15, 2020",Interventional,Clinical Trial of COVID-19 Therapeutic Vaccine Formulated as an Oral Pill
1465,Risk Factors Worsening COVID19 for Out-patient With Home Monitoring,COVID,"February 08, 2021",800,NCT04380662,RISK FACTORS,FRANCE,Not yet recruiting,"University Hospital, Grenoble","June 30, 2020",Observational,RRisk Factors Worsening COVID19 (Coronavirus Infectious Disease 2019) for Outpatient With Home Monitoring (COVID-A-DOMEVA Study)
1466,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,COVID,"February 08, 2021",62,NCT04380688,ACALABRUTINIB,UNITED STATES,Completed,AstraZeneca,"June 13, 2020",Interventional,"A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19"
1467,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults,"INFECTIONS, RESPIRATORY; VIRUS DISEASES; INFECTION VIRAL; VACCINE ADVERSE REACTION; RNA VIRUS INFECTIONS; PROTECTION AGAINST COVID AND INFECTIONS WITH SARS COV 2","February 08, 2021",456,NCT04380701,BNT162A1; BNT162B1; BNT162B2; BNT162C2,GERMANY,Recruiting,BioNTech SE,"April 23, 2020",Interventional,"A Multi-site, Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of Four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-2019 Using Different Dosing Regimens in Healthy and Immunocompromised Adults"
1468,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,PEOPLE INCARCERATED; COVID,"February 08, 2021",700,NCT04380714,,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,Changes in the Consumption of Psychoactive Substances by People Incarcerated at the Villeneuve-Lès-Maguelone Prison During Containment Linked to COVID-19.
1469,Almitrine and COVID-19 Related Hypoxemia,COVID; HYPOXIC RESPIRATORY FAILURE,"February 08, 2021",17,NCT04380727,,FRANCE,Completed,"Central Hospital, Nancy, France","March 20, 2020",Observational [Patient Registry],Almitrine and Severe COVID-19 Patients in ICU [Almitrine et Patients COVID-19 en Reanimation (French)]
1470,Covid-19 Pandemic and Pancreatic Surgery in Italy,PANCREATIC CANCER,"February 08, 2021",730,NCT04380766,EVALUATION OF CHANGES IN THE DIAGNOSTIC-THERAPEUTIC PATHWAY FOR PATIENTS AFFECTED BY PANCREATIC CANCER,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"January 1, 2019",Observational [Patient Registry],Effects of Covid-19 Pandemic on Pancreatic Surgery in Italy. A Multicenter Observational Clinical Study
1471,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,COVID,"February 08, 2021",2430,NCT04380779,,SPAIN,Completed,Manuel Monreal,"April 13, 2020",Observational,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses (BLEEDING Study)
1472,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,COVID,"February 08, 2021",2497,NCT04380792,,SPAIN,Completed,Manuel Monreal,"April 13, 2020",Observational,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital (SCREENING Study)
1473,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,"PNEUMONIA, VIRAL","February 08, 2021",106,NCT04380818,LOW-DOSE RADIOTHERAPY; HYDROXYCHLOROQUINE SULFATE; RITONAVIR/LOPINAVIR; TOCILIZUMAB INJECTION [ACTEMRA]; AZITHROMYCIN; CORTICOSTEROID; LOW MOLECULAR WEIGHT HEPARIN; OXYGEN SUPPLY,SPAIN,Recruiting,Grupo de Investigación Clínica en Oncología Radioterapia,"June 5, 2020",Interventional,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19: Multi-central Prospective Study
1474,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04380870,CHINESE HERBAL MEDICINE,UNITED STATES,Recruiting,Center for Integrated Care,"April 11, 2020",Observational,"Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Descriptive, Longitudinal, Pragmatic Cohort Study"
1475,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),SARS-CoV2 INFECTION,"February 08, 2021",1000,NCT04380896,BLOOD TEST; STANDARDISED QUESTIONNAIRES,UNITED KINGDOM,Recruiting,Great Ormond Street Hospital for Children NHS Foundation Trust,"April 27, 2020",Observational,COVID-19 Staff Testing of Antibody Responses Study (CO-STARS)
1476,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,"PSYCHOLOGICAL DISTRESS; ADJUSTMENT, PSYCHOLOGICAL; CORONAVIRUS","February 08, 2021",80,NCT04380909,INTERNET-BASED SELF-HELP; INTERNET-BASED SELF-HELP AFTER 3 WEEKS,SWITZERLAND,Recruiting,University of Bern,"May 6, 2020",Interventional,Randomized Controlled Trial (RCT) to Evaluate the Efficacy of an Internet-based Self-help Program for People With Psychological Distress Due to Covid-19
1477,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",60,NCT04380935,CONVALESCENT PLASMA; STANDARD OF CARE,INDONESIA,Recruiting,Indonesia University,"May 18, 2020",Interventional,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome in Referral Hospitals in Indonesia
1478,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,SEVERE OR CRITICAL CONFIRMED CORONAVIRUS DISEASE (COVID)-19,"February 08, 2021",270,NCT04380961,SIRUKUMAB; PLACEBO; STANDARD OF CARE (SOC),UNITED STATES,Recruiting,"Janssen Pharmaceutica N.V., Belgium","April 24, 2020",Interventional,"Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical COVID-19 Disease"
1479,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,COVID,"February 08, 2021",200,NCT04380987,BIOLOGICAL SAMPLING,LUXEMBOURG,Recruiting,Luxembourg Institute of Health,"May 4, 2020",Observational,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis
1480,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,CHRONIC PAIN,"February 08, 2021",170,NCT04381000,EXERCISE GROUP,GREECE,Completed,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,"April 1, 2020",Interventional,The Impact of Quarantine and the Effectiveness of Telerehabilitation in Patients With Chronic Pain During COVID-19 Pandemic.
1481,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),COVID,"February 08, 2021",4,NCT04381013,EMERGENCY VENTILATOR SPLITTER,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,Emergency Ventilator Splitting Between Two or More Patients Using a Single Ventilator to Address Critical Ventilator Shortages During a Pandemic
1482,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,COVID,"February 08, 2021",30,NCT04381052,CLAZAKIZUMAB; PLACEBO,UNITED STATES,Not yet recruiting,Columbia University,May 2020,Interventional,A Randomized Placebo-Controlled Safety and Dose-Finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
1483,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,COVID; PERIODONTAL DISEASES,"February 08, 2021",1000,NCT04381273,NO INTERVENTION,GERMANY,Recruiting,Heidelberg University,"May 8, 2020",Observational,Oral Health and Psychosocial Factors During the Covid-19 Pandemic
1484,Transpulmonary Driving Pressure in ARDS COVID19 Patients,MECHANICAL VENTILATION; SARS-CoV2; COVID,"February 08, 2021",40,NCT04381286,,FRANCE,Recruiting,"University Hospital, Montpellier","April 1, 2019",Observational,Transpulmonary Driving Pressure in ARDS COVID19 Patients / TRANSPULMONARY-COVID19
1485,Direct and Indirect Impact of COVID-19 In Older Populations,RISK FACTORS FOR COVID OUTCOMES IN ELDERLY POPULATIONS,"February 08, 2021",1000,NCT04381312,,FRANCE,Recruiting,"University Hospital, Grenoble","April 9, 2020",Observational,COVID-19 Chez la Personne âgée de Plus de 70 Ans : Impact Direct et Indirect à 3 Mois.
1486,Rehabilitation for People With COVID-19 in ICU,CORONA VIRUS DISEASE 19 (COVID); COVID; ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS); CRITICAL ILLNESS,"February 08, 2021",92,NCT04381338,PULMONARY AND MOTOR REHABILITATION,ITALY,Not yet recruiting,University of Padova,"May 10, 2020",Interventional,Pulmonary and Motor Rehabilitation for People With COVID-19 in Intensive Care Units to Reduce Length of Stay in Hospital
1487,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,COVID,"February 08, 2021",50,NCT04381351,,GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","April 16, 2020",Observational,The Role of Noncoding RNAs in COVID-19 and COVID-19 Associated Acute Kidney Injury (MiRCOVID)
1488,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),"COVID; PNEUMONIA, VIRAL; SARS-CoV2","February 08, 2021",446,NCT04381364,CICLESONIDE INHALATION AEROSOL,SWEDEN,Recruiting,"Ola Blennow, MD, PhD","May 29, 2020",Interventional,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
1489,Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19,"INFECTIONS, CORONAVIRUS","February 08, 2021",394,NCT04381377,AZOXIMER BROMIDE; PLACEBO,RUSSIAN FEDERATION,Recruiting,NPO Petrovax,"April 29, 2020",Interventional,"A Multi-centre, Adaptive, Randomized, Double-blind, Placebo-controlled Comparative Clinical Study of the Safety and Efficacy of Polyoxidonium®, Lyophilizate for Solution for Injections and Topical Application, 6 mg (NPO Petrovax Pharm LLC, Russia) in Patients With Coronavirus Disease (COVID-19)."
1490,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",1000,NCT04381819,SARS-COV-2 PCR,NORWAY,Recruiting,Oslo University Hospital,"March 2, 2020",Observational,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of Inpatients During the COVID-19 Outbreak: A Prospective Cohort Study"
1491,Immunity and Infections in the Psychiatric Population,COVID; PSYCHIATRIC DISORDERS,"February 08, 2021",200,NCT04381845,COVID19 IMMUNIZATION TESTING,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"December 10, 2020",Interventional,Immunity and COVID Infections in the Psychiatric Population
1492,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",196,NCT04381858,PLASMA FROM COVID-19 CONVALESCENT PATIENT; HUMAN IMMUNOGLOBULIN,MEXICO,Completed,Centenario Hospital Miguel Hidalgo,"May 6, 2020",Interventional,Efficacy and Safety of Convalescent Plasma vs Human Immunoglobulin for the Treatment of COVID-19 Pneumonia: A Randomized Controlled Trial
1493,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,COVID,"February 08, 2021",110,NCT04381871,ACACIA SENEGAL; PECTIN,SUDAN,Not yet recruiting,Al-Neelain University,"June 1, 2020",Interventional,"Phase II ,III Randomized Double Blind Parallel Arms Clinical Trial of Potential Role of Gum Arabic ( Acacia Senegal) as Immunomodulatory Agent Among COVID 19 Patients in Sudan"
1494,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,COVID DRUG TREATMENT,"February 08, 2021",45,NCT04381884,IVERMECTIN (IVER P®) ARM WILL RECEIVE IVM 600 ΜG / KG ONCE DAILY PLUS STANDARD CARE. CONTROL ARM WILL RECEIVE STANDARD CARE.,ARGENTINA,Completed,Laboratorio Elea Phoenix S.A.,"May 18, 2020",Interventional,"A Pilot, Proof of Concept Trial to Prove Ivermectin Efficacy in the Reduction of SARS-CoV-2 Replication at Early Stages of COVID-19"
1495,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HYPOXEMIC RESPIRATORY FAILURE; PNEUMONIA, VIRAL; COVID","February 08, 2021",200,NCT04381923,HELMET CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP); HIGH FLOW NASAL OXYGEN (HFNO),UNITED STATES,Not yet recruiting,University of Pennsylvania,"February 15, 2021",Interventional,High Flow Nasal Oxygen Versus Continuous Positive Airway Pressure Helmet Evaluation: A Randomized Crossover Trial in COVID-19 Pneumonia
1496,Randomised Evaluation of COVID-19 Therapy,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",20000,NCT04381936,LOPINAVIR-RITONAVIR; CORTICOSTEROID; HYDROXYCHLOROQUINE; AZITHROMYCIN; CONVALESCENT PLASMA; TOCILIZUMAB; IMMUNOGLOBULIN; SYNTHETIC NEUTRALISING ANTIBODIES; ASPIRIN; COLCHICINE,UNITED KINGDOM,Recruiting,University of Oxford,"March 19, 2020",Interventional,Randomised Evaluation of COVID-19 Therapy
1497,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),COVID,"February 08, 2021",800,NCT04381962,AZITHROMYCIN CAPSULE,UNITED KINGDOM,Recruiting,University of Oxford,"May 29, 2020",Interventional,A Multi-centre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID-19 (ATOMIC2)
1498,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,COVID; CANCER,"February 08, 2021",132,NCT04381988,HYDROXYCHLOROQUINE; PLACEBO; RADIATION THERAPY,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"May 7, 2020",Interventional,A Phase II Randomized Double-Blind Placebo-Controlled Clinical Trial Of Hydroxychloroquine For Prophylaxis Against Covid-19 In Patients Receiving Radiotherapy (COVID)
1499,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",COVID; CORONAVIRUS INFECTION; SARS-CoV2; CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",50,NCT04382040,ARTEMIC; PLACEBO,INDIA,Recruiting,MGC Pharmaceuticals d.o.o,"May 8, 2020",Interventional,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19"
1500,Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,"COVID PNEUMONIA, IMPAIRED RESPIRATORY FUNCTION","February 08, 2021",143,NCT04382053,DFV890; STANDARD OF CARE (SOC),ARGENTINA,Completed,Novartis Pharmaceuticals,"May 27, 2020",Interventional,"Phase 2, Randomized, Controlled, Open Label Multi-center Study to Assess Efficacy and Safety of DFV890 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients With Coronavirus Disease 2019 (COVID-19) Pneumonia and Impaired Respiratory Function"
1501,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,COVID,"February 08, 2021",46,NCT04382066,PLITIDEPSIN 1.5 MG/DAY; PLITIDEPSIN 2.0 MG/DAY; PLITIDEPSIN 2.5 MG/DAY,SPAIN,Completed,PharmaMar,"May 12, 2020",Interventional,"Multicenter, Randomized, Parallel and Proof of Concept Study to Evaluate the Safety Profile of Three Doses of Plitidepsin in Patients With COVID-19 Requiring Hospitalization"
1502,Co-infection Management in COVID-19 Critically Ill,COVID,"February 08, 2021",32,NCT04382092,FILMARRAY PNEUMONIA,BELGIUM,Completed,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"March 23, 2020",Interventional,Co-infections in COVID-19 Critically Ill and Antibiotic Management
1503,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),UPPER RESPIRATORY TRACT INFECTIONS; VIRUS; COVID; VIRUS SHEDDING; VIRUS DISEASES,"February 08, 2021",405,NCT04382131,NACL SOLUTION,UNITED KINGDOM,Recruiting,University of Edinburgh,"June 23, 2020",Interventional,Hypertonic Saline Nasal Irrigation and Gargling for Suspected or Confirmed COVID-19: Pragmatic Web-based Bayesian Adaptive Randomised Controlled Trial (ELVIS COVID-19)
1504,Impact of COVID-19 on Mental Health of Health Care Workers,MENTAL HEALTH; QUALITY OF LIFE,"February 08, 2021",497,NCT04382196,ONLINE SURVEY,BELGIUM,"Active, not recruiting","University Hospital, Ghent","April 17, 2020",Observational,The Impact of the COVID-19 Pandemic on Mental Health and Quality of Life of Healthcare Workers in a University Hospital
1505,Non-invasive Ventilatory Support of Patients Affected by COVID-19,COVID,"February 08, 2021",900,NCT04382235,NON-INVASIVE VENTILATORY SUPPORT,ITALY,"Active, not recruiting",University of Milano Bicocca,"March 26, 2020",Observational,Management Through Non-invasive Ventilatory Support of Patients Showing an Acute Respiratory Failure Related to COVID-19 in Non-intensive Wards
1506,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,"COVID; CORONAVIRUS INFECTION; RESPIRATORY FAILURE; RESPIRATORY DISTRESS SYNDROME, ADULT; ARDS, HUMAN; SARS (SEVERE ACUTE RESPIRATORY SYNDROME)","February 08, 2021",20,NCT04382391,GAMMACORE® SAPPHIRE (NON-INVASIVE VAGUS NERVE STIMULATOR); STANDARD OF CARE THERAPIES,UNITED STATES,Recruiting,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),"May 8, 2020",Interventional,"A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)"
1507,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,COVID; CRITICAL ILLNESS,"February 08, 2021",57,NCT04382417,OBSERVATIONAL STUDY,SWEDEN,Completed,Region Västmanland,"March 26, 2020",Observational,Characteristics and Outcomes of Critically Ill Patients With Covid-19 in a Large Swedish County Hospital - a Prospective Observational Cohort Study
1508,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,COVID,"February 08, 2021",48,NCT04382469,,EGYPT,Completed,Alexandria University,"February 1, 2020",Observational,Egyptian Initial Experience About 2019 Novel Corona Virus Disease (COVID-19): Single-center Study Analysis of 48 Patients in Alexandria-Egypt Regarding Radiological Patterns and Co-morbid Lung Diseases
1509,The Impact of COVID-19 Pandemic on Cancer Care,CANCER,"February 08, 2021",400,NCT04382495,SURVEY,EGYPT,Recruiting,El Zaitoun Specialized Hospital,"June 15, 2020",Observational,The Impact of COVID-19 Pandemic on Cancer Care From Patients' and Survivors' Perspective
1510,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,"IMMUNE SUPPRESSION; IMMUNE DEFICIENCY; INFECTION; COVID; CHILDREN, ADULT","February 08, 2021",1500,NCT04382508,QUESTIONNAIRE,UNITED KINGDOM,Enrolling by invitation,University Hospital Southampton NHS Foundation Trust,"March 22, 2020",Observational,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.
1511,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,COVID; RESPIRATORY REHABILITATION; CROSS-SECTIONAL STUDY; COHORT STUDY,"February 08, 2021",300,NCT04382534,RESPIRATORY REHABILITATION,CHINA,Recruiting,Peking University Third Hospital,"March 10, 2020",Observational,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction
1512,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,"COVID; COVID; CORONAVIRUS; PNEUMONIA; PNEUMONIA, VIRAL; PNEUMONIA, INTERSTITIAL; SARS-CoV2","February 08, 2021",40,NCT04382547,ALLOGENIC POOLED OLFACTORY MUCOSA-DERIVED MESENCHYMAL STEM CELLS; STANDARD TREATMENT ACCORDING TO THE CLINICAL PROTOCOLS,BELARUS,Enrolling by invitation,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,"May 11, 2020",Interventional,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells
1513,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,"BEHAVIOR, SOCIAL; AUTONOMIC IMBALANCE","February 08, 2021",69,NCT04382560,DEEP BREATHING TRAINING; COMPASSION FOCUSED INTERVENTION,ITALY,Completed,University of Parma,"May 2, 2020",Interventional,Resting Heart Rate Variability as a Predictor of Coping Strategies and Responsiveness to a Brief Online Intervention During Forced Quarantine
1514,Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,COVID PULMONARY COMPLICATIONS; COVID,"February 08, 2021",52,NCT04382586,ZANUBRUTINIB; SUPPORTIVE CARE; PLACEBO,BRAZIL,Recruiting,BeiGene,"July 6, 2020",Interventional,"A Phase 2, Randomized, Double Blind, Placebo-Controlled Study of Zanubrutinib Treatment in Patients Hospitalized for COVID-19 Infection and Pulmonary Distress"
1515,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,SARS-CoV2 PNEUMONIA; COVID,"February 08, 2021",0,NCT04382625,HYDROXYCHLOROQUINE,UNITED STATES,Withdrawn,Kootenai Health,October 2020,Interventional,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
1516,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,"COVID PNEUMONIA, IMPAIRED RESPIRATORY FUNCTION","February 08, 2021",140,NCT04382651,MAS825; MATCHING PLACEBO,UNITED STATES,"Active, not recruiting",Novartis Pharmaceuticals,"June 7, 2020",Interventional,"A Phase 2, Randomized, Placebo-controlled, Participant and Investigator Blinded, Multi-center Study to Assess Efficacy and Safety of MAS825 for the Treatment of SARS-CoV-2 Infected Patients With COVID-19 Pneumonia and Impaired Respiratory Function"
1517,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,COVID PNEUMONIA,"February 08, 2021",80,NCT04382729,NEUROMUSCULAR ELECTRICAL STIMULATION; PHYSICAL THERAPY EXERCISE,ITALY,Recruiting,"University of Turin, Italy","April 17, 2020",Interventional,Effects of Neuromuscular Electrical Stimulation Therapy on Physical Function in Patients With COVID-19 Associated Pneumonia: Study Protocol of a Randomized Controlled Trial
1518,Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,COVID,"February 08, 2021",81,NCT04382755,ZILUCOPLAN®; PLACEBO,BELGIUM,"Active, not recruiting","University Hospital, Ghent","May 22, 2020",Interventional,"A Prospective, Randomized, Open-label, Interventional Study to Investigate the Efficacy of Complement C5 Inhibition With Zilucoplan® in Improving Oxygenation and short-and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure"
1519,Inhaled Ibuprofen to Treat COVID-19,CORONAVIRUS INFECTION; RESPIRATORY DISEASE; SARS (DISEASE),"February 08, 2021",40,NCT04382768,INHALED HYPERTONIC IBUPROFEN,ARGENTINA,Recruiting,Química Luar SRL,"May 1, 2020",Interventional,"Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19."
1520,Immunosupressive Treatment in COVID-19 Patients,COVID INFECTION,"February 08, 2021",500,NCT04382781,NO-IMMUNOSUPPRESSIVE; IMMUNOSUPPRESSIVE; IMMUNOGLUBULINS,SPAIN,Recruiting,Spanish Network for Research in Infectious Diseases,May 2020,Observational,Effect of Immunosupressive Treatment in COVID-19 Patients Whit SAM-LIKE Profile: Retrospective Cohort Study (SAM-COVID Project)
1521,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,COVID,"February 08, 2021",338,NCT04382794,RETROSPECTIVE CASE-CONTROL ANALYSIS,ITALY,Completed,University of Milan,"May 14, 2020",Observational,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients: Retrospective Study
1522,Novel Regimens in COVID-19 Treatment,COVID; CORONAVIRUS INFECTION,"February 08, 2021",160,NCT04382846,NITAZOXANIDE,EGYPT,Recruiting,Tanta University,"May 8, 2020",Interventional,Nitazoxanide in Treatment of COVID-19
1523,Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,COVID,"February 08, 2021",682,NCT04382924,NP-120 (IFENPRODIL),AUSTRALIA,"Active, not recruiting",Algernon Pharmaceuticals,"August 5, 2020",Interventional,A Randomized Open Label Phase 2b/3 Study of the Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease
1524,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,COVID,"February 08, 2021",24,NCT04382950,RECOMBINANT BACTERIAL ACE2 RECEPTORS -LIKE ENZYME OF B38-CAP (RBACE2) PLUS AEROSOLIZED 13 CIS RETINOIC ACID,,Not yet recruiting,Kafrelsheikh University,July 2020,Interventional,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2
1525,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),COVID,"February 08, 2021",20,NCT04383002,NITRIC OXIDE,CANADA,Recruiting,"University Health Network, Toronto","September 2, 2020",Interventional,Use of High Dose Inhaled Nitric Oxide in Intubated Patients Admitted With COVID-19
1526,Surveillance of Individuals Following SARS-CoV-2 Infection,COVID,"February 08, 2021",1050,NCT04383444,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"July 7, 2020",Observational,Surveillance of Individuals Following SARS-CoV-2 Infection
1527,Covid-19 Triage Using Camera-based AI,CORONAVIRUS INFECTION,"February 08, 2021",214,NCT04383457,RIA-DEVICE (REMOTE INVESTIGATION AND ASSESSMENT),SWEDEN,Completed,Vastra Gotaland Region,"June 15, 2020",Observational [Patient Registry],Covid-19 Triage Using Camera-based AI
1528,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,MENTAL HEALTH WELLNESS 1; PANDEMIC,"February 08, 2021",100000,NCT04383470,,GREECE,Recruiting,University of Padova,"April 26, 2020",Observational,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic
1529,"CoV-ICU Score, Intensive Care Unit, SARS-CoV-2",CORONAVIRUS AS THE CAUSE OF DISEASES CLASSIFIED ELSEWHERE,"February 08, 2021",100,NCT04383483,COVICU,TURKEY,Recruiting,Bursa Yüksek İhtisas Education and Research Hospital,"June 15, 2020",Observational,CoV-ICU Score: Who Will Need Intensive Care in the Course of Corona Virus Disease?
1530,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,SARS VIRUS; SARS-CoV2; COVID,"February 08, 2021",333,NCT04383535,CONVALESCENT SARS COVID-19 PLASMA; PLACEBO,ARGENTINA,Completed,Hospital Italiano de Buenos Aires,"May 15, 2020",Interventional,"Randomized, Double-blind, Placebo-controlled Clinical Trial of Convalescent Plasma for the Treatment of COVID-19 Pneumonia With Severity Criteria"
1531,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,COVID,"February 08, 2021",100,NCT04383548,HYPER IMMUNOGLOBULINS CONTAINING ANTI-CORONA VS2 IMMUNOGLOBULIN,,Not yet recruiting,Assiut University,"June 1, 2020",Interventional,Randomized Prospective Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma in Prevention of Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients
1532,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),COVID,"February 08, 2021",422,NCT04383574,"TWO DOSES OF LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,28; TWO DOSES OF MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,28; TWO DOSES OF HIGH DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,28; TWO DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0,28",CHINA,"Active, not recruiting","Sinovac Research and Development Co., Ltd.","May 22, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged ≥60 Years"
1533,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,SARS-CoV2; COVID,"February 08, 2021",300,NCT04383587,SEROLOGIC TESTING,UNITED STATES,Completed,Mayo Clinic,"May 6, 2020",Interventional,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
1534,Prone Positioning for Patients on General Medical Wards With COVID19,COVID; ARDS,"February 08, 2021",350,NCT04383613,PRONE POSITIONING,CANADA,Recruiting,Unity Health Toronto,"May 15, 2020",Interventional,Prone Positioning for Patients on General Medical Wards With COVID19: A Multicenter Pragmatic Randomized Trial [COVID-PRONE]
1535,Fear Among Dentists During COVID-19 Pandemic,COVID,"February 08, 2021",216,NCT04383626,,EGYPT,Completed,Cairo University,"March 2, 2020",Observational,Fear and Practice Modification Among Dentists During COVID-19 Pandemic
1536,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,COVID,"February 08, 2021",200,NCT04383652,BIOLOGICAL SAMPLE AND CLINICAL DATA COLLECTION,AUSTRALIA,Recruiting,Kirby Institute,"May 6, 2020",Observational,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales
1537,Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome,COVID; EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",200,NCT04383678,EXTRACORPOREAL MEMBRANE OXYGENATION,FINLAND,Recruiting,Helsinki University Central Hospital,"March 1, 2020",Observational,Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Multicenter European Study
1538,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",60,NCT04383717,LEVAMISOLE AND ISOPRINOSINE; AZITHROMYCIN AND HYDROXYCHLOROQUINE,,Not yet recruiting,Cairo University,"May 5, 2020",Interventional,The Efficacy of Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
1539,Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),CRITICALLY ILLNESS; SEDATION; INVASIVE MECHANICAL VENTILATION; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",400,NCT04383730,INTRAVENOUS SEDATION; INHALED SEDATION,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 26, 2020",Observational,Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)
1540,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,EMERGENCY DEPARTMENT STAFF DURING THE COVID PANDEMIC; EMERGENCY DEPARTMENT STAFF'S LEVEL OF STRESS,"February 08, 2021",200,NCT04383886,STRESS AND ANXIETY QUESTIONNAIRE,FRANCE,Recruiting,Hospices Civils de Lyon,"April 18, 2020",Observational,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic
1541,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04383899,QUESTIONNAIRE,FRANCE,Recruiting,"University Hospital, Bordeaux","September 30, 2020",Observational,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019 (COVID-19) Infections: a Case-control Study
1542,The Geneva Covid-19 CVD Study,COVID; CVD,"February 08, 2021",7000,NCT04384029,COVID-19 + PATIENTS,SWITZERLAND,"Active, not recruiting",François MACH,"March 24, 2020",Observational,"Retrospective Observational Study to Compare the Short, Mid- and Long-term Prognosis and Outcomes of SRAS-CoV-2 Infected Hospitalized Patients With Cardiovascular Disease (CVD) to SARS-CoV-2 Infected Hospitalized Patients Without CVD: The Geneva Covid-19 CVD Study"
1543,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,SARS-COV INFECTION; COVID; ANOSMIA; DYSGEUSIA,"February 08, 2021",60,NCT04384042,PATIENT-REPORTED ONLINE QUESTIONNAIRE ON OLFACTORY & TASTE DISTURBANCES,MALAYSIA,Not yet recruiting,Hospital Sultanah Bahiyah,May 2020,Observational,Olfactory and Gustatory Disturbances as a Clinical Presentation of Coronavirus Disease 2019 (COVID-19) Infection in Malaysia - A Nationwide Multicentre Case-Control Study
1544,Predicting Outcomes for Covid-19 Using Sonography,"COVID; PNEUMONIA, VIRAL","February 08, 2021",200,NCT04384055,LUNG ULTRASOUND,UNITED STATES,Enrolling by invitation,Stanford University,"March 21, 2020",Observational,Predicting Outcomes for Covid-19 Using Sonography
1545,Genetic Basis of COVID-19 Infection,GENETIC BASIS OF COVID INFECTION,"February 08, 2021",50,NCT04384250,WHOLE EXOME SEQUENCING,EGYPT,Recruiting,Mansoura University,"May 10, 2020",Observational,Genetic Factors Influencing the Response to Infection With SARS-COV-2
1546,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",33,NCT04384380,HYDROXYCHLOROQUINE SULFATE 200 MG [PLAQUENIL],TAIWAN,Completed,Taoyuan General Hospital,"April 1, 2020",Interventional,"A Multi-center, Randomized, Open-label, Controlled Trial to Evaluate the Efficacy and Tolerability of Hydroxychloroquine (HCQ) in Adult Patients With Mild to Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment"
1547,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,CHRONIC DISABLING; COVID,"February 08, 2021",467,NCT04384406,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Assessment of the Consequences of the Abrupt Interruption of Physical and Rehabilitation Medicine Consultations During the Quarantine Period in France Between 2020 March 17th and May 11th
1548,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",MENTAL DISORDER; GENERAL POPULATION,"February 08, 2021",1000,NCT04384419,,FRANCE,Recruiting,"University Hospital, Montpellier","May 29, 2020",Observational,"Real or Concieved Death Number Perception in Depression, Anxiety and in Schizotypal Personality Disorder Following Covid-19 Pandemic Lockdown"
1549,Zofin (Organicell Flow) for Patients With COVID-19,CORONAVIRUS INFECTION; COVID; SARS; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",20,NCT04384445,ZOFIN; PLACEBO,UNITED STATES,Recruiting,Organicell Regenerative Medicine,"September 8, 2020",Interventional,"A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Zofin for the Treatment of Moderate to SARS Related to COVID-19 Infection vs Placebo"
1550,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04384458,HYDROXYCHLOROQUINE; IVERMECTIN,BRAZIL,Recruiting,Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara,"July 20, 2020",Interventional,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis
1551,Covid-19 Pandemic: Patients' Experience in T1D,TYPE1DIABETES; COVID,"February 08, 2021",384,NCT04384471,ONLINE SURVEY,CANADA,Enrolling by invitation,McGill University,"April 29, 2020",Observational,Patient Living With Type 1 Diabetes' Experience During the COVID-19 Pandemic in Quebec
1552,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,COVID,"February 08, 2021",50,NCT04384497,SARS-COV-2 CONVALESCENT PLASMA,SWEDEN,Recruiting,Joakim Dillner,"May 7, 2020",Interventional,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
1553,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,"INFECTION; VIRAL, AGENT AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE","February 08, 2021",1120,NCT04384549,BCG GROUP; PLACEBO GROUP,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 20, 2020",Interventional,Randomized Controlled Trial Evaluating the Efficacy of Vaccination With Bacillus Calmette and Guérin (BCG) in the Prevention of COVID-19 Via the Strengthening of Innate Immunity in Health Care Workers
1554,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),COVID INFECTION; CANCER PATIENTS; GENERAL POPULATION,"February 08, 2021",100,NCT04384588,CONVALESCENT PLASMA FROM COVID-19 DONORS,CHILE,Recruiting,Fundacion Arturo Lopez Perez,"April 7, 2020",Interventional,Investigational- Compassionate Use of Convalescent Plasma From COVID-19 Donors in Oncological and Non-Oncological Patients With Severity Criteria: FALP 001-2020 Trial (FALP-COVID)
1555,Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study,COVID; BCG VACCINATION,"February 08, 2021",0,NCT04384614,TEST PCR; TDR; CLINICAL EXAMINATION,TUNISIA,Withdrawn,Direction des Soins de Santé de Base,"May 15, 2020",Observational [Patient Registry],Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study Multicentric Study
1556,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital,SARS-COV INFECTION,"February 08, 2021",500,NCT04384705,RESEARCH SPECIFIC BLOOD SAMPLE,FRANCE,Recruiting,Centre Hospitalier Universitaire de la Réunion,"June 17, 2020",Observational,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital
1557,Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,"COVID; ARDS, HUMAN","February 08, 2021",20,NCT04384731,PORACTANT ALFA,FRANCE,Recruiting,Dr Christophe LENCLUD,"May 29, 2020",Interventional,Randomized Controlled Phase II Trial of Poractant Alfa (Curosurf®) by Fiberoptic Bronchoscopy-directed Endobronchial Administration in Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Viral Pneumonia
1558,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""","COVID; ANXIETY; DEPRESSION, POSTPARTUM","February 08, 2021",100,NCT04384887,COVID-19 POSITIVE PREGNANT WOMEN,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"April 25, 2020",Observational,"''(COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women"""
1559,Accelerated Prone Position Ventilation of Patients With COVID-19,COVID,"February 08, 2021",150,NCT04384900,PRONE POSITION VENTILATION,DENMARK,Recruiting,Nordsjaellands Hospital,"May 11, 2020",Interventional,Accelerated Prone Position Ventilation of Patients With COVID-19
1560,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,COVID; CORONAVIRUS; CANCER; SURGERY,"February 08, 2021",1000,NCT04384926,ELECTIVE CANCER SURGERY,SPAIN,Recruiting,University of Birmingham,"March 30, 2020",Observational,"Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis: an International, Multicentre, Observational Cohort Study (CovidSurg-Cancer)"
1561,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,MAJOR DEPRESSIVE DISORDER,"February 08, 2021",200,NCT04384965,"MAGPRO X100 STIMULATOR, B70 FLUID-COOLED COIL",CANADA,Recruiting,Centre for Addiction and Mental Health,"May 12, 2020",Interventional,A Novel and Practical Accelerated Intermittent Theta Burst Protocol as a Substitute for Depressed Patients Needing Electroconvulsive Therapy During the COVID-19 Pandemic
1562,"Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU",ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",320,NCT04385004,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 27, 2020",Observational,"Characterization of the Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in the Intensive Care Unit"
1563,Role of Inflammasomes in COVID-19 Disease,COVID BY SARS-CoV2 INFECTION,"February 08, 2021",40,NCT04385017,COVID-19 PATIENTS,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"May 11, 2020",Interventional,Role of Inflammasomes in COVID-19 Disease
1564,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,COVID,"February 08, 2021",400,NCT04385043,PLASMA HYPERIMMUNE; STANDARD THERAPY,ITALY,Recruiting,University of Catanzaro,"May 1, 2020",Interventional,Efficacy and Safety of Hyperimmune Plasma Treatment in Patients With COVID-19 Severe Infection
1565,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,COV-HI; COVID; COVID (COV) HYPERINFLAMMATORY (HI) SYNDROME,"February 08, 2021",500,NCT04385069,,UNITED KINGDOM,Recruiting,"University College, London","April 16, 2020",Observational,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study
1566,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,SARS-CoV2,"February 08, 2021",820,NCT04385095,SNG001; PLACEBO,UNITED KINGDOM,Recruiting,Synairgen Research Ltd.,"March 16, 2020",Interventional,A Randomised Double-blind Placebo-controlled Trial to Determine the Safety and Efficacy of Inhaled SNG001 (IFN-β1a for Nebulisation) for the Treatment of Patients With Confirmed SARS-CoV-2 Infection
1567,Predictive Immune Biomarkers for COVID-19 Pathogenesis,COVID,"February 08, 2021",400,NCT04385108,BLOOD COLLECTION ON ADMISSION AND LONGITUDINALLY; BLOOD COLLECTION ON THEIR FIRST CONSULTATION AND 10 TO 14 DAYS LATER,FRANCE,Recruiting,"University Hospital, Toulouse","March 4, 2020",Interventional,Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management
1568,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,"COVID; STRESS DISORDERS, POST-TRAUMATIC; ANXIETY; DEPRESSION","February 08, 2021",60,NCT04385121,QUESTIONNARY,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 16, 2020",Observational,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection
1569,Advanced Endoscopy During COVID-19,"CHOLANGITIS, SECONDARY BILIARY; CHOLANGIOCARCINOMA; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; COVID; SARS-CoV2","February 08, 2021",670,NCT04385147,ENDOSCOPIC MANAGEMENT ACCORDING TO STANDARD OF CARE,EGYPT,Completed,Al-Azhar University,"May 18, 2020",Observational,The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study
1570,Myeloproliferative Neoplasms (MPN) and COVID-19,MYELOPROLIFERATIVE NEOPLASM; COVID,"February 08, 2021",80,NCT04385160,,FRANCE,Recruiting,Fondazione per la Ricerca Ospedale Maggiore,"May 13, 2020",Observational,Myeloproliferative Neoplasms (MPN) and COVID-19
1571,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,"INFECTIONS, CORONAVIRUS","February 08, 2021",60,NCT04385186,INACTIVATED CONVALESCENT PLASMA; SUPPORT TREATMENT,COLOMBIA,Not yet recruiting,"National Blood Center Foundation, Hemolife","June 20, 2020",Interventional,Inactivated Convalescent Plasma as a Therapeutic Alternative in Hospitalized Patients CoViD-19
1572,Convalescent Plasma for Patients With COVID-19,CORONAVIRUS INFECTION; CORONAVIRUS; COVID,"February 08, 2021",30,NCT04385199,CONVALESCENT PLASMA,UNITED STATES,Recruiting,Henry Ford Health System,"May 4, 2020",Interventional,The Use of Convalescent Plasma for Patients Hospitalized With COVID-19 Disease
1573,Outcomes in Hospitalized Older Patients With COVID-19,CORONAVIRUS INFECTION; SARS-CoV2; ELDERLY INFECTION; OLD AGE; DEBILITY,"February 08, 2021",230,NCT04385212,,SWITZERLAND,Completed,"University Hospital, Geneva","March 13, 2020",Observational,COVIDAge Study- Hospital Des Trois-Chêne
1574,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,COVID; PREGNANCY COMPLICATIONS; MENTAL HEALTH WELLNESS 1; ANXIETY; DEPRESSION; PTSD; CORONAVIRUS,"February 08, 2021",6894,NCT04385238,THIS IS AN ONLINE SURVEY WITH NO INTERVENTION.,UNITED STATES,Completed,Pregistry,"May 15, 2020",Observational,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic
1575,International SARS-CoV-2 (COVID-19) Infection Observational Study,COVID; COVID; SARS-CoV2; DYSPNEA,"February 08, 2021",10000,NCT04385251,DATA COLLECTION,ARGENTINA,Recruiting,University of Minnesota,"June 18, 2020",Observational,An International Observational Study of Outpatients With SARS-CoV-2 Infection
1576,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,COVID,"February 08, 2021",800,NCT04385264,HYDROXYCHLOROQUINE; MANNITOL,SWITZERLAND,Not yet recruiting,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland","May 12, 2020",Interventional,"#StayHome: Efficacy of Early Hydroxychloroquine in Outpatients to Reduce Secondary Hospitalisation and Household Transmission of COVID-19 in Switzerland: A Double-blind, Randomised, Placebo-controlled Trial"
1577,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",COVID; AIRWAY,"February 08, 2021",30,NCT04385576,AEROSOL BOX; INTUBATION BOX,MALAYSIA,Recruiting,University of Malaya,"May 15, 2020",Interventional,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box"" : Clinical Evaluation of the ""Intubation Box"" for Ease of Intubation"
1578,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,CORONAVIRUS INFECTION; COVID; SARS-CoV2; RESPIRATORY FAILURE; CYTOKINE STORM; EXTRACORPOREAL MEMBRANE OXYGENATION,"February 08, 2021",80,NCT04385771,VV-ECMO + CYTOKINE ADSORPTION (CYTOSORB ADSORBER); VV-ECMO ONLY (NO CYTOKINE ADSORPTION),GERMANY,Recruiting,Dr. Alexander Supady,"September 1, 2020",Interventional,"Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation - Randomized, Controlled, Open-label Intervention, Multi-center Trial (CYCOV-II-study)"
1579,Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,MILD COGNITIVE IMPAIRMENT; DEMENTIA,"February 08, 2021",200,NCT04385797,TELEPHONE INTERVIEW,SPAIN,"Active, not recruiting",Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud,"May 4, 2020",Observational [Patient Registry],Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia
1580,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,COVID; SARS-CoV2,"February 08, 2021",23,NCT04385810,OPHTHALMOLOGIC EXAM,FRANCE,Completed,Fondation Ophtalmologique Adolphe de Rothschild,"April 27, 2020",Interventional,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19
1581,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,"RESPIRATORY SYNDROME, ACUTE, SEVERE; HYPOXIC RESPIRATORY FAILURE; VIRAL PNEUMONIA","February 08, 2021",62,NCT04385823,PATIENTS RECEIVING NASAL HIGH FLOW,FRANCE,Completed,Hôpital Louis Mourier,"March 1, 2020",Observational,Use of High Flow Nasal Cannula Oxygen During Acute Hypoxemic Respiratory Failure Related to Covid-19 and Interest of the Respiratory-oxygenation Index (ROX Index): an Observational Study
1582,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),CORONAVIRUS,"February 08, 2021",150,NCT04385836,ALPHA ONE ANTITRYPSIN INHALATION,SAUDI ARABIA,Recruiting,"Ministry of Health, Saudi Arabia","June 1, 2020",Interventional,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
1583,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,COVID,"February 08, 2021",30,NCT04385849,N-803; SALINE,,Not yet recruiting,"ImmunityBio, Inc.","June 1, 2020",Interventional,"Phase 1b, Randomized, Blinded, Placebo-controlled Study of the Safety of Therapeutic Treatment With an Immunomodulary Agent (N-803 in Adults With COVID-19"
1584,The Use of a Continuous Glucose Monitoring System (Dexcom G6) in Hospitalized Patients for Acute Care,CONTINUOUS GLUCOSE MONITORING,"February 08, 2021",30,NCT04385862,,CANADA,Not yet recruiting,Centre hospitalier de l'Université de Montréal (CHUM),"July 27, 2020",Observational,The Use of a Continuous Glucose Monitoring System (Dexcom G6) in Hospitalized Patients for Acute Care
1585,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,SARS-CoV2; SARS PNEUMONIA,"February 08, 2021",26,NCT04385901,THERAPY INTERVENTION,UNITED STATES,Completed,University of Missouri-Columbia,"May 19, 2020",Interventional,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth
1586,Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04385914,COVID POSITIVE VIA TESTING,,Not yet recruiting,Atlantic Health System,May 2020,Observational,Demographics and Outcomes of Pregnant COVID 19 Positive Women in a Community Health System
1587,Vitamin D and COVID-19 Management,COVID,"February 08, 2021",64,NCT04385940,"DDROPS® PRODUCTS, 50,000 IU, ORAL; VITAMIN D3",,Not yet recruiting,University of Alberta,June 2020,Interventional,Improving Vitamin D Status in the Management of COVID-19
1588,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,COVID; VITAMIN D DEFICIENCY,"February 08, 2021",1000,NCT04386044,,UNITED KINGDOM,Not yet recruiting,Tameside General Hospital,"June 1, 2020",Observational,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients
1589,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,PULMONARY COMPLICATIONS IN SURGICAL PATIENTS; COVID; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",6400,NCT04386070,LOPINAVIR-RITONAVIR; HYDROXYCHLOROQUINE,,Not yet recruiting,University of Birmingham,"November 15, 2020",Interventional,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
1590,Neurologic Manifestations of COVID-19,CORONAVIRUS DISEASE 2019,"February 08, 2021",1342,NCT04386083,,PHILIPPINES,Recruiting,University of the Philippines,"June 10, 2020",Observational,COVID-19 Outcomes: A Retrospective Study of Neurological Manifestations and Associated Symptoms (The Philippine CORONA Study)
1591,Neonatal Complications of Coronavirus Disease (COVID-19),NEONATAL COVID DISEASE,"February 08, 2021",500,NCT04386109,NO INTERVENTION - EXPOSURE IS TO COVID-19,UNITED KINGDOM,Recruiting,University of Oxford,"April 1, 2020",Observational,Neonatal Complications of Coronavirus Disease (COVID-19)
1592,Study on the Use of Sarilumab in Patients With COVID-19 Infection,COVID,"February 08, 2021",40,NCT04386239,SARILUMAB PREFILLED SYRINGE,ITALY,Recruiting,ASST Fatebenefratelli Sacco,January 2021,Interventional,Pilot Study on the Use of Sarilumab in Patients With COVID-19 Infection
1593,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,COVID,"February 08, 2021",175,NCT04386252,AV-COVID-19,,Not yet recruiting,"Aivita Biomedical, Inc.",February 2021,Interventional,"Adaptive Phase I-II Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies"
1594,Compassionate Use of Hyperbaric Oxygen Therapy,COVID,"February 08, 2021",100,NCT04386265,,POLAND,Enrolling by invitation,"SerenaGroup, Inc.","April 15, 2020",Observational [Patient Registry],The Compassionate Use of Hyperbaric Oxygen Therapy in the Treatment of COVID-19
1595,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,GENERALIZED ANXIETY; HEALTH ANXIETY,"February 08, 2021",360,NCT04386291,ANXIETY REDUCTION TRAINING; KUNDALINI YOGA AND ANXIETY REDUCTION TRAINING; MEDITATION AND ANXIETY REDUCTION TRAINING,UNITED STATES,Recruiting,"Research Foundation for Mental Hygiene, Inc.","May 25, 2020",Interventional,Meditation and Yoga for Heightened Anxiety Related to COVID-19
1596,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,ARDS; COVID,"February 08, 2021",17,NCT04386369,AIRWAY PRESSURE RELEASE VENTILATION,FRANCE,Completed,"Central Hospital, Nancy, France","April 15, 2020",Observational,Evaluation of Airway Pressure Release Ventilation on Oxygenation in Acute Respiratory Distress Syndrome in Adult Patients With COVID-19 Pneumonia
1597,Immune Changes in Severe COVID-19 Pulmonary Infections,SARS-CoV2; IMMUNE SYSTEM DISORDER,"February 08, 2021",15,NCT04386395,,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","March 30, 2020",Observational,Whole Blood Immune Cells Characterization in Critically Ill COVID-19 Patients: A Prospective Study
1598,Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,COVID; CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",0,NCT04386447,OXYTOCIN; STANDARD OF CARE,FRANCE,Withdrawn,Azienda Ospedaliero-Universitaria di Parma,"September 1, 2020",Interventional,"Phase II, Multicenter, Open-label, Rct With an Adaptive Design, to Assess Efficacy of Intravenous Administration of Oxytocin in Hospitalized Patients Affected by COVID-19"
1599,Covid-19 and Prevention of Malnutrition After Confinement by Dentists,NUTRITION POOR; INFECTION VIRAL; ORAL DISEASE,"February 08, 2021",100,NCT04386460,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"May 11, 2020",Observational,Covid-19 and Prevention of Malnutrition After Confinement by Dentists: Prospective Study Among 100 Adults Received in Dental Consultation at Nice University Hospital and Sent to Their Physician for Assessment and Nutritional Care
1600,Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1),COVID; LYMPHOMA,"February 08, 2021",89,NCT04386512,,FRANCE,Completed,Versailles Hospital,"May 15, 2020",Observational,Épidémiologie Clinique et caractéristiques Des Cas de Covid-19 Survenus Dans un Contexte de Lymphome Lors de la première Phase épidémique
1601,Detection of COVID-19 in Saliva Collection,SARS-CoV2; RT-PCR; SALIVA COLLECTION; NASOPHARYNGEAL SAMPLE,"February 08, 2021",501,NCT04386551,,FRANCE,Completed,"Centre Hospitalier Universitaire, Amiens","May 6, 2020",Observational,Evaluation of the Performance of a Saliva Sample Versus a Nasopharyngeal Sample in the Diagnosis of COVID-19 by RT-PCR
1602,Kidney Injury Severity and COVID-19,COVID; KIDNEY INJURY,"February 08, 2021",120,NCT04386564,MRNA IN URINE TEST,RUSSIAN FEDERATION,"Active, not recruiting",I.M. Sechenov First Moscow State Medical University,"May 15, 2020",Observational,Prospective Parallel-Group Study of the Relationship Between Kidney Injury Severity and Severity of COVID-19
1603,A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",410,NCT04386616,MSTT1041A; MSTT1041A-MATCHED PLACEBO; UTTR1147A; UTTR1147A-MATCHED PLACEBO,BRAZIL,"Active, not recruiting","Genentech, Inc.","June 2, 2020",Interventional,"A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MSTT1041A or UTTR1147A in Patients With Severe COVID-19 Pneumonia"
1604,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,COVID,"February 08, 2021",80,NCT04386668,LET IT OUT (LIO)-C; NEUTRAL WRITING CONTROL,UNITED KINGDOM,Terminated,"University College, London","May 26, 2020",Interventional,Let It Out (LIO) and COVID19: a Randomised Controlled Trial of an Online Emotional Disclosure-based Intervention for Adults During the COVID19 Pandemic
1605,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,COVID; RESPIRATORY FAILURE,"February 08, 2021",30,NCT04386694,ACTIVE PBMT/SMF; PLACEBO PBMT/SMF,BRAZIL,Completed,University of Nove de Julho,"May 18, 2020",Interventional,Is Photobiomodulation Therapy (PBMT) Combined With Static Magnetic Field (sMF) Able to Decrease the Intensive Care Unit (ICU) Length of Stay for Patients With COVID-19?
1606,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",20,NCT04386720,,FRANCE,Recruiting,"University Hospital, Bordeaux","May 25, 2020",Observational,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom With Pressure Volume Curve on the Ventilator and With Electrical Impedance Tomography (EIT) Derived Method in Comparison of the Curves in Patients With or Without Covid 19 Pneumoniae.
1607,COVID-19 Infection in Healthcare Workers,COVID,"February 08, 2021",6000,NCT04386759,COHORT,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,May 2020,Observational,COVID-19 Infection in Healthcare Workers: a Cohort Study
1608,Stress and Anxiety Levels of Mothers Lying in the Baby Newborn Intensive Care Unit,NEWBORN; ANXIETY,"February 08, 2021",60,NCT04386798,SURVEY WORK,TURKEY,Recruiting,Eskisehir Osmangazi University,"July 25, 2020",Interventional,Determination of Stress and Anxiety Levels of Mothers Lying in the Newborn Intensive Care Unit During Coronavirus Disease Pandemic Period
1609,Oral 25-hydroxyvitamin D3 and COVID-19,COVID,"February 08, 2021",1500,NCT04386850,ORAL 25-HYDROXYVITAMIN D3,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Tehran University of Medical Sciences,"April 14, 2020",Interventional,Preventive and Therapeutic Effects of Oral 25-hydroxyvitamin D3 on Coronavirus (COVID-19) in Adults
1610,"Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions",BIOEQUIVALENCE,"February 08, 2021",30,NCT04386876,LOPINAVIR/RITONAVIR 200 MG/50 MG FILM TABLET; LOPINAVIR/RITONAVIR 200 MG/50 MG FILM COATED TABLET,TURKEY,Completed,World Medicine ILAC SAN. ve TIC. A.S.,"April 30, 2020",Interventional,"Randomized, Single Oral Dose,Two Treatment,Four-period,Full-replicated,Cross-over Trial to Assess the BE of Orvical 200 mg/50 mg FT in Comparison With Kaletra 200 mg/50 mg FT in Healthy Male Subjects Under Fasting Conditions"
1611,COVID-19 Pandemic and Academic Performance of Veterinary Students,COVID,"February 08, 2021",1426,NCT04387214,SURVEY,EGYPT,Completed,South Valley University,"April 13, 2020",Observational,The Impact of COVID-19 Pandemic on the Academic Performance of Veterinary Medical Students and Researchers
1612,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,COVID POSITIVE; CORONAVIRUS INFECTION,"February 08, 2021",22,NCT04387240,ARTEMISININ / ARTESUNATE; PLACEBO,SAUDI ARABIA,Not yet recruiting,Princess Nourah Bint Abdulrahman University,December 2020,Interventional,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19
1613,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,IDENTIFICATION OF THE MOTHER OR FETUS CONTAMINATION BY SARS COV-2; RESEARCH THE PRESENCE OF VIRUSES AT DIFFERENT SITES OF THE MOTHER AND THE FETUS OR FATHER; THE SURVEY BUILDS ON A NETWORK WORK ALREADY ORGANIZED AROUND THE CPDPN OF POITOU-CHARENTES; ANALYSIS LABORATORIES OF THE POITIERS CHU,"February 08, 2021",80,NCT04387253,IDENTIFICATION BY PCR OF THE SARS-COV-2 VIRUS IN SAMPLES TAKEN FROM THE FETUS,FRANCE,Recruiting,Poitiers University Hospital,"May 23, 2020",Interventional,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID
1614,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,"COVID; PERCEPTION, SELF; FACILITIES AND SERVICES UTILIZATION","February 08, 2021",800,NCT04387279,INTERVIEW,"KOREA, REPUBLIC OF",Recruiting,Keimyung University Dongsan Medical Center,"April 24, 2020",Observational,The Effect of Patient's Perceptions for COVID-19 on the Inflammatory Bowel Disease-related Healthcare Utilization in the Hyperepidemic Area
1615,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,COVID; OPHTHALMOPATHY,"February 08, 2021",100,NCT04387292,OPHTHALMOLOGIC EXAM,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"September 7, 2020",Interventional,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
1616,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,"INFECTION, RESPIRATORY TRACT","February 08, 2021",59,NCT04387409,VPM1002; PLACEBO,GERMANY,"Active, not recruiting",Vakzine Projekt Management GmbH,"May 25, 2020",Interventional,"A Phase III, Double-blind, Randomized, Placebo-controlled Multicentre Clinical Trial to Assess the Efficacy and Safety of VPM1002 in Reducing Healthcare Professionals' Absenteeism in the SARS-CoV-2 Pandemic by Modulating the Immune System"
1617,Protecting Health Care Workers During the COVID-19 Outbreak,COVID,"February 08, 2021",52,NCT04387643,AYURVEDIC KADHA,INDIA,Completed,Aarogyam UK,"March 1, 2020",Observational,Protecting Health Care Workers During the COVID-19 Outbreak:Qualitative Study of AYUSH Initiative
1618,"NCI COVID-19 in Cancer Patients, NCCAPS Study",COVID INFECTION; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM; METASTATIC MALIGNANT SOLID NEOPLASM,"February 08, 2021",2000,NCT04387656,BIOSPECIMEN COLLECTION; DATA COLLECTION; QUALITY-OF-LIFE ASSESSMENT; QUESTIONNAIRE ADMINISTRATION,CANADA,Recruiting,National Cancer Institute (NCI),"May 21, 2020",Observational,NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
1619,Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID),ANOREXIA NERVOSA,"February 08, 2021",18,NCT04387708,,,Not yet recruiting,Centre Psychothérapique de Nancy,"May 14, 2020",Observational,Reorganization of Care in Patients Hospitalized in Child Psychiatry for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic in France: Qualitative Study Carried Out on Patients and Their Parents
1620,Favipiravir vs Hydroxychloroquine in COVID -19,SARS-CoV2; COVID,"February 08, 2021",150,NCT04387760,HYDROXYCHLOROQUINE; FAVIPIRAVIR; ROUTINE CARE FOR COVID-19 PATIENTS,BAHRAIN,Recruiting,Royal College of Surgeons in Ireland - Medical University of Bahrain,"August 11, 2020",Interventional,Treatment of Covid-19 With Favipiravir Versus Hydroxychloroquine: a Randomized Comparator Trial
1621,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),COVID; MECHANICAL VENTILATION,"February 08, 2021",5,NCT04387786,DORNASE ALFA,UNITED STATES,Completed,Feinstein Institute for Medical Research,"March 31, 2020",Observational,Nebulized In-line Endotracheal Dornase Alfa and Albuterol Administered to Mechanically Ventilated COVID-19 Patients: A Case Series
1622,Determinants of COVID-19 Pneumonia (MC-19),"PNEUMONIA, VIRAL; PNEUMONIA, BACTERIAL; CORONAVIRUS INFECTION; OBSTRUCTIVE LUNG DISEASE","February 08, 2021",520,NCT04387799,SEROLOGY FOR COVID-19,ITALY,Completed,Catholic University of the Sacred Heart,"May 13, 2020",Observational,Major Determinants of COVID-19 Associated Pneumonia
1623,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,SARS-CoV2,"February 08, 2021",900,NCT04387838,ANTI-SARS-COV2 SEROLOGY; QUESTIONNAIRE,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"May 14, 2020",Observational,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff
1624,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,COVID; SARS-CoV2; HEALTH PERSONNEL,"February 08, 2021",50,NCT04387890,SEROLOGIC SARS-COV-2 SCREENING,,Not yet recruiting,Hospital Italiano de Buenos Aires,"June 1, 2020",Observational,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care
1625,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,COVID,"February 08, 2021",6000,NCT04387929,DETECTION OF ANTI-COVID-19 ANTIBODY LEVEL,ITALY,Recruiting,Istituto Clinico Humanitas,"May 4, 2020",Observational [Patient Registry],Observational Cohort Study for the Detection of Anti-COVID-19 Antibody Levels in an Hospital Population
1626,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),COVID; CHILBLAINS,"February 08, 2021",30,NCT04387955,BIOLOGICAL SAMPLE COLLECTION,FRANCE,Recruiting,Poitiers University Hospital,"April 30, 2020",Interventional,Analysis of Chilblains Profile During COVID-19 Epidemic
1627,"Epidemiological Study of the Covid-19 Presto Test - The ""COVIDOR"" Study",CORONAVIRUS INFECTION,"February 08, 2021",5000,NCT04387968,COVID-19 PRESTO TEST,FRANCE,Recruiting,Raphael Serreau,"August 24, 2020",Observational,"Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public"
1628,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,COVID,"February 08, 2021",410,NCT04388410,CONVALESCENT PLASMA,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"August 25, 2020",Interventional,Phase 2b/3 Trial to Evaluate the Safety and Efficacy of Plasma Transfusion From Convalescent Patients With SARS-CoV-2 Infection on Severity and Mortality of COVID-19 in Hospitalized Patients.
1629,Post Covid-19 Cardiopulmonary and Immunological Changes,COVID,"February 08, 2021",100,NCT04388436,,EGYPT,"Active, not recruiting",Mansoura University,"May 11, 2020",Observational [Patient Registry],Cardiopulmonary and Immunological Impacts of Covid-19 in a Cohort of Survivors
1630,Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure,SARS-CoV2 RESPIRATORY FAILURE,"February 08, 2021",90,NCT04388514,MEDICAL OZONE PROCEDURE,ITALY,Recruiting,Azienda Sanitaria-Universitaria Integrata di Udine,"April 8, 2020",Interventional,Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure
1631,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,COVID,"February 08, 2021",50,NCT04388527,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"April 30, 2020",Interventional,"An Open-Label, Single Arm, Phase 1, Safety and Exploratory Efficacy Study of Convalescent Plasma for Severely Ill Mechanically Ventilated Participants With COVID-19 Caused by SARS-CoV-2"
1632,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,RESPIRATORY DISEASE,"February 08, 2021",100,NCT04388579,PULMONARY REHABILITATION,PORTUGAL,Completed,University of Lisbon,"March 20, 2020",Observational,PRAISE@COVID-19: Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation
1633,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,CORONAVIRUS INFECTION; COVID; PREGNANCY RELATED; EARLY PREGNANCY,"February 08, 2021",11000,NCT04388605,,UNITED STATES,Recruiting,"University of California, San Francisco","April 21, 2020",Observational [Patient Registry],Assessing the Safety of Pregnancy In the CoRonavirus pandEmic: a Nationwide Prospective Study
1634,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,ANOSMIA; AGEUSIA; COVID; CORONAVIRUS INFECTION,"February 08, 2021",250,NCT04388618,NHANES SMELL AND TASTE TESTS,SAUDI ARABIA,Recruiting,Princess Nourah Bint Abdulrahman University,"June 15, 2020",Observational,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia
1635,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,CORONAVIRUS DISEASE 2019,"February 08, 2021",200,NCT04388631,CORONAVIRUS DISEASE 2019,CHINA,Recruiting,Tongji Hospital,"May 10, 2020",Observational [Patient Registry],Detection Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Male Genitourinary System and Its Impact on Male Reproductive Health: an Observational Clinical Study.
1636,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04388644,,TAIWAN,Recruiting,Taipei City Hospital,"February 20, 2020",Observational,"Department of Chinese Medicine, Branch of Linsen, Chinese Medicine, and Kunming, Taipei City Hospital, Taipei, Taiwan Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan."
1637,"COVID-19, bLOod Coagulation and Thrombosis","COVID; EMBOLISM AND THROMBOSIS; PNEUMONIA, VIRAL","February 08, 2021",100,NCT04388657,ECHO-DOPPLER,FRANCE,Recruiting,Ramsay Générale de Santé,"May 1, 2020",Observational,Study of the Prevalence of Deep Vein Thrombosis in Patients Hospitalized in Intensive Care for Acute Respiratory Failure Linked to Pneumonia Documented With SARS-COV2
1638,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,COVID; CRITICAL ILLNESS,"February 08, 2021",1500,NCT04388670,,ITALY,Recruiting,Policlinico Hospital,"February 22, 2020",Observational,Epidemiological and Clinical Characteristics of Patients With COVID-19 Admitted in Italian Intensive Care Units: a Multicentric Retrospective-prospective Cohort Study.
1639,Inhaled Nitric Oxide for Preventing Progression in COVID-19,COVID,"February 08, 2021",42,NCT04388683,NITRIC OXIDE,UNITED STATES,"Active, not recruiting",Tufts Medical Center,"May 12, 2020",Interventional,Prevention of COVID-19 Progression Through Early Administration of Inhaled Nitric Oxide.
1640,Interferon Lambda Therapy for COVID-19,SARS-CoV2,"February 08, 2021",66,NCT04388709,PEGINTERFERON LAMBDA-1A,UNITED STATES,Not yet recruiting,Icahn School of Medicine at Mount Sinai,September 2020,Interventional,A Randomized Phase 2 Trial of Peginterferon Lambda-1a (Lambda) for the Treatment of Hospitalized Patients Infected With SARS-CoV-2 With Non-critical Illness
1641,Predictors of Severe COVID-19 Outcomes,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",1500,NCT04388813,,UNITED STATES,Recruiting,Verily Life Sciences LLC,"May 28, 2020",Observational,Predictors of Severe COVID-19 Outcomes (PRESCO)
1642,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",40,NCT04388826,VERU-111,UNITED STATES,"Active, not recruiting",Veru Inc.,"June 18, 2020",Interventional,"Randomized, Placebo-Controlled, Phase 2 Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)"
1643,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,COVID,"February 08, 2021",300,NCT04389294,SARS-COV2 SERUM ANTIBODY TESTING,UNITED STATES,Recruiting,"Hospital for Special Surgery, New York","May 5, 2020",Interventional,Hospital for Special Surgery COVID-19 Antibody Serology Among Anesthesiologists and Surgeons 2020
1644,Antimalarial and Covid 19 in Rheumatoid Arthritis,RHEUMATOID ARTHRITIS,"February 08, 2021",60,NCT04389320,HYDROXYCHLOROQUINE,EGYPT,Completed,Assiut University,"March 15, 2020",Observational,Antimalarial and Covid 19 in Rheumatoid Arthritis
1645,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,GASTROINTESTINAL DISEASE; INFECTIOUS DISEASE; CAPSULE ENDOSCOPY,"February 08, 2021",40,NCT04389333,NON-CONTACT MAGNETICALLY-CONTROLLED CAPSULE ENDOSCOPY,CHINA,Completed,Changhai Hospital,"March 26, 2020",Interventional,"Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic: a Prospective, Open-label, Pilot, Randomized Trial"
1646,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,COVID,"February 08, 2021",1500,NCT04389359,HYDROXYCHLOROQUINE SULFATE 200 MG,,Not yet recruiting,Cambridge University Hospitals NHS Foundation Trust,September 2020,Interventional,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion (PROTECT): a Basket Trial of Prophylactic Interventions Amongst At-risk Patients
1647,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",MIGRAINE HEADACHE,"February 08, 2021",50,NCT04389372,MINDFULNESS,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"March 15, 2020",Interventional,Feasibility and Effectiveness of Mindfulness Program by Smartphone for Patients With Chronic Migraine and Medication Overuse During Covid-19 Emergency
1648,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),CORONAVIRUS INFECTION; PNEUMONIA,"February 08, 2021",60,NCT04389385,COVID-19 SPECIFIC T CELL DERIVED EXOSOMES (CSTC-EXO),TURKEY,"Active, not recruiting",TC Erciyes University,"May 1, 2020",Interventional,Aerosol Inhalation of the Exosomes Derived From Allogenic COVID-19 T Cell in the Treatment of Early Stage Novel Coronavirus Pneumonia
1649,The COvid-19 Symptom MOntelukast Trial,COVID,"February 08, 2021",600,NCT04389411,MONTELUKAST 10MG,,Not yet recruiting,McGill University,"October 1, 2020",Interventional,Repurposing Montelukast for the Attenuation and Prophylaxis of Severe COVID-19 Symptoms: The COvid-19 Symptom MOntelukast (COSMO) Trial
1650,"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",COVID; ARDS,"February 08, 2021",140,NCT04389450,PLX-PAD; PLACEBO,UNITED STATES,Recruiting,Pluristem Ltd.,"October 1, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of Severe COVID-19"
1651,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic,PATIENTS UNDERGOING CARDIAC OR THORACIC SURGERY,"February 08, 2021",350,NCT04389463,NO INTERVENTION,FRANCE,Recruiting,Nantes University Hospital,"May 11, 2020",Observational,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic ; International Cohort Study
1652,The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes,THE PSYCHOLOGICAL IMPACT OF COVID,"February 08, 2021",2500,NCT04389476,STANDARDIZED CRISIS MANAGEMENT AND COPING PROTOCOL PLAN TOWARD CORONAVIRUS DISEASE 2019 (COVID-19),,Not yet recruiting,Kaohsiung Kai-Suan Psychiatric Hospital,"June 15, 2020",Observational,The Impact and Coping Strategy of Taiwan Society and Medical and Nursing Institutes Toward the Biological Disaster-- Corona Virus Disease 2019 (COVID-19) as An Example
1653,Postpartum Sexual Function in Pregnant Women With COVID-19,COVID; DYSPAREUNIA; POSTPARTUM PERIOD,"February 08, 2021",140,NCT04389489,,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 14, 2020",Observational,Evaluation of Pregnant Women Diagnosed With COVID-19 Using Carol Postpartum Sexual Function and Dyspareunia Scale
1654,"Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19",COVID; PRENATAL CARE; POSTOPERATIVE CARE,"February 08, 2021",75,NCT04389515,,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 14, 2020",Observational,"Evaluation of Pregnant Women Diagnosed With COVID-19 With ""Post-operative Recovery Index"" and ""Prenatal Care Satisfaction and Patient Expectations Scale"""
1655,D-dimer Levels in Pregnant With COVID-19,COVID; D-DIMER,"February 08, 2021",300,NCT04389554,BLOOD D-DIMER ASSAY,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"May 14, 2020",Observational [Patient Registry],Assessment of D-dimer Levels in Pregnant Women Diagnosed With COVID-19
1656,Famotidine Outpatient COVID-19 Treatment Study,COVID,"February 08, 2021",10,NCT04389567,FAMOTIDINE,UNITED STATES,Completed,Northwell Health,"May 12, 2020",Observational,Famotidine Use in Non-hospitalized Patients With COVID-19: A Case Series
1657,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,COVID,"February 08, 2021",160,NCT04389580,DRUG: ISOTRETINOIN PLUS TAMOXIFEN; AEROSOLIZED ISOTRETINOIN PLUS TAMOXIFEN,,Not yet recruiting,Kafrelsheikh University,June 2020,Interventional,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus
1658,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,COVID,"February 08, 2021",52,NCT04389645,IP-10 IN CDS PROTOCOL,ISRAEL,Completed,MeMed Diagnostics Ltd.,"April 7, 2020",Observational,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients
1659,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),COVID,"February 08, 2021",1526,NCT04389658,,SPAIN,Completed,Igenomix,"May 7, 2020",Observational,Retrospective Observational Study to Determine COVID-19 Contagious and Immunological Status in Asymptomatic Population of Highly Affected Areas
1660,The Safety and Preliminary Efficacy of Lucinactant in Adults With COVID-19,COVID; ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS),"February 08, 2021",30,NCT04389671,LUCINACTANT,UNITED STATES,Not yet recruiting,Windtree Therapeutics,October 2020,Interventional,"A Multicenter, Single-Treatment Study to Assess the Safety and Preliminary Efficacy of Lyophilized Lucinactant in Adults With COVID-19 Associated Acute Lung Injury"
1661,Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors,CHEMEOTHERAPY; IMMUNOTHERAPY; TREATMENT MOFIDIED; CORONAVIRUS; QUALITY OF LIFE,"February 08, 2021",120,NCT04389684,PSYCHO-SOCIAL QUESTIONNAIRE,FRANCE,Recruiting,Poitiers University Hospital,"May 27, 2020",Observational,Clinical and Psycho-Social Impact on Patients With Digestive Tumors of Treatment and Care Modifications Linked to COVID-19 in France
1662,Convalescent Plasma for the Treatment of COVID-19,COVID,"February 08, 2021",100,NCT04389710,CONVALESCENT PLASMA,UNITED STATES,Recruiting,Thomas Jefferson University,"April 15, 2020",Interventional,Convalescent Plasma for the Treatment of Patients With COVID-19
1663,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,COVID,"February 08, 2021",200,NCT04389801,DESFERAL 500 MG INJECTION,,Not yet recruiting,Hesham Al-Inany,"June 1, 2020",Interventional,The Use of Desferal and Adjuvants for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection: A Randomized Controlled Trial
1664,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,COVID; ACUTE LUNG INJURY; SARS-CoV2,"February 08, 2021",524,NCT04389840,DOCIPARASTAT SODIUM; PLACEBO,UNITED STATES,Recruiting,Chimerix,"June 3, 2020",Interventional,A Phase 2/3 Study to Evaluate the Safety and Efficacy of Dociparstat Sodium for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
1665,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,CORONAVIRUS DISEASE 2019 INFECTIOUS DISEASE (COVID INFECTION),"February 08, 2021",15,NCT04389944,CONVALESCENT PLASMA APPLICATION TO SARS-COV-2 INFECTED PATIENTS,SWITZERLAND,Completed,"University Hospital, Basel, Switzerland","March 31, 2020",Interventional,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe Coronavirus Disease 2019 Infectious Disease (COVID-19)
1666,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,CANCER,"February 08, 2021",5000,NCT04389996,NO INTERVENTION,DENMARK,"Active, not recruiting",Odense University Hospital,"May 14, 2020",Observational [Patient Registry],COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey
1667,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,COVID; CORONAVIRUS INFECTION; SARS-CoV2 INFECTION,"February 08, 2021",24,NCT04390022,IVERMECTIN; PLACEBO,SPAIN,Completed,"Clinica Universidad de Navarra, Universidad de Navarra","July 31, 2020",Interventional,Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission
1668,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,"PNEUMONITIS, INTERSTITIAL; COVID","February 08, 2021",116,NCT04390061,TOFACITINIB; HYDROXYCHLOROQUINE,,Not yet recruiting,Università Politecnica delle Marche,June 2020,Interventional,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With Early Onset SARS-CoV2 (COVID-19) Interstitial Pneumonia:a Multicenter Randomized Controlled Open Label Trial
1669,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,COVID; CRITICAL ILLNESS,"February 08, 2021",9905,NCT04390074,COVID-19 AND INTENSIVE CARE,SWEDEN,Completed,Uppsala University,"May 27, 2020",Observational,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality
1670,COVID-19 Related Lockdown Effects On Chronic Diseases,CHRONIC CORONARY SYNDROME; HEART FAILURE; AMD AND MACULAR EDEMA; CHRONIC RESPIRATORY FAILURE; HEMOPHILIA; MALIGNANT HEMOPATHY; MULTIPLE SCLEROSIS; HORTON'S DISEASE,"February 08, 2021",1200,NCT04390126,LIFE QUESTIONNAIRES; QUESTIONNAIRE,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"April 20, 2020",Observational,COVID-19 Related Lockdown Effects On Chronic Diseases
1671,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,COVID; SARS-CoV2; ADULT RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",30,NCT04390139,XCEL-UMC-BETA; PLACEBO,SPAIN,Recruiting,Banc de Sang i Teixits,"May 13, 2020",Interventional,"A Prospective, Double-blind, Randomized, Parallel, Placebo-controlled Pilot Clinical Trial for the Evaluation of the Efficacy and Safety of Two Doses of WJ-MSC in Patients With Acute Respiratory Distress Syndrome Secondary to Infection by COVID-19"
1672,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",40,NCT04390152,"WHARTON'S JELLY DERIVED MESENCHYMAL STEM CELLS.; HYDROXYCHLOROQUINE, LOPINAVIR/RITONAVIR OR AZITHROMYCIN AND PLACEBO (STANDARD THERAPY)",COLOMBIA,Recruiting,BioXcellerator,"January 13, 2020",Interventional,Safety and Efficacy of Intravenous Infusion of Wharton's Jelly Derived Mesenchymal Stem Cell Plus Standard Therapy for the Treatment of Patients With Acute Respiratory Distress Syndrome Diagnosis Due to COVID 19: A Randomized Controlled Trial
1673,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,SARS-COV INFECTION; COVID; ANOSMIA; DYSGEUSIA,"February 08, 2021",760,NCT04390165,PATIENT-REPORTED ONLINE QUESTIONNAIRE ON OLFACTORY & TASTE DISTURBANCES,MALAYSIA,Not yet recruiting,Hospital Sultanah Bahiyah,May 2020,Observational,Olfactory and Gustatory Disturbances as a Clinical Presentation of Coronavirus Disease 2019 (COVID-19) Infection in Malaysia - A Nationwide Multicentre Cross-Sectional Study
1674,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),COVID,"February 08, 2021",10,NCT04390178,SARS-COV-2 CONVALESCENT PLASMA,SWEDEN,"Active, not recruiting",Joakim Dillner,"April 10, 2020",Interventional,Plasma From Individuals Who Have Recovered From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection as Treatment for Acute COVID-19 Disease
1675,Early CPAP in COVID-19 Confirmed or Suspected Patients,COVID; COVID; CORONAVIRUS,"February 08, 2021",200,NCT04390191,CONTINUOUS POSITIVE AIRWAY PRESSURE,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"May 7, 2020",Interventional,Early Continuous Positive Airway Pressure (CPAP) in COVID-19 Confirmed or Suspected Patients
1676,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,COVID; CORONAVIRUS DISEASE 2019; COVID; COVID PNEUMONIA,"February 08, 2021",120,NCT04390217,LB1148; PLACEBO,,Not yet recruiting,"Leading BioSciences, Inc","October 31, 2020",Interventional,A Phase 2 Study to Evaluate LB1148 for the Treatment of Pulmonary Dysfunction Associated With COVID-19 Pneumonia
1677,Immunogenetics Predictors With COVID-19,GENETIC PREDISPOSITION TO DISEASE,"February 08, 2021",200,NCT04390269,,EGYPT,Not yet recruiting,Mansoura University,"September 10, 2020",Observational,Various Molecular Markers With Predictive and Prognostic Significance in COVID-19 Outcome
1678,Low Dose Radiotherapy in COVID-19 Pneumonia,COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",5,NCT04390412,LOW DOSE RADIOTHERAPY,"IRAN, ISLAMIC REPUBLIC OF","Active, not recruiting",Shahid Beheshti University of Medical Sciences,"May 4, 2020",Interventional,Assessment of Adding Low Dose Pulmonary Radiotherapy to the National Protocol of COVID-19 Management: A Pilot Trial
1679,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),COVID,"February 08, 2021",1167,NCT04390464,RAVULIZUMAB; BARICITINIB; STANDARD OF CARE,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"May 8, 2020",Interventional,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)
1680,Study to Evaluate the Effect of a Probiotic in COVID-19,COVID; CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04390477,PROBIOTIC,SPAIN,Recruiting,Bioithas SL,"May 4, 2020",Interventional,The Intestinal Microbiota as a Therapeutic Target in Hospitalized Patients With COVID-19 Infection
1681,Convalescent Plasma for COVID-19 Close Contacts,SARS-CoV2; COVID,"February 08, 2021",200,NCT04390503,CONVALESCENT PLASMA (ANTI-SARS-COV-2 PLASMA); CONTROL (ALBUMIN 5%),UNITED STATES,Recruiting,Columbia University,May 2020,Interventional,"A Phase 2 Randomized, Double-blinded Trial to Evaluate the Efficacy and Safety of Human Anti- SARS-CoV-2 Plasma in Close Contacts of COVID-19 Cases"
1682,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,COVID; CORONAVIRUS; MORTALITY; MECHANICAL VENTILATION,"February 08, 2021",197,NCT04390516,COVIAGE,UNITED STATES,Completed,Dascena,"March 24, 2020",Interventional,Prediction Of Respiratory Decompensation In Covid-19 Patients Using Machine Learning: The READY Trial
1683,Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy,BLOOD CANCER,"February 08, 2021",40,NCT04390542,PSYCHOEDUCATION,UNITED STATES,Not yet recruiting,Case Comprehensive Cancer Center,"February 1, 2021",Interventional,"A Pilot Study Evaluating Feasibility, Acceptability, Usability, Satisfaction and Preliminary Efficacy of an Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy"
1684,The Global PCHF-COVICAV Registry,COVID; CARDIOVASCULAR DISEASES; CARDIOVASCULAR RISK FACTOR; HEART FAILURE,"February 08, 2021",1500,NCT04390555,,SWITZERLAND,Recruiting,University of Zurich,"April 30, 2020",Observational [Patient Registry],COVID-19 in Hospitalised Patients With Preexisting CArdioVascular Diseases and/or Cardiac Involvement and/or Cardiovascular Risk Factors: the Global PCHF-COVICAV Registry
1685,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,COVID,"February 08, 2021",186,NCT04390594,NAFAMOSTAT MESILATE,SENEGAL,Recruiting,Institut Pasteur de Dakar,"August 13, 2020",Interventional,"Multicentre, Open Label, Randomised, Adaptative Clinical Trial of Efficacy and Safety of Treatment Regimens in Adult COVID-19 Patients in Senegal"
1686,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),SARS-CoV2,"February 08, 2021",231,NCT04391101,CONVALESCENT PLASMA,COLOMBIA,Not yet recruiting,Hospital San Vicente Fundación,June 2020,Interventional,"Efficacy of Convalescent Plasma for the Treatment of Severe SARS-CoV-2 Infection: A Randomized, Open Label Clinical Trial"
1687,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,COVID,"February 08, 2021",108,NCT04391127,HYDROXYCHLOROQUINE; IVERMECTIN; PLACEBO,MEXICO,Completed,Centenario Hospital Miguel Hidalgo,"May 4, 2020",Interventional,Efficacy and Safety of Hydroxychloroquine and Ivermectin in Hospitalized no Critical Patients Secondary to COVID-19 Infection: Randomized Controlled Trial
1688,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,COVID; ARDS; ACUTE RESPIRATORY DISTRESS SYNDROME; ACUTE RESPIRATORY FAILURE; CORONAVIRUS INFECTION,"February 08, 2021",248,NCT04391140,PRONE POSITION,SPAIN,Recruiting,Hospital Universitari Vall d'Hebron Research Institute,"May 13, 2020",Interventional,Effectiveness of Prone Positioning Combined With High-flow Nasal Cannula for Patients With COVID-19 Induced ARDS
1689,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,VISUAL IMPAIRMENT,"February 08, 2021",150,NCT04391166,NON INVASIVE VISUAL ACUITY TESTING,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"May 20, 2020",Observational,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic
1690,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,COVID; CORONAVIRUS INFECTION; COVID; SARS-CoV2 INFECTION,"February 08, 2021",160,NCT04391179,DIPYRIDAMOLE 100 MILLIGRAM(MG); PLACEBO ORAL TABLET,UNITED STATES,"Active, not recruiting",University of Michigan,"May 31, 2020",Interventional,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
1691,IC14 (Anti-CD14) Treatment in Patients With SARS-CoV-2 (COVID-19),SARS-CoV2,"February 08, 2021",300,NCT04391309,IC14; PLACEBO,UNITED STATES,Not yet recruiting,Implicit Bioscience,July 2020,Interventional,"Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)"
1692,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",SARS-CoV2,"February 08, 2021",500,NCT04391400,NASAL PHARYNGEAL (NP) SWAB SAMPLES; PERIPHERAL BLOOD DRAW,,Not yet recruiting,"Invivoscribe, Inc.","June 1, 2020",Observational,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines"
1693,Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,COVID; OBESITY,"February 08, 2021",90,NCT04391686,INDIRECT CALORIMETRY,FRANCE,Recruiting,Centre Hospitalier Arras,"July 3, 2020",Observational [Patient Registry],Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context
1694,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,COVID,"February 08, 2021",10,NCT04391712,MLS LASER; REGULAR INPATIENT MEDICAL CARE,UNITED STATES,Completed,Lowell General Hospital,"April 30, 2020",Interventional,Multiwave Locked System (MLS) Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease
1695,Association Between BMI and COVID-19,SARS-CoV2,"February 08, 2021",1200,NCT04391738,PATIENTS ADMITTED TO INTENSIVE CARE UNIT WITH SARS-COV2,FRANCE,"Active, not recruiting","University Hospital, Lille","February 1, 2020",Observational,Relationship Between Obesity and Severe Acute Respiratory Syndrome Coronavirus-2 in Patient With SARS-CoV-2 Admitted in Intensive Care : A Multicenter Retrospective Cohort Study
1696,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; PANDEMIC; PSYCHOLOGICAL STRESS,"February 08, 2021",700,NCT04391816,,UNITED STATES,Recruiting,National Institute on Alcohol Abuse and Alcoholism (NIAAA),"February 11, 2021",Observational,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
1697,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,COVID; SARS-CoV2; CORONAVIRUS INFECTION; SEMEN,"February 08, 2021",20,NCT04391829,EJACULATED SEMEN SAMPLE,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"August 31, 2020",Interventional,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males
1698,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,ORAL HEALTH AND COVID,"February 08, 2021",500,NCT04391881,,EGYPT,Recruiting,Cairo University,"May 30, 2020",Observational,Oral Manifestation of COVID19
1699,Registry of CytoSorb Therapy in COVID-19 ICU Patients,COVID,"February 08, 2021",500,NCT04391920,CYTOSORB 300 ML DEVICE,UNITED STATES,Recruiting,"CytoSorbents, Inc","August 28, 2020",Observational [Patient Registry],"Registry of CytoSorb Therapy in COVID-19 ICU Patients (CTC REGISTRY): Registry of Patient-level Clinical Data on CytoSorb Hemoadsorption Provided Via Integration of the CytoSorb Device Into Extracorporeal Membrane Oxygenation (ECMO), Continuous Renal Replacement Therapy (CRRT), or Hemoperfusion Extracorporeal Circuits in COVID-19 ICU Patients"
1700,Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19,"CHRONIC LYMPHOCYTIC LEUKEMIA, LYMPHOCYTIC LYMPHOMA OR WALDENSTROM DISEASE","February 08, 2021",50,NCT04391946,DATA REGISTRY,FRANCE,Recruiting,French Innovative Leukemia Organisation,"March 14, 2020",Observational [Patient Registry],National Prospective and Retrospective Follow-up of Patients With COVID-19 Infected Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenström Disease
1701,Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,COVID; RESPIRATORY FAILURE,"February 08, 2021",20,NCT04392089,"MASIMO, LIDCO",DENMARK,Recruiting,Hvidovre University Hospital,"May 1, 2020",Observational,Effects of Cardiovascular and Pulmonary Optimisation on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS
1702,The PREPARE for COVID Trial,COMORBIDITIES AND COEXISTING CONDITIONS; SOCIAL ISOLATION,"February 08, 2021",372,NCT04392115,THE PREPARE PROGRAM,,Not yet recruiting,Ottawa Hospital Research Institute,"June 15, 2020",Interventional,PRomoting Exercise During the Pandemic to Increase Activity and Reduce Effects of Social Isolation for COVID: The PREPARE for COVID Trial
1703,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),COVID; HEMATOLOGIC MALIGNANCY,"February 08, 2021",0,NCT04392128,HYDROXYCHLOROQUINE SULFATE 200 MG [PLAQUENIL]; AZITHROMYCIN 250 MG ORAL CAPSULE; PLACEBO ORAL TABLET; PLACEBO ORAL CAPSULE,FRANCE,Withdrawn,Institut de cancérologie Strasbourg Europe,"September 2, 2020",Interventional,"Randomised, Double-blind, Placebo-controlled Phase 2 Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies"
1704,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,COVID,"February 08, 2021",200,NCT04392141,STANDARD TREATMENT; ORAL ADMINISTRATION OF COLCHICINE PLUS HERBAL PHENOLIC MONOTERPENE FRACTIONS,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Kermanshah University of Medical Sciences,"April 1, 2020",Interventional,Application of Colchicine Plus Herbal Phenolic Monoterpene Fractions to Treat COVID-19
1705,"COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",CORONAVIRUS,"February 08, 2021",130,NCT04392219,EIDD-2801; PLACEBO,UNITED KINGDOM,Completed,"Ridgeback Biotherapeutics, LP","April 10, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Study Designed to Evaluate the Safety, Tolerability, and Pharmacokinetics of EIDD-2801 Following Oral Administration to Healthy Volunteers"
1706,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,CORONAVIRUS; COVID; CONVALESCENT PLASMA,"February 08, 2021",100,NCT04392232,CONVALESCENT PLASMA,UNITED STATES,Recruiting,TriHealth Inc.,"May 5, 2020",Interventional,A Phase 2 Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
1707,Proctologic Practice and Covid-19,PROCTOLOGIC PRACTICE DURING COVID,"February 08, 2021",1050,NCT04392245,,ITALY,Completed,Societa Italiana di Chirurgia ColoRettale,"April 15, 2020",Observational,A Worldwide Survey on Proctologic Practice During Covid-19 Lockdown
1708,Incidence of COVID-19 Test Conversion in Post-surgical Patients,SARS-CoV2,"February 08, 2021",500,NCT04392323,COVID-19 PCR AND SEROLOGY,UNITED STATES,Recruiting,Northwell Health,"May 13, 2020",Interventional,Incidence of COVID-19 Test Conversion in Post-surgical Patients
1709,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",SARS-CoV2,"February 08, 2021",110000,NCT04392388,NON APPLICABLE,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","May 1, 2020",Observational,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis - Serology"
1710,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,INTENSIVE CARE UNIT; SARS-CoV2,"February 08, 2021",200,NCT04392401,COLLECTION OF BLOOD SAMPLES IN ORDER TO CREATE A BIOCOLLECTION,FRANCE,Recruiting,Hospices Civils de Lyon,"May 11, 2020",Observational,Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study
1711,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,COVID,"February 08, 2021",60,NCT04392414,COVID-19 CONVALESCENT HYPERIMMUNE PLASMA; NON-CONVALESCENT FRESH FROZEN PLASMA (STANDARD PLASMA),RUSSIAN FEDERATION,Completed,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","May 1, 2020",Interventional,"Randomized, Open Label, Prospective Study of the Safety and Efficacy of Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease"
1712,New Antiviral Drugs for Treatment of COVID-19,COVID; DRUG EFFECT,"February 08, 2021",100,NCT04392427,"TREATMENT GROUP: WILL RECEIVE A COMBINATION OF NITAZOXANIDE, RIBAVIRIN AND IVERMECTIN FOR A DURATION OF SEVEN DAYS :",EGYPT,Not yet recruiting,Mansoura University,October 2020,Interventional,"Effect of a Combination of Nitazoxanide, Ribavirin and Ivermectin Plus Zinc Supplement on the Clearance of COVID-19: a Pilot Sequential Clinical Trial"
1713,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,STROKE,"February 08, 2021",40,NCT04392453,ROBOTIC THERAPY,,Not yet recruiting,Fondazione Don Carlo Gnocchi Onlus,May 2020,Interventional,Upper Limb Robotic Rehabilitation in Stroke Survivors Using a Portable Device During the COVID-19 Outbreak. A Feasibility Study
1714,Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19,COVID INFECTION,"February 08, 2021",120,NCT04392531,CYCLOSPORINE; STANDARD TREATMENT,SPAIN,Recruiting,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,"April 16, 2020",Interventional,"Open, Controlled, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Cyclosporine Plus Standard Treatment vs Standard Treatment Only in Hospitalized Patients With COVID-19 Infection"
1715,Efficacy of Ivermectin in COVID-19,COVID,"February 08, 2021",100,NCT04392713,IVERMECTIN 6 MG ORAL TABLET (2 TABLETS),PAKISTAN,Recruiting,"Combined Military Hospital, Pakistan","April 15, 2020",Interventional,Efficacy of Ivermectin in COVID-19 : A Randomized Controlled Trial
1716,Clinical Use of Stem Cells for the Treatment of Covid-19,COVID; PNEUMONIA; MULTIPLE ORGAN FAILURE; CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04392778,MSC TREATMENT; SALINE CONTROL,TURKEY,Recruiting,SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi,"April 1, 2020",Interventional,What is the Effect of Mesenchymal Stem Cell Therapy on Seriously Ill Patients With Covid 19 in Intensive Care? (Prospective Double Controlled Study)
1717,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,PSYCHOLOGICAL DISTRESS; LIFE STRESS; ANXIETY; PERFECTIONISM; EMOTIONAL INTELLIGENCE; CREATIVITY; ATTENTION; EMPATHY,"February 08, 2021",75,NCT04392869,THE CRAFT PROGRAM (ADAPTED DUE TO COVID-19); THE MBSR PROGRAM (ADAPTED DUE TO COVID-19),SPAIN,Completed,Universidad de Granada,"October 23, 2019",Interventional,Testing the Effects of Two Mindfulness-based Programs on Well Being and Academic Performance of Undergraduate Students of Translation and Interpreting: An Interventional Study
1718,FAvipiravir and HydroxyChloroquine Combination Therapy,COVID,"February 08, 2021",520,NCT04392973,FAVIPIRAVIR AND HYDROXYCHLOROQUINE,SAUDI ARABIA,Recruiting,King Abdullah International Medical Research Center,"May 21, 2020",Interventional,A Trial of Favipiravir and Hydroxychloroquine Combination in Adults Hospitalized With Moderate and Severe Covid-19
1719,ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,COVID,"February 08, 2021",1034,NCT04393038,ABX464; PLACEBO,BELGIUM,Recruiting,Abivax S.A.,"May 1, 2020",Interventional,"A Phase 2/3, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and the Safety of ABX464 in Treating Inflammation and Preventing COVID-19 Associated Acute Respiratory Failure in Patients Aged ≥ 65 and Patients Aged ≥18 With at Least One Additional Risk Factor Who Are Infected With SARS-CoV-2."
1720,Baricitinib Compared to Standard Therapy in Patients With COVID-19,COVID; SARS-CoV2; SARS PNEUMONIA,"February 08, 2021",126,NCT04393051,BARICITINIB ORAL TABLET,ITALY,Not yet recruiting,"Azienda Ospedaliero, Universitaria Pisana","May 20, 2020",Interventional,"BARICIVID-19 STUDY: MultiCentre, Randomised, Phase IIa Clinical Trial Evaluating Efficacy and Tolerability of Baricitinib as add-on Treatment of In-patients With COVID-19 Compared to Standard Therapy"
1721,Emotional Freedom Technique (EFT) Effect on Nurses,"STRESS; ANXIETY; BURNOUT, CAREGIVER","February 08, 2021",80,NCT04393077,EMOTIONAL FREEDOM TECHNIQUE,TURKEY,Completed,Istanbul Saglik Bilimleri University,"May 10, 2020",Interventional,"Emotional Freedom Technique (EFT) Effect on Nurses' Stress, Anxiety and Burnout Levels During the COVID-19 Pandemic Process: A Randomized Controlled Study"
1722,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",92,NCT04393142,,MEXICO,Recruiting,Hospital Universitario Dr. Jose E. Gonzalez,"May 5, 2020",Observational [Patient Registry],Observational Trial Evaluating the Serologic Status of Household Contacts of Patients Diagnosed With COVID-19
1723,Longitudinal COVID-19 Cohort Study,COVID; ACUTE RESPIRATORY FAILURE,"February 08, 2021",225,NCT04393155,COVID-19+ OBSERVATIONAL,UNITED STATES,Recruiting,University of Vermont,"April 16, 2020",Observational,"Inflammatory, Pulmonary, Physical & Neuropsychological Sequelae of COVID-19 Acute Respiratory Failure: A 1-Year Longitudinal Study"
1724,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,RHEUMATOID ARTHRITIS; COVID,"February 08, 2021",300,NCT04393233,,FRANCE,Recruiting,"University Hospital, Brest","April 23, 2020",Observational,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation
1725,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,COVID,"February 08, 2021",1407,NCT04393246,EDP1815; DAPAGLIFLOZIN; AMBRISENTAN; STANDARD OF CARE,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"July 3, 2020",Interventional,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms (TACTIC-E)
1726,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,COVID,"February 08, 2021",160,NCT04393311,ULINASTATIN; PLACEBO,UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,"A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Safety and Efficacy of Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients"
1727,The Critical Care Response to the COVID-19 Pandemic in Madrid,"COVID; ARDS, HUMAN","February 08, 2021",2500,NCT04393324,,SPAIN,Recruiting,"Hospital San Carlos, Madrid","April 24, 2020",Observational [Patient Registry],The Critical Care Resources Adaptation to the SARS-CoV-2 Pandemic in Madrid
1728,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),COVID,"February 08, 2021",14,NCT04393402,LUNG ULTRASOUND (LUS),FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"March 20, 2020",Observational,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care
1729,Using PRP and Cord Blood in Treatment of Covid -19,VIRUS,"February 08, 2021",100,NCT04393415,STEM CELLS,EGYPT,Recruiting,Aljazeera Hospital,"May 25, 2020",Interventional,the Effect of PRP and Cord Blood in Improving the Symptoms of Covid-19
1730,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),COVID; RENAL REPLACEMENT THERAPY; ACUTE KIDNEY INJURY,"February 08, 2021",100,NCT04393428,[TIMP-2]*[IGFBP-7],FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Urinary Biomarkers (TIMP-2 and IGFBP7) for Early Diagnostic Assessment of Acute Kidney Injury in Patients With SARS-CoV-2 (COVID-19)
1731,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,COVID; HEALTHY CONTROL,"February 08, 2021",100,NCT04393558,ADAM SENSOR,UNITED STATES,Recruiting,Shirley Ryan AbilityLab,"April 20, 2020",Observational,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms
1732,Digital Cardiac Counseling Trial: DCC Trial,CARDIOVASCULAR DISEASES; CARDIOVASCULAR RISK FACTOR,"February 08, 2021",394,NCT04393636,DIGITAL CARDIAC COUNSELING,NETHERLANDS,Recruiting,Academisch Ziekenhuis Maastricht,"June 5, 2020",Interventional,Randomized Controlled Trial of Digital Cardiac Counseling in Patients With Delayed Cardiac Surgical Treatment Due to Covid-19 Pandemic (DCC Trial)
1733,First Level Socio-geriatric Evaluation: ESOGER Databank,COVID; SOCIAL ISOLATION; ANXIETY; FRAILTY,"February 08, 2021",20000,NCT04393649,ESOGER,CANADA,Recruiting,Jewish General Hospital,"April 20, 2020",Observational [Patient Registry],First Level Socio-geriatric Evaluation in Period of Physical and Social Distancing in Frail Older Patients and Older Community Dwellers: ESOGER Databank
1734,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,COVID; SARS-CoV2,"February 08, 2021",1,NCT04393727,CONVALESCENT PLASMA,ITALY,Terminated,"Azienda Ospedaliero, Universitaria Pisana","May 1, 2020",Interventional,Transfusion of Convalescent Plasma for the Early Treatment of pneumonIa Due to SARSCoV2: a Multicenter Open Label Randomized Control Trial
1735,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04393792,POVIDONE-IODINE; NORMAL SALINE,UNITED KINGDOM,Recruiting,Hampshire Hospitals NHS Foundation Trust,May 2020,Interventional,Can a Sinus Rinse and Mouth Wash Reduce Viral Load in COVID-19 Positive Individuals and Their Co-residents?
1736,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,COVID; HYPERCOAGULABILITY,"February 08, 2021",877,NCT04393805,LOW MOLECULAR WEIGHT HEPARIN,ITALY,Recruiting,Quovadis Associazione,"June 1, 2020",Observational,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto
1737,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,MENTAL HEALTH DISORDER; DEPRESSION; POSTTRAUMATIC STRESS DISORDER; BURNOUT; ANXIETY DISORDERS,"February 08, 2021",560,NCT04393818,INTERVENTION APP,SPAIN,Completed,Fundació d'investigació Sanitària de les Illes Balears,"May 5, 2020",Interventional,A Double-blinded Randomized Controlled Trial to Examine the Effectiveness of a Mobile-based Intervention to Reduce Mental Health Problems in Healthcare Workers at the Frontline Against COVID-19 in Spain: the PsyCovidApp Trial
1738,Lung Irradiation for COVID-19 Pneumonia,SARS-CoV2,"February 08, 2021",48,NCT04393948,PHASE 1; PHASE 1; PHASE 2; PHASE 2; PHASE 2,UNITED STATES,Recruiting,Brigham and Women's Hospital,June 2020,Interventional,Pilot Study of Low-Dose Single or Bilateral Whole Lung Irradiation for SARS-CoV-2 Pneumonia
1739,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,COVID; COVID; CORONAVIRUS,"February 08, 2021",600,NCT04393961,PREMIER BIOTECH COVID-19 IGG/IGM RAPID TEST CASSETTE,UNITED STATES,Recruiting,ProofPilot,"April 5, 2020",Interventional,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
1740,COVID-19 and Cancer Patients,CANCER; SARS-CoV2,"February 08, 2021",1000,NCT04393974,,UNITED KINGDOM,Recruiting,Imperial College London,"March 24, 2020",Observational,OnCovid: Natural History and Outcomes of Cancer Patients During the COVID19 Epidemic
1741,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,COVID; THROMBOEMBOLISM,"February 08, 2021",72,NCT04394000,THROMBOPROFYLAXIS PROTOCOL; STANDARD PROTOCOL,BELGIUM,Completed,Jessa Hospital,"May 4, 2020",Observational [Patient Registry],Impact of Implementation of an Intensified Thromboprofylaxis Protocol in in Critically Ill ICU Patients With COVID-19: a Longitudinal Controlled Before-after Study
1742,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,MENTAL HEALTH ISSUE,"February 08, 2021",70,NCT04394013,MINDFULNESS INTERVENTION; NON-MINDFULNESS INTERVENTION,MALAYSIA,Recruiting,Monash University Malaysia,"August 26, 2020",Interventional,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period
1743,Imaging Feature of SARS-CoV2 Infection,VIRAL PNEUMONIA; COVID,"February 08, 2021",500,NCT04394026,,ITALY,Recruiting,Francesco De Cobelli,"April 16, 2020",Observational,COVID-19 Imaging Features
1744,Post-Pandemic Perception of Public Space in Singapore,STRESS; ANXIETY,"February 08, 2021",34,NCT04394039,PUBLIC SPACE EXPOSURE,SINGAPORE,Not yet recruiting,"National University, Singapore","June 1, 2020",Interventional,Effects of COVID-19-Related Self-isolation on Psychological Response to Different Outdoor Environments in Singapore - Before & After Brain and Behavior Study
1745,Impact of COVID-19 Pandemic on Depression and Quality of Life,DEPRESSION; QUALITY OF LIFE; COVID; SOCIAL ISOLATION,"February 08, 2021",543,NCT04394078,ONLINE SURVEY,TURKEY,Completed,Okan University,"May 6, 2020",Observational,Impact of COVID-19 Pandemic on Depression and Quality of Life: Cross Sectional Study on Turkish Society and Suggestions on Potential Solution
1746,COVID-19 Wellness Survey,HEALTH BEHAVIOR,"February 08, 2021",593,NCT04394104,SURVEY,UNITED STATES,Terminated,"Rutgers, The State University of New Jersey","May 27, 2020",Observational,COVID-19 Health and Wellness Self-Assessment Survey
1747,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,SARS-CoV2; COVID,"February 08, 2021",1500,NCT04394117,ANGIOTENSIN RECEPTOR BLOCKERS; PLACEBO,AUSTRALIA,Recruiting,The George Institute,"June 19, 2020",Interventional,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
1748,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,POST ICU SYNDROME; CHRONIC PAIN; COVID,"February 08, 2021",102,NCT04394169,INTERVENTION PROGRAM,SPAIN,Recruiting,Hospital Clinic of Barcelona,"May 25, 2020",Interventional,"Early Care, Therapeutic Education, and Psychological Intervention for the Management of Post-intensive Care Syndrome and Chronic Pain After Coronavirus Disease 2019 Infection. Simple-blind, Controlled, Randomized Trial."
1749,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,"PNEUMONIA, VIRAL; CYTOKINE STORM","February 08, 2021",15,NCT04394182,ULTRA-LOW-DOSE RADIOTHERAPY; VENTILATORY SUPPORT WITH OXYGEN THERAPY; LOPINAVIR/RITONAVIR; HYDROXYCHLOROQUINE; AZITHROMYCIN; PIPERACILLIN/TAZOBACTAM; LOW MOLECULAR WEIGHT HEPARIN; CORTICOSTEROID INJECTION; TOCILIZUMAB,SPAIN,Recruiting,Fundacion GenesisCare,"April 21, 2020",Interventional,Low Doses of Lung Radiation Therapy in Cases of COVID-19 Pneumonia: Prospective Multicentric Study in Radiation Oncology Centers
1750,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04394195,MEASUREMENT OF CIRCULATING SFLT1 CONCENTRATION,FRANCE,Recruiting,CHU de Reims,"March 25, 2020",Observational,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?
1751,Silymarin in COVID-19 Pneumonia,COVID; VIRAL PNEUMONIA HUMAN CORONAVIRUS,"February 08, 2021",50,NCT04394208,SILYMARIN; PLACEBO,EGYPT,Recruiting,Cairo University,"August 16, 2020",Interventional,Trial of Silymarin in Adults With COVID-19 Pneumonia
1752,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,CORONAVIRUS INFECTION,"February 08, 2021",600,NCT04394377,GROUP 1: RIVAROXABAN 20MG/D FOLLOWED BY ENOXAPARIN/UNFRACTIONATED HEPARIN WHEN NEEDED; GROUP 2: CONTROL GROUP WITH ENOXAPARIN 40MG/D,BRAZIL,Recruiting,Brazilian Clinical Research Institute,"June 21, 2020",Interventional,Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients With Coronavirus (COVID-19) - COALIZAO ACTION Trial
1753,Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?,COVID,"February 08, 2021",100,NCT04394390,VITAMIN D,TURKEY,Enrolling by invitation,Bursa City Hospital,"May 1, 2020",Observational [Patient Registry],Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?
1754,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,"STRESS; STRESS, PSYCHOLOGICAL","February 08, 2021",120,NCT04394403,INTERNET-BASED GUIDED SELF-HELP BASED ON CBT PRINCIPLES,ISRAEL,Recruiting,Hebrew University of Jerusalem,"May 14, 2020",Interventional,Pilot Internet-based Self-Help Program for Managing Corona Stress vs. Waitlist Control
1755,Trial of Imatinib for Hospitalized Adults With COVID-19,COVID,"February 08, 2021",204,NCT04394416,IMATINIB; PLACEBO ORAL TABLET,UNITED STATES,Recruiting,"University of Maryland, Baltimore","June 2, 2020",Interventional,Randomized Double-Blind Placebo-Controlled Trial on the Safety and Efficacy of Imatinib for Hospitalized Adults With COVID-19
1756,Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,SARS-CoV2,"February 08, 2021",184,NCT04394429,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 24, 2020",Observational,Analysis of Events of Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation
1757,Hydroxychloroquine in COVID-19 Patients,COVID,"February 08, 2021",200,NCT04394442,HYDROXYCHLOROQUINE,SAUDI ARABIA,Recruiting,Samah Lutfy,"March 21, 2020",Interventional,Use of Hydroxychloroquine in Patients With COVID-19: A Randomized Controlled Clinical Trial
1758,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,ANXIETY; DEPRESSIVE SYMPTOMS; POST TRAUMATIC STRESS SYMPTOMS; PERCEIVED STRESS,"February 08, 2021",236,NCT04394455,BRIEF COGNITIVE BEHAVIORAL THERAPY; CRISIS INTERVENTION THERAPY,HONDURAS,Enrolling by invitation,Universidad Nacional Autonoma de Honduras,"June 30, 2020",Interventional,Effect of Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry in Medical Staff During the COVID-19 Pandemic: A Multicentric Randomized Controlled Trial
1759,Low Dose Radiation Therapy for Covid-19 Pneumonia,COVID; PNEUMONIA,"February 08, 2021",10,NCT04394793,LOW DOSE RADIATION THERAPY,INDIA,"Active, not recruiting","All India Institute of Medical Sciences, New Delhi","June 13, 2020",Interventional,Low Dose Radiation Therapy for Covid-19 Pneumonia: A Pilot Study
1760,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND),COVID,"February 08, 2021",120,NCT04394884,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19
1761,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial","RESPIRATORY DISTRESS SYNDROME, ADULT; COVID","February 08, 2021",284,NCT04395105,DEXAMETHASONE (HIGH DOSE),ARGENTINA,Recruiting,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,"May 21, 2020",Interventional,High Versus Low Dose Dexamethasone for the Treatment of COVID-19 Related ARDS: a Multicenter and Randomized Open-label Clinical Trial
1762,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,CORONAVIRUS INFECTION; COVID; SEVERE ACUTE RESPIRATORY SYNDROME; RESPIRATORY FAILURE; RESPIRATORY INSUFFICIENCY; RESPIRATORY DISTRESS SYNDROME; ARDS; LUNG DISEASES,"February 08, 2021",346,NCT04395144,AWAKE PRONE POSITIONING; STANDARD CARE,CANADA,Recruiting,Hôpital de Verdun,"May 15, 2020",Interventional,Randomized-controlled Trial of HFNC Alone vs HFNC and Awake Self-proning for Treatment of Severe COVID-19
1763,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",75,NCT04395170,COVID-19 CONVALESCENT PLASMA; ANTI-COVID-19 HUMAN IMMUNOGLOBULIN; STANDARD (SPECIFIC) THERAPY FOR COVID-19,COLOMBIA,Not yet recruiting,"Lifefactors Zona Franca, SAS",September 2020,Interventional,"A Randomized, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Use of Convalescent Plasma (PC) and Human Intravenous Anti COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19."
1764,Sleep Quality in Healthcare Personnel During COVID-19,COVID; SLEEP QUALITY; GENERAL HEALTH,"February 08, 2021",143,NCT04395300,WEB BASED SURVEY,EGYPT,Completed,Assiut University,"March 30, 2020",Observational,Sleep Quality and Effect on General Health in Healthcare Personnel During COVID-19 Pandemic
1765,Home Usability Study of the SARS-CoV-2 (COVID-19) Test,COVID,"February 08, 2021",30,NCT04395391,SARS-COV-2,UNITED STATES,Completed,Exact Sciences Corporation,"May 18, 2020",Observational,Usability Study of Home Collection and Mailing With SARS-CoV-2 Test Specimen Collection Materials (2020-06)
1766,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,PEDIATRIC OBESITY; CLINICAL TRIAL,"February 08, 2021",40,NCT04395430,USUAL CARE; ONLINE KKH SPORTS SINGAPORE PROGRAM WITH USUAL CARE,,Not yet recruiting,KK Women's and Children's Hospital,"September 1, 2020",Interventional,Adapting the US-based Clinic-community Model of Child Obesity Treatment Into an Online Intervention Model in Singapore During COVID-19
1767,A Phase 2 Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),ACUTE RESPIRATORY DISTRESS SYNDROME DUE TO SARS-CoV2 INFECTION (SEVERE COVID),"February 08, 2021",144,NCT04395456,AMY-101; WFI 5% GLUCOSE,,Not yet recruiting,Amyndas Pharmaceuticals S.A.,July 2020,Interventional,"A Phase 2 Clinical Trial to Assess the Safety and Efficacy of Complement 3 Inhibitor, AMY-101, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 (SAVE)"
1768,Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,COVID,"February 08, 2021",500,NCT04395482,LUNG CT SCAN ANALYSIS IN COVID-19 PATIENTS,ITALY,Recruiting,University of Milano Bicocca,"May 7, 2020",Observational,Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury by Machine Learning: a Multicenter Retrospective Cohort Study.
1769,An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic,HER2-POSITIVE BREAST CANCER,"February 08, 2021",,NCT04395508,FIXED-DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB FOR SUBCUTANEOUS ADMINISTRATION (PH FDC SC),UNITED STATES,Available,"Genentech, Inc.",,Expanded Access,"An Expanded Access, Single-Arm, Multicenter Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic"
1770,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,SARS-CoV2; SURGERY; COVID,"February 08, 2021",40,NCT04395599,"CARTOGRAPHY OF AIR CONTAMINATION, ENVIRONMENT CONTAMINATION AND BIOLOGICAL FLUID BY SARS-COV2 DURING VISCERAL SURGERY IN COVID19 PATIENTS.",,Not yet recruiting,"University Hospital, Lille",May 2020,Interventional,Assessment of Air Contamination Risk by Sars-Cov2 During Visceral Surgery in COVID19 Patients: Pilot Study.
1771,Arrhythmias in Patients With COVID-19,COVID,"February 08, 2021",1000,NCT04395664,C3+ HOLTER MONITOR,DENMARK,Completed,Herlev and Gentofte Hospital,"April 16, 2020",Observational,The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring
1772,A Study of ResCure™ to Treat COVID-19 Infection,COVID; COVID; CORONAVIRUS INFECTION; SARS-CoV2; CORONAVIRUS-19; SARS PNEUMONIA; SARS-ASSOCIATED CORONAVIRUS AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE,"February 08, 2021",50,NCT04395716,RESCURE™,UNITED STATES,Not yet recruiting,ProgenaBiome,July 2020,Interventional,A Phase I Study of ResCure™ to Treat COVID-19 Infection
1773,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",CORONAVIRUS DISEASE 2019,"February 08, 2021",93,NCT04395742,DATA COLLECTION,,Not yet recruiting,Poitiers University Hospital,May 2020,Observational,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study"
1774,Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed,"INFERTILITY, FEMALE; ART; IVF; COVID","February 08, 2021",503,NCT04395755,GENERALIZED ANXIETY DISORDER-7 (GAD-7); PATIENT HEALTH QUESTIONNAIRE-9 (PHQ-9),ITALY,Completed,Ospedale Policlinico San Martino,"April 1, 2020",Observational,Impact of COVID-19 Pandemic on the Psychological Status of Infertile Patients Who Had in Vitro Fertilization Treatment Interrupted or Postponed
1775,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,COVID,"February 08, 2021",200,NCT04395768,VITAMIN C; HYDROXYCHLOROQUINE; AZITHROMYCIN; ZINC CITRATE; VITAMIN D3; VITAMIN B12,AUSTRALIA,Recruiting,"National Institute of Integrative Medicine, Australia","September 9, 2020",Interventional,"Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, Vitamin D, Vitamin B12 With or Without Vitamin C, a Multi-centre, International, Randomized Trial: The International ALLIANCE Study"
1776,Pediatric Acute and Critical Care COVID-19 Registry of Asia,COVID; PEDIATRIC DISORDER,"February 08, 2021",2000,NCT04395781,,CHINA,Recruiting,KK Women's and Children's Hospital,"May 18, 2020",Observational [Patient Registry],Pediatric Acute and Critical Care COVID-19 Registry of Asia
1777,SARS-CoV-2 Disguise Study,SARS-CoV2,"February 08, 2021",900,NCT04395794,SARS-COV-2-TEST; SARS-COV-2 QUESTIONNAIRE SURVEY,RUSSIAN FEDERATION,Recruiting,Meshalkin Research Institute of Pathology of Circulation,"May 7, 2020",Observational [Patient Registry],SARS-CoV-2 Positive Carriers Among Asymptomatic meDIcal employeeS in hiGh-volUme cardIovaScular cEnter
1778,Helmet CPAP Versus HFNC in COVID-19,COVID; ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",120,NCT04395807,HELMET CPAP; HFNC,SWEDEN,Recruiting,Lund University,"June 3, 2020",Interventional,Helmet Continuous Positive Airway Pressure Versus High-Flow Nasal Cannula in COVID-19: A Pragmatic Randomised Clinical Trial
1779,National Survey on the Lockdown of Children With Disabilities,IDENTIFY EMERGING HEALTH CHALLENGES FOR CHILDREN WITH MOTOR DISABILITIES AND THEIR PARENTS FACING THE COVID PANDEMIC,"February 08, 2021",2500,NCT04395833,,FRANCE,Completed,"University Hospital, Brest","April 7, 2020",Observational,Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic: Messages From Families Answering the ECHO French National Survey
1780,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,AGE RELATED MACULAR DEGENERATION; DIABETIC MACULAR EDEMA; RETINAL VEIN OCCLUSION,"February 08, 2021",1500,NCT04395859,QUESTIONNAIRE; DATA COLLECTION UP TO 1 YEAR,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"May 27, 2020",Observational,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents
1781,Psychiatric Consultation for COVID-19 Patients,"COVID; PSYCHIATRIC PROBLEM; ISOLATION, SOCIAL","February 08, 2021",54,NCT04395872,PSYCHIATRIC COUNSELING,,Not yet recruiting,Daegu Catholic University Medical Center,"May 28, 2020",Observational,Psychiatric Consultation for COVID-19 Patients
1782,Sexual Function During COVID 19 Pandemic,SEXUAL DYSFUNCTION,"February 08, 2021",306,NCT04395885,ELECTRONIC QUESTIONNAIRE,EGYPT,Completed,Assiut University,"June 1, 2020",Observational,Sexual Function Among Egyptian Healthcare Professionals During COVID 19 Pandemic
1783,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,AKI; ARDS; COVID,"February 08, 2021",30,NCT04395911,SCD,UNITED STATES,Recruiting,SeaStar Medical,"September 10, 2020",Interventional,A Multi-Center Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Patients Developing Acute Kidney Injury (AKI) or Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 Infection
1784,Maternal-foetal Transmission of SARS-Cov-2,MATERNAL FETAL INFECTION TRANSMISSION; COVID; SARS-CoV2,"February 08, 2021",50,NCT04395924,"DIAGNOSIS OF SARS-COV2 BY RT-PCR AND : IGG, IG M SEROLOGIES IN THE AMNIOTOC FLUID, THE BLOOD CORD AND THE PLACENTA",FRANCE,Recruiting,Centre Hospitalier Régional d'Orléans,"May 5, 2020",Observational,Maternal-Foetal Transmission of COVID-19
1785,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,COVID,"February 08, 2021",120,NCT04395976,AYURVEDA,UNITED KINGDOM,Not yet recruiting,British Ayurvedic Medical Council,"June 10, 2020",Interventional,Effect of Ayurveda as Prophylaxis for Suspected Covid-19 Patients: Randomised Controlled Trial
1786,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,COVID,"February 08, 2021",360,NCT04396067,AEROSOLIZED 13 CIS RETINOIC ACID; AEROSOLIZED ALL TRANS RETINOIC ACID; PLACEBO,,Not yet recruiting,Kafrelsheikh University,October 2020,Interventional,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
1787,Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),COVID,"February 08, 2021",190,NCT04396106,AT-527; PLACEBO,BELGIUM,Recruiting,"Atea Pharmaceuticals, Inc.","May 26, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-527 in Subjects With Moderate COVID-19"
1788,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,COVID; CRITICAL ILLNESS; ARDS; ICU ACQUIRED WEAKNESS,"February 08, 2021",92,NCT04396197,PHYSIOTHERAPY,UNITED KINGDOM,Completed,University Hospital Birmingham NHS Foundation Trust,"March 1, 2020",Observational,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care Requiring Invasive Ventilation: An Observational Study
1789,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,CORONAVIRUS; COVID; ART; FERTILITY ISSUES,"February 08, 2021",389,NCT04396210,QUESTIONNAIRE,BELGIUM,Completed,"University Hospital, Ghent","May 14, 2020",Observational,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic
1790,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,POSTTRAUMATIC STRESS DISORDER,"February 08, 2021",54,NCT04396314,BASIC BODY AWARENESS THERAPY; PSYCHOLOGICAL TREATMENT,,Not yet recruiting,Universitat de Lleida,"February 1, 2021",Interventional,"Effectiveness of Basic Body Awareness Therapy in Survivors of Covid-19, Health Workers and Women Suffering From Gender-based Violence Regarding Post-traumatic Stress Disorders: A Randomized Clinical Trial"
1791,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,COVID; SARS-CoV2; CORONAVIRUS INFECTION; SEDENTARY BEHAVIOR,"February 08, 2021",1574,NCT04396353,ELECTRONIC QUESTIONNAIRE,BRAZIL,Completed,University of Sao Paulo General Hospital,"June 4, 2020",Observational,"The Impact of EXercise TRAining, Physical Activity and Sedentary Lifestyle on Clinical Outcomes in Surviving Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2: Cross-sectional Study"
1792,The Professional Peer Resilience Initiative,"STRESS; STRESS DISORDER; STRESS, PSYCHOLOGICAL; TRAUMA, PSYCHOLOGICAL; ANXIETY; ANXIETY STATE; POST TRAUMATIC STRESS DISORDER; SECONDARY TRAUMATIC STRESS; PROFESSIONAL QUALITY OF LIFE; STRESS RELATED DISORDER; STRESS REACTION; STRESS RISK; MENTAL RESILIENCE; EMOTIONAL RESILIENCE","February 08, 2021",1200,NCT04396600,MINNRAP PEER SUPPORT PROGRAM,UNITED STATES,Enrolling by invitation,University of Minnesota,"June 8, 2020",Observational,The Professional Peer Resilience Initiative: Leveraging a Data-Driven Model to Maximize the Resilience of Healthcare Workers During the COVID-19 Pandemic
1793,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,COVID; CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",50,NCT04397172,STUDY ARM,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","April 9, 2020",Observational,"Characterization of ARDS, Critical Illness Myopathy and Their Long-term Consequences in Patients With Covid-19 Disease: Effects of Inflammation, Mitochondrial Dysfunction and Plasma Concentrations of Various Sedative Drugs"
1794,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,COVID; SYSTEMIC LUPUS ERYTHEMATOSUS; SJOGREN'S SYNDROME; AXIAL SPONDYLOARTHRITIS; RHEUMATOID ARTHRITIS; GIANT CELL ARTERITIS,"February 08, 2021",3100,NCT04397237,,FRANCE,"Active, not recruiting",Pitié-Salpêtrière Hospital,"June 10, 2020",Observational,"Prevalence, Seroconversion and Impact of COVID-19 in Autoimmune Diseases in Europe"
1795,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,COVID,"February 08, 2021",336,NCT04397328,HYDROXYCHLOROQUINE; PLACEBO,,Not yet recruiting,Lawson Health Research Institute,"May 19, 2020",Interventional,Safety and Efficacy of Post-exposure Prophylaxis With Hydroxychloroquine (HCQ) for the Prevention of COVID-19 in High-risk Older Individuals in Long-term and Specialized Care: A Double-blind Randomized Control Trial
1796,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,PYREXIA; COVID,"February 08, 2021",100,NCT04397380,THERMOGRAPHY; TYMPANIC TEMPERATURE,UNITED KINGDOM,Not yet recruiting,NHS Greater Clyde and Glasgow,"May 20, 2020",Observational,COVID-19 Response - Thermography Based Fever Detection for Triaging of Patients - A Feasibility Study
1797,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,HEALTHY VOLUNTEERS FOR BONE MARROW DONATION,"February 08, 2021",10,NCT04397471,BONE MARROW HARVEST,UNITED KINGDOM,Not yet recruiting,CCTU- Cancer Theme,May 2020,Observational,A Study to Collect Bone Marrow for Process Development and Production of Bone Marrow Mesenchymal Stromal Cells to Treat Severe COVID19 Pneumonitis
1798,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),"COVID; ACUTE RESPIRATORY FAILURE; ARDS, HUMAN; SARS-CoV2; VIRAL PNEUMONIA","February 08, 2021",50,NCT04397497,MAVRILIMUMAB; PLACEBO,ITALY,Not yet recruiting,Ospedale San Raffaele,"May 22, 2020",Interventional,"A Randomized, Double Blind, Placebo-controlled Trial of Mavrilimumab for Acute Respiratory Failure Due to COVID-19 Pneumonia With Hyper-inflammation (the COMBAT-19 Trial)"
1799,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,"COVID; ARDS, HUMAN; ACUTE LUNG INJURY","February 08, 2021",50,NCT04397510,HEPARIN; 0.9% SODIUM-CHLORIDE,UNITED STATES,Enrolling by invitation,Frederick Health,"June 1, 2020",Interventional,Nebulized Heparin vs. Placebo for the Treatment of COVID-19 Induced Lung Injury
1800,Efficacy and Safety of COVID-19 Convalescent Plasma,CONVALESCENT PLASMA; COVID; SARS-CoV2,"February 08, 2021",20,NCT04397523,ANTI-SARS-COV-2 CONVALESCENT PLASMA,NORTH MACEDONIA,Recruiting,Institute for Transfusion Medicine of RNM,"April 30, 2020",Interventional,Use of COVID-19 Convalescent Plasma in the Patients Infected With COVID-19 (SARS-CoV-2) - Efficacy and Safety
1801,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,COVID,"February 08, 2021",206,NCT04397562,LEVILIMAB; PLACEBO,RUSSIAN FEDERATION,Completed,Biocad,"April 29, 2020",Interventional,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptively Designed Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19"
1802,The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients,CANCER; COVID; SOLID TUMOR; SOCIAL INEQUALITY; FRENCH NATIONAL COHORT; CHEMOTHERAPY; IMMUNOTHERAPY; SURGERY; RADIOTHERAPY,"February 08, 2021",1509,NCT04397575,,FRANCE,"Active, not recruiting",Federation Francophone de Cancerologie Digestive,"April 3, 2020",Observational [Patient Registry],Cohorte Non Interventionnelle Ambispective Nationale Multicentrique de Patients Suivis Pour Cancer et infectés Par le SARS-CoV-2
1803,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,ARDS RELATED TO SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS (SARS-COV) 2; ACUTE REFRACTORY HEART FAILURE RELATED TO SARS-CoV2,"February 08, 2021",300,NCT04397588,,FRANCE,Recruiting,Rennes University Hospital,"April 21, 2020",Observational,Extracorporeal Membrane Oxygenation (ECMO) as a Therapeutic Option in Severe Form of COVID-19: a Nationwide Cohort Study
1804,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,SARS-CoV2; COVID,"February 08, 2021",500,NCT04397614,MHEALTH ASSESSMENTS,UNITED STATES,Recruiting,University of Oklahoma,"July 22, 2020",Observational,Mobile Health Study and Enhanced Symptom Monitoring to Prevent Severe Illness From COVID-19 in Cancer Patients
1805,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,SARS-COV INFECTION; PINKEYE,"February 08, 2021",68,NCT04397666,CONJUNCTIVAL RT PCR,FRANCE,Recruiting,Versailles Hospital,"May 15, 2020",Interventional,RT-PCR on Conjunctival Sample for the Detection of SARS-Cov-2 in Patients With Covid-19
1806,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),"CORONAVIRUS INFECTION; COVID; SARS-CoV2; NITRIC OXIDE; RESPIRATORY DISEASE; PNEUMONIA, VIRAL; INHALED NITRIC OXIDE","February 08, 2021",20,NCT04397692,NITRIC OXIDE DELIVERED VIA LUNGFIT™ SYSTEM,UNITED STATES,Recruiting,Beyond Air Inc.,"June 13, 2020",Interventional,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
1807,Remote Monitoring of Cancer Patients With Suspected Covid-19,COVID; ONCOLOGY; HAEMATOLOGICAL MALIGNANCY,"February 08, 2021",30,NCT04397705,PATIENT STATUS ENGINE,UNITED KINGDOM,Not yet recruiting,The Christie NHS Foundation Trust,June 2020,Interventional,Remote Monitoring of Cancer Patients Presenting With Symptoms Suggestive of Covid-19 - Pilot Phase.
1808,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,COVID,"February 08, 2021",198,NCT04397718,DEGARELIX; SALINE,UNITED STATES,Recruiting,VA Office of Research and Development,"July 6, 2020",Interventional,"Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization (HITCH): A Multicenter, Phase 2 Randomized Controlled Trial of Best Supportive Care (BSC) vs BSC Plus Degarelix"
1809,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,COVID,"February 08, 2021",80,NCT04397757,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"May 13, 2020",Interventional,"An Open-Label, Controlled, Phase 1, Safety and Exploratory Efficacy Study of Convalescent Plasma for Severely Ill, Hospitalized Participants With COVID-19 Pneumonia Caused by SARS-CoV-2."
1810,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,COVID,"February 08, 2021",45,NCT04397796,BM-ALLO.MSC; PLACEBO,UNITED STATES,Recruiting,"NantKwest, Inc.","August 3, 2020",Interventional,"Phase 1b Randomized, Double-Blind, Placebo-Controlled Study Of The Safety Of Therapeutic Treatment With Immunomodulatory Mesenchymal Stem Cells In Adults With COVID-19 Infection Requiring Mechanical Ventilation"
1811,COVID-19 : Study of INFLAmmasome and PLAtelets Functions,COVID,"February 08, 2021",110,NCT04397822,BLOOD SAMPLES,FRANCE,Recruiting,"University Hospital, Toulouse","April 16, 2020",Observational,Study of INFLAmmasome NLRP3 and PLAtelets Functions During Severe COVID-19 Infection
1812,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,COVID; ANXIETY; DEPRESSION; STRESS,"February 08, 2021",800,NCT04397835,,FRANCE,Recruiting,"University Hospital, Toulouse","April 17, 2020",Observational,Psychological Impact of Quarantine During the COVID-19 Outbreak and Worsening of Cardiovascular Risk in the French General Population: a Prospective Cohort Study
1813,Mental Health Outcomes in Healthcare Workers During COVID-19,MENTAL HEALTH WELLNESS 1; PTSD; ANXIETY; STRESS; DEPRESSION; COVID; HEALTHCARE WORKERS,"February 08, 2021",3852,NCT04397848,,CANADA,Completed,"University Health Network, Toronto","May 14, 2020",Observational,Hearing and Supporting the Healthcare Workers: Mental Health Outcomes in Healthcare Workers During COVID-19
1814,Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes,IDENTIFY THE VIRAL EPITOPES OF MEMORY CD8 T CELLS FROM INDIVIDUALS THAT HAVE RECOVERED FROM SARS-CoV2 INFECTION; DETERMINE WHICH SARS-CoV2 PROTEINS ARE FREQUENTLY RECOGNIZED BY T CELLS IN PATIENTS WITH VARYING HLA TYPES,"February 08, 2021",80,NCT04397900,,UNITED STATES,Recruiting,"TScan Therapeutics, Inc.","April 9, 2020",Observational,A Blood Collection Study From Volunteers Who Have Recovered From COVID-19 Infection to Identify Immunogenic Viral Epitopes in SARS-CoV-2
1815,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,COVID; MYOCARDIAL REPERFUSION INJURY; CARDIOVASCULAR DISEASES,"February 08, 2021",5000,NCT04397939,,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"May 8, 2020",Observational,Association of Early Myocardial Injury With Major Adverse Outcomes in Patients With COVID-19
1816,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,COVID; VIRUS DISEASES; CORONAVIRUS INFECTION,"February 08, 2021",90,NCT04398004,CLARITHROMYCIN,GREECE,Completed,Hellenic Institute for the Study of Sepsis,"May 6, 2020",Interventional,Anti-inflammatory Clarithromycin to Improve SARS-CoV-2 (COVID-19) Infection Early: The ACHIEVE Open-label Non-randomized Clinical Trial
1817,SARS-CoV 2 in Personal Protective Equipment,RT PCR; COVID; PERSONAL PROTECTIVE EQUIPMENT PPE; SARS-CoV2; HEALTH PERSONNEL ATTITUDE; VIRUS DISEASES,"February 08, 2021",16,NCT04398043,,,Not yet recruiting,Hospital de Clinicas José de San Martín,"May 15, 2020",Observational,Searching for SARS-CoV 2 in Personal Protective Equipment in Physicians in a University Hospital
1818,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,COVID,"February 08, 2021",696,NCT04398147,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR); PLACEBO,CANADA,Not yet recruiting,CanSino Biologics Inc.,"August 1, 2020",Interventional,"A Randomized, Observer-Blind, Dose-escalation Phase I/II Clinical Trial of Ad5-nCoV Vaccine in Healthy Adults From 18 to <85 Years of Age in Canada"
1819,Characteristics of COVID-19 Infection Among PREGnant Women,CORONAVIRUS INFECTION; PREGNANCY RELATED,"February 08, 2021",100,NCT04398264,COVID-19 POSITIVE VIA TESTING,UNITED STATES,Recruiting,Inova Health System,"July 22, 2020",Observational [Patient Registry],Characteristics of COVID-19 Infection Among PREGnant Women
1820,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,PSYCHOLOGICAL STRESS,"February 08, 2021",1000,NCT04398277,DAILY COPING TOOLKIT,UNITED STATES,Recruiting,Kent State University,"May 1, 2020",Interventional,A Daily Coping Toolkit for Medical Personnel and First-Responders During the COVID-19 Pandemic
1821,iNOPulse for COVID-19,COVID; HYPOXEMIA; HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",0,NCT04398290,INHALED NITRIC OXIDE (INO); NITROGEN GAS; OXYGEN GAS,UNITED STATES,Withdrawn,Roger Alvarez,"December 1, 2020",Interventional,Randomized Controlled Trial Of A Delivered Continuously By Nasal Cannula For The Treatment Of Patients With COVID-19 And Mild To Moderate Hypoxemia Requiring Supplemental Oxygen
1822,ACT-20 in Patients With Severe COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",70,NCT04398303,ACT-20-MSC; ACT-20-CM; PLACEBO,,Not yet recruiting,Aspire Health Science,May 2020,Interventional,"A Phase 1/2 Randomized, Placebo-Controlled Trial of ACT-20 in Patients With Severe COVID-19 Pneumonia"
1823,Evaluation of the Nextdoor KIND Challenge,LONELINESS; SOCIAL ISOLATION,"February 08, 2021",9000,NCT04398472,KIND CHALLENGE,AUSTRALIA,Not yet recruiting,Swinburne University of Technology,"July 7, 2020",Interventional,Evaluation of the Nextdoor KIND Challenge
1824,The Efficacy Comparing Daily and After-each-case Room Disinfection.,DAILY ROOM DISINFECTION; AFTER-EACH-CASE ROOM DISINFECTION,"February 08, 2021",240,NCT04399005,AFTER-EACH-CASE ROOM DISINFECTION; DAILY ROOM DISINFECTION,CHINA,Completed,The First Affiliated Hospital of Zhejiang Chinese Medical University,"May 25, 2020",Interventional,The Efficacy Comparing Daily and After-each-case Room Disinfection in the Endoscopy Unit During the COVID-19 Pandemic.
1825,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),COVID,"February 08, 2021",2000,NCT04399109,TCC-COVID MHEALTH SOLUTION,AUSTRALIA,Recruiting,Dr Sze-Yuan Ooi,"May 20, 2020",Interventional,ReCOVER (Remote COVID-19 Evaluation and Response): a Prospective Non-randomised Controlled Trial to Evaluate the Effect of a Novel Smartphone Application-centric Model of Care for the Remote Monitoring of COVID-19 Patients in the Community.
1826,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,MICROBIOME,"February 08, 2021",1000,NCT04399252,LACTOBACILTUS RHAMNOSUS GG; LACTOBACILTUS RHAMNOSUS GG PLACEBO,UNITED STATES,Recruiting,Duke University,"June 24, 2020",Interventional,A Randomized Trial of the Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19
1827,Flow Controlled Ventilation in ARDS Associated With COVID-19,ARDS ASSOCIATED WITH COVID,"February 08, 2021",20,NCT04399317,FLOW CONTROLLED VENTILATION (EVONE-VENTILATOR),QATAR,Recruiting,Hamad Medical Corporation,"May 28, 2020",Interventional,Flow Controlled Ventilation in ARDS Associated With COVID-19
1828,Niclosamide for Mild to Moderate COVID-19,COVID,"February 08, 2021",100,NCT04399356,NICLOSAMIDE; PLACEBO; TELEHEALTH MONITORING,UNITED STATES,Recruiting,Tufts Medical Center,"October 1, 2020",Interventional,Niclosamide for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19)
1829,Mechanisms of Multi-organ Failure in COVID-19,COVID,"February 08, 2021",120,NCT04399603,NO INTERVENTION-MECHANISTIC STUDY,UNITED KINGDOM,Not yet recruiting,Imperial College London,"May 18, 2020",Observational,Multi-organ Failure in SARS-CoV2: Identifying Mechanisms and Potential Therapeutic Targets
1830,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,"COVID; PNEUMONIA, VIRAL","February 08, 2021",100,NCT04399681,BEDSIDE LUNG ULTRASOUND,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 10, 2020",Interventional,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 at Emergency Department
1831,EMPOWER - BAME vs COVID,"COVID, SARS-CoV2 INFECTION; HEALTH DISPARITIES","February 08, 2021",12800,NCT04399733,,UNITED KINGDOM,Not yet recruiting,Future Genetics Limited,"February 1, 2021",Observational,EMPOWER - BAME vs COVID: A Multi-site Clinical Cohort Research Study to Identify Genetic Associations and Candidate Therapeutic Targets to Reduce COVID-19 Morbidity & Mortality Rates in BAME Populations
1832,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,COVID,"February 08, 2021",30,NCT04399746,IVERMECTIN; AZITHROMYCIN; CHOLECALCIFEROL,MEXICO,Recruiting,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,"March 15, 2020",Interventional,A Pilot Study for COVID-19 Outpatient Treatment With the Combination of Ivermectin-azithromycin-cholecalciferol
1833,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,CORONAVIRUS INFECTION,"February 08, 2021",13,NCT04399798,BARICITINIB,,Not yet recruiting,IRCCS Policlinico S. Matteo,"May 15, 2020",Interventional,"A proof-of Concept Study of the Use of Janus Kinase 1 and 2 Inhibitor, Baricitinib, in the Treatment of COVID-19-related Pneumonia"
1834,hCT-MSCs for COVID19 ARDS,COVID; CORONAVIRUS INFECTION; COVID,"February 08, 2021",30,NCT04399889,HUMAN CORD TISSUE MESENCHYMAL STROMAL CELLS,UNITED STATES,Recruiting,"Joanne Kurtzberg, MD","June 18, 2020",Interventional,Pilot Study of Safety and Efficacy of Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC) in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
1835,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",SMOKING CESSATION,"February 08, 2021",842,NCT04399967,CHAT-BASED SUPPORT; AWARD PLUS COVID-SPECIFIC ADVICE; AWARD ADVICE; COVID-19 RELATED HEALTH WARNING LEAFLET; HEALTH WARNING LEAFLET; SMS-BASED SUPPORT; REFERRAL CARD; COSH SELF-HELP SMOKING CESSATION BOOKLET,CHINA,Recruiting,The University of Hong Kong,"June 13, 2020",Interventional,"Building Capacity and Promoting Smoking Cessation in the Community Via ""Quit to Win"" Contest 2020: a Single-blind Randomized Controlled Trial on COVID-19 Related Brief Advice and Personalized Chat-based Intervention for Smoking Cessation"
1836,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,COVID; SARS-CoV2; PNEUMONIA,"February 08, 2021",30,NCT04399980,MAVRILIMUMAB; PLACEBOS,UNITED STATES,"Active, not recruiting",The Cleveland Clinic,"May 20, 2020",Interventional,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation
1837,Ozone Therapy in the Prevention of COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",71,NCT04400006,,TURKEY,Completed,Marmara University,"May 6, 2020",Observational,The Effectiveness of Ozone Therapy in the Prevention of COVID-19 Infection
1838,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),SARS-CoV2; CORONAVIRUS INFECTION; PREVENTION & CONTROL; NURSING HOME; HYDROXYCHLOROQUINE,"February 08, 2021",1930,NCT04400019,HYDROXYCHLOROQUINE ONLY PRODUCT IN ORAL DOSE FORM,,Not yet recruiting,University of Malaga,September 2020,Interventional,"Prevention of COVID19 Infection by the Administration of Hydroxychloroquine to Institutionalized Older People and Nursing Home Staff. Controlled Clinical Trial, Randomized Triple Blind by Clusters (PREVICHARM Study)"
1839,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",9,NCT04400032,MESENCHYMAL STROMAL CELLS,CANADA,Recruiting,Ottawa Hospital Research Institute,"May 15, 2020",Interventional,Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19) the Vanguard Study
1840,Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,COVID,"February 08, 2021",208,NCT04400058,OCTAGAM 10%; PLACEBO,RUSSIAN FEDERATION,"Active, not recruiting",Octapharma,"June 1, 2020",Interventional,Efficacy and Safety of Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression
1841,The COVID-19 Pandemic and Exercise Study,DEPRESSIVE SYMPTOMATOLOGY; PSYCHOLOGICAL DISTRESS; HEALTH BEHAVIOR,"February 08, 2021",334,NCT04400279,YOGA GROUP; HIGH INTENSITY INTERVAL TRAINING GROUP; COMBINATION,CANADA,Completed,University of British Columbia,"June 1, 2020",Interventional,COvid-19 Pandemic and Exercise (COPE) Trial: A Randomized Study Examining Physical Activities and Wellbeing in Individuals Mandated to Stay at Home
1842,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""","PHYSICAL ACTIVITY, HEALTHY PROMOTION","February 08, 2021",40,NCT04400305,DIGITAL HEALTH ONLINE PLATFORM,CANADA,Recruiting,University of Victoria,"May 20, 2020",Interventional,"""Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention"""
1843,Acceptance of Telemedicine During the COVID-19 Pandemic,COVID,"February 08, 2021",200,NCT04400448,,,Not yet recruiting,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,"June 1, 2020",Observational [Patient Registry],"Acceptance of Telemedicine in Outpatient Clinic Consultations During COVID-19 Pandemic. An International, Cross-sectional Study"
1844,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation,COVID,"February 08, 2021",50,NCT04400461,DATA COLLECTION AND CLINICAL TESTING OF SUBJECTS,SPAIN,Recruiting,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,"May 15, 2020",Observational,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation: A Cross-sectional Study
1845,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions",BIOEQUIVALENCE,"February 08, 2021",30,NCT04400682,FAVIRA 200 MG FILM TABLET; AVIGAN 200 MG FILM TABLETS,TURKEY,Completed,Novelfarma Ilaç San. ve Tic. Ltd. Sti.,"May 28, 2020",Interventional,"Open-label, Randomised, Single Oral Dose, Two-period, Cross-over Trial to Assess to Bioequivalence of Favira 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions"
1846,Esophagogastroduodenoscopy (EGD) is an Aerosol-generating Procedure: Proof of Concept Study,"AEROSOL-GENERATING PROCEDURE, ESOPHAGOGASTRODUODENOSCOPY","February 08, 2021",60,NCT04400734,"NO INTERVENTION, OBSERVATIONAL STUDY",HONG KONG,Recruiting,Chinese University of Hong Kong,"May 7, 2020",Observational,Esophagogastroduodenoscopy (EGD) is an Aerosol-generating Procedure: Proof of Concept Study
1847,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,"COVID; PULMONARY EMBOLISM, DEEP VEIN THROMBOSIS","February 08, 2021",1000,NCT04400799,ENOXAPARIN 40MG/0.4ML INJ SYRINGE 0.4ML,SWITZERLAND,Recruiting,University of Zurich,"June 15, 2020",Interventional,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With Coronavirus: The Multicenter Randomized Controlled Ovid Trial
1848,Attitude and Perception Towards COVID-19 Pandemic,COVID,"February 08, 2021",5000,NCT04400812,QUESTIONNAIRE,EGYPT,Enrolling by invitation,Zagazig University,"May 19, 2020",Observational,Attitude and Perception of General Population in Sharkia Governerate Towards COVID-19 Pandemic
1849,Investigating a Vaccine Against COVID-19,CORONAVIRUS,"February 08, 2021",12390,NCT04400838,CHADOX1 NCOV-19 (ABS 260); MENACWY VACCINE; CHADOX1 NCOV-19 (ABS 260) + 2.2X10^10VP (QPCR) BOOST; TWO DOSE MENACWY VACCINE; CHADOX1 NCOV-19 (QPCR); CHADOX1 NCOV-19 0.5ML PRIME PLUS BOOST; TWO DOSE MENACWY VACCINE MIN. 4 WEEKS APART; TWO DOSE CHADOX1 NCOV-19/COVISHIELD 0.5ML; TWO DOSE CHADOX1 NCOV-19/COVISHIELD 0.25ML & 0.5ML,UNITED KINGDOM,Recruiting,University of Oxford,"May 28, 2020",Interventional,"A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19"
1850,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,COVID; VENOUS THROMBOEMBOLISM; PULMONARY EMBOLISM; DEEP VEIN THROMBOSIS; SARS-CoV2,"February 08, 2021",7795,NCT04400877,DIAGNOSTIC EXAMINATION FOR VENOUS THROMBOEMBOLISM,SWEDEN,Completed,"University Hospital, Linkoeping","June 8, 2020",Observational,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
1851,Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of a Plant Polyphenol for COVID-19,COVID,"February 08, 2021",200,NCT04400890,PLANT POLYPHENOL; VITAMIN D3,UNITED STATES,Recruiting,"Marvin McCreary, MD","September 12, 2020",Interventional,Randomized Double-Blind Placebo-Controlled Proof-of-Concept Trial of a Plant Polyphenol for the Outpatient Treatment of Mild Coronavirus Disease (COVID-19)
1852,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,"COVID; SARS-CoV2; ARDS, HUMAN","February 08, 2021",30,NCT04400929,SARGRAMOSTIM; NORMAL SALINE 0.9%,SINGAPORE,Recruiting,Singapore General Hospital,"June 2, 2020",Interventional,Using GM-CSF as a Host Directed Therapeutic Against COVID-19 - a Phase 2 Investigator Initiated Trial
1853,Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study),SARS-CoV2; COVID,"February 08, 2021",450,NCT04401033,TELEPHONIC MEDICAL VISIT; GASTROINTESTINAL ENDOSCOPY; ABDOMINAL ULTRASOUND,SPAIN,Completed,Hospital del Río Hortega,"May 11, 2020",Observational [Patient Registry],Prospective Observational Study Evaluating the Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopic Procedures (DECORE Study)
1854,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,CANCER,"February 08, 2021",4000,NCT04401046,SURVEY TO ASSESS POST TRAUMATIC STRESS AND ANXIETY AT INCLUSION AND 6 MONTHS LATER,FRANCE,Recruiting,Institut Paoli-Calmettes,"May 20, 2020",Interventional,COVID-19 EPIDEMIC Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder
1855,Attitude of Egyptian Population Toward COVID 19 in Ramadan,COVID,"February 08, 2021",500,NCT04401072,,EGYPT,Recruiting,Damanhour University,"April 24, 2020",Observational,Survey Studying the Change in the Attitude and Behaviour of the Egyptian Population Toward COVID 19 Pandemic During the Holy Month Ramadan .
1856,COVID-19: Herd Immunity Study in the Czech Republic,COVID; SARS-CoV2,"February 08, 2021",27000,NCT04401085,SARS-COV-2 DIAGNOSTIC RAPID TEST; QUANTITATIVE ANALYSIS OF SARS-COV-2 ANTIBODIES,CZECHIA,Completed,Institute of Health Information and Statistics of the Czech Republic,"April 23, 2020",Observational,Herd Immunity Study SARS-CoV-2-CZ-Preval
1857,Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak,COVID,"February 08, 2021",700,NCT04401098,,EGYPT,Recruiting,Damanhour University,"May 2, 2020",Observational,"Survey Of Egyptian Population Change in Knowledge, Attitude and Behaviour Towards COVID 19 Outbreak"
1858,One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU),COVID; ARDS; QUALITY OF LIFE,"February 08, 2021",150,NCT04401111,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"June 16, 2020",Observational,Multiparametric Evaluation of One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia After Intensive Care Unit
1859,Status of Management of Surgery in Beijing During COVID-19,GASTRIC CANCER; COLORECTAL CANCER; GASTROINTESTINAL DISEASE,"February 08, 2021",500,NCT04401124,NO INTERVENTION,,Not yet recruiting,Beijing Friendship Hospital,"May 25, 2020",Observational,"A Descriptive Study on the Proper Management of Gastrointestinal Surgeries During the COVID-19 Pandemic, With an Emphasis on the Alteration of Surgical Protocol and Workflow"
1860,Lessening Organ Dysfunction With VITamin C - COVID-19,VITAMIN C; COVID; HOSPITALIZED PATIENTS,"February 08, 2021",800,NCT04401150,VITAMIN C; CONTROL,CANADA,Recruiting,Université de Sherbrooke,"August 14, 2020",Interventional,Lessening Organ Dysfunction With VITamin C - COVID
1861,Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,SARS-CoV2; COVID,"February 08, 2021",180,NCT04401163,IMAGING OF THE LUNGS,DENMARK,Not yet recruiting,University of Aarhus,May 2020,Observational [Patient Registry],Long-term Pulmonary Outcomes After Infection With Sars-CoV-2
1862,Nigella Sativa in COVID-19,COVID; SARS-CoV2,"February 08, 2021",200,NCT04401202,NIGELLA SATIVA,SAUDI ARABIA,Recruiting,King Abdulaziz University,"May 21, 2020",Interventional,"Effects of Nigella Sativa as a Treatment of Patients With Upper Respiratory Tract Infection Caused by SARS-coronavirus-2: a Prospective, Randomized, Open-label, Controlled Clinical Study"
1863,Predictive Models for Intensive Care Admission and Death of COVID-19,"COVID; PNEUMONIA, VIRAL; INFLAMMATORY RESPONSE","February 08, 2021",60,NCT04401228,"PREDICT ADMISSION OF COVID-19 PATIENTS TO ICU AND DEATH WITH ROUTINE AND QUICKLY AVALAIBLE CLINICAL, BIOLOGICAL AND RADIOLOGICAL VARIABLES?",BELGIUM,"Active, not recruiting",Clinique Saint Pierre Ottignies,"March 1, 2020",Observational,Development and Validation of Predictive Models for Intensive Care Admission and Death of COVID-19 Patients in a Secondary Care Hospital in Belgium.
1864,How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department,COVID,"February 08, 2021",257,NCT04401241,,MONACO,Completed,Centre Hospitalier Princesse Grace,"February 1, 2020",Observational,Accuracy of Routine Biomarkers and Blood Leucocytes Count to Assist Diagnosis of COVID-19-related Pneumonia in Adult Patients Visiting the Emergency Department
1865,Recovery of Patients From COVID-19 After Critical Illness,COVID; CRITICAL ILLNESS,"February 08, 2021",300,NCT04401254,,AUSTRALIA,Recruiting,Australian and New Zealand Intensive Care Research Centre,"July 1, 2020",Observational,The COVID-Recovery Study
1866,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,SARS-CoV2; COVID,"February 08, 2021",308,NCT04401293,ENOXAPARIN; PROPHYLACTIC/INTERMEDIATE DOSE ENOXAPARIN,UNITED STATES,Recruiting,Northwell Health,"April 26, 2020",Interventional,Systemic Anticoagulation With Full Dose Low Molecular Weight Heparin (LMWH) Vs. Prophylactic or Intermediate Dose LMWH in High Risk COVID-19 Patients (HEP-COVID Trial)
1867,Distance Learning for Dental Student During COVID-19 Pandemic,DISTANCE EDUCATION LEARNING ENVIRONMENT DURING COVID PANDEMIC,"February 08, 2021",418,NCT04401371,,EGYPT,Completed,Cairo University,"May 1, 2020",Observational,Assessment of Dental Students Opinion About Distance Education Learning Environment During COVID-19 Pandemic (Cross-Sectional Study)
1868,Anti-SARS Cov-2 T Cell Infusions for COVID 19,SARS-CoV2; VIRAL INFECTION; COVID,"February 08, 2021",58,NCT04401410,DOSE FINDING PHASE (MTD); PARTIALLY HLA-MATCHED SARS-COVSTS; ROUTINE CARE (NO SARS-COVSTS),UNITED STATES,Recruiting,Baylor College of Medicine,"November 4, 2020",Interventional,BAT IT: Banked Anti-SARS Cov-2 T Cell Infusions for Treatment of COVID 19
1869,TXA127 for the Treatment of Severe COVID-19,COVID,"February 08, 2021",100,NCT04401423,TXA127; PLACEBO,UNITED STATES,Recruiting,Columbia University,August 2020,Interventional,Randomized Controlled Trial of Angiotensin 1-7 (TXA127) for the Treatment of Severe COVID-19
1870,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO),CORONA VIRUS DISEASE 2019,"February 08, 2021",350,NCT04401436,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"May 22, 2020",Observational,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO)
1871,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,ACUTE AND LONG TERM EFFECTS OF COVID:ON SYSTEMIC INFLAMMATION; ACUTE AND LONG TERM EFFECTS OF COVID ON LUNG FUNCTION; ACUTE AND LONG TERM EFFECTS OF COVID ON MRAIN FUNCTION; ACUTE AND LONG TERM EFFECTS OF COVID ON CARDIAC FUNCTION; ACUTE AND LONG TERM EFFECTS OF COVID ON KIDNEY FUNCTION,"February 08, 2021",180,NCT04401449,,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"January 8, 2020",Observational,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons (COVID ARC 19)
1872,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19",COVID; ARDS,"February 08, 2021",396,NCT04401475,SOC PLUS 15MG/KG EB05 IV; SOC PLUS PLACEBO IV,CANADA,Recruiting,Edesa Biotech Inc.,"November 25, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19"
1873,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; ACUTE RESPIRATORY FAILURE,"February 08, 2021",0,NCT04401527,SODIUM NITRITE; NORMAL SALINE,UNITED STATES,Withdrawn,Hope Pharmaceuticals,"July 22, 2020",Interventional,"Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Study"
1874,Characteristics of Neonatal Covid-19 in Turkey,COVID; NEONATAL DISEASE; HEALTHY,"February 08, 2021",90,NCT04401540,,TURKEY,Recruiting,Recep Tayyip Erdogan University Training and Research Hospital,"May 1, 2020",Observational [Patient Registry],Clinical and Epidemiological Characteristics of COVID-19 Infection on Babies of Prenatal COVID-19 Positive Women in Turkey
1875,Adaptive COVID-19 Treatment Trial 2 (ACTT-2),COVID,"February 08, 2021",1034,NCT04401579,PLACEBO; REMDESIVIR; BARICITINIB,DENMARK,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"May 8, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-2)"
1876,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,DIAGNOSES DISEASE; CORONAVIRUS,"February 08, 2021",250,NCT04401644,NOVEL LASER INFEROMETRY TEST FOR CORONA VIRUS,UNITED KINGDOM,Not yet recruiting,Somerset NHS Foundation Trust,June 2020,Interventional,Laser Interferometry of Single Virus Particles Flowing Through Glass Microcapillaries to Detect Novel Coronavirus COVID-19
1877,Telerehabilitation in Disabled People: Proposal for Practical Intervention With Virtual Reality,DISABILITY PHYSICAL,"February 08, 2021",40,NCT04402034,APPLICATION OF TELE-REHABILITATION,BRAZIL,Completed,University of Sao Paulo,"May 15, 2020",Interventional,Telerehabilitation in Disabled People: Proposal for Practical Intervention With Virtual Reality
1878,A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,COVID; COVID; CORONAVIRUS; CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SARS-CoV2; ARDS; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",66,NCT04402060,APL-9; VEHICLE CONTROL,BRAZIL,Recruiting,"Apellis Pharmaceuticals, Inc.","May 28, 2020",Interventional,"A Randomized, Double-Blinded, Vehicle-Controlled, Multicenter, Parallel-Group Study of APL-9 in Mild to Moderate Acute Respiratory Distress Syndrome Due to COVID-19"
1879,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,COVID; FAVIPIRAVIR (FAVIPIRA),"February 08, 2021",50,NCT04402203,FAVIPIRAVIR; ONLY STANDARD TREATMENT,BANGLADESH,Recruiting,Bangladesh Medical Research Council (BMRC),May 2020,Interventional,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh
1880,Psychological Impact of the Covid-19 Pandemic on Student Nurses,NURSE; STUDENT; POST TRAUMATIC STRESS DISORDER; COVID,"February 08, 2021",2000,NCT04402229,,FRANCE,Completed,Versailles Hospital,"May 12, 2020",Observational,Psychological Impact of the Covid-19 Pandemic on Student Nurses :Prevalence and Risk Factors of Acute Post-traumatic Stress Symptoms 1 Month After the Epidemic Peak
1881,Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis,CYSTIC FIBROSIS,"February 08, 2021",140,NCT04402801,,UNITED STATES,Enrolling by invitation,University of Virginia,"June 1, 2020",Observational,Impact on Patient Outcomes of Clinic Transition From Face to Face Encounters to Telemedicine in the Cystic Fibrosis (CF) Adult Population at UVA
1882,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.,SARS-CoV2,"February 08, 2021",90,NCT04402814,CLUNGENE RAPID TEST CASSETTE,UNITED STATES,Recruiting,"Fadi Haddad, M.D.","May 5, 2020",Observational,Evaluation and Correlation of SARS-Cov2 Virus IgG/IgM Rapid Test Cassette Clungene Test With the Standard Method of COVID19 Testing in Inpatients With or Without COVID19
1883,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,"HEALTH CARE WORKER PATIENT TRANSMISSION; RECEPTOR SITE ALTERATION; SUSCEPTIBILITY, DISEASE; IMMUNE RESPONSE","February 08, 2021",60,NCT04402827,SUSCEPTIBILITY TO INFECTION,SPAIN,Recruiting,Asociacion para el Estudio de las Enfermedades Infecciosas,"August 1, 2020",Observational,"Differences in Susceptibility to SARS CoV-2 Infection According to ACE2 and CD26 Receptors, Specific CD4/CD8 T Cell Response to Viral Peptides, and KIR Receptors Among Health Care Workers Highly Exposed to Patients With COVID-19 Diagnosis."
1884,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",5,NCT04402840,STELLATE GANGLION BLOCK,UNITED STATES,Recruiting,West Virginia University,"April 24, 2020",Interventional,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)
1885,SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients,SARS-CoV2; TEAR,"February 08, 2021",100,NCT04402853,TEARS SWAB,ITALY,Completed,Università degli Studi dell'Insubria,"February 1, 2020",Observational,SARS Cov-2 in Conjunctival Secretions in an Italian Lombardia Cohort of Patients
1886,TD-0903 for ALI Associated With COVID-19,ACUTE LUNG INJURY (ALI) ASSOCIATED WITH COVID; LUNG INFLAMMATION ASSOCIATED WITH COVID,"February 08, 2021",222,NCT04402866,TD-0903; PLACEBO,"MOLDOVA, REPUBLIC OF",Recruiting,Theravance Biopharma,"June 24, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-center Study of an Inhaled Pan-Janus Kinase Inhibitor, TD-0903, to Treat Symptomatic Acute Lung Injury Associated With COVID-19"
1887,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; ARDS; HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",596,NCT04402879,PRONE POSITIONING (PP),CANADA,Recruiting,University of Calgary,"November 10, 2020",Interventional,A Prospective Randomized Trial of Prone Positioning Versus Usual Care for Patients With Do-not-intubate Goals of Care and Hypoxemic Respiratory Failure During the Coronavirus SARS-CoV-2 (COVID-19) Pandemic
1888,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,COVID; SARS-CoV2 INFECTION,"February 08, 2021",60,NCT04402892,"35 ML BLOOD, 5 TUBES LITHIUM HEPARINATE AT EACH TIME (HOSPITALIZED PATIENTS ); 35 ML BLOOD, 5 TUBES LITHIUM HEPARINATE AT EACH TIME (CURED PATIENTS)",,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"June 1, 2020",Interventional,SARS-CoV-2 Specific Memory B and T- CD4+ Cells
1889,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",CORONAVIRUS INFECTION,"February 08, 2021",450,NCT04402905,,FRANCE,Completed,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,"June 15, 2020",Observational,"Observational Study in Diagnosed Patients Covid-19, Supported on an Outpatient Basis."
1890,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,SARS-CoV2,"February 08, 2021",160,NCT04402918,BIOLOGICAL SAMPLES DAY OF DELIVERY,FRANCE,Recruiting,Centre Hospitalier Universitaire de Besancon,"May 17, 2020",Interventional,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 During Pregnancy
1891,Pulmozyme to Improve COVID-19 ARDS Outcomes,COVID,"February 08, 2021",60,NCT04402944,PULMOZYME; PLACEBO,UNITED STATES,Recruiting,Boston Children's Hospital,"July 5, 2020",Interventional,Pulmozyme to Improve COVID-19 ARDS Outcomes
1892,LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),COVID; SEVERE ACUTE RESPIRATORY SYNDROME; SARS-CoV2; ACUTE KIDNEY INJURY,"February 08, 2021",60,NCT04402957,LSALT PEPTIDE; PLACEBO,CANADA,Recruiting,Arch Biopartners Inc.,"October 14, 2020",Interventional,"Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of LSALT Peptide as Prevention of Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)"
1893,Dornase Alfa for ARDS in Patients With SARS-CoV-2,SARS-CoV2; ARDS,"February 08, 2021",10,NCT04402970,DORNASE ALFA INHALATION SOLUTION,UNITED STATES,Completed,University of Missouri-Columbia,"June 19, 2020",Interventional,Inhaled Dornase Alfa for Treatment of ARDS in Patients With SARS-CoV-2
1894,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,COVID; TELEREHABILITATION; PHYSICAL THERAPY,"February 08, 2021",34,NCT04402983,PHYSIOTHERAPY,TURKEY,Completed,Istanbul Medipol University Hospital,"May 27, 2020",Interventional,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients
1895,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,CORONAVIRUS DISEASE 2019; CHARACTER OF THE SEVERE PATIENTS,"February 08, 2021",100,NCT04403009,NO INTERVENTION,CHINA,Recruiting,The First Affiliated Hospital of Guangzhou Medical University,"February 1, 2020",Observational,The Clinical Difference Between the Nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the Fatal Cases With Severe COVID-19
1896,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,COVID,"February 08, 2021",100,NCT04403035,ID NOW VS. ACCULA,UNITED STATES,Recruiting,Ascension South East Michigan,"May 10, 2020",Observational,Comparison of the ID NOW and Accula Point-of-Care Assays for the Detection of Severe Acute Respiratory System CoV-2 (SARS-CoV-2)
1897,Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome,"DISEASE, VIRAL; CYTOKINE RELEASE SYNDROME; TLRS","February 08, 2021",106,NCT04403061,CYTOKINES MEASUREMENT; CELLULAR RESPONSE; TLRS ACTIVATION MEASUREMENT; KIR PHENOTYPE EVALUATION,SPAIN,Completed,Asociacion para el Estudio de las Enfermedades Infecciosas,"May 22, 2020",Observational,Th1/Th2/Th17/TREG Response and TLRs Activation/KIR Receptors for Predicting the Evolution of the SARS Cov-2 Infected Patients
1898,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",COVID; CORONAVIRUS INFECTION; VIRUS DISEASE; ACUTE RESPIRATORY INFECTION; SARS-COV INFECTION,"February 08, 2021",1968,NCT04403100,HYDROXYCHLOROQUINE SULFATE TABLETS; LOPINAVIR/ RITONAVIR ORAL TABLET; HYDROXYCHLOROQUINE SULFATE TABLETS PLUS LOPINAVIR/ RITONAVIR ORAL TABLETS; PLACEBO,BRAZIL,Recruiting,Cardresearch,"June 3, 2020",Interventional,"Hydroxychloroquine and Lopinavir/ Ritonavir for Hospitalization and Mortality Reduction in Patients With COVID-19 and Mild Disease Symptoms: ""The Hope Coalition"""
1899,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,COVID,"February 08, 2021",70,NCT04403243,COLCHICINE; RUXOLITINIB 5 MG; SECUKINUMAB 150 MG/ML SUBCUTANEOUS SOLUTION [COSENTYX]; STANDARD THERAPY,RUSSIAN FEDERATION,Recruiting,Lomonosov Moscow State University Medical Research and Educational Center,"May 8, 2020",Interventional,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial
1900,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",SARS-CoV2,"February 08, 2021",35,NCT04403269,IGIV,FRANCE,Recruiting,Versailles Hospital,"May 5, 2020",Interventional,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19"
1901,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",COVID,"February 08, 2021",200,NCT04403386,,UNITED STATES,Recruiting,National Institute of Environmental Health Sciences (NIEHS),"June 1, 2020",Observational,"A Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19"
1902,Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic,BEHCET DISEASE; COVID; FMF,"February 08, 2021",45,NCT04403438,"IT WILL BE COMPARED PAIN, SLEEP, FATIGUE, PHYSICAL ACTIVITY LEVEL AND QUALITY OF LIFE AND QUESTIONING EXERCISE HABITS BEFORE AND AFTER THE COVID-19 OUTBREAK IN PATIENTS WITH BEHÇET AND FMF.",TURKEY,Enrolling by invitation,Istanbul University,"April 1, 2020",Observational,"Pain, Sleep, Fatigue, Physical Activity Level, Quality of Life and Exercise Habits in Patients With Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic"
1903,Convalescent Plasma Therapy in Severe COVID-19 Infection,COVID; CONVALESCENCE,"February 08, 2021",20,NCT04403477,CONVALESCENT PLASMA,BANGLADESH,Recruiting,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","May 20, 2020",Interventional,"Convalescent Plasma Transfusion Therapy in Severe COVID-19 Patients- a Tolerability, Efficacy and Dose-response Phase II RCT"
1904,Ivermectin as a Novel Therapy in COVID-19 Treatment,COVID,"February 08, 2021",160,NCT04403555,IVERMECTIN,EGYPT,Recruiting,Tanta University,"June 1, 2020",Interventional,The Efficacy of Ivermectin in COVID-19 Treatment
1905,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",COVID,"February 08, 2021",384,NCT04403581,QUESTIONNAIRE,,Not yet recruiting,Ain Shams University,May 2020,Observational,"Cross-sectional Descriptive Study: Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic"
1906,Cardiac Imaging in SARS-CoV-2 (COVID-19),COVID,"February 08, 2021",180,NCT04403607,,UNITED KINGDOM,Recruiting,NHS Greater Glasgow and Clyde,"May 22, 2020",Observational,"Cardiovascular and Pulmonary Imaging in SARS-CoV-2: A Study of the Heart, Lungs and Wellbeing After COVID-19."
1907,Tannin Specific Natural Extract for COVID-19 Infection,COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",124,NCT04403646,ARBOX; PLACEBO,ARGENTINA,Terminated,Hospital de Clinicas José de San Martín,"June 12, 2020",Interventional,Efficacy of Tannin Specific Natural Extract for Coronavirus Disease (COVID-19): Randomized Controlled Trial
1908,Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,HIGH SENSITIVITY AND SPECIFICITY (WITH 95% CONFIDENCE INTERVAL) OF REALDETECT™ COVID RT-PCR KIT,"February 08, 2021",120,NCT04403672,PERFORMANCE EVALUATION STUDY OF REALDETECT RT-PCR KIT FOR COVID-19 DETECTION,BANGLADESH,Recruiting,Bangladesh Medical Research Council (BMRC),"May 18, 2020",Observational [Patient Registry],Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus
1909,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,COVID; SARS PNEUMONIA; CYTOKINE RELEASE SYNDROME,"February 08, 2021",129,NCT04403685,TOCILIZUMAB,BRAZIL,Terminated,Beneficência Portuguesa de São Paulo,"May 8, 2020",Interventional,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 and Increased Inflammatory Markers: a Phase III Randomized Clinical Trial (COVID-19 Coalition Brazil VI) (TOCIBRAS)
1910,Impact of COVID-19 on Personal Protection Among Dentist in Egypt,COVID,"February 08, 2021",323,NCT04403828,SURVEY,EGYPT,Completed,Fayoum University,"May 20, 2020",Observational,Impact of COVID-19 on Personal Protection Among Dentist in Egypt: A Quick Online Survey
1911,Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,SARS-CoV2; COVID,"February 08, 2021",727,NCT04403880,SAMPLE COLLECTION,MALAWI,Recruiting,HIV Vaccine Trials Network,"May 13, 2020",Observational,Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
1912,Somerset and South Essex Coronavirus Antigen Testing,COVID; SARS-CoV2,"February 08, 2021",200,NCT04403906,PCL COV05 - COVID 19 AG RAPID FIA TEST (RAPID ANTIGEN TEST),UNITED KINGDOM,Not yet recruiting,Somerset NHS Foundation Trust,June 2020,Interventional,Evaluation of the PCL Rapid Point of Care Antigen Test for Severe Acute Respiratory Syndrome Coronavirus 2
1913,Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",300,NCT04403932,,SPAIN,Completed,"Hospital San Carlos, Madrid","April 17, 2020",Observational,Cohort Study to Determine the Association Between Vitamin D Deficiency and Severity of the Disease in Patients With Coronarvirus Disease 2019 (COVID-19)
1914,Validation of COVID-19 Tests,COVID,"February 08, 2021",500,NCT04404062,COVID-19 RAPID TEST KIT (RAPG-COV-019); QUANTITATIVE IGG TEST,UNITED KINGDOM,"Active, not recruiting",Richmond Pharmacology Limited,"March 16, 2020",Observational,Validation of a Membrane-based Immunoassay for the Detection of IgG and IgM Antibodies to SARS-CoV-2/COVID-19
1915,Setting up a COVID-19 Care Facility at a Prison in Pakistan,COVID,"February 08, 2021",69,NCT04404179,COVID-19 FACILITY,PAKISTAN,Completed,"Services Institute of Medical Sciences, Pakistan","March 27, 2020",Observational,Setting up a COVID-19 Care Facility at a Prison in Pakistan
1916,PH94B in the Treatment of Adjustment Disorder With Anxiety,ADJUSTMENT DISORDER WITH ANXIOUS MOOD,"February 08, 2021",30,NCT04404192,PH94B,UNITED STATES,Not yet recruiting,"VistaGen Therapeutics, Inc.",November 2020,Interventional,A Phase 2a Open-label Study of the Efficacy and Safety of PRN PH94B Neuroactive Nasal Spray in the Treatment of Adjustment Disorder With Anxiety (AjDA) Associated With COVID-19
1917,The Açaí Berry COVID-19 Anti-Inflammation Trial,COVID,"February 08, 2021",480,NCT04404218,AÇAÍ PALM BERRY EXTRACT - NATURAL PRODUCT; PLACEBO,CANADA,Recruiting,"University Health Network, Toronto","August 4, 2020",Interventional,Randomized Clinical Trial of Açaí Palm Berry Extract as an Intervention in Patients Diagnosed With COVID-19
1918,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,CORONAVIRUS COVID,"February 08, 2021",100,NCT04404244,,EGYPT,Recruiting,Fatma Soliman Elsayed Ebeid,"January 1, 2020",Observational,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic
1919,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),SARS-CoV2,"February 08, 2021",2500,NCT04404270,ANTI-SARS-COV2 SEROLOGY; QUESTIONNAIRE; ANTI-SARS-COV2 SEROLOGICAL CONTROLS AND SERUM NEUTRALIZATION,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"May 26, 2020",Observational,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110)
1920,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,COVID; COVID; COVID,"February 08, 2021",364,NCT04404361,PACRITINIB; PLACEBO,UNITED STATES,Recruiting,CTI BioPharma,"May 22, 2020",Interventional,"A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of Pacritinib Plus Standard of Care Versus Placebo and Standard of Care in Hospitalized Patients With Severe COVID-19 With or Without Cancer"
1921,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,ARDS SECONDARY TO COVID PNEUMONIA,"February 08, 2021",32,NCT04404426,L-CITRULLINE; PLACEBO,FRANCE,Recruiting,Rennes University Hospital,"November 2, 2020",Interventional,CACOLAC : Randomized Trial of Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome
1922,Etiology of Lymphopenia in Covid19 Infection,LYMPHOPENIA,"February 08, 2021",90,NCT04404608,"COMPLETE BLOOD PICTURE, BONE MARROW ASPIRATION CYTOLOGY",,Not yet recruiting,Dr Medhat Khafagy,June 2020,Observational,Study of the Etiology of Lymphopenia in Covid19 Viral Infection
1923,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",SARS-CoV2,"February 08, 2021",600,NCT04405076,BIOLOGICAL: MRNA-1273; PLACEBO,UNITED STATES,"Active, not recruiting","ModernaTX, Inc.","May 29, 2020",Interventional,"A Phase 2a, Randomized, Observer-Blind, Placebo Controlled, Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 SARS-COV-2 Vaccine in Adults Aged 18 Years and Older"
1924,COVID-19 Ozanimod Intervention Study,COVID,"February 08, 2021",48,NCT04405102,OZANIMOD; STANDARD OF CARE,CANADA,Recruiting,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,"September 16, 2020",Interventional,A Randomized Trial on Efficacy and Safety of Ozanimod for the Treatment of COVID-19 Patients Requiring Oxygen Support - A Pilot Trial
1925,Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK,COVID; THROMBOSIS; BLEEDING; ANTICOAGULATION,"February 08, 2021",5000,NCT04405232,NON-INTERVENTIONAL,UNITED KINGDOM,Recruiting,Imperial College London,"May 25, 2020",Observational,Coagulopathy Associated With Coronavirus disease19 (CA-COVID19) A Multi-Centre Observational Study in UK
1926,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),HEALTHCARE WORKERS; COVID; SARS-CoV2,"February 08, 2021",1378,NCT04405271,EMTRICITABINE/TENOFOVIR ALAFENAMIDE 200 MG-25 MG ORAL TABLET; PLACEBO,ARGENTINA,Not yet recruiting,Hospital Italiano de Buenos Aires,"July 31, 2020",Interventional,"Randomized, Double-blind, Placebo-controlled Trial of TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)"
1927,The Use of Disinfectants Among Women in Egypt and the Toxicity by Bleach During the Coronavirus Lock-down.,TOXICITY BY BLEACH,"February 08, 2021",425,NCT04405284,USE AND EXPOSURE TO DISINFECTANTS DURING THE CORONAVIRUS PANDEMIC,EGYPT,Completed,Helwan University,"June 4, 2020",Observational,Disinfection Practices Among Women in Egypt During the Coronavirus Pandemic.
1928,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,SARS PNEUMONIA,"February 08, 2021",42,NCT04405310,CONVALESCENT PLASMA OF PATIENTS WITH COVID-19; PLACEBO (HARTMANN PLUS ALBUMINE),MEXICO,Completed,Grupo Mexicano para el Estudio de la Medicina Intensiva,"May 20, 2020",Interventional,"Plasma From Covalescent Donors With Covid-19 for the Management of Patients With SARS-COV-2 Fase II and III, a Doble Center Randomized Doble Blind Trial"
1929,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,SARS-CoV2; TRAUMATIC STRESS DISORDER,"February 08, 2021",753,NCT04405362,,,Not yet recruiting,"University Hospital, Lille",May 2020,Observational,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry
1930,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,COVID,"February 08, 2021",500,NCT04405466,BLOOD SAMPLING; THROAT SWAB,GERMANY,Recruiting,Miltenyi Biomedicine GmbH,"April 22, 2020",Observational,"A Prospective, Epidemiological, Cohort Study to Assess the Feasibility of Screening Healthy Asymptomatic Workers for the Presence of SARS-CoV-2 by Pharyngeal Swaps and Serology at Baseline, Day 21 and Day 40"
1931,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",SARS-CoV2; COVID,"February 08, 2021",1210,NCT04405492,"TAKING BLOOD SAMPLES (CAPILLARY AND VENOUS), SALIVA SAMPLING AND NASOPHARYNGEAL SAMPLING.; TAKING BLOOD SAMPLES (CAPILLARY AND VENOUS), SALIVA SAMPLING AND NASOPHARYNGEAL SAMPLING.; CAPILLARY AND SALIVARY SAMPLING",,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"May 25, 2020",Interventional,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19"
1932,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,ENCEPHALOPATHY; COVID,"February 08, 2021",51,NCT04405544,CT-SCAN; EEG; EP; PULSE OXIMETRY; BLOOD TESTS,RUSSIAN FEDERATION,Completed,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","May 22, 2020",Interventional,Determination of Acute Encephalopathy Predictors in Patients With COVID-19
1933,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",SARS-CoV2,"February 08, 2021",204,NCT04405570,EIDD-2801; PLACEBO (PBO),UNITED STATES,"Active, not recruiting","Ridgeback Biotherapeutics, LP","June 16, 2020",Interventional,"A Phase IIa Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19"
1934,Prognostic Factors of COVID19,SARS-CoV2,"February 08, 2021",500,NCT04405726,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","March 27, 2020",Observational,"Study of Clinical, Biological and Genetic Prognostic Factors of SARS-CoV-2 Infection in Patients Admitted in the Strasbourg University Hospitals"
1935,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),SARS-CoV2,"February 08, 2021",80,NCT04405739,EIDD-2801; PLACEBO (PB0),UNITED STATES,Recruiting,"Ridgeback Biotherapeutics, LP","June 16, 2020",Interventional,The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2
1936,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),COVID,"February 08, 2021",476,NCT04405843,IVERMECTIN ORAL PRODUCT; PLACEBO,COLOMBIA,Completed,Centro de Estudios en Infectogía Pediatrica,"July 14, 2020",Interventional,"Randomized, Placebo Controlled, Double Blind Clinical Trial to Evaluate the Efficacy of Molecule D11AX22 in Adults Patients From Valle Del Cauca, Colombia With Early Stages of SARS COV2 / COVID-19"
1937,Thromboembolic Events in Severe COVID-19 Patients,PULMONARY THROMBOEMBOLISM,"February 08, 2021",300,NCT04405869,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 29, 2020",Observational,Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France
1938,SCB-2019 as COVID-19 Vaccine,COVID,"February 08, 2021",150,NCT04405908,SCB-2019; SCB-2019 WITH AS03 ADJUVANT; SCB-2019 WITH CPG 1018 ADJUVANT PLUS ALUM ADJUVANT,AUSTRALIA,"Active, not recruiting",Clover Biopharmaceuticals AUS Pty Ltd,"June 19, 2020",Interventional,"A Phase 1, Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety and Immunogenicity of SCB 2019, a Recombinant SARS-CoV-2 Trimeric S Protein Subunit Vaccine for COVID-19 in Healthy Volunteers."
1939,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",SARS-CoV2 PNEUMONIA; COVID,"February 08, 2021",200,NCT04405921,HYDROXYCHLOROQUINE 200 MG ORAL TABLET; AZITHROMYCIN 250 MG,TUNISIA,Not yet recruiting,Centre Hôpital Universitaire Farhat Hached,July 2020,Interventional,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 Pneumonia: A Randomized,Open-label,Controlled Clinical Trial"
1940,COG-UK Project Hospital-Onset COVID-19 Infections Study,COVID; NOSOCOMIAL INFECTION; CORONAVIRUS; CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",2000,NCT04405934,USE OF VIRUS (COVID-19) GENOME SEQUENCE REPORT TO INFORM INFECTION PREVENTION CONTROL PROCEDURES,,Not yet recruiting,"University College, London",July 2020,Interventional,"A Phase III Prospective, Interventional, Cohort, Superiority Study to Evaluate the Benefit of Rapid COVID-19 Genomic Sequencing (the COVID-19 GENOMICS UK Project) on Infection Control in Preventing the Spread of the Virus in United Kingdom NHS Hospitals"
1941,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,COVID; SARS-CoV2; EXTRACORPOREAL MEMBRANE OXYGENATION; ARDS,"February 08, 2021",133,NCT04405973,VV-ECMO,GERMANY,Completed,Dr. Alexander Supady,"May 19, 2020",Observational,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation - a Retrospective Multi-center Registry Study
1942,Exploring Brain Damages After COVID-19 Infection,SARS-CoV2,"February 08, 2021",38,NCT04405986,AUDITORY EVOKED POTENTIALS (AEP); BLINK AND MASSETER INHIBITORY REFLEX,FRANCE,Recruiting,"University Hospital, Bordeaux","May 19, 2020",Interventional,Exploring Brain Damages After COVID-19 Infection
1943,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,INCREASED RISK OF SARS-CoV2 INFECTION,"February 08, 2021",50,NCT04405999,BROMHEXINE HYDROCHLORIDE,RUSSIAN FEDERATION,Completed,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","May 14, 2020",Interventional,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease: a Randomised Controlled Trial
1944,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",COVID,"February 08, 2021",1038,NCT04406038,,RUSSIAN FEDERATION,"Active, not recruiting",European University at St. Petersburg,"May 27, 2020",Observational,"A Population-Based Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Saint Petersburg, Russia: Longitudinal Cohort Study"
1945,Viral Specific T-cells for Treatment of COVID-19,VIRAL INFECTION,"February 08, 2021",0,NCT04406064,VIRAL SPECIFIC T-CELLS (VSTS),UNITED STATES,Withdrawn,"Children's Hospital Medical Center, Cincinnati",January 2021,Interventional,Viral Specific T-cells (VSTs) for Treatment of SARS-CoV-2/COVID-19
1946,Endovascular Thrombectomy in COVID-19 Infected Patients,ISCHEMIC STROKE; COVID,"February 08, 2021",50,NCT04406090,MECHANICAL TROMBECTOMY,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Endovascular Thrombectomy in COVID-19 Infected Patients: Intrahospital and Peri-operative Outcomes
1947,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,ANXIETY AND FEAR; ANXIETY DEPRESSION; ANXIETY POSTOPERATIVE; PSYCHOLOGICAL STRESS,"February 08, 2021",200,NCT04406181,HADS; A SURVEY,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"May 18, 2020",Interventional,Effect on the COVID-19 Pandemic-induced Reduction in Elective Surgery on Medical Events and Psychological Well-being of Patients Waiting for Cardiac Surgery
1948,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions",BIOEQUIVALENCE,"February 08, 2021",30,NCT04406194,FAVICOVIR 200 MG FILM TABLET; AVIGAN 200 MG FILM TABLETS,TURKEY,Completed,Atabay Kimya Sanayi Ticaret A.S.,"May 14, 2020",Interventional,"Open-label,Randomised,Single Oral Dose,Two-period,Cross-over Trial to Assess to Bioequivalence of Favicovir 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions"
1949,Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19,SARS-CoV2,"February 08, 2021",176,NCT04406233,,BRAZIL,Recruiting,University of Sao Paulo,"May 23, 2020",Observational,Muscle Mass and Strength as Predictors of Time to Medical Discharge and Mortality in Patients Hospitalized With COVID-19: A Prospective Observational Study
1950,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,CORONAVIRUS INFECTION,"February 08, 2021",150,NCT04406246,NITAZOXANIDE 500MG ORAL TABLET,MEXICO,Recruiting,Materno-Perinatal Hospital of the State of Mexico,"May 21, 2020",Interventional,Prevention of Coronavirus Disease (COVID-19) Outbreaks by Prophylactic Treatment With Nitazoxanide
1951,COVID-19: Respiratory and Sleep Follow-up,COVID,"February 08, 2021",400,NCT04406324,NO INTERVENTION,FRANCE,Recruiting,"University Hospital, Grenoble","June 1, 2020",Observational,"COVID-19: Prospective Follow-up of Pulmonary Function, Sleep Disorders, Quality of Life and Post-traumatic Stress"
1952,Confinement Effect on Low Back Pain Intensity in Chronic Low Back Pain Patients,CHRONIC LOW-BACK PAIN,"February 08, 2021",300,NCT04406363,NON INTERVENTIONAL,FRANCE,Not yet recruiting,"University Hospital, Angers","June 2, 2020",Observational,Confinement Effect on Low Back Pain Intensity in Chronic Low Back Pain Patients
1953,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),COVID,"February 08, 2021",186,NCT04406389,ENOXAPARIN SODIUM; UNFRACTIONATED HEPARIN; FONDAPARINIUX; ARGATROBAN,UNITED STATES,Recruiting,Weill Medical College of Cornell University,"October 13, 2020",Interventional,InterMediate ProphylACtic Versus Therapeutic Dose Anticoagulation in Critically Ill Patients With COVID-19: A Prospective Randomized Study (The IMPACT Trial)
1954,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,ARDS; COVID,"February 08, 2021",50,NCT04406493,LUNG IMPEDANCE TECHNIQUE,ISRAEL,Recruiting,Hillel Yaffe Medical Center,"April 28, 2020",Interventional,Monitoring of Lung Fluid Status of Hospitalized COVID-19 Patients by Lung Impedance Technique
1955,Home-Based Covid-19 Rehabilitation Program,COVID,"February 08, 2021",100,NCT04406532,PT-PAL; SELF-GUIDED EXERCISES,,Not yet recruiting,Albert Einstein College of Medicine,February 2021,Interventional,Home Based Covid-19 Rehabilitation Program: Pilot Clinical Trial
1956,Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.,CORONAVIRUS INFECTION; ENDOTHELIAL DYSFUNCTION; MICROVASCULAR RAREFACTION,"February 08, 2021",25,NCT04406545,EVALUATION OF SKIN MICROVASCULAR FLOW AND REACTIVITY,BRAZIL,Recruiting,"National Institute of Cardiology, Laranjeiras, Brazil","May 15, 2020",Observational,Investigation of Systemic Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of Coronavirus Disease-19.
1957,Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents,"PSYCHOLOGICAL ADAPTATION; PSYCHOLOGY, SOCIAL","February 08, 2021",400,NCT04406558,QUESTIONNAIRE,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 27, 2020",Observational,Psychological Impact of the Health Measures Generated by the SarsCov-2 Pandemic in Adolescents (COVADO)
1958,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,PANCREATIC ADENOCARCINOMA,"February 08, 2021",700,NCT04406571,DATA RECORD,FRANCE,Recruiting,CHU de Reims,"April 1, 2020",Observational,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer
1959,Prediction of Acute Kidney Injury in Patients With COVID-19,ACUTE KIDNEY INJURY; COVID; ARDS,"February 08, 2021",300,NCT04406688,,GERMANY,Recruiting,University Hospital Muenster,"June 22, 2020",Observational,Prediction of Acute Kidney Injury in Patients With COVID-19 Associated Acute Respiratory Distress Syndrome
1960,Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic,ONCOLOGY PATIENTS,"February 08, 2021",150,NCT04406844,,INDIA,Recruiting,Max Healthcare Insititute Limited,"May 9, 2020",Observational,An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown
1961,Rapid-Cycle Re-Implementation of TRAining Facilities in Norway,TRAINING,"February 08, 2021",4000,NCT04406909,ACCESS TO TRAINING FACILITY,NORWAY,"Active, not recruiting",Norwegian Department of Health and Social Affairs,"May 22, 2020",Interventional,Rapid-Cycle Re-Implementation of TRAining Facilities in Norway
1962,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions",BIOEQUIVALENCE,"February 08, 2021",30,NCT04407000,TEST: FAVIPIRAVIR 200 MG (LOQULAR); REFERENCE: FAVIPIRAVIR 200 MG (AVIGAN),TURKEY,Completed,World Medicine ILAC SAN. ve TIC. A.S.,"June 23, 2020",Interventional,"Open-label,Randomised,Single Oral Dose,Two-period,Cross-over Trial to Assess to Bioequivalence of Loqular 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions"
1963,Appendicitis During the National Lockdown During the COVID-19 Pandemic,APPENDICITIS,"February 08, 2021",6000000,NCT04407117,LOCK-DOWN AND SOCIAL DISTANCING,DENMARK,Completed,"Claus Anders Bertelsen, PhD, MD","March 23, 2017",Observational,Change in the Incidence of Appendicitis in a Controlled Environment During the National Lockdown Throughout the COVID-19 Pandemic
1964,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,COVID PATIENTS,"February 08, 2021",72,NCT04407130,IVERMECTIN + DOXYCYCLINE + PLACEBO; IVERMECTIN + PLACEBO; PLACEBO,BANGLADESH,Completed,"International Centre for Diarrhoeal Disease Research, Bangladesh","June 16, 2020",Interventional,"Ivermectin and Doxycycline in Combination or Ivermectin Alone for the Treatment of Adult Bangladeshi Patients Hospitalized for COVID-19: a Randomised, Double-blind, Placebo-controlled Trial."
1965,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,LUNG CANCER; COVID; CORONAVIRUS INFECTION,"February 08, 2021",128,NCT04407143,IGG TEST,SPAIN,Recruiting,Fundación GECP,"April 15, 2020",Observational,Study of Acquired Immunity in Patients With Lung Cancer and COVID-19 Infection
1966,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,COVID; AKI,"February 08, 2021",724,NCT04407156,ACUTE KIDNEY INJURY,UNITED KINGDOM,Completed,University Hospitals of Derby and Burton NHS Foundation Trust,"June 1, 2020",Observational,Acute Kidney Injury In Corona Virus Infection Disease (COVID19) in United Kingdom
1967,Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease,COVID,"February 08, 2021",617,NCT04407169,NO INTERVENTION,FRANCE,Completed,"Central Hospital, Nancy, France","June 1, 2020",Observational,Evaluation of the Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease Hospitalized for Severe Forms
1968,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,COVID; SARS-CoV2; DIABETE MELLITUS; CARDIOPATHY; PULMONARY DISEASE; RENAL DISEASE; LIVER DISEASES,"February 08, 2021",60,NCT04407182,VIUSID AND ASBRIP,ECUADOR,Completed,Catalysis SL,"May 4, 2020",Interventional,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients in Teodoro Maldonado Carbo Specialty's Hospital Infected and Diagnosed by SARS-Cov-2 With COVID-19
1969,COVID-19 and Mental Health,COVID; MENTAL HEALTH DISORDER,"February 08, 2021",2000,NCT04407195,EXPOSURE TO THE SARS-COV-2,UNITED STATES,"Active, not recruiting",Northeastern University,"June 1, 2020",Observational,Mental Health Outcomes Among US Healthcare Workers Exposed to COVID-19
1970,Convalescent Plasma Therapy in Patients With COVID-19,CONVALESCENCE; CORONAVIRUS INFECTION; PLAQUE,"February 08, 2021",10,NCT04407208,CONVALESCENT PLASMA,INDONESIA,Completed,Biofarma,"May 1, 2020",Interventional,Convalescent Plasma Therapy in Patients With COVID-19
1971,COVID-19 Research in Organ Transplant Recipients,TRANSPLANT RECIPIENTS,"February 08, 2021",1100,NCT04407221,,SWEDEN,Enrolling by invitation,Vastra Gotaland Region,"June 16, 2020",Observational,COVID-19 Research in Organ Transplant Recipients
1972,"The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study.",COVID -19; RESPIRATORY FAILURE; HYPOXIA,"February 08, 2021",136,NCT04407260,OXYGEN HOOD,UNITED STATES,Completed,Northwell Health,"March 6, 2020",Observational,"The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study."
1973,STATIN THERAPY AND COVID-19 INFECTION,COVID; STATIN; CARDIOVASCULAR DISEASES,"February 08, 2021",1200,NCT04407273,OBSERVATIONAL,SPAIN,"Active, not recruiting",Institut Investigacio Sanitaria Pere Virgili,"May 14, 2020",Observational,STATIN THERAPY AND COVID-19 INFECTION (STACOV PROJECT)
1974,Vitamin D Testing and Treatment for COVID 19,COVID; VITAMIN D DEFICIENCY,"February 08, 2021",41,NCT04407286,VITAMIN D3,UNITED STATES,Completed,Arizona State University,"May 19, 2020",Interventional,Vitamin D Testing and Treatment for Adults With COVID 19
1975,COVID-19 Impact on Rheumatic Patients,COVID,"February 08, 2021",360,NCT04407299,SELF-ADMINISTERED STRUCTURED QUESTIONNAIRE,EGYPT,Completed,Cairo University,"April 20, 2020",Observational,"Impact of COVID-19 Pandemic on Attitude, Behaviour and Mental Health of Patients With Rheumatic Diseases"
1976,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,COVID,"February 08, 2021",100,NCT04407390,NICOTINAMIDE RIBOSIDE; PLACEBO,DENMARK,Recruiting,University of Copenhagen,"June 1, 2020",Interventional,"Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly. A Randomized Double-blind, Placebo-controlled Trial of Nicotinamide Riboside NR-COVID19"
1977,Vienna Versus SARS-CoV-2 Virus Study,SARS-CoV2; COVID,"February 08, 2021",12000,NCT04407429,LABORATORY ANALYSES,AUSTRIA,Recruiting,Medical University of Vienna,"May 27, 2020",Observational,Vienna Versus SARS-CoV-2 Virus: A Prospective Large-scale Antibody Study of SARS-CoV-2 in Patients and Health Care Workers
1978,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,COVID; ARDS; PNEUMONIA,"February 08, 2021",827,NCT04407468,PRONE POSITION,MEXICO,Completed,Hospital General San Juan del Rio,"May 1, 2020",Observational,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 (APRONOX)
1979,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),COVID,"February 08, 2021",809,NCT04407494,"REPORTING OF ANOSMIA, AGEUSIA AND OTHER CLINICAL SYMPTOMS",FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders in a Population Tested for COVID-19
1980,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",COVID,"February 08, 2021",66,NCT04407507,IVERMECTIN; PLACEBO,,Not yet recruiting,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,June 2020,Interventional,"Multicenter, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Ivermectin in Mild Virus-positive Subjects (SARS-CoV)-2 With or Without Symptoms"
1981,Dietary Intake and Eating Habits During the COVID-19 Pandemic,COVID,"February 08, 2021",1920,NCT04407533,DIET TRACKING AND SURVEY,CANADA,Recruiting,McGill University,"May 25, 2020",Observational,Dietary Intake and Eating Habits During the COVID-19 Pandemic
1982,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,IMMUNOSUPPRESSION,"February 08, 2021",300,NCT04407546,,UNITED STATES,Recruiting,Jonsson Comprehensive Cancer Center,"May 27, 2020",Observational,Role of Children in the Transmission of SARS-CoV-2 in Households of Immunocompromised Persons
1983,COVID-SErology in Rheumatoid Arthritis (COVID-19),COVID; RHEUMATOID ARTHRITIS,"February 08, 2021",216,NCT04407559,SEROLOGICAL ANALYSES TO BE LEAD ON A PRE-EXISTING BIOBANK,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,Impact of the Rheumatoid Factor on Serological Testing Performance for Covid-19 in Rheumatoid Arthritis Patients
1984,Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,COVID; ZINC DEFICIENCY; VITAMIN D DEFICIENCY,"February 08, 2021",44,NCT04407572,"SERUM ZINC, VITAMIN D VITAMIN B12 LEVELS .",TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"April 20, 2020",Observational,Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women
1985,Testing the Accuracy of a Digital Test to Diagnose Covid-19,COVID,"February 08, 2021",1000000,NCT04407585,COVID-19 SWAB PCR TEST,UNITED KINGDOM,Recruiting,King's College London,"June 1, 2020",Observational,Validation of Machine Learning (ML) Models as Diagnostic Tools to Predict Infection With SARS-CoV-2
1986,COPD in the Time of COVID-19,COPD EXACERBATION; COPD,"February 08, 2021",160,NCT04407598,,UNITED KINGDOM,"Active, not recruiting",University of Leicester,"May 1, 2020",Observational,Cross-Sectional Observation Telephone Survey Study to Understand the Changes in COPD Exacerbation Patterns and Potential Causes of These During the COVID-19 Pandemic
1987,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near",BARIATRIC SURGERY CANDIDATE; PATIENT UNDERWENT BARIATRIC SURGERY,"February 08, 2021",138,NCT04407663,TELEMEDICINE TO REMOTE OUTPATIENT VISIT IN BARIATRIC PATIENT,ITALY,Completed,"University of Campania ""Luigi Vanvitelli""","March 3, 2020",Observational,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near. Brief Correspondence on a Single Center Experience. Cohort Study"
1988,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,COVID; LYMPHOCYTOPENIA,"February 08, 2021",48,NCT04407689,INTERLEUKIN-7; PLACEBO,FRANCE,Recruiting,Revimmune,"June 8, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection in France and Belgium"
1989,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment,JUVENILE IDIOPATHIC ARTHRITIS; COVID; TREATMENT,"February 08, 2021",150,NCT04407923,,FRANCE,Recruiting,"University Hospital, Brest","May 25, 2020",Observational,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context
1990,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,SARS-CoV2,"February 08, 2021",800,NCT04408001,CLINICAL INTERVIEW; BLOOD COLLECTION; SALIVA COLLECTION,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"June 4, 2020",Observational,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff
1991,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo,COVID; SARS-CoV2,"February 08, 2021",18901,NCT04408014,SEROLOGICAL TEST; NASOPHARYNGEAL SWAB; OROPHARYNGEAL SWAB,,Not yet recruiting,Butantan Institute,"June 1, 2020",Observational,Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
1992,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,ANXIETY DISORDER OF CHILDHOOD OR ADOLESCENCE,"February 08, 2021",20,NCT04408027,VIRTUAL-CARE COGNITIVE BEHAVIOURAL THERAPY,CANADA,Not yet recruiting,The Hospital for Sick Children,"June 1, 2020",Interventional,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions
1993,Use of Convalescent Plasma for COVID-19,COVID,"February 08, 2021",700,NCT04408040,CONVALESCENT PLASMA,UNITED STATES,Recruiting,"Northside Hospital, Inc.","July 14, 2020",Interventional,"Use of Convalescent Plasma Collected From Donors Recovered From COVID-19 Virus Disease for Transfusion, as an Empirical and Preemptive Treatment During Viral Pandemic Outbreak"
1994,COVID-19: A POC Test Under Research & Evaluation,COVID,"February 08, 2021",2000,NCT04408066,SAMPLE COLLECTION/PERFORMANCE EVALUATION (A); SAMPLE COLLECTION/PERFORMANCE EVALUATION (B),UNITED KINGDOM,Recruiting,LumiraDx UK Limited,"April 30, 2020",Interventional,Specimen Collection for Development and Performance Evaluation of the LumiraDx Platform Point of Care Tests for Sars-Cov-2 IgG/IgM & Antigen to be Used as an Aid in Diagnosis of COVID-19
1995,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,HOMELESS,"February 08, 2021",2000,NCT04408131,BLOOD SAMPLE; BLOOD SAMPLE,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"May 28, 2020",Interventional,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study
1996,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,COVID,"February 08, 2021",548,NCT04408157,SELF-MANAGEMENT BOOKLET (SWITCH: STAY WELL DURING COVID-19),UNITED KINGDOM,Recruiting,King's College London,"May 20, 2020",Interventional,A Research Study to Evaluate the Efficacy of a Self-management Booklet (Stay Well During COVID-19; SWitCh) to Promote Wellbeing During the COVID-19 Pandemic
1997,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),CORONAVIRUS INFECTION; COVID,"February 08, 2021",1000,NCT04408170,POINT-OF-CARE TEST FOR SARS-COV-2,UNITED KINGDOM,Recruiting,Manchester University NHS Foundation Trust,"June 19, 2020",Observational,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)
1998,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,SARS-CoV2; INFECTION,"February 08, 2021",225,NCT04408183,GLS-1200; PLACEBO,UNITED STATES,Recruiting,"GeneOne Life Science, Inc.","June 1, 2020",Interventional,"Efficacy, Safety, and Tolerability of GLS-1200 Topical Nasal Spray in the Prevention of Incident Confirmed, Symptomatic SARS-CoV-2 Infection in Healthcare Personnel"
1999,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,REHABILITATION,"February 08, 2021",200,NCT04408196,,ITALY,Recruiting,Fondazione Don Carlo Gnocchi Onlus,"May 26, 2020",Observational,Effects of Social Distancing on the Quality of Life and on the Emotional-affective Sphere of Caregivers and Patients Hospitalized in Residential Rehabilitation Departments: an Observational Study.
2000,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,COVID INFECTION,"February 08, 2021",60,NCT04408209,CONVALESCENT PLASMA,GREECE,Recruiting,National and Kapodistrian University of Athens,"April 23, 2020",Interventional,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection - A Multicenter Phase II Trial
2001,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,OXYGEN DEFICIENCY; CORONAVIRUS INFECTION,"February 08, 2021",29,NCT04408222,AWAKE PRONING,UNITED STATES,"Active, not recruiting",Columbia University,"April 16, 2020",Observational,Awake Proning in Patients With COVID-19-Induced Acute Hypoxemic Respiratory Failure
2002,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,"COVID; PNEUMONIA, VIRAL; COAGULATION DISORDER","February 08, 2021",300,NCT04408235,ENOXAPARIN,ITALY,Not yet recruiting,Azienda Ospedaliero-Universitaria di Modena,June 2020,Interventional,Randomised Controlled Trial Comparing High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy Not Requiring Invasive Mechanical Ventilation
2003,AKI Biomarkers in Coronavirus(COVID)-19,COVID; ACUTE RESPIRATORY FAILURE; ACUTE KIDNEY INJURY,"February 08, 2021",30,NCT04408248,,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"August 20, 2020",Observational,AKI Biomarkers for Prediction of Acute Kidney Injury in Critically Ill Patients With COVID-19 and Respiratory Disease
2004,Improving Activity Engagement Among Persons With SCI During COVID-19,SPINAL CORD INJURIES,"February 08, 2021",50,NCT04408287,WEBEX PHYSICAL ACTIVITY PROGRAM,CANADA,Not yet recruiting,Lawson Health Research Institute,"September 15, 2020",Interventional,Improving Activity Engagement Among Persons With SCI During COVID-19
2005,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",50,NCT04408326,ANGIOTENSIN II; INTERLEUKIN-1 RECEPTOR ANTAGONIST,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"June 1, 2020",Observational,Efficacy and Safety of Angiotensin II Use in COVID-19 Patients With Acute Respiratory Distress Syndrome
2006,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,CANCER; COVID,"February 08, 2021",500,NCT04408339,NO INTERVENTION,GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"April 15, 2020",Observational [Patient Registry],COVID-19 Disease in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care in the Hamburg Metropolitan Area Including Prospective Biobanking
2007,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",COVID; SHOCK,"February 08, 2021",82,NCT04408365,,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"August 5, 2020",Observational,"Endothelial Function, Inflammation, and Organ Dysfunction in Critically Ill Patients With COVID-19"
2008,Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,CORONAVIRUS INFECTION,"February 08, 2021",156,NCT04408378,OBSERVATION OF COVID 19 PNEUMONIA,TURKEY,Recruiting,Gaziosmanpasa Taksim Research and Education Hospital,"June 5, 2020",Observational,Retrospective Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients
2009,Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,COVID; ANOSMIA,"February 08, 2021",0,NCT04408391,BRAIN MRI SCAN,FRANCE,Withdrawn,Centre Hospitalier Universitaire de Nīmes,"May 20, 2020",Observational,Descriptive Pilot Study of Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia
2010,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,COVID,"February 08, 2021",325,NCT04408456,HCQ; STANDARD THERAPY,INDIA,Completed,Postgraduate Institute of Medical Education and Research,"March 1, 2020",Interventional,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 in Asymptomatic Individual at Risk for SARS-CoV-2 Infection-A Open Level Control Clinical Trial
2011,Low Intensity Internet Therapy for Chronic Illness,CHRONIC MEDICAL CONDITIONS,"February 08, 2021",54,NCT04408651,LIIT.CI ACT; LIIT.CI CFT,PORTUGAL,"Active, not recruiting",University of Coimbra,"May 1, 2020",Interventional,Testing the Efficacy of a Low Intensity Internet Therapy for Chronic Illness (@LIIT.CI): The Contribute of Explicit Compassion Practices in ACT
2012,Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection,COVID; SARS-CoV2,"February 08, 2021",0,NCT04409184,,,Withdrawn,Medical College of Wisconsin,"August 14, 2020",Observational,Evaluation of Whole Blood Samples From Coronavirus Disease 2019 (COVID-19) Convalescent Patients to Study Immune Response and Severity of Disease Predictors
2013,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",COMORBIDITIES; CONFINEMENT; OBESITY,"February 08, 2021",4789,NCT04409197,,FRANCE,Completed,"University Hospital, Grenoble","May 8, 2020",Observational,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network"
2014,Prognosis in Pregnant With COVID-19,COVID; PROGNOSTIC FACTORS; PREGNANCY,"February 08, 2021",155,NCT04409249,"IMAGING, BLOOD TESTS",TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 15, 2020",Observational,Prognostic Factors in Pregnant Women With COVID-19
2015,A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",650,NCT04409262,REMDESIVIR; TOCILIZUMAB; PLACEBO,BRAZIL,"Active, not recruiting",Hoffmann-La Roche,"June 16, 2020",Interventional,"A Phase III, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Patients With Severe COVID-19 Pneumonia"
2016,LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION,PULMONARY FIBROSIS,"February 08, 2021",500,NCT04409275,,SPAIN,Recruiting,Fundación para la Investigación del Hospital Clínico de Valencia,"May 21, 2020",Observational,STUDY OF THE APPEARANCE OF LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION
2017,Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,COVID,"February 08, 2021",36,NCT04409327,RTB101; PLACEBO,UNITED STATES,"Active, not recruiting",Restorbio Inc.,"July 11, 2020",Interventional,Randomized Double Blind Placebo-Controlled Study to Determine if Prophylaxis With RTB101 Compared to Placebo Reduces Severity of Lab Confirmed COVID19 in Adults ≥65 Years in a Nursing Home in Which ≥1 Person(s) Have Lab Confirmed COVID19
2018,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,COVID,"February 08, 2021",0,NCT04409483,LOPINAVIR-RITONAVIR DRUG COMBINATION; STANDARD CARE,,Withdrawn,Epicentre,"June 1, 2020",Interventional,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger
2019,Chat-based Support for Preventing Smoking Relapse,SMOKING CESSATION,"February 08, 2021",108,NCT04409496,CHAT-BASED INSTANT MESSAGING SUPPORT; SMS MESSAGE SUPPORT; SELF-HELP BOOKLET,HONG KONG,"Active, not recruiting",The University of Hong Kong,"June 2, 2020",Interventional,Chat-based Instant Messaging Support for Preventing Smoking Relapse in the Context of COVID-19 Outbreak: a Pilot Randomised Clinical Trial
2020,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",124,NCT04409509,"GARADACIMAB, FACTOR XIIA ANTAGONIST MONOCLONAL ANTIBODY; PLACEBO",UNITED STATES,Completed,CSL Behring,"July 1, 2020",Interventional,"A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 2019 (COVID 19)"
2021,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,COVID,"February 08, 2021",55,NCT04409522,MELATONIN; THE USUAL TREATMENT,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Mohammad Sadegh Bagheri Baghdasht,"May 12, 2020",Interventional,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients
2022,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,ACTIVITIES; MENTAL HEALTH ISSUE; LIFE STYLE,"February 08, 2021",500,NCT04409535,WHOQOL-BREF SURVEY,UNITED STATES,"Active, not recruiting",University of New Mexico,"May 7, 2020",Observational,Effects of the COVID-19 Health Emergency on the Biopsychosocial Health of Rural Residents of New Mexico Using Mixed Methods Research
2023,COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,"INFECTION, CORONAVIRUS","February 08, 2021",31,NCT04409574,,,Not yet recruiting,Assiut University,June 2020,Observational,COVID19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals
2024,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,SLEEP DISTURBANCE; INSOMNIA,"February 08, 2021",50,NCT04409743,REMOTE COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA,UNITED STATES,Recruiting,Stanford University,"June 7, 2020",Interventional,"Harnessing Telehealth to Mitigate the Impact of the COVID-19 Pandemic on Sleep, Suicidality, and Neuropsychiatric Symptoms"
2025,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,POSTTRAUMATIC STRESS DISORDER; PROLONGED GRIEF DISORDER; COVID,"February 08, 2021",50,NCT04409821,TELE-DELIVERED PSYCHOLOGICAL INTERVENTION,DENMARK,Recruiting,"Rigshospitalet, Denmark","May 29, 2020",Interventional,COVID-19 Caregiver Emotional Support
2026,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,COVID; VENOUS THROMBOEMBOLISM; ARTERIAL THROMBOSIS,"February 08, 2021",750,NCT04409834,UNFRACTIONATED HEPARIN IV; ENOXAPARIN 1 MG/KG; CLOPIDOGREL; UNFRACTIONATED HEPARIN SC; ENOXAPARIN 40 MG/0.4 ML INJECTABLE SOLUTION,UNITED STATES,Recruiting,The TIMI Study Group,"August 5, 2020",Interventional,"A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19 Patients"
2027,COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX),COVID; HYPERTENSION,"February 08, 2021",70,NCT04409847,ABPM; ECG; FMD; PWV; RAREFACTION,UNITED KINGDOM,Recruiting,NHS Greater Glasgow and Clyde,"June 1, 2020",Observational,COVID-19 Blood Pressure Endothelium Interaction Study
2028,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),COVID; SARS-CoV2; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS DISEASE; CORONAVIRUS INFECTION; PHARYNGEAL DISEASES,"February 08, 2021",150,NCT04409873,ORAL-B MOUTH SORE MOUTHWASH; CREST PRO-HEALTH MULTI-PROTECTION MOUTHWASH; CLOSYS MOUTHWASH; DISTILLED WATER; LISTERINE MOUTHWASH PRODUCT,UNITED STATES,Not yet recruiting,"University of California, San Francisco","December 7, 2020",Interventional,Effect of Antiseptic Mouthwash/Gargling Solutions and Pre-procedural Rinse on SARS-CoV-2 Load (COVID-19)
2029,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,"COVID, CORONAVIRUS","February 08, 2021",30,NCT04409886,HYPERBARIC CHAMBER,,Not yet recruiting,Maimonides Medical Center,"June 1, 2020",Interventional,The Application of Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients - Randomized Controlled Trial
2030,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,COVID; UROLOGIC DISEASES; SURGERY--COMPLICATIONS; EPIDEMIC DISEASE,"February 08, 2021",300,NCT04409899,BLOOD TESTS,SPAIN,"Active, not recruiting",Fundacio Puigvert,"March 20, 2020",Observational,The Utility of Enhanced Pre- and Post-surgical Protocols to Prevent the Spread of COVID-19 in a Large Urological Department (UroCovid Study)
2031,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),COVID INFECTION,"February 08, 2021",25,NCT04409925,RHDNASE I,CANADA,Recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"December 25, 2020",Interventional,Phase I Pilot Study Investigating the Safety and Feasibility of Inhaled rhDNase1 and Its Impact on Neutrophil Extracellular Traps (NETs) in Non-Ventilated COVID-19 Infected Patients
2032,Pharmacy Education During Covid-19 Outbreak,"EVENT, LIFE CHANGE","February 08, 2021",100,NCT04409951,,EGYPT,Not yet recruiting,Damanhour University,November 2020,Observational,Impact of Covid-19 on Pharmacist Student Education in Egypt
2033,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,MENTAL HEALTH WELLNESS 1,"February 08, 2021",45,NCT04410016,STAFF WELLBEING CENTRES,UNITED KINGDOM,Recruiting,University of Nottingham,"May 25, 2020",Interventional,Evaluation of a Workplace Intervention to Implement Supported COVID-19 Wellbeing Centres in a Healthcare Workplace During and After the Coronavirus Pandemic: The COVID-WELL Study
2034,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19",COVID; SARS-CoV2 INFECTION,"February 08, 2021",134,NCT04410107,"LUNG FUNCTION TESTS; EXERCISE CAPACITY; EXERCISE PHYSIOLOGY; HEALTH-RELATED QUALITY OF LIFE; RESPIRATORY SYMPTOMS, SYMPTOMS OF ANXIETY AND DEPRESSION, AND POST-TRAUMATIC STRESS SCREENING",BRAZIL,Recruiting,Federal University of Rio Grande do Sul,"May 15, 2020",Observational,"Short and Long Term Assessment of Lung Function, Exercise Capacity and Health-Related Quality of Life in Survivors of Severe COVID-19"
2035,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,COVID,"February 08, 2021",20,NCT04410159,POVIDONE-IODINE; ESSENTIAL OILS; TAP WATER,MALAYSIA,Completed,Universiti Sains Islam Malaysia,"June 22, 2020",Interventional,"A Pilot, Open-Labelled, Randomised Controlled Trial Of Povidone-Iodine Vs Essential Oil And Tap Water Gargling For COVID-19 Patients"
2036,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,CORONAVIRUS INFECTION; ARDS; COINFECTION,"February 08, 2021",300,NCT04410263,"SAMPLING (EDTA BLOOD, PHARYNGEAL AND NOSE SWABS, BRONCHOALVEOLAR LAVAGE ,URINE)",SWITZERLAND,Recruiting,University of Zurich,"April 9, 2020",Observational,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches
2037,Aggrenox To Treat Acute Covid-19,COVID,"February 08, 2021",132,NCT04410328,DIPYRIDAMOLE ER 200MG/ ASPIRIN 25MG ORALLY/ENTERALLY AND STANDARD OF CARE; STANDARD OF CARE,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","October 21, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Outcomes With Aggrenox in Patients With SARS-CoV-2 Infection
2038,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,COVID,"February 08, 2021",44,NCT04410354,MERIMEPODIB; MATCHING PLACEBO; REMDESIVIR,UNITED STATES,Terminated,"ViralClear Pharmaceuticals, Inc.","June 16, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Oral Merimepodib in Combination With Intravenous Remdesivir in Adult Patients With Advanced Coronavirus Disease 2019 (COVID-19)"
2039,Immune Response and Risk of Serious Infection to SARS-Cov2,"SARS COV2, IMMUNE RESPONSE","February 08, 2021",63,NCT04410432,BLOOD SAMPLE COLLECTION,FRANCE,Recruiting,Centre Hospitalier Universitaire Dijon,"September 29, 2020",Observational,Immune Response and Risk of Serious Infection to SARS-Cov2
2040,Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial）,BLOOD DONATION,"February 08, 2021",506517,NCT04410458,BLOOD DONATION SMS,CHINA,Enrolling by invitation,Guangzhou Blood Center,"May 31, 2020",Interventional,Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19（Repeat Trial）
2041,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,LIVER TRANSPLANT INFECTION; COVID; MORTALITY; IMMUNE RESPONSE,"February 08, 2021",300,NCT04410471,CLIA OF IGG AND IGM AGAINST SARS-COV-2,SPAIN,Recruiting,Magdalena Salcedo,"May 29, 2020",Observational [Patient Registry],Development and Persistence of Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients in Comparison With Immunocompetent Patients
2042,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,INFLAMMATORY BOWEL DISEASES; CORONAVIRUS INFECTION,"February 08, 2021",1500,NCT04410484,,UNITED KINGDOM,"Active, not recruiting",Hull University Teaching Hospitals NHS Trust,"May 22, 2020",Observational,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic
2043,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,COVID; CORONAVIRUS INFECTION; SARS-CoV2; COVID,"February 08, 2021",100,NCT04410510,P2ET (CAESALPINIA SPINOSA EXTRACT); PLACEBO,COLOMBIA,Recruiting,Hospital Universitario San Ignacio,"September 30, 2020",Interventional,"Study of the P2Et Extract Obtained From Caesalpinia Spinosa in the Symptomatic Treatment of Subjects With COVID-19 at the Hospital Universitario San Ignacio, Colombia."
2044,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,"MIGRAINE, HEMICRANIA","February 08, 2021",25,NCT04410536,SYMPTOMATIC DRUGS; BRIDGE THERAPY; MINDFULNESS PROGRAM,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"June 15, 2020",Interventional,Home-withdrawal Program Combined With Behavioural Approach in Patients With Medication Overuse Headache During Covid-19 Emergency: Incidence of Relapses in Overuse and Changes in Impact at One Year Follow up
2045,Pulmonary Optical Coherence Tomography in COVID-19 Patients,COVID; PULMONARY EMBOLISM,"February 08, 2021",10,NCT04410549,OPTICAL COHERENCE TOMOGRAPHY (OCT),BRAZIL,Recruiting,IRCCS San Raffaele,"June 1, 2020",Interventional,Optical Coherence Tomography for Microvascular Lung Vessels Obstructive Thromboinflammatory Syndrome Assessment in Patients With COVID-19: an Exploratory Study
2046,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum,PREGNANCY RELATED; COVID; COVID,"February 08, 2021",714,NCT04410562,HYDROXYCHLOROQUINE; PLACEBO,SPAIN,Recruiting,Barcelona Institute for Global Health,"May 13, 2020",Interventional,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum
2047,Can the Prediction Market Improve Predictions of COVID-19?,"HEALTH KNOWLEDGE, ATTITUDES, PRACTICE","February 08, 2021",560,NCT04410692,PREDICTION MARKET,SINGAPORE,Completed,"National University, Singapore","May 15, 2020",Interventional,Can the Prediction Market Improve Predictions of COVID-19?
2048,Glycaemia and Cardiac Function in Patients With COVID-19,"DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 1; COVID","February 08, 2021",100,NCT04410718,GLYCAEMIC LEVELS,DENMARK,Recruiting,Steno Diabetes Center Copenhagen,"April 20, 2020",Observational,Glycaemia and Cardiac Function in Patients With COVID-19
2049,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,CORONAVIRUS INFECTION; PSYCHIATRIC DISORDER; PSYCHOLOGICAL DISTRESS,"February 08, 2021",1000,NCT04410835,ONLINE SURVEY,AUSTRIA,Recruiting,Medical University of Graz,"April 28, 2020",Observational,Psychological Impact and Effect of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders - an Online Survey
2050,COVID-19 PCR Test Results in Asymptomatic Pregnants,COVID; ASYMPTOMATIC PREGNANT,"February 08, 2021",179,NCT04410939,REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION,TURKEY,Completed,Istanbul Medipol University Hospital,"April 10, 2020",Observational,COVID-19 PCR Test Results in Asymptomatic Pregnants Admitted for Birth and Other Interventions in Our Clinic
2051,A Study Comparing Time to Intubate With and Without a Barrier Box,INTUBATION,"February 08, 2021",78,NCT04411056,BARRIER BOX,UNITED STATES,Completed,The Guthrie Clinic,"May 7, 2020",Interventional,Time to Adapt in the Pandemic Era: A Prospective Randomized Study Comparing Time to Intubate With and Without the Barrier Box
2052,A Longitudinal Study of COVID-19 Sequelae and Immunity,COVID,"February 08, 2021",900,NCT04411147,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"June 17, 2020",Observational,A Longitudinal Study of COVID-19 Sequelae and Immunity
2053,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,SARS-CoV2; COVID,"February 08, 2021",1008,NCT04411433,FAVIPIRAVIR (3200 MG + 1200 MG); FAVIPIRAVIR (3600 MG + 1600 MG); FAVIPIRAVIR (3200 MG + 1200 MG) COMBINED WITH HYDROXYCHLOROQUINE; FAVIPIRAVIR (3200 MG + 1200 MG) COMBINED WITH AZITHROMYCIN; HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE COMBINED WITH AZITHROMYCIN,TURKEY,"Active, not recruiting","Ministry of Health, Turkey","May 8, 2020",Interventional,"An Open-Label, Multicenter, Parallel-Group, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19"
2054,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,COVID,"February 08, 2021",1264,NCT04411446,VITAMIN D; PLACEBO,ARGENTINA,Recruiting,Vitamin D Study Group,"August 11, 2020",Interventional,Randomized Controlled Trial of High Dose of Vitamin D as Compared With Placebo to Prevent Complications Among COVID-19 Patients
2055,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,COVID; MECHANICAL VENTILATION; QUALITY OF LIFE; RADIOLOGIC INCREASED DENSITY OF LUNG; SEDATION; COMPLICATION OF TREATMENT,"February 08, 2021",470,NCT04411459,INVASIVE MECHANICAL VENTILATION,ITALY,Completed,Azienda Usl di Bologna,"February 1, 2020",Observational,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome
2056,(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI,ACUTE KIDNEY INJURY DUE TO SEPSIS,"February 08, 2021",1600,NCT04411472,RECOMBINANT HUMAN ALKALINE PHOSPHATASE; PLACEBO,NETHERLANDS,Recruiting,AM-Pharma,"November 2, 2020",Interventional,"A DB, Placebo-Controlled, Two-Arm Parallel-Group, Phase 3 RCT to Investigate the Efficacy and Safety of Recombinant Human Alkaline Phosphatase for Treatment of Patients With SA-AKI"
2057,"COVID-19, Obesity and Lifestyle in Children","COVID; OBESITY, CHILDHOOD; LIFESTYLE; LIFESTYLE, HEALTHY; OVERWEIGHT, CHILDHOOD; CHILDREN, ONLY; FAMILY","February 08, 2021",4000,NCT04411511,EXPOSURE TO THE DUTCH MEASURES DUE TO THE COVID-19 PANDEMIC.,NETHERLANDS,Recruiting,Maastricht University Medical Center,"May 6, 2020",Observational,"The Influence of the Covid-19 Pandemia on the Health Behaviour of Primary School Children (and Their Parents) - COVID-19, Obesity and Lifestyle in Children"
2058,Epigenetic Tools as Prognostic Predictors in Covid19,PROGNOSIS,"February 08, 2021",105,NCT04411563,TAKING BIOLOGICAL SAMPLES,TURKEY,Recruiting,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,"May 21, 2020",Observational [Patient Registry],The Effect of miRNA and Epigenetic Modifications on Prognosis in Covid-19 Infection
2059,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare,SARS-CoV2,"February 08, 2021",40000,NCT04411576,THROAT SWAB SAMPLE FOR MEASURING CURRENT INFECTION WITH SARS-COV-2; BLOOD SAMPLE FOR SEROLOGY TO MEASURE PAST INFECTION WITH SARS-COV-2,SWEDEN,Recruiting,Karolinska University Hospital,"April 23, 2020",Observational,"Studies on Current and Past SARS-CoV-2 Infection (and COVID-19) in Healthcare in Stockholm, Sweden"
2060,Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD,SEVERE ACUTE RESPIRATORY SYNDROME; COVID,"February 08, 2021",90,NCT04411602,SARS-COV-2 PLASMA,UNITED STATES,Recruiting,Ascension South East Michigan,"April 7, 2020",Interventional,Convalescent Plasma to Treat Coronavirus - Associated Severe Pulmonary Complications: A Feasibility Study Assessing the Safety of Multiple Doses of Anti-SARS-CoV-2 Plasma in Patients With Severe Respiratory Distress Due to COVID-19
2061,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,COVID,"February 08, 2021",24,NCT04411628,LY3819253; PLACEBO,UNITED STATES,Completed,Eli Lilly and Company,"May 28, 2020",Interventional,"A Randomized, Placebo-Controlled, Double-Blind, Sponsor Unblinded, Single Ascending Dose, Phase 1 First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous LY3819253 in Participants Hospitalized for COVID-19"
2062,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,SARS-CoV2,"February 08, 2021",34,NCT04411667,OCTAGAM,UNITED STATES,"Active, not recruiting","George Sakoulas, MD","April 28, 2020",Interventional,Randomized Open Label Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection
2063,Study of Sargramostim in Patients With COVID-19,COVID; SARS-CoV2,"February 08, 2021",120,NCT04411680,SARGRAMOSTIM; STANDARD OF CARE,UNITED STATES,Recruiting,"Partner Therapeutics, Inc.","August 18, 2020",Interventional,A Phase 2 Trial Evaluating Sargramostim in Patients With COVID-19 Associated Acute Hypoxemia
2064,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis",INFLAMMATORY BOWEL DISEASES; COVID,"February 08, 2021",200,NCT04411784,,UNITED KINGDOM,"Active, not recruiting",Hull University Teaching Hospitals NHS Trust,"May 20, 2020",Observational,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis: A Multi-centre Observational Case- Control Study"
2065,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,COVID; INFLAMMATORY RESPONSE,"February 08, 2021",100,NCT04412018,ICOSAPENT ETHYL,CANADA,Recruiting,Canadian Medical and Surgical Knowledge Translation Research Group,"June 4, 2020",Interventional,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 (VASCEPA-COVID-19)
2066,Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient,TO PREDICT AN UNFAVORABLE EVOLUTION OF COVID AT THE HOSPITAL ADMISSION OF PATIENTS,"February 08, 2021",802,NCT04412031,NON APPLICABLE,FRANCE,Completed,Hospices Civils de Lyon,"November 11, 2019",Observational,Bayesian Network to Predict Transfer in Intensive Care Units or Death in Newly Covid-19 Hospitalized Patient
2067,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,COVID PNEUMONIA; ACUTE LUNG INJURY; ARDS,"February 08, 2021",82,NCT04412057,CERC-002; PLACEBO,UNITED STATES,Recruiting,"Aevi Genomic Medicine, LLC, a Cerecor company","June 9, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of CERC-002 in Adults With COVID 19 Pneumonia and Acute Lung Injury"
2068,Effect of Using Barrier Devices for Intubation in COVID-19 Patients,"INTUBATION, INTRATRACHEAL; COVID","February 08, 2021",13,NCT04412226,AEROSOL BOX; TRANSPARENT SHEET,TURKEY,Completed,Derince Training and Research Hospital,"June 10, 2020",Observational,"Effect of Using Barrier Devices for Intubation in COVID-19 Patients: Randomized, Prospective, Manikin Study"
2069,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,TB - TUBERCULOSIS; PATIENT SATISFACTION,"February 08, 2021",200,NCT04412239,PATIENT-CENTRED ADVICE ON TELEPHONE CONSULTATION IN TB PATIENTS:,PAKISTAN,Recruiting,Health Science Center of Xi'an Jiaotong University,"April 20, 2020",Interventional,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic
2070,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,COVID,"February 08, 2021",0,NCT04412252,TOFACITINIB; PLACEBO,UNITED STATES,Withdrawn,Pfizer,"July 6, 2020",Interventional,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY ASSESSING THE SAFETY AND EFFICACY OF TOFACITINIB IN HOSPITALIZED PARTICIPANTS WITH COVID-19 PNEUMONIA WHO ARE RECEIVING STANDARD OF CARE THERAPY"
2071,Frailty in Elderly Patients With COVID-19,COVID,"February 08, 2021",300,NCT04412265,RELATION BETWEEN FRAILTY AND CLINICAL OUTCOMES IN ELDERLY PATIENTS WITH COVID-19.,ITALY,Recruiting,University of Milano Bicocca,"April 16, 2020",Observational,Relationship Between Frailty and Clinical Outcomes in Elderly Patients With COVID-19
2072,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers,"COVID; ISOLATION, SOCIAL","February 08, 2021",392,NCT04412278,ONLINE SURVEY,TURKEY,Completed,Okan University,"June 1, 2020",Observational,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers: Cross Sectional Study on Turkish Society and Interpretation With Physical Activity Level
2073,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",COVID,"February 08, 2021",120,NCT04412291,ANAKINRA PREFILLED SYRINGE; TOCILIZUMAB PREFILLED SYRINGE; STANDARD-OF-CARE TREATMENT,SWEDEN,Recruiting,Karolinska University Hospital,"June 11, 2020",Interventional,"A Single-center, Randomized, Open-label Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study"
2074,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,COVID; THROMBOEMBOLIC EVENTS; BLEEDING,"February 08, 2021",166,NCT04412304,DOSE OF TINZAPARIN OR DALTEPARIN,SWEDEN,Completed,Karolinska Institutet,"March 6, 2020",Observational,"Patient Characteristics, Outcome and Thromboembolic Events Among Adult Critically Ill COVID-19 Patients With Different Anticoagulant Regimes at One of the Biggest Emergency Hospitals in Northern Europe, Sweden"
2075,Use of PCR-Sars-CoV-2 in Children,COVID,"February 08, 2021",600,NCT04412317,,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"June 3, 2020",Observational [Patient Registry],"National Observatory of the Care of Young Sick Children in Community or Not, Indications and Cost-effectiveness of PCR-Sars-CoV-2 - VIGIL Study"
2076,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,COVID; CRITICAL ILLNESS; POST INTENSIVE CARE UNIT SYNDROME; MUSCLE WEAKNESS,"February 08, 2021",20,NCT04412330,ICU RECOVERY + PHYSICAL THERAPY,UNITED STATES,Recruiting,University of Kentucky,"May 1, 2020",Interventional,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 (OPTImAL) - a Single Center Prospective Study
2077,The Seniors COvid-19 Pandemic and Exercise Study,WELL-BEING (PSYCHOLOGICAL FLOURISHING); DEPRESSION; QUALITY OF LIFE; LONELINESS; PHYSICAL ACTIVITY; SOCIAL IDENTIFICATION; PHYSICAL HEALTH,"February 08, 2021",241,NCT04412343,VIRTUAL GROUP INTERVENTION; PERSONAL EXERCISE INTERVENTION,CANADA,Completed,University of British Columbia,"May 23, 2020",Interventional,The Seniors COvid-19 Pandemic and Exercise Study: A Randomized Controlled Trial
2078,Timing of Tracheotomy in Covid-19 Patients,COVID; ARDS; TRACHEOSTOMY COMPLICATION; RESPIRATORY INSUFFICIENCY; CORONAVIRUS INFECTION,"February 08, 2021",180,NCT04412356,TRACHEOTOMY,SWEDEN,Recruiting,"Sahlgrenska University Hospital, Sweden","June 4, 2020",Interventional,"Timing of Tracheotomy in Covid-19 Positive Patients: a Randomized, Controlled Trial"
2079,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,COVID; CARDIOVASCULAR DISEASES,"February 08, 2021",20,NCT04412369,NON-INVASIVE CARDIAC IMAGING,UNITED KINGDOM,Not yet recruiting,University of Cambridge,June 2020,Observational,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury
2080,Covid-19: Possible Role of Neutrophil Extracellular Traps,COVID,"February 08, 2021",100,NCT04412382,NETOSIS MARKERS,ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"June 1, 2020",Observational [Patient Registry],Covid-19: Possible Role of Neutrophil Extracellular Traps
2081,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,CORONAVIRUS INFECTION; MIDDLE EAST RESPIRATORY SYNDROME (MERS); ACUTE RESPIRATORY DISTRESS SYNDROME; CORONAVIRUS INFECTION; COVID; SARS-CoV2,"February 08, 2021",516,NCT04412395,LACTOFERRIN (APOLACTOFERRIN); PLACEBO OF EXCIPIENT(S) WILL BE ADMINISTERED,EGYPT,Not yet recruiting,"National Research Centre, Egypt","June 1, 2020",Interventional,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory Therapy in Patients Diagnosed With COVID-19 Disease
2082,Echocardiography in Patients With Covid-19,"COVID; ARDS, HUMAN","February 08, 2021",500,NCT04412460,,GERMANY,Recruiting,University Hospital Tuebingen,"March 20, 2020",Observational,Echocardiography in Patients With Covid-19 Undergoing Intensive Care Therapy
2083,COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits,SARS-CoV2,"February 08, 2021",1000,NCT04412473,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 30, 2020",Observational,COVID-19 Respiratory Distress and Antithrombotic Drugs inSubject's Habits
2084,COVID-19 Convalescent Plasma (CCP) Transfusion,COVID,"February 08, 2021",100,NCT04412486,COVID CONVALESCENT PLASMA,UNITED STATES,Recruiting,"Gailen D. Marshall Jr., MD PhD","June 1, 2020",Interventional,An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients With Moderate to Severe COVID-19
2085,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,COVID,"February 08, 2021",942,NCT04412538,LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE; LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 14-DAY SCHEDULE; MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE; MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 14-DAY SCHEDULE; HIGH DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE; HIGH DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 14-DAY SCHEDULE; PLACEBO ON A 0- AND 28-DAY SCHEDULE; PLACEBO ON A 0- AND 14-DAY SCHEDULE,CHINA,Recruiting,Chinese Academy of Medical Sciences,"May 15, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Phase Ia/IIa Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged 18 to 59 Years"
2086,Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,CORONAVIRUS INFECTION; VIRUS DISEASES; CORONAVIRIDAE INFECTIONS,"February 08, 2021",50,NCT04412551,,SWEDEN,Recruiting,"Dalarna County Council, Sweden","May 20, 2020",Observational [Patient Registry],Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19
2087,Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry,ST ELEVATED MYOCARDIAL INFARCTION UNDERGOING MECHANICAL REPERFUSION,"February 08, 2021",6609,NCT04412655,PERCUTANEOUS CORONARY REVASCULARIZATION FOR STEMI,ITALY,"Active, not recruiting","Università degli Studi del Piemonte Orientale ""Amedeo Avogadro""","May 5, 2020",Observational,International Study on Acute Coronary Syndromes - ST-segment Elevation Myocardial Infarction COVID 19
2088,Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,SARS-CoV2 (COVID) SEVERE PNEUMONIA,"February 08, 2021",32,NCT04412668,ATYR1923 1 MG/KG; ATYR1923 3 MG/KG; PLACEBO,PUERTO RICO,Completed,"aTyr Pharma, Inc.","June 12, 2020",Interventional,A Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19)
2089,Covid-19 and Diabetes in West of Algeria,CORONAVIRUS INFECTION; DIABETES MELLITUS; PREVALENCE; RISK FACTORS; PATIENT OUTCOME ASSESSMENT; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",100,NCT04412746,MANAGEMENT OF COVID-19,ALGERIA,Recruiting,"Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen","April 1, 2020",Observational,Prevalence of Diabetes Among Hospitalized Patients With Covid-19 in West of Algeria. Identification of Diabetes-related Associated Factors Severe Forms
2090,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,COVID,"February 08, 2021",300,NCT04412772,TOCILIZUMAB; PLACEBO,UNITED STATES,Recruiting,Queen's Medical Centre,"June 12, 2020",Interventional,"A Randomized, Controlled Clinical Trial of the Safety and Efficacy of Tocilizumab for the Treatment of Severe COVID-19"
2091,Cyclosporine in Patients With Moderate COVID-19,COVID,"February 08, 2021",20,NCT04412785,CYCLOSPORINE,UNITED STATES,Recruiting,University of Pennsylvania,"June 30, 2020",Interventional,Phase I Trial for the Prevention of Cytokine Release Syndrome (CRS) With Cyclosporine in Patients With Moderate COVID-19
2092,Self-compassion for Chronic Pain Virtual Group Treatment Program,CHRONIC PAIN,"February 08, 2021",28,NCT04413006,SELF-COMPASSION FOR CHRONIC PAIN VIRTUAL GROUP TREATMENT PROGRAM,CANADA,Recruiting,University of Manitoba,"May 25, 2020",Interventional,A Self-compassion Group-based Treatment for Chronic Pain Via Video Conferencing During the COVID-19 Pandemic: Feasibility Study for a Potential New Mode of Treatment Delivery
2093,"Novel COVID-19, A National Analysis",COVID,"February 08, 2021",61,NCT04413045,PREVALENCE OF COVID-19,EGYPT,Completed,Assiut University,"May 20, 2020",Observational,Prevalence and Clinical Characteristics of Novel COVID-19 Cases at One Quarantine Hospital; a National Analysis
2094,Menstrual Cycle Characteristics of Healthcare Professionals,MENSTRUAL IRREGULARITY; COVID,"February 08, 2021",260,NCT04413058,,TURKEY,Completed,Haydarpasa Numune Training and Research Hospital,"April 10, 2020",Observational,Menstrual Cycle Characteristics of Healthcare Professionals at Covid 19 Pandemic Hospital
2095,Cardiac COVID-19 Health Care Workers,SARS-CoV2; COVID; CORONAVIRUS; CARDIAC MAGNETIC RESONANCE; MYOCARDITIS; CARDIAC ANOMALY,"February 08, 2021",142,NCT04413071,PASSED INFECTION OF SARS-COV-2,SPAIN,Completed,AORTICA Group,"May 25, 2020",Observational,Cardiac Involvement in Coronavirus (SARS-Cov-2) Infected Health Care Workers: The CCC Study
2096,Clinical Characteristics of Critically Ill Patients With COVID-19,CORONAVIRUS INFECTION; CRITICAL ILLNESS; CHARACTERISTICS DISEASE,"February 08, 2021",105,NCT04413435,FILE SCANNING,TURKEY,Completed,Nevsehir Public Hospital,"October 30, 2020",Observational,Clinical Characteristics of Critically Ill Patients With 2019 Novel Coronavirus (COVID-19): Do We Need a New Triage System?
2097,Yoga Pranayama Adjuvant to Treat Burden COVID-19,CORONAVIRUS INFECTION; CYTOKINE STORM; MENTAL DISORDER,"February 08, 2021",1000,NCT04413747,MORNING YOGA-BASED BREATHING SUPPORT; PRE_LUNCH YOGA-BASED BREATHING SUPPORT; PRE_DINNER YOGA-BASED BREATHING SUPPORT,ITALY,Not yet recruiting,Health Ricerca e Sviluppo S.R.L.,"August 15, 2020",Interventional,Yoga- Based Breathing for Vagus Nerve Stimulation as Home-care Adjuvant Treatment Against Burden COVID-19
2098,Fostering Exercise After Bariatric Surgery,BARIATRIC SURGERY; PHYSICAL ACTIVITY,"February 08, 2021",40,NCT04413812,FREEBASE EXERCISE PROGRAMME,SWITZERLAND,"Active, not recruiting",Lia Bally,"July 1, 2020",Interventional,Fostering Exercise After Bariatric Surgery
2099,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,"OBESITY, COVID INFECTION","February 08, 2021",120,NCT04413838,NIVOLUMAB; ROUTINE STANDARD OF CARE,FRANCE,Not yet recruiting,Hospices Civils de Lyon,"June 15, 2020",Interventional,"Study of the Efficiency and Security of NIVOLUMAB Therapy, Used in Immuno-stimulation, in Hospitalized Obese Individuals at Risk to Evolve Towards Severe Forms of COVID-19 Infection. Multicentric, Paralleled, Randomized, Controlled Trial"
2100,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,SARS-CoV2,"February 08, 2021",50,NCT04413864,INFLAMMATORY CYTOKINES AND CHEMOKINES PROFILES OF PATIENTS WITH DEXMEDETOMIDINE ADMINISTRATION,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 24, 2020",Interventional,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19
2101,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),FRAILTY SYNDROME; COVID; HEALTHY AGING; OLD AGE; DEBILITY,"February 08, 2021",600,NCT04413877,,,Not yet recruiting,University of Liege,October 2020,Observational [Patient Registry],Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE)
2102,Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA,COVID; SARS-CoV2,"February 08, 2021",100,NCT04413955,SERAPH®-100 MICROBIND® AFFINITY BLOOD FILTER,UNITED STATES,Recruiting,"Children's Hospital Medical Center, Cincinnati","June 1, 2020",Observational [Patient Registry],Seraph®-100 Microbind® Affinity Blood Filter for the Treatment of COVID-19 Under Emergency Use Authorization: Data Registry
2103,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",CORONAVIRUS; CORONAVIRUS INFECTION; COVID; SARS-CoV2,"February 08, 2021",600,NCT04413968,RAPID DETECTION TEST; NASOPHARYNGEAL SWAB; STOOL COLLECTION,FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"June 2, 2020",Interventional,"Contamination and Transmission of the SARS-CoV-2 Virus in Exposed, Confined and Community-based Infants: A Cross-sectional, Multicentre, Interventional Seroprevalence Study"
2104,Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients,SARS-CoV2; HOSPITALISATION-ASSOCIATED INFECTION,"February 08, 2021",155,NCT04414059,,FRANCE,Not yet recruiting,Elsan,March 2021,Observational,Complications Risk Factors in Patients Hospitalized for COVID-19 Infection: Role of Proteins Electrophoresis
2105,Ruxolitinib in the Treatment of Covid-19,COVID,"February 08, 2021",100,NCT04414098,INC424 / RUXOLITINIB,,Not yet recruiting,Marcelo Iastrebner,"June 1, 2020",Interventional,Safety and Efficacy Study of Ruxolitinib in the Treatment of Severe Acute Respiratory Syndrome Due to SARS-COV-2
2106,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,MILD-TO-MODERATE COVID,"February 08, 2021",350,NCT04414124,KB109 + SELF SUPPORTIVE CARE (SSC); SELF SUPPORTIVE CARE (SSC) ALONE,UNITED STATES,"Active, not recruiting",Kaleido Biosciences,"August 2, 2020",Interventional,"A Randomized, Open Label, Prospective, Parallel Group Study to Assess the Natural History of COVID-19 and Effects of KB109 in Addition to Supportive Self Care (SSC) Compared to SSC Alone on Measures of Health in Non-hospitalized Patients With Mild-Moderate COVID-19"
2107,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,SARS-CoV2,"February 08, 2021",320,NCT04414241,HYDROXYCHLOROQUINE,PERU,Not yet recruiting,Universidad Peruana Cayetano Heredia,June 2020,Interventional,"Hydroxychloroquine to Prevent SARS-CoV-2 Infection Among Healthcare Workers: Randomized Controlled, Open-label, Phase 3 Clinical Trial"
2108,Bacillus Calmette-guérin Vaccination to Prevent COVID-19,COVID; VIRUS DISEASES; CORONAVIRUS INFECTION; CORONARY HEART DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE,"February 08, 2021",900,NCT04414267,BCG VACCINE; PLACEBO,GREECE,Recruiting,Hellenic Institute for the Study of Sepsis,"May 26, 2020",Interventional,A Randomized Clinical Trial for Enhanced Trained Immune Responses Through Bacillus Calmette-Guérin Vaccination to Prevent Infections by COVID-19: The ACTIVATE II Trial
2109,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,"COVID; PNEUMONIA, VIRAL","February 08, 2021",41,NCT04414293,LUNG LOW DOSE RADIATION,SPAIN,Not yet recruiting,Hospital Provincial de Castellon,"October 1, 2020",Interventional,Phase II Study of Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis
2110,Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly,SARS-CoV2,"February 08, 2021",350,NCT04414319,,FRANCE,Recruiting,University Hospital Center of Martinique,"April 15, 2020",Observational,Impact of SARS-CoV-2 Infection in a Population Aged 70 Years or Older on Loss of Autonomy
2111,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,STRESS; ANXIETY; DEPRESSION; RESILIENCE; WELLBEING; MOOD,"February 08, 2021",200,NCT04414371,YOGA,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","May 20, 2020",Interventional,Tools for Wellbeing COVID-19 National Study of Undergraduate Students
2112,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,COVID; SARS-CoV2,"February 08, 2021",1500,NCT04414410,,FRANCE,Enrolling by invitation,Hospital Ambroise Paré Paris,"May 12, 2020",Observational,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia
2113,A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,CORONAVIRUS INFECTION,"February 08, 2021",42,NCT04414618,OPAGANIB; PLACEBO,ISRAEL,"Active, not recruiting",RedHill Biopharma Limited,"July 2, 2020",Interventional,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled Phase 2a Study, in Adult Subjects Hospitalized With SARS-CoV-2 Positive Pneumonia"
2114,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",120,NCT04414631,CONESTAT ALFA,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","August 6, 2020",Interventional,"Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19: a Randomized, Parallel-group, Open-label, Multi-center Pilot Trial (PROTECT-COVID-19)."
2115,USZ BioResource COVID,COVID,"February 08, 2021",500,NCT04414657,BLOOD SAMPLING FOR BIOBANK,SWITZERLAND,Recruiting,Regina Grossmann,"April 9, 2020",Observational,Development of a SARS-CoV-2 Research Biobank
2116,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness,LONELINESS,"February 08, 2021",120,NCT04414826,MINDFULNESS ALONE (MO) INTERVENTION; MINDFULNESS + COMPASSION INTERVENTION (MC),UNITED STATES,Recruiting,University of Texas at Austin,"May 25, 2020",Interventional,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness
2117,Determining the Reproductive Health of Men Post-COVID-19 Infection,"INFERTILITY, MALE; TESTOSTERONE DEFICIENCY","February 08, 2021",0,NCT04414904,EXPOSURE: COVID-19 INFECTION,UNITED KINGDOM,Withdrawn,Imperial College London,"June 10, 2020",Observational,Determining the Reproductive Health of Men Post-COVID-19 Infection
2118,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,COVID,"February 08, 2021",752,NCT04415060,ISOFLURANE INHALANT PRODUCT; SEVOFLURANE INHALANT PRODUCT,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"June 15, 2020",Interventional,"SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival. Multicentre Open-label, Pragmatic, Randomized Controlled Trial and a Parallel Prospective (Non-randomized) Cohort Study"
2119,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,CORONAVIRUS; COVID; ARDS; CYTOKINE STORM; CYTOKINE RELEASE SYNDROME,"February 08, 2021",186,NCT04415073,SNDX-6352; PLACEBO,UNITED STATES,Suspended,Syndax Pharmaceuticals,"May 30, 2020",Interventional,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Axatilimab for the Treatment of Hospitalized Patients With Respiratory Signs and Symptoms Secondary to Novel Coronavirus Disease (COVID-19)"
2120,Treatment of Patients With COVID-19 With Convalescent Plasma,COVID,"February 08, 2021",120,NCT04415086,CONVALESCENT PLASMA,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 1, 2020",Interventional,"Treatment of Patients With COVID-19 With Convalescent Plasma Transfusion: a Multicenter, Open-labeled, Randomized and Controlled Study"
2121,Tofacitinib for Treatment of Moderate COVID-19,COVID,"February 08, 2021",60,NCT04415151,TOFACITINIB 10 MG; PLACEBO,UNITED STATES,"Active, not recruiting",Yale University,"July 29, 2020",Interventional,Investigation of Tofacitinib to Mitigate the Impact of COVID-19 (I-TOMIC) in Moderate SARS-CoV-2 (MODERATE I-TOMIC)
2122,Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period,COVID,"February 08, 2021",700,NCT04415359,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","May 20, 2020",Observational,Evaluation of the Evolution of Pregnancies in the First Trimester Following a Medically Assisted Procreation (MAR) Management During a COVD-19 Pandemic Period
2123,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,COVID,"February 08, 2021",20,NCT04415879,N-95 RESPIRATOR; CLOTH FACE MASK; GRADED EXERCISE TEST,UNITED STATES,Completed,The Cleveland Clinic,"June 1, 2020",Interventional,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.
2124,Extracellular Water in Covid 19 Pneumonia,EXTRACELLULAR FLUID ALTERATION; CORONAVIRUS INFECTION,"February 08, 2021",52,NCT04416009,NİCAS,TURKEY,Recruiting,Gaziosmanpasa Taksim Research and Education Hospital,"July 5, 2020",Observational [Patient Registry],the Determination of Extracellular Water (ECW) Which is Detected by Bioimpedence Method on Severe and Mild Covid 19 Pneumonia Clinical Course
2125,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,COVID,"February 08, 2021",400,NCT04416048,RIVAROXABAN; STANDARD OF CARE (SOC),GERMANY,Not yet recruiting,"Charite University, Berlin, Germany","August 1, 2020",Interventional,Effect of Anticoagulation Therapy on Clinical Outcomes in Moderate to Severe Coronavirus Disease 2019 (COVID-19)
2126,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,COVID,"February 08, 2021",2500,NCT04416061,COVID 19 DIAGNOSTIC TEST,HONG KONG,"Active, not recruiting",Hong Kong Sanatorium & Hospital,"May 25, 2020",Observational,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic: A Descriptive Study of Patients With SARS-CoV-2 RT-PCR Performed
2127,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),COVID; PULMONARY FIBROSIS,"February 08, 2021",130,NCT04416100,PULMONARY FUNCTION TESTS; IMAGING; BLOOD SAMPLING,AUSTRIA,Recruiting,Medical University Innsbruck,"April 29, 2020",Observational,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection
2128,Photodynamic Therapy for the Treatment of COVID-19,PHOTODYNAMIC THERAPY& LOW LEVEL LASER IN MANAGEMENT OF COVID,"February 08, 2021",60,NCT04416113,PHOTOBIOMODULATION AND PHOTODYNAMIC THERAPY,,Not yet recruiting,Cairo University,August 2020,Interventional,Photobiomodulation and Photodynamic Therapy for the Treatment of COVID-19 A Randomized Controlled Clinical Trials
2129,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,COVID,"February 08, 2021",10,NCT04416139,INFUSION IV OF MESENCHYMAL STEM CELLS,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"May 1, 2020",Interventional,Mesenchymal Stem Cells for the Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID-19. Pilot Study
2130,COVID-19 Pandemic and Worldwide Organ Procurement,COVID,"February 08, 2021",230000,NCT04416256,,FRANCE,Recruiting,Paris Translational Research Center for Organ Transplantation,"February 1, 2020",Observational,Consequences of the COVID-19 Pandemic on Worldwide Organ Procurement and Transplantation
2131,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),CORONAVIRUS,"February 08, 2021",13000,NCT04416308,NG TEST; BLOOD TEST; SELF-QUESTIONNARY,FRANCE,Recruiting,Rennes University Hospital,"May 29, 2020",Interventional,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne
2132,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,SARS-CoV2 INFECTION (COVID),"February 08, 2021",954,NCT04416334,COLCHICINE PLUS SYMPTOMATIC TREATMENT (PARACETAMOL); SYMPTOMATIC TREATMENT (PARACETAMOL OR BEST SYMPTOMATIC TREATMENT BASED ON DOCTOR RECOMMENDATIONS),SPAIN,Recruiting,Instituto de Investigación Marqués de Valdecilla,"August 19, 2020",Interventional,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS SARS-CoV2 (COVID-19)
2133,COVID19 Clinical Predictors and Outcome,COVID; SARS-CoV2,"February 08, 2021",800,NCT04416347,SARS-COV2 INFECTION,UNITED KINGDOM,Recruiting,St George's University Hospitals NHS Foundation Trust,"June 15, 2020",Observational,"COVID-19, Clinical Predictors and Evolution of Disease in Hospitalised and Intensive Care Patients at St George's Hospital"
2134,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,AUTISM SPECTRUM DISORDER; ATTENTION-DEFICIT HYPERACTIVITY DISORDER,"February 08, 2021",40,NCT04416360,INTERVIEW BY PSYCHOLOGISTS,FRANCE,Recruiting,"University Hospital, Toulouse","May 5, 2020",Interventional,Clinical Evolution and Parenting in Children and Adolescents With Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder Quarantined Because of Covid-19 Outbreak
2135,COVID-19 and Pregnancy Outcomes,CORONAVIRUS INFECTION; PREGNANCY COMPLICATIONS; VERTICAL TRANSMISSION OF INFECTIOUS DISEASE; BREASTFEEDING; NEONATAL INFECTION,"February 08, 2021",300,NCT04416373,RT PCR SARS-COV-2,PORTUGAL,Recruiting,Universidade Nova de Lisboa,"March 22, 2020",Observational,COVID-19 and Pregnancy Outcomes: a Portuguese Collaboration Study
2136,STerOids in COVID-19 Study,CORONAVIRUS INFECTION,"February 08, 2021",146,NCT04416399,BUDESONIDE DRY POWDER INHALER,UNITED KINGDOM,Terminated,University of Oxford,"July 16, 2020",Interventional,Use of High Dose Inhaled Corticosteroids as Treatment of Early COVID-19 Infection to Prevent Clinical Deterioration and Hospitalisation
2137,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,MYELOPROLIFERATIVE NEOPLASM; COVID INFECTION,"February 08, 2021",50,NCT04416438,,FRANCE,Recruiting,French Innovative Leukemia Organisation,"May 18, 2020",Observational,Observational Study of the Impact of the COronaVirus Disease 2019 (COVID-19) Epidemic on Patients With Myeloproliferative Neoplasias
2138,Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19,QUALITY OF LIFE; LONG-TERM OUTCOMES; CORONAVIRUS INFECTION; MORALITY; REHOSPITALIZATION,"February 08, 2021",230,NCT04416464,COVID-19 PNEUMONIA,PORTUGAL,Not yet recruiting,Universidade do Porto,"June 15, 2020",Observational,"Quality of Life and Long-term Outcomes in Patients With Pneumonia Associated With SARS-Cov2 Infection, Survivors of Intensive Care Units: a Prospective Multicenter Cohort Study"
2139,Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2 ),COVID,"February 08, 2021",630,NCT04416893,RT-PCR SARS-COV2; SARS-COV2 SEROLOGY,,Not yet recruiting,Centre Hospitalier Intercommunal Creteil,"June 7, 2020",Observational,"Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children, a Cross-sectional, Prospective, Multicentre, Observational Study in Primary Care-Part 2 After the Lifting of the Lockdown"
2140,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,CORONAVIRUS INFECTION; DISEASE PREVENTION,"February 08, 2021",20,NCT04416919,ASSEMBLED MASK,UNITED STATES,Recruiting,University of Oklahoma,"July 15, 2020",Interventional,A Proposed Alternative to the N-95 Mask Shortage in the COVID-19 Pandemic. A Feasibility Study
2141,Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes,"STRESS, PSYCHOLOGICAL; SLEEP INITIATION AND MAINTENANCE DISORDERS","February 08, 2021",1000,NCT04417153,MINDFULNESS BASED INTERVENTION,SINGAPORE,Recruiting,"National University, Singapore","September 20, 2019",Observational,Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
2142,Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,COVID DISEASE,"February 08, 2021",240,NCT04417257,LAU-7B; PLACEBO ORAL CAPSULE,CANADA,Recruiting,Laurent Pharmaceuticals Inc.,"June 29, 2020",Interventional,"RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Pilot Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease"
2143,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,DIABETES MELLITUS,"February 08, 2021",50,NCT04417270,FREESTYLE LIBRE 14 DAY CGM SYSTEM; ACCUCHEK INFORM II PLATFORM,UNITED STATES,Recruiting,Northwell Health,"June 12, 2020",Interventional,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge
2144,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,COVID,"February 08, 2021",2014,NCT04417335,BCG VACCINE; PLACEBO,NETHERLANDS,"Active, not recruiting",Radboud University,"April 16, 2020",Interventional,"Reducing Hospital Admission of Elderly in SARS-CoV-2 Pandemic Via the Induction of Trained Immunity by Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial"
2145,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19",COVID; DISEASE OUTBREAK; MENTAL DISORDERS,"February 08, 2021",94,NCT04417374,DESCRIPTION OF GROUPS CARACTERISTICS,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context"
2146,Living With Sickle Cell Disease in the COVID-19 Pandemic,ISOLATION; ANXIETY; HEALTH CARE UTILIZATION; SICKLE CELL DISEASE; PAIN,"February 08, 2021",1000,NCT04417673,,UNITED STATES,Not yet recruiting,National Human Genome Research Institute (NHGRI),"February 11, 2021",Observational,A Longitudinal Survey Study on Living With Sickle Cell Disease in the COVID-19 Pandemic
2147,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,CORONAVIRUS INFECTION; COVID,"February 08, 2021",84,NCT04418128,NAFAMOSTAT MESYLATE,,Not yet recruiting,Gyeongsang National University Hospital,"June 10, 2020",Interventional,Treatment Effect of Nafamostat Mesylate in Patients With COVID-19 Pneumonia: Open Labelled Randomized Controlled Clinical Trial
2148,Patient Preference Trial for COVID-19 (PPT-COVID),CORONAVIRUS,"February 08, 2021",100,NCT04418193,,MONACO,Recruiting,Centre Hospitalier Princesse Grace,"April 6, 2020",Observational,"Therapeutic Management in Patients With COVID-19 Infection at Risk of Secondary Aggravation: Patient Preference Trial Comparing Routine Care, Treatment With Hydroxychloroquine or Treatment With Hydroxychloroquine Plus Azithromycin"
2149,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,COVID,"February 08, 2021",300,NCT04418206,PATIENTS COVID 19,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"June 1, 2020",Interventional,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
2150,CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,COVID,"February 08, 2021",1000,NCT04418245,IMAGING BY THORACIC SCANNER,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire de Nīmes,"March 1, 2020",Observational,Identification of Thoracic CT Scan Biomarkers by Deep Learning for Evaluating the Prognosis of Patients With COVID-19 Disease
2151,Online Learning of Veterinary Anatomy During COVID-19 Pandemic,COVID,"February 08, 2021",400,NCT04418284,SURVEY,EGYPT,Recruiting,South Valley University,"June 5, 2020",Observational,Evaluation of the Online Learning of Veterinary Anatomy During COVID-19 Pandemic
2152,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),COVID,"February 08, 2021",4000,NCT04418375,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 8, 2020",Observational,Identification of Markers Associated With the Risk of COVID-19 Infection and Symptomatic COVID+ Versus Asymptomatic COVID+ Status Through the Establishment of a Biological Collection During Serological Screening in APHP Professionals
2153,Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,COVID,"February 08, 2021",280,NCT04418505,VIELIGHT RX PLUS,CANADA,Recruiting,Vielight Inc.,"September 2, 2020",Interventional,A Randomized Study Evaluating the Efficacy of the Vielight RX Plus in the Treatment of COVID-19 Respiratory Symptoms
2154,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,COVID,"February 08, 2021",1200,NCT04418518,CONVALESCENT PLASMA,UNITED STATES,Recruiting,Weill Medical College of Cornell University,"June 24, 2020",Interventional,CONCOR-1: A Randomized Open-Label Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness
2155,Convalescent Antibodies Infusion in COVID 19 Patients,"PNEUMONIA, VIRAL; CORONAVIRUS INFECTION","February 08, 2021",10,NCT04418531,ANTI-CORONAVIRUS ANTIBODIES (IMMUNOGLOBULINS) OBTAINED WITH DFPP FORM CONVALESCENT PATIENTS,ITALY,Not yet recruiting,Piero Luigi Ruggenenti,June 2020,Interventional,A Pilot Study to Explore the Efficacy and Safety of Rescue Therapy With Antibodies From Convalescent Patients Obtained With Double-filtration Plasmapheresis (DFPP) and Infused in Patients With Coronavirus Disease 2019 (COVID-19) and Need of Oxygen Support Without Mechanical Ventilation
2156,Vocal Feature Analysis Algorithm for COVID-19 Detection,COVID,"February 08, 2021",400,NCT04418544,DEVICE USED TO RECORD VOICE FOR SCREENING,UNITED STATES,Recruiting,Soniphi LLC,"June 1, 2020",Observational,Testing of Soniphi Vocal Feature Analysis Algorithm for COVID-19
2157,COVID-19 and Obstetric Transmission,COVID; PREGNANCY COMPLICATIONS,"February 08, 2021",200,NCT04418557,RT-PCR AND ANTIBODY TESTING,UNITED STATES,Recruiting,University Hospitals Cleveland Medical Center,"April 28, 2020",Observational [Patient Registry],COVID-19 and Obstetric Transmission
2158,Neuro-COVID-19: Neurological Complications of COVID-19,NEUROLOGIC COMPLICATION,"February 08, 2021",30,NCT04418609,FURTHER PROCESSING OF HEALTH DATA,SWITZERLAND,Recruiting,Emanuela Keller,"May 1, 2020",Observational,Neuro-COVID-19: Neurological Complications of COVID-19
2159,Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells,WHOLE BLOOD DONATIONS AND LEUKOREDUCTION,"February 08, 2021",0,NCT04418934,HEMANEXT ONE,UNITED STATES,Withdrawn,Hemanext,"July 1, 2020",Interventional,Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells With CP2D Anticoagulant and AS-3 Additive - Pivotal Trial
2160,Project Resurgence Communication Trial,COMMUNICATION RESEARCH,"February 08, 2021",11120,NCT04418947,COMMUNICATION TYPE,UNITED STATES,Completed,University of Pennsylvania,"June 15, 2020",Interventional,Comparison of the Effectiveness of Communication Strategies on the Return to In-Person Visits to a Medical Center After the Emergence of COVID-19: A Randomized Trial
2161,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,COVID; SARS-CoV2; SARS-ASSOCIATED CORONAVIRUS AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE; OXIDATIVE STRESS,"February 08, 2021",200,NCT04419025,N-ACETYLCYSTEINE,UNITED STATES,Recruiting,Cambridge Health Alliance,"September 23, 2020",Interventional,Determination of Efficacy of N-Acetylcysteine in Preventing Those With Mild or Moderate COVID-19 From Progressing to Severe Disease
2162,Confirmation of Ventilation and Intubation by Determination With Ultrasonography,CRITICAL ILLNESS; MECHANICAL VENTILATION,"February 08, 2021",118,NCT04419064,POINT OF CARE ULTRASOUND,UNITED STATES,Completed,University of Pittsburgh,"January 1, 2019",Observational,Confirmation of Ventilation and Intubation by Determination With Ultrasonography: A Multicenter Observational Study
2163,Covid Radiographic Images Data-set for A.I,RADIOLOGY; ARTIFICIAL INTELLIGENCE,"February 08, 2021",2500,NCT04419545,NEURAL NETWORK DIAGNOSIS ALGORITHM,ITALY,Recruiting,Azienda Ospedaliera Città della Salute e della Scienza di Torino,"March 24, 2020",Observational,Covid Radiographic Images Data-set for A.I
2164,Outcomes in Emergency Laparotomies During COVID-19 Pandemic,COVID; EMERGENCY GENERAL SURGERY,"February 08, 2021",94,NCT04419571,EMERGENCY LAPAROTOMY,UNITED KINGDOM,Completed,"Barking, Havering and Redbridge University Hospitals NHS Trust","March 23, 2020",Observational,Emergency Laparotomies and Outcomes During the COVID-19 Pandemic - a Retrospective Cohort Study
2165,RAS and Coagulopathy in COVID19,COVID,"February 08, 2021",60,NCT04419610,TRV027; SODIUM CHLORIDE 0.9%,UNITED KINGDOM,Recruiting,Imperial College London,"October 9, 2020",Interventional,Investigating the Relationship Between the Renin Angiotensin System and the Coagulopathy Associated With COVID-19
2166,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,COVID; SARS-CoV2; CANCER; SOLID TUMOR; CARCINOMA; BLOOD CANCER,"February 08, 2021",146,NCT04419623,PART 1 - TL-895; PART 2 - TL-895; PART 2 - PLACEBO,UNITED STATES,Recruiting,"Telios Pharma, Inc.","July 9, 2020",Interventional,"A Phase 1/2, Double-Blind, Randomized, Placebo-Controlled Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer"
2167,"Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic",MITOCHONDRIAL DISEASE,"February 08, 2021",200,NCT04419870,,UNITED STATES,Recruiting,National Human Genome Research Institute (NHGRI),"February 11, 2021",Observational,"Acute Infection in Mitochondrial Disease: An Observational Prospective Natural History Study of Metabolism, Infection and Immunity During the COVID19 Pandemic"
2168,COVID-19 Virtual Care at Home,COVID,"February 08, 2021",2000,NCT04420182,VIRTUAL CARE AT HOME,CANADA,Recruiting,Lawson Health Research Institute,"August 17, 2020",Interventional,COVID-19 Virtual Care at Home
2169,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,COVID; COVID; SARS-CoV2; CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",142,NCT04420247,CHLOROQUINE; HYDROXYCHLOROQUINE; STANDARD CARE,BRAZIL,Completed,Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva,"April 16, 2020",Interventional,Multicentric Pragmatic Randomized Controled Trial to Evaluate the Efficacy Chloroquine or Hydroxychloroquine for Five Days in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19
2170,Primary Prevention of Infection by COVID-19 in Health Providers,COVID,"February 08, 2021",300,NCT04420260,GROUP A: OROPHARYGEAL SPRAY AND IMMUNOSTIMULANT; GROUP B: PLACEBO OROPHARYNGEAL SPRAY + ACTIVE PRINCIPLE IMMUNOSTIMULANT; GROUP C:ACTIVE PRINCIPLE OROPHARYNGEAL SPRAY + PLACEBO TAKEN PO; GROUP D:PLACEBO OROPHARYNGEAL SPRAY + PLACEBO TAKEN PO,,Not yet recruiting,Unidad de Investigación Genética Molecular,July 2020,Interventional,"Scheme of Primary Prevention of Infection by COVID-19, in Health Providers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia"
2171,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,MELANOMA,"February 08, 2021",1000,NCT04420273,SSE EDUCATIONAL INTERVENTION; HOME SAMPLE COLLECTION OF CONCERNING MOLE WITH PHYSICIAN SUPERVISION; ACTIVE CONTROL:HEALTHY LIVING,UNITED STATES,"Active, not recruiting",Northwestern University,"July 2, 2020",Interventional,Targeted Melanoma Detection With Skin Self-examination: Leveraging the Mammogram Encounter
2172,Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France,CORONAVIRUS INFECTION; COVID OUTBREAK IN FRANCE,"February 08, 2021",9000,NCT04420286,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nīmes,"May 6, 2020",Observational,Study of the Increase in ICU Beds Capacity and Caregivers During COVID-19 Pandemic in France : the FRENCH ICU Study
2173,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,COVID,"February 08, 2021",120,NCT04420299,BEMIPARIN; BEMIPARIN,SPAIN,Recruiting,Fundación de investigación HM,"June 4, 2020",Interventional,"A Randomized, Single-blind Study With a Parallel Control Group on the Efficacy and Safety of Bemiparin at Therapeutic Dose vs. Prophylactic Dose in Patients Hospitalized for COVID-19"
2174,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,PULMONARY EMBOLISM; COVID,"February 08, 2021",1024,NCT04420312,,FRANCE,Completed,Groupe Hospitalier Paris Saint Joseph,"March 1, 2020",Observational,Incidence and Characteristics of Pulmonary Embolism in COVID-19 Patients Hospitalized for Acute Respiratory Syndrome
2175,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",CHRONIC HEMODIALYSIS PATIENTS; CAREGIVERS OF CHRONIC HEMODIALYSIS PATIENTS,"February 08, 2021",800,NCT04420338,BLOOD SAMPLE; SERUM TUBE COLLECTION,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"June 5, 2020",Interventional,"SeroCOVIDial Study: Assessment of SARS-COV2 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study"
2176,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,COVID; KIDNEY TRANSPLANT; COMPLICATIONS; IMMUNOSUPPRESSION,"February 08, 2021",50,NCT04420364,MAINTENANCE OR REDUCTION OF IMMUNOSUPPRESSION,,Not yet recruiting,Brigham and Women's Hospital,"March 1, 2021",Interventional,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease
2177,Low Dose Radiotherapy for COVID-19 Pneumonitis,COVID,"February 08, 2021",41,NCT04420390,RADIOTHERAPY,SPAIN,Recruiting,"Hospital San Carlos, Madrid","May 1, 2020",Interventional,Low Dose Radiotherapy as Antinflammatory Treatment for COVID-19 Pneumonitis
2178,Mental Health and Academic Performance in COVID-19,"DEPRESSION, ANXIETY","February 08, 2021",720,NCT04420416,SURVEY,MEXICO,Recruiting,Instituto Mexicano del Seguro Social,"April 1, 2020",Observational,"dePression, Anxiety, aNd acaDemic pErforMance In Covid-19: PANDEMIC Study."
2179,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,COVID,"February 08, 2021",20,NCT04420468,,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,June 2020,Observational,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children
2180,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases,COVID,"February 08, 2021",1000,NCT04420637,,AUSTRIA,Enrolling by invitation,Medical University of Graz,"June 15, 2020",Observational,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases
2181,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,COVID,"February 08, 2021",120,NCT04420676,OMNIBIOTIC AAD; PLACEBO,AUSTRIA,Recruiting,Medical University of Graz,"September 24, 2020",Interventional,"Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection: A Randomized, Double-blind, Placebo Controlled, Telemedicine Study (SynCov Study)"
2182,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,COVID; RESPIRATORY FAILURE,"February 08, 2021",80,NCT04420741,ILOPROST; ISOTONIC SALINE,DENMARK,Recruiting,Pär Johansson,"June 15, 2020",Interventional,Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
2183,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,EXERCISE; DETRAINING; MUSCLE WEAKNESS; MUSCLE ATROPHY,"February 08, 2021",21,NCT04420806,HIT-EXERCISE; SHAM INTERVENTION,GERMANY,Completed,University of Erlangen-Nürnberg Medical School,"March 14, 2020",Interventional,Effects of Three Months of COVID-19 Lockdown Induced Deconditioning After 13 Months of High Intensity Exercise Training in Early Postmenopausal Women
2184,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,COVID; SARS-CoV2; SARS-COV INFECTION,"February 08, 2021",,NCT04420988,COVID-19 CONVALESCENT PLASMA,UNITED STATES,Available,"Rutgers, The State University of New Jersey",,Expanded Access,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients
2185,A Study of Baricitinib (LY3009104) in Participants With COVID-19,COVID,"February 08, 2021",1400,NCT04421027,BARICITINIB; PLACEBO,ARGENTINA,Recruiting,Eli Lilly and Company,"June 12, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection"
2186,QuadraMune(TM) for Prevention of COVID-19,COVID; CORONAVIRUS; SARS-CoV2,"February 08, 2021",500,NCT04421391,QUADRAMUNE(TM),UNITED STATES,Recruiting,Therapeutic Solutions International,"June 8, 2020",Interventional,Phase II Study of QuadraMune(TM) for Prevention of COVID-19 in High Risk Populations
2187,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,COVID; SARS-CoV2,"February 08, 2021",50,NCT04421404,COVID-19 CONVALESCENT PLASMA (CCP); PLACEBO,UNITED STATES,"Active, not recruiting","Priscilla Hsue, MD","June 9, 2020",Interventional,A Randomized Controlled Adaptive Study Comparing COVID-19 Convalescent Plasma (CCP) to Non-immune Plasma to Limit Coronavirus-associated Complications in Hospitalized Patients
2188,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,COVID; CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04421508,INOPULSE; PLACEBO,UNITED STATES,"Active, not recruiting",Bellerophon Pulse Technologies,"July 12, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus (COVID-19)"
2189,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,COVID,"February 08, 2021",150,NCT04421534,LACTOFERRIN,,Not yet recruiting,Cairo University,June 2020,Interventional,Efficacy and Safety of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19
2190,Coping With 2020 - No Health Without Mental Health,COVID; ANXIETY,"February 08, 2021",400,NCT04421612,CO-MESTRING (CO-COPING),NORWAY,Recruiting,Haukeland University Hospital,"April 2, 2020",Interventional,Coping With 2020 - No Health Without Mental Health
2191,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,COVID,"February 08, 2021",12000,NCT04421625,DIAGNOSTIC TEST FOR SARS-COV2 FOR PATIENTS AND HEALTH STAFF,FRANCE,Recruiting,Institut Cancerologie de l'Ouest,"June 15, 2020",Interventional,"Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic: Constitution of a Biological Collection Linked to a Prospective, Multicenter Cohort Study"
2192,Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),CORONAVIRUS INFECTION; SARS-COV INFECTION; CORONAVIRUS,"February 08, 2021",70,NCT04421664,HYDROXYCHLOROQUINE; PLACEBO ORAL TABLET,CANADA,Terminated,McGill University Health Centre/Research Institute of the McGill University Health Centre,"March 25, 2020",Interventional,Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)
2193,Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study,GENERALIZED ANXIETY DISORDER,"February 08, 2021",30,NCT04421690,COGNITIVE TRAINING; TRIVIA TRAINING,UNITED STATES,Recruiting,University of Missouri-Columbia,"June 8, 2020",Interventional,Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)
2194,Coronavirus Smell Therapy for Anosmia Recovery,ANOSMIA,"February 08, 2021",200,NCT04422275,BUDESONIDE; HIGH-CONCENTRATION ESSENTIAL OIL; PLACEBO; LOW-CONCENTRATION ESSENTIAL OIL,UNITED STATES,Not yet recruiting,Washington University School of Medicine,"June 1, 2021",Interventional,Coronavirus Smell Therapy for Anosmia Recovery
2195,Senior-COVID-Rea Multicentric Survey,"COVID DISEASE, SEVERE FORM","February 08, 2021",185,NCT04422340,GROUP1,FRANCE,Recruiting,Hospices Civils de Lyon,"April 1, 2020",Observational,A Multicentric Survey on Patients Over 60 Admitted to Intensive Care for Severe Forms of COVID Infection: Search for Prognostic Criteria Associated With Survival
2196,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,PARKINSON DISEASE; PARKINSON DISEASE 10,"February 08, 2021",60,NCT04422353,VIDEO DANCE CLASSES; UNSUPERVISED PHYSICAL ACTIVITIES,BRAZIL,Recruiting,Federal University of Rio Grande do Sul,"May 1, 2020",Interventional,The Impact of Video Dance Class and Unsupervised Physical Activity on Parkinson's People During the Covid-19 Pandemic: Interventional
2197,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,COVID,"February 08, 2021",314,NCT04422379,,INDIA,Not yet recruiting,Max Healthcare Insititute Limited,"June 7, 2020",Observational,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study
2198,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,CARDIOVASCULAR RISK FACTOR; BURNOUT; IMMUNE DEFICIENCY,"February 08, 2021",200,NCT04422418,,UNITED ARAB EMIRATES,Recruiting,Khalifa University for Science and Technology,"July 1, 2020",Observational,Multi-Center Prospective Cohort Study: Impact of Burnout on Cardiovascular and Immune Biomarkers Among Frontline Healthcare Professionals During Covid-19 Pandemic in Abu Dhabi Emirate
2199,Post Intensive Care Syndrome in COVID19 Patients,COVID; POST INTENSIVE CARE UNIT SYNDROME,"February 08, 2021",100,NCT04422444,QUESTIONNAIRES,SPAIN,Recruiting,Corporacion Parc Tauli,"June 1, 2020",Observational [Patient Registry],Characterization and Management of Post Intensive Care Syndrome in COVID19 Patients.
2200,Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients,SOLID TUMOR,"February 08, 2021",100,NCT04422457,68GA-DX600 PET/CT,CHINA,Recruiting,Beijing Cancer Hospital,"June 13, 2020",Interventional,Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients
2201,Registry of Patients With Hematologic Disease and COVID-19 in Russia,CORONAVIRUS INFECTION AND HEMATOLOGIC DISEASES,"February 08, 2021",200,NCT04422470,NON-INTERVENTIONAL STUDY,RUSSIAN FEDERATION,Recruiting,"National Research Center for Hematology, Russia","June 22, 2020",Observational [Patient Registry],Observational Prospective Cohort Study - Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)
2202,Lanadelumab for Treatment of COVID-19 Disease,COVID,"February 08, 2021",80,NCT04422509,LANADELUMAB; REGULAR CARE,NETHERLANDS,Recruiting,Radboud University,"October 3, 2020",Interventional,Lanadelumab for Treatment of COVID-19 Disease
2203,Fibromyalgia During the COVID-19 Pandemic,"FIBROMYALGIA, PRIMARY","February 08, 2021",45,NCT04422522,,EGYPT,"Active, not recruiting",Al-Azhar University,"March 15, 2020",Observational,Prevalence of Fibromyalgia in the Rheumatology Outpatient Clinics in the UAE During the COVID-19 Pandemic: a Cross-sectional Study
2204,Effects on the Qt Interval of COVID-19 Coronavirus Infection,CORONAVIRUS INFECTION; INTENSIVE CARE PATIENTS,"February 08, 2021",80,NCT04422535,,SPAIN,Recruiting,Matilde Zaballos,"May 29, 2020",Observational,Observational Study to Evaluate the Effects on the Qt Interval of COVID-19 Coronavirus Infection in Critically Ill Patients
2205,Prophylactic Ivermectin in COVID-19 Contacts,COVID,"February 08, 2021",340,NCT04422561,IVERMECTIN TABLETS,EGYPT,Completed,Zagazig University,"May 31, 2020",Interventional,Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close Contact for Patient With COVID-19
2206,COVID 19 Serology in Pulmonologists,COVID,"February 08, 2021",97,NCT04422574,,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,COVID 19 Serology in Pulmonologists : Pneumo Sero Cov
2207,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,EMERGENCIES,"February 08, 2021",1860,NCT04422587,RECOP UNIT PATIENT,FRANCE,Completed,"University Hospital, Toulouse","March 13, 2020",Observational [Patient Registry],Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea
2208,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,"PNEUMONIA, VIRAL","February 08, 2021",73,NCT04422613,PULMONARY ANOMALIES 4 MONTHS AFTER DOCUMENTED COVID-19 PNEUMONIA,FRANCE,"Active, not recruiting","University Hospital, Toulouse","May 28, 2020",Interventional,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia
2209,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,SARS-CoV2; COVID,"February 08, 2021",42,NCT04422626,,,Not yet recruiting,University of Pecs,"July 1, 2020",Observational,Data Collection on the Application of Cytokine Adsorption Therapy on Patients With Acute Respiratory Failure Caused by COVID-19
2210,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,COVID,"February 08, 2021",30,NCT04422678,IMATINIB MESYLATE; STANDARD OF CARE,,Not yet recruiting,Alexandria University,June 2020,Interventional,Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia: A Pilot Study
2211,Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection,"COVID; PNEUMONIA, VIRAL; PULMONARY INFECTION","February 08, 2021",200,NCT04422691,LUNG ULTRASOUND,NORWAY,Recruiting,St. Olavs Hospital,"July 1, 2020",Observational,Bruk av Ultralyd i Evaluering av Pasienter Med Mistenkt COVID-19 Infeksjon i Norge
2212,Needs of Persons With Spinal Cord Injury (SCI),SPINAL CORD INJURIES,"February 08, 2021",250,NCT04422769,,UNITED STATES,"Active, not recruiting",Washington University School of Medicine,"May 22, 2020",Observational,Tracking Needs of Persons With a Spinal Cord Injury (SCI) During the COVID-19 Pandemic
2213,The Impact of COVID-19 on Dialysis Users,END STAGE RENAL DISEASE; SARS-CoV2,"February 08, 2021",40,NCT04422873,,UNITED KINGDOM,Recruiting,University of Portsmouth,"June 3, 2020",Observational,"The Impact of Coronavirus (COVID-19) Restrictions on Wellbeing, Quality of Life and Physical Activity in People With End-stage Renal Disease, Currently Dialysing In-centre Versus at Home in the UK and Their Experience of Telemedicine"
2214,Serological Study of the Exposure of Personnel to Sars-cov-2,SARS-CoV2,"February 08, 2021",900,NCT04422977,SARS-COV-2 SEROLOGY,,Not yet recruiting,Centre Hospitalier Saint Joseph Saint Luc de Lyon,"June 8, 2020",Interventional,Serological Study of the Exposure of Personnel to Sars-cov-2 in an Urban Hospital Two Months After Managing an Influx of COVID Patients 19
2215,Endoscopic Interventions in Patients With COVID-19,"CHANGE; ENDOSCOPY, COVID","February 08, 2021",10,NCT04423003,ENDOSCOPIC INTERVENTION,GERMANY,Completed,University Hospital Tuebingen,"March 1, 2020",Observational [Patient Registry],"Impact of the COVID-19 Pandemic on an Interdisciplinary Endoscopy Unit in a German ""Hotspot"" Area: a Single Center Experience"
2216,Tocilizumab in Coronavirus-19 Positive Patients,COVID; COVID; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CORONAVIRUS; INFLAMMATION,"February 08, 2021",30,NCT04423042,TOCILIZUMAB,,Not yet recruiting,University of Calgary,"July 30, 2020",Interventional,A Nested Interventional Cohort Study to Assess the Efficacy and Safety of Adjunctive Humanized Monoclonal Interleukin-6 Receptor Blocker Tocilizumab (TCZ) Therapy to Standard of Care for the Reduction of Hyperinflammation Related Mortality in SARS-Cov2 Positive Patients
2217,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,FACE-TO-FACE RECONSULTATION TO EMERGENCY ROOM,"February 08, 2021",150,NCT04423289,FARMALARM,SPAIN,Completed,Hospital Universitari Vall d'Hebron Research Institute,"March 31, 2020",Interventional,COVID Follow-App: Telematic Monitoring Through a Mobile Application of Patients With COVID-19: A Randomized Clinical Trial
2218,Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia,CORONAVIRUS INFECTION; THROMBOEMBOLIC DISEASE,"February 08, 2021",70,NCT04423315,,TURKEY,Completed,Nisantasi University,"June 8, 2020",Observational,Thrombosis Risk Assessment May Predict Clinical Presentation and Length of Hospital Stay in Covid-19 Pneumonia
2219,Preoperative Inspiratory Muscle Training,MECHANICAL VENTILATION COMPLICATION,"February 08, 2021",40,NCT04423614,INSPIRATORY MUSCLE TRAINING; RELAXATION BREATHING,UNITED STATES,Not yet recruiting,University of Florida,February 2021,Interventional,Telehealth-Delivered Preoperative Inspiratory Muscle Training: An Innovative Solution to Conserve Scarce ICU Resources
2220,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,SARS-CoV2,"February 08, 2021",200,NCT04423640,ACTIVE COVID-19 DISEASE,MEXICO,Recruiting,"Coordinación de Investigación en Salud, Mexico","April 15, 2020",Observational,The Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With Coronavirus Disease 2019 (COVID-19)
2221,Knowledge About Covid-19 Infection in Pregnant Women,VIRAL INFECTION,"February 08, 2021",30,NCT04423692,LABS,EGYPT,Recruiting,Aljazeera Hospital,"June 1, 2020",Observational,Knowledge About Covid-19 Infection in Pregnant Women
2222,COVID-19 Related Health and Infection Control Practices Among Dentists,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",4000,NCT04423770,NO INTERVENTION,UNITED STATES,"Active, not recruiting",American Dental Association,"June 8, 2020",Observational,COVID-19 Related Health and Infection Control Practices Among Dentists
2223,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,COVID,"February 08, 2021",380,NCT04423861,NITAZOXANIDE; PLACEBO,,Not yet recruiting,Azidus Brasil,December 2020,Interventional,"A Phase III, Multicentre, Parallel, Randomized, Double-blind Clinical Trial to Assess the Efficacy and Safety of Nitazoxanide 600 mg Compared to Placebo in the Treatment of Hospitalized Patients With COVID-19 in Non-critical Condition"
2224,Implications of Covid-19 on the Lifestyle Changes,COVID,"February 08, 2021",1826,NCT04423978,,ITALY,Completed,Azienda Unità Sanitaria Locale Reggio Emilia,"May 4, 2020",Observational,Implications of Covid-19 on the Lifestyle Changes and Supports Used (ICOLS): a Survey in the Province of Reggio Emilia
2225,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,COVID; CORONAVIRUS; MORTALITY,"February 08, 2021",290,NCT04423991,COVIAGE,UNITED STATES,Completed,Dascena,"March 10, 2020",Interventional,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning: the IDENTIFY Trial
2226,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,COVID,"February 08, 2021",500,NCT04424004,COVID-19 PCR AND SEROLOGY TESTING,UNITED STATES,"Active, not recruiting",Duke University,"June 9, 2020",Observational,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study
2227,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,COVID; CORONAVIRUS INFECTION,"February 08, 2021",726,NCT04424017,SPECIFIC ANTI-SARS-COV-2 ANTIBODIES,EGYPT,Recruiting,Egyptian Center for Research and Regenerative Medicine,"June 7, 2020",Observational,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers
2228,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",COVID,"February 08, 2021",216,NCT04424056,ANAKINRA +/- RUXOLITINIB (STAGES 2B/3); ANAKINRA AND RUXOLITINIB (ADVANCED STAGE 3); TOCILIZUMAB +/- RUXOLITINIB (STAGES 2B/3); TOCILIZUMAB AND RUXOLITINIB (ADVANCED STAGE 3); STANDARD OF CARE,FRANCE,Not yet recruiting,Assistance Publique Hopitaux De Marseille,"September 1, 2020",Interventional,"An Open Randomized Therapeutic Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease"
2229,External Dead Space in Ventilated COVID-19 Patients,"CORONAVIRUS; ARDS, HUMAN","February 08, 2021",40,NCT04424082,REMOVAL OF DEAD SPACE FILTER,SWEDEN,Recruiting,Karolinska Institutet,"June 9, 2020",Interventional,Influence of External Dead Space on Volumetric Capnography Derived Parameters in Mechanically Ventilated COVID-19 Patients
2230,BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization,COVID,"February 08, 2021",80,NCT04424134,BROMHEXINE AND SPIRONOLACTONE; BASE THERAPY,RUSSIAN FEDERATION,Recruiting,Lomonosov Moscow State University Medical Research and Educational Center,"May 16, 2020",Interventional,Open Label Randomized Clinical Trial BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization
2231,ICBT for Mental Health Problems Related to the Coronavirus Pandemic,DEPRESSION AND QUALITY OF LIFE RELATED TO THE CORONAVIRUS PANDEMIC,"February 08, 2021",120,NCT04424212,INTERVENTION GROUP CORONACOPE,SWEDEN,Recruiting,Linkoeping University,"June 10, 2020",Interventional,CoronaCope - Internet-based Cognitive Behavioural Therapy for Adults Suffering From Mental Health Problems Related to the Coronavirus Pandemic
2232,Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.,CORONAVIRUS INFECTION; PNEUMONIA,"February 08, 2021",115,NCT04424355,CHEST MRI,RUSSIAN FEDERATION,Recruiting,Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department,"May 19, 2020",Observational,Possibilities of Chest Magnetic Resonance Imaging (MRI) in Diagnostics of COVID-19. The Use of MRI to Assess Lung Damage in Patients With Coronavirus Infection
2233,Saliva as Source of Detection for SARS-CoV-2,COVID,"February 08, 2021",5000,NCT04424446,,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"July 13, 2020",Observational,Evaluation of Saliva as Source of Detection for SARS-CoV-2
2234,Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia,COVID; POST TRAUMATIC STRESS DISORDER,"February 08, 2021",800,NCT04424771,MASLACH BURNOUT INVENTORY (MBI),ITALY,Completed,Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,"March 1, 2020",Observational,PTSD in Health Workers During COVID-19 Pandemia
2235,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,COVID,"February 08, 2021",100,NCT04424797,PRONE POSITIONING; SUPINE POSITIONING,UNITED STATES,Recruiting,Poudre Valley Health System,"July 13, 2020",Interventional,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol
2236,HFNC Treatment in COVID-19 Pneumonia,"CORONAVIRUS INFECTION; PNEUMONIA, VIRAL; ACUTE RESPIRATORY FAILURE","February 08, 2021",43,NCT04424836,HIGH FLOW NASAL CANNULA DEVICE,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"May 15, 2020",Observational,the Effect of HFNC Treatment on Mortality and Length of ICU Stay in Patient With COVID-19 Pneumonia
2237,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,COVID,"February 08, 2021",40,NCT04424849,CT-SCAN,TURKEY,Recruiting,Tepecik Training and Research Hospital,"March 15, 2020",Observational,Initial Thoracic CT Findings and Mechanical Ventilation Requirement in Patients Admitted to Intensive Care Unit With COVID-19
2238,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,COVID PNEUMONIA; VASCULAR COMPLICATIONS,"February 08, 2021",100,NCT04424901,DIPYRIDAMOLE,UNITED STATES,Recruiting,UConn Health,"May 3, 2020",Interventional,"A Randomized, Open-label Study of the Vascular and Microbiologic Efficacy of Dipyridamole Plus Standard Care vs. Standard Care in Hospitalized COVID19 Patients"
2239,COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach,COVID,"February 08, 2021",800,NCT04424940,,"CONGO, THE DEMOCRATIC REPUBLIC OF THE",Not yet recruiting,University of Kinshasa,"September 1, 2020",Observational [Patient Registry],TOMEKA® Project Was Sponsored by the University of Kinshasa: it's an Observational Study by Its Reviewed Documentation
2240,To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn,CORONAVIRUS INFECTION; VENTILATORY FAILURE; ANESTHESIA INTUBATION COMPLICATION,"February 08, 2021",28,NCT04424953,MCGRATH VIDEOLARYNGOSCOPE; DIRECT LARYNGOSCOPE,SINGAPORE,"Active, not recruiting",Singapore General Hospital,"June 1, 2020",Interventional,A Randomised Controlled Trial to Compare McGrath Videolaryngoscope Against Direct Laryngoscope for Endotracheal Intubation When Powered Air Purifying Respirator is Worn During the Current Coronavirus Disease 2019 Pandemic
2241,The Natural History of Hospitalized COVID-19 Patients,SARS-CoV2,"February 08, 2021",1433,NCT04424992,OBSERVATIONAL COHORT STUDY ON THE NATURAL HISTORY OF HOSPITALIZED SARS-COV-2 PATIENTS.,ITALY,Recruiting,University of Milano Bicocca,"February 28, 2020",Observational,Observational Cohort Study on the Natural History of Hospitalized SARS-COV-2 Patients: the STORM Trial
2242,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,BARIATRIC SURGERY; OBESITY,"February 08, 2021",55,NCT04425005,HOME-BASED EXERCISE,BRAZIL,Completed,University of Sao Paulo,"May 10, 2020",Interventional,Effect of Home-based Exercise Training Program During the Covid-19 Pandemic in Post-bariatric Patients: A Randomized Controlled Trial
2243,Handling Oxygenation Targets in COVID-19,HYPOXEMIC RESPIRATORY FAILURE; OXYGEN TOXICITY,"February 08, 2021",780,NCT04425031,OXYGEN; OXYGEN,DENMARK,Recruiting,Aalborg University Hospital,"August 25, 2020",Interventional,Handling Oxygenation Targets in COVID-19 Patients With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit: A Randomised Clinical Trial of a Lower Versus a Higher Oxygenation Target
2244,AiM Covid Self Monitoring,COVID,"February 08, 2021",1000,NCT04425044,OTHER,INDIA,Completed,Aarogyam UK,"April 12, 2020",Observational,Efficacy of AiM Covid Self Monitoring in Detecting Infection of COVID-19
2245,Obesity and Mortality of Critically Ill Patients With COVID-19,COVID; SEVERE ACUTE RESPIRATORY SYNDROME; OBESITY; COMORBIDITIES AND COEXISTING CONDITIONS,"February 08, 2021",250,NCT04425213,,FRANCE,Completed,"Central Hospital, Nancy, France","May 12, 2020",Observational,"Obesity as a Risk Factor for Mortality of Critically Ill Patients With Coronavirus Disease 2019 (COVID-19): a Cohort Study of the First Wave in Nancy, France"
2246,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,COVID,"February 08, 2021",23,NCT04425252,BREQUINAR; STANDARD OF CARE,UNITED STATES,Completed,"Clear Creek Bio, Inc.","August 1, 2020",Interventional,The CRISIS Study: A Randomized Open-label Study Assessing the Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Hospitalized Adults With Coronavirus-19 (COVID-19)
2247,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,INFERTILITY; COVID; IVF,"February 08, 2021",20,NCT04425317,BLOOD SAMPLE,BELGIUM,Recruiting,CRG UZ Brussel,"June 24, 2020",Interventional,Detection of SARS-CoV-2 in Follicular Fluid and Cumu-lus-oocyte-complexes From COVID-19 Patients During Controlled Ovarian Stimulation for ICSI Treatment
2248,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,CORONAVIRUS; COVID; PNEUMONIA,"February 08, 2021",200,NCT04425382,DARUNAVIR/COBICISTAT; LOPINAVIR/RITONAVIR,QATAR,Recruiting,Hamad Medical Corporation,"March 1, 2020",Observational,Efficacy and Safety of Darunavir/Cobicistat vs. Lopinavir/Ritonavir in the Management of Patients With COVID-19 Pneumonia in Qatar
2249,"A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",COVID,"February 08, 2021",256,NCT04425460,FAVIPIRAVIR; PLACEBO,CHINA,Not yet recruiting,Zhejiang Hisun Pharmaceutical Co. Ltd.,June 2020,Interventional,"A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Adult Patients With COVID-19-Moderate Type"
2250,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,ADVANCED SUTURING SKILLS; SURGICAL EDUCATION,"February 08, 2021",60,NCT04425499,LEARNING RUNNING SUBCUTICULAR SUTURES ON THE GAMIFIED EDUCATIONAL NETWORK,,Not yet recruiting,Université de Montréal,June 2020,Interventional,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial
2251,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,COVID,"February 08, 2021",17,NCT04425538,INFLIXIMAB,UNITED STATES,"Active, not recruiting",Tufts Medical Center,"June 1, 2020",Interventional,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
2252,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,CANCER; COVID,"February 08, 2021",1100,NCT04425616,EXERCISE; PSYCHOLOGICAL AND BEHAVIOUR CHANGE SUPPORT; NUTRITION,UNITED KINGDOM,Recruiting,University Hospital Southampton NHS Foundation Trust,"June 4, 2020",Interventional,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions to Maintain and Improve Mental and Physical Health in People With Cancer Who Are Following Social Distancing Guidance: A COVID-19 Targeted Trial
2253,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19",COVID,"February 08, 2021",6420,NCT04425629,REGN10933+REGN10987 COMBINATION THERAPY; PLACEBO,ROMANIA,Recruiting,Regeneron Pharmaceuticals,"June 16, 2020",Interventional,"A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients With COVID-19"
2254,Ivermectin In Treatment of COVID 19 Patients,COVID,"February 08, 2021",100,NCT04425707,IVERMECTIN,EGYPT,Recruiting,"Ministry of Health and Population, Egypt","June 9, 2020",Interventional,The Use of Ivermectin In the Treatment of COVID 19 Patients
2255,Use of Remote Monitoring for COVID-19 Patient,COVID,"February 08, 2021",300,NCT04425720,LIFESIGNALS BIOSENSOR 1AX*; STANDARD OF CARE,UNITED STATES,Recruiting,Montefiore Medical Center,"September 1, 2020",Interventional,Use of Remote Patient Monitoring (RPM) Platform for COVID-19 Patient
2256,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),CORONAVIRUS DISEASE 2019 (COVID); PNEUMONIA; HYPOXEMIA,"February 08, 2021",0,NCT04425733,MK-5475; PLACEBO,,Withdrawn,Merck Sharp & Dohme Corp.,"July 7, 2020",Interventional,"A Study to Assess the Safety, Tolerability, and Pharmacodynamics of Multiple Dose MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia"
2257,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),COVID; CORONAVIRUS INFECTION; SARS-CoV2; COVID,"February 08, 2021",2400,NCT04425759,BLOOD SAMPLE,SPAIN,Recruiting,Hospital de Mataró,"June 8, 2020",Observational [Patient Registry],"Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses and Assymptomatic Carriers Among a Cohort of 2,300 Healthcare Workers at the Consorci Sanitari Del Maresme (CSdM)"
2258,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）,COVID,"February 08, 2021",342,NCT04425772,FNC+STANDARD OF CARE; FNC DUMMY TABLET+STANDARD OF CARE,,Not yet recruiting,"HeNan Sincere Biotech Co., Ltd","June 12, 2020",Interventional,"A Randomized,Double Blinded, Double Dummy, Parallel Controlled Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）"
2259,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,SARS-CoV2; COVID,"February 08, 2021",236,NCT04425837,SARS-COV-2 CONVALESCENT PLASMA TREATMENT; STANDARD CARE,COLOMBIA,Not yet recruiting,Fundación Santa Fe de Bogota,July 2020,Interventional,"Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19: A Randomized, Controlled Study CRI-CP (Coronavirus Investigation - Convalescent Plasma)"
2260,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,COVID,"February 08, 2021",229,NCT04425850,IOTA CARRAGEENAN NASAL SPRAY AND IVERMECTIN ORAL DROPS (USED AS BUCCAL DROPS),ARGENTINA,Completed,Eurnekian Public Hospital,"June 1, 2020",Observational,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid Among Healthy People and Health Personnel
2261,"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19",SEVERE ACUTE RESPIRATORY SYNDROME; VENTILATION PNEUMONITIS,"February 08, 2021",167,NCT04425863,"IVERMECTIN 5 MG/ML ORAL SOLUTION, ASPIRIN 250 MG TABLETS; IVERMECTIN 5 MG/ML ORAL SOLUTION, DEXAMETHASONE 4-MG INJECTION, ASPIRIN 250 MG TABLETS; IVERMECTIN 5 MG/ML ORAL SOLUTION, DEXAMETHASONE 4-MG INJECTION, ENOXAPARIN INJECTION. INPATIENT TREATMENT WITH MECHANICAL VENTILATION IN ICU.",ARGENTINA,Completed,Eurnekian Public Hospital,"May 1, 2020",Observational,"Evaluation of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of covid19"
2262,COVID-19 Antibodies Among Healthcare Workers,COVID; SARS-CoV2,"February 08, 2021",156,NCT04425889,"COVID-19 IGG/IGM RAPID TEST CASSETTE TEST (HEALGEN SCIENTIFIC, HOUSTON, TEXAS, USA)",MEXICO,Completed,Hospital Universitario Dr. Jose E. Gonzalez,"May 5, 2020",Observational,Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers in a COVID-19 Unit
2263,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,COVID,"February 08, 2021",400,NCT04425915,CONVALESCENT PLASMA; STANDARD OF CARE,INDIA,Recruiting,"Institute of Liver and Biliary Sciences, India","June 14, 2020",Interventional,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19: A Randomized Control Trial
2264,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic,SARS-CoV2; SERUM; DISEASE,"February 08, 2021",550,NCT04426006,PRO-SERO-COV,FRANCE,"Active, not recruiting",Institut Bergonié,"June 1, 2020",Interventional,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic - PRO-SERO-COV
2265,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,BRAIN INJURIES; STROKE; SPINAL CORD INJURIES,"February 08, 2021",142,NCT04426071,,CANADA,Not yet recruiting,Lawson Health Research Institute,June 2020,Observational,COVID-19 and Disability: The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries
2266,Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study,COVID,"February 08, 2021",22784,NCT04426084,HYPERTENSION; DIABETES TYPE 2; OBESITY; ANTIHYPERTENSIVE AGENTS; STATINS (CARDIOVASCULAR AGENTS),SWEDEN,"Active, not recruiting",Karolinska Institutet,"March 1, 2020",Observational [Patient Registry],"Cardiovascular Disease, Cardiovascular Risk Factors, Treatments and Severe COVID-19 Outcomes. A Nationwide Registry-based Case-Control Study"
2267,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),COVID; LYMPHOCYTOPENIA,"February 08, 2021",48,NCT04426201,CYT107; PLACEBO,,Not yet recruiting,Revimmune,"December 20, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Oncology Cohort"
2268,"Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19",COVID; SARS-CoV2,"February 08, 2021",1000,NCT04426253,,HUNGARY,"Active, not recruiting",Szeged University,"June 5, 2020",Observational,"Identification of Genetic Factors Determining Disease Course and Preparation of Pharmacogenetic Applications in the New Type of Coronavirus Infection, COVID-19"
2269,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,QUESTIONNAIRE DESIGNS; COVID PANDEMIC; PSYCHOLOGICAL STRESS; COPING SKILLS; TWO-ITEM GENERALISED ANXIETY DISORDER SCALE; PATIENT HEALTH QUESTIONNAIRE ANXIETY AND DEPRESSION SCALE; HEALTH STATUS INDEX; SUBJECTIVE HEALTH COMPLAINT; MOOD,"February 08, 2021",441,NCT04426266,,HUNGARY,Completed,Szeged University,"May 1, 2020",Observational,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population
2270,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,SARS-CoV2; RHEUMATOID ARTHRITIS; RHEUMATIC DISEASES,"February 08, 2021",1500,NCT04426279,QUESTIONNAIRE ASSESMENT,FRANCE,Recruiting,"University Hospital, Lille","August 18, 2020",Observational,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants
2271,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,SARS-CoV2,"February 08, 2021",3500,NCT04426292,SEROLOGICAL TESTING,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"May 12, 2020",Interventional,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak
2272,Community Health Workers Against COVID19,COVID; SOCIAL ISOLATION; MENTAL HEALTH IMPAIRMENT,"February 08, 2021",140,NCT04426305,COMMUNITY HEALTH WORKER SUPPORT; CARE AS USUAL,BELGIUM,Enrolling by invitation,University Ghent,"May 21, 2020",Interventional,Community Health Workers Against COVID19 Tackling Psychosocial Suffering Due to Physical Distancing
2273,COVID-19 and the Healthy Minds Program for Educators,ANXIETY; DEPRESSION; PSYCHOLOGICAL STRESS; PSYCHOLOGICAL DISTRESS; WELL-BEING,"February 08, 2021",733,NCT04426318,HEALTHY MINDS PROGRAM FOUNDATIONS TRAINING,UNITED STATES,Completed,"University of Wisconsin, Madison","June 14, 2020",Interventional,COVID-19 and the Healthy Minds Program for Educators
2274,Core Warming of COVID-19 Patients,COVID,"February 08, 2021",0,NCT04426344,ENSOETM DEVICE,UNITED STATES,Withdrawn,Washington University School of Medicine,October 2020,Interventional,"Core Warming of COVID-19 Patients Undergoing Mechanical Ventilation: a Randomized, Single Center Pilot Study"
2275,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",COVID,"February 08, 2021",6900,NCT04426695,REGN10933+REGN10987 COMBINATION THERAPY; PLACEBO,BRAZIL,Recruiting,Regeneron Pharmaceuticals,"June 11, 2020",Interventional,"A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients With COVID-19"
2276,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,COVID,"February 08, 2021",300,NCT04427098,ENOXAPARIN 40 MG/0.4 ML INJECTABLE SOLUTION; ENOXAPARIN,ITALY,Recruiting,Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi,"May 22, 2020",Interventional,"Intermediate Dose Enoxaparin in Hospitalized Patients With Moderate-severe COVID19: A Pilot Phase II Single-arm Study, INHIXACOVID19"
2277,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,BIPOLAR DEPRESSION,"February 08, 2021",50,NCT04427137,"MAGPRO X100 STIMULATOR, B70 FLUID-COOLED COIL",CANADA,Recruiting,Centre for Addiction and Mental Health,"June 9, 2020",Interventional,A Novel and Practical Accelerated Low-frequency Right-sided Stimulation Protocol as a Substitute for Patients With Bipolar Depression Needing Electroconvulsive Therapy During the COVID-19 Pandemic
2278,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,NURSE,"February 08, 2021",15,NCT04427176,ARFC MASK,FRANCE,Completed,Centre Hospitalier Universitaire de Saint Etienne,"April 29, 2020",Observational,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).
2279,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,COVID,"February 08, 2021",500,NCT04427254,"CEREBROSPINAL FLUID SAMPLING, MENINGEAL AND BRAIN PARENCHYMA BIOPSIES",FRANCE,Not yet recruiting,Fondation Ophtalmologique Adolphe de Rothschild,January 2021,Interventional,Study of the Sars-Cov2 Neuroinvasiveness - COVID19
2280,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,THERMAL CONDITION OF HEALTH WORKERS WHO USE PERSONAL PROTECTIVE EQUIPMENT FROM BIOLOGICAL HAZARDS DURING THEIR WORK WITH COVID PATIENTS,"February 08, 2021",6,NCT04427267,PERSONAL PROTECTIVE EQUIPMENT FROM BIOLOGICAL HAZARD,RUSSIAN FEDERATION,Completed,"Federal State Budgetary Scientific Institution ""Izmerov Research Institute of Occupational Health""","June 3, 2020",Observational,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment for Biological Factors During Their Work With COVID-19 Patients
2281,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),INFECTIOUS DISEASE; CANCER; CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04427280,,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"May 26, 2020",Observational,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
2282,Smell and Taste Disorders in COVID-19 Patients,COVID,"February 08, 2021",376,NCT04427332,INVESTIGATION OF SMELL AND TASTE DISORDERS,ITALY,Completed,University of Milano Bicocca,"June 11, 2020",Observational,Smell and Taste Disorders in COVID-19 Patients: Prospective Observational Study
2283,Predictive Factors COVID-19 Patients,COVID,"February 08, 2021",1000,NCT04427345,PREDICTIVE FACTORS FOR CLINICAL RESPONSE IN PATIENTS WITH COVID-19.,ITALY,Recruiting,University of Milano Bicocca,"April 30, 2020",Observational,Predictive Clinical Response Factors in COVID-19 Patients
2284,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,COVID,"February 08, 2021",100,NCT04427358,,FRANCE,Completed,"University Hospital, Strasbourg, France","May 7, 2020",Observational,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population
2285,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,COVID,"February 08, 2021",3300,NCT04427501,LY3819253; LY3832479; PLACEBO,PUERTO RICO,Recruiting,Eli Lilly and Company,"November 17, 2019",Interventional,"A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness"
2286,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,COVID,"February 08, 2021",24,NCT04427566,RADIATION THERAPY,UNITED STATES,Recruiting,Ohio State University Comprehensive Cancer Center,"July 23, 2020",Interventional,Vented COVID: A Phase II Study Of The Use Of Ultra Low-Dose Bilateral Whole Lung Radiation Therapy in the Treatment Of Critically Ill Patients With COVID-19 Respiratory Compromise
2287,Exploring Interventions for Glue Ear During Covid-19,"HEARING IMPAIRED CHILDREN; GLUE EAR; HEARING LOSS, CONDUCTIVE","February 08, 2021",20,NCT04427631,BONE CONDUCTION HEADPHONES,UNITED KINGDOM,Not yet recruiting,Cambridgeshire Community Services NHS Trust,"June 22, 2020",Interventional,Exploring Interventions for Children With Chronic Otitis Media With Effusion ('Glue Ear') When Services Are Reduced During Covid-19
2288,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,STEMI,"February 08, 2021",200,NCT04427735,,CHINA,Recruiting,Beijing Friendship Hospital,"January 24, 2019",Observational,Effect of Covid-19 Epidemic on Primary PCI and Prognosis in Patients With Acute STEMI
2289,Sexual Health and Problems During the Covid -19 Infection,SEXUAL BEHAVIOR,"February 08, 2021",400,NCT04427813,QUESTIONAIRE TO HUSBAND AND WIFE,EGYPT,Not yet recruiting,Aljazeera Hospital,"June 11, 2020",Observational,Sexual and Marital Health and Problems During the Covid -19 in the Last Months
2290,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,COVID,"February 08, 2021",200,NCT04427865,PROPHYLACTIC LACTOFERRIN DAILY,,Not yet recruiting,Cairo University,July 2020,Interventional,Efficacy of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19
2291,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,COVID PATIENTS,"February 08, 2021",5,NCT04427878,BIOPSIES OF SUBCUTANEOUS ADIPOSE TISSUE,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nice,"July 1, 2020",Interventional,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread?
2292,Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients,COVID,"February 08, 2021",240,NCT04428008,THYMALFASIN,UNITED STATES,Recruiting,Inova Health System,"January 12, 2021",Interventional,A Pilot Trial of Thymalfasin (Ta1) to Prevent COVID-19 Infection in Renal Dialysis Patients
2293,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,COVID,"February 08, 2021",180,NCT04428021,STANDARD THERAPY PROTOCOL (STP); STP + STANDARD PLASMA (SP); STP + COVID-19 CONVALESCENT PLASMA (CP),ITALY,Recruiting,Azienda Ospedaliera Città della Salute e della Scienza di Torino,"June 15, 2020",Interventional,"Effectiveness of Adding Standard Plasma or COVID-19 Convalescent Plasma to Standard Treatment, Versus Standard Treatment Alone, in Patients With Recent Onset of COVID-19 Respiratory Failure. A Randomized, Three-arms, Phase 2 Trial"
2294,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,COVID,"February 08, 2021",32,NCT04428073,COVAX-19™,,Not yet recruiting,GeneCure Biotechnologies,July 2020,Interventional,A Phase I Trial of a Therapeutic Vaccine (Covax-19™) in SARS-CoV-2 Infected Patients
2295,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,"DEPRESSIVE DISORDER, TREATMENT-RESISTANT","February 08, 2021",186,NCT04428099,LIFESTYLE CHANGE PROMOTION PROGRAM; MINDFULLNESS BASED COGNITIVE PROGRAM; WRITTEN INFORMATION,SPAIN,Recruiting,University of the Balearic Islands,"January 13, 2020",Interventional,Effectiveness of a Healthy Lifestyle Promotion Program as Adjunctive Teletherapy for Treatment-resistant Major Depression During Covid 19 Pandemic: A Randomized Clinical Trial Protocol
2296,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",20,NCT04428268,CHLOROQUINE PHOSPHATE TABLETS,MEXICO,Recruiting,Hospital Universitario Dr. Jose E. Gonzalez,"March 10, 2020",Interventional,"Phase II, Randomized, Double-blind, Controlled Clinical Trial Evaluating the Efficacy and Safety of Chloroquine + Low Dose Losartan Compared to Chloroquine Monotherapy in Subjects With SARS-CoV-2 Pneumonia"
2297,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,COVID,"February 08, 2021",200,NCT04428801,AUTOLOGOUS ADIPOSE-DERIVED STEM CELLS,,Not yet recruiting,Celltex Therapeutics Corporation,"January 10, 2021",Interventional,Clinical Study for the Prophylactic Efficacy of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) Against Coronavirus 2019 (COVID-19)
2298,Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ,HIV INFECTIONS; PREGNANCY RELATED; STI; MENTAL HEALTH WELLNESS 1,"February 08, 2021",3200,NCT04429061,SKILLZ-GIRL ENHANCED FOOTBALL CURRICULUM,ZAMBIA,Recruiting,University of Alabama at Birmingham,"March 1, 2020",Interventional,Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ
2299,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",COVID,"February 08, 2021",60,NCT04429334,NANGIBOTIDE; PLACEBO,FRANCE,Not yet recruiting,Inotrem,August 2020,Interventional,"Exploratory Study of the Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation A Randomized, Double-blind, Placebo-controlled Study With Adaptive Features"
2300,Cerebral Compliance Impairment in COVID-19,INTRACRANIAL HYPERTENSION; CEREBRAL CIRCULATORY FAILURE,"February 08, 2021",50,NCT04429477,CEREBRAL COMPLIANCE AND HEMODYNAMICS MONITORING,BRAZIL,Completed,University of Sao Paulo,"May 1, 2020",Observational [Patient Registry],Assessment of Cerebral Compliance and Hemodynamics in Severe COVID-19
2301,"Safety of TY027, a Treatment for COVID-19, in Humans",CORONAVIRUS DISEASE-2019 (COVID),"February 08, 2021",32,NCT04429529,TY027; 0.9% SALINE,SINGAPORE,"Active, not recruiting",Tychan Pte Ltd.,"June 9, 2020",Interventional,"Phase 1 First-in-Human, Time Lagged, Randomised, Placebo Controlled, Double Blind, Single Ascending Dose Study of TY027 in Healthy Adult Volunteers"
2302,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS","PNEUMONIA, VIRAL","February 08, 2021",40,NCT04429555,IBUDILAST; PLACEBO,UNITED STATES,Recruiting,MediciNova,"January 11, 2021",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, Tolerability, Biomarkers and Pharmacokinetics of Ibudilast (MN-166) in COVID-19 Subjects at Risk for Developing Acute Respiratory Distress Syndrome"
2303,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04429594,BLOOD SAMPLING,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"July 28, 2020",Interventional,Study of the Incidence of SARS-CoV-2 Infection in the Alpes-Maritimes Department by Analysis of the Specific Humoral and Cellular Response During Deconfinement
2304,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,SARS-CoV2,"February 08, 2021",100,NCT04429620,IMMUNFLUORESCENCE,HUNGARY,Recruiting,Szeged University,"May 30, 2020",Observational,Prospective Assay for SARS-CoV-2 Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method
2305,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,COVID,"February 08, 2021",100,NCT04429711,IVERMECTIN ORAL PRODUCT,ISRAEL,Recruiting,Sheba Medical Center,"May 12, 2020",Interventional,"Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection and to Decrease Viral Shedding - A Double Blind , Randomized Controlled Trial"
2306,Health Professional Exposure Assessment to Covid-19,COVID,"February 08, 2021",2129,NCT04429724,DIAGNOSTIC TEST COVID-19,FRANCE,"Active, not recruiting",Tourcoing Hospital,"July 6, 2020",Interventional,Health Professional Exposure Assessment to Covid-19
2307,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,COVID,"February 08, 2021",30,NCT04429763,UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS; PLACEBO,,Not yet recruiting,Trustem,July 2020,Interventional,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19
2308,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,SMOKING BEHAVIORS,"February 08, 2021",489,NCT04429815,SEROLOGICAL TEST FOR COVID-19.,,Not yet recruiting,"Central Hospital, Nancy, France","July 1, 2020",Observational,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19
2309,COVID-19 Psychological Wellbeing for Healthcare Students,PSYCHOLOGICAL WELLBEING,"February 08, 2021",45,NCT04429828,COVID-19 E-PACKAGE: PSYCHOLOGICAL WELLBEING FOR HEALTHCARE WORKERS,,Not yet recruiting,University of Nottingham,"June 13, 2020",Interventional,PoWerS Study: Psychological Wellbeing for Healthcare Students: Evaluation of a COVID-19 Digital Learning Package
2310,Donated Antibodies Working Against nCoV,COVID,"February 08, 2021",483,NCT04429854,CONVALESCENT PLASMA; STANDARD OF CARE,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"May 2, 2020",Interventional,"A Randomized, Open-label, Adaptive, Proof-of-concept Clinical Trial of Donated Antibodies Working Against With COVID-19: DAWN-PLASMA"
2311,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,COVID,"February 08, 2021",700,NCT04429867,HYDROXYCHLOROQUINE; PLACEBO,UNITED STATES,"Active, not recruiting",WellStar Health System,"May 7, 2020",Interventional,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease
2312,"Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients",COVID; FAMILY MEMBERS; CRITICAL ILLNESS,"February 08, 2021",480,NCT04430049,COVID ICU CONTAINMENT MEASURES,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 22, 2020",Observational,"Impact of the Restrictive Visiting Policy During the Covid-19 Pandemic on Anxiety, Depression and Post-traumatic Stress Disorder for Relatives of ICU Patients"
2313,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,GENERAL SURGERY; DISEASE OUTBREAKS,"February 08, 2021",14,NCT04430062,SURGICAL PROCEDURES PERFORMED UNDER GENERAL ANESTHESIA,ITALY,Completed,Azienda Socio Sanitaria Territoriale di Lodi,"May 1, 2020",Observational,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital
2314,Does Delaying Curative Surgery for Colorectal Cancer Influence Long-term Disease Free Survival.,COLORECTAL CANCER,"February 08, 2021",602,NCT04430231,WAIT LIST TIME,,Completed,Fundación para la Investigación del Hospital Clínico de Valencia,"January 1, 2012",Observational,Does Delaying Curative Surgery for Colorectal Cancer Influence Long-term Disease Free Survival.: A COHORT STUDY
2315,Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study,COVID,"February 08, 2021",330,NCT04430322,,FRANCE,Recruiting,Centre Hospitalier Régional Metz-Thionville,"March 1, 2020",Observational,Coronavirus Disease 2019 (Covid-19) at the Regional Hospital Center Metz-Thionville: a Descriptive Study
2316,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,CARDIOVASCULAR DISEASES,"February 08, 2021",100,NCT04430374,NO INTERVERNTION,QATAR,Recruiting,Hamad Medical Corporation,"June 2, 2020",Observational [Patient Registry],Qatar Cardiovascular COVID-19 Registry
2317,Dental Isolation Methods in Pediatric Patients,"DENTAL PLAQUE; CALCULUS, DENTAL; AEROSOL DISEASE","February 08, 2021",180,NCT04430387,THE SALIVA EJECTOR; THE HIGH-VOLUME EVACUATOR; THE DRYSHIELD,UNITED STATES,Not yet recruiting,"The University of Texas Health Science Center, Houston","November 1, 2021",Interventional,Evaluation of Impact on Environmental Spatter Using Different Isolation Methods During Hygiene Appointment Among Pediatric Patients
2318,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,DIABETES; COVID; INFECTION,"February 08, 2021",72,NCT04430608,DEXCOM G6,DENMARK,Recruiting,Nordsjaellands Hospital,"May 25, 2020",Interventional,Remote Glucose Monitoring of Patients With Diabetes Quarantined During the COVID-19 Pandemic - a Hospital-Based Randomized Controlled Trial of the Effect of Remote Continuous Glucose Monitoring Compared to Usual Glucose Monitoring
2319,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,BLOOD DONATION,"February 08, 2021",403535,NCT04431180,BLOOD DONATION SMS,CHINA,Enrolling by invitation,Guangzhou Blood Center,"June 13, 2020",Interventional,Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19#Second Repeat Trial#
2320,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,FEEDING AND EATING DISORDERS,"February 08, 2021",37,NCT04431284,QUESTIONNAIRES,FRANCE,Completed,Hospices Civils de Lyon,"June 16, 2020",Observational,Impact of COVID-19 Lockdown on Severely Obese Patients With or Without Binge Eating Behaviors
2321,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,CHRONIC STRESS,"February 08, 2021",30,NCT04431297,MINDFULNESS ROUNDS,UNITED STATES,Not yet recruiting,Icahn School of Medicine at Mount Sinai,January 2021,Interventional,The Impact of Virtual Mindfulness Education Sessions on Staff Perceived Stress During COVID-19
2322,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,"COVID; HEALTH PERSONNEL; PERSONNEL, HOSPITAL","February 08, 2021",300,NCT04431310,SERIAL SEROCONVERSION MEASUREMENTS IN HOSPITAL EMPLOYEES DURING THE COVID-19 PANDEMIC,DENMARK,Recruiting,Nordsjaellands Hospital,"March 27, 2020",Observational,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic
2323,Intervention for Young Adults With Multiple Sclerosis,MULTIPLE SCLEROSIS,"February 08, 2021",60,NCT04431323,ESPRIMO,ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"May 13, 2020",Interventional,ESPRIMO: A Bio-psycho-social Co-created Intervention for Young Adults With Multiple Sclerosis: Study Protocol for a Feasibility Study
2324,A Study of Immune Responses to the Virus That Causes COVID-19,SARS-CoV2; COVID,"February 08, 2021",800,NCT04431414,SAMPLE COLLECTION,ARGENTINA,Recruiting,COVID-19 Prevention Network,"July 20, 2020",Observational,A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection
2325,"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",COVID,"February 08, 2021",52,NCT04431453,REMDESIVIR,ITALY,Recruiting,Gilead Sciences,"July 21, 2020",Interventional,"A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With COVID-19"
2326,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",64,NCT04431466,IVERMECTIN; STANDARD TREATMENT FOR COVID-19,BRAZIL,Recruiting,Universidade Federal de Sao Carlos,"July 1, 2020",Interventional,Phase 2 Clinical Trial to Compare the Efficacy and Safety of Different Doses of Ivermectin in Patients Diagnosed With the New Coronavirus Infection (SARS-CoV-2)
2327,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,ANXIETY; DEPRESSION; TRAUMATIC STRESS DISORDER,"February 08, 2021",80,NCT04431856,UNIFIED PROTOCOL FOR COVID-19 PARENTING STRESS (UP-COVID); SHG,UNITED STATES,Completed,University of Miami,"May 15, 2020",Interventional,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment
2328,In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,PREGNANCY RELATED; COVID; INTESTINAL ATRESIA; LIMB ANOMALY,"February 08, 2021",200,NCT04431869,,UNITED STATES,Recruiting,"University of Colorado, Denver","August 18, 2020",Observational [Patient Registry],In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers
2329,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,COVID,"February 08, 2021",250,NCT04431908,OLFACTORY DEVICE,UNITED STATES,Recruiting,Yale University,"June 15, 2020",Observational,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects
2330,Healthy Lifestyle or Pro-health Obsession During the Pandemic,ADULT; GLOBAL HEALTH,"February 08, 2021",50000,NCT04432038,,POLAND,Recruiting,Gdansk University of Physical Education and Sport,"June 19, 2020",Observational,Healthy Lifestyle or Pro-health Obsession During the Pandemic - a Multinational Study
2331,The Use of Lung Ultrasonography in COVID-19 Patients,ULTRASONOGRAPHY,"February 08, 2021",100,NCT04432051,MECHANICAL VENTILATOR SETTINGS AND POSITION,TURKEY,Recruiting,Gaziosmanpasa Taksim Research and Education Hospital,"May 26, 2020",Interventional,The Significance of Lung Ultrasonography in the Follow-up and Treatment of COVID-19 Patients With Respiratory Failure
2332,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,COVID,"February 08, 2021",36,NCT04432103,ANTI SARS-COV 2 CONVALESCENT PLASMA IN SEVERE COVID-19 PATIENTS; ANTI SARS-COV 2 CONVALESCENT PLASMA IN CRITICAL COVID-19 PATIENTS,,Not yet recruiting,Centro Medico ABC,"June 19, 2020",Interventional,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma
2333,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),COVID; SEVERE ACUTE RESPIRATORY SYNDROME (SARS); CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04432272,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",William Beaumont Hospitals,"July 16, 2020",Interventional,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)
2334,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease",COVID,"February 08, 2021",130,NCT04432298,PAMREVLUMAB; PLACEBO,UNITED STATES,Recruiting,FibroGen,"June 20, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Efficacy and Safety of Intravenous Pamrevlumab, a Monoclonal Antibody Against Connective Tissue Growth Factor (CTGF), in Hospitalized Patients With Acute COVID-19 Disease"
2335,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),COVID,"February 08, 2021",100,NCT04432324,INTRAVENOUS IMMUNE GLOBULIN; STANDARD MEDICAL TREATMENT,SPAIN,Recruiting,"Instituto Grifols, S.A.","June 2, 2020",Interventional,"A Multicenter, Randomized, Open-label Parallel Group Pilot Study to Evaluate Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Hospitalized Subjects With COVID-19"
2336,Assessment of Mortality Rates in SARS-CoV-2 Infected Populations Treated With Repurposed Medications,COVID; DRUG EFFECT; DRUG INTERACTION; RISK REDUCTION,"February 08, 2021",50000,NCT04432350,,,Not yet recruiting,Tabula Rasa HealthCare,"June 15, 2020",Observational,Assessment of Mortality Rates in SARS-CoV-2 Infected Populations Treated With Repurposed Medications
2337,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",174,NCT04432766,BAT2020,UNITED STATES,Not yet recruiting,Bio-Thera Solutions,"October 20, 2020",Interventional,"A Phase 1/2, Multi-Center, Randomized Study to Assess Safety, Pharmacokinetics, Immunogenicity, and Efficacy of BAT2020 in Hospitalized Patients Infected With SARS-CoV-2 (COVID-19)"
2338,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,PREGNANCY; COVID,"February 08, 2021",3000,NCT04432779,NO INTERVENTION,BELGIUM,Recruiting,Centre Hospitalier Universitaire Saint Pierre,"May 25, 2020",Observational,Impact of SARS-CoV-2 Infection During Pregnancy on Newborns and Young Children
2339,The California Home Abortion by Telehealth (CHAT) Study,ABORTION EARLY,"February 08, 2021",700,NCT04432792,TELEHEALTH CONSULTATION,UNITED STATES,Not yet recruiting,"University of California, San Francisco",November 2020,Interventional,The California Home Abortion by Telehealth (CHAT) Study
2340,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,PREGNANT WOMEN SUSPECTED OF COVID,"February 08, 2021",160,NCT04432805,PERFORMING OF LUNG ULTRASOUND,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"June 15, 2020",Interventional,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19
2341,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,COLON CANCER,"February 08, 2021",200,NCT04432870,,UNITED STATES,Enrolling by invitation,Massachusetts General Hospital,"June 9, 2020",Observational,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study
2342,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection",COVID,"February 08, 2021",15,NCT04432922,HOSPITALIZED PATIENTS FOR COVID-19 INFECTION,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"November 1, 2020",Observational,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized"
2343,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,COVID; MATERNAL PSYCHOLOGICAL DISTRESS; ANESTHESIA,"February 08, 2021",200,NCT04432948,PHQ-9 DEPRESSION SCALE; GAD-7 GENERAL ANXIETY DISORDER SCALE; 38-QUESTIONS QUESTIONNAIRE,GREECE,Recruiting,General and Maternity Hospital of Athens Elena Venizelou,"May 15, 2020",Observational,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.
2344,Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19),COVID,"February 08, 2021",200,NCT04432961,,,Not yet recruiting,Cambridge University Hospitals NHS Foundation Trust,July 2020,Observational,A Database and Analytics Study of Free Text Clinical Notes and Structured Data to Investigate Phenotype Associations With Outcomes in Patients With COVID-19
2345,Dornase Alpha for the Treatment of COVID-19,COVID,"February 08, 2021",60,NCT04432987,PULMOZYME,TURKEY,Recruiting,Acibadem University,"May 25, 2020",Interventional,Determination of Dornase Alpha Effectiveness in COVID-19 Treatment
2346,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",34,NCT04433000,BUTTERFLY,ITALY,Recruiting,University of Siena,"March 15, 2020",Observational,Comparison Between a Pocket Sized and a High End Ultrasound Scanner in the Evaluation of Lung Involvement in Patients With Covid-19 Pneumonia
2347,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,COVID,"February 08, 2021",300,NCT04433013,LIANHUA QINGWEN; PLACEBO,,Not yet recruiting,Nanyang Technological University,July 2020,Interventional,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19
2348,"BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19",COVID,"February 08, 2021",90,NCT04433026,"N TERMINAL PRO B TYPE NATRIURETIC PEPTIDE (NTPROBNP), D-DIMER, AND SERUM TROPININ - I",,Not yet recruiting,Assiut University,August 2020,Observational,"B-natriuretic Peptide (BNP), Serum Troponin-I, and D-dimer as Risk Factors for In-hospital Death in Patients With COVID-19"
2349,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,COVID,"February 08, 2021",130,NCT04433039,,EGYPT,Completed,Alexandria University,"May 22, 2020",Observational,COVID-19 Versus H1N1 Viral Pneumonia: A Retrospective Comparative Study for Spectrum of HRCT Findings Among 130 Patients
2350,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,CYTOKINE STORM; SARS-CoV2,"February 08, 2021",20,NCT04433078,DOXYCYCLINE; PLACEBO,UNITED STATES,Recruiting,Temple University,"June 22, 2020",Interventional,RepurpoSing Old Drugs TO SuppRess a Modern Threat: The STORM Trial
2351,COVID19 and Physical and Emotional Wellbeing of HCP,MENTAL HEALTH,"February 08, 2021",1050,NCT04433260,"QUESTIONNAIRE INCLUDING VALIDATED TOOLS SUCH AS PATIENT HEALTH QUESTIONNAIRE (PHQ-9), THE 7-ITEM GENERALISED ANXIETY DISORDER (GAD- 7), THE 7-ITEM INSOMNIA SEVERITY INDEX; QUESTIONNAIRE, SAME TOOLS AS BEFORE, WITH INCLUSION OF PCL5 QUESTIONNAIRE TOO.; INFORMED CONSENT",UNITED KINGDOM,Recruiting,Queen Mary University of London,"July 25, 2020",Observational,"Immediate and Mid-term Implications of the Covid-19 Pandemic on the Physical, Behavioural and Mental Health of Healthcare Workers: A Cohort Study of Doctor, Nurses and Other Health Care Workers"
2352,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,PHYSICAL STRESS; CAREER BURNOUT; SATISFACTION,"February 08, 2021",1000,NCT04433286,QUESTIONNAIRE,EGYPT,Not yet recruiting,Mansoura University,"June 15, 2020",Observational,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction
2353,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,"SATISFACTION, PATIENT; QUALITY OF LIFE","February 08, 2021",10000,NCT04433312,QUESTIONNAIRE,EGYPT,Not yet recruiting,Mansoura University,"July 1, 2020",Observational [Patient Registry],Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic
2354,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,COVID; INTENSIVE CARE UNIT SYNDROME,"February 08, 2021",150,NCT04433325,,FRANCE,Not yet recruiting,Rennes University Hospital,June 2020,Observational,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units
2355,COPE - COVID-19 in Pregnancy and Early Childhood,SARS-CoV2; COVID; PREGNANCY COMPLICATIONS; PREGNANCY PRETERM; PREGNANCY IN DIABETIC; NEONATAL INFECTION,"February 08, 2021",1200,NCT04433364,"BIOLOGICAL SAMPLES, QUESTIONNAIRES AND INTERVIEWS",SWEDEN,Recruiting,"Sahlgrenska University Hospital, Sweden","June 2, 2020",Observational [Patient Registry],COPE - COVID-19 in Pregnancy and Early Childhood - a Study Protocol for a Prospective Multicentre Cohort Study
2356,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",ACUTE RESPIRATORY DISTRESS SYNDROME; CORONAVIRUS; HYPOXIC RESPIRATORY FAILURE; HYPOXEMIC RESPIRATORY FAILURE; RESPIRATORY COMPLICATION; RESPIRATORY INSUFFICIENCY; CARDIAC DYSFUNCTION; PNEUMONIA; PULMONARY EDEMA; PULMONARY INFLAMMATION; RESPIRATORY FAILURE; CYTOKINE STORM; COVID; SARS-CoV2; CARDIAC EVENT; CARDIAC COMPLICATION; CARDIAC FAILURE; CARDIAC INFARCT,"February 08, 2021",54,NCT04433546,PEMZIVIPTADIL (PB1046); LOW DOSE (10 MG) CONTROL,UNITED STATES,Terminated,PhaseBio Pharmaceuticals Inc.,"July 15, 2020",Interventional,"A Randomized, Double-Blind, Parallel Group Study to Assess the Efficacy and Safety of Once Weekly Subcutaneous Injections of Pemziviptadil (PB1046), a Sustained-Release VIP (Vasoactive Intestinal Peptide) ANalogue, in Hospitalized COVID-19 Patients at HiGh Risk for Rapid Clinical Deterioration and ARDS (PB1046 VANGARD Study)"
2357,The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,PANCREATITIS,"February 08, 2021",500,NCT04433754,BIOCHEMICAL ANALYSIS,TURKEY,Completed,Uşak University,"March 1, 2020",Observational,Pancreatic Injury in Patients With COVID-19 Disease
2358,COVID-19 in Pediatric Oncology and Hematology Centers in France,COVID; CANCER,"February 08, 2021",300,NCT04433871,"NO INTERVENTION, OBSERVATIONAL",FRANCE,Recruiting,"University Hospital, Caen","April 27, 2020",Observational [Patient Registry],National SFCE Cohort of SARS-CoV-2 Infections (COVID-19) in Pediatric Oncology and Hematology
2359,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,COVID,"February 08, 2021",106,NCT04433910,CONVALESSCENT PLASMA,GERMANY,"Active, not recruiting",Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,"August 30, 2020",Interventional,"A Randomized, Prospective, Open Label Clinical Trial on the Use of Convalescent Plasma Compared to Best Supportive Care in Patients With Severe COVID-19"
2360,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,PNEUMONIA; SEVERE ACUTE RESPIRATORY SYNDROME; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",52,NCT04433949,BEST PRACTICE; LOW DOSE RADIATION THERAPY,UNITED STATES,Recruiting,Emory University,"June 12, 2020",Interventional,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19): A Randomized Phase III of Best Supportive Care +/- Whole Lung Low-Dose Radiation Therapy in Hospitalized Patients
2361,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,COVID,"February 08, 2021",200,NCT04433988,PENTOXIFYLLINE; PLACEBO,EGYPT,Not yet recruiting,Sadat City University,"June 13, 2021",Interventional,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients
2362,Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era,"DIET, HEALTHY","February 08, 2021",300,NCT04434014,PROPER DIET,EGYPT,Recruiting,October University for Modern Sciences and Arts,"June 8, 2020",Observational,Proper Nutrition and Its Relationship to Oral Diseases in the Era of Corona
2363,Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients,RHEUMATOID ARTHRITIS; COVID,"February 08, 2021",600,NCT04434118,TRADITIONAL ANTIRHEUMATIC DRUGS,EGYPT,Enrolling by invitation,Sadat City University,"March 20, 2020",Observational,"Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients: A Retrospective, Case-control Study"
2364,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,COVID,"February 08, 2021",30,NCT04434131,CONVALESCENT PLASMA,UNITED STATES,Recruiting,University of New Mexico,"April 28, 2020",Interventional,"Open, Non-comparative Pilot Study to Provide Access to Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19"
2365,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,IVERMECTIN; HYDROXYCHLOROQUINE; COVID,"February 08, 2021",116,NCT04434144,IVERMECTIN + DOXYCYCLINE; HYDROXYCHLOROQUINE + AZITHROMYCIN,BANGLADESH,Completed,"Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar","May 2, 2020",Observational [Patient Registry],A Comparative Observational Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
2366,Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients,COVID,"February 08, 2021",221,NCT04434157,,MEXICO,Completed,Hospital Regional de Alta especialidad de Ixtapaluca,"March 28, 2020",Observational,Association of the Neutrophil/Lymphocyte Ratio and Lymphocyte /Platelet Ratio With Clinical Complications and Mortality in COVID-19 Patients
2367,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,COVID,"February 08, 2021",330,NCT04434248,FAVIPIRAVIR; STANDARD OF CARE,RUSSIAN FEDERATION,"Active, not recruiting",Chromis LLC,"April 23, 2020",Interventional,"An Adaptive, Multicenter, Randomized, Open-label, Comparative Clinical Study to Assess Efficacy and Safety of Favipiravir in Hospitalized Patients With COVID-19"
2368,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,SARS-CoV2; ONCOLOGY; SURGERY,"February 08, 2021",1500,NCT04434261,PT-PCR TEST FOR SARS-COV-2,BRAZIL,"Active, not recruiting",Instituto Brasileiro de Controle do Cancer,"May 11, 2020",Observational,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2
2369,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,COVID,"February 08, 2021",1000,NCT04434417,2019-NCOV IGG/IGM RAPID TEST CASSETTE,ITALY,Recruiting,European Institute of Oncology,"April 15, 2020",Observational,"Clinical Validation of a Simple and Fast Immunochromatographic Assay for Qualitative Determination of Specific ImmunoGLObulin IgG/IgM Antibodies to 2019- nCoV in Whole bLood, Serum or Plasma Specimen"
2370,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,COAGULOPATHY; CARDIOVASCULAR COMPLICATION; COVID,"February 08, 2021",200,NCT04435015,"CAMOSTAT MESYLATE; MICROCRYSTALLINE CELLULOSE, NF",,Not yet recruiting,Yale University,"February 1, 2021",Interventional,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications
2371,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,BREAST CANCER; IRON CHELATION,"February 08, 2021",111,NCT04435028,KETOTIFEN 1 MG,EGYPT,Completed,Horus University,"January 14, 2019",Observational,Ketotifen: Novel Use as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy as Well as the Potential Beneficial Effects of Ketotifen in the Hypothetical Management of COVID-19
2372,Remote-by-Default Care in the COVID-19 Pandemic,COVID,"February 08, 2021",1,NCT04435041,,UNITED KINGDOM,"Active, not recruiting",University of Oxford,"June 1, 2020",Observational [Patient Registry],"Remote-by-Default Care in the COVID-19 Pandemic: Addressing the Micro-, Meso-, and Macro-level Challenges of a Radical New Service Model"
2373,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; REHABILITATION; INTENSIVE CARE UNIT ACQUIRED WEAKNESS; CRITICAL ILLNESS POLYNEUROMYOPATHY,"February 08, 2021",35,NCT04435080,,TURKEY,Completed,Koç University,"March 15, 2020",Observational,Physical Rehabilitation in Intensive Care Unit in Acute Respiratory Distress Syndrome Patients With COVID-19
2374,Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19),CORONAVIRUS INFECTION,"February 08, 2021",23,NCT04435106,OPAGANIB; STANDARD OF CARE,ISRAEL,Completed,Shaare Zedek Medical Center,"April 3, 2020",Observational,Compassionate Use of Opaganib in Patients With Severe COVID-19
2375,Covid-19 and Vitamin D in Nursing-home,CORONAVIRUS,"February 08, 2021",96,NCT04435119,,FRANCE,Completed,"University Hospital, Angers","March 15, 2020",Observational,COvid-19 et VITamine d en EHPAD
2376,Crizanlizumab for Treating COVID-19 Vasculopathy,COVID,"February 08, 2021",50,NCT04435184,CRIZANLIZUMAB; 0.9% SALINE,UNITED STATES,Completed,Johns Hopkins University,"July 9, 2020",Interventional,Crizanlizumab for Treating COVID-19 Vasculopathy
2377,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,COVID SEVERE PNEUMONIA; SEVERE PNEUMONIA DUE TO OTHER PATHOGENE,"February 08, 2021",62,NCT04435223,BIOLOGICAL ASSAYS IN PARTICULAR ON THE LIPID METABOLISM,FRANCE,Completed,Centre Hospitalier Universitaire Dijon,"April 7, 2020",Observational,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen
2378,Virtual Assistant for COVID-19 PPE,COVID,"February 08, 2021",50,NCT04435275,"VIRTUAL ASSISTANT FIRST, THEN HUMAN COACH; HUMAN COACH FIRST, THEN VIRTUAL ASSISTANT",CANADA,Recruiting,"University Health Network, Toronto","January 2, 2021",Interventional,Development of an Automated and Scalable Virtual Assistant to Aid in PPE Adherence and Clinical Protocols for Healthcare Worker Safety
2379,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,COVID,"February 08, 2021",200,NCT04435314,NITAZOXANIDE; PLACEBO,,Not yet recruiting,Azidus Brasil,June 2020,Interventional,"Prospective, Randomized, Double-blind, Parallel, Placebo Controlled Study to Evaluate the Safety and Efficacy of Nitazoxanide 600 mg Three Times a Day for Post Exposure Prophylaxis of COVID-19 in Subjects From Vulnerable Communities"
2380,Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19),"COVID; PNEUMONIA, VIRAL; BAROTRAUMA; INTERSTITIAL LUNG DISEASE; BRONCHIECTASIS ADULT; EMPHYSEMA","February 08, 2021",300,NCT04435327,,ITALY,Recruiting,University of Milano Bicocca,"August 17, 2020",Observational,SequelaeCov: a Prospective Study on Lung Damage Caused by SARS-CoV-2 Pneumonia
2381,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,RESPIRATORY DISTRESS SYNDROME; HYPOXEMIA,"February 08, 2021",200,NCT04435353,VIBROLUNG,KAZAKHSTAN,Recruiting,Astana Medical University,"March 22, 2020",Interventional,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19
2382,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,"INFECTION, RESPIRATORY TRACT","February 08, 2021",2038,NCT04435379,VPM1002; PLACEBO,GERMANY,"Active, not recruiting",Vakzine Projekt Management GmbH,"June 18, 2020",Interventional,"A Phase III, Randomized, Double-blind, Placebo-controlled, Multicentre, Clinical Trial to Assess the Efficacy and Safety of VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in the SARS-CoV-2 Pandemic by Modulating the Immune System"
2383,Cardiovascular Implications of COVID-19,SARS-CoV2; SARS PNEUMONIA; COVID; SARS-ASSOCIATED CORONAVIRUS AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE; CARDIAC COMPLICATION,"February 08, 2021",70,NCT04435457,,UNITED STATES,Recruiting,University of Texas Southwestern Medical Center,"September 1, 2020",Observational [Patient Registry],Uncovering the Cardiac Phenotype of Individuals With SARS-COV-2 and Cardiac Injury
2384,Maraviroc in Patients With Moderate and Severe COVID-19,COVID,"February 08, 2021",9,NCT04435522,MARAVIROC,UNITED STATES,Completed,Rhode Island Hospital,"October 1, 2020",Interventional,Open-Label Study of Maraviroc in Hospitalized Individuals Diagnosed With SARS-CoV-2
2385,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,ASYMPTOMATIC INFECTIONS; SARS-CoV2 INFECTION,"February 08, 2021",80,NCT04435587,IVERMECTIN PILL; COMBINED ART/HYDROXYCHLOROQUINE,THAILAND,Recruiting,Mahidol University,"July 13, 2020",Interventional,Comparative Efficacy of Ivermectin Versus Combination of Hydroxychloroquine Plus Darunavir/ Ritonavir for Shortening Duration of SARS-CoV2 Detection From Respiratory Secretion Among Asymptomatic or Afebrile COVID-19 Infection
2386,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),COVID,"February 08, 2021",78,NCT04435717,TOCILIZUMAB 20 MG/ML INTRAVENOUS SOLUTION [ACTEMRA]_#1; TOCILIZUMAB 20 MG/ML INTRAVENOUS SOLUTION [ACTEMRA]_#1 (2 DOSES),SPAIN,Recruiting,Hospital Universitario Ramon y Cajal,"May 4, 2020",Interventional,"Unicenter, Randomized, Open-label Clinical Trial on the Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19"
2387,Inhaled Ciclesonide for Outpatients With COVID19,COVID,"February 08, 2021",454,NCT04435795,NORMAL SALINE INTRANASAL,CANADA,Recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"September 14, 2020",Interventional,Ciclesonide Clinical Trial for COVID-19 Treatment
2388,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,COVID,"February 08, 2021",1,NCT04435808,HYDROXYCHLOROQUINE,UNITED STATES,Terminated,University of New Mexico,"April 14, 2020",Interventional,Off Label Study to Evaluate the Efficacy of Hydroxychloroquine as Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Health Care Workers at High Risk of Occupational Exposure to SARS-CoV-2
2389,A Study of Ad26.COV2.S in Adults (COVID-19),HEALTHY,"February 08, 2021",1045,NCT04436276,AD26.COV2.S; PLACEBO,BELGIUM,Recruiting,Janssen Vaccines & Prevention B.V.,"July 15, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26COVS1 in Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older"
2390,Niclosamide In Moderate COVID-19,COVID,"February 08, 2021",100,NCT04436458,NICLOSAMIDE ORAL TABLET; PLACEBO,,Not yet recruiting,"First Wave Bio, Inc.",December 2020,Interventional,"Phase 2, Multicentre, Randomized, Double Blind, 2 Arms Placebo-controlled Study in Adults With Moderate COVID-19 With Gastrointestinal Signs and Symptoms"
2391,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",PREVENTIVE IMMUNIZATION COVID,"February 08, 2021",38,NCT04436471,GAM-COVID-VAC,RUSSIAN FEDERATION,Completed,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","June 17, 2020",Interventional,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" a Solution for Intramuscular Injection With the Participation of Healthy Volunteers"
2392,Immune Biomarkers of Outcome From COVID-19,COVID,"February 08, 2021",200,NCT04436484,PERIPHERAL BLOOD SAMPLING,UNITED KINGDOM,Recruiting,University Hospital Plymouth NHS Trust,"April 29, 2020",Observational,Immune Dysfunction in COVID-19: Investigation of Mechanisms and Identification of Immune Biomarkers of Clinical Outcome
2393,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,EATING BEHAVIOR; COVID,"February 08, 2021",397,NCT04437121,ONLINE SURVEY ABOUT DIETARY AND LIFESTYLE HABITS,GREECE,Completed,University of Thessaly,"April 30, 2020",Observational,Dietary and Lifestyle Habits of Children and Adolescents and Their Parents During the Pandemic of COVID-19 in Greece: The COV-EAT Study
2394,On-line Neuromuscular Exercise and Education for Knee Osteoarthritis,KNEE OSTEOARTHRITIS,"February 08, 2021",500,NCT04437134,ON-LINE EXERCISE AND EDUCATION; ON-SITE EXERCISE AND EDUCATION,DENMARK,Recruiting,Slagelse Hospital,"June 12, 2020",Observational [Patient Registry],On-line Neuromuscular Exercise and Education for Knee Osteoarthritis
2395,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,POSTPARTUM DEPRESSION; PSYCHOLOGICAL STRESS; MATERNAL DISTRESS,"February 08, 2021",330,NCT04437342,PHQ-9 (PATIENT HEALTH QUESTIONNAIRE) DEPRESSION SCALE; GAD-7 (GENERAL ANXIETY DISORDER) SCALE; 38 QUESTIONS QUESTIONNAIRE; EPDS (EDINBURGH POSTNATAL DEPRESSION SCALE),GREECE,Completed,General and Maternity Hospital of Athens Elena Venizelou,"June 30, 2020",Observational,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia
2396,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,COVID,"February 08, 2021",500,NCT04437693,HYDROXYCHLOROQUINE,,Not yet recruiting,Hamad Medical Corporation,"August 31, 2020",Interventional,Post Exposure Prophylaxis (PEP) in Healthcare Workers Exposed to COVID-19 Patients: A Double-blind Randomized Clinical Trial
2397,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,COVID; SARS-CoV2,"February 08, 2021",200,NCT04437706,,UNITED STATES,Enrolling by invitation,Duke University,"December 11, 2020",Observational,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling
2398,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",ONCOLOGY; COVID,"February 08, 2021",100,NCT04437719,OBVIO-19 APP,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"June 29, 2020",Interventional,"Longitudinal Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group, Paris, France for a Period of 6 Months During the COVID-19 Pandemic in 2020"
2399,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04437823,INTRAVENOUS INFUSIONS OF STEM CELLS,PAKISTAN,Recruiting,Jinnah Hospital,"June 1, 2020",Interventional,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients
2400,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",PREVENTIVE IMMUNIZATION COVID,"February 08, 2021",38,NCT04437875,GAM-COVID-VAC LYO,RUSSIAN FEDERATION,Completed,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","June 17, 2020",Interventional,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac Lyo"" Lyophilizate for the Preparation of a Solution for Intramuscular Injection With the Participation of Healthy Volunteers"
2401,COVIDAR - Arrhythmias in COVID-19,"COVID; ARRHYTHMIA; TORSADES DE POINTE CAUSED BY DRUG; QT INTERVAL, VARIATION IN; ATRIOVENTRICULAR BLOCK; ATRIAL FIBRILLATION; BRADYARRHYTHMIA; VENTRICULAR ARRYTHMIA","February 08, 2021",10000,NCT04437901,,BELGIUM,Not yet recruiting,Hospital Clinic of Barcelona,June 2020,Observational [Patient Registry],COVIDAR - International Registry on Arrhythmias in COVID-19
2402,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,COVID; SARS-CoV2,"February 08, 2021",38,NCT04437940,VAGINAL FLUID COVID-19 PCR TEST,TURKEY,Completed,Acibadem University,"June 15, 2020",Observational,Evaluation of Vaginal Fluid for Covid-19 Positivity
2403,Chronic Disease Self-management Program for Hypertension Control in Churches,HYPERTENSION,"February 08, 2021",384,NCT04437966,ENHANCED CHRONIC DISEASE SELF-MANAGEMENT PROGRAM,BARBADOS,Recruiting,The University of The West Indies,"October 11, 2020",Interventional,Assessing Effectiveness of a Chronic Disease Self-management Program in Faith-based Organizations in Barbados: a Cluster Randomized Trial
2404,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,COVID,"February 08, 2021",150,NCT04438057,CCP,UNITED STATES,Recruiting,Metro Infectious Disease Consultants,"August 12, 2020",Interventional,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19
2405,COVID Screening Strategies in Homeless Shelters,COVID,"February 08, 2021",400,NCT04438070,COVID-19 SWAB,CANADA,Recruiting,St. Joseph's Healthcare Hamilton,"April 10, 2020",Interventional,COVID Screening Strategies in Homeless Shelters
2406,Rehabilitation Needs After COVID-19 Hospital Treatment,COVID,"February 08, 2021",150,NCT04438239,"NONE, THIS STUDY IS OBSERVATIONAL",ITALY,Completed,Azienda Unità Sanitaria Locale Reggio Emilia,"June 22, 2020",Observational,Rehabilitation Needs After COVID-19 Hospital Treatment (REACT): an Observational Study
2407,Evaluation of Immune Response in COVID-19 Patients,ALLERGY AND IMMUNOLOGY; INFECTION VIRAL,"February 08, 2021",80,NCT04438629,COVID-19 TREATMENT,ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"March 26, 2020",Observational,Evaluation of Immune Response in COVID-19 Patients
2408,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,COVID,"February 08, 2021",67,NCT04438694,CONVALESCENT PLASMA; STANDARD OF CARE,EGYPT,Recruiting,Cairo University,"June 1, 2020",Interventional,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection
2409,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,CORONAVIRUS DISEASE 2019 (COVID); POST-EXPOSURE PROPHYLAXIS,"February 08, 2021",582,NCT04438837,HYDROXYCHLOROQUINE,ISRAEL,Not yet recruiting,Rambam Health Care Campus,July 2020,Interventional,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers: A Randomized-Controlled Trial
2410,COVidIVERmectin: Ivermectin for Treatment of Covid-19,COVID,"February 08, 2021",102,NCT04438850,IVERMECTIN; PLACEBO,ITALY,Recruiting,IRCCS Sacro Cuore Don Calabria di Negrar,"July 31, 2020",Interventional,"Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the Early Treatment of COVID-19"
2411,Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19,COVID,"February 08, 2021",90,NCT04438863,HOME SPIROMETRY,ISRAEL,Recruiting,Sheba Medical Center,"August 8, 2020",Observational,A Descriptive Pilot Study of Daily Home Spirometry for Early Detection of Pulmonary Complications in High Risk Patients With COVID19
2412,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,SARS-CoV2,"February 08, 2021",100,NCT04438941,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","March 25, 2020",Observational,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic
2413,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels",MULTIPLE SCLEROSIS; COVID,"February 08, 2021",30,NCT04438954,,TURKEY,Completed,Ankara Yildirim Beyazıt University,"May 5, 2020",Observational,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels of Multiple Sclerosis Patients in the COVID-19 Pandemic"
2414,Brain Health in the Time of COVID-19,BRAIN HEALTH,"February 08, 2021",10000,NCT04438967,,UNITED STATES,Recruiting,Miro Health,"June 16, 2020",Observational,Brain Health in the Time of COVID-19
2415,Glucocorticoids in COVID-19 (CORTIVID),COVID PNEUMONIA,"February 08, 2021",72,NCT04438980,METHYLPREDNISOLONE; PLACEBO,SPAIN,Recruiting,Fundacion Miguel Servet,"May 15, 2020",Interventional,Treatment of COVID-19 Pneumonia With Glucocorticoids. A Randomized Controlled Trial
2416,The COVID-19 Disease and CARdiac Events Study,COVID; CORONAVIRUS,"February 08, 2021",100,NCT04438993,,UNITED KINGDOM,Recruiting,NHS Lanarkshire,"May 29, 2020",Observational,"An Observational Study of Hospitalised Patients With Coronavirus Disease 2019 (COVID-19) to Determine the Degree of Myocardial Injury Using Biomarkers and Echocardiography, and the Impact of This on Cardiovascular Outcomes"
2417,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,APLASTIC ANEMIA; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM; MONOCLONAL B-CELL LYMPHOCYTOSIS; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MYELODYSPLASTIC SYNDROME; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",72,NCT04439006,BEST PRACTICE; IBRUTINIB,UNITED STATES,Recruiting,Jennifer Woyach,"July 22, 2020",Interventional,Randomized Double-Blind Phase 2 Trial of Ibrutinib Versus Standard Treatment for COVID-19 Illness Requiring Hospitalization With Safety Lead-In
2418,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,SARS-CoV2 INFECTION,"February 08, 2021",3626,NCT04439045,VPM1002; PLACEBO,CANADA,Recruiting,"University Health Network, Toronto","June 24, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 3 Study: Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 Infection Rate and COVID-19 Severity"
2419,A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19),PNEUMONIA; COVID; CORONAVIRUS,"February 08, 2021",380,NCT04439071,PTC299; SOC; PLACEBO,AUSTRALIA,Recruiting,PTC Therapeutics,"July 9, 2020",Interventional,Evaluation of the Efficacy and Safety of PTC299 in Hospitalized Subjects With COVID-19 (FITE19)
2420,COVID-19 in Patients With Chronic Liver Diseases,COVID; CHRONIC LIVER DISEASE,"February 08, 2021",1000,NCT04439084,PROSPECTIVE CHART REVIEW,UNITED STATES,Enrolling by invitation,Stanford University,"March 6, 2020",Observational,COVID-19 in Patients With Chronic Liver Diseases
2421,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,MOOD,"February 08, 2021",45,NCT04439825,BOTULINUM NEUROTOXIN; PLACEBO,UNITED STATES,Not yet recruiting,DeNova Research,"July 15, 2020",Interventional,Randomized Controlled Single Blind Cross Over Trial Evaluating the Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction in a Post Covid Period.
2422,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,COVID,"February 08, 2021",80,NCT04440007,ABIVERTINIB; STANDARD OF CARE,UNITED STATES,Recruiting,"Sorrento Therapeutics, Inc.","October 9, 2020",Interventional,"A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19"
2423,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,LONELINESS; DEPRESSION; ANXIETY; ALCOHOL ABUSE; DRUG ABUSE,"February 08, 2021",1008,NCT04440098,,UNITED STATES,Completed,University of Miami,"April 22, 2020",Observational,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology
2424,Preoperative Immature Granulocyte Count and Percentage for Acute Appendisitis,ACUTE APPENDICITIS,"February 08, 2021",70,NCT04440150,APPENDECTOMY,TURKEY,Completed,Kahramanmaras Sutcu Imam University,"June 1, 2018",Interventional,Preoperative Immature Granulocyte Count and Percentage for Complicated and Uncomplicated Appendisitis
2425,Universal Anti-Viral Vaccine for Healthy Elderly Adults,VIRUS DISEASES,"February 08, 2021",40,NCT04441047,ALLOSTIM,UNITED STATES,Not yet recruiting,"Immunovative Therapies, Ltd.","March 6, 2021",Interventional,Safety and Efficacy of ALLOSTIM® Universal Anti-Viral Immunodulatory Vaccine for Healthy Elderly Adults
2426,VERARE : Effectiveness of Virtual Motor Actions for Improving Walking in Patients With Post-resuscitation Muscle Weakness,WEAKNESS OF THE LOWER LIMBS,"February 08, 2021",0,NCT04441164,OBSERVATION OF VIRTUAL ACTIONS; RELAXATION; ACCEPTABILITY QUESTIONNAIRE; OBSERVATION OF VIRTUAL ACTIONS (STEP 4); PERFORMING VIRTUAL ACTIONS; HAPTIC STIMULATION; WITHOUT HAPTIC STIMULATION,FRANCE,Withdrawn,Rennes University Hospital,"August 1, 2020",Interventional,VERARE : Effectiveness of Virtual Motor Actions for Improving Walking in Patients With Post-resuscitation Muscle Weakness
2427,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection,SARS-CoV2; COVID,"February 08, 2021",1200,NCT04441372,,BANGLADESH,Not yet recruiting,"Medecins Sans Frontieres, Spain","October 1, 2020",Observational [Patient Registry],Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection
2428,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,COVID,"February 08, 2021",200,NCT04441385,MARAVIROC 300 MG; STANDARD CARE THERAPY,SPAIN,Recruiting,Hospital Universitario Infanta Leonor,"June 26, 2020",Interventional,"Bicentric, Phase 2, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc Associated With Standard Treatment in Hospitalized Patients With Pulmonary SARS-CoV-2 Infection (COVID-19)."
2429,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,COVID,"February 08, 2021",300,NCT04441398,NITAZOXANIDE; PLACEBO,,Not yet recruiting,Azidus Brasil,July 2020,Interventional,"Prospective, Randomized, Double-blind, Parallel, Placebo Controlled Study to Evaluate the Safety and Efficacy of Nitazoxanide 600 mg Three Times a Day to Treat Ambulatory Adult Subjects Diagnosed With COVID-19 With Mild Symptoms Assisted in the Public Health System of the City of Mesquita -RJ"
2430,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,IMMUNOTHERAPY,"February 08, 2021",49,NCT04441424,CONVALESCENT PLASMA; HYDROXYCHLOROQUIN WITH AZITHROMYCIN,IRAQ,Completed,Alkarkh Health Directorate-Baghdad,"April 3, 2020",Interventional,"The Therapeutic Potential of Convalescent Plasma Therapy on Treating Critically-ill COVID-19 Patients Residing in Respiratory Care Units in Hospitals in Baghdad, Iraq"
2431,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis,PSYCHOLOGICAL STRAIN,"February 08, 2021",3000,NCT04441476,QUESTIONNAIRES; PSYCHOLOGICAL AND SOCIOLOGICAL INTERVIEWS,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"April 21, 2020",Observational,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis
2432,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,COVID; FDG PET/CT; INFLAMMATION,"February 08, 2021",13,NCT04441489,,MONACO,Completed,Centre Hospitalier Princesse Grace,"March 27, 2020",Observational,Assessment of Lung Inflammation With FDG PET/CT in COVID-19
2433,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,COVID; INTERSTITIAL PNEUMONIA,"February 08, 2021",240,NCT04441502,,ITALY,Recruiting,IRCCS Policlinico S. Donato,"March 30, 2020",Observational,Identification of Predictors for the Evolution of COVID-19 Related Interstitial Pneumonia by Transcriptomic and Seroproteomic Techniques
2434,Effect of Positive Attitudes on Behavior and Wellness,"BURNOUT; STRESS, EMOTIONAL","February 08, 2021",24,NCT04441632,POSITIVE FEEDBACK,UNITED STATES,Completed,Cedars-Sinai Medical Center,"June 15, 2020",Interventional,"The Impact of Positive Reinforcement on Teamwork Climate, Resiliency, and Burnout During the COVID-19 Pandemic: the TEAM-ICU Study (Transforming Employee Attitudes Via Messaging Strengthens Interconnection, Communication, and Unity)"
2435,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",SARS-CoV2 SEROLOGICAL STATUS; SARS-CoV2 SEROPREVALENCE,"February 08, 2021",1800,NCT04441684,BLOOD SAMPLE FOR SEROLOGICAL TEST,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 17, 2020",Interventional,"Study of the Seroprevalence of SARS-CoV-2 in Hospital Staff in Strasbourg University Hospital, Strasbourg, France"
2436,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,COVID,"February 08, 2021",2500,NCT04441710,QUESTIONNAIRE,FRANCE,Recruiting,Hospices Civils de Lyon,"October 27, 2020",Observational [Patient Registry],Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus
2437,FOUND - Ancillary Study to Smile Protocol NCT03654105,COVID; INFLAMMATORY STATUS,"February 08, 2021",960,NCT04441814,,ITALY,Enrolling by invitation,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","July 23, 2019",Observational,Frequency and OUtcome of Sub-solid Pulmonary Nodules in Asymptomatic Subjects Tested by Chest CT Screening Versus COVID-19 Patients (FOUND) - Ancillary Study to Smile Protocol NCT03654105
2438,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",COVID; AND HIGH INFECTION RISK OF SARS-CoV2,"February 08, 2021",40,NCT04441918,JS016 (ANTI-SARS-COV-2 MONOCLONAL ANTIBODY),CHINA,Recruiting,"Shanghai Junshi Bioscience Co., Ltd.","June 5, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Phase I Clinical Study to Evaluate the Tolerability, Safety, Pharmacokinetic Profile and Immunogenicity of JS016 (Anti-SARS-CoV-2 Monoclonal Antibody) Injection in Chinese Healthy Subjects After Intravenous Infusion of Single Dose"
2439,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,COVID,"February 08, 2021",20,NCT04441996,THERAPEUTIC PLASMA EXCHANGE (TPE); STANDARD OF CARE,UNITED STATES,"Active, not recruiting",Emory University,"July 17, 2020",Interventional,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity
2440,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,CANCER; COVID,"February 08, 2021",1500,NCT04442048,IMM-101; OBSERVATION,CANADA,Recruiting,Canadian Cancer Trials Group,"June 25, 2020",Interventional,"COV-IMMUNO: A Randomized, Phase III Trial of Immunization With IMM-101 Versus Observation for the Prevention of Severe Respiratory and COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure"
2441,Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP,SARS-CoV2,"February 08, 2021",400,NCT04442087,SEROLOGY SARS-COV2; DATA COLLECTION,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 19, 2020",Interventional,Seroprevalence of Anti-SARS-CoV2 Among Children According to Parents' SARS-CoV2 Serological Status. Study in a Hospital Population Assistance Publique-Hôpitaux Paris
2442,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,GENDER RELATIONS; PARTNER COMMUNICATION; DIVISION OF CAREWORK; COUPLE CONFLICT; STRESS,"February 08, 2021",1000,NCT04442152,MENCARE+/BANDEBEREHO FATHERS'/COUPLES' GROUP EDUCATION,RWANDA,Enrolling by invitation,"Promundo, United States",June 2020,Interventional,Phone Survey for Understanding the Impact of COVID-19 on Caregiving and Family Dynamics on Bandebereho Study Participants
2443,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,COVID,"February 08, 2021",15393,NCT04442165,,,Not yet recruiting,"Institute of Tropical Medicine, Belgium","July 15, 2020",Observational,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique Using Population-based (Sero)Surveillance
2444,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),COVID; LYMPHOCYTOPENIA,"February 08, 2021",48,NCT04442178,CYT107; PLACEBO,UNITED STATES,Recruiting,Revimmune,"September 15, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Infectious Cohort"
2445,Convalescent Plasma as a Possible Treatment for COVID-19,COVID,"February 08, 2021",50,NCT04442191,CONVALESCENT PLASMA; PLACEBO,UNITED STATES,Recruiting,University of Illinois at Chicago,"May 5, 2020",Interventional,"Infusion of Convalescent Plasma for the Treatment of Patients Infected With Severe Acute Respiratory Syndrome-Coronavirus-2 (COVID-19): A Double-blinded, Placebo-controlled, Proof-of-concept Study"
2446,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,DEPRESSION; ANXIETY,"February 08, 2021",4000,NCT04442204,PROSPECTIVE STUDY ACROSS TWO TIME-POINTS EXAMINING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic
2447,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,ADHERENCE TO WHO-ADVISED HYGIENE-RELATED BEHAVIOR; ADHERENCE TO VIRAL MITIGATION PROTOCOLS,"February 08, 2021",4000,NCT04442217,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic
2448,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),CORONAVIRUS INFECTION,"February 08, 2021",96,NCT04442230,NASOVAX; PLACEBO,UNITED STATES,Recruiting,"Altimmune, Inc.","October 10, 2020",Interventional,"Phase 2, Double-blind, Randomized, Placebo-controlled Study of NasoVAX in the Prevention of Clinical Worsening in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)"
2449,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,POST TRAUMATIC STRESS DISORDER; ANXIETY; DEPRESSION,"February 08, 2021",889,NCT04442243,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up
2450,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,ANXIETY; DEPRESSION; INTERPERSONAL PROBLEM; EMOTION REGULATION,"February 08, 2021",5041,NCT04442282,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,"Difficulties in Emotion-regulation and Interpersonal Problems, and Their Association With Anxiety and Depression During and After the COVID-19 Pandemic"
2451,Parental Stress After the Covid-19 Pandemic,PARENTING; ANXIETY; DEPRESSION; ANGER,"February 08, 2021",1440,NCT04442308,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Parental Stress After the Covid-19 Pandemic: Predictors and Outcome
2452,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,DEPRESSION; GENERALIZED ANXIETY; HEALTH ANXIETY,"February 08, 2021",4000,NCT04442360,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic
2453,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,PARENTAL BURNOUT,"February 08, 2021",1500,NCT04442386,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON PARENTAL BURNOUT,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors
2454,Sequelae of Sars-CoV-2 Infections,LUNG DISEASES; CARDIAC DISEASE; INFLAMMATORY REACTION,"February 08, 2021",30,NCT04442789,,GERMANY,Recruiting,University of Giessen,"May 20, 2020",Observational,Long-term Sequelae of Severe Sars-CoV-2 Infections
2455,Effectiveness of Convalescent Immune Plasma Therapy,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",60,NCT04442958,CONVALESCENT IMMUNE PLASMA,TURKEY,Completed,Bagcilar Training and Research Hospital,"May 15, 2020",Interventional,Effectiveness of Convalescent Immune Plasma Therapy in Severe COVID-19 Patients With Acute Respiratory Distress Syndrome
2456,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress,"STRESS DISORDERS, POST-TRAUMATIC","February 08, 2021",180,NCT04443075,FAECAL SAMPLE COLLECTOR,CHINA,Recruiting,First Affiliated Hospital Xi'an Jiaotong University,"June 24, 2020",Observational,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress of Fighting Against 2019-nCoV
2457,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,COVID; PREECLAMPSIA; PREGNANCY RELATED,"February 08, 2021",131,NCT04443140,"PCR, LUNG ULTRASOUND",TURKEY,Completed,Zeynep Kamil Maternity and Pediatric Research and Training Hospital,"March 15, 2020",Observational [Patient Registry],Evaluation of COVID-19 Incidence in Patients With Preeclampsia During Pandemic
2458,Brain Imaging in Babies Study,AUTISM SPECTRUM DISORDER; ATTENTION DEFICIT HYPERACTIVITY DISORDER; NEURODEVELOPMENTAL CONDITIONS; COVID,"February 08, 2021",790,NCT04443179,,UNITED KINGDOM,Recruiting,King's College London,"April 5, 2013",Observational,Brain Imaging and Infant Development
2459,REassessement After Hospitalization for Sars-COV-2 disordER,SARS-CoV2,"February 08, 2021",200,NCT04443257,ASSESSMENT OF THE SEQUELAE AFTER HOSPITALIZATION FOR SARS-COV-2,FRANCE,Enrolling by invitation,"University Hospital, Montpellier","July 8, 2020",Observational,REassessement After Hospitalization for Sars-COV-2 Infection : Standardized Assessment of Sequelae and Comorbidities 3 to 6 Months After Hospitalization
2460,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,COVID,"February 08, 2021",200,NCT04443270,CHLOROQUINE PHOSPHATE,MEXICO,Not yet recruiting,"CMN ""20 de Noviembre""","July 27, 2020",Interventional,Efficacy of Chloroquine Phosphate Prophylactic Use in First-line Health Personnel Exposed to COVID-19 Patients
2461,Insomnia After the COVID-19 Pandemic,INSOMNIA; METACOGNITIVE BELIEFS; ANXIETY; DEPRESSION; SLEEP,"February 08, 2021",5000,NCT04443361,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Insomnia After the COVID-19 Pandemic
2462,Glycine Supplement for Severe COVID-19,"COVID; SARS-COV INFECTION; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); SARS PNEUMONIA; ARDS, HUMAN; PNEUMONIA, VIRAL","February 08, 2021",82,NCT04443673,GLYCINE,MEXICO,Recruiting,Instituto Nacional de Enfermedades Respiratorias,"August 20, 2020",Interventional,Controlled and Randomized Clinical Trial for Evaluating the Effect of a Supplement of Glycine as Adjuvant in the Treatment of COVID-19 Pneumonia in Patients Initiating Mechanical Ventilation
2463,Predictors of Mental Well-being During the COVID-19 Pandemic,MENTAL WELL-BEING,"February 08, 2021",4000,NCT04443699,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Predictors of Mental Well-being During the COVID-19 Pandemic
2464,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",1900,NCT04443712,,EGYPT,Recruiting,Samia Girgis,"May 29, 2020",Observational,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)
2465,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,COVID,"February 08, 2021",100,NCT04443725,"HYDROXYCHLOROQUINE , SOFOSBUVIR, DACLATASVIR; STANDARD OF CARE TREATMENT",,Not yet recruiting,Cairo University,July 2020,Interventional,Efficacy and Safety of Anti-hepatitis C Drugs in the Treatment of COVID-19
2466,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,MIGRANTS; ANXIETY; DEPRESSION,"February 08, 2021",287,NCT04443764,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic
2467,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,COVID,"February 08, 2021",9,NCT04443803,,,Not yet recruiting,Randy Loftus,"July 1, 2020",Observational,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program
2468,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,SARS-COV INFECTION,"February 08, 2021",50,NCT04443868,NITRIC OXIDE-RELEASING DRUG,,Not yet recruiting,Sanotize Research and Development corp.,January 2021,Interventional,"Double-Blinded, Placebo-Controlled Parallel, Phase II Clinical Efficacy Study Evaluating NORS To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Mild COVID-19"
2469,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),COVID PNEMONIA,"February 08, 2021",180,NCT04443881,ANAKINRA 149 MG/ML PREFILLED SYRINGE [KINERET],SPAIN,Recruiting,Fundacion Miguel Servet,"May 8, 2020",Interventional,"Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19. A Phase 2/3, Randomized, Open-label, Parallel Group, 2-arm, Multicenter Study Investigating the Efficacy and Safety of Intravenous Administrations of Anakinra, an Interleukin-1(IL-1) Receptor Antagonist, Added to Standard of Care, Versus Standard of Care, in Reducing Hyper-inflammation and Respiratory Distress in Patients With SARS- CoV-2 Infection"
2470,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,LONELINESS DURING COVID,"February 08, 2021",10084,NCT04444115,,,Not yet recruiting,Modum Bad,"June 22, 2020",Observational,Loneliness During the COVID-19 Pandemic: Change and Predictors of Change From Strict to Lifted Social Distancing Protocols
2471,IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION,MYOCARDITIS; HEART FAILURE; MYOCARDIAL FIBROSIS,"February 08, 2021",3000,NCT04444128,CMR WITH T1 AND T2 MAPPING,GERMANY,Recruiting,Johann Wolfgang Goethe University Hospital,"November 15, 2016",Observational [Patient Registry],IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
2472,Mesenchymal Stem Cell Infusion for COVID-19 Infection,COVID,"February 08, 2021",20,NCT04444271,MESENCHYMAL STEM CELLS; PLACEBO,PAKISTAN,Recruiting,Dr. Zaineb Akram,"May 1, 2020",Interventional,"Prospective, Randomized Phase 2 Clinical Trial of Mesenchymal Stem Cells(MSCs) for the Treatment of Coronavirus Disease 2019(COVID-19)"
2473,3D Telemedicine During COVID-19: Non-clinical Validation,"TELEMEDICINE; SURGERY, PLASTIC","February 08, 2021",40,NCT04444297,3D TELEMEDICINE; 2D TELEMEDICINE,UNITED KINGDOM,Not yet recruiting,NHS Greater Glasgow and Clyde,"July 31, 2020",Interventional,3D Telemedicine During COVID-19: Non-clinical Validation
2474,Antibody Responses in Contacts of COVID-19 Patients,COVID,"February 08, 2021",100,NCT04444310,,EGYPT,"Active, not recruiting",Assiut University,"June 15, 2020",Observational [Patient Registry],Antibody Responses in Asymptomatic Close Contacts of COVID-19 Patients and Their Implications
2475,3D Telemedicine During COVID-19: Cohort Study,"TELEMEDICINE; SURGERY, PLASTIC","February 08, 2021",50,NCT04444323,3D TELEMEDICINE,UNITED KINGDOM,Not yet recruiting,NHS Greater Glasgow and Clyde,"September 1, 2020",Interventional,3D Telemedicine During COVID-19: Cohort Study
2476,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,DEPRESSION; ANXIETY,"February 08, 2021",4000,NCT04444336,CROSS-SECTIONAL STUDY EXAMINING THE IMPACT OF INFORMATION SOURCES TO OBTAIN INFORMATION ABOUT COVID-19 ON DEPRESSION AND ANXIETY SYMPTOMS,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study
2477,Registry on NEN Patients and COVID-19,NEUROENDOCRINE TUMORS; COVID,"February 08, 2021",50,NCT04444401,,ITALY,Recruiting,European Institute of Oncology,"June 15, 2020",Observational,InterNaTional rEgistry oN Sars-cov-2posItiVe nEuroendocrine Neoplasm Patients (INTENSIVE)
2478,Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia,COVID PNEUMONIA,"February 08, 2021",18,NCT04444531,,SPAIN,Completed,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,"March 20, 2020",Observational,Ozone Therapy for Patients With COVID-19 Pneumonia: Preliminary Report of a Prospective Case-control Study
2479,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,DEPRESSION; HEMODIALYSIS,"February 08, 2021",97,NCT04444557,BECK DEPRESSION INVENTORY (BDI),TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"April 17, 2020",Observational,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study
2480,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,COVID; SARS-CoV2,"February 08, 2021",100,NCT04444596,CONJUNCTIVAL SWAB AND NASOPHARYNGEAL SWAB,AUSTRIA,Recruiting,Medical University Innsbruck,"June 17, 2020",Interventional,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19
2481,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,"COVID; SARS-CoV2; ARDS, HUMAN; IMMUNE SYSTEM DISORDER","February 08, 2021",230,NCT04444609,"BLOOD TESTS SPUTUM, NASAL LAVAGE AND BRUSHING",UNITED KINGDOM,Recruiting,Imperial College London,"June 18, 2020",Observational,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
2482,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,OSTEOPOROSIS; SARCOPENIA,"February 08, 2021",21,NCT04444661,,GERMANY,"Active, not recruiting",University of Erlangen-Nürnberg Medical School,"June 10, 2020",Observational,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise in Older Men With Osteosarcopenia A Randomized Controlled Trial
2483,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,CORONAVIRUS,"February 08, 2021",2130,NCT04444674,CHADOX1 NCOV-19; NORMAL SALINE 0.9%,SOUTH AFRICA,"Active, not recruiting",University of Oxford,"June 24, 2020",Interventional,"An Adaptive Phase I/II Randomized Placebo-controlled Trial to Determine Safety, Immunogenicity and Efficacy of Non-replicating ChAdOx1 SARS-CoV-2 Vaccine in South African Adults Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV"
2484,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,COVID,"February 08, 2021",20,NCT04444687,TEST FOR SARS-COV-2,,Not yet recruiting,"University Hospital, Basel, Switzerland",August 2020,Observational,Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?
2485,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,"COVID; CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; THROMBOEMBOLISM, VENOUS; ANTICOAGULANTS AND BLEEDING DISORDERS","February 08, 2021",462,NCT04444700,THERAPEUTIC ANTICOAGULATION,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"July 4, 2020",Interventional,Utilização da Enoxaparina em Dose Anticoagulante em Pacientes Hospitalizados Com síndrome respiratória Aguda Grave Por COVID-19
2486,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,DEPRESSIVE SYMPTOMS; METACOGNITIVE VARIABLES,"February 08, 2021",10084,NCT04444713,,,Not yet recruiting,Modum Bad,"June 22, 2020",Observational,Centrality in the Cross-sectional Network of Depressive Symptom and Metacognitive Variables During COVID-19: Do Central Variables Predict Overall Symptom Reduction From Periods of Strict to Lifted Social Distancing Protocols?
2487,Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions,BIOEQUIVALENCE,"February 08, 2021",30,NCT04444986,FAVIR 200 MG FT; AVIGAN 200 MG FT,TURKEY,Completed,Kocak Farma,"June 5, 2020",Interventional,"Open-Label, Randomised, Single Oral Dose, Two-Period, Cross-Over Trial To Assess The Bioequivalence Of Favir 200 Mg Ft In Comparison With Avigan 200 Mg Ft In Healthy Male Subjects Under Fasting Conditions"
2488,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,CORONAVIRUS,"February 08, 2021",50,NCT04445194,RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) LOW-DOSE GROUP; RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELLS) HIGH-DOSE GROUP; RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELLS) PLACEBO GROUP,CHINA,"Active, not recruiting","Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","June 22, 2020",Interventional,"A Multi-center, Double-blind, Randomized, Placebo Parallel Controlled, Safety and Tolerability Phase I Clinical Trial of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Healthy People Between 18 and 59 Years of Age"
2489,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",,NCT04445207,CONVALESCENT PLASMA,UNITED STATES,Available,Jonathan Gerber,,Expanded Access,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19
2490,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,COVID; ACUTE KIDNEY INJURY,"February 08, 2021",22,NCT04445220,SBI-101,UNITED STATES,Recruiting,"Sentien Biotechnologies, Inc.","November 19, 2020",Interventional,"A Multi-center, Randomized, Case Controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 Therapy) in COVID-19 Subjects With Acute Kidney Injury Receiving Renal Replacement Therapy"
2491,COVID-19 Household Transmission Study,COVID,"February 08, 2021",315,NCT04445233,,UNITED STATES,"Active, not recruiting","University of North Carolina, Chapel Hill","April 29, 2020",Observational,The COVID-19 Household Transmission Study (CO-HOST) - Epidemiology of SARS-CoV-2 Transmission Within the Household
2492,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,"COVID; ARDS, HUMAN; HYPOXEMIC RESPIRATORY FAILURE","February 08, 2021",40,NCT04445246,INHALED ILOPROST,QATAR,Recruiting,Hamad Medical Corporation,"May 23, 2020",Interventional,Inhaled Iloprost for the Treatment of Suspected COVID-19 Respiratory Failure
2493,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,COVID; ACUTE KIDNEY INJURY; CRITICAL ILLNESS,"February 08, 2021",300,NCT04445259,,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"June 20, 2020",Observational,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury
2494,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",495,NCT04445272,TOCILIZUMAB,SPAIN,Completed,Fundacion SEIMC-GESIDA,"May 22, 2020",Interventional,"A Multicentre, Open-label Clinical Trial to Evaluate the Effectiveness and Safety of Intravenous Tocilizumab for Treating Patients With COVID-19 Pneumonia: the BREATH-19 Study"
2495,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,COVID,"February 08, 2021",44,NCT04445285,PULMOZYME/ RECOMBINANT HUMAN DEOXYRIBONUCLEASE (RH-DNASE); 0.9%SODIUM CHLORIDE,UNITED STATES,Recruiting,Jon Simmons,"April 28, 2020",Interventional,Double Blind Randomized Phase 2 Placebo Controlled Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
2496,Ivermectin in Treatment of COVID-19,COVID,"February 08, 2021",100,NCT04445311,IVERMECTIN,EGYPT,Recruiting,Zagazig University,"May 31, 2020",Interventional,Use of Ivermectin as a Therapeutic Option for Patients With COVID-19
2497,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,PSYCHOTIC DISORDERS; ANXIETY DEPRESSION,"February 08, 2021",30,NCT04445324,"TRANSITIONAL ONLINE PEER SUPPORT GROUP (N=20); CONTROL GROUP (PHARMACOTHERAPY AND/OR PSYCHOTHERAPY, N=10)",CANADA,"Active, not recruiting",Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal,"August 25, 2020",Interventional,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 : A Feasibility Study of a Trial
2498,Stellate Ganglion Blockade in COVID-19 Positive Patients,COVID; ARDS,"February 08, 2021",10,NCT04445337,STELLATE GANGLION BLOCK,,Not yet recruiting,University of Nebraska,July 2020,Interventional,Stellate Ganglion Blockade in COVID-19 Positive Patients
2499,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,COVID,"February 08, 2021",20,NCT04445376,PHYSICAL EXERCISES,PAKISTAN,Completed,Government College University Faisalabad,"July 3, 2020",Interventional,Effect of Aerobic Exercises on Cardio-respiratory Fitness and Quality of Life in Recovered COVID 19 Recovered Patients.
2500,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",SARS-CoV2,"February 08, 2021",210,NCT04445389,GX-19; SALINE,"KOREA, REPUBLIC OF",Recruiting,"Genexine, Inc.","June 17, 2020",Interventional,"A Phase 1/2a, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Immunogenicity of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Subjects"
2501,Pediatrics HOT COVID-19 Database in NY Tristate,PEDIATRIC CANCER; IMMUNE SYSTEM DISORDER; COVID; HEMOGLOBINOPATHIES,"February 08, 2021",1500,NCT04445402,,UNITED STATES,Recruiting,Columbia University,"April 30, 2020",Observational [Patient Registry],Retrospective and Prospective Database of COVID-19 Prevalence and Clinical Course in Pediatric and Young Adult Hematology/ Oncology/Stem Cell Therapy Patients in the New York Tri-State Area.
2502,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,COVID,"February 08, 2021",250,NCT04445415,COVID-19 ANTIBODIES TESTING,,Not yet recruiting,Assiut University,"July 1, 2020",Observational,Diagnostic Value of New- Covid 19 Antibodies Testing Among Laboratory Healthcare Workers
2503,OPV as Potential Protection Against COVID-19,"POLIOVIRUS VACCINE, ORAL; COVID; MORTALITY; MORBIDITY; NON-SPECIFIC EFFECTS OF VACCINES","February 08, 2021",3400,NCT04445428,ORAL POLIO VACCINE + INFORMATION; INFORMATION,GUINEA-BISSAU,Enrolling by invitation,Bandim Health Project,"July 15, 2020",Interventional,Oral Polio Vaccine as Potential Protection Against COVID-19: A Cluster-randomised Trial in Guinea-Bissau
2504,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,CORONAVIRUS INFECTION,"February 08, 2021",153,NCT04445441,,BURKINA FASO,Completed,Centre Muraz,"April 24, 2020",Observational,An Observational Study to Assess the Effectiveness of the Standard of Care (Hydroxychloroquine+Azythromicin or Chloroquine+Azythromicin) Recommended by the Ministry of Health for the Treatment of the Coronavirus Infection in Burkina Faso
2505,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04445454,MESENCHYMAL STROMAL CELLS,BELGIUM,Recruiting,University of Liege,"June 12, 2020",Interventional,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection
2506,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,COVID,"February 08, 2021",190,NCT04445467,FAVIPIRAVIR,AUSTRALIA,Recruiting,Bayside Health,"August 1, 2020",Interventional,An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection
2507,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ),"STROKE, ACUTE; COVID","February 08, 2021",250,NCT04445493,MINDRHYTHM HARMONY,,Not yet recruiting,"MindRhythm, Inc.","October 1, 2020",Observational,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic
2508,Short Term Corticosteroids in SARS-CoV2 Patients,CORTICOSTEROIDS; COVID; SARS-CoV2; STEROIDS; DEXAMETHASONE,"February 08, 2021",50,NCT04445506,DEXAMETHASONE,UNITED STATES,Completed,The Miriam Hospital,"April 1, 2020",Observational,"The Effect of the Short-term Use of Systemic Corticosteroids in COVID-19 Patients in Regard to Hospital Length of Stay, Morbidly and/or Mortality."
2509,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,SARS-CoV2,"February 08, 2021",90,NCT04445597,SAMPLING OF TISSUE,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"May 7, 2020",Interventional,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19
2510,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,CORONAVIRUS (COVID),"February 08, 2021",60,NCT04445610,,EGYPT,Not yet recruiting,Ain Shams University,"July 1, 2020",Observational,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
2511,Prasugrel in Severe COVID-19 Pneumonia,COVID; THROMBOSIS,"February 08, 2021",128,NCT04445623,PRASUGREL HYDROCHLORIDE 10 MG ORAL TABLET; PLACEBO,ITALY,Not yet recruiting,Azienda Ospedaliera Universitaria Integrata Verona,July 2020,Interventional,Prasugrel in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients
2512,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study,CANCER,"February 08, 2021",100,NCT04445870,DATA RECORD,FRANCE,Recruiting,CHU de Reims,"May 1, 2020",Observational,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study
2513,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,ANTICOAGULATION IN COVID ARDS,"February 08, 2021",100,NCT04445935,BIVALIRUDIN INJECTION; STANDARD TREATMENT,QATAR,Recruiting,Hamad Medical Corporation,"June 28, 2020",Interventional,Anticoagulation in Patients Suffering From COVID-19 Disease-The Anti-Co Trial
2514,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,SARS PNEUMONIA,"February 08, 2021",117,NCT04445961,RESPIRATORY MECHANICS MEASUREMENT; GAS EXCHANGE MEASUREMENT,RUSSIAN FEDERATION,Completed,I.M. Sechenov First Moscow State Medical University,"May 1, 2020",Observational,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure: Multicentral Observational Study
2515,Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers,COVID; SARS-CoV2,"February 08, 2021",524,NCT04446065,PREVIFENON®; PLACEBO,,Not yet recruiting,MELISA Institute Genomics & Proteomics Research SpA,"September 30, 2020",Interventional,"A Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Protect Health Workers Against COVID-19 by Using Previfenon® as Chemoprophylaxis During a SARS-CoV-2 Outbreak. The HERD Study"
2516,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,COVID,"February 08, 2021",4257,NCT04446104,HYDROXYCHLOROQUINE SULFATE TABLETS; IVERMECTIN 3MG TAB; ZINC; POVIDONE-IODINE; VITAMIN C,SINGAPORE,Completed,"National University Hospital, Singapore","May 13, 2020",Interventional,A Randomized Open-label Prophylaxis Trial Among Migrant Workers at High-risk of COVID-19 (DORM Trial)
2517,COVID-19 (SARS-CoV-2) in Urine and Semen,SARS-CoV2; SEXUAL FUNCTION AND FERTILITY DISORDERS; URINARY FUNCTION DISORDERS; URINE; SEMEN,"February 08, 2021",43,NCT04446169,SARS-COV 2 RNA PCR URINE; SARS-COV 2 RNA PCR SEMEN; SEMEN QUALITATIVE ANALYSIS; IIEF-5 QUESTIONNAIRE; MALE SEXUAL HEALTH QUESTIONNAIRE (MSHQ); IPSS QUESTIONNAIRE; SECRET QUESTIONNAIRE; INTERLEUKIN ASSESSMENT IN SEMEN,ITALY,"Active, not recruiting",University of Florence,"June 27, 2020",Observational,"COVID-19 (SARS-CoV-2) in Urine and Semen: Qualitative and Quantitative Analyses and Evaluation of STD, Sexual Function, Fertility and Urinary Function"
2518,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19,COVID,"February 08, 2021",50,NCT04446286,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","June 18, 2020",Observational,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19
2519,Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre,"HISTORY OF COVID, SEROPREVALENCE","February 08, 2021",300,NCT04446338,ANTIBODY TEST,GERMANY,Recruiting,University Hospital Tuebingen,"May 13, 2020",Observational,Immune Status: Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Sample of the Eye Department (University Eye Hospital and Research Institute Tübingen)
2520,A Study of LAM-002A for the Prevention of Progression of COVID-19,COVID DISEASE,"February 08, 2021",142,NCT04446377,APILIMOD DIMESYLATE CAPSULE; PLACEBO,UNITED STATES,Recruiting,"AI Therapeutics, Inc.","July 15, 2020",Interventional,"A Phase II Randomized, Double-Blind, Placebo-Controlled Study of LAM-002A for the Prevention of Progression of COVID-19"
2521,Anti-Androgen Treatment for COVID-19,COVID; SARS-CoV2; ANDROGENETIC ALOPECIA; PROSTATE CANCER; BENIGN PROSTATIC HYPERPLASIA; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",262,NCT04446429,PROXALUTAMIDE; STANDARD OF CARE,BRAZIL,Completed,"Applied Biology, Inc.","September 15, 2020",Interventional,Anti-Androgen Treatment for COVID-19
2522,Effect of COVID-19 on Platelet Aggregation,COVID; SARS-CoV2,"February 08, 2021",200,NCT04447131,VENIPUNCTURE IN PERIPHERAL VEIN,BRAZIL,Recruiting,University of Sao Paulo,"April 29, 2020",Observational,Effect of SARS-CoV-2 Infection on Platelet Aggregation and Other Coagulation Parameters
2523,"Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome",COVID; CHRONIC INFLAMMATION; NON-COMMUNICABLE CHRONIC DISEASES,"February 08, 2021",200,NCT04447144,,EGYPT,Recruiting,Cairo University,"June 1, 2020",Observational,"Nutritional Habits, Does it Affect Coronavirus Disease 2019 (COVID-19) Infection Outcome? An Egyptian Experience"
2524,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,DIETARY DIVERSITY,"February 08, 2021",300,NCT04447209,"DIETARY COUNSELLING ON FOOD GROUPS ACCORDING TO IYC FEEDING PRACTICES, WHO",MALAYSIA,Recruiting,University of Malaya,"June 6, 2020",Observational,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study
2525,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,COVID INFECTION; MALIGNANT SOLID NEOPLASM,"February 08, 2021",1242,NCT04447222,QUALITY-OF-LIFE ASSESSMENT; QUESTIONNAIRE ADMINISTRATION; SURVEY ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 12, 2020",Observational,COVID-19: Well-Being and HRQOL in Cancer Patients Who Participated in Prior Behavioral Clinical Trials
2526,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,CANCER; COVID; CORONAVIRUS INFECTION,"February 08, 2021",176,NCT04447235,PLACEBO; IVERMECTIN; LOSARTAN,BRAZIL,Recruiting,Instituto do Cancer do Estado de São Paulo,"July 23, 2020",Interventional,"Randomized, Doubled-blind Phase II Trial Evaluating the Use of Ivermectin Plus Losartan for Prophylaxis of Severe Events in Cancer Patients With Recent Diagnosis of COVID-19"
2527,"DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury",SARS-CoV2,"February 08, 2021",80,NCT04447404,DUR-928; PLACEBO,UNITED STATES,Recruiting,Durect,"September 21, 2020",Interventional,"A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Safety and Efficacy of DUR-928 in Subjects Infected With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury"
2528,Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,COVID,"February 08, 2021",573,NCT04447469,MAVRILIMUMAB; PLACEBO,BRAZIL,Recruiting,"Kiniksa Pharmaceuticals, Ltd.","July 27, 2020",Interventional,"A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Mavrilimumab (KPL-301) Treatment in Adult Subjects Hospitalized With Severe COVID-19 Pneumonia and Hyper-inflammation"
2529,Self-sampling for the Study of COVID-19,CORONAVIRUS,"February 08, 2021",500,NCT04447495,IAMP TEST,,Not yet recruiting,Medical College of Wisconsin,"July 1, 2020",Observational,Self-sampling for the Study of COVID-19
2530,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,COVID,"February 08, 2021",200,NCT04447534,CHLOROQUINE; ZINC,EGYPT,Recruiting,Tanta University,"June 23, 2020",Interventional,Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine in Treatment of COVID-19?
2531,Percutaneous Tracheostomy With COVID-19,TRACHEOSTOMY,"February 08, 2021",24,NCT04447638,TRACHEOSTOMY WITH AEROSOL BOX IN COVID-19 POSITIVE PATIENTS,TURKEY,Completed,Çanakkale Onsekiz Mart University,"March 20, 2020",Observational,Percutaneous Tracheostomy With Aerosol Box in COVID-19 Positive Patients in Intensive Care Unit: a Clinical Trial
2532,Prevalence of Mental Health Problems Among Undergraduate Students at the Universidad de Los Andes,"STUDENT; MENTAL HEALTH; DEPRESSION, ANXIETY; DEPRESSION; ANXIETY; COLLEGE DRINKING; STRESS","February 08, 2021",5553,NCT04447690,,CHILE,"Active, not recruiting","Universidad de los Andes, Chile","August 3, 2020",Observational,Prevalence of Mental Health Problems Among Undergraduate Students at the Universidad de Los Andes
2533,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",160,NCT04447781,INO-4800; CELLECTRA® 2000; SALINE-SODIUM CITRATE (SSC) BUFFER,"KOREA, REPUBLIC OF",Recruiting,International Vaccine Institute,"July 15, 2020",Interventional,"A Phase I/IIa, Dose-Ranging Trial to Evaluate Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers"
2534,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,"ARDS, HUMAN; COVID","February 08, 2021",9,NCT04447833,MESENCHYMAL STROMAL STEM CELLS - KI-MSC-PL-205,SWEDEN,Recruiting,Uppsala University,"June 17, 2020",Interventional,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome Validation of Mechanistic Pathways and Clinical Efficacy
2535,"Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial",LIVER CIRRHOSIS,"February 08, 2021",476,NCT04448028,PLACEBO; ESOMEPRAZOLE 20MG,GERMANY,Not yet recruiting,Universitätsklinikum Hamburg-Eppendorf,January 2021,Interventional,"Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial"
2536,"Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas","ESTIMATE, WITH THE CONTRIBUTION OF OPTIMIZED MRI, THE PREVALENCE OF NEUROLOGICAL AND NEUROVASCULAR MANIFESTATIONS ON IMAGING IN THE EVENT OF SARS-CoV2","February 08, 2021",100,NCT04448054,MRI,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"May 20, 2020",Observational,"Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas"
2537,Control of COVID-19 Outbreaks in Long Term Care,COVID; SARS-CoV2,"February 08, 2021",760,NCT04448119,FAVIPIRAVIR; FAVIPIRAVIR PLACEBO,CANADA,Recruiting,Appili Therapeutics Inc.,"October 16, 2020",Interventional,Control of COVID-19 Outbreaks in Long Term Care (CONTROL-COVID)
2538,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,COVID; CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",250,NCT04448145,,UNITED STATES,Recruiting,Columbia University,"March 26, 2020",Observational,"Characterizing SARS-CoV-2 Persistence in Host Reservoirs, Post-viral Sequelae, and Associations With Host and Viral Determinants in a Cohort of Convalescent COVID-19 Cases"
2539,Covid-19 Lockdown and Deviant Sexual Fantasies,DEVIANT SEXUAL FANTASIES,"February 08, 2021",100,NCT04448405,QUESTIONNAIRE FOR EVALUATION OF CONFINEMENT ON DEVIANT SEXUAL FANTASIES,FRANCE,Completed,"University Hospital, Montpellier","June 18, 2020",Observational,Descriptive Study on the Impact of Covid-19 Lockdown on Deviant Sexual Fantasies
2540,The Impact of COVID-19 Outbreak on Trans-population's Health in Italy,TRANSGENDER PERSONS; CORONAVIRUS; CORONAVIRUS INFECTION; COVID; COVID,"February 08, 2021",300,NCT04448418,WEB BASED SURVEY,ITALY,"Active, not recruiting",Unita Complessa di Ostetricia e Ginecologia,"May 20, 2020",Observational,Observational Evaluation of the Impact of COVID-19 Outbreak on Transgender Subject's Health and on the Organization of Trans-population Health Care Services
2541,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,MENTAL HEALTH ISSUE,"February 08, 2021",1288,NCT04448704,,SINGAPORE,Completed,Yale-NUS College,"June 22, 2020",Observational,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak
2542,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,SARS-CoV2; COVID,"February 08, 2021",8000,NCT04448717,COVID-19 ANTIBODY TESTING,SWITZERLAND,Recruiting,University of Zurich,"June 16, 2020",Observational,Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in a Public School Population - a Population-based Observational Study to Inform Policy Making
2543,Role of Microparticles in Covid-19 Infection,COVID,"February 08, 2021",175,NCT04448743,BLOOD SAMPLE,,Not yet recruiting,"University Hospital, Strasbourg, France",June 2020,Observational,Role of Circulating Microparticles in Covid-19 Infection
2544,Study of M5049 in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia,CORONAVIRUS DISEASE 2019,"February 08, 2021",150,NCT04448756,M5049; M5049; PLACEBO,BRAZIL,Recruiting,"EMD Serono Research & Development Institute, Inc.","July 29, 2020",Interventional,"A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of M5049 in Hospitalized Participants With COVID-19 Pneumonia"
2545,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),CORONAVIRUS INFECTION; PREVALENCE,"February 08, 2021",2006,NCT04448769,ANTI-SARS-COV-2 IGT SEROPOSITIVITY,FRANCE,Completed,"Central Hospital, Nancy, France","June 26, 2020",Interventional,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) in the Population of the Grand Nancy Metropolitan Area
2546,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,MECHANICAL VENTILATION COMPLICATION,"February 08, 2021",32,NCT04448782,ASYNCHRONIES DETECTION,SPAIN,Completed,Corporacion Parc Tauli,"March 9, 2020",Observational,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation
2547,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,AIRWAY MANAGEMENT; COVID,"February 08, 2021",15000,NCT04449042,AIRWAY MANAGEMENT DURING SEDATION OR GENERAL ANESTHESIA,UNITED STATES,Recruiting,Boston Children's Hospital,"April 1, 2020",Observational [Patient Registry],"Pediatric Airway Management Complications During the COVID-19 Pandemic. An International, Multicenter, Observational Registry: The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry"
2548,"Knowledge, Attitude and Practice of Dental Students About COVID-19",ACUTE RESPIRATORY DISTRESS SYNDROME; CORONAVIRUS INFECTION; ACUTE LUNG INJURY; FEVER; MYALGIA; COUGH; DYSPNEA; SEPTIC SHOCK; BLEEDING,"February 08, 2021",215,NCT04449081,"KNOWLEDGE, ATTITUDE, PRACTICE, AWARENESS, PREFERENCE",MALAYSIA,Completed,Melaka Manipal Medical College,"April 25, 2020",Observational,"Knowledge, Attitude and Practice About COVID-19 and Awareness of Infection Control to Prevent COVID-19 Transmission in Clinics and Perception About Online Learning During Lock Down Period: A Cross-sectional Study"
2549,Emergence of the COVID 19 Epidemic in the City of Nice,COVID,"February 08, 2021",200,NCT04449094,,FRANCE,Completed,Centre Hospitalier Universitaire de Nice,"February 28, 2020",Observational,Socio-demographic Factors and Emergence of the COVID 19 Epidemic in the City of Nice in 2020
2550,"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",SEVERE ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; SARS-CoV2; COVID,"February 08, 2021",280,NCT04449276,CVNCOV VACCINE; PLACEBO,BELGIUM,"Active, not recruiting",CureVac AG,"June 18, 2020",Interventional,"COVID-19: A Phase 1, Partially Blind, Placebo-controlled, Dose Escalation, First-in-human, Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity After 1 and 2 Doses of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV Administered Intramuscularly in Healthy Adults"
2551,Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients,COVID VIRUS INFECTION,"February 08, 2021",126,NCT04449380,INTERFERON-SS-1A; STANDARD OF CARE (SOC),ITALY,Recruiting,Emanuele Bosi,"November 2, 2020",Interventional,"Randomized, Controlled, Open Label, Phase 2 Clinical Trial of Interferon-β-1a (IFNβ-1a) in COVID-19 Patients"
2552,Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,COVID PNEUMONIA,"February 08, 2021",368,NCT04449588,BDB-001 INJECTION; CONVENTIONAL TREATMENT,CHINA,Recruiting,"Staidson (Beijing) Biopharmaceuticals Co., Ltd","July 23, 2020",Interventional,"A Multi-center, Open-label, Randomized Parallel Controlled Evaluation on the Efficacy and Safety of BDB-001 Injection in the Treatment of Progressive Severe COVID-19 in Phase II/III"
2553,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention,ANXIETY DISORDERS; POST TRAUMATIC STRESS DISORDER; DEPRESSIVE DISORDER; COVID,"February 08, 2021",125,NCT04449627,FEELING GOOD DIGITAL APP,,Not yet recruiting,Royal Free Hospital NHS Foundation Trust,"August 31, 2020",Observational,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention
2554,Vitamin D Supplementation in Patients With COVID-19,COVID,"February 08, 2021",240,NCT04449718,VITAMIN D; PLACEBO,BRAZIL,Completed,University of Sao Paulo,"June 1, 2020",Interventional,"Vitamin D Supplementation in Patients With COVID-19: A Randomized, Double-blind, Placebo-controlled Trial"
2555,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int),COVID,"February 08, 2021",30000,NCT04449731,,SPAIN,Recruiting,Universidad de Granada,"March 20, 2020",Observational,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population
2556,Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study,OPIOID-USE DISORDER,"February 08, 2021",30,NCT04449744,MYSAFERX INSPIRE PLUS; MYSAFERX INSPIRE FLEX,UNITED STATES,Recruiting,University of South Florida,"July 13, 2020",Interventional,Effects of Remote Motivational Enhancement & MySafeRx on Post-Detox Engagement and Retention in Buprenorphine Treatment (MySafeRx) - A Pilot Study
2557,Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery,COVID; CANCER,"February 08, 2021",150,NCT04449783,PRE-OPERATIVE SCREENING; TELEPHONE CONSULT,UNITED KINGDOM,Recruiting,Liverpool University Hospitals NHS Foundation Trust,"June 25, 2020",Observational,A Cohort Study to Assess the Effectiveness of Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery Patients in the COVID-19 Pandemic
2558,Povidone-Iodine Rinses in the Management of COVID-19,COVID,"February 08, 2021",81,NCT04449965,POVIDONE-IODINE; PLACEBO,,Not yet recruiting,"St. Paul's Hospital, Canada","July 1, 2020",Interventional,The Efficacy of Topical Povidone-Iodine Rinses in the Management of the Coronavirus Disease 2019 (COVID-19)
2559,TARGet Kids! COVID-19 Study of Children and Families,CORONAVIRUS; COVID; VIRUS; FAMILY AND HOUSEHOLD; INFECTION VIRAL,"February 08, 2021",1082,NCT04449978,,CANADA,Recruiting,The Hospital for Sick Children,"April 9, 2020",Observational,TARGet Kids! COVID-19 Study of Children and Families
2560,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",SARS-CoV2,"February 08, 2021",180,NCT04450004,INTRAMUSCULAR VACCINE,CANADA,"Active, not recruiting",Medicago,"July 10, 2020",Interventional,"A Randomized, Partially-Blinded, Dose-Ranging Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of a Recombinant Coronavirus-Like Particle COVID 19 Vaccine in Adults 18-55 Years of Age"
2561,Clinical Features of Severe Patients With COVID-19,SARS-CoV2,"February 08, 2021",150,NCT04450017,"THE DEMOGRAPHIC, CLINICAL, LABORATORY, AND INSTRUMENTAL DATA",RUSSIAN FEDERATION,Recruiting,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","April 6, 2020",Observational,Clinical Features of Severe Patients With COVID-19
2562,Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic,COVID; EMERGENCY SURGERY,"February 08, 2021",15,NCT04450277,EMERGENCY SURGERY,SINGAPORE,Completed,Khoo Teck Puat Hospital,"April 1, 2020",Observational [Patient Registry],Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic Based on Case Series
2563,Social Anxiety Telehealth Therapy Study,SOCIAL ANXIETY,"February 08, 2021",25,NCT04450303,TELEHEALTH CBT,,Not yet recruiting,Stanford University,"October 30, 2020",Interventional,Social Anxiety Telehealth Therapy Study
2564,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",184,NCT04451174,PREDNISONE,CHILE,Recruiting,University of Chile,"June 23, 2020",Interventional,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia (PREDCOVID)
2565,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,KERATONJUNCTIVITIS,"February 08, 2021",12,NCT04451239,TOPICAL STEROIDS AND CYCLOSPORIN-A,KUWAIT,Not yet recruiting,Ameera Gamal Abdelhameed,"June 30, 2020",Interventional,Combined Topical Corticosteroid and Topical Cyclosporine-A for Management of COVID-19 Keratoconjunctivitis; a Pilot Study
2566,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",20,NCT04451291,DECIDUAL STROMAL CELLS (DSC),CANADA,Not yet recruiting,"University Health Network, Toronto","August 24, 2020",Interventional,DSC-COVID-19: An Open-label Study on the Safety and Efficacy of Decidual Stromal Cells in Respiratory Failure Induced by COVID-19
2567,Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients,PHYSICAL ACTIVITY; COVID,"February 08, 2021",600,NCT04451317,"QUESTIONNAIRE, PHONE CALL",FRANCE,Recruiting,"University Hospital, Toulouse","June 12, 2020",Observational,"Changes in Physical and Sports Activity, Anxiety and Sleep Patterns Following the Containment Period Imposed by the COVID-19 Pandemic in Patients With Chronic Medical Conditions and in Healthy Athletes."
2568,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection",COVID,"February 08, 2021",5000,NCT04451577,NO INTERVENTION,ITALY,Recruiting,Istituto Clinico Humanitas,"June 1, 2020",Observational,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection: a Retrospective-prospective Cohort Study"
2569,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19,COVID,"February 08, 2021",800,NCT04451694,NUTRITIONAL INTERVENTION,FRANCE,Recruiting,"Central Hospital, Nancy, France","April 1, 2020",Observational,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19
2570,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,COVID,"February 08, 2021",15,NCT04451889,MINIPROBE ALVEOFLEX,RUSSIAN FEDERATION,Recruiting,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","August 1, 2020",Interventional,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients
2571,COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic,RARE DISEASES,"February 08, 2021",80,NCT04451902,,,Not yet recruiting,Imagine Institute,"June 30, 2020",Observational [Patient Registry],COVID-19 and Rare Skin Diseases. European Observational Study (Data Research) During an Epidemic
2572,Physical Activity Level in Patients With OSAS During Covid-19 Pandemic,OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME,"February 08, 2021",63,NCT04451993,,TURKEY,Completed,Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital,"June 25, 2020",Observational,"Are the Sleep Quality and Physical Activity Levels of Osas Patients Differently From Healthy People During the COVID-19 Pandemic:a Prospective, Descriptive Study"
2573,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,COVID; ARDS; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",39,NCT04452097,HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS + BEST SUPPORTIVE CARE; PLACEBO CONTROL + BEST SUPPORTIVE CARE,,Not yet recruiting,Baylx Inc.,"March 1, 2021",Interventional,A Phase 1/2a Study of the Safety and Efficacy of BX-U001 for the Treatment of Severe COVID-19 Pneumonia With Moderate to Severe Acute Respiratory Distress Syndrome (ARDS).
2574,COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,HEALTHY PARTICIPANTS,"February 08, 2021",2450,NCT04452318,REGN10933 + REGN10987; PLACEBO,"MOLDOVA, REPUBLIC OF",Recruiting,Regeneron Pharmaceuticals,"July 13, 2020",Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-CoV-2 Infection in Household Contacts of Individuals Infected With SARS-CoV-2"
2575,Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology,DEEP VENOUS THROMBOSIS,"February 08, 2021",30,NCT04452422,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","June 23, 2020",Observational,High Prevalence of Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology
2576,Safety and Efficacy of C21 in Subjects With COVID-19,COVID,"February 08, 2021",106,NCT04452435,C21; PLACEBO,INDIA,Completed,Vicore Pharma AB,"July 21, 2020",Interventional,"A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial Investigating the Safety and Efficacy of C21 in Hospitalised Subjects With COVID-19 Infection Not Requiring Mechanical Ventilation"
2577,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,COVID,"February 08, 2021",376,NCT04452474,OLOKIZUMAB 64 MG; PLACEBO,UNITED STATES,Not yet recruiting,R-Pharm,"June 30, 2020",Interventional,"A Multicenter, Randomized, Double-blind, Adaptive, Placebo-controlled Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe SARS-CoV-2 Infection (COVID-19)"
2578,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT),PATIENT HOSPITALIZED IN DISEASE INFECTIOUS UNIT; PATIENT HOSPITALIZED IN INTENSIVE REANIMATION UNIT; PATIENT HOPSITALIZED IN INTERNAL MEDICINE UNIT,"February 08, 2021",2500,NCT04452487,DECISIONS OF LIMITATIONS AND STOP PROCESSING,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 1, 2020",Observational,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments
2579,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection",CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",525,NCT04452565,DRUG: NA-831; NA-831 AND ATAZANAVIR; NA-831AND DEXAMETHASONE; ATAZANAVIR AND DEXAMETHASONE,UNITED STATES,Recruiting,"NeuroActiva, Inc.","October 15, 2020",Interventional,"Randomized Controlled Phase 2/3 Clinical Trial of NA-831 Alone or With Atazanavir, or NA-831 With Dexamethasone, or Atazanavir With Dexamethasone in the Treatment of COVID-19 Infection"
2580,Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19,ACUTE MYELOBLASTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; SARS-CoV2,"February 08, 2021",30,NCT04452604,,,Not yet recruiting,French Innovative Leukemia Organisation,"August 1, 2020",Observational,National Retrospective Monitoring of Patients With Acute Leukemia Infected by COronaVirus Disease 2019 (COVID-19)
2581,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19,COVID,"February 08, 2021",40,NCT04452617,,FRANCE,Completed,Institut Mutualiste Montsouris,"March 19, 2020",Observational,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19
2582,Cardiovascular Consequences After COVID-19,CARDIOVASCULAR CONSEQUENCES AFTER AN EPISODE OF COVID,"February 08, 2021",200,NCT04452630,INFECTIOUS DISEASE AND CARDIOLOGY CLINICAL CONSULTATIONS,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"June 23, 2020",Observational,The CardioPostCovid Study: Cardiovascular Consequences After COVID-19
2583,Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel,COVID,"February 08, 2021",0,NCT04452643,BACMUNE (MV130); PLACEBO,MEXICO,Withdrawn,Inmunotek S.L.,October 2020,Interventional,"Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to SARS-CoV-2 Infection in Healthcare Personnel"
2584,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,COVID,"February 08, 2021",20,NCT04452669,VENTAPROST (INHALED EPOPROSTENOL DELIVERED VIA A DEDICATED DELIVERY SYSTEM),UNITED STATES,Recruiting,Aerogen Pharma Limited,"September 15, 2020",Interventional,"Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of VentaProst (Inhaled Epoprostenol Delivered Via Dedicated Delivery System) in Subjects With COVID-19 Requiring Mechanical Ventilation"
2585,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,COVID; CRITICAL LIMB ISCHEMIA,"February 08, 2021",998,NCT04452682,COVID 19 IMPACT,EGYPT,Completed,Mansoura University,"May 25, 2020",Observational,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice
2586,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19,COVID; TELEMEDICINE; ROBOTICS; EMERGENCIES; EMERGING INFECTIOUS DISEASE,"February 08, 2021",40,NCT04452695,DOCTOR SPOT,UNITED STATES,Completed,Brigham and Women's Hospital,"March 10, 2020",Observational,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19
2587,HFNC and NIV for COVID-19 Complicated by Respiratory Failure,RESPIRATORY FAILURE,"February 08, 2021",15,NCT04452708,HFNC,HONG KONG,Recruiting,Chinese University of Hong Kong,"June 11, 2020",Observational,The Safety of High Flow Nasal Cannula and Noninvasive Ventilation for Treatment of Patients With COVID-19 Complicated by Respiratory Failure
2588,Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,COVID,"February 08, 2021",315,NCT04452773,MANREMYC; PLACEBO,SPAIN,Recruiting,Reig Jofre Group,"July 14, 2020",Interventional,"Double-blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of the Manremyc® Food Supplement to Prevent SARS-CoV-2 Infection"
2589,Hesperidin and Diosmin for Treatment of COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04452799,HESPERIDIN AND DIOSMIN MIXTURE,,Not yet recruiting,Tanta University,"July 1, 2020",Interventional,Randomized Double-blind Controlled Parallel Study of (Hesperidin and Diosmin Mixture) for Treatment of COVID-19 Newly Diagnosed Patients in Egypt
2590,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,COVID PNEUMONIA; CONVALESCENT PLASMA,"February 08, 2021",15,NCT04452812,CONVALESCENT PLASMA,MEXICO,Not yet recruiting,Universidad Autonoma de Coahuila,"July 6, 2020",Interventional,"Pilot Clinical, Statistical and Epidemiological Study on Efficacy and Safety of Convalescent Plasma for the Management of Patients With COVID-19"
2591,Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19),COVID,"February 08, 2021",30,NCT04452942,,UNITED STATES,Not yet recruiting,EicOsis Human Health Inc.,July 2020,Observational,Dynamic Changes in Cytokine and Eicosanoid Mediators Among Hospitalized Patients With Coronavirus Infectious Disease 2019 (COVID-19)
2592,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity),COVID; SARS-CoV2,"February 08, 2021",695,NCT04453280,QUANTITATIVE ANALYSIS OF ANTI-SARS-COV-2-ANTIBODIES; SARS-COV-2 DIAGNOSTIC RAPID TEST,CZECHIA,Completed,Institute of Health Information and Statistics of the Czech Republic,"May 18, 2020",Observational,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
2593,Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19),ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",50,NCT04453371,TISSUE PLASMINOGEN ACTIVATOR; RINGER SOLUTION,,Not yet recruiting,Negovsky Reanimatology Research Institute,"October 15, 2020",Interventional,Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (Microvascular COVID-19 Lung Vessels Obstructive Thromboinflammatory Syndrome (MicroCLOTS): A Multicentral Randomized Trial (AtTAC-trial)
2594,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,SARS VIRUS,"February 08, 2021",414,NCT04453384,XAV-19; PLACEBO,FRANCE,Recruiting,Nantes University Hospital,"September 1, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 2 (2a and 2b) Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia"
2595,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,"PSYCHOSOMATIC DISORDER; PARKINSON; PSYCHOLOGICAL DISTRESS; PSYCHOLOGICAL STRESS; PSYCHOLOGICAL DISEASE; PSYCHOLOGICAL DISORDER; PSYCHOLOGICAL IMPAIRMENT; PSYCHOLOGICAL DISABILITY; PSYCHOLOGICAL ADJUSTMENT; PSYCHOLOGICAL ADAPTATION; COMMUNICATION; HEALTH CARE SEEKING BEHAVIOR; ANXIETY; BEHAVIOR, HEALTH; HEALTH RISK BEHAVIORS; HEALTHY LIFESTYLE","February 08, 2021",1230,NCT04453475,TRAINING SESSION ADRESSING INFORMATION AND HEALTH LITERACY,GERMANY,Recruiting,Jacobs University Bremen gGmbH,"July 1, 2020",Interventional,Therapies to Achieve Treatment Goals While Being Exposed to Hygiene and Distance Rules: Feasibility and Benefits of Digital Services During the COVID19 Pandemic (Anhand-COVID19)
2596,Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,COVID; SARS-CoV2,"February 08, 2021",315,NCT04453488,RUTI® VACCINE; PLACEBO,SPAIN,Not yet recruiting,Fundació Institut Germans Trias i Pujol,"July 30, 2020",Interventional,"Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of the RUTI® Vaccine to Prevent SARS-CoV-2 Infection"
2597,Anti Infective Agents Impact in COVID-19 Pneumonia,"COVID; PNEUMONIA, VIRAL","February 08, 2021",132,NCT04453501,FAVORABLE OUTCOME,FRANCE,Completed,Centre d'Investigation Clinique et Technologique 805,"March 2, 2020",Observational,Interest of Azithromycin With or Without Hydroxychloroquine for the Treatment of COVID-19 Pneumonia : a Retrospective Observational Study
2598,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,ANXIETY,"February 08, 2021",200,NCT04453514,TRAUMA-INFORMED YOGA VIDEO RECORDING,UNITED STATES,Recruiting,National University of Natural Medicine,"July 21, 2020",Interventional,Cultivating Calm During COVID-19: A Feasibility Study of Video-based Trauma-informed Yoga
2599,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19,CORONAVIRUS,"February 08, 2021",100,NCT04453527,,UNITED KINGDOM,Recruiting,Portsmouth Hospitals NHS Trust,"May 28, 2020",Observational,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Coronavirus Disease 2019
2600,FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context,INFECTIOUS DISEASE; PNEUMONIA; MOLECULAR DIAGNOSIS; COVID; ANTIBIOTIC STEWARDSHIP,"February 08, 2021",150,NCT04453540,FILMARRAY PCR ON RESPIRATORY SAMPLES,,Not yet recruiting,"Central Hospital, Nancy, France","July 1, 2020",Observational,Impact of the Syndromic PCR System FilmArray on Management of ICU Patients With Severe Pulmonary Disease in the Context of the Covid-19 Pandemic.
2601,CICERO- A Care Home Study of COVID-19,COVID,"February 08, 2021",50,NCT04453553,Q16 TESTING; NASOPHARYNGEAL SWAB AND MAIN LABORATORY,UNITED KINGDOM,Not yet recruiting,Queen Mary University of London,"July 2, 2020",Interventional,COVID-19 in Vitro Diagnostic Near-patient Testing in Care Environments Using a Cluster Randomised Open-label Trial Design in an East London Care Home Population
2602,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.",COVID; LIFE SATISFACTION; ANXIETY; MENTAL HEALTH WELLNESS 1; ATHLETE; STRESS,"February 08, 2021",120,NCT04453566,ONLINE SURVEY,TURKEY,Recruiting,Uskudar University,"May 27, 2020",Observational,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes."
2603,"Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health",OBESE; MORBID OBESITY,"February 08, 2021",116,NCT04453579,TELEPHONIC INTERVIEW DURING THE ITALIAN LOCKDOWN.,ITALY,Completed,University of Rome Tor Vergata,"March 9, 2020",Observational [Patient Registry],Was it Right to Stop Bariatric Surgery During COVID-19 Lockdown?
2604,"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19","STRESS, PSYCHOLOGICAL; CHILD BEHAVIOR; SOCIAL COMPETENCE","February 08, 2021",270,NCT04453657,FAMILYCHILDCARE (PROVISIONAL NAME OF APP),UNITED STATES,Enrolling by invitation,Johns Hopkins University,"February 4, 2021",Interventional,"Adapting and Delivering a Tele-Wellness Supported Digital Toolkit to Baltimore City's Approved Family Child Care Home Providers Caring for Children of Essential Workers: Promoting Health, Early Literacy, and Quality Parent Engagement Amid COVID-19: A Pilot Study"
2605,Neuropathology in Adults Intensive Care Unit Patients With COVID 19,COVID,"February 08, 2021",7,NCT04453670,AUTOPSY,FRANCE,Completed,University of Versailles,"March 10, 2020",Observational,A Prospective Observational Autopsy Study of Neuropathology in Adults Intensive Care Unit Patients With COVID 19
2606,"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications",COVID; CORONAVIRUS INFECTION; SARS-CoV2; COMPLICATIONS,"February 08, 2021",200,NCT04453748,COMPLEX DIAGNOSTIC PANEL,POLAND,Enrolling by invitation,Silesian Centre for Heart Diseases,"June 8, 2020",Observational [Patient Registry],"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications"
2607,At Home Monitoring for Patients With Covid19,CORONAVIRUS,"February 08, 2021",1000,NCT04453774,COVIDFREE@HOME,CANADA,Not yet recruiting,"University Health Network, Toronto","October 16, 2020",Interventional,Covidfree@Home: At Home Monitoring Using Mobile Devices for Patients With Covid19
2608,RLF-100 (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE),CRITICAL COVID WITH RESPIRATORY FAILURE,"February 08, 2021",,NCT04453839,RLF-100 (AVIPTADIL),UNITED STATES,Available,"NeuroRx, Inc.",,Expanded Access,RLF-100 (Aviptadil) Intermediate Population Expanded Access Protocol
2609,Monovalent Recombinant COVID19 Vaccine,CORONAVIRUS INFECTION; COVID,"February 08, 2021",40,NCT04453852,COVID19 VACCINE; SALINE,AUSTRALIA,Recruiting,Vaxine Pty Ltd,"June 30, 2020",Interventional,"A Randomised, Controlled, Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Adjuvanted Recombinant Protein SARS-COV-2 Vaccine in Healthy Adult Subjects"
2610,Hexoskin Feasibility Study With COVID-19 Patients,COVID,"February 08, 2021",16,NCT04453891,MONITORING PHYSIOLOGICAL DATA WITH THE HEXOSKIN SMART SHIRT,,Not yet recruiting,Nguyen Thu Ngan Trinh,"July 15, 2020",Observational,"Evaluating the Feasibility of Monitoring Symptomatic COVID-19 Patients, and Predicting Disease Progression Using a Validated Digital Health Program"
2611,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,SARS-CoV2; BREASTMILK,"February 08, 2021",50,NCT04453969,COVID-19,CANADA,Recruiting,Deborah O'Connor,"May 24, 2020",Observational,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a
2612,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b,SARS-CoV2; BREASTMILK,"February 08, 2021",500,NCT04453982,HUMAN MILK DONORS,CANADA,Recruiting,Deborah O'Connor,"June 21, 2020",Observational,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b
2613,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,COVID,"February 08, 2021",100,NCT04454307,TRAMADOL; STANDARD CARE DELIVERED IN THE ISOLATION HOSPITALS.,,Not yet recruiting,Tanta University,July 2020,Interventional,Safety and Efficacy of Tramadol Adjuvant Therapy to Standard Care for COVID-19 Egyptian Patients: A Randomized Double Blind Controlled Clinical Trial
2614,COVID-19 in Pain Perspective,INFECTION; COVID; PAIN,"February 08, 2021",466,NCT04454333,,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"June 3, 2020",Observational,COVID-19 in Pain Perspective
2615,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19),COVID,"February 08, 2021",187,NCT04454372,DEMOGRAPHIC AND CLINICAL DATA OBTAINED FROM HOSPITAL'S ELECTRONIC MEDICAL RECORD.,,Not yet recruiting,Hospital Sao Domingos,"July 15, 2020",Observational,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With COVID-19
2616,Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19,COVID,"February 08, 2021",0,NCT04454398,COVI-GUARD; STANDARD OF CARE; PLACEBO,,Withdrawn,"Sorrento Therapeutics, Inc.",September 2020,Interventional,"A Randomized, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of a Single Dose of STI-1499 (COVI-GUARD™) in Hospitalized Patients With Moderate COVID-19"
2617,The New Silicone N99 Half-Piece Respirator,COVID; PERSONAL PROTECTIVE EQUIPMENT,"February 08, 2021",43,NCT04454606,FIT TEST; FILTRATION TEST,THAILAND,Completed,Bangkok Metropolitan Administration Medical College and Vajira Hospital,"May 1, 2020",Interventional,The New Silicone N99 Half-Piece Respirator:VJR-NMU N99:New and Effective Tool to Prevent COVID-19
2618,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,COVID,"February 08, 2021",1180,NCT04455243,N-ACETYL CYSTEINE; PLACEBO,,Not yet recruiting,Dr. Tariq Alhawassi,"August 1, 2020",Interventional,Pilot Double Blinded Randomized Placebo Controlled Multi Central Clinical Trial on Inflammatory Regulation Effect of NAC on COVID-19
2619,COVID-19 and Chilblains,CHILBLAINS; COVID,"February 08, 2021",269,NCT04455308,BIOLOGICAL SAMPLE COLLECTION,FRANCE,Completed,Rennes University Hospital,"July 21, 2020",Interventional,"Chilblains, COVID-19 and Lockdown: Epidemiologic Study"
2620,Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked,COVID INFECTION,"February 08, 2021",80,NCT04455347,,FRANCE,Recruiting,Imagine Institute,"June 15, 2020",Observational [Patient Registry],Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked
2621,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,POST TRAUMATIC STRESS DISORDER; INTENSIVE CARE PSYCHIATRIC DISORDER; ANXIETY DISORDERS; DEPRESSION; CRITICAL CARE; COVID,"February 08, 2021",26,NCT04455360,EYE MOVEMENT DESENSITISATION AND REPROCESSING RECENT TRAUMATIC EVENT PROTOCOL,UNITED KINGDOM,Recruiting,University Hospital Southampton NHS Foundation Trust,"October 1, 2020",Interventional,EMERALD: Can a Virtual Eye Movement Desensitisation and Reprocessing Intervention Improve Psychological Outcome Following Covid-19 Related Critical Illness: A Feasibility Trial
2622,Intensive Care Therapy of Covid-19 Disease in Germany,COVID; ARDS,"February 08, 2021",2000,NCT04455451,,GERMANY,Recruiting,University Hospital Tuebingen,"August 6, 2020",Observational,Intensive Care Therapy of Covid-19 Disease in Germany an Multi-center Observational Study
2623,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home,COVID INFECTION,"February 08, 2021",389,NCT04455815,CAMOSTAT,UNITED KINGDOM,Recruiting,Cancer Research UK,"September 25, 2020",Interventional,"A Randomised Phase II/III Trial in a Community Setting, Assessing Use of Camostat in Reducing the Clinical Progression of COVID-19 by Blocking SARS-CoV-2 Spike Protein-initiated Membrane Fusion"
2624,Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year,HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",75,NCT04455958,LOPINAVIR/RITONAVIR; PLACEBO ADMINISTRATION; QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Not yet recruiting,OHSU Knight Cancer Institute,"November 1, 2020",Interventional,"A Double-Blind, Randomized, Placebo-Controlled Phase II Study of Lopinavir/Ritonavir Versus Placebo in COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year"
2625,COVID-19 in ART: Perception and Experience,COVID; FERTILITY ISSUES; ART,"February 08, 2021",600,NCT04456010,QUESTIONNAIRE,FRANCE,Completed,"University Hospital, Montpellier","June 1, 2020",Observational,Assessing the Perception and the Personal Experience of the COVID19 Pandemic Among Infertile Couples Undergoing Assisted Reproductive Treatment (ART)
2626,Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care,COVID,"February 08, 2021",100,NCT04456036,,ITALY,Recruiting,Università Politecnica delle Marche,"July 1, 2020",Observational [Patient Registry],"Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care: Study of Functional Evolution, Predictors of Activities and Participation Recovery After Severe Covid-19 and Rehabilitation Role"
2627,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,COVID INFECTION,"February 08, 2021",90,NCT04456049,ENZALUTAMIDE,SWITZERLAND,Not yet recruiting,Ricardo Pereira Mestre,July 2020,Interventional,COVID_ENZA Trial: Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1
2628,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,PSYCHIATRIC HOSPITALIZATION,"February 08, 2021",150,NCT04456062,CARING CONTACTS,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"August 4, 2020",Interventional,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic
2629,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19,SARS-CoV2; COVID,"February 08, 2021",100,NCT04456075,,GERMANY,Recruiting,Heidelberg University,"April 1, 2020",Observational,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19
2630,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial),"COVID; SARS-CoV2; RESPIRATORY DISEASE; PNEUMONIA, VIRAL; CORONAVIRUS INFECTION","February 08, 2021",0,NCT04456088,150 PPM NITRIC OXIDE DELIVERED THROUGH LUNGFIT DELIVERY SYSTEM; 80 PPM NITRIC OXIDE DELIVERED THROUGH LUNGFIT DELIVERY SYSTEM,,Withdrawn,Beyond Air Inc.,"July 15, 2020",Interventional,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2
2631,"Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients",COVID,"February 08, 2021",240,NCT04456101,,CHINA,Recruiting,"Wuhan Union Hospital, China","June 19, 2020",Observational,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"
2632,Atovaquone for Treatment of COVID-19,COVID,"February 08, 2021",60,NCT04456153,EXPERIMENTAL GROUP; PLACEBO GROUP,UNITED STATES,Recruiting,University of Texas Southwestern Medical Center,"July 22, 2020",Interventional,Atovaquone for Treatment of COVID-19
2633,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,"ARDS, HUMAN; COVID","February 08, 2021",9,NCT04456361,MESENCHYMAL STEM CELLS DERIVED FROM WHARTON JELLY OF UMBILICAL CORDS,MEXICO,"Active, not recruiting",Instituto de Medicina Regenerativa,"April 16, 2020",Interventional,A Study of Mesenchymal Stem Cells as a Treatment in Patients With Acute Respiratory Distress Syndrome Caused by COVID-19
2634,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,COVID,"February 08, 2021",306,NCT04456413,CONVALESCENT PLASMA; BEST SUPPORTIVE CARE,UNITED STATES,Recruiting,Hackensack Meridian Health,"November 6, 2020",Interventional,Phase II Randomized Study of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Subjects With Early COVID-19 Infection
2635,"Characteristics of Patients and Healthcare Workers With COVID-19 in Meta State, Colombia",COVID; SARS-CoV2; SARS PNEUMONIA; SARS (DISEASE); SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",250,NCT04456426,,,Not yet recruiting,Hospital Departamental de Villavicencio,July 2020,Observational,"Evaluation of the Characteristics of Patients and Healthcare Workers With Suspected or Confirmed of COVID-19 in Villavicencio and Meta State, Colombia"
2636,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) ASSOCIATED WITH CORONAVIRUS DISEASE (COVID),"February 08, 2021",,NCT04456439,REMESTEMCEL-L; HYDROCORTISONE; DIPHENHYDRAMINE,,Available,Mesoblast International Sàrl,,Expanded Access,"Intermediate-size Expanded Access of Remestemcel-L, Human Mesenchymal Stromal Cells, for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)"
2637,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,COVID,"February 08, 2021",10,NCT04456452,AMPION; STANDARD OF CARE,UNITED STATES,Completed,Ampio Pharmaceuticals. Inc.,"July 27, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Safety of Intravenous Ampion™ in Adult COVID-19 Patients Requiring Oxygen Supplementation
2638,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19),ENDOPHTHALMITIS AND ORBITAL CELLULITIS,"February 08, 2021",5,NCT04456556,,EGYPT,Completed,Minia University,"April 27, 2020",Observational,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
2639,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,COVID,"February 08, 2021",13060,NCT04456595,ADSORBED COVID-19 (INACTIVATED) VACCINE; PLACEBO,BRAZIL,Recruiting,Butantan Institute,"July 21, 2020",Interventional,"Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety in Healthcare Professionals of the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac"
2640,Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study,COLON CANCER,"February 08, 2021",148,NCT04456933,EXTRACORPOREAL LEFT HEMICOLECTOMY ANASTOMOSIS; INTRACORPOREAL LEFT HEMICOLECTOMY ANASTOMOSIS,SPAIN,Recruiting,Corporacion Parc Tauli,"June 29, 2020",Observational,RESECTION AND INTRACORPOREAL ANASTOMOSIS IN LAPAROSCOPIC LEFT COLECTOMY AS AN ADAPTATION TO THE PANDEMIC CAUSED BY SARS-CoV-2 (COVID19). A COMPARATIVE COHORT STUDY
2641,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,COVID,"February 08, 2021",10,NCT04457349,THERAPEUTIC PLASMA EXCHANGE (TPE),EGYPT,Recruiting,Alexandria University,"July 25, 2020",Interventional,Does Therapeutic Plasma Exchange Have A Role in Resistant Cytokine Storm State Of COVID-19 Infection?
2642,Tele-Yoga Therapy for Chronic Pain,CHRONIC PAIN,"February 08, 2021",18,NCT04457388,TELE-YOGA THERAPY,UNITED KINGDOM,Completed,Aarogyam UK,"March 25, 2020",Interventional,Tele- Yoga Therapy for Patients With Chronic Pain During Covid-19 Lockdown: A Prospective Non-randomized Single Arm Clinical Trial
2643,One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19,ACUTE RESPIRATORY DISTRESS SYNDROME; SEVERE PNEUMONIA; RESPIRATORY FAILURE,"February 08, 2021",5000,NCT04457505,,SPAIN,Recruiting,"Consorcio Centro de Investigación Biomédica en Red, M.P.","May 8, 2020",Observational [Patient Registry],"Risk Factors, Personalized Prognoses and 1-year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19"
2644,Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer,"COVID, CANCER","February 08, 2021",600,NCT04457570,MORTALITY,FRANCE,Recruiting,Hospices Civils de Lyon,"June 15, 2020",Observational,ONCOVID-AURA: Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer
2645,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,COVID; PULMONARY INFECTION; SARS-CoV2,"February 08, 2021",40,NCT04457609,OSELTAMIVIR; AZITHROMYCIN; UMBILICAL CORD MESENCHYMAL STEM CELLS,INDONESIA,Recruiting,Indonesia University,July 2020,Interventional,Application of Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy for Critically-Ill COVID-19 Patients
2646,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,COVID,"February 08, 2021",18,NCT04457726,SARS-COV-2 SPECIFIC T CELLS,SINGAPORE,Recruiting,KK Women's and Children's Hospital,"July 1, 2020",Interventional,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19
2647,Betadine Effect on Nasal Mucosa Cilia,RHINOPLASTY,"February 08, 2021",30,NCT04457765,POVIDONE-IODINE (PVP-I),UNITED STATES,Not yet recruiting,Boston Medical Center,April 2021,Interventional,Povidine-Iodine Effect on Nasal Mucosa Cilia in Rhinoplasty Patients
2648,Compensatory Reserve Index (CRI) for Management of COVID-19,COVID,"February 08, 2021",100,NCT04457817,CRI MANAGEMENT,UNITED STATES,Enrolling by invitation,"University of Colorado, Denver","December 1, 2020",Interventional,CRI and Continuous Assessment of Hemodynamic Compensation to Guide Fluid and Pressor Management in Severely Ill Patients With COVID-19
2649,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,CHRONIC DISEASE; CHRONIC DISEASES IN ADOLESCENCE; CHRONIC DISEASE OF IMMUNE SYSTEM; CHRONIC KIDNEY DISEASES,"February 08, 2021",140,NCT04458246,EXERCISE TRAINING GROUP,BRAZIL,Recruiting,University of Sao Paulo,July 2020,Interventional,"Online, Home-based, Aerobic Training Program Among Adolescents With Chronic Diseases During COVID-19 Pandemic: A Randomized Controlled Trial"
2650,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,COVID,"February 08, 2021",24,NCT04458298,OP-101; PLACEBO,UNITED STATES,Recruiting,"Orpheris, Inc.","July 1, 2020",Interventional,"A Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of OP-101 (Dendrimer N-acetyl-cysteine) in Patients With Severe COVID-19"
2651,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19),"COVID; SARS-CoV2; SURGERY; SURGICAL PROCEDURE; COMPLICATIONS, LATE EFFECT OF COMPLICATIONS; POSTOPERATIVE COMPLICATIONS","February 08, 2021",120,NCT04458337,,CANADA,Recruiting,Centre hospitalier de l'Université de Montréal (CHUM),"March 13, 2020",Observational,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study
2652,Convalescent Plasma in Pediatric COVID-19,COVID,"February 08, 2021",3,NCT04458363,CONVALESCENT PLASMA (CP); STANDARD COVID-19 THERAPIES,UNITED STATES,Completed,Emory University,"July 4, 2020",Interventional,Convalescent Plasma to Optimize Treatment of COVID-19 Disease in Pediatric Patients: A Feasibility Study
2653,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,COVID INFECTION,"February 08, 2021",40,NCT04458519,PROBIORINSE; SALINE SOLUTION,CANADA,Recruiting,Centre hospitalier de l'Université de Montréal (CHUM),"July 16, 2020",Interventional,Randomised Single Blinded Clinical Study of Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection
2654,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,COVID,"February 08, 2021",10000,NCT04458948,HYDROXYCHLOROQUINE; AZITHROMYCIN,UNITED STATES,"Active, not recruiting",University of New Mexico,"March 24, 2020",Interventional,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients With Moderate or Severe COVID-19 Infection
2655,"Short Term, High Dose Vitamin D Supplementation for COVID-19",COVID,"February 08, 2021",30,NCT04459247,VIT D,INDIA,"Active, not recruiting",Postgraduate Institute of Medical Education and Research,"June 15, 2020",Interventional,"Short Term, High Dose Vitamin D Supplementation for COVID-19 Disease: Double Blind, Controlled, Study"
2656,The Nitazoxanide Plus Atazanavir for COVID-19 Study,COVID,"February 08, 2021",98,NCT04459286,NITAZOXANIDE AND ATAZANAVIR/RITONAVIR; STANDARD OF CARE,NIGERIA,Recruiting,Obafemi Awolowo University,"October 9, 2020",Interventional,"A Randomized, Open Label Trial to Investigate the Efficacy and Safety of Nitazoxanide Plus Atazanavir/Ritonavir for the Treatment of COVID-19: a Pilot Study"
2657,National Covid-19 Surveillance Physicians,ANTIBODY COVID,"February 08, 2021",600,NCT04459312,ANTIBODY TEST (SARS-COV2),GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","June 1, 2020",Observational,National Covid-Surveillance Physicians
2658,Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,COVID; CORONAVIRUS DISEASE 2019,"February 08, 2021",100,NCT04459325,TIGERASE® AND BEST AVAILABLE CARE; BEST AVAILABLE CARE,RUSSIAN FEDERATION,Completed,AO GENERIUM,"June 1, 2020",Interventional,A Prospective Open-label Study of the Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19
2659,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs,CORONAVIRUS; CORONAVIRUS INFECTION; COVID; 2019NCOV; 2019 NOVEL CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04459351,,UNITED KINGDOM,Recruiting,Chelsea and Westminster NHS Foundation Trust,"June 19, 2020",Observational,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs
2660,The Prevalence of Pulmonary Hypertension in Patients With COVID-19.,"HYPERTENSION, PULMONARY; RIGHT VENTRICULAR OVERLOAD; COVID","February 08, 2021",67,NCT04459364,,SWEDEN,Completed,Attgeno AB,"June 1, 2020",Observational [Patient Registry],"The Prevalence of Pulmonary Hypertension, With or Without Right Ventricular Loading, in Patients With COVID-19 Who Are Being Treated With a Respirator in the Intensive Care Unit."
2661,Association of Comorbidities With COVID19,COVID,"February 08, 2021",100,NCT04459390,REALTIME PCR,EGYPT,Recruiting,Assiut University,"July 20, 2020",Observational,Impact of Comorbidities on COVID19 Outcome
2662,Psychiatric Disturbances and COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04459403,,EGYPT,Completed,Cairo University,"June 8, 2020",Observational,Psychiatric Disturbances in Patients Infected With COVID-19: A Cross Sectional Study
2663,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",ANXIETY,"February 08, 2021",500,NCT04459455,CONTAIN COVID ANXIETY SSI; REMAIN COVID FREE SSI,UNITED STATES,Completed,Stony Brook University,"August 19, 2020",Interventional,"Project HF-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic"
2664,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,COVID,"February 08, 2021",1400,NCT04459520,POSITIVE COVID TEST RESULT - HYPOTHETICAL SCENARIO; NEGATIVE COVID TEST RESULT - HYPOTHETICAL SCENARIO; UNAVAILABLE COVID TEST RESULT - HYPOTHETICAL SCENARIO,UNITED STATES,Completed,"University of California, Los Angeles","July 23, 2020",Interventional,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance
2665,Sparing in Neuromuscular Blockade in COVID 19 ICU,NEUROMUSCULAR BLOCKADE; HUMAN CHARACTERISTICS; COMPLICATION OF MEDICAL CARE; INTENSIVE CARE UNIT ACQUIRED WEAKNESS,"February 08, 2021",250,NCT04459533,TOF PROTOCOL,FRANCE,Completed,Hospices Civils de Lyon,"June 1, 2020",Observational,The Use of Neuromuscular Blockade Monitor as a Strategy for Neuromuscular Blockade Agents Saving in ICU COVID-19 Patients
2666,COVID-19 Surveillance Based on Smart Wearable Device,COVID,"February 08, 2021",200,NCT04459637,,CHINA,Not yet recruiting,Peking University First Hospital,"July 1, 2020",Observational [Patient Registry],Surveillance of COVID-19 Using Smart Wearable Devices: a Prospective Study
2667,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,COVID; PNEUMONIA,"February 08, 2021",100,NCT04459676,STANDARD OF CARE (SOC) + ANG-3777; STANDARD OF CARE (SOC) + PLACEBO,BRAZIL,Recruiting,Angion Biomedica Corp,"July 31, 2020",Interventional,"A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess Safety and Efficacy of ANG- 3777 in Patients Hospitalized With Confirmed COVID-19 Pneumonia"
2668,COVID-19 in PID Survey,PRIMARY IMMUNE DEFICIENCY; COVID,"February 08, 2021",200,NCT04459689,,FRANCE,Recruiting,Imagine Institute,"March 15, 2020",Observational [Patient Registry],Worldwide COVID-19 in Children and Adult Patients With Primary ImmunoDeficiencies (PID) Survey
2669,A Study of Combination Therapies to Treat COVID-19 Infection,COVID; COVID; CORONAVIRUS INFECTION; CORONAVIRUS INFECTION; CORONAVIRUS SARS-ASSOCIATED AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE; CORONAVIRUS-19; SARS-CoV2; SARS PNEUMONIA,"February 08, 2021",200,NCT04459702,HYDROXYCHLOROQUINE; AZITHROMYCIN; RITONAVIR; LOPINAVIR,UNITED STATES,Not yet recruiting,ProgenaBiome,July 2020,Interventional,"A Phase IIa Randomized, Controlled Study of Combination Therapies to Treat COVID-19 Infection"
2670,Respiratory Physiotherapy in Severe COVID-19 Patients,COVID,"February 08, 2021",80,NCT04459819,RESPIRATORY PHYSIOTHERAPY,ITALY,Recruiting,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","March 1, 2020",Observational,"Monocentric, Observational, Retrospective Study on Respiratory Physiotherapy in Severe COVID-19 Patients: the FTR-COVID Study."
2671,Covid-19 Breath Test,COVID INFECTION,"February 08, 2021",330,NCT04459962,BREATH TEST & CHEEK SWAB,UNITED KINGDOM,Completed,Ancon Technologies Ltd,"June 29, 2020",Interventional,Breath Test Feasibility Trial for Covid-19 Infection Diagnosis
2672,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units,ON OCCURRENCE OF ACURATE KIDNEY INJURY DURING INTENSIVE CARE UNIT; ABNORMALITIES OF URINARY ANALYSIS,"February 08, 2021",200,NCT04459975,NON INTERVENTIONAL STUDY,FRANCE,Recruiting,Hospices Civils de Lyon,"April 1, 2020",Observational,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units
2673,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,INTRUSIVE MEMORIES OF TRAUMATIC EVENT(S); POST TRAUMATIC STRESS DISORDER,"February 08, 2021",164,NCT04460014,SIMPLE COGNITIVE TASK INTERVENTION; ATTENTION PLACEBO,SWEDEN,Recruiting,Karolinska Institutet,"September 30, 2020",Interventional,"Reducing Intrusive Memories After Trauma Via a Simple Cognitive Intervention During COVID-19 in Hospital Staff: ""EKUT-P"" (Enkel Kognitiv Uppgift Efter Trauma Under COVID-19 - sjukvårdspersonal) - A Randomized Controlled Trial (RCT)"
2674,W-SUDs for COVID-19,SUBSTANCE USE DISORDERS; ALCOHOL USE DISORDER,"February 08, 2021",180,NCT04460027,WOEBOT SUBSTANCE USE DISORDER,UNITED STATES,Completed,Athena Robinson,"June 22, 2020",Interventional,Woebot for Substance Use Disorders During COVID-19
2675,Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",0,NCT04460105,LANADELUMAB; PLACEBO,,Withdrawn,Shire,"October 31, 2020",Interventional,"A Phase 1b, Randomized, Double-blind, Single and Repeat Dosing Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Lanadelumab When Added to Standard-of-Care in Subjects Hospitalized With COVID-19 Pneumonia"
2676,COVID-19 Follow up Intensive Care Studies,QUALITY OF LIFE; COVID,"February 08, 2021",100,NCT04460170,,NETHERLANDS,Recruiting,University Medical Center Groningen,"July 1, 2020",Observational [Patient Registry],COVID-19 Follow up Intensive Care Studies
2677,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,COVID,"February 08, 2021",300,NCT04460183,"RESP301, A NITRIC OXIDE GENERATING SOLUTION; STANDARD OF CARE",UNITED KINGDOM,Recruiting,Thirty Respiratory Limited,"July 29, 2020",Interventional,"An Open-label, Adaptive Randomized, Controlled Multicenter Study to Evaluate the Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 WHO Grade 3&4 (NOCoV2)"
2678,Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments,EMERGENCY MEDICINE,"February 08, 2021",900,NCT04460196,SURVEY,FRANCE,Completed,"University Hospital, Angers","July 8, 2020",Observational [Patient Registry],Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments
2679,Forecast Number of Covid-19 Cases Worldwide,COVID,"February 08, 2021",7882471,NCT04460274,MODEL BUILDING; MODEL VALIDATION,TURKEY,Completed,Turkish Ministry of Health Izmir Teaching Hospital,"December 31, 2019",Observational,Time Series Model For Forecasting the Number of Covid-19 Cases Worldwide - A Prospective Cohort Study
2680,Sofosbuvir in Treatment of COVID 19,COVID,"February 08, 2021",60,NCT04460443,SOFOSBUVIR; SOFOSBUVIR LEDIPSAVIR; DACLATASVIR,EGYPT,Recruiting,Tanta University,"August 1, 2020",Interventional,Sofosbuvir Based Regimens in Treatment of COVID 19 Patients
2681,Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic,ANXIETY; COVID; ORAL HYGIENE,"February 08, 2021",1500,NCT04460469,,EGYPT,Recruiting,Cairo University,"July 1, 2020",Observational,Self-assessment of Anxiety Level and Oral Hygiene Practice in Dental Students of Cairo University During Covid-19 Pandemic
2682,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),COVID,"February 08, 2021",100,NCT04460534,DIAGNOSTIC,FRANCE,Recruiting,GCS Ramsay Santé pour l'Enseignement et la Recherche,"May 7, 2020",Interventional,Detection of SARS-CoV-2 in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab)
2683,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic,COVID,"February 08, 2021",200,NCT04460547,CONVALESCENT PLASMA TRANSFUSION; HYDROXYCHLOROQUINE; DAS181; IVERMECTIN; INTERFERON BETA-1A,,Not yet recruiting,Qassim University,"July 25, 2020",Observational,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic: An Observational Study
2684,Neurological Features During COVID19,ENCEPHALITIS,"February 08, 2021",30,NCT04460599,OBSERVATION,FRANCE,Recruiting,Centre d'Investigation Clinique et Technologique 805,"March 8, 2020",Observational,Description of neurolOgical Involvement Observed During SARS COV2 Infection
2685,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling,SARS-CoV2,"February 08, 2021",600,NCT04460638,SALIVA COLLECTION; CLINICAL ASSESSMENT,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"July 23, 2020",Observational,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling
2686,PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial,COVID,"February 08, 2021",2000,NCT04460651,ICOSAPENT ETHYL (IPE); PLACEBO,ARGENTINA,Recruiting,Estudios Clínicos Latino América,"August 14, 2020",Interventional,PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial
2687,Coagulation Changes Associated With COVID-19 Infection,COVID; DISSEMINATED INTRAVASCULAR COAGULATION; COAGULATION DISORDER,"February 08, 2021",50,NCT04460664,QUANTRA SYSTEM,UNITED STATES,Enrolling by invitation,HemoSonics LLC,"August 14, 2020",Observational,Exploratory Assessment of the Coagulation Changes Associated With Severe Inflammation in COVID-19 Patients
2688,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,"PSYCHOLOGICAL DISTRESS; STRESS, PSYCHOLOGICAL; AUTISM SPECTRUM DISORDER","February 08, 2021",80,NCT04460677,EMOTIONAL SUPPORT PLAN; DAILY MONITORING,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","August 12, 2020",Interventional,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 (Coronavirus Disease)
2689,"Rapid, Onsite COVID-19 Detection",COVID; SARS-CoV2,"February 08, 2021",10000,NCT04460690,RAPID ONSITE COVID-19 DETECTION,UNITED STATES,Enrolling by invitation,"University of Wisconsin, Madison","July 13, 2020",Interventional,"Rapid, Onsite COVID-19 Detection"
2690,"COVID-19 Vaccine Messaging, Part 1",VACCINATION; COVID,"February 08, 2021",4000,NCT04460703,CONTROL MESSAGE; BASELINE MESSAGE; PERSONAL FREEDOM MESSAGE; ECONOMIC FREEDOM MESSAGE; SELF-INTEREST MESSAGE; COMMUNITY INTEREST MESSAGE; ECONOMIC BENEFIT MESSAGE; GUILT MESSAGE; EMBARRASSMENT MESSAGE; ANGER MESSAGE; TRUST IN SCIENCE MESSAGE; NOT BRAVERY MESSAGE,UNITED STATES,Completed,Yale University,"July 3, 2020",Interventional,"Persuasive Messages for COVID-19 Vaccine Uptake: a Randomized Controlled Trial, Part 1"
2691,Efficacy and Safety of Sirolimus in COVID-19 Infection,COVID,"February 08, 2021",40,NCT04461340,SIROLIMUS,EGYPT,Recruiting,Alexandria University,"August 15, 2020",Interventional,Efficacy and Safety of Sirolimus for Treating COVID-19 Infection
2692,"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",12,NCT04461353,AEROLIZED HYDROXYCHLOROQUINE SULFATE; PLACEBO,UNITED STATES,Completed,"Pulmoquine Therapeutics, Inc","June 25, 2020",Interventional,"A Phase 1 Randomized Double Blind Placebo Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers"
2693,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers",BCG; COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",908,NCT04461379,BCG VACCINE; PLACEBO,MEXICO,"Active, not recruiting",Hospital Universitario Dr. Jose E. Gonzalez,"July 21, 2020",Interventional,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19- Randomized Clinical Trial"
2694,Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep,SLEEP; SLEEP HYGIENE,"February 08, 2021",13,NCT04461769,TRANSCRANIAL ELECTRICAL STIMULATION,UNITED STATES,Completed,Brain Electrophysiology Laboratory Company,"September 1, 2019",Interventional,Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep
2695,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,COVID PNEUMONIA,"February 08, 2021",30,NCT04461925,PLACENTA-DERIVED MMSCS; CRYOPRESERVED PLACENTA-DERIVED MULTIPOTENT MESENCHYMAL STROMAL CELLS; ANTIBIOTICS; HORMONES; ANTICOAGULANT THERAPY; ОXYGEN THERAPY,UKRAINE,Recruiting,Institute of Cell Therapy,"May 2, 2020",Interventional,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic Multipotent Mesenchymal Stem Cells of the Placenta and Umbilical Cord
2696,IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study,COVID,"February 08, 2021",100,NCT04462120,,EGYPT,"Active, not recruiting",Assiut University,"June 16, 2020",Observational,Association Between IL-12RB and TNF-alpha Gene Polymorphism With Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study
2697,Mobile Health (mHealth) App for Safe Opioid Use,OPIOID USE,"February 08, 2021",15,NCT04462250,PRESCRIPTION OPIOID MANAGEMENT APP,UNITED STATES,Not yet recruiting,"Rutgers, The State University of New Jersey","March 1, 2021",Interventional,"Development of a Mobile Health App to Improve the Safe Use, Storage, and Disposal of Opioid Medications"
2698,Northeast COVID-19 and Pregnancy Study Group,COVID; CORONAVIRUS INFECTION; PREGNANCY DISEASE; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",180,NCT04462367,,BRAZIL,Not yet recruiting,Instituto Materno Infantil Prof. Fernando Figueira,"July 1, 2020",Observational,Clinical and Laboratory Predictors of COVID-19 Progression and Maternal and Perinatal Outcomes in Infected Pregnant and Postpartum Women in Six Reference Centers in the Northeast of Brazil
2699,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19,COVID; CRITICAL ILLNESS,"February 08, 2021",1563,NCT04462393,ADMISSION TO ICU FOR COVID-19,SWEDEN,Completed,Linkoeping University,"March 6, 2020",Observational,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 During the First 60 Days of the 2020 Pandemic
2700,Reduction of COVID 19 Transmission to Health Care Professionals,COVID,"February 08, 2021",500,NCT04462627,BLOOD GROUP DETERMINATION; ANTIBODY TITRATION; PROBIOTIC,BELGIUM,Recruiting,Hanane EL KENZ,"April 14, 2020",Interventional,Reduction of COVID 19 Transmission to Health Care Professionals
2701,SCIL-1Ra in COVID-19 Feasibility & PK/PD,COVID,"February 08, 2021",5,NCT04462757,ANAKINRA 100MG/0.67ML INJ SYRINGE,UNITED KINGDOM,Suspended,University of Manchester,"May 28, 2020",Interventional,Subcutaneous and Intravenous IL-1Ra (Anakinra) in COVID-19 Infection - Feasibility & Pharmacokinetics/Pharmacodynamics Study
2702,Emergency Department (ED) Self-Monitoring Pilot COVID-19,COVID; COVID; SARS-CoV2,"February 08, 2021",200,NCT04462783,SYMPTOMS ENTERED INTO THE COVIDX APPLICATION,,Not yet recruiting,University of Michigan,February 2021,Interventional,Feasibility of Self-monitoring and Patient Decision Support for Suspected COVID-19 Patients After Emergency Department Discharge
2703,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04462848,ANTI-SARS-COV-2 HUMAN CONVALESCENT PLASMA,UNITED STATES,Not yet recruiting,"University of California, Los Angeles",August 2020,Interventional,Phase I Study of the Safety and Pharmacokinetics of Human Convalescent Plasma in High Risk Children Exposed or Infected With SARS-CoV-2
2704,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,COVID; SARS-CoV2; PNEUMONIA,"February 08, 2021",60,NCT04463004,MAVRILIMUMAB; PLACEBOS,UNITED STATES,Recruiting,Virginia Commonwealth University,"September 2, 2020",Interventional,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation
2705,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),COVID,"February 08, 2021",135,NCT04463264,NITAZOXANIDE; PLACEBO,ARGENTINA,Recruiting,Laboratorios Roemmers S.A.I.C.F.,"June 26, 2020",Interventional,"Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoC-2 Virus Infection (COVID-19). A Pilot, Randomized, Simple Blind, Placebo-controlled, Parallel-group Study"
2706,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,COVID,"February 08, 2021",224,NCT04463420,PHR160 SPRAY; PLACEBO; STANDARD TREATMENT,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Baqiyatallah Medical Sciences University,"August 15, 2020",Interventional,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 a Multi-center Randomized Blinding Clinical Trial Study
2707,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,PARENT-CHILD RELATIONSHIP AND COUPLE RELATIONSHIP UNDER COVID IN CHINA,"February 08, 2021",300,NCT04463433,COGNITIVE AND BEHAVIORAL INTERVENTION.; PROBLEM-SOLVING AND RELATIONSHIP IMPROVEMENT INTERVENTION.,CHINA,Recruiting,Beijing Normal University,"February 1, 2020",Interventional,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China
2708,Study of COVID-19 DNA Vaccine (AG0301-COVID19),COVID,"February 08, 2021",30,NCT04463472,AG0301-COVID19; AG0301-COVID19,JAPAN,"Active, not recruiting","AnGes, Inc.","June 29, 2020",Interventional,"A Non-randomized, Open-label, Non-controlled Phase I/II Study to Assess Safety and Immunogenicity of Two Doses of Intramuscular AG0301-COVID19 (1mg/2mg) in Healthy Adults"
2709,Desidustat in the Management of COVID-19 Patients,COVID,"February 08, 2021",24,NCT04463602,DESIDUSTAT; STANDARD OF CARE,MEXICO,"Active, not recruiting",Cadila Healthcare Limited,"July 25, 2020",Interventional,"A Phase 2b, Multicenter, Open-label, Randomized, Comparator-Controlled, Study to Evaluate the Efficacy and Safety of Desidustat Tablet for the Management of COVID-19 Patients"
2710,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic",CYSTIC FIBROSIS IN CHILDREN; CYSTIC FIBROSIS,"February 08, 2021",1200,NCT04463628,QUESTIONNAIRE; INTERVIEW,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 15, 2020",Observational,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic"
2711,COVID19 Severity Prediction and Health Services Research Evaluation,COVID,"February 08, 2021",20000,NCT04463706,PREDICTORS ADVERSE EVOLUTION; PREDICTORS OF HEALTH CARE PROVIDE,SPAIN,Recruiting,Hospital Galdakao-Usansolo,"June 1, 2020",Observational,Clinical Characterization of CoVid19 Infection: Prognostic Stratification and Complications
2712,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,COVID INFECTION; PREGNANCY COMPLICATIONS; NEONATAL COMPLICATIONS,"February 08, 2021",3060,NCT04463758,AN AUTO-QUESTIONNAIRE COMPRISING THREE PSYCHOMETRIC SCALES,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 11, 2020",Observational,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns
2713,"""NORPLASMA"" Covid-19 Convalescent Plasma Treatment Monitoring Study",COVID,"February 08, 2021",500,NCT04463823,,NORWAY,Not yet recruiting,Oslo University Hospital,"July 6, 2020",Observational,Covid-19 Convalescent Plasma Used for Treatment of Patients in Norway - a Monitoring Study
2714,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,COVID; BETA-CELL FUNCTION,"February 08, 2021",24,NCT04463849,STIMULATION TEST WITH ARGININE INFUSION IN ORDER TO VERIFY THE POSSIBLE EXISTENCE OF DAMAGE TO THE BETA CELL FUNCTION INDUCED BY COVID-19 INFECTION,ITALY,Recruiting,University of Milan,"June 30, 2020",Interventional,Effects of SARS-CoV-2 Infection on Beta-cell Function in Euglycemic Patients
2715,COVID - AirPollution,COVID CONFIRMED CASES; COVID MORTALITY,"February 08, 2021",250,NCT04463862,,BELGIUM,Recruiting,"University Hospital, Strasbourg, France","June 4, 2020",Observational [Patient Registry],Air Pollution and COVID-19 Mortality in Geriatric Patients: a Multicenter Study
2716,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,COVID,"February 08, 2021",70,NCT04464395,CPI-006; STANDARD OF CARE,UNITED STATES,Recruiting,"Corvus Pharmaceuticals, Inc.","July 1, 2020",Interventional,Immunotherapy of COVID-19 With B-Cell Activating CPI-006 Monoclonal Antibody
2717,Favipiravir Therapy in Adults With Mild COVID-19,COVID,"February 08, 2021",576,NCT04464408,FAVIPIRAVIR; PLACEBO,SAUDI ARABIA,Recruiting,King Abdullah International Medical Research Center,"July 23, 2020",Interventional,A Trial of Favipiravir Therapy in Adults With Mild Coronavirus Disease COVID-19
2718,"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults",CORONAVIRUS DISEASE,"February 08, 2021",0,NCT04464460,TAK-671; TAK-671 PLACEBO,,Withdrawn,Takeda,"September 25, 2020",Interventional,"A Randomized, Double-blind, Placebo-Controlled Multicenter Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of 2 Different Intravenous Doses of TAK-671 for the Treatment of Coronavirus Disease 2019 in Adults"
2719,Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic,ONCOLOGY,"February 08, 2021",300,NCT04464486,SCH INTERVENTION,UNITED STATES,Enrolling by invitation,University of Utah,"April 21, 2020",Interventional,Remote COVID-19 Symptom Tracking and Improved Cancer Symptom Control for Cancer Patients at Home During the Pandemic
2720,Characteristics of Critically Ill COVID 19 Patients,COVID,"February 08, 2021",50,NCT04465058,COVID19,EGYPT,Recruiting,Assiut University,"July 8, 2020",Observational,Clinical Characteristics and Outcome in Critically Ill COVID 19 Patients
2721,Sustainable UNiversity Life (SUN) Study,MENTAL HEALTH ISSUE; MUSCULOSKELETAL PAIN,"February 08, 2021",5000,NCT04465435,WEB-BASED SELF-REPORT QUESTIONNAIRES; FOCUS GROUP INTERVIEWS,SWEDEN,Enrolling by invitation,Sophiahemmet University,"August 19, 2019",Observational,Sustainable UNiversity Life (SUN): Mental Illness and Pain Conditions Among Students - a Cohort Study to Identify Modifiable Risk and Prognostic Factors
2722,"Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)",COVID,"February 08, 2021",3000,NCT04465474,NON INTERVENTION,CHINA,Recruiting,Chinese University of Hong Kong,"May 1, 2020",Observational [Patient Registry],"Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)"
2723,Investigation of Safety and Efficacy of CARDIO Softgels in Former Smokers and Asthma Patients With COVID-19 Infection,ASTHMA; EOSINOPHILIC; COVID; COVID,"February 08, 2021",100,NCT04465513,BEST STANDARD OF CARE + CARDIO; BEST STANDARD OF CARE,CANADA,Not yet recruiting,Hofseth Biocare ASA,"August 31, 2020",Interventional,"Randomized, Open-label, Parallel Study to Investigate Safety and Efficacy of CARDIO Softgels Plus Best Standard-of-care vs. Best Standard-of-care Alone on a Former Smoker and/or Steroid-resistant Asthma Population With COVID-19 Infection"
2724,Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",750,NCT04465552,PATIENTS RECEIVED STANDARD OF CARE TREATMENT DURING HOSPITALIZATION,UNITED STATES,Recruiting,Kansas City Heart Rhythm Research Foundation,"July 10, 2020",Observational,Arrhythmic Manifestations and Management Strategies in Hospitalized COVID-19 Patients: Proposal for a Multicenter Registry
2725,Hypertonic Saline for COVID-19 Symptoms,COVID,"February 08, 2021",50,NCT04465604,WEARING SURGICAL FACE MASK SPRAYED WITH HYPERTONIC SALINE,SAUDI ARABIA,Recruiting,King Faisal Specialist Hospital & Research Center,"July 1, 2020",Interventional,HYPERTONIC SALINE COATED FACE MASK FOR REDUCING RESPIRATORY SYMPTOM SEVERITY IN PATIENTS WITH COVID-19
2726,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic,PULMONARY EMBOLISM,"February 08, 2021",250,NCT04465656,SEROLOGY TEST FOR COVID-19,FRANCE,Recruiting,"Hospital St. Joseph, Marseille, France","July 7, 2020",Observational,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic: Retrospective and Prospective Multicentric Study.
2727,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,COVID,"February 08, 2021",81,NCT04465695,INTERFERON BETA-1B; CLOFAZIMINE,CHINA,Recruiting,The University of Hong Kong,"July 14, 2020",Interventional,"An Open-label Randomised Controlled Trial on Dual Therapy With Interferon Beta-1b and Clofazimine Combination, as Treatment for COVID-19 Infection"
2728,Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins,COVID; CORONAVIRUS INFECTION,"February 08, 2021",80,NCT04465981,SAMPLING,UNITED STATES,Recruiting,INanoBio Inc.,July 2020,Observational,"A Longitudinal, Non-randomized Study to Evaluate the Utility of the INanoBio's Protein Arrays in Detecting Unique Antibodies in COVID-19 Patients"
2729,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),ACUTE RESPIRATORY DISTRESS SYNDROME; ARDS (MODERATE OR SEVERE); COVID PNEUMONIA,"February 08, 2021",30,NCT04466098,MESENCHYMAL STROMAL CELLS; PLACEBO,UNITED STATES,Recruiting,"Masonic Cancer Center, University of Minnesota","July 30, 2020",Interventional,"Multi-center, Randomized, Placebo Controlled, Interventional Phase 2A Clinical Trial Evaluating the Safety and Potential Efficacy of Multiple Dosing of Mesenchymal Stromal Cells in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2)"
2730,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,COVID; COVID DRUG TREATMENT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",294,NCT04466241,LOPINAVIR/RITONAVIR 200 MG-50 MG ORAL TABLET; TELMISARTAN 40MG ORAL TABLET; ATORVASTATIN 20 MG ORAL TABLET,CÔTE D'IVOIRE,Recruiting,French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS),"November 27, 2020",Interventional,Combination Therapies to Reduce the Nasopharyngeal Carriage of SARS-CoV-2 and Improve the Outcome of COVID-19 Infection in Ivory Coast (INTENSE-COV): a Phase IIb Randomized Clinical Trial
2731,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19",COVID,"February 08, 2021",180,NCT04466280,HYDROXYCHLOROQUINE; MUCODENTOL; PERSONAL PROTECTIVE EQUIPMENT,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Baqiyatallah Medical Sciences University,"July 15, 2020",Interventional,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 Disease in Healthcare Providers at Baqiyatallah Hospital in Tehran"
2732,Pediatric Acute Kidney Injury in COVID-19,ACUTE KIDNEY INJURY; COVID,"February 08, 2021",250,NCT04466306,,CANADA,Enrolling by invitation,Children's Healthcare of Atlanta,"April 15, 2020",Observational [Patient Registry],SARS-CoV2 Pediatric Acute Kidney Injury Registry and Collaborative
2733,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching,COVID,"February 08, 2021",9209,NCT04466371,QUESTIONNAIRE,,Not yet recruiting,Misr International University,"October 15, 2020",Observational,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching and Learning in the Wake of COVID-19 Pandemic in an Egyptian Private University: A Cross-Sectional Study
2734,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel,SARS-CoV2 INFECTION,"February 08, 2021",1000,NCT04466462,,SPAIN,Completed,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","May 26, 2020",Observational,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel
2735,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),COVID,"February 08, 2021",1300,NCT04466540,HYDROXYCHLOROQUINE; PLACEBO,BRAZIL,Recruiting,Hospital Alemão Oswaldo Cruz,"May 12, 2020",Interventional,"Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19"
2736,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,CHRONIC MUSCULOSKELETAL PAIN,"February 08, 2021",64,NCT04466605,TELE-YOGA THERAPY; PRIMARY CARE,INDIA,Completed,Aarogyam UK,"March 30, 2020",Interventional,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown: Randomized Clinical Trial
2737,COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics),COVID,"February 08, 2021",340,NCT04466644,ELISA; RT-PCR,UNITED STATES,Completed,Igenomix,"June 8, 2020",Observational,"A Multicenter, Prevalence Study to Evaluate the Infectious and Immunological Status of COVID-19 in Asymptomatic Subjects Attending ART Centres After the Pandemic Lockdown in the USA"
2738,Antioxidant Therapy for COVID-19 Study,COVID,"February 08, 2021",90,NCT04466657,ANTIOXIDATION THERAPY; STANDARD OF CARE,NIGERIA,Not yet recruiting,Obafemi Awolowo University,"November 1, 2020",Interventional,A Study to Evaluate Antioxidant Therapy for Moderate to Severe COVID-19 With or Without Comorbidities
2739,Hemostasis in COVID-19: an Adaptive Clinical Trial,COVID,"February 08, 2021",310,NCT04466670,UNFRACTIONATED HEPARIN; UNFRACTIONATED HEPARIN NEBULIZED; ACETYLSALICYLIC ACID; ENOXAPARIN,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"July 8, 2020",Interventional,Dynamics of Hemostatic Parameters in COVID-19 and Comparison of Intervention Strategies Through Adaptive Clinical Trial
2740,Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,COVID; SARS-CoV2; PNEUMONIA,"February 08, 2021",100,NCT04466683,LOW DOSE RADIATION 35 CGY; HIGH DOSE RADIATION 100 CGY,UNITED STATES,Recruiting,Ohio State University Comprehensive Cancer Center,"August 28, 2020",Interventional,Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia
2741,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),COVID,"February 08, 2021",160,NCT04466800,INTERVENTION GROUP_REHABILITATION PROGRAM,FRANCE,Recruiting,Rennes University Hospital,"July 30, 2020",Interventional,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients
2742,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients,PARKINSON DISEASE; COVID,"February 08, 2021",411,NCT04466839,QUESTIONNAIRE AND INTERVIEW,FRANCE,Completed,"University Hospital, Toulouse","July 2, 2020",Observational,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients
2743,Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection,OLFACTORY DISORDER; COVID; SARS-CoV2; ANOSMIA; MICROSOMIA; SMELL DISORDER; QUALITY OF LIFE,"February 08, 2021",90,NCT04466982,,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"July 2, 2020",Observational,"Objective Assessment of Olfactory Dysfunction and Impact on Quality of Life in SARS CoV-2 (COVID-19)Infection Using the UPSIT, eQOD and SNOT-22 Questionnaires: A Prospective Observational Cohort Study"
2744,Covid-19 Rapid Diagnostic Tests on Blood Drop,COVID,"February 08, 2021",113,NCT04467008,,FRANCE,Completed,CMC Ambroise Paré,"July 15, 2020",Observational,Evaluation of Covid-19 Rapid Diagnostic Tests on Blood Drop
2745,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,COVID; SARS-CoV2,"February 08, 2021",10,NCT04467047,MESENCHYMAL STROMAL CELLS INFUSION,,Not yet recruiting,Hospital de Clinicas de Porto Alegre,"July 25, 2020",Interventional,Safety and Feasibility of Allogenic Mesenchymal Stromal Cells in the Treatment of COVID-19
2746,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,MECHANICAL VENTILATION; SEDATION; CRITICAL ILLNESS; COVID,"February 08, 2021",108,NCT04467086,PROPRANOLOL HYDROCHLORIDE,CANADA,Recruiting,Ottawa Hospital Research Institute,"December 11, 2020",Interventional,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation: An Open-label Randomized Controlled Trial (PROACTIVE)
2747,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols,COVID,"February 08, 2021",100,NCT04467112,BREATH BIOPSY FACE MASKS WITH REMOVABLE FILTERS AND FITTED PVA STRIP,UNITED KINGDOM,Recruiting,Owlstone Ltd,"July 30, 2020",Observational,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols
2748,"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19",COVID,"February 08, 2021",0,NCT04467151,ANTI-SARS-COV-2 PLASMA; PLACEBO,,Withdrawn,Kashif Khan,October 2020,Interventional,"A Randomized, Double-blind, Placebo-controlled Trial of Anti-SARS-CoV-2 Plasma in Hospitalized Non-ICU Patients With COVID-19"
2749,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia",COVID; LUNG INFECTION,"February 08, 2021",270,NCT04467840,OPAGANIB; PLACEBO,BRAZIL,Recruiting,RedHill Biopharma Limited,"August 21, 2020",Interventional,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled Phase 2/3 Study, in Adult Subjects Hospitalized With Severe SARS-CoV-2 Positive Pneumonia"
2750,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,SARS-CoV2,"February 08, 2021",100,NCT04467918,CANNABIDIOL; PLACEBO,BRAZIL,"Active, not recruiting",University of Sao Paulo,"July 6, 2020",Interventional,"Cannabidiol (CBD) in Patients With Mild to Moderate Symptoms of Coronavirus 2019: A Randomized, Double-blind, Placebo-controlled Clinical Trial"
2751,ACEI or ARB and COVID-19 Severity and Mortality in US Veterans,HYPERTENSION; COVID,"February 08, 2021",10000,NCT04467931,ACEI/ARB; NON-ACEI/ARB; ACEI; ARB,UNITED STATES,"Active, not recruiting",University of Utah,"January 19, 2020",Observational,Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and COVID-19 Severity and Mortality Among US Veterans
2752,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,SARS-ASSOCIATED CORONAVIRUS; COVID; SARS-COV INFECTION,"February 08, 2021",36,NCT04468009,CONVALESCENT PLASMA,ARGENTINA,Recruiting,Hospital de Infecciosas Francisco Javier Muniz,"June 25, 2020",Interventional,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma
2753,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation,COVID,"February 08, 2021",30,NCT04468035,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"June 1, 2020",Observational,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS (Acute Respiratory Distress Syndrome) on SARS-CoV2 Viral Pneumonia Requiring Mechanical Ventilation
2754,Antiviral Agents Against COVID-19 Infection,COVID,"February 08, 2021",1005,NCT04468087,ATAZANAVIR; DACLATASVIR 60 MG; SOFUSBUVIR + DACLASTAVIR 60 MG; PLACEBO ATAZANAVIR; PLACEBO DACLATASVIR 60 MG; PLACEBO SOFUSBUVIR + DACLATASVIR 60 MG,BRAZIL,Not yet recruiting,Hospital do Coracao,"December 1, 2020",Interventional,"Antiviral for Adult Patients Hospitalized for SARS-CoV-2 Infection: a Randomized, Phase 2/3, Multicenter, Placebo Controlled, Adaptive, Multi-arm, Multi-stage Clinical Trial - Coalition Brazil COVID-19 IX: REVOLUTIOn"
2755,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",COVID,"February 08, 2021",60,NCT04468139,QUERCETIN; BROMELAIN; ZINC; VITAMIN C,SAUDI ARABIA,Recruiting,"Ministry of Health, Saudi Arabia","June 20, 2020",Interventional,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19"
2756,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR,COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",150,NCT04468217,"OBTAINMENT OF NASOPHARYNGEAL, OROPHARYNGEAL, BUCCAL, NASAL AND SALIVA SAMPLES",CHILE,Recruiting,Neurognos,"June 2, 2020",Observational,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR
2757,The Heart Hive COVID-19 Study,COVID; CARDIOMYOPATHIES,"February 08, 2021",1000,NCT04468256,COVID-19 EXPERIENCE SURVEYS,UNITED KINGDOM,Recruiting,Imperial College London,"July 26, 2020",Observational,The Heart Hive COVID-19 Study: A Longitudinal Observational Study of the Impact and Clinical Outcomes of the COVID-19 Pandemic on Individuals With Heart Muscle Disease
2758,VRQOL in Cataract Patients During the COVID-19 Pandemic,SENILE CATARACT,"February 08, 2021",116,NCT04468308,QUESTIONNAIRE,AUSTRIA,Recruiting,Medical University Innsbruck,"September 8, 2020",Observational,Assessment of Vision-related Quality of Life (VRQOL) in Cataract Patients During the COVID-19 Pandemic
2759,Specimen Collection Study Protocol,FOCUS IN ON COLLECTING PAIRED SPECIMENS FOR MATRIX EQUIVALENCY,"February 08, 2021",40,NCT04468386,,UNITED STATES,"Active, not recruiting",Biomerica,"July 7, 2020",Observational,Specimen Collection Study Protocol; Internal Biomerica Normal Specimen Collection and Banking for Use in COVID-19 Serological Product Development
2760,Influence of COVID-19 on Vascular Endothelial Function,COVID; VASCULAR; DAMAGE,"February 08, 2021",203,NCT04468412,CAROTID ARTERY REACTIVITY TESTING,NETHERLANDS,"Active, not recruiting",Radboud University,"July 14, 2020",Observational,Influence of COVID-19 on Vascular Endothelial Function
2761,Characteristics of TraceTogether Users,CORONAVIRUS,"February 08, 2021",505,NCT04468581,USE OF MOBILE APPLICATION,SINGAPORE,Completed,Yale-NUS College,"April 3, 2020",Observational,Characteristics of TraceTogether Users
2762,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,"NEUROKININ 1 RECEPTOR, SUBSTANCE P, RESPIRATORY ILLNESS, INFLAMMATION, COVID, CORONAVIRUS","February 08, 2021",100,NCT04468646,NK-1R ANTAGONIST,PAKISTAN,Recruiting,Prof. Dr. Fridoon Jawad Ahmad,"June 15, 2020",Interventional,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients
2763,Evaluation of Six-month HIV Treatment Dispensing in South Africa,HIV,"February 08, 2021",150945,NCT04468789,SIX-MONTH ARV DISPENSING,SOUTH AFRICA,Not yet recruiting,Boston University,April 2021,Observational,Evaluation of the National Department of Health's Six-month Antiretroviral Treatment Dispensing Demonstration Pilot in Primary Health Care Clinics in the Context of the COVID-19 Pandemic and Response in South Africa
2764,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?,COVID; MEASLES VACCINE; MORTALITY,"February 08, 2021",32,NCT04468802,CASE FATALITY RATE,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"February 1, 2020",Observational,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by SARS CoV-2 in OECD Countries?
2765,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,ANXIETY; DEPRESSION; SLEEP DISTURBANCE,"February 08, 2021",128,NCT04468893,ONLINE INTERVENTION MENTAL HEALTH COVID-19,MEXICO,Recruiting,Universidad Internacional de Valencia,"May 20, 2020",Interventional,"Effectiveness of a Self-applied Positive Psychology Online Intervention Program ""Mental Health COVID-19"" in Mexican Population: A Randomized Controlled Trial."
2766,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants",COVID; SARS-CoV2,"February 08, 2021",28,NCT04468958,SAB-185; NORMAL SALINE,UNITED STATES,Recruiting,"SAb Biotherapeutics, Inc.","August 5, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of SAB-185 in Healthy Subjects"
2767,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,COVID; ARDS,"February 08, 2021",45,NCT04468971,CK0802; PLACEBO,UNITED STATES,Recruiting,"Cellenkos, Inc.","September 29, 2020",Interventional,"Phase 1 Double-Blinded, Randomized, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) In The Treatment Of COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS)"
2768,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",260,NCT04469114,TOFACITINIB 10 MG; PLACEBO,BRAZIL,"Active, not recruiting",Hospital Israelita Albert Einstein,"September 16, 2020",Interventional,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-design Trial of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia"
2769,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19,THE PROGNOSTIC VALUE OF FERRITIN; GLYCOSYLATED FERRITIN IN SARS-CoV2 INFECTION IN HOSPITALIZED COVID PATIENTS,"February 08, 2021",57,NCT04469153,NO INTERVENTION / EVALUATION OF THE FERRITIN AND GLYCOSYLATED FERRITIN BY STANDARD APPROVED SEROLOGICAL TESTS,FRANCE,Recruiting,Hospices Civils de Lyon,"June 29, 2020",Observational,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19
2770,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19",COVID; SARS-CoV2,"February 08, 2021",21,NCT04469179,SAB-185; NORMAL SALINE,UNITED STATES,Recruiting,"SAb Biotherapeutics, Inc.","August 20, 2020",Interventional,"A Phase 1B, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of SAB-185 in Ambulatory Subjects With COVID-19"
2771,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,COVID; INTERFERON; NEBULIZATION,"February 08, 2021",60,NCT04469491,INHALED TYPE I INTERFERON; WFI WATER NEBULIZATION,FRANCE,Suspended,"Centre Hospitalier Universitaire, Amiens","September 20, 2020",Interventional,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study
2772,A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",68,NCT04469621,SAR443122; PLACEBO,ARGENTINA,Completed,Sanofi,"July 17, 2020",Interventional,"A Phase 1b, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety and Immunomodulatory Effect of the RIPK1 Inhibitor SAR443122 in Hospitalized Patients With Severe COVID-19"
2773,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,SARS-CoV2; COVID,"February 08, 2021",150,NCT04469634,"ASSESSING ANTIBODY RESPONSES, NEUTRALIZING CAPACITY AND MEMORY B-CELL FUNCTION",BELGIUM,"Active, not recruiting","Institute of Tropical Medicine, Belgium","July 31, 2020",Interventional,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
2774,COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH,COVID,"February 08, 2021",1200,NCT04469647,SEROLOGY TEST,SAUDI ARABIA,Enrolling by invitation,Johns Hopkins Aramco Healthcare,"July 19, 2020",Observational,COVID 19 Antibody Seroprevalence Amongst Healthcare Workers in Johns Hopkins Aramco Healthcare
2775,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India,PSYCHOLOGICAL STRESS,"February 08, 2021",1300,NCT04469660,,INDIA,Recruiting,Max Healthcare Insititute Limited,"May 18, 2020",Observational,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare
2776,Elmo Respiratory Support Project - COVID-19,COVID; RESPIRATORY FAILURE WITH HYPOXIA,"February 08, 2021",10,NCT04470258,ELMO PROJECT AT COVID-19: STUDY IN HUMANS; ELMO PROJECT AT COVID-19: PROOF OF CONCEPT AND USABILITY,BRAZIL,Recruiting,Escola de Saúde Pública do Ceará,"August 2, 2020",Interventional,Elmo Respiratory Support Project for Patients With Hypoxemic Respiratory Insufficiency in Covid-19: Proof Of Concept and Usability
2777,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,COVID; LUNG INJURY,"February 08, 2021",100,NCT04470297,RAMELTEON 8MG,,Not yet recruiting,Associação Fundo de Incentivo à Pesquisa,September 2020,Interventional,Adjuvant Therapeutic Effects of Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19
2778,Functional Exhaustion of T Cells in COVID19 Patients,T CELL DEFICIENCY,"February 08, 2021",100,NCT04470323,FLOW CYTOMETRY,EGYPT,Recruiting,Assiut University,"July 22, 2020",Observational,Functional Exhaustion of T Cells in COVID19 Patients
2779,COVID-19 IgG Antibodies in the Serum of Recovered Patients,COVID,"February 08, 2021",100,NCT04470414,IGG ANTIBODIES IMMUNOASSAY,EGYPT,Not yet recruiting,Assiut University,"August 1, 2020",Observational,COVID-19 IgG Antibodies in the Serum of Recovered Patients: a Longitudinal Study
2780,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19",SARS-CoV2,"February 08, 2021",30000,NCT04470427,MRNA-1273; PLACEBO,UNITED STATES,"Active, not recruiting","ModernaTX, Inc.","July 27, 2020",Interventional,"A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older"
2781,Role of Co-trimoxazole in Severe COVID-19 Patients,COVID; SEVERE COVID PATIENTS,"February 08, 2021",94,NCT04470531,ORAL CO-TRIMOXAZOLE,BANGLADESH,Recruiting,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","July 12, 2020",Interventional,Role of Co-trimoxazole in Severe COVID-19 Patients
2782,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",264,NCT04470544,CAMOSTAT MESILATE; STANDARD OF CARE,UNITED STATES,Recruiting,Alan Bryce,"July 28, 2020",Interventional,"RECOVER: Phase 2 Randomized, Double-Blind Trial TREating Hospitalized Patients With COVID-19 With Camostat MesilatE, a TMPRSS2 Inhibitor"
2783,Relation Between Lab Finding and COVID-19 Severity,COVID,"February 08, 2021",100,NCT04470557,"D-DIMER,CBC.ESR,CRP,; LIVER FUNCTION TESTS ,SERUM FERRITIN AND PCR FOR COVID-19 .",,Not yet recruiting,Assiut University,"July 15, 2020",Observational,The Relationship Between Lab Finding and COVID-19 Severity: Multicenter Study
2784,Evaluating Clinical Parameters of COVID-19 in Pregnancy,COVID; 2019 NOVEL CORONAVIRUS INFECTION; COVID INFECTION,"February 08, 2021",116,NCT04470583,,UNITED KINGDOM,Recruiting,Chelsea and Westminster NHS Foundation Trust,"October 9, 2020",Observational,Evaluation of Clinical Parameters Following COVID-19 Infection in Pregnancy (COpregVID)
2785,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years,COVID,"February 08, 2021",471,NCT04470609,LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE; MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE; HIGH DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE; PLACEBO ON A 0- AND 28-DAY SCHEDULE,CHINA,Enrolling by invitation,Chinese Academy of Medical Sciences,"July 10, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Phase Ib/IIb Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged ⩾60 Years"
2786,Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),COVID,"February 08, 2021",100,NCT04470622,APREPITANT INJECTABLE EMULSION; SALINE PLACEBO,PUERTO RICO,Recruiting,Heron Therapeutics,"July 20, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Aprepitant Injectable Emulsion in Early Hospitalized Adult Patients With COVID-19"
2787,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey,SARS-CoV2 INFECTION,"February 08, 2021",220,NCT04470648,BLOOD TEST FOR SARS-COV2 SEROLOGY,FRANCE,Not yet recruiting,"Institut National de la Santé Et de la Recherche Médicale, France",July 2020,Observational,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey
2788,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,COVID; THYMIC HYPOPLASIA,"February 08, 2021",20,NCT04470739,CHEST X-RAY,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 30, 2020",Interventional,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?
2789,Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement.,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",130,NCT04470869,PHONE CALL,FRANCE,Recruiting,"University Hospital, Toulouse","June 12, 2020",Interventional,Impact of the Psychiatric Intervention OLAF on the Post Traumatic Disorder in the Relatives of Patients Hospitalized in Intensive Care Unit During the SARS-Cov-2 Pandemic Confinement in France.
2790,Changes in Cellular Immune Profile During COVID-19 Infection,COVID; SARS-CoV2,"February 08, 2021",25,NCT04470999,LEUKAPHERESIS,UNITED STATES,Recruiting,"Serhat Gumrukcu, MD PhD","April 15, 2020",Interventional,Cellular Immune Profile Changes in Individuals With Active or Past COVID-19 Infection
2791,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",150,NCT04471051,,UNITED STATES,Recruiting,"University of Colorado, Denver","April 30, 2020",Observational,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients
2792,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,COVID; SARS-CoV2 INFECTION,"February 08, 2021",755,NCT04471519,BBV152A - PHASE I; BBV152B - PHASE I; BBV152C - PHASE I; PLACEBO - PHASE I; BBV152A - PHASE II; BBV152B - PHASE II,INDIA,"Active, not recruiting",Bharat Biotech International Limited,"July 13, 2020",Interventional,"An Adaptive Phase 1, Followed by Phase 2 Randomized, Double-blind, Multicenter Study to Evaluate the Safety, Reactogenicity, Tolerability, and Immunogenicity of BBV152 in Healthy Volunteers"
2793,Telemedicine in Outpatient Covid-19 Patients,COVID; CARDIOVASCULAR RISK FACTOR,"February 08, 2021",600,NCT04471636,WITHINGS SCANWATCH,GERMANY,Recruiting,Ludwig-Maximilians - University of Munich,"September 18, 2020",Interventional,Munich Remote SpO2 and Electrocardiogram Assessment in Covid-19 Patients
2794,Hydroxy Chloroquine and Covid in RA Patients,COVID,"February 08, 2021",80,NCT04471649,,EGYPT,Recruiting,Tanta University,"June 15, 2020",Observational,Clinical Course of COVID-19 in Patients With Rheumatoid Arthritis Treated With or Without Hydroxychloroquine: a Case-control Study
2795,Italian Web-based Cross-sectional Survey on COVID-19,"COVID; SARS-COV INFECTION; SURVEY, FAMILY LIFE; EPIDEMIC DISEASE; SELF-ASSESSMENT","February 08, 2021",200000,NCT04471701,ENVIRONMENTAL EXPOSURE AND CLINICAL FEATURES,ITALY,Recruiting,"Institute of Biomedical Technologies-National Research Council, Italy","April 13, 2020",Observational,Italian Web-based EPICOVID19 Cross-sectional Survey
2796,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,COVID; RESPIRATORY ILLNESS,"February 08, 2021",40000,NCT04471766,CERTIFIED CLOTH FACE MASK PLUS PREVENTIVE INFORMATION; PREVENTIVE INFORMATION,GUINEA-BISSAU,Enrolling by invitation,Bandim Health Project,"July 20, 2020",Interventional,Evaluation of Locally Produced Cloth Face Mask on COVID-19 and Respiratory Illnesses Prevention at the Community Level - a Cluster-randomized Trial
2797,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",CORONAVIRUS INFECTION; STROKE,"February 08, 2021",30,NCT04471831,REHABILITATION EXERCISE PROTOCOL,,Not yet recruiting,"University of Lagos, Nigeria","July 13, 2020",Interventional,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study"
2798,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19",COVID DISEASE,"February 08, 2021",40,NCT04472013,DATA COLLECTION FROM LUMBAR PUNCTURE; DATA COLLECTION FROM BLOOD DRAW; CNS MAGNETIC RESONANCE IMAGING (MRI) IMAGING; MICROSCOPY OF DEFINED BRAIN REGIONS ON AUTOPSY SPECIMENS,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","August 12, 2020",Observational,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19"
2799,Frequency of Perforated Appendicitis in Times of COVID-19,PERFORATED APPENDICITIS; COVID,"February 08, 2021",143,NCT04472052,APPENDECTOMY,GERMANY,Completed,University Hospital Tuebingen,"March 16, 2020",Observational,Incidence of Perforated Appendicitis in Times of Corona Crisis
2800,"Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina",SARS-CoV2,"February 08, 2021",873,NCT04472078,SEROLOGICAL ASSAY OR IGG FOR SARS-COV-2,ARGENTINA,Completed,Hospital Italiano de Buenos Aires,"June 10, 2020",Observational [Patient Registry],"Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina"
2801,Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,COVID; SARS-CoV2,"February 08, 2021",129,NCT04472494,ABATACEPT; PLACEBO,PUERTO RICO,Recruiting,Bristol-Myers Squibb,"August 24, 2020",Interventional,"Phase 2, Randomized, Double-Blind Placebo Controlled Study of Intravenous Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise"
2802,Acupressure for COVID-19 Related Quality of Life and Stress,QUALITY OF LIFE; STRESS,"February 08, 2021",200,NCT04472559,SELF-ACUPRESSURE,,Not yet recruiting,"University of California, Los Angeles","December 25, 2020",Interventional,Randomized Controlled Trial of Acupressure for Health-Related Quality of Life and Perception of Stress Among Health Care Providers During the COVID-19 Pandemic
2803,Expanded Access to Convalescent Plasma for Treatment of COVID-19,COVID,"February 08, 2021",,NCT04472572,CONVALESCENT PLASMA,UNITED STATES,Available,Hackensack Meridian Health,,Expanded Access,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19
2804,Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients,CORONAVIRUS INFECTION; COVID; SARS-CoV2,"February 08, 2021",60,NCT04472585,IVERMECTIN INJECTABLE SOLUTION; INJECTABLE PLACEBO; ZINC; PLACEBO EMPTY CAPSULE,PAKISTAN,Recruiting,Sohaib Ashraf,"November 14, 2020",Interventional,Sub-cutaneous Ivermectin in Combination With and Without Oral Zinc: a Placebo Randomized Control Trial on Mild to Moderate COVID-19 Patients
2805,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,SARS-CoV2,"February 08, 2021",466,NCT04472611,STANDARD OF CARE (SOC) AND COLCHICINE+ROSUVASTATIN,UNITED STATES,Not yet recruiting,Yale University,"August 1, 2020",Interventional,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial
2806,Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,COVID; SARS-CoV2,"February 08, 2021",310,NCT04472728,BIO101; PLACEBO,BELGIUM,Recruiting,Biophytis,"June 16, 2020",Interventional,"Adaptive Design Phase 2 to 3, Randomized, Double-blind, to Evaluate Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BIO101 in the Prevention of the Respiratory Deterioration in Hospitalized COVID-19 Patients"
2807,Repeated Employee Testing for Understanding Our Recovery to Normal,COVID,"February 08, 2021",200,NCT04472793,SARS-COV-2,UNITED STATES,Recruiting,"Children's Hospital Medical Center, Cincinnati","May 11, 2020",Observational,Repeated Employee Testing for Understanding Our Recovery to Normal
2808,Rapid Experimental Medicine for COVID-19,COVID,"February 08, 2021",60,NCT04473053,NAFAMOSTAT MESILATE; TD139; STANDARD CARE,UNITED KINGDOM,Recruiting,University of Edinburgh,"July 3, 2020",Interventional,Rapid Experimental Medicine for COVID-19 - DEFINE COVID-19
2809,Optimising Resource Allocation Via Prediction of Outcomes for Covid-19,COVID,"February 08, 2021",500,NCT04473105,,UNITED KINGDOM,Recruiting,Nottingham University Hospitals NHS Trust,"May 1, 2020",Observational,Optimising Resource Allocation Via Prediction of Outcomes for Suspected and Proven Covid-19
2810,Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients,COVID,"February 08, 2021",25000,NCT04473118,SURVEY,QATAR,Recruiting,Hamad Medical Corporation,"July 11, 2020",Observational,"Burnout, Anxiety, Depression, Stress (BADS) and Post-Trauma Stress Disorder (PTSD) in Healthcare Workers Exposed to COVID-19 Patients"
2811,Immune Profiling of COVID19-patients Admitted to ICU,COVID,"February 08, 2021",300,NCT04473131,NO INTERVENTION,QATAR,Recruiting,Hamad Medical Corporation,"April 27, 2020",Observational,Immune Profiling of COVID-19-infected Patients Admitted to the Intensive Care Unit (ICU): the IMPROVISE Study
2812,COVID-19 in Patients With Anosmia in Egypt,ANOSMIA; COVID; DYSGEUSIA,"February 08, 2021",58,NCT04473157,,EGYPT,Completed,Ain Shams University,"July 1, 2020",Observational,Detection of SARS-CoV-2 in Patients Presenting With Anosmia During COVID-19 Pandemic Era in Egypt
2813,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",146,NCT04473170,AUTOLOGOUS NON-HEMATOPOIETIC PERIPHERAL BLOOD STEM CELLS (NHPBSC); COVID-19 STANDARD CARE,UNITED ARAB EMIRATES,Completed,Abu Dhabi Stem Cells Center,"April 4, 2020",Interventional,"Adaptive Open-label Study Evaluating the Safety and Efficacy of Autologous Non- Hematopoietic Peripheral Blood Stem Cells Therapy in COVID-19 Outbreak in Abu Dhabi, 2020 (SENTAD-COVID Study)"
2814,Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota,COVID; SARS-COV INFECTION; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",3000,NCT04473183,SPECIMEN COLLECTION; SURVEYS,UNITED STATES,Recruiting,University of Minnesota,"July 21, 2020",Observational,Epidemiologic Assessment of SARS-CoV-2 Prevalence in Minnesota
2815,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,COVID,"February 08, 2021",27,NCT04473248,SPARTAN COVID-19 SYSTEM,CANADA,Completed,Spartan Bioscience Inc.,"June 28, 2020",Interventional,Evaluation of Clinical Sample Collection Project: Spartan COVID-19
2816,Efficacy of Iodine Complex Against COVID-19 Patients,COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04473261,IODINE COMPLEX; IODINE COMPLEX; PLACEBO; IDOINE COMPLEX,PAKISTAN,Recruiting,Sohaib Ashraf,"July 14, 2020",Interventional,Efficacy of Iodine Complex in Mild to Moderate COVID-19 Patients
2817,"GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study",CORONAVIRUS INFECTION; DIABETES,"February 08, 2021",10,NCT04473274,PIOGLITAZONE,UNITED STATES,Completed,Samaritan Health Services,"May 21, 2020",Interventional,"GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study"
2818,Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography,CRITICAL ILLNESS; ARDS,"February 08, 2021",20,NCT04473300,,JAPAN,Recruiting,Osaka University,"May 11, 2020",Observational,Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography: a Prospective Observational Study
2819,COVID-19 Detection Tests in Different Body Fluids,COVID,"February 08, 2021",80,NCT04473352,,,Not yet recruiting,Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara,September 2020,Observational [Patient Registry],Diagnostic Accuracy of COVID-19 Detection Tests in Different Body Fluids of Infected Men and Concordance With Viral Cultures
2820,Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19),SARS-CoV2; COVID,"February 08, 2021",186,NCT04473365,,ETHIOPIA,Recruiting,Mekelle University,"July 20, 2020",Observational,Rapid Diagnostic Profiling of SARS-CoV-2 in the Context of Persistent Immune Activation in Sub-Saharan Africa (Profile-Cov)
2821,Combined Simultaneous EGD-colonoscopy Trial (CoSi Endoscopy),PROCEDURE TIME,"February 08, 2021",51,NCT04473456,SIMULTANEOUS EGD AND COLONOSCOPY,COLOMBIA,Completed,EmuraCenter LatinoAmerica,"June 13, 2020",Interventional,Combined Simultaneous EGD-colonoscopy (CoSi Endoscopy) Harmlessly Reduces Procedure Times: a Randomized Control Trial
2822,COVID 19 Preventive Measures Among Mansoura Nursing Students,COVID,"February 08, 2021",215,NCT04473547,,EGYPT,Recruiting,Mansoura University,"July 15, 2020",Observational,Adherence of Nursing Students to Preventive Measures Towards Coronavirus Disease 19 During Written Exams
2823,Stay Well at Home: a Text-messaging Study Social Distancing,DEPRESSIVE SYMPTOMS; ANXIETY; COVID,"February 08, 2021",200,NCT04473599,UNIFORM RANDOM MESSAGE DELIVERY; REINFORCEMENT LEARNING MESSAGE DELIVERY,UNITED STATES,Recruiting,"University of California, Berkeley","April 17, 2020",Interventional,Stay Well at Home: A Text-messaging Study to Improve Mood and Help Cope With Social Distancing
2824,KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,COVID,"February 08, 2021",180,NCT04473690,LOW DOSE OF KBP-COVID-19; HIGH DOSE OF KBP-COVID-19; PLACEBO,UNITED STATES,Recruiting,"Kentucky BioProcessing, Inc.","December 30, 2020",Interventional,"A First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of KBP-COVID-19 SARS-CoV-2 Vaccine With Adjuvant in Healthy Seronegative Adults Aged 18-49 and 50-70"
2825,Telerehabilitation After Coronavirus,COVID,"February 08, 2021",36,NCT04473898,AEROBIC EXERCISE TRAINING; PATIENT EDUCATION; RESPIRATORY EXERCISE TRAINING,TURKEY,Recruiting,KTO Karatay University,"June 19, 2020",Interventional,Telerehabilitation After Covid-19: Effectiveness of Respiratory and Aerobic Training
2826,An Epidemiological Investigation on the Correct Wearing of Face Mask,RESPIRATORY INFECTIOUS DISEASES,"February 08, 2021",6000,NCT04474028,,CHINA,Completed,Fuwai Yunnan Cardiovascular Hospital,"June 19, 2020",Observational,An Epidemiological Investigation on the Prevention of Respiratory Infectious Diseases by Wearing Mask Correctly
2827,COVID-19 - Cytokine Storm,COVID,"February 08, 2021",300,NCT04474067,NO INTERVENTION,ISRAEL,Recruiting,Hadassah Medical Organization,"June 28, 2020",Observational,A Multi-Center Study Evaluating Clinical Course in Patients With COVID-19 and Its Relationship to Cytokine Storm
2828,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,BURNOUT,"February 08, 2021",1080,NCT04474080,VIRTUAL PEER SUPPORT PLATFORM; CONTROL PERIOD,CANADA,Not yet recruiting,St. Joseph's Healthcare Hamilton,"January 15, 2021",Interventional,The Role of Virtual Peer Support Platforms for Reducing Stress and Burnout Among Frontline Healthcare Workers During COVID-19: A Randomized Controlled Trial
2829,Lung Ultrasound for COVID-19 Initial Triage and Monitoring,COVID; ACUTE RESPIRATORY FAILURE; TRIAGE; LUNG ULTRASOUND; CT SCAN,"February 08, 2021",148,NCT04474236,THORACIC LUNG ULTRASOUND,FRANCE,Recruiting,"University Hospital, Toulouse","May 27, 2020",Observational,Use of Lung Ultrasound for COVID-19 Patient's Initial Triage Assessment and Early Monitoring: a Pilot Study
2830,Follow-up of Critical COVID-19 Patients,COVID; ARDS; AKI; CIRCULATORY FAILURE; COAGULATION DISORDER; INFLAMMATORY RESPONSE,"February 08, 2021",300,NCT04474249,,SWEDEN,Recruiting,Uppsala University,"June 25, 2020",Observational,Uppföljning av Patienter Som intensivvårdats för COVID-19
2831,The COVID-19 PUI Reality Check (CPRC) Study,COVID IMMUNOLOGY,"February 08, 2021",400,NCT04474288,SARS-COV-2 ANTIBODY TESTING,UNITED STATES,Recruiting,Bassett Healthcare,"July 16, 2020",Observational,SARS-CoV-2 Specific Immune Responses in Hospitalized Persons Under Investigation (PUIs) With Negative Nasopharyngeal PCR Swabs - The COVID-19 PUI Reality Check (CPRC) Study
2832,Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic,COVID INFECTION; MELANOMA,"February 08, 2021",1152,NCT04474301,SURVEY ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"June 11, 2020",Observational,Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic
2833,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,"MODERATE COVID PNEUMONIA, SEVERE COVID PNEUMONIA; PNEUMONIA, VIRAL","February 08, 2021",300,NCT04474340,COVID-19 CONVALSCENT PLASMA,KUWAIT,Recruiting,"Ministry of Health, Kuwait","May 21, 2020",Interventional,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients: Multicenter Interventional Study
2834,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP),"ALCOHOL USE, UNSPECIFIED; SUBSTANCE USE; INTOXICATION ALCOHOL; EMERGENCIES; COVID PANDEMIC; TREATMENT","February 08, 2021",55000,NCT04474444,ATTENDANCE BY AMBULANCE CREW,UNITED KINGDOM,Recruiting,University of Lincoln,"March 23, 2019",Observational,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP): Exploring Attendance at Incidents Involving Substance and/or Alcohol Use During COVID-19 Pandemic
2835,Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age,COVID,"February 08, 2021",1000,NCT04474457,FAVIPIRAVIR,TURKEY,"Active, not recruiting","Ministry of Health, Turkey","June 11, 2020",Observational,An ObservationaI Study to Evaluate the Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age Who Are Receiving Favipiravir
2836,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,COVID,"February 08, 2021",30,NCT04474483,MELATONIN; PLACEBO (METHYLCELLULOSE) CAPSULE,UNITED STATES,Recruiting,State University of New York at Buffalo,"November 6, 2020",Interventional,A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection
2837,Impact of COVID-19 on Marshallese Communities in the U.S.,COVID,"February 08, 2021",2000,NCT04474496,ASSESSING IMPACT OF COVID19,UNITED STATES,Enrolling by invitation,University of Arkansas,"July 27, 2020",Observational,Impact of COVID-19 on Marshallese Communities in the U.S.
2838,Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection,SARS-CoV2; ARDS,"February 08, 2021",12,NCT04475068,LATERAL POSITION (LEFT AND RIGHT LATERAL DECUBITUS),PERU,Recruiting,Hospital Nacional Edgardo Rebagliati Martins,"July 17, 2020",Observational,Feasibility and Physiological Effects of a Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection
2839,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,SEPSIS SYNDROME,"February 08, 2021",60,NCT04475081,MMR VACCINE,,Not yet recruiting,Louisiana State University Health Sciences Center in New Orleans,"August 17, 2020",Interventional,Use of a Live Attenuated Vaccine Repurposed as an Innate Immune-based Preventive Against COVID-19-associated Sepsis/Inflammation
2840,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,COVID,"February 08, 2021",76,NCT04475107,PYRONARIDINE-ARTESUNATE; PLACEBO,"KOREA, REPUBLIC OF",Recruiting,Shin Poong Pharmaceutical Co. Ltd.,"July 9, 2020",Interventional,"A Multi-center, Randomized, Double-blind, Parallel, Placebo-Controlled, Phase Ⅱ Clinical Trial to Evaluate Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients"
2841,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,COVID,"February 08, 2021",60,NCT04475120,LIPOSOMAL LACTOFERRIN,ITALY,Completed,University of Rome Tor Vergata,"April 15, 2020",Interventional,Interventional Pilot Study to Assess the Use of Oral and Intra-nasal Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients
2842,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",117,NCT04475185,MAKAIR,FRANCE,Recruiting,Nantes University Hospital,"July 20, 2020",Interventional,"Interventional, Open, Non-comparative, Multicenter Study to Assess the Safety and Effectiveness of the Use of the MakAir Artificial Ventilator in the Expected Situation of a Shortage of Technical Devices for Invasive Mechanical Ventilation, Linked to the Coronavirus COVID-19"
2843,LILLE COVID RESEARCH NETWORK (Covid-19),SARS-CoV2,"February 08, 2021",1000,NCT04475211,,FRANCE,Recruiting,"University Hospital, Lille","August 10, 2020",Observational,Predictors of Mortality at Day 28 of Patients Treated at Lille University Hospital for COVID-19
2844,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,COVID,"February 08, 2021",2175,NCT04475302,BCG VACCINE (FREEZE-DRIED),INDIA,Recruiting,"Tuberculosis Research Centre, India","July 1, 2020",Interventional,Study to Evaluate the Effectiveness of BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots in India
2845,WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey,COVID; CARDIOVASCULAR DISEASES,"February 08, 2021",5200,NCT04475471,,ARGENTINA,Recruiting,Public Health Foundation of India,"June 11, 2020",Observational,WHF COVID-19 and Cardiovascular Disease Survey
2846,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children,INVESTIGATING PSYCHOLOGICAL IMPACT; CONFINEMENT MEASURES; CORONAVIRUS OUTBREAK; SCHOOL-AGE CHILDREN,"February 08, 2021",30000,NCT04475484,ONLINE QUESTIONNAIRE,FRANCE,Recruiting,Hospices Civils de Lyon,"June 10, 2020",Observational,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children
2847,Can the Electronic Nose Smell COVID-19?,SARS-COV INFECTION; COVID,"February 08, 2021",219,NCT04475562,AEONOSE,NETHERLANDS,Completed,Maastricht University Medical Center,"April 6, 2020",Interventional,Can the Electronic Nose Smell COVID-19? A Proof-of-principle Study
2848,Can the Electronic Nose Smell COVID-19 Antibodies?,SARS-COV INFECTION; COVID,"February 08, 2021",222,NCT04475575,AEONOSE,NETHERLANDS,Completed,Maastricht University Medical Center,"April 6, 2020",Interventional,Can the Electronic Nose Smell COVID-19 Antibodies? A Proof-of-principle Study
2849,Efficacy and Safety of Itolizumab in COVID-19 Complications,ACUTE RESPIRATORY DISTRESS SYNDROME; CYTOKINE RELEASE SYNDROME; COVID,"February 08, 2021",30,NCT04475588,"ITOLIZUMAB IV INFUSION; BEST SUPPORTIVE CARE"" WHICH INCLUDES ANTIVIRALS /ANTIBIOTICS/ HYDROXYCHLOROQUINE; OXYGEN THERAPY",INDIA,Completed,Biocon Limited,"May 1, 2020",Interventional,"A Multi-Centre, Open Label, Two Arm Randomized, Pivotal Phase 2 Trial to Study the Efficacy and Safety of Itolizumab in COVID-19 Complications"
2850,Enzalutamide Treatment in COVID-19,COVID; CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04475601,ENZALUTAMIDE PILL,SWEDEN,Recruiting,Andreas Josefsson,"July 15, 2020",Interventional,"A Prospective, Multicenter, Randomized PHASE II Clinical Trial of Enzalutamide Treatment to Decrease the Morbidity in Patients With Corona Virus Disease 2019 (COVID-19)"
2851,Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women,PREGNANCY RELATED; POSTPARTUM SADNESS,"February 08, 2021",85,NCT04475718,FOURTH TRIMESTER MOBILE TOOL,UNITED STATES,Recruiting,HealthCore-NERI,"July 6, 2020",Interventional,Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women
2852,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,EDENTULOUS MOUTH,"February 08, 2021",56,NCT04475913,DIG AXIAL; DIG TILTED; CIG AXIAL; CIG TILTED,EGYPT,"Active, not recruiting",October University for Modern Sciences and Arts,"July 11, 2018",Interventional,"In a Post -Covid-19 World, What is the Clinical Influence of Digital vs Analog Impression in Cases of All-on-4 - Prosthesis ?"
2853,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,COVID,"February 08, 2021",100,NCT04475991,MARAVIROC + CURRENTLY USED THERAPY; CURENTLY USED THERAPY FOR COVID-19 NON-CRITICAL PATIENTS; FAVIPIRAVIR + CURRENTLY USED THERAPY; MARAVIROC+FAVIPIRAVIR+CT,MEXICO,Not yet recruiting,Hospital General de México Dr. Eduardo Liceaga,January 2021,Interventional,"Phase2, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Maraviroc and/or Favipiravir Plus Standard Therapy in Adult Patients With Severe Non-critical COVID-19"""
2854,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,COVID; COMA; CONSCIOUSNESS DISORDER,"February 08, 2021",100,NCT04476589,FUNCTIONAL MRI,UNITED STATES,Recruiting,Massachusetts General Hospital,"July 1, 2020",Observational,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19
2855,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol,COVID (SARS-CoV2),"February 08, 2021",500,NCT04476602,,UNITED STATES,Recruiting,Northwell Health,"April 27, 2020",Observational,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol
2856,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",MENTAL HEALTH ISSUE; COVID; ANXIETY DISORDERS; DEPRESSION,"February 08, 2021",80,NCT04476667,E-PSYCHOTHERAPY,CANADA,Recruiting,Queen's University,"June 15, 2020",Interventional,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19"
2857,Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease,SARS-COV INFECTION; VITAMIN D DEFICIENCY; COVID; ACUTE RESPIRATORY TRACT INFECTION,"February 08, 2021",4400,NCT04476680,VITAMIN D 1000 IU; PLACEBO,UNITED KINGDOM,Not yet recruiting,Royal Centre for Defence Medicine,"September 1, 2020",Interventional,Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease
2858,Canakinumab MAP in COVID-19 Pneumonia With CRS,CYTOKINE RELEASE SYNDROME IN COVID-INDUCED PNEUMONIA,"February 08, 2021",,NCT04476706,CANAKINUMAB,,No longer available,Novartis Pharmaceuticals,,Expanded Access,Managed Access Program (MAP) to Provide Access to Canakinumab Treatment of Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
2859,"The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions",BIOEQUIVALENCE,"February 08, 2021",18,NCT04476719,ATAFENOVIR 200 MG KAPSUL; ARBIDOL 100 MG KAPSUL,TURKEY,"Active, not recruiting",Atabay Kimya Sanayi Ticaret A.S.,"July 9, 2020",Interventional,"Open-Label, Randomised, Single Oral Dose, Two-Period, Cross-Over Trial To Assess The Bioequivalence Of Atafenovir 200 Mg Kapsul In Comparison With Arbidol 100 Mg Kapsul In Healthy Male Subjects Under Fasting Conditions"
2860,The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People,CYTOKINE STORM,"February 08, 2021",100,NCT04476745,VITAMIN D3,JORDAN,Enrolling by invitation,Applied Science Private University,"October 5, 2020",Interventional,"The Effect of Weekly 50,000 IU Vitamin D3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People With Vitamin D Deficiency"
2861,European Pathology Laboratories and COVID-19,CLINICAL PRACTICE DURING THE COVID CRISIS,"February 08, 2021",71,NCT04476823,ACTIVITY,FRANCE,Completed,Centre Hospitalier Universitaire de Nice,"March 15, 2020",Observational,Practice in Clinical and Molecular Thoracic European Pathology Laboratories During the COVID-19 Pandemic.
2862,Convalescent Plasma Treatment in COVID-19,COVID,"February 08, 2021",110,NCT04476888,CONVALESCENT PLASMA (CP); DRUGS AND SUPPORTIVE CARE,PAKISTAN,Completed,Aga Khan University,"April 26, 2020",Interventional,Convalescent Plasma Treatment in COVID-19 Patients at a Tertiary Care Center in Pakistan
2863,Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU,RESPIRATORY FAILURE; SARS-CoV2; CORONAVIRUS INFECTION; POST INTENSIVE CARE UNIT SYNDROME; FAMILY MEMBERS; POST TRAUMATIC STRESS DISORDER; ANXIETY; DEPRESSION,"February 08, 2021",250,NCT04476914,,UNITED STATES,Recruiting,"University of Colorado, Denver","June 29, 2020",Observational,Psychological Distress Symptoms in Family Members of Patients With COVID-19 Respiratory Failure in Intensive Care Units
2864,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,COVID,"February 08, 2021",300,NCT04476927,DIANOSE,,Not yet recruiting,Nanose Medical Ltd.,"August 1, 2020",Interventional,Collecting and Evaluating Data of Potential Volatile Biomarkers in the Exhaled Air of Subjects With and Without COVID-19 by DiaNose
2865,COVID-19 Breastfeeding Guideline for African-Americans,COVID; EXCLUSIVE BREASTFEEDING,"February 08, 2021",200,NCT04476940,COVID-19 BREASTFEEDING SUPPORT,UNITED STATES,Not yet recruiting,Meharry Medical College,September 2020,Interventional,An Intervention to Promote COVID-19 Breastfeeding Guideline Adherence Among African American Mothers
2866,COVID-FISETIN: Pilot in Covid-19 of Fisetin to Alleviate Dysfunction and Inflammation,COVID,"February 08, 2021",70,NCT04476953,PLACEBO; FISETIN,UNITED STATES,Enrolling by invitation,Mayo Clinic,"August 3, 2020",Interventional,COVID-FISETIN: A Phase 2 Placebo-Controlled Pilot Study in Covid-19 of Fisetin to Alleviate Dysfunction and Excessive Inflammatory Response in Hospitalized Adults
2867,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,CORONAVIRUS INFECTION; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); VIRUS DISEASES; CORONAVIRIDAE INFECTIONS; NIDOVIRALES INFECTIONS; RNA VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RESPIRATORY TRACT DISEASE,"February 08, 2021",120,NCT04476979,TOCILIZUMAB; DEXAMETHASONE,FRENCH GUIANA,Recruiting,Assistance Publique - Hôpitaux de Paris,"July 16, 2020",Interventional,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
2868,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,"HYPOXEMIA; PNEUMONIA, VIRAL; CORONAVIRUS INFECTION","February 08, 2021",20,NCT04476992,NITRIC OXIDE-SESSIONS; NITRIC OXIDE-CONTINUOUS AND SESSIONS,RUSSIAN FEDERATION,"Active, not recruiting","Federal State Budgetary Scientific Institution, Research Institute of Cardiology","July 24, 2020",Interventional,A Safety Study on the Use of Intermittent Versus Continuous Inhalation of NO in Spontaneous Breathing COVID-19 Patients
2869,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",COVID; HYDROXYCHLOROQUINE ADVERSE REACTION,"February 08, 2021",40,NCT04477083,INHALABLE HYDROXYCHLOROQUINE (HCQ); SUPPORTIVE AND SYMPTOMATIC TREATMENT,EGYPT,"Active, not recruiting",Mansoura University,"July 15, 2020",Interventional,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19"
2870,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.,COVID; HEALTHCARE WORKERS,"February 08, 2021",600,NCT04477213,,,Not yet recruiting,NMC Specialty Hospital,"January 15, 2021",Observational,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers- A Multicentric Retrospective Study
2871,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group,COVID PANDEMIC; VULNERABLE SUBJECTS; LONG-TERM NON-INVASIVE VENTILATION,"February 08, 2021",100,NCT04477473,QUESTIONNAIRE-BASED OBSERVATIONAL STUDY,SWITZERLAND,Recruiting,"University Hospital, Geneva","June 30, 2020",Observational,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group: Patients Under Long Term Noninvasive Ventilation for Chronic Hypercapnic Respiratory Failure in Geneva. An Observational Monocentric Study
2872,Abatacept for Patients With COVID-19 and Respiratory Distress,COVID,"February 08, 2021",0,NCT04477642,ABATACEPT,UNITED STATES,Withdrawn,Beth Israel Deaconess Medical Center,August 2020,Interventional,Abatacept for Patients With COVID-19 and Respiratory Distress
2873,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,COVID,"February 08, 2021",200,NCT04477655,AWAKE PRONE POSITIONING; STANDARD OXYGEN THERAPY,MEXICO,Recruiting,Hospital Civil de Guadalajara,"May 3, 2020",Interventional,Prone Positioning in Non-intubated Patients With Severe COVID-19: a Randomized Controlled Trial
2874,Helmet Non-Invasive Ventilation for COVID-19 Patients,COVID; ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",320,NCT04477668,HELMET NON-INVASIVE VENTILATION,SAUDI ARABIA,Not yet recruiting,King Abdullah International Medical Research Center,October 2020,Interventional,Helmet Non-Invasive Ventilation for COVID-19 Patients
2875,Methodist Health System COVID-19 Patient Registry,COVID,"February 08, 2021",500,NCT04477889,TREATMENT FOR COVID-19,UNITED STATES,Recruiting,Methodist Health System,"June 20, 2020",Observational,Methodist Health System COVID-19 Patient Registry
2876,Long-Term Experience and Health Effects of COVID-19,COVID; CORONAVIRUS INFECTION; QUALITY OF LIFE; RISK REDUCTION,"February 08, 2021",50000,NCT04477902,NONE - OBSERVATIONAL,UNITED STATES,Recruiting,Altura,"July 1, 2020",Observational,"A Longitudinal, Long-Term, Observational Study of COVID-19 Experience and Health Effects"
2877,General Population Level Estimation for Type 1 Diabetes Risk in Children 0-5 Years Old During Routine Care Delivery,TYPE 1 DIABETES; CELIAC DISEASE,"February 08, 2021",3000,NCT04477928,SERA AND WHOLE BLOOD SAMPLING; DIFFERENTIAL GENE EXPRESSION (DGE),UNITED STATES,Recruiting,Sanford Health,"July 17, 2020",Observational,Sanford Population Level Estimation of Type 1 Diabetes Risk GEnes in Children
2878,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,COVID,"February 08, 2021",40,NCT04477954,HYPERBARIC OXYGEN,ARGENTINA,Terminated,Asociación Argentina de Medicina Hiperbárica e Investigación,"July 6, 2020",Interventional,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia
2879,Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SARS-CoV2,"February 08, 2021",200,NCT04477993,JANUS KINASE INHIBITOR (RUXOLITINIB); PLACEBO,BRAZIL,Recruiting,Vanderson Geraldo Rocha,"July 17, 2020",Interventional,"Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection"
2880,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,COVID; SARS-CoV2,"February 08, 2021",94,NCT04478019,10% POVIDONE-IODINE NASAL DECOLONIZATION SWAB PLUS 0.12% CHG ORAL RINSE,UNITED STATES,Recruiting,"University of Wisconsin, Madison","July 7, 2020",Interventional,Role of NaSo-oropHaryngeal Antiseptic dEcolonizaiton to Reduce Covid-19 Viral Shedding and Disease Transmission: SHIELD Study
2881,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),ACUTE RESPIRATORY DISTRESS SYNDROME; CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04478071,VADADUSTAT; PLACEBO,UNITED STATES,Recruiting,"The University of Texas Health Science Center, Houston","August 22, 2020",Interventional,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
2882,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,COVID,"February 08, 2021",35,NCT04478539,EXTRACORPOREAL BLOOD PURIFICATION USING THE OXIRIS® (AN69ST) HEMOFILTER,NORTH MACEDONIA,Recruiting,Zan Mitrev Clinic,"June 1, 2020",Interventional,Clinical Efficacy and Safety of Extracorporeal Blood Purification to Control Hyperinflammation and Hypercoagulability in COVID-19 Patients
2883,EXCEL: Exercise for Cancer to Enhance Living Well,CANCER; HEAD AND NECK CANCER; COLON CANCER; BREAST CANCER; PROSTATE CANCER; CANCER CAREGIVERS,"February 08, 2021",1500,NCT04478851,GROUP EXERCISE CLASSES,CANADA,Recruiting,University of Calgary,"September 2, 2020",Interventional,"Project EXCEL: Dissemination, Implementation, and Effectiveness of the Exercise Oncology Survivorship Partnership Model - Reaching Rural Cancer Survivors to Enhance Quality of Life"
2884,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul,TRAUMA; COVID,"February 08, 2021",2000,NCT04479124,COVID-19 PCR,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 10, 2020",Observational,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul
2885,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul,"COVID; RISK FACTOR, MORTALITY","February 08, 2021",5000,NCT04479137,PCR FOR COVID-19,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 10, 2020",Observational,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul
2886,Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic,COVID; SURGERY--COMPLICATIONS,"February 08, 2021",3000,NCT04479150,,SPAIN,Recruiting,Hospital Universitari de Bellvitge,"March 1, 2020",Observational [Patient Registry],Postoperative Complications and Mortality of Patients Submited to Emergency Digestive Surgery During the COVID-19 Pandemic (COVIDCIR Study): a Multicenter Cohorts' Study Protocol
2887,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,COVID,"February 08, 2021",165,NCT04479163,CONVALESCENT PLASMA; PLACEBO,ARGENTINA,Completed,Fundacion Infant,"June 4, 2020",Interventional,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2.
2888,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,BERBERINE; COVID,"February 08, 2021",76,NCT04479202,BERBERINE; MONTMORRILLONITE,CHINA,Completed,Chinese Medical Association,"February 8, 2020",Interventional,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19
2889,Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.,COAGULATION DISORDER,"February 08, 2021",70,NCT04479280,"SONCLOT COAGULATION AND PLATELET FUNCTION ANALYZER SCP1, SIENCO, USA",EGYPT,Completed,Assiut University,"July 20, 2020",Observational,Evaluation of the Role of Sonoclot Signature in Assessment of Coagulopathy in Critically Ill COVID 19 Patients
2890,Post COVID-19 Functional Status in Egypt,COVID; CORONAVIRUS DISEASE; SARS-CoV2,"February 08, 2021",400,NCT04479293,POST COVID-19 FUNCTIONAL SATUS SCALE,EGYPT,Recruiting,Assiut University,"July 1, 2020",Observational,Assessment of Functional Recovery From COVID-19 Using the Proposed Post- COVID-19 Functional Status Score
2891,Decision Support System Algorithm for COVID-19 Diagnosis,COVID,"February 08, 2021",10000,NCT04479319,THORAX CT,TURKEY,Recruiting,Ankara University,"December 31, 2020",Observational,Developing Hybrid Decision Support System Algorithm for COVID-19 Diagnosis Between RT-PCR Graphics and Thorax CT Images Using Deep Learning
2892,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),CORONAVIRUS INFECTION; CRITICAL ILLNESS,"February 08, 2021",334,NCT04479332,TRACHEAL INTUBATION AND CARDIOPULMONARY RESUSCITATION,,Not yet recruiting,National Taiwan University Hospital,"August 1, 2020",Interventional,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19)
2893,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era","KNOWLEDGE, ATTITUDES, PRACTICE","February 08, 2021",100,NCT04479345,QUESTIONNAIRE,,Not yet recruiting,Assiut University,July 2020,Observational,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era"
2894,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,COVID,"February 08, 2021",332,NCT04479358,TOCILIZUMAB; TOCILIZUMAB; STANDARD OF CARE; STANDARD OF CARE,UNITED STATES,Recruiting,University of Chicago,"September 10, 2020",Interventional,"COVIDOSE-2: A Multi-center, Randomized, Controlled Phase 2 Trial Comparing Early Administration of Low-dose Tocilizumab to Standard of Care in Hospitalized Patients With COVID-19 Pneumonitis Not Requiring Invasive Ventilation"
2895,Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil),COVID; SARS-COV INFECTION,"February 08, 2021",2000,NCT04479488,HOSPITAL ADMISSION; NON-HOSPITALIZATION PROCEDURES,BRAZIL,Recruiting,Hospital Israelita Albert Einstein,"July 27, 2020",Observational [Patient Registry],"Brazilian COVID-19 Registry for Clinical Presentation of Individuals With COVID-19: a National, Multicentre, Prospective Observational Study (SARS-Brazil)"
2896,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,"PNEUMONIA, VIRAL","February 08, 2021",120,NCT04479540,ANGIOGRAPHY SCANNER,FRANCE,Recruiting,Hopital Foch,"May 26, 2020",Interventional,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With SARS Coronavirus (COV-2) Lung Disease
2897,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",COVID,"February 08, 2021",16,NCT04479631,BRII-196; PLACEBO,CHINA,"Active, not recruiting",Brii Biosciences Limited,"July 12, 2020",Interventional,"A Phase 1 Randomized, Single-blind, Placebo-controlled, Single Ascending Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Human Monoclonal Antibody, BRII-196 Administered Intravenously to Healthy Adult Volunteers"
2898,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",COVID,"February 08, 2021",17,NCT04479644,BRII-198; PLACEBO,CHINA,"Active, not recruiting",Brii Biosciences Limited,"July 13, 2020",Interventional,"A Phase 1 Randomized, Single-blind, Placebo-controlled, Single Ascending Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Human Monoclonal Antibody, BRII-198 Administered Intravenously to Healthy Adult Volunteers"
2899,Microbial Infection and AMR in Hospitalized Patients With Covid 19,COVID,"February 08, 2021",70,NCT04479982,,EGYPT,Recruiting,Assiut University,"September 24, 2020",Observational,Microbial Infections and Antimicrobial Resistance (AMR) Patterns Associated With Hospitalized Patients With 2019 Novel Coronavirus Disease (COVID 19)
2900,Obesity Surgery During 2020 Italian Pandemic,"BARIATRIC SURGERY CANDIDATE; COVID; COMPLICATION OF SURGICAL PROCEDURE; PNEUMONIA, VIRAL; VIRAL INFECTION; OBESITY, MORBID; SAFETY ISSUES; READMISSION","February 08, 2021",1600,NCT04480034,BARIATRIC PROCEDURES,ITALY,Recruiting,University of Roma La Sapienza,"July 15, 2020",Observational,"Laparoscopic Bariatric Surgery During Phase 2-3 Covid-19 Pandemic in Italy: a Multicenter, Prospective, Observational Study."
2901,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic,COVID,"February 08, 2021",100000,NCT04480060,COVID-19 DIAGNOSTIC PCR,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 10, 2020",Observational,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic: Retrospective Cohort Study
2902,Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults,MEMORY DISORDERS; ALZHEIMER DISEASE; MILD COGNITIVE IMPAIRMENT,"February 08, 2021",150,NCT04480112,TECHNOLOGY BASED SOCIAL INTERACTIONS; NO RESEARCH RELATED TECHNOLOGY BASED SOCIAL INTERACTIONS,UNITED STATES,Enrolling by invitation,Boston University,"June 2, 2020",Interventional,Impact of Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults With and Without Cognitive Impairment
2903,Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19),COVID,"February 08, 2021",40,NCT04480138,PEGYLATED INTERFERON-Α2B; STANDARD OF CARE,MEXICO,Recruiting,Cadila Healthcare Limited,"August 11, 2020",Interventional,"A Phase II, Multicenter, Open-label, Randomized, Comparator Controlled Study to Evaluate the Efficacy and Safety of Pegylated Interferon - α2b in the Treatment of Adult Patients Diagnosed With SARS-CoV2 (COVID-19)"
2904,NICU2HOME+: Supporting Illinois Families,PREMATURE BIRTH; NICU; PREMATURE; INFANT,"February 08, 2021",600,NCT04480255,GROUP 1: STANDARD OF CARE; GROUP 2: NICU2HOME+ APP,UNITED STATES,Recruiting,Craig Garfield,"August 3, 2020",Interventional,NICU2HOME+: Supporting Illinois Families of Premature Infants With Smartphone Technology
2905,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831",COVID; CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA; SEVERE ACUTE RESPIRATORY SYNDROME OF UPPER RESPIRATORY TRACT; NEURODEGENERATION; NEUROINFLAMMATORY RESPONSE,"February 08, 2021",45,NCT04480333,DRUG: NA-831 - 0.10 MG/KG; PLACEBO- 0.10 MG/KG; DRUG: NA-831 - 0.20 MG/KG; PLACEBO- 0.20 MG/KG; DRUG: GS-5734 - 1.00 MG/KG; PLACEBO- 1.00 MG/KG; DRUG: GS-5734 - 2.00 MG/KG; PLACEBO- 2.00 MG/KG; DRUGS: NA-831 (0.10 MG/KG) PLUS GS-5734 (1.00 MG/KG); PLACEBO 0.10 MG + 1.00 MG/KG; DRUGS: NA-831 (0.20 MG/KG) PLUS GS-5734 (2.00 MG/KG); PLACEBO 0.20 MG + 2.00 MG/KG,UNITED STATES,Recruiting,"NeuroActiva, Inc.","September 15, 2020",Interventional,"A Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and in Combination With NA-831 in Healthy Volunteers"
2906,Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients,COVID; ASYMPTOMATIC CONDITION,"February 08, 2021",91,NCT04480398,GUDUCHI GHAN VATI,INDIA,Completed,Aarogyam UK,"May 12, 2020",Observational,A Retrospective Study on Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients
2907,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,DIAGNOSES DISEASE; COVID,"February 08, 2021",50,NCT04480411,DOCTORGRAM PATIENT KIT,UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients
2908,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),COVID,"February 08, 2021",100,NCT04480424,GAMUNEX-C; STANDARD MEDICAL TREATMENT,UNITED STATES,Recruiting,Grifols Therapeutics LLC,"September 17, 2020",Interventional,"A Multicenter, Randomized, Open-label Parallel Group Pilot Study to Evaluate Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Subjects With COVID-19 Requiring Admission to the Intensive Care Unit"
2909,Does COVID-19 Pandemic Reduce In-hospital Mortality?,COVID; IN-HOSPITAL CARDIAC ARREST,"February 08, 2021",5000,NCT04480515,IN-HOSPITAL MORTALITY RATE,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 11, 2020",Observational,Does COVID-19 Pandemic Reduce In-hospital Mortality?
2910,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery,COVID; SURGERY; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",100,NCT04480580,SARS-COV-2 AB,ITALY,Completed,University of Cagliari,"March 30, 2020",Observational,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery
2911,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,COVID,"February 08, 2021",120,NCT04480593,BRAZILIAN GREEN PROPOLIS EXTRACT (EPP-AF); STANDARD CARE,BRAZIL,Completed,D'Or Institute for Research and Education,"June 2, 2020",Interventional,"The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19: a Randomized, Open and Pilot Clinical Study."
2912,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,EXERCISE PROGRAM,"February 08, 2021",88,NCT04480606,HOME EXERCISE PROGRAM,,Not yet recruiting,Istinye University,"August 1, 2020",Interventional,"Effects of Home Exercise Program Applied to the Socially Isolated Elderly Due to COVID-19 on Physical Activity Level, Functional Capacity and Quality of Life"
2913,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,COVID,"February 08, 2021",44,NCT04480632,CONVALESCENT PLASMA,COLOMBIA,Not yet recruiting,Fundación Cardiovascular de Colombia,"August 1, 2020",Interventional,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis / Plasmaféresis terapéutica en Pacientes Adultos críticamente Enfermos Con diagnóstico Confirmado de COVID-19
2914,Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects,SARS-CoV2,"February 08, 2021",92,NCT04480957,ARCT-021 DOSE 1; ARCT-021 DOSE 2; ARCT-021 DOSE 3; ARCT-021 DOSE 4; ARCT-021 DOSE REGIMEN 1; ARCT-021 DOSE REGIMEN 2; PLACEBO,SINGAPORE,Recruiting,"Arcturus Therapeutics, Inc.","August 4, 2020",Interventional,"A Phase 1/2 Randomised, Double Blinded, Placebo Controlled, Ascending Dose Study to Assess the Safety, Tolerability, and Immunogenicity of ARCT-021 in Healthy Adult Subjects"
2915,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital,CORONAVIRUS,"February 08, 2021",100,NCT04481360,CT OF THE CHEST,,Not yet recruiting,Assiut University,August 2020,Observational,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut
2916,Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19,COVID,"February 08, 2021",450,NCT04481477,"NURSING CARE TO REDUCE ANXIETY, FEAR AND LONELINESS",SPAIN,Not yet recruiting,Corporacion Parc Tauli,September 2020,Observational,Impact on Patients of Nurses' Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19
2917,Yoga in NHS Health Care Workers With COVID-19 Related Stress,STRESS,"February 08, 2021",30,NCT04481516,YOGA,UNITED KINGDOM,Recruiting,Doncaster And Bassetlaw Hospitals NHS Foundation Trust,"July 1, 2020",Observational,Effect of Breathing-based Meditation (Sudarshan Kriya Yoga) in NHS Health Care Workers With Possible COVID-19 Related Stress and Anxiety Disorder
2918,COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector,INFECTION VIRAL,"February 08, 2021",1576,NCT04481529,HEALTH QUESTIONNAIRE,FRANCE,"Active, not recruiting","University Hospital, Limoges","July 29, 2020",Observational,Study of the COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector in 3 French Regions Facing the COVID-19 Epidemic With Varying Degrees of Intensity
2919,"Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT",COVID,"February 08, 2021",1315,NCT04481620,,FRANCE,Recruiting,"University Hospital, Bordeaux","August 31, 2020",Observational,"Evelopment and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT"
2920,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,COVID,"February 08, 2021",800,NCT04481633,COVID 19 SEROLOGY; COVID 19 SELF-QUESTIONNAIRE,FRANCE,Recruiting,"University Hospital, Toulouse","September 9, 2020",Interventional,Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease
2921,Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool,COVID,"February 08, 2021",630,NCT04481646,FACE MASK SAMPLING,UNITED KINGDOM,Recruiting,University of Leicester,"June 12, 2020",Observational [Patient Registry],The Efficacy and Feasibility of Face Mask Sampling for Hospitalised Adult Patients and Healthcare Workers With Suspected COVID-19
2922,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)",COVID,"February 08, 2021",36,NCT04481685,ATI-450; PLACEBO,UNITED STATES,Recruiting,University of Kansas Medical Center,"July 20, 2020",Interventional,"A Double-blind, Randomized, Controlled Trial of ATI-450 in Patients With Moderate-severe COVID-19"
2923,Emotional Support and Stress Management in Patients Diagnosed With COVID-19,COVID,"February 08, 2021",150,NCT04482023,"TRAINING VIDEO ON ANXIETY, FEAR AND LONELINESS IN THE COVID-19 ENVIRONMENT.",SPAIN,Not yet recruiting,Corporacion Parc Tauli,September 2020,Observational,Emotional Support and Stress Management Activities Offered by Nurses to Patients Diagnosed With COVID-19 During Hospital Admission
2924,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures,ECONOMIC BURDEN,"February 08, 2021",840,NCT04482205,,PAKISTAN,Completed,Aga Khan University,"March 16, 2020",Observational,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures in Musculoskeletal Service Line of a Tertiary Care Hospital
2925,SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES,COVID,"February 08, 2021",5900,NCT04482361,PRESENCE OF SPECIFIC ANTI-SARS-COV-2 ANTIBODIES,ARGENTINA,Completed,Ministerio de Salud de Ciudad Autónoma de Buenos Aires,"August 6, 2020",Observational [Patient Registry],SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES
2926,DigiVis: Self-testing Vision App for Telephone Consultations,VISUAL IMPAIRMENT; AMBLYOPIA SUSPECT,"February 08, 2021",250,NCT04482387,DIGIVIS VISUAL ACUITY APP,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"July 24, 2020",Interventional,DigiVis: Validation of Self-testing Visual Acuity Web-based App to Aid Ophthalmic Telephone Consultations During Covid19 Lockdown and Subsequent Social Distancing Crisis
2927,BIO 300 Oral Suspension in Discharged COVID-19 Patients,PULMONARY FIBROSIS,"February 08, 2021",66,NCT04482595,BIO 300 ORAL SUSPENSION; PLACEBO,UNITED STATES,Recruiting,Humanetics Corporation,"November 11, 2020",Interventional,A Phase 2 Study of BIO 300 Oral Suspension in Discharged COVID-19 Patients
2928,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,COVID,"February 08, 2021",40,NCT04482621,DECITABINE; PLACEBO SALINE,UNITED STATES,Recruiting,Johns Hopkins University,"September 14, 2020",Interventional,Decitabine for COVID-19 Pneumonia-ARDS Treatment: DART Trial
2929,Tele-rehabilitation Versus Home Exercise Program in COVID-19,PULMONARY REHABILITATION; COVID,"February 08, 2021",122,NCT04482634,REMOTE CONTROLLED EXERCISE; HOME EXERCISE,TURKEY,Recruiting,Koç University,"September 1, 2020",Interventional,Is Tele-rehabilitation Superior to Home Exercise Program in the Pulmonary Rehabilitation of the Patients With COVID-19 With Post-intensive Care Syndrome? A Randomized Controlled Trial
2930,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,COVID INFECTION,"February 08, 2021",50,NCT04482647,MEDIA INTERVENTION; MEDITATION THERAPY; QUALITY-OF-LIFE ASSESSMENT; QUESTIONNAIRE ADMINISTRATION; YOGA,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"June 17, 2020",Interventional,Breathing Techniques and Meditation for Health Care Workers During COVID-19
2931,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,COVID; VITAMIN D DEFICIENCY; RESPIRATORY VIRAL INFECTION,"February 08, 2021",140,NCT04482673,DAILY VITAMIN D3; DAILY PLACEBO; BOLUS VITAMIN D3; BOLUS PLACEBO,UNITED STATES,Recruiting,Medical University of South Carolina,"July 31, 2020",Interventional,The Role of Vitamin D in Mitigating COVID-19 Infection Severity: Focusing on Reducing Health Disparities in South Carolina
2932,Trial of Combination Therapy to Treat COVID-19 Infection,COVID; COVID; CORONAVIRUS INFECTION; CORONAVIRUS INFECTION; CORONAVIRUS-19; SARS-CoV2; SARS-COV INFECTION,"February 08, 2021",30,NCT04482686,IVERMECTIN; DOXYCYCLINE HCL; ZINC; VITAMIN D3; VITAMIN C,UNITED STATES,Recruiting,ProgenaBiome,"December 9, 2020",Interventional,A Phase II Double-Blind Randomized Placebo-Controlled Trial of Combination Therapy to Treat COVID-19 Infection
2933,RAPA-501-Allo Off-the-Shelf Therapy of COVID-19,SEVERE COVID DISEASE,"February 08, 2021",88,NCT04482699,RAPA-501-ALLO OFF-THE-SHELF THERAPY OF COVID-19; PLACEBO,UNITED STATES,Recruiting,Rapa Therapeutics LLC,"December 30, 2020",Interventional,"Phase I/Phase II Trial of Off-the-Shelf Allogeneic Hybrid TREG/Th2 Cell (RAPA-501-ALLO) Therapy for Severe, Post-Intubation Stage 3 COVID-19 Disease"
2934,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS,ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS); RESPIRATORY FAILURE; SARS-CoV2,"February 08, 2021",20,NCT04482712,RAPAMYCIN; PLACEBO,UNITED STATES,Not yet recruiting,The University of Texas Health Science Center at San Antonio,January 2021,Interventional,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of Acute Respiratory Distress Syndrome (RAPA-CARDS)
2935,The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm,CYTOKINE STORM; CYTOKINES,"February 08, 2021",100,NCT04483271,300 MG OF OMEGA3-FA,JORDAN,Enrolling by invitation,Applied Science Private University,"October 2, 2020",Interventional,The Effect of Omega-3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People
2936,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects",CORONAVIRUS DISEASE 2019(COVID),"February 08, 2021",33,NCT04483375,SCTA01; PLACEBO,CHINA,Completed,Sinocelltech Ltd.,"July 24, 2020",Interventional,"A Randomized, Double-blinded, Placebo-controlled, Single Ascending Dose, Phase I Study to Evaluate the Tolerability, Safety, Pharmacokinetics of SCTA01 in Healthy Subjects"
2937,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,COVID,"February 08, 2021",30,NCT04483622,,EGYPT,Recruiting,Sohag University,"June 12, 2020",Observational,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients
2938,PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,COVID,"February 08, 2021",2414,NCT04483635,PLACEBO; VITAMIN D,CANADA,Not yet recruiting,St. Justine's Hospital,"November 30, 2020",Interventional,PROTECT RCT (PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams
2939,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,COV2 SARS PNEUMONIA,"February 08, 2021",100,NCT04483752,CHEST CT SCAN,FRANCE,Recruiting,Centre Chirurgical Marie Lannelongue,"June 8, 2020",Interventional,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images
2940,Suloexide in the Treatment of Early Stages of COVID-19,COVID,"February 08, 2021",243,NCT04483830,SULODEXIDE; PLACEBO,MEXICO,Completed,Clinedem,"June 5, 2020",Interventional,Sulodexide in the Treatment of Early Stages of COVID-19
2941,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses,COVID INFECTION,"February 08, 2021",550,NCT04483908,BLOOD DRAW; FINGERTIP TESTS FOR POC ASSAYS; SALIVA COLLECTION; COLLECTION OF SWABS,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","April 10, 2020",Observational,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses (SERO-BL-COVID-19)
2942,Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial,SARS-CoV2 INFECTION (COVID),"February 08, 2021",2400,NCT04483960,NAFAMOSTAT MESILATE; CONVALESCENT PLASMA; ENOXAPARIN; DALTEPARIN; TINZAPARIN; ASPIRIN,AUSTRALIA,Recruiting,University of Melbourne,"July 28, 2020",Interventional,"A Multi-centre Randomised Adaptive Platform Clinical Trial to Assess Clinical, Virological and Immunological Outcomes in Patients With SARS-CoV-2 Infection (COVID-19)"
2943,SPI-1005 Treatment in Severe COVID-19 Patients,COVID; CORONAVIRUS; CORONAVIRUS INFECTION; CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04483973,EBSELEN; PLACEBO,,Not yet recruiting,"Sound Pharmaceuticals, Incorporated",December 2020,Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Severe COVID-19 Patients"
2944,SPI-1005 Treatment in Moderate COVID-19 Patients,COVID; CORONAVIRUS INFECTION; CORONAVIRUS; CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04484025,EBSELEN; PLACEBO,,Not yet recruiting,"Sound Pharmaceuticals, Incorporated",December 2020,Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Moderate COVID-19 Patients"
2945,Addressing COVID-19 Mental Health Problems Among US Veterans,BRIEF VIDEO-BASED INTERVENTION; VIGNETTE BASED INTERVENTION; NON INTERVENTION CONTROL ARM,"February 08, 2021",200,NCT04484207,A SHORT VIDEO INTERVENTION; A VIGNETTE INTERVENTION,UNITED STATES,Recruiting,"Research Foundation for Mental Hygiene, Inc.","July 6, 2020",Interventional,Addressing COVID-19 Mental Health Problems Among US Veterans
2946,Corticosteroid Nasal Spray in COVID-19 Anosmia,COVID; ANOSMIA,"February 08, 2021",100,NCT04484493,MOMETASONE FUROATE NASAL SPRAY,EGYPT,Completed,Benha University,"August 8, 2020",Interventional,Role of Corticosteroid Nasal Spray in Recovery of Smell Sensation in COVID-19 Patients
2947,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection,COVID,"February 08, 2021",250,NCT04484545,PROGNOSTIC SCORE,UNITED KINGDOM,"Active, not recruiting",Glasgow Royal Infirmary,"April 1, 2020",Observational,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection
2948,Predictors of COVID-19 Infection and Disease Progression,POSITIVE COVID BY PCR,"February 08, 2021",100,NCT04484597,RT PCR,EGYPT,Recruiting,Port Said University,"March 15, 2020",Observational,Predictors of COVID-19 Infection and Disease Progression
2949,Online 1-Day CBT-Based Workshops for PPD,POSTPARTUM DEPRESSION,"February 08, 2021",388,NCT04485000,ONLINE 1-DAY COGNITIVE BEHAVIOURAL THERAPY (CBT)-BASED WORKSHOP,CANADA,Recruiting,McMaster University,"April 20, 2020",Interventional,Online 1-Day CBT-Based Workshops for Postpartum Depression
2950,DISulfiram for COvid-19 (DISCO) Trial,COVID,"February 08, 2021",60,NCT04485130,DISULFIRAM; PLACEBO,UNITED STATES,Not yet recruiting,"University of California, San Francisco","February 1, 2021",Interventional,"DISulfiram for COvid-19 (DISCO) Trial: A Phase 2 Double-Blind, Randomized Placebo-Controlled Trial of Disulfiram Compared to Standard Care in Patients With Symptomatic COVID-19"
2951,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,COVID; CYTOKINE RELEASE SYNDROME,"February 08, 2021",280,NCT04485169,THERAPEUTIC PLASMA EXCHANGE,PAKISTAN,Completed,UNICEF,"April 1, 2020",Interventional,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; a Retrospective Propensity Matched Control Study
2952,Chest Radiography in COVID-19 Patients,COVID,"February 08, 2021",200,NCT04485338,,NETHERLANDS,Recruiting,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"August 1, 2020",Observational,Radiographic Assessment of Lung Edema in Invasively Ventilated COVID-19 Patients (RALE-COVID) - Protocol for an International Multicenter Retrospective Study
2953,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes,DIABETES MELLITUS; CORONAVIRUS INFECTION; METABOLIC DISEASE; GLUCOSE METABOLISM DISORDERS,"February 08, 2021",700,NCT04485351,NO INTERVENTION,FRANCE,Recruiting,"Central Hospital, Nancy, France",July 2020,Observational,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes: a Monocentric Cross-sectional Study
2954,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia,CORONAVIRUS; COVID,"February 08, 2021",100,NCT04485364,,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"April 14, 2020",Observational,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia: BioCovid Study
2955,Safety Net Support Use in California,HOUSEHOLDS,"February 08, 2021",530,NCT04485377,,UNITED STATES,Recruiting,"University of California, Berkeley","August 1, 2020",Observational,Assessing Californians Communities' Experiences With Safety Net Supports Survey
2956,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",268,NCT04485429,METHYLPREDNISOLONE; HEPARIN,BRAZIL,Recruiting,D'Or Institute for Research and Education,"July 20, 2020",Interventional,"Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia: A Randomized, Controlled, 2x2 Factorial Study"
2957,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,COVID,"February 08, 2021",20,NCT04486001,PSC-04,UNITED STATES,Recruiting,"Sorrento Therapeutics, Inc.","December 15, 2020",Interventional,COVID-19 Stem Cell Therapy: A Phase I Study of Intravenous Administration of Allogeneic Adipose Stem Cells
2958,Impact Nerium Oleander on Symptoms and Mortality: A Feasibility Study,COVID POSITIVE PATIENT; COVID CLOSE CONTACT,"February 08, 2021",100,NCT04486144,PROPRIETARY EXTRACT OF NERIUM OLEANDER,UNITED STATES,Enrolling by invitation,HealthQuilt,"May 20, 2020",Interventional,Impact of a Proprietary Extract of Nerium Oleander on Symptoms and Mortality :A Feasibility Study
2959,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,COVID,"February 08, 2021",1092,NCT04486313,NITAZOXANIDE; PLACEBO; VITAMIN SUPER B-COMPLEX,UNITED STATES,"Active, not recruiting",Romark Laboratories L.C.,"August 13, 2020",Interventional,"Phase 3, Randomized, Double-Blind, Placebo-Controlled, Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19"
2960,"Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America",ACUTE STRESS DISORDER,"February 08, 2021",2500,NCT04486404,ONLINE SURVEY,ARGENTINA,Enrolling by invitation,Universidad Miguel Hernandez de Elche,"April 1, 2020",Observational,"Personal Protective Equipmente Needs, Perceptions and Acute Stress Among Healthcare Workers Caring for COVID-19 Patients in South America"
2961,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19,OBESITY; TELEMEDICINE; BARIATRIC SURGERY,"February 08, 2021",20,NCT04486417,,ITALY,Recruiting,University of Roma La Sapienza,"June 1, 2020",Observational,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Center of Excellence During Covid-19 Phase 2: a Prospective Observational Study
2962,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,MILD-TO-MODERATE COVID,"February 08, 2021",50,NCT04486482,KB109 + SELF SUPPORTIVE CARE (SSC); SELF SUPPORTIVE CARE (SSC) ALONE,UNITED STATES,Recruiting,Kaleido Biosciences,July 2020,Interventional,"An Exploratory, Open Label, Clinical Study to Evaluate the Physiologic Effects of KB109 in Adult Patients With Mild-to-Moderate COVID-19 on Gut Microbiota Structure and Function in the Outpatient Setting"
2963,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,COVID,"February 08, 2021",600,NCT04486508,INTERMEDIATE DOSE ENOXAPARIN/ UNFRACTIONATED HEPARIN; STANDARD PROPHYLACTIC DOSE ENOXAPARIN/ UNFRACTIONATED HEPARIN; ATORVASTATIN 20MG; MATCHED PLACEBO,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Rajaie Cardiovascular Medical and Research Center,"July 30, 2020",Interventional,Intermediate-dose Versus Standard Prophylactic Anticoagulation In cRitically-ill pATIents With COVID-19: An opeN Label Randomized Controlled Trial---A Randomized Trial of Atorvastatin vs. Placebo In Critically-ill Patients With COVID-19
2964,Clinical Outcome of Anti-IL6 vs Anti-IL6 Corticosteroid Combination in Patients With SARS-CoV-2 Cytokine Release Syndrome,CRITICAL ILLNESS; CORONAVIRUS INFECTION; CYTOKINE RELEASE SYNDROME,"February 08, 2021",11000,NCT04486521,INTERLEUKIN 6 (IL6) ANTAGONIST; INTERLEUKIN 6 (IL6) ANTAGONIST AND CORTICOSTEROIDS,SAUDI ARABIA,Recruiting,King Faisal Specialist Hospital & Research Center,"July 22, 2020",Observational,Clinical Outcome of Anti-IL6 vs Anti-IL6 Corticosteroid Combination in Patients With SARS-CoV-2 Cytokine Release Syndrome
2965,Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2,"COVID; ARDS, HUMAN","February 08, 2021",15,NCT04486729,HIGH PEEP WITH END INSPIRATORY PAUSE; LOW PEEP - FIO2 HIGH; HIGH PEEP WITHOUT END INSPIRATORY PAUSE; LOW PEEP - FIO2 LOW,ARGENTINA,Recruiting,Sanatorio Anchorena San Martin,"July 1, 2020",Observational,Respiratory System Mechanics and Gas Exchange Characteristics Applying Different Ventilatory Strategies in Patients With SARS-CoV-2
2966,Hematology and Clinical Picture in Pediatric COVID-19 Infection,COVID,"February 08, 2021",29,NCT04487119,,EGYPT,Completed,Benha University,"August 12, 2020",Observational,Pediatric COVID-19 Infection; Do Clinical Features and Hematological Parameters Predict the Need for ICU Admission?
2967,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,POSTPARTUM DEPRESSION; COVID; PREVALENCE; SOCIAL DISTANCE,"February 08, 2021",248,NCT04487171,QUESTIONNAIRE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","July 21, 2020",Interventional,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic
2968,"SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)",KIDNEY TRANSPLANT; PANCREATIC TRANSPLAT; PANCREATIC ISLETS LANGERHANS,"February 08, 2021",300,NCT04487197,BLOOD SAMPLE FOR SEROEPIDEMIOLOGICAL INVESTIGATION,ITALY,Recruiting,Antonio Secchi,"July 15, 2020",Observational,"SARS-CoV2 (COVID-19) Seroepidemiological Investigation in Transplanted Population Subjects of Kidney, Kidney-pancreas, Isolated Pancreas, Langerhans Islets"
2969,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,COVID,"February 08, 2021",45,NCT04487210,MVC-COV1901,TAIWAN,"Active, not recruiting",Medigen Vaccine Biologics Corp.,"October 7, 2020",Interventional,"A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901"
2970,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,COVID,"February 08, 2021",80,NCT04487444,THYMALFASIN,UNITED STATES,Recruiting,Rhode Island Hospital,"September 10, 2020",Interventional,A Pilot Trial of Thymalfasin (Ta1) to Treat COVID-19 Infection in Patients With Lymphocytopenia
2971,Exploring the Impact of a Sleep App on Sleep Quality,SLEEP,"February 08, 2021",101,NCT04487483,SLEEP APP,UNITED KINGDOM,"Active, not recruiting","University College, London","February 13, 2020",Interventional,Exploring the Impact of a Sleep App on Sleep Quality: a Randomised Controlled Pilot Study
2972,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,SARS-CoV2 INFECTION,"February 08, 2021",118,NCT04487574,XC221; PLACEBO,RUSSIAN FEDERATION,Completed,RSV Therapeutics LLC,"July 25, 2020",Interventional,"A Multicenter, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of XC221, Tablets, 100 mg in Patients With COVID-19"
2973,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,SPERM PRESERVATION IN ONCOLOGICAL PATIENTS; FERTILITY; CRYOPRESERVATION,"February 08, 2021",250,NCT04487639,"SARS-COV-2 RESEARCH IN NASOPHARYNGEAL SWAB, SPERM AND SEROLOGICS",FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","July 10, 2020",Interventional,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients During the COVID-19 Pandemic ?
2974,Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study,COVID,"February 08, 2021",50,NCT04487665,,,Not yet recruiting,Cairo University,"September 15, 2020",Observational,Oral Manifestations of COVID-19: a Multicentre Observational Study
2975,Nebulized PL for Post-COVID-19 Syndrome,COVID,"February 08, 2021",40,NCT04487691,NEBULIZED PLATELET LYSATE; NEBULIZED STERILE SALINE,UNITED STATES,Recruiting,"Regenexx, LLC","December 8, 2020",Interventional,Autologous Nebulized Platelet Lysate for Post COVID-19 Syndrome
2976,Lung Ultrasound in COVID-19 Patients,COVID; ULTRASOUND; ARDS,"February 08, 2021",30,NCT04487769,,NETHERLANDS,Recruiting,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"June 1, 2020",Observational,Early Lung Ultrasound Score Predicts Duration of Ventilation and ICU Mortality in COVID-19 Invasively Ventilated Patients
2977,COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic,COVID; BRONCHIECTASIS,"February 08, 2021",28,NCT04487873,,TURKEY,Recruiting,Hacettepe University,"July 23, 2020",Observational,COVID-19 Phobia and Quality of Life in Patients With Bronchiectasis During Covid-19 Pandemic
2978,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),COVID,"February 08, 2021",80,NCT04487886,DUVELISIB; PLACEBO,UNITED STATES,Recruiting,Emory University,"November 18, 2020",Interventional,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection
2979,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",100,NCT04487951,"PRO BNP , VITAMIN D",EGYPT,Recruiting,Cairo University,"July 1, 2020",Observational,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia
2980,Complementary Intervention for COVID-19,COVID,"February 08, 2021",70,NCT04487964,LICORICE EXTRACT,EGYPT,Recruiting,Egyptian Biomedical Research Network,"January 1, 2020",Interventional,Evaluation of The Potential Therapeutic Effects of Licorice and Boswellia Serrata Gum in Egyptian Patients With COVID-19 as a Complementary Medicine
2981,Survey on COVID-19 Airway Management,AIRWAY MANAGEMENT,"February 08, 2021",5000,NCT04487977,SURVEY,SPAIN,Recruiting,Spanish Society of Anesthesia and Critical Care (SEDAR),"April 22, 2020",Observational,International Survey on Airway Management in COVID-19 Patients (ISAM-COVID)
2982,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,ACUTE KIDNEY INJURY; COVID,"February 08, 2021",90,NCT04487990,UNFRACTIONATED HEPARIN,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 29, 2020",Interventional,CoV-Hep Study: Randomized and Paired Clinical Trial Comparing Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19
2983,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,COVID,"February 08, 2021",1500,NCT04488081,REMDESIVIR; CENICRIVIROC; ICATIBANT; RAZUPROTAFIB; APREMILAST,UNITED STATES,Recruiting,QuantumLeap Healthcare Collaborative,"July 31, 2020",Interventional,I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
2984,Impact of Isolation in Patients With IBD During the COVID-19 Crisis,INFLAMMATORY BOWEL DISEASES,"February 08, 2021",232,NCT04488471,,UNITED KINGDOM,Recruiting,Sheffield Teaching Hospitals NHS Foundation Trust,"June 30, 2020",Observational,Impact of Isolation in Patients With IBD During the 2020 COVID-19 Crisis: a Mixed Methods Study
2985,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,COVID,"February 08, 2021",450,NCT04488484,SEROLOGY TEST FOLLOW-UP,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"July 1, 2020",Interventional,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group
2986,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:,COVID; VENTILATOR ASSOCIATED PNEUMONIA; NOSOCOMIAL PNEUMONIA,"February 08, 2021",150,NCT04488510,,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"May 6, 2020",Observational,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia: COVAP Study
2987,Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19),COLO-RECTAL CANCER; COLON CANCER; RECTAL CANCER; ONCOLOGY; SURGERY,"February 08, 2021",1051,NCT04488549,SURVEY,ITALY,Completed,Treviso Regional Hospital,"May 20, 2020",Observational,DElayed COloRectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)
2988,Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands,COVID; PULMONARY FIBROSIS,"February 08, 2021",150,NCT04488562,,NETHERLANDS,Recruiting,Erasmus Medical Center,"May 8, 2020",Observational [Patient Registry],Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands
2989,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,COVID,"February 08, 2021",60,NCT04488575,EDP1815; PLACEBO,UNITED STATES,Recruiting,"Evelo Biosciences, Inc.","August 26, 2020",Interventional,A Phase 2 Double-blind Placebo-controlled Study Investigating the Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With SARS-CoV-2 Infection
2990,Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt,COVID; CORONAVIRUS DISEASE; SARS-CoV2,"February 08, 2021",1064,NCT04488588,KAPLAN MEIER ANALYSIS,EGYPT,Completed,Assiut University,"March 15, 2020",Observational,Survival and 30-days Hospital Outcome in Hospitalized COVID-19 Patients in Upper Egypt: Multi-center Study
2991,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,HEALTH BEHAVIOUR CHANGE,"February 08, 2021",145,NCT04488796,ASSIGNED STRATEGIES: OPT-IN; ASSIGNED STRATEGIES: ACTIVE CHOICE; ASSIGNED STRATEGIES: ENHANCED ACTIVE CHOICE; CHOICE OF ASSIGNMENT: OPT-IN; CHOICE OF ASSIGNMENT: ACTIVE CHOICE; CHOICE OF ASSIGNMENT: ENHANCED ACTIVE CHOICE,CANADA,Recruiting,"Western University, Canada","September 7, 2020",Interventional,"STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers, a Pilot Randomized Controlled Trial"
2992,Can Remote Photoplethysmography Be Used for Contactless Vital Sign Acquisition in a Healthcare Setting? A Prospective Comparative Study.,CORONAVIRUS; CARDIAC DISEASE; RESPIRATORY DISEASE; VASCULAR DISEASES,"February 08, 2021",350,NCT04489407,REMOTE PHOTOPLETHYSMOGRAPHY (RPPG) VITAL SIGN ACQUISITION,,Not yet recruiting,Lady Davis Institute,"August 1, 2020",Interventional,Can Remote Photoplethysmography Be Used for Contactless Vital Sign Acquisition in a Healthcare Setting? A Prospective Comparative Study.
2993,Sildenafil in COVID-19,COVID; SARS-CoV2 INFECTION,"February 08, 2021",40,NCT04489446,SILDENAFIL; PLACEBO,CHILE,Recruiting,Universidad Nacional Andres Bello,"August 19, 2020",Interventional,Sildenafil for Treating Patients With COVID-19 and Perfusion Mismatch: A Pilot Randomised Trial
2994,Tele-health Enabled Clinical Trial for COVID-19,SARS-COV INFECTION,"February 08, 2021",110,NCT04489628,VITAMIN D3 OR PLACEBO; DOCTELLA TELEHEALTH MONITORING,UNITED STATES,Not yet recruiting,University Hospitals Cleveland Medical Center,"August 1, 2020",Interventional,Tele-health Enabled Clinical Trial for COVID-19: Vitamin D as an Immunomodulator to Prevent Complications and Reduce Resource Utilization in Outpatients
2995,Serological Surveillance for COVID-19 in Central North Carolina,COVID,"February 08, 2021",2500,NCT04490174,,UNITED STATES,Recruiting,National Institute of Environmental Health Sciences (NIEHS),"January 8, 2020",Observational,Serological Surveillance for COVID-19 in Central North Carolina
2996,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,"COVID; SARS-COV INFECTION; WORKER-PATIENT TRANSMISSION, HEALTHCARE","February 08, 2021",1000,NCT04490200,VESTA RESPIRATOR; CONVENTIONAL N95 RESPIRATOR,,Not yet recruiting,University of Brasilia,"November 30, 2020",Interventional,Effectiveness of a Novel Respirator With Chitosan Nanoparticles to Reduce the Incidence of SARS-CoV-2 Infection in Healthcare Professionals: Randomized Controlled Trial (VESTA Trial)
2997,Intranasal Heparin Tolerability Study,COVID,"February 08, 2021",6,NCT04490239,INTRANASAL HEPARIN SODIUM (PORCINE),UNITED STATES,"Active, not recruiting",Joshua Sharp,"October 9, 2020",Interventional,Intranasal Heparin Tolerability Study
2998,CoV-PICS: A Virtual Post-ICU Clinic,POST ICU SYNDROME,"February 08, 2021",80,NCT04490278,MEDICAL RECORD REVIEW - INPATIENT TREATMENT; ONLINE QUESTIONNAIRES,UNITED STATES,Recruiting,Washington University School of Medicine,"September 29, 2020",Interventional,"COVID-19 Virtual Post Intensive Care Syndrome (CoV-PICS) Clinic: Modern, Convenient and Practical Recovery Care"
2999,Turkish of the SARS-CoV-2 Anxiety Scale,ANXIETY; SARS-COV INFECTION,"February 08, 2021",300,NCT04490473,SURVEY WORK,TURKEY,Recruiting,DILEK SAYIK,"July 24, 2020",Interventional,Turkish Validity And Reliability of the SARS-CoV-2 Anxiety Scale
3000,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; CORONAVIRUS INFECTION,"February 08, 2021",21,NCT04490486,UCMSCS; PLACEBO,UNITED STATES,Not yet recruiting,Joshua M Hare,"September 1, 2021",Interventional,"Phase I, Randomized, Double Blinded, Placebo Control Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 With Moderate to Severe Symptoms"
3001,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19,INFECTIOUS,"February 08, 2021",200,NCT04490772,LABORATORY TESTS,,Not yet recruiting,Assiut University,July 2020,Observational,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19
3002,Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children,COVID,"February 08, 2021",800,NCT04490811,NO INTERVENTION. OBSERVATIONAL COHORT STUDY,FRANCE,Recruiting,Hôpital Necker-Enfants Malades,"April 9, 2020",Observational,Seroprevalence and Immunoprotection Against SARS-CoV2 in Children Hospitalized in Paris
3003,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,COVID,"February 08, 2021",100,NCT04490824,KELEA EXCELLERATED WATER; WATER WITHOUT AN ELEVATED LEVEL OF KELEA,UNITED STATES,Recruiting,Institute of Progressive Medicine,"October 1, 2020",Interventional,Can Inhalation of KELEA Excellerated Water Reduce the Time Required for Covid-19 Infected Individuals to Become Symptom-Free and to Test Negative Using Either the PCR or Antigen Assay
3004,Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID),COVID,"February 08, 2021",3500,NCT04490837,ELISA AND RAPID TEST TO DETECT ANTIBODIES AGAINST COVID-19,SPAIN,"Active, not recruiting",Corporacion Parc Tauli,"June 22, 2020",Observational [Patient Registry],Rapid Diagnostic Test for COVID-19 Based on Antibody Detection
3005,COVID-19 Seroprevalence Study in French Guiana,CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; SARS-COV INFECTION; COVID,"February 08, 2021",1500,NCT04490850,BLOOD SAMPLE,FRENCH GUIANA,Recruiting,Institut Pasteur,"July 15, 2020",Interventional,COVID-19 Seroprevalence Study in French Guiana
3006,Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.,STRESS DISORDER,"February 08, 2021",405,NCT04491071,GENERALIZED ANXIETY DISORDER-7 (GAD 7); BACKGROUND QUESTIONNAIRE; IMPACT OF COVID-19 QUESTIONNAIRE; CONFINEMENT AND COMMUNICATION DURING THE COVID-19 PANDEMIC; MENTAL HEALTH QUESTIONNAIRE; PATIENT HEALTH QUESTIONNAIRE (PHQ-9); POST TRAUMATIC STRESS DISORDER QUESTIONNAIRE (PTSD-8); EXPERIENCES IN CLOSE RELATIONSHIP SCALE QUESTIONNAIRE (ECR-S),FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Saint Etienne,September 2020,Observational,Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.
3007,National Survey of the Impact of COVID-19 Pandemics,COVID PANDEMICS; OBSTETRICS AND GYNECOLOGY; WORKLOAD; QUESTIONNAIRE; NATIONAL SURVEY; CHINA,"February 08, 2021",6000,NCT04491201,CUSTOMIZED QUESTIONNAIRE,CHINA,Recruiting,Lei Li,"July 27, 2020",Observational,National Survey of the Impact of COVID-19 Pandemics on Chinese Physicians of Obstetrics and Gynecology
3008,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19),COVID; FOLLOW UP; REHABILITATION,"February 08, 2021",131,NCT04491214,QUALITY OF LIVE ASSESSMENT,FRANCE,Recruiting,"University Hospital, Strasbourg, France","July 24, 2020",Observational,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)
3009,Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection,"COVID; AKI; CKD; ESRD; TRANSPLANT;FAILURE,KIDNEY","February 08, 2021",2000,NCT04491227,,BOLIVIA,Enrolling by invitation,"University of California, San Diego","May 5, 2020",Observational,Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
3010,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,COVID; SARS-CoV2 PNEUMONIA; COVID,"February 08, 2021",30,NCT04491240,EXO 1 INHALATION; EXO 2 INHALATION; PLACEBO INHALATION,RUSSIAN FEDERATION,Completed,"State-Financed Health Facility ""Samara Regional Medical Center Dinasty""","July 20, 2020",Interventional,The Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Two-Sided Pneumonia
3011,Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce,COVID INFECTION,"February 08, 2021",20000,NCT04491292,QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 18, 2020",Observational,Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce
3012,COVID-19 Quarantine on Musculoskeletal Status in Hemophilia,HEMOPHILIA ARTHROPATHY,"February 08, 2021",27,NCT04491318,OBSERVATIONAL,SPAIN,Recruiting,Investigación en Hemofilia y Fisioterapia,"July 1, 2020",Observational,Effects of COVID-19 Quarantine on the Musculoskeletal Status of Adult Hemophilia Patients. An Observational Study
3013,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,COVID; PROGRESSION,"February 08, 2021",540,NCT04491994,HCQ,PAKISTAN,Completed,UNICEF,"April 10, 2020",Interventional,Clearing the Fog: Is HCQ Effective in Reducing COVID-19 progression-a Randomized Controlled Trial
3014,Containment Measures and Eating Disorders,EATING DISORDERS; COVID,"February 08, 2021",40,NCT04492189,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Impact of Containment Measures in People With Eating Disorders: a Descriptive Study
3015,"Knowledge, Attitudes, and Practices Towards COVID-19 Among Health Care Professionals Among Healthcare Professionals","COVID; KNOWLEDGE, ATTITUDES, PRACTICE","February 08, 2021",200,NCT04492202,SURVEY,,Not yet recruiting,Istinye University,"August 1, 2020",Observational,"Comparison of the Knowledge, Attitudes, and Practices Towards COVID-19 Between Different Healthcare Professionals"
3016,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,COVID; KETOGENIC DIETING,"February 08, 2021",100,NCT04492228,KETOGENIC DIET,ITALY,Recruiting,Ospedale Policlinico San Martino,"September 1, 2020",Interventional,Randomized Open Controlled Clinical Trial to Evaluate the Effectiveness of a Eucaloric Ketogenic Nutrition in Comparison With a Standard Nutrition in Covid-19 Disease in Reducing Cytokine Storm Syndrome and ARDS
3017,Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,COVID,"February 08, 2021",1370,NCT04492254,ENOXAPARIN,,Not yet recruiting,Thrombosis Research Institute,July 2020,Interventional,"Early Thromboprophylaxis in COVID-19 (ETHIC Trial): an Open Label, Randomized Phase IIIb Trial of Community-based (LMWH) Versus Standard of Care in COVID-19 Positive Patients"
3018,Inflammatory Bowel Disease (IBD) and Covid-19 Infection,INFLAMMATORY BOWEL DISEASE,"February 08, 2021",700,NCT04492267,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","July 7, 2020",Observational,"SARS-CoV-2 Infection in Patients From Two Tertiary Inflammatory Bowel Disease (IBD) Centres: Frequency of Suspected and Confirmed Infections, Severity and Outcome Management"
3019,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",COVID,"February 08, 2021",144,NCT04492358,COLCHICINE; PREDNISONE TABLET; STANDARD OF CARE,SPAIN,Recruiting,Maria Joyera Rodríguez,"October 22, 2020",Interventional,"Phase 2/3, Randomized, Open Study to Compare the Efficacy and Safety of Colchicine and Glucocorticoids Compared With the Standard of Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center"
3020,COVID-19 Infection and Multiple Myeloma,MULTIPLE MYELOMA; COVID; CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04492371,,AUSTRIA,Recruiting,European Myeloma Network,"July 1, 2020",Observational,COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS: AN EUROPEAN OBSERVATIONAL STUDY
3021,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients,COVID; SARS-CoV2 INFECTION; PNEUMONIA; COPD; CKD; CARDIAC EVENT; OVERWEIGHT AND OBESITY; CARDIOVASCULAR DISEASES; DIABETES; HYPERTENSION; CORONARY HEART DISEASE,"February 08, 2021",3500,NCT04492384,NON-INTERVENTIONAL,RUSSIAN FEDERATION,Completed,Eurasian Association of Therapists,"June 11, 2020",Observational,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients
3022,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),CANCER,"February 08, 2021",500,NCT04492410,RAPID SEROLOGICAL TEST,FRANCE,Recruiting,Centre Antoine Lacassagne,"July 21, 2020",Interventional,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)
3023,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection",EXPOSURE DURING PREGNANCY; CORONAVIRUS INFECTION,"February 08, 2021",260,NCT04492449,CONGENITAL MALFORMATION,,Not yet recruiting,University of Sao Paulo,January 2021,Observational,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to Coronavirus SARS-CoV-2"
3024,Adaptive COVID-19 Treatment Trial 3 (ACTT-3),COVID,"February 08, 2021",969,NCT04492475,INTERFERON BETA-1A; PLACEBO; REMDESIVIR,JAPAN,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"August 4, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-3)"
3025,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,COVID; CYTOKINE RELEASE SYNDROME; CRITICAL ILLNESS; ARDS,"February 08, 2021",600,NCT04492501,THERAPEUTIC PLASMA EXCHANGE; CONVALESCENT PLASMA; TOCILIZUMAB; REMDESIVIR; MESENCHYMAL STEM CELL THERAPY,PAKISTAN,Completed,UNICEF,"April 1, 2020",Interventional,"Role of Investigational Therapies Alone or in Combination to Treat Moderate, Severe and Critical COVID-19"
3026,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,COVID; SARS-CoV2; PNEUMONIA,"February 08, 2021",60,NCT04492514,MAVRILIMUMAB; PLACEBO,UNITED STATES,Recruiting,Kristin Hudock,"May 20, 2020",Interventional,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
3027,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,"CHRONIC DISEASE; AGING; AGING PROBLEMS; HEALTH BEHAVIOR; MULTIPLE CHRONIC CONDITIONS; CHRONIC ILLNESS; CHRONIC ILLNESSES, MULTIPLE; HEALTHY LIFESTYLE; HEALTHY AGING; AGING WELL; HEALTHY LIFE STYLE; SELF-MANAGEMENT; SELF CARE","February 08, 2021",75,NCT04492527,TELEHEALTH COACHING SESSIONS,CANADA,Recruiting,University of British Columbia,"July 28, 2020",Interventional,A Student-delivered Community Outreach teleheAlth Program for Covid Education and Health Promotion (COACH)
3028,MSCT Chest in Suspected COVID-19 Patients,COVID,"February 08, 2021",150,NCT04492865,MSCT,EGYPT,Not yet recruiting,Assiut University,"July 30, 2020",Observational,MSCT Chest in Suspected COVID-19 Patients in Correlation With Symptomology and Laboratory Findings
3029,Cyclosporine For The Treatment Of COVID-19(+),SARS (DISEASE),"February 08, 2021",75,NCT04492891,CYCLOSPORINE; STANDARD OF CARE TREATMENT,UNITED STATES,Recruiting,"Bryan Burt, MD","November 23, 2020",Interventional,Randomized Phase IIa Clinical Trial Of Cyclosporine For The Treatment Of COVID-19(+) Non-ICU Hospital Inpatients
3030,Singapore COVID-19 Chemosensory Tracking (SCCT) Study,COVID,"February 08, 2021",5000,NCT04492904,HOME-USE TEST AND FOLLOW-UP QUESTIONNAIRE,SINGAPORE,Recruiting,"Clinical Nutrition Research Centre, Singapore","July 23, 2020",Observational,Singapore COVID-19 Chemosensory Tracking (SCCT) Study
3031,To Observe Whether Isoflurane Can Treat COVID-19 Patients,COVID,"February 08, 2021",35,NCT04492943,,UNITED STATES,Completed,Massachusetts General Hospital,"April 20, 2020",Observational,To Observe Whether Isoflurane Can Treat COVID-19 Patients
3032,Extracellular Vesicle Infusion Therapy for Severe COVID-19,"COVID; ARDS; PNEUMONIA, VIRAL","February 08, 2021",60,NCT04493242,DB-001,,Not yet recruiting,"Direct Biologics, LLC","September 1, 2020",Interventional,Extracellular Vesicle Infusion Treatment for Severe COVID-19
3033,HYPONATREMIA IN COVID-19 PATIENTS,HYPONATREMIA; COVID; CORONAVIRUS INFECTION,"February 08, 2021",250,NCT04493268,,ARGENTINA,Completed,Hospital Nacional Profesor Alejandro Posadas,"March 7, 2020",Observational,HYPONATREMIA AND INFLAMMATION AND CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS
3034,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,COVID PNEUMONITIS,"February 08, 2021",500,NCT04493294,LOW DOSE WHOLE LUNG RADIOTHERAPY FOR OLDER PATIENTS WITH COVID-19 PNEUMONITIS,,Not yet recruiting,International Geriatric Radiotherapy Group,November 2020,Interventional,Low Dose Whole Lung Radiotherapy for Older Patients With Coronavirus 19 Disease (COVID-19) Pneumonitis: Practical Protocol by the International Geriatric Radiotherapy Group
3035,The Evaluation of Hemostasis in Hospitalized COVID-19 Patients,COVID,"February 08, 2021",100,NCT04493307,PHLEBOTOMY,UNITED STATES,Recruiting,LifeBridge Health,"June 30, 2020",Observational,"The Evaluation of Hemostasis by Thromboelastography, Platelet Function Testing, and Biomarker Analysis in Hospitalized COVID-19 Patients"
3036,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,COVID; ANGIOTENSIN II RECEPTOR ANTAGONIST ADVERSE REACTION,"February 08, 2021",240,NCT04493359,RENIN-ANGIOTENSIN SYSTEM INHIBITORS,BRAZIL,Recruiting,University of Sao Paulo,"July 25, 2020",Interventional,Switch or Maintenance of Renin-Angiotensin System Inhibitors in Patients With Covid-19: A Randomized Proof of Concept Trial
3037,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,TREATMENT OF COVID VIRUS INFECTION,"February 08, 2021",100,NCT04494204,IMMUNOFREE TABLETS AND REGINMUNE CAPSULE,INDIA,Completed,PUNEET MITTAL,"August 7, 2020",Interventional,"An Open Label, Multicenter, Randomized, Controlled, Clinical Study to Evaluate the Efficacy and Safety of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets Compared With Standard Treatment Protocol in the Treatment of Mild to Moderate COVID-19 Patients."
3038,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,COVID; CORONAVIRUS INFECTION; SARS-COV INFECTION; ARDS; CORONAVIRUS,"February 08, 2021",60,NCT04494386,UMBILICAL CORD LINING STEM CELLS (ULSC); PLACEBO (CARRIER CONTROL),UNITED STATES,Recruiting,"Restem, LLC.","July 23, 2020",Interventional,Phase 1/2a Study of Umbilical Cord Lining Stem Cells (ULSC) in Patients With ARDS Due to COVID-19
3039,IFN Beta-1b and Ribavirin for Covid-19,COVID,"February 08, 2021",96,NCT04494399,INTERFERON BETA-1B; RIBAVIRIN,HONG KONG,Recruiting,The University of Hong Kong,"July 29, 2020",Interventional,"An Open-label Randomised Controlled Trial on IFN Beta-1b and Ribavirin Combination, as Treatment for Covid-19 Infection"
3040,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),COVID,"February 08, 2021",440,NCT04494646,BARDOXOLONE METHYL; PLACEBO,UNITED STATES,Recruiting,NYU Langone Health,"September 8, 2020",Interventional,"BARCONA: A Phase II/III, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)"
3041,Clazakizumab vs. Placebo - COVID-19 Infection,COVID INFECTION,"February 08, 2021",60,NCT04494724,CLAZAKIZUMAB; PLACEBO,UNITED STATES,Recruiting,The Methodist Hospital System,"July 13, 2020",Interventional,A Phase 2 Trial to Evaluate the Safety and Tolerability of Clazakizumab® [Anti-Interleukin (IL)-6 Monoclonal] Compared to Placebo for the Treatment of COVID-19 Infection
3042,SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study,SARS-CoV2 INFECTION; KIDNEY TRANSPLANT INFECTION,"February 08, 2021",500,NCT04494776,,BRAZIL,Recruiting,Helio Tedesco Silva Junior,"May 21, 2020",Observational,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Infection (COVID-19) in Kidney Transplant Recipients: a Brazilian Multicenter Study
3043,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,COVID,"February 08, 2021",20,NCT04494867,CORE WARMING; STANDARD OF CARE,UNITED STATES,Recruiting,Sharp HealthCare,"August 19, 2020",Interventional,"Core Warming of COVID-19 Patients Undergoing Mechanical Ventilation: a Randomized, Single Center Pilot Study"
3044,ImmuneRACE - Immune Response Action to COVID-19 Events,COVID,"February 08, 2021",1000,NCT04494893,,UNITED STATES,Recruiting,Adaptive Biotechnologies,"April 24, 2020",Observational,ImmuneRACE - Immune Response Action to COVID-19 Events
3045,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.",COVID,"February 08, 2021",242,NCT04494984,INM005; PLACEBO,ARGENTINA,"Active, not recruiting",Inmunova S.A.,"July 27, 2020",Interventional,"A Stage 2/3, Adaptive, Randomized, Controlled, Double-blind Study to Investigate the Pharmacokinetics, Efficacy and Safety of the Hyperimmune Equine Serum (INM005) in Adult Patients With Moderate to Severe Confirmed SARS-CoV2 Disease."
3046,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,COVID,"February 08, 2021",100,NCT04495101,PROLASTIN; STANDARD MEDICAL TREATMENT,SPAIN,Recruiting,"Instituto Grifols, S.A.","July 29, 2020",Interventional,"A Multicenter, Randomized, Open-label, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of Prolastin Plus Standard Medical Treatment (SMT) Versus SMT Alone in Hospitalized Subjects With COVID-19"
3047,Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy,COLON CANCER; BREAST CANCER; CHEMOTHERAPEUTIC TOXICITY,"February 08, 2021",100,NCT04495387,CHEMOTHERAPY,,Not yet recruiting,University of Florence,January 2021,Observational,Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy
3048,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',SUICIDAL IDEATION; SUICIDE; MENTAL HEALTH ISSUE; DEPRESSION,"February 08, 2021",75,NCT04495543,BRIEF SKILLS FOR SAFER LIVING,CANADA,Recruiting,Unity Health Toronto,"December 1, 2020",Interventional,"Mitigating Suicide Risk During the COVID-19 Pandemic Via Telehealth Using an Intensive Single Session of ""Brief Skills for Safer Living"""
3049,Registry of Sustained Immunity to COVID-19 Among ESKD Patients,SARS-CoV2 INFECTION; ANTI-SARS-CoV2 INFECTION,"February 08, 2021",2504,NCT04495764,,UNITED STATES,"Active, not recruiting",Davita Clinical Research,"July 20, 2020",Observational,Registry of Sustained Immunity to COVID-19 Among ESKD Patients
3050,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),PERINATAL ANXIETY; COVID,"February 08, 2021",120,NCT04495803,COGNITIVE BEHAVIOURAL GROUP THERAPY FOR PERINATAL ANXIETY,,Not yet recruiting,St. Joseph's Healthcare Hamilton,"August 10, 2020",Interventional,Augmented Cognitive Behavioural Group Therapy for Perinatal Anxiety During a Global Pandemic (COVID-19)
3051,COVID-19 Anosmia Study,ANOSMIA; COVID,"February 08, 2021",126,NCT04495816,OMEGA-3 FATTY ACID SUPPLEMENT; PLACEBO/CONTROL,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"July 15, 2020",Interventional,COVID-19 Anosmia Study
3052,The Effect of Aromatherapy on COVID-19-induced Anxiety,STRESS; COVID; ANXIETY,"February 08, 2021",65,NCT04495842,ESSENTIAL OIL BLEND; CONTROL BLEND,UNITED STATES,Recruiting,Franklin School of Integrative Health Sciences,"October 1, 2020",Interventional,The Effect of Aromatherapy on COVID-19-induced Anxiety
3053,COVID-19 Progression in End-Stage Kidney Disease,SARS-CoV2 INFECTION (ASYMPTOMATIC); SARS-CoV2 INFECTION (SYMPTOMATIC),"February 08, 2021",1000,NCT04495907,,UNITED STATES,Recruiting,Davita Clinical Research,"August 6, 2020",Observational,COVID-19 Progression in End-Stage Kidney Disease
3054,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults",SARS-CoV2; COVID,"February 08, 2021",216,NCT04495933,MF59 ADJUVANTED SARS-COV-2 SCLAMP VACCINE 5MCG; MF59 ADJUVANTED SARS-COV-2 SCLAMP VACCINE 15MCG; MF59 ADJUVANTED SARS-COV-2 SCLAMP VACCINE 45MCG; PLACEBO,AUSTRALIA,Recruiting,The University of Queensland,"July 13, 2020",Interventional,"A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Dosage-Escalation, Single Centre Study to Evaluate the Safety and Immunogenicity of an Adjuvanted SARS-CoV-2 Sclamp Protein Subunit Vaccine in Healthy Adults Aged 18 to 55 Years Old and Healthy Older Adults, Aged 56 Years and Over"
3055,COVID-19 Brain Injury,SARS-CoV2; SEVERE NEUROLOGIC INJURY; ISCHEMIC STROKE; HEMORRHAGIC STROKE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY; STATUS EPILEPTICUS,"February 08, 2021",300,NCT04496076,,UNITED STATES,Enrolling by invitation,University of Pittsburgh,"April 2, 2020",Observational,Severe Neurologic Injury Outcomes During COVID-19 Crisis
3056,COVID19 Neurological Manifestation,SARS-CoV2; NEUROLOGIC MANIFESTATIONS,"February 08, 2021",300,NCT04496128,,UNITED STATES,Enrolling by invitation,University of Pittsburgh,"April 13, 2020",Observational,Neurological Complications of COVID-19
3057,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,COVID,"February 08, 2021",70,NCT04496141,SARS-COV-2 ANTIBODY IMMUNOASSAYS,HONG KONG,"Active, not recruiting",Hong Kong Sanatorium & Hospital,"July 27, 2020",Observational,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
3058,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,RESPIRATORY VIRAL INFECTION; COVID,"February 08, 2021",1000,NCT04496245,BRONCHO-VAXOM®,AUSTRALIA,Recruiting,The University of Queensland,"August 24, 2020",Interventional,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85
3059,Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI),CORONAVIRUS,"February 08, 2021",500,NCT04496466,,UNITED STATES,Enrolling by invitation,Johns Hopkins University,"April 9, 2020",Observational,Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI)
3060,Pilot Study of Video and Telephone Primary Care Visits,TELEMEDICINE,"February 08, 2021",200,NCT04496713,INTERNET-CONNECTED COMPUTER TABLET,,Not yet recruiting,Johns Hopkins University,"January 24, 2021",Interventional,Pilot Study - Randomized Controlled Trial of Video and Telephone Primary Care Visits
3061,Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment,INFERTILITY TREATMENT; WOMEN,"February 08, 2021",600,NCT04496869,ONLINE QUESTIONNAIRE,FRANCE,Not yet recruiting,Hospices Civils de Lyon,July 2020,Observational,"Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment, a French Cohort"
3062,Registry of COVID-19 Patients at AOUI Verona,CORONAVIRUS DISEASE 2019,"February 08, 2021",500,NCT04497194,NOT APPLICABLE (OBSERVATIONAL STUDY),ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"March 1, 2020",Observational [Patient Registry],"Registry of Biological Samples, Clinical Information and Epidemiological Data of COVID-19 Patients Admitted at the University Hospital of Verona (AOUI Verona)"
3063,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)",COVID,"February 08, 2021",5000,NCT04497246,QUESTIONNAIRE,BELGIUM,Recruiting,Murielle Surquin,"May 29, 2020",Observational,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)"
3064,Assesment of the Metabolomic Signature in COVID-19 Patients,COVID,"February 08, 2021",150,NCT04497272,COVID-19 PATIENTS,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"August 7, 2020",Interventional,Assesment of the Metabolomic Signature in COVID-19 Patients (SignCov Study)
3065,Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,COVID,"February 08, 2021",90,NCT04497298,TWO COVID-19 VACCINE CANDIDATE (TMV-083) ADMINISTRATIONS - LOW DOSE; TWO COVID-19 VACCINE CANDIDATE (TMV-083) ADMINISTRATIONS - HIGH DOSE; ONE COVID-19 VACCINE CANDIDATE (TMV-083) ADMINISTRATION - HIGH DOSE; PLACEBO,BELGIUM,Recruiting,Institut Pasteur,"August 10, 2020",Interventional,"A Randomized, Placebo-controlled Trial, to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine, a Measles Vector-based Vaccine Candidate Against COVID-19 in Healthy Volunteers Consisting of an Unblinded Dose Escalation and a Blinded Treatment Phase"
3066,Tomographic Findings in COVID-19 and Influenza,SARS-CoV2; COVID; H1N1 INFLUENZA; COMPUTED TOMOGRAPHY,"February 08, 2021",100,NCT04497311,THORAXIC COMPUTED TOMOGRAPHY,MEXICO,Recruiting,Universidad de Guanajuato,"June 15, 2020",Observational,Pulmonary Tomographic Findings in COVID-19 and Influenza H1N1 Patients
3067,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,COVID,"February 08, 2021",100,NCT04497324,CONVALESCENT PLASMA,PERU,Not yet recruiting,Universidad Peruana Cayetano Heredia,"August 20, 2020",Interventional,PERUCONPLASMA: Randomized Clinical Trial to Evaluate Safety and Efficacy of the Use of Convalescent Plasma in Hospitalized Patients With COVID-19
3068,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,SARS COV-2,"February 08, 2021",60,NCT04497389,HUMAN AMNIOTIC FLUID,UNITED STATES,Recruiting,University of Utah,"October 28, 2020",Interventional,A Phase I/II Randomized Double-blinded Placebo-controlled Clinical Trial to Determine Safety and Feasibility of Using an Acellular Sterile Filtered Amniotic Fluid as a Treatment for COVID-19 Patients
3069,Sex-Informed Data in the COVID-19 Pandemic.,COVID,"February 08, 2021",88,NCT04497402,,ITALY,Recruiting,University of Roma La Sapienza,"September 1, 2020",Observational [Patient Registry],Sex-Informed Data in the COVID-19 Pandemic.
3070,The COVID-19 and Healthcare Workers: An Active Intervention,BRIEF VIDEO-BASED INTERVENTION; NON INTERVENTION CONTROL,"February 08, 2021",1200,NCT04497415,VIDEO-BASED INTERVENTION,UNITED STATES,Recruiting,"Research Foundation for Mental Hygiene, Inc.","October 21, 2020",Interventional,The COVID-19 and Healthcare Workers: An Active Intervention
3071,Netizens' Perception of COVID-19 Information & Information Sources.,"COVID; INFORMATION SEEKING BEHAVIOR; SOCIAL MEDIA; PERCEPTION, SELF","February 08, 2021",385,NCT04497441,ELECTRONIC SURVEY QUESTIONNAIRE,SAUDI ARABIA,Recruiting,Qassim University,"June 10, 2020",Observational,Perceptions of Netizens Regarding COVID-19 Information & Information Sources: A Cross Sectional Study
3072,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),RESPIRATORY DISTRESS SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME DUE TO CORONAVIRUS (SARS-CoV2); MECHANICAL VENTILATION,"February 08, 2021",128,NCT04497454,EIT-GROUP; ARDSNET,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"May 8, 2020",Interventional,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) - COVEN Study
3073,Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic,PATIENT PREFERENCE,"February 08, 2021",1200000,NCT04497467,,TAIWAN,Recruiting,National Taiwan University Hospital,"August 1, 2020",Observational,An Analysis of Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic
3074,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,COVID,"February 08, 2021",12,NCT04497519,INHALED HYDROXYCHLOROQUINE,NETHERLANDS,Completed,University Medical Center Groningen,"September 15, 2020",Interventional,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers; a Pilot Study
3075,SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem,COVID,"February 08, 2021",1000,NCT04497610,BREATH SAMPLE,COSTA RICA,Not yet recruiting,Instituto Costarricense de Investigaciones Clínicas ICIC,"August 4, 2020",Observational [Patient Registry],SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
3076,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",COVID,"February 08, 2021",5,NCT04497623,INVASIVE MECHANICAL VENTILATION USING THE UNISABANA-HERONS VENTILATOR DURING 24 HOURS,COLOMBIA,Completed,Fundación Neumologica Colombiana,"July 28, 2020",Interventional,"Clinical Evaluation of Ventilator Innovation Product in Colombia in the SARS Pandemic Covid 19, Unisabana Herons - A Cohort Study - Phase 1"
3077,Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile,"ANXIETY; DEPRESSION; STRESS, PSYCHOLOGICAL; LONELINESS; SOCIAL ISOLATION","February 08, 2021",1092,NCT04497636,,CHILE,Recruiting,Pontificia Universidad Catolica de Chile,"July 3, 2020",Observational,"Mental Health Impact of the COVID-19 Pandemic Among Immigrants in Santiago, Chile (STRING-COVID)"
3078,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,COVID,"February 08, 2021",100,NCT04497649,SOFOSBUVIR; DACLATASVIR,EGYPT,Recruiting,Tanta University,"July 1, 2020",Interventional,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients: A Randomized Controlled Trial.
3079,An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test,RESPIRATORY INFECTIOUS DISEASES,"February 08, 2021",6000,NCT04497675,,CHINA,Completed,Fuwai Yunnan Cardiovascular Hospital,"June 19, 2020",Observational,An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test
3080,An Epidemiological Investigation on Correct Wearing of Mask by Hood Test,RESPIRATORY INFECTIOUS DISEASES,"February 08, 2021",6000,NCT04497753,,CHINA,Completed,Fuwai Yunnan Cardiovascular Hospital,"June 19, 2020",Observational,An Epidemiological Investigation on Correct Wearing of Mask by Hood Test
3081,Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,ASYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",800,NCT04497779,BIOSPECIMEN COLLECTION; DIAGNOSTIC LABORATORY BIOMARKER ANALYSIS; ELECTRONIC HEALTH RECORD REVIEW; QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,City of Hope Medical Center,"July 13, 2020",Observational,Evaluation of Coronavirus Disease 19 (COVID-19) Convalescent Plasma
3082,Correlation Fear of COVID-19 & Dental Treatment Anxiety,COVID; FEAR; DENTAL ANXIETY,"February 08, 2021",385,NCT04497818,CROSS SECTIONAL STUDY USING SCIENTIFICALLY VALIDATED PSYCHOMETRIC SCALES,SAUDI ARABIA,Completed,Qassim University,"June 16, 2020",Observational,Correlation of Fear of COVID-19 Infection and Dental Treatment Anxiety Among Netizens: A Cross-sectional Study.
3083,Virtual White Boards for Patient Satisfaction,"SATISFACTION, PATIENT; COVID; EMERGENCIES; SATISFACTION; INFORMATION DISCLOSURE","February 08, 2021",100,NCT04497922,E-INK SCREEN; TREATMENT AS USUAL,UNITED STATES,Recruiting,Brigham and Women's Hospital,"January 25, 2021",Interventional,Improving Patient Satisfaction Through Information Display Using Virtual White Boards
3084,Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19,COVID,"February 08, 2021",8,NCT04497948,ACALABRUTINIB,BRAZIL,Terminated,Acerta Pharma BV,"September 21, 2020",Interventional,"An Open-label, Multiple-dose Study of Acalabrutinib, Co Administered With a Proton-pump Inhibitor, in Participants Hospitalized With COVID-19"
3085,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,COVID; SARS-CoV2,"February 08, 2021",5000,NCT04497987,LY3819253; PLACEBO; LY3832479,UNITED STATES,Recruiting,Eli Lilly and Company,"August 2, 2020",Interventional,"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of LY3819253 Alone and in Combination With LY3832479 in Preventing SARS-CoV-2 Infection and COVID-19 in Skilled Nursing and Assisted Living Facility Residents and Staff; a NIAID and Lilly Collaborative Study"
3086,MYocardial DOmmages Related to COVID-19,COVID; NON ISCHEMIC MYOCARDIAL INJURY; MYOCARDIAL INFARCTION; MYOCARDITIS; TROPONIN ELEVATION,"February 08, 2021",200,NCT04498065,BIOLOGICAL DATA; CLINICAL DATA,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"March 1, 2020",Observational,MYocardial DOmmages Related to COVID-19
3087,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19,ACUTE MYOCARDIAL INFARCTION,"February 08, 2021",35,NCT04498091,BIOLOGICAL DATA; CLINICAL DATA,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"March 15, 2020",Observational,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19
3088,"A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)",CORONAVIRUS DISEASE (COVID),"February 08, 2021",260,NCT04498247,V591; PLACEBO,AUSTRIA,"Active, not recruiting",Merck Sharp & Dohme Corp.,"August 27, 2020",Interventional,"A Phase 1/Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety, Tolerability and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Younger and Older Participants"
3089,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,COVID,"February 08, 2021",7000,NCT04498273,APIXABAN 2.5 MG; APIXABAN 5MG; ASPIRIN; PLACEBO,UNITED STATES,Recruiting,Frank C Sciurba,"September 7, 2020",Interventional,COVID-19 Outpatient Thrombosis Prevention Trial: A Multi-center Adaptive Randomized Placebo-controlled Platform Trial Evaluating the Efficacy and Safety of Anti-thrombotic Strategies in COVID-19 Adults Not Requiring Hospitalization at Time of Diagnosis
3090,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients,MULTIPLE SCLEROSIS,"February 08, 2021",800,NCT04498286,TESTING OF SARS-COV-2 ANTIBODIES,NETHERLANDS,Recruiting,Zoé van Kempen,"August 6, 2020",Observational,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients: a Large Study in the Amsterdam MS Cohort
3091,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness,"ECHOCARDIOGRAPHY, STRESS; COVID; HYPERTENSION, PULMONARY","February 08, 2021",30,NCT04498299,ECHOCARDIOGRAM 2D,MEXICO,Recruiting,Miguel Ayala León,"September 1, 2020",Observational,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness
3092,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",COVID; SARS-CoV2,"February 08, 2021",42,NCT04498325,"NT-I7; PLACEBO; BLOOD FOR RESEARCH PURPOSES; BLOOD FOR PHARMACOKINETIC SAMPLES; NASOPHARYNGEAL, OROPHARYNGEAL, OR SALIVA SWAB; BLOOD FOR ANTI-DRUG ANTIBODY (ADA)",UNITED STATES,Not yet recruiting,Washington University School of Medicine,"February 28, 2021",Interventional,"A Phase I and Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2"
3093,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,COVID,"February 08, 2021",38,NCT04498377,F-652; PLACEBO,UNITED STATES,Recruiting,Generon (Shanghai) Corporation Ltd.,"January 26, 2021",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Multicenter Study to Evaluate the Efficacy and Safety of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19"
3094,CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19,MENTAL HEALTH DISORDER,"February 08, 2021",70,NCT04498416,QUANTITATIVE AND QUALITATIVE ASSESSMENTS OF MENTAL HEALTH,FRANCE,Recruiting,Fondation Lenval,"April 27, 2020",Observational,"Methodology of "" CoCo 20 "": a Longitudinal Follow-up Study of the Paediatric Population and Their Families During and After the Coronavirus Pandemic and the Confinement"
3095,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",COVID; STRESS; ANXIETY DEPRESSION,"February 08, 2021",8519,NCT04498442,SIMHA KRIYA; READING A BOOK,UNITED STATES,Completed,Beth Israel Deaconess Medical Center,"May 22, 2020",Interventional,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls"
3096,Psychosocial Outcomes in Families of COVID-19 ICU Patients,CRITICAL ILLNESS; FAMILY; PSYCHOLOGICAL STRESS; COVID,"February 08, 2021",39,NCT04498507,HADS QUESTIONNAIRE,BELGIUM,Completed,University of Liege,"April 16, 2020",Observational,Psychosocial Outcomes in Families of Patients Admitted in ICU for COVID-19 During the Pandemic in Belgium
3097,Mask Usage and Exercise During the COVİD-19 Pandemic,EXERCISE TEST,"February 08, 2021",60,NCT04498546,,TURKEY,Recruiting,KTO Karatay University,"July 20, 2020",Observational [Patient Registry],The Effects of Mask Usage on Exercise Capacity and Related Parameters During the COVİD-19 Pandemic
3098,Wearable Technology and a Virtual Lifestyle Program for Type 2 Diabetics,TYPE 2 DIABETES; COMORBIDITIES AND COEXISTING CONDITIONS,"February 08, 2021",20,NCT04498819,"WEARABLE ACTIVITY TRACKERS, EXERCISE PRESCRIPTION AND VIRTUAL CARE",CANADA,Recruiting,"Western University, Canada","November 9, 2020",Interventional,Virtually Delivered Lifestyle Program Integrating Wearable Technology and Exercise Prescriptions in Patients With Type 2 Diabetes (STAND-VAT): A Feasibility Study
3099,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,COVID,"February 08, 2021",240,NCT04498936,SOFOSBUVIR AND LEDIPASVIR; NITAZOXANIDE,EGYPT,Completed,Assiut University,"July 15, 2020",Interventional,"Efficacy of Adding Sofosbuvir/Ledipasvir Combination, or Nitazoxanide to the Standard of Care in Treatment of COVID-19: A Randomized Controlled Trial"
3100,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age,COVID,"February 08, 2021",50,NCT04499300,DATA COLLECTION FROM MEDICAL FILES,BELGIUM,Recruiting,Murielle Surquin,"June 9, 2020",Observational,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age
3101,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,COVID; ARDS,"February 08, 2021",60,NCT04499313,DEXAMETHASONE; METHYLPREDNISOLONE,BANGLADESH,Recruiting,Chattogram General Hospital,"August 2, 2020",Interventional,The Outcome of Dexamethasone and Methylprednisolone Treatment for Patients With ARDS Caused by COVID-19
3102,Tomographic Findings in COVID-19 and Influenza H1N1,"COVID; INFLUENZA A H1N1; INTUBATION COMPLICATION; MORALITY; LUNG INJURY, ACUTE","February 08, 2021",200,NCT04499378,LUNG CT,,Not yet recruiting,Universidad de Guanajuato,"August 15, 2020",Observational,Pulmonary Tomographic Findings in COVID-19 and Influenza H1N1 Patients at IMSS Guanajuato
3103,COVID-19 Project ECHO in Nursing Homes,COVID,"February 08, 2021",100,NCT04499391,PROJECT ECHO,UNITED STATES,Recruiting,Milton S. Hershey Medical Center,"December 4, 2020",Interventional,"COVID-19 Project ECHO for Nursing Homes: A Patient-centered, Randomized-controlled Trial to Implement Infection Control and Quality of Life Best Practice"
3104,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,COVID,"February 08, 2021",240,NCT04499677,FAVIPIRAVIR; LOPINAVIR/ RITONAVIR; FAVIPIRAVIR PLACEBO; LOPINAVIR/ RITONAVIR PLACEBO,UNITED KINGDOM,Recruiting,"University College, London","September 24, 2020",Interventional,"Favipiravir, Lopinavir/Ritonavir or Combination Therapy: a Randomised, Double Blind, 2x2 Factorial Placebo-controlled Trial of Early Antiviral Therapy in COVID-19"
3105,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",COVID; PNEUMONIA,"February 08, 2021",76,NCT04500067,IVIG,UKRAINE,Completed,Biopharma Plasma LLC,"May 7, 2020",Interventional,"An Open-label Multicenter Randomized Trial to Evaluate the Efficacy of Bioven, Manufactured by Biopharma Plasma, LLC, in Complex Therapy of Patients With Pneumonia Induced by COVID-19 / SARS-CoV-2"
3106,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,COVID,"February 08, 2021",60,NCT04500132,EC-18; PLACEBO EC-18,"KOREA, REPUBLIC OF",Recruiting,Enzychem Lifesciences Corporation,"May 28, 2020",Interventional,"Phase 2, Multi-center, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia"
3107,GERAS Frailty Rehabilitation at Home During COVID-19,FRAILTY,"February 08, 2021",70,NCT04500366,SOCIALIZATION; VIRTUAL GROUP EXERCISE; NUTRITION CONSULT AND PROTEIN SUPPLEMENTATION; MEDICATION REVIEW,CANADA,Recruiting,McMaster University,"August 26, 2020",Interventional,GERAS Frailty Rehabilitation at Home: Virtual Bundled Care for Seniors Who Are Frail to Build Strength and Resilience During COVID-19
3108,Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,COVID,"February 08, 2021",183,NCT04500418,CENICRIVIROC (CVC); PLACEBO,GERMANY,Recruiting,"Charite University, Berlin, Germany","August 25, 2020",Interventional,Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients
3109,Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic,COVID INFECTION; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM,"February 08, 2021",50000,NCT04500600,QUALITY-OF-LIFE ASSESSMENT; QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"June 11, 2020",Observational,Well-Being and Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic
3110,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,COVID,"February 08, 2021",234,NCT04500626,OXYGEN,CANADA,Not yet recruiting,Ottawa Hospital Research Institute,October 2020,Interventional,Multicentre Randomized Controlled Trial of Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients
3111,Over-the-counter Medications & COVID-19,SARS-CoV2 INFECTION; COVID,"February 08, 2021",14000,NCT04500639,,CANADA,Recruiting,University of Alberta,"July 23, 2020",Observational,Do Common Medications Alter the Course of COVID-19?
3112,Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic,ANXIETY; DEPRESSION; INSOMNIA; COVID; CORONAVIRUS,"February 08, 2021",310,NCT04500652,,TURKEY,Recruiting,Dokuz Eylul University,"June 27, 2020",Observational,Evaluation of Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians During the Covid-19 Pandemic
3113,Impact of Spectacles on Compliance to Mask-wearing Directives,COVID,"February 08, 2021",1214,NCT04501172,QUESTIONNAIRE COMPLETION,GREECE,Completed,Democritus University of Thrace,"June 25, 2020",Observational,Impact of Spectacles on Compliance to Mask-wearing Directives in Greece
3114,Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19,CARDIAC REHABILITATION,"February 08, 2021",27,NCT04501432,NO INTERVENTION,AUSTRIA,Completed,Ludwig Boltzmann Institute for Digital Health and Prevention,"July 14, 2020",Observational,Cardiac Rehabilitation and Ongoing Physical Activity During the Coronavirus Disease (COVID-19) Pandemic: An Exploratory Mixed-Methods Study
3115,Psychological Symptoms and Families of COVID-19 Patients,FAMILY MEMBERS; POST INTENSIVE CARE UNIT SYNDROME; POST TRAUMATIC STRESS DISORDER,"February 08, 2021",100,NCT04501445,WRITTEN SUMMARY OF ROUNDS,UNITED STATES,Recruiting,Rush University Medical Center,"September 14, 2020",Interventional,Relieving the Burden of Psychological Symptoms Among Families of Critically Ill Patients With COVID-19
3116,Western Kenya Integrated COVID-19 Response,COVID,"February 08, 2021",200000,NCT04501458,"TRAINING OF YOUTH, COMMUNITY HEALTH ASSISTANTS AND COMMUNITY HEALTH WORKERS.; TRAINING CLINICIANS IN BASIC CRITICAL CARE AND THE MANAGEMENT OF SEVERE COVID-19 CASES",KENYA,Recruiting,Surgical Systems Research Group,"May 18, 2020",Interventional,"Western Kenya Integrated COVID-19 Response Leveraging the Community Health Strategy, Youth, and Technology to Flatten the COVID-19 Curve and Improve COVID-19 Case Detection, Isolation and Management in Western Kenya"
3117,Parent Telehealth Intervention for Children With Autism,AUTISM SPECTRUM DISORDER; AUTISM,"February 08, 2021",40,NCT04501588,RESPONSIVE TRAINING WITH NO VIDEO FEEDBACK; RESPONSIVE TRAINING WITH VIDEO FEEDBACK,UNITED STATES,Recruiting,Northwestern University,"March 6, 2020",Interventional,Parent Language Intervention for Autism
3118,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,COVID,"February 08, 2021",168,NCT04501783,FAVIPIRAVIR; STANDARD OF CARE (SOC); STANDARD CONCOMITANT THERAPY,RUSSIAN FEDERATION,"Active, not recruiting",R-Pharm,"May 20, 2020",Interventional,Randomized Open-label Multicenter Parallel-group Study of Efficacy and Safety of TL-FVP-t vs. Standard of Care Therapy in Patients With Mild to Moderate Coronavirus Disease (SARS-CoV-2/COVID-19)
3119,A Trial of NT-I7 in COVID-19 (SPESELPIS),COVID,"February 08, 2021",30,NCT04501796,DOUBLE-BLIND NT-I7; DOUBLE-BLIND PLACEBO,UNITED STATES,Recruiting,NeoImmuneTech,August 2020,Interventional,"A Double-blind, Randomized, Placebo-controlled, Phase 1, Single-dose, Dose-escalating Trial of Long-acting Recombinant Human IL-7 (NT-I7) for COVID-19"
3120,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia,COVID; CARDIAC COMPLICATION,"February 08, 2021",380,NCT04501822,"EVALUATION OF CLINICAL, INSTRUMENTAL AND LABORATORY DIAGNOSTICS TESTS",RUSSIAN FEDERATION,Recruiting,Tomsk National Research Medical Center of the Russian Academy of Sciences,"July 19, 2020",Observational,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia
3121,Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting,COVID,"February 08, 2021",1264,NCT04501952,RDV; PLACEBO TO MATCH RDV,DENMARK,Recruiting,Gilead Sciences,"September 18, 2020",Interventional,"A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of COVID-19 in an Outpatient Setting"
3122,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,COVID,"February 08, 2021",231,NCT04501965,HYDROXYCHLOROQUINE/AZITHROMYCINE; QUINQUINA-STEVIA/AZYTHROMYCIN; 4PLANTS/AZYTHROMYCIN,GUINEA,Enrolling by invitation,Institute for Research and Development of Medicinal and Food Plants of Guinea,"June 1, 2020",Interventional,"Evaluation de l'efficacité et de la tolérance de Quinquina et d'un phytomédicament "" ACAR "" en Comparaison Avec l'Hydroxychloroquine Chez Des Adultes Malades de Covid-19 Sans symptômes"
3123,ACTIV-3: Therapeutics for Inpatients With COVID-19,COVID,"February 08, 2021",10000,NCT04501978,LY3819253; PLACEBO; REMDESIVIR; VIR-7831; BRII-196/BRII-198,DENMARK,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"August 4, 2020",Interventional,"A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19"
3124,Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes,TYPE 2 DIABETES; METABOLIC CONTROL,"February 08, 2021",114,NCT04501991,ANTIDIABETIC TREATMENT,ITALY,Completed,University of Pisa,"March 11, 2020",Observational,Determining the Impact of COVID-19 Lockdown on Metabolic Control in Individuals With Type 2 Diabetes
3125,Covid-19 Messaging to Underserved Communities - 2nd Experiment,COVID,"February 08, 2021",20000,NCT04502056,ACKNOWLEDGEMENT RACIAL INJUSTICE AMA; AFRICAN AMERICAN SENDER ACKNOWLEDGEMENT; AFRICAN AMERICAN SENDER IN INFORMATIONAL VIDEOS.; RACIAL INEQUALITY HIGHLIGHTED; AMA ACKNOWLEDGEMENT DRUG PRICING; WHITE SENDER IN ACKNOWLEDGEMENT; WHITE SENDER IN INFORMATIONAL VIDEOS; NO RACIAL INEQUALITY HIGHLIGHTING; PLACEBO VIDEOS,UNITED STATES,"Active, not recruiting","National Bureau of Economic Research, Inc.","July 31, 2020",Interventional,Covid-19 Messaging to Underserved Communities - 2nd Experiment
3126,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen,COVID; LUNG INFECTION,"February 08, 2021",0,NCT04502069,OPAGANIB,ISRAEL,Withdrawn,RedHill Biopharma Limited,August 2020,Interventional,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen But Not Mechanical Ventilation
3127,Behavior During and After COVID-19 Crisis,EXERCISE; NUTRITIONAL STATUS; SLEEP,"February 08, 2021",1000,NCT04502108,COVID19,SWITZERLAND,Recruiting,Slavko Rogan,"April 1, 2020",Observational,Online Survey About Physical Activity and Nutrition During and After Coronavirus Pandemic
3128,"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients",COVID,"February 08, 2021",30,NCT04502342,HYDROXYCLOROQUINE AND AZYTHROMYCINE; COSPHERUNATE/AZYTHROMYCINE; COSPHERUNATE/PHYTOMEDICINE/AZYTHROMYCIEN,GUINEA,Enrolling by invitation,Institute for Research and Development of Medicinal and Food Plants of Guinea,"June 1, 2020",Interventional,Évaluationefficacité et tolérance d'Une médication à Base de Cosphérunate et d'un phytomédicament Antiviral Par Voie Orale en Comparaison Avec un Traitement à Base d'Hydroxychloroquine Chez Des Adultes Malades Covid-19 Sans Complications
3129,Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients,FIBEROPTIC BRONCHOSCOPY (FOB); BRONCHOALVEOLAR LAVAGE (BAL); RESPIRATORY DISEASE,"February 08, 2021",15,NCT04502368,FIBEROPTIC BRONCHOSCOPY (FOB); BRONCHOALVEOLAR LAVAGE (BAL); ELECTRICAL IMPEDANCE TOMOGRAPHY (EIT); ARTERIAL BLOOD GAS TEST (ABG),BELGIUM,Recruiting,Erasme University Hospital,"September 1, 2020",Observational,Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients: Impact on Respiratory Mechanics and Gas Exchange
3130,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",85,NCT04502433,CUROSURF® (PORACTANT ALFA),UNITED KINGDOM,Recruiting,Chiesi Farmaceutici S.p.A.,"January 6, 2021",Interventional,"Multicenter, Open-label, Randomised Trial to Assess the Efficacy and Tolerability of Poractant Alfa(Porcine Surfactant, Curosurf®) in Hospitalized Patients With SARS-COV-19 Acute Respiratory Distress Syndrome (ARDS)"
3131,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,COVID,"February 08, 2021",200,NCT04502472,CONVALESCENT PLASMA TRANSFUSION,UNITED STATES,Recruiting,Inova Health Care Services,"June 6, 2020",Interventional,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma Collected From Individuals With Documented Infection and Recovery From COVID-19 (SARS-CoV-2)
3132,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,"COVID; VITAMIN D; CHILDREN, ONLY","February 08, 2021",40,NCT04502667,CHOLECALCIFEROL,MEXICO,Recruiting,"Coordinación de Investigación en Salud, Mexico","July 15, 2020",Interventional,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19: Open Controlled Clinical Trial
3133,Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS),"COVID; ARDS, HUMAN; ALI","February 08, 2021",300,NCT04503057,,SWEDEN,Recruiting,Lund University Hospital,"May 1, 2020",Observational [Patient Registry],Exhaled Breath Particles as a Clinical Indicator for Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrom (ARDS) in COVID-19 Positive and Negative Patients
3134,Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,PATIENT PREFERENCE; COVID,"February 08, 2021",517,NCT04503434,,SPAIN,Completed,Hospital Clinic of Barcelona,"May 15, 2020",Observational [Patient Registry],Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support
3135,COVID-19 Seroprevalence Study in ITM Staff,COVID,"February 08, 2021",330,NCT04503447,,BELGIUM,Completed,"Institute of Tropical Medicine, Belgium","August 1, 2020",Observational,Severe Acute Respiratory Syndrome Coronavirus (CoV) 2 (SARS-CoV-2) Seroprevalence Study in Institute of Tropical Medicine (ITM) Staff
3136,Nutritional Assessment of Hospitalized Patients With COVID-19,SARS-COV; NUTRITION DISORDERS,"February 08, 2021",50,NCT04503525,NUTRITIONAL ASSESSMENT,FRANCE,Recruiting,Lille Catholic University,"May 25, 2020",Observational,Nutritional Assessment of French Hospitalized Patients Infected With COVID-19
3137,A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19),COVID,"February 08, 2021",600,NCT04504032,RIVAROXABAN; PLACEBO,UNITED KINGDOM,Recruiting,Bill & Melinda Gates Medical Research Institute,"September 2, 2020",Interventional,"A Randomized, Controlled, Phase 2b Study to Evaluate Safety and Efficacy of Rivaroxaban (Xarelto®) for High Risk People With Mild COVID-19"
3138,Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients,COVID,"February 08, 2021",200,NCT04504240,FAMOTIDINE 20 MG,BANGLADESH,Recruiting,Chattogram General Hospital,"August 1, 2020",Interventional,Role of Famotidine in the Symptomatic Improvement of Moderate to Severe COVID-19 Patients
3139,Bucillamine in Treatment of Patients With COVID-19,COVID,"February 08, 2021",1000,NCT04504734,BUCILLAMINE; PLACEBO; BUCILLAMINE,UNITED STATES,Enrolling by invitation,"Revive Therapeutics, Ltd.","November 27, 2020",Interventional,"Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Bucillamine in Patients With Mild-Moderate COVID-19"
3140,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,COVID; BURN OUT; POST TRAUMATIC STRESS DISORDER,"February 08, 2021",120,NCT04504877,CANNABIDIOL,BRAZIL,"Active, not recruiting",University of Sao Paulo,"June 16, 2020",Interventional,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling (Bonsai Study) wIth COVID-19: a Randomised Controlled Trial
3141,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,COVID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; UPPER RESPIRATORY TRACT INFECTIONS,"February 08, 2021",16500,NCT04505098,ICOSAPENT ETHYL,UNITED STATES,Recruiting,Kaiser Permanente,"August 7, 2020",Interventional,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults (MITIGATE)
3142,Tenecteplase in Patients With COVID-19,COVID; RESPIRATORY FAILURE; ARDS,"February 08, 2021",60,NCT04505592,TENECTEPLASE; PLACEBO,UNITED STATES,Recruiting,Hooman Poor,"September 25, 2020",Interventional,Tenecteplase With Concomitant Anticoagulation for Severe Acute Respiratory Failure in Patients With COVID-19
3143,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia,COMMUNITY-ACQUIRED PNEUMONIA; COVID,"February 08, 2021",200,NCT04505605,BLOOD SAMPLES,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"May 14, 2020",Observational,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia: the LPSARS2 Study
3144,Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19,COVID; DYSPNEA,"February 08, 2021",100,NCT04505631,,FRANCE,Recruiting,Groupe Hospitalier de la Region de Mulhouse et Sud Alsace,"June 10, 2020",Observational,Follow-up of Respiratory Sequelae of Patients Hospitalized With SARS-CoV-2: a Prospective Multicenter Observational Study
3145,"Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19",COVID,"February 08, 2021",1000,NCT04505709,,SPAIN,Enrolling by invitation,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,"August 1, 2020",Observational [Patient Registry],"STOP-Coronavirus: Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19"
3146,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,PARTICIPANTS WITH OR WITHOUT STABLE CO-MORBIDITIES ASSOCIATED WITH PROGRESSION TO SEVERE COVID AT DIFFERENT STAGES OF THE PROTOCOL,"February 08, 2021",44325,NCT04505722,AD26.COV2.S; PLACEBO,ARGENTINA,"Active, not recruiting",Janssen Vaccines & Prevention B.V.,"September 7, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older"
3147,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",CORONAVIRUS; POST INTENSIVE CARE UNIT SYNDROME,"February 08, 2021",40,NCT04505761,VIRTUAL REALITY,NETHERLANDS,Recruiting,Radboud University,"August 1, 2020",Interventional,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19: An Explorative Study"
3148,Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),COVID,"February 08, 2021",2000,NCT04505774,THERAPUTIC HEPARIN; PROPHYLACTIC HEPARIN,SPAIN,Recruiting,Matthew Neal MD,"September 4, 2020",Interventional,"A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults With COVID-19"
3149,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function,COVID,"February 08, 2021",60,NCT04506229,WHOLE EXOME SEQUENCING,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"August 20, 2020",Observational,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function
3150,COVID-19 SAFE Enrollment,COVID,"February 08, 2021",1200,NCT04506268,OPT-OUT RECRUITMENT EMAIL; OPT-IN RECRUITMENT EMAIL,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"September 9, 2020",Interventional,Opt-In Versus Opt-Out for COVID Screening Assessment for Exposure
3151,Psychological Impact of COVID-19 Pandemic in Healthcare Workers,"COVID; STRESS, PSYCHOLOGICAL; WORK RELATED STRESS; EPIDEMIC DISEASE; SARS-COV INFECTION","February 08, 2021",3000,NCT04506515,PSYCHOLOGICAL STRESS AND ADAPTATION AT WORK SCORE (PSAS),SPAIN,Completed,Hospital General Universitario de Valencia,"April 9, 2020",Observational,Psychological Impact of COVID-19 Pandemic in Healthcare Workers in Spain: A Cross-sectional Study. PSIMCOV Group
3152,The C3I COVID-19 Project,COVID; CANCER; NICOTINE DEPENDENCE; PULMONARY DISEASE; CARDIOVASCULAR DISEASES; IMMUNOSUPPRESSION DISORDERS,"February 08, 2021",170000,NCT04506528,,UNITED STATES,Recruiting,"University of Wisconsin, Madison","August 10, 2020",Observational [Patient Registry],Investigating the Association Between Smoking Status and COVID-19 Outcomes: Collecting Data From Health Systems Affiliated With the National Cancer Institute's Cancer Center Cessation Initiative (C3I)
3153,Burden for STaff Working in the NHS,COVID; MENTAL HEALTH BURDEN,"February 08, 2021",100,NCT04506632,,UNITED KINGDOM,Recruiting,Sheffield Teaching Hospitals NHS Foundation Trust,"June 2, 2020",Observational,COST-NHS: COvid Burden in STaff Working in the NHS: A Study to Assess the Mental Health Burden of the COVID-19 Pandemic on NHS Healthcare Staff
3154,COVID-19 Associated Coagulopathy in Egypt,COAGULOPATHY,"February 08, 2021",150,NCT04507230,,EGYPT,Recruiting,Assiut University,"August 7, 2020",Observational,Assessment of COVID-19 Associated Coagulopathy and Hypercoagulable State in Upper Egypt
3155,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,COVID,"February 08, 2021",60,NCT04507256,AZD7442; PLACEBO,UNITED KINGDOM,"Active, not recruiting",AstraZeneca,"August 18, 2020",Interventional,"A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD7442 in Healthy Adults"
3156,Eosinophil and Anticoagulation in COVID-19 Patients,COVID,"February 08, 2021",80,NCT04507282,LMWH,TURKEY,Completed,Bursa Postgraduate Hospital,"May 15, 2020",Observational,Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
3157,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,COVID; DIABETES MELLITUS; HYPERTENSION; OBESITY,"February 08, 2021",240,NCT04507867,NUTRITIONAL SUPPORT SYSTEM (NSS); CONTROL,,Not yet recruiting,Anahuac University,August 2020,Interventional,Effect of a Nutritional Support System to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
3158,Comparison Between Positive and Negative COVID-19 Pneumonia,COVID; INTERSTITIAL PNEUMONIA,"February 08, 2021",80,NCT04507893,"CLINICAL, LABORATORY AND IMAGING CHARACTERISTICS OF PNEUMONIA",ITALY,Recruiting,University of Palermo,"March 15, 2020",Observational,"Clinical, Laboratory and Imaging Comparison Between COVID-19 Pneumonia Confirmed by PCR Detection on Nasopharyngeal Swab and Negative Swab Pneumonia"
3159,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection",CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",4000,NCT04508023,RIVAROXABAN; PLACEBO; STANDARD OF CARE (SOC),UNITED STATES,Recruiting,"Janssen Research & Development, LLC","August 13, 2020",Interventional,"A Multicenter, Randomized, Placebo-Controlled, Pragmatic Phase 3 Study Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic COVID-19 Infection"
3160,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",SARS-CoV2 INFECTION,"February 08, 2021",1620,NCT04508075,SARS-COV-2 VACCINE (INACTIVATED); PLACEBO,INDONESIA,Recruiting,PT Bio Farma,"August 10, 2020",Interventional,"A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years in Indonesia"
3161,Technology-assisted Index on Improving Hand Hygiene of Registered Nurses,HAND HYGIENE,"February 08, 2021",120,NCT04508114,TECHNOLOGY-ASSISTED INDEX,TAIWAN,Recruiting,National Taiwan University Hospital,"August 10, 2020",Interventional,The Effectiveness of Technology-assisted Index on Improving Hand Hygiene of Registered Nurses - An Experimental Research
3162,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,COVID; PNEUMONIA; COAGULATION DISORDER; PULMONARY EMBOLISM,"February 08, 2021",130,NCT04508439,ENOXAPARIN,MEXICO,Recruiting,Hospital Regional de Alta especialidad de Ixtapaluca,"June 20, 2020",Interventional,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection
3163,Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study,COVID,"February 08, 2021",500,NCT04508556,BREATH BIOPSY FACE MASKS WITH REMOVABLE FILTERS AND FITTED PVA STRIP; NASOPHARYNGEAL SWAB; OROPHARYNGEAL SWABS,,Not yet recruiting,Owlstone Ltd,September 2020,Observational,Performance Assessment of SARS-CoV-2 Detection Through Analysis of Exhaled Breath Aerosols
3164,Long-term Outcomes in Patients With COVID-19,COVID,"February 08, 2021",900,NCT04508712,,CHINA,Recruiting,RenJi Hospital,"August 10, 2020",Observational [Patient Registry],Long-term Outcomes in Patients With COVID-19
3165,COVID SAFE: COVID-19 Screening Assessment for Exposure,COVID,"February 08, 2021",600,NCT04508777,SALIVA-BASED TESTING,UNITED STATES,Enrolling by invitation,University of Pennsylvania,"September 9, 2020",Observational,COVID SAFE: COVID-19 Screening Assessment for Exposure
3166,Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19,DEPRESSION; DEPRESSIVE SYMPTOMS,"February 08, 2021",41,NCT04508868,BRIEF BEHAVIORAL ACTIVATION WITH MENTAL IMAGERY; MINIMAL ATTENTION CONTROL INTERVENTION,SWEDEN,Terminated,Uppsala University,"August 31, 2020",Interventional,Behavioral Activation and Mental Imagery Delivered Via Telephone for the Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19: A Randomized Clinical Trial
3167,A Survey to Assess Effects of Covid-19 on Cardiovascular Patients,CARDIOVASCULAR DISEASES; HEART FAILURE,"February 08, 2021",76,NCT04508920,"SYMPTOMATOLOGY, TREATMENT. DAILY ACTIVITIES AND ANXIETY FOR CARDIOVASCULAR PATIENTS SURVEY (STRATA)",MEXICO,Recruiting,"Centro en Insuficiencia Cardiaca, Mexico","May 15, 2019",Observational [Patient Registry],"A Survey to Assess Effects of the Covid-19 Pandemic on Symptomatology, Treatment and Medical Care for Cardiovascular Patients"
3168,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients","RESPIRATORY DISTRESS SYNDROME, ADULT; VENTILATION PERFUSION MISMATCH; PULMONARY EDEMA; COVID","February 08, 2021",10,NCT04508933,EXTRAVASCULAR LUNG WATER INDEX; PULMONARY VASCULAR PERMEABILITY INDEX,TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,"September 1, 2020",Observational,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients"
3169,The McMaster Multi-Regional COVID-19 Hospital Case Registry,CORONAVIRUS INFECTION; CORONAVIRUS; SARS-CoV2 INFECTION; COVID,"February 08, 2021",1500,NCT04508959,,CANADA,Recruiting,McMaster University,"April 15, 2020",Observational [Patient Registry],A Rapid Research Platform to Inform Prevention & Improve the Clinical Management of COVID-19 Illness for Priority Older Adult Groups: The McMaster Multi-regional Hospital Coronavirus Registry
3170,The VOICE-COVID-19,COVID,"February 08, 2021",200,NCT04508972,ALEXA AMAZON,CANADA,Recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"July 1, 2020",Observational,Voice-based Identification of Clinical Features Requiring Emergent Action in Patients With Suspected COVID-19 Infection (VOICE-COVID) Study
3171,The McGill RAAS-COVID-19 Trial,COVID; CARDIOVASCULAR DISEASES,"February 08, 2021",40,NCT04508985,TEMPORARILY HOLDING THE RAAS INHIBITOR [INTERVENTION]; RAAS INHIBITOR [CONTINUED STANDARD OF CARE],,Not yet recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"September 1, 2020",Interventional,Management of Renin-Angiotensin-Aldosterone System Blockade in Patients Admitted in Hospital With Confirmed Coronavirus Disease (COVID-19) Infection: The McGill RAAS-COVID-19 Randomized Controlled Trial
3172,Virtual Teaching Kitchen,CARDIAC HEALTH; METABOLIC SYNDROME,"February 08, 2021",25,NCT04509206,NUTRITIONAL EDUCATION,UNITED STATES,Enrolling by invitation,Boston University,"September 28, 2020",Interventional,A Virtual Nutritional Education Delivered Through a Hospital Teaching Kitchen : a Proof-of-concept Study
3173,Canine COVID-19 Detection,COVID,"February 08, 2021",16250,NCT04509713,COLLECTION OF ODOUR SAMPLES,UNITED KINGDOM,Recruiting,ARCTEC,"July 2, 2020",Observational,Using Medical-detection Dogs to Identify People With SARS-CoV-: Phase I: Proof-of-concept Studies
3174,Dysphagia Management During COVID-19 Pandemic,DYSPHAGIA; COVID,"February 08, 2021",50,NCT04509752,SURVEY,TURKEY,Recruiting,Hacettepe University,"October 8, 2020",Observational,Experiences in Dysphagia Management During COVID-19 Pandemic
3175,A Study of Ad26.COV2.S in Adults (COVID-19),HEALTHY,"February 08, 2021",250,NCT04509947,AD26.COV2.S; PLACEBO,JAPAN,"Active, not recruiting",Janssen Pharmaceutical K.K.,"August 11, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S in Adults"
3176,Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia,COVID; HYPOXIA,"February 08, 2021",1000,NCT04509973,DEXAMETHASONE,DENMARK,Recruiting,Scandinavian Critical Care Trials Group,"August 27, 2020",Interventional,Higher vs. Lower Doses of Dexamethasone in Patients With COVID-19 and Severe Hypoxia
3177,GlobalSurg-CovidSurg Week,SURGERY; COVID; POST-OP COMPLICATION,"February 08, 2021",1000,NCT04509986,,,Not yet recruiting,University of Birmingham,"October 1, 2020",Observational,GlobalSurg-CovidSurg Week: Determining the Optimal Timing for Surgery Following SARS-CoV-2 Infection
3178,Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,COVID,"February 08, 2021",100,NCT04509999,BICALUTAMIDE 150 MG ORAL TABLET; PLACEBO,UNITED STATES,Recruiting,University of Florida,"October 26, 2020",Interventional,Randomized Trial of Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection
3179,Characterizing the Immune Response and Neuronal Damage in COVID-19,SARS-COV INFECTION; COVID,"February 08, 2021",150,NCT04510012,"ANALYSIS OF CYTOKINE RESPONSE, INNATE AND ADAPTIVE IMMUNE RESPONSE, COMPLEMENT ACTIVATION, AND SERUM NEUROFILAMENTS AS A MARKER OF NEUROLOGICAL DAMAGE.",SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","March 5, 2020",Observational,Characterizing the Immune Response and Neuronal Damage in SARS-CoV-2 Infected Individuals
3180,Capturing MultiORgan Effects of COVID-19,CORONAVIRUS INFECTION; MULTI-ORGAN DISORDER,"February 08, 2021",616,NCT04510025,MAGNETIC RESONANCE IMAGING,UNITED KINGDOM,Recruiting,University of Oxford,"May 13, 2020",Observational,"Assessing the Effects of Coronavirus Disease (COVID-19) on Multiple Organ Systems and Impact on Quality of Life, Functional Capacity and Mental Health"
3181,Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury,COVID; MYOCARDIAL INJURY,"February 08, 2021",75,NCT04510038,COLCHICINE; COVID-19 STANDARD OF CARE,,Not yet recruiting,Miami Cardiac and Vascular Institute,"September 1, 2020",Interventional,Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)
3182,MET-COVID -- Outpatient Metformin Use for COVID-19,COVID; SARS-COV INFECTION,"February 08, 2021",70,NCT04510194,METFORMIN; PLACEBO,UNITED STATES,Recruiting,University of Minnesota,"January 1, 2021",Interventional,MET-COVID Trial - Metformin for Outpatient Treatment and Post-exposure Prophylaxis (PEP) of COVID-19
3183,"A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",COVID,"February 08, 2021",45000,NCT04510207,INACTIVATED SARS-COV-2 VACCINE (VERO CELL); INACTIVATED SARS-COV-2 VACCINE (VERO CELL); PLACEBO,BAHRAIN,Recruiting,China National Biotec Group Company Limited,"July 16, 2020",Interventional,"Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above"
3184,Ivermectin Nasal Spray for COVID19 Patients,COVID,"February 08, 2021",60,NCT04510233,IVERMECTIN NASAL; IVERMECTIN ORAL; STANDARD CARE,,Not yet recruiting,Tanta University,September 2020,Interventional,Ivermectin Inhalation Forms in the Management of COVID-19 Egyptian Patients
3185,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,COVID; POVIDONE IODINE ADVERSE REACTION,"February 08, 2021",50,NCT04510402,POVIDINE IODINE NASAL SWABS,,Not yet recruiting,Brigham and Women's Hospital,August 2020,Interventional,Phase I/II Trial (Safety and Dosing) of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects
3186,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms,CORONAVIRUS,"February 08, 2021",2000,NCT04510441,NIL INTERVENTION,UNITED KINGDOM,Recruiting,Imperial College London,"May 26, 2020",Observational,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms and Imaging
3187,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,CANCER; COVID,"February 08, 2021",200,NCT04510454,NASOPHARYNGEAL AND THROAT/OROPHARYNGEAL SWABS ANALYSES BY RT-PCR AND DDPCR,,Not yet recruiting,Centre Leon Berard,September 2020,Interventional,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19
3188,Mental Health Consequences of COVID19 Infection in the French RMD Cohort,COVID; SYSTEMIC AUTOIMMUNE DISEASE; INFLAMMATORY RHEUMATISM; AUTO INFLAMMATORY DISEASES,"February 08, 2021",1313,NCT04510467,,,Not yet recruiting,"University Hospital, Lille",January 2021,Observational,Mental Health Consequences of COVID19 Infection in the French Rheumatic Musculoskeletal Diseases (RMD) Cohort
3189,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,"CORONAVIRUS INFECTION; DIABETES MELLITUS, TYPE 2","February 08, 2021",116,NCT04510493,CANAKINUMAB; PLACEBO,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","October 23, 2020",Interventional,Canakinumab in Patients With COVID-19 and Type 2 Diabetes - CanCovDia Trial
3190,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers,MAJOR DEPRESSIVE DISORDER; GENERALIZED ANXIETY,"February 08, 2021",50,NCT04510519,,,Not yet recruiting,"Kintsugi Mindful Wellness, Inc.","September 1, 2020",Observational,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers: An Observational Study
3191,Host Response Mediators in Coronavirus (COVID-19) Infection,COVID; SARS-CoV2,"February 08, 2021",500,NCT04510623,ARBS AND/OR ACE INHIBITORS; USUAL CARE,CANADA,Recruiting,University of British Columbia,"March 17, 2020",Observational,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Angiotensin II Type 1 Receptor Blockers (ARBs) on Outcomes of Coronavirus Infection?
3192,Telmisartan in Respiratory Failure Due to COVID-19,"COVID; RESPIRATORY INSUFFICIENCY; TELMISARTAN; RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",60,NCT04510662,TELMISARTAN,MEXICO,Recruiting,Abraham Edgar Gracia-Ramos,August 2020,Interventional,Effectiveness and Safety of Telmisartan in Acute Respiratory Failure Due to COVID-19
3193,Transparent Elastomeric Respirator for Aerosol-based Protection,PERSONAL PROTECTIVE EQUIPMENT,"February 08, 2021",100,NCT04511390,"TRANSPARENT, REUSABLE RESPIRATOR",UNITED STATES,Recruiting,Brigham and Women's Hospital,"July 25, 2020",Interventional,Transparent Elastomeric Respirator to Protect Against Aerosol Transmission of Infectious Agents
3194,COVID-19 in Immunosuppressed Children,"INFECTIONS, CORONAVIRUS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; CANCER; COVID","February 08, 2021",200,NCT04511429,,BRAZIL,Recruiting,D'Or Institute for Research and Education,"June 30, 2020",Observational [Patient Registry],COVID-19 in Immunosuppressed Children
3195,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)",COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",180,NCT04511650,RAZUPROTAFIB SUBCUTANEOUS SOLUTION; PLACEBO SUBCUTANEOUS SOLUTION,UNITED STATES,Recruiting,Aerpio Therapeutics,"October 21, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose Escalation and Proof-of-Concept Study to Evaluate the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) (RESCUE Study)"
3196,Psychological Impact of COVID-19 Outbreak on Caregivers,"CRITICAL ILLNESS; COVID; STRESS DISORDERS, POST-TRAUMATIC","February 08, 2021",5000,NCT04511780,QUESTIONNAIRE FILLING,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nīmes,January 2021,Observational,"Psychological Impact of COVID-19 Outbreak on Caregivers Involved in Intensive Care Unit Patient Management: Impact on the Occurrence of Post-traumatic Stress Disorder, Anxiety, Depression and Burn Out Syndrome"
3197,Losmapimod Safety and Efficacy in COVID-19,COVID,"February 08, 2021",410,NCT04511819,LOSMAPIMOD ORAL TABLET; PLACEBO ORAL TABLET,BRAZIL,Recruiting,Fulcrum Therapeutics,"August 28, 2020",Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Losmapimod in Adult Subjects With COVID-19 (LOSVID STUDY)"
3198,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,"COVID; ARDS, HUMAN; LUNG INJURY, ACUTE; VENTILATION PERFUSION MISMATCH","February 08, 2021",40,NCT04511923,NEBULISED HEPARIN,IRELAND,Recruiting,University College Hospital Galway,"December 23, 2020",Interventional,Can Nebulised HepArin Reduce acuTE Lung Injury in Patients With SARS-CoV-2 Requiring Respiratory Support in Ireland
3199,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04511949,"COVID-19 IGG / IGM RAPID TEST (WHOLE BLOOD, SERUM, PLASMA)",FRANCE,Completed,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,"July 12, 2020",Interventional,Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease
3200,"Feasibility, of Tele-rehabilitation Following COVID-19",PULMONARY DISEASE,"February 08, 2021",40,NCT04511962,TELE-PULMONARY REHABILITATION,UNITED KINGDOM,Not yet recruiting,Hull University Teaching Hospitals NHS Trust,"August 12, 2020",Observational,"A Feasibility, Randomised Controlled Trial of Tele-rehabilitation Following COVID-19"
3201,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,COVID,"February 08, 2021",10,NCT04512027,PROLECTIN-M; A (1-6)-ALPHA-D-MANNOPYRANOSE CLASS; STANDARD OF CARE,INDIA,Completed,Composite Interceptive Med Science,"September 15, 2020",Interventional,"Effect of Prolectin-M; a (1-6)-Alpha-D-Mannopyranose on SarsCoV2 Viral Copy Numbers: A Proof of Concept, Open Label Randomized Controlled Trial"
3202,FREEDOM COVID-19 Anticoagulation Strategy,COVID; SARS-CoV2,"February 08, 2021",3600,NCT04512079,ENOXAPARIN; APIXABAN,UNITED STATES,Recruiting,Valentin Fuster,"September 8, 2020",Interventional,FREEDOM COVID Anticoagulation Strategy Randomized Trial
3203,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients,PRESENCE OF COVID COMPATIBLE CT ABNORMALITIES,"February 08, 2021",22,NCT04512118,PET-CT OF 18F-FDG,FRANCE,Completed,"Central Hospital, Nancy, France","March 15, 2020",Observational,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients
3204,Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic,DENTAL TREATMENT DURING COVID -19,"February 08, 2021",267,NCT04512300,,EGYPT,Completed,Cairo University,"June 15, 2020",Observational,Parental Attitude Toward Children Dental Treatment and Care During COVID-19 Pandemic (Cross -Sectional Study)
3205,Group CBT for Intolerance of Uncertainty,GENERALIZED ANXIETY DISORDER; INTOLERANCE OF UNCERTAINTY; ANXIETY,"February 08, 2021",20,NCT04512378,BEHAVIOURAL EXPERIMENTS FOR INTOLERANCE OF UNCERTAINTY,CANADA,Recruiting,University of Manitoba,"February 1, 2021",Interventional,Facing the Unknown Together: Piloting a Group-based CBT Protocol for Intolerance of Uncertainty
3206,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,COVID,"February 08, 2021",100,NCT04513158,CONVALESCENT PLASMA,UNITED STATES,Recruiting,"Joseph M. Flynn, D.O., MPH","August 14, 2020",Interventional,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection
3207,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,COVID,"February 08, 2021",60,NCT04513184,IV DEXAMETHASONE; NASAL DEXAMETHASONE,MEXICO,Recruiting,Edda Sciutto Conde,"July 14, 2020",Interventional,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
3208,Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection,COVID,"February 08, 2021",300,NCT04513210,,POLAND,Enrolling by invitation,Jagiellonian University,"October 10, 2020",Observational,"Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity, Length of Hospitalization and Long-term Complications and of Covid-19 Infection"
3209,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,"COVID; HYPERACTIVE DELIRIUM; PNEUMONIA, VIRAL","February 08, 2021",20,NCT04513314,VALPROATE; QUETIAPINE; STANDARD OF CARE,UNITED STATES,Not yet recruiting,University of Miami,"November 1, 2021",Interventional,"A Practical, Pilot, Randomized, Controlled Trial of Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium"
3210,Allocetra-OTS in COVID-19,COVID,"February 08, 2021",5,NCT04513470,ALLOCETRA-OTS,ISRAEL,"Active, not recruiting",Hadassah Medical Organization,"August 1, 2020",Interventional,"A Multi-Center, Open-Label Study, Evaluating Safety of Allocetra-OTS for the Prevention of Organ-Failure Deterioration in Severe Patients With COVID-19 and Respiratory Dysfunction"
3211,Telemedicine in HIV Care in Buenos Aires,TELEMEDICINE; HIV-1-INFECTION,"February 08, 2021",4000,NCT04513496,,,Not yet recruiting,Fundacion Ibis,"September 1, 2020",Observational,"Delivery of HIV Care Through Telemedicine in Public Hospitals in Buenos Aires, Argentina During COVID-19 Pandemic: Implementation Research"
3212,Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19,INFLAMMATORY DISEASE; COVID,"February 08, 2021",4500,NCT04513561,,,Not yet recruiting,"University Hospital, Lille",December 2020,Observational,"Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU (Rheumatology, Dermatology, Internal Medicine, Pneumology, Gastroenterology, Neurology)."
3213,PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis,PSORIASIS; COVID,"February 08, 2021",661,NCT04513847,,CANADA,Completed,Dermatrials Research,"August 13, 2020",Observational,PsoVac: A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic
3214,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation,HEART FAILURE; COVID,"February 08, 2021",60,NCT04513964,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"November 1, 2020",Observational,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation
3215,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),COVID INFECTION,"February 08, 2021",1500,NCT04513990,BIOSPECIMEN COLLECTION; QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"April 9, 2020",Interventional,Evaluation of a Novel Point-of-Care Diagnostic Test for SARS-CoV-2
3216,The Corona and COVID-19 Study in Telemark and Agder,COVID,"February 08, 2021",5000,NCT04514003,,NORWAY,Recruiting,Sykehuset Telemark,"July 1, 2020",Observational,The Corona and COVID-19 Study in Telemark and Agder - COVITA
3217,Cross Sectional CFAR HIV/COVID Study,SARS-COV INFECTION; COVID,"February 08, 2021",100,NCT04514016,,UNITED STATES,Recruiting,University of Miami,"August 12, 2020",Observational,"Cross Sectional Survey Of Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (COV-2) Infection And Seroprevalence In A Cohort Of HIV-Infected Children, Youth, And Adolescents Receiving Care At A Single Tertiary Care Medical Center In Miami-Dade County, Florida"
3218,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,COVID,"February 08, 2021",51,NCT04514302,PLACEBO; ANTI-SARS-COV-2 EQUINE IMMUNOGLOBULIN FRAGMENTS (INOSARS),MEXICO,Not yet recruiting,Hospital San Jose Tec de Monterrey,"October 20, 2020",Interventional,Pilot Study to Evaluate Safety and Efficacy of Anti-SARS-CoV-2 Equine Immunoglobulin F(ab')2 Fragments (INOSARS) in Hospitalized Patients With COVID-19
3219,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,COVID,"February 08, 2021",100,NCT04514627,AURICULAR PERCUTANEOUS NEUROSTIMULATION,UNITED STATES,Recruiting,Olive View-UCLA Education & Research Institute,"July 13, 2020",Interventional,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19
3220,Characteristics in Post Covid-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04514705,EXERCISE,BRAZIL,Recruiting,Universidade Metodista de Piracicaba,"August 11, 2020",Interventional,Clinical Respiratory Investigation in Post Covid-19 Patients
3221,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020,COVID; SARS-COV INFECTION,"February 08, 2021",500,NCT04514874,QUESTIONNAIRE,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 1, 2020",Observational,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020
3222,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,OBESITY,"February 08, 2021",120,NCT04514900,VIDEO CHAT +PERSONALIZED FEEDBACK; VIDEO CHAT + BASIC FEEDBACK; DISCUSSION BOARD FOR SOCIAL SUPPORT +BASIC FEEDBACK; DISCUSSION BOARD FOR SOCIAL SUPPORT+PERSONALIZED FEEDBACK,UNITED STATES,"Active, not recruiting",University of South Carolina,"September 23, 2020",Interventional,Exploring the Optimal Treatment Components for a Contactless Online Group-based Behavioral Weight Loss Program for the COVID 19 Pandemic
3223,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies,"PREGNANCY, INFECTIONS IN; COVID","February 08, 2021",108,NCT04515108,CLINICAL ASSESSMENT,TURKEY,Completed,Ankara City Hospital Bilkent,"March 10, 2020",Observational,Comparison of Hematological Parameters and Perinatal Outcomes in COVID-19 Pregnancies and Healthy Pregnancy Cohort
3224,"A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19",CORONAVIRUS; COVID; SARS-CoV2; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",674,NCT04515147,CVNCOV 6 ΜG; CVNCOV 12 ΜG; HEPATITIS A VACCINE; PNEUMOCOCCAL VACCINE; CVNCOV 12ΜG,PANAMA,"Active, not recruiting",CureVac AG,"September 28, 2020",Interventional,"COVID-19: A Phase 2a, Partially Observer-blind, Multicenter, Controlled, Dose-confirmation Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults >60 Years of Age and 18 to 60 Years of Age"
3225,Home Management of Adult Egyptian Mild COVID-19 Cases,COVID; TELEMEDICINE; QUALITY OF LIFE; SAFETY ISSUES; SYMPTOMS,"February 08, 2021",400,NCT04515199,,EGYPT,Recruiting,Cairo University,"July 1, 2020",Observational [Patient Registry],Effectiveness of Telemedicine Use in Home Management of Adult Egyptian Mild COVID-19 Cases
3226,COVID-19 Prevalence in HIV-infected Patients,HIV INFECTIONS,"February 08, 2021",500,NCT04515225,BLOOD SAMPLE,,Not yet recruiting,"University Hospital, Strasbourg, France","September 15, 2020",Observational,Seroprevalence of SARS-CoV-2 Antibodies Among Adult Patients Living With HIV
3227,Improving Patient-Provider Communication to Reduce Mental Health Disparities,HEALTHCARE DISPARITIES; MENTAL HEALTH,"February 08, 2021",50,NCT04515771,PARTNER-MH,UNITED STATES,Recruiting,VA Office of Research and Development,"August 17, 2020",Interventional,Improving Patient-provider Communication to Reduce Mental Health Disparities (CDA 16-153)
3228,Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients,"RESPIRATORY DISTRESS SYNDROME, ADULT; COVID","February 08, 2021",180,NCT04516486,RETROSPECTIVE METAGENOMICS ON CLINICAL SAMPLES COLLECTED DURING HOSPITALIZATION,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 9, 2020",Observational,Characterization and Prognostic Impact of Inflammatory Responses by Host Transcriptomics and Co-infection by Metagenomics in Patients With ARDS COVID-19 in Intensive Care
3229,Assessment of SARS-CoV-2 Seroprevalence in Detention,COVID,"February 08, 2021",2500,NCT04516512,BLOOD DRAW,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"September 1, 2020",Interventional,SARS-CoV-2 Seroprevalence Among Adults People Living in Jail
3230,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects",CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",32,NCT04516564,AK119; PLACEBO,NEW ZEALAND,Recruiting,Akesobio Australia Pty Ltd,September 2020,Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, First-In-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AK119 in Healthy Subjects"
3231,Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression,POST PARTUM DEPRESSION,"February 08, 2021",250,NCT04516668,,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,November 2020,Observational,Survey About Anxious and Depressive Symptoms During COVID-19 in Women Who Have Medical History of Post-partum Depression: Interest of Tele-consultation
3232,"Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults",COVID; SARS-CoV2,"February 08, 2021",30000,NCT04516746,AZD1222; PLACEBO,ARGENTINA,Recruiting,AstraZeneca,"August 28, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19"
3233,AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,COVID,"February 08, 2021",150,NCT04516759,AZD1656; PLACEBO,CZECHIA,Recruiting,St George Street Capital,"August 12, 2020",Interventional,"A Phase II, Randomised, Double-blind, Placebo-controlled Clinical Trial to Assess the Safety and Efficacy of AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19"
3234,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,COVID; SARS-CoV2 INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",600,NCT04516811,COVID-19 CONVALESCENT PLASMA (CCP) PLUS STANDARD OF CARE (SOC); STANDARD OF CARE (SOC) PLUS PLACEBO,SOUTH AFRICA,Recruiting,South African National Blood Service,"September 21, 2020",Interventional,"A Prospective, Randomized, Placebo-controlled, Double-blinded, Phase III Clinical Trial of the Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19"
3235,Experience of Orthopaedic and Spine Center Pakistan During COVID-19,ORTHOPAEDIC DISORDERS,"February 08, 2021",2160,NCT04516824,ORTHOPAEDIC SURGICAL PROCEDURES,PAKISTAN,Completed,Ghurki Trust and Teaching Hospital,"March 19, 2020",Observational,Experience of Workforce From Orthopaedic and Spine Center Ghurki Trust Hospital Pakistan During COVID-19
3236,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),IMMUNE THROMBOCYTOPENIA,"February 08, 2021",120,NCT04516837,ELTROMBOPAG; RHTPO,CHINA,Recruiting,Peking University People's Hospital,"August 31, 2020",Interventional,The Combination of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) Versus Eltrombopag Monotherapy as Subsequent Treatment for Immune Thrombocytopenia During the COVID-19 Pandemic
3237,HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients,COVID,"February 08, 2021",500,NCT04516850,EXPRESSION OF RECEPTORS AND ACTIVATING PROTEASES; POLYMORPHISM OF THE HSD3B1,SWITZERLAND,Not yet recruiting,Ricardo Pereira Mestre,"September 1, 2020",Observational,An Exploratory Analysis of the Expression of Receptors and Activating Proteases Mediating SARS-CoV-2 Entry and the Association Between HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients
3238,IMU-838 and Oseltamivir in the Treatment of COVID-19,COVID,"February 08, 2021",120,NCT04516915,IMU-838; OSELTAMIVIR,UNITED KINGDOM,Recruiting,University Hospitals Coventry and Warwickshire NHS Trust,"June 15, 2020",Interventional,"Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination With Oseltamivir, in Adults With COVID-19"
3239,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel,SARS-COV INFECTION; COVID,"February 08, 2021",950,NCT04516928,ANTI-SARS-COV2 SEROLOGY; QUESTIONNAIRE,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 21, 2020",Observational,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel
3240,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,SARS-COV INFECTION; COVID,"February 08, 2021",420,NCT04516941,EDOXABAN TABLETS; COLCHICINE TABLETS,SWITZERLAND,Not yet recruiting,"University Hospital Inselspital, Berne","October 1, 2020",Interventional,Efficacy and Safety of Edoxaban and or Colchicine for Patients With SARS-CoV-2 Infection Managed in the Out of Hospital Setting
3241,Convalescent Plasma for COVID-19 Patients,COVID,"February 08, 2021",10,NCT04516954,CONVALESCENT COVID 19 PLASMA,VIETNAM,Enrolling by invitation,Vinmec Research Institute of Stem Cell and Gene Technology,"August 1, 2020",Interventional,Assessment of the Safety of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above Illness
3242,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,HAPPINESS; ANXIETY; DEPRESSION; MORALITY,"February 08, 2021",1542,NCT04517006,SELF-FOCUSED ACTS; PROSOCIAL ACTS,,Not yet recruiting,University of Toronto,January 2021,Interventional,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic: A Randomized Clinical Trial
3243,Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic,CANCER,"February 08, 2021",1680,NCT04517097,BLOOD SAMPLE,FRANCE,Completed,Centre Georges Francois Leclerc,"May 12, 2020",Observational,Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic
3244,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study","COVID; PNEUMONIA, VIRAL","February 08, 2021",100,NCT04517123,PRONE POSITIONING,UNITED STATES,Recruiting,Johns Hopkins University,"September 1, 2020",Interventional,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study"
3245,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions,"COVID; SARS-COV INFECTION; BURNOUT, CAREGIVER; BURNOUT, PROFESSIONAL","February 08, 2021",60,NCT04517136,ASSESSMENT OF WORK-RELATED STRESS; SALIVA SAMPLE COLLECTION; CARDIAC AND ELECTRODERMAL RECORDINGS; ASSESSMENT OF BEHAVIORAL RESPONSE TO EMOTIONAL STIMULATION,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 14, 2020",Observational,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions
3246,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,COVID; CYTOKINE STORM; REGULATION OF INFLAMMATORY RESPONSE; PULMONARY FIBROSIS,"February 08, 2021",90,NCT04517162,COLLAGEN-POLYVINYLPYRROLIDONE,MEXICO,Recruiting,Janette Furuzawa Carballeda,"August 19, 2020",Interventional,Effect of Collagen-Polyvinylpyrrolidone for the Treatment of Hyperinflammation and the Pulmonary Fibrosis in COVID-19 Patients. Double Blind Placebo-controlled Pilot Trial
3247,Halodine Nasal Antiseptic in Patients With COVID-19,SARS-CoV2 INFECTION,"February 08, 2021",40,NCT04517188,POVIDONE-IODINE SOLUTION 1.25% W/W [0.125% AVAILABLE IODINE] USP,,Not yet recruiting,Halodine LLC,"October 15, 2020",Interventional,A Phase 4 Study to Evaluate Nasopharyngeal SARS-CoV-2 Viral Shedding After Halodine Nasal Antiseptic in Patients With COVID-19
3248,FEnofibRate as a Metabolic INtervention for COVID-19,COVID,"February 08, 2021",700,NCT04517396,FENOFIBRATE/FENOFIBRIC ACID; PLACEBO; USUAL CARE,UNITED STATES,Enrolling by invitation,University of Pennsylvania,"August 18, 2020",Interventional,FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019
3249,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,SARS-COV INFECTION,"February 08, 2021",300,NCT04517422,PROBIOTICS; PLACEBO,MEXICO,"Active, not recruiting","AB Biotics, SA","August 19, 2020",Interventional,Efficacy and Safety of Lactobacillus Plantarum and Pediococcus Acidilactici as Co-adjuvant Therapy for Reducing the Risk of Severe Disease in Adults With SARS-CoV-2 and Its Modulation of the Fecal Microbiota: A Randomized Clinical Trial
3250,Renal Biomarkers in AKI and COVID-19,CORONAVIRUS INFECTION; COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); AKI,"February 08, 2021",90,NCT04517630,"URINARY NGAL, TIMP-2, IGFBP7, IL-6, VIRAL LOAD AND METABOLOMIC",MEXICO,Recruiting,Instituto Nacional de Enfermedades Respiratorias,"June 1, 2020",Observational [Patient Registry],Acute Kidney Injury In Subjects With Severe Acute Respiratory Syndrome Due to SARS-CoV2 Infection
3251,COVID-19 and SARS-CoV-2 Detection in Saliva,RNA VIRUS INFECTIONS,"February 08, 2021",300,NCT04517682,RT-PCR,UNITED STATES,Enrolling by invitation,Ambry Genetics,"May 21, 2020",Observational,SARS -CoV-2 Detection in Saliva Samples: A Test Validation Protocol
3252,Blood Volume Assessment in COVID-19 ICU Patients - BVAC19,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",30,NCT04517695,BVA-100,UNITED STATES,Recruiting,NYU Langone Health,"August 1, 2020",Observational,"Blood Volume, Components and Capillary Leak in SARS-CoV-2 Infections"
3253,ACTIV-2: A Study for Outpatients With COVID-19,CORONAVIRUS; COVID,"February 08, 2021",2000,NCT04518410,LY3819253; PLACEBO,PUERTO RICO,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"August 19, 2020",Interventional,Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)
3254,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),PATIENTS UNDERGOING ELECTIVE SURGERY WITH ANESTHESIA,"February 08, 2021",100,NCT04518514,TAPE-SOFTWARE,GERMANY,Recruiting,RWTH Aachen University,"April 20, 2020",Interventional,Telemedical Risk Assessment and Preoperative Evaluation for Anesthesia During the COVID-19 Pandemic
3255,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study),COVID,"February 08, 2021",1707,NCT04518735,ANTITHROMBOTIC THERAPY (ANTICOAGULANT AND/OR ANTIPLATELET) BEFORE ADMISSION FOR COVID19,SPAIN,Completed,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,"April 1, 2020",Observational,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients
3256,Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER),IMMUNE THROMBOCYTOPENIA,"February 08, 2021",30,NCT04518878,ELTROMBOPAG; RHTPO,CHINA,Recruiting,Peking University People's Hospital,"August 31, 2020",Interventional,Combination of Fixed Low-dose Eltrombopag and rhTPO for Treatment of Immune Thrombocytopenia
3257,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,COVID,"February 08, 2021",24,NCT04518969,CYTOSORB,BELGIUM,Recruiting,Dr David DE BELS,"May 3, 2020",Interventional,"Comparing the Cytokine Clearances of Pro-, and Anti-inflammatory Mediators, Chemokines and Complement in the COVID-19 Patients Treated With CytoSorb as Compared to the Same Patient Population Who do Not Receive Blood Purification Treatment"
3258,Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection,COVID,"February 08, 2021",27000,NCT04519034,NO INTERVENTION,UNITED KINGDOM,Not yet recruiting,Guy's and St Thomas' NHS Foundation Trust,"September 1, 2020",Observational,Retrospective Pilot Study of Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection
3259,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; COVID,"February 08, 2021",950,NCT04519125,TENOFOVIR/ EMTRICITABINE ( 300 MG / 200 MG DAILY DURING 60 DAYS) + PERSONAL PROTECTIVE EQUIPMENT (PPE); PLACEBO (1 TABLET DAILY DURING 60 DAYS) + PERSONAL PROTECTIVE EQUIPMENT (PPE),,Not yet recruiting,Hospital Universitario San Ignacio,"August 30, 2020",Interventional,Effectiveness of the Use of Personal Protective Equipment in Addition to Tenofovir/Emtricitabine for the Prevention of the Transmission of SARS-COV-2 to Health Care Personnel. Randomized Clinical Trial
3260,Breastfeeding Education in the Time of COVID-19,"BREASTFEEDING; BREASTFEEDING, EXCLUSIVE; BREASTFEEDING JAUNDICE; EDUCATIONAL PROBLEMS","February 08, 2021",39,NCT04519216,TELESIMULATION,UNITED STATES,Recruiting,"University of California, Davis","July 31, 2020",Interventional,"Breastfeeding Education in the Time of COVID-19. Hybrid Telesimulation With Standardized Patients for Pediatric and Family Medicine Trainees, a Randomized Trial"
3261,Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT,PET/CT; COVID; RESPIRATORY FUNCTION; INFLAMMATORY LESIONS,"February 08, 2021",60,NCT04519255,,CHINA,"Active, not recruiting","Fifth Affiliated Hospital, Sun Yat-Sen University","July 1, 2020",Observational,"Single-center, Open, Prospective, Randomized Pilot Study for Quantitative Analysis of Whole Body Inflammatory Lesions in Recovered COVID-19 Patients by 18F-FDG-PET/CT"
3262,Evaluation of Newborns Presenting With Suspected COVID 19,VIRAL INFECTION,"February 08, 2021",72,NCT04519307,,TURKEY,"Active, not recruiting",Dr. Behcet Uz Children's Hospital,"March 1, 2020",Observational,Evaluation of Newborns Presenting With Suspected COVID 19: A Single Center Experience
3263,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,SARS-CoV2,"February 08, 2021",140,NCT04519320,PULMONARY FUNCTION TESTING,FRANCE,Recruiting,Centre Hospitalier Universitaire de Besancon,"May 18, 2020",Interventional,Medium and Long Term Follow-up of SARS-COV-2 Infected Patients Treated at Besançon and Dijon Hospitals: Research and Characterization of Pulmonary Sequelae
3264,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting,COVID; SARS-CoV2,"February 08, 2021",4099,NCT04519372,TESTING FOR SARS-COV-2,SWITZERLAND,"Active, not recruiting","University Hospital, Basel, Switzerland","April 1, 2020",Observational,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting (Covid-Screen Quality Control Study)
3265,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,"PNEUMONIA, VIRAL","February 08, 2021",69,NCT04519385,TOCILIZUMAB; DEXAMETHASONE,EGYPT,Completed,South Valley University,"March 1, 2020",Interventional,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases
3266,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events,"COVID; CORONAVIRUS INFECTION; THROMBOSIS; ARDS; THROMBOPHILIA; THROMBOSES, INTRACRANIAL; THROMBOSES, DEEP VEIN; RAAS","February 08, 2021",60,NCT04519398,COMPLETE THROMBOPHILIC PROFILE TESTING BY MULTIPLEX PCR,ROMANIA,Recruiting,Grigore T. Popa University of Medicine and Pharmacy,"August 18, 2020",Observational,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events
3267,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,COVID,"February 08, 2021",10,NCT04519411,TRANSPULMONARY PRESSURE MEASUREMENTS,UNITED STATES,Recruiting,Mayo Clinic,"May 21, 2020",Interventional,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure
3268,CSL324 in COVID-19,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",0,NCT04519424,CSL324; PLACEBO,,Withdrawn,CSL Behring,September 2020,Interventional,"A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate CSL324 in Coronavirus Disease 2019 (COVID-19)"
3269,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19",HEALTHY; CHRONIC STABLE ILLNESS,"February 08, 2021",974,NCT04519437,REGN10933+REGN10987; PLACEBO,UNITED STATES,"Active, not recruiting",Regeneron Pharmaceuticals,"July 26, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers"
3270,Maternal Morbidity and Mortality During the COVID-19 Pandemic,COVID; PREGNANCY COMPLICATIONS,"February 08, 2021",26400,NCT04519502,,UNITED STATES,Recruiting,The George Washington University Biostatistics Center,"June 23, 2020",Observational,Maternal Morbidity and Mortality During the COVID-19 Pandemic
3271,Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement,COVID REALTED DISRUPTION IN PATIENT WITH DIABETES AND CKD,"February 08, 2021",529,NCT04520191,,,Not yet recruiting,University of New Mexico,"September 1, 2020",Observational,Home-based Kidney Care in Native Americans of New Mexico (HBKC) -COVID-19 Related Disruption in Health and Health Care
3272,Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention,SARS-CoV2,"February 08, 2021",0,NCT04520620,LOVENOX 40 MG IN 0.4 ML PREFILLED SYRINGE; ULTRASOUND OF THE LOWER LIMBS,FRANCE,Withdrawn,Centre Hospitalier Universitaire de Saint Etienne,"May 2, 2020",Interventional,Evaluation of the Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention in COVID-19 Intensive Unit Care Patients.
3273,Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory Distress,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",200,NCT04520815,,FRANCE,Recruiting,Centre Hospitalier Universitaire de la Réunion,"June 24, 2020",Observational,Assessment of the Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory Distress
3274,Antibodies Responses to COVID-19 Infection in Hospitalized Patients,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2 INFECTION); HOSPITALIZED PATIENTS; LABORATORY-CONFIRMED SARS-CoV2 INFECTION,"February 08, 2021",158,NCT04520880,TESTING PROCEDURE FOR BINDING ANTIBODIES; NEUTRALIZING ANTIBODIES,SAUDI ARABIA,Not yet recruiting,Dammam University,August 2020,Observational,Antibodies Responses to SARS-CoV 2 Infection (COVID-19) in Hospitalized Patients. A Prospective Observational Study
3275,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic,COVID PANDEMIC,"February 08, 2021",700,NCT04521010,COVID-19 PANDEMIC,POLAND,Completed,Poznan University of Medical Sciences,"January 1, 2020",Observational,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic at Wiktor Dega Orthopedic and Rehabilitation Clinical Hospital in Poznań
3276,Convalescent Plasma for COVID-19 Patients (CPCP),COVID,"February 08, 2021",44,NCT04521036,CONVALESCENT PLASMA AS THERAPY FOR COVID-19 PATIENTS,VIETNAM,Not yet recruiting,Vinmec Research Institute of Stem Cell and Gene Technology,"December 1, 2020",Interventional,Assessment of the Safety and Efficacy of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above Illness
3277,Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic,COVID,"February 08, 2021",1000,NCT04521088,,GERMANY,Recruiting,Wissenschaftliches Institut Bethanien e.V,"July 2, 2020",Observational [Patient Registry],Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic
3278,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,MILD TO MODERATE COVID,"February 08, 2021",90,NCT04521296,DWJ1248; PLACEBO,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,August 2020,Interventional,"A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase II Study to Evaluate the Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19"
3279,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,COVID,"February 08, 2021",50,NCT04521309,SARS-COV-2 ANTIBODY BASED IVIG THERAPY,PAKISTAN,Recruiting,Dow University of Health Sciences,"June 19, 2020",Interventional,Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Antibodies Based Intravenous Immunoglobulin (IVIG) Therapy for Severe and Critically Ill COVID-19 Patients
3280,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,COVID,"February 08, 2021",400,NCT04521322,IOTA-CARRAGEENAN,ARGENTINA,Recruiting,Ariel Dogliotti,"July 24, 2020",Interventional,"Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19. Multicenter, Randomized, Double-blind, Placebo-controlled Trial (CARR-COV-02)"
3281,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",COVID,"February 08, 2021",100,NCT04521400,HIGH DOSE INTERFERON-BETA 1A; LOPINAVIR/RITONAVIR; LOW DOSE INTERFERON-BETA 1A,,Not yet recruiting,Shahid Beheshti University of Medical Sciences,"August 20, 2020",Interventional,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19"
3282,Providing Suboxone and PrEP Using Telemedicine,OPIOID USE; OPIOID-USE DISORDER; RISK REDUCTION; HIV,"February 08, 2021",20,NCT04521920,SUBOXONE; PREP,UNITED STATES,Recruiting,Duke University,"November 9, 2020",Interventional,Providing Comprehensive Harm Reduction Via Telemedicine for PWID Using Syringe Services Programs: a Feasibility Study
3283,Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients,PATIENTS HOSPITALIZED IN THE HOSPICES CIVILS OF LYON; COVID DISEASE; MODERATE TO SEVERE DYSPNEA; WITHOUT RESUSCITATION OBJECTIVE MANAGEMENT,"February 08, 2021",200,NCT04522037,NO INTERVENTION / COMPARE THE DIFFERENCE IN RESPIRATORY RATE BETWEEN H0 AND H12 OF THE INITIATION OF MORPHINE BETWEEN THE CONTROL AND INTERVENTIONAL GROUPS,FRANCE,Recruiting,Hospices Civils de Lyon,"June 1, 2020",Observational,Retrospective Study of the Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients With Moderate to Severe Impairment Without Objective of Resuscitation Management (Level of Care 3 and 4) at the Hospices Civils of Lyon
3284,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia,COVID,"February 08, 2021",1124,NCT04522076,,RUSSIAN FEDERATION,"Active, not recruiting",National Research Center for Preventive Medicine,"April 6, 2020",Observational,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia
3285,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,COVID,"February 08, 2021",70,NCT04522089,ADIMRSC-2F,TAIWAN,Recruiting,Adimmune Corporation,"August 24, 2020",Interventional,"A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers"
3286,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,COVID; QUALITY OF LIFE; BEHAVIOR; SOCIAL ISOLATION,"February 08, 2021",969,NCT04522128,BEHAVIOUR CHANGE TECHNIQUE INTERVENTION TO IMPROVE QUALITY OF LIFE,UNITED KINGDOM,Recruiting,University of Manchester,"May 22, 2020",Interventional,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?
3287,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis,COVID,"February 08, 2021",183,NCT04522310,MR-PRO-ADM,FRANCE,Recruiting,Centre Hospitalier de Lens,"May 20, 2020",Observational,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis
3288,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,SARS-CoV2,"February 08, 2021",7,NCT04522466,HYDROXYCHLOROQUINE (HCQ),FRANCE,Terminated,Centre Hospitalier Universitaire de Saint Etienne,"April 3, 2020",Interventional,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients
3289,Impact of COVID-19 on Mental Health of Patients With Skin Picking,SKIN PICKING,"February 08, 2021",18,NCT04522492,INTERNET-BASED COGNITIVE BEHAVIORAL THERAPY; QUALITY OF LIFE PROMOTION,BRAZIL,"Active, not recruiting",Hospital de Clinicas de Porto Alegre,"August 11, 2020",Interventional,Impact of COVID-19 Pandemia on the Mental Health of Patients With Skin Picking Disorder and Their Treatment With Remote Cognitive Behavioral Therapy: Controlled Clinical Trial
3290,A Transdiagnostic Course for Common Mental Health Problems in Primary Care,DEPRESSION; ANXIETY,"February 08, 2021",68,NCT04522713,"BEHAVIORAL ACTIVATION, EVIDENCE-BASED SLEEP STRATEGIES INCLUDING SLEEP RESTRICTION, EXPOSURE-BASED STRATEGIES, PROMOTION OF PHYSICAL ACTIVITY AND RECUPERATING ACTIVITIES, PSYCHOEDUCATIONAL MATERIAL",SWEDEN,Recruiting,Karolinska Institutet,"August 24, 2020",Interventional,Single-Arm Feasibility Study of a Transdiagnostic Course for Common Mental Health Problems in Primary Care
3291,CLBS119 for Repair of COVID-19 Induced Pulmonary Damage,COVID,"February 08, 2021",0,NCT04522817,CLBS119,UNITED STATES,Withdrawn,"Caladrius Biosciences, Inc.","October 5, 2020",Interventional,CLBS119 (Autologous Peripheral Blood Derived CD34+ Cells) for Repair of COVID-19 Induced Pulmonary Damage
3292,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,SARS-CoV2 INFECTION,"February 08, 2021",40,NCT04522830,BTL-TML-COVID; PLACEBO,UNITED STATES,Recruiting,"Beech Tree Labs, Inc.","July 30, 2020",Interventional,"A Double-blind, Placebo-controlled, Phase 2 Trial of Sublingual Low-Dose Thimerosal in Adults With Symptomatic SARS-CoV-2 Infection"
3293,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",6,NCT04522986,MESENCHYMAL STEM CELL,JAPAN,Not yet recruiting,"Rohto Pharmaceutical Co., Ltd.",September 2020,Interventional,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection
3294,COVID-19 and HIV Patients,COVID,"February 08, 2021",2200,NCT04523012,SEROPREVALENCE OF SARS-COV-2 INFECTION IN PATIENTS WITH HIV INFECTION,FRANCE,Recruiting,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,"July 1, 2020",Observational,Seroprevalence of SARS-CoV-2 Infection in Patients With HIV Infection
3295,Rehabilitation After Admission in Intensive Care Unit for COVID-19,COVID,"February 08, 2021",40,NCT04523051,,FRANCE,Recruiting,Centre Hospitalier Régional Metz-Thionville,"April 1, 2020",Observational,Rehabilitation After Admission in Intensive Care Unit for COVID-19: an Observational Study
3296,Catalysing the Containment of COVID-19,COVID,"February 08, 2021",960,NCT04523090,NITAZOXANIDE; PLACEBO,SOUTH AFRICA,Recruiting,University of Cape Town,"August 27, 2020",Interventional,"The C3 Nitazoxanide for Mild to Moderate COVID-19 in HIV-infected and HIV-uninfected Adults With Enhanced Risk: a Double-blind, Randomised, Placebo-controlled Trial in a Resource-poor Setting"
3297,Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,COVID,"February 08, 2021",174,NCT04523181,ANTROQUINONOL; PLACEBO,ARGENTINA,Recruiting,Golden Biotechnology Corporation,"October 8, 2020",Interventional,"A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients With Mild to Moderate Pneumonia Due to COVID-19"
3298,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,HERPES ZOSTER; ALLERGY AND IMMUNOLOGY; CORONAVIRUS INFECTION,"February 08, 2021",250,NCT04523246,"SHINGRIX (ZOSTER VACCINE RECOMBINANT, ADJUVANTED); NORMAL SALINE",UNITED STATES,Recruiting,Barbara Carlson,"September 1, 2020",Interventional,"Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational Study"
3299,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects,SARS-CoV2,"February 08, 2021",144,NCT04523571,BNT162B1; PLACEBO,CHINA,"Active, not recruiting",BioNTech RNA Pharmaceuticals GmbH,"July 28, 2020",Interventional,"Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects: A Phase I, Randomized, Placebo-controlled, Observer-blind Study"
3300,Telehealth Intervention Program for Older Adults,"DEPRESSION, ANXIETY; COGNITIVE IMPAIRMENT; STRESS","February 08, 2021",258,NCT04523610,TELEHEALTH PHONE CALLS; VOLUNTEER OF TIP-OA PROGRAM; STAKEHOLDER OF TIP-OA PROGRAM,,Not yet recruiting,Lady Davis Institute,October 2020,Interventional,Telehealth Intervention Program for Older Adults (TIP-OA) Struggling With Mental Health/Cognitive Issues
3301,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,COVID,"February 08, 2021",400,NCT04523831,IVERMECTIN AND DOXYCYCLINE; STANDARD OF CARE,BANGLADESH,Completed,Dhaka Medical College,"June 1, 2020",Interventional,A Phase III Trial to Promote Recovery From Covid 19 With Combined Doxycycline and Ivermectin Along Standard Care
3302,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19",HEALTHY,"February 08, 2021",32,NCT04524052,DWRX2003; PLACEBO,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,August 2020,Interventional,"Phase I Study to Evaluate the Safety, Tolerability, Pharmacodynamics (PD) and Pharmacokinetics (PK) of DWRX2003 (Niclosamide IM Depot) Injection Following Intramuscular Administration in Healthy Volunteers"
3303,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; ENDOTHELIAL DYSFUNCTION,"February 08, 2021",100,NCT04524156,PHYSIOLOGY,BELGIUM,Not yet recruiting,Erasme University Hospital,"October 4, 2020",Interventional,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2
3304,Cardiac Dysfunction in Critically Ill Patients With COVID-19,COVID; LEFT VENTRICULAR DYSFUNCTION; RIGHT VENTRICULAR DYSFUNCTION; PULMONARY HYPERTENSION,"February 08, 2021",132,NCT04524234,ECHOCARDIOGRAPHY,SWEDEN,Completed,"Sahlgrenska University Hospital, Sweden","April 20, 2020",Observational,Cardiac Dysfunction in Critically Ill Patients With COVID-19
3305,Role of Midwifery Continuity of Care in Reducing Health Inequalities,"HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; SOCIAL DETERMINANTS; PUBLIC HEALTH; PREGNANCY RELATED","February 08, 2021",60,NCT04524286,INTERVIEWS ONLY.,UNITED KINGDOM,Recruiting,Bournemouth University,"November 6, 2020",Observational,The Role of a Midwifery Continuity of CARE Model in Reducing Health Inequalities in Childbearing Women and Babies Living on a Low-income: The Mi-CARE Study
3306,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,COVID,"February 08, 2021",56,NCT04524507,HIGH-TITER CONVALESCENT COVID-19 PLASMA (CCP1); STANDARD-TITER CONVALESCENT COVID-19 PLASMA (CCP2),UNITED STATES,Recruiting,"University of North Carolina, Chapel Hill","August 27, 2020",Interventional,"IGHID 12021 - A Randomized, Phase II Study Comparing the Efficacy and Safety of Standard Versus High-Titer Anti-SARS-CoV2 Neutralizing Antibody Plasma in Hospitalized Patients With COVID-19"
3307,"COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery",EXPLORING RISK ASSESSMENT AND RECOVERY FROM COVID INFECTION IN HOSPITALISED PATIENTS,"February 08, 2021",30,NCT04524520,,UNITED KINGDOM,Recruiting,Western Sussex Hospitals NHS Trust,"May 5, 2020",Observational,"COVID19-OR (SARS-CoV-2):Observation, Risk & Recovery. An Observational Study Exploring Risk Assessment and Recovery From COVID-19 (SARS-CoV-2) Infection in Hospitalised Patients"
3308,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,DEPRESSION,"February 08, 2021",410,NCT04524598,LIMBIX SPARK; PSYCHOEDUCATION,UNITED STATES,Recruiting,"Limbix Health, Inc.","July 20, 2020",Interventional,Limbix Spark: A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19
3309,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,COVID,"February 08, 2021",120,NCT04524663,CAMOSTAT MESILATE; PLACEBO; STANDARD OF CARE TREATMENT,UNITED STATES,Recruiting,Stanford University,"December 19, 2020",Interventional,"A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Camostat Mesilate Compared to Standard of Care in Subjects With Mild-Moderate COVID-19"
3310,LLLT Treatment of Lung Inflammation in COVID-19,COVID,"February 08, 2021",64,NCT04524715,NON-INVASIVE RED LLLT TREATMENT TO CHEST OF PATIENT.; SHAM DEVICE TREATMENT,UNITED STATES,Not yet recruiting,Ward Photonics LLC,"March 31, 2021",Interventional,Low-Level Laser Therapy Treatment of Lung Inflammation in COVID-19 Patients
3311,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19,ANOSMIA,"February 08, 2021",218,NCT04524754,,EGYPT,Recruiting,Ain Shams University,"July 11, 2020",Observational,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19
3312,Study of Descartes-30 in Acute Respiratory Distress Syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",30,NCT04524962,DESCARTES 30,UNITED STATES,Recruiting,Cartesian Therapeutics,"September 15, 2020",Interventional,Phase I/IIA Study of Descartes-30 in Acute Respiratory Distress Syndrome
3313,"To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects",SARS-CoV2 INFECTION,"February 08, 2021",32,NCT04525079,CT-P59; PLACEBO,"KOREA, REPUBLIC OF",Recruiting,Celltrion,"July 18, 2020",Interventional,"A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Group, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects"
3314,Prediction Models for Diagnosis and Prognosis of Severe COVID-19,CORONAVIRUS INFECTION; COVID,"February 08, 2021",1000,NCT04525287,,CHINA,Recruiting,"Second Affiliated Hospital, School of Medicine, Zhejiang University","February 20, 2020",Observational,Prediction Models for Diagnosis and Prognosis of Severe COVID-19
3315,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,"COVID; ARDS, HUMAN","February 08, 2021",20,NCT04525378,MESENCHYMAL STROMAL CELL-BASED THERAPY,BRAZIL,Recruiting,D'Or Institute for Research and Education,"July 1, 2020",Interventional,Mesenchymal Stromal Cell-based Therapy for COVID-19-associated Acute Respiratory Distress Syndrome: a Pilot Clinical Study
3316,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients,COVID; CORONAVIRUS INFECTION; SARS-COV INFECTION,"February 08, 2021",228,NCT04525404,"MRI (HEART, BRAIN, LUNGS, LIVER); BLOODWORK; COGNITIVE TESTING; OLFACTION TESTING; SPIROMETRY; WALK TEST",CANADA,Recruiting,University of Alberta,"November 12, 2020",Observational,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients
3317,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,COVID IMMUNE STATUS OF HEALTHCARE WORKERS,"February 08, 2021",75,NCT04525417,AAZ COVID-19 RAPID TEST,FRANCE,Completed,Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux,"April 25, 2020",Interventional,Use of Rapid Covid-19 Antibody Test Marketed by AAZ Laboratories in Healthcare Workers Presumably Being Infected by SARS-CoV-2
3318,Endothelial Function and COVID-19,COVID,"February 08, 2021",100,NCT04525443,,SPAIN,Recruiting,"Hospital San Carlos, Madrid","June 3, 2020",Observational,Assessment of Endothelial Vasodilator Function in COVID-19 Patients
3319,Hand Sanitizer Effects on the Skin Barrier,DERMATITIS HAND; SKIN ABNORMALITIES; ATOPIC DERMATITIS; ATOPIC DERMATITIS ECZEMA,"February 08, 2021",40,NCT04525521,HAND SANITIZER AND HAND WASHING,UNITED STATES,Recruiting,National Jewish Health,"September 8, 2020",Observational,Hand Sanitizer Effects on the Skin Barrier
3320,The Effect of Covid-19 on Patient Outcomes Among Operated Patients,COVID; SURGERY,"February 08, 2021",2000,NCT04525716,COVID-19 INFECTION STATUS,SWEDEN,Recruiting,Karolinska Institutet,"March 1, 2020",Observational,"How Does Covid-19 Affect Patient Outcome Following Surgery? A Hospital Based Cohort in Stockholm, Sweden"
3321,COVID-19 Pandemic and Parents of Disabled Children,COVID; DISABILITIES MULTIPLE; CEREBRAL PALSY; MUSCULAR DYSTROPHIES,"February 08, 2021",309,NCT04525742,DIFFICULTIES LIVED BY DISABLED CHILDREN'S PARENTS IN THE PERIOD OF COVID-19 PANDEMIC,TURKEY,Completed,Gaziosmanpasa Taksim Research and Education Hospital,"July 5, 2020",Interventional,COVID-19 Pandemic From the Perspective of Parents of Disabled Children
3322,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",COVID; VITAMIN D DEFICIENCY; CORONAVIRUS INFECTION; ARDS; CORONAVIRUS; SARS-COV INFECTION,"February 08, 2021",80,NCT04525820,SINGLE HIGH DOSE VITAMIN D; PLACEBO; TREATMENT AS USUAL VITAMIN D,SWITZERLAND,Recruiting,Prof. Dr. Jörg Leuppi,"December 15, 2020",Interventional,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study"
3323,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital,COVID,"February 08, 2021",258,NCT04525911,DIAGNOSTIC TEST: SEROLOGY TEST FOR COVID-19,FRANCE,Recruiting,Hôpital Européen Marseille,"August 26, 2020",Observational,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital
3324,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,OLFACTION DISORDERS; COVID,"February 08, 2021",30,NCT04526054,ENT EXAM; OLFACTOMETRY; BRAIN MRI,FRANCE,Recruiting,Hopital Foch,"September 3, 2020",Interventional,Longitudinal and Comparative Study of Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients
3325,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,"STRESS, PSYCHOLOGICAL","February 08, 2021",30,NCT04526145,STRESS AND EMOTION MANAGEMENT,,Not yet recruiting,Ohio State University,"January 31, 2021",Interventional,Operating Under Resilience (OUR) Project: Stress and Emotion Management for Black/African American Women With Hypertension In a Covid--19 Social Distancing Society
3326,Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases,THALASSEMIA MAJOR; COVID,"February 08, 2021",63,NCT04526405,SARS-COV-2 S1/S2 IGG,ITALY,Completed,University of Milano Bicocca,"July 14, 2020",Observational,Study on the Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases Subject to Chronic Transfusion Support.
3327,Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection,COVID,"February 08, 2021",15,NCT04526717,MPT0B640,,Not yet recruiting,Joseah Bio,December 2020,Interventional,"Phase 1, Open Label, Single Arm Study to Evaluate the Safety, Tolerability and Efficacy of MPT0B640 in Patients With COVID-19 Infection"
3328,Detecting SARS-CoV-2 in Tears,COVID; COVID; CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",30,NCT04526769,TEAR COLLECTION,UNITED STATES,Not yet recruiting,University of Minnesota,September 2020,Observational,Detecting SARS-CoV-2 Virus in Tears From Patients With COVID-19
3329,Lactoferrin for Prevention of COVID-19 in Health Care Workers,SARS-CoV2,"February 08, 2021",336,NCT04526821,BOVINE LACTOFERRIN; MALTODEXTRIN,PERU,Not yet recruiting,Universidad Peruana Cayetano Heredia,"September 1, 2020",Interventional,"Bovine Lactoferrin for the Prevention of COVID-19 Infection in Physicians and Nurses in Hospitals in Lima, Peru: a Double Blinded Randomized Clinical Trial (LF-COVID)"
3330,Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection,ACUTE LUNG INJURY,"February 08, 2021",48,NCT04526912,VIB7734; PLACEBO,UNITED STATES,Recruiting,Viela Bio,"August 28, 2020",Interventional,A Proof of Concept Study of the Safety and Efficacy of VIB7734 for the Treatment and Prevention of Acute Lung Injury (ALI) in Patients With SARS-CoV-2 Infection
3331,The Effects of Filter During CPET on WOB and Aerosol Particle Concentrations,"TRANSMISSION, PATIENT-PROFESSIONAL","February 08, 2021",10,NCT04526925,RESPIRATORY FILTER IN-LINE PLACED WITH THE STANDARD MOUTHPIECE; STANDARD MOUTHPIECE,UNITED STATES,Completed,Rush University Medical Center,"August 29, 2020",Interventional,A Physiologic Research to Assess the Effect of an Inline Filter During Cardiopulmonary Exercise Testing (CPET): A Healthy Volunteer Study
3332,Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).,COVID; IMMUNE SUPPRESSION; HIV-1-INFECTION,"February 08, 2021",90,NCT04526977,IMMUNE RESPONSE STUDY,SPAIN,Recruiting,Asociacion para el Estudio de las Enfermedades Infecciosas,"January 10, 2021",Observational,"Differences in Susceptibility and Cytokine Profile, Specific CD4/CD8 T Cell Response, Toll Like Receptors (TLRs) and Killer Immunoglobulin-like Receptors (KIRs) Among HIV-1-infected Individuals With Previous or Current COVID-19"
3333,Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,COVID,"February 08, 2021",40000,NCT04526990,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR); PLACEBO,ARGENTINA,Recruiting,CanSino Biologics Inc.,"September 15, 2020",Interventional,"A Global Multicenter, Randomized, Double-blind, Placebo -Controlled, Adaptive Designed Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of Ad5-nCoV in Adults 18 Years of Age and Older"
3334,Study of COVID-19 DNA Vaccine (AG0302-COVID19),COVID,"February 08, 2021",30,NCT04527081,AG0302-COVID19; AG0302-COVID19; AG0302-COVID19,JAPAN,"Active, not recruiting","AnGes, Inc.","August 31, 2020",Interventional,"A Randomized, Open-label, Non-controlled Phase I/II Study to Assess Safety and Immunogenicity of Twice or Three Times Dosing of Intramuscular AG0302-COVID19 (2mg) in Healthy Adults"
3335,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,COVID,"February 08, 2021",30,NCT04527133,APROTININ,RUSSIAN FEDERATION,"Active, not recruiting",Aviron LLC,"June 11, 2020",Interventional,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19
3336,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,COVID,"February 08, 2021",40,NCT04527198,BRAINSTEM RESPONSES ASSESSMENT SEDATION SCORE (BRASS); ELECTROENCEPHALOGRAM WITH EKG LEAD,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,September 2020,Interventional,Brainstem Dysfunction in Ventilated and Deeply Sedated COVID-19 Critically Ill Patients: a Prospective Observational Study
3337,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,COVID; HEALTHCARE WORKER PATIENT TRANSMISSION,"February 08, 2021",550,NCT04527211,IVERMECTIN,COLOMBIA,Not yet recruiting,Javeriana University,"September 7, 2020",Interventional,"Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel at All Levels of Care, During the 2020 Pandemic: A Randomized Clinical Controled Trial"
3338,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,COVID,"February 08, 2021",10,NCT04527224,ASTROSTEM-V,,Not yet recruiting,Nature Cell Co. Ltd.,"December 1, 2020",Interventional,A Phase I/Ⅱa Trial to Explore the Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stem Cell (AstroStem-V) Therapy in Patients With COVID-19 Pneumonia
3339,COVID-19 Survivorship Registry,COVID,"February 08, 2021",350,NCT04527315,QUESTIONNAIRES,UNITED STATES,Recruiting,NYU Langone Health,"July 17, 2020",Observational [Patient Registry],Assessment of ICU and Non-ICU Survivors: A Creation of a COVID Survivorship Database
3340,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,SARS-CoV2 INFECTION; FIBROSIS LUNG,"February 08, 2021",60,NCT04527354,TREAMID; PLACEBO,RUSSIAN FEDERATION,"Active, not recruiting",PHARMENTERPRISES LLC,"September 8, 2020",Interventional,"Multicenter, Randomized, Double-blind, Placebo-controlled Pilot Study of Treamid Efficacy and Safety in the Rehabilitation of Patients After COVID-19 Pneumonia"
3341,COVID-19 Health Professional Impact Study,CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",3000,NCT04527432,SURVEY; SARS-COV-2 ANTIBODY TEST,UNITED KINGDOM,Recruiting,The Royal Wolverhampton Hospitals NHS Trust,"December 16, 2020",Interventional,"A Pilot Assessment of the COVID-19 Antibody Status and Associated Factors, in Individuals Employed by a Large Acute NHS Trust During the Coronavirus Pandemic"
3342,Case Fatalities in Hospitalised COVID-19 Patients in the UK,COVID,"February 08, 2021",70000,NCT04527458,PATIENT CHARACTERISTICS; COVID-19 TREATMENTS; DIFFERENCES IN TRIAGE; SURGE CAPACITY,UNITED KINGDOM,Completed,University of Edinburgh,"February 24, 2020",Observational,Case Fatalities in Hospitalised COVID-19 Patients in the UK: An ISARIC Study
3343,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,CORONAVIRUS INFECTION; COVID; SARS-CoV2,"February 08, 2021",45,NCT04527471,ENSIFENTRINE DOSE 1; PLACEBO PMDI,UNITED STATES,"Active, not recruiting",Verona Pharma Inc,"September 4, 2020",Interventional,"A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients With COVID-19"
3344,Clinical Course and Treatment of COVID-19 Inpatients in Hospital,COVID,"February 08, 2021",50,NCT04527497,,GERMANY,Recruiting,Wissenschaftliches Institut Bethanien e.V,"August 1, 2020",Observational,Clinical Course and Treatment of COVID-19 Inpatients in Hospital
3345,Colchicine in Moderate Symptomatic COVID-19 Patients,COVID,"February 08, 2021",299,NCT04527562,COLCHICINE; PLACEBO,BANGLADESH,Completed,Dhaka Medical College,"July 14, 2020",Interventional,"Colchicine in Moderate Symptomatic COVID-19 Patients: Double Blind, Randomized, Placebo Controlled Trial to Observe the Efficacy"
3346,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19",COVID,"February 08, 2021",100,NCT04527575,"EPIVACCORONA (EPIVACCORONA VACCINE BASED ON PEPTIDE ANTIGENS FOR THE PREVENTION OF COVID-19); PLACEBO (SODIUM CHLORIDE BUFUS, SOLVENT FOR THE PREPARATION OF DOSAGE FORMS FOR INJECTION 0.9%)",RUSSIAN FEDERATION,"Active, not recruiting","Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector""","July 27, 2020",Interventional,"Simple, Blind, Placebo-controlled, Randomized Study of the Safety, Reactogenicity and Immunogenicity of Vaccine Based on Peptide Antigens for the Prevention of COVID-19 (EpiVacCorona), in Volunteers Aged 18-60 Years (I-II Phase)"
3347,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments,EXTREME PREMATURITY; COVID,"February 08, 2021",885,NCT04527601,,DENMARK,Completed,"Rigshospitalet, Denmark","August 21, 2020",Observational,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments
3348,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection,"INFLUENZA, HUMAN; SARS VIRUS; COVID; ESPIRATORY TRACT INFECTIONS","February 08, 2021",2000,NCT04527614,QRT-PCR AND SEROLOGY,BELGIUM,Enrolling by invitation,Sciensano,"September 24, 2020",Interventional,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection (PICOV) A Multicentre Academic Prospective Cohort Study in Nursing Home During the Winter Season 2020-2021
3349,"Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis",VIRAL MYOCARDITIS,"February 08, 2021",18,NCT04527835,"ELIZA, EXTRACTION OF NUCLEIC ACID ,DETERMINATION OF VIRAL GENOME BY USING PCR, QUANTITATIVE REAL-TIME PCR TO ASSESS VIRAL LOAD ,IMMUNOHISTOCHEMISTRY ANALYSIS OF EMB.",EGYPT,Recruiting,Assiut University,"October 1, 2020",Observational,"Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis"
3350,Anosmia and / or Ageusia and Early Corticosteroid Use,COVID; ANOSMIA,"February 08, 2021",300,NCT04528329,EARLY-DEXAMETHASONE; LATE DEXAMETHAZONE,EGYPT,Recruiting,ClinAmygate,"August 30, 2020",Interventional,Time to Recover of Anosmia and / or Ageusia and Early Corticosteroid Use
3351,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,COVID,"February 08, 2021",60,NCT04528368,CONVALESCENT PLASMA,BRAZIL,Recruiting,D'Or Institute for Research and Education,"December 11, 2020",Interventional,Efficacy and Safety of Using Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support
3352,GRAd-COV2 Vaccine Against COVID-19,COVID,"February 08, 2021",90,NCT04528641,GRAD-COV2,ITALY,Recruiting,ReiThera Srl,"August 10, 2020",Interventional,"A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects"
3353,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,COVID,"February 08, 2021",400,NCT04528667,STI-5656; PLACEBO,BRAZIL,Recruiting,"Sorrento Therapeutics, Inc.","January 6, 2021",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-controlled Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19"
3354,S-Nitrosylation Therapy of COVID-19,SARS-CoV2 INFECTION; COVID,"February 08, 2021",21,NCT04528771,SNO; NITROGEN GAS,UNITED STATES,Not yet recruiting,Robert Schilz,"October 31, 2020",Interventional,Phase 1b Safety Trial for S-Nitrosylation Therapy to Treat COVID-19 Induced Respiratory Distress
3355,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,"COVID; SARS-COV INFECTION; PNEUMONIA, VIRAL; COAGULOPATHY","February 08, 2021",210,NCT04528888,ENOXAPARIN; METHYLPREDNISOLONE; UNFRACTIONATED HEPARIN,,Not yet recruiting,Massimo Girardis,"September 1, 2020",Interventional,"Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection. A Multicenter, Interventional, Randomized, Three Arms Study Design"
3356,Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital),COVID,"February 08, 2021",1080,NCT04528901,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","September 4, 2020",Observational,Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)
3357,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia",COVID; PATIENTS HOSPITALIZED,"February 08, 2021",0,NCT04528927,HCQ; AZITHROMYCIN; DOXYCYCLINE; ZINC,TUNISIA,Withdrawn,Abderrahmane Mami Hospital,"May 15, 2020",Interventional,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia Multicentric Randomized Comparative Study"
3358,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up,COVID; PULMONARY DISEASE,"February 08, 2021",60,NCT04529408,EARSATS PULSE OXIMETER PROBE,UNITED KINGDOM,Recruiting,Imperial College London,"August 26, 2020",Observational,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up
3359,Assocation Between In-person Instruction and COVID-19 Risk,INFECTION; INFECTION CONTROL,"February 08, 2021",70000,NCT04529421,ONLINE INSTRUCTION; IN-PERSON INSTRUCTION,NORWAY,Not yet recruiting,Oslo Metropolitan University,September 2020,Observational,Relationship Between In-person Instruction and COVID-19 Incidence Among University Students: A Prospective Cohort Study
3360,Response of Korean Medicine Hospital to COVID-19,COVID,"February 08, 2021",485,NCT04529447,SURVEY,"KOREA, REPUBLIC OF",Completed,Jaseng Hospital of Korean Medicine,"June 10, 2020",Observational,Hospital Operational Response Strategy and Experience During the COVID-19 Pandemic in a Spine-specialty Korean Medicine Training Hospital
3361,Healthy Volunteer COVID-19 Antibody Testing Study,COVID,"February 08, 2021",200,NCT04529460,COVID-19 ANTIBODY POINT OF CARE TEST KIT,,Not yet recruiting,Royal Free Hospital NHS Foundation Trust,"September 1, 2020",Observational,Post Market Clinical Study of a Point of Care COVID-19 IgG-IgM Rapid Test in Healthy Volunteers
3362,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,COVID,"February 08, 2021",780,NCT04529499,AVIGAN; PLACEBO COMPARATOR,KUWAIT,"Active, not recruiting",Dr. Reddy's Laboratories Limited,"August 20, 2020",Interventional,"A Multi-center, Randomized, Double Blind, Placebo Controlled Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients"
3363,Ivermectin to Prevent Hospitalizations in COVID-19,COVID,"February 08, 2021",500,NCT04529525,IVERMECTIN; PLACEBO,ARGENTINA,Recruiting,Instituto de Cardiología de Corrientes,"August 19, 2020",Interventional,"Ivermectin to Prevent Hospitalizations in COVID-19: Randomized, Double-blind, Placebo-controlled"
3364,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,CONFIRMED CORONAVIRUS DISEASE,"February 08, 2021",120,NCT04530136,RUCONEST,UNITED STATES,Recruiting,Pharming Technologies B.V.,"November 30, 2020",Interventional,"Recombinant Human C1 Esterase Inhibitor (Ruconest®) in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19: a Randomized, Parallel-group, Open-label, Multi-center Pilot Trial in the United States (PROTECT-COVID-19-US)"
3365,Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDS,"ARDS; ARDS, HUMAN","February 08, 2021",68,NCT04530188,SEVOFLURANE; PROPOFOL,,Not yet recruiting,Bicetre Hospital,November 2020,Interventional,Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With Acute Respiratory Distress Syndrome
3366,"Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine",COVID; SARS-COV INFECTION; VACCINE ADVERSE REACTION,"February 08, 2021",244,NCT04530357,QAZCOVID-IN® - COVID-19 INACTIVATED VACCINE; PLACEBO,KAZAKHSTAN,Completed,Research Institute for Biological Safety Problems,"September 19, 2020",Interventional,"Randomized, Blind, Placebo-controlled Phase- i Study and Randomized, Open Phase Phase-ii Study of QAZCOVID-IN®- COVID-19 Inactivated Vaccine in Healthy Adult Volunteers From 18 Years Old and Elder"
3367,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,COVID,"February 08, 2021",30,NCT04530370,RECOVERED COVID 19 PATIENTS PLASMA,EGYPT,Recruiting,South Valley University,"May 29, 2020",Interventional,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients
3368,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19",COVID PREVENTION,"February 08, 2021",33758,NCT04530396,GAM-COVID-VAC; PLACEBO,RUSSIAN FEDERATION,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","September 7, 2020",Interventional,"Randomized Double-blind Placebo-controlled Multi-center Clinical Trial in Parallel Assignment of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine in SARS-СoV-2 Infection Prophylactic Treatment"
3369,Timing of Corticosteroids in COVID-19,COVID; CORTICOSTEROIDS,"February 08, 2021",450,NCT04530409,EARLY-DEXAMETHASONE; LATE-DEXAMETHASONE,EGYPT,Recruiting,ClinAmygate,"August 26, 2020",Interventional,Timing of Corticosteroids in COVID-19
3370,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,COVID,"February 08, 2021",250,NCT04530422,SOFOSBUVIR PLUS LEDIPASVIR,EGYPT,Completed,Almaza Military Fever Hospital,"April 15, 2020",Interventional,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
3371,PEP Flute-selfcare in COVID-19,COVID; SARS-CoV2,"February 08, 2021",400,NCT04530435,PEP FLUTE,DENMARK,Recruiting,Bispebjerg Hospital,"October 6, 2020",Interventional,PEP Flute-selfcare to Prevent Respiratory Deterioration and Hospitalization Among COVID-19 Patients: a Randomized Trial
3372,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,COVID; CORONAVIRUS; CORONAVIRUS INFECTION; AKI; ACUTE KIDNEY INJURY,"February 08, 2021",40,NCT04530448,SODIUM BICARBONATE; STANDARD OF CARE,UNITED STATES,Recruiting,West Virginia University,"October 5, 2020",Interventional,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
3373,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases,SARS-COV INFECTION; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SJOGREN'S SYNDROME; SARCOIDOSIS; INFLAMMATORY MYOPATHY; BEHÇET DISEASE; RHEUMATOID ARTHRITIS; SPONDYLOARTHRITIS,"February 08, 2021",200,NCT04530461,SEROLOGICAL TEST,TUNISIA,Recruiting,faida agili,"June 1, 2020",Observational,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
3374,Outpatient Use of Ivermectin in COVID-19,COVID,"February 08, 2021",200,NCT04530474,IVERMECTIN PILL; PLACEBO,UNITED STATES,Not yet recruiting,Temple University,"October 1, 2020",Interventional,Outpatient Use of Ivermectin in COVID-19
3375,COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression,COVID; ANDROGEN RECEPTOR GENE OVEREXPRESSION,"February 08, 2021",200,NCT04530500,COVID-19 ANDROGEN SENSITIVITY TEST (COVAST),UNITED STATES,Enrolling by invitation,"University of California, Irvine","August 13, 2020",Observational,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
3376,The Effect of Melatonin and Vitamin C on COVID-19,COVID; SARS-COV INFECTION,"February 08, 2021",150,NCT04530539,VITAMIN C; MELATONIN; PLACEBO; SYMPTOM SURVEY,UNITED STATES,Not yet recruiting,Lancaster General Hospital,"September 18, 2020",Interventional,The Effect of Melatonin and Vitamin C on COVID-19
3377,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,COVID; PNEUMONIA,"February 08, 2021",200,NCT04530578,HEPARIN SODIUM; ENOXAPARIN,ARGENTINA,Recruiting,"Clinica San Camilo, Argentina","June 1, 2020",Interventional,Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2)
3378,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),COVID; SARS-CoV2; COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",12,NCT04530604,DEFIBROTIDE,UNITED STATES,Recruiting,Gregory Yanik,"October 1, 2020",Interventional,Defibrotide Therapy for SARS-CoV2 Acute Respiratory Distress Syndrome (ARDS)
3379,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,COVID; DIABETES; HYPERTENSION; OBESITY,"February 08, 2021",360,NCT04530617,CAMOSTAT MESILATE; ARTEMISIA ANNUA LEAF,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"October 5, 2020",Interventional,"Randomized, Double-blind, Placebo-controlled, Multicenter, Multi-arm, Phase II Trial of Novel Agents for the Treatment of Mild to Moderate COVID-19 Positive Outpatients"
3380,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),COVID,"February 08, 2021",168,NCT04530656,"TWO DOSES OF MIDDLE-DOSE RECOMBINANT SARS-COV-2 VACCINE (SF9 CELL) AT THE SCHEDULE OF DAY 0, 28; TWO DOSES OF HIGH-DOSE RECOMBINANT SARS-COV-2 VACCINE (SF9 CELL) AT THE SCHEDULE OF DAY 0, 28; THREE DOSES OF HIGH-DOSE RECOMBINANT SARS-COV-2 VACCINE (SF9 CELL) AT THE SCHEDULE OF DAY 0, 14, 28; TWO DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0, 28（MIDDLE-DOSE GROUP）; TWO DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0, 28（HIGH-DOSE GROUP）; THREE DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0, 14, 28（HIGH-DOSE GROUP）",CHINA,Not yet recruiting,Jiangsu Province Centers for Disease Control and Prevention,"August 28, 2020",Interventional,"Safety, Tolerability and Immunogenicity of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) in Chinese Healthy Population Aged 18 Years and Older: A Phase I, Single-center, Randomized, Placebo-controlled, Double-blind Study"
3381,COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs,RHEUMATOID ARTHRITIS,"February 08, 2021",5000,NCT04530682,,FRANCE,Not yet recruiting,"University Hospital, Montpellier","February 1, 2021",Observational,Seroprevalence and Clinical Expression of SARS-CoV-2 Infection in Patients With Chronic Inflammatory Rheumatisms and Impact of Immuno-suppressive Drugs on the Persistence of Anti-SARS-CoV2 Antibodies During Two Years of Follow-up
3382,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt,TYPE 1 DIABETES; COVID,"February 08, 2021",150,NCT04531111,,EGYPT,Recruiting,Ain Shams University,"July 7, 2020",Observational,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt: A Pilot Study
3383,CORE Study COVID-19,CORONAVIRUS INFECTION (COVID),"February 08, 2021",2000,NCT04531202,,BRAZIL,Recruiting,D'Or Institute for Research and Education,"March 2, 2020",Observational [Patient Registry],Clinical Characterization Protocol for Severe Emerging Infections: Coronavirus
3384,Back to School COVID-19 Simulation Study,COVID; SCHOOLS,"February 08, 2021",240,NCT04531254,PERSONAL BEHAVIOURS,CANADA,"Active, not recruiting",The Hospital for Sick Children,"August 10, 2020",Observational,Understanding the Impact of Public Health Measures Planned for School Reopening During COVID-19 Using Simulation Exercises
3385,Immune Cell Subgroups in Covid 19 Patients,COVID,"February 08, 2021",50,NCT04531319,FLOW CYTOMETRIC ANALYSIS,TURKEY,Completed,Istanbul Training and Research Hospital,"August 15, 2020",Observational,Evaluation of Immune Cell Subgroups in Covid 19 Patients
3386,Cytokine Status of Covid-19 Patients,COVID,"February 08, 2021",60,NCT04531345,FLOW CYTOMETRIC ANALYSIS,TURKEY,Completed,Istanbul Training and Research Hospital,"October 1, 2020",Observational,The Cytokine Status of Covid-19 Patients
3387,COVID-19 Saliva Test Research Study,COVID,"February 08, 2021",400,NCT04531501,SALIVA AND NPS TEST,UNITED KINGDOM,Recruiting,Chronomics Limited,"June 29, 2020",Observational,COVID-19 Saliva Test Research Study - Evaluation of High Throughput COVID-19 Testing Via Saliva Based Sampling and Alternative RNA Extraction Methods.
3388,Mother-infant Bonding During COVID-19,CHILD DEVELOPMENT; MOTHER-INFANT INTERACTION; COVID,"February 08, 2021",280,NCT04531618,FAMILY NURTURE INTERVENTION (FNI),UNITED STATES,Recruiting,Columbia University,"August 13, 2020",Interventional,Promoting Mother-Infant Emotional Connection During the COVID-19 Pandemic: an Randomized Controlled Trial (RCT) of Virtual Family Nurture Intervention
3389,Respiratory Syncytial Virus Infection May be More Dangerous in Neonate,RSV INFECTION; COVID,"February 08, 2021",28,NCT04531735,,TURKEY,"Active, not recruiting",Dr. Behcet Uz Children's Hospital,"March 1, 2020",Observational,Is Respiratory Syncytial Virus Infection More Dangerous Than Covid 19 in the Neonatal Period?
3390,Selective Estrogen Modulation and Melatonin in Early COVID-19,COVID,"February 08, 2021",390,NCT04531748,TOREMIFENE; MELATONIN; PLACEBO,,Not yet recruiting,"Reena Mehra, MD",March 2021,Interventional,Selective Estrogen Modulation and Melatonin in Early COVID-19
3391,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,STRESS; BURNOUT; ANXIETY; DEPRESSION; COVID,"February 08, 2021",160,NCT04531774,RECHARGE; SELF STUDY,SWITZERLAND,Recruiting,Naser Morina,"August 28, 2020",Interventional,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19
3392,Biocontainment Device for Aerosol Generating Procedures,PROTECTIVE DEVICE (PHYSICAL OBJECT); AEROSOL DISEASE; DROPLET SPREAD,"February 08, 2021",150,NCT04532112,BIOCONTAINMENT DEVICE FOR AEROSOL GENERATING PROCEDURES (BIOBOX); CONTROL FOR AEROSOL GENERATING PROCEDURES,UNITED STATES,Recruiting,University of Pennsylvania,"December 7, 2020",Interventional,Biocontainment Device With Aerosol Clearance for Aerosol Generating Procedures
3393,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants",COVID,"February 08, 2021",30,NCT04532294,BGB DXP593; PLACEBO,AUSTRALIA,Recruiting,BeiGene,"September 8, 2020",Interventional,"A First-in-Human, Randomized, Double-Blind, Placebo Controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of SARS-CoV-2 Neutralizing Antibody BGB-DXP593 in Healthy Subjects"
3394,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",30,NCT04532372,BEST PRACTICE; LEFLUNOMIDE; PLACEBO ADMINISTRATION,UNITED STATES,Recruiting,City of Hope Medical Center,"January 7, 2021",Interventional,A Phase 1/2 Trial of Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
3395,COVID-19 Testing Sample Acquisition Throughput and Efficiency,SARS-COV INFECTION; RESPIRATORY VIRAL INFECTION; PERSONAL PROTECTIVE EQUIPMENT; COVID,"February 08, 2021",25000,NCT04532411,PERSONAL PROTECTIVE TESTING BOOTH,UNITED STATES,"Active, not recruiting",Massachusetts General Hospital,"March 1, 2020",Observational,Evaluation of SARS-CoV-2 Sample Acquisition Efficiency and PPE Usage With and Without the Hexapod Personal Protective Booth
3396,Growth Hormone in Obese Cases With Covid-19,COVID,"February 08, 2021",0,NCT04532554,GROWTH HORMONE; PLACEBO,EGYPT,Withdrawn,ClinAmygate,"October 26, 2020",Interventional,The Impact of Growth Hormone in Obese Cases With Covid-19
3397,Taste and Smell Impairment in Critically Ill COVID-19 Patients,SMELL DISORDER; TASTE DISORDERS; CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04532632,,TURKEY,Completed,Pinar Ay Sayin,"September 1, 2020",Observational [Patient Registry],Taste and Smell Impairment in Critically Ill COVID-19 Patients
3398,Optimizing Maintenance Therapy in COPD Patients,COPD,"February 08, 2021",1176,NCT04532853,,AUSTRALIA,Recruiting,General Practitioners Research Institute,"October 21, 2020",Observational,"Optimizing Maintenance Therapy in COPD Patients: Real-world Observational Study of Peak Inspiratory Flow Rate, Inhalation Technique, and Medication Adherence"
3399,COVID-19 Treatment in South Africa,COVID,"February 08, 2021",250,NCT04532931,STANDARD OF CARE (PARACETAMOL); ARTESUNATE-AMODIAQUINE; PYRONARIDINE-ARTESUNATE; FAVIPIRAVIR PLUS NITAZOXANIDE; SOFOSBUVIR/DACLATASVIR,SOUTH AFRICA,Recruiting,Shin Poong Pharmaceutical Co. Ltd.,"September 3, 2020",Interventional,"Phase 2, Exploratory, Single Center, Randomized, Open Label, Adaptive Clinical Trial to Compare Safety and Efficacy of Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19"
3400,A Clinical Study to Evaluate MW33 Injection,COVID,"February 08, 2021",42,NCT04533048,MW33 INJECTION; MW33 INJECTION PLACEBO,CHINA,"Active, not recruiting","Mabwell (Shanghai) Bioscience Co., Ltd.","August 7, 2020",Interventional,"A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Immunogenicity of a Single Dose of MW33 Injection in Healthy Subjects"
3401,A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 Disease,COVID DISEASE,"February 08, 2021",275,NCT04533347,TAFENOQUINE ORAL TABLET; PLACEBO,,Not yet recruiting,60 Degrees Pharmaceuticals LLC,October 2020,Interventional,A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 Disease
3402,Prevalence of COVID-19 Antibodies Kingman AZ,COVID,"February 08, 2021",3000,NCT04533360,VITROS ANTI-SARS-COV-2 IGG TEST,UNITED STATES,Enrolling by invitation,Kingman Regional Medical Center,"September 28, 2020",Observational [Patient Registry],Seroprevalence of SARS CoV2 Antibodies Among Adults in Kingman AZ
3403,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,SARS-CoV2 INFECTION; COVID,"February 08, 2021",4400,NCT04533399,SARS-COV-2 RS/MATRIX-M1 ADJUVANT; PLACEBO,SOUTH AFRICA,Recruiting,Novavax,"August 17, 2020",Interventional,"A Phase 2A/B, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity, and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in South African Adult Subjects Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV"
3404,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure,SARS-CoV2 INFECTION; RESPIRATORY FAILURE WITH HYPOXIA,"February 08, 2021",1000,NCT04534400,THORACIC CT-SCAN,FRANCE,Recruiting,"University Hospital, Strasbourg, France","September 1, 2020",Observational,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic
3405,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,COVID PNEUMONIA,"February 08, 2021",120,NCT04534478,PREDNISONE,,Not yet recruiting,Hospital Universitari Vall d'Hebron Research Institute,"September 7, 2020",Interventional,"Randomized, Open, Parallel, Single-center, Non-inferiority Clinical Trial, With an Active Control Group, Comparing Two Oral Prednisone Regimens With the Aim of Optimizing the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19 Infection"
3406,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF),COVID; ACUTE RESPIRATORY FAILURE; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",40,NCT04534569,EXPERTS CONSENSUS,UNITED ARAB EMIRATES,Completed,NMC Specialty Hospital,"September 4, 2020",Observational,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) Using Modified Delphi Methodology
3407,Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire,COVID EXPERIENCE,"February 08, 2021",1500,NCT04534595,COVID-19,CANADA,Recruiting,Unity Health Toronto,"April 30, 2019",Observational,Data Collection on the Model Schools Pediatric Health Initiative at 5 School Based Health Clinic (SBHC) Sites: COVID-19 Questionnaire
3408,COVID-19 Child Health Investigation of Latent Disease in Hamburg,SARS-CoV2; COVID,"February 08, 2021",6000,NCT04534608,,GERMANY,"Active, not recruiting",Universitätsklinikum Hamburg-Eppendorf,"May 11, 2020",Observational,Prevalence of Infection and Seroconversion and the Clinical Course of the Novel Coronavirus SARS-CoV-2 Infection in Children Between 0 to 18 Years of Age in Hamburg and Surroundings
3409,How Brazilian Chiropractors Are Facing the COVID-19 Pandemic,COVID,"February 08, 2021",948,NCT04534621,ELECTRONIC SURVEY,,Not yet recruiting,Trate - Tratamentos Especializados,"August 26, 2020",Observational,How Brazilian Chiropractors Are Being Affected and What Strategies They Have Developed for Facing the COVID-19 Pandemic
3410,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,COVID,"February 08, 2021",40,NCT04534673,LAMBDA 180 MCG S.C,ISRAEL,Recruiting,Soroka University Medical Center,"August 5, 2020",Interventional,Pegylated Interferon Lambda for Treatment of COVID-19 Infection- A Randomized Open Label Pilot Trial
3411,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19,COVID,"February 08, 2021",100,NCT04534712,LYMPHOCYTE MONOCYTE RATIO,INDIA,Not yet recruiting,Postgraduate Institute of Medical Education and Research,"September 1, 2020",Observational,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19
3412,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,CANCER; COVID; RESPIRATORY VIRAL INFECTION,"February 08, 2021",2282,NCT04534725,INTERFERON ALFA; SELINEXOR; LENZILUMAB,AUSTRALIA,Recruiting,"Peter MacCallum Cancer Centre, Australia","December 17, 2020",Interventional,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.
3413,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",30,NCT04534790,LOW DOSE RADIOTHERAPY,MEXICO,Recruiting,Instituto Mexicano del Seguro Social,"July 24, 2020",Interventional,"Randomized Trial, Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia"
3414,BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST),COVID,"February 08, 2021",2100,NCT04534803,BCG VACCINE; PLACEBO,,Not yet recruiting,Harvard Medical School,September 2020,Interventional,Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial
3415,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",200,NCT04535063,COVID19 CONVALESCENT PLASMA INFUSION,ARGENTINA,Recruiting,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,"April 18, 2020",Interventional,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia
3416,"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications",COVID; THROMBOSIS EMBOLISM; DVT; PULMONARY EMBOLISM; MYOCARDIAL INFARCTION; STROKE,"February 08, 2021",10000,NCT04535128,NO INTERVENTION,UNITED STATES,Recruiting,Brigham and Women's Hospital,"March 24, 2020",Observational [Patient Registry],"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE NETWORK)"
3417,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19,COVID; LUNG FUNCTION DECREASED,"February 08, 2021",264,NCT04535154,NO INTERVENTIONS,NORWAY,"Active, not recruiting","University Hospital, Akershus","March 31, 2020",Observational,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19
3418,"First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.",VIRAL DISEASE,"February 08, 2021",72,NCT04535167,PF-07304814; PLACEBO,UNITED STATES,Recruiting,Pfizer,"September 9, 2020",Interventional,"A PHASE 1B, 2-PART, DOUBLE-BLIND, PLACEBO-CONTROLLED, SPONSOR-OPEN STUDY, TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING (24-HOUR, PART 1) AND EXTENDED (120-HOUR, PART 2) INTRAVENOUS INFUSIONS OF PF-07304814 IN HOSPITALIZED PARTICIPANTS WITH COVID-19"
3419,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke,PARKINSON DISEASE; STROKE,"February 08, 2021",198,NCT04535297,EXPOSURE,ISRAEL,Completed,University of Haifa,"May 10, 2020",Observational,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke
3420,A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents,HEALTHY,"February 08, 2021",1210,NCT04535453,AD26.COV2.S; PLACEBO,CANADA,Recruiting,Janssen Vaccines & Prevention B.V.,"August 28, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 2a Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older and to Evaluate 2 Dose Levels of Ad26.COV2.S in Healthy Adolescents Aged 12 to 17 Years Inclusive"
3421,Asunercept in Patients With Severe COVID-19,COVID INDUCED PNEUMONIA; COVID,"February 08, 2021",400,NCT04535674,ASUNERCEPT,RUSSIAN FEDERATION,Recruiting,Apogenix AG,"October 9, 2020",Interventional,"A Multicenter, Randomised, Controlled, Open Label Trial on the Efficacy and Safety of Asunercept for Patients With Severe COVID-19 Disease"
3422,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,TYPE 2 DIABETES,"February 08, 2021",76,NCT04535700,PIOGLITAZONE 30 MG; STANDARD OF CARE,SPAIN,Recruiting,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,"September 18, 2020",Interventional,"Non-blinded, Randomized and Controlled Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19"
3423,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,TREATMENT OF ILLNESS-RELATED DISTRESS IN PHYSICAL LTCS,"February 08, 2021",200,NCT04535778,COMPASS; STANDARD CHARITY RESOURCES,UNITED KINGDOM,Not yet recruiting,King's College London,"September 28, 2020",Interventional,Pilot RCT for COMPASS: an Online CBT Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic.
3424,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,COVID; VITAMIN D,"February 08, 2021",400,NCT04535791,CHOLECALCIFEROL,MEXICO,Recruiting,"Coordinación de Investigación en Salud, Mexico","July 15, 2020",Interventional,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring or Evolving Into the Severe Form of COVID-19 in Healthcare Workers Caring for Patients With the Disease. Blinded Randomized Clinical Trial
3425,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,COVID; CORONAVIRUS INFECTION; SAR,"February 08, 2021",9,NCT04535856,ALLOGENEIC MESENCHYMAL STEM CELL; PLACEBO,INDONESIA,Completed,Ina-Respond,"November 14, 2020",Interventional,"Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients: Randomized, Double-blind, and Placebo-controlled"
3426,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),COVID,"February 08, 2021",50,NCT04535869,SOFOSBUVIR 400 MG PLUS DACLATASVIR 200MG,EGYPT,Recruiting,Mansoura University,"December 30, 2020",Interventional,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
3427,A Study of a Candidate COVID-19 Vaccine (COV003),CORONAVIRUS,"February 08, 2021",10300,NCT04536051,CHADOX1 NCOV-19 SINGLE DOSE + PARACETAMOL; MENACWY SINGLE DOSE + PARACETAMOL; CHADOX1 NCOV-19 TWO DOSE + PARACETAMOL; MENACWY PRIME & SALINE PLACEBO BOOST + PARACETAMOL,BRAZIL,Recruiting,University of Oxford,"June 2, 2020",Interventional,"A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine"
3428,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,COVID,"February 08, 2021",150,NCT04536090,ISOQUERCETIN (IQC-950AN),,Not yet recruiting,Institut de Recherches Cliniques de Montreal,November 2020,Interventional,An Open-Label Randomized Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of 2019 Novel Coronavirus Disease (COVID-19)
3429,Assessing People's Hospital Outpatient Appointment Preferences in the United Kingdom,HOSPITAL OUTPATIENT CLINICS; CHRONIC DISEASE,"February 08, 2021",1481,NCT04536259,VIDEO DEFAULT; IN-PERSON DEFAULT; ACTIVE CHOICE,UNITED KINGDOM,Completed,University of Warwick,"September 11, 2020",Interventional,Assessing People's Hospital Outpatient Appointment Preferences in the United Kingdom
3430,Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt,TYPE 1 DIABETES; COVID,"February 08, 2021",36,NCT04536285,,EGYPT,Completed,Ain Shams University,"May 1, 2020",Observational,Clinical Characteristics and Outcome of Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic: Data From a Single Center Surveillance Study in Egypt
3431,Vitamin D and COVID-19 Trial,COVID,"February 08, 2021",2700,NCT04536298,VITAMIN D; PLACEBO,UNITED STATES,Recruiting,Brigham and Women's Hospital,"December 28, 2020",Interventional,"A Cluster-Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vitamin D3 Supplementation to Reduce Disease Severity in Persons With Newly Diagnosed COVID-19 Infection and to Prevent Infection in Household Members"
3432,Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS,COVID; CORONAVIRUS INFECTION; ARDS; AVIPTADIL,"February 08, 2021",80,NCT04536350,AVIPTADIL 67ΜG; PLACEBO 0.9% NACL SOLUTION,SWITZERLAND,Not yet recruiting,Prof. Dr. Jörg Leuppi,January 2021,Interventional,"Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS: a Randomized, Placebo Controlled, Multicenter Trial"
3433,Cri Analog PG1 Effectiveness and Safety in Covid-19,COVID,"February 08, 2021",284,NCT04536363,"ANALOGS, PROSTAGLANDIN E1; STANDARD THERAPEUTIC PROTOCOL",,Not yet recruiting,Alonso Vera Torres,"October 1, 2020",Interventional,Effectiveness and Safety of the Administration of Intravenous Prostaglandin E1 Analog in the Reduction of Mortality and Complications of Patients With COVID-19
3434,First Responder Resiliency Program During COVID-19,RESILIENCE; STRESS; SLEEP,"February 08, 2021",10,NCT04536376,RESILIENCE PROGRAM,UNITED STATES,Recruiting,Mayo Clinic,"January 15, 2021",Interventional,First Responder Resiliency Program for Health Care Professionals During a Pandemic
3435,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,MENTAL HEALTH WELLNESS; PSYCHOLOGICAL SECURITY; PSYCHOLOGICAL DISTRESS,"February 08, 2021",161,NCT04536441,ULTRA BRIEF ONLINE MINDFULNESS-BASED INTERVENTION; CONTROL,MALAYSIA,Completed,Universiti Tunku Abdul Rahman,"April 1, 2020",Interventional,Effects of an Ultra-brief Online Mindfulness-based Intervention on Mental Health During the Coronavirus Disease (COVID-19) Outbreak in Malaysia: A Randomised Controlled Trial
3436,Mobile Mental Health Apps for Suicide Prevention,DEPRESSION; ANXIETY; EMOTIONAL REGULATION,"February 08, 2021",2000,NCT04536935,MOBILE MENTAL HEALTH APP - 1; MOBILE MENTAL HEALTH APP - 2; MOBILE MENTAL HEALTH APP - 3; MOBILE MENTAL HEALTH APP - 4,UNITED STATES,Enrolling by invitation,University of Washington,January 2021,Interventional,"Acceptability, Usability and Effectiveness of Mental Health Apps for Suicide Prevention in Essential Workers and the Unemployed During SARS-CoV-2"
3437,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19",COVID,"February 08, 2021",202,NCT04537117,QUESTIONAIRE,EGYPT,Completed,Fayoum University,"April 20, 2020",Observational,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19"
3438,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,PULMONARY FIBROSIS; COVID,"February 08, 2021",40,NCT04537130,IN01 VACCINE,SPAIN,Not yet recruiting,Instituto Oncológico Dr Rosell,"December 1, 2020",Interventional,Phase Ib Controlled Exploratory Trial for Treatment of Fibrosing Interstitial Lung Disease Patients Secondary to SARS-CoV-2 Infection With IN01 Vaccine (COVINVAC)
3439,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,COVID (HEALTHY VOLUNTEERS),"February 08, 2021",440,NCT04537208,SARS-COV-2 VACCINE FORMULATION 1 WITH ADJUVANT 1; SARS-COV-2 VACCINE FORMULATION 1 WITH ADJUVANT 2; SARS-COV-2 VACCINE FORMULATION 2 WITH ADJUVANT 1; SARS-COV-2 VACCINE FORMULATION 2 WITH ADJUVANT 2; SARS-COV-2 VACCINE FORMULATION 2 WITHOUT ADJUVANT; PLACEBO (0.9% NORMAL SALINE),UNITED STATES,"Active, not recruiting","Sanofi Pasteur, a Sanofi Company","September 3, 2020",Interventional,Immunogenicity and Safety of SARS-CoV-2 Recombinant Protein Vaccine Formulations (With or Without Adjuvant) in Healthy Adults 18 Years of Age and Older
3440,COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes,COVID; SARS-COV INFECTION,"February 08, 2021",150,NCT04537299,FISETIN; PLACEBO,UNITED STATES,Not yet recruiting,Mayo Clinic,December 2020,Interventional,COVID-FIS: A Phase 2 Placebo-Controlled Pilot Study in COVID-19 of Fisetin to Alleviate Dysfunction and Excessive Inflammatory Response in Older Adults in Nursing Homes
3441,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,COVID,"February 08, 2021",2000,NCT04537338,1. CHARACTERIZE THE IMMUNE RESPONSE AFTER INFECTION WITH SARS-COV-2,,Not yet recruiting,Agencia Costarricense de Investigaciones Biomedicas,"September 14, 2020",Observational,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica
3442,The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",24,NCT04537351,CYP-001,AUSTRALIA,Recruiting,Cynata Therapeutics Limited,"August 24, 2020",Interventional,"A Pilot, Open-label, Randomised Controlled Clinical Trial to Investigate Early Efficacy of CYP-001 in Adults Admitted to Intensive Care With COVID-19"
3443,Impact of COVID-19 Outbreak on Non-COVID-19 Patients,COVID,"February 08, 2021",40000,NCT04537559,,SWITZERLAND,Enrolling by invitation,"University Hospital, Geneva","March 1, 2020",Observational,Impact of the COVID-19 Pandemic on the Morbidity and Mortality of Non-COVID-19 Patients Hospitalized Around the Epidemic Peak in the Geneva Area (Switzerland) (No COVID Impact)
3444,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,COVID,"February 08, 2021",300,NCT04537572,COMPARISON OF SAMPLE COLLECTION METHODS,,Not yet recruiting,Salveo Diagnostics,September 2020,Interventional,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing
3445,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7",COVID,"February 08, 2021",2000,NCT04537585,"TOMEKA®; ""VERNONIA AMYGDALINA""","CONGO, THE DEMOCRATIC REPUBLIC OF THE",Not yet recruiting,"Guyguy K Tshima, MD",November 2020,Interventional,"A Multi-center, Investigator-blinded, Randomized Clinical Trial, 18-months, Parallel-group to Compare the Efficacy of Tomeka® Foods Versus Vernonia Amygdalina in the Prevention and Maintenance of Remission of COVID-19 in DRC"
3446,Swallowing Impairment After COVID-19 Infection,COVID,"February 08, 2021",75,NCT04537650,VIDEOFLUOROSCOPIC SWALLOWING STUDY (VFSS),CANADA,Enrolling by invitation,"University Health Network, Toronto","January 1, 2021",Observational,The Pathophysiology of Swallowing Impairment in People Recovering From COVID-19
3447,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,RESPIRATORY TRACT INFECTIONS; COVID,"February 08, 2021",5200,NCT04537663,BACILLE CALMETTE-GUÉRIN (BCG); PLACEBO,NETHERLANDS,Recruiting,UMC Utrecht,"August 25, 2020",Interventional,Bacillus Calmette-Guérin Vaccination To Prevent Serious Respiratory Tract Infection And Covid-19 In Vulnerable Elderly - An Adaptive Randomized Controlled Trial
3448,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",100,NCT04537806,BREXANOLONE; PLACEBO,UNITED STATES,Recruiting,Sage Therapeutics,"December 18, 2020",Interventional,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
3449,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,COVID; INPATIENT,"February 08, 2021",50,NCT04537858,VIRTUAL REALITY THERAPY FIRST; CONVENTIONAL THERAPY FIRST,BRAZIL,"Active, not recruiting",University of Sao Paulo,"June 18, 2020",Interventional,Analysis of the Influence of Rehabilitation With Virtual Reality on the Heart Rate Variability of Individuals Under Treatment of COVID-19 in a Hospital Unit.
3450,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,COVID; PROTECTION AGAINST COVID,"February 08, 2021",120,NCT04537949,BNT162B3,GERMANY,Recruiting,BioNTech SE,"September 9, 2020",Interventional,"A Multi-site, Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of a Prophylactic SARS-CoV-2 RNA Vaccine (BNT162b3) Against COVID-19 Using Different Dosing Regimens in Healthy Adults"
3451,"Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study",CORONAVIRUS INFECTION,"February 08, 2021",70,NCT04537962,COLGATE PERIOGARD MOUTHWASH; COLGATE PEROXYL MOUTHWASH; COLGATE TOTAL MOUTHWASH; PLACEBO MOUTHWASH (WATER),BRAZIL,Enrolling by invitation,Hospital Israelita Albert Einstein,"June 11, 2020",Interventional,"Avaliação do Covid-19 na Cavidade Oral, Orofaringe e Saliva após desinfecção Com soluções Antimicrobianas Orais: Estudo Piloto."
3452,C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19,CONTINUOUS RENAL REPLACEMENT THERAPY; PULMONARY EDEMA; COVID,"February 08, 2021",0,NCT04537975,C2RX; STANDARD OF CARE (SOC),,Withdrawn,SeaStar Medical,"September 15, 2020",Interventional,A Randomized Clinical Trial of CLR2.0 Hemofiltration Treatment (C2Rx) in Severe or Critically Ill Adults With COVID-19 Infection
3453,Impact of COVID-19 on Lung Cancer Patients,LUNG CANCER; PROM; COVID; PSYCHOLOGICAL,"February 08, 2021",800,NCT04538456,QUESTIONNAIRE AND OPTIONAL INTERVIEW,UNITED KINGDOM,Recruiting,The Christie NHS Foundation Trust,"October 15, 2020",Observational,"Understanding the Physical, Social and Psychological Impact of COVID-19 on Frail and Shielded Lung Cancer Patients"
3454,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff",CARDIOVASCULAR DISEASES; DELIRIUM; CRITICAL ILLNESS; INTENSIVE CARE UNIT DELIRIUM; THORACIC DISEASES; RESPIRATORY FAILURE; CARDIAC DISEASE; CARDIAC FAILURE,"February 08, 2021",1000,NCT04538469,COVID VISITATION RESTRICTIONS,,Not yet recruiting,University of Glasgow,September 2020,Observational,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff"
3455,Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease,KAWASAKI DISEASE; INFLAMMATION,"February 08, 2021",100,NCT04538495,,UNITED STATES,Recruiting,"University of California, San Diego","August 1, 2020",Observational,Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease
3456,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)",COVID SCREENING,"February 08, 2021",1000,NCT04538586,,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","May 1, 2020",Observational,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures"
3457,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",COVID,"February 08, 2021",152,NCT04539262,REMDESIVIR (RDV); PLACEBO,UNITED STATES,Recruiting,Gilead Sciences,"September 14, 2020",Interventional,"A Phase 1b/2a Study in Participants With Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation"
3458,COVID-19 (VA CURES-1),COVID,"February 08, 2021",702,NCT04539275,CONVALESCENT PLASMA; MASKED SALINE PLACEBO,UNITED STATES,Recruiting,VA Office of Research and Development,"November 16, 2020",Interventional,VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1)
3459,Estrogen Therapy in Non-severe COVID-19 Patients,COVID,"February 08, 2021",60,NCT04539626,ESTROGEN THERAPY,,Not yet recruiting,"CMN ""20 de Noviembre""","October 1, 2020",Interventional,Estrogen Therapy in Non-severe COVID-19 Patients: Proposed Treatment Scheme in a Tertiary Hospital
3460,Writing Activities and Emotions,HEALTHY,"February 08, 2021",250,NCT04539756,POSITIVE PSYCHOLOGICAL INTERVENTION; ACTIVE CONTROL CONDITION,UNITED STATES,Recruiting,University of Pittsburgh,"September 8, 2020",Interventional,Does an Online Two-week Positive Psychological Intervention Improve Positive Affect in Young Adults?
3461,COVID-19 Study of Safety and Tolerability of Alvelestat,COVID,"February 08, 2021",15,NCT04539795,ALVELESTAT; PLACEBO,UNITED STATES,Recruiting,University of Alabama at Birmingham,"November 1, 2020",Interventional,"A Phase Ib/II, Single Center, Placebo-Controlled, Randomized, Blinded Study in Adult Patients (> 18 Years) With COVID-19 Respiratory Disease, to Evaluate, Safety, Tolerability and Mechanistic Effect of Alvelestat on Top of Standard of Care (COSTA)"
3462,Virtual Pain Care Management (COVID-19),CHRONIC PAIN,"February 08, 2021",60,NCT04539821,VCPM,UNITED STATES,Recruiting,VA Office of Research and Development,"October 1, 2020",Interventional,Virtual Pain Care for High Risk Veterans on Opioids During COVID19 (and Beyond)
3463,Electrolyte State in Patients With COVID-19,ELECTROLYTE IMBALANCE,"February 08, 2021",52,NCT04539834,ELECTROLYTES,EGYPT,"Active, not recruiting",Zagazig University,"May 1, 2020",Observational,Electrolyte State in Patients With COVID-19
3464,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",128,NCT04539873,COLCHICINE 0.5 MG; CONTROL GROUP,COLOMBIA,Not yet recruiting,Fundación Universitaria de Ciencias de la Salud,"November 30, 2020",Interventional,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19
3465,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure,PRENATAL STRESS,"February 08, 2021",600,NCT04540029,MATERNAL STRESS,ITALY,Recruiting,"IRCCS National Neurological Institute ""C. Mondino"" Foundation","May 6, 2020",Observational,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure
3466,Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,COVID; CYTOKINE RELEASE SYNDROME,"February 08, 2021",80,NCT04540120,DAPANSUTRILE CAPSULES; PLACEBO CAPSULES,SWITZERLAND,Recruiting,Olatec Therapeutics LLC,"September 25, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Orally Administered Dapansutrile Capsules for the Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome"
3467,A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19,COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); SARS-COV INFECTION; SARS-CoV2,"February 08, 2021",3600,NCT04540185,BIOLOGICAL: ORAL POLIO VACCINE; COMPARABLE PLACEBO; NA-831; COMPARABLE PLACEBO OF DRUG; COMBINATION OF ORAL POLIO VACCINE AND NA-831; COMPARABLE PLACEBO OF ORAL POLIO VACCINE AND PLACEBO OF DRUG,NEW ZEALAND,Enrolling by invitation,"NeuroActiva, Inc.","November 1, 2020",Interventional,"A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Polio Vaccine and NA-831 for Prophylaxis and Treatment of Early Onset of Covid-19"
3468,AZD1222 Vaccine for the Prevention of COVID-19,COVID,"February 08, 2021",100,NCT04540393,AZD1222,RUSSIAN FEDERATION,Suspended,AstraZeneca,"September 2, 2020",Interventional,"A Phase III Open-label Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19"
3469,NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes,SUSPECTED OR CONFIRMED COVID,"February 08, 2021",100,NCT04540406,NBT-NM108; USUAL CARE ONLY,UNITED STATES,Not yet recruiting,Notitia Biotechnologies Company,"January 29, 2021",Interventional,Modulation of Gut Microbiota With NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes Mellitus
3470,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,COVID,"February 08, 2021",500,NCT04540419,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR); PLACEBO,RUSSIAN FEDERATION,"Active, not recruiting",NPO Petrovax,"September 11, 2020",Interventional,"Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group Study Evaluating Efficacy, Reactogenicity and Safety of Recombinant Vaccine Ad5-nCoV Against Novel Coronavirus Infection in Adult Volunteers"
3471,COVID-19 IgG Formation in Physicians at ALGH and Their Household Members,COVID; SARS-COV INFECTION; COMMUNICABLE DISEASE,"February 08, 2021",900,NCT04540484,,UNITED STATES,Recruiting,Advocate Health Care,"August 26, 2020",Observational,The Prevalence of SARS-CoV-2 IgG Antibody Formation in Physicians at Advocate Lutheran General Hospital and Their Household Members
3472,Self-Management Across the Care Continuum,SPINAL CORD INJURIES,"February 08, 2021",60,NCT04540679,VIP4SCI,,Not yet recruiting,Lawson Health Research Institute,"September 1, 2020",Interventional,An Integrated Self-Management Service Delivery Model for Persons With SCI Across the Care Continuum
3473,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,COVID PNEUMONIA,"February 08, 2021",200,NCT04540926,CYCLOSPORIN A,MEXICO,Not yet recruiting,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,September 2020,Interventional,"Utility of Low Doses of Corticosteroids and Cyclosporine Combined With Enoxaparin, in Patients With COVID-19 Pneumonia at the ISSSTE Regional Hospital, Puebla, During the Contingency Period Due to the SARS-Cov2 Pandemic"
3474,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,TRAUMA,"February 08, 2021",60,NCT04540939,MINDFULNESS-BASED COGNITIVE THERAPY; MUSCLE RELAXATION THERAPY,UNITED STATES,Recruiting,University of Michigan,"October 19, 2020",Interventional,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy
3475,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery),DENTAL SURGEON,"February 08, 2021",1000,NCT04541472,,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","May 1, 2020",Observational,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons
3476,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)",COVID PATIENTS,"February 08, 2021",40,NCT04541485,DWRX2003; PLACEBO,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,"October 6, 2020",Interventional,"Phase I Study to Evaluate the Safety, Tolerability, and Pharmacodynamics (PD) of DWRX2003 (Niclosamide IM Depot) Injection Following Intramuscular Administration in COVID-19 Patients"
3477,Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis,SARS-CoV2 INDUCED PULMONARY FIBROSIS,"February 08, 2021",250,NCT04541680,NINTEDANIB 150 MG [OFEV]; PLACEBO,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 29, 2020",Interventional,"""Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis"""
3478,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,COVID,"February 08, 2021",100,NCT04541979,AEROSOLIZED DNASE; NACL,SWEDEN,Recruiting,Region Skane,"June 4, 2020",Interventional,"Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 - a Phase 2, Single-blinded, Randomized Study"
3479,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,COVID; RHEUMATIC DISEASES,"February 08, 2021",7911,NCT04542031,QUESTIONNAIRE,UNITED KINGDOM,Not yet recruiting,The Royal Wolverhampton Hospitals NHS Trust,October 2020,Interventional,COVID-19 Prevalence in a Single Large UK Rheumatology Centre and the Impact on Quality of Life From Stringent Social Distancing
3480,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia,COVID; PNEUMONIA,"February 08, 2021",40,NCT04542044,MANAGEMENT STRATEGY OF OUTPATIENT WITH MILD TO MODERATE SARS-COV-2 PNEUMONIA,SWITZERLAND,Completed,"University Hospital, Geneva","April 2, 2020",Observational,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia (PneumoCoV-Ambu)
3481,"Covid-19, Acute Myocardial Infarctions and Strokes in France",COVID; ACUTE CARDIOVASCULAR CONDITION; ACUTE NEUROVASCULAR CONDITION; STROKE; ACUTE MYOCARDIAL INFARCTION,"February 08, 2021",4000,NCT04542083,,FRANCE,Not yet recruiting,"University Hospital, Montpellier","January 20, 2021",Observational,Impact of COVID-19 on Unplanned Admissions for Acute Cardiovascular and Neurovascular Conditions in France
3482,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,MORALS,"February 08, 2021",500,NCT04542122,CHOICES AND JUDGEMENTS,,Not yet recruiting,"University Hospital, Caen","September 3, 2020",Interventional,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic: a Randomized Experimental Study
3483,Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment,COVID,"February 08, 2021",70812,NCT04542200,ANTIBODY TESTING,UNITED STATES,Enrolling by invitation,Northwell Health,"January 1, 2021",Observational,Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment
3484,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,HYPERGLYCEMIA; COVID,"February 08, 2021",28,NCT04542213,LINAGLIPTIN TABLET; INSULIN,MEXICO,Recruiting,Hospital Regional de Alta Especialidad del Bajio,"August 1, 2020",Interventional,Effect of the Combination of Dipeptidyl Peptidase-4 Inhibitor (DPP4i) and Insulin in Comparison to Insulin on Metabolic Control and Prognosis in Hospitalized Patients With COVID-19
3485,Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19,"INFECTIONS, CORONAVIRUS","February 08, 2021",81,NCT04542226,POLYOXIDONIUM,BELARUS,Completed,NPO Petrovax,"March 31, 2020",Observational,Open Observational Study of Efficacy and Safety of Polyoxidonium in Complex Therapy of Hospitalized Patients With COVID-19
3486,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,COVID; NON-SPECIFIC EFFECTS OF VACCINES; HETEROLOGOUS IMMUNITY; MORBIDITY; IMMUNOSENESCENCE; VACCINE PREVENTABLE DISEASE,"February 08, 2021",1900,NCT04542330,BCG-DENMARK; SALINE,DENMARK,Recruiting,Bandim Health Project,"September 15, 2020",Interventional,Using BCG Vaccine to Enhance Non-specific Protection of Senior Citizens During the COVID-19 Pandemic. A Randomized Clinical Trial.
3487,COVID-19 Risk Reduction Among African American Parishioners,CORONAVIRUS,"February 08, 2021",265,NCT04542343,"CHANGE IN KNOWLEDGE, MOTIVATION, SKILLS, RESOURCES",UNITED STATES,Recruiting,Charles Drew University of Medicine and Science,"November 1, 2020",Interventional,"Multilevel, Multidisciplinary, Faith-Based Participatory Interventions to Reduce COVID-19 Related-Risks Among Underserved African Americans"
3488,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,CORONAVIRUS,"February 08, 2021",310,NCT04542395,INCREASING WILLINGNESS AND UPTAKE OF COVID-19 TESTING AND VACCINATION,,Not yet recruiting,Charles Drew University of Medicine and Science,"June 1, 2021",Interventional,Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents
3489,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,COVID,"February 08, 2021",172,NCT04542408,ANTICOAGULATION AGENTS (EDOXABAN AND/OR HIGH DOSE LMWH); LOW DOSE LOW MOLECULAR WEIGHT HEPARIN OR PLACEBO,GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"November 12, 2020",Interventional,Hamburg Edoxaban for Anticoagulation in COVID-19 Study
3490,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,COVID,"February 08, 2021",90,NCT04542421,LUNG ULTRASOUND USE IN PATIENTS HOSPITALIZED WITH COVID,UNITED STATES,Recruiting,"University of Colorado, Denver","July 1, 2020",Interventional,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19
3491,Niclosamide in COVID-19,COVID,"February 08, 2021",148,NCT04542434,NICLOSAMIDE ORAL TABLET; PLACEBO,,Not yet recruiting,"First Wave Bio, Inc.","November 1, 2020",Interventional,"A Phase 2 Randomized Double Blind, Placebo-controlled Study on the Safety and Efficacy of Niclosamide in Patients With COVID-19"
3492,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,COVID,"February 08, 2021",10,NCT04542447,NUVASTATIC,INDIA,Recruiting,Natureceuticals Sdn Bhd,"September 1, 2020",Interventional,An Open Label Proof of Concept Study to Assess Aspects of Safety and Efficacy of Nuvastatic™ (C5OSEW5050ESA) as an Immunomodulator Adjuvant Therapy to the Standard Care of Treatment in Covid 19 Patients.
3493,Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.,"CHOLECYSTITIS, ACUTE; CHOLECYSTITIS; GANGRENOUS; CHOLECYSTITIS SUPPURATIVE; COVID","February 08, 2021",800,NCT04542512,,FRANCE,Recruiting,Poissy-Saint Germain Hospital,"October 1, 2020",Observational [Patient Registry],Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic: the ChoCO-WSES Prospective Multicenter Observational Study.
3494,The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome,"SEPSIS; CORONAVIRUS INFECTION; ARDS, HUMAN","February 08, 2021",15000,NCT04542538,"NO INTERVENTION, OBSERVATIONAL STUDY",SWEDEN,"Active, not recruiting",Uppsala University,"April 11, 2018",Observational,The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome
3495,"A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic",OPIOID-USE DISORDER,"February 08, 2021",130,NCT04542642,RESET-O; PEAR-008,UNITED STATES,Recruiting,"Pear Therapeutics, Inc.",February 2021,Interventional,"A Randomized, Controlled, Open-Label, Decentralized Study, to Evaluate Patient Engagement With PEAR-008, a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder"
3496,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,COVID,"February 08, 2021",200,NCT04542694,FAVIPIRAVIR; STANDARD OF CARE,RUSSIAN FEDERATION,Completed,"Promomed, LLC","May 21, 2020",Interventional,"Open-label Randomized Multicenter Comparative Study on the Efficacy and Safety of Areplivir Film-coated Tablets (PROMOMED RUS LLC, Russia) in Patients Hospitalized With COVID-19"
3497,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",SARS-CoV2; COVID,"February 08, 2021",40,NCT04542850,5-ALA-PHOSPHATE + SFC (5-ALA + SFC),BAHRAIN,Recruiting,Royal College of Surgeons in Ireland - Medical University of Bahrain,"November 15, 2020",Interventional,"An Open-Label, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-Aminolevulinic Acid Phosphate and Sodium Ferrous Citrate (5-ALA-Phosphate + SFC) in Subjects With SARS-CoV-2 Infection (COVID-19)"
3498,The Molecular Imaging Research of F-18 Labeled DX600 PET Probe,SOLID TUMOR,"February 08, 2021",100,NCT04542863,18F-DX600 PET/CT,CHINA,Recruiting,Beijing Cancer Hospital,"September 11, 2020",Interventional,The Molecular Imaging Research of F-18 Labeled DX600 PET Probe
3499,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,COVID,"February 08, 2021",46,NCT04542876,GUDUCHI GHAN VATI,INDIA,Completed,Aarogyam UK,"May 1, 2020",Interventional,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection: An Open Label Feasibility Study
3500,COVID-19-Related Health and Practices Among Dental Hygienists,SARS-COV INFECTION; ANXIETY; DEPRESSION; OCCUPATIONAL PROBLEMS; SEVERE ACUTE RESPIRATORY SYNDROME; CORONAVIRUS INFECTION,"February 08, 2021",4776,NCT04542915,NO INTERVENTION,UNITED STATES,"Active, not recruiting",American Dental Association,"September 29, 2020",Observational,COVID-19-Related Health and Practices Among Dental Hygienists
3501,Assessment of Safety and Efficacy of CCP,COVID,"February 08, 2021",136,NCT04542941,COVID CONVALESCENT PLASMA,UGANDA,Completed,Makerere University,"June 16, 2020",Interventional,Assessment of Safety and Efficacy of COVID-19 Convalescent Plasma for Treatment of COVID-19 in Adults in Uganda; A Randomised Controlled Trial
3502,Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East,"COVID; KIDNEY TRANSPLANT INFECTION; RISK FACTOR, CARDIOVASCULAR; IMMUNOSUPPRESSION; OUTCOME, FATAL; GRAFT FAILURE","February 08, 2021",104,NCT04542954,OPTIMIZED MANAGEMENT OF COVID-19 POSITIVE KIDNEY TRANSPLANT RECIPIENTS: SINGLE CENTER EXPERIENCE FROM THE MIDDLE EAST,KUWAIT,Completed,Hamid Al-Essa Organ Transplant Center,"March 1, 2020",Observational [Patient Registry],Renal Dysfunction Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (Covid-19) Patients: Kuwait Experience
3503,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,SEVERE COVID DISEASE,"February 08, 2021",150,NCT04542967,BIOLOGICAL,MEXICO,Recruiting,Hospital Central Militar,"June 23, 2020",Interventional,Convalescent Plasma as a Treatment for Patients With Severe COVID-19 Disease
3504,Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19,SARS-CoV2 INFECTION; COVID,"February 08, 2021",200,NCT04542980,SARS-COV2 AUTOANTIBODY DETECTION,,Not yet recruiting,Namida Lab,"September 15, 2020",Observational,"Qualitative Evaluation of Tear Fluid and Blood for IgM and IgG Produced in Response to SARS-CoV2, the Virus Responsible for COVID-19."
3505,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,COVID; SARS-COV INFECTION,"February 08, 2021",60,NCT04542993,ZINC PICOLINATE; RESVERATROL; ZINC PICOLINATE PLACEBO; RESVERATROL PLACEBO,UNITED STATES,Recruiting,Swedish Medical Center,"September 8, 2020",Interventional,"Can SARS-CoV-2 Viral Shedding in COVID-19 Disease be Reduced by Resveratrol-assisted Zinc Ingestion, a Direct Inhibitor of SARS-CoV-2-RNA Polymerase? A Single Blinded Phase II Protocol (Reszinate Trial)"
3506,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,COVID,"February 08, 2021",170,NCT04543006,SEROLOGY,,Not yet recruiting,"University Hospital, Grenoble","September 8, 2020",Interventional,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
3507,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,COVID,"February 08, 2021",18,NCT04543760,PRONE POSITION; SUPINE POSITION,FRANCE,Recruiting,"Hospital St. Joseph, Marseille, France","October 1, 2020",Interventional,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to Sars-covid-2: a Randomized Crossover Trial.
3508,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients,COVID,"February 08, 2021",120,NCT04544033,INTERLEUKEN 6 LEVEL MEASURMENT; INTERLEUKIN-6 GENE-174C DETECTION,EGYPT,Recruiting,Tanta University,"September 15, 2020",Observational,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients
3509,Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards,SARS-COV INFECTION; ANTIMICROBIAL STEWARDSHIP; RESPIRATORY TRACT INFECTIONS; ANTIBIOTIC RESISTANCE,"February 08, 2021",400,NCT04544072,,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"May 1, 2020",Observational,A Prospective Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards of a Tertiary University Hospital During the COVID-19 Pandemic
3510,Gastrointestinal Manifestations Among Patients With COVID19,COVID,"February 08, 2021",220,NCT04544150,,EGYPT,Completed,Assiut University,"June 1, 2020",Observational,Gastrointestinal Manifestations in COVID-19: Symptoms and Signs and Its Impact on the Outcome
3511,COVID-19 Risk From Attending Outpatient Appointments,COVID,"February 08, 2021",34000,NCT04544176,OBSERVATIONAL,UNITED KINGDOM,"Active, not recruiting",Nottingham University Hospitals NHS Trust,"January 1, 2020",Observational,Determining the Risk of Developing Symptomatic COVID-19 After Attending Hospital Outpatient Clinics
3512,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients,POST COVID,"February 08, 2021",150,NCT04544605,INDIVIDUALIZED-CHINESE HERBAL MEDICINE,CHINA,Recruiting,Hong Kong Baptist University,"September 7, 2020",Observational,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients: An Observational Study
3513,Pediatric Intensive Care and COVID-19,COVID; PEDIATRIC ALL; INFECTION; CRITICAL ILLNESS; SARS-COV INFECTION,"February 08, 2021",100,NCT04544878,,FRANCE,Recruiting,Bicetre Hospital,"March 26, 2020",Observational [Patient Registry],Clinical and Biological Characteristics of Critically Ill Patients With COVID-19 Admitted to Pediatric Intensive Care Unit
3514,TREM-1 Pathway Activation in COVID-19,COVID,"February 08, 2021",1000,NCT04544891,BLOOD SAMPLING,FRANCE,Not yet recruiting,"Central Hospital, Nancy, France","October 1, 2020",Observational [Patient Registry],Prognostic Significance of the TREM-1 Pathway Activation in COVID-19
3515,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,COVID,"February 08, 2021",42,NCT04545008,FAMOTIDINE; N-ACETYL CYSTEINE,,Not yet recruiting,Prisma Health-Upstate,September 2020,Interventional,A Phase I Clinical Trial of the Combination of Famotidine (FAM) and Oral N-Acetyl Cysteine (NAC) Open Label for Outpatient Treatment of Subjects With Newly Diagnosed SARS-CoV-2 Infection
3516,Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",10000,NCT04545047,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",VA Office of Research and Development,"May 1, 2020",Observational,CSP #2030 - Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19
3517,VIR-7831 for the Early Treatment of COVID-19 in Outpatients,COVID,"February 08, 2021",1360,NCT04545060,VIR-7831; PLACEBO,AUSTRIA,Recruiting,"Vir Biotechnology, Inc.","August 27, 2020",Interventional,"A Randomized, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Monoclonal Antibody VIR-7831 for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Non-hospitalized Patients"
3518,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",980,NCT04545242,DEXAMETHASONE,SPAIN,Not yet recruiting,Dr. Negrin University Hospital,"February 8, 2021",Interventional,Efficacy of Higher vs. Lower Doses of Dexamethasone in Patients With Acute Hypoxemic Respiratory Failure (Including ARDS) Caused by Infections (Including COVID-19)
3519,Trial of Therapeutic Hypothermia in Patients With ARDS,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",340,NCT04545424,HYPOTHERMIA; NEUROMUSCULAR BLOCKING AGENTS; STANDARD OF CARE,UNITED STATES,Not yet recruiting,"University of Maryland, Baltimore","January 31, 2021",Interventional,Cooling to Help Injured Lungs (CHILL) Phase IIB Randomized Control Trial of Therapeutic Hypothermia in Patients With ARDS
3520,Nebulised Heparin in Patients With Severe COVID-19,COVID; RESPIRATORY FAILURE,"February 08, 2021",300,NCT04545541,NEBULISED UNFRACTIONATED HEPARIN (UFH),UNITED STATES,Recruiting,Australian National University,"November 1, 2020",Interventional,Can Nebulised HepArin Reduce morTality and Time to Extubation in Patients With COVID-19 Requiring Mechanical Ventilation Meta-Trial (CHARTER-MT): Protocol for an Investigator-initiated International Meta-trial of Randomised Studies
3521,Positive Minds Strong Bodies Implementation,DEPRESSION; ANXIETY; PHYSICAL DISABILITY,"February 08, 2021",450,NCT04545593,POSITIVE MINDS STRONG BODIES ENHANCED; ENHANCED USUAL CARE,UNITED STATES,Recruiting,Massachusetts General Hospital,"January 15, 2021",Interventional,Building Community Capacity for Disability Prevention for Minority Elders - Renewal
3522,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",COVID,"February 08, 2021",60,NCT04545749,UB-612,TAIWAN,Recruiting,"United Biomedical Inc., Asia","September 25, 2020",Interventional,"A Phase I, Open-label Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 Vaccine in Healthy Adult Volunteers"
3523,Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland,COVID,"February 08, 2021",1580,NCT04546191,,ICELAND,Completed,Landspitali University Hospital,"July 1, 2020",Observational [Patient Registry],Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland
3524,Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC),COVID; COVID; SARS-CoV2; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",500,NCT04546581,HYPERIMMUNE IMMUNOGLOBULIN TO SARS-COV-2 (HIVIG); PLACEBO; REMDESIVIR,DENMARK,Recruiting,University of Minnesota,"October 8, 2020",Interventional,"An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19"
3525,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",COVID; NEUROLOGICAL MANIFESTATIONS; BRAIN DAMAGE,"February 08, 2021",20,NCT04546737,MAGNETIC RESONANCE SPECTROSCOPY (MRS).,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 8, 2020",Interventional,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients"
3526,COVID-19 Persistence in Stool,SARS-COV INFECTION,"February 08, 2021",200,NCT04546776,,UNITED KINGDOM,Enrolling by invitation,Quadram Institute Bioscience,"September 8, 2020",Observational,Prevalence and Persistence of SARS-CoV-2 in Stool of COVID-19 Positive Subjects
3527,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,COVID VACCINE,"February 08, 2021",36,NCT04546841,MULTIPEPTIDE COCKTAIL,GERMANY,Recruiting,University Hospital Tuebingen,"November 27, 2020",Interventional,P-pVAC-SARS-CoV-2: Phase I Single-center Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
3528,Influenza 2020/2021,INFLUENZA VACCINE,"February 08, 2021",200,NCT04546854,APPEALS,UNITED KINGDOM,Completed,University of Warwick,"September 21, 2020",Interventional,Influenza 2020/2021. A Survey to Assess How People's Political Attitudes and Messages Influence Their Behavioral Intentions in the United Kingdom.
3529,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects,SARS-CoV2 INFECTION,"February 08, 2021",200,NCT04547114,MULTICAPILLARY COLUMN COUPLED ION MOBILITY SPECTROMETRY,GERMANY,Recruiting,Klinikum Bayreuth GmbH,"September 14, 2020",Observational,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects
3530,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),COVID,"February 08, 2021",200,NCT04547127,CONVALESCENT ANTI-SARS-COV-2 MBT PLASMA; STANDARD MEDICAL TREATMENT,SPAIN,Recruiting,"Instituto Grifols, S.A.","April 29, 2020",Interventional,"A Multicenter, Randomized, Open-label, Parallel Group Pilot Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) With Standard Medical Treatment (SMT) Versus SMT Alone in Subjects With COVID-19 Requiring Admission to the Intensive Care Unit (ICU)"
3531,Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),COVID,"February 08, 2021",100,NCT04547140,LIQUID ALPHA1-PROTEINASE INHIBITOR (HUMAN); PLACEBO; STANDARD MEDICAL TREATMENT,BRAZIL,Recruiting,Grifols Therapeutics LLC,January 2021,Interventional,"A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) Plus Standard Medical Treatment (SMT) Versus Placebo Plus SMT in Hospitalized Subjects With COVID-19"
3532,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population,"AGE PROBLEM; SURGERY; DEPRESSION, ANXIETY","February 08, 2021",150,NCT04547218,,MALAYSIA,Completed,University of Malaya,"June 22, 2020",Observational,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population
3533,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,COVID,"February 08, 2021",42,NCT04547257,SERAPH 100,NETHERLANDS,Not yet recruiting,ExThera Medical Europe BV,"February 1, 2021",Interventional,Safety and Performance Evaluation of Seraph 100 Filter in the Treatment of Patients With COVID-19
3534,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,COVID; RESPIRATORY FAILURE,"February 08, 2021",40,NCT04547283,USUAL CARE; APPS,UNITED STATES,Recruiting,Atrium Health,"June 14, 2020",Interventional,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19: A Pilot Randomized Controlled Trial
3535,Telerehabilitation in Oncology Patients,CANCER METASTATIC; CANCER; SURVIVORSHIP,"February 08, 2021",30,NCT04547634,THERAPEUTIC EXERCISE AND EDUCATION,SPAIN,Enrolling by invitation,University of Malaga,"July 1, 2020",Interventional,Effect of a Telerehabilitation-exercise Intervention in Oncology Patients in the Covid-19 Pandemic
3536,Convalescent Plasma for Severe COVID-19 Patients,COVID,"February 08, 2021",160,NCT04547660,CONVALESCENT PLASMA; BEST SUPPORTIVE CARE,BRAZIL,Recruiting,Hospital de Clinicas de Porto Alegre,"July 16, 2020",Interventional,"Convalescent Plasma for Severe COVID-19 Patients: a Randomized, Open-label, Phase 3 Trial"
3537,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals,THE USE OF MODERN TECHNOLOGY APPLICATIONS IN HOME ISOLATION,"February 08, 2021",175,NCT04548492,SURVEY,,Not yet recruiting,Ain Shams University,"September 14, 2020",Observational,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Randomized Survey for Health Care Professionals
3538,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff,SARS-COV INFECTION,"February 08, 2021",100,NCT04548505,,FRANCE,Not yet recruiting,Direction Centrale du Service de Santé des Armées,October 2020,Observational,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff
3539,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,COLON CANCER,"February 08, 2021",800,NCT04548531,SHARED DECISION MAKING,UNITED STATES,Enrolling by invitation,Massachusetts General Hospital,"September 10, 2020",Interventional,Engaging Patients in Colon Cancer Screening Decisions During COVID-19
3540,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,HEALTHY,"February 08, 2021",21,NCT04548544,"TRAINING FOR AWARENESS, RESILIENCE, AND ACTION (TARA)",UNITED STATES,Completed,"University of California, San Francisco","October 18, 2019",Interventional,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During the COVID-19 Pandemic
3541,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,COVID,"February 08, 2021",60,NCT04548557,INTRAVENOUS IMMUNOGLOBULIN THERAPY,PAKISTAN,Not yet recruiting,University of Health Sciences Lahore,"September 15, 2020",Interventional,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial
3542,Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19,COVID; COMMUNITY-ACQUIRED RESPIRATORY TRACT INFECTION,"February 08, 2021",30,NCT04548895,OBSERVATIONAL MEASUREMENT OF BIOMETRIC DATA. NO CHANGE TO HEALTH CARE PROVIDED.,UNITED STATES,Recruiting,"Health Stream Analytics, LLC","December 30, 2020",Observational,Non-invasive Biometric Monitoring for the Prevention of COVID-19 Transmission and Deaths in Nursing Homes
3543,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,COVID,"February 08, 2021",1300,NCT04548908,"SERELOGY TESTING, RT PCR",FRANCE,Recruiting,Centre Hospitalier Sud Essonne,"August 3, 2020",Observational,Prevalence Of COVID-19 Among Health-workers in a French General Hospital
3544,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,CARDIOPULMONARY RESUSCITATION; PERSONAL PROTECTIVE EQUIPMENT,"February 08, 2021",34,NCT04548934,PERSONAL PROTECTIVE EQUIPMENT (PPE); NO PERSONAL PROTECTIVE EQUIPMENT (PPE),ITALY,Completed,Institute of Mountain Emergency Medicine,"September 13, 2020",Interventional,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic
3545,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,COVID,"February 08, 2021",10,NCT04549337,EXERCISE TRAINING,DENMARK,Recruiting,"Rigshospitalet, Denmark","September 25, 2020",Interventional,Investigator-blinded Randomized Controlled Trial Examining the Safety and Feasibility of Different Exercise Training Programs in Patients Who Have Survived COVID-19
3546,Sleep Quality Among HCWs,SLEEP QUALITY,"February 08, 2021",217,NCT04549350,PSQI,EGYPT,Completed,Zagazig University,"May 19, 2020",Observational,Sleep Quality Among Health Care Workers During COVID-19 Pandemic: Kuwait Experience
3547,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,COVID,"February 08, 2021",200,NCT04549376,POVIDONE-IODINE 0.4% NI; POVIDONE-IODINE 0.5% NI; POVIDONE-IODINE 0.6% NI; POVIDONE-IODINE 0.5% NS; POVIDONE-IODINE 0.6% NS; PLACEBO COMPARATOR: DW-NI; PLACEBO COMPARATOR: DW-NS,BANGLADESH,Recruiting,"Pi Research Consultancy Center, Bangladesh","July 1, 2020",Interventional,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo: an Open Label Randomized Clinical Trial
3548,COVID-19 Related Lung Ventilation and Perfusion Injury,COVID; ASTHMA; HEALTHY,"February 08, 2021",92,NCT04549636,V/Q SPECT-CT; ST. GEORGE'S RESPIRATORY QUESTIONNAIRE (SGRQ); MMRC (MODIFIED MEDICAL RESEARCH COUNCIL) DYSPNEA SCALE; SIX-MINUTE WALK TEST (6MWT); SPIROMETRY; PLETHYSMOGRAPHY & DLCO; AIRWAVE OSCILLOMETRY,CANADA,Recruiting,McMaster University,"September 18, 2020",Observational,Prospective Longitudinal Study to Characterize and Understand the Clinical Relevance of SARS-CoV2 Related Ventilation and Perfusion Injury Evaluated by V/Q SPECT-CT in an Asthmatic and Healthy Population
3549,Genetic Bases of COVID-19 Clinical Variability,COVID,"February 08, 2021",2000,NCT04549831,MASSIVE PARALLEL SEQUENCING OF HOST GENOME,ITALY,Recruiting,University of Siena,"April 8, 2020",Observational,Identification of the Genetic Bases Determining COVID-19 Clinical Variability in the Italian Population
3550,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,COVID,"February 08, 2021",111,NCT04549922,ISIS 721744; NORMAL SALINE,BRAZIL,"Active, not recruiting",Hospital do Coracao,"October 22, 2020",Interventional,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19: A Phase II Randomized Controlled Trial
3551,The Impact of Lifestyle Changes on Non-COVID Deaths,LIFESTYLE ALTERATION; NON-COVID DEATHS,"February 08, 2021",80000,NCT04550312,,CHINA,Recruiting,The First Affiliated Hospital with Nanjing Medical University,September 2020,Observational,The Impact of Lifestyle Alteration by Strict Prevention Measures on Non-COVID Deaths in the Region With Low COVID-19 Transmission Rate
3552,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19","COVID; PNEUMONIA, VIRAL","February 08, 2021",12,NCT04550325,KAMADA ANTI-SARS-COV-2,ISRAEL,Completed,"Kamada, Ltd.","August 5, 2020",Interventional,"A Phase 1/2 Open Label, Multicenter, Single Arm Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose Kamada Anti-SARS-CoV-2 in COVID-19 Hospitalized Patients With Pneumonia"
3553,Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure,COVID,"February 08, 2021",100,NCT04550338,TRANEXAMIC ACID; PLACEBO,,Not yet recruiting,University of Alabama at Birmingham,"December 1, 2020",Interventional,Antiviral Effects of Tranexamic Acid (TXA) as a Preventative Treatment Following COVID-19 Exposure
3554,Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old),CORONAVIRUS,"February 08, 2021",50,NCT04550351,BIOLOGICAL/VACCINE: RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) LOW-DOSE GROUP; BIOLOGICAL/VACCINE: RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELLS) HIGH-DOSE GROUP; BIOLOGICAL/VACCINE: RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELLS) PLACEBO GROUP,CHINA,"Active, not recruiting","Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","August 19, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Tolerability of Recombinant New Coronavirus Vaccines (CHO Cells) in Healthy People Aged 60 Years and Above"
3555,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19.,SARS-COV INFECTION,"February 08, 2021",2400,NCT04550390,SALIVA COLLECTION,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 15, 2020",Observational,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19.
3556,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes,DIABETES MELLITUS; COVID,"February 08, 2021",700,NCT04550403,,ITALY,Recruiting,Azienda Ospedaliero-Universitaria di Parma,"July 30, 2020",Observational,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes
3557,Music Therapy in Frontline Healthcare Workers,MOOD; EMOTIONAL STRESS,"February 08, 2021",20,NCT04551274,MUSIC THERAPY,CANADA,Not yet recruiting,Simon Fraser University,"October 1, 2020",Interventional,Investigating the Use of Virtual Music Therapy in Frontline Healthcare Workers During COVID-19
3558,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,HEALTHY; HEALTH CARE WORKER PATIENT TRANSMISSION; AGING,"February 08, 2021",4500,NCT04551339,PRESERVISION AREDS FORMULATION SOFT GELS OR TABLETS; MULTIVITAMIN WITH 11MG OF ZINC,UNITED STATES,Enrolling by invitation,Mayo Clinic,"September 28, 2020",Interventional,Zinc Versus Multivitamin Micronutrient Supplementation to Support Immune Health in the Setting of COVID-19 Pandemic: A Randomized Study
3559,The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors,COVID INFECTION; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM,"February 08, 2021",600,NCT04551378,QUALITY-OF-LIFE ASSESSMENT; SURVEY ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"July 13, 2020",Observational,Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Adolescent and Young Adult (AYA) Cancer Patients and Survivors
3560,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19,COVID,"February 08, 2021",552,NCT04551547,"TWO DOSES OF LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,28; TWO DOSES OF MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,28; TWO DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0,28",CHINA,Recruiting,"Sinovac Research and Development Co., Ltd.","October 31, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged 3-17 Years"
3561,Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE),PREGNANCY; COVID; LABOR (OBSTETRICS)--COMPLICATIONS; DEMOGRAPHY,"February 08, 2021",720,NCT04551690,,CHILE,Completed,"Hospital San Juan de Dios, Santiago","April 15, 2020",Observational,"Analysis of Prevalence, Pregnancy Outcomes and Sociodemographic Conditions in Women at Labour With and Without Coronavirus 19 Disease COVID-19 in a Public Hospital in Chile"
3562,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,COVID,"February 08, 2021",188,NCT04551755,IVERMECTIN AND DOXYCYCLINE; PLACEBO,,Not yet recruiting,Bangladesh Medical Research Council (BMRC),September 2020,Interventional,The Safety and Efficacy Outcome of Ivermectin Plus Doxycycline in Treatment of RT-PCR Positive Adult Mild Covid-19 Cases: a Randomized Double Blind Placebo Controlled Trial
3563,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,COVID,"February 08, 2021",50,NCT04551768,50 MG/ML VIRAZOLE; 100 MG/ML VIRAZOLE,,Not yet recruiting,"Bausch Health Americas, Inc.",February 2021,Interventional,"An Open-Label Study to Evaluate the Safety and Efficacy of VIRAZOLE® (RIBAVIRIN FOR INHALATION SOLUTION, USP) in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19"
3564,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,COVID,"February 08, 2021",450,NCT04551781,20 MG PREDNISONE FOR 14 DAYS; CONTROL,EGYPT,Completed,South Valley University,"April 1, 2020",Interventional,Short Term Low Dose Corticosteroids for Management of Post Covid-19 Pulmonary Fibrosis
3565,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),COVID,"February 08, 2021",180,NCT04551898,BGB-DXP593; PLACEBO,,Not yet recruiting,BeiGene,"October 30, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody BGB-DXP593 in Patients WithMild-to-Moderate COVID-19"
3566,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,COVID; CORONAVIRUS; SARS-CoV2 INFECTION,"February 08, 2021",160,NCT04551911,RAYALDEE 30MCG EXTENDED-RELEASE (ER) CAPSULE; PLACEBO,UNITED STATES,Recruiting,"OPKO Health, Inc.","October 26, 2020",Interventional,"A Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of Rayaldee (Calcifediol) Extended-release Capsules to Treat Symptomatic Patients Infected With SARS-CoV-2 (REsCue)"
3567,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.",COVID,"February 08, 2021",1500,NCT04552340,PATIENT WITH SAR-COV-2 INFECTION,ITALY,Recruiting,Istituto Clinico Humanitas,"March 16, 2020",Observational,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV: A Retrospective-Prospective Cohort Study."
3568,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,COVID,"February 08, 2021",149,NCT04552366,AD5-NCOV,CHINA,"Active, not recruiting","Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China","September 29, 2020",Interventional,A Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults Aged 18 Years and Older
3569,The Containing Coronavirus Disease 19 (COVID-19) Trial,SARS-COV INFECTION; INTERFERON; COVID,"February 08, 2021",1240,NCT04552379,PEGINTERFERON BETA-1A,CHILE,Recruiting,Pontificia Universidad Catolica de Chile,"December 1, 2020",Interventional,A Cluster Randomised Trial of Interferon Versus Standard of Care in the Reduction of Transmission of SARS-Cov-2. The Containing Coronavirus Disease 19 Trial (ConCorD-19)
3570,Psychological Impact of Institutional Quarantine as a Precautionary Measure Against COVID-19,QUARANTINE,"February 08, 2021",100,NCT04552392,NO INTERVENTION,INDIA,Not yet recruiting,Dr. Ram Manohar Lohia Hospital,"September 20, 2020",Observational,Psychological Impact of Institutional Quarantine - A Cross-Sectional Observational Study
3571,Effects of Early Use of Nitazoxanide in Patients With COVID-19,COVID; CORONAVIRUS,"February 08, 2021",392,NCT04552483,NITAZOXANIDE; PLACEBO,BRAZIL,Completed,Universidade Federal do Rio de Janeiro,"June 8, 2020",Interventional,Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19
3572,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,COVID,"February 08, 2021",80,NCT04552951,CHOLECALCIFEROL,SPAIN,Recruiting,Fundación para la Investigación Biosanitaria del Principado de Asturias,"April 4, 2020",Interventional,Estudio Destinado a Valorar la Utilidad de Vitamina D Sobre Morbilidad y Mortalidad de la infección Por Virus SARS-COV-2 (COVID-19) en el Hospital Universitario Central de Asturias
3573,Antibiotic Misuse During COVID-19 Pandemic,COVID,"February 08, 2021",413,NCT04553055,ONLINE QUESTIONNAIRES,EGYPT,Completed,Beni-Suef University,"July 20, 2020",Observational [Patient Registry],Assessment of Community Pharmacies Related Antibiotic Misuse and Application of Infection Control Measures During COVID-19 Pandemic
3574,CoViD-19 Patient in Reims University Hospital in March to April 2020,CORONAVIRUS INFECTION,"February 08, 2021",499,NCT04553575,SEROLOGY,FRANCE,Recruiting,CHU de Reims,"September 25, 2020",Observational [Patient Registry],Follow-up CoViD-19 Patients Hospitalized in Reims University Hospital Between the 01/03/2020 and 30/04/2020
3575,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",COVID; IMMUNODEFICIENCY,"February 08, 2021",200,NCT04553705,OMEGA 3/NIGELLA SATIVA OIL; OMEGA 3/NIGELLA SATIVA OIL/INDIAN COSTUS; OMEGA 3/NIGELLA SATIVA OIL/QUININE PILLS; OMEGA 3/NIGELLA SATIVA OIL/ANISE SEED CAPSULE; OMEGA 3/NIGELLA SATIVA OIL/DEGLYCYRRHIZINATED LICORICE; ACTIVE COMPARATOR,SAUDI ARABIA,Recruiting,Beni-Suef University,"September 20, 2020",Interventional,Impact of Different Treatment Modalities on Immunity Against COVID-19
3576,Global Impact of COVID-19 on Pulmonology Special Units,COVID; GLOBAL IMPACT; PULMONOLOGY,"February 08, 2021",100,NCT04554251,SURVEY,EGYPT,Enrolling by invitation,Assiut University,"September 1, 2020",Observational,"Global Impact of COVID-19 on Pulmonology Special Units (Bronchoscopy, Thoracoscopy, Ultrasonography and Sleep Lab)"
3577,Complicated Grief in ICU in the Aftermath of COVID-19,COMPLICATED GRIEF; INTENSIVE CARE; COVID,"February 08, 2021",160,NCT04554264,QUESTIONNAIRE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 1, 2020",Interventional,Complicated Grief in ICU in the Aftermath of COVID-19
3578,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,COVID; DRUG EFFECT,"February 08, 2021",80,NCT04554433,ETHANOL WITH ASPRIN,,Not yet recruiting,Mansoura University,"December 1, 2020",Interventional,Disinfection of SARS-COV-2 ( COVID-19 ) in Human Respiratory Tract by Controlled Ethanol Vapor Inhalation Combined With Oral Asprin .
3579,COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience,COVID; DIARRHEA,"February 08, 2021",199,NCT04554979,HYDROXYCHLOROQUINE PILL,EGYPT,Completed,Cairo University,"June 1, 2020",Observational,Corona Virus (COVID-19) Disease Duration and Gastrointestinal Tract (GIT) Manifestations; Can be New Disease Severity Classification. A Pilot Egyptian Single National Center Experience
3580,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),COVID,"February 08, 2021",350,NCT04554992,COVID 19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",The Methodist Hospital System,"March 20, 2020",Interventional,Convalescent Plasma for the Treatment of Coronavirus Disease 2019
3581,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,MINDFULNESS; COVID; HEALTHCARE WORKER,"February 08, 2021",1000,NCT04555005,MINDFULNESS BASED INTERVENTION,SPAIN,Completed,Instituto de Investigación Hospital Universitario La Paz,"March 10, 2020",Interventional,"Implementation of a Mindfulness-based Crisis Intervention for Frontline Healthcare Workers During the COVID-19 Outbreak in a Public General Hospital in Madrid, Spain"
3582,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,COVID; SARS-CoV2 INFECTION,"February 08, 2021",50,NCT04555096,GC4419; PLACEBO,UNITED STATES,Recruiting,"Galera Therapeutics, Inc.","September 9, 2020",Interventional,"A Pilot, Randomized, Placebo-Controlled Trial of GC4419 (Avasopasem Manganese) in Patients With Critical Illness Due to SARS-CoV-2 Infection (COVID-19)"
3583,Convalescent Plasma for COVID-19 Research Donor Study,COVID,"February 08, 2021",1000,NCT04555109,,CANADA,Recruiting,The Hospital for Sick Children,"June 30, 2020",Observational,Convalescent Plasma for COVID-19 Research (CONCOR) Donor Study
3584,COVID-19 Ad Intervention,SOCIAL DISTANCE,"February 08, 2021",52500,NCT04555122,SOCIAL DISTANCING ADVERTISEMENTS,UNITED STATES,Not yet recruiting,"University of California, Irvine","September 29, 2020",Interventional,COVID-19 Ad Intervention for Social Distancing
3585,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),COVID,"February 08, 2021",60,NCT04555148,GC5131; PLACEBO,"KOREA, REPUBLIC OF",Recruiting,Green Cross Corporation,"September 20, 2020",Interventional,"A Prospective, Open-label, Randomized, Multi-center, Phase 2a Study to Evaluation the Dose Response, Efficacy and Safety of Hyper-Ig (Hyper-immunoglobulin) GC5131 in Patients With COVID-19"
3586,Cardiovascular Risk Stratification in Covid-19,COVID; CARDIOVASCULAR RISK FACTOR,"February 08, 2021",60000,NCT04555187,,UNITED STATES,"Active, not recruiting",Oregon Health and Science University,"June 8, 2020",Observational,Cardiovascular Risk Stratification in Covid-19
3587,A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,COVID,"February 08, 2021",40,NCT04555213,NOX66,"MOLDOVA, REPUBLIC OF",Recruiting,Noxopharm Limited,"September 30, 2020",Interventional,A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 Infection (NOXCOVID)
3588,Determining the Physical Activity Level of Healthy Adults During Pandemic,"HEALTH, SUBJECTIVE; HEALTHY","February 08, 2021",205,NCT04555954,SURVEYS AND QUESTIONNAIRES,TURKEY,Completed,Pamukkale University,"April 11, 2020",Observational,"Determining the Physical Activity Level of Healthy Adults During Novel Coronavirus (COVID-19) (SARS-CoV-2 Infection) Pandemic: a Descriptive, Cross-sectional Study"
3589,"imPulse™ Una Full-spectrum, Over Clothing E-stethoscope",CORONAVIRUS INFECTION; CORONAVIRUS,"February 08, 2021",34,NCT04556149,IMPULSE™ UNA E-STETHOSCOPE; PHILIPS LUMIFY ULTRASOUND SYSTEM,UNITED STATES,Completed,"Level 42 AI, Inc.","October 1, 2020",Observational,SARS-CoV-2/COVID-19 Study of the Audible and Inaudible Vibroacoustic E-stethoscope - imPulse™ Una
3590,Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19),COVID,"February 08, 2021",392,NCT04556318,ION MOBILITY SPECTROMETRY (IMS),GERMANY,Recruiting,B. Braun Melsungen AG,"September 23, 2020",Observational,Study to Identify Differences of Exhaled Breath Components Using Ion Mobility Spectrometry (IMS) in Patients Tested Positive or Negative on SARS-CoV-2
3591,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status,COVID; ARDS; FUNCTIONAL RECOVERY,"February 08, 2021",500,NCT04556513,PARACLINICAL EXAMINATION; CLINICAL EXAMINATION; SEMI-DIRECTIVE INTERVIEW; QUALITY OF LIFE QUESTIONNAIRES,FRANCE,Recruiting,Centre Hospitalier Universitaire Dijon,"September 18, 2020",Observational,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
3592,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain,COVID; MENTAL HEALTH DISORDER; MENTAL HEALTH CONDITIONS,"February 08, 2021",16000,NCT04556565,,SPAIN,Recruiting,Jordi Alonso,"May 8, 2020",Observational,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain
3593,Surgical Consent During the COVID-19 Pandemic,CONSENT,"February 08, 2021",45,NCT04556604,EDUCATIONAL MEETINGS AND VISUAL PROMPTS,UNITED KINGDOM,Completed,Medway Primary Care Trust,"April 10, 2020",Observational,Consent for Surgery During the COVID-19 Pandemic
3594,Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood,ASSISTED REPRODUCTION,"February 08, 2021",360,NCT04556630,,,Not yet recruiting,"University Hospital, Lille",October 2020,Observational,Evaluation of the Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood of the Couples Followed in Assisted Reproduction
3595,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19,"COVID; HEMODYNAMIC INSTABILITY; ARDS, HUMAN","February 08, 2021",67,NCT04556864,,SPAIN,Not yet recruiting,Juan Victor Lorente,"October 1, 2020",Observational,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to SARS-CoV-2 Infection
3596,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,COVID,"February 08, 2021",400,NCT04557046,NASAL SWAB; NASOPHARYNGEAL SWAB; THROAT SWAB; FINGERSTICK; SALIVA SPECIMEN,UNITED STATES,Recruiting,LumiraDx UK Limited,"June 26, 2020",Interventional,A Multicenter COVID-19 Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 Ag Test at Point of Care Testing Sites
3597,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,COVID BEHAVIORAL PROPHYLAXIS,"February 08, 2021",1000,NCT04557241,BRIEF INFORMATIONAL INFOGRAPHIC; PLACEBO CONTROL (NON-BEHAVIORAL INFOGRAPHIC),,Not yet recruiting,Indiana University,October 2020,Interventional,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis
3598,Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic,RHEUMATOID ARTHRITIS; QUALITY OF LIFE,"February 08, 2021",346,NCT04557358,COVID-19 SURVEY; RAPID-3; WHOQOL-BREF; DASS-21 INSTRUMENT (DEPRESSION AND ANXIETY); IER-R (POSTTRAUMATIC STRESS),MEXICO,Recruiting,"National Institute of Medical Sciences and Nutrition, Salvador Zubiran","July 1, 2020",Observational,Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic
3599,Effects of a Face Mask on Oxygenation During Exercise,HYPOXEMIA,"February 08, 2021",14,NCT04557605,PROGRESSIVE CYCLING EXERCISE TEST TO EXHAUSTION,CANADA,Completed,University of Saskatchewan,"September 14, 2020",Interventional,The Effects of Wearing a Face Mask During COVID-19 on Blood and Muscle Oxygenation While Performing Exercise
3600,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,COVID,"February 08, 2021",200,NCT04558021,NICLOSAMIDE SUSPENSION; PLACEBO,TURKEY,Recruiting,Imuneks Farma ilac San. Tic. A.S.,"October 8, 2020",Interventional,"A Phase III, Randomized, Placebo-controlled, Clinical Trial to Evaluate the Efficacy and Safety of Co-administered Niclosamide in Patients Treated With an Established Regimen for Novel Coronavirus Infectious Disease (COVID-19)"
3601,Evaluation of Two Eating Disorders Prevention Interventions in At-Risk Female Students With Body Dissatisfaction,BODY DISSATISFACTION,"February 08, 2021",90,NCT04558073,BODY PROJECT (BP); HEALTHY WEIGHT PROGRAM (HW),,Not yet recruiting,School of Health Sciences Geneva,"December 1, 2020",Interventional,Prevention of Eating Disorders in At-Risk Female Students: Adaptation and Evaluation of Two Interventions in French-Speaking Switzerland
3602,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,PULMONARY EMBOLISM; COVID,"February 08, 2021",45,NCT04558125,TNKASE,UNITED STATES,"Active, not recruiting",Cedars-Sinai Medical Center,"September 8, 2020",Interventional,"Low-Dose Tenecteplase in Covid-19 Patients With Acture Pulmonary Embolism: A Randomized, Double-Blind, Placebo-Controlled Trial"
3603,"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice",COVID,"February 08, 2021",450,NCT04558203,,EGYPT,Recruiting,ClinAmygate,"September 22, 2020",Observational [Patient Registry],"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice"
3604,Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations,CORONAVIRUS DISEASE (COVID),"February 08, 2021",1000,NCT04558307,PILOT A RAPID SARS-COV-2 TESTING STRATEGY; COMMUNITY-DRIVEN MESSAGES TO PROMOTE COVID-19 TESTING,UNITED STATES,Enrolling by invitation,Mayo Clinic,"June 3, 2020",Observational,Enhancing Rapid Health Response in National Crises: Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations Through Community-Academic Partnerships
3605,COVID-19 and Lactating Mothers,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04558320,,UNITED STATES,Recruiting,University of Rochester,"July 2, 2020",Observational,COVID-19 and Lactating Mothers
3606,Genosvid Diagnostic Test for Early Detection of COVID-19,COVID,"February 08, 2021",1999,NCT04558372,EXHALED BREATH SAMPLING; EXHALED BREATH SAMPLING; EXHALED BREATH SAMPLING,INDONESIA,Completed,Gadjah Mada University,"April 1, 2020",Interventional,Genosvid Diagnostic Test for Early Detection of COVID-19: UGM Electronic-Nose Innovation for Indonesia
3607,Seroconversion in COVID-19 Recovered Population,COVID,"February 08, 2021",275,NCT04558385,IGG SARS COV2,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"July 1, 2020",Observational,Seroconversion in COVID-19 Recovered Population: an Observational Study
3608,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",EMOTIONAL REGULATION; AFFECT,"February 08, 2021",150,NCT04558411,DIALECTICAL BEHAVIORAL THERAPY (DBT) SKILLS,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","September 12, 2020",Interventional,"Pilot Study of a Brief, Scaleable Intervention for COVID-19 Mental Health Sequelae in College Students"
3609,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",COVID,"February 08, 2021",50,NCT04558424,ZINC GLUCONATE AND ASCORBIC ACID,BANGLADESH,Not yet recruiting,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","October 1, 2020",Interventional,"Randomized, Double -Blind, Placebo Controlled, Trial to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU"
3610,"COVID-Impact ""Psychological IMPACT of Covid-19 on AP-HP Staff""",POST TRAUMATIC STRESS DISORDER (PTSD); ANXIETY; DEPRESSION; EPIDEMIC DISEASE; COVID,"February 08, 2021",20000,NCT04558437,QUESTIONNAIRE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 12, 2020",Observational,Prevalence and Development of Post-traumatic Stress Disorder and Anxiety and Depressive Symptoms Among AP-HP Staff During the Covid-19 Epidemic
3611,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),COVID; ARTERIAL STIFFNESS; ENDOTHELIAL DYSFUNCTION; DIASTOLIC DYSFUNCTION,"February 08, 2021",360,NCT04558450,CAROTID-FEMORAL PULSE-WAVE VELOCITY,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,September 2020,Interventional,Covid-19 Effects on ARTErial StIffness and Vascular AgiNg
3612,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,COVID,"February 08, 2021",100,NCT04558463,FAVIPIRAVIR; OSELTAMIVIR 75MG,INDONESIA,Recruiting,Indonesia University,"April 16, 2020",Interventional,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19: An Open Label Trial
3613,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,COVID; MECHANICAL VENTILATION COMPLICATION; CORONAVIRUS INFECTION; RESPIRATORY FAILURE; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",500,NCT04558476,CONVALESCENT PLASMA; STANDARD OF CARE,BELGIUM,Recruiting,University of Liege,"September 1, 2020",Interventional,A Multicenter Randomized Trial to Assess the Efficacy of CONvalescent Plasma Therapy in Patients With Invasive COVID-19 and Acute Respiratory Failure Treated With Mechanical Ventilation: the CONFIDENT Trial
3614,Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic,TYPE 1 DIABETES MELLITUS; COVID,"February 08, 2021",118,NCT04558645,ONLINE SURVEY,TURKEY,Completed,Gazi University,"September 18, 2020",Observational,"Evaluation of Quality of Life, Physical Activity and Depression in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic"
3615,Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic,COVID,"February 08, 2021",150,NCT04558749,STATE-TRAIT ANXIETY INVENTORY SCALE; EDINBURGH POSTNATAL DEPRESSION SCALE (EDPS),EGYPT,Recruiting,Assiut University,"October 1, 2020",Observational,Assessment of Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic
3616,Impact of a Hybrid Medical Care Model in the Rheumatoid Arthritis Patient-reported-outcomes Measures: A Non-inferiority Study,RHEUMATOID ARTHRITIS; TELEHEALTH,"February 08, 2021",156,NCT04558905,FACE-TO-FACE MEDICAL VISITS; ALTERNATING FACE-TO-FACE MEDICAL VISITS AND VIDEO MEDICAL CONSULTATIONS,MEXICO,Not yet recruiting,"National Institute of Medical Sciences and Nutrition, Salvador Zubiran","October 1, 2020",Interventional,Impact of a Hybrid Medical Care Model (Face-to-face Medical Visits Alternating With Video Medical Consultations) in the Rheumatoid Arthritis Patient-reported-outcomes Measures: A Non-inferiority Study
3617,Spanish Registry of Pregnant Women With COVID-19,COVID; PREGNANCY COMPLICATIONS; PREMATURE RUPTURE OF MEMBRANE; ABRUPTIO PLACENTAE; PRELABOR RUPTURE OF MEMBRANES; STILLBIRTH,"February 08, 2021",3000,NCT04558996,,SPAIN,Recruiting,Puerta de Hierro University Hospital,"March 1, 2020",Observational [Patient Registry],REGISTRO EPIDEMIOLOGICO DE COVID 19 EN GESTANTES
3618,COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry,COVID; AMYOTROPHIC LATERAL SCLEROSIS,"February 08, 2021",100,NCT04559009,,UNITED STATES,Recruiting,Atrium Health,"October 15, 2020",Observational [Patient Registry],COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
3619,Nasal Irrigation to Reduce COVID-19 Morbidity,COVID,"February 08, 2021",200,NCT04559035,NASAL LAVAGE,UNITED STATES,Enrolling by invitation,Augusta University,"September 24, 2020",Interventional,Nasal Irrigation to Reduce COVID-19 Morbidity
3620,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,HYPERTENSION,"February 08, 2021",1000,NCT04559074,AMLODIPINE,UNITED KINGDOM,Recruiting,Queen Mary University of London,"October 23, 2020",Interventional,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic
3621,Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus,COVID,"February 08, 2021",112,NCT04559100,CHEST RADIOGRAPHY; THORACIC COMPUTED TOMOGRAPHY SCAN; SPIROMETRY; DIFFUSING CAPACITY OF CARBON MONOXIDE; 6 MINUTE WALK TEST; SAINT GEORGE RESPIRATORY QUESTIONNAIRE,,Not yet recruiting,Fundacion Clinica Valle del Lili,"November 21, 2020",Observational,"Clinical, Radiological, Lung Function, and Quality of Life Characterization of Patients With Severe/Critical Infection by SARS-COV-2 (COVID-19) Virus, After 6 and 12 Months of Hospital Discharge"
3622,Methylprednisolone in COVID-19 Patients (Methyl19LGH),SARS-COV INFECTION; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",200,NCT04559113,METHYLPREDNISOLONE INJECTABLE PRODUCT,PAKISTAN,Recruiting,Lahore General Hospital,"May 1, 2020",Interventional,Perks of Methylprednisolone for Hospitalized COVID-19 Patients: A Clinical Trial
3623,"Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes",BODY WEIGHT CHANGES; EATING DISORDER SYMPTOM; SEXUAL HARASSMENT; COVID; RED S,"February 08, 2021",200,NCT04559542,,NORWAY,Recruiting,Norwegian School of Sport Sciences,"September 10, 2020",Observational,"Management of Body Weight Regulation, Symptoms of Low Energy Availability, Body Acceptance, Eating Disorders, and Sexual Harassment Among Female Martial Art Athletes, and Impact of COVID-19 on Training and Sport Participation"
3624,Tocilizumab in COVID-19 Lahore General Hospital,SARS-COV INFECTION,"February 08, 2021",50,NCT04560205,TOCILIZUMAB,PAKISTAN,Recruiting,Lahore General Hospital,"May 1, 2020",Interventional,Tocilizumab: A Therapeutic Cache Against the Treatment of Severe Cases of COVID-19
3625,Remdesivir in COVID-19 Lahore General Hospital,SARS-COV INFECTION,"February 08, 2021",30,NCT04560231,REMDESIVIR,PAKISTAN,Recruiting,Lahore General Hospital,"June 1, 2020",Interventional,Is Remdesivir a Possible Therapeutic Option for SARS-CoV-2 : An Interventional Study
3626,High Flow Nasal Cannula HFNC In Covid-19 Patients,SARS-COV INFECTION; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",30,NCT04560257,HIGH FLOW NASAL CANNULA HFNC,PAKISTAN,Recruiting,Lahore General Hospital,"May 1, 2020",Interventional,Prone Positioning and High Flow Nasal Canula (HFNC) Therapy: A Game Changer in COVID-19 Outcome
3627,"Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients",SARS-CoV2; POST-STROKE DEPRESSION; ANXIETY AND FEAR,"February 08, 2021",77,NCT04560413,,TURKEY,Completed,Fatih Sultan Mehmet Training and Research Hospital,"June 1, 2020",Observational,"Depression, Anxiety and SARS-CoV-2 Phobia in Post-stroke Patients During SARS-CoV-2 Pandemic"
3628,The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients,COVID,"February 08, 2021",76,NCT04560530,NON-ENHANCED CT SCAN OF THE CHEST,SAUDI ARABIA,Completed,Tanta University,"March 1, 2020",Observational,The Use of Preoperative CT Chest Scan in the Pre-anesthetic Assessment of COVID-19
3629,"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19",COVID,"February 08, 2021",255,NCT04560608,,FRANCE,Recruiting,"University Hospital, Angers","March 15, 2020",Observational [Patient Registry],"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19"
3630,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home,COVID,"February 08, 2021",400,NCT04560855,CONNECTED DEVICES MEASUREMENTS,FRANCE,Recruiting,Withings,"September 14, 2020",Observational,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home
3631,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)",COVID VIRUS INFECTION,"February 08, 2021",3000,NCT04560881,INACTIVATED SARS-COV-2 VACCINE (VERO CELL); PLACEBO/ALUMINUM ADJUVANT OF INACTIVATED SARS-COV-2 VACCINE,ARGENTINA,"Active, not recruiting",Laboratorio Elea Phoenix S.A.,"September 16, 2020",Interventional,"Randomized, Double Blind, Placebo Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (Vero Cell) in Argentine Healthy Population Aged Between 18 and 85 Years"
3632,Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm,COVID,"February 08, 2021",4000,NCT04561024,AI MODEL,HONG KONG,"Active, not recruiting","Ensemble Group Holdings, LLC","March 1, 2020",Observational,Evaluation of a Chest X-Ray AI Neural Network (RadGen SARS-CoV2 Detection System) for the Detection of RT-PCR Confirmed SARS-Cov2 Covid-19 Pneumonia
3633,COVID-19 Prophylaxis South Africa (COVER HCW),COVID; SARS-COV INFECTION,"February 08, 2021",1950,NCT04561063,NITAZOXANIDE; SOFOSBUVIR/DACLATASVIR,SOUTH AFRICA,Recruiting,"University of Witwatersrand, South Africa","December 8, 2020",Interventional,"A Multi-center, Randomised, Open Label Study of Nitazoxanide (NTZ), or Sofosbuvir and Daclatasvir (SOF/DCV), Compared to no Pharmacological Intervention for the Prevention of COVID-19 Disease in Healthcare Workers at High Risk of Exposure to SARS-CoV-2"
3634,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,COVID,"February 08, 2021",24,NCT04561076,HLX70; PLACEBO,,Not yet recruiting,Hengenix Biotech Inc,"December 9, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Phase I Clinical Study to Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers"
3635,Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel,SARS-CoV2,"February 08, 2021",2000,NCT04561089,COVIDSEQ TEST,UNITED STATES,Enrolling by invitation,"Illumina, Inc.","July 13, 2020",Observational,Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel
3636,Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population,SARS-CoV2,"February 08, 2021",2500,NCT04561102,DIAGNOSTIC TEST FOR DETECTION OF SARS-COV-2,UNITED STATES,Enrolling by invitation,"Illumina, Inc.","September 11, 2020",Observational,Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population
3637,Post Covid Syndrome: Clinical Pattern and Functional Assessment,COVID,"February 08, 2021",85,NCT04561141,,,Not yet recruiting,Assiut University,"December 1, 2020",Observational,Post Covid Syndrome: Clinical Pattern and Functional Assessment
3638,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,SARS-CoV2; COVID,"February 08, 2021",134,NCT04561154,QUESTIONNAIRE,FRANCE,Recruiting,Centre Hospitalier le Mans,"June 11, 2020",Interventional,Identifying Functional and Psycho-social Complaints After Hospitalization for Severe SARS-CoV-2 Infection (COVID19)- REPERCOV
3639,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,PNEUMONIA AS ONE OF THE LUNG COMPLICATIONS CAUSED BY SARS-CoV2 INFECTION,"February 08, 2021",96,NCT04561180,EG-HPCP-03A; EG-HPCP-03A PLACEBO; STANDARD OF CARE; DEXAMETHASONE,,Not yet recruiting,"Evergreen Therapeutics, Inc.",December 2020,Interventional,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to Dexamethasone in Patients With Moderate/Severe (Non-intubated, Non-mechanical Ventilation) COVID-19 Pneumonia"
3640,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19),COVID,"February 08, 2021",200,NCT04561193,OBSERVATIONAL,UNITED STATES,Recruiting,Methodist Health System,"May 30, 2020",Observational,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)
3641,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,"COVID; CORONAVIRUS INFECTION; PNEUMONIA, VIRAL","February 08, 2021",500,NCT04561219,NITAZOXANIDE; PLACEBO,BRAZIL,Completed,Universidade Federal do Rio de Janeiro,"April 19, 2020",Interventional,"Nitazoxanide for Moderate to Severe COVID-19 Pneumonia: a Multicenter, Randomized, Placebo-controlled, Double-Blind Clinical Trial"
3642,SARS-CoV-2 IgG and IgM Serologic Assays,COVID,"February 08, 2021",500,NCT04562246,SEROLOGIC ASSAYS FOR ANTIBODIES TO SARS-COV-2,UNITED STATES,Recruiting,Henry Ford Health System,"August 14, 2020",Observational,Laboratory Validation of SARS-CoV-2 IgG and IgM Serologic Assays on an Automated Immunoassay System
3643,Sustained Immunity to SARS-CoV-2,COVID,"February 08, 2021",500,NCT04562285,SEROLOGIC IMMUNOASSAYS TO SARS-COV-2 ANTIBODIES,UNITED STATES,Recruiting,Henry Ford Health System,"June 23, 2020",Observational,Initial and Sustained Immunity to SARS-CoV-2 Measured by Serologic Assays on an Automated Immunoassay System
3644,"XatJove Anoia, as a Tool to Bring Health Services Closer to Teenagers",HEALTHY,"February 08, 2021",500,NCT04562350,XATJOVE ANOIA APLICATION,SPAIN,Recruiting,Jordi Gol i Gurina Foundation,"October 1, 2020",Interventional,"XatJove Anoia, as a Tool to Bring Health Services Closer to Teenagers"
3645,Community Applications of the MindShift App,ANXIETY; DEPRESSION; ANXIETY GENERALIZED; ANXIETY DISORDERS AND SYMPTOMS,"February 08, 2021",250,NCT04562948,,CANADA,Recruiting,University of Windsor,"November 11, 2020",Observational,Community Applications of the MindShift App
3646,Active Pregnancy Against COVID-19,"PREGNANCY COMPLICATIONS; PREGNANCY, HIGH RISK; PREGNANCY INDUCED HYPERTENSION; NEWBORN MORBIDITY; FETAL GROWTH RETARDATION; FETUS DISORDER; WEIGHT GAIN, MATERNAL; MATERNAL-FETAL RELATIONS","February 08, 2021",280,NCT04563065,EXERCISE PROGRAM; HEALTHY LIFESTYLE ADVISE,SPAIN,Recruiting,Universidad Politecnica de Madrid,"August 1, 2020",Interventional,"Active Pregnancy, Prevention Against the Effects of COVID-19"
3647,Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection,COVID,"February 08, 2021",100,NCT04563156,LUNG FUNCTION TEST,BRAZIL,Enrolling by invitation,University of Sao Paulo General Hospital,"June 23, 2020",Observational,Follow-up and Rehabilitation of Survivors of Severe Covid-19 Infection
3648,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,COVID; SARS-COV INFECTION,"February 08, 2021",40,NCT04563208,PLACEBO; DUACT,SOUTH AFRICA,Recruiting,"University of Witwatersrand, South Africa","December 9, 2020",Interventional,"A Randomized, Double-Blind, Study Comparing the Efficacy, Safety, and Tolerability of Oral Administration of Ribavirin (RBV) and Nitazoxamide (NTZ)Versus Placebo in SARS-CoV-2 Virus Infected Participants (DuACT)"
3649,Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs,COVID,"February 08, 2021",700,NCT04563247,IGG SARS COV 2 ANTIBODIES,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"July 1, 2020",Observational,Seroprevalence of SARS-CoV 2 Among Asymptomatic Frontline Healthcare Workers During COVID 19: A Cross Sectional Study
3650,Comorbidities And Complications Associated With Covid-19 Infection,COVID,"February 08, 2021",200,NCT04563442,COMPLICATION,,Not yet recruiting,Assiut University,"October 15, 2020",Observational [Patient Registry],Comorbidities And Complications Associated With Covid-19 Infection
3651,"The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain","NAUSEA AND VOMITING, POSTOPERATIVE","February 08, 2021",126,NCT04563494,DEXAMETHASONE,,Not yet recruiting,"University of Colorado, Denver","October 1, 2020",Interventional,"The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, Pain, and Drug Cost in Children Undergoing Tonsillectomy: A Randomized Controlled Prospective Non-inferiority Study"
3652,COVID-19 Serology and Immunosenescence,COVID; GERIATRIC MEDICINE; SEROCONVERSION; IMMUNOSENESCENCE,"February 08, 2021",330,NCT04563650,BLOOD SAMPLE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 18, 2020",Interventional,Kinetics of COVID-19-neutralising Antibodies in Patients Residing in EHPAD / USLD: Influence of Immunosenescence
3653,Physiopathology and Sequelae of COVID-19 Infection,COVID; TSH; CORTISOL,"February 08, 2021",400,NCT04563676,BLOOD TEST,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 22, 2020",Interventional,Physiopathology and Sequelae of COVID-19 Infection
3654,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,COVID,"February 08, 2021",23,NCT04563689,CHX0.12+CPC0.05 ORAL RINSE (PERIOAIDACTIVE CONTROL); PLACEBO RINSE,COLOMBIA,Completed,Dentaid SL,"June 18, 2020",Interventional,Efecto de un Enjuague Bucal Con Clorhexidina al 0.12% y Cloruro de Cetil Piridinio al 0.05% en la Carga Viral en Saliva en Pacientes COVID-19 + Hospitalizados o Que Esten Recibiendo Cuidado médico en Casa en Cali - 2020.
3655,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,COVID,"February 08, 2021",35,NCT04563702,VXA-COV2-1,UNITED STATES,"Active, not recruiting",Vaxart,"September 21, 2020",Interventional,"A Phase 1 Open-Label, Dose-Ranging Trial to Determine the Safety and Immunogenicity of an Adenoviral-Vector Based Vaccine (VXA-CoV2-1) Expressing a SARS-CoV-2 Antigen and dsRNA Adjuvant Administered Orally to Healthy Adult Volunteers"
3656,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,MANTLE CELL LYMPHOMA; COVID,"February 08, 2021",20,NCT04564040,ACALABRUTINIB TREATMENT A; ACALABRUTINIB TREATMENT B; ACALABRUTINIB TREATMENT C; ACALABRUTINIB TREATMENT D,GERMANY,Completed,AstraZeneca,"October 12, 2020",Interventional,"A 2-Part, Phase I, Open-label, Single-dose, Sequential, Randomized, Crossover Study of Acalabrutinib Tablet Suspension Delivered Via Nasogastric Tube in Healthy Subjects to Evaluate Relative Bioavailability and Proton-pump Inhibitor (Rabeprazole) Effect"
3657,Advancing Prevention of Pulmonary Fibrosis,IPF; PULMONARY FIBROSIS; ILD,"February 08, 2021",1000,NCT04564183,SAMPLE COLLECTION; QUESTIONNAIRES; HIGH RESOLUTION CT SCAN OF THE CHEST; PULMONARY FUNCTION TEST,,Not yet recruiting,"University of Colorado, Denver","December 1, 2020",Observational,Advancing Prevention of Pulmonary Fibrosis - A Cohort Study of Preclinical Pulmonary Fibrosis
3658,COV2Base-A Rare Disease by COVID Study,CHRONIC HEALTH CONDITIONS; OLDER AGE IS ASSOCIATED WITH INCREASED PATHOGENICITY,"February 08, 2021",5000,NCT04564274,,UNITED STATES,Recruiting,"National Heart, Lung, and Blood Institute (NHLBI)","February 11, 2021",Observational,Natural History Study: COV2Base-a Rare Disease by COVID Study
3659,An Observational Study of Neurologic Function After COVID-19 Infection,COVID,"February 08, 2021",100,NCT04564287,,UNITED STATES,Enrolling by invitation,National Institute of Neurological Disorders and Stroke (NINDS),"October 28, 2020",Observational,An Observational Study of Neurologic Function After COVID-19 Infection
3660,Developing and Testing a Technology-Based Translation of the DPP to Address Prediabetes in a Primary Care Setting,"PREDIABETES; METABOLIC SYNDROME, PROTECTION AGAINST","February 08, 2021",32,NCT04564586,DPPFIT,UNITED STATES,"Active, not recruiting",Augusta University,"January 1, 2020",Interventional,Developing and Testing a Technology-Based Translation of the Diabetes Prevention Program for Adult Primary Care Patients At-Risk of Developing Type 2 Diabetes Mellitus
3661,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus",COVID,"February 08, 2021",100,NCT04564716,GAM-COVID-VAC; PLACEBO,BELARUS,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","September 28, 2020",Interventional,"Сlinical Trial of Efficacy, Safety and Immunogenicity of Combined Vector Vaccine Gam-COVID-Vac in SARS-СoV-2 Infection Prophylactic Treatment in Republic of Belarus"
3662,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans,COVID,"February 08, 2021",120,NCT04565067,,UNITED STATES,Recruiting,National Institute on Aging (NIA),"February 11, 2021",Observational,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans a Clinical Observation Trial
3663,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD),PARKINSON'S DISEASE; FUNCTIONAL MOVEMENT DISORDERS; COVID,"February 08, 2021",150,NCT04565080,,UNITED STATES,Recruiting,National Institute of Neurological Disorders and Stroke (NINDS),"February 11, 2021",Observational,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)
3664,Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure,COVID; HYPOXEMIC RESPIRATORY FAILURE; HYPOXEMIA,"February 08, 2021",16,NCT04565106,CLOSED-LOOP CONTROL OF OXYGEN SUPPLEMENTATION BY O2MATIC,DENMARK,Completed,Hvidovre University Hospital,"April 15, 2020",Observational,Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure
3665,Convalescent Plasma Therapy for COVID-19 Patients,SARS-COV INFECTION,"February 08, 2021",20,NCT04565197,CONVALESCENT PLASMA,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"May 1, 2020",Interventional,Convalescent Plasma for Passive Immunization in COVID-19 ICU Patients: An Interventional Study
3666,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19",ACUTE RESPIRATORY DISTRESS SYNDROME; SARS-CoV2,"February 08, 2021",36,NCT04565249,PLN-74809; PLACEBO,UNITED STATES,Recruiting,"Pliant Therapeutics, Inc.","October 22, 2020",Interventional,"A Randomized, Double-blind, Dose-ranging, Placebo Controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 (INTEGRIS-ARDS)"
3667,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates,"INFLUENZA, HUMAN","February 08, 2021",80000,NCT04565353,FLU SHOT TEXT MESSAGES,UNITED STATES,Recruiting,University of Pennsylvania,"September 20, 2020",Interventional,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates
3668,Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients,COVID PNEUMONIA,"February 08, 2021",60,NCT04565379,NUSEPIN® 0.1 MG; NUSEPIN® 0.2 MG; PLACEBO,ROMANIA,Recruiting,Shaperon,"September 25, 2020",Interventional,"A Randomized, Double Blind, Placebo-controlled, Phase 2 Clinical Trial to Investigate the Efficacy and Safety of 2 Doses of NuSepin® Intravenous Infusion in COVID-19 Pneumonia Patients"
3669,Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19),COVID,"February 08, 2021",150,NCT04565392,FAMOTIDINE 20 MILLIGRAM TABLET,UNITED STATES,Not yet recruiting,drpykessupplements.com,"May 1, 2021",Interventional,Proof-of-concept Randomized Placebo-controlled Trial of Famotidine for Outpatients With COVID-19
3670,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,COVID; INTELLECTUAL DISABILITY; DEVELOPMENTAL DISABILITY; CHILD DEVELOPMENT DISORDER,"February 08, 2021",2500,NCT04565509,GENERAL COMMUNICATION MESSAGE; FOCUSED/TARGETED MESSAGE; BEST MESSAGE ALONE; BEST MESSAGE + AUGMENTED MESSAGE OR IMPLEMENTATION STRATEGY,UNITED STATES,Recruiting,Washington University School of Medicine,"November 20, 2020",Interventional,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic
3671,Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers,COVID; DIALYSIS; NURSE-PATIENT RELATIONS,"February 08, 2021",5000,NCT04565522,PROSPECTIVE OBSERVATION,ITALY,Not yet recruiting,"Simeone Andrulli, MD","September 21, 2020",Observational,Transmission of COVID-19 Among Patients and Health Personnel in Dialysis Centers: a Cohort Prospective Study (DIAL-COVID-19)
3672,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,COVID INFECTION; COVID-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",70,NCT04565665,BEST PRACTICE; MESENCHYMAL STEM CELL,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"July 29, 2020",Interventional,Emergency Use Pilot Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of COVID-19 Related Acute Respiratory Distress Syndrome
3673,Corona Virus Infection Among Liver Transplant Recipients,SARS-COV INFECTION; CORONAVIRUS INFECTION; LIVER TRANSPLANT RECIPIENT; COVID,"February 08, 2021",150,NCT04565782,,EGYPT,Recruiting,Assiut University,"September 15, 2020",Observational,Corona Virus Infection Among Liver Transplant Recipients: A Multicenter Study
3674,ChulaCov19 mRNA Vaccine in Healthy Adults,COVID VACCINE; SAFETY ISSUES,"February 08, 2021",96,NCT04566276,CHULACOV19 MRNA VACCINE,THAILAND,Not yet recruiting,Chulalongkorn University,January 2021,Interventional,"A Phase 1/2, Dose-finding Study to Evaluate Safety, Tolerability, and Immunogenicity of the ChulaCov19 mRNA Vaccine in Healthy Adults"
3675,LLIN Evaluation in Uganda Project,MALARIA,"February 08, 2021",200000,NCT04566510,"LONG LASTING INSECTICIDAL NETS WITH ALPHA-CYPERMETHRIN + PYRIPROXYFEN (PPF LLIN, ROYAL GUARD)); LONG LASTING INSECTICIDAL NETS WITH DELTAMETHRIN + PIPERONYL BUTOXIDE (PBO LLIN, PERMANET 3.0)); SOCIAL BEHAVIOUR CHANGE COMMUNICATION",UGANDA,Recruiting,"University of California, San Francisco","October 17, 2020",Interventional,Impact of Long-lasting Insecticidal Nets (LLINs) Treated With Pyrethroid Plus Pyriproxyfen vs LLINs Treated With Pyrethroid Plus Piperonyl Butoxide on Malaria Incidence in Uganda: a Cluster-randomised Trial
3676,Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies,"NEOPLASM, COLORECTAL; NEOPLASM OF LUNG; NEOPLASM, BLADDER; NEOPLASMS PANCREATIC; BILIARY TRACT NEOPLASMS; GASTRO INTESTINAL STROMAL TUMOUR","February 08, 2021",112,NCT04566614,CTDNA BLOOD SAMPLING,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"June 18, 2020",Observational,Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
3677,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),COVID,"February 08, 2021",481,NCT04566770,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR); RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) -PLACEBO,CHINA,Recruiting,CanSino Biologics Inc.,"September 24, 2020",Interventional,"A Randomized, Double-blind, Placebo -Controlled Phase IIb Clinical Trial to Evaluate the Safety and Immunogenicity of Ad5-nCoV in Person 6 Years of Age and Older and Those Who Have Previously Been Vaccinated With Ad5-EBOV"
3678,Serology to Covid for Recording Exposures and Evaluating Needs,COVID; CORONAVIRUS; SARS-COV INFECTION,"February 08, 2021",230,NCT04566965,SARS-COV-2,UNITED STATES,Recruiting,"Children's Hospital Medical Center, Cincinnati","August 18, 2020",Observational,Serology to Covid for Recording Exposures and Evaluating Needs (SCREEN)
3679,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,COVID,"February 08, 2021",136,NCT04567173,ANTI-SARS-COV-2 CONVALESCENT PLASMA,PHILIPPINES,Recruiting,University of the Philippines,"September 21, 2020",Interventional,"A Randomized, Open-Label, Single Center Clinical Trial to Assess the Efficacy and Safety of Convalescent Plasma to Hospitalized Adult COVID-19 Patients as Adjunctive Therapy to Reduce the Need for ICU Admission: Co-CLARITY Trial"
3680,Predictive Factors for COVID-19 in Rheumatology,RHEUMATIC DISEASES; COVID,"February 08, 2021",150,NCT04567576,DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS),,Not yet recruiting,Fundación Santa Fe de Bogota,October 2020,Observational,Predictive Factors for COVID-19 in Rheumatology Study Based on Information Collected in The COVID-19 Global Rheumatology Alliance
3681,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)",COVID,"February 08, 2021",48,NCT04567810,ANTI-SARS-COV-2 IGY; PLACEBO,AUSTRALIA,Completed,Stanford University,"September 18, 2020",Interventional,"A Phase 1 Study in Healthy Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single -Ascending and Multiple Doses of an Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY)"
3682,Screening of Health-care Workers in an University Hospital for SARS-CoV-2,COVID,"February 08, 2021",3000,NCT04567836,INVESTIGATION OF THE PREVALENCE OF TEST POSITIVITY,ITALY,Recruiting,University of Milano Bicocca,"June 1, 2020",Observational,Screening of Health-care Workers in an University Hospital: an Observational Prospective Study on the Screening of Hospital Workers for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
3683,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19,SARS VIRUS,"February 08, 2021",80,NCT04567927,ULTRASONOGRAPHY,SWITZERLAND,Completed,Chiesa Alessandro Felice,"March 3, 2020",Observational,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With SARS-CoV-2 Infection
3684,COVID-19 Tests With Saliva Specimens,COVID,"February 08, 2021",2000,NCT04567953,SALIVA COLLECTION,UNITED STATES,"Active, not recruiting",Paradigm Laboratories LLC,"July 28, 2020",Interventional,COVID-19 Tests With Saliva Specimens
3685,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,COVID; CANCER; TUMOR,"February 08, 2021",149,NCT04567979,,MEXICO,"Active, not recruiting",Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"June 11, 2020",Observational,Prospective Determination of COVID-19 Infection Rate in Patients With Solid Tumors and Healthcare Workers of the Chemotherapy and Radiotherapy Unit at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador.
3686,Evaluation of Lymphedema Patients Status During Covid-19 Pandemic,LYMPHEDEMA,"February 08, 2021",60,NCT04568005,,TURKEY,Completed,Fatih Sultan Mehmet Training and Research Hospital,"June 1, 2020",Observational [Patient Registry],"Evaluation of Lymphedema Patients Treatment Processes, Health Status, Coronavirus Phobia, Quality of Life, Anxiety and Depression During Covid-19 Pandemic"
3687,Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19,ARDS DUE TO COVID,"February 08, 2021",120,NCT04568018,SURFACTANT,RUSSIAN FEDERATION,Recruiting,Biosurf LLC.,"July 3, 2020",Observational,"Open-label Trial to Assess the Efficacy and Safety of Inhalation Use of the Approved Drug Surfactant-BL (Biosurf LLC, Russia) as a Part of Complex Therapy of Acute Respiratory Distress Syndrome (ARDS) in Patients With SARS-CoV-2 Coronavirus Infection (COVID-19)"
3688,Study of AZD1222 for the Prevention of COVID-19 in Japan,COVID,"February 08, 2021",256,NCT04568031,AZD1222; 0.9% (W/V) SALINE,JAPAN,"Active, not recruiting",AstraZeneca,"August 23, 2020",Interventional,"A Phase I/II Randomized, Double-blind, Placebo-controlled Multicentre Study in Participants Aged 18 Years or Older to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19"
3689,Evaluation of Humoral Immunity Following COVID-19 in Pregnancy,"COVID; PREGNANCY RELATED; INFLUENZA, HUMAN","February 08, 2021",96,NCT04568044,BLOOD SAMPLE,UNITED KINGDOM,Recruiting,Imperial College London,"September 16, 2020",Observational,Evaluation of Cell-mediated and Humoral Immunity Following COVID-19 in Pregnancy
3690,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,THE LUNG COMPLICATION OF COVID,"February 08, 2021",160,NCT04568096,AEROSOLIZED ALL-TRANS RETINOIC ACID PLUS ORAL TAMOXIFEN; STANDARD TREATMENT,,Not yet recruiting,Kafrelsheikh University,November 2020,Interventional,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19
3691,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",COVID,"February 08, 2021",3015,NCT04568122,SALIVA TEST KIT,UNITED STATES,Recruiting,Stanford University,"November 20, 2020",Interventional,"Rapid Turnaround, Home-based Saliva Testing for COVID-19"
3692,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis,COVID,"February 08, 2021",1000,NCT04568135,SURVEY,,Not yet recruiting,Siyan Clinical Corporation,"October 31, 2020",Observational,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis
3693,COVID-19 Biorepository,COVID; SARS-CoV2; CORONAVIRUS; COVID,"February 08, 2021",50,NCT04568148,,UNITED STATES,Recruiting,University of Kansas Medical Center,"April 15, 2020",Observational,COVID-19 Biorepository
3694,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,SARS COV-2,"February 08, 2021",200,NCT04568356,DIRECT ANTIGEN TESTS FOR COVID-19,UNITED STATES,Completed,"E25Bio, Inc.","April 24, 2020",Interventional,"A Clinical Performance Evaluation of the SARS-COV-2 Direct Antigen Rapid Test ""DART"""
3695,Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection,RHEUMATIC DISEASES,"February 08, 2021",3000,NCT04568421,IMMUNOSUPPRESSIVE AGENTS,ARGENTINA,Recruiting,Sociedad Argentina de Reumatologia,"August 18, 2020",Observational [Patient Registry],Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection
3696,"Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings",COVID,"February 08, 2021",1000,NCT04568499,,,Not yet recruiting,Johns Hopkins Bloomberg School of Public Health,October 2020,Observational,"Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings: a Prospective Cohort Study in South Sudan and DRC"
3697,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,COVID,"February 08, 2021",195,NCT04568525,PASSIVE MICROWAVE RADIOMETRY,KYRGYZSTAN,Completed,Kyrgyz State Medical Academy,"July 1, 2020",Interventional,Microwave Radiation for Early Diagnostics of Pneumonia in Patients With COVID-19
3698,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor",ANXIETY STATE,"February 08, 2021",300,NCT04568551,,GERMANY,Recruiting,Martin-Luther-Universität Halle-Wittenberg,"October 1, 2020",Observational,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor - CAASPtrial"
3699,Telerehabilitation in Lung Surgery Patients,LUNG CANCER; PHYSIOTHERAPY,"February 08, 2021",40,NCT04568564,"BREATHING EXERCISE, INTENSIVE SPIROMETRY USE, SUPPORTED COUGH, PROGRESSIVE MOBILISATION AND AMBULATION; EXERCISE BOOKLET",TURKEY,Recruiting,Istanbul Medipol University Hospital,"October 1, 2020",Interventional,Telerehabilitation of Reduced Physiotherapy Service in SARS-CoV-2 Pandemic Process in Lung Surgery Patients
3700,The Noninvasive Ventilation to COVID-19 Patients,NONINVAVIE VENTILATION TO PATIENTS WITH COVID,"February 08, 2021",23,NCT04568655,NONINVASIVE VENTILATION,CHINA,Completed,The First Affiliated Hospital of Guangzhou Medical University,"February 1, 2020",Observational,The Noninvasive Ventilation to COVID-19 Patients With Respiratory Failure
3701,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),COVID; NEUROLOGIC MANIFESTATIONS; PSYCHIATRIC MANIFESTATIONS,"February 08, 2021",200,NCT04568707,BLOOD SAMPLE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"October 15, 2020",Interventional,Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
3702,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,ADENOVIRUS TYPE-5 VECTORED COVID VACCINE,"February 08, 2021",89,NCT04568811,ADENOVIRUS TYPE-5 VECTORED COVID-19 VACCINE,CHINA,"Active, not recruiting",Jiangsu Province Centers for Disease Control and Prevention,"September 26, 2020",Interventional,"The Single-center, Open-label Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine in Healthy Adults Aged 18-60 Years"
3703,Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population,COVID,"February 08, 2021",50,NCT04568850,PLASMA IGG LEVELS,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"July 1, 2020",Observational,Waxing and Waning of Serum SARS CoV 2 IgG Level: A Prospective Study
3704,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,COVID; SARS-CoV2; CORONAVIRUS INFECTION,"February 08, 2021",18,NCT04568863,MELATONIN INTRAVENOUS; PLACEBO INTRAVENOUS,SPAIN,Recruiting,Pharmamel S.L.,"June 20, 2020",Interventional,"A Phase II, Single-center, Double-blind, Randomized Placebo-controlled Trial to Explore the Efficacy and Safety of Intravenous Melatonin in Patients With COVID-19 Admitted to the Intensive Care Unit (MelCOVID Study)"
3705,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,COVID,"February 08, 2021",40,NCT04568876,"MICRONIZED AND ULTRA-MICRONIZED PALMITOYLETHANOLAMIDE (MPEA AND UMPEA, 300MG + 600MG) ORAL SUSPENSION; STANDARD THERAPY",ITALY,Recruiting,Epitech Group SpA,"October 23, 2020",Interventional,"Efficacy of Palmitoylethanolamide, in add-on to Standard Therapy, on Inflammatory Markers of Patients With Interstitial Pneumonia Due to COVID-19. A Pilot Controlled, Randomized, Open Lable Clinical Study"
3706,Minnesota COVID-19 Testing Project,COVID; INFECTIOUS DISEASE,"February 08, 2021",1000,NCT04568889,A $10 SURVEY INCENTIVE; A $20 SURVEY INCENTIVE; EMPHASIS OF GOVERNMENT INVOLVEMENT; EMPHASIS OF ACADEMIC RESEARCHERS INVOLVEMENT; COST-BENEFIT FRAME; DUTY FRAME; RACIAL/ETHNIC FRAME; NO MESSAGING,,Not yet recruiting,Harvard University,"September 28, 2020",Interventional,Minnesota COVID-19 Testing Project
3707,Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw,VACCNATION IN HCW,"February 08, 2021",1000,NCT04569019,VACCIANTION STATUS IN HEALTH CARE WORKERS,POLAND,Recruiting,Medical University of Warsaw,"September 1, 2020",Observational,Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of the University Clinical Center of the Medical University of Warsaw
3708,Convalescent Plasma in COVID-19 Elderly Patients,COVID,"February 08, 2021",21,NCT04569188,CONVALESCENT PLASMA,ITALY,Completed,Azienda Socio Sanitaria Territoriale di Mantova,"May 15, 2020",Interventional,Real-time Evaluation of Safety and Efficacy of Convalescent Plasma Units Transfused to Elderly Patients With COVID-19
3709,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,COVID PNEUMONIA,"February 08, 2021",60,NCT04569227,EC-18; PLACEBO,,Not yet recruiting,Enzychem Lifesciences Corporation,"November 16, 2020",Interventional,"Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EC-18 in Preventing the Progression of COVID-19 Infection to Severe Pneumonia or ARDS"
3710,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,DYSPNEA,"February 08, 2021",200,NCT04569266,SPECIFIC EXERCISE REHABILITATION TREATMENT,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"August 7, 2020",Interventional,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU
3711,COVID-19 Infection in Cancer Pantients,COVID,"February 08, 2021",150,NCT04569292,NO INTERVENTION ON PATIENTS,ITALY,Recruiting,Ospedale Andrea Tortora di Pagani,"January 1, 2020",Observational,Clinical Course of Cancer Patients Who Contracted COVID 19 Infection: An Observational Study
3712,COVID-19 and Venous Thromboembolism Risk,VENOUS THROMBOEMBOLISM; COVID,"February 08, 2021",40000,NCT04569344,LABORATORY TEST POSITIVE FOR SARS-COV-2 VIRUS,UNITED STATES,Enrolling by invitation,"University of California, San Francisco","January 1, 2020",Observational,COVID-19 and Venous Thromboembolism Risk
3713,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",COVID,"February 08, 2021",30,NCT04569383,MVA-SARS-2-S VACCINATIONS (DAYS 0 & 28),GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"October 5, 2020",Interventional,"An Open, Single-center Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-SARS-2-S"
3714,Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001),CORONAVIRUS DISEASE (COVID),"February 08, 2021",252,NCT04569786,V590; PLACEBO,UNITED STATES,"Active, not recruiting",Merck Sharp & Dohme Corp.,"October 29, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of V590 in Healthy Adults"
3715,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,CLINICAL TRIAL,"February 08, 2021",250,NCT04569825,OPHTAMESONE,IRAQ,Recruiting,University Of Anbar,"August 1, 2020",Interventional,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease
3716,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019),COVID INFECTION,"February 08, 2021",100000,NCT04569851,,SPAIN,Enrolling by invitation,Medsavana,"January 1, 2020",Observational,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 Using Big Data and Artificial Intelligence Techniques (BigCoviData)
3717,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA; COVID PNEUMONIA,"February 08, 2021",238,NCT04569877,MOLGRAMOSTIM NEBULISER SOLUTION; PLACEBO NEBULISER SOLUTION,GERMANY,Recruiting,University of Giessen,"September 24, 2020",Interventional,Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID)
3718,"Evaluating Auscul-X, a Touch Free Digital Stethoscope",COVID,"February 08, 2021",40,NCT04570189,AUSCUL-X,CANADA,Recruiting,AusculSciences Canada Inc.,"October 1, 2020",Observational,"Evaluating Auscul-X, a Touch Free Digital Stethoscope, for Physical Distancing to Protect Patients and Health Care Professionals From COVID-19 (The Auscul-X Study)"
3719,Health cAre woRkers exposeD to COVID-19,"DEPRESSION; BURNOUT, PROFESSIONAL; POST TRAUMATIC STRESS DISORDER","February 08, 2021",900,NCT04570202,EMDR,FRANCE,Recruiting,"University Hospital, Tours","November 20, 2020",Interventional,"Symptoms of Depression, Stress and Burnout, and Long-term Psychological Impact in Health Care Professionals Exposed to the Novel Coronavirus Disease 2019 Outbreak (HARD-COVID-19 - Health cAre woRkers exposeD to covID-19)"
3720,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,"PNEUMONIA, VIRAL; COVID; ARDS; OXIDATIVE STRESS","February 08, 2021",11,NCT04570254,VITAMIN C; VITAMIN E; MELATONIN; N-ACETYL CYSTEINE; PENTOXIFYLLINE,MEXICO,"Active, not recruiting",Unidad Temporal COVID-19 en Centro Citibanamex,"August 19, 2020",Interventional,Open Clinical Trial of the Use of Antioxidants and Pentoxifylline as Adjuvant Therapy to Standard Therapy in Patients With and Without Septic Shock Secondary to COVID-19 Severe Pneumonia
3721,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",60,NCT04570384,L-CITRULLINE; PLACEBO,UNITED STATES,Recruiting,"Asklepion Pharmaceuticals, LLC","October 15, 2020",Interventional,"Prospective, Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Intravenous L-Citrulline (Turnobi) to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness"
3722,Ravulizumab and COVID-19,COVID; THROMBOTIC MICROANGIOPATHIES; ACUTE KIDNEY INJURY,"February 08, 2021",32,NCT04570397,RAVULIZUMAB,UNITED STATES,Recruiting,Brigham and Women's Hospital,"December 18, 2020",Interventional,C5 Complement Inhbition Using Ravulizumab for the Treatment of COVID-19 Induced Thrombotic Microangiopathy
3723,Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),COVID,"February 08, 2021",0,NCT04570449,FLUOXETINE; PLACEBO,UNITED STATES,Withdrawn,Milton S. Hershey Medical Center,November 2020,Interventional,Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)
3724,Mild Hypothermia for COVID-19 ARDS,COVID ARDS,"February 08, 2021",20,NCT04570462,HYPOTHERMIA VIA COOLING MACHINE- ARCTIC SUN 5000,UNITED STATES,Recruiting,Northwell Health,"May 18, 2020",Interventional,Application of Mild Hypothermia for COVID-19 Acute Respiratory Distress
3725,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,COVID; CORONAVIRUS INFECTION; ADVERSE EVENT,"February 08, 2021",1200,NCT04570488,EPIC RISK SCORE DISPLAY,UNITED STATES,Recruiting,NYU Langone Health,"May 15, 2020",Interventional,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients
3726,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,COVID,"February 08, 2021",160,NCT04570501,ANGIOTENSIN-(1-7); PLACEBO,UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,"A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Safety and Efficacy of Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients"
3727,Online Education Intervention to Reduce Ageism Among Undergraduate Students,AGEISM,"February 08, 2021",121,NCT04570917,ONLINE EDUCATIONAL INTERVENTION TO REDUCE AGEISM; ONLINE EDUCATIONAL INTERVENTION TO ENHANCE CULTURAL COMPETANCE,,Not yet recruiting,"University of Mississippi, Oxford","September 28, 2020",Interventional,Effectiveness of an Online Educational Intervention to Reduce Ageism in Undergraduate Students in an Entry-level Nutrition Class
3728,Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal,COVID,"February 08, 2021",200,NCT04570982,CONVALESCENT PLASMA,NEPAL,Recruiting,"Dr. Pradip Gyanwali,MD","July 30, 2020",Observational,Compassionate Use of Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Prospective Observational Study (Amended Protocol)
3729,Remote Yoga Nidra for Anxiety and Sleep,INSOMNIA DUE TO ANXIETY AND FEAR,"February 08, 2021",74,NCT04571593,YOGA NIDRA,UNITED STATES,Completed,National University of Natural Medicine,"April 15, 2020",Interventional,Digital Delivery of Yoga Nidra for Anxiety and Sleep: A Feasibility Study
3730,New Educational Tool for FM,FIBROMYALGIA,"February 08, 2021",300,NCT04571853,PNE-EXPLAINED GROUP; PNE-READ GROUP; TAU GROUP,SPAIN,Recruiting,Hospital Universitari Vall d'Hebron Research Institute,"September 21, 2020",Interventional,Usefulness of a New Educational Tool for Understanding Pain for Fibromyalgia Patients
3731,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,CORONAVIRUS DISEASE (COVID),"February 08, 2021",172,NCT04572360,CARDIORESPIRATORY EXERCISE; MODIFIED BAI HE GU JIN TANG,HONG KONG,Not yet recruiting,Hong Kong Baptist University,"October 1, 2020",Interventional,Would Cardiorespiratory Exercise and Chinese Herbal Medicine Facilitate Rehabilitation From Pulmonary Fibrosis Among Post-discharge Patients With COVID-19? Clinical Efficacy and Mechanisms
3732,UVA Light Device to Treat COVID-19,CORONAVIRUS,"February 08, 2021",5,NCT04572399,UV LIGHT TREATMENT,UNITED STATES,Completed,Cedars-Sinai Medical Center,"October 30, 2020",Interventional,Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study
3733,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,COVID,"February 08, 2021",13,NCT04572412,LOW DOSE RADIOTHERAPY,UNITED KINGDOM,Recruiting,Lancashire Teaching Hospitals NHS Foundation Trust,"November 25, 2020",Interventional,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia (a Phase I Feasibility Trial)
3734,A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy,TRACHEOSTOMY COMPLICATION; COVID; VENTILATOR LUNG,"February 08, 2021",2500,NCT04572438,TRACHEOSTOMY,UNITED KINGDOM,Recruiting,"University College, London","August 1, 2020",Observational,COVIDTrach; a UK National Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy
3735,Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health,POST-CORONAVIRUS DISEASE 19,"February 08, 2021",1200,NCT04573062,,UNITED STATES,Recruiting,National Institute of Neurological Disorders and Stroke (NINDS),"February 11, 2021",Observational,Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
3736,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,COVID,"February 08, 2021",400,NCT04573153,HYDROXYCHLOROQUINE + METABOLIC COFACTOR SUPPLEMENTATION; HYDROXYCHLOROQUINE + SORBITOL,TURKEY,Recruiting,ScandiBio Therapeutics AB,"September 21, 2020",Interventional,"A Multi Centre, Randomised, Controlled, Open-Label Phase 2/3 Study to Evaluate The Efficacy, Tolerability and Safety of Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients"
3737,Mesenchymal Stem Cells for the Treatment of COVID-19,COVID; PROPHYLAXIS,"February 08, 2021",40,NCT04573270,PRIMEPRO; PLACEBO,UNITED STATES,Completed,Thomas Advanced Medical LLC,"April 24, 2020",Interventional,A Pilot Phase Study Evaluating the Effects of a Single Mesenchymal Stem Cell Injection in Patients With Suspected or Confirmed COVID-19 Infection and Healthcare Providers Exposed to Coronavirus Patients
3738,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,SARS-CoV2 (COVID),"February 08, 2021",224,NCT04573322,TRANS SODIUM CROCETINATE; NORMAL SALINE,ROMANIA,Recruiting,Diffusion Pharmaceuticals Inc,"September 10, 2020",Interventional,"Open-label, Pharmacokinetic, Pharmacodynamic, Ascending Dose Safety lead-in Followed by a Single-center, Placebo-controlled, Double-blind, Adaptive, Safety and Efficacy, Pilot Study of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 Infected Subjects"
3739,Diabetes Outcomes in COVID-19 Pandemic,"DIABETES; COVID; ISOLATION, SOCIAL","February 08, 2021",1282,NCT04573335,,PAKISTAN,Completed,"Services Institute of Medical Sciences, Pakistan","June 1, 2020",Observational,Health-related Outcomes and Behaviour Changes in a Cohort of Diabetic Population During COVID-19 Pandemic: Results of a Telephonic Survey
3740,T Cells Response to SARS COV 2 Peptides,COVID; CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04573348,SAVICELL'S IMMUNOBIOPSY™,ISRAEL,Recruiting,Savicell Diagnostics Ltd,"October 14, 2020",Observational,"Prospective, One Center, Four Groups, Open, Comparative, Controlled Study to Explore T Cells Response to SARS COV 2 Peptides by Metabolic Activity Method in Convalesce and Healthy Individuals Versus Antibody Response"
3741,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,MUSCULOSKELETAL PAIN; DISABILITY PHYSICAL; PSYCHOLOGICAL DISTRESS,"February 08, 2021",723,NCT04573361,CHIROPRACTIC CARE (ONE VISIT); CHIROPRACTIC CARE (MORE THAN ONE VISIT),SPAIN,Completed,Real Centro Universitario Maria Cristina,"May 2, 2020",Interventional,Access to Chiropractic Care During the State of Emergency Generated by the COVID-19 Pandemic in Spain: a Pragmatic Controlled Trial
3742,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition,COVID; SARS-COV INFECTION,"February 08, 2021",960,NCT04573634,,UNITED STATES,Recruiting,Jill M Kolesar,"May 15, 2020",Observational,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition (START) - Assessment of COVID19 Penetrance in HCW and Non HCW in Kentucky
3743,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,COVID,"February 08, 2021",12,NCT04573764,"D-BETA-HYDROXYBUTYRATE-(R)-1,3 BUTANEDIOL MONOESTER; PLACEBO",,Not yet recruiting,Steno Diabetes Center Copenhagen,"October 1, 2020",Interventional,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19
3744,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,COVID,"February 08, 2021",41,NCT04573855,ANTI-SARS-COV-2 IMMUNOGLOBULIN,,Not yet recruiting,D'Or Institute for Research and Education,"December 1, 2020",Interventional,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19: A PHASE I / II STUDY
3745,"National Study ""AEC COVID-19""",MORTALITY,"February 08, 2021",1000,NCT04573868,,SPAIN,Recruiting,Hospitales Universitarios Virgen del Rocío,"March 1, 2020",Observational [Patient Registry],"National Study ""AEC COVID-19"" on Patients Undergoing Surgical Intervention During the SARS-CoV-2 Pandemic."
3746,SELF-BREATHE RCT for Chronic Breathlessness,CANCER; COPD; ASTHMA; BRONCHIECTASIS ADULT; INTERSTITIAL LUNG DISEASE; CYSTIC FIBROSIS; CHRONIC HEART FAILURE; SICKLE CELL DISEASE; RENAL FAILURE; LIVER FAILURE; POST COVID; DYSPNEA,"February 08, 2021",40,NCT04574050,SELF-BREATHE,,Not yet recruiting,King's College Hospital NHS Trust,"December 3, 2020",Interventional,"A Self - Guided, Internet - Based Intervention for Patients With Chronic Breathlessness (SELF-BREATHE): Feasibility Randomised Controlled Trial"
3747,Virtual Parental Presence on Induction,ANXIETY; SURGERY,"February 08, 2021",184,NCT04574219,USE OF FACETIME WITH CHILD AND PARENTS DURING INDUCTION,CANADA,Recruiting,"Children's Hospital Medical Center, Cincinnati","November 3, 2020",Interventional,Feasibility and Acceptability of Virtual Parental Presence on Induction of Anesthesia - Modernizing Solutions for Pediatric Anesthesia in Response to COVID-19
3748,Scaling-up Psychological Interventions With Syrian Refugees in Switzerland (STRENGTHS_CH): RCT,DISTRESS; PTSD; ANXIETY; DEPRESSION; TRAUMA; FUNCTIONAL DISABILITIES; COMMON MENTAL HEALTH PROBLEMS,"February 08, 2021",380,NCT04574466,PROBLEM MANAGEMENT PLUS,SWITZERLAND,Recruiting,University of Zurich,"August 25, 2020",Interventional,Scaling-up Psychological Interventions With Syrian Refugees in Switzerland: RCT
3749,A Research Platform to Screen Healthcare Workers,HEALTHCARE WORKER; COVID,"February 08, 2021",100000,NCT04574765,NASOPHARYNGEAL SWAB; QUESTIONNAIRE COLLECTION; OPTIONAL BLOOD COMPLETION; OPTIONAL QUESTIONNAIRE COMPLETION,CANADA,Recruiting,"University Health Network, Toronto","April 16, 2020",Observational,"A Research Platform to Screen and Protect Individuals That Work Within a Food Production, Healthcare, Research or Clinical Organization - RESPECT"
3750,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,ACUTE LUNG INJURY; ALI; COVID,"February 08, 2021",42,NCT04574869,RLS-0071; RLS-0071; PLACEBO; RLS-0071; RLS-0071; PLACEBO,UNITED STATES,Not yet recruiting,"ReAlta Life Sciences, Inc.",October 2020,Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, PK, & PD of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure"
3751,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,COVID INFECTION,"February 08, 2021",100,NCT04575038,BREQUINAR; PLACEBO,UNITED STATES,Recruiting,"Clear Creek Bio, Inc.","November 19, 2020",Interventional,"The CRISIS2 Study: A Phase 2, Randomized, Double Blind, Placebo-controlled, Multi-center Study Assessing the Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Out-patient Adults With SARS-CoV-2"
3752,An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY,SARS-CoV2 INFECTION; COVID; MODERATE AND SEVERE COVID,"February 08, 2021",400,NCT04575064,STANDARD OF CARE (SOC); REMDESIVIR,GERMANY,"Active, not recruiting",Professor Dr. Bernd Mühlbauer,"June 29, 2020",Interventional,An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
3753,Clinical Study Spartan COVID-19 V2 System,COVID,"February 08, 2021",100,NCT04575168,SPARTAN COVID-19 TEST,UNITED STATES,Recruiting,Spartan Bioscience Inc.,"October 30, 2020",Observational,Assess the Performance of Spartan COVID-19 V2 System in a Clinical Setting in Comparison to a Laboratory (Standard of Care (SOC)) PCR Method
3754,Detection of COVID-19 Decompensation,COVID,"February 08, 2021",400,NCT04575532,"USE OF THE PINPOINTIQ SOLUTION (PHYSIQ, INC.)",UNITED STATES,Enrolling by invitation,"physIQ, Inc.","October 5, 2020",Observational,Personalized Analytics and Wearable Biosensor Platform for Early Detection of COVID-19 Decompensation
3755,Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP,COVID; VIRUS-HIV,"February 08, 2021",600,NCT04575545,SEROLOGY TEST FOR COVID-19,FRANCE,Not yet recruiting,Hôpital Européen Marseille,October 2020,Observational,Prevalence of COVID-19 Infection in a Cohort of Patient Infected by the HIV and Patients Taking PrEP Pre-exposure Prophylaxis
3756,HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19,SARS-CoV2,"February 08, 2021",0,NCT04575558,HYDROXYCHLOROQUINE AND AZITHROMYCIN,BRAZIL,Withdrawn,Latin American Cooperative Oncology Group,"June 30, 2020",Interventional,"A Randomized, Multi-institutional, Phase 2 Study of Hydroxichloroquine Plus Azithromycin for High Risk SARS-CoV-2 Positive Patients (COVID-19)"
3757,MAVIPAN: My Life and the COVID-19 Pandemic,PSYCHOSOCIAL IMPACTS OF THE COVID PANDEMIC,"February 08, 2021",5000,NCT04575571,"NO INTERVENTION, THIS IS AN OBSERVATIONAL STUDY THAT USES VALIDATED QUESTIONNAIRES AND QUALITATIVE INTERVIEWS..",CANADA,Recruiting,Laval University,"April 29, 2020",Observational,The MAVIPAN Protocol: For a Structured Response to the Psychosocial Consequences of the Restrictive Measures Imposed by the Global Health COVID-19 Pandemic
3758,Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001),CORONAVIRUS DISEASE (COVID),"February 08, 2021",1300,NCT04575584,MOLNUPIRAVIR; PLACEBO,BRAZIL,Recruiting,Merck Sharp & Dohme Corp.,"October 19, 2020",Interventional,"A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults With COVID-19"
3759,Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),CORONAVIRUS DISEASE (COVID),"February 08, 2021",1450,NCT04575597,MOLNUPIRAVIR; PLACEBO,BRAZIL,Recruiting,Merck Sharp & Dohme Corp.,"October 19, 2020",Interventional,"A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults With COVID-19."
3760,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),COVID,"February 08, 2021",68,NCT04575610,PF-06650833; PLACEBO,UNITED STATES,Recruiting,Yale University,"November 30, 2020",Interventional,Investigation of IRAK4 Inhibition to Mitigate the Impact of COVID-19 in Severe SARS-CoV-2 (I-RAMIC)
3761,"Effect of CBT Intervention to Improve Sleep on Wellbeing, Dietary Intake and Food Preference",SLEEP; DIET; WELL BEING,"February 08, 2021",40,NCT04576260,COGNITIVE BEHAVIOURAL THERAPY FOR INSOMNIA,UNITED KINGDOM,Recruiting,University of Glasgow,"October 16, 2020",Interventional,"Effect of a Cognitive Behavioural Therapy Intervention to Improve Sleep on Wellbeing, Dietary Intake and Food Preference: a Feasibility Study."
3762,Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic,PATIENT SAFETY,"February 08, 2021",800,NCT04576299,GROUP 1,CHILE,"Active, not recruiting",Universidad Miguel Hernandez de Elche,"September 1, 2020",Observational,Health Care Workers' Perception of Patient Safety During the COVID-19 Pandemic: Opportunities and Challenges
3763,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,COVID,"February 08, 2021",64,NCT04576312,UNI911 INHALATION,DENMARK,"Active, not recruiting",UNION therapeutics,"June 29, 2020",Interventional,"Phase 1 Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19"
3764,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19,COVID,"February 08, 2021",150,NCT04576351,OBSERVATION,NORWAY,Recruiting,Oslo University Hospital,"September 1, 2020",Observational,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19
3765,Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures,"INFLUENZA, HUMAN","February 08, 2021",820,NCT04576377,FLUBLOK; PLACEBO,HONG KONG,Recruiting,The University of Hong Kong,"October 5, 2020",Interventional,The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE) Study - a Randomized Controlled Trial
3766,Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,COVID,"February 08, 2021",164,NCT04576728,TRIMODULIN; PLACEBO (HUMAN ALBUMIN 1%),BRAZIL,Recruiting,Biotest,"October 6, 2020",Interventional,"A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase II Trial Investigating the Efficacy and Safety of Trimodulin (BT588) as add-on Therapy to Standard of Care in Adult Subjects With Severe COVID-19"
3767,Risk Factors and Computed Tomography Findings in COVID-19.,"COVID; ARDS; PNEUMONIA, VIRAL; COMPUTED TOMOGRAPHY","February 08, 2021",233,NCT04577105,SIMPLE CHEST TOMOGRAPHY,MEXICO,Completed,Instituto Nacional de Cardiologia Ignacio Chavez,"April 1, 2020",Observational,"Risk Factors, Prognosis and Findings by Computed Tomography in Patients Infected by COVID-19 and Its Association With Severity."
3768,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,COVID,"February 08, 2021",29,NCT04577235,SEVERITY OF LUNG INVOLVEMENT WITH COVID-19.,TURKEY,Completed,Gaziosmanpasa Taksim Research and Education Hospital,"June 5, 2020",Interventional,Evaluation of the Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores of Patients With Severe COVID 19 Pneumonia in Intensive Care.
3769,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,COVID,"February 08, 2021",45,NCT04577378,DRUG: ISOTRETINOIN(AEROSOLIZED 13 CIS RETINOIC ACID) PLUS AEROSOLIZED ITRACONAZOLE; DRUG: ISOTRETINOIN(AEROSOLIZED 13 CIS RETINOIC ACID),EGYPT,Not yet recruiting,Kafrelsheikh University,"October 20, 2020",Interventional,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach
3770,COVID-19: Salvage TOcilizumab as a Rescue Measure,COVID,"February 08, 2021",90,NCT04577534,IV TOCILLIZUMAB (TCZ),FINLAND,Recruiting,Jarmo Oksi,"August 14, 2020",Interventional,COVID-19: Salvage TOcilizumab as a Rescue Measure. Use of Tocilizumab in the Inflammatory Phase of COVID-19 / New Coronavirus Disease
3771,Description of the Population With Genitourinary Tumors and COVID-19,COVID; GENITO URINARY CANCER,"February 08, 2021",250,NCT04578132,,SPAIN,Recruiting,Spanish Oncology Genito-Urinary Group,"November 24, 2020",Observational,Observational Retrospective-prospective Study in Patients With Genitourinary Tumors Presenting COVID-19 Infection (SOGUG-COVID-19)
3772,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,COVID,"February 08, 2021",200,NCT04578158,STANDARD COVID-19 CARE; QUERCETIN PHYTOSOME,PAKISTAN,Recruiting,Liaquat University of Medical & Health Sciences,"September 29, 2020",Interventional,"A Prospective, Randomized, Open-labelled, Controlled Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With Diagnosis of COVID-19."
3773,NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients,COVID,"February 08, 2021",100,NCT04578197,,SWEDEN,Recruiting,Karolinska University Hospital,"August 18, 2020",Observational,"NeuroCOVID - A Study of Activation and Inhibition of the Immune and Coagulation Systems, the Presence of Biochemical (Blood / CSF) and Structural Brain Changes and Their Association With Long-term Cognitive Dysfunction in Intensive Care-requiring Covid-19 Patients"
3774,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,CORONAVIRUS INFECTION,"February 08, 2021",58,NCT04578210,T MEMORY CELLS AND NK CELLS,SPAIN,Recruiting,Instituto de Investigación Hospital Universitario La Paz,"September 4, 2020",Interventional,A Phase I/II Dose-escalation Multi Center Study to Evaluate the Safety of Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in coronaviruS pnEumonia and/or Lymphopenia
3775,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",COVID,"February 08, 2021",360,NCT04578236,AEROSOLIZED 13 CIS RETINOIC ACID PLUS INHALATION ADMINISTRATION BY NEBULIZATION CAPTOPRIL 25MG; DRUG: STANDARD TREATMENT STANDARD TREATMENT,,Not yet recruiting,Kafrelsheikh University,November 2020,Interventional,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)"
3776,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva,SARS-CoV2 INFECTION; COVID,"February 08, 2021",2750,NCT04578509,NASOPHARYNGEAL SWAB; SALIVA SAMPLE; DATA COLLECTION; AXILLARY SWEAT SAMPLE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 19, 2020",Observational,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva (COVID-19)
3777,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions,COVID,"February 08, 2021",230,NCT04579289,QUESTIONNAIRE,FRANCE,Completed,Rennes University Hospital,"June 15, 2020",Observational,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions_COVID-19
3778,Fostamatinib for Hospitalized Adults With COVID-19,CORONAVIRUS DISEASE 2019,"February 08, 2021",80,NCT04579393,PLACEBO; FOSTAMATINIB,UNITED STATES,Recruiting,"National Heart, Lung, and Blood Institute (NHLBI)","January 27, 2020",Interventional,A Phase II Study Evaluating Fostamatinib for Hospitalized Adults With COVID-19
3779,Assessment of COVID-19 in Tearfilm,COVID; OPHTHALMOPATHY; EYE DISEASES,"February 08, 2021",0,NCT04579458,COLLECTION OF TEARS AND SALIVA.,UNITED STATES,Withdrawn,Vanderbilt University Medical Center,"December 28, 2020",Observational,Assessment of COVID (Coronavirus Disease)-19 in Tearfilm
3780,Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study,COVID; SARS-COV INFECTION; TRANSPLANTATION INFECTION,"February 08, 2021",2000,NCT04579471,SARS-COV-2 IGG,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"July 1, 2020",Observational,Prevalence and Outcome of SARS-CoV-2 Infection in Solid Organ and Hematopoietic Cell Transplant Recipients: The COVITRA Study
3781,Repeat Testing for SARS-CoV-2,COVID; SARS-CoV2,"February 08, 2021",10000,NCT04579549,SALIVA ASSAY,UNITED STATES,Enrolling by invitation,"University of Wisconsin, Madison","September 29, 2020",Interventional,Repeat Saliva Testing for SARS-CoV-2 Using RT-LAMP Assay
3782,Regional COVID Epidemiology in England (RECEDE),ACUTE KIDNEY INJURY,"February 08, 2021",5000,NCT04579562,NO INTERVENTION,,Not yet recruiting,University Hospitals of Derby and Burton NHS Foundation Trust,"November 1, 2020",Observational,Regional Epidemiology of COVID-19 and Acute Kidney Injury in England
3783,Understanding Immunity to the Flu Vaccine in COVID-19 Patients,CORONAVIRUS INFECTION; FLU VACCINE; IMMUNITY,"February 08, 2021",100,NCT04579588,FLU SHOT,UNITED STATES,Enrolling by invitation,Stanford University,"October 29, 2020",Observational,Understanding Immunity to the Flu Vaccine in COVID-19 Patients
3784,"Facial Hair, PPE and COVID-19",COVID; SAFETY ISSUES,"February 08, 2021",358,NCT04579627,QUESTIONNAIRE,UNITED KINGDOM,Completed,Royal Cornwall Hospitals Trust,"May 14, 2020",Observational,How Has the Increased Use of FFP3 Style Respirators During the COVID-19 Pandemic Affected Hospital Doctor's Facial Hair? Implications for Staff Safety and Welfare.
3785,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,COVID; ACUTE RESPIRATORY TRACT INFECTION,"February 08, 2021",6200,NCT04579640,VITAMIN D,UNITED KINGDOM,"Active, not recruiting",Queen Mary University of London,"October 27, 2020",Interventional,Phase 3 Randomised Controlled Trial of Vitamin D Supplementation to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections in the UK Population
3786,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,COVID; MICROBIOTA,"February 08, 2021",50,NCT04581018,HEALTH SUPPLEMENTS,HONG KONG,Recruiting,Siew Chien NG,"August 13, 2020",Interventional,An Evaluation of a Synbiotic Formula for Symptom Improvement in Hospitalised Patients With COVID-19 Infection
3787,COntinuous Signs Monitoring In Covid-19 Patients,COVID,"February 08, 2021",60,NCT04581031,CONTINUOUS VITAL SIGN MONITORING - ISANSYS PATIENT STATUS ENGINE; MACHINE LEARNING/AI ALGORITHM,UNITED KINGDOM,Recruiting,The Christie NHS Foundation Trust,"July 11, 2020",Interventional,COntinuous Signs Monitoring In Covid-19 Patients
3788,Impact of COVID-19 on Psoriasis Practice,PSORIASIS; COVID,"February 08, 2021",197,NCT04581044,,EGYPT,Completed,Cairo University,"September 17, 2020",Observational,Impact of COVID-19 on Psoriasis Practice: A Cross Sectional Study
3789,"The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic""",CANCER; COVID,"February 08, 2021",4,NCT04581070,,IRELAND,Terminated,Cancer Trials Ireland,"April 29, 2020",Observational,"COVID-IYON Study. Prospective, Multisite, Descriptive, Observational Clinical/Epidemiological Study Examining Data Pertaining to Clinical Outcomes and Organizational Responses to the 2020 SARS-Coronavirus-2 (SARS-CoV-2) Pandemic"
3790,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic",COVID,"February 08, 2021",30,NCT04581083,RT-PCR; LAMP; POOL RT-PCR; POOL LAMP,BOLIVIA,Completed,Hunter College of City University of New York,"October 8, 2020",Observational,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic, Tarija-Bolivia"
3791,Mapping COVID-19 Spread in a Tertiary Hospital,COVID; SPATIAL VISUALIZATION; NEURAL NETWORK; RESPIRATORY DISEASE; PANDEMIC; DISEASE SPREAD,"February 08, 2021",3000,NCT04581096,NO INTERVENTION,SPAIN,Recruiting,Hospital General Universitario de Valencia,"October 2, 2020",Observational [Patient Registry],Evaluation of the Response of COVID-19 Spread With a Spatiotemporal Analysis in a Tertiary Hospital
3792,Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,COVID,"February 08, 2021",500,NCT04581135,COVID-19,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","May 1, 2020",Observational [Patient Registry],Prospective Observational Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
3793,SARS-CoV2 Antibodies in Pediatric Patients (COVID-19),SARS-CoV2,"February 08, 2021",2000,NCT04581148,BLOOD TEST FOR IGG ANTIBODIES AGAINST SARS-COV-2,,Not yet recruiting,University of Erlangen-Nürnberg Medical School,"October 5, 2020",Observational,Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients
3794,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,ACUTE RESPIRATORY FAILURE; COVID,"February 08, 2021",10,NCT04581161,LIFE2000® VENTILATOR,UNITED STATES,Recruiting,Hill-Rom,"August 28, 2020",Interventional,A Novel Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients
3795,An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies,HEMATOLOGIC MALIGNANCIES,"February 08, 2021",400,NCT04581187,QUALITY OF LIFE ASSESSMENT,,Not yet recruiting,Gruppo Italiano Malattie EMatologiche dell'Adulto,October 2020,Observational [Patient Registry],An onLine-pLatform to Improve Patient-centered Care During the COVID-19 pAndemic: a GIMEMA surveillaNce Program in hematologiC malignanciEs
3796,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,COVID; CARDIORESPIRATORY FAILURE,"February 08, 2021",300,NCT04581200,LIFT,UNITED STATES,Recruiting,Duke University,"January 25, 2021",Interventional,"Addressing Psychological Distress Symptoms Among Serious Illness Survivors of a Viral Pandemic With a Completely Self-directed, Symptom-responsive Mobile Mindfulness Intervention: a Randomized Controlled Trial"
3797,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,COVID,"February 08, 2021",30,NCT04581291,MODERATE INTENSITY AEROBIC EXERCISES,TURKEY,Completed,Istanbul Gelisim University,"January 1, 2020",Interventional,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial
3798,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders,NEUROMUSCULAR DISEASES; NEUROLOGICAL DISEASES OR CONDITIONS,"February 08, 2021",75,NCT04581577,SEMI-STRUCTURED TELEPHONE QUESTIONNAIRE,UNITED KINGDOM,Recruiting,Royal Brompton & Harefield NHS Foundation Trust,"September 11, 2020",Observational,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders
3799,Group CBT For Perinatal Anxiety,PERINATAL ANXIETY,"February 08, 2021",50,NCT04581681,GROUP COGNITIVE BEHAVIOUR THERAPY FOR PERINATAL ANXIETY (CBT-PA); NO TREATMENT (WAITLIST CONTROL),CANADA,Recruiting,University of Manitoba,"December 2, 2020",Interventional,Group Cognitive Behaviour Therapy for Perinatal Anxiety: A Randomized Controlled Trial
3800,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),VIRUS-HIV; COVID,"February 08, 2021",1800,NCT04581746,QUESTIONNAIRE,FRANCE,Recruiting,Tourcoing Hospital,"November 25, 2020",Interventional,Evaluation of the Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)
3801,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),ARDS; COVID; ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",52,NCT04581811,PROLONGED PRONED POSITIONING; TRADITIONAL PRONING ARM,UNITED STATES,Recruiting,University of Alabama at Birmingham,"November 10, 2020",Interventional,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS): A Pilot Study
3802,COVID-19 Watch + COVID-19 Pulse,COVID,"February 08, 2021",850,NCT04581863,PULSE OXIMETER; COVID WATCH,UNITED STATES,Recruiting,University of Pennsylvania,"November 30, 2020",Interventional,Randomized Trial of Adding Pulse Oximetry to an Automated Text-messaging Program for Remotely Monitoring Patients at Home With COVID-19
3803,Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",2380,NCT04581889,DIAGNOSTIC TEST,GERMANY,Recruiting,University Hospital Tuebingen,"July 2, 2020",Observational,"Prospective, Seroepidemiological, Non-invasive Cohort Study in Tübingen Children Age-stratified by Nursery and School Attendance"
3804,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,COVID,"February 08, 2021",420,NCT04581915,TRIAZAVIRIN (RIAMILOVIR); PLACEBO,SOUTH AFRICA,Recruiting,Fatima Mayat,"September 8, 2020",Interventional,"A Pragmatic, Individually Randomised, Double-blind, Placebo-controlled Trial of Triazavirin (TZV) for the Treatment of Mild-moderate SARS-CoV-2 Infection A Phase II and III Clinical Trial"
3805,Patients Reactions Towards Their Diagnosis as Having COVID-19,COVID,"February 08, 2021",300,NCT04581928,,EGYPT,Recruiting,ClinAmygate,"October 10, 2020",Observational,Patients Reactions Towards Their Diagnosis as Having COVID-19: A Cohort Study
3806,Inflammatory Signal Inhibitors for COVID-19 (MATIS),CORONAVIRUS; COVID; PNEUMONIA,"February 08, 2021",456,NCT04581954,RUXOLITINIB; FOSTAMATINIB; STANDARD OF CARE,UNITED KINGDOM,Recruiting,Imperial College London,"October 2, 2020",Interventional,Randomised Multi-arm Trial of Ruxolitinib (RUX) and Fostamatinib (FOS) for COVID-19 Pneumonia
3807,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",55,NCT04582201,AGENT-797,UNITED STATES,Recruiting,"AgenTus Therapeutics, Inc.","September 21, 2020",Interventional,A Phase 1 Study of agenT-797 to Treat Moderate to Severe Acute Respiratory Syndrome in COVID-19 Patients
3808,Oscillation and Lung Expansion Therapy in Patients With COVID-19,COVID; OSCILLATION AND LUNG EXPANSION; VENTILATION,"February 08, 2021",30,NCT04582214,METANEB® SYSTEM,UNITED STATES,Recruiting,Hill-Rom,"September 28, 2020",Interventional,A Pilot Study of the Use of Oscillation and Lung Expansion (OLE) Therapy in Patients Hospitalized With COVID-19
3809,PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US,COVID,"February 08, 2021",40,NCT04582266,REMDESIVIR,PUERTO RICO,Not yet recruiting,International Maternal Pediatric Adolescent AIDS Clinical Trials Group,"October 15, 2020",Observational,Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States
3810,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19",SARS-CoV2 INFECTION,"February 08, 2021",48,NCT04582318,NGM621; PLACEBO,AUSTRALIA,Recruiting,"NGM Biopharmaceuticals, Inc","November 8, 2020",Interventional,"A Randomized, Double Blind, Placebo Controlled, Combined Phase 1/2 Single Dose and Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of NGM621 in Healthy Volunteers and the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy in Subjects With Confirmed SARS-CoV-2 Infection"
3811,Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,COVID,"February 08, 2021",300,NCT04582331,SMARTPHONE-BASED VOICE AND SELF-REPORTED SYMPTOM COLLECTION,INDIA,Recruiting,Sonde Health,"September 10, 2020",Observational,Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis
3812,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),COVID,"February 08, 2021",13000,NCT04582344,CORONAVAC; PLACEBO,TURKEY,Recruiting,Health Institutes of Turkey,"September 14, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated"
3813,Photoplethysmographic Scaling of Dyspnoea,RESPIRATORY FAILURE,"February 08, 2021",60,NCT04582838,PULSE OXIMETER; ECG,ROMANIA,Recruiting,Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu,"October 1, 2020",Observational,Photoplethysmographic Signal Analysis as a Proxy for Excessive Effort and Impending Respiratory Failure
3814,Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence,COVID INFECTION,"February 08, 2021",500,NCT04582903,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,Send-in Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
3815,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,COVID,"February 08, 2021",500,NCT04583189,PERFORMANCE OF THE TEST ANTIGENIC AND TEST RT-PCR,FRANCE,Completed,Centre Hospitalier Intercommunal Creteil,"October 1, 2020",Interventional,Evaluation Des Performances du Test Rapide antigénique Covid-19 Ag BSS Chez l'Enfant Symptomatique Dans un Service d'Urgences pédiatriques
3816,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects",COVID,"February 08, 2021",40,NCT04583228,HLX71; PLACEBO,,Not yet recruiting,Hengenix Biotech Inc,"November 30, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 in Healthy Adult Subjects"
3817,Acute kIDnEy Injury in coviD-19,ACUTE KIDNEY INJURY,"February 08, 2021",220,NCT04583293,NO INTERVENTION,UNITED KINGDOM,Recruiting,University Hospitals of Derby and Burton NHS Foundation Trust,"December 8, 2020",Observational,Long-term Outcomes After Acute Kidney Injury in Coronavirus Disease (COVID-19)
3818,The Salivary Raman COVID-19 Fingerprint,COVID,"February 08, 2021",120,NCT04583306,"RAMAN ANALYSIS OF SALIVA, CHARACTERIZATION OF THE RAMAN DATABASE AND BUILDING OF THE CLASSIFICATION MODEL",ITALY,Recruiting,Fondazione Don Carlo Gnocchi Onlus,"June 1, 2020",Observational [Patient Registry],Characterization of the COVID-19 Raman Signature of Saliva as a Potential Tool for the Fast Discrimination of SARS-CoV-2 Infection and Severity
3819,"Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection",SARS-COV,"February 08, 2021",160,NCT04583319,EASYCOV POC,TURKEY,Recruiting,Firalis SA,October 2020,Observational,"A Prospective, Non-interventional Study for Validation of a Rapid, Non-invasive IVD as a Point-of-care Test for Diagnosis of SARS-COV-2 Infection"
3820,Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic,HYPERTENSION; SOCIAL ISOLATION; COVID,"February 08, 2021",32,NCT04583345,QUESTIONNAIRES,TURKEY,Recruiting,Ebru Calik Kutukcu,"June 1, 2020",Observational,Comparison of Physical Activity Levels and Disease Attitudes of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic
3821,Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers,COVID; SARS-ASSOCIATED CORONAVIRUS AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE,"February 08, 2021",1633,NCT04583410,NICOTINE PATCH; PLACEBO PATCH,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 22, 2020",Interventional,Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers
3822,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,VIRAL INFECTION; COVID,"February 08, 2021",250,NCT04583449,MENTAL IMAGERY,UNITED KINGDOM,Recruiting,University of East London,"August 19, 2020",Interventional,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic
3823,"Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients",CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04583566,COVID-19 DIAGNOSTIC AND ASSESSMENT TESTS,EGYPT,Recruiting,Tanta University,"October 4, 2020",Observational [Patient Registry],"Studies on the Differential Expression of Cytokines, Transcriptome and miRNA in the Context of COVID-19 Infection in Egyptian Community"
3824,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),COVID,"February 08, 2021",300,NCT04583592,CAMOSTAT MESILATE; PLACEBO,UNITED STATES,Recruiting,Sagent Pharmaceuticals Inc.,"November 9, 2020",Interventional,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Camostat Mesilate for Treatment of COVID-19 in Outpatients"
3825,Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19),COVID,"February 08, 2021",700,NCT04583761,QUESTIONNAIRE,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"October 12, 2020",Observational,Tobacco and Nicotine Consumption and the Risk of Acquisition of COVID-19: A Case Control Study Among Healthcare Workers
3826,Feasibility and Quality of TeleConsultation in Pediatric Anesthesia,ANESTHESIA,"February 08, 2021",400,NCT04583865,TELECONSULTATION,FRANCE,"Active, not recruiting","University Hospital, Toulouse","October 7, 2020",Observational,Assessment of the Feasibility and Quality of the Consultation by TeleConsultation in Pediatric Anesthesia in the Context of the Covid 19 Pandemic
3827,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,COVID,"February 08, 2021",200,NCT04583956,PLACEBO; REMDESIVIR; RISANKIZUMAB,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"October 14, 2020",Interventional,A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
3828,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,COVID,"February 08, 2021",200,NCT04583969,LENZILUMAB; PLACEBO; REMDESIVIR,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"October 19, 2020",Interventional,A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
3829,ImmuneSense™ COVID-19 Study,CORONAVIRUS DISEASE (COVID); SARS-CoV2 INFECTION,"February 08, 2021",180,NCT04583982,T-DETECT™ SARS-COV-2 ASSAY,UNITED STATES,Completed,Adaptive Biotechnologies,"October 9, 2020",Observational,ImmuneSense™ COVID-19 Study
3830,"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom",SARS-CoV2 INFECTION; COVID,"February 08, 2021",15000,NCT04583995,SARS-COV-2 RS/MATRIX M1-ADJUVANT; PLACEBO; LICENSED SEASONAL INFLUENZA VACCINE,UNITED KINGDOM,Recruiting,Novavax,"September 28, 2020",Interventional,"A Phase 3, Randomised, Observer-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants 18-84 Years of Age in the United Kingdom"
3831,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance,COVID,"February 08, 2021",50,NCT04584411,CARDIAC MAGNETIC RESONANCE IMAGING,,Not yet recruiting,Assiut University,"November 1, 2020",Observational,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance
3832,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia,EPIDEMIOLOGY; CLINICAL; NUTRITIONAL-STATUS; IMMUNOLOGIC DEFECT,"February 08, 2021",6390,NCT04584424,THE STUDY DOES NOT REQUIRED,ETHIOPIA,Not yet recruiting,Ethiopian Public Health Institute,"October 30, 2020",Observational,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia: Multi-Site Cohort Study
3833,Treatment of Covid-19 Using Infrared and/or Vitamin C,COVID,"February 08, 2021",400,NCT04584437,INFRARED ENERGY AND DIETARY SUPPLEMENT,CANADA,Not yet recruiting,GAAD Medical Research Institute Inc.,"January 31, 2021",Interventional,The Treatment and Prevention of Covid-19 Pandemic Using Infrared and /or Vitamin C.
3834,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale,COVID,"February 08, 2021",100,NCT04584450,QUESTIONNAIRE,TURKEY,Completed,Hacettepe University,"September 2, 2020",Observational,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale
3835,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,SPONDYLOARTHRITIS; RHEUMATOID ARTHRITIS; COVID,"February 08, 2021",150,NCT04584541,BLOOD TESTS; NASOPHARYNGEAL SWABS; STOOLS,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 11, 2020",Interventional,Study of the Viral Load and Humoral and Cellular B and T Responses in Patients With Rheumatoid Arthritis and Spondyloarthritis Under Immunosuppressive Treatments
3836,"OD-doxy-PNV-COVID-19 Old Drug "" DOXY "" for Prevention of New Virus "" COVID-19 """,COVID,"February 08, 2021",1100,NCT04584567,DOXYCYCLIN,TUNISIA,Recruiting,Hedi Gharsallah,"November 20, 2020",Interventional,Covid-19 Infection Prophylaxis With Low Dose of Doxycycline and Zinc in Health Care Workers
3837,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,CORONAVIRUS DISEASE (COVID)19,"February 08, 2021",50,NCT04584580,LOW-MOLECULAR-WEIGHT HEPARIN,EGYPT,Recruiting,Ain Shams University,"August 1, 2020",Interventional,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia
3838,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,COVID,"February 08, 2021",50,NCT04584593,SAMPLE,FRANCE,Recruiting,"University Hospital, Toulouse","October 2, 2020",Interventional,Pilot Study to Detect SARS-CoV-2 Virus in Sperm : a COVID-19 Study.
3839,Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04584606,LAB WORKUP (ON ADMISSION AND REGULARLY DURING FOLLOW UP).,EGYPT,Recruiting,Ain Shams University,"June 27, 2020",Observational,Ain Shams University Experience: Clinical Characteristics and Outcome Determinants of Hospitalized Covid-19 Patients at Ain Shams University Obour Hospital
3840,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study),DYSPHAGIA; DYSPHONIA; SUBGLOTTIC STENOSIS; VOICE DISORDERS; SWALLOWING DISORDER; COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); SARS PNEUMONIA; QUALITY OF LIFE; SARS-CoV2 INFECTION,"February 08, 2021",36,NCT04584658,FIBREOPTIC ENDOSCOPIC EVALUATION OF SWALLOWING (FEES); VIDEOFLUOROSCOPY; DYSPHAGIA HANDICAP INDEX (DHI); VOICE SYMPTOM SCALE (VOISS),UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"September 15, 2020",Observational,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19): A Prospective Observational Cohort Study.
3841,Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection,COVID,"February 08, 2021",200,NCT04584671,HYPERPOLARIZED XENON-129 MRI OF THE LUNGS; COMPUTED TOMOGRAPHY (CT); PULMONARY FUNCTION TESTS (PFT); SIX MINUTE WALK TEST (6MWT); SPUTUM ANALYSIS; BLOOD ANALYSIS; QUESTIONNAIRES,CANADA,Not yet recruiting,"Western University, Canada","December 1, 2020",Observational,Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI and CT For Rapid Evaluations and NExt-wave Healthcare Planning
3842,Mouth Rinses for Inactivation of COVID-19,COVID; CORONAVIRUS INFECTION; SARS-CoV2 INFECTION,"February 08, 2021",480,NCT04584684,1.5-2% W/V HYDROGEN PEROXIDE; 0.12% CHLORHEXIDINE GLUCONATE; 21% ETHANOL PLUS ESSENTIAL OILS; 1% W/V POVIDONE-IODIDE; 0.075% CETYLPYRIDINIUM CHLORIDE; SALINE,UNITED STATES,Recruiting,"University of North Carolina, Chapel Hill","December 18, 2020",Interventional,Antiviral Efficacy and Acceptability of Therapeutic Antiseptic Mouth Rinses for Inactivation of COVID SARS-2 Virus
3843,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19",COVID,"February 08, 2021",50,NCT04584697,COVI-AMG; PLACEBO,,Not yet recruiting,"Sorrento Therapeutics, Inc.",December 2020,Interventional,"A Randomized, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Outpatients With COVID-19 Who Are Asymptomatic or Have Mild Symptoms"
3844,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,COVID,"February 08, 2021",60,NCT04584710,RTB101; PLACEBO,UNITED STATES,Recruiting,Restorbio Inc.,"October 13, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Adults Age ≥65 Years"
3845,COVID-19 on Placental Gene Expression and Pathology,COVID; SARS-CoV2 INFECTION,"February 08, 2021",100,NCT04585945,POSITIVE FOR SARS-COV-2 INFECTION,UNITED STATES,Recruiting,Prisma Health-Upstate,"August 4, 2020",Observational,Pregnancy Outcomes During the Pandemic: Using Placental Pathology and Gene Expression to Understand Fetal Risk
3846,Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19,ACUTE RESPIRATORY DISTRESS SYNDROME SECONDARY TO COVID,"February 08, 2021",200,NCT04586114,CORTICOSTEROIDS AND DERIVATIVES,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","March 1, 2020",Observational,Effect of Early Corticosteroid Therapy on Mortality in Patient With Acute Respiratory Distress Syndrome Secondary to Covid-19
3847,Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period,COVID; ETHICS,"February 08, 2021",30,NCT04586140,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"November 9, 2020",Observational,Operation of the Groupe Hospitalier Paris Saint-Joseph Clinical Ethical Reflection Assistance Group During the COVID-19
3848,Study to Assess the Effect of Meplazumab on COVID-19,COVID,"February 08, 2021",456,NCT04586153,MEPLAZUMAB FOR INJECTION; STERILE NORMAL SALINE (0.9%),,Not yet recruiting,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd,"December 30, 2020",Interventional,"A Multicenter, Seamless, Randomized, Third-Party-Blind, Clinical Trial to Evaluate the Safety and Efficacy of Meplazumab in Addition to Standard of Care for the Treatment of COVID-19 in Hospitalized Adults"
3849,Digital Mental Health and Wellness Intervention for Adults: A Randomized Control Trial of COMET,DEPRESSIVE SYMPTOMS; ANXIETY,"February 08, 2021",2500,NCT04586192,COMMON ELEMENTS TOOLBOX- ADULT VERSION (COMET-A); SELF-AWARENESS CONTROL,UNITED STATES,Recruiting,University of Pennsylvania,"January 31, 2021",Interventional,Developing and Assessing a Digital Mental Health and Wellness Intervention for Adults: Randomized Control Trial of the Common Elements Toolbox (COMET)
3850,Improving the Mental Health of Resident Physicians and Fellows Through Transcendental Meditation,"BURNOUT, PROFESSIONAL; STRESS, PSYCHOLOGICAL; DEPRESSION; JOB STRESS","February 08, 2021",50,NCT04586309,TRANSCENDENTAL MEDITATION,,Not yet recruiting,University of Arizona,November 2020,Interventional,Improving the Mental Health of Resident Physicians and Fellows : Reducing Burnout & Enhancing Resilience Through Transcendental Meditation
3851,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg),COVID,"February 08, 2021",100,NCT04586413,NO INTERVENTION - QUALITY OF LIFE MEASURE,UNITED KINGDOM,Recruiting,Medialis Ltd.,"October 7, 2020",Observational,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)
3852,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",CORONAVIRUS INFECTION,"February 08, 2021",110,NCT04587219,GAM-COVID-VAC,RUSSIAN FEDERATION,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","October 22, 2020",Interventional,"An Open Study of the Safety, Tolerability and Immunogenicity of the ""Gam-COVID-Vac""Vaccine Against COVID-19 (Solution for Intramuscular Injection) With the Participation of Volunteers in the Age Group Over 60 Years"
3853,The Provider Insurance Revenue Study in Healthcare Providers in the United States of America,COVID; FINANCIAL DISCLOSURE,"February 08, 2021",100,NCT04587245,ONLINE QUESTIONNAIRE AND INTERVIEWS,UNITED STATES,Recruiting,"ND Sciences, LLC","October 1, 2020",Observational,The Provider Insurance Revenue Study
3854,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,BREAST CANCER; COLORECTAL CANCER; COVID,"February 08, 2021",100,NCT04587258,INFORMATIONAL VIDEOS AND SOCIAL MEDIA CAMPAIGNS ENCOURAGING CANCER SCREENING.,UNITED STATES,Recruiting,Rhode Island Hospital,"August 28, 2020",Observational,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island: A Community Based Quality Improvement Project of the Lifespan Cancer Institute
3855,VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease,COVID DISEASE,"February 08, 2021",100,NCT04587323,,UNITED STATES,Recruiting,University of Alabama at Birmingham,"May 22, 2020",Observational,COVID-19 RELATED SUBMISSION: VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease
3856,Diagnosis of Endocrine Dysfunctions in Covid-19,COVID,"February 08, 2021",50,NCT04587375,,FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Diagnosis of Endocrine Dysfunctions in Covid-19 : Explorations of the Plasma Renin and Aldosterone Levels in Patients With Covid-19 Infection.
3857,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,TYPE2 DIABETES,"February 08, 2021",122,NCT04587414,EHEALTH +COUNSELLING CONTACTS; EHEALTH; USUAL CARE,FINLAND,"Active, not recruiting",UKK Institute,"March 6, 2019",Interventional,Personalized eHealth Intervention in Patients With Type 2 Diabetes to Promote Daily Physical Activity Utilizing 24h Self-monitoring - Implementation Frustrated by COVID-19 Epidemic
3858,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,OXIMETRY; COVID,"February 08, 2021",90,NCT04587921,DIGITAL OXIMETER MONITORING,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 22, 2020",Interventional,Feasibility and Impact of Remote Oximetry and Cardiac Frequency Monitoring in Patients Hospitalized and Isolated With Covid-19
3859,COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2); MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C); CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",250,NCT04588363,SARS-COV-2 AND/OR MIS-C EXPOSURE,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"November 19, 2020",Observational,An Observational Cohort Study to Determine Late Outcomes and Immunological Responses After Infection With SARS-CoV-2 in Children With and Without Multisystem Inflammatory Syndrome (MIS-C)
3860,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,BEREAVEMENT; SEVERE GRIEF REACTION,"February 08, 2021",200,NCT04588415,BEREAVEMENT VIRTUAL SUPPORT GROUP,,Not yet recruiting,Ottawa Hospital Research Institute,"November 1, 2020",Interventional,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic
3861,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,ACUTE RESPIRATORY DISTRESS,"February 08, 2021",30,NCT04588441,ADENOSINE,,Not yet recruiting,University of Florida,March 2021,Interventional,Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19 (The ARCTIC Trial)
3862,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",SARS-CoV2 INFECTION; COVID,"February 08, 2021",160,NCT04588480,BNT162B2; PLACEBO,JAPAN,"Active, not recruiting",BioNTech SE,"October 21, 2020",Interventional,"A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, AND OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTHY JAPANESE ADULTS"
3863,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,COVID; RESPIRATORY FAILURE,"February 08, 2021",640,NCT04588792,NEBULIZED FUROSEMIDE; NEBULIZED SALINE,CANADA,Recruiting,Queen's University,"February 1, 2021",Interventional,Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19 - A Phase 2/3 Study
3864,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy,COLO-RECTAL CANCER,"February 08, 2021",100,NCT04588909,COLORECTAL RESECTIONS,INDIA,"Active, not recruiting",Sheri Kashmir Institute of Medical Sciences,"March 23, 2020",Observational,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy
3865,Expressive Writing for COVID-19 Resilience,DISTRESS DUE TO COVID,"February 08, 2021",63,NCT04589104,EXPRESSIVE WRITING,UNITED STATES,Completed,Duke University,"May 26, 2020",Interventional,Expressive Writing for COVID-19 Resilience
3866,Expressive Writing for COVID-19 Resilience for Parents,PARENTS DURING COVID,"February 08, 2021",11,NCT04589117,EXPRESSIVE WRITING,UNITED STATES,Completed,Duke University,"May 27, 2020",Interventional,Expressive Writing for COVID-19 Resilience for Parents
3867,Mindfulness to Mitigate Psychological Threat and Improve Engagement and Learning in Introductory Physics Courses,STRESS,"February 08, 2021",150,NCT04589377,MINDFULNESS TRAINING,UNITED STATES,Recruiting,University of Pittsburgh,"October 26, 2020",Interventional,Mobile Mindfulness Training and Physics Learning
3868,The VISION-Acute Study,HYPERTENSION; HYPOXIA; HYPOTENSION,"February 08, 2021",200,NCT04589923,LIFELIGHT® DATA COLLECT BLOOD PRESSURE GROUP; LIFELIGHT® DATA COLLECT OXYGEN SATURATION GROUP,UNITED KINGDOM,Not yet recruiting,Xim Limited,October 2020,Observational,The Measurement of VItal SIgns by Lifelight® Data Collect Software in comparisON to the Standard of Care in Acutely Unwell Patients - The VISION-Acute Study
3869,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,PNEUMONIA; COVID,"February 08, 2021",56,NCT04589936,PRONE POSITIONING,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"September 3, 2020",Interventional,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care (PRONE-COVID Study)
3870,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),COVID,"February 08, 2021",690,NCT04589949,CONVP; FFP,NETHERLANDS,Recruiting,Erasmus Medical Center,"October 12, 2020",Interventional,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)
3871,"Allocetra-OTS in COVID-19, Phase II",COVID,"February 08, 2021",24,NCT04590053,ALLOCETRA-OTS,ISRAEL,Recruiting,Hadassah Medical Organization,"October 20, 2020",Interventional,"A Multi-Center Open-Label Study, Evaluating Safety and Preliminary Efficacy of Allocetra-OTS for the Treatment and Prevention of Organ-Failure Deterioration in Severe and Critical Patients With COVID-19 and Respiratory Dysfunction"
3872,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy,"INFLUENZA, HUMAN","February 08, 2021",734383,NCT04590066,FLU SHOT TEXT MESSAGES,UNITED STATES,Completed,University of Pennsylvania,"September 25, 2020",Interventional,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy
3873,French Cohort of COVID-19 Patients With Post-intensive Care Syndrome,COVID,"February 08, 2021",100,NCT04590170,POST-INTENSIVE CARE UNIT SYNDROME,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 30, 2020",Observational,French Cohort of covid19 Patients With Post-intensive Care Syndrome : Rehabilitation From Intensive Care Unit to Home Return
3874,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,ADULT PATIENTS WITH LESIONS ON FINGERS OR TOES,"February 08, 2021",25,NCT04590209,BLOOD SAMPLING; SKIN BIOPSY,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,October 2020,Interventional,Clinical and Mechanistic Study of Patients With a Recent Acrosyndrome
3875,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19,SARS-CoV2 INFECTION,"February 08, 2021",80,NCT04590222,BLOOD SAMPLE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,November 2020,Observational,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19
3876,Myeloid Cells in Patients With Covid-19 Pneumonia,COVID; SARS-CoV2,"February 08, 2021",120,NCT04590261,BLOOD SAMPLING; NASAL BRUSHING,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 1, 2020",Interventional,Myeloid Cells in Patients With Covid-19 Pneumonia
3877,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",5000,NCT04590274,HYDROXYCHLOROQUINE; VITAMINS AND MINERALS; AZITHROMYCIN,,Not yet recruiting,International Brain Research Foundation,November 2020,Interventional,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
3878,Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients,SARS-CoV2 INFECTION,"February 08, 2021",187,NCT04590352,NASOPHARYNGEAL AND THROAT SWAB; COLLECTION OF MUCOSAL LINING FLUID; BLOOD COLLECTION VIA FINGERPRICK,NETHERLANDS,Completed,Radboud University,"March 26, 2020",Observational,Mucosal Immunity in Patients Diagnosed With SARS-CoV-2 Infection and Their Household Contacts
3879,Iota-carrageenan Nasal Spray COVID-19 Prophylaxis for Healthcare Professionals,COVID; SARS-CoV2,"February 08, 2021",480,NCT04590365,CARRAGEENAN NASAL AND THROAT SPRAY; SALINE NASAL AND THROAT SPRAY,,Not yet recruiting,Swansea University,"January 30, 2021",Interventional,Efficacy of Iota-carrageenan Nasal Spray Prophylaxis for Healthcare Professionals Treating Patients During the COVID-19 Pandemic - A Double Blind Randomised Placebo-controlled Trial
3880,Pulmonary Embolism and COVID-19,COVID; PULMONARY EMBOLISM,"February 08, 2021",600,NCT04590378,INTENSIVE CARE UNIT ADMISSION RATIO,TURKEY,Recruiting,Uşak University,"March 1, 2020",Observational,Evaluation of the Patients With COVID-19 in Terms of Pulmonary Embolism
3881,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults",HEALTHY,"February 08, 2021",24,NCT04590430,HFB30132A; PLACEBO,UNITED STATES,"Active, not recruiting",HiFiBiO Therapeutics,"October 20, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose First-in-Human Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenously Administered HFB30132A, a Monoclonal Antibody Directed Against SARS-CoV-2, in Healthy Adult Subjects"
3882,Improving Wellbeing and Health for Care Home Residents During COVID-19,DEMENTIA,"February 08, 2021",2880,NCT04590469,COVID WHELD,,Not yet recruiting,University of Exeter,"November 20, 2020",Interventional,Evidence-Based Supported Digital Intervention for Improving Wellbeing and Health of People Living in Care Homes and Care Home Staff (WHELD) During COVID-19: An RCT to Evaluate COVID-19 Adapted E-WHELD: Benefits and Cost-Effectiveness
3883,GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19),PNEUMONITIS; SARS-COV INFECTION,"February 08, 2021",132,NCT04590547,GLS-1027; PLACEBO,,Not yet recruiting,"GeneOne Life Science, Inc.",February 2021,Interventional,"Safety, Tolerability and Efficacy of GLS-1027 in the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection"
3884,Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,COVID,"February 08, 2021",1400,NCT04590586,STANDARD OF CARE; APREMILAST; APREMILAST PLACEBO; LANADELUMAB; LANADELUMAB PLACEBO; ZILUCOPLAN; ZILUCOPLAN PLACEBO,SOUTH AFRICA,Recruiting,Amgen,"November 24, 2020",Interventional,Industry Alliance Platform Trial to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
3885,SuPAR in Adult Patients With Covid-19,COVID,"February 08, 2021",500,NCT04590794,SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR,GREECE,"Active, not recruiting",University of Thessaly,"October 11, 2020",Observational,A Prospective Observational Study on Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Adult Patients With Covid-19
3886,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,"DIABETES MELLITUS, TYPE 2; COVID","February 08, 2021",172,NCT04591015,HOSPITAL: DD-CA; HOSPITAL: USUAL CARE (UC),,Not yet recruiting,Scripps Whittier Diabetes Institute,"February 1, 2021",Interventional,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19
3887,COVID-19 and Lung Ultrasound Utility,COVID; LUNG INFECTION,"February 08, 2021",100,NCT04591158,BUTTERFLY IQ,CANADA,Recruiting,Bridge to Health Medical and Dental USA,"September 15, 2020",Interventional,The Utility of Self-administered Lung Ultrasound in Patients With COVID-19
3888,A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,SARS-CoV2,"February 08, 2021",72,NCT04591184,COVIGENIX VAX-001 PLACEBO; COVIGENIX VAX-001,,Not yet recruiting,Entos Pharmaceuticals Inc.,February 2021,Interventional,"Phase I/II Trial to Evaluate Safety, Tolerability, Immunogenicity of a Prophylactic Plasmid DNA Vaccine for SARS CoV-2 [Covigenix VAX-001] in Healthy Adults From 18 to <85 Years of Age"
3889,The COVID-RASi Trial (COVID-19),COVID; CARDIOVASCULAR DISEASES,"February 08, 2021",1155,NCT04591210,ANGIOTENSIN CONVERTING ENZYME INHIBITOR; ANGIOTENSIN II RECEPTOR BLOCKERS,CANADA,Not yet recruiting,Ottawa Heart Institute Research Corporation,"October 30, 2020",Interventional,"Evaluation of the Potential Benefit of Renin-angiotensin System Inhibitors (RASi, ACEi/ARB) in High-risk Patients With COVID-19. The COVID-RASi Trial"
3890,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,COVID,"February 08, 2021",140,NCT04591600,IVERMECTIN AND DOXYCYLINE; STANDARD OF CARE,IRAQ,Completed,Alkarkh Health Directorate-Baghdad,"July 1, 2020",Interventional,"Controlled Randomized Clinical Trial on Using Ivermectin With Doxycycline for Treating COVID-19 Patients in Baghdad, Iraq"
3891,Late Clinical Events Associated With COVID-19 Infection,COVID,"February 08, 2021",1000,NCT04591613,QUESTIONNAIRE; BIOCOLLECTION; FOLLOW-UP VISIT,FRANCE,Recruiting,Tourcoing Hospital,"December 31, 2020",Interventional,Late Clinical Events Associated With COVID-19 Infection: Multicenter Cohort
3892,The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19,COVID; DIABETES MELLITUS,"February 08, 2021",2000,NCT04591704,"HOSPITALISATION, NECESSITY OF ICU, MORTALITY RATE, LUNG INVOLVEMENT",TURKEY,Recruiting,Uşak University,"March 20, 2020",Observational,The Effect of Diabetes Mellitus on the Morbidity and Mortality Rates in Patients With COVID-19
3893,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers,COVID,"February 08, 2021",35,NCT04591717,HAD5-S-FUSION+N-ETSD VACCINE,UNITED STATES,Recruiting,"ImmunityBio, Inc.","October 19, 2020",Interventional,"Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of Prophylactic Vaccination With 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers"
3894,Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department,"CRITICAL ILLNESS; INFECTIONS, RESPIRATORY; EMERGENCY SERVICE, HOSPITAL; TELEMEDICINE","February 08, 2021",100,NCT04591873,TELEMEDICINE; TRADITIONAL COMMUNICATION TOOLS,TAIWAN,Not yet recruiting,National Taiwan University Hospital,"October 10, 2020",Observational,Application of Telemedicine to Optimize Teamwork and Infection Control of Critical Patients in Isolation Rooms in the Emergency Department During Novel Coronavirus Disease 2019 Outbreak
3895,"The Peer-Delivered ""Mind. Body. Voice."" Program for High School Women (Mbv) - Remote",EATING DISORDERS IN ADOLESCENCE,"February 08, 2021",140,NCT04591912,MIND. BODY. VOICE,UNITED STATES,Recruiting,"University of Colorado, Boulder","October 9, 2020",Interventional,"Randomized Controlled Trial of the Peer-Delivered ""Mind. Body. Voice."" Eating Disorder Prevention Program Among High School Women - Remote"
3896,The Effect of COVID-19 on Diabetes Mellitus,DIABETES MELLITUS; COVID,"February 08, 2021",500,NCT04592055,,TURKEY,Recruiting,Uşak University,"March 20, 2020",Observational,The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus
3897,Cancer Information Your Way: Get What You Need to Make Your Decisions,CANCER,"February 08, 2021",40,NCT04592224,,UNITED KINGDOM,Recruiting,University of Southampton,"November 12, 2020",Observational,Cancer Information Your Way: Get What You Need to Make Your Decisions - a Qualitative Study of Decision Making by Patients With Lower Health Literacy Receiving Care for Incurable Cancer
3898,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,TREATMENT OF FATIGUE AFTER RESOLUTION OF COVID INFECTION,"February 08, 2021",40,NCT04592354,OXALOACETATE MEDICAL FOOD/DIETARY SUPPLEMENT,UNITED STATES,Recruiting,Terra Biological LLC,"October 15, 2020",Interventional,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors
3899,Impact of COVID-19 on Pediatric Dental Practice During First and Second Wave In Egypt.,SARS-CoV2,"February 08, 2021",345,NCT04592510,,,Not yet recruiting,Cairo University,February 2021,Observational,Impact of COVID-19 on Pediatric Dental Practice During First and Second Wave In Egypt : A Cross -Sectional Study Among Egyptian Pediatric Dentists
3900,"This is a Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820, a Monoclonal Antibody Cocktail Being Tested for the Treatment and Prevention of COVID-19",SARS-CoV2,"February 08, 2021",40,NCT04592549,ADM03820; PLACEBO,UNITED STATES,Recruiting,Ology Bioservices,"December 4, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820 in Adults"
3901,Evaluating an Online Wellness Intervention for Indian College Students,DEPRESSIVE SYMPTOMS; ANXIETY; HAPPINESS,"February 08, 2021",500,NCT04592588,COMMON ELEMENTS TOOLBOX; WAIT-LIST CONTROL,INDIA,Recruiting,University of Pennsylvania,"October 19, 2020",Interventional,Online Wellness Activities for Indian College Students
3902,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,COVID,"February 08, 2021",10,NCT04592705,THERAPEUTIC PLASMA EXCHANGE,UNITED STATES,Recruiting,Larkin Community Hospital,"September 11, 2020",Interventional,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients
3903,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003",COVID PATIENTS,"February 08, 2021",24,NCT04592835,DWRX2003,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,"October 19, 2020",Interventional,"A Double-blind, Randomized, Placebo-controlled, Single-ascending Dose Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Following Intramuscular Administration in Healthy Volunteers"
3904,The COGCOV Study in ICU Patients,COVID; COGNITIVE IMPAIRMENT,"February 08, 2021",60,NCT04593069,NEUROCOGNITIVE ASSESSMENT,BELGIUM,Recruiting,Ziekenhuis Oost-Limburg,"October 7, 2020",Interventional,"Long-term Cognitive Impairment in ICU Patients, Admitted for COVID-19 Pneumonia: a Single Centre, Prospective Cohort Study"
3905,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,SOCIAL ISOLATION; QUALITY OF LIFE; WELL AGING; FRAILTY,"February 08, 2021",40,NCT04593433,MUSEUM VIRTUAL GUIDED TOURS,CANADA,Not yet recruiting,Jewish General Hospital,"January 4, 2021",Interventional,"A 3-month Cycle of Virtual Weekly Montreal Museum of Fine Arts Tours to Promote Social Inclusion, Well-being, Quality of Life and Health in Older Community Members : a Pilot Study"
3906,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)",SARS-CoV2 INFECTION,"February 08, 2021",18,NCT04593641,CT-P59,"KOREA, REPUBLIC OF","Active, not recruiting",Celltrion,"September 4, 2020",Interventional,"A Pilot Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Group, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Virology of CT-P59 in Patient With Mild Symptoms of SARS-CoV-2 Infection"
3907,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients,COVID; THROMBOEMBOLISM,"February 08, 2021",257,NCT04593654,DOSE OF TINZAPARIN OR DALTEPARIN,SWEDEN,Completed,Karolinska Institutet,"March 1, 2020",Observational,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients - More Patients Included and 90-day Follow up
3908,Immune Modulators for Treating COVID-19,COVID,"February 08, 2021",2160,NCT04593940,INFLIXIMAB; ABATACEPT; REMDESIVIR; CENICRIVIROC,UNITED STATES,Recruiting,Daniel Benjamin,"October 15, 2020",Interventional,Randomized Master Protocol for Immune Modulators for Treating COVID-19
3909,COVID-19 Burnout Study,STRESS,"February 08, 2021",100,NCT04594278,MINDFULNESS BASED INTERVENTION,,Not yet recruiting,"University Health Network, Toronto","November 1, 2020",Interventional,Remote Delivery of a Mindfulness-based Intervention to Decrease Anxiety Levels and Burnout Among Health-care Professionals During the Covid-19 Pandemic
3910,MRI Changes of Acute Kidney Injury in COVID-19,ACUTE KIDNEY INJURY,"February 08, 2021",60,NCT04594291,MRI SCANS,UNITED KINGDOM,Recruiting,University Hospitals of Derby and Burton NHS Foundation Trust,"October 7, 2020",Observational,Long-term Outcomes After Acute Kidney Injury in Coronavirus Disease (COVID-19) as Determined by Multiparametric Magnetic Resonance Imaging (MRI)
3911,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04594330,VIRGIN COCONUT OIL (VCO); PLACEBO,INDONESIA,Recruiting,Gadjah Mada University,"June 1, 2020",Interventional,Pilot Trial for the Benefit of Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients
3912,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,COVID,"February 08, 2021",200,NCT04594343,DISULFIRAM; PLACEBO,BRAZIL,Recruiting,ETICA,"November 20, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Safety and Clinical Outcomes Study of Disulfiram in Subjects With Moderate COVID-19"
3913,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist",COVID,"February 08, 2021",126,NCT04594356,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"November 19, 2020",Observational,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist"
3914,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers,HEALTHY VOLUNTEERS,"February 08, 2021",2700,NCT04594395,,CAMBODIA,Not yet recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in Healthy Volunteers
3915,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),COVID; HYDROGEN-OXYGEN GAS; AMS-H-03,"February 08, 2021",198,NCT04594460,"HYDROGEN-OXYGEN GENERATOR WITH NEBULIZER, AMS-H-03; OLO-1 MEDICAL MOLECULAR SIEVE OXYGEN GENERATOR",CHINA,Not yet recruiting,Guangzhou Institute of Respiratory Disease,"October 31, 2020",Interventional,A Clinical Trial to Evaluate the Efficacy and Safety of Hydrogen-oxygen Mixed Gas Inhalation in Convalescent Severe/Critically Ill Patients With Novel Coronavirus Pneumonia (COVID-19)
3916,Maternal Telemental Health Interventions in Response to Covid-19*,PERINATAL DEPRESSION; SPECIFIC PHOBIA; PERINATAL ANXIETY,"February 08, 2021",58,NCT04594525,LOW-INTENSITY PSYCHOSOCIAL INTERVENTIONS THROUGH TELEMENTAL HEALTH,,Not yet recruiting,Hamad Medical Corporation,November 2020,Interventional,Low-intensity Psychosocial Interventions in Pregnant Women in Response to COVID-19: Maternal Mental Health Matters An Interventional Study
3917,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,"ARDS, HUMAN; COVID","February 08, 2021",46,NCT04594668,SENICAPOC,DENMARK,Recruiting,University of Aarhus,"April 24, 2020",Interventional,"Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency - A Randomized, Open-Label, Phase II Trial"
3918,"Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection",STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PYOGENES INFECTION; NEISSERIA MENINGITIDES MENINGITIS,"February 08, 2021",150,NCT04594785,,FRANCE,Recruiting,"University Hospital, Montpellier","October 1, 2020",Observational,"Evaluation of Post Infectious Inflammatory Reaction (PIIR) in a Retrospective Study Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection"
3919,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,"DEPRESSION; ANXIETY; SUBSTANCE USE; STRESS, PSYCHOLOGICAL; STRESS, EMOTIONAL; ALCOHOL USE, UNSPECIFIED; DRUG USE; COVID","February 08, 2021",240,NCT04595084,MINDFULNESS BASED COGNITIVE THERAPY FOR RESILIENCE DURING COVID-19 PLUS CHAMINDWELL; INTERNET COGNITIVE BEHAVIORAL THERAPY PLUS CHAMINDWELL; CHAMINDWELL,,Not yet recruiting,Cambridge Health Alliance,"February 15, 2021",Interventional,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use
3920,Inspiratory Muscle Training in COVID-19 Patients,COVID; EXERCISE,"February 08, 2021",120,NCT04595097,INSPIRATORY MUSCLE TRAIING,BRAZIL,Not yet recruiting,Escola Superior de Ciencias da Saude,"February 1, 2021",Interventional,Adjunctive Inspiratory Muscle Training for Patients With COVID-19
3921,Hemostatic Profile in Patients Affected by COVID-19,COVID; THROMBOSIS,"February 08, 2021",400,NCT04595110,OBSERVATIONAL STUDY,ITALY,Recruiting,ANNA FALANGA,"March 25, 2020",Observational,Extensive Investigation of the Hemostatic Profile in a Prospective Cohort of Patients Affected by COVID-19
3922,Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19),POST TRAUMATIC STRESS DISORDER; DEPRESSION; ANXIETY; PSYCHOLOGICAL DISTRESS,"February 08, 2021",3900,NCT04595123,,ALBANIA,Recruiting,University of Minho,"June 15, 2020",Observational,Impact of COVID-19 Pandemic in Perinatal Mental Health
3923,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,SARS-CoV2 INFECTION,"February 08, 2021",60,NCT04595136,DRUG COVID19-0001-USR; NORMAL SALINE,COLOMBIA,Not yet recruiting,United Medical Specialties,"November 2, 2020",Interventional,A Two-arm Randomized Double-blind Study With COVID19-0001-USR Administered Via Nebulization to Patients With Mild and/or Moderate Severe Acute Respiratory Syndrome (SARS-COV-2) Infection to Decrease Viral Load
3924,Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW),COVID INFECTION,"February 08, 2021",2000,NCT04595175,,UNITED STATES,Recruiting,"Brian Tiffany, MD","June 10, 2020",Observational [Patient Registry],Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW)
3925,Semen Analysis Changes in Covid-19 Positivepatients,COVID,"February 08, 2021",100,NCT04595240,SEMEN ANALYSIS,EGYPT,Completed,Assiut University,"May 1, 2020",Observational,Semen Analysis Changes in Covid-19 Positive Patients
3926,The Effect of Clear Masks in Improving Patient Relationships,COMMUNICATION; TRUST; COVID; SURGERY,"February 08, 2021",200,NCT04595695,TRANSPARENT MASK; TYPICAL SURGICAL COVERED MASK,UNITED STATES,Completed,"University of North Carolina, Chapel Hill","September 3, 2020",Interventional,The Effect of Clear Masks in Improving Patient Relationships
3927,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",COVID,"February 08, 2021",90,NCT04595773,AEROBIC EXERCISE TRAINING; EDUCATION,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"January 22, 2021",Interventional,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): A Randomized Controlled Trial"
3928,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device,SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",40,NCT04595903,HEMOPURIFIER,UNITED STATES,Not yet recruiting,Aethlon Medical Inc.,January 2021,Interventional,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device
3929,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)",COVID,"February 08, 2021",124,NCT04596085,INVESTIGATIONAL PRODUCT - VIRACIDE; PLACEBO - STARCH POWDER SOFT GELS,INDIA,Recruiting,"The Herb, Inc","September 16, 2020",Interventional,"A Double Blind, Randomized, Placebo Controlled Study to Evaluate Efficacy and Safety of ""VIRACIDE"" in the Management of Corona Virus Disease 2019 (COVID-19)"
3930,Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.,SARS-CoV2,"February 08, 2021",100,NCT04596098,BLOOD SAMPLING,FRANCE,Recruiting,"University Hospital, Grenoble","April 30, 2020",Observational,Immune Responses to COVID-19 (SARS-CoV-2 Related Infection); Isolation of Human Neutralizing Monoclonal Antibodies for Therapeutics and Vaccine Design Approaches: a Prospective Monocentric Trial With Collaborative Sample Collection.
3931,SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida,CORONAVIRUS INFECTION,"February 08, 2021",1200,NCT04596579,SARS-COV-2 ANTIBODY ANALYSIS; WECK-CEL SWAB COLLECTION; WEB BASED QUESTIONNAIRE,UNITED STATES,Enrolling by invitation,H. Lee Moffitt Cancer Center and Research Institute,"October 9, 2020",Observational,SARS-CoV-2 Immune Surveillance Among a Population Based Sample of Adults in Florida
3932,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,RESPIRATORY TRACT INFECTIONS; COVID; FLU LIKE ILLNESS,"February 08, 2021",2099,NCT04596657,VITAMIN D SUPPLEMENTATION,UNITED STATES,Recruiting,The Cooper Health System,"October 27, 2020",Interventional,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections in Hospital Workers: a Pragmatic Study
3933,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),COVID,"February 08, 2021",60,NCT04596839,REMDESIVIR; STANDARD OF CARE,BANGLADESH,Recruiting,Dr. Md. Alimur Reza,"September 4, 2020",Interventional,"Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19): An Open Label, Multi-Center, Randomized Controlled Trial"
3934,RGD PET/CT Imaging in COVID-19 Patients,COVID; ENDOTHELIAL DYSFUNCTION; PET IMAGING,"February 08, 2021",10,NCT04596943,[68GA]GA-DOTA-(RGD)2 PET/CT,NETHERLANDS,Recruiting,Radboud University,"October 15, 2020",Observational,[68Ga]Ga-DOTA-(RGD)2 PET/CT Imaging of Activated Endothelium in Lung Parenchyma of COVID-19 Patients
3935,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,COVID; AKI,"February 08, 2021",35,NCT04597034,AN69-OXIRIS; AN69-STANDARD,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"October 2, 2020",Interventional,"A Randomized, Controlled Trial to Evaluate Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) in Comparison With a Semi Selective Semipermeable Membrane (Standard AN-69) in COVID-19 Associated Acute Kidney Injury: oXAKI-COV Study."
3936,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,COVID,"February 08, 2021",200,NCT04597047,CAPILLARY COLLECTION & TESTING; VENOUS DRAW & TESTING,UNITED STATES,Recruiting,LumiraDx UK Limited,"August 20, 2020",Interventional,"A Multicenter Covid-19 Study Conducted to Evaluate the Agreement Between Fingerstick Whole Blood, Venous Whole Blood, Plasma & Serum as Determined on the LumiraDx POC SARS-CoV-2 Ab Test & to Evaluate the Ease of Use at Point of Care Sites"
3937,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),COVID,"February 08, 2021",200,NCT04597216,SAMPLE OF BLOOD AND SALIVA,FRANCE,Recruiting,"University Hospital, Grenoble","October 15, 2020",Interventional,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix
3938,Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia,MRSA BLOODSTREAM INFECTION; MRSA BACTEREMIA; MRSA RIGHT-SIDED ENDOCARDITIS; COVID,"February 08, 2021",,NCT04597242,EXEBACASE,UNITED STATES,Available,ContraFect,,Expanded Access,Expanded Access Study of a Single Dose of Exebacase in Addition to Antistaphylococcal Antibiotics for the Treatment of Persistent Methicillin-Resistant Staphylococcus Aureus (MRSA) Bloodstream Infections (Including Right Sided Endocarditis) in Patients Who Are Hospitalized With Coronavirus Disease 2019 (COVID-19)
3939,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),COVID; CONTACT CASE,"February 08, 2021",100,NCT04597736,"BIOLOGICAL COLLECTION WITH NASOPHARYNGEAL SAMPLES, SALIVA, BLOOD, STOOL AND URINE",FRANCE,Not yet recruiting,"University Hospital, Clermont-Ferrand",November 2020,Interventional,Biological Collection for the Study of the Relationship Between the Biological Profiles Observed and the Clinical Evolutions Within the Same Cluster of Transmission of the Coronavirus SARS-CoV-2
3940,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,SARS-COV INFECTION,"February 08, 2021",93,NCT04597775,HYDROXYCHLOROQUINE,,Not yet recruiting,"Regional Center for Disease Control and Prevention, Jordan","October 27, 2020",Interventional,"A Prospective, Randomized, Adaptive Phase II/III Clinical Trial, Controlled, Open-label, 3-arms, Parallel, Multi-centred, Chemoprevention of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis For COVID-19"
3941,Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome,COVID; ARDS,"February 08, 2021",25,NCT04597853,ASSESSMENT OF LUNG MECHANICS AND HEART-LUNG INTERACTIONS,,Not yet recruiting,University of Zurich,"October 20, 2020",Observational,"Assessment of Lung Mechanics in SARS-CoV-2/ COVID-19 Acute Respiratory Distress Syndrome: A Holistic, Longitudinal Analysis of the Lung-heart-ventilator Interaction"
3942,Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic,COVID,"February 08, 2021",77,NCT04598256,ENDOSCOPIC PROCEDURE,TURKEY,Completed,Tepecik Training and Research Hospital,"June 1, 2020",Observational [Patient Registry],Evaluation of Children Who Were Underwent Endoscopic Procedures in the Normalization Process of Covid-19 Pandemic
3943,Cytokine Storm Among Bangladeshi Patients With COVID-19,"CYTOKINE STORM, COVID","February 08, 2021",75,NCT04598334,,BANGLADESH,Not yet recruiting,"International Centre for Diarrhoeal Disease Research, Bangladesh","February 15, 2021",Observational,"Investigating the Inflammatory Cytokines and Cytokine Storm Among Bangladeshi Patients With COVID-19: a Prospective, Observational Study"
3944,Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19,COVID; PREGNANCY RELATED,"February 08, 2021",225,NCT04598347,,SPAIN,Recruiting,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,"August 8, 2020",Observational [Patient Registry],Valuation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19
3945,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19",SEVERE-ACUTE-RESPIRATORY-SYNDROME-CORONAVIRUS-2 (SARS-CoV2),"February 08, 2021",22,NCT04598581,LOW DOSE RADIATION THERAPY (LD-RT); SHAM IRRADIATION,SWITZERLAND,"Active, not recruiting","University Hospital, Basel, Switzerland","November 2, 2020",Interventional,Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)
3946,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,COVID; SARS-ASSOCIATED CORONAVIRUS AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE,"February 08, 2021",220,NCT04598594,"PATCH, NICOTINE; PATCH, PLACEBO",FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"November 6, 2020",Interventional,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients
3947,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,COVID; CORONAVIRUS INFECTION,"February 08, 2021",50,NCT04598620,,DENMARK,Recruiting,Inger Lise Gade,"September 19, 2020",Observational,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate
3948,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive,OLFACTION DISORDERS,"February 08, 2021",80,NCT04598763,SMELL THE ODORS OF THE OLFACTORY REHABILITATION KIT ACCORDING TO THE CLASSIC OR INTENSIVE METHOD,FRANCE,Recruiting,"Central Hospital, Nancy, France","July 1, 2020",Interventional,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive
3949,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR,COVID,"February 08, 2021",144,NCT04599959,SAMPLING OF SARS-COV-2 RNA FROM NASOPHARYNGEAL SWAB SPECIMEN OR SALIVA COLLECTED VIA SALIVETTE CORTISOL,MEXICO,Completed,Boehringer Ingelheim,"October 26, 2020",Interventional,"COVID-19 Tests: a Systematic Comparison of Viral RNA Test Sample Taking for RT-qPCR, in This Case With a Nasopharyngeal Swab or Saliva Collected With Salivette® Cortisol, to Diagnose SARS-CoV-2 Virus Infection"
3950,Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia,COVID,"February 08, 2021",37,NCT04599998,"SPIROMETRY, THORACIC CT, CPET, 6 MINUTE WALKING TEST, SF-36 QUESTIONNAIRE",TURKEY,Enrolling by invitation,Koc University Hospital,"October 15, 2020",Observational,"Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia Related to Lung Functions, Radiology and Exercise Capacity"
3951,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection: a Randomized Clinical Trial,COVID,"February 08, 2021",308,NCT04600141,TOCILIZUMAB; HEPARIN - THERAPEUTIC DOSAGE; HEPARIN - PROPHYLACTIC DOSAGE,,Not yet recruiting,University of Sao Paulo,"October 20, 2020",Interventional,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection: a Randomized Clinical Trial
3952,Convalescent Plasma in the Treatment of Covid-19,COVID; RESPIRATORY INSUFFICIENCY,"February 08, 2021",100,NCT04600440,CONVALESCENT PLASMA,SWEDEN,Recruiting,Skane University Hospital,"April 25, 2020",Interventional,Convalescent Plasma in the Treatment of Covid-19
3953,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,ATRIAL FIBRILLATION PAROXYSMAL,"February 08, 2021",180,NCT04600713,PT-X AND IMT,,Not yet recruiting,Vastra Gotaland Region,January 2021,Interventional,Physiotherapist Led Exercise Within Cardiac Rehabilitation and Inspiratory Muscle Training and Patients With Paroxysmal Atrial Fibrillation - a Randomized Controlled Trial
3954,The Prevent Severe COVID-19 (PRESECO) Study,COVID,"February 08, 2021",826,NCT04600895,FAVIPIRAVIR; PLACEBO,UNITED STATES,Recruiting,Appili Therapeutics Inc.,"November 30, 2020",Interventional,Favipiravir for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19)
3955,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,SARS-CoV2 INFECTION,"February 08, 2021",150,NCT04600999,FAVIPIRAVIR,HUNGARY,Recruiting,University of Pecs,"October 7, 2020",Interventional,An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients With Mild Pneumonia - An Open-label Randomized Controlled Study -
3956,OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection,COVID,"February 08, 2021",40,NCT04601012,OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY,ITALY,Completed,Federico II University,"September 20, 2020",Observational,Optical Coherence Tomography Angiography in Patients Affected by SARS-CoV-2 Infection: a Pilot Study
3957,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,COVID,"February 08, 2021",100,NCT04601077,"NITRIC OXIDE LOZENGES, 30 MG; PLACEBO",UNITED STATES,Recruiting,Nitric Oxide Innovations LLC,"November 1, 2020",Interventional,Pilot Study: The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American Origin
3958,Survival Rates and Longterm Outcomes After COVID-19,COVID; ACUTE RESPIRATORY FAILURE; ACUTE RESPIRATORY DISTRESS SYNDROME; POST INTENSIVE CARE UNIT SYNDROME; SURVIVORSHIP,"February 08, 2021",250,NCT04601090,ICU TREATMENT,NORWAY,Recruiting,Oslo University Hospital,"September 16, 2020",Observational [Patient Registry],Survival Rates and Long-term Outcomes for Patients With COVID-19 Admitted to Norwegian ICUs
3959,Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis,HEART FAILURE,"February 08, 2021",1500,NCT04601415,ECG FROM HANDHELD DEVICE,,Not yet recruiting,Imperial College London,"February 1, 2021",Observational,"Diagnosis of Heart Failure in the Post-COVID-19 Clinic, Primary Care and Hospital Setting Using a Digital Stethoscope With Artificial Intelligence (AI) Electrocardiogram (ECG)"
3960,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,SARS-CoV2 INFECTION,"February 08, 2021",1020,NCT04602000,CT-P59/PLACEBO,"KOREA, REPUBLIC OF",Recruiting,Celltrion,"September 25, 2020",Interventional,"A Phase 2/3, Randomized, Parallel-group, Placebo-controlled, Double-Blind Study to Evaluate the Efficacy and Safety of CT-P59 in Combination With Standard of Care in Outpatients With Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Infection"
3961,Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study,COVID; CORONAVIRUS INFECTION; MOBILITY LIMITATION; FRAILTY,"February 08, 2021",211,NCT04602260,,CANADA,Recruiting,McMaster University,"June 9, 2020",Observational,Functional Recovery of Older Hospitalised Patients With COVID-19: a Prospective and Retrospective Cohort Study Extension to the Coronavirus Registry (COREG)
3962,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),"PAIN, INTRACTABLE; PAIN, CHRONIC","February 08, 2021",292,NCT04602286,MEDITATION (1 X 20-MINUTE GUIDED AUDIO TRAINING),AUSTRALIA,Recruiting,The University of Queensland,"October 28, 2020",Interventional,"An Online Randomized Controlled Trial Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Pain Experience in Adults With Recurrent and Chronic Pain"
3963,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),CATASTROPHIZING CORONAVIRUS (COVID),"February 08, 2021",624,NCT04602312,MEDITATION (1 X 20-MINUTE GUIDED AUDIO TRAINING),AUSTRALIA,Recruiting,The University of Queensland,"October 28, 2020",Interventional,"Online RCT Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Coronavirus-related Catastrophizing in Adults"
3964,Communication in ICU During COVID-19,COVID; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",200,NCT04602351,COMMUNICATION,UNITED ARAB EMIRATES,Not yet recruiting,NMC Specialty Hospital,"January 15, 2021",Observational,"Communication in ICU During COVID-19: Multinational, Multicentric Cross-sectional Survey (ComICU)"
3965,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,COVID; SARS-CoV2 PNEUMONIA; COVID,"February 08, 2021",90,NCT04602442,EXO 1 INHALATION; EXO 2 INHALATION; PLACEBO INHALATION,RUSSIAN FEDERATION,Enrolling by invitation,Olga Tyumina,"October 1, 2020",Interventional,The Extended Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Two-Sided Pneumonia
3966,COVID-19 in People With Primary Ciliary Dyskinesia,PRIMARY CILIARY DYSKINESIA,"February 08, 2021",1000,NCT04602481,,SWITZERLAND,Recruiting,University of Bern,"May 31, 2020",Observational,COVID-19 in People With Primary Ciliary Dyskinesia
3967,Ivermectin in Adults With Severe COVID-19.,COVID; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",100,NCT04602507,IVERMECTIN; PLACEBO,COLOMBIA,Recruiting,CES University,"December 7, 2020",Interventional,Ivermectin in Adults With Severe COVID-19. Double-blind Randomized Clinical Trial
3968,Preserving Compassionate End of Life Care in the Pandemic,"DEATH; COMMUNICATION, MULTIDISCIPLINARY; EMPATHY; COMPASSION; FAMILY MEMBERS; BEREAVEMENT; EMPOWERMENT; PATIENT ENGAGEMENT","February 08, 2021",135,NCT04602520,3 WISHES PROJECT,CANADA,Recruiting,McMaster University,"March 16, 2020",Observational,Dying During the Pandemic: Preserving Compassionate End-of-Life Care
3969,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study,MONITOR TRAINING LOAD,"February 08, 2021",3,NCT04602637,TRAINING LOAD,ARGENTINA,"Active, not recruiting",Kine Kinesiologia Deportiva y Funcional,"December 15, 2019",Observational,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study
3970,Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,WELL-BEING,"February 08, 2021",350,NCT04602832,ENDURING HAPPINESS AND CONTINUED SELF-ENHANCEMENT (ENHANCE) FOR COVID-19,CANADA,Enrolling by invitation,University of British Columbia,"October 14, 2020",Interventional,A Randomized Controlled Trial of an Online Well-Being Intervention (The ENHANCE Program) for Improving Individuals Health and Well-Being During the COVID-19 Pandemic
3971,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,COVID,"February 08, 2021",108,NCT04602871,BREATH BIOPSY,ISRAEL,Recruiting,Scentech Medical Technologies Ltd,"July 3, 2020",Interventional,Early Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Feasibility Study
3972,Early Detection of COVID-19 Using Breath Analysis,COVID,"February 08, 2021",50,NCT04602884,BREATH BIOPSY SAMPLING USING THE RECIVA BREATH SAMPLER,ISRAEL,Suspended,Scentech Medical Technologies Ltd,"September 22, 2020",Interventional,Early Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis: First Cross-Sectional Study
3973,Detection of COVID-19 Using Breath Analysis - Validation Study,COVID,"February 08, 2021",4000,NCT04602949,BREATH BIOPSY ANALYSIS,ISRAEL,Not yet recruiting,Scentech Medical Technologies Ltd,"November 12, 2020",Interventional,Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study
3974,Nurse Leadership for Hospital Infection Control,NURSE'S ROLE; INFECTION,"February 08, 2021",200,NCT04603079,INTERVENTION FOR COVID-19 PREVENTIVE PROTOCOLS,,Not yet recruiting,"Forman Christian College, Pakistan","April 1, 2021",Interventional,A Randomized Control Trial to Change Nurse Leadership in Maintaining Minimum Service Delivery Standards for Hospital Infection Control in the Era of COVID-19
3975,Digital Health Literacy Intervention for Disadvantaged Women During Corona,HEALTH LITERACY,"February 08, 2021",1000,NCT04603092,DIGITAL HEALTH LITERACY INTERVENTION,,Not yet recruiting,"Forman Christian College, Pakistan","April 1, 2021",Interventional,Digital Health Literacy Intervention by Community Health Workers for Corona Preventive Behaviors for Disadvantaged Women at Primary Level
3976,CCP Cancer UK Companion Study,CANCER; COVID,"February 08, 2021",9000,NCT04603105,,,Not yet recruiting,The Clatterbridge Cancer Centre NHS Foundation Trust,"February 28, 2021",Observational,Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK) - a Prospective Companion Study for Patients With Cancer and COVID-19
3977,Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19,COVID,"February 08, 2021",,NCT04603651,BAMLANIVIMAB,,No longer available,Eli Lilly and Company,,Expanded Access,Expanded Access Information for Physicians for Bamlanivimab (LY3819253) Emergency Investigational New Drug [EIND]
3978,Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection,"BIOCHEMICAL MARKERS ,NGAL,CYSTATIN C, ACUTE KIDNEYINJURY, COVID","February 08, 2021",88,NCT04603664,SERUM NGAL AND CYSTATIN C,EGYPT,Recruiting,Ain Shams University,"October 30, 2020",Observational,Role of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C in Prediction of Acute Kidney Injury in Patients With Covid-19 Infection
3979,Northern Colorado COVID-19 Biobank,COVID,"February 08, 2021",200,NCT04603677,,UNITED STATES,Enrolling by invitation,Colorado State University,"July 8, 2020",Observational,Northern Colorado Coronavirus Biobank: A Biorepository for Acute and Convalescent Patient Samples From Coloradoans Infected With SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2)
3980,Study to Investigate the Benefits of Colchicine in Patients With COVID-19,COVID,"February 08, 2021",0,NCT04603690,COLCHICINE,,Withdrawn,Liaquat University of Medical & Health Sciences,"December 15, 2020",Interventional,"A Randomized, Open-labeled, and Controlled Trial to Study the Benefits of Colchicine in Patients With COVID-19"
3981,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,COVID DISEASE,"February 08, 2021",100,NCT04603729,DEXAMETHASONE 2 MG/ML; METHYLPREDNISOLONE INJECTION,PAKISTAN,Completed,Fatima Memorial Hospital,"May 30, 2020",Interventional,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease
3982,"Anakinra, COVID-19, Cytokine Storm",COVID; CYTOKINE STORM; MECHANICAL VENTILATION COMPLICATION,"February 08, 2021",100,NCT04603742,ANAKINRA; 0.9% SALINE,UNITED STATES,Not yet recruiting,Weill Medical College of Cornell University,November 2020,Interventional,"Anakinra in Adults With Severe COVID-19 and Features of Cytokine Storm Syndrome: A Randomized, Double-blind, Placebo-controlled Trial"
3983,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome,SARS-COV INFECTION; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",15,NCT04603755,ELECTRICAL IMPEDANCE TOMOGRAPHY,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"October 26, 2020",Observational,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome
3984,CBD Oil for Reducing Emotional Impact of COVID-19,ANXIETY DEPRESSION; ALCOHOL ABUSE; SUBSTANCE ABUSE; ANGER; SLEEP DISTURBANCE; STRESS REACTION,"February 08, 2021",120,NCT04603781,CBD ISOLATE; FULL SPECTRUM CBD OIL; PLACEBO OIL,UNITED STATES,Recruiting,University of Texas at Austin,"December 4, 2020",Interventional,Use of CBD Oil for Reducing the Negative Emotional Impact of COVID-19: A Randomized Placebo-Controlled Clinical Trial
3985,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,COVID,"February 08, 2021",60,NCT04603794,0.5% POVIDONE IODINE; 0.12% CHLORHEXIDINE GLUCONATE MOUTH RINSE; 1% HYDROGEN PEROXIDE; 0.9% NORMAL SALINE,UNITED STATES,Recruiting,Ohio State University,"October 1, 2020",Interventional,"Comparison of Normal Saline, Hydrogen Peroxide, Chlorhexidine and Povidone-Iodine Mouth Rinses in COVID-19 Patients"
3986,Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients,COVID,"February 08, 2021",436,NCT04603924,NICLOSAMIDE; PLACEBO,UNITED STATES,Recruiting,ANA Therapeutics,"October 7, 2020",Interventional,A Phase 2/3 Randomized and Placebo-Controlled Study of ANA001 in Moderate and Severe COVID-19 Patients
3987,Inspiratory Muscle Training in Patients With COVID-19,COVID; RESPIRATORY DISEASE,"February 08, 2021",55,NCT04603963,POWER BREATHE,BRAZIL,Terminated,Elaine Cristina Pereira <elaine.cpereira@einstein.br>,"June 1, 2020",Interventional,Efects of Inspiratory Muscle Training in Patients With COVID-19 After Acute Phase. Prospective Study
3988,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan,"DEPRESSION, ANXIETY","February 08, 2021",390,NCT04604080,SERVICE OF QUESTIONNAIRE,PAKISTAN,Completed,Islamia University of Bahawalpur,"November 1, 2020",Observational,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan
3989,Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic,SARS-CoV2; ANXIETY; BURNOUT,"February 08, 2021",104,NCT04604119,,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"May 1, 2020",Observational [Patient Registry],Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic
3990,Evaluation of Self-Collected Saliva Samples Without Viral Transport Media for SARS-CoV-2 Testing Via RT-PCR,SARS-COV INFECTION; POLYMERASE CHAIN REACTION; LABORATORY TESTING,"February 08, 2021",600,NCT04604145,SARS-COV-2 TESTING ON THE EPPENDORF THERMAL CYCLER PCR SYSTEM USING SELF-COLLECTED SALIVA AS THE SPECIMEN,,Not yet recruiting,David Grant U.S. Air Force Medical Center,October 2020,Interventional,Evaluation of Self-Collected Saliva Samples Without Viral Transport Media for SARS-CoV-2 Testing Via RT-PCR
3991,ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19,COVID,"February 08, 2021",130,NCT04604184,BI 764198; PLACEBO,BRAZIL,Recruiting,Boehringer Ingelheim,"November 3, 2020",Interventional,BI 764198 Efficacy and Safety in Prevention/Progression of ARDS and ARDS-related Complications Secondary to COVID-19 (ACTION ON COVID-19)
3992,Effect of Pioglitazone on T2DM Patients With COVID-19,COVID; TYPE 2 DIABETES,"February 08, 2021",1506,NCT04604223,PIOGLITAZONE 45 MG,,Not yet recruiting,Dasman Diabetes Institute,"November 15, 2020",Interventional,Effect of Pioglitazone on Inflammatory Response and Clinical Outcome in T2DM Patients With COVID-19
3993,Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World,COVID; HIGH ALTITUDE,"February 08, 2021",200,NCT04604249,"SARS-COV-2 RAPID DIAGNOSTIC TEST (COVID-PRESTO® IGM/IGG, AAZ, BOULOGNE-BILLANCOURT, FRANCE)",PERU,"Active, not recruiting",Centre d'Expertise sur l'Altitude EXALT,"October 26, 2020",Observational,"Prevalence of COVID-19 and Risk Factors Associated With Seroconversion in La Rinconada, the Highest City of the World - 5,100 m"
3994,Comparison of Two Different Doses of Bemiparin in COVID-19,COVID,"February 08, 2021",164,NCT04604327,BEMIPARIN SODIUM,SPAIN,Recruiting,"Clinica Universidad de Navarra, Universidad de Navarra","October 26, 2020",Interventional,"Ensayo clínico Aleatorizado, Abierto, Para Evaluar el Efecto de Dosis profilácticas o terapéuticas de Bemiparina en Pacientes Con COVID-19"
3995,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,COVID,"February 08, 2021",80,NCT04604678,METFORMIN; NALTREXONE,UNITED STATES,Not yet recruiting,AgelessRx,February 2021,Interventional,Pilot Study Into the Use of Metformin and Low Dose Naltrexone (LDN) for Patients With Coronavirus Disease 2019 (COVID-19) - Assessment of Short and Long Term Effects
3996,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,COVID; LONG COVID; POST-COVID SYNDROME,"February 08, 2021",60,NCT04604704,NALTREXONE; NAD+; PLACEBO,UNITED STATES,Recruiting,AgelessRx,"January 28, 2021",Interventional,Pilot Study Into Low Dose Naltrexone (LDN) and Nicotinamide Adenine Dinucleotide (NAD+) for Treatment of Patients With Post-COVID-19 Syndrome (Long-COVID19)
3997,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,VACCINE REFUSAL,"February 08, 2021",4,NCT04604743,"INTERVENTION, TBN",UNITED STATES,Not yet recruiting,University of Alabama at Birmingham,"January 1, 2021",Interventional,Exploratory Sequential Mixed Methods Cluster Randomized Controlled Implementation Science Trial to Develop a Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for African American Older Adolescents in Rural Alabama
3998,Perceived Stress Among ICU Medical Staff During COVID-19 Crisis,CORONAVIRUS; NURSE'S ROLE; PROFESSIONAL STRESS,"February 08, 2021",60,NCT04604769,,BELGIUM,Completed,University of Liege,"June 26, 2019",Observational,Perceived Stress and Needs Among Medical Staff in ICU During COVID-19 Crisis
3999,Delivering EMT Via Telehealth to Children and Families,LANGUAGE IMPAIRMENT,"February 08, 2021",28,NCT04604821,ENHANCED MILIEU TEACHING; PARENT EDUCATION,,Not yet recruiting,Oregon Health and Science University,"October 20, 2020",Interventional,Delivering Enhanced Milieu Teaching (EM-Teach) Via Telehealth to Children and Families in Rural Communities
4000,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,HEADACHES CHRONIC,"February 08, 2021",25,NCT04604977,MINDFULNESS,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"September 15, 2020",Interventional,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Chronic Migraine and High Frequency Migraine Without Aura After the Covid-19 Emergency
4001,Lockdown Impact on Spontaneous Premature Birth in a Level III NICU,PREMATURE BIRTH; PRETERM LABOR,"February 08, 2021",1000,NCT04605172,HOSPITALIZATION FOR PREMATURE BIRTH,FRANCE,Enrolling by invitation,"Central Hospital, Nancy, France","November 2, 2020",Observational,The Impact of the SARS CoV-2 Lockdown Policy on Spontaneous Premature Birth at the Regional University Maternity Hospital of Nancy
4002,A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19,SARS-COV INFECTION; COVID,"February 08, 2021",70,NCT04605588,NITAZOXANIDE; PLACEBO NITAZOXANIDE; RIBAVIRIN; PLACEBO RIBAVIRIN; HYDROXYCHLOROQUINE; PLACEBO HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","December 2, 2020",Interventional,"A Triple Combination Antiviral Coronavirus Therapy (TriACT) RCT Comparing Nitazoxanide, Ribavirin and Hydroxychloroquine vs. Placebo"
4003,Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic,BURNOUT; COVID; DENTISTRY; FILIATION; PANDEMIC,"February 08, 2021",706,NCT04605692,,TURKEY,Completed,Akdeniz University,"March 9, 2020",Observational,Attitudes and Predictive Factors of Psychological Distress and Occupational Burnout Among Dentists During COVID-19 Pandemic in Turkey
4004,Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study,SARS-CoV2 PNEUMONIA,"February 08, 2021",100,NCT04605757,"CLINICAL, FUNCTIONAL AND RADIOLOGICAL LUNG INVOLVEMENT EVOLUTION",ITALY,Recruiting,Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi,"July 30, 2020",Observational,Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Long-term Impact and Predictors of Possible Lasting Damage: Follow the Covid Study
4005,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,COVID,"February 08, 2021",120,NCT04605887,ANGIOTENSIN 1-7,ISRAEL,Recruiting,Rambam Health Care Campus,"January 18, 2021",Interventional,Angiotensin 1-7 as a Therapy for Pneumonia Caused by Coronavirus 2(SARS-CoV-2)
4006,A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19,CORONAVIRUS,"February 08, 2021",0,NCT04605926,EQ001; EQ001 PLACEBO,COLOMBIA,Withdrawn,Equillium,November 2020,Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Itolizumab in Subjects Hospitalized With COVID-19"
4007,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,COVID,"February 08, 2021",201,NCT04605952,REPEAT SARS-COV-2 IGG ANTIBODIES AT 45-65 DAYS,INDIA,Completed,Tata Main Hospital,"July 1, 2020",Observational,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive
4008,WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19,COVID; CARDIOVASCULAR COMPLICATION; BEHAVIORAL CHANGES,"February 08, 2021",100,NCT04605965,,UNITED STATES,Recruiting,Tulane University,"June 9, 2020",Observational [Patient Registry],Wearable Health Data to Investigate Long-term Cardiovascular and Behavioral Health Outcomes in COVID-19 Patients After Discharge: The WEAICOR Study
4009,Treat COVID-19 Patients With Regadenoson,COVID; LUNG INFLAMMATION,"February 08, 2021",40,NCT04606069,REGADENOSON; PLACEBO CONTROL,UNITED STATES,Not yet recruiting,"University of Maryland, Baltimore","November 1, 2020",Interventional,Clinical Trial on the Safety and Efficacy of Regadenoson for Moderate to Severe COVID-19 Adult Patients
4010,Inhaled NO for the Treatment of Viral Pneumonia in Adults,"VIRAL PNEUMONIA; NITRIC OXIDE; RESPIRATORY DISEASE; PNEUMONIA, VIRAL; INHALED NITRIC OXIDE; COVID; SARS-COV INFECTION","February 08, 2021",90,NCT04606407,LUNGFIT™,ISRAEL,Recruiting,Beyond Air Inc.,"November 25, 2020",Interventional,"Prospective, Open-label, Randomized, Multi-Center Study for Safety and Efficacy Evaluation of Inhaled Nitric Oxide (NO) Given Intermittently to Adults With Viral Pneumonia"
4011,Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study,COVID,"February 08, 2021",200,NCT04606498,OBSERVATIONAL,UNITED STATES,Recruiting,Henry M. Jackson Foundation for the Advancement of Military Medicine,"December 18, 2020",Observational,Blood Purification With Seraph® 100 Microbind® Affinity Blood Filter for the Treatment of Severe COVID-19: An Observational Study (PURIFY-OBS-1)
4012,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,COVID; SARS-COV INFECTION,"February 08, 2021",1372,NCT04606563,LOSARTAN,BELGIUM,Recruiting,University of British Columbia,"October 9, 2020",Interventional,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?
4013,CardioVascular Disease Progression and Prognosis in COVID-19,COVID,"February 08, 2021",2000,NCT04606732,,ITALY,Recruiting,University of Bologna,"September 20, 2020",Observational [Patient Registry],"Cardiovascular Clinical Features and Cardiovascular Therapies in the Development, Progression and Outcome of Patients With SARS-Cov-2 Related Pneumonia"
4014,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,COVID,"February 08, 2021",40,NCT04606784,AMPION; STANDARD OF CARE,UNITED STATES,Recruiting,Ampio Pharmaceuticals. Inc.,"October 28, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Nebulized Ampion In Adults With Respiratory Distress Secondary to COVID-19 Infection
4015,Harnessing Network Science to Personalize Scalable Interventions for Adolescent Depression (TRACK to TREAT Phase 2),DEPRESSION,"February 08, 2021",216,NCT04607902,SUPPORTIVE THERAPY SSI; BEHAVIORAL ACTIVATION SSI; GROWTH MINDSET SSI,UNITED STATES,Not yet recruiting,Stony Brook University,February 2021,Interventional,Harnessing Network Science to Personalize Scalable Interventions for Adolescent Depression: Do Idiographic Symptom Structures Predict Response to Single Session Interventions?
4016,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,TYPE 2 DIABETES,"February 08, 2021",30,NCT04607915,INTERVENTION FOR TECC MODEL,,Not yet recruiting,Centre for Addiction and Mental Health,"February 5, 2021",Interventional,Technology-enabled Collaborative Care for Diabetes (TECC-Diabetes) Management During COVID: A Feasibility Study
4017,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,FIBROTIC PULMONARY SEQUELAE POST-COVID INFECTION,"February 08, 2021",148,NCT04607928,PIRFENIDONE; PLACEBO,SPAIN,Recruiting,Institut d'Investigació Biomèdica de Bellvitge,"August 1, 2020",Interventional,Phase-II Randomized Clinical Trial to Evaluate the Effect of Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis
4018,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19",COVID,"February 08, 2021",57720,NCT04607941,QUESTIONNAIRES; PHONE INTERVIEWS,FRANCE,Recruiting,Institut Pasteur,"October 27, 2020",Observational,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2"
4019,Understanding Reactions to Emotional Material in the Media During COVID-19,HEALTHY PARTICIPANTS; INTRUSIVE MEMORIES,"February 08, 2021",66,NCT04608097,SIMPLE COGNITIVE TASK INTERVENTION; ATTENTION PLACEBO,SWEDEN,Recruiting,Uppsala University,"October 28, 2020",Interventional,Understanding Reactions to Emotional Material in the Media During COVID-19 and the Connections to Cognitive Activities
4020,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,SARS-CoV2,"February 08, 2021",220,NCT04608201,NICOTINE 7 MG/ 24H TRANSDERMAL PATCH - 24 HOUR; PLACEBO OF NICOTINE TRANSDERMAL PATCH,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"December 9, 2020",Interventional,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
4021,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),SARS-CoV2,"February 08, 2021",100,NCT04608214,ALISPORIVIR; STANDARD OF CARE (SOC),FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 1, 2020",Interventional,"Evaluation of the Efficacy, Safety and Tolerability of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19). A Randomised, Open-label, Proof of Concept, Phase 2 Study"
4022,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,COVID,"February 08, 2021",596,NCT04608266,CAMOSTAT MESYLATE; PLACEBO,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"December 3, 2020",Interventional,A Multicenter Randomized Trial to Evaluate the Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients (CAMOVID)
4023,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine",COVID,"February 08, 2021",1040,NCT04608305,"IIBR-100, LOW DOSE (PRIME); IIBR-100 MEDIUM DOSE (PRIME); IIBR-100 HIGH-DOSE (PRIME); IIBR-100 LOW-DOSE (PRIME-BOOST); SALINE PLACEBO; SALINE PLACEBO",ISRAEL,Recruiting,Israel Institute for Biological Research (IIBR),"October 28, 2020",Interventional,"A Phase I/II Randomized, Multi-Center, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine (IIBR-100) in Adults"
4024,Laparoscopy and COVID-19 Contamination,COVID,"February 08, 2021",20,NCT04608383,ADDITIONAL AND MINIMAL COLLECTION OF PRODUCTS OF THE HUMAN BODY CARRIED OUT DURING A SAMPLE FOR STANDARD OF CARE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 1, 2020",Observational,Laparoscopy and COVID-19 Contamination
4025,Long-term Follow up in Survivors of Critical Illness,POST INTENSIVE CARE UNIT SYNDROME,"February 08, 2021",160,NCT04608994,,ITALY,Recruiting,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,"June 1, 2020",Observational,Long-term Follow-up in Survivors of Critical Illness: An Longitudinal Assessment of Critically Ill Patients Discharged Alive From the Intensive Care Unit
4026,SARS-COV2 Pandemic Serosurvey in a Rare Disease Population,SARS-CoV2 VIRUS,"February 08, 2021",5000,NCT04609085,,UNITED STATES,Enrolling by invitation,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,SARS-COV2 Pandemic Serosurvey in a Rare Disease Population
4027,Endothelial Damage and Angiogenesis Biomarkers During COVID-19,COVID; ANGIOGENESIS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR MORBIDITY,"February 08, 2021",40,NCT04609332,ENDOTHELIAL DAMAGE AND ANGIOGENIC BIOMARKERS,CHILE,Recruiting,University of Chile,"November 10, 2020",Observational [Patient Registry],Association of Endothelial Damage and Angiogenesis Biomarkers With Morbidity and Mortality in SARS-CoV-2 Infection
4028,PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics,"MENTAL HEALTH WELLNESS 1; COACHING; PANDEMIC; DEPRESSION, ANXIETY; SELF-CARE TOOLS","February 08, 2021",176,NCT04609371,SELF-CARE TOOLS; LAY TELEPHONE COACHING,CANADA,Enrolling by invitation,"St. Mary's Research Center, Canada","October 21, 2020",Interventional,Assisting Family Physicians With Gaps in Mental Health Care Generated by the COVID-19 Pandemic: A Randomized Controlled Trial
4029,Cod Liver Oil for Covid-19 Prevention Study,COVID; RESPIRATORY TRACT INFECTIONS,"February 08, 2021",80000,NCT04609423,COD LIVER OIL; CORN OIL (PLACEBO),NORWAY,Recruiting,Oslo University Hospital,"November 10, 2020",Interventional,"A Randomized, Parallel-group Treatment, Quadruple Masked, Two-arm Study, to Assess the Effectiveness of Cod Liver Oil Compared to Placebo in the Prevention of Covid-19 and Airway Infections in Healthy Adults"
4030,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,COVID; ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",196,NCT04609462,CONVENTIONAL OXYGEN THERAPY; HIGH FLOW NASAL CANNULA,COLOMBIA,Recruiting,Fundacion Clinica Valle del Lili,"August 11, 2020",Interventional,A Trial of High-Flow Nasal Cannula vs. Conventional Oxygen Therapy in Patients With SARS-CoV-2-Related Acute Respiratory Failure: the HiFlo-COVID Trial.
4031,Surfactant Levels in the Lungs of COVID-19 Patients,TO ASSESS SURFACTANT LEVELS IN LUNG FLUID,"February 08, 2021",30,NCT04609488,SURFACTANT ASSESSMENT,,Not yet recruiting,Zealand University Hospital,"November 1, 2020",Observational,An Exploratory Study to Assess Surfactant Levels in COVID-19 Patients Who Will be on Ventilatory Support Due to Severe Respiratory Failure
4032,"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship",DELIVERY; TRAUMA; COVID,"February 08, 2021",440,NCT04609501,,ISRAEL,"Active, not recruiting",Hillel Yaffe Medical Center,"June 1, 2020",Observational [Patient Registry],"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship in the Shadow of a Socioeconomic Crisis"
4033,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,ANXIETY; PARENTS; COVID,"February 08, 2021",60,NCT04609722,SOLUTION-FOCUSED SUPPORT PROGRAM,TURKEY,Recruiting,Adiyaman University Research Hospital,"July 1, 2020",Interventional,Effect of Solution-Focused Support Program on Anxiety Levels of Parents With Children Aged 3-6 Years During the COVID-19 Pandemic
4034,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019,CORONAVIRUS DISEASE (COVID),"February 08, 2021",8,NCT04609774,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 DETECTION,ARGENTINA,Completed,Hospital Italiano de Buenos Aires,"October 8, 2020",Observational,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus: a Dilemma
4035,FOLLOW-UP OF PATIENTS WITH COVID-19.,PATIENT ADMITTED TO INTENSIVE CARE UNIT FOR COVID,"February 08, 2021",200,NCT04609839,FOLLOW-UP OF PATIENTS WITH COVID-19,FRANCE,Recruiting,"University Hospital, Strasbourg, France","October 27, 2020",Observational,TeleRea'nCo : FOLLOW-UP OF PATIENTS WITH COVID-19.
4036,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS); COVID; CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04609865,LIDOCAINE 2%; CONTROL,FRANCE,Recruiting,"University Hospital, Strasbourg, France","November 4, 2020",Interventional,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
4037,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,COVID; SARS-CoV2 INFECTION,"February 08, 2021",200,NCT04609969,RT-QPCR TEST; COVID-VIRO® TEST,FRANCE,Completed,Centre Hospitalier Régional d'Orléans,"October 13, 2020",Interventional,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test on Nasopharyngeal Specimens i
4038,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,COVID,"February 08, 2021",276,NCT04610138,CNM-ZNAG; PLACEBO,,Not yet recruiting,Clene Nanomedicine,February 2021,Interventional,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ZnAg Liquid Solution to Treat COVID-19 in Acutely Symptomatic Non-Hospitalized Participants"
4039,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),COVID,"February 08, 2021",800,NCT04610489,QUIDEL SOFIA SARS ANTIGEN FIA,,Not yet recruiting,Carilion Clinic,"November 1, 2020",Interventional,Diagnostic Performance of an Antigen Test for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)
4040,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,COVID,"February 08, 2021",26,NCT04610502,ADMINISTRATION OF EQUINE IMMUNOGLOBULIN ANTI SARS-COV-2,COSTA RICA,"Active, not recruiting",Caja Costarricense de Seguro Social,"September 6, 2020",Interventional,"Randomized, Controlled, Double-blind, Multicenter Clinical Study to Compare the Efficacy and Safety of the Administration of Two Hyperimmune Equine Anti-Sars-CoV-2 (""S"" and ""M"") Serum Formulations in Hospitalized Patients With COVID-19"
4041,Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE),COVID; ME/CFS; SARS COV2; NOVEL CORONAVIRUS INFECTION; NEUROCOGNITIVE DISORDERS; CARDIOVASCULAR DISEASES,"February 08, 2021",4800,NCT04610515,,UNITED STATES,Recruiting,Rush University Medical Center,"December 15, 2020",Observational [Patient Registry],Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)
4042,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,SARS-CoV2 INFECTION,"February 08, 2021",2000,NCT04610541,REMDESIVIR-HU,HUNGARY,"Active, not recruiting",University of Pecs,"October 12, 2020",Interventional,Open-label Study to Assess the Safety of REMdesivir-HU as Eligible Novel therapY for Moderate and Severe Covid-19 Patients
4043,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19,COVID PNEUMONIA,"February 08, 2021",74,NCT04610554,,ITALY,Completed,"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy","May 14, 2020",Observational,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19
4044,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),CORONAVIRUS; INFLAMMATION; COVID,"February 08, 2021",100,NCT04610567,METHOTREXATE-LDE PHASE 1; METHOTREXATE-LDE PHASE 2; PLACEBO-LDE PHASE 2,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"October 27, 2020",Interventional,Two Phases Clinical Trial to Evaluate Safety and Efficacy of Methotrexate Associated to LDL Like Nanoparticles (LDE-MTX) in the Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease.
4045,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,COVID,"February 08, 2021",200,NCT04610801,NASAL SPRAY,UNITED STATES,Recruiting,Larkin Community Hospital,"August 8, 2020",Interventional,A Randomized Placebo Control Trial to Evaluate the Efficacy of Xylitol Nasal Spray vs. Placebo for Acute COVID-19 Infection
4046,"A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois",SEVERE ACUTE RESPIRATORY SYNDROME - CORONAVIRUS 2 (SARS-CoV2),"February 08, 2021",1250,NCT04611230,,UNITED STATES,Recruiting,AbbVie,"November 5, 2020",Observational,"EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois: CONTACT"
4047,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19",LUNG FUNCTION; EXERCISE CAPACITY; QUALITY OF LIFE; COVID,"February 08, 2021",80,NCT04611243,KALETRA AND BETA INTERFERON,HONG KONG,Recruiting,Chinese University of Hong Kong,"May 22, 2020",Observational,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19"
4048,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,COVID,"February 08, 2021",20,NCT04611256,MSC; CONTROL,MEXICO,Recruiting,Hospital Reg. Lic. Adolfo Lopez Mateos,"August 1, 2020",Interventional,Adjuvant Therapy With Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 in Critical Condition
4049,Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina,RESPIRATORY FAILURE; COVID; MECHANICAL VENTILATION,"February 08, 2021",950,NCT04611269,,ARGENTINA,Completed,Argentinian Intensive Care Society,"March 20, 2020",Observational [Patient Registry],"Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina: a Prospective, Multicenter Cohort Study"
4050,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,STRESS RELATED DISORDER,"February 08, 2021",90,NCT04611399,VR FOR PSYCHOEDUCATION AND RELAXATION; TEXT MATERIAL FOR PSYCHOEDUCATION AND AUDIO FOR RELAXATION TECHNIQUES,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"February 3, 2021",Interventional,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support
4051,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",ACUTE RESPIRATORY FAILURE; COVID; TRAUMA; STROKE; SEPSIS; SHOCK,"February 08, 2021",30,NCT04611425,REMIMAZOLAM,FRANCE,Not yet recruiting,Nantes University Hospital,"November 1, 2020",Interventional,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19. The Non-randomized, Non-controlled, Pilot, Open, Mono-centric REHSCU Study"
4052,"A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2",SARS-COV INFECTION; COVID,"February 08, 2021",30000,NCT04611802,SARS-COV-2 RS/MATRIX-M1 ADJUVANT; PLACEBO,MEXICO,Recruiting,Novavax,"December 27, 2020",Interventional,"A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years"
4053,Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2,COVID,"February 08, 2021",250,NCT04611841,,RUSSIAN FEDERATION,Enrolling by invitation,Federal Research and Clinical Center of Physical-Chemical Medicine,"July 21, 2020",Observational,Medical-biological Research of the Pathogenesis of Disease Caused by SARS-CoV-2
4054,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru",COVID,"February 08, 2021",6000,NCT04612972,INACTIVATED SARS COV 2 VACCINE (VERO CELL). WUHAN,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"September 10, 2020",Interventional,"Ensayo Clínico de Fase III, Aleatorio, Doble Ciego y Controlado Con Placebo Paralelo, Para Evaluar la Seguridad y la Eficacia Protectora de la Vacuna Inactivada Contra el SARS-CoV-2 en la Población Sana de 18 años o más, en Perú"
4055,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,COVID INFECTION,"February 08, 2021",80,NCT04613050,RESPIRATORY TRAINING; AEROBIC TRAINING,EGYPT,Recruiting,Cairo University,"July 2, 2020",Interventional,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients
4056,Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19,ASTHMA CHRONIC; BRONCHIAL ASTHMA,"February 08, 2021",400,NCT04613245,,EGYPT,Recruiting,Cairo University,"May 1, 2020",Observational [Patient Registry],Health-Related Quality of Life of Patients With Asthma and Its Associated Factors During the Pandemic of COVID-19
4057,Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia,INFECTIOUS DISEASE; SARS-COV INFECTION; COVID,"February 08, 2021",210,NCT04613271,FAVIPIRAVIR; AZITHROMYCIN,INDONESIA,Suspended,Ina-Respond,"October 15, 2020",Interventional,"Phase III, Random-Open, Clinical Trials on the Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia"
4058,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,COVID,"February 08, 2021",120,NCT04613297,BASELINE AND DURING HOSPITALIZATION BLOOD SAMPLES; BASELINE BLOOD SAMPLE,FRANCE,Recruiting,Hopital Foch,"October 19, 2020",Interventional,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment
4059,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),COVID; SARS-CoV2,"February 08, 2021",1250,NCT04613310,RAPID DIAGNOSTIC TEST VS PCR,SWITZERLAND,Recruiting,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland","September 25, 2020",Interventional,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2: a Comparative Clinical Trial
4060,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,ASTHMA,"February 08, 2021",430,NCT04613739,INSURANCE NAVIGATION,UNITED STATES,Recruiting,Harvard Pilgrim Health Care,"December 8, 2020",Interventional,Comparing Patient-Centered Outcomes for Adults and Children With Asthma in High-Deductible Health Plans With and Without Preventive Drug Lists: COVID Enhancement
4061,Sero-prevalence COVID-19 Among Belgian Children,SARS-CoV2; SARS-COV INFECTION; COVID,"February 08, 2021",1640,NCT04613817,,BELGIUM,Recruiting,Sciensano,"December 3, 2020",Observational [Patient Registry],Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children Measured for One Year in Belgium: a Sero-epidemiological Prospective Cohort Study
4062,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,SEVERE COVID,"February 08, 2021",20,NCT04613986,THERAPEUTIC PLASMAEXCHNAGE,,Not yet recruiting,University of Zurich,December 2020,Interventional,"Randomized, Prospective, Open-label, Controlled Parallel-group Trial Investigating the Efficacy of Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat the Systemic Inflammatory Response Against SARS-CoV2 and the Associated Coagulopathy"
4063,Hyperimmune Plasma for Patients With COVID-19,COVID,"February 08, 2021",100,NCT04614012,TREATED WITH HYPERIMMUNE PLASMA,ITALY,Recruiting,ANNA FALANGA,"July 2, 2020",Interventional,The Use of Hyperimmune Plasma for the Treatment of COVID-19 Infection
4064,Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,COVID; ARDS,"February 08, 2021",40,NCT04614025,PLX-PAD,GERMANY,Recruiting,Pluristem Ltd.,November 2020,Interventional,"A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19"
4065,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),PHYSICIAN STRESS LEVELS,"February 08, 2021",84,NCT04614844,SIMULATION INTERVENTION; CONTROL,UNITED STATES,Not yet recruiting,Yale University,"December 15, 2020",Interventional,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS) Randomized Control Trial
4066,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,COVID,"February 08, 2021",100,NCT04614883,VOLATILE ORGANIC COMPOUNDS ANALYSIS; CANINE ODOR DETECTION OF VOLATILE ORGANIC COMPOUNDS,FRANCE,Recruiting,Hopital Foch,"October 21, 2020",Interventional,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in Patients Referred to the Emergency Reception Service for Suspected COVID-19 Infection: Diagnostic Value and for Rapid Screening
4067,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults,PARTICIPANTS WITH OR WITHOUT STABLE CO-MORBIDITIES ASSOCIATED WITH PROGRESSION TO SEVERE COVID,"February 08, 2021",30000,NCT04614948,AD26.COV2.S; PLACEBO,BELGIUM,Recruiting,Janssen Vaccines & Prevention B.V.,"November 12, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older"
4068,SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort,"COVID; CHILDREN, ONLY","February 08, 2021",1000,NCT04615000,SARS-COV-2 SEROLOGICAL ASSESSMENT (IGG),BELGIUM,Recruiting,"University Hospital, Ghent","October 29, 2020",Observational [Patient Registry],SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort
4069,Prevalence of Thrombosis in COVID-Patients,COVID,"February 08, 2021",400,NCT04615026,DUPLEX SONOGRAPHY,GERMANY,Recruiting,University Hospital Augsburg,"November 4, 2020",Observational [Patient Registry],Prevalence of Thrombosis in COVID-Patients in Correlation to Humoral and Cellular Immunity
4070,Home-based Exercise in COVID-19 Survivors,COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); SARS-COV INFECTION,"February 08, 2021",60,NCT04615052,EXERCISE TRAINING,BRAZIL,Recruiting,University of Sao Paulo,"September 26, 2020",Interventional,Home-based Exercise Training in COVID-19 Survivors: a Randomized Controlled Trial
4071,Effect of COVID19-related COntainment in ChildreN,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",1000,NCT04615195,CRIES 13 QUESTIONNAIRE,FRANCE,Recruiting,"University Hospital, Toulouse","June 10, 2020",Observational,Effect of COVID19-related COntainment in ChildreN
4072,Screening for COVID-19,BEING SUSPECTED OF COVID INFECTION,"February 08, 2021",200,NCT04615208,SUSPECTED OF COVID-19 INFECTION,,Not yet recruiting,University of Manitoba,"November 15, 2020",Observational,A Touchless Tool to Screen for COVID-19 for Reopening Industries
4073,Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation,COVID_REHABILITATION,"February 08, 2021",200,NCT04615390,EARLY REHABILITATION; SUBACUTE REHABILITATION; MINDFULNESS TRAINING; PERSONALIZED AMBULATORY TRAINING,ITALY,Recruiting,University Hospital of Ferrara,"March 30, 2020",Observational,Recovery Profiles in Patients With COVID 19 Outcomes Undergoing Rehabilitation
4074,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,"DISTRESS, EMOTIONAL; EMOTIONAL DYSFUNCTION; ANXIETY; DEPRESSION","February 08, 2021",100,NCT04615416,EMOTION REGULATION TRAINING VIA TELEHEALTH,UNITED STATES,Recruiting,"Teachers College, Columbia University","May 1, 2020",Interventional,Open Trial of Emotion Regulation Training Via Telehealth for Distressed Adults During the COVID-19 Pandemic
4075,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID PNEUMONIA,"February 08, 2021",20,NCT04615429,MESENCHYMAL STROMAL CELLS; PLACEBO,SPAIN,"Active, not recruiting",Cristina Avendaño Solá,"September 15, 2020",Interventional,"Double-blind, Randomized, Controlled, Clinical Trial to Assess the Efficacy of Allogenic Mesenchymal Stromal Cells in Patients With Acute Respiratory Distress Syndrome Due to COVID-19"
4076,Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus,SARS-CoV2,"February 08, 2021",4734,NCT04615676,FOLLOW-UP PHONE CALL,FRANCE,Completed,"University Hospital, Toulouse","April 27, 2020",Observational [Patient Registry],Prospective Evaluation of the Predictive Criteria of Severity Related to Patient Calling Emergency Centre for Low or High Respiratory Infection With or Without Fever and Suspected to be COVID-19.
4077,MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC,ACUTE APPENDICITIS,"February 08, 2021",207,NCT04615728,LAPAROSCOPIC OR OPEN APPENDICECTOMY,UNITED KINGDOM,Completed,Cambridge University Hospitals NHS Foundation Trust,"November 1, 2019",Observational,"APPENDICITIS DURING THE COVID-19 PANDEMIC: TO OPERATE OR NOT TO OPERATE, THAT IS THE QUESTION: COHORT STUDY FROM A TERTIARY CENTRE"
4078,Finding Wellness in the Pandemic,"MENTAL HEALTH WELLNESS 1; ADDICTION; STRESS, PSYCHOLOGICAL; COVID","February 08, 2021",200,NCT04615741,TRAUMA INFORMED YOGA; TRAUMA INFORMED PSYCHOTHERAPY,CANADA,Recruiting,University of Lethbridge,"November 1, 2020",Interventional,Improving Health and Wellness During COVID-19
4079,Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,COVID; MYOCARDIAL INJURY,"February 08, 2021",400,NCT04615871,SEMAGLUTIDE,BRAZIL,Not yet recruiting,Vladimír Džavík,"November 30, 2020",Interventional,Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 Randomized Controlled Trial
4080,Nasal Photodisinfection COVID Proof of Concept Study,COVID; CORONAVIRUS INFECTION; SARS-CoV2,"February 08, 2021",100,NCT04615936,METHYLENE-BLUE PHOTODISINFECTION,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"July 10, 2020",Interventional,Methylene Blue-mediated Photodisinfection for SARS-CoV-2 in the Upper Respiratory Tract
4081,Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,COVID; CARDIOVASCULAR DISEASES; CARDIOVASCULAR RISK FACTOR,"February 08, 2021",422,NCT04615949,"CANNABIDIOL, PHARMACEUTICALLY PRODUCED WITH < 5 PPM THC; PLACEBO",,Not yet recruiting,Cardiol Therapeutics Inc.,December 2020,Interventional,"Study to Evaluate the Efficacy and Safety of CardiolRx™ in Patients With COVID-19 and Cardiovascular Disease or Risk Factors A Double-blind, Placebo-controlled Trial"
4082,Ketogenic Diet as Protective Factor During COVID-19,COVID,"February 08, 2021",28,NCT04615975,KETOGENIC DIET WITH PHYTOEXTRACTS,ITALY,Recruiting,University of Padova,"November 1, 2020",Interventional,Pilot Study: Ketogenic Diet as Protective Factor During SARS-CoV-2 Infection
4083,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,COVID; SARS-COV INFECTION,"February 08, 2021",10,NCT04616001,IVIG,UNITED STATES,Not yet recruiting,Sharp HealthCare,"November 1, 2020",Interventional,Pilot Study of the Use of IVIG in Patients With Severe COVID-19 Infections Requiring Mechanical Ventilation and to Assess Their Biological Responses to IVIG Therapy
4084,SILtuximab in Viral ARds (SILVAR) Study,ACUTE RESPIRATORY DISTRESS SYNDROME; LUNG DISEASES; PNEUMONIA; RESPIRATORY TRACT INFECTIONS; RESPIRATORY TRACT DISEASE,"February 08, 2021",555,NCT04616586,SILTUXIMAB; NORMAL SALINE,UNITED STATES,Recruiting,EusaPharma (UK) Limited,"November 13, 2020",Interventional,A Study Comparing the Efficacy and Safety of Standard of Care With or Without Siltuximab in Selected Hospitalized Patients With Viral Acute Respiratory Distress Syndrome (SILVAR)
4085,PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers,CANCER; LUNG CANCER; GASTRO-INTESTINAL,"February 08, 2021",125,NCT04616768,PRO QUESTIONNAIRE; STEP MONITORING; ACTIVE NUDGE TEXT FEEDBACK; PROSTEP DASHBOARD (CLINICIANS),UNITED STATES,Recruiting,University of Pennsylvania,"November 19, 2020",Interventional,"A Feasibility Trial Using Remote Patient-reported Outcomes and Wearable Technology-reported Step Data to Compare Engagement, Utilization, and Functional Status in Patients With Incurable Lung and Gastrointestinal Cancers"
4086,Thromboembolic Risk Screening in Patients With Cancer and COVID-19,NEOPLASMS MALIGNANT; COVID; THROMBOEMBOLISM,"February 08, 2021",120,NCT04616846,PERIPHERAL VENOUS ULTRASOUND,FRANCE,Recruiting,Centre Antoine Lacassagne,"August 4, 2020",Interventional,Thromboembolic Risk Screening in Patients With Cancer and COVID-19
4087,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System,COVID; CANCER,"February 08, 2021",800,NCT04616950,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"December 1, 2020",Observational,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System: Description of Typical Pathways and Simulation Model
4088,COVID-19 With Convalescent Plasma,COVID CONVALESCENT PLASMA TREATMENT,"February 08, 2021",78,NCT04616976,CONVALESCENT PLASMA,CHINA,Completed,"Southeast University, China","January 1, 2020",Observational,Efficiency of Convalescent Plasma Therapy in Management of Critically Ill Patients With COVID-19: a Matched Case-control Study
4089,Mental Health in Communities Affected by COVID-19 in Uganda,COMMUNITY MENTAL HEALTH,"February 08, 2021",840,NCT04616989,PSYCHO-EDUCATION; COMPARATOR,,Not yet recruiting,Makerere University,"January 1, 2021",Interventional,Integration of Mental Health Care in Communities Affected by the COVID-19 Pandemic in Central Uganda
4090,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,COVID; SEVERE SYSTEMIC ILLNESS RESPIRATORY MUSCLE FATIGUE,"February 08, 2021",38,NCT04617119,THRESHOLD IMT DEVICE; CONVENTIONAL PHYSICAL THERAPY,KUWAIT,Not yet recruiting,DR. JASSIM ALGHAITH,"November 1, 2020",Interventional,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU: A Pilot Study
4091,Online MBI for Families Affected by PPDA,POSTPARTUM DEPRESSION; POSTPARTUM ANXIETY,"February 08, 2021",40,NCT04617132,MBCT/MBSR,CANADA,"Active, not recruiting",British Columbia Children's Hospital,"October 20, 2020",Observational,Online Mindfulness Groups for Families Affected by Postpartum Depression and Anxiety: Study Protocol
4092,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,DEPRESSION; ANXIETY DISORDERS; PSYCHOLOGICAL DISTRESS,"February 08, 2021",100,NCT04617262,REMOTE PROBLEM MANAGEMENT PLUS,,Not yet recruiting,The New School,November 2020,Interventional,Pilot Feasibility Study of Remote Problem Management Plus to Improve Well-being and Functioning of Adults Affected by COVID-
4093,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults",COVID,"February 08, 2021",1040,NCT04617483,"TWO DOSES OF COMMERCIAL SCALE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,14; TWO DOSES OF PILOT SCALE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,14; TWO DOSES OF PILOT SCALE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,14 IN ELDERLY",CHINA,Recruiting,"Sinovac Research and Development Co., Ltd.","October 31, 2020",Interventional,"A Randomized, Double-Blinded Clinical Trial, to Evaluate the Non-inferiority of the Commercial Scale Inactivated SARS-CoV-2 Vaccine Against That of the Pilot Scale Among Adults Aged 26-45 Years, and the Open-labelled, Bridging Non-inferiority of the Vaccine Induced Immunogenicity in Elderly Against That in Adults"
4094,Compassionate Use of REGN-COV2 for the Treatment of COVID-19,COVID,"February 08, 2021",,NCT04617535,REGN10933+REGN10987 COMBINATION THERAPY,,Available,Regeneron Pharmaceuticals,,Expanded Access,Compassionate Use of REGN-COV2 for the Treatment of COVID-19
4095,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,ARDS; COVID; PNEUMONIA,"February 08, 2021",50,NCT04618042,FX06; PLACEBO OF FX06,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"November 13, 2020",Interventional,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia
4096,A Clinical Study of Online Active Play Program With Adolescents,ANXIETY; DEPRESSION,"February 08, 2021",32,NCT04618341,,UNITED KINGDOM,Completed,Revival Active,"March 30, 2020",Observational,A Clinical Study of Online Active Play Program With Adolescents During COVID-19 Lockdown
4097,Effect of COVID-19 Pandemic on Vaccination Compliance,VACCINE REFUSAL,"February 08, 2021",100,NCT04618796,VACCINE,,Not yet recruiting,Assiut University,"April 1, 2021",Observational,Effect of COVID-19 Pandemic on Vaccination Compliance Among Children Attending Assiut University Children Hospital
4098,Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19,COVID; MEDICAL EMERGENCIES,"February 08, 2021",1000,NCT04618835,40-STEPS-TEST,UNITED KINGDOM,Recruiting,Betsi Cadwaladr University Health Board,"November 3, 2020",Observational,Exertional Desaturation as a Marker of Risk - Validation Study for the 40-steps-test; A Multi-centre Prospective Observational Cohort Study
4099,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study,COVID; PNEUMONIA; SURFACTANT PROTEIN DEFICIENCY,"February 08, 2021",127,NCT04618861,,TURKEY,Completed,Kafkas University,"October 13, 2020",Observational,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study
4100,A Comparison of Fiberoptic Endotracheal Intubation Between the Intubating Laryngeal Tube Suction and the LMA Protector,DIFFICULT AIRWAY,"February 08, 2021",80,NCT04618926,DEVICE INTUBATING LARYNGEAL TUBE SUCTION DISPOSABLE,,Not yet recruiting,Bnai Zion Medical Center,"November 1, 2020",Observational,A Prospective Randomized Study Comparing Fiberoptic Bronchoscope Endotracheal Intubation Between the Intubating Laryngeal Tube Suction and the LMA Protector
4101,Outpatient Treatment With CoVid-19 With Prexablu,SARS COV 2,"February 08, 2021",46,NCT04619290,SUBLINGUAL METHYLENE BLUE; CONTROL PATIENTS,MEXICO,Recruiting,Hospital Reg. Lic. Adolfo Lopez Mateos,"October 12, 2020",Interventional,Treatment in Outpatient Patients With Covid-19 With Methylene Blue and Photodynamic
4102,Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19,HUMAN ARDS; CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04619368,FOLLOW UP CALLS,FRANCE,Recruiting,"University Hospital, Toulouse","July 27, 2020",Observational [Patient Registry],Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-CoV-2 (COVID-19)
4103,"Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers",SARS-CoV2,"February 08, 2021",300,NCT04619407,NASOPHARYNGEAL SWAB; SERUM TESTING,GERMANY,Recruiting,University Medicine Greifswald,"November 4, 2020",Observational,"Screening for SARS-CoV-2-Infections in Teachers, Childcare Educators, Pupils and Preschoolers in the State of Mecklenburg-Vorpommern"
4104,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers,OCCUPATIONAL HEALTH,"February 08, 2021",1000,NCT04619576,OCCUPATIONAL HEALTH WORKERS,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 1, 2020",Observational,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers
4105,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19",COVID,"February 08, 2021",48,NCT04619628,COVI-VAC; PLACEBO,UNITED KINGDOM,Recruiting,"Codagenix, Inc","December 11, 2020",Interventional,"First-in-human, Randomised, Double-blind, Placebo-controlled, Dose-escalation Study in Healthy Young Adults Evaluating the Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Candidate for Prevention of COVID-19"
4106,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,PULMONARY FIBROSIS; INTERSTITIAL LUNG DISEASE; RESPIRATORY DISEASE,"February 08, 2021",120,NCT04619680,NINTEDANIB; PLACEBO,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"November 18, 2020",Interventional,Early Nintedanib Deployment in COVID-19 Interstitial Fibrosis
4107,Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia,"PNEUMONIA, VIRAL; SARS-CoV2","February 08, 2021",100,NCT04619693,,FRANCE,Recruiting,"University Hospital, Montpellier","November 18, 2020",Observational,Determination of Biomarkers for the Prediction of Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
4108,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,COVID,"February 08, 2021",350,NCT04619706,FSD201; PLACEBO,UNITED STATES,Recruiting,"FSD Pharma, Inc.","December 14, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIA Study of FSD201 (Ultramicronized PEA) + Standard of Care (SOC) Vs SOC in the Treatment of Hospitalized Patients With COVID-19"
4109,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Respiratory Distress,COVID,"February 08, 2021",600,NCT04619719,HYPERBARIC OXYGEN THERAPY (HBOT),UNITED STATES,Not yet recruiting,NYU Langone Health,"February 15, 2021",Interventional,"Multi-Center, Randomized Control Trial to Study the Effectiveness of Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Respiratory Distress"
4110,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,SARS-CoV2; SEROLOGY; STUDENTS,"February 08, 2021",1700,NCT04620798,IMMEDIATE VS. DELAYED PROVISION OF ANTIBODY TEST RESULTS,UNITED STATES,"Active, not recruiting",Indiana University,"September 14, 2020",Interventional,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students
4111,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,SAR; SARS PNEUMONIA,"February 08, 2021",108,NCT04621058,VITAMIN D; PLACEBO,SPAIN,Recruiting,Bioaraba Health Research Institute,"November 9, 2020",Interventional,Efficacy of Treatment With Vitamin D in Patients Diagnosed With COVID-19 Who Presenting Vitamin D Deficiency and Pneumonia.
4112,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,COVID,"February 08, 2021",84,NCT04621071,PROBIOTICS (2 STRAINS 10X10^9 UFC); PLACEBO (POTATO STARCH AND MAGNESIUM STEARATE),CANADA,Recruiting,Centre de recherche du Centre hospitalier universitaire de Sherbrooke,"January 5, 2021",Interventional,"Evaluation of the Efficacy of Probiotics to Reduce the Duration and Symptoms of COVID-19 (PROVID-19 Study): a Randomized, Double-blind, Controlled Trial"
4113,Influence of the COVId-19 Pandemic on STRESS and Eating Habits,NUTRITION,"February 08, 2021",1000,NCT04621084,EATING HABITS,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","April 1, 2020",Observational,Influence of the COVId-19 Pandemic on STRESS and Eating Habits
4114,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,SARS-CoV2 INFECTION; SAFETY AND EFFICACY,"February 08, 2021",474,NCT04621123,CONVALESCENT ANTI-SARS-COV-2 MBT PLASMA; CONTROL GROUP,SPAIN,Recruiting,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","October 30, 2020",Interventional,Convalescent Methylene Blue Treated (MBT) Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients: a Randomized Double Blind Study (COnV-ert)
4115,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,COVID,"February 08, 2021",120,NCT04621149,"CHLORINE DIOXIDE; ZINC ACETATE; FAMOTIDINE; PLACEBO; LACTOFERRIN, GREEN TEA EXTRACT",UNITED STATES,Recruiting,"Profact, Inc.","November 15, 2020",Interventional,"A Phase 2 Screening Study of Candidate Non-prescription Treatments for COVID-19: A Patient-driven, Randomized, Factorial Study Evaluating Patient-reported Outcomes (PROFACT-01)"
4116,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy,AUDIO-VISUAL TRIAGE SYSTEM; ANXIETY LEVELS; COVID SPREAD; GAD-7 SCORE; HEALTHCARE PROFESSIONALS; SCREENING STRATEGY,"February 08, 2021",60,NCT04621214,AUDIO-VISUAL TRIAGE SYSTEM (AVT),PAKISTAN,Completed,University of Lahore,"March 21, 2020",Observational,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy
4117,Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting,CORONAVIRUS INFECTION,"February 08, 2021",750,NCT04621461,ZINC SULFATE 220 MG; PLACEBO,UNITED STATES,Not yet recruiting,"St. Francis Hospital, New York","December 20, 2020",Interventional,"A Randomized, Placebo-Controlled Study Evaluating the Efficacy of Zinc for the Treatment of COVID-19 in the Outpatient Setting"
4118,Virtual Simulation for Woven EndoBridge Device Sizing,ANEURYSM; INTRACRANIAL ANEURYSM,"February 08, 2021",186,NCT04621552,WEB EMBOLIZATION,FRANCE,Completed,"University Hospital, Montpellier","January 1, 2015",Observational,Comparison of Woven EndoBridge Device Sizing With Conventional Measurements and Virtual Simulation Using the Sim&Size Software: A Multi-Center Experience
4119,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,COVID,"February 08, 2021",26,NCT04621903,SHANSHAMANI VATI PLUS,UNITED KINGDOM,Completed,Aarogyam UK,"October 8, 2020",Interventional,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19: Community Based Participatory Research
4120,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04622332,SIR1-365; MATCHING PLACEBO,,Not yet recruiting,"Sironax USA, Inc.","December 15, 2020",Interventional,"A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19"
4121,Neurocognitive Functions of Recovered COVID-19 Patients,COGNITION; COVID,"February 08, 2021",160,NCT04622748,TRIER SOCIAL STRESS TEST,CHINA,Recruiting,"National Institute on Drug Dependence, China","July 10, 2020",Observational,An Investigation of Neurocognitive Functions and the Influencing Factors in Recovered Patients With COVID-19
4122,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,COVID PNEUMONIA,"February 08, 2021",50,NCT04622826,IMMUNE PLASMA,ITALY,Recruiting,Azienda USL Toscana Nord Ovest,"May 15, 2020",Interventional,"Studio in Aperto Sulla Somministrazione di Plasma di Paziente Convalescente da COVID- 19 a Paziente Con Polmonite COVID-19 Ospedalizzato, Non in Terapia Intensiva"
4123,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,SARS-CoV2; COVID; CORONAVIRUS DISEASE 2019,"February 08, 2021",200,NCT04622865,MASITINIB; ISOQUERCETIN; BEST SUPPORTIVE CARE,FRANCE,Recruiting,AB Science,"June 1, 2020",Interventional,"Randomized, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Masitinib Combined With Isoquercetin, and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19"
4124,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,COVID,"February 08, 2021",300,NCT04622891,CLARITHROMYCIN 500MG; AZITHROMYCIN; PLACEBO,EGYPT,Completed,South Valley University,"April 1, 2020",Interventional,"Efficacy of Clarithromycin in Comparison to Azithromycin in Treatment of Mild COVID-19 Infection, Randomized Controlled Trial"
4125,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,COVID,"February 08, 2021",104,NCT04623021,NAFAMOSTAT MESILATE,RUSSIAN FEDERATION,Completed,Chong Kun Dang Pharmaceutical,"September 25, 2020",Interventional,"An Open-label, Randomized, Multicenter, Controlled Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia"
4126,Using Smart Watches to Detect and Monitor COVID-19,COVID,"February 08, 2021",100000,NCT04623047,,UNITED STATES,Recruiting,Duke University,"April 2, 2020",Observational,Using Smart Watches to Detect and Monitor COVID-19
4127,A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections,COVID; SARS-COV INFECTION,"February 08, 2021",950,NCT04623138,,,Not yet recruiting,Evidation Health,November 2020,Observational,"A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and SARS-CoV-2 Infection"
4128,Thromboprophylaxis for Patients in ICU With COVID-19,COVID; ANTICOAGULANT THERAPY; THROMBOSIS,"February 08, 2021",950,NCT04623177,,SPAIN,"Active, not recruiting",Instituto de Investigacion Sanitaria La Fe,"March 1, 2020",Observational,"Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study."
4129,Randomised Study of Plasma Exchange in Severe COVID-19,COVID,"February 08, 2021",20,NCT04623255,OCTAPLAS,UNITED KINGDOM,Recruiting,"University College, London","October 16, 2020",Interventional,A Randomised Controlled Trial of Plasma Exchange With Standard of Care Compared to Standard of Care Alone in the Treatment of Severe COVID-19 Infection (COVIPLEX)
4130,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic,ANKLE FRACTURES; PROXIMAL HUMERAL FRACTURE; WRIST FRACTURE,"February 08, 2021",262,NCT04623346,OBSERVATION FOR STUDY GROUP,TURKEY,"Active, not recruiting",Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization,"March 11, 2020",Observational,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic
4131,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,COVID,"February 08, 2021",1000,NCT04623385,AEROSOLIZED 13 CIS RETINOIC ACID PLUS INHALATION INHALED TESTOSTERONE; THE STANDARD THERAPY,,Not yet recruiting,Kafrelsheikh University,November 2020,Interventional,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?
4132,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,COVID,"February 08, 2021",100,NCT04623619,ACETYL L-CARNITINE,,Not yet recruiting,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,"December 15, 2020",Interventional,Use of Acetyl L-Carnitine in Patients With Covid-19 Pneumonia
4133,Intravenous Infusion of CAP-1002 in Patients With COVID-19,COVID,"February 08, 2021",60,NCT04623671,CAP-1002; PLACEBO,UNITED STATES,Recruiting,Capricor Inc.,"November 15, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Intravenous Infusion of CAP-1002 in Patients With COVID-19 (INSPIRE)"
4134,Covid-19 Infection and New Onset Type 1 Diabetes,COVID; TYPE1DIABETES,"February 08, 2021",600,NCT04623697,,DENMARK,Recruiting,Hospital of South West Jutland,"November 1, 2020",Observational [Patient Registry],Covid-19 and Type 1 Diabetes - a Multicenter Study
4135,Exercise Influence on COVID-19,INFECTION VIRAL; EXERCISE; CORONAVIRUS; HABITS,"February 08, 2021",30000,NCT04624048,COVID-19 SURVEY,,Not yet recruiting,University of Salamanca,"December 4, 2020",Observational,"""Influence of Physical Exercise on the Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19"""
4136,Go/No-Go Intervention for Weight Loss,OVERWEIGHT AND OBESITY,"February 08, 2021",100,NCT04624087,FOOD-SPECIFIC GO/NO-GO COMPUTERIZED TRAINING; NONFOOD-SPECIFIC GO/NO-GO COMPUTERIZED TRAINING,UNITED STATES,Recruiting,University of Minnesota,"October 19, 2020",Interventional,"The Effect of Go/No-Go Training Dosage on Weight Loss, Food Evaluation, and Disinhibition in Overweight and Obese Individuals: A Randomized Controlled Trial"
4137,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19,COVID; MYOCARDIAL INJURY; CARDIOVASCULAR DISEASES; HEART FAILURE; CARDIOVASCULAR MORBIDITY,"February 08, 2021",500,NCT04624503,,ITALY,Recruiting,"Humanitas Hospital, Italy","October 1, 2020",Observational,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19 (Rilevanza Clinica e Prognostica Del Coinvolgimento Cardiovascolare Nei Pazienti Affetti da COVID-19)
4138,Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection,COVID; SARS-CoV2 INFECTION,"February 08, 2021",1000,NCT04624997,BIOLOGICAL SAMPLE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 8, 2020",Observational,Evaluation de la COagulopathie et de la Dysfonction enDOthéliale Comme Facteur prédictif de la gravité de l'Infection Par SARS-CoV-2 / COVID-19
4139,NO-mediated Vascular Function in Covid-19 Patient,COVID PNEUMONIA,"February 08, 2021",30,NCT04625036,SINGLE PASSIVE LEG MOVEMENT,ITALY,Recruiting,Istituti Clinici Scientifici Maugeri SpA,"May 30, 2020",Observational [Patient Registry],Pilot Study on Peripheral Vascular Function in Covid-19 Patient
4140,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19),COVID,"February 08, 2021",40,NCT04625075,CARDIAC MRI; CARDIAC CT; ELECTROCARDIOGRAM (ECG); BLOOD SAMPLES,UNITED KINGDOM,Recruiting,University of Edinburgh,"June 10, 2020",Observational,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (MEMORY- COVID)
4141,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,COVID,"February 08, 2021",150,NCT04625114,CAMOSTAT; PLACEBO; CAMOSTAT; PLACEBO,BELGIUM,Recruiting,"University Hospital, Ghent","November 4, 2020",Interventional,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden
4142,Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study,COVID PNEUMONIA,"February 08, 2021",40,NCT04625218,,,Not yet recruiting,"University Hospital, Toulouse",January 2021,Observational,Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) in the Critically Ill Patient: Pharmacokinetic Study. (CHLORO-VID)
4143,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)",CORONAVIRUS INFECTIOUS DISEASE 2019 (COVID),"February 08, 2021",3000,NCT04625257,SALIVA BASED ASSAY: CRUDE RNA EXTRACTION; VALIDATION OF THE NGS METHOD; VALIDATION OF THE LAMP ASSAYS; VALIDATION OF THE POCT ANTIGEN TESTS,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","October 24, 2020",Observational,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)"
4144,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic,HEALTHCARE WORKER FACING COVID,"February 08, 2021",75,NCT04625296,SEMI-DIRECTIVE INTERVIEW; QUESTIONNAIRE : PREPAREDNESS FOR CAREGIVING SCALE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"September 17, 2020",Observational,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 Epidemic
4145,Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence,"ALCOHOL CONSUMPTION; VIOLENCE, DOMESTIC; STRESS, PSYCHOLOGICAL; AGGRESSION","February 08, 2021",480,NCT04625465,CBT TEXT MESSAGING; ATTENTION CONTROL TEXT MESSAGING,UNITED STATES,Recruiting,Georgia State University,"November 12, 2020",Interventional,Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence
4146,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.",COVID,"February 08, 2021",5000,NCT04625725,AZD7442; PLACEBO,BELGIUM,Recruiting,AstraZeneca,"November 21, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19."
4147,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,COVID ARDS,"February 08, 2021",30,NCT04625738,EX VIVO EXPANDED WHARTON'S JELLY MESENCHYMAL STEM CELLS; PLACEBO,,Not yet recruiting,"Central Hospital, Nancy, France","November 6, 2020",Interventional,Efficacy of Infusions of Mesenchymal Stem Cells From Wharton Jelly in the Moderate to Severe SARS-Cov-2 Related Acute Respiratory Distress Syndrome (COVID-19): A Phase IIa Double-blind Randomized Controlled Trial
4148,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults",COVID,"February 08, 2021",1125,NCT04625972,AZD7442; PLACEBO,UNITED KINGDOM,Recruiting,AstraZeneca,"December 2, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Post-exposure Prophylaxis of COVID-19"
4149,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",20,NCT04625985,METFORMIN GLYCINATE; PLACEBO ORAL TABLET,MEXICO,Recruiting,Laboratorios Silanes S.A. de C.V.,"July 14, 2020",Interventional,"Adaptive Study to Demonstrate Efficacy and Safety of Metformin Glycinate for the Treatment of Hospitalized Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb"
4150,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",POST-TRAUMATIC STRESS DISORDER; MORAL INJURY,"February 08, 2021",120,NCT04626050,MEDICAL MUSIC; NARRATIVE WRITING; PROLONGED EXPOSURE THERAPY; INTERPERSONAL PSYCHOTHERAPY,UNITED STATES,Not yet recruiting,Weill Medical College of Cornell University,January 2021,Interventional,"A Brief Phased Two-Step Intervention for Treating General Psychological Distress, PTSD and Co-Morbidities in Healthcare Workers Consequent to the COVID-19 Pandemic"
4151,International Registry of Healthcare Workers Exposed to COVID-19 Patients,SARS-COV INFECTION; COVID,"February 08, 2021",10000,NCT04626076,COMPARATIVE OBSERVATIONAL COHORT STUDY,PAKISTAN,Recruiting,Certara,"August 13, 2020",Observational [Patient Registry],International Registry of Healthcare Workers Exposed to COVID-19 Patients
4152,"Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; METABOLIC SYNDROME; TYPE 2 DIABETES,"February 08, 2021",20,NCT04626089,METFORMIN GLYCINATE; PLACEBO ORAL TABLET,MEXICO,Not yet recruiting,Laboratorios Silanes S.A. de C.V.,"November 30, 2020",Interventional,"Adaptive Study for Efficacy and Safety of Metformin Glycinate for the Treatment of Patients With MS and DM2, Hospitalized With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb."
4153,Characteristics of COVID-19 Patients in Kazakhstan in Early 2020,"COVID; PNEUMONIA, VIRAL","February 08, 2021",1000,NCT04627194,,KAZAKHSTAN,"Active, not recruiting",Semey State Medical University,"February 20, 2020",Observational,"Epidemiological and Clinical Characteristics of COVID-19 Patients in Kazakhstan in Early 2020: a Retrospective, Observational Cohort Study"
4154,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,COVID; TREATMENT; CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04627233,HUMAN EZRIN PEPTIDE 1 (HEP1); PLACEBO,"IRAN, ISLAMIC REPUBLIC OF",Not yet recruiting,Shahid Beheshti University of Medical Sciences,"December 20, 2020",Interventional,The Clinical Trial of Application of Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection
4155,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),COVID,"February 08, 2021",3217,NCT04627467,CHLOROQUINE,COLOMBIA,"Active, not recruiting",Fundacion Clinica Valle del Lili,"March 28, 2020",Interventional,Prophylaxis With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19)
4156,Improving Physical Activity and Mobility Via Live Online Exercise Sessions for Older Adults,AGING,"February 08, 2021",32,NCT04627493,ONLINE EXERCISE,CANADA,Recruiting,McMaster University,November 2020,Interventional,"Improving Physical Activity and Mobility, During a Pandemic, Via Live Online Exercise Sessions for Older Persons: a Pilot RCT"
4157,Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,COVID,"February 08, 2021",69,NCT04627519,RHEA HEALTH TONE®,,Not yet recruiting,Universitas Padjadjaran,"December 1, 2020",Interventional,"A Multicenter, Randomized, Open-label, Controlled Trial to Assess Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia"
4158,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,COVID,"February 08, 2021",150,NCT04627584,MW33 INJECTION; MW33 INJECTION PLACEBO,,Not yet recruiting,"Mabwell (Shanghai) Bioscience Co., Ltd.",January 2021,Interventional,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of MW33 Injection to Evaluate the Efficacy and Safety in Patients With Mild or Moderate COVID-19"
4159,Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration,COVID; RESPIRATORY TRACT INFECTIONS; SEVERE ACUTE RESPIRATORY SYNDROME; CORONAVIRUS INFECTION; RNA VIRUS INFECTIONS; VIRUS DISEASE; RESPIRATORY TRACT DISEASE,"February 08, 2021",6000,NCT04627623,IGM AND IGG ANTIBODIES ASSAY,POLAND,Recruiting,Medical University of Silesia,"June 22, 2020",Observational,Prevalence and Risk Factors of COVID-19 Infection in the Upper Silesian Agglomeration Population in 2020
4160,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),SARS-CoV2,"February 08, 2021",36,NCT04627675,CORVAX; IL-12 PLASMID; CLINIPORATOR,UNITED STATES,Recruiting,Providence Health & Services,"December 30, 2020",Interventional,"CORVax12 - a Phase I Trial of SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine (CORVax) +/- pIL-12 (Tavokinogene Telseplasmid) in Healthy Volunteers, With Immunodynamic Biomarker Monitoring of Coordinated Cellular/Humoral Response"
4161,Baseline Vitamin D Deficiency and COVID-19 Disease Severity,VITAMIN D DEFICIENCY; COVID,"February 08, 2021",50,NCT04628000,VITAMIN D,UNITED STATES,Recruiting,Parkview Medical Center,"October 27, 2020",Observational,Baseline Vitamin D Deficiency and COVID-19 Disease Severity/Need for Escalation of Care
4162,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",COVID,"February 08, 2021",506,NCT04628039,REHABILITATION-FOCUSED PROGRAM,UNITED STATES,Not yet recruiting,VA Office of Research and Development,"March 1, 2021",Interventional,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)"
4163,CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction,MYOCARDIAL INFARCTION,"February 08, 2021",60,NCT04628104,CARDIAC MAGNETIC RESONANCE,,Not yet recruiting,Assiut University,"January 1, 2021",Observational [Patient Registry],CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction
4164,Efficacy of Yoga Based Self-Management Program for Chronic Pain,CHRONIC PAIN,"February 08, 2021",42,NCT04628130,YOGA THERAPY,UNITED KINGDOM,Completed,Aarogyam UK,"September 17, 2020",Observational,Efficacy of Yoga Based Self-Management Program for Chronic Pain: Community Based Clinical Efficacy Study
4165,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,COVID,"February 08, 2021",100,NCT04628143,NAFAMOSTAT MESILATE,,Not yet recruiting,Chong Kun Dang Pharmaceutical,"November 20, 2020",Interventional,"Open-label, Multi-center, Randomized Controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19"
4166,Cardiac Performance in Mechanically Ventilated COVID-19 Patients,COVID; ACUTE COR PULMONALE; CARDIAC FAILURE,"February 08, 2021",100,NCT04628195,,CHILE,Completed,Pontificia Universidad Catolica de Chile,"April 1, 2020",Observational,Cardiac Performance in Mechanically Ventilated Patients With Severe Pneumonia by SARS-CoV-2: Echo-COVID Study
4167,Clinical Study Spartan COVID-19 V2 System (Canada Alternate),COVID,"February 08, 2021",60,NCT04628208,SPARTAN COVID-19 V2 SYSTEM,CANADA,Recruiting,Spartan Bioscience Inc.,"November 17, 2020",Observational,Assess the Performance of Spartan COVID-19 V2 System in a Clinical Setting in Comparison to a Laboratory (Standard of Care (SOC)) PCR Method (Canada Alternate)
4168,High GRP78 Levels in Covid-19 Infection: A Case-Control Study,COVID; ENDOPLASMIC RETICULUM STRESS,"February 08, 2021",144,NCT04628637,SERUM PROTEIN LEVEL ANALYSIS,TURKEY,Completed,Kafkas University,"April 16, 2020",Observational,High GRP78 Levels in Covid-19 Infection: A Case-Control Study
4169,Effect of Covid-19 on Outcomes of Pregnancy,PREGNANCY WITHOUT COMPLICATIONS EXCEPT GETTING COVID INFECTION,"February 08, 2021",1000,NCT04629001,"COVID-19 PCR , IGM",EGYPT,"Active, not recruiting",Assiut University,"September 1, 2020",Observational [Patient Registry],Effect of Covid-19 on Outcomes of Pregnancy
4170,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),"ARDS, HUMAN; COVID","February 08, 2021",70,NCT04629105,LONGEVERON MESENCHYMAL STEM CELLS (LMSCS); PLACEBO,UNITED STATES,Recruiting,Longeveron LLC,"July 24, 2020",Interventional,"A Phase 1 Double-blinded, Randomized, Placebo-controlled Study for COVID-19 and Influenza Virus-Elicited Acute Respiratory Distress Syndrome (ARDS) Using Longeveron Mesenchymal Stem Cells (LMSCs)"
4171,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,THIS IS A PILOT STUDY WHICH AIMS TO ASSESS THE VALIDITY AND APPLICABILITY OF LATERAL FLOW ASSAYS (LFAS) WHICH CAN BE USED AS A POINT OF CARE TEST FOR COVID; COVID,"February 08, 2021",400,NCT04629157,INNOVA LATERAL FLOW DEVICE,UNITED KINGDOM,Recruiting,Alder Hey Children's NHS Foundation Trust,"November 5, 2020",Interventional,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19
4172,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department,COVID,"February 08, 2021",400,NCT04629183,INTEGRATED CLINICAL EVALUATION,ITALY,Recruiting,Azienda Ospedaliera Città della Salute e della Scienza di Torino,"November 1, 2020",Observational,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department
4173,Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients,VENTILATION LUNG SCINTIGRAPHY DURING COVID INFECTION,"February 08, 2021",10,NCT04629222,,FRANCE,Completed,Pierre Yves MARIE,"March 11, 2020",Observational,Tracheobronchitis May Constitute the Main Sign of Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients
4174,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women,"COVID; DEPRESSION, ANXIETY; PREGNANCY RELATED","February 08, 2021",500,NCT04629638,"MATERNAL ATTACHMENT, EDINBURGH DEPRESSION SCORING AND POSTPARTUM ANXIETY SCALE SCORES",TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"August 1, 2020",Observational,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women
4175,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects","COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); SARS PNEUMONIA; SARS-ASSOCIATED CORONAVIRUS AS CAUSE OF DISEASE CLASSIFIED ELSEWHERE; PNEUMONIA; PNEUMONIA, VIRAL","February 08, 2021",308,NCT04629703,FOSTAMATINIB; PLACEBO,,Not yet recruiting,Rigel Pharmaceuticals,December 2020,Interventional,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects"
4176,A Smartphone Intervention for Relational and Mental Well Being,"DEPRESSION; LONELINESS; RELATION, INTERPERSONAL; COVID","February 08, 2021",1765,NCT04629755,INTERVENTION,UNITED STATES,Completed,University of Washington,"April 4, 2020",Interventional,A Smartphone Intervention for Relational and Mental Well Being
4177,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,COVID; HYPOXEMIA,"February 08, 2021",27,NCT04629989,STANDARD OXYGEN DELIVERY SYSTEM; DOUBLE-TRUNK MASK; SURGICAL MASK,BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"November 13, 2020",Interventional,The Effects of Two Systems Above Low-flow Nasal Cannula on Arterial Oxygen Tension in Patients With COVID-19 : Surgical Face Mask Versus Double-trunk Mask
4178,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth,COVID INFECTION; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM,"February 08, 2021",250,NCT04630015,SURVEY ADMINISTRATION,UNITED STATES,Recruiting,"University of California, San Francisco","August 31, 2020",Observational,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
4179,Face Masks to Reduce COVID-19 in Bangladesh,COVID,"February 08, 2021",450000,NCT04630054,FACE MASK; FACE MASK AWARENESS,BANGLADESH,Recruiting,Yale University,"November 15, 2020",Interventional,Can Face Masks Reduce Transmission of SARS-CoV-2 in Bangladesh? A Cluster Randomized Controlled Trial
4180,Covid-19 Anxiety and Phobia Levels of the Parents,SARS-CoV2; ANXIETY AND FEAR; PARENTS,"February 08, 2021",150,NCT04631172,"CORONAVIRUS ANXIETY SCALE , COVID-19 PHOBIA SCALE",TURKEY,Completed,Selcuk University,"May 1, 2020",Observational [Patient Registry],Evaluation of Covid-19 Anxiety and Phobia Levels of the Parents of Pediatric Patients
4181,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,"KNOWLEDGE, ATTITUDES, PRACTICE; COVID","February 08, 2021",404,NCT04631367,KUKAA SALAMA: MHEALTH INTERVENTION; FACE MASK + SOAP,,Not yet recruiting,University of Toronto,"February 1, 2021",Interventional,"Kukaa Salama (Staying Safe): A Pre-Post Trial of a mHealth Social Group for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Kampala, Uganda"
4182,Prayer in Commbate to Corona Virus - Covid -19,COVID,"February 08, 2021",200,NCT04631380,PRAYER,BRAZIL,Recruiting,Hospital do Coracao,"August 1, 2020",Interventional,"A Double Blind, Controlled, Randomized, Prospective Study That Will Evaluate the Impact of Remote Intercession Prayer on the Clinical Evolution of Patients Diagnosed With COVID -19 in HCOR."
4183,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19",DEPRESSION,"February 08, 2021",100,NCT04631497,TEST,POLAND,Recruiting,Jagiellonian University,"July 1, 2020",Observational,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19"
4184,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,COVID,"February 08, 2021",80,NCT04631536,ATORVASTATIN + L-ARGININE + FOLIC ACID + NICORANDIL + NEBIVOLOL; PLACEBO,,Not yet recruiting,Lebanese American University Medical Center,"January 10, 2021",Interventional,Managing Endothelial Dysfunction in Moderate COVID-19 : A Randomized Controlled Trial at the Lebanese American University Medical Center- Rizk Hospital
4185,COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Infusion),SARS-COV INFECTION,"February 08, 2021",69,NCT04631666,HUMAN MONOCLONAL ANTIBODY DZIF-10C (GROUP 1A-2D); PLACEBO (NACL 0.9%) (GROUP 2D),,Not yet recruiting,University of Cologne,"November 23, 2020",Interventional,A Phase 1/2a Trial of the Intravenous Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c in SARS-CoV-2-Infected and -Uninfected Individuals
4186,COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Inhalation),SARS-COV INFECTION,"February 08, 2021",69,NCT04631705,HUMAN MONOCLONAL ANTIBODY DZIF-10C (GROUP 1A-2D); PLACEBO (NACL 0.9%) (GROUP 2D),,Not yet recruiting,University of Cologne,"November 23, 2020",Interventional,A Phase 1/2a Trial of the Inhaled Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c in SARS-CoV-2-Infected and -Uninfected Individuals
4187,Physical Activity and the Risk of COVID-19 Infection and Mortality,COVID,"February 08, 2021",132069,NCT04631861,,,Completed,Wonju Severance Christian Hospital,"January 1, 2014",Observational,Physical Activity and the Risk of COVID-19 Infection and Mortality
4188,Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health,DRY MOUTH; HALITOSIS,"February 08, 2021",3000,NCT04632004,INVITATION TO PARTICIPATE,GERMANY,Enrolling by invitation,University of Göttingen,"November 20, 2020",Interventional,Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health
4189,Early Versus Delayed Intubation of Patients With COVID-19,COVID; ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",80,NCT04632043,ENDOTRACHEAL INTUBATION,GREECE,Not yet recruiting,Evangelismos Hospital,"November 18, 2020",Interventional,Effect of Early versUs Delayed intubatiOn on Clinical Outcomes of Patients With COVID-19 (EUDOCO): a Feasibility Randomized Controlled Trial
4190,Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19,MENTAL HEALTH WELLNESS 1; COVID; EMOTIONAL DISTRESS; DEPRESSIVE SYMPTOMS; ANXIETY SYMPTOMS; IRRITABILITY; TELEPSYCHOTHERAPY,"February 08, 2021",2200,NCT04632082,TELEPSYCHOEDUCATION WITH PERSONALIZED VIDEOS; TELEPSYCHOEDUCATION WITHOUT PERSONALIZED VIDEOS,BRAZIL,Enrolling by invitation,Hospital de Clinicas de Porto Alegre,"November 5, 2020",Interventional,A Pragmatic Superiority Randomized Controlled Trial Comparing Telepsychoeducation Plus Personalized Videos vs. Telepsychoeducation Without Personalized Videos for the Prevention of Future Emotional Distress in Professionals From Essential Services With Low to Moderate Levels of Emotional Distress in Brazil in the Context of COVID-19
4191,Head and Neck cancERs International cOviD-19 collabOraTion,HEAD AND NECK CANCER; COVID,"February 08, 2021",750,NCT04632173,NON INTERVENTIONAL STUDY,,Not yet recruiting,Hellenic Cooperative Oncology Group,"December 1, 2020",Observational,HERODOTUS: Head and Neck cancERs International cOviD-19 collabOraTion
4192,Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care,COVID,"February 08, 2021",100,NCT04632355,INTERVIEW,ITALY,Not yet recruiting,Fondazione Don Carlo Gnocchi Onlus,"December 1, 2020",Observational,After the First and Second Wave in Italy: What Effects of Musculoskeletal Pain Did the Covid-19 in Patients Who Have Hospital Care?
4193,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,"BURNOUT, PROFESSIONAL; STRESS, PSYCHOLOGICAL","February 08, 2021",80,NCT04632368,TRANSCENDENTAL MEDITATION,UNITED STATES,Recruiting,Duke University,"November 20, 2020",Interventional,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic
4194,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,CORONAVIRUS INFECTION,"February 08, 2021",36,NCT04632381,ZOTATIFIN; PLACEBO,,Not yet recruiting,Effector Therapeutics,"November 16, 2020",Interventional,"A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial of Intravenous Zotatifin in Adults With Mild or Moderate Coronavirus Disease 2019 (COVID-19)"
4195,BCG Vaccination to Prevent COVID-19,COVID,"February 08, 2021",550,NCT04632537,TICE® BCG (FOR INTRAVESICAL USE) BCG LIVE STRAIN OF THE BCG (MERCK) VACCINE; PRESERVATIVE-FREE SALINE,UNITED STATES,Recruiting,Henry M. Jackson Foundation for the Advancement of Military Medicine,"December 7, 2020",Interventional,Novel Use of an Existing Vaccine (BCG) Alliance: The NUEVA Trial
4196,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,RESPIRATORY FAILURE,"February 08, 2021",20,NCT04632602,PHYSIOLOGICAL EFFECTS OF AWAKE PRONE POSITION IN COVID 19 PATIENTS,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"April 4, 2020",Interventional,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure: a Randomized Cross Over Electrical Impedance Tomography Study
4197,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak,"SLEEP; ATHLETE; TRAINING; EXERCISE; COVID; ISOLATION, SOCIAL","February 08, 2021",230,NCT04632615,,ITALY,Recruiting,Istituto Ortopedico Galeazzi,"May 22, 2020",Observational,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak
4198,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,COVID,"February 08, 2021",24,NCT04632706,IVERMECTIN; PLACEBO,UNITED KINGDOM,Recruiting,MedinCell S.A,"September 22, 2020",Interventional,"A Randomised, Double-Blind, Placebo-Controlled, Exploratory Phase I Trial Assessing the Pharmacokinetic Profile, Safety and Tolerability of a Continuous Daily Dosing Regimen of Active IMP in Healthy Volunteers"
4199,The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,"COGNITIVE IMPAIRMENT; COVID; COGNITIVE DYSFUNCTION; DEPRESSION, ANXIETY; QUALITY OF LIFE","February 08, 2021",200,NCT04632719,THE USE OF THE MENTALPLUS® DIGITAL GAME FOR ASSESSMENT AND REHABILITATION OF COGNITIVE FUNCTION AFTER REMISSION OF THE SYMPTOMS OF COVID-19,BRAZIL,Recruiting,University of Sao Paulo,"November 8, 2020",Interventional,MentalPlus® for Assessment and Rehabilitation of Cognitive Functions After Remission of Symptoms of COVID-19
4200,Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,COVID,"February 08, 2021",140,NCT04632732,COVID-19 TEST; BLOOD SAMPLING,CANADA,Recruiting,Centre de recherche du Centre hospitalier universitaire de Sherbrooke,"October 26, 2020",Observational [Patient Registry],Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).
4201,Online Trial of Meditation and Behavior,MEDITATION,"February 08, 2021",68,NCT04632875,LOVING-KINDNESS MEDITATION; RELAXATION MEDITATION,UNITED STATES,Recruiting,Georgetown University,"December 4, 2020",Interventional,Identifying Neural Correlates of Altruism
4202,Use of Angiotensin-(1-7) in COVID-19,"INFECTION, CORONAVIRUS; RESPIRATORY FAILURE","February 08, 2021",130,NCT04633772,ANGIOTENSIN-(1-7); PLACEBO,BRAZIL,Recruiting,Erasme University Hospital,"August 5, 2020",Interventional,Randomized Clinical Trial Phase I/II for the Use of Angiotensin-(1-7) in the Treatment of Severe Infection by Sars-CoV-2
4203,Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.,DIALYSIS; COVID,"February 08, 2021",40,NCT04633915,,RUSSIAN FEDERATION,Recruiting,"Saint Petersburg State University, Russia","November 26, 2020",Observational,A Comparison of Antibody Response Against SARS-CoV-2 in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.
4204,Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic,"DIABETES MELLITUS, TYPE 2; OBESITY, MORBID; BARIATRIC SURGERY CANDIDATE","February 08, 2021",272,NCT04633941,STANDARD CARE,SINGAPORE,Completed,Singapore General Hospital,"June 1, 2020",Observational,Comparing the Impact of Social Distancing and Lockdown on Bariatric Patients Versus Non-Surgical Obese Patients During COVID-19 Pandemic - Cross Sectional Study
4205,Hydrogen Therapy in Patients With Moderate Covid-19,COVID,"February 08, 2021",10,NCT04633980,"MIXTURE 3,6% H2 IN N2 (96.4%)",,Not yet recruiting,"University Hospital, Grenoble","December 1, 2020",Interventional,Hydrogen Inhalation Therapy in Patients With Moderate Covid-19: Phase-1 Clinical Trial
4206,The Severity of COVID 19 in Diabetes and Non-diabetes Patients,COVID; TYPE2 DIABETES,"February 08, 2021",1050,NCT04634214,,INDIA,Not yet recruiting,India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals,"November 16, 2020",Observational,Study on Characteristics and Prognosis of Diabetes and Non Diabetes Patients With COVID 19 Among Southern Indian Population
4207,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),COVID,"February 08, 2021",118,NCT04634318,RESPIRATORY REHABILITATION PROGRAM (RR).; RESPIRATORY TELE-REHABILITATION PROGRAM (TRR).,FRANCE,Recruiting,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"December 10, 2020",Interventional,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae. Assessment and Therapeutic Indication of Tele-rehabilitation Versus Conventional Rehabilitation
4208,Fase I Clinical Trial on NK Cells for COVID-19,COVID; SARS-CoV2,"February 08, 2021",24,NCT04634370,NATURAL KILLER CELLS INFUSION,BRAZIL,Not yet recruiting,Hospital de Clinicas de Porto Alegre,"January 2, 2021",Interventional,Fase I Clinical Trial on Natural Killer Cells for COVID-19
4209,A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,COVID,"February 08, 2021",700,NCT04634409,LY3819253; LY3832479; PLACEBO; VIR-7831,PUERTO RICO,Recruiting,Eli Lilly and Company,"October 29, 2020",Interventional,"A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)"
4210,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,"RESPIRATORY FAILURE; RENAL FAILURE, ACUTE","February 08, 2021",220,NCT04634422,PLASMA EXCHANGE AND CONVALESCENT PLASMA,DENMARK,Recruiting,Wladimir Szpirt,"November 16, 2020",Interventional,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure - the COVID PLEX+CCP Trial
4211,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,COVID,"February 08, 2021",80,NCT04634799,TM5614; PLACEBO,UNITED STATES,Recruiting,Northwestern University,"January 8, 2021",Interventional,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 (STOP Severe COVID-19)
4212,Video Home Visits for Dietary Counselling,TECHNOLOGY; DIET HABIT,"February 08, 2021",100,NCT04634851,VIRTUAL HOME VISITS,,Not yet recruiting,"University of California, San Francisco","January 1, 2021",Interventional,Optimizing Dietary Habits for Kidney Stone Formers Using Telehealth Directed Individualized Nutritional Counseling
4213,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19",DEPRESSION,"February 08, 2021",2409,NCT04634903,SUPPORTIVE THERAPY SSI; BEHAVIORAL ACTIVATION SSI; GROWTH MINDSET SSI,UNITED STATES,"Active, not recruiting",Stony Brook University,"November 19, 2020",Interventional,Comparing Two Online Single-Session Interventions for Adolescent Depression: Outcomes of a Randomized Trial
4214,Inhaled Heparin for Hospitalised COVID-19 Patients,COVID,"February 08, 2021",712,NCT04635241,UNFRACTIONATED HEPARIN,ARGENTINA,Recruiting,Australian National University,"June 1, 2020",Interventional,INHALEd Unfractionated HEParin for the Treatment of Hospitalised Patients With COVID-19 Meta-trial
4215,Serological Diagnostics of COVID-19 in Health Care Workers,SARS-COV INFECTION,"February 08, 2021",300,NCT04635592,SARS-COV2 NASAL SWAB,SLOVENIA,Not yet recruiting,University Medical Centre Ljubljana,November 2020,Observational,Serological Diagnostics of COVID-19 and Risk Factors for Infection Among Different Groups of Health Care Workers at Surgical Division at Tertiary Hospital
4216,Methylene Blue Treatment of COVID-19,SARS-CoV2,"February 08, 2021",64,NCT04635605,METHYLENE BLUE; CONTROL TEST,SWITZERLAND,Recruiting,Fondazione Epatocentro Ticino,"November 5, 2020",Interventional,"Evaluation of the Efficacy of Methylene Blue Administration in SARS-CoV2- Affected Patients: a Phase 2, Randomized, Placebo- Controlled, Single Blind Clinical Trial"
4217,Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19,MENTAL DISORDER; COVID; EMOTIONAL DISTRESS; DEPRESSION; ANXIETY; IRRITABLE MOOD,"February 08, 2021",999,NCT04635618,COGNITIVE BEHAVIORAL BRIEF-TELEPSYCHOTHERAPY; BRIEF INTERPERSONAL TELEPSYCHOTHERAPY; TELEPSYCHOEDUCATION,BRAZIL,Enrolling by invitation,Hospital de Clinicas de Porto Alegre,"November 5, 2020",Interventional,"A Pragmatic Superiority Randomized Controlled Trial Comparing Brief Cognitive Behavioral Telepsychotherapy, Brief Interpersonal Telepsychotherapy and Telepsychoeducation for the Reduction of Emotional Distress During COVID-19 Outbreak in Professionals and Students From Essential Services With a High Level of Emotional Distress in Brazil in the Context of COVID-19"
4218,Vital Sensor Monitors for CV19 Detection,COVID,"February 08, 2021",300,NCT04635787,ANNE ONE,UNITED STATES,Enrolling by invitation,Northwestern University,"November 5, 2020",Observational,ICU-Grade Wearable Sensors With Novel Respiratory Biomarkers to Diagnose and Detect Pre- and Very Early Symptomatic COVID-19 Infection Using Predictive Machine Learning Algorithms
4219,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study,THYROID DISEASE,"February 08, 2021",3800,NCT04635813,THYROIDECTOMY,ITALY,Completed,University of Cagliari,"March 10, 2020",Observational,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study
4220,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,COVID; CORONAVIRUS INFECTION; SARS-COV INFECTION,"February 08, 2021",68,NCT04635943,IVERMECTIN; PLACEBO,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"August 28, 2020",Interventional,Randomized Phase IIA Clinical Trial to Compare the Efficacy of Ivermectin Versus Placebo to Obtain Negative PCR Results in Patients With Early Phase COVID-19
4221,Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04636021,COVID-19 TESTING,UNITED STATES,Recruiting,Pinnacle Health Cardiovascular Institute,"August 1, 2020",Observational [Patient Registry],Restoring Non-Emergent Cardiovascular Care in the Peri-COVID 19 Era
4222,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,HEADACHE; COVID; SPHENOPALATINE GANGLION BLOCK; PERSISTENT HEADACHE FOLLOWING COVID,"February 08, 2021",60,NCT04636034,"SPHENOPALATINE GANGLION BLOCK WITH LOCAL ANESTHETIC; SPHENOPALATINE GANGLION BLOCK WITH PLACEBO (ISOTONE NACL); ""SHAM""-BLOCK WITH PLACEBO (ISOTONE NACL)",DENMARK,Recruiting,University Hospital Bispebjerg and Frederiksberg,"January 12, 2021",Interventional,"The Effect of Ganglion Sphenopalatine Block (SPG-block) Versus Placebo on Persistent Headache Following COVID-19 Infection: a Randomised, Blinded, Clinical Trial"
4223,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,COVID,"February 08, 2021",100,NCT04636086,CHOLECALCIFEROL; PLACEBO,BELGIUM,Recruiting,University of Liege,"November 12, 2020",Interventional,"Vitamin D Supplementation and Covid-19: a Randomised, Double- Blind, Controlled Study"
4224,Burden of COVID-19 Infection in Populations With High or Low Risk of Infection,SARS-CoV2 INFECTION; COVID,"February 08, 2021",3500,NCT04636203,,,Not yet recruiting,Neuromed IRCCS,"December 15, 2020",Observational,Burden of SARS-CoV-2 Infection in Populations With High or Low Risk of Infection
4225,Borderline COVID-19 PCR Test Result,COVID; VIRUS,"February 08, 2021",30000,NCT04636294,SARS-COV-2 PCR,BELGIUM,"Active, not recruiting",Jessa Hospital,"August 1, 2020",Observational,Follow-up of Patients With a Borderline COVID-19 PCR Test Result
4226,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,COVID; VIRUS DISEASE,"February 08, 2021",240,NCT04636320,CONTRAST-ENHANCED CMR; EXERCISE TEST ECG; BLOOD SAMPLE; RESTING 12 LEAD ECG; 24 HOUR HOLTER ECG,FRANCE,Recruiting,"University Hospital, Bordeaux","June 13, 2020",Interventional,Prevalence of Silent Myocardial Scars on Cardiac Magnetic Resonance Following COVID-19 Infection
4227,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),COVID,"February 08, 2021",216,NCT04636333,"TWO DOSES OF MIDDLE-DOSE RECOMBINANT SARS-COV-2 VACCINE (CHO CELL) AT THE SCHEDULE OF DAY 0, 14; THREE DOSES OF MIDDLE-DOSE RECOMBINANT SARS-COV-2 VACCINE (CHO CELL) AT THE SCHEDULE OF DAY 0, 14, 28; TWO DOSES OF HIGH-DOSE RECOMBINANT SARS-COV-2 VACCINE (CHO CELL) AT THE SCHEDULE OF DAY 0, 14; THREE DOSES OF HIGH-DOSE RECOMBINANT SARS-COV-2 VACCINE (CHO CELL) AT THE SCHEDULE OF DAY 0, 14, 28; TWO DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0, 14 #MIDDLE-DOSE GROUP#; THREE DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0, 14, 28 #MIDDLE-DOSE GROUP#; TWO DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0, 14 #HIGH-DOSE GROUP#; THREE DOSES OF PLACEBO AT THE SCHEDULE OF DAY 0, 14, 28 #HIGH-DOSE GROUP#",CHINA,Recruiting,Jiangsu Province Centers for Disease Control and Prevention,"October 30, 2020",Interventional,Safety and Immunogenicity of a Recombinant COVID-19 Vaccine (CHO Cell) in Healthy Population Aged 18 Years and Older: A Phase I Study
4228,Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia,COVID; BACTEREMIA; SEPTICEMIA; ACINETOBACTER BAUMANNII INFECTION; PSEUDOMONAS AERUGINOSA INFECTION; STAPH AUREUS INFECTION,"February 08, 2021",,NCT04636554,PHAGE THERAPY,,Available,"Adaptive Phage Therapeutics, Inc.",,Expanded Access,"Expanded Access Study of Phage Treatment in Covid-19 Patients on Anti-Microbials for Pneumonia or Bacteremia/Septicemia Due to A. Baumannii, P. Aeruginosa or S. Aureus"
4229,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),COVID; VIRAL PNEUMONIA HUMAN CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",680,NCT04636671,METHYLPREDNISOLONE; DEXAMETHASONE,,Not yet recruiting,University of Trieste,"November 25, 2020",Interventional,Randomized Controlled Trial of Methylprednisolone Versus Dexamethasone in COVID-19 Pneumonia (MEDEAS Trial)
4230,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,SARS-CoV2 INFECTION,"February 08, 2021",30918,NCT04636697,INTRAMUSCULAR INJECTION; INTRAMUSCULAR VACCINE,CANADA,Recruiting,Medicago,"November 19, 2020",Interventional,"Randomized, Observer-Blind, Placebo-Controlled, Phase 2/3 Study to Assess the Safety, Efficacy, and Immunogenicity of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults 18 Years of Age or Older"
4231,Management of Depression and Anxiety in HF,HEART FAILURE; DEPRESSION; ANXIETY,"February 08, 2021",13,NCT04636944,WEB-BASED COMPASS INTERVENTION,UNITED KINGDOM,Recruiting,King's College London,"October 2, 2020",Observational,Learning From Heart Failure Nurses and Patients: Exploring Their Perspectives in the Management of Depression and Anxiety in Primary Care Settings
4232,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19",NEOPLASMS MALIGNANT,"February 08, 2021",1000,NCT04637295,,UNITED STATES,Recruiting,University of Nebraska,"January 27, 2021",Observational,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19"
4233,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,COVID,"February 08, 2021",178,NCT04637828,GNS561,FRANCE,Recruiting,Genoscience Pharma,"November 18, 2020",Interventional,"Cure COVID: A Prospective, Controlled, Randomized Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection"
4234,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),INFECTION VIRAL,"February 08, 2021",200,NCT04637867,"COLLECTION OF BLOOD, SALIVARY AND NASOPHARYNGEAL SAMPLES.",FRANCE,Recruiting,Hospices Civils de Lyon,"November 23, 2020",Interventional,Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study
4235,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study,COLORECTAL CANCER,"February 08, 2021",1000,NCT04637893,COLONOSCOPY,,Not yet recruiting,Istituto Clinico Humanitas,"December 16, 2020",Observational,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study
4236,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),COVID,"February 08, 2021",290,NCT04637906,BIOARGININA®,ITALY,Recruiting,"University of Campania ""Luigi Vanvitelli""","November 18, 2020",Interventional,"Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Randomized, Parallel Group, Double-blind Placebo-controlled Clinical Trial"
4237,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects",CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",24,NCT04638634,CSL760,,Not yet recruiting,CSL Behring,"January 21, 2021",Interventional,"A Single Center, Phase 1, Single-Ascending Dose, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects"
4238,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,CORONAVIRUS; COVID,"February 08, 2021",30,NCT04638673,SOTERIX TAVNS MODEL 0125-LTE STIMULATOR - ACTIVE-ACTIVE GROUP; SOTERIX TAVNS MODEL 0125-LTE STIMULATOR - SHAM-ACTIVE GROUP,UNITED STATES,Recruiting,Medical University of South Carolina,"November 19, 2020",Interventional,Testing a Wearable Telemedicine-controllable taVNS Device for NeuroCovid Recovery and Rehab
4239,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,GRIEF; ANXIETY; DEPRESSION; SLEEP DISTURBANCE; QUALITY OF LIFE,"February 08, 2021",42,NCT04638842,ONLINE INTERVENTION GRIEF COVID-19,MEXICO,Recruiting,Universidad Internacional de Valencia,"December 24, 2020",Interventional,"Effectiveness of a Self-applied Multi-component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: A Randomized Clinical Trial"
4240,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,"February 08, 2021",40,NCT04639349,EXERCISE GROUP; CONTROL GROUP,EGYPT,Recruiting,Cairo University,"November 19, 2020",Interventional,Effect of Home Exercise Activity on Cortisol and Depression in COPD Patients During the Pandemic COVID-19
4241,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),SARS-CoV2,"February 08, 2021",300,NCT04639375,VACCINATED WITH POLIO VACCINE (IPV),UNITED STATES,Recruiting,E-MO Biology Inc,"November 15, 2020",Interventional,A Proof-of-concept Study of Poliovirus Vaccine (IPV) Activity to Induce an Immune Response That Cross-reacts With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2)
4242,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases,ORAL-LINGUO-FACIAL PRAXIES; COVID,"February 08, 2021",4,NCT04639427,,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,November 2020,Observational,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases
4243,Impact of Adipose Tissue in COVID-19,COVID,"February 08, 2021",60,NCT04639440,ADIPOSE TISSUE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 23, 2020",Observational,Impact of Adipose Tissue in COVID-19 : From Pathophysiology to Therapeutic Perspectives
4244,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19",COVID,"February 08, 2021",129,NCT04639466,PLACEBO ADMINISTRATION; VACCINE THERAPY,UNITED STATES,Recruiting,City of Hope Medical Center,"December 11, 2020",Interventional,"Phase 1 Dose Escalation Study to Evaluate the Safety and Biologically Effective Dose of COH04S1, a Synthetic MVA-Based SARS-CoV-2 Vaccine, Administered as One or Two Injections to Healthy Adult Volunteers"
4245,Building Regulation in Dual Generations - Telehealth Model,DUAL-GENERATION INTERVENTION FOR MOTHERS WITH DEPRESSION,"February 08, 2021",40,NCT04639557,BRIDGE THERAPY PROGRAM,CANADA,Enrolling by invitation,University of Manitoba,"September 1, 2020",Interventional,"Building Regulation in Dual Generations - A Telehealth Parenting Program for Depressed Mothers of Preschoolers, Matched With Dialectical Behavior Therapy Skills"
4246,Predictors of Periodontal Outcomes Post-sanative Therapy,PERIODONTAL DISEASES; PERIODONTAL POCKET,"February 08, 2021",200,NCT04639661,,CANADA,Enrolling by invitation,Brock University,"November 25, 2020",Observational,Predictors of Periodontal Outcomes in Patients 5 to 10 Years Post-sanative Therapy
4247,Contrast Enhanced Ultrasound in COVID-19,COVID; MIS-C,"February 08, 2021",30,NCT04640038,SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES,UNITED STATES,Recruiting,Children's Hospital of Philadelphia,"December 18, 2020",Interventional,Contrast Enhanced Ultrasound (CEUS) Detection of Microvascular Perfusion Impairment in COVID-19 Pediatric Patients
4248,Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group,TYPE1DIABETES; CHILDHOOD ALL,"February 08, 2021",500,NCT04640064,,ARGENTINA,Not yet recruiting,Hospital General Puyo,"November 22, 2020",Observational,Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group
4249,Adaptive COVID-19 Treatment Trial 4 (ACTT-4),COVID,"February 08, 2021",1500,NCT04640168,BARICITINIB; DEXAMETHASONE; PLACEBO; REMDESIVIR,JAPAN,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"November 24, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-4)"
4250,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),COVID,"February 08, 2021",150,NCT04640181,ENOXAPARIN; RIVAROXABAN,,Not yet recruiting,St. David's HealthCare,"December 1, 2020",Interventional,"A Phase 2-3, Multi-Center, Randomized Trial to Study the Potential Benefit of Factor Xa Inhibitor (Rivaroxaban) Versus Standard of Care Low Molecular Weight Heparin (Lovenox) in Hospitalized Patients With COVID-19 (XACT)"
4251,A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",270,NCT04640194,ALTEPLASE; STANDARD OF CARE,BELGIUM,Recruiting,Boehringer Ingelheim,"December 16, 2020",Interventional,"The TRISTARDS Trial - ThRombolysIS Therapy for ARDS A Phase IIb/III Operationally Seamless, Open-label, Randomised, Sequential, Parallel-group Adaptive Study to Evaluate the Efficacy and Safety of Daily Intravenous Alteplase Treatment Given up to 5 Days on Top of Standard of Care (SOC) Compared With SOC Alone, in Patients With Acute Respiratory Distress Syndrome (ARDS) Triggered by COVID-19"
4252,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection,COVID PREVENTION,"February 08, 2021",1600,NCT04640233,GAM-COVID-VAC; PLACEBO,INDIA,Recruiting,Dr. Reddy's Laboratories Limited,"November 30, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase II/III Adaptive Clinical Trial to Assess the Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for SARS-Сov-2 Infection in Indian Healthy Subjects"
4253,A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),COVID,"February 08, 2021",960,NCT04640402,LOW-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (18-59 YEARS) & TWO DOSE REGIMEN; LOW-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (18-59 YEARS) & THREE DOSE REGIMEN; HIGH-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (18-59 YEARS) & TWO DOSE REGIMEN; HIGH-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (18-59 YEARS) & THREE DOSE REGIMEN; LOW-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (60-85 YEARS) & TWO DOSE REGIMEN; LOW-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (60-85 YEARS) & THREE DOSE REGIMEN; HIGH-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (60-85 YEARS) & TWO DOSE REGIMEN; HIGH-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (60-85 YEARS) & THREE DOSE REGIMEN; LOW-DOSE PLACEBO (18-59 YEARS) & TWO DOSE REGIMEN; LOW-DOSE PLACEBO (18-59 YEARS) & THREE DOSE REGIMEN; HIGH-DOSE PLACEBO (18-59 YEARS) & TWO DOSE REGIMEN; HIGH-DOSE PLACEBO (18-59 YEARS) & THREE DOSE REGIMEN; LOW-DOSE PLACEBO (60-85 YEARS) & TWO DOSE REGIMEN; LOW-DOSE PLACEBO (60-85 YEARS) & THREE DOSE REGIMEN; HIGH-DOSE PLACEBO (60-85 YEARS) & TWO DOSE REGIMEN; HIGH-DOSE PLACEBO (60-85 YEARS) & THREE DOSE REGIMEN,CHINA,Recruiting,Jiangsu Province Centers for Disease Control and Prevention,"November 17, 2020",Interventional,"A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱ Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 Years and Above"
4254,COVID-19 Stroke Apical Lung Examination Study,"COVID; STROKE, ACUTE; STROKE, ISCHEMIC; STROKE HEMORRHAGIC","February 08, 2021",1000,NCT04640428,,UNITED KINGDOM,Recruiting,King's College Hospital NHS Trust,"May 26, 2020",Observational,COVID-19 Stroke Apical Lung Examination Study - A Multi-centre Prospective Study
4255,Angiotensin-converting Enzyme 2 (ACE2) Expression in Tonsils and Adenoids,ADENOIDECTOMY; TONSILLECTOMY,"February 08, 2021",40,NCT04640610,STORAGE OF OPERATING WASTE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,December 2020,Observational,"Study of the Expression of Angiotensin-converting Enzyme 2 (ACE2), a Cell Membrane Receptor for SARS-CoV-2 and the TMPRSS2 Serine Protease in Tonsils and Adenoids of Children and Adults"
4256,Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure,COVID; ARDS; RESPIRATORY FAILURE,"February 08, 2021",66,NCT04641182,PRONE POSITION,CHILE,Completed,Pontificia Universidad Catolica de Chile,"July 6, 2020",Observational [Patient Registry],Observational Study of Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure
4257,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,COVID,"February 08, 2021",700,NCT04641195,VITAMIN D3 (CHOLECALCIFEROL); ZINC (ZINC GLUCONATE); ZINC (ZINC GLUCONATE) & VITAMIN D (CHOLECALCIFEROL); PLACEBO,INDIA,Not yet recruiting,Harvard School of Public Health,"December 7, 2020",Interventional,A Randomized Trial to Determine the Effect of Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India
4258,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,COVID; SARS-COV INFECTION,"February 08, 2021",25800,NCT04641481,BBV152; PLACEBO,INDIA,Recruiting,Bharat Biotech International Limited,"November 25, 2020",Interventional,"An Event-Driven, Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Efficacy, Safety, Immunogenicity, Lot-to-Lot Consistency of BBV152, a Whole-Virion Inactivated SARS-CoV-2 Vaccine in Adults≥18 Yrs of Age"
4259,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma,B-CELL LYMPHOMA; COVID,"February 08, 2021",120,NCT04641806,,,Not yet recruiting,Versailles Hospital,"December 15, 2020",Observational,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma
4260,BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,COVID; MORBIDITY; ABSENTEEISM,"February 08, 2021",1050,NCT04641858,BCG-DENMARK; SALINE,CAPE VERDE,Recruiting,University of Southern Denmark,"December 3, 2020",Interventional,BCG Vaccine to Reduce Unplanned Absenteeism Due to Illness of Health Care Workers During the COVID-19 Pandemic. A Multi-center Randomised Controlled Trial (BCG-COVID-RCT)
4261,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19),COVID,"February 08, 2021",111,NCT04641988,,FRANCE,Completed,"University Hospital, Montpellier","February 1, 2020",Observational,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) : COROBIOCHIC
4262,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,COVID CONVALESCENT PLASMA TREATMENT,"February 08, 2021",500,NCT04642014,COVID-19 CONVALESCENT PLASMA TREATMENT,POLAND,Not yet recruiting,Wroclaw Medical University,"December 1, 2020",Interventional,"A Multi-centre, 18-months, Single-group Study of Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Metabolomic and Laboratory Evaluation of Plasma Therapy Effectiveness"
4263,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,COVID; COVID PNEUMONIA; SARS-CoV2 PNEUMONIA,"February 08, 2021",100,NCT04642040,PULMONARY REHABILITATION,TURKEY,Recruiting,Sisli Hamidiye Etfal Training and Research Hospital,"June 30, 2020",Interventional,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia
4264,COVID-19 in Home Healthcare,COVID,"February 08, 2021",155,NCT04642196,,SWEDEN,Completed,"University Hospital, Linkoeping","May 2, 2020",Observational,COVID-19 in Home Healthcare and Mortality
4265,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,COVID,"February 08, 2021",50,NCT04642326,TEST GROUP: EXPERIMENTAL - UVC THERAPY APPLIED,TURKEY,"Active, not recruiting",RD Global Araştirma Geliştirme Sağlik Ilaç Inşaat Yatirimlari A.Ş.,"June 26, 2020",Interventional,"Prospective, Parallel, Multicenter Randomized Controlled Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis"
4266,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela",COVID,"February 08, 2021",2000,NCT04642339,GAM-COVID-VAC; PLACEBO,,Not yet recruiting,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",November 2020,Interventional,"Randomized, Double-blind, Placebo Controlled, Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Combined Vector Vaccine in Prophylactic Treatment for SARS-СoV-2 Infection"
4267,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",CORONAVIRUS INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2); COVID DISEASE,"February 08, 2021",6578,NCT04642638,INO-4800; CELLECTRA® 2000; PLACEBO; CELLECTRA® 2000,UNITED STATES,Recruiting,Inovio Pharmaceuticals,"November 30, 2020",Interventional,"Phase 2/3 Randomized, Blinded, Placebo-Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of INO-4800, a Prophylactic Vaccine Against COVID-19 Disease, Administered Intradermally Followed by Electroporation in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure"
4268,Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy,MECHANICAL VENTILATION; COVID; TRACHEOSTOMY,"February 08, 2021",100,NCT04642703,,CHILE,Recruiting,University of Chile,"March 3, 2020",Observational,Mortality in Patients With Severe SARS-CoV-2 Pneumonia Who Underwent Tracheostomy Due to Prolonged Mechanical Ventilation
4269,Management of Type 1 Supracondylar Humeral Fractures,ELBOW FRACTURE; TRAUMA,"February 08, 2021",52,NCT04642807,LONG ARM SOFT CAST; LONG ARM FULL CAST,,Not yet recruiting,University of British Columbia,January 2021,Interventional,Management of Type 1 Supracondylar Humeral Fractures: A Multicentre Randomized Control Trial
4270,A Phase II/III Study of Sargramostim,COVID,"February 08, 2021",60,NCT04642950,SARGRAMOSTIM; PLACEBO,JAPAN,Recruiting,Nobelpharma,"December 17, 2020",Interventional,A Phase II/III Study of Sargramostim in Patients With Coronavirus Disease-2019 (COVID-19)
4271,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,COVID,"February 08, 2021",100,NCT04643054,OVOTRANSFERRIN,ITALY,Not yet recruiting,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,"December 1, 2020",Interventional,Efficacy and Safety of Ovotransferrin in COVID-19 Patients With Mild-to-Moderate Disease
4272,Police COVID-19 Serosurvey,SARS-CoV2 INFECTION; VOLUNTEERS; HEALTHY,"February 08, 2021",1000,NCT04643444,BLOOD SAMPLING; ONLINE QUESTIONNAIRE,SWITZERLAND,Recruiting,University of Bern,January 2021,Observational,"Police Officer COVID-19 Seroprevalence Survey in the Canton of Bern, Switzerland"
4273,Semen Parameters and COVID-19 in Infertile Men,"SPERM COUNT, LOW; HORMONE DISTURBANCE; COVID","February 08, 2021",21,NCT04643522,CLINICAL ASSESSMENT,TURKEY,Completed,Ankara City Hospital Bilkent,"January 7, 2020",Observational,Does COVID-19 Worsen the Semen Parameters? Early Results of a Tertiary Health Center
4274,WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients,SARS-CoV2 INFECTION; INTENSIVE CARE UNIT PATIENT; NEUROLOGICAL ABNORMALITY; DELIRIUM; ENCEPHALOPATHY,"February 08, 2021",20,NCT04643548,,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","October 13, 2020",Observational,Neurological Abnormalities in SARS-CoV-2 ICU Patients. A Prospective Study. NeuroCOVID Study
4275,Using Travelan to Boost Immune Response in Vitro to COVID-19,COVID,"February 08, 2021",5,NCT04643561,TRAVELAN OTC,ISRAEL,"Active, not recruiting",Hadassah Medical Organization,"November 1, 2020",Interventional,A Feasibility Trial Using Trevalan in Healthy Volunteers for Increasing an in Vitro Immune Response to COVID-19 Proteins
4276,Anakinra in the Management of COVID-19 Infection,COVID; PNEUMONIA; CYTOKINE RELEASE SYNDROME; CORONAVIRUS INFECTION; VIRAL INFECTION,"February 08, 2021",80,NCT04643678,ANAKINRA; STANDARD OF CARE,QATAR,Recruiting,Hamad Medical Corporation,"October 30, 2020",Interventional,Efficacy of Anakinra in the Management of Patients With COVID-19 Infection in Qatar: A Randomized Clinical Trial
4277,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,COVID; ARDS,"February 08, 2021",90,NCT04643691,LOSARTAN 50 MG AND SPIRONOLACTONE 25 MG PILLULES ORAL USE,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"September 11, 2020",Interventional,Benefit of Treatment With Losartan and Spironolactone on the Regulation of the Renin-angiotensin System in the Prognosis of Patients Infected With COVID-19 and Suffering From Acute Respiratory Distress Syndrome
4278,Differential Leucocyte Count and Covid-19 Diagnosis,SARS-CoV2 INFECTION COVID,"February 08, 2021",1000,NCT04643860,DIFFERENTIAL LEUCOCYTE COUNT (CLDC) DEVICE AND ALGORITHM,ITALY,Not yet recruiting,Neuromed IRCCS,December 2020,Observational,"A New Point-of-care Test Based on Differential Leucocyte Count, Suitable for a Mass Screening Program to Detect SARS-CoV-2: A Diagnostic Accuracy Study"
4279,Brief Video Interventions for Depression,DEPRESSIVE SYMPTOMS,"February 08, 2021",501,NCT04643964,ENTRÉE: COGNITIVE SKILLS; ENTRÉE: BEHAVIORAL SKILLS; ENTRÉE: INTERPERSONAL SKILLS; SAMPLER SKILLS,UNITED STATES,Recruiting,Ohio State University,November 2020,Interventional,Building Mental Health Resilience in the COVID-19 Pandemic.
4280,Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 Moves Through the Body of Adult Participants Hospitalized With Coronavirus Disease 2019 (COVID-19),CORONAVIRUS DISEASE-2019 (COVID),"February 08, 2021",32,NCT04644120,ABBV-47D11; PLACEBO FOR ABBV-47D11,ISRAEL,Recruiting,AbbVie,"December 10, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ABBV-47D11 in Adults Hospitalized With COVID-19"
4281,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection),COVID,"February 08, 2021",40,NCT04644146,GENETIC,FRANCE,Recruiting,Hospices Civils de Lyon,"December 1, 2020",Observational,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) in Patients Without Comorbidities
4282,"Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]",SARS (SEVERE ACUTE RESPIRATORY SYNDROME); COVID,"February 08, 2021",2000,NCT04644159,HUMAN BIOLOGICAL SAMPLES,FRANCE,Recruiting,Institut Pasteur,"November 13, 2020",Observational,Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation in Early 2020
4283,Improving Thinking in Everyday Life After Covid-19,COVID; COGNITIVE IMPAIRMENT,"February 08, 2021",40,NCT04644172,SPEED OF PROCESSING TRAINING; INSTRUMENTAL ACTIVITIES OF DAILY LIVING SHAPING; TRANSFER PACKAGE FROM CI THERAPY; USUAL CARE,UNITED STATES,Recruiting,University of Alabama at Birmingham,"November 1, 2020",Interventional,Improving Thinking in Everyday Life: Pilot Study C
4284,The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,COVID,"February 08, 2021",795,NCT04644185,SCTA01; PLACEBO,ARGENTINA,Not yet recruiting,Sinocelltech Ltd.,"February 10, 2021",Interventional,"A Multicenter, Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial to Evaluate the Efficacy and Safety of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in Hospitalized Patients With Severe COVID-19"
4285,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,"COVID, CONVALESCENT PLASMA TREATMENT","February 08, 2021",30,NCT04644198,CONVALESCENT PLASMA INFUSION,JAMAICA,Recruiting,The University of The West Indies,"February 1, 2021",Interventional,Pilot Study of Convalescent COVID-19 Plasma Transfusion in Severe COVID-19 Patients at a Type A Teaching Hospital in Jamaica
4286,Mask Adhesive Institutional Study,RESPIRATORY FAILURE; COVID,"February 08, 2021",30,NCT04644276,MASK WITH MASK ADHESIVE/ARM 1; MASK WITHOUT MASK ADHESIVE / ARM 2,UNITED STATES,Not yet recruiting,Philips Clinical & Medical Affairs Global,"January 18, 2021",Interventional,Feasibility Study of a Mask Adhesive in Patients Treated With NIV in an Institutional Setting
4287,Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis,VIRAL PNEUMONIA; SEPSIS,"February 08, 2021",25,NCT04644302,MICROCIRCULATION RECORDING,CZECHIA,Recruiting,University Hospital Hradec Kralove,"February 1, 2020",Observational,"Circulatory and Endothelial Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis - Prospective, Observational Pilot Study"
4288,The Doctors for Coronavirus Prevention Project Thanksgiving Messaging Campaign,COVID,"February 08, 2021",20000000,NCT04644328,FACEBOOK ADS ON THE IMPORTANCE OF STAYING SAFE DURING THE THANKSGIVING HOLIDAY,UNITED STATES,Not yet recruiting,"National Bureau of Economic Research, Inc.","November 14, 2020",Interventional,The Doctors for Coronavirus Prevention Project Thanksgiving Messaging Campaign
4289,Tele-monitoring of COVID-19 Survivors for Long-Term Impacts,COVID,"February 08, 2021",20,NCT04644341,CARDIOVASCULAR AND RESPIRATORY SYSTEMS MONITORING,,Not yet recruiting,University of Manitoba,"December 1, 2020",Observational,Post Discharge Tele-monitoring of COVID-19 Survivors for Long-Term Impacts and Point-of-Care
4290,Effects of a Biomechanical-based Tai Chi Program on Gait and Posture in People With Parkinson's Disease,PARKINSON DISEASE,"February 08, 2021",40,NCT04644367,TAI CHI INTERVENTION; REGULAR PHYSICAL ACTIVITY (CONTROL) GROUP,,Not yet recruiting,University of Ottawa,January 2021,Interventional,THE EFFECTS OF A BIOMECHANICAL BASED TAI CHI INTERVENTION PROGRAM ON POSTURAL STABILITY AND GAIT IN PEOPLE WITH PARKINSON'S DISEASE
4291,Telerehabilitation Following Meniscectomy,MENISCECTOMY,"February 08, 2021",60,NCT04644640,TELEREHABILITATION THERAPY; IN-PERSON REHABILITATION THERAPY,UNITED STATES,Not yet recruiting,NYU Langone Health,"December 1, 2020",Interventional,Telerehabilitation Following Meniscectomy: A Randomized Clinical Trial
4292,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,HEALTHY VOLUNTEERS,"February 08, 2021",28,NCT04644705,NICLOSAMIDE; PLACEBO,GERMANY,Recruiting,Charité Research Organisation GmbH,"November 2, 2020",Interventional,A 3-part Study to Investigate the Safety and Pharmacokinetics of a Novel Niclosamide Solution as a Treatment Option for COVID-19 in Combination With Camostat
4293,"Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19","FIBROSES, PULMONARY","February 08, 2021",160,NCT04645368,BOVHYALURONIDASE AZOXYMER,RUSSIAN FEDERATION,Recruiting,NPO Petrovax,"July 1, 2020",Observational,"Multicenter, Open-label Prospective Cohort Study of the Efficacy and Safety of the Inclusion of Longidaze in the Prevention and Treatment of Post-inflammatory Pulmonary Fibrosis and Interstitial Lung Diseases Caused by COVID-19."
4294,Effects of Fuzheng Huayu Tablets on COVID-19,NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",66,NCT04645407,FUZHENG HUAYU TABLET,CHINA,Completed,ShuGuang Hospital,"February 1, 2020",Interventional,Efficacy of Fuzheng Huayu Tablets for Treating Pulmonary Inflammation in Patients With COVID-19: A Case-Control Study
4295,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit,MORTALITY; INTENSIVE CARE UNIT,"February 08, 2021",100,NCT04645433,,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"March 15, 2020",Observational,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit: Single Center Experience
4296,COVID-19 and Hereditary Metabolic Diseases,"COVID; METABOLISM, INBORN ERRORS","February 08, 2021",77,NCT04645498,,,Not yet recruiting,"University Hospital, Lille",January 2021,Observational,Prospective Study on the Impact of COVID-19 on the Equilibrium of Hereditary Metabolic Disease (MHM) in Patients With or Who Have Contracted COVID-19
4297,Using Whatsapp for the Consultation,COVID,"February 08, 2021",144,NCT04645563,SENDING THORAX CT VIDEO IMAGES VIA SMARTPHONE APPLICATIONS,TURKEY,Completed,Kafkas University,"March 11, 2020",Observational,Using Whatsapp for the Consultation of Covid-19 Suspected Patients in Pandemic Polyclinics; A Retrospective Case Control Study
4298,Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19,COVID,"February 08, 2021",,NCT04646031,T89 CAPSULE,UNITED STATES,Available,"Tasly Pharmaceuticals, Inc.",,Expanded Access,"Expanded Access Use of T89 in An Intermediate-size Patients Population for the Treatment of Severe ""Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)"" Infection Disease Patients (COVID-19)"
4299,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,COVID; CORONAVIRUS DISEASE 2019,"February 08, 2021",30,NCT04646044,BEMPEGALDESLEUKIN; STANDARD OF CARE; PLACEBO,UNITED STATES,Recruiting,Nektar Therapeutics,"November 13, 2020",Interventional,"A Phase 1b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) Plus Standard of Care Versus Placebo Plus Standard of Care in Adults With Mild COVID-19"
4300,Ivermectin for Severe COVID-19 Management,COVID,"February 08, 2021",66,NCT04646109,IVERMECTIN,TURKEY,Completed,Afyonkarahisar Health Sciences University,"May 11, 2020",Interventional,The Effectiveness and Safety of Ivermectin as add-on Therapy in Severe COVID-19 Management
4301,Biomarkers of Trained Immunity Following MMR Vaccination,COVID,"February 08, 2021",80,NCT04646239,HETEROLOGOUS STIMULI,UNITED STATES,Recruiting,Washington University School of Medicine,"December 17, 2020",Observational,"Determining Biomarkers of Trained Immunity in a Randomized Controlled Trial of the Measles, Mumps, and Rubella Vaccine - a Sub-study of the CROWN CORONATION Trial"
4302,"Retrospective Study on the Use, Efficiency, and Safety of the At-home Mosie Kit","INFERTILITY; INFERTILITY, FEMALE; INFERTILITY, MALE","February 08, 2021",350,NCT04646291,INSEMINATION WITH THE MOSIE BABY KIT,UNITED STATES,Completed,Mosie Baby,"August 5, 2020",Observational,"Retrospective Study on the Use, Efficiency, and Safety of the At-home Mosie Kit"
4303,Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden.,PROBLEM GAMBLING; GAMBLING DISORDER,"February 08, 2021",3626,NCT04646421,MOTIVATIONAL TELEPHONE INTERVENTION,SWEDEN,Recruiting,Lund University,"November 30, 2020",Observational,"Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden. Effectiveness, User Satisfaction and Acceptability of the Motivational Telephone Intervention of AB Svenska Spel."
4304,The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs,COVID; IMMUNE DEFICIENCY; TONSILLITIS; TONSIL HYPERTROPHY; ADENOIDITIS; ADENOID HYPERTROPHY,"February 08, 2021",300,NCT04646525,PHYSICAL EXAMINATION,TURKEY,Recruiting,Selcuk University,"October 1, 2020",Observational,The Relationship Between Mild Covid-19 Infection in Pediatric Patients and Protection of Secondary Lymphoid Organs
4305,Covid-19 Risk Factors and Pattern Between Healthcare Workers,COVID,"February 08, 2021",165,NCT04646551,,,Not yet recruiting,Assiut University,December 2020,Observational,Assessment of the Pattern and Risk Factors of Covid-19 Between Infected Healthcare Workers at Assiut University Hospitals
4306,A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,PREVENTION OF COVID; SAFETY AND EFFICACY,"February 08, 2021",29000,NCT04646590,RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) GROUP; RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELLS) PLACEBO GROUP,CHINA,Recruiting,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","December 16, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled Clinical Trial in 18 Years of Age and Above to Determine the Safety and Efficacy of ZF2001, a Recombinant Novel Coronavirus Vaccine (CHO Cell) for Prevention of COVID-19"
4307,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,COVID,"February 08, 2021",18,NCT04646603,MRG-001; PLACEBO,UNITED STATES,Recruiting,MedRegen LLC,"January 28, 2021",Interventional,"A Combined Phase I Double-Blind Randomized Placebo Controlled Study in Healthy Subjects /Phase IIa, Randomized, Double-blind, Placebo Controlled, Multi-center Study in Subjects Infected With SARS CoV-2 to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of MRG-001"
4308,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,COVID; MENTAL HEALTH ISSUE; VIOLENCE,"February 08, 2021",800,NCT04646616,COMMUNITY POPULAR OPINION LEADER (POL) BASED INTERVENTION,UNITED STATES,Not yet recruiting,Drexel University,"January 6, 2021",Interventional,CRISOL: Building Community Resilience and Integrating Efforts to Understand and Address Syndemic Health Conditions Afflicting Young LatinoImmigrants
4309,"Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers",COPING SKILLS; HEALTHCARE WORKERS; COVID,"February 08, 2021",160,NCT04646642,,,Not yet recruiting,David Grant U.S. Air Force Medical Center,December 2020,Observational,"Psychological Health, Coping Strategies and Preferences of David Grant USAF Medical Center COVID-19 Deployers: A Critical Needs Assessment"
4310,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,COVID; THROMBOSIS,"February 08, 2021",300,NCT04646655,ENOXAPARIN,ITALY,Recruiting,ASST Fatebenefratelli Sacco,"July 27, 2020",Interventional,Enoxaparin at Prophylactic or Therapeutic Doses With Monitoring of Outcomes in Subjects Infected With COVID-19: a Pilot Study on 300 Cases Enrolled at ASST-FBF-Sacco
4311,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,SARS-CoV2 INFECTION,"February 08, 2021",233,NCT04647305,CLOSED FACE SHIELD WITH SURGICAL FACE MASK USE; SURGICAL FACE MASK USE ONLY,,Not yet recruiting,"University of Los Andes, Columbia",December 2020,Interventional,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission: A Randomized Controlled Trial
4312,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,COVID,"February 08, 2021",40,NCT04647604,OMEGAVEN®; SODIUM CHLORIDE,SWEDEN,Recruiting,Karolinska University Hospital,"June 23, 2020",Interventional,"Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - A Single-blind, Randomized, Placebo-controlled Feasibility Study"
4313,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,COVID; NEUROCOGNITIVE DYSFUNCTION,"February 08, 2021",70,NCT04647656,HYPERBARIC OXYGEN; SHAM,ISRAEL,Not yet recruiting,Assaf-Harofeh Medical Center,"January 1, 2021",Interventional,"Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome: a Prospective, Randomized, Double Blind Study."
4314,World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments,COVID,"February 08, 2021",100,NCT04647669,REMDESIVIR; ACALABRUTINIB; INTERFERON BETA-1A; STANDARD OF CARE,JAMAICA,Not yet recruiting,The University of The West Indies,"February 1, 2021",Interventional,"WHO Public Health Emergency ""Solidarity"" Clinical Trial for COVID-19 Treatments"
4315,Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults,COVID INFECTION,"February 08, 2021",30,NCT04647682,PHYSICAL ACTIVITY PROGRAM,FRANCE,Recruiting,"University Hospital, Toulouse","November 1, 2020",Observational,Feasibility and Effect of Implementing Physical Activity Program Implementation During Covid-19 in Hospitalized Positive Covid-19 Older Adults
4316,IFN-beta 1b and Remdesivir for COVID19,COVID,"February 08, 2021",100,NCT04647695,INTERFERON BETA-1B; REMDESIVIR,HONG KONG,Recruiting,The University of Hong Kong,"November 20, 2020",Interventional,An Open-label Randomized Controlled Trial on Interferon β-1b and Remdesivir Combination Versus Remdesivir as Treatment for COVID-19 Infection
4317,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,"COVID, SARS-CoV2","February 08, 2021",40,NCT04647734,HIGH INTENSITY INTERVAL TRAINING; STANDARD CARE,DENMARK,Not yet recruiting,"Rigshospitalet, Denmark","January 1, 2021",Interventional,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19
4318,Silent Hypoxia and Awake Proning in COVID-19 Patients,COVID; HYPOXEMIA,"February 08, 2021",40,NCT04647747,SELF MEASUREMENT WITH PULSE OXIMETER,NORWAY,Recruiting,Ostfold Hospital Trust,"November 30, 2020",Interventional,Silent Hypoxia and Awake Proning in COVID-19 Patients: Home Monitoring and Self-Reporting
4319,Packaging and Disseminating the JOIN for ME Program in Low-Income Settings,PEDIATRIC OBESITY,"February 08, 2021",128,NCT04647760,JOIN FOR ME,UNITED STATES,Recruiting,The Miriam Hospital,January 2021,Interventional,Packaging and Disseminating the JOIN for ME Program in Low-Income Settings
4320,Exploratory Study: COVID-19 and Pregnancy,PREGNANT WOMEN; COVID,"February 08, 2021",500,NCT04647994,SARS-COV-2 SEROLOGY,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"September 21, 2020",Observational,Exploratory Study in COVID-19 During Pregnancy
4321,Implementing Peri-operative Mobile Application for Contactless Vital Signs,"BLOOD PRESSURE, HEART RATE, BREATHING RATE, HEART RATE VARIABILITY (HRV: STRESS), AND OXYGEN LEVEL","February 08, 2021",200,NCT04648111,VITAL SIGN MEASUREMENT,CANADA,Not yet recruiting,"University Health Network, Toronto","December 15, 2020",Observational,Implementing Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement (MAC-VITAL): A Proof of Concept Trial
4322,Starling Registry Study,HEMODYNAMIC MONITORING,"February 08, 2021",1000,NCT04648293,STARLING,UNITED STATES,Recruiting,Baxter Healthcare Corporation,"November 12, 2020",Observational [Patient Registry],Starling Registry Study
4323,Corticosteroids in Severe COVID-19(ASAP-C Study),SEVERE COVID,"February 08, 2021",2000,NCT04648410,QUESTIONNAIRE,CZECHIA,Not yet recruiting,Brno University Hospital,"February 1, 2021",Observational,Administration of Systemic Corticosteroids Among Critically Ill Patients With COVID-19: Electronic Survey (ASAP-C Study)
4324,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19,COVID,"February 08, 2021",100,NCT04648709,ELISPOT; QUANTIFERON,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Saint Etienne,"February 1, 2021",Observational,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19
4325,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,COVID; BCG VACCINATION REACTION; SARS-COV INFECTION,"February 08, 2021",1000,NCT04648800,BCG-10 VACCINE; 0.9% SALINE,POLAND,Recruiting,Hanna Czajka,"July 7, 2020",Interventional,"A Multi-centre, Randomised, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland"
4326,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population,SARS-CoV2,"February 08, 2021",960,NCT04649021,BNT162B2; PLACEBO,CHINA,Recruiting,BioNTech SE,"December 4, 2020",Interventional,"Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population: A Phase II, Randomized, Placebo-controlled, Observer-blinded Study"
4327,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,COVID; SARCOPENIA; MUSCLE WEAKNESS,"February 08, 2021",120,NCT04649086,REHABILITATION BY ECCENTRIC EXERCISES; REHABILITATION BY CONCENTRIC EXERCISES,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 5, 2020",Interventional,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection: Research Protocol for Randomized Controlled Trial (CovExc)
4328,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19",SARS-CoV2,"February 08, 2021",3000,NCT04649151,MRNA-1273; PLACEBO,UNITED STATES,Recruiting,"ModernaTX, Inc.","December 9, 2020",Interventional,"A Phase 2/3, Randomized, Observer-Blind, Placebo Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS CoV 2 Vaccine in Healthy Adolescents 12 to <18 Years of Age"
4329,Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias,COVID,"February 08, 2021",300,NCT04649320,QUESTIONNAIRE,AUSTRIA,Recruiting,Medical University Innsbruck,"November 23, 2020",Observational,Investigation of the Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias Using Patient-reported Outcome Measures (PROMs)
4330,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures,COVID,"February 08, 2021",1336,NCT04649333,,AUSTRIA,Completed,Medical University Innsbruck,"June 15, 2020",Observational,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures
4331,COVID-19 Nasal Swab Trial,COVID,"February 08, 2021",72,NCT04649424,CANSWAB,CANADA,Not yet recruiting,Orthopaedic Innovation Centre,December 2020,Interventional,Comparative Evaluation of Nasopharyngeal Swabs for Sampling and Detection of SARS-CoV2
4332,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans",CORONAVIRUS DISEASE-2019 (COVID),"February 08, 2021",1305,NCT04649515,TY027; TY027; 0.9% SALINE,SINGAPORE,Recruiting,Tychan Pte Ltd.,"December 4, 2020",Interventional,"Phase 3 Multi-Site, Randomised, Placebo Controlled, Double Blind, Single Dose Study of TY027 for Early Treatment of COVID-19"
4333,Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support,COVID,"February 08, 2021",93,NCT04649658,PRONE POSITION,ITALY,Completed,University of Modena and Reggio Emilia,"March 1, 2020",Observational,Awake Prone Position in Critical and Severe COVID-19 Patients Undergoing Noninvasive Respiratory Support: a Retrospective Multicenter Cohort Study
4334,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,COVID; RESPIRATORY DISEASE; MENTAL HEALTH DISORDER,"February 08, 2021",108,NCT04649736,RESPIRATORY AND PSYCHOLOGICAL REHABILITATION,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"October 26, 2020",Interventional,Prevalence of Altered Pulmonary Function Post-infection by COVID-19 and Impact of Participation in a Pilot Program of Comprehensive Rehabilitation in the Short and Medium-term
4335,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,CORONAVIRUS INFECTION; RESPIRATORY RATE; HYPOXIA; COVID,"February 08, 2021",50,NCT04649775,AIRFLO2,,Not yet recruiting,Duke University,"January 30, 2021",Interventional,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19
4336,A Clinical Trial for Hospitalized Patients With COVID-19 in Ceará: ResCOVID Study,COVID,"February 08, 2021",3000,NCT04649827,CLINICAL OBSERVATION,BRAZIL,Recruiting,Escola de Saúde Pública do Ceará,"April 2, 2020",Observational,"SARS-CoV-2 Epidemiology Study at e Referenced Hospital in Fortaleza, Brazil: ResCOVID Study"
4337,Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients,COVID,"February 08, 2021",60,NCT04649840,HUMORAL AND CELLULAR IMMUNITY,BELARUS,Enrolling by invitation,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,"October 1, 2020",Observational,Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients
4338,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,COVID,"February 08, 2021",920,NCT04649879,SARS-COV-2 CONVALESCENT PLASMA; STANDARD OF CARE,SWEDEN,Not yet recruiting,Joakim Dillner,"December 3, 2020",Interventional,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial
4339,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19,COVID; SARS-COV INFECTION; PULMONARY REHABILITATION; QUALITY OF LIFE,"February 08, 2021",50,NCT04649918,PULMONARY REHABILITATION,GERMANY,Recruiting,Schön Klinik Berchtesgadener Land,"November 25, 2020",Observational,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 - an Observational Trial
4340,Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease),SARS (SEVERE ACUTE RESPIRATORY SYNDROME); COVID,"February 08, 2021",400,NCT04649931,ION MOBILITY SPECTROMETRY (IMS),GERMANY,Recruiting,B. Braun Melsungen AG,"December 14, 2020",Observational,Study to Evaluate Whether Differences in Exhaled Breath Can be Identified Using Ion Mobility Spectrometry (IMS) in Subjects Tested Positive for SARS-CoV-2 Infection and Subjects Tested Negative
4341,Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member,COVID,"February 08, 2021",40,NCT04649944,SEROLOGICAL TEST AND PHONE INTERVIEW,ITALY,Not yet recruiting,University of Milan,"February 5, 2021",Observational,Assessment of the Serological Profile of Children and Adolescents Between 4 and 16 Years of Age Cohabiting With at Least One Family Member Who Tested Positive to COVID-19: an Observational Study
4342,Profiling Recovery of Those Discharged Into the Community With COVID-19,"INFECTIONS, RESPIRATORY; RESPIRATORY PHYSIOLOGY; RESPIRATORY MUSCLE; SYMPTOMS AND GENERAL PATHOLOGY","February 08, 2021",100,NCT04649957,,UNITED KINGDOM,Not yet recruiting,University of Derby,"January 4, 2021",Observational,Profiling the Determinants of Recovery to Establish Novel Rehabilitation Guidelines to Improve Clinically Relevant and Patient-reported Outcomes in the Post-COVID-19 Period
4343,Variation in Acute Appendicitis During COVID-19 Pandemic in Italy,ACUTE APPENDICITIS,"February 08, 2021",532,NCT04649996,APPENDECTOMY,ITALY,Completed,University of Milano Bicocca,"September 1, 2020",Observational,Variation of Incidence and Clinical Presentation of Acute Appendicitis During a Pandemic.
4344,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak,COVID,"February 08, 2021",60,NCT04650035,,JORDAN,Completed,Yarmouk University,"November 1, 2020",Observational,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak : A Survey
4345,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,COVID,"February 08, 2021",5320,NCT04650087,APIXABAN 2.5 MG; PLACEBO,,Not yet recruiting,"Thomas Ortel, M.D., Ph.D.",April 2021,Interventional,"COVID-19 Post-hospital Thrombosis Prevention Trial: An Adaptive, Multicenter, Prospective, Randomized Platform Trial Evaluating the Efficacy and Safety of Antithrombotic Strategies in Patients With COVID-19 Following Hospital Discharge"
4346,Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials,COVID INFECTION; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM; NEUROPATHY,"February 08, 2021",274,NCT04650178,QUALITY-OF-LIFE ASSESSMENT; QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 26, 2020",Observational,COVID-19: Well-Being in Cancer Patients With Neuropathy Who Participated in Prior Clinical Trials
4347,Surfactant Protein Genetic Variants in COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04650191,IDENTIFICATION OF GENETIC VARIANTS,UNITED STATES,Recruiting,Milton S. Hershey Medical Center,"March 1, 2020",Observational [Patient Registry],Surfactant Protein Genetic Variants in COVID-19 Infection
4348,COVID-19 And Geko Evaluation: The CAGE Study,COVID,"February 08, 2021",40,NCT04651374,GEKO T3,CANADA,Not yet recruiting,Lawson Health Research Institute,December 2020,Interventional,COVID-19 And Geko Evaluation: The CAGE Study
4349,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,SARS-COV INFECTION,"February 08, 2021",74,NCT04651387,OZONIZED OIL (HOO,,Not yet recruiting,Neuromed IRCCS,January 2021,Interventional,Efficacy and Safety of Ozonised Oil (HOO) as Adjuvant Nutrition Supplement in COVID-19 Patients With Mild-to-Moderate Disease - HOO-COVID Project
4350,"Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection",COVID,"February 08, 2021",300,NCT04651400,ANTITHROMBIN III,AUSTRIA,Recruiting,Octapharma,"October 19, 2020",Observational,"Multinational, Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection"
4351,PCR Cycle Threshold Values and COVID-19 Outcomes,COVID,"February 08, 2021",800,NCT04651413,PCR VALUE,UNITED KINGDOM,Recruiting,University Hospitals of North Midlands NHS Trust,"November 24, 2020",Observational,Can Quantitative (Real-time) Polymerase Chain Reaction (PCR) Cycle Threshold (Ct) Values be Used to Predict Poor Outcomes for Patients Infected With SARS-CoV-2? A Local Exploratory Sub-study at The University Hospitals of North Midlands NHS Trust in Collaboration With the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 Trial
4352,"Efficacy, Safety, and Immunogenicity of an Inactivated Vaccine Against COVID-19 in High Infection Risk Adults",COVID; VACCINES,"February 08, 2021",2300,NCT04651790,SARS-COV-2 INACTIVATED VACCINE; PLACEBO,CHILE,Recruiting,Pontificia Universidad Catolica de Chile,"November 27, 2020",Interventional,"Multi-center, Phase 3, Double-blind, Randomized, Placebo-controlled, Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of an Inactivated Vaccine Against the SARS-CoV-2 Infection in High Risk of Infection Adults"
4353,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions",BIOEQUIVALENCE,"February 08, 2021",30,NCT04651959,AVICOD 200 MG FILM TABLET; AVIGAN 200 MG FILM TABLETS,TURKEY,"Active, not recruiting",Pharma Plant,"November 13, 2020",Interventional,"Open-label, Randomised, Single Oral Dose, Two-period, Cross-over Trial to Assess to Bioequivalence of Favira 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions"
4354,A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19,COVID; SARS-CoV2,"February 08, 2021",36500,NCT04652102,CVNCOV; PLACEBO,BELGIUM,Recruiting,CureVac AG,"December 14, 2020",Interventional,"COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older"
4355,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,COVID,"February 08, 2021",42,NCT04652115,DEFIBROTIDE,UNITED STATES,Not yet recruiting,Brigham and Women's Hospital,"January 1, 2021",Interventional,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19
4356,"Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study",COVID INFECTION; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM,"February 08, 2021",700,NCT04652505,QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"July 13, 2020",Observational,Coping With COVID: The Effect of the COVID-19 Public Health Crisis on Mental Well-Being in Cancer Patients Seen at the Psychiatric Oncology Clinic
4357,LYT-100 in Post-acute COVID-19 Respiratory Disease,COVID,"February 08, 2021",168,NCT04652518,LYT-100; PLACEBO,ROMANIA,Recruiting,PureTech,"December 11, 2020",Interventional,"A Phase 2 Randomized, Double-blind, Placebo-controlled Safety and Efficacy Trial of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease"
4358,Reducing Food Insecurity During COVID-19,FOOD INSECURITY,"February 08, 2021",250,NCT04652596,PRODUCE PRESCRIPTION PROGRAM; GROCERY STORE GIFT CARDS,UNITED STATES,Not yet recruiting,Boston Medical Center,January 2021,Interventional,Comparative Effectiveness of Two Interventions to Reduce Food Insecurity During the COVID-19 Pandemic
4359,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,COVID; HYDROXYCHLOROQUINE; CORONAVIRUS INFECTION; TRANSMISSION; PROPHYLAXIS,"February 08, 2021",54,NCT04652648,HYDROXYCHLOROQUINE,UNITED STATES,Completed,Bryn Mawr Hospital,"May 27, 2020",Interventional,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts
4360,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial,"COVID; SATISFACTION, PATIENT; TELEMEDICINE","February 08, 2021",70,NCT04652674,TELEMEDICINE VISIT; IN-PERSON POSTOPERATIVE VISIT,UNITED STATES,Recruiting,Cedars-Sinai Medical Center,"September 28, 2020",Interventional,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial
4361,Camostat With Bicalutamide for COVID-19,COVID; SARS-COV INFECTION; CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04652765,CAMOSTAT MESILATE; BICALUTAMIDE 150 MG,UNITED STATES,Recruiting,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,February 2021,Interventional,COMBO Trial: Camostat With Bicalutamide for COVID-19
4362,Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19,COVID; INFLUENZA A; RESPIRATORY DISEASE,"February 08, 2021",3000,NCT04653727,CROSS-SECTIONAL SURVEY,GERMANY,Recruiting,"Charite University, Berlin, Germany","January 6, 2021",Observational,Effects of Interventions and Lifestyle Modifications in Integrative Medicine and the Course of Infectious Respiratory Diseases Including COVID-19
4363,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,COVID; ARDS,"February 08, 2021",100,NCT04653831,PIRFENIDONE; STANDARD OF CARE,ISRAEL,Recruiting,Soroka University Medical Center,"November 8, 2020",Interventional,Treatment With Pirfenidone for COVID-19 Related Severe ARDS An Open Label Pilot Trial
4364,RT-PCR Database Analysis for COVID-19 Infections and Re-infection,COVID; SARS-COV INFECTION,"February 08, 2021",7000000,NCT04653844,,FRANCE,"Active, not recruiting","University Hospital, Montpellier","February 1, 2020",Observational,SARS-Cov2 (COVID-19) Infection and Reinfection Through the Analysis of a RT-PCR Results Database
4365,Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population,COVID,"February 08, 2021",250,NCT04653857,,FRANCE,"Active, not recruiting","University Hospital, Montpellier","April 1, 2020",Observational,Evaluation of Cardiological Tests Before Returning to Sport in Athletes After COVID-19 Infection (CADE Study)
4366,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,SARS-CoV2,"February 08, 2021",1280,NCT04654325,CONJUNCTIVAL SWAB,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,December 2020,Interventional,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients
4367,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine,COVID,"February 08, 2021",301,NCT04654416,CORTICOSTEROID WITH OR WITHOUT COLCHICINE,COLOMBIA,Completed,Clínica Medellín - Grupo Quirónsalud,"March 20, 2020",Observational,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine in Colombia
4368,Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample,COVID; SARS-CoV2,"February 08, 2021",60,NCT04654442,TESTNPASS,FRANCE,Not yet recruiting,"University Hospital, Grenoble","December 15, 2020",Observational,Evaluation of the Feasibility and Analytic Performance of TestNPass (In Vitro Diagnosis Medical Device) for CoViD-19 Diagnosis on Saliva Sample. : a Pilot Study
4369,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CHRONIC COUGH; COVID,"February 08, 2021",30,NCT04654481,HCFWO; STANDARD CARE PLUS MONITORING,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,December 2020,Interventional,Feasibility of Using a Home-Based High Frequency Chest Wall Oscillation Device (AffloVest) in At-Risk Respiratory Patients to Decrease Acute Respiratory Care Burden During the COVID-19 Pandemic
4370,"Preference-based Tools for Smoking Cessation Among Disadvantaged Smokers, a Pragmatic Randomised Controlled Trial",SMOKING; SMOKING CESSATION,"February 08, 2021",528,NCT04654585,THE STOP INTERVENTION; STANDARD CARE,FRANCE,Not yet recruiting,Société de Formation Thérapeutique du Généraliste Recherche,"December 15, 2020",Interventional,"Sevrage Tabagique à l'Aide Des Outils dédiés Selon la Préférence, un Essai randomisé contrôlé Pragmatique"
4371,Multiple Interactive With Nutrition and Exercise Strategies in Frailty Cancer Patients,CANCER,"February 08, 2021",128,NCT04654637,NUTRITION AND EXERCISE STRATEGIES,TAIWAN,Recruiting,Tzu Chi University,"November 1, 2020",Interventional,"Department of Nursing, Tzu Chi University, Hualien, Taiwan"
4372,Revisiting A Mobile Intervention to Reduce Pain and Improve Health,PAIN; OBESITY; SEDENTARY BEHAVIOR,"February 08, 2021",100,NCT04655001,MORPH,UNITED STATES,Not yet recruiting,Wake Forest University,January 2021,Interventional,MORPH II: Revisiting A Mobile Intervention to Reduce Pain and Improve Health (MORPH)
4373,Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2,COVID; SARS-CoV2; VIRAL INFECTION,"February 08, 2021",300,NCT04655521,,GERMANY,Recruiting,Universität des Saarlandes,"December 2, 2020",Observational,The Dynamics of the Immune Response to Infection by SARS Coronavirus 2
4374,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19",COVID,"February 08, 2021",100,NCT04655586,RNAPC2; HEPARIN,UNITED STATES,Recruiting,"ARCA Biopharma, Inc.","December 10, 2020",Interventional,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN-COVID-19)"
4375,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases,COVID; SARS-COV INFECTION; RHEUMATOID ARTHRITIS; SPONDYLOARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS,"February 08, 2021",5000,NCT04655612,,FRANCE,Recruiting,"University Hospital, Montpellier","December 1, 2020",Observational,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases
4376,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),COVID,"February 08, 2021",500,NCT04655625,GROUP A (AG0302-COVID19); GROUP A (PLACEBO); GROUP B (AG0302-COVID19); GROUP B (PLACEBO),JAPAN,Recruiting,"AnGes, Inc.","November 23, 2020",Interventional,"A Randomized, Double-blind, Placebo Controlled Phase II / III Study to Assess Safety, Immunogenicity and Efficacy of Twice Dosing of Intramuscular AG0302-COVID19 (2mg) in Healthy Adults"
4377,HFNT vs. COT in COVID-19,COVID; ACUTE RESPIRATORY FAILURE,"February 08, 2021",364,NCT04655638,HIGH FLOW NASAL THERAPY; CONVENTIONAL OXYGEN THERAPY,ITALY,Not yet recruiting,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,"January 10, 2021",Interventional,High-Flow Nasal Therapy Versus Conventional Oxygen Therapy in Patients With COVID-19: A Randomized Controlled Trial (The COVID-HIGH Trial)
4378,Urine Alkalinisation to Prevent AKI in COVID-19,COVID,"February 08, 2021",80,NCT04655716,SODIUM BICARBONATE 150MEQ/L/D5W INJ,,Not yet recruiting,Guy's and St Thomas' NHS Foundation Trust,"February 1, 2021",Interventional,Urine Alkalinisation to Prevent Acute Kidney Injury in COVID-19
4379,A Study in Healthy Men to Test if Different Formulations of BI 764198 With or Without Food Influence the Amount of BI 764198 in the Blood,HEALTHY,"February 08, 2021",28,NCT04656288,BI 764198 - FORMULA A; BI 764198 - FORMULA B; BI 764198 - FORMULA C; BI 764198 - FORMULA D,BELGIUM,Recruiting,Boehringer Ingelheim,"January 15, 2021",Interventional,"A Two-part Phase I Trial Investigating the Relative Bioavailability and Food Effect of Different Oral Formulations of BI 764198 in Healthy Subjects (an Open-label, Single-dose, Randomised, Crossover Study)"
4380,Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France,COVID,"February 08, 2021",250,NCT04656444,,FRANCE,Not yet recruiting,Fondation Lenval,April 2021,Observational [Patient Registry],Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France
4381,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,COVID; SARS-COV INFECTION,"February 08, 2021",1000,NCT04656613,GAM-COVID-VAC; PLACEBO,,Not yet recruiting,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",December 2020,Interventional,"A Phase III, Randomized, Double -Blind, Placebo-controlled Trial to Evaluate Immunogenicity and Safety of the Gam-COVID-Vac Combined Vector Vaccine in Prophylactic Treatment for SARS-СoV-2 Infection in the United Arab Emirates"
4382,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,"STRESS, PSYCHOLOGICAL","February 08, 2021",146,NCT04656626,BRIEF MINDFULNESS BASED INTERVENTION; PROGRESSIVE MUSCLE RELAXATION,SAUDI ARABIA,Completed,Imam Abdulrahman Bin Faisal University,"July 7, 2020",Interventional,"Brief Mindfulness Based Intervention for Front-Line Medical Staff in the COVID19 Pandemic to Improve Psychological Wellbeing, a Randomized Controlled Multicenter Trial"
4383,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,COVID,"February 08, 2021",7500,NCT04656691,BAMLANIVIMAB,UNITED STATES,Enrolling by invitation,Daniel Griffin,"January 4, 2021",Interventional,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
4384,Impact of the COVID-19 Pandemic on Vaccination,COVID,"February 08, 2021",500,NCT04657263,VACCINE COVERAGE ASSESSMENT,FRANCE,Recruiting,"University Hospital, Montpellier","November 1, 2020",Observational,Impact of the COVID-19 Pandemic on Vaccination in Patients at Risk of Infection
4385,Expanded Access to ZofinTM (OrganicellTM Flow) for Patients With COVID-19,COVID; CORONAVIRUS INFECTION; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",,NCT04657406,ZOFINTM,,Available,Organicell Regenerative Medicine,,Expanded Access,Expanded Access to ZofinTM (OrganicellTM Flow) for the Treatment of Patients With Mild to Moderate COVID-19 Due to SARS-Cov-2 for Outpatient and Inpatient Population
4386,Fatigue and Sleep in Patients With COVID-19,COVID,"February 08, 2021",720,NCT04657419,SURVEY,,Not yet recruiting,"University Hospital, Bordeaux","December 5, 2020",Observational,Fatigue and Sleep in Patients With COVID-19
4387,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY",OLFACTORY AND TASTE DYSFUNCTION IN SARS-CoV2 INFECTION,"February 08, 2021",100,NCT04657445,VISUAL ANALOGUE SCALE,GREECE,Recruiting,"University Hospital, Ioannina","November 17, 2020",Observational,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY"
4388,Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS,COVID; ARDS; HYPOXIA; CYTOKINE STORM,"February 08, 2021",,NCT04657458,BONE MARROW MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES INFUSION TREATMENT,,Available,"Direct Biologics, LLC",,Expanded Access,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment: Expanded Access Protocol for Patients With COVID-19 Associated ARDS Who Do Not Qualify for Phase II Randomized Control Trial
4389,Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study,CORONAVIRUS INFECTION,"February 08, 2021",1300,NCT04657471,REVISED HOME-COV SCORE,FRANCE,Recruiting,"University Hospital, Angers","December 8, 2020",Interventional,Hospitalization or Outpatient ManagEment of Patients With Suspected or Confirmed SRAS-CoV-2 Infection: the Revised HOME-CoV Score Study.
4390,Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease,POST COVID DIFFUSE LUNG DISEASE,"February 08, 2021",100,NCT04657484,MEDIUM DOSE PREDNISOLONE; LOW DOSE PREDNISOLONE,INDIA,Recruiting,Postgraduate Institute of Medical Education and Research,"December 8, 2020",Interventional,Comparison of the Efficacy and Safety of Two Corticosteroid Regimens in the Treatment of Diffuse Lung Disease After Coronavirus Disease 2019 (COVID-19) Pneumonia
4391,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),SARS-CoV2 INFECTION (COVID),"February 08, 2021",110,NCT04657497,FOY-305; PLACEBO,JAPAN,Recruiting,Ono Pharmaceutical Co. Ltd,"November 9, 2020",Interventional,"A Placebo-controlled, Multicenter, Double-blind, Randomized, Parallel-group Comparative Study in SARS-CoV-2 Infection (COVID-19)"
4392,Femoral frACturEs and COVID-19.,COVID; FEMUR FRACTURE; FRAGILITY FRACTURE,"February 08, 2021",140,NCT04657510,COVID-19,ITALY,Recruiting,Istituto Ortopedico Galeazzi,"November 14, 2020",Observational,Femoral frACturEs and COVID-19. Retrospective Comparative Cohort Study on the Early Prognosis of Patients Affected by Proximal Femur Fractures and COVID-19.
4393,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,ANOSMIA,"February 08, 2021",40,NCT04657809,INSULIN FILM; FAST DISSOLVING FILM,EGYPT,"Active, not recruiting",Soad Ali,"December 1, 2020",Interventional,"""Insulin Fast Dissolving Film for Intranasal Delivery Via Olfactory Region, a Promising Approach for the Treatment of Anosmia in COVID 19 Patients: Design, In-vitro Characterization and Clinical Evaluation."""
4394,SARS-CoV-2/COVID-19 PREVALENCE STUDY,COVID,"February 08, 2021",3920,NCT04658121,,PUERTO RICO,Not yet recruiting,COVID-19 Prevention Network,"December 15, 2020",Observational,SARS-CoV-2 PREVALENCE STUDY
4395,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,CARDIOVASCULAR RISK FACTOR; COVID,"February 08, 2021",100,NCT04658433,300 MG OF OMEGA3-FA,JORDAN,Recruiting,Applied Science Private University,"December 5, 2020",Interventional,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the COVID-19 Uninfected Jordanian People
4396,Remote vs In Person Weight Loss Study,OBESITY,"February 08, 2021",120,NCT04658550,REMOTE BEHAVIOUR MODIFICATION PROGRAM; IN PERSON BEHAVIOUR MODIFICATION PROGRAM,CANADA,Recruiting,St. Joseph's Healthcare Hamilton,"October 16, 2020",Observational,"A Mixed Retrospective-prospective, Observational Study Evaluating the Efficacy of Counselling in a Remote Setting Compared to an In-person Setting on Weight Loss, in Obese Patients With Body Mass Index > 35 Kg/m2 and Enrolled in the Behaviour Modification Program at the Bariatric Centre of Excellence at St Joseph's Healthcare Hamilton."
4397,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,CHRONIC PULMONARY DISEASE,"February 08, 2021",30,NCT04658979,PULMONARY TELE-REHABILITATION,CANADA,Recruiting,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,December 2020,Interventional,Evaluation of the Feasibility and Safety of a Pulmonary Tele-rehabilitation Program in the Times of COVID-19
4398,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,SARS-COV INFECTION; ACUTE RESPIRATORY DISTRESS SYNDROME; COVID; ARDS,"February 08, 2021",60,NCT04659109,GLENZOCIMAB; PLACEBO,,Not yet recruiting,Acticor Biotech,December 2020,Interventional,"A Randomized, Double Blind, Multicenter, Placebo Controlled, Parallel Group, Exploratory Efficacy and Safety Study of Glenzocimab in SARS-Cov-2-related Acute Respiratory Distress Syndrome"
4399,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,COVID,"February 08, 2021",9,NCT04659122,AT-100,,Not yet recruiting,"Airway Therapeutics, Inc.",January 2021,Interventional,"Phase 1b Open-label, Single Arm, Cohort Dose Escalation Study Evaluating the Safety, Tolerability, and Feasibility of Intervention With AT-100 (rhSP-D) in Intubated Patients Receiving Invasive Mechanical Ventilation With Severe COVID-19 Infection"
4400,ASCO Survey on COVID-19 in Oncology (ASCO) Registry,NEOPLASMS; CORONAVIRUS,"February 08, 2021",2000,NCT04659135,,UNITED STATES,Recruiting,American Society of Clinical Oncology,"April 19, 2020",Observational [Patient Registry],ASCO Survey on Coronavirus Disease 2019 (COVID-19) in Oncology (ASCO) Registry
4401,CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany,COVID,"February 08, 2021",4000,NCT04659187,,GERMANY,Recruiting,Asklepios proresearch,"March 26, 2020",Observational,"""CORONA Germany"" - Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany"
4402,Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients,COVID INFECTION; THYROID FUNCTION TESTS; INFLAMMATION; THYROID; INFLAMMATORY MARKERS,"February 08, 2021",20,NCT04659200,VENOUS BLOOD WAS COLLECTED FOR BIOCHEMISTRY TESTING.,TURKEY,Completed,Bezmialem Vakif University,"September 1, 2020",Observational,"Thyroid Function Tests and the Status of Thyroid Autoantibodies in Hospitalized Covid-19 Patients and Their Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer"
4403,"The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19",COVID,"February 08, 2021",34020,NCT04659239,INACTIVATED SARS-COV-2 VACCINE (VERO CELL); PLACEBO,BRAZIL,Enrolling by invitation,Chinese Academy of Medical Sciences,"January 28, 2021",Interventional,"A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above"
4404,CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid),MULTIPLE MYELOMA,"February 08, 2021",70,NCT04659252,N/A - SAMPLES COLLECTED ALONG ROUTINE CARE SAMPLES ONLY,,Not yet recruiting,"Institute of Cancer Research, United Kingdom","January 15, 2021",Observational,Circulating Tumour Protein Quantification From Capillary Blood for Patient Selfsampling and Safe Remote Monitoring of Multiple Myeloma During COVID-19
4405,"Study Evaluating Safety, Tolerability and Efficacy of Allocetra-OTS in Patients With COVID-19",COVID,"February 08, 2021",50,NCT04659304,ALLOCETRA-OTS; RINGER'S LACTATE,,Not yet recruiting,Enlivex Therapeutics Ltd.,March 2021,Interventional,"A Multi-Center Study, Placebo-Controlled, Evaluating Safety, Tolerability and Efficacy of Different Doses and Regimens of Allocetra-OTS in Patients With COVID-19"
4406,NOSOcomial COVID-19 in ICU (NOSOCOVID),CORONAVIRUS INFECTIOUS DISEASE (COVID); NOSOCOMIAL INFECTION; NOSOCOMIAL COVID,"February 08, 2021",600,NCT04659356,PATIENTS ADMITTED IN INTENSIVE CARE UNITS,FRANCE,Recruiting,Nantes University Hospital,"September 1, 2020",Observational,"Evaluation of a SARS-CoV-2 Infectious Risk Management Protocol on the Transmission of Nosocomial COVID in Intensive Care Unit"""
4407,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,COVID; CORONAVIRUS INFECTION; ACUTE LUNG INJURY; ISCHEMIA LIMB; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",30,NCT04659460,REMOTE ISCHEMIC CONDITIONING,,Not yet recruiting,Unity Health Toronto,"December 15, 2020",Interventional,Remote Ischemic Conditioning as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study
4408,Spanish Survey on Third Wave of COVID-19,COVID,"February 08, 2021",1000,NCT04659473,ONLINE SURVEY,SPAIN,Not yet recruiting,University of Salamanca,"December 9, 2020",Observational,"COVID-19, the Third Wave Update People Coping With the COVID-19. A Cross-sectional Online Spanish Survey"
4409,Adolescents With COVID-19/MIS-C at HCFMUSP,COVID; CORONAVIRUS INFECTION; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); SARS-COV INFECTION,"February 08, 2021",100,NCT04659486,HOME-BASED EXERCISE TRAINING,BRAZIL,Enrolling by invitation,University of Sao Paulo,"September 24, 2020",Interventional,Prospective Studies in School-aged Children and Adolescents With COVID-19 Treated at HCFMUSP
4410,An Exploratory Study Investigating the Potential of a Rectal Mucus Sample for Development of Biomarker Assays in Subjects With Gastrointestinal Diseases,BOWEL CANCER; BOWEL DISEASE; GENOMIC; EPIGENETIC DISORDER,"February 08, 2021",600,NCT04659590,,UNITED KINGDOM,Recruiting,Origin Sciences,"November 6, 2020",Observational,An Exploratory Study Investigating the Potential of a Rectal Mucus Sample for Development of Biomarker Assays in Subjects With Gastrointestinal Diseases
4411,Hyperpolarized 129Xe MRI of Survivors of COVID-19,COVID,"February 08, 2021",20,NCT04659707,HYPERPOLARIZED XE129,,Not yet recruiting,University of Kansas Medical Center,"January 1, 2021",Interventional,Evaluating Lung Structure and Function in Survivors of COVID-19 Using Hyperpolarized 129Xe MRI
4412,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,QUALITY OF LIFE; STRESS; EMOTIONAL ADJUSTMENT,"February 08, 2021",96,NCT04659746,MEJORACARE,PARAGUAY,Recruiting,Universidad Autónoma de Encarnación,"December 9, 2020",Interventional,mHealth Technology to Optimize Mental Health in Chronic Patients During the COVID-19 Outbreak in Paraguay
4413,"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes",COVID,"February 08, 2021",300,NCT04659759,COVID-19 EXPOSURE; COVID-19 VACCINE,UNITED STATES,Recruiting,Thomas Jefferson University,"November 17, 2020",Observational,COVID-19 in Pregnancy: Utilizing Immunology Through Epidemiology to Improve Perinatal/Neonatal Outcomes
4414,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,COVID; RESPIRATORY FAILURE,"February 08, 2021",30,NCT04659772,CLAZAKIZUMAB; PLACEBO,UNITED STATES,Enrolling by invitation,Ayan Sen,December 2020,Interventional,A Randomized Placebo-Controlled Safety And Dose-Finding Study For The Use Of The Il-6 Inhibitor Clazakizumab in Patients With Life-Threatening COVID-19 Infection
4415,Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19,COVID AND MORTALITY,"February 08, 2021",445,NCT04659876,CLINICAL FEATURES AND LABORATORY VALUES,TURKEY,Completed,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,"March 22, 2020",Observational,Clinical Characteristics and Laboratory Values Affecting Mortality in Critical COVID 19 Patients Followed in the Intensive Care Unit
4416,Clinical and Haematological Phenotypes in Long COVID,LONG COVID; COVID,"February 08, 2021",100,NCT04659889,BLOOD SAMPLING (VENESECTION),UNITED KINGDOM,Recruiting,HCA International Limited,December 2020,Observational,Analysis of the Relationship Between Clinical and Haematological Phenotypes in Long COVID
4417,Evaluation of Aerosol in a Dental Clinic,COVID,"February 08, 2021",50,NCT04659928,HIGH VOLUME EVACUATION (HVE); EXTRAORAL VACUUM ASPIRATOR (EVA); EXTERNAL EVACUATION DEVICE (EED); HYDROGEN PEROXIDE,UNITED STATES,Not yet recruiting,"The University of Texas Health Science Center, Houston","December 1, 2020",Interventional,Evaluation of Aerosol in a Dental Clinic
4418,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,COVID VACCINE,"February 08, 2021",1000,NCT04659941,BCG VACCINE,BRAZIL,Recruiting,Universidade Federal do Rio de Janeiro,"October 1, 2020",Interventional,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
4419,"Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP",PNEUMONIA,"February 08, 2021",1060,NCT04660084,ULTRA-RAPID MOLECULAR POINT-OF-CARE TESTING,NORWAY,Recruiting,Haukeland University Hospital,"September 25, 2020",Interventional,"Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP in Norway: a Pragmatic Randomised Controlled Trial"
4420,Advance Care Planning: Communicating With Outpatients for Vital Informed Decision,ADVANCED CARE PLANNING; SHARED DECISION MAKING; VIDEO DECISION AIDS; COMMUNICATION SKILLS; ADVANCE DIRECTIVES; NATURAL LANGUAGE PROCESSING; COVID,"February 08, 2021",13150,NCT04660422,VITALTALK COMMUNICATION SKILLS TRAINING; ACP DECISIONS VIDEO PROGRAM; INTERVENTION TRAINING:; MEDICAL RECORD REVIEW,UNITED STATES,Recruiting,Dana-Farber Cancer Institute,"December 15, 2020",Observational,Advance Care Planning: Communicating With Outpatients for Vital Informed Decisions
4421,The Cognitive and spOrt Virtual EPIC Training Study for Cardiovascular Diseases,CARDIOVASCULAR DISEASES,"February 08, 2021",118,NCT04661189,PHYSICAL EXERCISE TRAINING; COGNITIVE TRAINING,CANADA,Recruiting,Montreal Heart Institute,"May 18, 2020",Interventional,The Cognitive and spOrt Virtual EPIC Training Study: Investigating the Effects of Home-based Exercise and Cognitive Training in Cardiovascular Diseases
4422,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,BULIMIA NERVOSA; BULIMIA; ATYPICAL; BINGE EATING; BINGE-EATING DISORDER,"February 08, 2021",60,NCT04661410,REWARD RE-TRAINING; SUPPORTIVE THERAPY,UNITED STATES,Recruiting,Drexel University,"December 1, 2020",Interventional,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic
4423,Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era,POST ICU REHABILITATION,"February 08, 2021",60,NCT04661423,REMOTE AUTOMATED MONITORING SYSTEM,FRANCE,Not yet recruiting,IHU Strasbourg,January 2021,Interventional,Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
4424,Health After Covid-19 in Tyrol,COVID,"February 08, 2021",1000,NCT04661462,ONLINE SURVEY,AUSTRIA,Recruiting,Medical University Innsbruck,"September 30, 2020",Observational,Health After COVID-19 in the European Region Tyrol - South Tyrol
4425,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,COVID DRUG TREATMENT,"February 08, 2021",60,NCT04661527,SARILUMAB,SPAIN,Recruiting,"Clinica Universidad de Navarra, Universidad de Navarra","April 22, 2020",Interventional,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19
4426,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,PNEUMONIA,"February 08, 2021",36,NCT04661540,CM4620-IE (INJECTABLE EMULSION); PLACEBO,UNITED STATES,Not yet recruiting,"CalciMedica, Inc.",February 2021,Interventional,A Single-Blind Dose-Ranging Pharmacodynamic Study of Auxora for the Treatment of Patients With Critical COVID-19 Pneumonia
4427,Surgery and Lung Ultrasound in COVID-19 Infection,ULTRASONOGRAPHY; LUNG DISEASES; SURGICAL PROCEDURE; COVID; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",451,NCT04661631,LUNG ULTRASOUND,COLOMBIA,Recruiting,Fundacion Clinica Valle del Lili,"May 8, 2020",Observational [Patient Registry],Lung Ultrasound in COVID-19 Infection Screening for Patients With Indication of Emergency Surgery
4428,COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry,COVID; CARDIAC DISEASE; CARDIAC ARRHYTHMIA; MYOCARDITIS; LEFT VENTRICULAR DYSFUNCTION,"February 08, 2021",70,NCT04661657,TRANSTHORACIC ECHOCARDIOGRAM (TTE); CARDIOVASCULAR MAGNETIC RESONANCE (CMR) IMAGING,UNITED STATES,Recruiting,Columbia University,"December 28, 2020",Observational [Patient Registry],COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae (COLUMBIA CARDS) Registry
4429,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,HIV-1-INFECTION; HYPERTENSION,"February 08, 2021",75,NCT04661813,EXTRA-CVD VIRTUAL CARE,UNITED STATES,Not yet recruiting,Case Western Reserve University,February 2021,Interventional,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV
4430,Phase 1 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered as a Single Dose or a Repeat Dose in Healthy Adults,SARS-CoV2,"February 08, 2021",56,NCT04661839,COVID-HIGIV; PLACEBO (SALINE),UNITED STATES,Recruiting,Emergent BioSolutions,December 2020,Interventional,"A Phase 1, Double-blind, Randomized, Placebo-controlled Study to Evaluate Safety and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) Administered as a Single Dose or a Repeat Dose Regimen to Healthy Adults"
4431,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,CORONA VIRUS DISEASE (COVID); RESPIRATORY DISTRESS SYNDROME; SARS-CoV2 INFECTION,"February 08, 2021",50,NCT04661930,TRICOR® 145MG TABLETS; USUAL CARE; PLACEBO,ISRAEL,Recruiting,Hebrew University of Jerusalem,"December 13, 2020",Interventional,Controlled Trial of Fenofibrate for Patients With COVID-19 Requiring Hospitalization
4432,Offering Support and Electronic Resources for Care Partners of Those With Multiple Sclerosis,MULTIPLE SCLEROSIS; CAREGIVERS,"February 08, 2021",150,NCT04662008,TELE-COACHING; WEBSITE,,Not yet recruiting,Case Western Reserve University,"January 10, 2021",Interventional,CLOSER_MS: Communicating With Local or Distance Caregivers Offering Support and Electronic Resources
4433,Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety,ANXIETY DEPRESSION DISORDER,"February 08, 2021",40,NCT04662021,AEROBIC EXERCISES,EGYPT,Enrolling by invitation,Cairo University,"December 10, 2020",Interventional,"The Effect of Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety, Depression and Stress-related to Covid 19 Pandemics Among University Students: a Comparative Study"
4434,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,COVID,"February 08, 2021",120,NCT04662060,ACEBILUSTAT; PLACEBO,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,"COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19"
4435,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,COVID,"February 08, 2021",120,NCT04662073,CAMOSTAT; PLACEBO,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,"COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19"
4436,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,COVID,"February 08, 2021",240,NCT04662086,ACEBILUSTAT; CAMOSTAT,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,"COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19"
4437,The Status of Parathyroid Hormone Secretion in Covid-19 Patients,COVID INFECTION; PARATHYROID GLAND; PARATHYROID HORMONE; CALCIUM; PHOSPHORUS; ALKALINE PHOSPHATASE,"February 08, 2021",150,NCT04662437,VENOUS BLOOD WAS COLLECTED FOR BIOCHEMISTRY TESTING,TURKEY,Completed,Bezmialem Vakif University,"September 10, 2020",Observational,"The Status of Parathyroid Hormone Secretion and Its Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer in Hospitalized Covid-19 Patients"
4438,Koa Family Study--A Community-Based Intervention to Improve Health and Well-Being,"OBESITY; OVERWEIGHT; DIET, HEALTHY; SOCIAL INTERACTION; WEIGHT LOSS","February 08, 2021",120,NCT04662593,WHOLE HEALTH PROGRAM,UNITED STATES,Not yet recruiting,"University of California, Davis",January 2021,Interventional,Koa Family Study--A Community-Based Intervention to Improve Health and Well-Being
4439,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",COVID,"February 08, 2021",60,NCT04662671,RD-X19,UNITED STATES,Recruiting,EmitBio Inc.,"November 18, 2020",Interventional,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19"
4440,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,COVID; VENOUS THROMBOEMBOLISM,"February 08, 2021",320,NCT04662684,RIVAROXABAN 10 MG,BRAZIL,Recruiting,Science Valley Research Institute,"October 16, 2020",Interventional,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial
4441,Formative Evaluation of The HERizon Project,PHYSICAL ACTIVITY,"February 08, 2021",42,NCT04662775,HERIZON PROJECT,IRELAND,Completed,Liverpool John Moores University,"April 15, 2020",Interventional,Formative Evaluation of a Home-based Physical Activity Intervention for Adolescent Girls - The HERizon Project: A Randomised Controlled Trial
4442,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,COVID; ARDS,"February 08, 2021",300,NCT04663555,DEXAMETHASONE,CZECHIA,Recruiting,Brno University Hospital,"February 2, 2021",Interventional,"Effect of Dexamethasone in Patients With ARDS and COVID-19 - Prospective, Multi-centre, Open-label, Parallel-group, Randomized Controlled Trial (REMED Trial)"
4443,Online Culture for Mental Health in People Aged 16-24,DEPRESSION; ANXIETY,"February 08, 2021",400,NCT04663594,WOFB; ASHMOLEAN WEBSITE,UNITED KINGDOM,Recruiting,University of Oxford,"December 4, 2020",Interventional,An Online Cultural Experience to Support Mental Health in People Aged 16-24 During COVID-19: the O-ACEPOP (Online Active Community Engagement Proof of Principle) Study
4444,The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19,COVID; DIABETES MELLITUS,"February 08, 2021",150,NCT04663659,NO INTERVENTION,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"March 15, 2020",Observational,The Effect of Diabetes Mellitus on Mortality in Patients Hospitalized in the COVID Intensive Care Unit in the COVID-19 Pandemic
4445,MoveStrong at Home,ARTHRITIS; CANCER; CARDIOVASCULAR DISEASES; CHRONIC LUNG DISEASE; CONGESTIVE HEART FAILURE; DIABETES; HYPERTENSION; KIDNEY DISEASES; OBESITY; OSTEOPOROSIS; STROKE; FRAILTY,"February 08, 2021",25,NCT04663685,EXERCISE PROGRAM; NUTRITION EDUCATION,CANADA,Recruiting,University of Waterloo,"October 5, 2020",Interventional,"MoveStrong at Home: A Model for Remote Delivery of Strength Training and Nutrition Education for Older Adults in Canada, A Pilot Study"
4446,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",COVID,"February 08, 2021",20,NCT04663737,SILMITASERTIB; SOC,UNITED STATES,Recruiting,"Chris Recknor, MD","December 3, 2020",Interventional,"A Phase II, Randomized and Controlled Investigator Initiated Trial Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Outpatient Adult Subjects With Moderate Coronavirus Disease 2019 (COVID-19)"
4447,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform,COVID; INFLUENZA; RESPIRATORY TRACT INFECTIONS; ACUTE RESPIRATORY TRACT INFECTION; ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100000,NCT04663776,,UNITED STATES,Recruiting,Boston Children's Hospital,"November 4, 2020",Observational,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform
4448,Oral Isotretinoin and Covid-19 Infection,ISOTRETINOIN ADVERSE REACTION; COVID,"February 08, 2021",300,NCT04663906,,,Not yet recruiting,University of Aberdeen,"January 15, 2021",Observational,"Does Oral Isotretinoin Increase the Risk of Developing Infection With and Complications From Covid-19, Compared to an Age-matched Background Population"
4449,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,COVID; DECONDITIONING,"February 08, 2021",45,NCT04663945,BIOBEHAVIORAL TELE-REHABILITATION SESSIONS,UNITED STATES,Recruiting,"University of Colorado, Denver","December 11, 2020",Interventional,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID Survivors
4450,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),COVID,"February 08, 2021",60,NCT04664010,"ALPHA-INTERFERON ALPHA, ABIDOL, RIBAVIRIN, BUZHONG YIQI PLUS AND MINUS FORMULA, HUHUANG DETOXICITY PASTE, BAIMU QINGRE JIEDU PASTE, FUMIGATION/INHALATION OF VITAMIN C; ALPHA-INTERFERON, ABIDOL, RIBAVIRIN, BUZHONG YIQI PLUS AND MINUS FORMULA, HUHUANG DETOXICITY PASTE, BAIMU QINGRE JIEDU PASTE AND 5% GLUCOSE; ALPHA-INTERFERON, ABIDOL, RIBAVIRIN, BUZHONG YIQI PLUS AND MINUS FORMULA, HUHUANG DETOXICITY PASTE, BAIMU QINGRE JIEDU PASTE AND HIGH-DOSE VITAMIN C TREATMENT",CHINA,"Active, not recruiting",Xi'an International Medical Center Hospital,"February 6, 2020",Interventional,Efficacy and Safety of High-dose Vitamin C Combined With Traditional Chinese Medicine in the Treatment of Moderate and Severe Coronavirus Pneumonia (COVID-19)
4451,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution",COVID,"February 08, 2021",120,NCT04664023,"BLOOD COLLECTION AT DAY 8, DAY 16, DAY 24, MONTH 6 AND MONTH 12 AFTER FIRST SYMPTOMS FROM SARS-COV-2 INFECTION",FRANCE,Recruiting,Poitiers University Hospital,"December 9, 2020",Observational,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 and Its Resolution"
4452,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection,SARS-CoV2; COVID,"February 08, 2021",51000,NCT04664049,NRICM101,TAIWAN,Recruiting,"National Research Institute of Chinese Medicine, Ministry of Health and Welfare","December 23, 2020",Observational,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection
4453,Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19),"INFLUENZA; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); RESPIRATORY VIRAL INFECTION; RESPIRATORY TRACT INFECTIONS; INFECTION, BACTERIAL; INFECTION VIRAL; COVID; RNA VIRUS INFECTIONS","February 08, 2021",100,NCT04664075,RESPIRATORY INFECTIONS,UNITED KINGDOM,Not yet recruiting,Imperial College London,January 2021,Observational,Predicting Severity and Disease Progression in Influenza-like Illness
4454,"REmotely Monitored, Mobile Health Supported High Intensity Interval Training for Survivors of COVID-19",COVID; CRITICAL ILLNESS; HIGH INTENSITY INTERVAL TRAINING; ICU; INTENSIVE CARE UNITS; FITNESS TRACKERS,"February 08, 2021",30,NCT04664101,"REMOTELY MONITORED, MHEALTH (REMM) SUPPORTED HIGH INTENSITY INTERVAL TRAINING (HIIT)",UNITED STATES,Not yet recruiting,Duke University,"April 1, 2021",Interventional,"REmotely Monitored, Mobile Health Supported High Intensity Interval Training to Improve Functional Recovery of Survivors of Critical Illness (REMM-HIIT-ICU-COVID)"
4455,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor),INFECTION VIRAL,"February 08, 2021",75,NCT04664296,REVIEW OF MEDICAL PATIENT FILE; PHONE CALL INTERVIEW,,Not yet recruiting,Hospices Civils de Lyon,"January 1, 2021",Observational,Epidemiology of CoV-2 SARS Infections: Dynamics of Community Contamination in Children and Adults
4456,Understanding Immunity to the COVID-19 Vaccines,COVID; IMMUNITY; VACCINE,"February 08, 2021",1000,NCT04664309,NO INTERVENTION,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Observational,Understanding Immunity to the COVID-19 Vaccines
4457,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),ASYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED; B-CELL NEOPLASM; CHRONIC LYMPHOCYTIC LEUKEMIA; CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; SMALL LYMPHOCYTIC LYMPHOMA; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED; WALDENSTROM MACROGLOBULINEMIA,"February 08, 2021",134,NCT04665115,IBRUTINIB; QUALITY-OF-LIFE ASSESSMENT,UNITED STATES,Not yet recruiting,Academic and Community Cancer Research United,"June 30, 2021",Interventional,A Prospective Study of Patients With B-Cell Hematologic Malignancies on Ibrutinib Therapy Who Are Infected With Coronavirus Disease 2019 (COVID-19)
4458,An Approach to Screening for COVID-19 at Vancouver Airport,ASYMPTOMATIC CONDITION; HEALTHY,"February 08, 2021",900,NCT04665193,RAPID ANTIGEN TEST,CANADA,Recruiting,University of British Columbia,"November 23, 2020",Interventional,An Approach to Screening for SARS-CoV-2 at YVR: UBC-PHC-WestJet-YVR COVID-19 Screening Study
4459,Symptom-Based Markers for COVID-19 Transmission,COVID,"February 08, 2021",500,NCT04665245,,UNITED STATES,Enrolling by invitation,University of Iowa,"December 15, 2020",Observational,Contact Network Transmission Modeling of Healthcare Associated Infections: Symptom-Based Markers for COVID-19 Transmission
4460,COVID-19 Vaccine and Impact on Fertility Study,"INFERTILITY, MALE","February 08, 2021",60,NCT04665258,,UNITED STATES,Recruiting,University of Miami,"December 14, 2020",Observational,Corona Virus Disease 19 (COVID-19) Vaccine and Impact on Fertility Study
4461,Evaluating Dove Confident Me Single Session in Indonesia,BODY IMAGE,"February 08, 2021",2000,NCT04665557,DOVE CONFIDENT ME INDONESIA SINGLE SESSION,UNITED KINGDOM,Not yet recruiting,University of the West of England,January 2021,Interventional,"Evaluating ""Dove Confident Me Indonesia""; A School-Based Single Session Intervention to Improve Body Image and Wellbeing Among Indonesian Adolescents"
4462,Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors,COVID,"February 08, 2021",150,NCT04665752,,UNITED STATES,Recruiting,National Eye Institute (NEI),"February 11, 2021",Observational,"Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors, a Natural History, Observational Study"
4463,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation,COVID; EMERGENCIES,"February 08, 2021",1516,NCT04665778,HOSPITAL BEDROOM BOOKING,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","December 4, 2020",Observational,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation
4464,Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2,COVID; SARS-COV INFECTION; SARS PNEUMONIA; CORONAVIRUS INFECTION; INFECTION,"February 08, 2021",40,NCT04665960,,UNITED ARAB EMIRATES,Not yet recruiting,NMC Specialty Hospital,"January 15, 2021",Observational,Expert Statements on Infection Control in Intensive Care Unit for Severe Acute Respiratory Syndrome Coronavirus 2
4465,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,COVID,"February 08, 2021",150,NCT04666012,ADCLD-COV19,"KOREA, REPUBLIC OF",Recruiting,"Cellid Co., Ltd.","December 29, 2020",Interventional,"A Phase 1/2a Study (Dose Escalation, Single Center, Open, Phase 1 and Multicenter, Randomized, Open, Phase 2a) to Assess the Safety and Immunogenicity of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers"
4466,SARS-CoV-2 Donor-Recipient Immunity Transfer,"ACCELERATED PHASE CML, BCR-ABL1 POSITIVE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; CHRONIC LYMPHOCYTIC LEUKEMIA; CHRONIC PHASE CML, BCR-ABL1 POSITIVE; COVID INFECTION; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; HODGKIN LYMPHOMA; LYMPHOBLASTIC LYMPHOMA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOPROLIFERATIVE NEOPLASM; NON-HODGKIN LYMPHOMA","February 08, 2021",36,NCT04666025,BIOSPECIMEN COLLECTION; DIAGNOSTIC LABORATORY BIOMARKER ANALYSIS; ELECTRONIC HEALTH RECORD REVIEW; QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,City of Hope Medical Center,"September 23, 2020",Observational,Observational Study of SARS-CoV-2 Donor-Recipient Immunity Transfer
4467,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room,COVID; LUNG ULTRASOUND; RESPIRATORY COMPLICATION,"February 08, 2021",100,NCT04666064,COVID19 RT-PCR; LUNG ULTRASOUND,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","December 10, 2020",Observational,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room
4468,Changes in Viral Load in COVID-19 After Probiotics,COVID,"February 08, 2021",96,NCT04666116,DIETARY SUPPLEMENTATION IN PATIENTS WITH COVID DISEASE ADMITTED TO HOSPITAL,SPAIN,Recruiting,Hospital de Sagunto,"April 1, 2020",Interventional,Changes in Viral Load in Patients With COVID-19 Disease After Dietary Supplementation With Probiotics: A Randomized Clinical Trial
4469,"Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19",COVID,"February 08, 2021",20,NCT04666207,PCR,DENMARK,Recruiting,"Rigshospitalet, Denmark","May 25, 2020",Observational,"A Cohort Study of Non-hospitalized SARS-CoV-2 Positive Children in Denmark: Viral Shedding, Symptoms and Exposure"
4470,Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation,NEONATES NEEDING RESUSCITATION AT BIRTH,"February 08, 2021",48,NCT04666233,NEONATAL RESUSCITATION WITH PPE FOR THE PREVENTION OF SARS-COV-2 INFECTION; NEONATAL RESUSCITATION WITHOUT PPE FOR THE PREVENTION OF SARS-COV-2 INFECTION,,Not yet recruiting,University Hospital Padova,January 2021,Interventional,Does Personal Protective Equipment for the Prevention of SARS-Cov-2 Infection Impact the Timing of Ventilation in Neonates Needing Resuscitation at Birth? A Crossover Randomized Controlled Trial
4471,Inspiratory Effort in COVID-19,ACUTE RESPIRATORY FAILURE; COVID,"February 08, 2021",40,NCT04666246,,ITALY,Recruiting,University of Modena and Reggio Emilia,"March 1, 2020",Observational,Inspiratory Effort Assessment in Patients With COVID-19 Pneumonia Undergoing Non Invasive Respiratory Support
4472,Southampton Women's Survey COVID-19 Study,MENTAL HEALTH WELLNESS 1,"February 08, 2021",1000,NCT04666285,EXPERIENCE OF PANDEMIC,UNITED KINGDOM,Not yet recruiting,University of Southampton,December 2020,Observational,A Survey of Southampton Women's Survey Women's and Offspring's Health and Wellbeing During the COVID-19 Pandemic and Lockdown.
4473,Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis,PULMONARY TUBERCULOSIS; TUBERCULOSIS DIAGNOSIS; COVID; HIV,"February 08, 2021",1400,NCT04666311,ACCURACY OF CAD4TB AND AFINION CRP ASSAY FOR PULMONARY TB; CAD4COVID+WBC AND COVID-19 RDT FOR SARS-COV-2 INFECTION,LESOTHO,Not yet recruiting,Klaus Reither,December 2020,Observational,"Prospective, Multicentre Evaluation of the Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for the Diagnosis of Pulmonary Tuberculosis in Presumptive Adult TB Patients (TB TRIAGE+ Accuracy)"
4474,COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,COVID,"February 08, 2021",1400,NCT04666441,REGN10933+REGN10987 COMBINATION THERAPY; PLACEBO,UNITED STATES,Recruiting,Regeneron Pharmaceuticals,"December 15, 2020",Interventional,A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection
4475,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,AUTISM SPECTRUM DISORDER,"February 08, 2021",100,NCT04666493,"COGNITIVE BEHAVIOR THERAPY (CBT), SPECIFICALLY USING THE FACING YOUR FEARS (FYF) CURRICULUM",CANADA,Recruiting,Evdokia Anagnostou,"December 4, 2020",Interventional,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19: A Research Project to Provide and Evaluate Virtual Mental Health Care
4476,Heal-Me Personalized Online Nutrition and Exercise Routines,CANCER; LUNG DISEASES; LIVER DISEASES,"February 08, 2021",216,NCT04666558,EXERCISE & NUTRITION; EXERCISE & NUTRITION,CANADA,Recruiting,University of Alberta,"November 30, 2020",Interventional,Heal-Me PiONEeR (Personalized Online Nutrition and Exercise Routines) - Reconnecting Vulnerable Outpatients With Multidisciplinary Care - a Randomized Controlled Trial Assessing 3 Levels of Online Programming in the Time of COVID
4477,Pandemic-adapted Caries Care Multicentre Case Series,DENTAL CARIES IN CHILDREN,"February 08, 2021",420,NCT04666597,MODIFIED CARIESCARE INTERNATIONAL MANAGEMENT,ARGENTINA,Recruiting,"Universidad El Bosque, Bogotá","November 15, 2020",Observational,CariesCare International Adapted for the Pandemic in Children: Caries OUT Multicentre Single-group Interventional Study
4478,Retrospective Study of ImmunoFormulation for COVID-19,COVID,"February 08, 2021",40,NCT04666753,IMMUNOFORMULATION,SPAIN,Completed,Fagron Iberica S.A.U.,"July 2, 2020",Observational,Retrospective Observational Study to Describe the Evolution of SARS-CoV-2 Disease and the Profile of Patients Treated or Not With Imuno TF® and a Combination of Nutraceuticals and Who Have Tested Positive for COVID-19
4479,Access to Chiropractic Care During the COVID-19 Pandemic,ACCESS TO CHIROPRACTIC CARE SERVICES,"February 08, 2021",500,NCT04666779,CHIROPRACTIC CARE,SPAIN,Not yet recruiting,Real Centro Universitario Maria Cristina,"December 14, 2020",Observational [Patient Registry],Access to Chiropractic Care During the COVID-19 Pandemic: a Prospective Comparative Cohort Trial
4480,Mushroom-based Product for COVID-19,COVID,"February 08, 2021",66,NCT04667247,FOTV,UNITED STATES,Recruiting,Gordon Saxe,"December 3, 2020",Interventional,"Multicenter Double Blind, Placebo Controlled RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19"
4481,Awake Pronation for Covid-19 Treatment,COVID INFECTION,"February 08, 2021",100,NCT04667286,PRONE POSITION (PP),,Not yet recruiting,Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi,"December 30, 2020",Interventional,"Pronation in Spontaneously Breathing Patients With Acute Respiratory Failure Deu to Covid-19: Multicenter, Randomised Study"
4482,Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects,COVID,"February 08, 2021",60,NCT04667442,NANOMIX ELAB® COVID-19 RAPID ANTIGEN PANEL (NON-INTERVENTIONAL),UNITED STATES,Recruiting,Nanomix,"December 1, 2020",Observational,An Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
4483,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19,COVID,"February 08, 2021",102,NCT04667780,COLCHICINE; STANDARD COVID-19 CARE,PAKISTAN,Recruiting,Ayub Teaching Hospital,"December 10, 2020",Interventional,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19
4484,Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome,COVID; ARDS,"February 08, 2021",50,NCT04667923,RESPIRATORY MONITORING; RESPIRATORY MUSCLES ULTRASOUND; ELECTRO IMPEDANCE TOMOGRAPHY; CAPNOGRAPHY; ARTERIAL BLOOD GAS; QUASISTATIC PRESSURE-VOLUME CURVE,RUSSIAN FEDERATION,Recruiting,I.M. Sechenov First Moscow State Medical University,"October 1, 2020",Observational,Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome to Prevent Tracheal Intubation: the COVID-NIV Study
4485,Evaluation of Sedation in COVID-19 ARDS,PRONE POSITION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HYPNOTICS AND SEDATIVES; PULMONARY VENTILATION,"February 08, 2021",100,NCT04667936,TREATMENT GROUP,GERMANY,Recruiting,Goethe University,"March 1, 2020",Observational,Evaluation of Impaired Sedation in Patients With Moderate to Severe COVID-19 ARDS
4486,Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain,"BURNOUT, CAREGIVER","February 08, 2021",302,NCT04667962,ONLINE QUESTIONNAIRE,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"December 23, 2020",Observational,Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain
4487,Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management,COVID,"February 08, 2021",340,NCT04668170,BLOOD COLLECTION ON ADMISSION AND LONGITUDINALLY; BLOOD COLLECTION ON THEIR FIRST CONSULTATION AND 10 TO 14 DAYS LATER,FRANCE,Recruiting,"University Hospital, Toulouse","May 5, 2020",Observational,Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management
4488,Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR),COVID; ACUTE RESPIRATORY FAILURE; CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04668196,HIGH-FLOW NASAL CANNULA TREATMENT; CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) TREATMENT; NONINVASIVE VENTILATION TREATMENT,SPAIN,Recruiting,Hospital Universitari Vall d'Hebron Research Institute,"May 22, 2020",Observational,Noninvasive Respiratory Support Outside the Intensive Care Unit in COVID-19 Pneumonia: a Multicentric Study (CATCOVID-AIR)
4489,Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19),CORONAVIRUS,"February 08, 2021",40,NCT04668209,SILMITASERTIB,UNITED STATES,Recruiting,University of Arizona,"January 1, 2021",Interventional,"Phase II, Randomized, Investigator Initiated Trial to Evaluate Safety and to Explore Clinical Benefit of Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)"
4490,Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents,COVID; HERBAL MEDICINE,"February 08, 2021",480,NCT04668222,"YU-PING-FENG FORMULA; XIANG-SHA-LIU-JUN FORMULA; LIU-WEI-DI-HUANG FORMULA; PLACEBO FOR ""DEFICIENCY OF QI AND YANG""; PLACEBO FOR ""DEFICIENCY OF QI AND YIN""",HONG KONG,Not yet recruiting,The University of Hong Kong,"December 15, 2020",Interventional,"Based on the Theory of ""Body Constitution of Chinese Medicine"" and ""Combination of Prescription and Syndrome"" to Improve COVID-19 Susceptible Body Constitution of Residents in Hong Kong"
4491,Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected),COVID,"February 08, 2021",342,NCT04668235,AZVUDINE; AZVUDINE PLACEBO,BRAZIL,Not yet recruiting,HRH Holdngs Limited,December 2020,Interventional,"Evaluation of Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected): Phase III, Randomized, Double-blind, PLACEBO Controlled Trial"
4492,COVID-19 Advanced Respiratory Physiology (CARP) Study,RESPIRATORY FAILURE; COVID; BIOSENSOR,"February 08, 2021",150,NCT04668313,,UNITED KINGDOM,Recruiting,NHS Greater Glasgow and Clyde,"September 29, 2020",Observational [Patient Registry],COVID-19 Advanced Respiratory Physiology (CARP) Study
4493,A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults,COVID; SARS-COV INFECTION; CORONAVIRUS INFECTION,"February 08, 2021",600,NCT04668339,"ARCT-021 SINGLE DOSE PRIMING; ARCT-021 TWO LOWER DOSE PRIMING; ARCT-021 TWO HIGHER DOSE PRIMING; PLACEBO (TWO DOSES), PRIMING; RANDOMIZED BOOSTER; PLACEBO BOOSTER",SINGAPORE,Recruiting,"Arcturus Therapeutics, Inc.","January 7, 2021",Interventional,"A Phase 2 Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Safety, Reactogenicity, and Immunogenicity of the SARS CoV-2 Vaccine ARCT-021 in Healthy Adult Participants"
4494,Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19,COVID; HYPERCOAGULABLE STATES NEC,"February 08, 2021",50,NCT04668404,SONOCLOT,INDIA,Recruiting,Postgraduate Institute of Medical Education and Research,"August 24, 2020",Observational [Patient Registry],Study of Coagulation Profile and Role of Heparin-like Effect in Patients With COVID-19
4495,Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic,COVID,"February 08, 2021",600,NCT04668469,IVERMECTIN; HYDROXYCHLOROQUINE; PERSONAL PROTECTIVE MEASURES,EGYPT,Completed,Benha University,"June 8, 2020",Interventional,Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
4496,"Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures",COVID (SARS-CoV2),"February 08, 2021",1000,NCT04668625,PARTICIPATE IN A MASSIVE MUSICAL EVENT,SPAIN,Completed,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","November 30, 2020",Interventional,Risk of Infection of SARS-CoV-2 in a Massive Musical Show With Transmission Prevention Measures: Randomized Study
4497,"Reliability and Acceptability of Real-time Virtual Video Pediatric Gait, Arms, Legs and Spine (V-pGALS)",MUSCULOSKELETAL ABNORMALITY; PEDIATRIC,"February 08, 2021",15,NCT04668820,"VIDEO PEDIATRIC GAIT, ARMS, LEGS AND SPINE (V-PGALS)",TURKEY,Not yet recruiting,Marmara University,"February 1, 2021",Interventional,"Reliability and Acceptability of Real-time Virtual Video Pediatric Gait, Arms, Legs and Spine (V-pGALS) Assessment for Musculoskeletal Assessment of Children for Telemedicine Visits"
4498,"Oral Health, Microbial Burden and COVID-19",COVID; PERIODONTITIS,"February 08, 2021",150,NCT04668911,SWAB,UNITED KINGDOM,Recruiting,Eastman Dental Insitute and Hospital,"December 13, 2020",Observational,"Oral Health, Microbial Burden and COVID-19"
4499,Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy Pediatric Emergency Services,NUMBER OF PATIENTS DURING THE STUDYING PERIOD; REASON FOR CONSULTATION,"February 08, 2021",11000,NCT04668937,,FRANCE,Completed,"Central Hospital, Nancy, France","March 18, 2020",Observational,Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy
4500,Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2),COVID; CORONAVIRUS,"February 08, 2021",1100,NCT04668950,FLUVOXAMINE; PLACEBO,CANADA,Recruiting,Washington University School of Medicine,"December 22, 2020",Interventional,"Fluvoxamine for Early Treatment of Covid-19: a Fully-remote, Randomized Placebo Controlled Trial"
4501,Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19,COVID,"February 08, 2021",914,NCT04669015,NOVAFERON; PLACEBO,,Not yet recruiting,Genova Inc.,January 2021,Interventional,"NOVATION-1: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon + SOC vs. Placebo + SOC in Hospitalized Adult Patients With Moderate to Severe COVID-19"
4502,Hospital Interns Psychological State During the COVID-19,"COVID; DEPRESSION; STRESS DISORDERS, POST-TRAUMATIC","February 08, 2021",102,NCT04669054,,FRANCE,"Active, not recruiting","University Hospital, Montpellier","December 1, 2020",Observational,Hospital Interns Psychological State During the COVID-19 Pandemic
4503,Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit,COVID; LIVER INJURY; MORTALITY,"February 08, 2021",532,NCT04669509,LIVER FUNCTION TESTS,TURKEY,Completed,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,"April 1, 2020",Observational,Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit
4504,COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management,TYPE 1 DIABETES,"February 08, 2021",77,NCT04669912,GLUCOSE CONTROL AND SENSOR USAGE,FRANCE,Completed,Centre Hospitalier Sud Francilien,"January 15, 2021",Observational,Observational Study of Glycemic Control and Self-management of Young People (Aged 13 to 25 Years ) With Type 1 Diabetes During COVID-19 Lockdown.
4505,COVID-19 Impact on the Lombardy Region's Emergency System,COVID,"February 08, 2021",10000,NCT04669925,,ITALY,"Active, not recruiting",Mario Negri Institute for Pharmacological Research,"September 1, 2020",Observational,Tsunami Project - Description and Prediction of COVID-19 Impact on the Lombardy Region's Emergency System
4506,"Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients",COVID,"February 08, 2021",200,NCT04669938,OROPHARYNGEAL AND INTESTINAL MICROBIOTA; HOST GENOTYPE; HOST IMMUNE FACTORS; VIRAL SEQUENCE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"December 4, 2020",Observational,Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease in Hospitalized Patients
4507,Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study,COVID,"February 08, 2021",2000,NCT04669990,REMDESIVIR,NEPAL,Recruiting,Nepal Health Research Council,"November 19, 2020",Observational,Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study
4508,Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application,COVID,"February 08, 2021",20000,NCT04670003,USERS,,Not yet recruiting,Weprom,January 2021,Observational [Patient Registry],Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application: an Observational Study
4509,Comorbidities and Risk Score in COVID-19 Patients,COVID,"February 08, 2021",2500,NCT04670094,,ITALY,"Active, not recruiting",University of Milano Bicocca,"December 30, 2020",Observational,Comorbidities and Risk Score for Severity and Outcome in Patients With Infection by SARS-CoV-2.
4510,Validation of the Telematic Version of the Fugl-Meyer Scale,STROKE,"February 08, 2021",50,NCT04670315,TELEMATIC EVALUATION OF MOTOR FUNCTION,SPAIN,Not yet recruiting,University of Salamanca,"March 1, 2021",Observational,Validation of theTelematic Spanish Version of the Fugl-Meyer Assessment of Motor Recovery After Stroke
4511,Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity,COVID,"February 08, 2021",101,NCT04670328,NOT REQUIRED,PAKISTAN,Completed,FMH College of Medicine and Dentistry,"May 1, 2020",Observational,Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity
4512,Mask Hypoxia in Subjects Using Masks to Prevent Infection Spread,HYPOXIA,"February 08, 2021",30,NCT04670484,WEARING MASK,UNITED STATES,Not yet recruiting,University of New Mexico,"January 1, 2021",Interventional,To Determine the Presence of Mask Hypoxia in Subject Wearing Masks as Personal Protective Equipment (PPE) Due to the Federal Guidelines
4513,"Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults",SARS-CoV2 VIRUS INFECTION,"February 08, 2021",153,NCT04671017,VLA2001,UNITED KINGDOM,"Active, not recruiting",Valneva Austria GmbH,"December 16, 2020",Interventional,"A Phase I/II Randomized, Two Parts, Dose-Finding Study To Evaluate The Safety, Tolerability and Immunogenicity Of An Inactivated, Adjuvanted Sars-Cov-2 Virus Vaccine Candidate (VLA2001), Against Covid-19 In Healthy Subjects"
4514,Learning to Evaluate Blood Pressure at Home (LEANBH),HYPERTENSION IN PREGNANCY,"February 08, 2021",500,NCT04671602,,IRELAND,Recruiting,University College Cork,"August 19, 2020",Observational,Implementing LEANBH Ambulatory Integrated Blood Pressure Monitoring in Maternity Services
4515,Nasal Poly-ICLC (Hiltonol®) for Prophylaxis of COVID-19 in Healthy Adults,COVID - 19,"February 08, 2021",43,NCT04672291,POLY-ICLC (HILTONOL®); POLY-ICLC (HILTONOL®),CANADA,Not yet recruiting,"Oncovir, Inc.","January 15, 2021",Interventional,"A Phase I-Ib, Double-blinded, Randomized Repeated Dose Multicenter, Safety and Immunogenicity Study of Nasal Poly-ICLC (Hiltonol®) for Prophylaxis of COVID-19 in Healthy Adults"
4516,Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2,SARS-CoV2,"February 08, 2021",300,NCT04672343,DATA COLLECTION; QUERYING THE INSEE DATABASE,FRANCE,Recruiting,Centre Hospitalier Universitaire Dijon,"October 19, 2020",Observational,IPrognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2
4517,A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19,COVID,"February 08, 2021",34000,NCT04672395,AS03-ADJUVANTED SCB-2019 VACCINE; PLACEBO; 0.9% SALINE,BELGIUM,Not yet recruiting,Clover Biopharmaceuticals AUS Pty Ltd,January 2021,Interventional,"A Double-Blind, Randomized, Controlled, Phase 2/3 Study to Evaluate the Efficacy, Immunogenicity, and Safety of SCB 2019, a Recombinant SARS-CoV-2 Trimeric S Protein Subunit Vaccine for the Prevention of COVID-19 in Participants Aged 18 Years and Older"
4518,"PRIDE - Pilot Trial of an Online Digital Problem-solving Intervention for School-going Adolescents in Goa, India","MENTAL HEALTH ISSUE; DEPRESSION, ANXIETY; STRESS","February 08, 2021",120,NCT04672486,POD ADVENTURES,,Not yet recruiting,Sangath,"December 18, 2020",Interventional,"PRIDE - Pilot Trial of an Online Digital Problem-solving Intervention for School-going Adolescents in Goa, India"
4519,Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients,CORONAVIRUS DISEASE 2019,"February 08, 2021",300,NCT04672564,CARRIMYCIN; PLACEBO,ARGENTINA,Not yet recruiting,"Shenyang Tonglian Group CO., Ltd","January 14, 2021",Interventional,"A Phase 3, Randomized, Multicenter, Placebo-controlled, Double-blind Clinical Study of the Safety and Efficacy of Carrimycin for Treatment of Severe COVID-19 in Hospitalized Patients"
4520,COVID-19 Neurological Disease: A Prospective Study,DISEASES OF THE NERVOUS SYSTEM; OTHER SPECIFIED VIRAL DISEASES,"February 08, 2021",681,NCT04672590,PRIMARY EXPOSURE IS HYPOXIA (NO INTERVENTION),,Not yet recruiting,University of Liverpool,January 2021,Observational,"COVID-19 Neurological Disease: A Prospective Study in Brazil, India and Malawi"
4521,GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19),SARS-CoV2,"February 08, 2021",345,NCT04673149,GLS-5310; PLACEBO,"KOREA, REPUBLIC OF",Recruiting,"GeneOne Life Science, Inc.","December 23, 2020",Interventional,"Multicenter, Randomized, Combined Phase I Dose-escalation and Phase IIa Double-blind, Placebo-controlled Study of the Safety, Tolerability, and Immunogenicity of GLS-5310 DNA Vaccine, Administered Intradermally Against SARS-CoV-2 in Healthy Adults"
4522,Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients,COVID,"February 08, 2021",260,NCT04673162,"METHYLPREDNISOLONE, PLACEBO",ITALY,Not yet recruiting,Azienda Unità Sanitaria Locale Reggio Emilia,December 2020,Interventional,"A Randomized, Multicentre, Double-blind Study to Evaluate the Efficacy of High-dose Administration of Methylprednisolone in Addition to Standard Treatment, in SARS-CoV2 (COVID-19) Pneumonia Patients"
4523,Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment,COVID,"February 08, 2021",62,NCT04673214,AZITHROMYCIN / IVERMECTIN / RIBAROXABAN / PARACETAMOL; AZITHROMYCIN / RIBAROXABAN / PARACETAMOL,MEXICO,Recruiting,Gilberto Cruz Arteaga,"December 16, 2020",Interventional,Prognostic Modification in Patients With COVID-19 Under Early Intervention Treatment at U.M.F 13 and U.M.F 20
4524,Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina,CORONAVIRUS DISEASE 2019,"February 08, 2021",189,NCT04673279,SEROLOGY,ARGENTINA,Recruiting,Hospital Italiano de Buenos Aires,"December 2, 2020",Observational [Patient Registry],"Long-term Persistence of Immunoglobulin G Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Vulnerable Neighbourhood in Buenos Aires, Argentina"
4525,Community Collaboration to Combat COVID-19 (C-FORWARD),CORONAVIRUS INFECTION,"February 08, 2021",3000,NCT04673292,"FIXED SITE STANDARD OF CARE TESTING; COMMUNITY-BASED, MOBILE VAN TESTING; SELF-COLLECTED, HOME-BASED TESTING",,Not yet recruiting,Johns Hopkins University,February 2021,Interventional,Community Collaboration to Combat COVID-19
4526,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy,COVID; PHYSICAL DISABILITY,"February 08, 2021",87,NCT04673318,HEAT THERAPY; EXERCISE TRAINING,,Not yet recruiting,"University of Massachusetts, Amherst",January 2021,Interventional,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy
4527,"Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic",CYSTIC FIBROSIS,"February 08, 2021",24,NCT04673331,EXERCISE CAPACITY,TURKEY,Recruiting,Hacettepe University,"November 4, 2020",Observational,"Comparison of Physical Activity, Exercise Capacity, Quality of Life, Cognitive Function and Coronavirus Phobia Levels of Adult Cystic Fibrosis Patients With Healthy Individuals With Telerehabilitation in the COVID-19 Pandemic"
4528,Cognitive Behavioral Therapy for Depression: Helping Clients Learn New Skills,DEPRESSION,"February 08, 2021",150,NCT04673513,PSYCHOTHERAPY,UNITED STATES,Recruiting,Ohio State University,"December 11, 2020",Interventional,Cognitive Behavioral Therapy for Depression: Helping Clients Learn New Skills
4529,Monitoring Spondyloarthritis With SpA-Net,SPONDYLOARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS; SPONDYLOARTHROPATHY,"February 08, 2021",200,NCT04673825,PATIENT INITIATED CARE + TELEMONITORING,NETHERLANDS,Recruiting,Maastricht University Medical Center,"December 2, 2020",Interventional,Effectiveness and Cost-effectiveness of Monitoring Spondyloarthritis With the Integrated eHealth System SpA-Net: a Randomized Controlled Trial
4530,A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19,CORONAVIRUS; COVID; SARS-CoV2; SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",2520,NCT04674189,CVNCOV VACCINE; PLACEBO,GERMANY,Recruiting,CureVac AG,"December 23, 2020",Interventional,"COVID-19: A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Clinical Study Evaluating the Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care Workers in Mainz (Germany)"
4531,Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients,COVID; CORONAVIRUS INFECTION; PNEUMONIA,"February 08, 2021",100000,NCT04674410,ANTIBIOTIC,UNITED STATES,"Active, not recruiting",National Institutes of Health Clinical Center (CC),"March 1, 2020",Observational,Utility of Empiric Antibiotics on Admission for Non-intubated Patients With Novel Coronavirus Diseases 2019 (COVID-19): A Retrospective Cohort Study of Electronic Health Records
4532,Effect of Obesity Among COVID-19 Patients in Critical Care Settings,OBESITY; COVID,"February 08, 2021",100,NCT04674553,,PAKISTAN,Completed,"Services Institute of Medical Sciences, Pakistan","November 10, 2020",Observational,Effect of Obesity Among COVID-19 Patients in Critical Care Settings
4533,Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19,COVID,"February 08, 2021",45,NCT04674566,COR-101; PLACEBO,,Not yet recruiting,Corat Therapeutics Gmbh,"January 31, 2021",Interventional,"Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, First-in-human, Phase Ib/II Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Efficacy of COR-101 in Hospitalized Patients"
4534,Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales,COVID PANDEMIC,"February 08, 2021",850,NCT04674644,THE PSYCHOSOCIAL EFFECTS OF COVID-19 PANDEMIC ON DENTAL PROFESSIONALS,TURKEY,Completed,Suleyman Demirel University,"October 16, 2020",Interventional,Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department
4535,Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection,"COVID; PNEUMONIA, VIRAL","February 08, 2021",0,NCT04675086,ALPHA1-PROTEINASE INHIBITOR; ANTIVIRAL AGENTS,UNITED STATES,Withdrawn,"Blessing Corporate Services, Inc",January 2021,Interventional,"A Randomized, Open-Label Study of the Efficacy and Safety of Aralast NP, an Alpha-1 Antitrypsin Infusion Therapy With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection"
4536,Pathological Findings of Fatal COVID-19,SARS-CoV2; COVID; PATHOLOGY; INTENSIVE CARE UNITS; RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100,NCT04675281,2 POST-MORTEM TRANSCUTANEOUS LUNG BIOPSIES (1 ANTERIOR ; 1 POSTERIOR) USING ANATOMICAL LANDMARKS,FRANCE,Recruiting,Nantes University Hospital,"April 24, 2020",Observational,Pathological Findings in Critically-ill Patients Who Died From SARS-CoV-2 Related Acute Respiratory Distress Syndrome
4537,Stay Active Physical Activity Program,HEALTHY LIFESTYLE; SEDENTARY BEHAVIOR,"February 08, 2021",515,NCT04675658,CBPA + FAMILY SUPPORT; CBPA,UNITED STATES,"Active, not recruiting",Children's Mercy Hospital Kansas City,"October 5, 2020",Interventional,"Stay Active Physical Activity Program for Teachers, Students, and Families"
4538,Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19,COVID,"February 08, 2021",208,NCT04676867,DALCETRAPIB; PLACEBO,CANADA,Recruiting,DalCor Pharmaceuticals,"January 11, 2021",Interventional,"A Double-blind, Placebo-controlled, Phase 2a Proof-of-concept Trial of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19"
4539,Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",105,NCT04676971,HZVSF-V13; PLACEBO (NORMAL SALINE SOLUTION),ITALY,Recruiting,"ImmuneMed, Inc.","December 11, 2020",Interventional,"Efficacy and Safety of Intravenously Administered hzVSF-v13 in Patients With COVID-19 Pneumonia: a Phase II, Proof of Concept, Multicentre, Randomized, Parallel-group, Double-blind, Placebo-controlled Study"
4540,Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic,PROBLEM SOLVING,"February 08, 2021",397,NCT04677270,DIGITAL PROBLEM SOLVING TOOL,SWEDEN,Completed,Karolinska Institutet,"August 31, 2020",Interventional,Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic
4541,"Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.",SYMPTOMS RELATED TO COVID,"February 08, 2021",2020,NCT04677283,,FRANCE,Recruiting,Gérond'if,"April 5, 2020",Observational,"Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France."
4542,Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19,TUBERCULOSIS; COVID,"February 08, 2021",20,NCT04677478,IMPACT OF RESPIRATORY ISOLATION ON QUALITY OF LIFE,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,December 2020,Observational,Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19
4543,A Study of TAK-919 in Healthy Japanese Adults (COVID-19),PREVENTION OF INFECTIOUS DISEASE CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV2),"February 08, 2021",200,NCT04677660,TAK-919; PLACEBO,JAPAN,Recruiting,Takeda,"January 21, 2021",Interventional,"A Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of TAK-919 by Intramuscular Injection in Healthy Japanese Male and Female Adults Aged 20 Years and Older (COVID-19)"
4544,European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol,HIV INFECTIONS; TUBERCULOSIS INFECTION; HEPATITIS C; COVID,"February 08, 2021",10000,NCT04677842,ART THERAPY,,"Active, not recruiting",PENTA Foundation,"January 1, 2013",Observational [Patient Registry],European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC): Paediatric Protocol
4545,Sensitivity Evaluation of Serological Tests for Covid-19,COVID,"February 08, 2021",410,NCT04678024,,ITALY,Enrolling by invitation,Istituto Ortopedico Galeazzi,"November 18, 2020",Observational,Multicentric Sensitivity Assessment of Antibody Diagnostic Tests Developed for Diagnosis of SARS-CoV2 Infection
4546,COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy,COVID,"February 08, 2021",27000,NCT04678193,COROMEC REGISTRY WITH ECL-19,INDIA,Enrolling by invitation,"Aventyn, Inc.","December 24, 2020",Observational [Patient Registry],COVID-19 Risk Assessment Hospitalization Outcomes Epidemiology Efficacy
4547,COVID-19 and Tissue Damage in Vital Organs,COVID; POSTMORTEM CHANGES,"February 08, 2021",10,NCT04678687,"LIVER, LUNG, HEART AND KIDNEY BIOPSY",TURKEY,"Active, not recruiting",Dokuz Eylul University,"January 1, 2021",Interventional,Evaluation of Postmortem Biopsy Specimens of COVID-19 Cases
4548,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance,COVID- CORONAVIRUS- SARS-CoV2,"February 08, 2021",40,NCT04678700,CHEST PHYSIOTHERAPY POST-COVID19,SPAIN,Recruiting,European University of Madrid,"March 1, 2021",Interventional,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance
4549,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial,COVID; COVID ARDS,"February 08, 2021",150,NCT04678739,REMDESIVIR; TOCILIZUMAB,BANGLADESH,Recruiting,M Abdur Rahim Medical College and Hospital,"August 15, 2020",Interventional,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
4550,Virtual Reality Study - COVID-19 Protocol,HEALTHY AGING,"February 08, 2021",11,NCT04678778,PHYSICAL AND COGNITIVE ACTIVITY,UNITED STATES,Recruiting,University of Southern California,"March 19, 2019",Interventional,Targeted Physical and Cognitive Activity in a VR Environment - COVID-19 Protocol
4551,COVID-19 Long-Haulers Study,CORONAVIRUS DISEASE 2019,"February 08, 2021",102,NCT04678830,PLACEBOS; LERONLIMAB (700MG),,Not yet recruiting,"CytoDyn, Inc.","January 21, 2021",Interventional,"A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab in Patients Experiencing Prolonged Coronavirus Disease 2019 (COVID-19) Symptoms [Long-Haulers]"
4552,Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond,ANOREXIA NERVOSA,"February 08, 2021",36,NCT04678843,VIRTUAL FAMILY-BASED TREATMENT,,Not yet recruiting,Jennifer Couturier,January 2021,Interventional,Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond
4553,Study on Kidney Disease and EnviromenTal Chemical,COVID; ENVIRONMENTAL EXPOSURE; CHRONIC KIDNEY DISEASES,"February 08, 2021",310,NCT04679168,,"KOREA, REPUBLIC OF",Recruiting,Seoul National University Hospital,"June 1, 2020",Observational [Patient Registry],Change of Environmental Chemical Exposures and Prevalence of Chronic Kidney Disease After Epidemiological Spread of SARS-CoV-2 (COVID-19)
4554,Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients,COVID; RHEUMATOID ARTHRITIS,"February 08, 2021",2000,NCT04679272,,FRANCE,Enrolling by invitation,"University Hospital, Montpellier","December 1, 2020",Observational,Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients : ProCOVRA
4555,Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",48,NCT04679350,HZVSF-V13; PLACEBO (NORMAL SALINE SOLUTION),"KOREA, REPUBLIC OF",Not yet recruiting,"ImmuneMed, Inc.",March 2021,Interventional,"A Multi Center, Randomized, Double-blind, Parallel Design, Phase 2 Study to Evaluate the Efficacy and Safety of hzVSFv13 Compared to Standard of Care After Intravenous(IV) Administration With Add-on Standard of Care in COVID-19 Moderate to Severe Patients"
4556,Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia,COVID,"February 08, 2021",63,NCT04679415,HZVSF-V13; PLACEBO (NORMAL SALINE SOLUTION),INDONESIA,Recruiting,"ImmuneMed, Inc.","December 17, 2020",Interventional,"A Multi Center, Randomized, Double-blind, Parallel Design, Phase 2 Study to Evaluate the Efficacy and Safety of hzVSFv13 Compared to Standard of Care After Intravenous (IV) Administration With Add-on Standard of Care in COVID-19 Moderate to Severe Patients"
4557,Immunological Characteristics of COVID-19 Patients,COVID,"February 08, 2021",230,NCT04679428,,SLOVENIA,Recruiting,The University Clinic of Pulmonary and Allergic Diseases Golnik,"May 7, 2020",Observational,Immunological Characteristics of COVID-19 Patients and Determination of Neutralizing Antibodies Against SARS-CoV-2 Virus
4558,"Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 in Healthy Volunteers",COVID; HEALTHY VOLUNTEERS,"February 08, 2021",16,NCT04679493,XC7 100 MG SINGLE; XC7 200 MG SINGLE; PLACEBO SINGLE; XC7 200 MG MULTIPLE; PLACEBO MULTIPLE,RUSSIAN FEDERATION,Not yet recruiting,NP Therapeutics,December 2020,Interventional,"Double Blind, Randomized, Placebo-controlled Study of Safety, Tolerability, and Pharmacokinetics of Ascending Doses of XC7 After Single and Multiple Oral Administration in Healthy Volunteers"
4559,COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life,COVID,"February 08, 2021",2000,NCT04679584,OBSERVATION OF DIFFERENT COURSES OF SARS-COV-2 INFECTION IN DIFFERENT PHASES (ACUTE VS. POST-ACUTE) AND SETTINGS,GERMANY,Recruiting,University Hospital Schleswig-Holstein,"November 16, 2020",Observational,COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life (NAPKON-POP)
4560,Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study),HEALTHY VOLUNTEERS,"February 08, 2021",180,NCT04679909,ADCOVID; PLACEBO,,Not yet recruiting,"Altimmune, Inc.",February 2021,Interventional,"A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-Human Study of the Safety and Immunogenicity of AdCOVID Administered as One or Two Doses"
4561,Chronic Pain Management In Primary Care Using Behavioral Health Consultants,CHRONIC PAIN,"February 08, 2021",716,NCT04680000,BRIEF COGNITIVE BEHAVIORAL THERAPY FOR CHRONIC PAIN (BCBT-CP); BCBT-CP BOOSTER,UNITED STATES,Not yet recruiting,The University of Texas Health Science Center at San Antonio,February 2021,Interventional,"Targeting Chronic Pain in Primary Care Settings Using Behavioral Health Consultants, A Randomized Pragmatic Trial"
4562,Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals,COVID,"February 08, 2021",50,NCT04680819,ANATOLIAN PROPOLIS,,Not yet recruiting,Ataturk University,"December 25, 2020",Observational [Patient Registry],Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals
4563,INSPIRES Hearing Health Trial - INnovative Psychological Intervention to REduce Stigma in Hearing Health Trial,HEARING LOSS,"February 08, 2021",3000,NCT04680845,SELF-AFFIRMATION,UNITED KINGDOM,Recruiting,University of Manchester,"January 18, 2021",Interventional,INSPIRES Hearing Health Trial - INnovative Psychological Intervention to REduce Stigma in Hearing Health Trial
4564,Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19,ENDOSCOPY; COMMUNICATION,"February 08, 2021",500,NCT04680858,DECT,GERMANY,Enrolling by invitation,University of Ulm,"July 1, 2020",Interventional,Impact of Digital Enhanced Telecommunication for Team Communication in Endoscopic Procedures During COVID-19 Pandemic
4565,suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19,COVID,"February 08, 2021",600,NCT04680949,ANAKINRA; PLACEBO,GREECE,Recruiting,Hellenic Institute for the Study of Sepsis,"December 23, 2020",Interventional,"suPAR-Guided Anakinra Treatment for Validation of the Risk and Early Management of Severe Respiratory Failure by COVID-19: The SAVE-MORE Double-blind, Randomized, Phase III Confirmatory Trial"
4566,"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers",RESPIRATORY VIRAL INFECTION; COMMON COLD; SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA; COVID; CORONA VIRUS DISEASE,"February 08, 2021",300,NCT04681001,NASAL SPRAY,AUSTRIA,Recruiting,Marinomed Biotech AG,"December 20, 2020",Interventional,Clinical Trial to Evaluate the Efficacy of an Iota-Carrageenan Nasal Spray to Reduce Symptoms Caused by SARS-CoV-2 and Other Respiratory Viruses in Healthcare Workers Managing COVID-19 Patients
4567,Risk Stratification of COVID-19 Using Urine Biomarkers,COVID; URINE; BIOMARKER; ACUTE RESPIRATORY FAILURE WITH HYPOXIA,"February 08, 2021",1000,NCT04681040,,BRAZIL,Recruiting,"National Center for Global Health and Medicine, Japan","December 19, 2020",Observational,Monitoring of COVID-19 Using Urine POC Kit
4568,Inhaled Ivermectin and COVID-19,COVID,"February 08, 2021",80,NCT04681053,IVERMECTIN POWDER,,Not yet recruiting,Mansoura University,"January 1, 2021",Interventional,Efficacy and Safety of Inhaled Ivermectin in the Treatment of SARS-COV-2 (COVID-19)
4569,Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19,COVID,"February 08, 2021",10,NCT04681079,ALBUTEROL SULFATE (MDI); ALBUTEROL SULFATE (NEBULIZER),UNITED STATES,Not yet recruiting,Theravance Biopharma,January 2021,Observational,"A 2-Period, Crossover Study to Assess the Impact of Nebulizer With Filtered Mouthpiece vs MDI With Spacer on Viral Load in Rooms of Subjects With Mild to Moderate COVID-19"
4570,Anti-COVID19 AKS-452 - ACT Study,COVID,"February 08, 2021",130,NCT04681092,AKS-452,NETHERLANDS,Not yet recruiting,University Medical Center Groningen,"January 18, 2021",Interventional,Anti-COVID19 AKS-452 Phase I/II VaccinaTion Study
4571,Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19,COVID,"February 08, 2021",300,NCT04681157,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 3, 2020",Observational,Retrospective Study on Anosmias and Ageusias Linked to Infection by SARS-Cov 2
4572,"Occupational Balance, Fear and Agoraphobia",COVID,"February 08, 2021",699,NCT04681261,THIS STUDY IS NOT AN INTERVENTION STUDY,TURKEY,Completed,Hacettepe University,"May 4, 2020",Observational,"Evaluation of Occupational Balance, Fear and Agoraphobia in Adults"
4573,Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia,COMMUNITY ACQUIRED PNEUMONIA IN CHILDREN; ANTIBIOTIC STEWARDSHIP,"February 08, 2021",200,NCT04681339,ANTIBIOTIC TREATMENT; NO ANTIBIOTIC TREATMENT,GERMANY,Not yet recruiting,ARCIM Institute Academic Research in Complementary and Integrative Medicine,February 2021,Observational,"Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study"
4574,Evaluating Bubble-PAPR for Healthcare Workers,COVID,"February 08, 2021",66,NCT04681365,STAFF WILL WEAR AND EVALUATE BUBBLE-PAPR (NON-CE MARKED PAPR),,Not yet recruiting,Manchester University NHS Foundation Trust,"February 1, 2021",Observational,A Phase I Study of an 'In-house' Developed Prototype Powered Air Purifying Respirator (PAPR) for Use as Personal Protective Equipment (PPE) for Healthcare Workers (Bubble PAPR)
4575,Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals,CORONAVIRUS INFECTION; SARS-CoV2 INFECTION; SARS-CoV2 PCR TEST POSITIVE; SARS-CoV2 ACUTE RESPIRATORY DISEASE,"February 08, 2021",1094,NCT04681430,CONVALESCENT PLASMA; CAMOSTAT MESILATE; PLACEBO FOR CAMOSTAT MESILATE; STANDARD OF CARE (SOC),GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","January 8, 2021",Interventional,Reconvalescent Plasma / Camostat Mesylate Early in Sars-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
4576,Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection,COVID,"February 08, 2021",55,NCT04681755,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","May 19, 2020",Observational,Rehabilitation Required Due to Functional Neurological Impairment and Respiratory Disorders After Severe SARS-CoV-2 Infection in ICU Units
4577,Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients,COVID; HYPOXEMIA,"February 08, 2021",40,NCT04681859,HIGH FLOW NASAL OXYGEN (HFNO) TREATMENT; CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) THERAPY USING OXYJET,BANGLADESH,Not yet recruiting,Bangladesh University of Engineering and Technology,"December 30, 2020",Interventional,Safety and Efficacy Evaluation of a Low-cost CPAP Device for Hypoxemic COVID-19 Patients: A Pilot Study
4578,Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program,SUBJECTS POSSIBLY EXPOSED TO COVID,"February 08, 2021",500,NCT04681950,,UNITED STATES,Recruiting,Biocerna LLC,"November 24, 2020",Observational,Assessment of Unsupervised Self-Collected Saliva Sample Compared to Clinician CollectedSaliva Sample and Clinician Collected Anterior Nares Sample in a COVID-19 and Influenza A/Influenza B Screening Program
4579,Evaluating the Impact of EnteraGam In People With COVID-19,COVID,"February 08, 2021",420,NCT04682041,BOVINE PLASMA-DERIVED IMMUNOGLOBULIN CONCENTRATE; STANDARD OF CARE,SPAIN,Recruiting,"Entera Health, Inc","December 22, 2020",Interventional,"Randomized Open-Label Clinical Study Evaluating the Impact of EnteraGam, a Nutritional Intervention Containing Bovine Plasma-Derived Immunoglobulin CoNcentrate, on Clinical Outcomes In People With COVID-19"
4580,Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED,COVID,"February 08, 2021",8000,NCT04682093,,CROATIA,Enrolling by invitation,European Society for Emergency Medicine (EUSEM) Research Network,"March 9, 2020",Observational,Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED (EUROCOV Study)
4581,Polk COVID-19 and Flu Response,COVID,"February 08, 2021",686,NCT04682132,"COVID-19 ANTIGEN AND ANTIBODY TESTS, AND INFLUENZA RAPID TEST",UNITED STATES,"Active, not recruiting",Polk County Fire Rescue,"May 26, 2020",Observational,County-wide Emergency Personnel Assessment of COVID-19 and Influenza Status
4582,Cereset Research In Healthcare Workers During COVID-19,HEALTH PERSONNEL; STRESS; ANXIETY; INSOMNIA; HYPERAROUSAL; CORONAVIRUS INFECTION; COVID,"February 08, 2021",100,NCT04682197,CERESET RESEARCH,,Not yet recruiting,Wake Forest University Health Sciences,February 2021,Interventional,Cereset Research To Reduce Stress And Anxiety In Healthcare Workers In The Time Of COVID-19
4583,Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients,MULTIPLE SCLEROSIS; COVID,"February 08, 2021",1000,NCT04682548,,UNITED STATES,Not yet recruiting,NYU Langone Health,January 2021,Observational,"Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients With and Without Ocrelizumab Treatment, and Comparing Immune Responses to COVID-19 in MS Patients on Ocrelizumab and Healthy Controls"
4584,STEP: Building Trauma Resilience Among Nurses and Personal Support Workers During COVID-19,STRESS; TRAUMA; MENTAL HEALTH ISSUE; HEALTHCARE WORKERS,"February 08, 2021",40,NCT04682561,SUPPORTIVE TRAUMA EXPOSURE PREPARATION PROGRAM,CANADA,Not yet recruiting,Unity Health Toronto,January 2021,Interventional,The STEP Program: Building Trauma Resilience Among Nurses and Personal Support Workers at Providence Healthcare During and Beyond the COVID-19 Pandemic
4585,Role of Mega Dose of Vitamin C in Critical COVID-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",15,NCT04682574,VITAMIN C,PAKISTAN,Recruiting,University of Lahore,"November 2, 2020",Interventional,Efficacy of Mega Dose Vitamin C in Critically Ill COVID-19 Patients
4586,A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19,COVID DISEASE,"February 08, 2021",700,NCT04682873,ENISAMIUM IODIDE; PLACEBO,UKRAINE,Recruiting,"Joint Stock Company ""Farmak""","May 15, 2020",Interventional,"A Multi-centre, Double-blind, Randomised, Placebo-controlled, Trial to Assess the Efficacy and Safety of Amizon® Max, Manufactured by Farmak JSC, in Combination With Basic Treatment, in Subjects With Moderate Covid-19"
4587,Blood Types in Children With COVID-19,COVID INFECTION,"February 08, 2021",2000,NCT04682912,,TURKEY,Recruiting,Mersin Training and Research Hospital,"January 30, 2021",Observational,ABO-Rh Blood Types and COVID-19 Infection in Children: Is There a Link?
4588,"A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine",COVID; SARS-CoV2; CORONAVIRUS,"February 08, 2021",7320,NCT04683224,UB-612; PLACEBO,,Not yet recruiting,COVAXX,"February 1, 2021",Interventional,"A Phase 2/3 Randomized, Multicenter, Double-Blind, Placebo Controlled, Dose-Response Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 Vaccine in Adults"
4589,The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care,COVID,"February 08, 2021",560,NCT04683328,SCTA01; SCTA01 PLACEBO,,Not yet recruiting,Sinocelltech Ltd.,"February 25, 2021",Interventional,"An Adaptive, Randomized, Double-blinded, Placebo-controlled, Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in Patients With Severe COVID-19 Admitted to High Dependence or Intensive Care Unit (MASP3 Trial)"
4590,A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers,COVID,"February 08, 2021",620,NCT04683484,NANOCOVAX; PLACEBO,VIETNAM,Recruiting,Nanogen Pharmaceutical Biotechnology Joint Stock Company,"December 10, 2020",Interventional,"Clinical Trials of Phase 1, 2 of Nanocovax Manufactured by Nanogen"
4591,Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation,COLORECTAL CANCER SCREENING,"February 08, 2021",100,NCT04683744,SEMI-STRUCTURED INTERVIEWS-PATIENTS; SEMI-STRUCTURED INTERVIEWS-HEALTH SYSTEM,UNITED STATES,Recruiting,Indiana University,January 2021,Observational,Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation
4592,Surgery in the Time of COVID-19 Pandemic,COVID,"February 08, 2021",707,NCT04684433,DATA EXTRACTION FROM MEDICAL FILES,BELGIUM,Recruiting,Brugmann University Hospital,"April 14, 2020",Observational,Surgery in the Time of COVID-19 Pandemic
4593,AZD1222 Vaccine in Combination With rAd26-S (Component of Gam-COVID-Vac Vaccine) for the Prevention of COVID-19,COVID,"February 08, 2021",100,NCT04684446,AZD1222; RAD26-S,,Not yet recruiting,AstraZeneca,"March 16, 2021",Interventional,"A Phase I/II Open-label Randomized Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID 19"
4594,Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19),SARS-COV INFECTION; COVID; INFECTION VIRAL,"February 08, 2021",556,NCT04684550,STABILIZED HYPOCHLOROUS ACID; PLACEBO,,Not yet recruiting,Hospital Universitario San Ignacio,"February 15, 2021",Interventional,Randomized Controlled Clinical Study (RCT) Phase 3 of the Safety and Efficacy of Hypochlorous Acid in the Prophylaxis of Healthcare Personnel at High Risk of Infection by SARS-CoV2 (COVID19) Versus Placebo
4595,Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions,AUTOIMMUNE DISEASES; CARDIOVASCULAR DISORDERS; DIABETES COMPLICATIONS; INTEGUMENTARY DISEASE; MUSCULOSKELETAL DISORDERS; NEURODEGENERATIVE DISORDERS; NEUROLOGIC DISORDERS; PULMONARY DISORDERS; SEXUAL DYSFUNCTION; UROLOGIC DISORDERS; VIRAL ILLNESS,"February 08, 2021",5000,NCT04684602,PRIMEPRO™/ PRIMEMSK™,UNITED STATES,Recruiting,Thomas Advanced Medical LLC,"July 9, 2020",Interventional,"Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions"
4596,Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen,DEPRESSION; ANXIETY; BIPOLAR DISORDER,"February 08, 2021",1000,NCT04684615,,UNITED STATES,Enrolling by invitation,National Institute of Mental Health (NIMH),"February 11, 2021",Observational,Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen
4597,Comparative Effectiveness of Telemedicine in Primary Care,ASTHMA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD; CONGESTIVE HEART FAILURE; DIABETES; HYPERTENSION,"February 08, 2021",216000,NCT04684836,"EXPOSURE TO TELEMEDICINE, AFTER THE ONSET OF THE PANDEMIC",UNITED STATES,Not yet recruiting,Weill Medical College of Cornell University,February 2021,Observational,Evaluating the Comparative Effectiveness of Telemedicine in Primary Care: Learning From the COVID-19 Pandemic
4598,Electrical Stimulation for Critically Ill Covid-19 Patients,COVID; PAIN; MUSCLE ATROPHY,"February 08, 2021",20,NCT04685213,ELECTRICAL STIMULATION; ELECTRICAL STIMULATION - SHAM,UNITED STATES,Recruiting,Baylor College of Medicine,"August 18, 2020",Interventional,Electrical Stimulation Therapy for Preventing Hospital-acquired Weakness in Critically Ill COVID-19 Patients - A Proof of Concept Randomized Controlled Trial
4599,Portable Ultrasound for Interventional Procedures,ULTRASOUND THERAPY; COMPLICATIONS,"February 08, 2021",200,NCT04685330,ULTRASOUND GUIDED PROCEDURE; PORTABLE ULTRASOUND,,Not yet recruiting,Massachusetts General Hospital,"January 1, 2021",Observational,Portable Ultrasound for Interventional Procedures
4600,Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients,COVID; HEMODIALYSIS COMPLICATION; INFLAMMATORY RESPONSE,"February 08, 2021",30,NCT04685447,EXPANDED HEMODIALYSIS FOR COVID19 MAINTENANCE HEMODIALYSIS PATIENTS; HEMODIALYSIS BY PROTEIN-LEAKING DIALYZER FOR COVID19 MAINTENANCE HEMODIALYSIS PATIENTS,ITALY,Recruiting,Universita degli Studi di Genova,"March 16, 2020",Interventional,Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients Affected by COVID-19: Effects of 2 Different Dialysis Strategies
4601,Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home,COVID,"February 08, 2021",180,NCT04685512,TENOFOVIR DISOPROXIL AND EMTRICITABINE,FRANCE,Recruiting,"University Hospital, Caen","November 18, 2020",Interventional,Effect of Tenofovir/Emtricitabine Short Course on Viral Clearance in Patients Recently Infected With SARS-COV2 (Covid-19) Not Requiring Hospitalization: a Phase IIB/III Multicenter Open-label Randomized Controlled Trial
4602,Dendritic Cell Vaccine to Prevent COVID-19,COVID,"February 08, 2021",27,NCT04685603,AV-COVID-19,INDONESIA,Recruiting,Indonesia-MoH,"December 7, 2020",Interventional,"Adaptive Phase I Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From SARS-CoV-2, in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies"
4603,Covid-19 Long-term Revalidation Follow-up,COVID,"February 08, 2021",50,NCT04685629,25 POST ICU-PATIENTS; 25 POST NON-ICU PATIENTS,BELGIUM,Recruiting,"University Hospital, Antwerp","May 7, 2020",Observational,Long-term Follow-up of Covid-19 Patients in Their Home Environment After Hospitalization in a Covid Department or Intensive Care Unit
4604,RescuE pLAsma eXchange in Severe COVID-19,THERAPEUTIC PLASMA EXCHANGE; COVID,"February 08, 2021",228,NCT04685655,THERAPEUTIC PLASMA EXCHANGE,GERMANY,Recruiting,Heidelberg University,"January 7, 2020",Interventional,RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19)
4605,The Get Outside Study,COVID; RISK REDUCTION; STRESS; SLEEP,"February 08, 2021",50,NCT04685681,HIKING CHALLENGE; ACTIVITY LIST,,Not yet recruiting,State University of New York at Buffalo,"January 1, 2021",Interventional,Examining Adults' Activity Choices During COVID-19: The UB GO Study
4606,Exercise Regimens and Neoadjuvant Chemotherapy,CANCER OF GASTROINTESTINAL TRACT,"February 08, 2021",50,NCT04685759,IN-PERSON EXERCISE PROTOCOL; VIRTUAL EXERCISE PROTOCOL,,Not yet recruiting,University of Texas Southwestern Medical Center,March 2021,Interventional,Assessing the Non-inferiority of Virtual vs. In-person Concurrent Exercise Regimens in Patients Receiving Neoadjuvant Therapy Prior to Surgical Resection of a Primary GI Tumor
4607,App-based Symptom Tracking After Corona Vaccination (CoCoV),ADVERSE EVENTS IN COVID VACCINATION,"February 08, 2021",500,NCT04686409,COVID-19 VACCINES,GERMANY,Not yet recruiting,University of Ulm,"January 11, 2021",Observational,App-based Symptom Tracking After Corona Vaccination (CoCoV)
4608,Synthetic CBD as a Therapy for COVID-19,COVID; CBD,"February 08, 2021",50,NCT04686539,CBD; PLACEBO,,Not yet recruiting,Sheba Medical Center,"December 20, 2020",Interventional,Synthetic CBD Oil Droplets as a Therapy for Mild to Moderate SARS-CoV-2 Infection. Assesment of Efficacy and Safety.
4609,Covid-19 Pandemic and Cerebral Palsy,"CEREBRAL PALSY; COVID; TELEMEDICINE; CAREGIVER QUALITY OF LIFE; DISABILITY, DEVELOPMENTAL","February 08, 2021",100,NCT04686565,,TURKEY,Recruiting,Diskapi Yildirim Beyazit Education and Research Hospital,"February 15, 2020",Observational,Evaluation The Effect of The Covid-19 Pandemic on Children With CerebralPalsy and The Caregivers' Quality of Life
4610,The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia,FIBROMYALGIA; COVID FEAR; COVID ANXIETY; DAILY LIFE; SLEEP QUALITY; ANXIETY DEPRESSION,"February 08, 2021",100,NCT04686578,,TURKEY,Recruiting,Diskapi Yildirim Beyazit Education and Research Hospital,"December 1, 2020",Observational,"Investigation the Effect of Covid-19 Fear, Anxiety on Daily Life, Sleep Quality, and Anxiety-depression of the Patients With Fibromyalgia"
4611,COVID-19 Pandemic and General Surgery Emergencies,EMERGENCIES,"February 08, 2021",750,NCT04686708,EMERGENCY GENERAL SURGICAL ADMISSIONS,TURKEY,Completed,Gulhane Training and Research Hospital,"March 11, 2019",Observational,Impact of the COVID-19 Pandemic on Emergency General Surgery Outcomes: a Single-center Cohort Study
4612,Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients,TRACHEAL STENOSIS,"February 08, 2021",200,NCT04686721,CHEST CT SCAN + BASELINE SPIROMETRY,ITALY,Recruiting,Istituto Clinico Humanitas,"December 20, 2020",Observational [Patient Registry],"A Retrospective and Prospective Observational, Multicentric, Case-control Clinical Study for the Evaluation of Tracheal Stenosis Among Patients With COVID-19 and Prolonged Intubation or Tracheostomy."
4613,Long-term Effects of COVID-19 in Adolescents,COVID,"February 08, 2021",500,NCT04686734,NO ACTIVE INTERVENTION (OBSERVATIONAL ONLY),,Not yet recruiting,"University Hospital, Akershus","January 6, 2021",Observational,Long-term Effects of COVID-19 in Adolescents
4614,COVID - 19 and Advanced Gastro-intestinal Cancer Treatment,PANCREATIC CANCER; GASTRIC CANCER; ESOPHAGUS CANCER; COLORECTAL CANCER,"February 08, 2021",2000,NCT04686747,,ITALY,Enrolling by invitation,S.M. Misericordia Hospital,January 2021,Observational,COVID - 19 and Advanced Gastro-intestinal Cancer Treatment
4615,Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04686760,NITROGLYCERIN,PAKISTAN,Recruiting,University of Lahore,"November 15, 2020",Interventional,Efficacy of Inhaled Nitroglycerin in Moderate to Severe Cases of COVID-19 Patients
4616,"Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19.",COVID,"February 08, 2021",100,NCT04686773,AZD1222; RAD26-S,AZERBAIJAN,Not yet recruiting,R-Pharm,"February 10, 2021",Interventional,"A Phase II Open-label Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID 19"
4617,Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations,AEROSOL GENERATION AND DROPLET DISPERSION AND DEPOSITION DURING NASO-GASTRIC INTUBATION FOR GASTROINTESTINAL MOTILITY INVESTIGATIONS,"February 08, 2021",15,NCT04687488,FLUORESCEIN; PARTICLE MEASUREMENT,BELGIUM,Completed,Universitaire Ziekenhuizen Leuven,"July 23, 2020",Interventional,COVID-19: The Study of Aerosol Generation and Droplet Dispersion and Deposition During Naso-gastric Intubation for Gastrointestinal Motility Investigations
4618,Comparison of the Efficacy of Pharmacology and Non-pharmacological Treatment in Women With Primary Dysmenorrhea.,PELVIC FLOOR; EXERCISE; TELEREHABILITATION; ACUPRESSURE; DYSMENORRHEA PRIMARY; DRUG EFFECT,"February 08, 2021",85,NCT04687852,CONSERVATIVE AND NON-CONSERVATIVE TREATMENTS,TURKEY,Recruiting,Istanbul Medipol University Hospital,"June 9, 2020",Interventional,Comparison of the Efficacy of Pharmacology and Non-pharmacological Treatment in Women With Primary Dysmenorrhea.
4619,Hospital COVID-19 Surge and Associated Mortality Risk,VOLUME OUTCOME RELATIONSHIP AMONG COVID INPATIENTS IN US HOSPITALS,"February 08, 2021",100000,NCT04688372,SURGE INDEX,UNITED STATES,"Active, not recruiting",National Institutes of Health Clinical Center (CC),"October 1, 2020",Observational,Association Between Hospital Case Burden and Mortality Risk Among Patients Hospitalized With COVID-19: A Retrospective Cohort Study of U.S. Hospitals
4620,Effects of Wearing a Face Mask During CrossFit Exercise,DYSPNEA,"February 08, 2021",24,NCT04688502,HIGH INTENSITY INTERVAL TRAINING; CONTINUOUS EXERCISE TRAINING,CANADA,Not yet recruiting,University of Saskatchewan,"January 11, 2021",Interventional,The Effects of Wearing a Face Mask During COVID-19 on Performance and Intensity Markers During CrossFit Exercise
4621,Patient-driven Internet Delivered Psychological Treatment,ANXIETY DISORDERS AND SYMPTOMS; INTERNET-BASED INTERVENTION,"February 08, 2021",56,NCT04688567,PATIENT-DRIVEN ICBT; STANDARDIZED ICBT (TAU),SWEDEN,"Active, not recruiting",Vastra Gotaland Region,"November 1, 2019",Interventional,Patient-driven Internet Delivered Psychological Treatment in a Primary Care Context: a Randomized Controlled Trial
4622,Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty,TELEMEDICINE,"February 08, 2021",167,NCT04688840,HIP ARTHROPALSTY,EGYPT,Completed,Tanta University,"January 1, 2020",Observational,Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty During COVID-19 Pandemic
4623,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test,COVID; RAPID ANTIGEN TEST; SARS-CoV2,"February 08, 2021",4000,NCT04689399,"STANDARD Q COVID-19 AG - TEST, PRODUCED BY SD BIOSENSOR INC.",DENMARK,Recruiting,"Rigshospitalet, Denmark","December 26, 2020",Interventional,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test
4624,COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients,COVID; ANXIETY; DEPRESSION,"February 08, 2021",500,NCT04689464,,IRAQ,Recruiting,Alhasan Mujtaba Al-Mudhaffer,"December 1, 2020",Observational,COVID19 and Psychological Health: a Cross Sectional Evaluation of the Risks of Anxiety and Depression Among Patients Diagnosed With Covid 19
4625,Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients,COVID; ENDOTHELIAL FUNCTION,"February 08, 2021",612,NCT04689477,VASCULAR OCCLUSION TEST,BRAZIL,Recruiting,Corporacion Parc Tauli,"May 25, 2020",Observational [Patient Registry],Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients
4626,Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients,COVID; DYSPNEA,"February 08, 2021",50,NCT04689490,CARDIOPULMONARY EXERCISE TEST,SPAIN,Recruiting,Hospital Clínico Universitario de Valladolid,"August 1, 2020",Observational,Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients
4627,Surgical Face Mask Effects in Patients With COVID-19,COVID,"February 08, 2021",30,NCT04689542,SIT-TO-STAND TEST,BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"January 1, 2021",Interventional,Effects of Surgical Face Mask on Submaximal Exercise Test in Patients With COVID-19
4628,Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity,COVID,"February 08, 2021",600,NCT04689672,LUNG ULTRASOUND,ITALY,Recruiting,IRCCS San Raffaele,"December 16, 2020",Observational,Predictivity of hEmoGasAnalysis Associated to Bedside Lung UltraSound in Determining COVID-19 Severity in the Emergency Departement
4629,Prognostic Models for COVID-19 Care,COVID,"February 08, 2021",16,NCT04689711,,UNITED STATES,Enrolling by invitation,Tufts Medical Center,"December 7, 2020",Observational,Generalizable Prognostic Models for Patient-Centered Decisions in COVID-19
4630,Covid-19 Airway Management,COVID_AIRWAYS MANAGEMENT,"February 08, 2021",250,NCT04689724,,CANADA,Recruiting,"University Health Network, Toronto","August 10, 2020",Observational,Determining Airway Management Related Outcomes in COVID19 Patients and in Health Care Providers
4631,COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity,SARS-CoV2 INFECTION,"February 08, 2021",2000,NCT04690114,,ISRAEL,Recruiting,Shaare Zedek Medical Center,"October 1, 2020",Observational [Patient Registry],"Incidence, Prevalence. Risk Factors and Epidemiology of SARS-CoV-2 Seropositivity in the Pediatric Population"
4632,"Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection",COVID,"February 08, 2021",27,NCT04690387,AV-COVID-19; GM-CSF,INDONESIA,"Active, not recruiting","Aivita Biomedical, Inc.","December 7, 2020",Interventional,"Adaptive Phase I Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From SARS-CoV-2, in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies"
4633,Telehealth Stretching Exercise Program for Women With Fibromyalgia During the Covid-19 Pandemic,"FIBROMYALGIA; FIBROMYALGIA, PRIMARY","February 08, 2021",28,NCT04690400,EXPERIMENTAL: ACTIVE CARE GROUP; ACTIVE COMPARATOR: SELF-CARE GROUP,,Not yet recruiting,Federal University of Pelotas,"January 18, 2021",Interventional,"Adaptations From a Telehealth Stretching Exercise Program on Painful Conditions, Depression, Sleep and Functionality of Women With Fibromyalgia During the Covid-19 Pandemic: a Randomized Clinical Trial"
4634,NOWDx Test for the Detection of Antibodies to COVID-19,COVID; SARS-CoV2; CORONAVIRUS,"February 08, 2021",60,NCT04690413,NOWDX COVID-19 TEST,UNITED STATES,Enrolling by invitation,"NOWDiagnostics, Inc.","September 1, 2020",Interventional,NOWDx Test for the Detection of Antibodies to COVID-19
4635,Comparison of Tracheal Ultrasound With Capnography for Intubation Confirmation During CPR Wearing PPE,CARDIOPULMONARY ARREST,"February 08, 2021",34,NCT04690517,TRACHEAL ULTRASOUND,"KOREA, REPUBLIC OF",Not yet recruiting,Samsung Medical Center,December 2020,Interventional,Comparison of Tracheal Ultrasound With Capnography for Intubation Confirmation During CPR (Cardiopulmonary Resuscitation) Wearing PPE (Personnel Protective Equipment): A Prospective Comparative Study
4636,Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases,SYSTEMIC AUTOIMMUNE DISEASES,"February 08, 2021",350,NCT04690816,,UNITED STATES,Recruiting,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),"February 11, 2021",Observational,The Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases; An Observational Prospective Study
4637,Biomarkers in Ocular Inflammation and Uveitis,UVEITIS; OCULAR INFLAMMATION,"February 08, 2021",1000,NCT04690829,,UNITED STATES,Enrolling by invitation,National Eye Institute (NEI),"February 11, 2021",Observational,Biomarkers in Ocular Inflammation and Uveitis
4638,Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins,CORONA VIRUS DISEASE 2019 (COVID),"February 08, 2021",200,NCT04690920,TOCILIZUMAB,PAKISTAN,Completed,University of Lahore,"July 23, 2020",Interventional,Theranostic Implication of Complimentary Medicines Against IL-6/Gp-130 in COVID-19.: An in Vitro and in Silco Approach
4639,"A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",COVID,"February 08, 2021",24,NCT04691180,BRII-196 AND BRII-198; PLACEBO,CHINA,Recruiting,Brii Biosciences Limited,"January 5, 2021",Interventional,"A Phase 1 Randomized, Single-blind, Placebo-controlled, Single Ascending Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Human Monoclonal Antibodies, Brii-196 and BRII-198, Administered Intravenously to Healthy Adult Volunteers"
4640,Assiut University Registry for ACS Patients During COVID-19 Pandemic,ACS-COVID-ASSIUT,"February 08, 2021",2500,NCT04691609,,EGYPT,Recruiting,Assiut University,"March 1, 2020",Observational,Assiut University Registry for ACS Patients During COVID-19 Pandemic
4641,Gastrointestinal Symptoms in COVID-19,COVID DISEASE,"February 08, 2021",2000,NCT04691895,SARS-COV2 INFECTION,ITALY,"Active, not recruiting",University of Bologna,"May 1, 2020",Observational [Patient Registry],Gastrointestinal Symptoms of SARS-CoV-2 Infection: a Prospective Multicentre Study
4642,"Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine",COVID; SARS-COV INFECTION; VACCINE ADVERSE REACTION,"February 08, 2021",3000,NCT04691908,QAZCOVID-IN®-VACCINE AGAINST COVID-19; PLACEBO,KAZAKHSTAN,Enrolling by invitation,Research Institute for Biological Safety Problems,"December 25, 2020",Interventional,"Multicenter, Randomized, Blind, Placebo-controlled Clinical Study of III Phase on Assessment of Preventive Efficiency, Safety and Immunogenicity QazCovid-in®-Vaccine Against COVID-19 in Healthy Adult Volunteers"
4643,Current Pharmacological Practices in Severe COVID-19,COVID,"February 08, 2021",1000,NCT04691921,CURRENT CLINICAL PRACTICES OF PARTICIPATING PHYSICIANS,INDIA,Recruiting,NMC Specialty Hospital,"January 4, 2021",Observational,Nation-wide Cross-sectional Survey on Current Pharmacological Practices in Severe COVID-19
4644,Obstetric Anesthesia Experiences in COVID-19 Positive Patients,COVID; OBSTETRIC ANESTHESIA,"February 08, 2021",61,NCT04691934,ANESTHESIA MANAGEMENT,TURKEY,Completed,Turkiye Yuksek Ihtisas Education and Research Hospital,"March 11, 2020",Observational,Our Anesthesia Experiences in COVID-19 Positive Patients Undergoing Cesarean Section: A Retrospective Single-center Cohort Study
4645,Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC,COVID VACCINE,"February 08, 2021",44,NCT04691947,ERUCOV-VAC; PLACEBO VACCINE,TURKEY,Recruiting,Health Institutes of Turkey,"November 5, 2020",Interventional,"Phase 1 Study for the Determination of Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC, Given Twice Intramuscularly to Healthy Volunteers, in a Placebo Controlled Study Design."
4646,Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients,"COVID; ARDS, HUMAN","February 08, 2021",100,NCT04692129,,BRAZIL,Recruiting,Corporacion Parc Tauli,"May 29, 2020",Observational,"Short-term Effects of Prone Positioning on Tissue Oxygen Saturation, Measured by Near-infrared Spectroscopy, in COVID-19 Patients With Acute Respiratory Distress Syndrome"
4647,A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients,COVID; ARDS,"February 08, 2021",60,NCT04692779,LUNG ULTRASOUND (LUS),,Not yet recruiting,Rush University Medical Center,"January 31, 2021",Observational,"A Prospective Clinical Study to Explore the Mechanism of Patients' Response to Prone Positioning in ARDS Patients, Including COVID-19"
4648,Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients,COVID; COVID ARDS,"February 08, 2021",150,NCT04693026,REMDESIVIR; BARICITINIB; TOCILIZUMAB,BANGLADESH,Recruiting,M Abdur Rahim Medical College and Hospital,"September 10, 2020",Interventional,Efficacy of Ramdicivir and Baricitinib Combination Therapy for the Treatment of COVID 19 ARDS
4649,Attitudes Towards Receiving Mental Health Care Using Telehealth During the COVID-19 Pandemic,PSYCHIATRIC DISORDER; MENTAL HEALTH DISORDER; STRESS; ADJUSTMENT DISORDERS,"February 08, 2021",600,NCT04693052,NO INTERVENTIONS,UNITED STATES,Enrolling by invitation,Northwestern University,"December 10, 2020",Observational,Attitudes Towards Receiving Mental Health Care Using Telehealth During the COVID-19 Pandemic
4650,"Novelty, Conformity and Trust in Vaccines",TRUST,"February 08, 2021",32400,NCT04693689,RNA VACCINE; 20% ADOPTION RATE; 40% ADOPTION RATE; 60% ADOPTION RATE; 80% ADOPTION RATE; CONVENTIONAL VACCINE; 0% ADOPTION RATE,,Not yet recruiting,"National University, Singapore","January 15, 2021",Interventional,"Novelty, Conformity and Trust in Vaccines"
4651,Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases,CHRONIC OBSTRUCTIVE PULMONARY DISEASE; IDIOPATHIC PULMONARY FIBROSIS; ASTHMA CHRONIC,"February 08, 2021",94,NCT04693975,,BRAZIL,Recruiting,Universidade Estadual de Londrina,"October 16, 2020",Observational [Patient Registry],Impact of Social Distancing During the COVID-19 Pandemic on Non-infected People With Chronic Respiratory Diseases
4652,Emotional Intelligence Skills Health Leaders Need During Covid-19,EMOTIONAL INTELLIGENCE; LEADERSHIP; HEALTH PERSONNEL ATTITUDE; COVID,"February 08, 2021",20,NCT04694014,EI OPEN ENDED PRE-SURVEY AND SEMI STRUCTURED INTERVIEW; BEHAVIORAL AND COGNITIVE ASSESSMENT; GENEVA EMOTIONAL COMPETENCE TEST (GECO),KENYA,Enrolling by invitation,African Wood Inc,"October 15, 2020",Observational,Emotional Intelligence Skills Leaders and Managers Need to Engage Frontline Healthcare Professionals During Covid-19 Pandemic
4653,The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology,PSYCHOSIS;SCHIZOPHRENIC; PERSONALITY DISORDERS; MOOD DISORDERS; ANXIETY DISORDERS; POST TRAUMATIC STRESS DISORDER,"February 08, 2021",200,NCT04694482,PSYCHOMETRIC SCALE ADMINISTRATION,ITALY,Recruiting,University of Milano Bicocca,"November 12, 2020",Observational,The Psychopathological Impact of the SARS-CoV-2 Epidemic on Subjects Suffering From Mental Disorders: Data From ASST Monza
4654,Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies,COVID; KIDNEY TRANSPLANT; COMPLICATIONS; KIDNEY TRANSPLANT FAILURE AND REJECTION; LIVER TRANSPLANT; COMPLICATIONS; LIVER TRANSPLANT FAILURE AND REJECTION,"February 08, 2021",600,NCT04694573,,GERMANY,Recruiting,Heidelberg University,"December 28, 2020",Observational [Patient Registry],Collaborative Transplant Study (CTS) Pre- and Post-Transplantation Covid-19 Serum Studies: Antibody Development Following a SARS-CoV-2 Infection
4655,Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal,COVID,"February 08, 2021",676,NCT04694612,FAVIPIRAVIR; PLACEBO; REMDESIVIR,NEPAL,Recruiting,Nepal Health Research Council,"January 1, 2021",Interventional,"Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal: a Multi-center, Randomized, Open-labelled, Phase III Clinical Trial"
4656,"Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection",PRONE POSITIONING; COVID; HYPOXEMIC RESPIRATORY FAILURE; ARDS; NON INVASIVE VENTILATION; HIGH FLOW NASAL CANNULLA,"February 08, 2021",24,NCT04694638,BODY POSITION CHANGE,UNITED STATES,Recruiting,Mayo Clinic,"May 21, 2020",Interventional,"The Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure Secondary to COVID-19 Infection: A Feasibility, Safety Phase One, Open Label Study"
4657,Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt,COVID,"February 08, 2021",400,NCT04694651,,EGYPT,Recruiting,Assiut University,"December 15, 2020",Observational [Patient Registry],A National Survey of Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt
4658,COVID-19 Vaccine Confidence Among Pregnant Women and Mothers,PREGNANCY RELATED; MOTHERS,"February 08, 2021",18000,NCT04694664,THIS IS AN ONLINE SURVEY WITH NO INTERVENTION.,UNITED STATES,Completed,Pregistry,"October 1, 2020",Observational,Vaccine Confidence Among Pregnant Women and Mothers During the COVID-19 Pandemic
4659,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19",COVID,"February 08, 2021",20,NCT04694703,COVID-19 GROUP,TURKEY,Recruiting,Izmir Bakircay University,"January 6, 2021",Observational,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Patients Diagnosed With COVID-19 Before and After COVID-19 Treatment"
4660,Determination of Serum Trace Element and Physical Activity Levels in COVID-19,COVID,"February 08, 2021",40,NCT04694716,NO INTERVENTION,TURKEY,Recruiting,Izmir Bakircay University,"January 6, 2021",Observational,Determination of Serum Trace Element and Physical Activity Levels in COVID-19 Patients
4661,Ventilatory Efficiency in Critically Ill COVID-19 Patients,ARDS,"February 08, 2021",100,NCT04694742,DATA COLLECTING,ITALY,Recruiting,ASST Fatebenefratelli Sacco,"September 1, 2020",Observational,Ventilatory Efficiency in Critically Ill COVID-19 Patients
4662,Implementation of Rehabilitation Program for Post COVID-19,POST COVID SYNDROME; REHABILITATION,"February 08, 2021",100,NCT04694768,REHABILITATION,EGYPT,Recruiting,Assiut University,"July 1, 2020",Observational,The Effect of Implementing a Nursing Program Intervention on Improvement of Health Quality of Post Covid-19 Patients
4663,Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19,"COVID; DIABETES MELLITUS, TYPE 2","February 08, 2021",60,NCT04695158,COVID-19 GROUP (GROUP I); TYPE II DIABETES MELLITUS AND COVID-19 GROUP (GROUP II),TURKEY,Recruiting,Izmir Bakircay University,"January 6, 2021",Observational,"Determination of Hemoglobin A1c, Lipid Profiles, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Patients With Type II Diabetes and/or COVID-19"
4664,Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso,COVID; MALARIA,"February 08, 2021",142,NCT04695197,ARTEMETHER-LUMEFANTRINE (AL); PYRONARIDINE-ARTESUNATE (PA),BURKINA FASO,Not yet recruiting,Liverpool School of Tropical Medicine,"January 8, 2021",Interventional,Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
4665,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation,COVID; CORONAVIRUS INFECTION; EXERCISE THERAPY,"February 08, 2021",50,NCT04695301,REHABILITATION PROTOCOL THROUGH A DIGITAL PLATFORM,BRAZIL,Recruiting,Hospital Israelita Albert Einstein,"July 1, 2020",Interventional,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation
4666,Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection,MYASTHENIA GRAVIS,"February 08, 2021",150,NCT04695379,,FRANCE,Recruiting,"University Hospital, Bordeaux","May 26, 2020",Observational,Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection: Consequences on the Severity of Myasthenic Syndrome and Reciprocal Impact of the Two Pathologies on Their Respective Treatments
4667,Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps,COVID; NURSING HOME,"February 08, 2021",74,NCT04695457,,FRANCE,Completed,Centre Hospitalier Annecy Genevois,"July 15, 2020",Observational,Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps
4668,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult,COVID VACCINE,"February 08, 2021",3700,NCT04695652,MVC-COV1901(S PROTEIN WITH ADJUVANT); MVC-COV1901(SALINE),TAIWAN,Recruiting,Medigen Vaccine Biologics Corp.,"December 30, 2020",Interventional,"A Phase II, Prospective, Double-blinded, Multi-Center, Multi-Regional Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901"
4669,Epidemiological Multicohort Study of Latent COVID-19 Infections,COVID,"February 08, 2021",4000,NCT04695678,COVID-19 NASAL/PHARYNGEAL SWAB,GERMANY,"Active, not recruiting",Wissenschaftliches Institut Bethanien e.V,"July 1, 2020",Observational,Epidemiological Multicohort Study of Latent COVID-19 Infections in Residents and Staff of Nursing Homes in the City of Solingen
4670,Montelukast Clinical Trial in Mild-moderate Respiratory Symptoms in Patients With Long-COVID (ESPERANZA COVID),COVID; SARS (DISEASE),"February 08, 2021",284,NCT04695704,MONTELUKAST; PLACEBO,,Not yet recruiting,Jordi Gol i Gurina Foundation,"April 1, 2021",Interventional,"Double-blind Randomized Clinical Trial, Placebo-controlled to Assess the Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID: E-SPERANZA COVID PROJECT"
4671,Group CST Using Zoom: A Proof of Concept Study,DEMENTIA,"February 08, 2021",50,NCT04695743,ONLINE COGNITIVE STIMULATION THERAPY,UNITED KINGDOM,Recruiting,"University College, London","September 1, 2020",Interventional,Virtual CST - A Collaborative Proof of Concept Study With FaceCog HK in Response to the Covid-19 Pandemic
4672,Liver Transplantation and Coronavirus Disease 2019 (COVID-19),COVID; LIVER TRANSPLANT,"February 08, 2021",1000,NCT04695756,COVID-19 PANDEMIC,ARGENTINA,Recruiting,Hospital Italiano de Buenos Aires,"December 15, 2020",Observational,Impact of Coronavirus Disease 2019 (COVID-19) Epidemic in Patients Requiring Liver Transplantation
4673,Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology in Covid-19,COVID,"February 08, 2021",10,NCT04695821,SENTI V1.0 DEVICE,UNITED KINGDOM,Not yet recruiting,Senti Tech Ltd,January 2021,Interventional,"A Small-scale Study to Capture Acoustic Pathophysiological Parameters, in the Community, Through a Wearable Device, and to Evaluate the Technical and Practical Feasibility of Utilising This Data as Part of a Medical Device System for the Monitoring and Evaluation of Covid-19 at Home"
4674,Effectiveness of Coping Strategies on the Control of Chronic Non-Cancer Pain and Quality of Life (CNCP_CopQol),CHRONIC PAIN; MUSCULOSKELETAL DISEASES; QUALITY OF LIFE; PAIN MEASUREMENT,"February 08, 2021",144,NCT04696107,PSYCHOEDUCATIVE INTERVENTION,SPAIN,Not yet recruiting,Hospital San Juan de Dios del Aljarafe de Sevilla,"April 1, 2021",Interventional,Effectiveness of Coping Strategies on the Control of Musculoskeletal Chronic Non-Cancer Pain and Quality of Life: A Randomized Clinical Trial
4675,"Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure",RESPIRATORY FAILURE,"February 08, 2021",250,NCT04696406,RESPINOR DXT,FRANCE,Not yet recruiting,Respinor AS,"March 1, 2021",Observational [Patient Registry],"Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure"
4676,"The Effect of Deep Breathing Exercise on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19",COVID,"February 08, 2021",44,NCT04696562,DEEP BREATHING EXERCISE WITH TRIFLO,,Not yet recruiting,Ankara University,"January 1, 2021",Interventional,"The Effect of Deep Breathing Exercise Applied With Triflo on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19: Randomized Controlled StudyPatients Treated for COVID-19: A Randomized Controlled Study"
4677,Rapid Screening for Olfactory Disorders in Covid-19 Infection,OLFACTION DISORDERS; COVID TESTING,"February 08, 2021",2000,NCT04696601,OLFACTORY TEST,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nice,"January 10, 2021",Interventional,Rapid Screening for Olfactory Disorders in Covid-19 Infection
4678,Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic,VERY PRETERM CHILDREN WITH DYSEXECUTIVE DISORDERS,"February 08, 2021",170,NCT04696679,PATIENT QUALITY OF LIFE ASSESSMENT; CONTROL GROUP QUALITY OF LIFE ASSESSMENT,FRANCE,Completed,Assistance Publique Hopitaux De Marseille,"June 19, 2020",Observational,Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic
4679,Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?,COVID; PULMONARY EMBOLISM,"February 08, 2021",347,NCT04696913,EXPOSURE: POSITIVE COVID-19 INFECTION; EXPOSURE: NEGATIVE COVID-19 INFECTION,,Not yet recruiting,University of Aberdeen,"January 1, 2021",Observational,Does COVID-19 Infection Increase the Risk of Pulmonary Embolism? A Retrospective Case-control Study
4680,Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan,"BURNOUT, PSYCHOLOGICAL; COVID PANDEMIC","February 08, 2021",443,NCT04697030,,PAKISTAN,Completed,Sialkott College of Physical Therapy,"September 15, 2020",Observational,Behavioral Outcomes Among Adolescent Population During Covid-19 Pandemic Lockdown in Pakistan: A Lower Middle Income Country Experience
4681,"The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers",COVID,"February 08, 2021",30,NCT04697654,TLC19; TLC19 VEHICLE,AUSTRALIA,"Active, not recruiting",Taiwan Liposome Company,"October 14, 2020",Interventional,"A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers"
4682,A Study of Risk Factors for the COVID-19 Virus Infection,COVID INFECTIONS IN CANCER PATIENTS,"February 08, 2021",10000,NCT04697927,QUESTIONNAIRES,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"December 30, 2020",Observational,Ascertainment of Epidemiologic Risk Information to Assess Susceptibility to and Severity of SARS-CoV-2 Infection
4683,Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period,ANXIETY; DEPRESSION; COVID; CANCER; CHRONIC DISEASE,"February 08, 2021",1107,NCT04698044,HOSPITAL ANXIETY DEPRESSION SCALE,TURKEY,Completed,"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey","May 8, 2020",Observational,Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period: A Population-based Comparative Study
4684,"Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19",COVID,"February 08, 2021",160,NCT04698083,"ELECTROCARDIOGRAPHY ,TOMOGRAPHIC IMAGING",TURKEY,Completed,Ankara Education and Research Hospital,"July 22, 2020",Observational,Retrospective Evaluation of Electrocardiographic Findings of Right Ventricular Overload in Covid 19 Patients With Respiratory Distress
4685,"Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis",SEPSIS; SEPTIC SHOCK,"February 08, 2021",5000,NCT04698382,,UNITED STATES,"Active, not recruiting",National Institutes of Health Clinical Center (CC),"August 1, 2020",Observational,"Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis"
4686,Skeletal Muscle Wasting in SARS-CoV-2,CACHEXIA; MUSCLE LOSS; MUSCLE WASTING; MUSCLE ATROPHY; CRITICAL ILLNESS,"February 08, 2021",16,NCT04698798,MUSCLE BIOPSY,BELGIUM,Recruiting,Hasselt University,January 2021,Interventional,Skeletal Muscle Wasting in SARS-CoV-2 Infected ICU (Intensive Care Unit) Patients
4687,Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2,SARS-CoV2,"February 08, 2021",30,NCT04698837,,SWITZERLAND,Not yet recruiting,"University Hospital Inselspital, Berne",January 2021,Observational,AeroCOVID 1: Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2 Using Patient Proximity Environmental Sampling With a Highly Efficient Bioaerosol and Droplet Collection Dummy
4688,Dräger COVID-19 Antigen Test Clinical Performance Study,COVID,"February 08, 2021",1650,NCT04698993,DRÄGER ANTIGEN TEST SARS-COV-2,GERMANY,Not yet recruiting,Drägerwerk AG & Co. KGaA,January 2021,Interventional,Dräger Antigen Test SARS-CoV-2 Clinical Performance Study
4689,COVID-19 Sero-prevalence Health Care Workers Kinshasa,SARS-COV INFECTION; SEROPREVALENCE,"February 08, 2021",1650,NCT04699058,COVID-ANTIBODY TEST,"CONGO, THE DEMOCRATIC REPUBLIC OF THE",Recruiting,"Institute of Tropical Medicine, Belgium","July 17, 2020",Observational,"Sero-prevalence and Sero-conversion Study of Health Care Workers and Their Households, Democratic Republic of the Congo"
4690,The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children,AZITHROMYCIN ADVERSE REACTION; COVID; LONG QT SYNDROME,"February 08, 2021",105,NCT04699097,AZITHROMYCIN,TURKEY,Completed,Kayseri City Hospital,"July 1, 2020",Observational,Azitromycin Use in COVID-19 Positive Pediatric Patients; Effect on Ventricle Repolarization
4691,Can RIC Prevent Deterioration to Critical Care in Covid19,COVID; ISCHEMIA,"February 08, 2021",20,NCT04699227,CUFF APPLICATION WITH INFLATION; SHAM INFLATION,UNITED KINGDOM,Recruiting,Derek Yellon,"April 23, 2020",Interventional,"CAN REMOTE ISCHAEMIC CONDITIONING REDUCE INFLAMMATORY MARKERS IN COVID-19 PATIENTS - A MULTI-SITE, RANDOMISED PILOT STUDY"
4692,COVID-19 Infection and Fetal-neonatal Outcomes,COVID; OBSTETRIC COMPLICATION; SARS-COV INFECTION; PRETERM BIRTH; MISCARRIAGE; PLACENTA DISEASES,"February 08, 2021",230,NCT04699578,COVID-19 POSITIVE,ITALY,Recruiting,"University of Campania ""Luigi Vanvitelli""","December 28, 2020",Observational,Impact of COVID-19 Infection on the Course of Pregnancy and Fetal-neonatal Outcomes
4693,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens,COVID; TAILORED RECOMMENDATIONS; CITIZEN SELF-REPORTED SYMPTOMS,"February 08, 2021",1200,NCT04699851,TAILORED RECOMMENDATIONS; GENERAL RECOMMENDATION,CANADA,Recruiting,Laval University,"November 18, 2020",Interventional,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens
4694,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood","SARS-CoV2, COVID","February 08, 2021",215,NCT04699903,POC SARS-COV-2 IGG ANTIBODY TEST,UNITED STATES,Not yet recruiting,Rapid Pathogen Screening,"December 28, 2020",Observational,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood"
4695,EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia,SEDATION COMPLICATION; COVID,"February 08, 2021",44,NCT04699916,EEG BASED PROTOCOL FOR DEEP SEDATION,,Not yet recruiting,University of Chile,"January 4, 2021",Interventional,EEG-based Protocol to Guide Deep Sedation Decreases the Days of Mechanical Ventilation in COVID-19 Patients: Randomized Clinical Trial
4696,Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients,HYPOXEMIA,"February 08, 2021",23,NCT04699942,CONVENTIONAL (LOW FLOW) OXYGEN DELIVERY VIA NASAL CANNULA; REVOXA OXYGEN REBREARTHER,CANADA,Not yet recruiting,Dr. David Maslove,"January 4, 2021",Interventional,Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients
4697,"Mental Health Among Patients, Providers, and Staff During the COVID-19 Era",COVID; MENTAL HEALTH,"February 08, 2021",660,NCT04700137,CARING CONTACTS PLUS INTRODUCTORY PHONE CALL (CC+); CARING CONTACTS WITHOUT AN INTRODUCTORY PHONE CALL (CC),UNITED STATES,Enrolling by invitation,"St. Luke's Health System, Boise, Idaho","January 18, 2021",Interventional,"Investigating the Mental Health Impact of COVID-19 and Comparing the Effectiveness of Two Caring Contact Interventions on Patients, Providers, and Staff of St. Luke's Health System"
4698,RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers,COVID,"February 08, 2021",15,NCT04700163,C144-LS AND C-135-LS,UNITED STATES,Recruiting,Rockefeller University,"January 11, 2021",Interventional,"A Phase 1, Open Label, Dose-escalation Study of the Safety and Pharmacokinetics of a Combination of Two Anti-SARS-CoV-2 mAbs (C144-LS and C135-LS) in Healthy Volunteers"
4699,"Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece",DIABETES MELLITUS; SARS-CoV2,"February 08, 2021",150,NCT04700254,DASS QUESTIONNAIRE; EAT-26 QUESTIONNAIRE,GREECE,Completed,"Chania General Hospital ""St. George""","December 28, 2020",Observational,"The Effect of COVID-19 National Lockdown on People With Diabetes Mellitus Regarding Their Anxiety, Depression and Eating Attitudes, in Relation to Adjusted Work and Family Conditions"
4700,COVID-19 Preventive Behavior in African Americans,COVID; HEALTH BEHAVIOR,"February 08, 2021",250,NCT04700462,SM-EMA,,Not yet recruiting,Johns Hopkins University,"February 5, 2021",Interventional,Optimizing Tailored-feedback Message to Promote Adherence Behavior to Prevent COVID-19 in African Americans
4701,UNITE Study (UMN-GE) for COVID-19,COVID; CYTOKINE STORM; INFLAMMATION,"February 08, 2021",30,NCT04701489,SPLENIC ULTRASOUND,UNITED STATES,Enrolling by invitation,University of Minnesota,January 2021,Interventional,Ultrasound Neural and Immunomodulation Treatment Evaluation Study (UMN-GE) for COVID-19
4702,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19,COVID; RESPIRATORY DISEASE; IMMUNE SYSTEM; IMMUNOMODULATOR; ANTISEPTIC; SUPPORTIVE CARE,"February 08, 2021",60,NCT04701502,VIUSID; ASBRIP; STANDARD CARE,BULGARIA,Recruiting,Catalysis SL,"November 9, 2020",Interventional,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19
4703,Cardiovascular Manifestations of COVID-19,COVID,"February 08, 2021",500,NCT04701515,CHART REVIEW,UNITED STATES,Recruiting,Methodist Health System,"June 10, 2020",Observational,Cardiovascular Manifestations of COVID-19
4704,Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients,COVID; KIDNEY TRANSPLANT INFECTION,"February 08, 2021",20,NCT04701528,VOCLOSPORIN; TACROLIMUS,NETHERLANDS,Recruiting,Leiden University Medical Center,"November 15, 2020",Interventional,An Open-Label Study Evaluating Anti-Viral Effects of Voclosporin in SARS-CoV-2 Positive Kidney Transplant Recipients - the VOCOVID Study
4705,The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients,COVID,"February 08, 2021",402,NCT04701606,ARTECOM® (PYRONARIDINE-ARTESUNATE); PLACEBO,PHILIPPINES,Not yet recruiting,Shin Poong Pharmaceutical Co. Ltd.,"February 15, 2021",Interventional,"A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2/3 Clinical Trial to Evaluate the Safety and Efficacy of Pyronaridine-artesunate (Artecom®) in COVID-19 Patients"
4706,A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19),COVID,"February 08, 2021",3000,NCT04701658,BAMLANIVIMAB,,Not yet recruiting,Eli Lilly and Company,"January 8, 2021",Interventional,"A Prospective Cohort Study to Evaluate the Real-world Effectiveness of Bamlanivimab in Participants With Mild-to-moderate COVID-19 at High Risk for Progressing to Severe Illness, With Matched Controls"
4707,Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan,COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",300,NCT04701710,IVERMECTIN / IOTA-CARRAGEENAN,ARGENTINA,Completed,Maria de los Angeles Peral de Bruno,"October 15, 2020",Interventional,A Randomized Trial - Intensive Treatment Based in Ivermectin and Iota-carrageenan as Prophylaxis for Covid-19 In Healthcare Agents
4708,poSt Covid-19 Infection centraL Sensitisation 2,COVID,"February 08, 2021",200,NCT04701892,INDICATORS OF CENTRAL SENSITISATION,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"January 19, 2021",Observational,Central Sensitisation in Post Covid-19 Infection Patients: a Prospective Cohort Study
4709,The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19,COVID PANDEMIC,"February 08, 2021",450,NCT04701905,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 30, 2020",Observational,The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19
4710,Clinical Study of Pregnant Women With COVID-19,COVID,"February 08, 2021",54,NCT04701944,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 21, 2020",Observational,Clinical Study of Pregnant Women With COVID-19: A Retrospective Review of Medical Records at Strasbourg University Hospitals
4711,Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo,COVID,"February 08, 2021",1600,NCT04701996,SEROLOGICAL SURVEILLANCE,"CONGO, THE DEMOCRATIC REPUBLIC OF THE",Recruiting,"Institute of Tropical Medicine, Belgium","September 23, 2020",Observational,Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo
4712,A Clinical Trial of COVAC Vaccines in Healthy Adults,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",108,NCT04702178,COVAC-2; SALINE PLACEBO,CANADA,Recruiting,University of Saskatchewan,January 2021,Interventional,"A Randomized, Observer-Blind, Dose-Escalation Phase 1/2 Clinical Trial of COVAC Vaccines in Healthy Adults"
4713,ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE),CONNECTIVE TISSUE DISEASES; RARE DISEASES; RHEUMATOLOGIC DISORDER,"February 08, 2021",250,NCT04702295,,,Not yet recruiting,University of Pisa,February 2021,Observational,COVID Vaccination in Rare and Complex Connective Tissue Diseases: ERN ReCONNET Multicentre Prospective Cohort Study
4714,Canadian COVID-19 Emergency Department Registry,COVID,"February 08, 2021",200000,NCT04702945,,CANADA,Recruiting,University of British Columbia,"March 1, 2020",Observational [Patient Registry],Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) - Population-based Registry of Suspected and Confirmed COVID-19 Cases
4715,TRANSFORM-HF Ancillary Mechanistic Study,HEART FAILURE,"February 08, 2021",750,NCT04702958,,UNITED STATES,Enrolling by invitation,Inova Health Care Services,"December 10, 2020",Observational,Mechanistic Insights From Longitudinal Changes in Blood and Urine Proteins to Explain Efficacy and Safety of Torsemide vs Furosemide After a Heart Failure Hospitalization
4716,"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19",COVID,"February 08, 2021",64,NCT04703036,GLYCINE; N-ACETYLCYSTEINE; ALANINE,UNITED STATES,Recruiting,Baylor College of Medicine,"January 11, 2021",Interventional,Randomized Trial of Supplementing Glycine and N-acetylcysteine vs. Placebo in COVID-19
4717,Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV),COVID; SARS-CoV2,"February 08, 2021",80,NCT04703114,BLOOD COUNT; BLOOD COLLECTION; NASOPHARYNGEAL SWAB; SALIVA SAMPLES; FAECES SAMPLES; GENETIC BLOOD COLLECTION; DATA COLLECTION,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,February 2021,Interventional,Study of the Immunological and Virological Response of Patients Infected With SARS-CoV-2 and Presenting an Asymptomatic or Pauci-symptomatic Form
4718,COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19,COVID; SARS-CoV2,"February 08, 2021",350,NCT04703140,RAPID DIAGNOSTIC TEST VS PCR,,Not yet recruiting,CMC Ambroise Paré,"January 15, 2021",Interventional,Evaluation of the Performance of COVIDISC Rapid Test for Diagnosis of SARS-CoV-2
4719,Study in COvid-19 Patients With iveRmectin (CORVETTE-01),COVID,"February 08, 2021",240,NCT04703205,IVERMECTIN 3 MG; PLACEBO,JAPAN,Recruiting,Kitasato University,"September 16, 2020",Interventional,"A Placebo-controlled, Randomized, Double-blind Study in COvid-19 Patients With iveRmectin; An inVEstigator iniTiaTEd Trial"
4720,Understanding COVID-19 Infection in Pregnant Women and Their Babies,CORONAVIRUS INFECTION; PREGNANCY RELATED; NEONATAL INFECTION; BREASTFEEDING,"February 08, 2021",1200,NCT04703270,,UNITED KINGDOM,Recruiting,"St George's, University of London","January 4, 2021",Observational,Understanding COVID-19 Infection in Pregnant Women and Their Babies
4721,Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina,SURGICAL EDUCATION,"February 08, 2021",195,NCT04703400,ANONYMOUS SURVEY,ARGENTINA,Completed,"Clinica Universitaria Reina Fabiola, Universidad Catolica de Cordoba","August 15, 2020",Observational,Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina: A Cross-sectional Study
4722,poSt Covid-19 Infection centraL sENsitisaTion,COVID,"February 08, 2021",100,NCT04703452,INDICATORS OF CENTRAL SENSITISATION,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"January 19, 2021",Observational,Central Sensitisation in Post Covid-19 Infection Patients: a Cross-sectional Study
4723,RespiraConNosotros:a Mobile Application for COVID-19 Respiratory Rehabilitation.,COVID,"February 08, 2021",20,NCT04703478,BREATHING EXERCISE,SPAIN,Not yet recruiting,University of Salamanca,"January 20, 2021",Interventional,RespiraConNosotros: Creation and Implementation of a Mobile Application for the Rehabilitation of Patients With Respiratory Sequelae of the SARS-CoV-2 (COVID-19)
4724,Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia,COVID,"February 08, 2021",1200,NCT04703608,IVERMECTIN; ASP; PLACEBO,GAMBIA,Recruiting,London School of Hygiene and Tropical Medicine,January 2021,Interventional,Prevention and Treatment for COVID -19 Associated Severe Pneumonia in The Gambia: a Single-Blinded Randomised Clinical Trial (PaTS-COVID)
4725,Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic,COVID,"February 08, 2021",500,NCT04703777,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 4, 2020",Observational,"Retrospective Study on the Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic in Bas-Rhin, France"
4726,Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods,COVID; VACCINE ACCEPTABILITY,"February 08, 2021",1200,NCT04703790,,,Not yet recruiting,Columbia University,February 2021,Observational,Acceptability Across Two Time Periods of a SARS-CoV-2 Vaccine Among a Representative Sample of Adults Within the United States
4727,Auricular Stimulation for Relief of Stress and Anxiety,STRESS AND ANXIETY,"February 08, 2021",60,NCT04703907,AURICULAR STIMULATION,GERMANY,Recruiting,University Medicine Greifswald,"December 3, 2020",Interventional,"Auricular Stimulation (AS) vs. ""Waiting List"" for Relief of Stress and Anxiety in Health Care Workers During COVID-19 Pandemic - a Prospective Controlled Investigation"
4728,Study Project Comparing the Sequelae of SARS-CoV-2 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care,COVID,"February 08, 2021",830,NCT04704388,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 1, 2020",Observational,Study Project Comparing the Sequelae of SARS-CoV-2 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care
4729,Impact of Covid-19 Pandemic on Management of Head and Neck Cancers,HEAD AND NECK CANCER; COVID; PATIENT CARE,"February 08, 2021",150,NCT04704466,,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","January 7, 2021",Observational,Observational Study Evaluating the Impact of the Covid-19 Pandemic on the Management of Patients With Head and Neck Cancer in the Maxillofacial Surgery Department
4730,Effectiveness of Tele-rheumatology During the COVID-19 Crisis,RHEUMATIC DISEASES,"February 08, 2021",320,NCT04704544,TELE-RHEUMATOLOGY,UNITED STATES,Not yet recruiting,University of Alabama at Birmingham,"March 1, 2021",Interventional,Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis
4731,Remote Exercise Programs and Preventive Training in Asymptomatic Individuals,HEALTHY PEOPLE,"February 08, 2021",20,NCT04704570,EXERCISE,TURKEY,Not yet recruiting,Hacettepe University,"January 25, 2021",Interventional,Investigation of The Effects of Remote Exercise Programs and Preventive Training on Muscle Architecture and Functional Level in Asymptomatic Individuals
4732,COVID-19 Vaccines International Pregnancy Exposure Registry,COVID,"February 08, 2021",5000,NCT04705116,COVID-19 VACCINE,UNITED STATES,Not yet recruiting,Pregistry,"January 15, 2021",Observational [Patient Registry],COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER)
4733,"Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Participants ≥ 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure",COVID,"February 08, 2021",132,NCT04705597,BGE-175; PLACEBO,UNITED STATES,Not yet recruiting,"BioAge Labs, Inc.",February 2021,Interventional,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Patients Over 60 Years of Age With COVID-19"
4734,"Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients",COVID; VIRAL INFECTION; RESPIRATORY VIRAL INFECTION,"February 08, 2021",20,NCT04705753,CRETAN IAMA,GREECE,Completed,University of Crete,"April 1, 2020",Interventional,"Evaluation of the Clinical Outcomes and the Quality of Life of Patients Exhibiting Symptoms Characteristic of Viral Respiratory Infection (VRI), Including Infection by SARS-CoV-2 (COVID-19), and Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in These Patients and the People Cohabiting With Them Via an Open-label, Single-arm Trial"
4735,KIDney Injury in Times of COVID-19 (KIDCOV),SARS-COV INFECTION; COVID; CORONAVIRUS INFECTION; ACUTE KIDNEY INJURY; KIDNEY INJURY,"February 08, 2021",2000,NCT04705766,URINE COLLECTION,UNITED STATES,Not yet recruiting,"University of California, San Francisco",January 2021,Observational [Patient Registry],The KIDCOV Study: ASSESSMENT of SARS-CoV-2 Without HOSPITALIZATION as a RISK FACTOR for ACUTE KIDNEY INJURY
4736,Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection,POST-VIRAL FATIGUE SYNDROME; POST-VIRAL DISORDER (DISORDER); COVID,"February 08, 2021",40,NCT04705831,RUCONEST,UNITED STATES,Recruiting,IMMUNOe Research Centers,"December 30, 2020",Interventional,"A Randomized, Double Blind, Placebo Controlled, Cross-Over, Proof-of-Concept Study to Evaluate the Benefit of RUCONEST (C1 Esterase Inhibitor [Recombinant]) in Improving Neurological Symptoms in Post-SARS-CoV-2 Infection"
4737,Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19,MILD TO MODERATE COVID,"February 08, 2021",1444,NCT04705844,ADALIMUMAB; PLACEBO,,Not yet recruiting,Ology Bioservices,February 2021,Interventional,"Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Adalimumab (Humira) or Placebo in Patients With Mild-Moderate COVID-19"
4738,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,COVID,"February 08, 2021",3000,NCT04706039,PERFORMANCE EVALUATION (SENSITIVITY AND SPECIFICITY) FOR COVID-19 DIAGNOSIS OF THE VOCUS PTR-TOF PROCESS,FRANCE,Not yet recruiting,Hospices Civils de Lyon,January 2021,Interventional,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air
4739,Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians,COVID VACCINES,"February 08, 2021",100,NCT04706143,COVID-19 VACCINES,,Not yet recruiting,Assiut University,"January 15, 2021",Observational,"T Cell, Antibody and Cytokine Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians"
4740,Oral Side Effects of COVID-19 Vaccine,ORAL MANIFESTATIONS; COVID; VACCINE ADVERSE REACTION,"February 08, 2021",1540,NCT04706156,COVID-19 VACCINE,,Not yet recruiting,Masaryk University,"January 27, 2021",Observational,Oral Side Effects of COVID-19 Vaccine: A Multicenter Cross-sectional Study
4741,Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals,COVID,"February 08, 2021",600,NCT04706260,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 14, 2020",Observational,Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at the University Hospitals of Strasbourg : A Retrospective Observational Study
4742,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing",PREVENTION OF COVID,"February 08, 2021",20,NCT04706299,RESISTANCE EXERCISE,UNITED STATES,Recruiting,The Cleveland Clinic,"January 12, 2021",Interventional,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing"
4743,COVID-19 RELATED KIDNEY DAMAGE,ACUTE KIDNEY INJURY,"February 08, 2021",100,NCT04706325,ACUTE KIDNEY INJURY,TURKEY,Recruiting,Kocaeli Derince Education and Research Hospital,"January 1, 2021",Observational,INVESTIGATION OF RISK FACTORS RELATED TO COVID-19 RELATED KIDNEY DAMAGE: A PROSPECTIVE OBSERVATIONAL STUDY
4744,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination,COVID,"February 08, 2021",2500,NCT04706390,COVID-19 VACCINE,NORWAY,Recruiting,University of Bergen,"January 12, 2021",Observational,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
4745,Views on COVID-19 and Vaccination,COVID,"February 08, 2021",3000,NCT04706403,HEALTHCARE PROVIDERS' COMMUNICATION ABOUT THE COVID-19 VACCINE,,Not yet recruiting,"University of Massachusetts, Worcester",January 2021,Interventional,"If We Build It, Will They Come? A Pilot Study to Develop and Test Messages to Maximize Uptake of Coronavirus Vaccine When Available"
4746,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19),CORONAVIRUS; COVID,"February 08, 2021",50,NCT04706416,N-ACETYL GLUCOSAMINE (NAG),UNITED STATES,"Active, not recruiting",Quantinosis.ai LLC,"November 14, 2020",Interventional,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
4747,"Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19",COVID; KIDNEY DISEASES; INFLAMMATION; SARS-COV INFECTION,"February 08, 2021",2000,NCT04706533,BIOMARKERS OF INFLAMMATION,UNITED STATES,Recruiting,University of Michigan,"March 23, 2020",Observational,"Prospective Observational Study Examining Clinical Characteristics, Inflammatory Markers, Treatments and Outcomes of Patients Hospitalized for COVID-19 at the University of Michigan Healthcare System in Ann Arbor"
4748,Management of Acute Appendicitis at District General Hospital,APPENDICITIS ACUTE; COVID,"February 08, 2021",200,NCT04707339,APPENDICECTOMY,UNITED KINGDOM,Recruiting,Princess Alexandra Hospital NHS Trust,"January 30, 2020",Observational,Management of Acute Appendicitis at District General Hospital
4749,Dexamethasone for COVID-19,COVID,"February 08, 2021",300,NCT04707534,DEXAMETHASONE,UNITED STATES,Recruiting,University of Oklahoma,"January 21, 2021",Interventional,Effects of Higher Dose and Lower Dose of Dexamethasone for Hospitalized Patients With COVID-19
4750,Sargramostim Use in COVID-19 to Recover Patient Health,COVID; SARS-COV INFECTION,"February 08, 2021",400,NCT04707664,SARGRAMOSTIM; PLACEBO,,Not yet recruiting,"Partner Therapeutics, Inc.",February 2021,Interventional,A Randomized Phase 2b Trial Evaluating Clinical Outcomes of Inhaled Sargramostim in High-risk Patients With Mild-moderate COVID-19
4751,Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ASPERGILLOSIS INVASIVE,"February 08, 2021",162,NCT04707703,ISAVUCONAZONIUM INJECTION [CRESEMBA]; PLACEBO,UNITED STATES,Not yet recruiting,"Jeffrey Jenks, MD, MPH",January 2021,Interventional,Isavuconazole for the Prevention of SARS-CoV-2-associated Invasive Aspergillosis in Critically-Ill Patients
4752,Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients,COVID,"February 08, 2021",84,NCT04707742,BETADINE© BUCAL 100 MG/ML; OXIMEN® 3%; CLORHEXIDINE DENTAL PHB©; VITIS XTRA FORTE©; DISTILLED WATER,SPAIN,Completed,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,"June 15, 2020",Interventional,Clinical Evaluation of Antiseptic Mouth Rinses to Reduce Salivary Viral Load of SARS-CoV-2 in COVID-19 Patients
4753,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection,CORONAVIRUS INFECTION,"February 08, 2021",80,NCT04707820,ELISPOT,FRANCE,Recruiting,"University Hospital, Rouen","April 16, 2020",Interventional,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
4754,Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,CORONAVIRUS INFECTION,"February 08, 2021",385,NCT04707833,SEROLOGICAL TESTING FOR COVID-19 INFECTION,FRANCE,Recruiting,"University Hospital, Rouen","November 26, 2020",Interventional,Protocol for the Collection of Clinical Samples for Evaluation and Implementation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
4755,Novaferon for COVID-19 Treatment Trial (NCTT-005),COVID,"February 08, 2021",385,NCT04708158,NOVAFERON; PLACEBO,,Not yet recruiting,Genova Inc.,January 2021,Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon vs. Placebo in Hospitalized Adult Patients With ModerateCOVID-19"
4756,A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia,COVID,"February 08, 2021",18,NCT04708236,ORTD-1 LOW DOSE; ORTD-1 MID DOSE; ORTD-1 HIGH DOSE; VEHICLE CONTROL,UNITED STATES,Recruiting,"Oryn Therapeutics, LLC",January 2021,Interventional,"A Blinded, Controlled, Escalating Dose Study of ORTD-1 for Treatment of Hospitalized Patients With SARS-CoV-2 (COVID-19) Related Pneumonia."
4757,Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19,COVID,"February 08, 2021",75,NCT04708327,NALTREXONE HYDROCHLORIDE,,Not yet recruiting,"Cytocom, Inc.",April 2021,Interventional,"A Randomized, Placebo-controlled, Phase 2 Study to Evaluate Safety and Efficacy of CYTO-205 (Low-dose Naltrexone) in Adult Patients With Mild COVID-19 Infection Who Are at High Risk for Disease Progression"
4758,Tolerability and Efficacy of RJX in Patients With COVID-19,COVID; ACUTE RESPIRATORY DISTRESS SYNDROME; SARS-CoV2; HYPOXEMIA,"February 08, 2021",237,NCT04708340,REJUVEINIX (RJX) ACTIVE COMPARATOR; PLACEBO COMPARATOR,,Not yet recruiting,"Reven Pharmaceuticals, Inc.","February 1, 2021",Interventional,"A Two-part, Two-cohort, Double-blind, Randomized, Placebo-controlled, Multicenter Phase 1/2 Study to Evaluate the Safety, Tolerability and Efficacy of REJUVEINIX (RJX) in Patients With COVID-19"
4759,"The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO",MECHANICAL VENTILATION COMPLICATION; SEVERE ACUTE RESPIRATORY INFECTION; COVID,"February 08, 2021",12,NCT04708457,VV-ECMO,AUSTRALIA,Not yet recruiting,Australian and New Zealand Intensive Care Research Centre,"February 1, 2021",Interventional,"A Pilot Feasibility RCT of Early ECMO to DE-sedate, Extubate, and Mobilise in Severe Acute Respiratory Infection"
4760,Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool,AIRWAY EXTUBATION,"February 08, 2021",72,NCT04708509,EXTUBATION ADVISOR,CANADA,Not yet recruiting,Ottawa Hospital Research Institute,March 2021,Interventional,Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool
4761,Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19),COVID,"February 08, 2021",100,NCT04708912,OBSERVATION,TURKEY,Recruiting,Basaksehir Cam & Sakura Şehir Hospital,"December 15, 2020",Observational,TUSEB-Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19)
4762,Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI),COVID; CORONAVIRUS INFECTION; VACCINE EFFECTIVENESS,"February 08, 2021",4504,NCT04709003,SEROLOGIC TEST; RESPIRATORY SWABS,ISRAEL,Recruiting,Clalit Health Services,"December 23, 2020",Observational,Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI): A Prospective Cohort Study
4763,Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization,COVID,"February 08, 2021",2050,NCT04709068,CURRENT HEALTH,,Not yet recruiting,Current Health,"January 20, 2021",Observational,Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization
4764,Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection,"COVID; COMORBIDITIES AND COEXISTING CONDITIONS; RISK FACTOR, CARDIOVASCULAR; DEATH; DIABETES; COPD; ATRIAL FIBRILLATION; DVT; CKD","February 08, 2021",2500,NCT04709120,,RUSSIAN FEDERATION,Recruiting,Eurasian Association of Therapists,"January 11, 2021",Observational [Patient Registry],Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
4765,The Influence of Covid-19 on the Audio-vestibular System,COVID,"February 08, 2021",70,NCT04709146,AUDIO-VESTIBULAR EVALUATION,,Not yet recruiting,"HaEmek Medical Center, Israel","March 1, 2021",Interventional,The Influence of Covid-19 on the Audio-vestibular System
4766,Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia,COVID PNEUMONIA,"February 08, 2021",30,NCT04709172,CEFDITOREN PIVOXIL 400MG,SPAIN,Recruiting,Meiji Pharma Spain S.A.,"January 5, 2021",Interventional,"Prospective, Non-controlled Pilot Study to Evaluate the Efficacy and Safety of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia"
4767,Heart Failure Patients Registry,HEART FAILURE,"February 08, 2021",20000,NCT04709263,,RUSSIAN FEDERATION,Recruiting,AstraZeneca,"December 23, 2020",Observational,Heart Failure Patients Registry A Prospective Observational Multicenter Registry of Patients With Chronic Heart Failure in the Population of the Russian Federation (PRIORITY-HF)
4768,Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa,COVID; HIV; ART,"February 08, 2021",342,NCT04709302,COVID-19; HIV; ART,NIGERIA,Recruiting,Medical University of Graz,February 2021,Observational [Patient Registry],"COVID-19 and Its Effects on Endothelium in HIV-Positive Patients in Sub-Saharan Africa: Cardiometabolic Risk, Thrombosis and Vascular Function"
4769,To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19,COVID; SARS-CoV2,"February 08, 2021",690,NCT04709328,SCTA01; PLACEBO,,Not yet recruiting,Sinocelltech Ltd.,"March 1, 2021",Interventional,"An Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in High-Risk Outpatients With COVID-19 (MAOP3 Trial)"
4770,Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic,COVID,"February 08, 2021",38,NCT04709744,VITAMIN D; ELISA,EGYPT,Completed,Mansoura University,"April 1, 2020",Observational,Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic
4771,Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19,COVID,"February 08, 2021",220,NCT04709835,AT-527; PLACEBO,BULGARIA,Not yet recruiting,Hoffmann-La Roche,"January 15, 2021",Interventional,"A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Otherwise Healthy Non-Hospitalized Adult Patients With Mild or Moderate COVID-19"
4772,Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19),VIRUS DISEASES,"February 08, 2021",40,NCT04710199,MARAVIROC EXPERIMENTAL GROUP; STANDARD TREATMENT,SPAIN,Not yet recruiting,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,February 2021,Interventional,Proof-of-concept Trial to Evaluate the Safety and Efficacy of Maraviroc in Severe Acute Respiratory Syndrome (SARS) Coronavirus-2 (CoV-2) Infected Patients Hospitalized for COVID-19
4773,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults,COVID,"February 08, 2021",35,NCT04710303,HAD5-S-FUSION+N-ETSD VACCINE,,Not yet recruiting,"ImmunityBio, Inc.",February 2021,Interventional,"Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of a City of a Prophylactiv COVID-19 Vaccination Using a 2nd Generation (E1/E2b/E3-Deleted) Adenoviral Platform in Healthy South African Adults (ProVIVA-SA-1)"
4774,"Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali",COVID,"February 08, 2021",450,NCT04710316,SARS-COV-2 SCREENING BY MOLECULAR BIOLOGY; SEROLOGICAL SCREENING,MALI,Not yet recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","January 30, 2021",Interventional,"Étude de l'épidémie de SARS-CoV-2 Dans Les Services Hospitaliers de Bamako, Mali"
4775,High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients,"RESPIRATORY DISTRESS SYNDROME, ADULT; COVID","February 08, 2021",78,NCT04710329,ASCORBIC ACID,TURKEY,"Active, not recruiting",Sisli Hamidiye Etfal Training and Research Hospital,"January 16, 2021",Observational,"High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients, A Retrospective Cohort Study"
4776,IMUNOR® Preparation in the Prevention of COVID-19,COVID,"February 08, 2021",100,NCT04710381,IMUNOR,CZECHIA,Not yet recruiting,University Hospital Ostrava,"February 1, 2021",Interventional,"Pilot, Monocentre, Phase-IV Clnical Trial Assessing the Clinical Effect of Per Oral Immunomodulation Treatment Using the IMUNOR® Preparation in the Prevention of COVID-19 Disease"
4777,Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell,ANOSMIA; COVID; AGEUSIA; HYPOSMIA; HYPOGEUSIA; SARS-CoV2 INFECTION; COVID PANDEMIC,"February 08, 2021",240,NCT04710394,SMELL TRAINING,UNITED STATES,Recruiting,Washington University School of Medicine,"January 11, 2021",Interventional,Efficacy of Bimodal Visual-Olfactory Training in Participants With COVID-19 Resultant Hyposmia or Anosmia Using Participant-Preferred Scents
4778,Effect of Prone Positioning in Patients With COVID-19,COVID,"February 08, 2021",30,NCT04710771,PRONE LYING POSITION; ALTERNATE NOSTRIL BREATHING,PAKISTAN,Recruiting,Sialkott College of Physical Therapy,"November 23, 2020",Observational,Effect of Prone Positioning and Alternate Nostril Breathing Technique in Patients With COVID-19: A Prospective Cohort Study.
4779,NoRCoRP Assessment Clinic,COVID,"February 08, 2021",500,NCT04710836,,UNITED KINGDOM,Recruiting,Nottingham University Hospitals NHS Trust,"December 3, 2020",Observational,The Nottingham Recovery From COVID-19 Research Platform Assessment Clinic
4780,Fluvoxamine for Adults With Mild to Moderate COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CORONAVIRUS INFECTION; MILD TO MODERATE COVID,"February 08, 2021",400,NCT04711863,FLUVOXAMINE; PLACEBO,"KOREA, REPUBLIC OF",Recruiting,Asan Medical Center,"January 16, 2021",Interventional,"Fluvoxamine for Adults With Mild to Moderate COVID-19: A Single-blind, Randomized, Placebo-controlled Trial"
4781,HIV/COV in Ukraine-NL,HIV; COVID,"February 08, 2021",2000,NCT04711954,,NETHERLANDS,Recruiting,Erasmus Medical Center,"November 1, 2020",Observational [Patient Registry],COVID-19 in People Living With HIV in Light of the 90-90-90 Goals: A Netherlands/Ukraine Research Collaboration.
4782,Rational Use of Personal Protective Equipment During COVID-19 Pandemic,COVID; PERSONAL PROTECTIVE EQUIPMENT,"February 08, 2021",67,NCT04712045,NEW PPE; OLD PPE,UNITED KINGDOM,Completed,University of Oxford,"August 1, 2020",Interventional,Rational Use of Personal Protective Equipment: a Randomised Trial and Quality Improvement Intervention During COVID-19 Pandemic
4783,A Study of TAK-019 in Healthy Japanese Adults (COVID-19),PREVENTION OF INFECTION DISEASE CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV2),"February 08, 2021",200,NCT04712110,TAK-019; PLACEBO,JAPAN,Not yet recruiting,Takeda,"February 20, 2021",Interventional,"A Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of TAK-019 by Intramuscular Injection in Healthy Japanese Male and Female Adults Aged 20 Years and Older (COVID-19)"
4784,Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry,COVID,"February 08, 2021",250,NCT04712175,NASOPHARYNGEAL SAMPLING; SALIVA SAMPLING,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nīmes,January 2021,Observational,Validation Diagnostique de la détection Rapide du Virus SARS-CoV-2 Dans Des échantillons Salivaires Par spectrométrie de Masse
4785,The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial),COVID,"February 08, 2021",294,NCT04712279,IVERMECTIN 0.6MG/KG/DAY; IVERMECTIN 1.0MG/KG/DAY; PLACEBO; HYDROXYCHLOROQUINE,,Not yet recruiting,Corpometria Institute,"January 25, 2021",Interventional,High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial
4786,Effects of COVID-19 Pandemic on the Diagnosis and Outcomes of Colorectal Cancer (COVID-CRC),COLORECTAL NEOPLASMS MALIGNANT,"February 08, 2021",2000,NCT04712292,SURGICAL PROCEDURE FOR CANCER,ITALY,Recruiting,Matteo Rottoli,"September 8, 2020",Observational,"Impact of the Healthcare Lockdown Due to COVID-19 Pandemic on the Diagnosis, Treatment and Outcomes of Patients Affected by Colorectal Cancer Requiring Surgery: Results From a Retrospective Multicentric Study in Northern Italy"
4787,Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO),SEVERE COVID,"February 08, 2021",58,NCT04712344,COVID-19 CONVALESCENT PLASMA,GERMANY,Recruiting,University of Erlangen-Nürnberg Medical School,"January 18, 2021",Interventional,Randomized Controlled Phase 2b Clinical Study in Parallel Groups for the Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma Plus Standard Treatment vs. Standard Treatment Alone of Subjects With Severe COVID-19
4788,Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19,COVID,"February 08, 2021",219,NCT04712357,VITAMIN C 500 MG ORAL TABLET; TENOFOVIR DISOPROXYL FUMARATE 300 MG ORAL TABLET; TENOFOVIR DISOPROXYL FUMARATE 300 MG PLUS EMTRICITABINE 200 MG ORAL TABLET,BRAZIL,Recruiting,Universidade Federal do Ceara,"November 9, 2020",Interventional,"Clinical, Control, Double-blind, Randomized Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19"
4789,Serum Prevalence of Dars-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE),HEALTHY; CHRONIC DISEASE,"February 08, 2021",3500,NCT04712448,ANTI-COVID TEST,ITALY,"Active, not recruiting",IRCCS San Raffaele,"December 30, 2020",Observational,Serum Prevalence of Antibodies Anti-SARS-2Cov in Healthy Subjects and in Patients With Chronic Diseases in Pre-pandemic Blood Samples
4790,Stress and Recovery in Frontline COVID-19 Workers,COVID; STRESS; WEARABLES,"February 08, 2021",383,NCT04713111,LIFESTYLE (MEDITATION); LIFESTYLE (EXERCISE),UNITED STATES,Completed,4YouandMe,"May 4, 2020",Interventional,Stress and Recovery in Frontline Healthcare COVID-19 Workers: A Feasibility Study Using Wearable and Smartphone Devices
4791,HEALthy Brain and Child Development Study - COVID-19 Supplement,CHILD DEVELOPMENT; PRENATAL INFECTION; PRENATAL STRESS; COVID,"February 08, 2021",75,NCT04713150,NO INTERVENTION,UNITED STATES,Recruiting,Boston Children's Hospital,"October 5, 2020",Observational,HEALthy Brain and Child Development Study - COVID-19 Supplement
4792,COVID-19 Vaccine Induced Immunity,COVID,"February 08, 2021",200,NCT04713163,COVID19 VACCINE,,Not yet recruiting,University of Manitoba,January 2021,Observational [Patient Registry],Prospective Evaluation of COVID-19 Vaccine Induced Immunity
4793,Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients,SEVERE COVID,"February 08, 2021",1120,NCT04713176,DWJ1248 WITH REMDESIVIR; PLACEBO WITH REMDESIVIR,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,"January 18, 2021",Interventional,"A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of DW1248 With Remdesivir in Severe COVID-19 Patients"
4794,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" Vaccine",COVID PREVENTION,"February 08, 2021",110,NCT04713488,SPUTNIK LIGHT,RUSSIAN FEDERATION,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","January 15, 2021",Interventional,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" t Vaccine for Prevention of Coronavirus Infection Caused by the SARS-CoV-2 Viruso"
4795,Rehabilitation in Intensive Care Unit,COVID,"February 08, 2021",58,NCT04713540,,TURKEY,Recruiting,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,"January 1, 2021",Observational,The Intensive Care Rehabilitation Experiences of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients of Pandemic Hospital in Turkey
4796,"Study to Evaluate the Lot Consistency, Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Adults",SARS-CoV2 INFECTION; COVID,"February 08, 2021",1280,NCT04713553,BNT162B2,,Not yet recruiting,BioNTech SE,"January 28, 2021",Interventional,"A PHASE 3, RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE LOT CONSISTENCY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF THE VACCINE CANDIDATE BNT162b2 AGAINST COVID-19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE"
4797,"Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections",IMMUNE HEALTH,"February 08, 2021",140,NCT04713735,CONTROL: PLACEBO; BOVINE LACTOFERRIN SUPPLEMENT,UNITED STATES,Recruiting,Mead Johnson Nutrition,"December 28, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Impact of Lactoferrin Dietary Supplementation on Respiratory Tract Infections in an Elderly Population"
4798,Tasso-SST OnDemand Comparator Pilot Study,C3PI STUDY TESTING GROUP,"February 08, 2021",100,NCT04713748,TASSO-SST ON DEMAND; REGULAR PHLEBOTOMY,UNITED STATES,Not yet recruiting,Duke University,January 2021,Interventional,Pilot Study to Compare Serology Results From Blood Collected Using Tasso-SST OnDemand Device Compared to Venipuncture
4799,Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients,COVID,"February 08, 2021",116,NCT04713852,,BELGIUM,Completed,Jessa Hospital,"March 13, 2020",Observational,Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients: a Longitudinal Single-center Study
4800,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,CORONAVIRUS DISEASE 2019 (COVID) PNEUMONIA,"February 08, 2021",21,NCT04713878,MESENCHYMAL STEM CELLS,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"May 8, 2020",Interventional,A 8-Week Trial of Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia
4801,Covid-19 and ONline GAmbling,GAMBLING; COVID,"February 08, 2021",180000,NCT04714008,,FRANCE,Recruiting,Nantes University Hospital,"December 1, 2020",Observational,Impact of the COVID-19 Pandemic on Online Gambling in France and Sweden
4802,Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients,COVID; SARS-COV INFECTION,"February 08, 2021",250,NCT04714125,,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 19, 2020",Observational,Prognostic Value of Flow-mediated Dilation in Hospitalized Patients With SARS-CoV-2 Infection: an Observational Prospective Study
4803,Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection,COVID,"February 08, 2021",190,NCT04714138,,FRANCE,Recruiting,Groupe Hospitalier du Havre,"January 5, 2021",Observational,Remote Evaluation of Quality of Life and Functional Capacities in Patients Hospitalised for COVID-19: a Prospective Observational Study
4804,Cognitive Behavioral Therapy Group for Older Adults Delivered by Telethealth,MAJOR DEPRESSIVE DISORDER; GENERALIZED ANXIETY DISORDER; SOCIAL ANXIETY DISORDER; PANIC DISORDER,"February 08, 2021",20,NCT04714164,GROUP COGNITIVE BEHAVIORAL THERAPY,,Not yet recruiting,Nova Scotia Health Authority,February 2021,Interventional,Feasibility of Delivering Group Cognitive Behavioral Therapy for Older Adults With Depression and Anxiety by Telehealth
4805,Neuropsychiatry and Cognition in SCA3/MJD,SPINOCEREBELLAR ATAXIA TYPE 3; MACHADO-JOSEPH DISEASE; SCA3; MJD,"February 08, 2021",144,NCT04714307,SCA3/MJD MOLECULAR DIAGNOSIS; COGNITIVE TESTING; PSYCHIATRIC EVALUATION; CLINICAL NEUROLOGICAL EVALUATION; EMOTIONAL ATTRIBUTION EVALUATION; ACTIVITIES OF DAILY LIVING,BRAZIL,Recruiting,Hospital de Clinicas de Porto Alegre,"December 13, 2019",Observational,Neuropsychiatry and Cognition in the Context of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD)
4806,Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath,COVID,"February 08, 2021",1000,NCT04714333,,CANADA,Enrolling by invitation,British Columbia Cancer Agency,"May 6, 2020",Observational,Detection of COVID-19 by Volatile Organic Compounds in Exhaled Breath (VOCs) - a Pilot Study
4807,Montelukast - a Treatment Choice for COVID-19,COVID; SARS-CoV2 INFECTION,"February 08, 2021",150,NCT04714515,MONTELUKAST; HYDROXYCHLOROQUINE; IVERMECTIN,CHINA,Completed,University of Sargodha,"February 20, 2020",Observational,Using Montelukast to Treat the Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
4808,Feasibility RCT of an 8-session Group Intervention for Siblings of Children Who Have ASD,AUTISM SPECTRUM DISORDER,"February 08, 2021",25,NCT04714606,SIBLING SUPPORT GROUP; NONE - CONTROL CONDITION,UNITED KINGDOM,Recruiting,University of Surrey,"December 14, 2020",Interventional,Supporting Those Who Have A Relative Experiencing Autism Spectrum Disorders (SHARE-ASD): Feasibility RCT of an 8-session Group Intervention for Siblings of Children Who Have ASD
4809,Mechanisms Underlying Individual Variations of Taste and Smell in Obesity,OBESITY,"February 08, 2021",248,NCT04714892,,UNITED STATES,Not yet recruiting,National Institute on Alcohol Abuse and Alcoholism (NIAAA),"February 11, 2021",Observational,Mechanisms Underlying Individual Variations of Taste and Smell in Obesity
4810,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients",ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY COVID,"February 08, 2021",360,NCT04715243,HIGH FLOW NASAL CANNULA (HFNC); HELMET NIV; FACE-MASK NIV,OMAN,Recruiting,Sultan Qaboos University,January 2021,Interventional,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients"
4811,Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19,COVID,"February 08, 2021",200,NCT04715295,DOXYCYCLINE TABLETS; RIVAROXABAN 15MG TAB; HYDROXYCHLOROQUINE AND AZITHROMYCIN,CAMEROON,Recruiting,Yaounde Central Hospital,"October 5, 2020",Interventional,"Open-label, Randomized Trial of the Safety and Efficacy of Doxycycline and Rivaroxaban Therapy Versus National Standard Therapy in Ambulatory Patients With Mild Symptomatic COVID-19"
4812,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy,"COVID; SARS-CoV2 INFECTION; ARDS, HUMAN; SEVERE COVID","February 08, 2021",30,NCT04715360,AUTOLOGOUS ACTIVATED PLATELET-RICH PLASMA; AVIGAN,INDONESIA,Recruiting,Hayandra Peduli Foundation,"December 29, 2020",Interventional,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy
4813,Vaccination Against COVID-19 in Cancer,CANCER,"February 08, 2021",873,NCT04715438,,NETHERLANDS,Recruiting,University Medical Center Groningen,"January 8, 2021",Observational,Vaccination Against cOvid In CancEr
4814,Intensive Care Anxiety in SARS-CoV-2 Patients,ANXIETY,"February 08, 2021",100,NCT04715477,HOSPITAL ANXIETY DEPRESSION MEASURE,TURKEY,Recruiting,Derince Training and Research Hospital,"January 17, 2021",Observational,Intensive Care Anxiety in SARS-CoV-2 (COVID 19) Patients
4815,"COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens",SARS-COV INFECTION; COVID; CORONAVIRUS,"February 08, 2021",22000,NCT04715607,SEQUENCE OF TESTING.,DENMARK,Recruiting,"Rigshospitalet, Denmark","January 22, 2021",Interventional,"Comparison of Detection Rate of SARS-CoV-2 in Saliva, Oropharyngeal and Nasopharyngeal Specimens in a Public COVID-19 Test Setting"
4816,INvestigating TELmisartin Study,COVID,"February 08, 2021",40,NCT04715763,TELMISARTAN ORAL PRODUCT; PLACEBO,,Not yet recruiting,University of Hawaii,"February 1, 2021",Interventional,"Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Treatment of COVID-19 in Hospitalized Patients"
4817,COVID-19 and Its Effects on Chronic Pain Patients,CHRONIC PAIN,"February 08, 2021",30,NCT04715815,NO INTERVENTION (ONLY INTERVIEW),,Not yet recruiting,Prince of Songkla University,February 2021,Observational,Effects of COVID-19 on Chronic Pain Patients in Terms of Pain and Pain Management
4818,Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas,HYPOXEMIC RESPIRATORY FAILURE; EMERGENCIES; COVID,"February 08, 2021",15,NCT04715854,MASK,BELGIUM,Not yet recruiting,"Laboratory of Movement, Condorcet, Tournai, Belgium","January 15, 2021",Interventional,Comparison of the Addition of an Aerosol Mask Above Nasal Canula on Oxygenation in Hypoxemic Failure
4819,Project COPE (Coping Options for Parent Empowerment),ANXIETY DISORDERS; DEPRESSION,"February 08, 2021",500,NCT04715906,UP-CAREGIVER,UNITED STATES,Not yet recruiting,University of Miami,"February 1, 2021",Interventional,Coping Options for Parent Empowerment
4820,Long Term Outcomes of Coronavirus Disease-19 (COVID-19),COVID,"February 08, 2021",80,NCT04715919,CHEST COMPUTED TOMOGRAPHY; PULMONARY FUNCTION TESTS; SIX MINUTES WALK TEST; QUALITY OF LIFE,TURKEY,Recruiting,Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital,"January 15, 2021",Observational,"Long Term Outcomes in Patients With Coronavirus Disease-19 (COVID-19) on Pulmonary Functions, Exercise Capacity, Lung Structure and Quality of Life"
4821,Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN),"COVID; ANOSMIA; FEVER; COUGH; SHORTNESS OF BREATH; SORE THROAT; NAUSEA; VOMITING; HEADACHE; MUSCLE WEAKNESS; PAIN, MUSCLE; PAIN, CHEST; PAIN, JOINT; PAIN, ABDOMINAL; PAIN; IRRITABLE MOOD; CONFUSION","February 08, 2021",216,NCT04715932,HESPERIDIN; PLACEBO,,Not yet recruiting,Montreal Heart Institute,"January 21, 2021",Interventional,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study of Hesperidin Therapy on COVID-19 Symptoms: The Hesperidin Coronavirus Study (Hesperidin)"
4822,"Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults",SARS-CoV2,"February 08, 2021",170,NCT04715997,GX-19N,"KOREA, REPUBLIC OF",Recruiting,"Genexine, Inc.","December 30, 2020",Interventional,"A Phase 1/2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Subjects"
4823,Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19,COPD; COVID; ASTHMA; SMALL AIRWAYS DISEASE,"February 08, 2021",42,NCT04716023,,UNITED KINGDOM,Recruiting,Imperial College London,"August 23, 2019",Observational,Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19
4824,Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19,SARS-CoV2 RAPID ANTIGEN TEST,"February 08, 2021",36,NCT04716088,RAPID ANTIGEN TEST FOR SARS COV2,SLOVENIA,Completed,The University Clinic of Pulmonary and Allergic Diseases Golnik,"November 18, 2020",Observational,Usefulness of Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19 in the Hospital: a Pilot Study
4825,Prospective Two-arm Study of Fertility in Men With COVID-19,COVID; FERTILITY ISSUES,"February 08, 2021",88,NCT04716179,"SPERM TEST; HORMONE LEVELS (TESTOSTERONE, FSH, LH, PROLACTIN); SARS-COV-2 IG G LEVELS; TESTIS PATHOLOGY SAMPLES",RUSSIAN FEDERATION,Recruiting,I.M. Sechenov First Moscow State Medical University,"January 18, 2021",Interventional,Prospective Two-arm Study of Fertility in Men With COVID-19
4826,APT™ T3X on the COVID-19 Contamination Rate,COVID,"February 08, 2021",100,NCT04716426,TETRACYCLINE HYDROCHLORIDE 3%; PLACEBO,BRAZIL,Recruiting,University of Nove de Julho,"January 28, 2021",Interventional,Use of APT™ T3X to Decrease the COVID-19 Contamination Rate in Humans
4827,Dysautonomia in Patients Post COVID-19 Infection,COVID,"February 08, 2021",200,NCT04716465,DYSAUTONOMIA,BELGIUM,Recruiting,Moens Maarten,"January 19, 2021",Observational,Dysautonomia in Patients Post COVID-19 Infection
4828,Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals,INFLUENZA -LIKE ILLNESS; COVID,"February 08, 2021",5400,NCT04716543,ILI AND COVID-19 DETECTION,,Not yet recruiting,French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS),March 2021,Observational,One-health Approach in Epidemiological Investigation of SARS-CoV-2 in Laos
4829,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients,"COVID; CORONAVIRUS INFECTION; PNEUMONIA, VIRAL","February 08, 2021",474,NCT04716556,CONVALESCENT PLASMA,ITALY,"Active, not recruiting",Istituto Superiore di Sanità,"July 16, 2020",Interventional,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa Due to SARS-CoV2 (TSUNAMI Study): a Multicenter Open Label Randomized Control Trial
4830,Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19,COVID,"February 08, 2021",150,NCT04716569,INTRANASAL IVERMECTIN SPRAY,EGYPT,Recruiting,South Valley University,"January 20, 2021",Interventional,"Faculty of Medicine ,South Valley University"
4831,Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research,COVID,"February 08, 2021",28,NCT04716647,AYURVEDA,UNITED KINGDOM,Completed,Aarogyam UK,"October 9, 2020",Interventional,A Community-Based Participatory Research to Assess the Feasibility of Ayurveda Intervention in Patients With Mild-to-Moderate COVID-19
4832,Thymic Function in Patients With COVID-19,COVID,"February 08, 2021",36,NCT04716907,SINGLE-NUCLEOTIDE POLYMORPHISMS (SNP) WITHIN THE TCRA/D REGION; BLOOD SAMPLE; CT SCAN,FRANCE,Not yet recruiting,CMC Ambroise Paré,"February 1, 2021",Observational,Thymic Function in Patients With COVID-19
4833,Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes,COVID,"February 08, 2021",200,NCT04716972,SURVEY; INTERVIEW,,Not yet recruiting,The Royal Wolverhampton Hospitals NHS Trust,"April 1, 2021",Observational,Evaluating the Impact of COVID-19 on Research in Care Homes
4834,Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care,SARS-CoV2; COVID; AMBULATORY CARE,"February 08, 2021",450,NCT04716985,MOLECULAR HYDROGEN; PLACEBO MAGNESIUM,FRANCE,Recruiting,AGIR à Dom,"January 22, 2021",Interventional,"Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care. Double-blind, Randomized, Comparative Study"
4835,Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19,COVID,"February 08, 2021",35,NCT04716998,MESENCURE,ISRAEL,Recruiting,BonusBio Group Ltd,January 2021,Interventional,A Controlled Study to Evaluate the Safety and Efficacy of Allogeneic MesenCure for the Treatment of Pulmonary Manifestations in Patients With COVID19
4836,Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients,SARS-CoV2,"February 08, 2021",100,NCT04717011,PCR TEST,SPAIN,Recruiting,Igenomix,January 2021,Observational,Case Series Biomedical Study to Detect the Presence of SARS-CoV-2 in Semen of Patients Diagnosed With COVID-19 Disease
4837,The Nanowear Wearable Covid-19 Observational and Analysis Trend,COVID,"February 08, 2021",100,NCT04717024,OBSERVATIONAL STUDY - NO INTERVENTION,UNITED STATES,Recruiting,Nanowear Inc.,"September 15, 2020",Observational,The Nanowear Wearable Covid-19 Observational and Analysis Trend
4838,Extended Recovery During COVID-19: Multi-perspective Value-based Analysis,OVERNIGHT INTENSIVE RECOVERY; POSTOPERATIVE CARE,"February 08, 2021",300,NCT04717089,OVERNIGHT INTENSIVE RECOVERY / EXTENDED RECOVERY,HONG KONG,Recruiting,Tuen Mun Hospital,"February 10, 2020",Observational,The Rapid Conversion of Ordinary Recovery Beds to an Overnight Intensive Recovery (OIR) to Alleviate the High Pressure on Postoperative Intensive Care Demands During COVID-19 Pandemics in a Local Tertiary Hospital: a Multi-perspective Value-based Analysis
4839,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19",COVID; PREGNANCY RELATED; MATERNAL COMPLICATION OF PREGNANCY; CORONAVIRUS; NEONATAL INFECTION; PRENATAL STRESS; PRETERM BIRTH,"February 08, 2021",420,NCT04718220,ANTIBODY TESTING FOR SARS-COV-2 IGG; TESTING FOR SARS-COV-2 RNA; TESTING FOR SARS-COV-2 IGM/IGG,,Not yet recruiting,Washington University School of Medicine,February 2021,Interventional,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19"
4840,Investigation the Effect of Montelukast in COVID-19,COVID; SARS-CoV2,"February 08, 2021",380,NCT04718285,MONTELUKAST ORAL TABLET; MONTELUKAST PLUS FAVICOVIR (FAVIPIRAVIR); FAVICOVIR (STANDARD TREATMENT),TURKEY,Not yet recruiting,Bahçeşehir University,"January 30, 2021",Interventional,"A National, Multi-Center, Open-Label, Three-Arm, Phase II Study to Investigate the Effect of Montelukast Between Emergency Room Visits and Hospitalizations in COVID-19 Pneumonia in Comparison With Standard Treatment"
4841,Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells),COVID,"February 08, 2021",4000,NCT04718467,RECOMBINANT COVID-19 VACCINE (SF9 CELLS); PLACEBO,CHINA,Not yet recruiting,Jiangsu Province Centers for Disease Control and Prevention,"February 1, 2021",Interventional,"A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱb Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 to 85 Years Old"
4842,Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients,COVID,"February 08, 2021",100,NCT04718480,PLACEBO; FLUVOXAMINE,HUNGARY,Recruiting,SigmaDrugs Research Ltd.,"November 27, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Adaptive-design Study to Assess the Safety and Efficacy of Daily 200 mg Fluvoxamine as add-on Therapy to Standard of Care in Moderate Severity COVID-19 Patients"
4843,Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention,COVID; POST-COVID SYNDROME,"February 08, 2021",56,NCT04718506,EXERCISE; CONTROLS,SPAIN,Recruiting,Universidad de Murcia,"January 12, 2021",Interventional,"Rehabilitation for Post-COVID-19 Syndrome Through a Multicomponent, Educational and Supervised Exercise Intervention [RECOVE]"
4844,Individual and Institutional Resilience in Migrant Workers During the COVID-19 Pandemic,CORONAVIRUS,"February 08, 2021",1288,NCT04718519,FACTORS PROMOTING RESILIENCE,SINGAPORE,Completed,Yale-NUS College,"June 22, 2020",Observational,Individual and Institutional Resilience in Migrant Workers During the COVID-19 Pandemic
4845,The Effect of Yoga Self-Practice on Sleep Disturbance,YOGA,"February 08, 2021",30,NCT04719039,RESTORATIVE YOGA INTERNVENTION,HONG KONG,Not yet recruiting,Chinese University of Hong Kong,February 2021,Interventional,The Effect of Restorative Yoga Self-Practice on Sleep Disturbance: A Pilot Randomized Controlled Trial
4846,Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19,"COVID; PNEUMONIA; THROMBOSIS; THROMBOEMBOLISM; ANTICOAGULANTS; INCREASED; ARDS, HUMAN","February 08, 2021",1000,NCT04719182,ADJUNCTIVE THERAPIES,NETHERLANDS,"Active, not recruiting",Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"September 1, 2020",Observational,Practice of Adjunctive Treatments in Intensive Care Unit Patients With Coronavirus Disease 2019 (PRoAcT-COVID) - an Observational Study in the Netherlands
4847,[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse,COVID,"February 08, 2021",60,NCT04719208,WATER (E) MOUTH RINSE WITH THE SOLUTION PROVIDED; CHLORHEXIDINE GLUCONATE (A) MOUTH RINSE WITH THE SOLUTION PROVIDED; HYDROGEN PEROXIDE (B) MOUTH RINSE WITH THE SOLUTION PROVIDED; BETADINE (C) MOUTH RINSE WITH THE SOLUTION PROVIDED; ALCOHOL MOUTHWASH (LISTERINE) (D) MOUTH RINSE WITH THE SOLUTION PROVIDED,UNITED STATES,Recruiting,Augusta University,"October 6, 2020",Interventional,Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse
4848,Lung Ultrasonography in COVID-19 Pneumonia,LUNG ULTRASOUND; PNEUMONIA; COVID,"February 08, 2021",60,NCT04719234,LUNG ULTRASONOGRAPHY,TURKEY,Completed,Bursa Yüksek İhtisas Education and Research Hospital,"June 15, 2020",Interventional,Comparison of Lung Ultrasonography Findings With Chest Computerized Tomography Results in Corona virüs (COVID-19) Pneumonia
4849,PD-Ballet: Effectiveness and Implementation in Parkinson's Disease,PARKINSON DISEASE,"February 08, 2021",160,NCT04719468,DANCE WITH BALLET ELEMENTS,UNITED KINGDOM,Not yet recruiting,King's College Hospital NHS Trust,"February 1, 2021",Interventional,Efficacy of Ballet Dancing on Motor and Non-motor Symptoms of Parkinson's Disease: a Hybrid Type 2 Effectiveness-implementation Trial
4850,Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic,"PARKINSON DISEASE; COVID; SATISFACTION, PATIENT; QUALITY OF LIFE","February 08, 2021",150,NCT04720118,NO INTERVENTION,UNITED STATES,Recruiting,Towson University,February 2021,Observational [Patient Registry],Does Locus of Control Affect Satisfaction and Quality of Life During COVID - 19?
4851,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit,COVID; CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04720235,LUCIRA COVID-19 ALL-IN-ONE TEST KIT,UNITED STATES,Recruiting,Lucira Health Inc,"December 9, 2020",Interventional,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit As Compared To The Hologic Panther Fusion SARS-CoV-2 RT-PCR Assay Among Asymptomatic Subjects
4852,Safety and Tolerability Study of IV ST266 in COVID-19 Subjects,CYTOKINE RELEASE SYNDROME,"February 08, 2021",12,NCT04720378,ST266,,Not yet recruiting,"Noveome Biotherapeutics, formerly Stemnion",February 2021,Interventional,"A Phase 1, Multi-Center, Open-Label, Safety and Tolerability Study of Intravenous Administration of ST266 in Subjects With Confirmed COVID-19 Infection"
4853,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP),MINDFULNESS; RANDOMIZED CONTROLLED TRIAL; PSYCHOPATHOLOGY; HEALTH PERSONNEL,"February 08, 2021",220,NCT04720404,MINDFULNESS-BASED STRESS REDUCTION; SELF-HELP MINDFULNESS/COMPASSION EXERCISES; SUPPORT AS USUAL,NETHERLANDS,Recruiting,Radboud University,"June 23, 2020",Interventional,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP)
4854,COVID-19 Immunologic Antiviral Therapy With Omalizumab,COVID,"February 08, 2021",200,NCT04720612,OMALIZUMAB; PLACEBO,CANADA,Not yet recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,February 2021,Interventional,COVID-19 Immunologic Antiviral Therapy With Omalizumab - An Adaptive Phase II Randomized-Controlled Clinical Trial
4855,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion,COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME); CORONAVIRUS INFECTION,"February 08, 2021",101,NCT04720794,LUCIRA COVID-19 ALL-IN-ONE TEST KIT,UNITED STATES,Completed,Lucira Health Inc,"September 25, 2020",Interventional,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit As Compared To The Hologic Panther Fusion SARS-CoV-2 RT-PCR Assay
4856,Early Use of Hyperimmune Plasma in COVID-19,COVID,"February 08, 2021",300,NCT04721236,HYPERIMMUNE PLASMA,ITALY,Recruiting,Catherine Klersy,"November 19, 2020",Interventional,COVID-19 Wave II Study for Assessing the Early Use of Hyperimmune Plasma for the Treatment of COVID-19 Patients Needing Non-invasive or Invasive Mechanical Ventilation
4857,Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19),LUNG CANCER; COVID; PNEUMONITIS,"February 08, 2021",1500,NCT04721444,MACHINE LEARNING CLASSIFICATION OF PARENCHYMAL LUNG CHANGE CAUSE; MACHINE LEARNING CLASSIFICATION OF RECURRENCE AND NON-RECURRENCE,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"March 1, 2021",Observational,Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence
4858,The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load,SARS-CoV2; COVID; MOUTHWASHES; VIRAL LOAD; POLYMERASE CHAIN REACTION,"February 08, 2021",120,NCT04721457,DISTILLED WATER; 1% POVIDONE IODINE (PVP-I); 1.5% HYDROGEN PEROXIDE (H2O2); 0.075% CETYLPYRIDINIUM CHLORIDE (CPC); 0.1% SODIUM HYPOCHLORITE,SAUDI ARABIA,Recruiting,King Abdulaziz University,"January 3, 2021",Interventional,The Efficacy of Pre-procedural Mouth Rinses on SARS-CoV-2 Saliva Viral Load: A Randomized Control Clinical Trial
4859,A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2,COVID; SARS-CoV2 INFECTION,"February 08, 2021",1012,NCT04721535,DWJ1248; PLACEBO,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,January 2021,Interventional,A Randomized Double-blinded Controlled Clinical Trial of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
4860,Prevention of Child Mental Health Problems in Southeastern Europe - Phase 3,CHILD MENTAL DISORDER,"February 08, 2021",864,NCT04721730,PLH-YC; LECTURE,"MOLDOVA, REPUBLIC OF",Recruiting,University of Bremen,"December 7, 2020",Interventional,"Prevention of Child Mental Health Problems in Southeastern Europe - Adapt, Optimize, Test, and Extend Parenting for Lifelong Health ' - 'RISE' - The Randomized Controlled Trial (Phase 3 of MOST)"
4861,COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020,COVID,"February 08, 2021",4000,NCT04723290,SEROLOGICAL TESTS FOR SARS COV-2,BELGIUM,Completed,Grand Hôpital de Charleroi,"June 20, 2020",Interventional,SARS-CoV-2 Seroconversion Study Among GHdC Staff Members
4862,Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults,COVID,"February 08, 2021",1324,NCT04723394,AZD7442; PLACEBO,UNITED KINGDOM,Not yet recruiting,AstraZeneca,"January 22, 2021",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442 for the Treatment of COVID-19 in Non-hospitalized Adults"
4863,Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism,RHEUMATISM,"February 08, 2021",950,NCT04723407,QUESTIONNAIRES,FRANCE,Not yet recruiting,"University Hospital, Limoges","February 1, 2021",Observational,Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism According to a Management Strategy in the Rheumatology Department of Limoges University Hospital
4864,Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva,COVID; CORONAVIRUS,"February 08, 2021",40,NCT04723446,CORSODYL® ALCOHOL FREE -0.2 % CHLORHEXIDINE DIGLUCONATE; COLGATE PEROXYL® -1.5% HYDROGEN PEROXIDE; ORAL-B® GUM & ENAMEL CARE -CETYLPYRIDINIUM CHLORIDE; NO RINSING,,Not yet recruiting,Queen Mary University of London,"February 1, 2021",Interventional,Efficacy of Three Antimicrobial Mouthwashes in Reducing SARS-CoV-2 Viral Load in the Saliva of Patients Diagnosed With COVID-19: A Pilot Study
4865,Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff,COVID,"February 08, 2021",150,NCT04723459,IVERMECTIN IMPREGNATED MASK,EGYPT,Recruiting,South Valley University,"January 23, 2021",Interventional,Nano-Ivermectin Impregnated Masks Versus Ordinary Surgical Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff
4866,Jinhua Qinggan Granules in the Treatment of COVID-19,COVID,"February 08, 2021",300,NCT04723524,"JINHUA QINGGAN (JHQG) GRANULES, TRADITIONAL CHINESE MEDICINE; PLACEBO COMPARATOR",PAKISTAN,Recruiting,University of Karachi,"September 22, 2020",Interventional,"Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Effectiveness and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID 19 Patients"
4867,"Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease",COVID,"February 08, 2021",310,NCT04723537,PART A: UPAMOSTAT 200 MG; PART A: UPAMOSTAT 400 MG; PART A AND B: PLACEBO; PART B: UPAMOSTAT 200 OR 400 MG,UNITED STATES,Not yet recruiting,RedHill Biopharma Limited,February 2021,Interventional,"Phase 2/3 Study of Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease"
4868,COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes,TYPE 2 DIABETES MELLITUS,"February 08, 2021",120,NCT04723550,HOSPITAL TELEMEDICINE MANAGEMENT SYSTEM; USUAL CARE,CHINA,Recruiting,Wenwen Yin,"January 5, 2021",Interventional,Impact of Telemedicine on Young and Middle-aged Obese Patients With Type 2 Diabetes Mellitus During COVID-19 Pandemic
4869,Nebulized Heparin for the Treatment of COVID-19,"COVID; PNEUMONIA, VIRAL","February 08, 2021",50,NCT04723563,HEPARIN; 0.9%SODIUM CHLORIDE,UNITED STATES,Not yet recruiting,Frederick Health,"February 1, 2021",Interventional,INHALEd Unfractionated HEParin for the Treatment of Hospitalized Patients With COVID-19 Pneumonia
4870,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19),HEALTHY,"February 08, 2021",2132,NCT04723576,STRESS FIRST AID,UNITED STATES,Recruiting,RAND,"December 3, 2020",Interventional,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19)
4871,Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC),COVID,"February 08, 2021",40,NCT04723589,THAWED PLASMA,,Not yet recruiting,University of Alabama at Birmingham,"February 1, 2021",Interventional,Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC)
4872,"Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults",EBOLA VIRUS DISEASE; MARBURG VIRUS DISEASE,"February 08, 2021",32,NCT04723602,CAD3-MARBURG; CAD3-EBO-S,UNITED STATES,Recruiting,Albert B. Sabin Vaccine Institute,"January 6, 2021",Interventional,"Phase 1b Trial to Evaluate Safety, Tolerability and Immune Responses of 2 Monovalent Chimpanzee Adenoviral Vectored Filovirus (Ebola-S and Marburg) Vaccines to Healthy Adults, Collection of Plasma/Serum for the Purposes of Assay Development"
4873,Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients,"HEMATOLOGIC DISORDERS AND BONE MARROW FAILURE, HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR CELLULAR THERAPY (CART)","February 08, 2021",150,NCT04723706,COVID-19 SEROLOGY IGG,UNITED STATES,Not yet recruiting,Henry Ford Health System,"February 1, 2021",Observational,Immunological Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients
4874,Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19,COVID,"February 08, 2021",800,NCT04724395,HOSPITALIZATION,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,January 2021,Observational,Prospective Multicenter Cohort Study to Evaluate Disability Following Hospitalization in People of Working-age Surviving COVID-19
4875,Follow-up Study of COVID-19 Patients in the District Konstanz,SARS-CoV2 POSITIVE PATIENTS,"February 08, 2021",400,NCT04724434,,GERMANY,Enrolling by invitation,Hegau-Bodensee-Klinikum Singen,"December 4, 2020",Observational,Single Center Prospective Controlled Follow-up Study of COVID-19 Patients in the District Konstanz (FSC19-KN)
4876,Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19,"COVID; PNEUMONIA, VIRAL","February 08, 2021",15,NCT04724538,99MTC-PERTECHNETATE; 99MTC-PERTECHNETATE AEROSOL; 99MTC-PERTECHNETATE AEROSOL,RUSSIAN FEDERATION,Recruiting,National Medical Research Radiological Centre of the Ministry of Health of Russia,"October 15, 2020",Interventional,Inhalation Low Dose Radionuclide Therapy in Comprehensive Treatment of COVID-19 Viral Pneumonia
4877,CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN,COVID; PEDIATRIC PSYCHIATRIC DISORDER; PSYCHOLOGICAL STRESS,"February 08, 2021",60,NCT04724616,EDUCATIONAL PROGRAM (CARTOON),AUSTRIA,Recruiting,Medical University of Vienna,"January 6, 2021",Interventional,CARTOON: CoronAviRus educaTional prOgram fOr childreN to Promote Knowledge and Hygiene Measures and Dispel Fear During the COVID- 19 Pandemic
4878,Survival TRial Using CytoKines in COVID-19 (STRUCK Trial),COVID,"February 08, 2021",60,NCT04724629,IXEKIZUMAB; ALDESLEUKIN; COLCHICINE; STANDARD OF CARE (SOC),BRAZIL,Recruiting,University of Sao Paulo,"January 5, 2021",Interventional,"Prospective-randomized Adaptive Study, With Active Control to Evaluate the Efficacy and Safety of Interleukin (IL)-17 Inhibitor Treatment Versus Low Doses of IL-2 Versus Indirect IL-6 Inhibitor in Hospitalized Patients With Severe Forms of COVID-19"
4879,"COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency",ALLOGENIC HEMATOPOIETIC CELL TRANSPLANT; CAR-T THERAPY; PRIMARY IMMUNODEFICIENCY,"February 08, 2021",110,NCT04724642,,ISRAEL,Recruiting,Tel-Aviv Sourasky Medical Center,"December 28, 2020",Observational,"Efficacy and Safety of COVID-19 Vaccine in Patients After Allogeneic Hamatopoietic Cell Transplantation, CAR-T Therapy and With Primary Immune Deficiency - a Post Marketing Prospective Cohort Study"
4880,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection,CLINICAL DETERIORATION,"February 08, 2021",800,NCT04724681,WARD CSS,DENMARK,Recruiting,University Hospital Bispebjerg and Frederiksberg,"February 1, 2021",Interventional,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection
4881,Russian Cardiovascular Registry of COVID-19,COVID; ACUTE CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASES,"February 08, 2021",900,NCT04724707,,RUSSIAN FEDERATION,Recruiting,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","September 11, 2020",Observational [Patient Registry],An Open Multicenter Observational Study (Registry) of Patients Recovered From Novel Coronavirus Infection (COVID-19) With Involvement of the Cardiovascular System or With Baseline Severe Cardiovascular Diseases
4882,Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19,COVID,"February 08, 2021",84,NCT04724720,FAMOTIDINE; PLACEBO,UNITED STATES,Recruiting,Northwell Health,"January 19, 2021",Interventional,"A Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Famotidine vs Placebo for the Treatment of Non-Hospitalized Symptomatic Adults With COVID-19"
4883,Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura,CORONAVIRUS DISEASE 2019,"February 08, 2021",5000,NCT04724850,,,Not yet recruiting,Juan Fernando Masa Jiménez,"February 1, 2021",Observational,Observational Study About the Characteristics and Evolution of Patients Diagnosed With COVID-19 in Extremadura
4884,Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2),"February 08, 2021",300,NCT04725084,USE OF HIGH FLOW NASAL CANNULA ALONE; USE OF NON-INVASIVE VENTILATION; USE OF CONTINUOUS POSITIVE AIRWAY PRESSURE,FRANCE,Completed,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"July 1, 2020",Observational,Comparison of Non-invasive Oxygenation Strategies in ICU Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome
4885,A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection,COVID,"February 08, 2021",10000,NCT04725097,,INDIA,Recruiting,Mayo Clinic,"December 10, 2020",Observational,Rapid Throughput Screening for Human COVID-19 Infection: A ECG Study
4886,Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome,"COVID; SARS-COV INFECTION; ARDS; ARDS, HUMAN","February 08, 2021",250,NCT04725110,INSTILLED T3; PLACEBO THERAPY,,Not yet recruiting,University of Minnesota,March 2021,Interventional,"Phase II Trial of Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 ARDS - A Multi-Site, Randomized, Double-blinded, Placebo-Controlled Clinical Trial"
4887,Nicotinamide to Prevent Delirium,DELIRIUM CONFUSIONAL STATE,"February 08, 2021",146,NCT04725253,NICOTINAMIDE; PLACEBO TABLETS,CHILE,Not yet recruiting,University of Chile,"January 21, 2021",Interventional,"Nicotinamide, an Inhibitor of PARP-1, for Preventing Delirium in Older Adults"
4888,Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19,COVID; CORTICOSTEROIDS,"February 08, 2021",198,NCT04726098,DEXAMETHASONE HIGH DOSE; DEXAMETHASONE LOW DOSE,SPAIN,Recruiting,Manuel Taboada Muñiz,"January 15, 2021",Interventional,Efficacy of Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19
4889,COVID-19 and Pregnancy: Placental and Immunological Impacts,COVID,"February 08, 2021",200,NCT04726111,SPECIMENS SPECIFIC FOR THE STUDY,FRANCE,Recruiting,Hopital Foch,"December 30, 2020",Interventional,COVID-19 and Pregnancy: Placental and Immunological Impacts
4890,European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19,SARS-CoV2 ANTIBODIES IN CHILDREN AND ADOLESCENTS LIVING WITH HIV,"February 08, 2021",1150,NCT04726137,,,Not yet recruiting,PENTA Foundation,"March 30, 2021",Observational,European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol
4891,Effect of CoVid-19 (CoronaVirusDisease-19) and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias,COVID; ATHLETES HEART; MYOCARDITIS VIRAL; VENTRICULAR ARRYTHMIA,"February 08, 2021",250,NCT04726150,ILR IMPLANTATION,,Not yet recruiting,"University Hospital, Antwerp",April 2021,Observational [Patient Registry],Effect of CoVid-19 and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias (CovidEx)
4892,Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection,"DIABETIC PATIENT (TYPE 1,2, MODY, SECONDARY) OR WITH CORTICOSTEROID-INDUCED DIABETES FOLLOWING INITIATION OF CORTICOSTEROID TREATMENT","February 08, 2021",60,NCT04726163,CONTINUOUS BLIND GLUCOSE MEASUREMENT DEVICE (FREE STYLE PRO),FRANCE,Recruiting,"University Hospital, Strasbourg, France","January 29, 2021",Interventional,Tele-expertise for Glycemic Control Monitoring in Patients With Diabetes Hospitalized for Covid-19 Infection
4893,COVID-19 and the Brain,COVID; BRAIN; NEUROCOGNITION; FMRI,"February 08, 2021",40,NCT04726176,EXPOSURE TO COVID-19,BELGIUM,Recruiting,Vrije Universiteit Brussel,"January 30, 2021",Observational,COVID-19 and Brain Health
4894,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings,INTELLECTUAL DISABILITY; DEVELOPMENTAL DISABILITY; AXIS I DIAGNOSIS; MENTAL ILLNESS; COVID; CORONAVIRUS,"February 08, 2021",5350,NCT04726371,GENERIC BEST PRACTICES; TAILORED BEST PRACTICES,UNITED STATES,Recruiting,Massachusetts General Hospital,"January 8, 2021",Interventional,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings
4895,COVID-19 Pandemic and Medical Students,THE EFFECT OF COVID PANDEMIC,"February 08, 2021",415,NCT04726865,NASER AL-HUSBAN,JORDAN,Completed,University of Jordan,"October 1, 2020",Observational,Effects of COVID-19 Pandemic on Medical Students in Jordanian Universities: A Multi-center Cross-sectional Study
4896,"MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey",MULTIPLE MYELOMA; SMOLDERING MULTIPLE MYELOMA; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; CORONAVIRUS,"February 08, 2021",1500,NCT04727294,QUESTIONNAIRE,UNITED STATES,Recruiting,HealthTree Foundation,"January 22, 2021",Observational,"Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Myeloma (SMM), and Multiple Myeloma Patient Experience With COVID-19 Survey"
4897,Social Acceptability of COVID-19 Vaccines in Pakistan,"SOCIAL ACCEPTANCE, SOCIAL ANXIETY","February 08, 2021",1000,NCT04727372,QUESTIONNAIRE,PAKISTAN,Enrolling by invitation,Islamia University of Bahawalpur,"January 23, 2021",Observational [Patient Registry],Social Acceptability of COVID-19 Vaccines in Pakistan: Fear and Social Trends
4898,Repurposed Approved Therapies for Outpatient Treatment of Patients With Early-Onset COVID-19 and Mild Symptoms,COVID; SARS-ASSOCIATED CORONAVIRUS,"February 08, 2021",2724,NCT04727424,FLUVOXAMINE MALEATE 100 MG [LUVOX]; METFORMIN EXTENDED RELEASE ORAL TABLET; IVERMECTIN TABLETS; PLACEBO,BRAZIL,Recruiting,Cardresearch,"January 19, 2021",Interventional,"A Multicenter, Prospective, Adaptive, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effect of Fluvoxamine, Ivermectin and Metformin in Reducing Hospitalization of Patients With Mild COVID-19 and a High Risk of Complications"
4899,Use of the Mask and Current Pandemic,FACE MASK SQUEEZE,"February 08, 2021",500,NCT04727762,,SPAIN,Recruiting,University of Valencia,"February 4, 2021",Observational,Population Impact on the Continued Use of the Mask Due to the Avoidance of COVID-19
4900,Antiviral Drugs on the Treatment of SARS-CoV-2,"COMPLICATION OF MEDICAL CARE; PNEUMONIA, VIRAL","February 08, 2021",300,NCT04727775,FAVIPIRAVIR; REMDESIVIR,KAZAKHSTAN,Recruiting,Astana Medical University,"November 25, 2020",Interventional,A Retrospective Study of the Effect of Antiviral Drugs on the Treatment of SARS-CoV-2 COVID19
4901,WHO QualityRights E-training in Ghana,KNOWLEDGE; ATTITUDES; PRACTICES,"February 08, 2021",216,NCT04728243,WHO QUALITYRIGHTS E-TRAINING; WHO COVID-19 ONLINE TRAINING,,Not yet recruiting,Mental Health Society of Ghana,February 2021,Interventional,WHO QualityRights Online Training for Mental Health Workers in Ghana
4902,Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021,SARS-CoV2,"February 08, 2021",106,NCT04728347,ARCT-021,SINGAPORE,Recruiting,"Arcturus Therapeutics, Inc.","January 4, 2021",Interventional,"A Phase 2a, Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021"
4903,Emails Promoting COVID-19 Vaccination Among Healthcare Workers,VACCINATION REFUSAL; COMMUNICATION,"February 08, 2021",9656,NCT04728594,SOCIAL PROOF; REFRAMING; SCARCITY MESSAGE,UNITED STATES,Completed,Geisinger Clinic,"January 15, 2021",Interventional,Evaluation of an Email Intervention Promoting COVID-19 Vaccination Among Healthcare Workers
4904,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,COVID; ARDS,"February 08, 2021",100,NCT04728698,COVI-MSC; PLACEBO,UNITED STATES,Not yet recruiting,"Sorrento Therapeutics, Inc.",March 2021,Interventional,Treatment of COVID-19-Induced Acute Respiratory Distress: A Phase 2 Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells
4905,Proxalutamide Treatment for Hospitalized COVID-19 Patients,COVID; SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",600,NCT04728802,PROXALUTAMIDE; STANDARD OF CARE,BRAZIL,Not yet recruiting,"Applied Biology, Inc.","February 1, 2021",Interventional,Proxalutamide Treatment for Hospitalized COVID-19 Patients
4906,COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients,COVID,"February 08, 2021",500,NCT04728828,SEROLOGICAL COVID-19 VACCINE IMMUNOGENICITY,FRANCE,Recruiting,Centre Hospitalier de Cornouaille,"January 25, 2021",Observational,Immune Response After COVID19 Vaccination in a Multicenter Cohort of In-center Haemodialysis Patients in France
4907,Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience,"PNEUMONIA, VIRAL","February 08, 2021",300,NCT04728880,REMDESIVIR,EGYPT,Recruiting,Mansoura University,"January 26, 2021",Observational,Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience
4908,Heart Patch for Myocardial Infarction COVID-19,MYOCARDIAL INFARCTION; HEART DISEASES,"February 08, 2021",10,NCT04728906,HEART PATCH SEEDED WITH AUTOLOGOUS CARDIOMYOCYTES AND AMNION EPITHELIAL STEM CELLS,,Not yet recruiting,Rumah Sakit Pusat Angkatan Darat Gatot Soebroto,"March 5, 2021",Interventional,Targeted-cell Therapy Using Epithelial Stem Cells and Patients' Cardiomyocytes Loaded in Amnion Bilayer to Regenerate Myocardial Infarction Post COVID-19 Complication
4909,Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection,COVID; SARS-CoV2 INFECTION,"February 08, 2021",80,NCT04728919,,FINLAND,Recruiting,Tampere University Hospital,"January 15, 2021",Observational,Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection
4910,Reflective Tasks With Healthcare Workers During COVID-19,"WELLBEING; PSYCHOLOGICAL DISTRESS; PSYCHOLOGICAL STRESS; EMOTIONAL DISTRESS; STRESS, PSYCHOLOGICAL; STRESS; ANXIETY; DEPRESSION; HAPPINESS; SATISFACTION; OCCUPATIONAL STRESS; AFFECT","February 08, 2021",219,NCT04728958,GRATITUDE,,Not yet recruiting,University of Sheffield,July 2021,Interventional,Studying the Effect of Written Reflective Tasks With Healthcare Staff Working During the COVID-19 Health Pandemic
4911,"Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset","ARDS, HUMAN; COVID","February 08, 2021",1800,NCT04729075,ARDS AND COVID19 TREATMENTS,UNITED STATES,Completed,Northwell Health,"January 19, 2021",Observational [Patient Registry],"Towards Precision Medicine for COVID-19 ARDS - An Analysis of the NorthCARDS (Northwell Health COVID-19 ARDS) Dataset to Identify Associations Between Patient-level Factors, Inpatient Treatment and Clinical Trajectories on Mechanical Ventilation Liberation and Survival"
4912,An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization,COVID,"February 08, 2021",150,NCT04729140,IVERMECTIN TABLETS; DOXYCYCLINE TABLETS; PLACEBO,UNITED STATES,Recruiting,"Max Health, Subsero Health","December 28, 2020",Interventional,A Randomized Double-blinded Placebo-controlled Outpatient Clinical Trial in High Risk Population Confirmed COVID-19 Patients Using Ivermectin and Doxycycline to Prevent COVID-19 Illness-related Hospitalization (COVIVER-OUT PLUS)
4913,Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity,COVID,"February 08, 2021",100,NCT04729153,DAAD COMPOUND,,Not yet recruiting,Assiut University,February 2021,Observational,Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity
4914,COVID-19 Vaccine Induced Adaptive Immune Responses,SARS-CoV2; VACCINE; COVID,"February 08, 2021",200,NCT04729374,,CHINA,Recruiting,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,"January 27, 2021",Observational,"Longidutinal, Dynamic Analysis of COVID-19 Vaccine Induced Adaptive Immune Responses"
4915,Characterisation of the Immune Response to SARS-CoV-2,COVID,"February 08, 2021",200,NCT04729452,BLOOD TEST,UNITED KINGDOM,Recruiting,Lucy Jones,"June 1, 2020",Observational,Characterisation of the Immune Response to SARS-CoV-2 Infection
4916,EAT-DUTA AndroCoV Trial,COVID,"February 08, 2021",138,NCT04729491,DUTASTERIDE 0.5 MG; AZITHROMYCIN; NITAZOXANIDE; PLACEBO,BRAZIL,Completed,Corpometria Institute,"June 30, 2020",Interventional,Early Antiandrogen Treatment (EAT) With Dutasteride for COVID-19 (EAT-DUTA AndroCoV Trial)
4917,Study to Evaluate Tempol (MBM-02) to Help Prevent Hospitalizations in COVID-19 Patients.,COVID,"February 08, 2021",310,NCT04729595,TEMPOL; PLACEBO,,Not yet recruiting,Adamis Pharmaceuticals Corporation,"April 1, 2021",Interventional,"A Phase 2/3, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of Tempol (MBM-02) on Preventing COVID-19 Related Hospitalization in Subjects With COVID-19 Infection"
4918,The DAWN Camostat Trial for Ambulatory COVID-19 Patients,COVID; SARS-COV INFECTION,"February 08, 2021",1306,NCT04730206,CAMOSTAT; PLACEBO,,Not yet recruiting,KU Leuven,March 2021,Interventional,The DAWN Camostat Trial: the Efficacy of Camostat for COVID-19 Infections Presenting to Ambulatory Care: a Randomized Controlled Trial
4919,Evaluation of a Synbiotic Formula in Patient With COVID-19,CORONAVIRUS,"February 08, 2021",20,NCT04730284,HEALTH SUPPLEMENTS,HONG KONG,Recruiting,Chinese University of Hong Kong,"August 25, 2020",Interventional,Evaluation of a Synbiotic Formula in Patient With COVID-19
4920,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience,COVID,"February 08, 2021",93,NCT04730323,TOCILIZUMAB,PAKISTAN,Completed,FMH College of Medicine and Dentistry,"May 12, 2020",Interventional,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience
4921,Convalescent Plasma in the Treatment of Covid-19,COVID,"February 08, 2021",390,NCT04730401,CONVALESCENT PLASMA FROM COVID-19 DONORS; PLACEBO,FINLAND,Recruiting,Helsinki University Central Hospital,"January 27, 2021",Interventional,"Randomized, Double-Blind, Placebo-Controlled Study of Convalescent Plasma in the Treatment of Covid-19"
4922,Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19,COVID,"February 08, 2021",40,NCT04730427,GX-I7; GX-I7 VEHICLE,"KOREA, REPUBLIC OF",Recruiting,"Genexine, Inc.",January 2021,Interventional,A Phase 1b Study to Investigate the Safety and Preliminary Efficacy of GX-I7 in Patients With COVID-19
4923,Efficacy of the Sit to Stand Test (STST) in the Decision to Hospitalize a Patient Consulting the Emergency Department for COVID 19 (Coronavirus Infectious Disease),SARS-COV INFECTION,"February 08, 2021",146,NCT04730661,SIT TO STAND TEST,FRANCE,Recruiting,"University Hospital, Rouen","December 21, 2020",Interventional,Efficacy of the Sit to Stand Test (STST) in the Decision to Hospitalize a Patient Consulting the Emergency Department for COVID 19 (Coronavirus Infectious Disease)
4924,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID),COVID; THROMBOSIS,"February 08, 2021",600,NCT04730856,TINZAPARIN,SPAIN,Not yet recruiting,Hospital Universitario Infanta Leonor,"January 29, 2021",Interventional,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)
4925,Isotretinoin (13- Cis-Retinoic Acid) Versus Spike Protein Based Vaccine for Providing Complete Protection Against COVID-19 and Preventing the Expected Long Term Serious Side Effects Which May Caused by Spike Protein Based Vaccine-An Urgent Protective Clinical Trial,COVID VACCINE,"February 08, 2021",360,NCT04730895,ORAL 13 CIS RETINOIC ACID; AEROSOLIZED 13 CIS RETINOIC ACID; 13 CIS RETINOIC ACID DOSES ORALLY IN COMBINATION WITH SPIKE PROTEIN BASED VACCINE; AEROSOLIZED 13 CIS RETINOIC ACID IN COMBINATION WITH SPIKE PROTEIN BASED VACCINE; BIOLOGICAL: SPIKE PROTEIN BASED VACCINE SUCH AS CHADOX1 NCOV-19 VACCINE,,Not yet recruiting,Kafrelsheikh University,February 2021,Interventional,(Isotretinoin (13- Cis-Retinoic Acid) Versus Spike Protein Based Vaccine
4926,Effects of the COVID-19 Pandemic on Fibromyalgia Patients,FIBROMYALGIA; CHRONIC LOW-BACK PAIN,"February 08, 2021",1395,NCT04730934,"PERCEIVED STRESS SCALE; FIBROMYALGIA IMPACT QUESTIONNAIRE; THE DRUGS USED BEFORE AND DURING THE PANDEMIC, THE PATIENT'S JOB STATUS, PHYSICAL ACTIVITY CONDITIONS, PAIN STATUS",TURKEY,Recruiting,Kars State Hospital,"January 1, 2021",Observational [Patient Registry],Evaluation of the Physical and Emotional Effects of the COVID-19 Pandemic on Fibromyalgia Patients
4927,The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients,2019 NOVEL CORONAVIRUS,"February 08, 2021",28,NCT04731051,HCQ01; STANDARD OF CARE (SOC) FOR COVID-19,JORDAN,Not yet recruiting,King Hussein Cancer Center,March 2021,Interventional,"A Pilot, Randomized, Open-label Trial to Determine the Feasibility, Safety, Efficacy, and Pharmacokinetics of Nebulized HCQ01 for the Treatment of Patients With COVID-19 and Cancer"
4928,Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection,COVID,"February 08, 2021",40,NCT04731116,CANNABIDIOL,ISRAEL,Recruiting,Rabin Medical Center,"January 10, 2021",Interventional,Cannabidiol Treatment for Severe and Critical COVID-19 Pulmonary Infection
4929,"Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers",HEALTHY,"February 08, 2021",42,NCT04731324,ZYIL1 CAPSULE,INDIA,Recruiting,Cadila Healthcare Limited,"January 5, 2021",Interventional,"A Phase 1, Prospective Open Label, Single Dose, Single Arm Study of ZYIL1 Administered Via Oral Route to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Adult Human Subjects"
4930,Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines,CORONAVIRUS,"February 08, 2021",632,NCT04731870,SURVEY RESEARCH,,Not yet recruiting,East Carolina University,February 2021,Observational,Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines Among a Cross-section of US Healthcare Providers and Key At-risk Subgroups in the Rural South
4931,COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA,COVID,"February 08, 2021",65,NCT04732468,HAD5-S-FUSION+N-ETSD (SUSPENSION FOR INJECTION); HAD5-SFUSION+ N-ETSD (ORAL CAPSULE),UNITED STATES,Not yet recruiting,"ImmunityBio, Inc.",February 2021,Interventional,"Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of Subcutaneously and Orally Administered Prophylactic Vaccination With 2nd Generation (E1/E2B/E3-Deleted) Adenoviral COVID-19 in Normal Healthy Volunteers"
4932,Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for Detection of SARS-CoV-2 Via RT-PCR and ELISA,COVID,"February 08, 2021",300,NCT04732637,"TEST AT HOME'S PROPRIETARY ""LOLLIPOP"" BUCCAL CAVITY SWAB",INDIA,Not yet recruiting,Datar Cancer Genetics Limited,"February 1, 2021",Observational,Evaluating the Use of Flavoured Simulated Oral Fluids Collection Method for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Enzyme Linked Immunosorbent Assay (ELISA) Method : A Concordance Study Plan
4933,Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19,COVID; DYSPNEA,"February 08, 2021",225,NCT04732663,NO INTERVENTION,CANADA,Not yet recruiting,University of Alberta,February 2021,Observational,Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19
4934,Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents,MOTHER-CHILD INTERACTION,"February 08, 2021",30,NCT04732702,NO INTERVENTION,GERMANY,Recruiting,University of Cologne,"October 29, 2020",Observational,"Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents in Terms of Mother-infant Interaction, Parental Well-being, Expression and Methylation of Candidate Genes of Stress Signaling Pathways"
4935,Evaluation of COVID-19 IgG Antibodies in Maternal and Cord Blood Samples,COVID; PREGNANCY RELATED; ANTIBODY RESPONSE,"February 08, 2021",50,NCT04732767,,,Not yet recruiting,Atrium Health,"January 20, 2021",Observational,Prospective Study of Maternal and Umbilical Cord Blood Collection to Evaluate for Presence of COVID-19 Antibody Response in COVID-19 Positive Women
4936,Improving COVID-19 Vaccine Uptake in Nursing Homes,COVID VACCINES,"February 08, 2021",22500,NCT04732819,HIGH TOUCH MULTI-PRONGED BEHAVIORAL INTERVENTION,UNITED STATES,Recruiting,Brown University,"January 4, 2021",Interventional,IMPACT-C: Improving Vaccine Uptake in Skilled Nursing Facilities
4937,"Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey",COVID,"February 08, 2021",50,NCT04732858,CROSS SECTIONAL E-SURVEY ON SURGEONS EXPOSED TO ANY EDUCATIONAL INTERVENTION,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 1, 2020",Observational,"Educational Interventions to Integrate Surgical Staff Within Medical Units During the COVID-19 Pandemic: EDUCOVID Cross-sectional, E-survey"
4938,Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; COVID,"February 08, 2021",610,NCT04732949,SNG001; PLACEBO,UNITED KINGDOM,Recruiting,Synairgen Research Ltd.,"January 12, 2021",Interventional,"A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Determine the Efficacy and Safety of Inhaled SNG001 for the Treatment of Patients Hospitalised Due to Moderate COVID-19"
4939,Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure,ACUTE RESPIRATORY FAILURE,"February 08, 2021",530,NCT04733105,,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,February 2021,Observational,Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure: a Multicenter Observational Study
4940,Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen,COVID,"February 08, 2021",600,NCT04733170,KNOWNOW SARS-COV-2 RAPID ANTIGEN TEST,,Not yet recruiting,Vatic Ltd.,"February 15, 2021",Observational,Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen
4941,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection,COVID; SARS-COV INFECTION,"February 08, 2021",56,NCT04733625,CHOLECALCIFEROL; PLACEBO,EGYPT,Completed,Kasr El Aini Hospital,"September 15, 2020",Interventional,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection
4942,Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19,COVID,"February 08, 2021",250,NCT04733651,HOSPITAL STANDARD OF CARE FOR COVID-19; ISOQUERCETIN,,Not yet recruiting,Nepal Health Research Council,"February 20, 2021",Interventional,"A Randomized, Open-labelled and Controlled Clinical Trial to Investigate the Clinical Efficacy of Isoquercetin in the Treatment of Mild-to-moderate Hospitalised COVID-19 Patients"
4943,User Experience of the OSR M-1,COVID,"February 08, 2021",200,NCT04733677,,UNITED STATES,Not yet recruiting,Wake Forest University Health Sciences,February 2021,Observational,User Experience of the OSR M1 Reusable Elastomeric Air Purifying Respirator in Non-Clinical Settings
4944,Covid-19 in Hematological Malignancies,COVID INFECTION IN HEMATOLOGICAL MALIGNANCIES PATIENTS,"February 08, 2021",3000,NCT04733729,,ITALY,Recruiting,Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne,"March 1, 2020",Observational [Patient Registry],Epidemiology of COVID-19 Infection in Patients With Hematological Malignancies: A European Haematology Association Survey
4945,Antibodies Response to mRNA Vaccine Against Covid-19,COVID,"February 08, 2021",500,NCT04733807,BNT162B2 MRNA COVID-19 VACCINE,ITALY,Recruiting,University of Roma La Sapienza,"January 28, 2021",Observational,SARS-Cov-2 Antibodies Response to BNT162b2 mRNA Vaccine to Prevent Covid-19
4946,A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19,SEVERE COVID,"February 08, 2021",30,NCT04733833,VB-201 + STANDARD OF CARE; STANDARD OF CARE,ISRAEL,Recruiting,Vascular Biogenics Ltd. operating as VBL Therapeutics,"January 26, 2021",Interventional,"A Randomized, Controlled Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19"
4947,Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy,EYE TRAUMA,"February 08, 2021",9,NCT04733846,DATA COLLECTION,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Saint Etienne,February 2021,Observational,Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy
4948,"Social Activity, Loneliness and Stigma During COVID-19 Outbreak",COVID; FEAR; LONELINESS,"February 08, 2021",1200,NCT04734171,DIGITAL SOCIAL ACTIVITY VIDEO INTERVENTION; INFORMATIONAL SHEET; STIGMA AWARENESS VIDEO INTERVENTION,UNITED STATES,Completed,Columbia University,"April 2, 2020",Interventional,"COVID-19 and Its Implications on Social Activity, Loneliness and Stigma"
4949,Neuroimaging Findings in Patients With COVID-19,NEUROIMAGING; COVID,"February 08, 2021",436,NCT04734223,NEUROIMAGING FINDINGS IN PATIENTS WITH COVID-19,TURKEY,Completed,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,"April 1, 2020",Observational,Correlation of Neuroimaging Findings With Clinical Presentation and Laboratory Data in Patients With COVID-19: A Single Center Study
4950,LIFEHOUSE: Description of the Tent Bucket -Immune Support,IMMUNE RESPONSE,"February 08, 2021",150,NCT04734288,"VIT.D3 5000 IU, IMMUNE ACTIVE",UNITED STATES,Enrolling by invitation,"Metagenics, Inc.","January 22, 2021",Interventional,LIFEHOUSE: a Lifestyle Intervention and Functional Evaluation- a Health OUtcome SurvEy; Description of the Tent Bucket -Immune Support
4951,Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease,COVID; RESPIRATORY MUSCLE TRAINING; RESPIRATORY FUNCTION TEST; QUALITY OF LIFE; PSYCHOSOCIAL FACTOR,"February 08, 2021",88,NCT04734561,INSPIRATORY MUSCLE TRAINING GROUP; INSPIRATORY MUSCLE TRAINING PLACEBO GROUP; INSPIRATORY + EXPIRATORY MUSCLE TRAINING GROUP; INSPIRATORY + EXPIRATORY MUSCLE TRAINING PLACEBO GROUP,,Not yet recruiting,Universidad Complutense de Madrid,"February 8, 2021",Interventional,"Effects of Respiratory Muscle Training on Quality of Life, Physical and Pulmonary Function and Psychological Status in Patients Who Have Had COVID-19 Disease"
4952,Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome,COVID; CYTOKINE STORM; CORONAVIRUS INFECTION,"February 08, 2021",84,NCT04734678,TOCILIZUMAB; INFLIXIMAB,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome
4953,Coordination and Locomotor Problems in Patients With Covid-19 Virus,COVID; MOTILITY DISORDER; BALANCE,"February 08, 2021",2,NCT04734717,NEUROLOGY TEST,HUNGARY,Enrolling by invitation,Somogy Megyei Kaposi Mór Teaching Hospital,"January 12, 2021",Interventional,Coordination and Locomotor Problems in Patients With Covid-19 Virus
4954,The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma,DYSFUNCTIONAL BREATHING; ASTHMA IN CHILDREN; ASTHMA,"February 08, 2021",500,NCT04734795,,DENMARK,Recruiting,Kolding Sygehus,February 2021,Observational,The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma
4955,Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms,COVID,"February 08, 2021",500,NCT04734860,COVI-AMG; PLACEBO,,Not yet recruiting,"Sorrento Therapeutics, Inc.",March 2021,Interventional,"A Randomized, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms"
4956,CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients,COVID,"February 08, 2021",1000,NCT04734873,CPI-006 2 MG/KG + SOC; CPI-006 1 MG/KG + SOC; PLACEBO + SOC,UNITED STATES,Recruiting,"Corvus Pharmaceuticals, Inc.","February 1, 2021",Interventional,"Phase 3, Randomized, Placebo Controlled, Double-blind, Multicenter, Stratified Study of CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients"
4957,The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19,COVID,"February 08, 2021",400,NCT04734886,L. REUTERI DSM 17938 + VITAMIN D; PLACEBO + VITAMIN D,SWEDEN,Recruiting,"Örebro University, Sweden","November 27, 2020",Interventional,Exploratory Study on the Effects of Probiotic Supplementation on SARS-CoV-2 Antibody Response in Healthy Adults
4958,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic,ENDOSCOPY,"February 08, 2021",500,NCT04734912,GASTROSCOPY IN TRANSNASAL TECHIQUE,GERMANY,Recruiting,Johannes Gutenberg University Mainz,"January 13, 2021",Interventional,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic
4959,The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) Outcomes Study,MULTIPLE SCLEROSIS,"February 08, 2021",10000,NCT04735406,,UNITED STATES,Not yet recruiting,"EMD Serono Research & Development Institute, Inc.","January 29, 2021",Observational,The MS Leadership and Innovation Network (MS-LINK™) Outcomes Study: A Comprehensive Prospective Longitudinal Assessment of Patient and Clinical Reported Outcomes in Multiple Sclerosis Patients Across North America
4960,"National Retrospective and Prospective Observational Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP",IMMUNE THROMBOCYTOPENIA; ITP; COVID; ITP SECONDARY TO INFECTION,"February 08, 2021",140,NCT04735588,,,Not yet recruiting,Gruppo Italiano Malattie EMatologiche dell'Adulto,April 2021,Observational,"IMMUNE THROMBOCYTOPENIA (ITP) AND COVID-19: National Retrospective and Prospective Observational Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP"
4961,Evaluation of Allied Healthcare in Patients Recovering From COVID-19,COVID; ALLIED HEALTH PROFESSIONALS; PRIMARY CARE; RETROSPECTIVE COHORT; PROMS; PERFORMANCE MEASURES; PROSPECTIVE COHORT; NATIONAL DUTCH PROGRAM,"February 08, 2021",1315,NCT04735744,PATIENTS RECOVERING FROM COVID19 RECEIVE USUAL CARE BY ALLIED HEALTH PROFESSIONALS,,Not yet recruiting,Radboud University,"February 15, 2021",Observational,Evaluation of Allied Healthcare in Patients Recovering From COVID-19
4962,"Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI",DIAPHRAGM DISEASE; COVID,"February 08, 2021",40,NCT04735757,CONTRAST-ENHANCED MRI; MEASUREMENT OF RESPIRATORY MUSCLE FORCE,,Not yet recruiting,VU University Medical Center,"February 2, 2021",Observational,"Effects of COVID-19-infection and Mechanical Ventilation on Movement and Tissue Characteristics of the Diaphragm, Visualized by Magnetic Resonance Imaging: a Proof-of-concept Study"
4963,Personalized Responses to Dietary Composition Trial 3,DIABETES; HEART DISEASES; DIET HABIT; DIET MODIFICATION; HEALTHY; OBESITY; METABOLISM; MICROBIAL COLONIZATION,"February 08, 2021",3000,NCT04735835,DIETARY INTERVENTION,UNITED STATES,Recruiting,Zoe Global Limited,"July 20, 2020",Interventional,Personalized Responses to Dietary Composition Trial 3
4964,Hearts of Athletes,CARDIAC INVOLVEMENT WITH COVID,"February 08, 2021",500,NCT04736004,,UNITED STATES,Not yet recruiting,Duke University,"February 15, 2021",Observational,Hearts of Athletes Study: Prospective Evaluation of Athletes for Cardiac Involvement With COVID-19
4965,Immune Response Following COVID-19 Vaccination,IGM AND IGG IN BLOOD,"February 08, 2021",500,NCT04736524,RAPID ANTIBODY TEST,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"January 15, 2021",Observational,Immune Response Following COVID-19 Vaccination (IFVAC)
4966,Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital,TELEHEALTH,"February 08, 2021",667,NCT04736680,,,Not yet recruiting,Hospital General de Niños Pedro de Elizalde,"March 1, 2021",Observational,"Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital. Missed Appointments Rates, Associated Factors, Generation and Validation of Predictive Models"
4967,The IRCM POST-COVID-19 (IPCO) Clinic,COVID,"February 08, 2021",570,NCT04736732,MEDICAL FOLLOW-UP,CANADA,Recruiting,Institut de Recherches Cliniques de Montreal,"January 1, 2021",Observational,The IRCM POST-COVID-19 (IPCO) Clinic: A Multidisciplinary Approach to Evaluate Short and Long-term Complications of COVID-19
4968,Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19,COVID; CORONAVIRUS INFECTION; HYPERCOAGULABILITY,"February 08, 2021",90,NCT04736901,ENOXAPARIN; ENOXAPARIN; RIVAROXABAN; RIVAROXABAN; APIXABAN; APIXABAN,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19
4969,Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME; COVID,"February 08, 2021",20,NCT04737161,T REGULATORY CELLS,UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,A Phase 1 Study to Assess the Safety of Living Related Donor Derived T Regulatory Cell Therapy in Subjects With COVID 19 Induced Acute Respiratory Distress Syndrome (ARDS)
4970,"Development and Initial Testing of a Couple-Based Intervention to Optimize Suicide and Self-Injury Treatment: COMPASS (Connecting, Overcoming, and Moving Past Suicide and Self-Injury)",SELF-INJURIOUS THOUGHTS AND BEHAVIOURS; BORDERLINE PERSONALITY DISORDER,"February 08, 2021",40,NCT04737252,"CONNECTING, OVERCOMING AND MOVING PAST SUICIDE AND SELF-INJURY",CANADA,Recruiting,York University,"January 18, 2021",Interventional,"Development and Initial Testing of a Couple-Based Intervention to Optimize Suicide and Self-Injury Treatment: COMPASS (Connecting, Overcoming, and Moving Past Suicide and Self-Injury)"
4971,A First-in-Human Study of AV-001 in Healthy Subjects,COVID-ASSOCIATED ARDS; COVID; ARDS,"February 08, 2021",48,NCT04737486,AV-001; PLACEBO,UNITED STATES,Recruiting,"Vasomune Therapeutics, Inc.","December 16, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 1 Single and Multiple-Dose Pharmacokinetic First-in-Human Study of AV-001 in Healthy Subjects"
4972,Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic,TYPE2 DIABETES,"February 08, 2021",76,NCT04738032,DIGITAL STORYTELLING INTERVENTION,UNITED STATES,Completed,Mayo Clinic,"August 26, 2020",Observational,Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic
4973,Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients,COVID,"February 08, 2021",90,NCT04738045,REMDESIVIR; LOPINAVIR/ RITONAVIR AND REMDESIVIR COMBINATION,EGYPT,"Active, not recruiting",Ahmed Essam,"November 1, 2020",Interventional,Comparative Therapeutic Efficacy and Safety of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
4974,"Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia",COVID; SARS-CoV2 INFECTION,"February 08, 2021",30,NCT04738136,S-1226,,Not yet recruiting,SolAeroMed Inc.,"February 15, 2021",Interventional,"A Randomized, Open-Label, Controlled, Phase II Study to Evaluate the Safety, Tolerability and Efficacy Of S-1226 In Hospitalized Subjects With Moderate Severity Covid-19 Bronchiolitis/Pneumonia"
4975,Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19,COVID,"February 08, 2021",209,NCT04738175,COVI-AMG; PLACEBO,,Not yet recruiting,"Sorrento Therapeutics, Inc.",April 2021,Interventional,"A Randomized, Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19"
4976,Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database,COVID; SARS-COV INFECTION,"February 08, 2021",10000000,NCT04738331,,FRANCE,Recruiting,"University Hospital, Montpellier","February 1, 2021",Observational,Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database : CovPCR
4977,"Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina",COVID,"February 08, 2021",600,NCT04738435,,ARGENTINA,Recruiting,Hospital Italiano de Buenos Aires,"January 5, 2021",Observational,"Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina"
4978,SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19),COVID; SARS-CoV2 INFECTION,"February 08, 2021",3036,NCT04738695,POINT-OF-CARE RAPID ANTI-SARS-COV-2 ANTIBODY TEST (ORIENT GENE BIOTECH) AND DRY BLOOD SPOT COLLECTION (EUROIMMUN),BELGIUM,Recruiting,Sciensano,"February 1, 2021",Observational,SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents in Belgium
4979,Physical Activity and Physical Fitness Parameters in COVID-19 Quarantine,"ASSESSMENT, SELF","February 08, 2021",87,NCT04738721,EVALUATION,TURKEY,Not yet recruiting,Medipol University,"February 5, 2021",Observational [Patient Registry],Comparison of Physical Activity and Physical Fitness Parameters of Young Adults Before and After COVID-19 Quarantine
4980,Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients,COVID; CORONAVIRUS INFECTION; CYTOKINE STORM; VITAMIN D DEFICIENCY,"February 08, 2021",150,NCT04738760,,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients
4981,Aerosols in PCR SARS-CoV-2 Positive and Negative Patients,SARS-CoV2 INFECTION; COVID,"February 08, 2021",525,NCT04739020,RESP-AER-METER; SPIROMETRY; QUALITATIVE AND QUANTITATIVE VIRUS PCR OF RESPIRATORY SECRETIONS IN PATIENTS WITH HIGH AEROSOL CONCENTRATIONS,GERMANY,Recruiting,Johann Wolfgang Goethe University Hospital,"January 18, 2021",Interventional,Measurement of Respiratory Aerosols in PCR SARS-CoV-2 Positive and Negative Children and Adults
4982,New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection,COVID; CORONAVIRUS INFECTION; CYTOKINE STORM,"February 08, 2021",50,NCT04739345,,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection
4983,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients,COVID,"February 08, 2021",50,NCT04739410,IVERMECTIN,PAKISTAN,Completed,FMH College of Medicine and Dentistry,"May 1, 2020",Interventional,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
4984,'4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission,SARS-COV INFECTION; COVID,"February 08, 2021",100,NCT04739449,"COACHING, CLEANING, COMMUNICATION, COLLABORATION",,Not yet recruiting,University of Michigan,"February 10, 2021",Interventional,"'4C' Intervention to Reduce SARS-CoV-2 Transmission: Coaching, Cleaning, Communication and Collaboration"
4985,SMS Maama Project COVID-19,PREGNANCY COMPLICATIONS; BIRTH INJURIES,"February 08, 2021",248,NCT04739462,MHEALTH PLATFORM,UNITED STATES,Not yet recruiting,University of Minnesota,February 2021,Interventional,mHealth for Improvement of Access to Maternal Health Services in the Era of COVID-19 Pandemic (SMS Maama Project)
4986,Food Insecurity Screening and Intervention: From Hospital to Home,FOOD INSECURITY,"February 08, 2021",1000,NCT04739540,,UNITED STATES,Not yet recruiting,Baylor College of Medicine,"February 19, 2021",Observational,Food Insecurity Screening and Intervention: From Hospital to Home
4987,SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY,HEALTH CARE WORKERS,"February 08, 2021",368,NCT04740125,,TUNISIA,Completed,"General Administration of Military Health, Tunisia","May 1, 2020",Observational,"PSYCHOLOGICAL IMPACT, STRESS FACTORS AND BEHAVIOURS IN HEALTH CARE PROFESSIONALS DURING THE COVID-19 PANDEMIC IN TUNISIA"
4988,Moderate-intensity Flow-based Yoga Effects on Cognition and Stress,STRESS; PSYCHOLOGICAL,"February 08, 2021",88,NCT04740229,YOGA,UNITED STATES,Not yet recruiting,University of Illinois at Urbana-Champaign,"February 10, 2021",Interventional,"Testing the Impact of Flow-based, Moderate-intensity Yoga on Executive Functioning and Stress Among Low Active Working Adults Having Symptoms of Stress"
4989,COVID-19 SARS-CoV-2 Screening Protocol,COVID,"February 08, 2021",250,NCT04740320,,UNITED KINGDOM,Recruiting,Imperial College London,"December 15, 2020",Observational [Patient Registry],Screening Protocol for a Dose Finding Human Experimental Infection Study in Healthy Subjects Using a GMP-produced SARS-COV-2 Wild Type Strain
4990,"Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ","COVID, PATIENT REPORTED OUTCOME MEASURES, QUALITY OF LIFE","February 08, 2021",350,NCT04740372,NO INTERVENTION. METHOD STUDY. PSYCHOMETRIC TESTING,NORWAY,Recruiting,Oslo University Hospital,"November 20, 2020",Observational,"Development of an International Questionnaire to Assess Patient-reported Quality of Life Related to COVID-19 Disease, the Oslo COVID-19 Quality of Life Questionnaire (QLQ) - ## © Phase III of Questionnaire Development"
4991,Online Wellness Intervention for College Students,DEPRESSION; ANXIETY; WELL-BEING,"February 08, 2021",850,NCT04740411,THE COMMON ELEMENTS TOOLBOX (COMET),,Not yet recruiting,University of Pennsylvania,"February 3, 2021",Interventional,An Online Wellness Intervention for American College Students: Investigating the Efficacy of The Common Elements Toolbox
4992,The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff,HEART DISEASES,"February 08, 2021",30,NCT04740489,PHASE 3 CARDIAC REHABILITATION,,Not yet recruiting,Ant Shepherd,"February 1, 2021",Observational,"A Pilot Study Examining Participants Psychosocial Health, Physical Activity and Staff Experiences: Is Adapted Home-based Phase 3 Cardiac Rehabilitation Feasible and Beneficial?"
4993,Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents,COVID,"February 08, 2021",9600,NCT04740658,NO INTERVENTION,FRANCE,Not yet recruiting,"University Hospital, Toulouse","February 1, 2021",Observational,Effect of Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents During and After the Epidemic Period
4994,"Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light",COVID PREVENTION,"February 08, 2021",6000,NCT04741061,SPUTNIK LIGHT; PLACEBO,RUSSIAN FEDERATION,Not yet recruiting,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","February 15, 2021",Interventional,"A Phase III, Randomized, Double-blind, Placebo-controlled International Multicenter Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light Vector Vaccine in the Parallel Assignment of the Subjects in Prophylactic Treatment for SARS-СoV-2 Infection"
4995,PAtterns and Extension in Sars-Cov-2 Related Interstitial Pneumonia: CT Analysis,COVID,"February 08, 2021",600,NCT04741178,,ITALY,Recruiting,Morgagni Pierantoni Hospital,"March 20, 2020",Observational,PAtterns and Extension in Sars-Cov-2 Related Interstitial Pneumonia: CT Analysis
4996,Aerosolisation During Respiratory Procedures,HEALTHY; RESPIRATORY TRACT INFECTIONS; LUNG INFECTION; DROPLET SPREAD,"February 08, 2021",10,NCT04741217,NOT AN INTERVENTIONAL STUDY,,Not yet recruiting,Guy's and St Thomas' NHS Foundation Trust,"March 1, 2021",Observational,A Proof of Concept Study to Evaluate Aerosol Generation During Non-Invasive Positive Pressure Respiratory Procedures
4997,Pulmonary Tele-rehabilitation and Progressive Muscle Relaxation on Discharged Covid-19 Patients,COVID,"February 08, 2021",52,NCT04741282,PULMONARY TELEREHABILITATION; PROGRESSIVE MUSCLE RELAXATION TRAINING,,Not yet recruiting,Iran University of Medical Sciences,"February 15, 2021",Interventional,Effect of Pulmonary Tele-rehabilitation With and Without Progressive Muscle Relaxation Program in Covid-19 Patients After Hospital Discharge: Randomized Clinical Trial
4998,The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study,COVID; CHRONIC KIDNEY DISEASES,"February 08, 2021",850,NCT04741386,SARS-COV-2 VACCINATION,NETHERLANDS,Not yet recruiting,University Medical Center Groningen,"February 1, 2021",Observational [Patient Registry],"The Immune-response and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant - A Prospective, Controlled, Multicenter Cohort Study by the RECOVAC Consortium"
4999,"Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences",HYPOHIDROTIC ECTODERMAL DYSPLASIA,"February 08, 2021",230,NCT04741412,,GERMANY,Recruiting,University Hospital Erlangen,"June 3, 2020",Observational [Patient Registry],"SARS-CoV-2 Infections in Children and Adolescents: Course of COVID-19, Immune Responses, Complications and Long-term Consequences in Entire Households With Members Younger Than 18 Years"
5000,"The Effects of Telerehabilitation on Muscle Function, Physical Activity and Sleep in Cystic Fibrosis During Pandemic",CYSTIC FIBROSIS; COVID; SOCIAL ISOLATION,"February 08, 2021",30,NCT04742049,TELEREHABILITATION-BASED; FOLLOW-UP BASED,TURKEY,Recruiting,Hacettepe University,"December 28, 2020",Interventional,"The Effects of Telerehabilitation on Peripheral Muscle Function, Physical Activity Level and Sleep Quality in Pediatric Cystic Fibrosis Patients Having Social Isolation Due to Pandemic"
5001,Home-Care Bronchiectasis,BRONCHIECTASIS ADULT,"February 08, 2021",22,NCT04742270,SIMEOX+ RESPIRATORY PHYSIOTHERAPY TELECARE,FRANCE,Not yet recruiting,Physio-Assist,February 2021,Interventional,Feasibility of Implementing SIMEOX® Using Tele-physiotherapy and Evaluation of Compliance With SIMEOX® at Home for Bronchial Drainage in Patients With Bronchiectasis Other Than Cystic Fibrosis and Who Have Difficulties in Accessing Regular Respiratory Physiotherapy Sessions.
5002,Personal Protective Equipment Affect Team Performance During Medical Emergencies,SAFETY ISSUES; COMMUNICATION; CARDIOPULMONARY ARREST,"February 08, 2021",22,NCT04742426,WHO RECOMMENDED PPE; SUPER-SAFE SETUP,,Not yet recruiting,Roman Sýkora,"May 1, 2021",Interventional,Does the Choice of Personal Protective Equipment Affect Team Performance During Medical Emergencies? Simulation-Based Randomised Controlled Trial
5003,Wearable Diagnostic for Detection of COVID-19 Infection,COVID,"February 08, 2021",2352,NCT04742569,,UNITED STATES,Recruiting,"ClinOne, Inc.","December 21, 2020",Observational,Wearable Diagnostic for Detection of COVID-19 Infection
5004,SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer,COVID-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME; COVID-ASSOCIATED PNEUMONIA; HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM; MALIGNANT SOLID NEOPLASM; SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",16,NCT04742595,SARS-COV-2 ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"December 18, 2020",Interventional,"Administration of Expanded, Most Closely HLA Matched SARS-CoV-2-Specific T Cells for the Treatment of COVID-19 in Patients With Cancer"
5005,A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19,SARS-COV INFECTION,"February 08, 2021",40,NCT04742712,CORONACHECK DEVICE,UNITED KINGDOM,Recruiting,Portsmouth Hospitals NHS Trust,"October 27, 2020",Observational,A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 - FIND SARS CoV-2 Covid-19
5006,A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19),CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",200,NCT04742725,PLACEBO; PROTHIONE™ (6G),,Not yet recruiting,"Prothione, LLC","February 15, 2021",Interventional,"A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)"
5007,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19),COVID (HEALTHY VOLUNTEERS),"February 08, 2021",260,NCT04742738,GBP510 ADJUVANTED WITH ALUM (RBD 10ΜG/DOSE) - STAGE 1; NORMAL SALINE (0.9% SODIUM CHLORIDE SOLUTION) - STAGE 1; GBP510 ADJUVANTED WITH ALUM (RBD 25ΜG/DOSE) - STAGE 1; NORMAL SALINE (0.9% SODIUM CHLORIDE SOLUTION) - STAGE 1; GBP510 ADJUVANTED WITH ALUM (RBD 10ΜG/DOSE) - STAGE 2; GBP510 ADJUVANTED WITH ALUM (RBD 25ΜG/DOSE)- STAGE 2; NORMAL SALINE (0.9% SODIUM CHLORIDE SOLUTION)- STAGE 2,"KOREA, REPUBLIC OF",Recruiting,"SK Bioscience Co., Ltd.","January 20, 2021",Interventional,"A 2-Stage, Phase I/II, Placebo-controlled, Randomized, Observer-blinded, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide in Healthy Younger and Older Adults"
5008,The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers,SARS-CoV2 COVID,"February 08, 2021",150,NCT04742842,COVIGEN 0.8 MG ID OR PLACEBO ID; COVIGEN 2.0 MG IM OR PLACEBO IM; COVIGEN 4.0 MG IM OR PLACEBO IM,AUSTRALIA,Not yet recruiting,University of Sydney,"February 15, 2021",Interventional,"A Phase I, Double-blind, Dose-ranging, Randomised, Placebo-controlled Trial to Study the Safety and Immunogenicity of a DNA-based Vaccine Against COVID-19 (COVIGEN) in Healthy Participants Aged 18 to 75 Years Old"
5009,Telerehabilitation in Covid-19 After Hospital Discharge,COVID,"February 08, 2021",237,NCT04742946,TELEREHABILITATION INTERVENTION,SPAIN,Not yet recruiting,Universidad de Granada,"February 15, 2021",Interventional,Telerehabilitation Intervention in Patients With Covid-19 After Hospital Discharge to Improve Functional Capacity and Quality of Life. Study Protocol for a Multicenter Randomized Clinical Trial
5010,Enriched Heparin Anti COVID-19 Trial,COVID,"February 08, 2021",50,NCT04743011,HEPARIN SODIUM; PLACEBO,BRAZIL,Not yet recruiting,UPECLIN HC FM Botucatu Unesp,"February 15, 2021",Interventional,Nebulized Enriched Heparin to Treat no Critical Patients With Sars-Cov-2 - Triple Blind Clinical Trial
5011,COVID Resuscitation Plans and Decisions on Escalation and Limitation of Treatment,COVID; CARDIAC ARREST,"February 08, 2021",1000,NCT04743232,DECISION TOOL FOR CLINICIANS,NETHERLANDS,Recruiting,Erasmus Medical Center,"March 1, 2021",Interventional,Corona Virus Disease Pandemic Resuscitation Plans and Decisions on Escalation and Limitation of Treatment
5012,Steam Inhalations in COVID-19 Patients,COVID; CORONAVIRUS INFECTION; CORONAVIRUS,"February 08, 2021",200,NCT04743349,STEAM INHALATIONS,ITALY,Recruiting,Meyer Children's Hospital,"January 26, 2021",Interventional,Steam Inhalations in Asymptomatic and Paucisymptomatic COVID-19 Patients
5013,Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System,COVID; HEALTHY VOLUNTEERS; CHRONIC DISEASE; HEMATOLOGICAL MALIGNANCIES; SOLID TUMOR,"February 08, 2021",600,NCT04743388,BNT162B2; OTHER VACCINE AGAINST SARS-COV-2,GREECE,Recruiting,National and Kapodistrian University of Athens,"January 4, 2021",Observational [Patient Registry],Study of the Kinetics of Antibodies Against SARS-CoV-2 and of Cellular Subpopulations of the Immune System in Volunteers Receiving the BNT162b2 Vaccine or Other Approved Vaccine Against SARS-CoV-2
5014,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients,COVID; REHABILITATION,"February 08, 2021",60,NCT04743401,TELE-EXERGAMING TABLET,UNITED STATES,Not yet recruiting,VA Office of Research and Development,"April 1, 2021",Interventional,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients
5015,RSV Burden in Outpatient Settings,"RSV INFECTION; CHILDREN, ONLY; OUTPATIENT; BRONCHIOLITIS; OTITIS MEDIA; PNEUMONIA","February 08, 2021",1600,NCT04743609,NASOPHARYNGEAL SAMPLES,FRANCE,Not yet recruiting,Association Clinique Thérapeutique Infantile du val de Marne,"February 1, 2021",Observational,"Ambulatory Respiratory Tract Infection Survey, Burden of Respiratory Syncitial Virus in the Era of Covid-19"
5016,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US,COVID,"February 08, 2021",2400,NCT04743908,SOCIAL NETWORK STRATEGY + COVID-19 MESSAGING,,Not yet recruiting,University of Chicago,February 2021,Interventional,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US (C3)
5017,SARS-CoV-2 Vaccination in Chronic Kidney Disease,SARS-CoV2 VACCINATION IN DIALYSIS AND KIDNEY TRANSPLANT PATIENTS,"February 08, 2021",400,NCT04743947,NO INTERVAENTION; OBSERVATIONAL STUDY,GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","December 21, 2020",Observational,Observational Study on the Effects of SARS-CoV-2 Vaccination in Dialysis and Kidney Transplant Patients
5018,A Study to Asses Wellness Using a Brain Sensing Device on Physicians,"STRESS, EMOTIONAL; SLEEP; QUALITY OF LIFE","February 08, 2021",20,NCT04743973,MUSE S™ HEADBAND SYSTEM,UNITED STATES,Not yet recruiting,Mayo Clinic,"March 1, 2021",Interventional,A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing A Wearable Wellness Brain Sensing Device (Muse-S) in Practicing Physicians
5019,Exploring the Efficacy of myAsthma in Secondary Care,ASTHMA,"February 08, 2021",60,NCT04744272,MYASTHMA,UNITED KINGDOM,Not yet recruiting,my mhealth Ltd,March 2021,Interventional,A Randomised Controlled Feasibility Study to Explore the Efficacy of Digital Self-management Within Secondary Care in an Asthmatic Population
